PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonnema, G; Lee, JG; Wang, SH; Lagarrigue, D; Bucher, J; Wehrens, R; de Vos, R; Beekwilder, J				Bonnema, Guusje; Lee, Jun Gu; Wang Shuhang; Lagarrigue, David; Bucher, Johan; Wehrens, Ron; de Vos, Ric; Beekwilder, Jules			Glucosinolate variability between turnip organs during development	PLOS ONE			English	Article							CRUCIFEROUS VEGETABLES; GERMPLASM COLLECTION; INSECT RESISTANCE; DEFENSE COMPOUNDS; ARABIDOPSIS; IDENTIFICATION; BIOSYNTHESIS; CANCER; PATTERNS; GENES	Turnip (Brassica rapa spp. rapa) is an important vegetable species, with a unique physiology. Several plant parts, including both the turnip tubers and leaves, are important for human consumption. During the development of turnip plants, the leaves function as metabolic source tissues, while the tuber first functions as a sink, while later the tuber turns into a source for development of flowers and seeds. In the present study, chemical changes were determined for two genotypes with different genetic background, and included seedling, young leaves, mature leaves, tuber surface, tuber core, stalk, flower and seed tissues, at seven different time points during plant development. As a basis for understanding changes in glucosinolates during plant development, the profile of glucosinolates was analysed using liquid chromatography (LC) coupled to mass spectrometry (MS). This analysis was complemented by a gene expression analysis, focussed on GLS biosynthesis, which could explain part of the observed variation, pointing to important roles of specific gene orthologues for defining the chemical differences. Substantial differences in glucosinolate profiles were observed between aboveground tissues and turnip tuber, reflecting the differences in physiological role. In addition, differences between the two genotypes and between tissues that were harvested early or late during the plant lifecycle. The importance of the observed differences in glucosinolate profile for the ecophysiology of the turnip and for breeding turnips with optimal chemical profiles is discussed.	[Bonnema, Guusje; Wang Shuhang; Lagarrigue, David; Bucher, Johan] Wageningen Univ & Res, Plant Breeding, Wageningen, Netherlands; [Lee, Jun Gu] Chonbuk Natl Univ, Coll Agr & Life Sci, Dept Hort, Jeonju, South Korea; [Wehrens, Ron; de Vos, Ric; Beekwilder, Jules] Wageningen Plant Res, Wageningen, Netherlands; [Lee, Jun Gu] Chonbuk Natl Univ, Dept Hort, Jeonju, South Korea	Wageningen University & Research; Jeonbuk National University; Wageningen University & Research; Jeonbuk National University	Beekwilder, J (corresponding author), Wageningen Plant Res, Wageningen, Netherlands.	jules.beekwilder@wur.nl	Wehrens, Ron/M-8781-2015; Beekwilder, Jules/A-6802-2011	Wehrens, Ron/0000-0002-8798-5599; Beekwilder, Jules/0000-0003-3238-4427	National Agrobiodiversity Centre, Rural Development Administration, Korea	National Agrobiodiversity Centre, Rural Development Administration, Korea	This research was supported by the National Agrobiodiversity Centre, Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani N, 2015, J AGR FOOD CHEM, V63, P6120, DOI 10.1021/acs.jafc.5b02425; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Bruce TJA, 2014, ANN APPL BIOL, V164, P348, DOI 10.1111/aab.12128; Burdock GA, 2001, FENAROLIS HANDBOOK O; Burow M, 2017, CURR OPIN PLANT BIOL, V38, P142, DOI 10.1016/j.pbi.2017.04.009; Burow M, 2010, CURR OPIN PLANT BIOL, V13, P348, DOI 10.1016/j.pbi.2010.02.002; CARLSON DG, 1981, J AGR FOOD CHEM, V29, P1235, DOI 10.1021/jf00108a034; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Francisco M, 2009, J CHROMATOGR A, V1216, P6611, DOI 10.1016/j.chroma.2009.07.055; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Golicz AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13390; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2008, PLANT PHYSIOL, V148, P2096, DOI 10.1104/pp.108.129981; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Jensen LM, 2014, BIOL CHEM, V395, P529, DOI 10.1515/hsz-2013-0286; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Justen VL, 2012, HORTIC ENVIRON BIOTE, V53, P108, DOI 10.1007/s13580-012-0106-3; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kim SJ, 2001, SOIL SCI PLANT NUTR, V47, P167, DOI 10.1080/00380768.2001.10408379; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Klopsch R, 2017, FOOD RES INT, V100, P392, DOI 10.1016/j.foodres.2017.04.016; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lee JG, 2013, J AGR FOOD CHEM, V61, P3984, DOI 10.1021/jf400890p; Li SM, 2007, J AGR FOOD CHEM, V55, P8452, DOI 10.1021/jf070816k; Lin K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-250; Monfort WS, 2007, CROP PROT, V26, P1359, DOI 10.1016/j.cropro.2006.11.008; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Padilla G, 2005, EUPHYTICA, V145, P171, DOI 10.1007/s10681-005-0895-x; Padilla G, 2007, PHYTOCHEMISTRY, V68, P536, DOI 10.1016/j.phytochem.2006.11.017; Pino Del Carpio D, 2014, THESIS; Qiao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111012; Seo MS, 2016, PLANT MOL BIOL, V90, P503, DOI 10.1007/s11103-016-0437-z; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Song JC, 2015, J EXP BOT, V66, P5067, DOI 10.1093/jxb/erv133; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Tsunoda T, 2017, J ECOL, V105, P1256, DOI 10.1111/1365-2745.12793; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Voorrips LE, 2000, AM J EPIDEMIOL, V152, P1081, DOI 10.1093/aje/152.11.1081; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x	55	5	5	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217862	10.1371/journal.pone.0217862	http://dx.doi.org/10.1371/journal.pone.0217862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170222	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700072
J	Garcia-Valero, J; Olloquequi, J; Montes, JF; Rodriguez, E; Martin-Satue, M; Texido, L; Sancho, JF				Garcia-Valero, Jose; Olloquequi, Jordi; Montes, Juan F.; Rodriguez, Esther; Martin-Satue, Mireia; Texido, Laura; Ferrer Sancho, Jaume			Deficient pulmonary IFN-beta expression in COPD patients	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; RHINOVIRUS INFECTION; VIRAL-INFECTIONS; DISEASE; INFLAMMATION; ASTHMA; EXACERBATIONS; REGULATORS; IRF-7	COPD patients are prone to acute infectious exacerbations that impair their quality of life and hamper prognosis. The purpose of the present study was to investigate the in situ IFN-there exists response in the lungs of stable COPD and non-COPD patients. Lung samples from 70 subjects (9 control never smokers, 19 control smokers without COPD, 21 patients with moderate COPD and 21 patients with very severe COPD) were studied for the expression of IFN-there exists, its main transcription factor, IRF-7, and two products of its autocrine function, namely RIG-I and MDA-5, by immunohistochemical techniques and quantitative real-time PCR. IFN-beta, IRF-7, RIG-I and MDA-5 were widely detected in most lung cell types. In epithelial tissues and alveolar macrophages, IFN-there exists and IRF-7 labeling scores were decreased up to 65% and 74%, respectively, for COPD patients, paralleling an analogous reduction (43% and 65%, respectively) in the amount of their lung mRNA. Moreover, this decreased production of IFN-there exists in COPD patients correlated with a similar decrease in the expression of RIG-I and MDA-5, two essential members of the innate immune system. Our study indicates that most lung cells from stable COPD patients show a constitutive decreased expression of IFN-beta, IRF-7, RIG-I and MDA-5, suggesting that this deficiency is the main cause of their acute viral exacerbations.	[Garcia-Valero, Jose; Olloquequi, Jordi; Montes, Juan F.] Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Olloquequi, Jordi] Univ Autonoma Chile, Inst Ciencias Biomed, Talca, Chile; [Rodriguez, Esther; Ferrer Sancho, Jaume] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pneumol, Barcelona, Spain; [Rodriguez, Esther; Ferrer Sancho, Jaume] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Martin-Satue, Mireia; Texido, Laura] Univ Barcelona, Dept Pathol & Expt Therapeut, Fac Med, Barcelona, Spain; [Martin-Satue, Mireia] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain	University of Barcelona; Universidad Autonoma de Chile; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Garcia-Valero, J (corresponding author), Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.	jgarcia@ub.edu	Olloquequi, Jordi/ABI-2452-2020	Olloquequi, Jordi/0000-0002-6492-2739; Garcia, Jose/0000-0002-7616-1519; Texido, Laura/0000-0002-2780-4434	Health Research Fund (Madrid, Spain) [FIS 04/0635]; Sociedad Espanola de Pneumologia [SEPAR 165\2012]	Health Research Fund (Madrid, Spain); Sociedad Espanola de Pneumologia	This study was supported by the grants received by JFS from the Health Research Fund (Madrid, Spain; FIS 04/0635) and the Sociedad Espanola de Pneumologia (SEPAR 165 vertical bar 2012). None of the funders played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines KJ, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-15; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Dewhurst JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07101-2; Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; George SN, 2014, EUR RESPIR J, V44, P87, DOI 10.1183/09031936.00223113; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2018, GLOB STRAT DIAGN MAN; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hilzendeger C, 2016, INT J CHRONIC OBSTR, V11, P1485, DOI 10.2147/COPD.S105948; Hodgson DB, 2012, THORAX, V67, P164, DOI 10.1136/thoraxjnl-2011-201231; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hsu ACY, 2016, AM J RESP CELL MOL, V55, P117, DOI 10.1165/rcmb.2015-0306OC; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Leung JM, 2017, RESPIROLOGY, V22, P634, DOI 10.1111/resp.13032; Makris S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00259; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; Perrotti E, 2013, FUTURE VIROL, V8, P1007, DOI 10.2217/fvl.13.88; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Razzuoli R, 2016, INNATE IMMUNE RESPON, P192; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Simpson JL, 2016, CHEST, V149, P704, DOI 10.1016/j.chest.2015.12.018; Singanayagam A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-27; SONNENFELD G, 1986, CANCER RES, V46, P2779; Spann KM, 2014, AM J PATHOL, V184, P1795, DOI 10.1016/j.ajpath.2014.02.026; Sze MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006677; Thomas BJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07176; Utokaparch S, 2014, COPD, V11, P197, DOI 10.3109/15412555.2013.836166; Zwaans WAR, 2014, J CLIN VIROL, V61, P181, DOI 10.1016/j.jcv.2014.06.025	39	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217803	10.1371/journal.pone.0217803	http://dx.doi.org/10.1371/journal.pone.0217803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170225	Green Published, gold			2022-12-27	WOS:000470263700058
J	Hou, QL; Zhang, ZG; Lei, T; Gan, MZ; Wu, XJ; Yue, WG; Li, B; Deng, L; Gong, HC				Hou, Qiliang; Zhang, Zhigang; Lei, Ting; Gan, Maozhou; Wu, Xiangjun; Yue, Weigang; Li, Bin; Deng, Lin; Gong, Hongchang			Clinical efficacy of high-flow nasal humidified oxygen therapy in patients with hypoxemia	PLOS ONE			English	Article							CARE PATIENTS; CANNULA; VENTILATION; INTUBATION; DELIVERY; FAILURE	To evaluate the effectiveness of high-flow nasal humidified oxygen (HFNHO) therapy in patients with mild hypoxemia after extubation. This study included 316 patients with mild hypoxemia after extubation from May 2016 to May 2018 from two intensive care units in China. Compare the effects of the Venturi Mask and High-Flow Nasal Humidified Oxygen (HFNHO) therapy on Heart Rate (HR), Respiratory Rate (RR), Oxygen Saturation (SpO(2)), Oxygen Partial Pressure (PO2), Partial Pressure Of Carbon Dioxide (PCO2), Oxygenation Index (PO2/FiO(2)) after extubation, the use of noninvasive mechanical ventilation and tracheal intubation after treatment failure were observed and recorded. Patients have both lower HR and RR than those who received mask treatment (75.4 +/- 18.5 vs. 83.0 +/- 20.4, p = 0.0004; 18 +/- 6.5 vs. 23.6 +/- 10.3, p<0.001, respectively). There was significant difference between those who had HFNHO and mask administration's SpO(2) and PO2 (94.1 6.4 vs. 87.5 +/- 1.5, p<0.001; 88.16 +/- 2.9 vs. 77.3 +/- 2.3, p<0.001, respectively). For the HFNHO group, patients had lower PCO2 with the mask group. (41.3 +/- 0.99 vs 42.2 +/- 1.2, p<0.001). On the other hand, the levels of PO2/FiO(2) was significantly higher in the HFNHO Group, (181.0 +/- 8.3 vs. 157.2 4.9, p<0.05). We concluded HFNHO therapy could significantly relieve the symptoms of dyspnea, improve oxygenation, reduce the use of noninvasive mechanical ventilation and reduce the rate of secondary tracheal intubation in patients with mild hypoxemia after extubation.	[Hou, Qiliang; Deng, Lin; Gong, Hongchang] Guanghan Peoples Hosp, Dept Crit Care Med, Guanghan, Sichuan, Peoples R China; [Hou, Qiliang; Zhang, Zhigang; Yue, Weigang; Li, Bin] Lanzhou Univ, Hosp 1, Dept Crit Care Med, Lanzhou, Gansu, Peoples R China; [Lei, Ting] Lanzhou Univ, Hosp 1, Dept Obstet & Gynecol, Lanzhou, Peoples R China; [Gan, Maozhou; Wu, Xiangjun] Guanghan Peoples Hosp, Guanghan, Sichuan, Peoples R China	Lanzhou University; Lanzhou University	Hou, QL (corresponding author), Guanghan Peoples Hosp, Dept Crit Care Med, Guanghan, Sichuan, Peoples R China.; Hou, QL (corresponding author), Lanzhou Univ, Hosp 1, Dept Crit Care Med, Lanzhou, Gansu, Peoples R China.	Qilianghou@outlook.com						Azoulay E, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2492-z; Brotfain E, 2014, ISR MED ASSOC J, V16, P718; Collins JA, 2015, BREATHE, V11, P195, DOI 10.1183/20734735.001415; CONWAY JH, 1992, RESP MED, V86, P109, DOI 10.1016/S0954-6111(06)80225-8; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; Cortegiani A, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0623-4; Durey A, 2016, AM J EMERG MED, V34, P2222, DOI 10.1016/j.ajem.2016.06.033; Dysart K, 2009, RESP MED, V103, P1400, DOI 10.1016/j.rmed.2009.04.007; Frat JP, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.52; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Frizzola M, 2011, PEDIATR PULM, V46, P67, DOI 10.1002/ppul.21326; Futier E, 2016, INTENS CARE MED, V42, P1888, DOI 10.1007/s00134-016-4594-y; Groves Nicole, 2007, Aust Crit Care, V20, P126; Hanouz JL, 2019, EUR J ANAESTH, V36, P335, DOI 10.1097/EJA.0000000000000954; Hasani A, 2008, Chron Respir Dis, V5, P81, DOI 10.1177/1479972307087190; Kang BJ, 2015, INTENS CARE MED, V41, P623, DOI 10.1007/s00134-015-3693-5; Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071; Kim ES, 2018, J THORAC DIS, V10, P882, DOI 10.21037/jtd.2018.01.125; Lampland AL, 2009, J PEDIATR-US, V154, P177, DOI 10.1016/j.jpeds.2008.07.021; Lee JH, 2013, INTENS CARE MED, V39, P247, DOI 10.1007/s00134-012-2743-5; Lucangelo U, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/506382; Lyu Shan, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P84, DOI 10.3760/cma.j.issn.2095-4352.2016.01.018; Mas A, 2014, INT J CHRONIC OBSTR, V9, P837, DOI 10.2147/COPD.S42664; Mauri T, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2039-4; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Moore CP, 2019, CLIN BIOMECH, V65, P73, DOI 10.1016/j.clinbiomech.2019.04.004; Peters SG, 2013, RESP CARE, V58, P597, DOI 10.4187/respcare.01887; Plotnikow GA, 2018, RESP CARE, V63, P1016, DOI 10.4187/respcare.06031; Ricard JD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022983; Sarkar M, 2017, LUNG INDIA, V34, P47, DOI 10.4103/0970-2113.197116; Sehgal IS, 2015, INDIAN J CRIT CARE M, V19, P743, DOI 10.4103/0972-5229.171414; Shippam W, 2019, ANAESTHESIA, V74, P450, DOI 10.1111/anae.14567; Siegel MD, HYPOXEMIA HYPERCAPNE; Simon M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0712-9; Sztrymf B, 2011, INTENS CARE MED, V37, P1780, DOI 10.1007/s00134-011-2354-6; Tiruvoipati R, 2010, J CRIT CARE, V25, P463, DOI 10.1016/j.jcrc.2009.06.050; Wagstaff TAJ, 2007, ANAESTHESIA, V62, P492, DOI 10.1111/j.1365-2044.2007.05026.x; Ward JJ, 2013, RESP CARE, V58, P98, DOI 10.4187/respcare.01941	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216957	10.1371/journal.pone.0216957	http://dx.doi.org/10.1371/journal.pone.0216957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170182	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700012
J	Stawski, D; Nowak, A				Stawski, Dawid; Nowak, Aleksandra			Thermal properties of poly(N,N-dimethylaminoethyl methacrylate)	PLOS ONE			English	Article								Poly(N, N-dimethylaminoethyl methacrylate) (PDMAEMA) is a promising quite new polymer with very interesting properties. The thermal degradation process of PDMAEMA was investigated. The polymer was heated at specific time intervals, then heating was stopped, and infrared analysis was performed to obtain information on the structure of the solid residue. The thermal degradation process has a two-stage character. The limit temperature for the first decomposition step was about 390 degrees C, after which the second stage of sample decomposition began. The order of disintegration of the macromolecules was determined. Activation energy values for the thermal decomposition process have been calculated; they are 89.8 kJ/mol for the first stage and 17.7 kJ/mol for the second stage of the degradation process.	[Stawski, Dawid; Nowak, Aleksandra] Lodz Univ Technol, Dept Mat & Commod Sci & Text Metrol, Div Phys Chem Polymers, Lodz, Poland	Lodz University of Technology	Stawski, D (corresponding author), Lodz Univ Technol, Dept Mat & Commod Sci & Text Metrol, Div Phys Chem Polymers, Lodz, Poland.	dawid.stawski@p.lodz.pl		Stawski, Dawid/0000-0002-7916-0239	Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland [14-148-1-21-28]	Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland	The authors disclose the receipt of the following financial support for the research, authorship, and/or publication of this article: The manuscript was financed from funds assigned for 14-148-1-21-28 statuary activity, by Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland.	Amiji MM, 1999, US Patent US, Patent No. 19970862854; Christy AA, 2010, VIB SPECTROSC, V54, P42, DOI 10.1016/j.vibspec.2010.06.003; COATS AW, 1965, J POLYM SCI POL LETT, V3, P917, DOI 10.1002/pol.1965.110031106; Cunningham V. L., 1978, US Patent, Patent No. [4129534A, 4129534]; Cunningham VL, 1977, US Patent US, Patent No. [4052343A, 4052343]; Fukutomi T, 1996, US Patent, Patent No. [5543045A, 5543045]; Gutarowska B, 2015, TEXT RES J, V85, P1083, DOI 10.1177/0040517514559581; Huang KS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091578; Hurlock JR, 2000, US Patent US, Patent No. 6025426; Jana S, 2007, CHEM COMMUN, P2962, DOI 10.1039/b702067h; Karjalainen E, 2014, MACROMOLECULES, V47, P2103, DOI 10.1021/ma5000706; Nakano H, 1988, US Patent, Patent No. [4787977A, 4787977]; Nita LE, 2018, MAT SCI ENG C-MATER, V87, P22, DOI 10.1016/j.msec.2018.02.016; Orakdogen N, 2012, J POLYM RES, V19, DOI 10.1007/s10965-012-9914-5; Plamper FA, 2007, MACROMOLECULES, V40, P8361, DOI 10.1021/ma071203b; Rawlinson LAB, 2011, J MED MICROBIOL, V60, P968, DOI 10.1099/jmm.0.025619-0; Rawlinson LAB, 2010, BIOMACROMOLECULES, V11, P443, DOI 10.1021/bm901166y; Romano Jr CE, 2000, US Patent, Patent No. [6020032A, 6020032]; Stawski D, 2013, J TEXT I, V104, P883, DOI 10.1080/00405000.2013.764753; Zielinska D, 2016, TEXT RES J, V86, P1837, DOI 10.1177/0040517515617420	20	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217441	10.1371/journal.pone.0217441	http://dx.doi.org/10.1371/journal.pone.0217441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166982	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800029
J	Peach, DAH; Ko, E; Blake, AJ; Gries, G				Peach, Daniel A. H.; Ko, Elton; Blake, Adam J.; Gries, Gerhard			Ultraviolet inflorescence cues enhance attractiveness of inflorescence odour to Culex pipiens mosquitoes	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; AEDES-AEGYPTI; NECTAR SOURCES; DIPTERA; VISION; COMPLEX; LIGHT; EYES; PHYTOCHEMICALS; PHOTORECEPTORS	Inflorescence patterns of ultraviolet (UV) absorption and UV-reflection are attractive to many insect pollinators. To understand whether UV inflorescence cues affect the attraction of nectar-foraging mosquitoes, we worked with the common house mosquito, Culex pipiens and with two plant species exhibiting floral UV cues: the tansy, Tanacetum vulgare, and the common hawkweed Hieraciumm lachenalii. Electroretinograms revealed that Cx. pipiens eyes can sense UV wavelengths, with peak sensitivity at 335 nm. Behavioural bioassays divulged that UV inflorescence cues enhance the attractiveness of inflorescence odour. In the presence of natural floral odour, female Cx. pipiens were attracted to floral patterns of UV-absorption and UV-reflection but preferred uniformly UV-dark inflorescences. Moreover, Cx. pipiens females preferred UV-dark and black inflorescence models to UV-dark and yellow inflorescence models. With feathers and pelts of many avian and mammalian hosts also being UV-dark and dark-coloured, foraging Cx. pipiens females may respond to analogous visual cues when they seek nectar and vertebrate blood resources.	[Peach, Daniel A. H.; Ko, Elton; Blake, Adam J.; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada	Simon Fraser University	Peach, DAH (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.	dan@danpeach.info	Peach, Daniel AH/C-9323-2019; Blake, Adam/ABE-5234-2020	Peach, Daniel AH/0000-0002-8913-5133; Blake, Adam/0000-0002-4143-6981	Natural Sciences and Engineering Research Council of Canada [NSERC] PGSD; SFU Provost's Prize of Distinction; John H Borden Scholarship; NSERC - Undergraduate Student Research Award; NSERC -Industrial Research Chair; Scotts Canada Ltd.	Natural Sciences and Engineering Research Council of Canada [NSERC] PGSD(Natural Sciences and Engineering Research Council of Canada (NSERC)); SFU Provost's Prize of Distinction; John H Borden Scholarship; NSERC - Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC -Industrial Research Chair(Canada Research Chairs); Scotts Canada Ltd.	The research was supported by scholarships to DP (Natural Sciences and Engineering Research Council of Canada [NSERC; https://www.canada.ca/en/science-engineering-research.html] PGSD; SFU Provost's Prize of Distinction [https://www.sfu.ca/dean-gradstudies/awards/entrance-scholarships/provost-awards/ppd.html]; John H Borden Scholarship [http://esc-sec.ca/student/student-awards/#toggle-id-5]), a scholarship to EK (NSERC - Undergraduate Student Research Award), and by an NSERC -Industrial Research Chair to GG, with Scotts Canada Ltd. as the industrial sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON IH, 1987, MED VET ENTOMOL, V1, P59, DOI 10.1111/j.1365-2915.1987.tb00323.x; Arnold SEJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014287; Bernath B, 2016, J INSECT PHYSIOL, V95, P8, DOI 10.1016/j.jinsphys.2016.08.011; BRANTJES NBM, 1976, ACTA BOT NEERL, V25, P281, DOI 10.1111/j.1438-8677.1976.tb00240.x; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brodie BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145055; BURKHARDT D, 1989, J COMP PHYSIOL A, V164, P787, DOI 10.1007/BF00616750; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Clements AN., 1999, SENSORY RECEPTION BE; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Dieng H, 2018, ACTA TROP, V185, P230, DOI 10.1016/j.actatropica.2018.05.019; Dinkel T, 2001, J INSECT PHYSIOL, V47, P1111, DOI 10.1016/S0022-1910(01)00080-4; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Foster WA, 2008, J AM MOSQUITO CONTR, V24, P138, DOI 10.2987/8756-971X(2008)24[138:PAPSL]2.0.CO;2; FREE J B, 1970, Behaviour, V37, P269, DOI 10.1163/156853970X00376; Giraldo-Calderon GI, 2017, BMC EVOL BIOL, V17, P1, DOI [10.1186/s12862-016-0855-1, DOI 10.1186/S12862-016-0855-1]; GRIMSTAD PR, 1974, J MED ENTOMOL, V11, P331, DOI 10.1093/jmedent/11.3.331; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; HAUFE WO, 1964, CAN ENTOMOL, V96, P118, DOI 10.4039/Ent96118-1; HOROVITZ A, 1972, AM J BOT, V59, P706, DOI 10.2307/2441142; Horth L, 2014, BIOL OPEN, V3, P221, DOI 10.1242/bio.20146445; Hu XB, 2014, J EXP BIOL, V217, P1003, DOI 10.1242/jeb.096347; Hu XB, 2012, J NEUROSCI, V32, P13661, DOI 10.1523/JNEUROSCI.1816-12.2012; Hu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023121; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; JEPSON PC, 1988, B ENTOMOL RES, V78, P641, DOI 10.1017/S0007485300015492; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Kirschfeld K, 1977, NATURE, V267, P192; Koski MH, 2014, FUNCT ECOL, V28, P868, DOI 10.1111/1365-2435.12242; Land MF, 1999, J COMP PHYSIOL A, V185, P91, DOI 10.1007/s003590050369; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; MAGNARELLI LA, 1977, ENVIRON ENTOMOL, V6, P237, DOI 10.1093/ee/6.2.237; MAGNARELLI LA, 1979, ENVIRON ENTOMOL, V8, P949, DOI 10.1093/ee/8.5.949; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Mellor HE, 1996, MED VET ENTOMOL, V10, P371, DOI 10.1111/j.1365-2915.1996.tb00759.x; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; MUIR LE, 1992, J MED ENTOMOL, V29, P278, DOI 10.1093/jmedent/29.2.278; Muller H, 1873, BEFRUCHTUNG BLUMEN D; Nyasembe VO, 2014, PHYTOCHEM LETT, V8, P196, DOI 10.1016/j.phytol.2013.10.003; Orban LL, 2014, INSECT SOC, V61, P325, DOI 10.1007/s00040-014-0366-2; Peach DAH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39748-4; Peach DAH, 2016, ARTHROPOD-PLANT INTE, V10, P497, DOI 10.1007/s11829-016-9445-9; PRIMACK R B, 1982, Arnoldia (Jamaica Plain), V42, P139; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; SANDHOLM HOLLACE A., 1962, MOSQUITO NEWS, V22, P346; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; SATO SHOZO, 1957, SCI REPTS TOHOKU UNIV SER 4 BIOL, V23, P83; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; Shekar SN, 2008, PHOTOCHEM PHOTOBIOL, V84, P719, DOI 10.1111/j.1751-1097.2007.00237.x; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Silva IM, 2005, J AM MOSQUITO CONTR, V21, P229, DOI 10.2987/8756-971X(2005)21[229:LEOMTB]2.0.CO;2; SIPPELL WL, 1953, B ENTOMOL RES, V43, P567, DOI 10.1017/S0007485300026651; Song B, 2015, J PLANT ECOL, V8, P173, DOI 10.1093/jpe/rtv012; STADDON BW, 1980, COMP BIOCHEM PHYS A, V65, P371, DOI 10.1016/0300-9629(80)90046-8; Stavenga DG, 2017, J PHYSIOL-LONDON, V595, P5481, DOI 10.1113/JP273674; Stoutamire W, 1968, MICH BOT, V7, P203; THIEN LB, 1969, AM J BOT, V56, P232, DOI 10.2307/2440711; UTECH FH, 1975, BOT MAG TOKYO, V88, P9, DOI 10.1007/BF02498877; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; WEISS MR, 1991, NATURE, V354, P227, DOI 10.1038/354227a0; WILTON DP, 1972, J MED ENTOMOL, V9, P301, DOI 10.1093/jmedent/9.4.301; WILTON DP, 1975, MOSQ NEWS, V35, P522	65	16	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217484	10.1371/journal.pone.0217484	http://dx.doi.org/10.1371/journal.pone.0217484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163041	gold, Green Submitted, Green Published			2022-12-27	WOS:000470086200013
J	Ali, B; Zhou, YC; Zhang, QY; Niu, CY; Zhu, ZH				Ali, Bahar; Zhou, Yicheng; Zhang, Qiuyuan; Niu, Changying; Zhu, Zhihui			Development of an easy and cost-effective method for non-invasive genotyping of insects	PLOS ONE			English	Article							DNA; AMPLIFICATION; SEQUENCE; GENES; PCR	Non-invasive genotyping methods provide valuable information on insect populations. However, poor DNA amplification and time-consuming sampling procedures limit these methods, especially for small insects. An efficient and convenient method was developed for non-invasive, non-lethal genotyping of a large insect, Mythimna separata, and a small insect, Drosophila melanogaster, by amplification of endogenous and exogenous, nuclear and mitochondrial genes from insect frass, exuviae, and food waste. For M. separata, the chitin synthesis gene MsCHSB and the COI gene were successfully detected by PCR from exuviae DNA. However, a COI fragment could not be detected directly by PCR from frass, probably due to DNA degradation. To improve the detection rate, DNA from frass was first amplified by Multiple Displacement Amplification with phi29 DNA polymerase, after which the COI fragment was detected from all samples by PCR. For D. melanogaster, second instar larvae were reared individually for three days and then DNA was extracted from food waste of each individual. The endogenous fragment serendipity a (srya), exogenous transgene FC31 integrase, and the kl-5 gene, a Y-chromosome-located male-specific marker gene were successfully detected from most samples. We developed a simple, non-invasive, non-lethal method to determine gender and identify transgenic individuals early in the larval stage. This universal method is applicable to most insects and has potential application in genetic and ecological studies of insects and other arthropods.	[Ali, Bahar; Zhou, Yicheng; Zhang, Qiuyuan; Niu, Changying; Zhu, Zhihui] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Zhu, ZH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China.	zhihui@mail.hzau.edu.cn		Zhu, Zhihui/0000-0002-6650-1241; Zhou, Yicheng/0000-0003-3659-9951	National Natural Science Foundation of China [31572329]; Fundamental Research Funds for the Central Universities [2012ZYTS046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (grant no. 31572329 to ZZ), Fundamental Research Funds for the Central Universities (Program No. 2012ZYTS046 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashfaq M, 1999, S PACIFIC STUDY, V19; Barros EM, 2010, ENTOMOL EXP APPL, V137, P237, DOI 10.1111/j.1570-7458.2010.01058.x; Carvalho GB, 2009, BIOTECHNIQUES, V46, P312, DOI 10.2144/000113088; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Essays UK, 2013, REV LAB REAR DROS ME; Feinstein J, 2004, CONSERV GENET, V5, P103, DOI 10.1023/B:COGE.0000014058.34840.94; Fincke OM, 2001, EVOLUTION, V55, P762, DOI 10.1554/0014-3820(2001)055[0762:UOSITD]2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fumanal B, 2005, J BIOTECHNOL, V119, P15, DOI 10.1016/j.jbiotec.2005.04.011; Ganbaatar O, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0328-7; Gerken T, 1998, ELECTROPHORESIS, V19, P3069, DOI 10.1002/elps.1150191804; GOLDSTEIN LSB, 1982, P NATL ACAD SCI-BIOL, V79, P7405, DOI 10.1073/pnas.79.23.7405; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hoy MA, 2003, INSECT MOL GENETICS, P737, DOI [10.1016/B978-0-12-357031-4.X5018-3, DOI 10.1016/B978-0-12-357031-4.X5018-3]; IBNSOUDA S, 1993, DEVELOPMENT, V119, P971; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Lefort M-C, 2015, PEERJ, DOI DOI 10.7287/PEERJ.PREPRINTS.655V3; Lushai G, 2000, BIOL CONSERV, V94, P43, DOI 10.1016/S0006-3207(99)00165-2; Oja R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179463; Rea RV, 2016, J FISH WILDL MANAG, V7, P461, DOI 10.3996/112015-JFWM-115; ROSE OC, 1994, MOL ECOL, V3, P275, DOI 10.1111/j.1365-294X.1994.tb00064.x; Scriven JJ, 2013, MOL ECOL RESOUR, V13, P225, DOI 10.1111/1755-0998.12036; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Starks PT, 2002, INSECT SOC, V49, P20, DOI 10.1007/s00040-002-8272-4; Venken KJT, 2016, WIRES DEV BIOL, V5, P233, DOI 10.1002/wdev.214; Watts PC, 2005, ODONATOLOGICA, V34, P183	28	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216998	10.1371/journal.pone.0216998	http://dx.doi.org/10.1371/journal.pone.0216998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158235	Green Submitted, gold, Green Published			2022-12-27	WOS:000469915700005
J	Coffin, PO; Santos, GM; Behar, E; Hern, J; Walker, J; Matheson, T; Kinnard, EN; Silvis, J; Vittinghoff, E; Fox, R; Page, K				Coffin, Phillip O.; Santos, Glenn-Milo; Behar, Emily; Hern, Jaclyn; Walker, John; Matheson, Tim; Kinnard, Elizabeth N.; Silvis, Janelle; Vittinghoff, Eric; Fox, Rena; Page, Kimberley			Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; ANTIVIRAL TREATMENT; COST-EFFECTIVENESS; HCV INFECTION; USERS; PREVENTION; PROGRAMS; RISK; TRANSMISSION	Aims The advent of direct-acting antivirals for hepatitis C virus (HCV) and limited effectiveness of prevention have generated interest in "Treatment as Prevention" (TasP), in which those most likely to transmit HCV (i. e. people who inject drugs [PWID]) are treated to reduced secondary transmission. However, there are scant data regarding the feasibility of treating PWID at high risk for secondary transmission or the optimal approach to treatment delivery. Methods We conducted a 2: 1 randomized trial of modified directly-observed (mDOT) versus unobserved HCV treatment with ledipasvir-sofosbuvir daily for 8 weeks among PWID with 36 weeks of follow-up in San Francisco from 2015-2017. We evaluated recruitment-enrollment, treatment completion, end-of-treatment and 12-week response, and reinfection rate. Results Of 83 individuals eligible for screening, 72 (87.6%) attended the screening visit, 33 were eligible, and 31 enrolled; mean age was 42 years, 81% were male, 74% white. All but one participant (in the mDOT arm) completed treatment and 89.4% of mDOT and 96.6% of unobserved arm visits were attended. HCV was undetectable for 96.8% (30/31) at end of treatment and 89.7% (26/29) 12 weeks later (1 relapse, 1 reinfection), with no differences by arm. Two additional reinfections were subsequently identified, for a reinfection rate of 16.3 (95% CI 5.3-50.5) per 100 person-years of observation. Conclusions It was feasible to recruit active PWID for HCV treatment and achieve high retention, viral response, and satisfaction with either mDOT or unobserved protocols, supporting treatment of PWID at risk of transmitting HCV to others. The reinfection rate suggests we successfully reached a high-risk population and that successful HCV TasP initiatives may aim to be sufficient in scope to significantly lower prevalence in the community.	[Coffin, Phillip O.; Santos, Glenn-Milo; Behar, Emily; Hern, Jaclyn; Walker, John; Matheson, Tim; Kinnard, Elizabeth N.; Silvis, Janelle] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Coffin, Phillip O.; Santos, Glenn-Milo; Vittinghoff, Eric; Fox, Rena; Page, Kimberley] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kinnard, Elizabeth N.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.; Coffin, PO (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	phillip.coffin@sfdph.org	Coffin, Phillip/G-3286-2012	Coffin, Phillip/0000-0002-3891-6570; Santos, Glenn-Milo/0000-0003-1009-5317	National Institute on Drug Abuse at the National Institutes of Health [R34DA039333]; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA039333, K24DA042720] Funding Source: NIH RePORTER	National Institute on Drug Abuse at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse at the National Institutes of Health [grant#R34DA039333]. Study drug was donated by Gilead Sciences. Neither the funder nor study drug provider determined the conduct of the study, the content or interpretation of data, or the intent to publish this manuscript.	Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Buckley GJ, 2017, ANN INTERN MED, V166, P895, DOI 10.7326/M17-0766; Butt AA, 2016, LIVER INT, V36, P1275, DOI 10.1111/liv.13103; Centers for Disease Control and Prevention, 2018, HEP C OV STAT; Cheng ST, 2006, INT J GERIATR PSYCH, V21, P333, DOI 10.1002/gps.1467; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dore GJ, 2016, ANN INTERN MED, V165, P625, DOI 10.7326/M16-0816; Falster K., 2009, J URBAN HEALTH, V86, P106, DOI DOI 10.1007/S11524-008-9330-7; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Grebely J, 2017, NAT REV GASTRO HEPAT, V14, P641, DOI 10.1038/nrgastro.2017.106; Grebely J, 2016, CLIN INFECT DIS, V63, P1405, DOI 10.1093/cid/ciw580; Heimer R, 2018, J INFECT DIS, V217, P466, DOI 10.1093/infdis/jix427; Holtzman D, 2009, PREV MED, V49, P68, DOI 10.1016/j.ypmed.2009.04.014; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Martin NK, 2017, J HEPATOL, V67, P5, DOI 10.1016/j.jhep.2017.03.008; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2013, HEPATOLOGY; Montgomery ME, 2013, J URBAN HEALTH, V90, P500, DOI 10.1007/s11524-012-9718-2; Morris MD, DRUG ALCOHOL DEPEND; Morris MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109282; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Palmateer NE, 2013, INT J DRUG POLICY, V24, P85, DOI 10.1016/j.drugpo.2012.08.006; Samandari T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx076; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Ward Z., 2018, ADDICTION; World Health Organization, 2016, COMB HEP B C REACH E; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	33	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217471	10.1371/journal.pone.0217471	http://dx.doi.org/10.1371/journal.pone.0217471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158245	Green Published, gold			2022-12-27	WOS:000469915700017
J	Loi, F; Laddomada, A; Coccollone, A; Marrocu, E; Piseddu, T; Masala, G; Bandino, E; Cappai, S; Rolesu, S				Loi, Federica; Laddomada, Alberto; Coccollone, Annamaria; Marrocu, Elena; Piseddu, Toni; Masala, Giovanna; Bandino, Ennio; Cappai, Stefano; Rolesu, Sandro			Socio-economic factors as indicators for various animal diseases in Sardinia	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; VIRUS SEROTYPE 8; WEST NILE VIRUS; BLUETONGUE VIRUS; CONTAGIOUS AGALACTIA; CULICOIDES-IMICOLA; CURRENT KNOWLEDGE; RISK-FACTORS; MORTALITY; EPIDEMIOLOGY	The need to consider the role of social factors in the efficacy of farm management and, consequently, in the onset and persistence of diseases typical to animal farms is increasingly being realized increasingly worldwide. Many risk analysis studies have been conducted to assess the role of various factors in the development of animal diseases; however, very few have accounted for the role of social factors. The aim of this work was to bridge this gap, with the main hypothesis that different socio-economic factors could be valid indicators for the occurrence of different animal diseases. A socio-economic analysis was performed using demographic characteristics of the farmers and data from 44 social indicators released by the Italian Statistician National Institute of Statistics (ISTAT) database. African swine fever (ASF) in wild boars (WB) and domestic pigs and other endemic animal diseases and zoonoses in Sardinia were considered, such as cistic echinococcosis (CE), contagious agalactia (CA), trichinellosis, West Nile disease (WND), and bluetongue (BT). Seven different negative binomial regression models were fitted using the number of cases between 2011-2017. Three indicators-cultural demand, employment rate, and legality-showed a statistically significant association with risk for all the diseases considered, but with varying effects. Some indicators, such as the age and sex of the farmer, material deprivation index, number of farms and animals, micro-criminality index, and rate of reported thefts were common to ASF, CA, trichinellosis, and CE cases. Others such as the forest surface and the energy produced from renewable sources were common to BT, WND, and ASF in WB. Tourism in seasons other than summer was a valid predictor of ASF and trichinellosis, while out-of-region hospital use had a statistically significant role in CE risk identification. These results may help understand the social context in which these diseases may occur and thus guide the design and implementation of additional risk management measures that go beyond well-known veterinary measures.	[Loi, Federica; Coccollone, Annamaria; Marrocu, Elena; Cappai, Stefano; Rolesu, Sandro] OEVR Osservatorio Epidemiol Vet Reg Sardegna, Cagliari, Italy; [Laddomada, Alberto; Bandino, Ennio] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy; [Piseddu, Toni; Masala, Giovanna] CeNRE Ctr Nazl Referenza Echinococcosi Idatidosi, Sassari, Italy	IZS Della Sardegna	Loi, F (corresponding author), OEVR Osservatorio Epidemiol Vet Reg Sardegna, Cagliari, Italy.	federica.loi@izs-sardegna.it	LOI, FEDERICA/AAG-2563-2020	LOI, FEDERICA/0000-0003-3045-3150; Piseddu, Toni/0000-0002-1024-5250; , Giovanna Masala/0000-0001-5301-2580				Abbott P., 1994, SOC HLTH ILLNESS, V16, P254; Akaike H., 1973, SELECTED PAPERS HIRO, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albarella U., 2006, ARCHAEOZOOLOGICAL ST, P285; [Anonymous], 6 CENS GEN AGR SARD, P82; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Barnes AP, 2015, PREV VET MED, V122, P42, DOI 10.1016/j.prevetmed.2015.09.003; Beaudeau F, 1996, PREV VET MED, V25, P327, DOI 10.1016/0167-5877(95)00509-9; Beck JD, 1998, COMMUNITY DENT ORAL, V26, P220, DOI 10.1111/j.1600-0528.1998.tb01954.x; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Bhat H. S., 2010, DERIVATION BAYESIAN; Bishwajit G, SOCIAL DETERMINANTS, V2014, P1, DOI [10.1155/2014/135243, DOI 10.1155/2014/135243]; Bollen K., 1989, STRUCTURAL EQUATIONS; Brundu D, 2014, ACTA TROP, V140, P91, DOI 10.1016/j.actatropica.2014.08.011; Bulter-Jones D, 2016, CAN COMMUN DIS RE S1, V18; Cadum E, 1999, Epidemiol Prev, V23, P175; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cappai S, 2018, PREV VET MED, V155, P75, DOI 10.1016/j.prevetmed.2018.04.004; Cappai S, 2018, PREV VET MED, V152, P1, DOI 10.1016/j.prevetmed.2018.01.004; Chenais E, 2017, TRANSBOUND EMERG DIS, V64, P101, DOI 10.1111/tbed.12347; Chenais E, 2017, PREV VET MED, V144, P134, DOI 10.1016/j.prevetmed.2017.06.002; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2003, J VET MED B, V50, P139, DOI 10.1046/j.1439-0450.2003.00632.x; Contini A, 1983, CEC FAO EXPERT CONSU; Costard S, 2009, PREV VET MED, V92, P199, DOI 10.1016/j.prevetmed.2009.08.010; Craddock S, 2015, SOC SCI MED, V129, P1, DOI 10.1016/j.socscimed.2014.11.016; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Djordjevic M, 2003, J PARASITOL, V89, P226, DOI 10.1645/0022-3395(2003)089[0226:SPAEFR]2.0.CO;2; Donkin A, 2002, HLTH STAT Q, V15, P5; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drewe JA, 2011, PREV VET MED, V101, P113, DOI 10.1016/j.prevetmed.2011.05.006; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Enticott G, 2009, SOCIOL RURALIS, V49, P327, DOI 10.1111/j.1467-9523.2009.00498.x; FAO (Food and Agriculture Organization of the United Nations), 2002, 153 FAO; Firinu A, 1988, QUADERNI I ZOOPROFIL, V5, P179; Gao X, 2017, PREV VET MED, V138, P88, DOI 10.1016/j.prevetmed.2017.01.012; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gibney KB, 2012, AM J TROP MED HYG, V86, P895, DOI 10.4269/ajtmh.2012.11-0502; Hidano A, 2017, 3 INT C AN HLTH SURV; Hidano A, 2017, IN M ISESSA AV INT S, P91; Hidano A, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00137; Hilbe J., 2011, NEGATIVE BINOMIAL RE; HINCHLIFFE S, 2018, PALGR COMMUN, V4, DOI DOI 10.1057/S41599-018-0113-9; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hurt LS, 2004, J EPIDEMIOL COMMUN H, V58, P315, DOI 10.1136/jech.2003.007351; ISTAT, 2006, IND DEPR AN DIS TRA; ISTAT, ANN STAT IT 2017; ISTAT, 2013, AGR DAT; Judge GeorgeG., 1985, THEORY PRACTICE ECON, V2nd ed.; Jurado C, 2018, TRANSBOUND EMERG DIS, V65, P557, DOI 10.1111/tbed.12740; King LJ, 2008, JAVMA-J AM VET MED A, V233, P259, DOI 10.2460/javma.233.2.259; Laddomada A, 2019, TRANSBOUND EMERG DIS, P1, DOI [10.1111/tbed.13004, DOI 10.1111/TBED.13004]; Lawrence DH, 1921, SEA SARDINIA; Liu H, 2011, SCI TOTAL ENVIRON, V409, P4235, DOI 10.1016/j.scitotenv.2011.07.012; Loi F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214224; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Madanat A, 2001, ACTA VET BRNO, V70, P403, DOI 10.2754/avb200170040403; Mark J., 2001, APPRAISAL J, V56, P89; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martinez-Lopez B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00314; Mur L, 2018, TRANSBOUND EMERG DIS, V65, P123, DOI 10.1111/tbed.12636; Mur L., 2014, TRANSBOUND EMERG DIS, V3, P113, DOI DOI 10.1111/TBED.12264; OIE, 2009, MANUAL DIAGNOSTIC TE, V1; OIE, 2014, GUID AN DIS CONTR; Okuthe S., 2012, PIG SECTOR KENYA FAO; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; Patterson S, 2017, J ANIM ECOL, V86, P442, DOI 10.1111/1365-2656.12649; Piccolo D., 1998, STATISTICA, P872; Piseddu T, PLOS NEGLECTED TROPI; Pozio E, 2006, VET PARASITOL, V140, P177, DOI 10.1016/j.vetpar.2006.03.012; Proudfoot K, 2015, VET J, V206, P15, DOI 10.1016/j.tvjl.2015.05.024; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Regione Autonoma de la Sardegna (RAS), 2004, AN SBOCCH MERC PROD; Rolesu Sandro, 2007, Vet Ital, V43, P463; Rolesu S, 2018, SMALL RUMINANT RES, V164, P39, DOI 10.1016/j.smallrumres.2018.04.013; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204, 10.3201/eid2204.151073]; Stewart G.W., 1987, STAT SCI, V2, P68, DOI DOI 10.1214/ss/1177013439; Swallow B. M., 2000, PAAT TECHNICAL SCI S; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; WILKINSON PJ, 1984, PREV VET MED, V2, P71, DOI 10.1016/0167-5877(84)90050-3; Wilkinson R.G, 2006, PREV CHRONIC DIS, V3, pA26; World Health Organization, 2008, COMM SOC DET HLTH 20; World Health Organization, 2003, SOCIAL DETERMINANTS; Yu H, 2015, SOC SCI RES, V53, P118, DOI 10.1016/j.ssresearch.2015.04.008	88	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217367	10.1371/journal.pone.0217367	http://dx.doi.org/10.1371/journal.pone.0217367			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158242	Green Submitted, Green Published, gold			2022-12-27	WOS:000469915700013
J	Fultang, N; Illendula, A; Chen, B; Wu, C; Jonnalagadda, S; Baird, N; Klase, Z; Peethambaran, B				Fultang, Norman; Illendula, Abhinav; Chen, Brian; Wu, Chun; Jonnalagadda, Subash; Baird, Nathan; Klase, Zachary; Peethambaran, Bela			Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3 beta activity	PLOS ONE			English	Article							PROTEIN-STRUCTURE; ACCURATE DOCKING; PREDICTION; GLIDE; PHOSPHORYLATION; APOPTOSIS; PATHWAY; ROR1	Triple Negative Breast Cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by the absence of hormone receptors usually targeted by hormone therapies like Tamoxifen. Because therapy success and survival rates for TNBC lag far behind other breast cancer subtypes, there is significant interest in developing novel anti-TNBC agents that can target TNBC specifically, with minimal effects on non-malignant tissue. To this aim, our study describes the anti-TNBC effect of strictinin, an ellagitanin previously isolated from Myrothamnus flabellifolius. Using various in silico and molecular techniques, we characterized the mechanism of action of strictinin in TNBC. Our results suggest strictinin interacts strongly with Receptor Tyrosine Kinase Orphan like 1 (ROR1). ROR1 is an oncofetal receptor highly expressed during development but not in normal adult tissue. It is highly expressed in several human malignancies however, owing to its numerous pro-tumor functions. Via its interaction and inhibition of ROR1, strictinin reduced AKT phosphorylation on ser-473, inhibiting downstream phosphorylation and inhibition of GSK3 beta. The reduction in AKT phosphorylation also correlated with decreased cell survival and activation of the caspase-mediated intrinsic apoptotic cascade. Strictinin treatment also repressed cell migration and invasion in a beta-catenin independent manner, presumably via the reactivated GSK3 beta's repressing effect on microtubule polymerization and focal adhesion turnover. This could be of potential therapeutic interest considering heightened interest in ROR1 and other receptor tyrosine kinases as targets for development of anti-cancer agents. Further studies are needed to validate these findings in other ROR1-expressing malignancies but also in more systemic models of TNBC. Our findings do however underline the potential of strictinin and other ROR1targeting agents as therapeutic tools to reduce TNBC proliferation, survival and motility.	[Fultang, Norman; Illendula, Abhinav; Klase, Zachary; Peethambaran, Bela] Univ Sci Philadelphia, Dept Biol, Philadelphia, PA 19104 USA; [Chen, Brian; Wu, Chun; Jonnalagadda, Subash] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ USA; [Baird, Nathan] Univ Sci Philadelphia, Dept Chem & Biochem, Philadelphia, PA USA	Rowan University	Peethambaran, B (corresponding author), Univ Sci Philadelphia, Dept Biol, Philadelphia, PA 19104 USA.	b.peethambaran@usciences.edu	; Jonnalagadda, Subash/O-3388-2015	Chen, Brian/0000-0002-5401-688X; Fultang, Norman/0000-0002-8115-7231; Peethambaran, Bela/0000-0002-2719-3928; Jonnalagadda, Subash/0000-0001-5234-1235	Milton Lev Faculty Research Fund - University of the Sciences; University of the Sciences	Milton Lev Faculty Research Fund - University of the Sciences; University of the Sciences	Funding was provided through the Milton Lev Faculty Research Fund, an internal grant awarded to Dr. Peethambaran by The University of the Sciences.	Aghebati-Maleki L, 2017, BIOMED PHARMACOTHER, V88, P814, DOI 10.1016/j.biopha.2017.01.070; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Borcherding N, 2014, PROTEIN CELL, V5, P496, DOI 10.1007/s13238-014-0059-7; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brar J., 2018, Journal of Medicinal Plants Research, V12, P7, DOI 10.5897/jmpr2017.6518; Cao JY, 2018, THERANOSTICS, V8, P2739, DOI 10.7150/thno.21477; Choi MY, 2015, AM SOC HEMATOLOGY; Damodar G, 2014, ANN MED HEALTH SCI R, V4, P74, DOI 10.4103/2141-9248.126619; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fultang N, 2018, INT J APPL RES NAT P, V11, P24; Gentile A, 2011, CANC RES; Gianni L, 2007, CARDIOVASC TOXICOL, V7, P67, DOI 10.1007/s12012-007-0013-5; Gohil S, 2017, LANCET, V389, P40; Grainger S, 2018, PROG MOL BIOL TRANSL, V153, P321, DOI 10.1016/bs.pmbts.2017.11.002; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hojjat-Farsangi M, 2018, LEUKEMIA, V32, P2291, DOI 10.1038/s41375-018-0113-1; Hula KT, 2006, MOL CARCINOGEN, V45, P551, DOI 10.1002/mc.20226; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Min BK, 2012, IEEE INT SYMP SIGNAL, P37, DOI 10.1109/ISSPIT.2012.6621257; Nath O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01254-w; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tao ZQ, 2015, CELL BIOCHEM BIOPHYS, V72, P333, DOI 10.1007/s12013-014-0459-6; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang X, 2018, ONCOL REP, V39, P2635, DOI 10.3892/or.2018.6379; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zhang H, 2018, AM SOC HEMATOLOGY; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	46	15	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217789	10.1371/journal.pone.0217789	http://dx.doi.org/10.1371/journal.pone.0217789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150511	gold, Green Published			2022-12-27	WOS:000469759100110
J	Kim, YO; Chung, CR; Gil, E; Park, CM; Suh, GY; Ryu, JA				Kim, Yong Oh; Chung, Chi Ryang; Gil, Eunmi; Park, Chi-Min; Suh, Gee Young; Ryu, Jeong-Am			Safety and feasibility of ultrasound-guided placement of peripherally inserted central catheter performed by neurointensivist in neurosurgery intensive care unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD-STREAM INFECTION; LARGE VEIN-THROMBOSIS; INTRAHOSPITAL TRANSPORT; ADVERSE EVENTS; RISK-FACTORS	We evaluated the safety and feasibility of ultrasound-guided peripherally-inserted central venous catheters (PICC) by a neurointensivist at the bedside compared to fluoroscopy-guided PICC and conventional central venous catheter (CCVC). This was a retrospective study of adult patients who underwent central line placement and were admitted to the neurosurgical intensive care unit (ICU) between January 2014 and March 2018. In this study, the primary endpoint was central line-induced complications. The secondary endpoint was initial success of central line placement. Placements of ultrasound-guided PICC and CCVC performed at the bedside if intra-hospital transport was inappropriate. Other patients underwent PICC placement at the interventional radiology suite under fluoroscopic guidance. A total of 191 patients underwent central line placement in the neurosurgery ICU during the study period. Requirement for central line infusion (56.0%) and difficult venous access (28.8%) were the most common reasons for central line placement. The basilic vein (39.3%) and the subclavian vein (35.1%) were the most common target veins among patients who underwent central line placement. The placements of ultrasound-guided PICC and CCVC at the bedside were more frequently performed in patients on mechanical ventilation (p = 0.001) and with hemodynamic instability (p < 0.001) compared to the fluoroscopy-guided PICC placement. The initial success rate of central line placement was better in the fluoroscopy-guided PICC placement than in the placements of ultrasound-guided PICC and CCVC at the bedside (p = 0.004). However, all re-inserted central lines were successful. There was no significant difference in procedure time between the three groups. However, incidence of insertional injuries was higher in CCVC group compared to PICC groups (p = 0.038). Ultrasound-guided PICC placement by a neurointensivist may be safe and feasible compared to fluoroscopy-guided PICC placement by interventional radiologists and CCVC placement for neurocritically ill patients.	[Kim, Yong Oh; Chung, Chi Ryang; Gil, Eunmi; Park, Chi-Min; Suh, Gee Young; Ryu, Jeong-Am] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Crit Care Med, Seoul, South Korea; [Gil, Eunmi; Park, Chi-Min] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea; [Ryu, Jeong-Am] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, JA (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Crit Care Med, Seoul, South Korea.; Ryu, JA (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, Seoul, South Korea.	lamyud.ryu@samsung.com						ANDREWS JC, 1992, AM J ROENTGENOL, V158, P427, DOI 10.2214/ajr.158.2.1729802; Black IH, 2000, CRIT CARE MED, V28, P3833, DOI 10.1097/00003246-200012000-00014; Chittick P, 2013, INFECT CONT HOSP EP, V34, P980, DOI 10.1086/671726; DeLemos C, 2011, CRIT CARE NURSE, V31, P70, DOI 10.4037/ccn2011911; Dillon RC, 2018, J INTENSIVE CARE MED, V33, P48, DOI 10.1177/0885066617702590; Donovan M S, 1996, J Am Board Fam Pract, V9, P235; Evans RS, 2010, CHEST, V138, P803, DOI 10.1378/chest.10-0154; Fletcher JJ, 2011, NEUROCRIT CARE, V15, P454, DOI 10.1007/s12028-011-9554-3; Griffiths Vivien R, 2002, Intensive Crit Care Nurs, V18, P37, DOI 10.1054/iccn.2002.1615; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lee DS, 2014, J ACUTE CARE SURG, V4, P13; Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001; Park KB, 2008, J VASC INTERV RADIOL, V19, P552, DOI 10.1016/j.jvir.2007.10.010; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Pittiruti M, 2012, CRIT CARE, V16, DOI 10.1186/cc11181; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Potet J, 2015, DIAGN INTERV IMAG, V96, P1147, DOI 10.1016/j.diii.2014.12.012; RYDER MA, 1993, NURS CLIN N AM, V28, P937; Ryu JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138150; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Wilson TJ, 2012, INTENS CARE MED, V38, P272, DOI 10.1007/s00134-011-2418-7	23	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217641	10.1371/journal.pone.0217641	http://dx.doi.org/10.1371/journal.pone.0217641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150465	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100079
J	Klusmann, B; Wessel, I				Klusmann, Birte; Wessel, Ineke			Manipulating the reported age in earliest memories in a Dutch community sample	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; EXPERIENCES; GENDER; TIME	Background Childhood amnesia in adults can be defined as the relative paucity of autobiographical memories from the first years of life. An earlier study by Wessel, Schweig and Huntjens demonstrated that 'how' we ask for an earliest memory may bias adults' estimations of when the earliest childhood memory actually happened. They suggested that snapshot memories (i.e., mental pictures) were less sensitive to an age manipulation than event memories (i.e. narratives). We aimed at replicating and extending these findings using a Dutch community sample stratified for age, gender and educational level. Method Participants (N = 619) were randomized into one of three experimental conditions. Prior to recalling their earliest memory, participants in the early and late conditions were presented with examples referring to memories from age 1-2 or 5-6, respectively. The example memories in the control group did not contain any age cues. Participants reported the estimated age in their earliest memory and their strategy for arriving at this estimate. They also rated their memory's phenomenology (e.g. vividness). Independent judges rated memory type (e.g., snapshot memories). Results Compared to the control group, participants in the early condition estimated the age in their memory to be significantly earlier. The difference between the late and control conditions was too small to be of interest. We did not observe a statistically significant interaction between memory type and condition. Snapshot memories were from a younger age than event memories and showed differences with respect to phenomenology (e.g., emotional intensity). Conclusion The results of this community study replicate earlier findings that instructions including age cues influence estimates of age in earliest memories. Although snapshot and event memories seem to be qualitatively different, the idea that they respond differently to an age manipulation could not be corroborated.	[Klusmann, Birte] Univ Med Ctr Groningen, Dept Hlth Psychol, Sect Hlth Sci, Groningen, Netherlands; [Wessel, Ineke] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen; University of Groningen	Klusmann, B (corresponding author), Univ Med Ctr Groningen, Dept Hlth Psychol, Sect Hlth Sci, Groningen, Netherlands.	b.klusmann@rug.nl		Klusmann, Birte/0000-0002-2859-0546; Wessel, Ineke/0000-0001-6312-376X	Department of Psychology, University of Groningen	Department of Psychology, University of Groningen	I.W. received an internal Internet Research Fund grant from the Department of Psychology, University of Groningen, for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S., 2018, FICTIONAL 1 MEMORIES; Arbuthnott KD, 2009, MEMORY, V17, P279, DOI 10.1080/09658210802665829; Bauer P. J., 2014, WILEY BLACKWELL HDB, P519; Bauer PJ, 2014, MEMORY, V22, P907, DOI 10.1080/09658211.2013.854806; Bruce D, 2005, MEM COGNITION, V33, P567, DOI 10.3758/BF03195324; Bruce D, 2007, APPL COGNITIVE PSYCH, V21, P307, DOI 10.1002/acp.1275; Centraal Bureau voor Statistiek / Central Bureau of Statistics, STAND OND, P1; Centraal Bureau voor Statistiek / Central Bureau of Statistics, 2016, BEGR PERS MET NED AC; Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5; Delacre M, 2017, INT REV SOC PSYCHOL, V30, P92, DOI 10.5334/irsp.82; FRIEDMAN WJ, 1993, PSYCHOL BULL, V113, P44, DOI 10.1037/0033-2909.113.1.44; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; George D., 2016, SPSS WINDOWS STEP ST; Greenberg DL, 2017, MEMORY, V25, P1303, DOI 10.1080/09658211.2017.1297833; Howe ML, 2013, NAT REV NEUROSCI, V14, P869, DOI 10.1038/nrn3627; Jack F, 2007, MEMORY, V15, P647, DOI 10.1080/09658210701467087; Janssen SMJ, 2006, MEM COGNITION, V34, P138, DOI 10.3758/BF03193393; KIHLSTROM JF, 1982, J PERS, V50, P134, DOI 10.1111/j.1467-6494.1982.tb01019.x; Kingo OS, 2013, PSYCHOL AGING, V28, P646, DOI 10.1037/a0031356; Kingo OS, 2013, MEMORY, V21, P280, DOI 10.1080/09658211.2012.729598; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Loftus EF, 2006, ANNU REV CLIN PSYCHO, V2, P469, DOI 10.1146/annurev.clinpsy.2.022305.095315; Luchetti M, 2016, MEMORY, V24, P592, DOI 10.1080/09658211.2015.1031679; MacDonald S, 2000, MEMORY, V8, P365, DOI 10.1080/09658210050156822; Malinoski PT, 1999, INT J CLIN EXP HYP, V47, P320, DOI 10.1080/00207149908410040; Peterson T, 2009, APPL COGNITIVE PSYCH, V23, P267, DOI 10.1002/acp.1455; Qualtrics, 2005, COMPUTER SOFTWARE; Scoboria A, 2017, MEMORY, V25, P146, DOI 10.1080/09658211.2016.1260747; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Tustin K, 2010, DEV PSYCHOL, V46, P1049, DOI 10.1037/a0020105; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wang Q, 2004, J PERS, V72, P911, DOI 10.1111/j.0022-3506.2004.00285.x; Wang Q, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02038; Wang Q, 2014, DEV PSYCHOL, V50, P1680, DOI 10.1037/a0036001; Wessel I, 2019, MEMORY, V27, P6, DOI 10.1080/09658211.2017.1396345; West TA, 1999, MEMORY, V7, P257, DOI 10.1080/096582199387913	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217436	10.1371/journal.pone.0217436	http://dx.doi.org/10.1371/journal.pone.0217436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150431	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100050
J	Lawrence, YA; Guard, BC; Steiner, JM; Suchodolski, JS; Lidbury, JA				Lawrence, Yuri A.; Guard, Blake C.; Steiner, Joerg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.			Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HEPATOCELLULAR-CARCINOMA; PROTEIN-METABOLISM; LIVER; BIOMARKERS; PLATFORM; INSULIN	Chronic hepatic disease can present a diagnostic challenge with different etiologies being associated with similar clinical and laboratory findings. The histopathological assessment of a liver biopsy specimen is usually required in order to make a definitive diagnosis and the availability of non-invasive prognostic biomarkers is limited. The emerging science of me is used to detect changes in endogenous low molecular weight metabolites in biological samples and offers the possibility of identifying noninvasive markers of disease. The objective of this study was to investigate differences in the urine metabolome between healthy dogs, dogs with chronic hepatitis, dogs with hepatocellular carcinoma, and dogs with a congenital portosystemic shunt. Stored urine samples from 10 healthy dogs, 10 dogs with chronic hepatitis, 6 dogs with hepatocellular carcinoma, and 5 dogs with a congenital portosystemic shunt were analyzed. The urine metabolome was analyzed by gas chromatography-quadrupole time of flight mass spectrometry and 220 known metabolites were identified. Principal component analysis and heat dendrogram plots of the metabolomics data showed clustering between groups. Random forest analysis showed differences in the abundance of various metabolites including putrescine, gluconic acid, sorbitol, and valine. Based on univariate statistics, 37 metabolites were significantly different between groups. In, conclusion, the urine metabolome varies between healthy dogs, dogs with chronic hepatitis, dogs with hepatocellular carcinoma, and dogs with a congenital portosystemic shunt. Further targeted assessment of these metabolites is needed to assess their diagnostic utility.	[Lawrence, Yuri A.; Guard, Blake C.; Steiner, Joerg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Lawrence, YA (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	ylawrence@cvm.tamu.edu	Lawrence, Yuri A/I-3701-2019	Lawrence, Yuri A/0000-0001-9078-2293				Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253; Center SA, 2002, AM J VET RES, V63, P1187, DOI 10.2460/ajvr.2002.63.1187; Charlton MR, 1996, BAILLIERE CLIN ENDOC, V10, P617, DOI 10.1016/S0950-351X(96)80771-3; D'Anjou MA, 2004, VET RADIOL ULTRASOUN, V45, P424, DOI 10.1111/j.1740-8261.2004.04076.x; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Dong S, 2017, WORLD J GASTROENTERO, V23, P2771, DOI 10.3748/wjg.v23.i15.2771; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gao R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18175; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gromski PS, 2015, METABOLOMICS, V11, P684, DOI 10.1007/s11306-014-0738-7; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kawaguchi T, 2009, CURR MED CHEM, V16, P4843, DOI 10.2174/092986709789909620; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Liang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep19763; Liu Y, 2014, INT J CANCER, V135, P658, DOI 10.1002/ijc.28706; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; MCCULLOUGH AJ, 1991, SEMIN LIVER DIS, V11, P265, DOI 10.1055/s-2008-1040445; MUNRO HN, 1975, LANCET, V1, P722; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; SCHAEFFER MC, 1991, LIFE SCI, V48, P2215, DOI 10.1016/0024-3205(91)90335-9; Schnackenberg LK, 2017, METABOLITES, V7, DOI 10.3390/metabo7030046; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; STEIN WH, 1954, J CLIN INVEST, V33, P410, DOI 10.1172/JCI102913; Van den Bossche L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186491; van Straten G, 2015, VET J, V204, P282, DOI 10.1016/j.tvjl.2015.04.020; Vigil A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006304; Webster CRL, 2019, J VET INTERN MED, V33, P1173, DOI 10.1111/jvim.15467; Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Zhou LN, 2012, ANAL BIOANAL CHEM, V403, P203, DOI 10.1007/s00216-012-5782-4	40	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217797	10.1371/journal.pone.0217797	http://dx.doi.org/10.1371/journal.pone.0217797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150490	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100113
J	Lee, DH; Cho, JH; Jung, JI; Baik, JM; Jun, DS; Hwang, CJ; Lee, CS				Lee, Dong-Ho; Cho, Jae Hwan; Jung, Jin Il; Baik, Jong-Min; Jun, Deuk Soo; Hwang, Chang Ju; Lee, Choon Sung			Does stopping at C7 in long posterior cervical fusion accelerate the symptomatic breakdown of cervicothoracic junction?	PLOS ONE			English	Article							SPINE; DISEASE; TRENDS; LEVEL	Object To compare the clinical and radiological outcomes between patients with long posterior cervical fusion (PCF) in which fusion stopped at C7 versus patients in which fusion crossed the cervicothoracic junction (CTJ). Methods The patients were divided into 2 groups on the basis of the lower-most instrumented vertebra (LIV); C7 group patients (n = 25) and upper thoracic (UT) group (n = 21). We analyzed the visual analogue scale of arm/neck pain, Japanese Orthopedic Association (JOA) score, and neck disability index (NDI). And we also measured the following parameters: (1) pseudomotion of fused segments; (2) C2-C7 sagittal vertical axis; (3) T1 slope; and (4) C2-C7 lordosis. Results Arm and neck pain were similar in both groups pre- and postoperatively. Interestingly, mean postoperative NDI score in the UT group was significant worse when compared with the C7 group (9.7 +/- 4.6 vs. 14.2 +/- 3.7, p = 0.006). Although UT patients had longer fusion levels, the fusion rates were not significantly different between the C7 and UT groups (96.0% vs. 90.5%; p = 0.577). The radiographic parameters did not show any significant differences between the groups at final follow-up. Conclusions Our study demonstrates that multi-level PCF stopping at C7 does not negatively affect C7-T1 segment failure, fusion rate, neck pain, neurologic outcomes, and global sagittal alignment of the cervical spine. Hence, it is unnecessary to extend the long PCF levels caudally across the healthy CTJ for fear of development of adjacent segmental disease (ASD) at the C7-T1 segment.	[Lee, Dong-Ho; Cho, Jae Hwan; Jung, Jin Il; Hwang, Chang Ju; Lee, Choon Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Baik, Jong-Min; Jun, Deuk Soo] Univ Gachon, Coll Med, Gil Med Ctr, Dept Orthoped Surg, Incheon, South Korea	University of Ulsan; Asan Medical Center; Gachon University	Baik, JM (corresponding author), Univ Gachon, Coll Med, Gil Med Ctr, Dept Orthoped Surg, Incheon, South Korea.	bbaik@hanmail.net		Baik, Jong-Min/0000-0002-6646-2449				AN HS, 1994, SPINE, V19, P2557, DOI 10.1097/00007632-199411001-00011; Boyle JJW, 1996, SPINE, V21, P544, DOI 10.1097/00007632-199603010-00003; Bydon Mohamad, 2014, Surg Neurol Int, V5, pS74, DOI 10.4103/2152-7806.130676; Carrier CS, 2013, SPINE J, V13, P1370, DOI 10.1016/j.spinee.2013.05.050; Cheng I, 2015, GLOB SPINE J, V5, P282, DOI 10.1055/s-0035-1546418; Cho SK, 2013, J AM ACAD ORTHOP SUR, V21, P3, DOI 10.5435/JAAOS-21-01-3; Daffner SD, 2002, AM J ORTHOP, V31, P3223; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Komotar Ricardo J, 2006, Spine J, V6, p252S, DOI 10.1016/j.spinee.2006.04.029; Lawrence BD, 2012, SPINE, V37, pS52, DOI 10.1097/BRS.0b013e31826d60fb; Schroeder GD, 2016, SPINE, V41, P1845, DOI 10.1097/BRS.0000000000001864; Song KS, 2014, J BONE JOINT SURG AM, V96A, P557, DOI 10.2106/JBJS.M.00167; STANESCU S, 1994, SPINE, V19, P2082, DOI 10.1097/00007632-199409150-00014; Stein BE, 2014, SPINE, V39, P1178, DOI 10.1097/BRS.0000000000000376; Truumees E, 2018, SPINE J, V18, P782, DOI 10.1016/j.spinee.2017.09.010; Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5; Wang VY, 2007, NEUROSURG CLIN N AM, V18, P365, DOI 10.1016/j.nec.2007.02.012	17	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217792	10.1371/journal.pone.0217792	http://dx.doi.org/10.1371/journal.pone.0217792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150496	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100111
J	Ray, DK; West, PC; Clark, M; Gerber, JS; Prishchepov, AV; Chatterjee, S				Ray, Deepak K.; West, Paul C.; Clark, Michael; Gerber, James S.; Prishchepov, Alexander, V; Chatterjee, Snigdhansu			Climate change has likely already affected global food production	PLOS ONE			English	Article							WHEAT YIELDS; RICE YIELDS; TEMPERATURE; MODELS; TRENDS; SCENARIOS; SECURITY; INCREASE; IMPACTS; CROPS	Crop yields are projected to decrease under future climate conditions, and recent research suggests that yields have already been impacted. However, current impacts on a diversity of crops subnationally and implications for food security remains unclear. Here, we constructed linear regression relationships using weather and reported crop data to assess the potential impact of observed climate change on the yields of the top ten global crops-barley, cassava, maize, oil palm, rapeseed, rice, sorghum, soybean, sugarcane and wheat at similar to 20,000 political units. We find that the impact of global climate change on yields of different crops from climate trends ranged from -13.4% (oil palm) to 3.5% (soybean). Our results show that impacts are mostly negative in Europe, Southern Africa and Australia but generally positive in Latin America. Impacts in Asia and Northern and Central America are mixed. This has likely led to similar to 1% average reduction (-3.5 X 10(13) kcal/year) in consumable food calories in these ten crops. In nearly half of food insecure countries, estimated caloric availability decreased. Our results suggest that climate change has already affected global food production.	[Ray, Deepak K.; West, Paul C.; Gerber, James S.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Clark, Michael] Univ Minnesota, Dept Nat Resources Sci & Management, St Paul, MN 55108 USA; [Clark, Michael] Univ Oxford, Oxford Martin Sch, Oxford, England; [Clark, Michael] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Prishchepov, Alexander, V] Univ Copenhagen, Dept Geosci & Nat Resource Management IGN, Copenhagen, Denmark; [Chatterjee, Snigdhansu] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; University of Oxford; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities	Ray, DK (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	dray@umn.edu	West, Paul C./J-1665-2015; Prishchepov, Alexander/H-6708-2012; Ray, Deepak K/F-7720-2012	West, Paul C./0000-0001-9024-1657; Prishchepov, Alexander/0000-0003-2375-1651; Chatterjee, Snigdhansu/0000-0002-7986-0470; Gerber, James/0000-0002-6890-0481; Clark, Michael/0000-0001-7161-7751; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Belmont Forum/FACCE-JPI [NE/M021327/1]; Institute on the Environment; Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP) [205212/Z/16/Z]; National Science Foundation (NSF) [DMS-1622483, DMS-1737918]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Belmont Forum/FACCE-JPI; Institute on the Environment; Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP); National Science Foundation (NSF)(National Science Foundation (NSF))	DKR, PCW and JSG were partially supported by funding from the Gordon and Betty Moore Foundation and the Belmont Forum/FACCE-JPI funded DEVIL project (NE/M021327/1), and the Institute on the Environment. MC was supported by the Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP), award number 205212/Z/16/Z. SC was partially supported by the National Science Foundation (NSF) grants DMS-1622483 and DMS-1737918. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aggarwal PK, 2002, CLIMATIC CHANGE, V52, P331, DOI 10.1023/A:1013714506779; [Anonymous], 2016, GLOBAL HUNGER INDEX; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Brown M.E., 2015, CLIMATE CHANGE GLOBA, DOI [10.7930/J0862DC7, DOI 10.7930/J0862DC7]; Butler EE, 2018, P NATL ACAD SCI USA, V115, P11935, DOI 10.1073/pnas.1808035115; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/nclimate1585, 10.1038/NCLIMATE1585]; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Deutsch CA, 2018, SCIENCE, V361, P916, DOI 10.1126/science.aat3466; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/NCLIMATE2941, 10.1038/nclimate2941]; Elliott J., 2015, GEOSCI MODEL DEV, V8, P261, DOI [10.5194/gmd-8-261-2015, DOI 10.5194/gmd-8-261-2015, DOI 10.5194/GMD-8-261-2015]; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green JK, 2019, NATURE, V565, P476, DOI 10.1038/s41586-018-0848-x; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hochman Z, 2017, GLOBAL CHANGE BIOL, V23, P2071, DOI 10.1111/gcb.13604; Kukal MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21848-2; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Liu B, 2016, NAT CLIM CHANGE, V6, P1130, DOI 10.1038/NCLIMATE3115; Lobell DB, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa518a; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Matiu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178339; Meng QF, 2014, CLIMATIC CHANGE, V122, P341, DOI 10.1007/s10584-013-1009-8; Mourtzinis S, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.26, 10.1038/nplants.2014.26]; Muller C, 2017, GEOSCI MODEL DEV, V10, P1403, DOI 10.5194/gmd-10-1403-2017; Muller D, 2016, IMPACT CLIMATE CHANG, V41; Nawrotzki RJ, 2016, POPUL ENVIRON, V38, P164, DOI 10.1007/s11111-016-0260-0; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Roshydromet, 2014, 2 ROSH ASS REP CLIM, V54; Schauberger B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13931; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Siebert S., 2017, ENVIRON RES LETT, V12, DOI 10.1088/ 1748-9326/aa702f; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Tao FL, 2017, AGR FOREST METEOROL, V239, P1, DOI 10.1016/j.agrformet.2017.02.033; Tigchelaar M, 2018, P NATL ACAD SCI USA, V115, P6644, DOI 10.1073/pnas.1718031115; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Wang E, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.102; Wiebe K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085010; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; Zampieri M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa723b; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114; Zhu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21049	50	229	232	32	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217148	10.1371/journal.pone.0217148	http://dx.doi.org/10.1371/journal.pone.0217148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150427	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100033
J	Takac, M; Collett, J; Blom, KJ; Conduit, R; Rehm, I; De Foe, A				Takac, Marcel; Collett, James; Blom, Kristopher J.; Conduit, Russell; Rehm, Imogen; De Foe, Alexander			Public speaking anxiety decreases within repeated virtual reality training sessions	PLOS ONE			English	Article							SOCIAL PHOBIA; EXPOSURE THERAPY; FEAR; DISORDERS; SYMPTOMS; STATE	Therapy for public speaking phobia using virtual reality exposure (VRE) has focused on distress arousal rather than distress habituation. Understanding habituation will help optimise session duration, making treatment more affordable and accessible. This pilot study utilised within-speech repeated measures to examine distress habituation during three brief public speaking scenarios in a non-clinical sample (n = 19; 18-76 years). VRE elicited significant distress in all three scenarios. Although within-scenario distress habituation was not observed, between-scenario habituation was partially supported. An increase in distress during the second scenario indicated that three consecutive speech performances were critical in achieving habituation. Brief repeated VRE scenarios using an agent audience were effective in eliciting public speaking distress, as well as habituation.	[Takac, Marcel; Collett, James; Conduit, Russell; Rehm, Imogen; De Foe, Alexander] RMIT Univ, Melbourne, Vic, Australia; [Blom, Kristopher J.] Virtual Human Technol, Vinohrady, Czech Republic	Royal Melbourne Institute of Technology (RMIT)	De Foe, A (corresponding author), RMIT Univ, Melbourne, Vic, Australia.	alexander.defoe@rmit.edu.au		Conduit, Russell/0000-0001-9356-6844; Rehm, Imogen/0000-0002-0053-2272				American Psychiatric Association DSMTF, 2013, DIAGNOSTIC STAT MANU; Anderson PL, 2017, COGNITIVE THER RES, V41, P230, DOI 10.1007/s10608-016-9820-y; Anderson PL, 2013, J CONSULT CLIN PSYCH, V81, P751, DOI 10.1037/a0033559; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Botella C, CYBERTHERAPY ADVANTA, P77; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Crisan LG, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00005; Finn AN, 2009, COMMUN EDUC, V58, P92, DOI 10.1080/03634520802450549; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Freeman A., 2004, CLIN APPL COGNITIVE; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; HEIMBERG RG, 1993, COGNITIVE THER RES, V17, P325, DOI 10.1007/BF01177658; Hook JN, 2008, PERS INDIV DIFFER, V44, P1306, DOI 10.1016/j.paid.2007.11.021; Keough ME, 2010, BEHAV THER, V41, P567, DOI 10.1016/j.beth.2010.04.002; Kessler RC, 1998, AM J PSYCHIAT, V155, P613, DOI 10.1176/ajp.155.5.613; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; Kozasa EH, 1998, J BEHAV THER EXP PSY, V29, P317, DOI 10.1016/S0005-7916(98)00025-1; Krijn M, 2004, CLIN PSYCHOL REV, V24, P259, DOI 10.1016/j.cpr.2004.04.001; Ling Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096144; MacIntyre VA, 2010, COMMUN RES REP, V27, P286, DOI 10.1080/08824096.2010.496323; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McCullough SC, 2006, COMMUN Q, V54, P101, DOI 10.1080/01463370500270520; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Overholser James C, 2002, J CONTEMP PSYCHOTHER, V32, P125; Owens ME, 2015, J PSYCHOPATHOL BEHAV, V37, P296, DOI 10.1007/s10862-014-9454-x; Paul G. L., 1966, INSIGHT VS DESENSITI; Ponniah K, 2008, PSYCHOL MED, V38, P3, DOI 10.1017/S0033291707000918; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Reuland E, 2010, CURR ANTHROPOL, V51, pS99, DOI 10.1086/651260; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Shcherbina A, 2017, J PERS MED, V7, DOI 10.3390/jpm7020003; Sheridan T.B., 1992, PRESENCE TELEOPERATO, V1, P120, DOI [10.1162/pres.1992.1.1.120, DOI 10.1162/PRES.1992.1.1.120]; Smith CD, 2005, COMMUN REP, V18, P31, DOI 10.1080/08934210500084206; Stein MB, 1996, ARCH GEN PSYCHIAT, V53, P169; van Minnen A, 2006, J TRAUMA STRESS, V19, P427, DOI 10.1002/jts.20146; Wallach HS, 2011, ISR J PSYCHIATR REL, V48, P91; Wallach HS, 2009, BEHAV MODIF, V33, P314, DOI 10.1177/0145445509331926; Wolpe J., 1990, PRACTICE BEHAV THERA	41	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216288	10.1371/journal.pone.0216288	http://dx.doi.org/10.1371/journal.pone.0216288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150399	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000469759100017
J	Torrie, LS; Zuccotto, F; Robinson, DA; Gray, DW; Gilbert, IH; De Rycker, M				Torrie, Leah S.; Zuccotto, Fabio; Robinson, David A.; Gray, David W.; Gilbert, Ian H.; De Rycker, Manu			Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinase	PLOS ONE			English	Article							DRUG DISCOVERY; MECHANISM	The discovery of 20 unconventional kinetochore proteins in Trypanosoma brucei has opened a new and interesting area of evolutionary research to study a biological process previously thought to be highly conserved in all eukaryotes. In addition, the discovery of novel proteins involved in a critical cellular process provides an opportunity to exploit differences between kinetoplastid and human kinetochore proteins to develop therapeutics for diseases caused by kinetoplastid parasites. Consequently, we identified two of the unconventional kinetochore proteins as key targets (the highly related kinases KKT10 and KKT19). Recombinant T. bruceiKKT19 (TbKKT19) protein was produced, a peptide substrate phosphorylated by TbKKT19 identified (KKLRRTLSVA), Michaelis constants for KKLRRTLSVA and ATP were determined (179 mu M and 102 mu M respectively) and a robust high-throughput compatible biochemical assay developed. This biochemical assay was validated pharmacologically with inhibition by staurosporine and hypothemycin (IC50 values of 288 nM and 65 nM respectively). Surprisingly, a subsequent high-throughput screen of a kinase-relevant compound library (6,624 compounds) yielded few hits (8 hits; final hit rate 0.12%). The low hit rate observed was unusual for a kinase target, particularly when screened against a compound library enriched with kinase hinge binding scaffolds. In an attempt to understand the low hit rate a TbKKT19 homology model, based on human cdc2-like kinase 1 (CLK1), was generated. Analysis of the TbKKT19 sequence and structure revealed no obvious features that could explain the low hit rates. Further work will therefore be necessary to explore this unique kinetochore kinase as well as to assess whether the few hits identified can be developed into tool molecule(s) or new drugs.	[Torrie, Leah S.; Zuccotto, Fabio; Robinson, David A.; Gray, David W.; Gilbert, Ian H.; De Rycker, Manu] Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Drug Discovery Unit, Dundee, Scotland	University of Dundee	Gilbert, IH; De Rycker, M (corresponding author), Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Drug Discovery Unit, Dundee, Scotland.	I.H.Gilbert@dundee.ac.uk; M.DeRycker@dundee.ac.uk	Gray, David W/F-6674-2011; Zuccotto, Fabio/E-7144-2017	Gray, David W/0000-0001-9512-3828; Gilbert, Ian/0000-0002-5238-1314; De Rycker, Manu/0000-0002-3171-3519; Zuccotto, Fabio/0000-0002-3888-7423	Wellcome Trust [092340, 204672]; Wellcome Centre for Anti-Infectives Research (WCAIR)	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Centre for Anti-Infectives Research (WCAIR)	This work was funded by Wellcome Trust (https://wellcome.ac.uk/) awards 092340 and 204672. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bungo Akiyoshi for provision of the TbKKT19 plasmid and helpful discussions. We also acknowledge the support of the Protein Production, Compound Management and Data Management Teams within the Wellcome Centre for Anti-Infectives Research (WCAIR).	Akiyoshi B, 2016, BIOCHEM SOC T, V44, P1201, DOI 10.1042/BST20160112; Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Alves F, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00048-18; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Buscher P, 2017, LANCET, V390, P2397, DOI 10.1016/S0140-6736(17)31510-6; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; Cleghorn LAT, 2011, CHEMMEDCHEM, V6, P2214, DOI 10.1002/cmdc.201100344; De Rycker M, 2018, NATURE, V559, P498, DOI 10.1038/s41586-018-0327-4; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kim JH, 2017, JAMA ONCOL, V3, P1001, DOI 10.1001/jamaoncol.2017.0509; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mackey ZB, 2011, CHEM BIOL DRUG DES, V78, P454, DOI 10.1111/j.1747-0285.2011.01156.x; Menegay HJ, 2000, J CELL SCI, V113, P3241; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; Monda JK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214577; Nerusheva OO, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150206; Nishino M, 2013, ELIFE, V2, DOI 10.7554/eLife.00712; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Prowse CN, 2001, J BIOL CHEM, V276, P99, DOI 10.1074/jbc.M008137200; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; van Hooff JJE, 2017, EMBO REP, V18, P1559, DOI 10.15252/embr.201744102; Woodland A, 2013, CHEMMEDCHEM, V8, P1127, DOI 10.1002/cmdc.201300072; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217828	10.1371/journal.pone.0217828	http://dx.doi.org/10.1371/journal.pone.0217828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150492	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100119
J	McGinniss, JE; Imai, I; Simon-Soro, A; Brown, MC; Knecht, VR; Frye, L; Ravindran, PM; Dothard, MI; Wadell, DA; Sohn, MB; Li, HZ; Christie, JD; Diamond, JM; Haas, AR; Lanfranco, AR; DiBardino, DM; Bushman, FD; Collman, RG				McGinniss, John E.; Imai, Ize; Simon-Soro, Aurea; Brown, Melanie C.; Knecht, Vincent R.; Frye, Laura; Ravindran, Priyanka M.; Dothard, Marisol I.; Wadell, Dylan A.; Sohn, Michael B.; Li, Hongzhe; Christie, Jason D.; Diamond, Joshua M.; Haas, Andrew R.; Lanfranco, Anthony R.; DiBardino, David M.; Bushman, Frederic D.; Collman, Ronald G.			Molecular analysis of the endobronchial stent microbial biofilm reveals bacterial communities that associate with stent material and frequent fungal constituents	PLOS ONE			English	Article							ENDOTRACHEAL-TUBE BIOFILMS; CORYNEBACTERIUM-STRIATUM; RESPIRATORY-INFECTIONS; DENTAL PLAQUE; AIRWAYS; COLONIZATION; SEQUENCES; RISK	Endobronchial stents are increasingly used to treat airway complications in multiple conditions including lung transplantation but little is known about the biofilms that form on these devices. We applied deep sequencing to profile luminal biofilms of 46 endobronchial stents removed from 20 subjects primarily with lung transplantation-associated airway compromise. Microbial communities were analyzed by bacterial 16S rRNA and fungal ITS marker gene sequencing. Corynebacterium was the most common bacterial taxa across biofilm communities. Clustering analysis revealed three bacterial biofilm types: one low diversity and dominated by Corynebacterium; another was polymicrobial and characterized by Staphylococcus; and the third was polymicrobial and associated with Pseudomonas, Streptococcus, and Prevotella. Biofilm type was significantly correlated with stent material: covered metal with the Staphylococcus-type biofilm, silicone with the Corynebacterium-dominated biofilm, and uncovered metal with the polymicrobial biofilm. Subjects with sequential stents had frequent transitions between community types. Fungal analysis found Candida was most prevalent, Aspergillus was common and highly enriched in two of three stents associated with airway anastomotic dehiscence, and fungal taxa not typically considered pathogens were highly enriched in some stents. Thus, molecular analysis revealed a complex and dynamic endobronchial stent biofilm with three bacterial types that associate with stent material, a central role for Corynebacterium, and that both expected and unexpected fungi inhabit this unique niche. The current work provides a foundation for studies to investigate the relationship between stent biofilm composition and clinical outcomes, mechanisms of biofilm establishment, and strategies for improved stent technology and use in airway compromise.	[McGinniss, John E.; Imai, Ize; Simon-Soro, Aurea; Brown, Melanie C.; Knecht, Vincent R.; Frye, Laura; Ravindran, Priyanka M.; Dothard, Marisol I.; Wadell, Dylan A.; Christie, Jason D.; Diamond, Joshua M.; Haas, Andrew R.; Lanfranco, Anthony R.; DiBardino, David M.; Collman, Ronald G.] Univ Penn, Dept Med, Perelman Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Sohn, Michael B.; Li, Hongzhe; Christie, Jason D.] Univ Penn, Dept Epidemiol Biostat & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bushman, Frederic D.; Collman, Ronald G.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Collman, RG (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA.; Bushman, FD; Collman, RG (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@pennmedicine.upenn.edu; collmanr@pennmedicine.upenn.edu	McGinniss, John/ADU-0446-2022; McGinniss, John/AAY-8886-2020; Simon-Soro, Aurea/CAF-7784-2022	McGinniss, John/0000-0002-6451-5121; McGinniss, John/0000-0002-6451-5121; Simon-Soro, Aurea/0000-0003-3656-6834; Collman, Ronald/0000-0002-0508-3701; Christie, Jason/0000-0003-0519-218X	NIH National Heart, Lung, and Blood Institute [R01-HL113252, T32-HL007586]; NIH National Institute of Allergy and Infectious Diseases [P30-AI045008]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R61HL137063, T32HL007586, R33HL137063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by RGC, FDC, JDC: NIH National Heart, Lung, and Blood Institute grant R01-HL113252; http://grantome.com/grant/NIH/R01-HL113252-04.RGC: NIH National Institute of Allergy and Infectious Diseases grant P30-AI045008; http://grantome.com/grant/NIH/P30-AI045008-20.JEM: NIH National Heart, Lung, and Blood Institute training grant T32-HL007586; http://grantome.com/grant/NIH/T32-HL007586-33.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrafiotis M, 2009, RESPIRATION, V78, P69, DOI 10.1159/000213244; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Bomar L, 2016, MBIO, V7, DOI 10.1128/mBio.01725-15; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Clarke EL, 2018, AM J RESP CRIT CARE, V197, P225, DOI 10.1164/rccm.201705-0891OC; Crespo MM, 2018, J HEART LUNG TRANSPL, V37, P548, DOI 10.1016/j.healun.2018.01.1309; Dalili D, 2015, COLLOID SURFACE B, V135, P425, DOI 10.1016/j.colsurfb.2015.07.005; Danin PE, 2015, RESP CARE, V60, P21, DOI 10.4187/respcare.02722; Davis NM, 2018, MICROBIOME, P1; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Diez-Aguilar M, 2013, EUR J CLIN MICROBIOL, V32, P769, DOI 10.1007/s10096-012-1805-5; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Grosu HB, 2013, CHEST, V144, P441, DOI 10.1378/chest.12-1721; Gweon HS, 2015, METHODS ECOL EVOL, V6, P973, DOI 10.1111/2041-210X.12399; Herth FJF, 2016, CURR OPIN PULM MED, V22, P252, DOI 10.1097/MCP.0000000000000266; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kim D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41332; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Knecht VR, 2019, INFECT CONT HOSP EP, V40, P171, DOI 10.1017/ice.2018.319; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Lee PP, 2005, J INFECTION, V50, P338, DOI 10.1016/j.jinf.2004.05.005; Lee P, 2010, CLIN CHEST MED, V31, P141, DOI 10.1016/j.ccm.2009.08.002; Lohse MB, 2018, NAT REV MICROBIOL, V16, P19, DOI 10.1038/nrmicro.2017.107; Los-Arcos I, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.00142-18, 10.1128/JCM.00142-18]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marino PJ, 2017, J CRIT CARE, V39, P149, DOI 10.1016/j.jcrc.2017.02.020; Noppen M, 1999, AM J RESP CRIT CARE, V160, P672, DOI 10.1164/ajrccm.160.2.9812081; Nouraei S A Reza, 2006, Arch Otolaryngol Head Neck Surg, V132, P1086, DOI 10.1001/archotol.132.10.1086; Ost DE, 2012, CHEST, V141, P1473, DOI 10.1378/chest.11-2005; Pan Y, 2017, EXP THER MED, V14, P1450, DOI 10.3892/etm.2017.4631; Peterson SN, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00108; Ramsey MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01230; Renom F, 2014, New Microbes New Infect, V2, P106, DOI 10.1002/nmi2.48; Renom F, 2007, J CLIN MICROBIOL, V45, P2064, DOI 10.1128/JCM.00152-07; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Sands KM, 2017, J CRIT CARE, V37, P30, DOI 10.1016/j.jcrc.2016.07.019; Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137; Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113; Zakharkina T, 2017, THORAX, V72, P803, DOI 10.1136/thoraxjnl-2016-209158	43	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217306	10.1371/journal.pone.0217306	http://dx.doi.org/10.1371/journal.pone.0217306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141557	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000049
J	Yamamoto, K				Yamamoto, Kyosuke			Distillation of crop models to learn plant physiology theories using machine learning	PLOS ONE			English	Article							IMAGE-ANALYSIS; DEEP; IDENTIFICATION	Convolutional neural networks (CNNs) can not only classify images but can also generate key features, e.g., the Google neural network that learned to identify cats by simply watching YouTube videos, for the classification. In this paper, crop models are distilled by CNN to evaluate the ability of deep learning to identify the plant physiology knowledge behind such crop models simply by learning. Due to difficulty in collecting big data on crop growth, a crop model was used to generate datasets. The generated datasets were fed into CNN for distillation of the crop model. The models trained by CNN were evaluated by the visualization of saliency maps. In this study, three saliency maps were calculated using all datasets (case 1) and using datasets with spikelet sterility due to either high temperature at anthesis (case 2) or cool summer damage (case 3). The results of case 1 indicated that CNN determined the developmental index of paddy rice, which was implemented in the crop model, simply by learning. Moreover, CNN identified the important individual environmental factors affecting the grain yield. Although CNN had no prior knowledge of spikelet sterility, cases 2 and 3 indicated that CNN realized about paddy rice becoming sensitive to daily mean and maximum temperatures during specific periods. Such deep learning approaches can be used to accelerate the understanding of crop models and make the models more portable. Moreover, the results indicated that CNN can be used to develop new plant physiology theories simply by learning.	[Yamamoto, Kyosuke] SoftBank Corp, Tokyo, Japan		Yamamoto, K (corresponding author), SoftBank Corp, Tokyo, Japan.	kyosuke.yamamoto01@g.softbank.co.jp			PS Solutions Corp; PS Solutions Corp.	PS Solutions Corp; PS Solutions Corp.	The author is an employee of PS Solutions Corp. and SoftBank Corp. This work was supported by PS Solutions Corp and SoftBank Corp. PS Solutions Corp. provided supports in the form of salaries for the author, and funding for computational resources and English corrections. SoftBank Corp. provided fundings for publication. The specific roles of the author are articulated in the "author contributions" section.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, CROPSIM; Boniecki P, 2015, COMPUT ELECTRON AGR, V110, P9, DOI 10.1016/j.compag.2014.09.013; Bouman B., 2001, ORYZA2000 MODELING L, V1; da Silva FL, 2015, COMPUT ELECTRON AGR, V114, P68, DOI 10.1016/j.compag.2015.03.012; Delerce S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161620; Ferentinos KP, 2018, COMPUT ELECTRON AGR, V145, P311, DOI 10.1016/j.compag.2018.01.009; Ghosal S, 2018, P NATL ACAD SCI USA, V115, P4613, DOI 10.1073/pnas.1716999115; Gonzalez-Sanchez A, 2014, SPANISH J AGR RES, V12; Guo W, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0047-9; Guo W, 2013, COMPUT ELECTRON AGR, V96, P58, DOI 10.1016/j.compag.2013.04.010; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Heckmann D, 2017, MOL PLANT, V10, P878, DOI 10.1016/j.molp.2017.04.009; Horie T., 03404007 MIN ED SCI; Horie T, 1995, MODELING IMPACT CLIM, P51; Huang SP, 2015, COMPUT ELECTRON AGR, V118, P167, DOI 10.1016/j.compag.2015.08.031; Ishak AJ, 2009, COMPUT ELECTRON AGR, V66, P53, DOI 10.1016/j.compag.2008.12.003; Jimenez D, 2009, COMPUT ELECTRON AGR, V69, P198, DOI 10.1016/j.compag.2009.08.008; Jones J. W., 1998, Understanding options for agricultural production., P157; JONES JW, 1991, T ASAE, V34, P663; Keating BA, 2003, EUROPEAN J AGRONOMY; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kurtulmus F, 2014, PRECIS AGRIC, V15, P57, DOI 10.1007/s11119-013-9323-8; Linker R, 2012, COMPUT ELECTRON AGR, V81, P45, DOI 10.1016/j.compag.2011.11.007; Ma JC, 2015, COMPUT ELECTRON AGR, V111, P92, DOI 10.1016/j.compag.2014.12.007; Marko O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184198; McMennamy JA, 1983, IRRI RES PAPER SERIE; Mutka AM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00734; Ohno H., 2016, CLIMATE BIOSPHERE, V16, P71, DOI 10.2480/cib.J-16-028; Rahman M, 2015, COMPUT ELECTRON AGR, V113, P14, DOI 10.1016/j.compag.2014.12.012; Rahnemoonfar M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040905; Sa I, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081222; Safa B, 2004, ARTIFICIAL NEURAL NE; Shekoofa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097288; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K., 2013, DEEP INSIDE CONVOLUT; Sladojevic S, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/3289801; Stockle CO, 2003, EUROPEAN J AGRONOMY; Su YX, 2017, SAUDI J BIOL SCI, V24, P537, DOI 10.1016/j.sjbs.2017.01.024; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Tang L, 2009, NJAS WAGENINGEN J LI; Ubbens J, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0273-z; Uehara G, 1987, P INT WORKSH IMP WEA, P271; van Diepen CA, 1989, SOIL USE MANAGEMENT; Venugoban Kanesh, 2014, International Journal of Machine Learning and Computing, V4, P1, DOI 10.7763/IJMLC.2014.V4.376; Yamamoto K., 2019, DISTILLATION CROP MO, DOI [10.5281/zenodo.2582678, DOI 10.5281/ZENODO.2582678]; Yamamoto K, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112557; Yamamoto K, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071044; Yamamoto K, 2014, SENSORS-BASEL, V14, P12191, DOI 10.3390/s140712191	50	1	1	9	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217075	10.1371/journal.pone.0217075	http://dx.doi.org/10.1371/journal.pone.0217075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141528	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000039
J	van Rensburg, C; Berhanu, R; Hirasen, K; Evans, D; Rosen, S; Long, L				van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence			Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa	PLOS ONE			English	Article								Background Drug resistant-tuberculosis is a growing burden on the South African health care budget. In response the National Department of Health implemented two important strategies in 2011; universal access to drug-sensitivity testing for rifampicin with Xpert MTB/RIF as the first-line diagnostic test for TB; and decentralization of treatment for RR/MDR-TB to improve access and reduce costs of treatment. Objective Estimate the costs by treatment outcome of decentralized care for rifampicin and multi-drug resistant tuberculosis under routine conditions. The study was set at an outpatient drug resistant-tuberculosis treatment facility at a public academic hospital in Johannesburg, South Africa. During the study period 18-24 month long course treatment was offered for rifampicin-resistant and multi-drug-resistant tuberculosis. Methods Data are from a prospective observational cohort study. Costs of treatment were estimated from the provider perspective using bottom-up micro-costing. Costs were estimated as patient-level resource use multiplied by the unit cost of the resource. Clinic visits, drugs, laboratory tests, and total days hospitalized were collected from patients' medical records. Staff time was estimated through a time and motion study. A successful treatment outcome was defined as cure or completion of the regimen. Results We enrolled 124 patients with 52% having a successful outcome. The average total cost/patient for all patients was $3,430 and $4,530 for successfully treated patients. The largest contributors to total cost across all outcomes were drugs (43%) and staff (28%). The average cost to achieve a successful outcome including all patients who started treatment ("production cost") in the cohort is $6,684. Conclusions Decentralized, outpatient RR/MDR-TB care under South Africa's 2011 strategy costs 74% less per patient than the previous strategy of inpatient care. The treatment cost of RR/MDR-TB is primarily driven by drug and staff costs, which are in turn dependant on treatment length.	[van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence] Univ Witwatersrand, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Berhanu, Rebecca; Rosen, Sydney; Long, Lawrence] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; Boston University	van Rensburg, C (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; van Rensburg, C (corresponding author), Univ Witwatersrand, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	cvanrensburg@heroza.org		Berhanu, Rebecca/0000-0002-9692-8748; van Rensburg, Craig/0000-0003-0458-3306	President's Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-674-A-12-00029, 72067419CA00004]; National Institute of Health Fogarty International Center [D43TW009340]; National Institute of Allergy and Infectious Disease [T32A1052074]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreements AID-674-A-12-00029 and 72067419CA00004 to HE2RO and LL. The contents are the responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID or the United States Government. RB received support from National Institute of Health Fogarty International Center under award number D43TW009340 and the National Institute of Allergy and Infectious Disease under award number T32A1052074.	Berhanu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164974; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Caminero J., 2013, GUIDELINES CLIN OPER, V2013; Cox H, 2015, TROP MED INT HEALTH, V20, P1337, DOI 10.1111/tmi.12544; Department of Health Republic of South Africa, 2011, S AFR NAT TUB MAN GU; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Loveday M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196003; National Department of Health Republic of South Africa, NEW BED DAT SHOWS RE; National Department of Health Republic of South Africa, 2015, INTR NEW DRUGS DRUG; National Institute for Communicable Diseases, 2017, S AFR TUB DRUG RES S; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Republic Of South Africa, 2011, MULT RES TUB POL FRA, P77; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Sinanovic E, 2015, INT J TUBERC LUNG D, V19, P172, DOI 10.5588/ijtld.14.0421; WHO, 2017, GLOB TUB REP	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217820	10.1371/journal.pone.0217820	http://dx.doi.org/10.1371/journal.pone.0217820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170207	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700061
J	Ishaq, SL; Lachman, MM; Wenner, BA; Baeza, A; Butler, M; Gates, E; Olivo, S; Geddes, JB; Hatfield, P; Yeoman, CJ				Ishaq, Suzanne L.; Lachman, Medora M.; Wenner, Benjamin A.; Baeza, Amy; Butler, Molly; Gates, Emily; Olivo, Sarah; Geddes, Julie Buono; Hatfield, Patrick; Yeoman, Carl J.			Pelleted-hay alfalfa feed increases sheep wether weight gain and rumen bacterial richness over loose-hay alfalfa feed	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTION; GASTROINTESTINAL-TRACT; CHEWING ACTIVITY; NEONATAL LAMBS; FORAGE; DIGESTIBILITY; DIGESTION; PASSAGE; FERMENTATION; PERFORMANCE	Diet composed of smaller particles can improve feed intake, digestibility, and animal growth or health, but in ruminant species can reduce rumination and buffering-the loss of which may inhibit fermentation and digestibility. However, the explicit effect of particle size on the rumen microbiota remains untested, despite their crucial role in digestion. We evaluated the effects of reduced particle size on rumen microbiota by feeding long-stem (loose) alfalfa hay compared to a ground and pelleted version of the same alfalfa in yearling sheep wethers during a two-week experimental period. In situ digestibility of the pelleted diet was greater at 48 h compared with loose hay; however, distribution of residual fecal particle sizes in sheep did not differ between the dietary treatments at any time point (day 7 or 14). Both average daily gain and feed efficiency were greater for the wethers consuming the pelleted diet. Observed bacterial richness was very low at the end of the adaptation period and increased over the course of the study, suggesting the rumen bacterial community was still in flux after two weeks of adaptation. The pelleted-hay diet group had a greater increase in bacterial richness, including common fibrolytic rumen inhabitants. The pelleted diet was positively associated with several Succiniclasticum, a Prevotella, and uncultured taxa in the Rumino-coccaceae and Rickenellaceae families and Bacteroidales order. Pelleting an alfalfa hay diet for sheep does shift the rumen microbiome, though the interplay of diet particle size, retention and gastrointestinal transit time, microbial fermentative and hydrolytic activity, and host growth or health is still largely unexplored.	[Ishaq, Suzanne L.; Olivo, Sarah] Univ Oregon, Biol & Built Environm Ctr, Eugene, OR 97403 USA; [Lachman, Medora M.; Baeza, Amy; Butler, Molly; Gates, Emily; Geddes, Julie Buono; Hatfield, Patrick; Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Wenner, Benjamin A.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	University of Oregon; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University	Yeoman, CJ (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	carl.yeoman@montana.edu	Yeoman, Carl/ABA-1906-2021; Wenner, Benjamin/AAF-9983-2020	Yeoman, Carl/0000-0002-8775-7879; Ishaq, Suzanne/0000-0002-2615-8055	Montana Agricultural Experiment Station [MONB00113]; Multistate Research Project, Enhancing the Competitiveness of U.S. Beef [W4177, MONB00195]	Montana Agricultural Experiment Station; Multistate Research Project, Enhancing the Competitiveness of U.S. Beef	This study was generously supported by the Montana Agricultural Experiment Station (project MONB00113) and is a contributing project to the Multistate Research Project, W4177, Enhancing the Competitiveness of U.S. Beef (MONB00195) to CJY.	Al-Saiady MY, 2010, ASIAN AUSTRAL J ANIM, V23, P475, DOI 10.5713/ajas.2010.90364; ALLEN MS, 1988, J NUTR, V118, P261, DOI 10.1093/jn/118.2.261; [Anonymous], 2018, ISMEANS TITLE LEAST, P5, DOI [10.1080/00031305.1980.10483031, DOI 10.1080/00031305.1980.10483031]; [Anonymous], 2019, MERCK VET MANUAL; Archer E., 2018, ESTIMATE PERMUTATION; BALISH E, 1972, INFECT IMMUN, V6, P112, DOI 10.1128/IAI.6.2.112-118.1972; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beauchemin KA, 2008, J DAIRY SCI, V91, P2077, DOI 10.3168/jds.2007-0726; Beauchemin KA, 2018, J DAIRY SCI, V101, P4762, DOI 10.3168/jds.2017-13706; BEAUCHEMIN KA, 1991, VET CLIN N AM-FOOD A, V7, P439, DOI 10.1016/S0749-0720(15)30794-5; BELYEA RL, 1989, J DAIRY SCI, V72, P958, DOI 10.3168/jds.S0022-0302(89)79189-X; BJORNDAL KA, 1990, PHYSIOL ZOOL, V63, P710, DOI 10.1086/physzool.63.4.30158172; BOMBA A, 1995, ARCH ANIM NUTR, V48, P231, DOI 10.1080/17450399509381844; BOURGET S. J., 1957, CANADIAN JOUR SOIL SCI, V37, P60; BOYD JW, 1976, J COMP PATHOL, V86, P23, DOI 10.1016/0021-9975(76)90023-2; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; COLUCCI PE, 1982, J DAIRY SCI, V65, P1445, DOI 10.3168/jds.S0022-0302(82)82367-9; Committee on Nutrient Requirements of Small Ruminants, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; Cotanch K, 2008, CORN NUTR C IT NY; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DEHORITY BA, 1961, J DAIRY SCI, V44, P2242, DOI 10.3168/jds.S0022-0302(61)90051-0; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; DOMINGUE BMF, 1990, PROC NEW ZEAL SOC AN, V50, P39; GOONERATNE SR, 1980, RES VET SCI, V28, P351, DOI 10.1016/S0034-5288(18)32722-X; Gooneratne SR, SULFUR INDUCED POLIO; GRANT RJ, 1990, J DAIRY SCI, V73, P3158, DOI 10.3168/jds.S0022-0302(90)79005-4; Hammond AC, 1997, FLOR RUM NUTR S; HELM JF, 1982, GASTROENTEROLOGY, V83, P69; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hernandez Joaquin, 2014, ScientificWorldJournal, V2014, P702572, DOI 10.1155/2014/702572; HIRONAKA R, 1979, CAN J ANIM SCI, V59, P395, DOI 10.4141/cjas79-049; Hogue DE, 1991, CORN NUTR C, P83; Huws S. A., 2014, Journal of Microbial and Biochemical Technology, V6, P080; Ishaq SL, 2017, MICROB ECOL, V73, P417, DOI 10.1007/s00248-016-0861-2; Izumi K, 2010, INT BIODETER BIODEGR, V64, P601, DOI 10.1016/j.ibiod.2010.06.013; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; JASTER EH, 1983, J DAIRY SCI, V66, P802, DOI 10.3168/jds.S0022-0302(83)81860-8; Kammes KL, 2012, J DAIRY SCI, V95, P3288, DOI 10.3168/jds.2011-5022; Karimizadeh E, 2017, ANIM NUTR, V3, P139, DOI 10.1016/j.aninu.2017.01.004; KASKE M, 1992, BRIT J NUTR, V67, P235, DOI 10.1079/BJN19920027; Keady TWJ, 2013, ANIMAL, V7, P1088, DOI 10.1017/S1751731113000104; Khalid MF, 2011, AFR J AGR RES, V6, P5198; KOCK MD, 1987, J WILDLIFE DIS, V23, P652, DOI 10.7589/0090-3558-23.4.652; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; MARTZ FA, 1986, J DAIRY SCI, V69, P1996, DOI 10.3168/jds.S0022-0302(86)80626-9; McAllister T. A., 1994, Asian-Australasian Journal of Animal Sciences, V7, P303; McClements DJ, 2012, FOOD FUNCT, V3, P202, DOI 10.1039/c1fo10193e; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mertens DR, 1997, J DAIRY SCI, V80, P1463, DOI 10.3168/jds.S0022-0302(97)76075-2; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Moreira Leonardo Marmo, 2013, Rev. bras. saúde prod. anim., V14, P382; Norouzian MA, 2014, J ANIM PHYSIOL AN N, V98, P1095, DOI 10.1111/jpn.12183; Norouzian MA, 2011, TROP ANIM HEALTH PRO, V43, P1169, DOI 10.1007/s11250-011-9819-z; Oksanen J., 2022, R PACKAGE VERSION; Oshita T, 2004, LIVEST PROD SCI, V91, P107, DOI 10.1016/j.livprodsci.2004.07.015; R Development Core Team, 2009, R LANG ENV STAT COMP; RODE LM, 1985, CAN J ANIM SCI, V65, P101, DOI 10.4141/cjas85-011; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Russell JB, 1996, J DAIRY SCI, V79, P1503, DOI 10.3168/jds.S0022-0302(96)76510-4; Sekin S, 1996, Turk Veterinerlik ve Hayvancilik Dergisi, V20, P225; SICILIANOJONES J, 1991, J DAIRY SCI, V74, P896, DOI 10.3168/jds.S0022-0302(91)78238-6; SOARES JH, 1970, J ANIM SCI, V31, P733, DOI 10.2527/jas1970.314733x; Suarez FX, 2014, PARTICLE SIZE CALF S; Tafaj M, 1999, ARCH ANIM NUTR, V52, P167, DOI 10.1080/17450399909386160; UDEN P, 1988, ANIM FEED SCI TECH, V19, P145, DOI 10.1016/0377-8401(88)90063-6; VAN DYNE G. M., 1964, J RANGE MGMT, V17, P204, DOI 10.2307/3895768; Van Soest J.P., 1994, NUTR ECOLOGY RUMINAN; Vanzant ES, 1998, J ANIM SCI, V76, P2717; Wang M, 2011, ANIM SCI J, V82, P78, DOI 10.1111/j.1740-0929.2010.00809.x; WATTIAUX MA, 1992, J ANIM SCI, V70, P1262, DOI 10.2527/1992.7041262x; WATTIAUX MA, 1992, J ANIM SCI, V70, P3597, DOI 10.2527/1992.70113597x; WELCH JG, 1982, J ANIM SCI, V54, P885, DOI 10.2527/jas1982.544885x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xu M, 2009, LIVEST SCI, V123, P34, DOI 10.1016/j.livsci.2008.10.003; Yang WZ, 2002, J DAIRY SCI, V85, P1958, DOI 10.3168/jds.S0022-0302(02)74272-0; Yansari AT, 2004, J DAIRY SCI, V87, P3912, DOI 10.3168/jds.S0022-0302(04)73530-4; Yeoman CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21440-8; Yeoman CJ, 2014, ANNU REV ANIM BIOSCI, V2, P469, DOI 10.1146/annurev-animal-022513-114149; Zali SM, 2015, RES REV J VET SCI, V1, P47	80	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0215797	10.1371/journal.pone.0215797	http://dx.doi.org/10.1371/journal.pone.0215797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166949	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800007
J	Jeong, HG; Yoon, JS; Lee, J; Bae, HJ				Jeong, Han-Gil; Yoon, Jae Sun; Lee, Juneyoung; Bae, Hee-Joon			Incidence of neutropenia in patients with ticlopidine/Ginkgo biloba extract combination drug for vascular events: A post-marketing cohort study	PLOS ONE			English	Article							OXIDATIVE STRESS; RECURRENT STROKE; MINOR STROKE; EGB 761; CLOPIDOGREL; ASPIRIN; PREVENTION; EFFICACY; TRIAL; SAFETY	Background and purpose The ticlopidine/Ginkgo biloba ext. combination drug (Yuclid) is used as an antiplatelet agent for prevention of vascular events since its approval in 2008. The purpose of this study is to explore the safety of ticlopidine/Ginkgo biloba combination, mainly regarding the incidence of neutropenia, through a post-marketing surveillance study. Methods From March 2009 to October 2015, a total of 4839 subjects had been enrolled in this study. The enrollments were conducted by 152 doctors of 89 hospitals according to the regulations for post-marketing surveillance programs in Korea. If a subject was administered the drug once, he/she was included in the safety analysis set for any adverse events and bleedings, and the primary safety evaluation regarding neutropenia was conducted in subjects who completed 3-month blood test follow-up. We predefined that 1% reduction in neutropenia incidence by ticlopidine/Ginkgo biloba ext. combination from the previously reported incidence of ticlopidine of 2.3% was clinically meaningful. Results Among the safety analysis set of 4831 patients (99.8% of the enrolled subjects), 3150 (65.1%) completed evaluation for neutropenia at 3 months which is the primary safety endpoint. The major causes of dropout were no follow-up visit at 3 months (n = 1016) and violation of the follow-up period (n = 503). Nine patients experienced neutropenia (Absolute neutrophil count [ANC] <= 1200mm(3)) and the estimated cumulative incidence at 3 months is 0.29% (95% confidence interval, 0.13%-0.54%). Severe neutropenia (ANC <= 450mm(3)) did not occur in any patients. Conclusions The incidence of neutropenia with addition of Ginkgo biloba ext. to ticlopidine may be lower than the previously reported incidence of neutropenia with ticlopidine, which needs to be confirmed in randomized controlled trials.	[Jeong, Han-Gil; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea; [Jeong, Han-Gil; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Seongnam, South Korea; [Yoon, Jae Sun; Lee, Juneyoung] Korea Univ, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University	Bae, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea.; Bae, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Seongnam, South Korea.	braindoc@snu.ac.kr		Lee, Juneyoung/0000-0001-8073-9304; Bae, Hee-Joon/0000-0003-0051-1997	YuYu Pharma, Inc., Seoul, South Korea	YuYu Pharma, Inc., Seoul, South Korea	This research was supported by YuYu Pharma, Inc., Seoul, South Korea, which collaborated in the execution of the study and collected the data. Since this study was a postmarketing surveillance study, YuYu Pharma was required to collaborate in the execution of the study and collection of the data including electronic case report system management and participating center recruitment. However, the study design, statistical analysis, preparation of the manuscript and decision to publish were performed independently by the investigators.	Ahn HS, 2007, DONGDUK PHARM RES, V11, P1; Aleil B, 2007, J THROMB HAEMOST, V5, P879, DOI 10.1111/j.1538-7836.2007.02338.x; An AR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0555-3; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; Chung JW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00044; DroyLefaix MT, 1997, AGE, V20, P141, DOI 10.1007/s11357-997-0013-1; Fukuuchi Y, 2008, CEREBROVASC DIS, V25, P40, DOI 10.1159/000111498; GENT M, 1989, LANCET, V1, P1215, DOI 10.1016/S0140-6736(89)92327-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; HARBISON JW, 1992, STROKE, V23, P1723, DOI 10.1161/01.STR.23.12.1723; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; Hong JM, 2013, THROMB RES, V131, pE147, DOI 10.1016/j.thromres.2013.01.026; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Kim BH, 2010, CLIN THER, V32, P380, DOI 10.1016/j.clinthera.2010.01.027; Kim YS, 1998, THROMB RES, V91, P33, DOI 10.1016/S0049-3848(98)00075-9; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Liu ZC, 2000, DRUG METAB DISPOS, V28, P726; Maeda A, 2011, CLIN PHARMACOL THER, V89, P229, DOI 10.1038/clpt.2010.268; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Muller C, 2000, CIRCULATION, V101, P590, DOI 10.1161/01.CIR.101.6.590; Pan YS, 2017, CIRCULATION, V135, P21, DOI 10.1161/CIRCULATIONAHA.116.024913; Rong YG, 1996, FREE RADICAL BIO MED, V20, P121, DOI 10.1016/0891-5849(95)02016-0; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Steinhubl SR, 1999, JAMA-J AM MED ASSOC, V281, P806, DOI 10.1001/jama.281.9.806; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Taniuchi M, 2001, CIRCULATION, V104, P539, DOI 10.1161/hc3001.093435; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662; WEISBERG LA, 1993, NEUROLOGY, V43, P27, DOI 10.1212/WNL.43.1_Part_1.27	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217723	10.1371/journal.pone.0217723	http://dx.doi.org/10.1371/journal.pone.0217723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166961	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800035
J	Keller, AA; Fox, J				Keller, Arturo A.; Fox, Jessica			Giving credit to reforestation for water quality benefits	PLOS ONE			English	Article							CONSERVATION PRACTICES; CARBON SEQUESTRATION; TRADING PROGRAMS; NITROGEN LOSSES; SOIL; SIMULATION; IMPACTS; MODEL; TOOL; MANAGEMENT	While there is a general belief that reforesting marginal, often unprofitable, croplands can result in water quality benefits, to date there have been very few studies that have attempted to quantify the magnitude of the reductions in nutrient (N and P) and sediment export. In order to determine the magnitude of a credit for water quality trading, there is a need to develop quantitative approaches to estimate the benefits from forest planting in terms of load reductions. Here we first evaluate the availability of marginal croplands (i.e. those with low infiltration capacity and high slopes) within a large section of the Ohio River Basin (ORB) to assess the magnitude of the land that could be reforested. Next, we employ the Nutrient Tracking Tool (NTT) to study the reduction in N, P and sediment losses from converting corn or corn/soy rotations to forested lands, first in a case study and then for a large region within the ORB. We find that after reforestation, N losses can decrease by 40 to 80 kg/ha-yr (95-97% reduction), while P losses decrease by 1 to 4 kg/ha-yr (96-99% reduction). There is a significant influence of local conditions (soils, previous crop management practices, meteorology), which can be considered with NTT and must be taken into consideration for specific projects. There is also considerable interannual and monthly variability, which highlights the need to take the longer view into account in nutrient credit considerations for water quality trading, as well as in monitoring programs. Overall, there is the potential for avoiding 60 million kg N and 2 million kg P from reaching the streams and rivers of the northern ORB as a result of conversion of marginal farmland to tree planting, which is on the order of 12% decrease for TN and 5% for TP, for the entire basin. Accounting for attenuation, this represents a significant fraction of the goal of the USEPA Gulf of Mexico Hypoxia Task Force to reduce TN and TP reaching the dead zone in the Gulf of Mexico, the second largest dead zone in the world. More broadly, the potential for targeted forest planting to reduce nutrient loading demonstrated in this study suggests further consideration of this approach for managing water quality in waterways throughout the world. The study was conducted using computational models and there is a need to evaluate the results with empirical observations.	[Keller, Arturo A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Fox, Jessica] Elect Power Res Inst, Palo Alto, CA USA	University of California System; University of California Santa Barbara; Electric Power Research Institute (EPRI)	Keller, AA (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu	Keller, Arturo A/I-9119-2016	Keller, Arturo A/0000-0002-7638-662X	Electric Power Research Institute (EPRI) [10008480]; US Department of Agriculture, Natural Resources Conservation Service [69-3A75-16-022]; U.S. Endowment for Forestry and Communities	Electric Power Research Institute (EPRI); US Department of Agriculture, Natural Resources Conservation Service(United States Department of Agriculture (USDA)); U.S. Endowment for Forestry and Communities	Funding was provided by the Electric Power Research Institute (EPRI #10008480) to AAK, by the US Department of Agriculture, Natural Resources Conservation Service (69-3A75-16-022) and by the U.S. Endowment for Forestry and Communities to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 1996, OECOLOGIA, V106, P257, DOI 10.1007/BF00328606; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Azevedo JC, 2005, FOREST SCI, V51, P321; Azevedo JC, 2005, WATER RESOUR MANAG, V19, P95, DOI 10.1007/s11269-005-1503-5; Bachelet Dominique, 2001, MC1 DYNAMIC VEGETATI; Torres AB, 2010, ECOL ECON, V69, P469, DOI 10.1016/j.ecolecon.2009.09.007; Baranzini A, 2018, J FOREST ECON, V32, P1, DOI 10.1016/j.jfe.2018.02.004; Berlekamp J, 2007, ENVIRON MODELL SOFTW, V22, P239, DOI 10.1016/j.envsoft.2005.07.021; Blanco JA, 2005, FOREST ECOL MANAG, V213, P209, DOI 10.1016/j.foreco.2005.03.042; Blanco-Canqui H, 2007, GEODERMA, V141, P355, DOI 10.1016/j.geoderma.2007.06.012; Cacho OJ, 2003, AUST J AGR RESOUR EC, V47, P153, DOI 10.1111/1467-8489.00208; Corrales J, 2017, J ENVIRON MANAGE, V196, P544, DOI 10.1016/j.jenvman.2017.03.061; Cunningham SC, 2015, PERSPECT PLANT ECOL, V17, P301, DOI 10.1016/j.ppees.2015.06.001; Delgado JA, 2008, COMPUT ELECTRON AGR, V63, P193, DOI 10.1016/j.compag.2008.02.009; Delgado JA, 2010, ADV AGRON, V105, P117, DOI 10.1016/S0065-2113(10)05004-2; EPRI, 2014, WARMF WAT MOD NUTR T; Fang F, 2005, J AM WATER RESOUR AS, V41, P645, DOI 10.1111/j.1752-1688.2005.tb03761.x; FANG F, 2003, AM AGR EC ASS ANN M; Fisher-Vanden K, 2013, J ECON PERSPECT, V27, P147, DOI 10.1257/jep.27.1.147; Fox J, EPRI OHIO RIVER BASI; Gassman P, 2009, 09TR49; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Green CH, 2008, ENVIRON MODELL SOFTW, V23, P422, DOI 10.1016/j.envsoft.2007.06.002; Gross CM, 2008, J SOIL WATER CONSERV, V63, p44A, DOI 10.2489/63.2.44A; Johnson M. V. V., 2009, International Agricultural Engineering Journal, V18, P51; Keller AA, 2000, 100 EPRI; Keller AA, 2014, ENVIRON SCI TECHNOL, V48, P6788, DOI 10.1021/es500202x; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Kiyani NF, 2008, 2008 14TH ASIA-PACIFIC CONFERENCE ON COMMUNICATIONS, (APCC), VOLS 1 AND 2, P431; Kumar S, 2012, SOIL SCI SOC AM J, V76, P1798, DOI 10.2136/sssaj2012.0055; Kumar S, 2011, AGROFOREST SYST, V83, P51, DOI 10.1007/s10457-010-9350-7; Lal H, 2009, ENVIRON SCI POLICY, V12, P1028, DOI 10.1016/j.envsci.2009.05.003; Li C., 2005, 3 INT NITR C, P893; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Lin WT, 2008, ECOL MODEL, V211, P444, DOI 10.1016/j.ecolmodel.2007.09.025; MacDonald JD, 2008, J ENVIRON ENG SCI, V7, pS127, DOI 10.1139/S08-008; Marden M, 2012, NEW ZEAL GEOGR, V68, P24, DOI 10.1111/j.1745-7939.2012.01218.x; MCDONOUGH A, 2012, J REG ANAL POLICY, V42; Moriasi DN, 2016, AGR WATER MANAGE, V177, P146, DOI 10.1016/j.agwat.2016.07.009; Motallebi M, 2017, J ENVIRON MANAGE, V193, P483, DOI 10.1016/j.jenvman.2017.02.039; NEILSON RP, 1995, ECOL APPL, V5, P362, DOI 10.2307/1942028; Nejadhashemi AP, 2007, 2007 ASAE ANN M AM S; Nishizawa E, 2003, MAR POLLUT BULL, V47, P169, DOI 10.1016/S0025-326X(02)00408-3; Olley J, 2015, HYDROL PROCESS, V29, P2290, DOI 10.1002/hyp.10369; Ouyang Y, 2015, ECOL ENG, V75, P449, DOI 10.1016/j.ecoleng.2014.11.032; Ouyang Y, 2013, ECOL ENG, V61, P394, DOI 10.1016/j.ecoleng.2013.09.057; Parton W.J., 1994, QUANTITATIVE MODELIN, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Paul KI, 2016, LAND USE POLICY, V51, P135, DOI 10.1016/j.landusepol.2015.10.027; Saleh A, 2002, ASAE PUBL, P595; Saleh A, 2011, J SOIL WATER CONSERV, V66, P400, DOI 10.2489/jswc.66.6.400; Saleh A, 2015, J SOIL WATER CONSERV, V70, P115, DOI 10.2489/jswc.70.5.115A; Santhi C, 2014, J ENVIRON QUAL, V43, P177, DOI 10.2134/jeq2011.0460; Shortle J, 2016, AGRIC RESOUR ECON RE, V45, P367, DOI 10.1017/age.2016.18; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Stephenson K, 2017, J AM WATER RESOUR AS, V53, P1178, DOI 10.1111/1752-1688.12565; Stephenson K, 2017, COAST MANAGE, V45, P24, DOI 10.1080/08920753.2017.1237240; Sui Y, 2008, T ASABE, V51, P1263, DOI 10.13031/2013.25243; TetraTech Inc, 2012, STEPL REG 5 MOD; Thacher T, 1997, AGROFOREST SYST, V35, P269, DOI 10.1007/BF00044458; Thamo T, 2017, MITIG ADAPT STRAT GL, V22, P1095, DOI 10.1007/s11027-016-9716-x; Tuppad P, 2010, APPL ENG AGRIC, V26, P779; van Kooten GC, 2000, FOREST CHRON, V76, P165, DOI 10.5558/tfc76165-1; Vanegas P, 2012, OPTIM ENG, V13, P247, DOI 10.1007/s11081-011-9138-2; Watson B., 2005, SWAT 2005 3 INT SWAT, P142; WILLIAMS JR, 1989, MODEL DOCUMENTATION, V1768; Williams JR, 2000, 0006 BRC; Williams MR, 2016, J SOIL WATER CONSERV, V71, p9A, DOI 10.2489/jswc.71.1.9A; Wu Dong, 2015, Huanjing Kexue, V36, P3825; Zammit C, 2005, ECOL MODEL, V187, P60, DOI 10.1016/j.ecolmodel.2005.01.024; Zhang B, 2004, CATENA, V57, P77, DOI 10.1016/j.catena.2003.07.001; Zhang DW, 2001, LAND ECON, V77, P443, DOI 10.2307/3147135; Zhang W, 2009, J AM WATER RESOUR AS, V45, P1009, DOI 10.1111/j.1752-1688.2009.00343.x; Zhang XM, 2010, INT J SEDIMENT RES, V25, P283, DOI 10.1016/S1001-6279(10)60045-5; Zheng Y, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004539; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	77	6	6	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217756	10.1371/journal.pone.0217756	http://dx.doi.org/10.1371/journal.pone.0217756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163057	gold, Green Submitted, Green Published			2022-12-27	WOS:000470086200032
J	Marcusson-Clavertz, D; Kjell, ONE; Persson, SD; Cardena, E				Marcusson-Clavertz, David; Kjell, Oscar N. E.; Persson, Stefan D.; Cardena, Etzel			Online validation of combined mood induction procedures	PLOS ONE			English	Article							DEMAND CHARACTERISTICS; NEGATIVE AFFECT; VELTEN; VALIDITY; RECALL; STATES; TASK	Film clips, music, and self-referential statements (termed Velten, after their originator) have been successfully used to temporarily induce sadness and happiness. However, there is little research on the effectiveness of these procedures combined, particularly in internet-based settings, and whether Velten statements contribute to alter mood beyond the effect of simple instructions to close one's eyes and enter the targeted mood. In Study 1 (N = 106) we examined the effectiveness 80 Velten statements (positive, negative, neutral-self, neutral-facts) to create brief and effective sets that might be used in future research. In Study 2 (N = 445) we examined the effect size of 8-min combined mood induction procedures, which presented video clips in the first half and music excerpts with Velten statements or closed eyes instructions in the second half. Participants answered questionnaires on social desirability, joviality, and sadness before being randomly assigned to 1 of 7 groups varying in Valence (positive, negative, neutral) and Velten (closed eyes control, self-referential Velten, and, in the case of neutral condition, factual statements). Subsequently, participants completed the joviality and sadness scales a second time. Compared to the neutral conditions, the positive mood inductions increased joviality (Hedges G = 1.35, 95% CI [1.07, 1.63]), whereas the negative mood inductions increased sadness (Hedges G = 1.28, 95% CI [1.01, 1.55]). We did not observe any significant difference between Velten and closed eyes instructions in inducing joviality or sadness, nor did we observe any significant difference between neutral Velten statements referring to self and facts. Although social desirability bias was associated with reports of greater joviality and lower sadness, it could not account for the effects of the positive and negative mood induction procedures. We conclude that these combined mood induction procedures can be used in online research to study happy and sad mood.	[Marcusson-Clavertz, David; Kjell, Oscar N. E.; Persson, Stefan D.; Cardena, Etzel] Lund Univ, Dept Psychol, Lund, Sweden; [Marcusson-Clavertz, David] Ludwig Maximilian Univ Munich, Dept Psychol, Munich, Germany	Lund University; University of Munich	Marcusson-Clavertz, D (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.; Marcusson-Clavertz, D (corresponding author), Ludwig Maximilian Univ Munich, Dept Psychol, Munich, Germany.	david.marcusson-clavertz@psy.lu.se		Cardena, Etzel/0000-0001-6775-8017; Marcusson-Clavertz, David/0000-0002-0730-9954	Swedish Research Council (Vetenskapsradet) [2016-00337]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	DMC was supported through a research grant from the Swedish Research Council (Vetenskapsradet; https://www.vr.se/english.html; project number 2016-00337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2019, WELLCOME OPEN RES, V4, P63, DOI 10.12688/wellcomeopenres.15191.1; [Anonymous], 2002, MODERN MARVELS MAGNE; Bates GW, 1999, J PSYCHOL, V133, P245, DOI 10.1080/00223989909599737; BERKOWITZ L, 1986, MOTIV EMOTION, V10, P337, DOI 10.1007/BF00992108; BLACKBURN IM, 1990, PERS INDIV DIFFER, V11, P725, DOI 10.1016/0191-8869(90)90258-S; BUCHWALD AM, 1981, J CONSULT CLIN PSYCH, V49, P478, DOI 10.1037/0022-006X.49.3.478; CLARK DM, 1983, ADV BEHAV RES THER, V5, P27, DOI 10.1016/0146-6402(83)90014-0; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Ferrer RA, 2015, EMOTION, V15, P752, DOI 10.1037/emo0000035; Fidell LS, 2007, USING MULTIVARIATE S, pXXVII; Gasper K, 2018, EMOT REV, V10, P255, DOI 10.1177/1754073918765660; Hahn D., 1994, THE LION KING; Jennings PD, 2000, MOTIV EMOTION, V24, P285, DOI 10.1023/A:1010745016868; Kalina C, MIND WANDERING SELF; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Lessard MD, 1993, THESIS; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; Martin MA, 1997, ART PSYCHOTHER, V24, P447, DOI 10.1016/S0197-4556(97)00020-8; MATHEWS A, 1983, BEHAV RES THER, V21, P233, DOI 10.1016/0005-7967(83)90204-8; MORROW J, 1990, J PERS SOC PSYCHOL, V58, P519, DOI 10.1037/0022-3514.58.3.519; Nuevo R, 2008, AN PSICOL, V24, P106; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Rottenberg J, 2007, HDB EMOTION ELICITAT, P9, DOI DOI 10.1016/J.ENCEP.2006.08.003; Scott SB, 2018, COORDINATED ANAL VAR, DOI [10.1177/1073191118799460, DOI 10.1177/1073191118799460]; SEIBERT PS, 1991, MEM COGNITION, V19, P507, DOI 10.3758/BF03199574; Slavish DC, 2018, PERS INDIV DIFFER, V123, P217, DOI 10.1016/j.paid.2017.11.023; SLYKER JP, 1991, COGNITIVE THER RES, V15, P33, DOI 10.1007/BF01172941; Stein KD, 2000, J ABNORM PSYCHOL, V109, P106, DOI 10.1037/0021-843X.109.1.106; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; TEASDALE JD, 1983, BRIT J CLIN PSYCHOL, V22, P163, DOI 10.1111/j.2044-8260.1983.tb00597.x; Terhune DB, 2016, AM J CLIN HYPN, V59, P155, DOI 10.1080/00029157.2016.1201454; Vastfjall D, 2001, MUSIC SCI, V5, P173; VELTEN E, 1968, BEHAV RES THER, V6, P473, DOI 10.1016/0005-7967(68)90028-4; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, PANAS X MANUAL POSIT, DOI DOI 10.17077/48VT-M4T2; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Zhu H-L., 2015, THESIS; Zoellner LA, 2007, J BEHAV THER EXP PSY, V38, P252, DOI 10.1016/j.jbtep.2006.06.003	42	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217848	10.1371/journal.pone.0217848	http://dx.doi.org/10.1371/journal.pone.0217848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163062	gold, Green Submitted, Green Published			2022-12-27	WOS:000470086200038
J	Nguyen, TMD; Klett, D; Filliatreau, L; Combarnous, Y				Thi Mong Diep Nguyen; Klett, Daniele; Filliatreau, Laura; Combarnous, Yves			Inhibition by fluoxetine of LH-stimulated cyclic AMP synthesis in tumor Leydig cells partly involves AMPK activation	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; PROTEIN-KINASE; ADENOSINE-MONOPHOSPHATE; ADENYLATE-CYCLASE; EXTRACELLULAR ATP; METFORMIN; MECHANISM; PHOSPHODIESTERASE; MODULATION; MEMBRANE	Fluoxetine (FLX), a widely used antidepressant primarily acting as a selective serotonin reuptake inhibitor (SSRI), has been shown to exhibit other mechanisms of action in various cell types. Consequently, it might have unexpected adverse effects not related to its intended use, possibly in the endocrine regulation of reproduction. We show in the present report that after a 1-hour preincubation of MLTC-1 Leydig cells with FLX, the intracellular cyclic adenosine monophosphate (cAMP) responses to Luteinizing Hormone (LH) and forskolin (FSK) are reduced through AMPK-dependent and -independent pathways respectively. FLX at low concentrations (12.5 mu M and 25 mu M) induced this inhibition without triggering AMPK phosphorylation, while higher FLX concentrations (50 mu M and 100 mu M) induced AMPK phosphorylation and lowered ATP concentration similarly to Metformin. Pretreatment with the specific AMPK inhibitor Compound C (CpdC), significantly diminished the inhibition of cAMP synthesis caused by high concentration of FLX. Moreover, as expected FLX also caused a decline of steroidogenesis which is under the control of cAMP. Taken together, these findings demonstrate that the inhibition of cAMP synthesis by FLX is dose-dependent and occurs in MLTC-1 cells through two mechanisms, AMPK-independent and AMPK-dependent, at low and high concentrations, respectively. FLX also inhibited hormone-induced steroidogenesis in MLTC-1 cells and mouse testicular Leydig cells, suggesting similar mechanisms in both cell types.	[Thi Mong Diep Nguyen; Klett, Daniele; Filliatreau, Laura; Combarnous, Yves] INRA, CNRS, Physiol Reprod & Comportements Nouzilly, Nouzilly, France; [Thi Mong Diep Nguyen] Quy Nhon Univ, Fac Biol Agr Engn, Quy Nhon, Vietnam	Centre National de la Recherche Scientifique (CNRS); INRAE; Quy Nhon University	Nguyen, TMD (corresponding author), INRA, CNRS, Physiol Reprod & Comportements Nouzilly, Nouzilly, France.; Nguyen, TMD (corresponding author), Quy Nhon Univ, Fac Biol Agr Engn, Quy Nhon, Vietnam.	diepdhqn@ymail.com	Nguyen, Thi Mong Diep/AAB-3939-2020; Combarnous, Yves/K-4161-2019	Nguyen, Thi Mong Diep/0000-0001-6534-9041; Combarnous, Yves/0000-0002-0574-2025; filliatreau, ghislaine/0000-0001-8789-1704	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.01-2017.307]; Institut National de Recherche Agronomique, INRA for TMDN internships in France	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Institut National de Recherche Agronomique, INRA for TMDN internships in France	This research was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.01-2017.307. This work was also supported by Institut National de Recherche Agronomique, INRA for TMDN internships in France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou HS, 2014, MOL CELL BIOL, V34, P4257, DOI 10.1128/MCB.00734-14; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bell Stewart, 2006, Ann Clin Psychiatry, V18, P19, DOI 10.1080/10401230500464612; Brambilla P, 2005, PHARMACOPSYCHIATRY, V38, P69, DOI 10.1055/s-2005-837806; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Charles E, 2017, ONCOTARGET, V8, P3181, DOI 10.18632/oncotarget.13689; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Curti C, 1999, MOL CELL BIOCHEM, V199, P103, DOI 10.1023/A:1006912010550; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; DUFAU ML, 1980, P NATL ACAD SCI-BIOL, V77, P5837, DOI 10.1073/pnas.77.10.5837; FREEMAN DA, 1981, P NATL ACAD SCI-BIOL, V78, P6309, DOI 10.1073/pnas.78.10.6309; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Green AS, 2011, CELL CYCLE, V10, P2115, DOI 10.4161/cc.10.13.16244; GUZE BH, 1994, J FAM PRACTICE, V38, P49; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Halls ML, 2017, PHARMACOL THERAPEUT, V172, P171, DOI 10.1016/j.pharmthera.2017.01.001; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Howlett HCS, 1999, DRUG SAFETY, V20, P489, DOI 10.2165/00002018-199920060-00003; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Klett D, 2016, MOL CELL ENDOCRINOL, V434, P144, DOI 10.1016/j.mce.2016.06.028; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Lai ZW, 2013, J IMMUNOL, V191, P2236, DOI 10.4049/jimmunol.1301005; Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02; Liu JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/932414; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Motlagh K.K., 2012, J PHARM BIOMED SCI, V2, P87; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; ODONNELL JM, 1993, J PHARMACOL EXP THER, V264, P1168; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; QUINN PG, 1981, ENDOCRINOLOGY, V109, P1790, DOI 10.1210/endo-109-5-1790; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Sonntag T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173013; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Svechnikov K, 2009, J APPL TOXICOL, V29, P673, DOI 10.1002/jat.1456; Tartarin P, 2012, ENDOCRINOLOGY, V153, P3468, DOI 10.1210/en.2011-1911; Theriault O, 2015, EUR J PHARMACOL, V764, P395, DOI 10.1016/j.ejphar.2015.06.053; Nguyen TMD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00025; Nguyen TMD, 2018, GEN COMP ENDOCR, V261, P23, DOI 10.1016/j.ygcen.2018.01.018; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Walker JMV, 2017, DIABETES OBES METAB, V19, P997, DOI 10.1111/dom.12912; Willoughby D, 2012, J CELL SCI, V125, P5850, DOI 10.1242/jcs.111427; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217519	10.1371/journal.pone.0217519	http://dx.doi.org/10.1371/journal.pone.0217519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163038	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200015
J	Grecucci, A; Sulpizio, S; Tommasello, E; Vespignani, F; Job, R				Grecucci, Alessandro; Sulpizio, Simone; Tommasello, Elisa; Vespignani, Francesco; Job, Remo			Seeing emotions, reading emotions: Behavioral and ERPs evidence of the regulation of pictures and words	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; NEURAL RESPONSE; REAPPRAISAL; UNPLEASANT; MODULATION; AROUSAL; PERCEPTION; ATTENTION; DYNAMICS	Background Whilst there has been extensive study of the mechanisms underlying the regulation for pictures, the ability and the mechanisms beyond the regulation of words remains to be clarified. Similarly, the effect of strategy when applying a regulatory process is still poorly explored. The present study seeks to elucidate these issues comparing the effect of regulation and of strategy to both neutral and emotional words and pictures. Methodology/Principal findings Thirty young adults applied the strategy of distancing to the emotions elicited by unpleasant and neutral pictures and words while their subjective ratings and ERPs were recorded. At a behavioral level, participants successfully regulated the arousal and the valence of both pictures and words. At a neural level, unpleasant pictures produced an increase in the late positive potential modulated during the regulate condition. Unpleasant linguistic stimuli elicited a posterior negativity as compared to neutral stimuli, but no effect of regulation on ERP was detectable. More importantly, the effect of strategy independently of stimulus type, produced a significant larger Stimulus Preceding Negativity. Dipole reconstruction localized this effect in the middle frontal areas of the brain. Conclusions As such, these new psychophysiological findings might help to understand how pictures and words can be regulated by distancing in daily life and clinical contexts, and the neural bases of the effect of strategy for which we suggest an integrative model.	[Grecucci, Alessandro; Tommasello, Elisa; Vespignani, Francesco; Job, Remo] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy; [Sulpizio, Simone] Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy	University of Trento; Vita-Salute San Raffaele University	Grecucci, A (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy.	alessandro.grecucci@unitn.it	Vespignani, Francesco/AAF-6441-2019; grecucci, alessandro/O-4609-2019; Sulpizio, Simone/AAA-7077-2019	Vespignani, Francesco/0000-0002-0474-6921; grecucci, alessandro/0000-0001-6043-2196; Sulpizio, Simone/0000-0002-4051-9494; Tommasello, Elisa/0000-0002-7140-6142				Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bradford MCJ, 1999, CATAL REV, V41, P1, DOI 10.1081/CR-100101948; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Brunia C.H.M., 2012, OXFORD HDB EVENT REL, DOI [10.1016/0013-4694(88)90132-0, DOI 10.1016/0013-4694(88)90132-0]; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Carretie L, 2008, PSYCHOPHYSIOLOGY, V45, P188, DOI 10.1111/j.1469-8986.2007.00617.x; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Crawford LE, 2002, PSYCHOL SCI, V13, P449, DOI 10.1111/1467-9280.00479; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dadomo H, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01987; Deveney CM, 2008, PSYCHOPHYSIOLOGY, V45, P435, DOI 10.1111/j.1469-8986.2007.00641.x; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Farb NAS, 2010, EMOTION, V10, P25, DOI 10.1037/a0017151; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Franken IHA, 2009, NEUROREPORT, V20, P776, DOI 10.1097/WNR.0b013e32832b02fe; Freud S., 1992, COMPLETE PSYCHOL WOR; Gan SZ, 2015, COGN NEURODYNAMICS, V9, P399, DOI 10.1007/s11571-015-9339-z; Grecucci A., 2016, ANXIETY ITS REGULATI, DOI [10.5772/65374, DOI 10.5772/65374]; Grecucci A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00985; Grecucci A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116541; Grecucci A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00523; Grecucci A, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00616; Grecucci A, 2013, CEREB CORTEX, V23, P399, DOI 10.1093/cercor/bhs028; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2011, SOC COGN AFFECT NEUR, V6, P653, DOI 10.1093/scan/nsq082; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Hinojosa JA, 2009, COGN AFFECT BEHAV NE, V9, P173, DOI 10.3758/CABN.9.2.173; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kanske P, 2011, NEUROPSYCHOLOGIA, V49, P3121, DOI 10.1016/j.neuropsychologia.2011.07.022; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kircanski K, 2012, PSYCHOL SCI, V23, P1086, DOI 10.1177/0956797612443830; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Kross E, 2017, ADV EXPT SOCIAL PSYC; Lang PJ, 2008, INT AFFECTIVE PICTUR; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moratti S, 2011, J NEUROSCI, V31, P17278, DOI 10.1523/JNEUROSCI.2917-11.2011; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Moser JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04047-3; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Paul S, 2013, BIOL PSYCHOL, V94, P136, DOI 10.1016/j.biopsycho.2013.05.019; Qi SQ, 2017, COGN AFFECT BEHAV NE, V17, P516, DOI 10.3758/s13415-016-0494-4; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Sarlo M, 2013, BIOL PSYCHOL, V94, P507, DOI 10.1016/j.biopsycho.2013.09.006; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schmeichel BJ, 2010, EMOTION, V10, P739, DOI 10.1037/a0019355; Schonfelder S, 2014, SOC COGN AFFECT NEUR, V9, P1310, DOI 10.1093/scan/nst116; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Shafir R, 2015, SOC COGN AFFECT NEUR, V10, P1329, DOI 10.1093/scan/nsv022; Speed BC, 2017, NEUROPSYCHOLOGIA, V3932, P30161; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; Yoder KJ, 2014, NEUROPSYCHOLOGIA, V60, P39, DOI 10.1016/j.neuropsychologia.2014.05.022	72	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0209461	10.1371/journal.pone.0209461	http://dx.doi.org/10.1371/journal.pone.0209461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150397	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100003
J	Klune, CB; Larkin, AE; Leung, VSY; Pang, D				Klune, Cassandra B.; Larkin, Amy E.; Leung, Vivian S. Y.; Pang, Daniel			Comparing the Rat Grimace Scale and a composite behaviour score in rats	PLOS ONE			English	Article							POSTOPERATIVE PAIN; NEUROPATHIC PAIN; POSTSURGICAL PAIN; COMMON ANALGESICS; BUPRENORPHINE; EFFICACY; KETOPROFEN; DURATION; PHARMACOKINETICS; LAPAROTOMY	There is a growing interest in the use of voluntarily displayed ongoing behaviours in laboratory animals to assess the pain experience. In rats, two behavioural pain scales, the Rat Grimace Scale (RGS, a facial expression scale) and a composite behaviour score (CBS, a behavioural ethogram reliant on postural changes), are both promising pain assessment methods. Both scales have been used to assess pain in a laparotomy model, however, they have never been compared directly and the knowledge of how different analgesics may affect these two scales is limited. This study aimed to provide a comparison to discriminate the temporal and analgesic response in a laparotomy model. Female Wistar (n = 26) and Sprague Dawley rats (n = 26) were block randomized to receive saline, meloxicam (2 mg/kg) or buprenorphine (0.05 mg/kg) 30 minutes before laparotomy. Rats were video-recorded before surgery (BL) and at 30, 150, 270, and 390 minutes post-operatively. Videos were assessed according to both scales by a trained, blinded observer. Both CBS and RGS scores increased significantly at all post surgical timepoints in the saline group. Both buprenorphine and meloxicam reduced CBS scores to baseline levels following laparotomy; however, RGS scores were only reduced following buprenorphine. RGS scores in the meloxicam group remained similar to scores of the saline group. These findings suggest that the CBS and RGS differ in their sensitivity to discriminating analgesic effects.	[Klune, Cassandra B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Larkin, Amy E.] Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK, Canada; [Leung, Vivian S. Y.; Pang, Daniel] Univ Montreal, Fac Vet Med, St Hyacinthe, PQ, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Saskatchewan; Universite de Montreal	Pang, D (corresponding author), Univ Montreal, Fac Vet Med, St Hyacinthe, PQ, Canada.	daniel.pang@umontreal.ca		Pang, Daniel/0000-0002-6420-477X	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant [424022-2013]; Fondation Levesque; NSERC Undergraduate Student Research Awards; Markin Undergraduate Student Research Program of the University of Calgary; Investigative Medicine veterinary student rotation of the Faculty of Veterinary Medicine, University of Calgary	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fondation Levesque; NSERC Undergraduate Student Research Awards(Natural Sciences and Engineering Research Council of Canada (NSERC)); Markin Undergraduate Student Research Program of the University of Calgary; Investigative Medicine veterinary student rotation of the Faculty of Veterinary Medicine, University of Calgary	This work was supported by: Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (ID: 424022-2013, http://www.nserc-crsng.gc.ca, DP), Fondation Levesque (DP), NSERC Undergraduate Student Research Awards (CK), Markin Undergraduate Student Research Program of the University of Calgary (CK), Investigative Medicine veterinary student rotation of the Faculty of Veterinary Medicine, University of Calgary (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2018, AM J VET RES, V79, P697, DOI 10.2460/ajvr.79.7.697; Andrews N, 2012, EUR J PAIN, V16, P485, DOI 10.1016/j.ejpain.2011.07.012; Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; BATESON P, 1991, ANIM BEHAV, V42, P827, DOI 10.1016/S0003-3472(05)80127-7; Bennett GJ, 2012, J PAIN, V13, P921, DOI 10.1016/j.jpain.2012.05.008; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Gades NM, 2000, CONTEMP TOP LAB ANIM, V39, P8; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Kawano T, 2016, LIFE SCI, V148, P145, DOI 10.1016/j.lfs.2016.01.046; Kawano T, 2014, J ANESTH, V28, P932, DOI 10.1007/s00540-014-1821-y; Leung V, 2016, SCI REPORTS, V6, P12, DOI [10.1038/s41598-016-0010-7, DOI 10.1038/S41598-016-0010-7]; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Monassi CR, 2003, EUR J NEUROSCI, V17, P1907, DOI 10.1046/j.1460-9568.2003.02627.x; Moody DE, 2011, DRUG ALCOHOL DEPEN, V118, P479, DOI 10.1016/j.drugalcdep.2011.03.024; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Philips BH, 2017, COMPARATIVE MED, V67, P34; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Roughan JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103362; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Schuster CJ, 2018, LAB ANIM-UK, V52, P142, DOI 10.1177/0023677217712539; Sheahan Tayler D, 2017, Neurobiol Pain, V2, P1, DOI 10.1016/j.ynpai.2017.09.001; Shientag LJ, 2016, J AM ASSOC LAB ANIM, V55, P7; Shientag LJ, 2012, J AM ASSOC LAB ANIM, V51, P832; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Tuttle AH, 2018, MOL PAIN, V14, DOI 10.1177/1744806918763658; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; Waite ME, 2015, J AM ASSOC LAB ANIM, V54, P420; Zhang EQ, 2019, J AM ASSOC LAB ANIM, V58, P178, DOI [10.30802/AALAS-JAALAS-18-000044, 10.30802/aalas-jaalas-18-000044]	36	15	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0209467	10.1371/journal.pone.0209467	http://dx.doi.org/10.1371/journal.pone.0209467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150408	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100004
J	Masih, J; Belschak, F; Verbeke, JMIW				Masih, Jolly; Belschak, Frank; Verbeke, J. M. I. Willem			Mood configurations and their relationship to immune system responses: Exploring the relationship between moods, immune system responses, thyroid hormones, and social support	PLOS ONE			English	Article							DEPRESSION; STRESS; ANXIETY; INFLAMMATION; LONELINESS; CYTOKINES; PATHOPHYSIOLOGY; EMOTIONS; IL-6	Analyzing data on 2,057 healthy subjects in the Dutch Lifelines database we explore the relationship between immune system responses, thyroid hormone functioning and people's mood that is expected to be moderated by social support. We focus (1) on the innate immune system cell count: monocytes, eosinophil granulocytes, basophilic granulocytes, neutrophil granulocytes; and thrombocytes; and (2) on the adaptive immune system cell count: lymphocytes (T, B and NK cells). Moods were measured on the positive (PA) and negative (NA) dimensions of the PANAS scale, divided in four groups based on their PA and NA median scores: hedonic, positive mood, negative mood and anhedonic. We focus further on (3) thyroid cells: T3 and T4; and (4) on social support. We found significant differences between mood groups and mean cell counts for basophilic granulocytes and thrombocytes but not for monocytes, eosinophil granulocytes and neutrophil granulocytes in the innate immune system. However, in the adaptive immune system we found mean lymphocyte cell counts to be different in all four mood groups. We also found that T3 and T4 levels differ significantly across all mood groups and work in very close association with lymphocytes to activate the adaptive immune system. These differences were most significant in the hedonic and anhedonic groups. The findings allow us to better understand mood groups, especially the hedonic and anhedonic groups, and open up new avenues for intervention.	[Masih, Jolly; Verbeke, J. M. I. Willem] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [Belschak, Frank] Univ Amsterdam, Sch Econ, Amsterdam, Netherlands	Erasmus University Rotterdam; University of Amsterdam	Verbeke, JMIW (corresponding author), Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands.	verbeke@ese.eur.nl						Ashby F. G., 2002, EMOTIONAL COGNITION, V44, P245, DOI DOI 10.1075/AICR.44.11ASH; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P433, DOI 10.1017/CBO9780511546396.019; Bise S, 2011, PREVALENCE CARDIOVAS, V1; Botella-Carretero JI, 2005, EUR J ENDOCRINOL, V153, P223, DOI 10.1530/eje.1.01951; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; CARTON S, 1995, J AFFECT DISORDERS, V34, P219, DOI 10.1016/0165-0327(95)00020-N; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Colic L, 2018, EUROPEAN NEUROPSYCHO; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; COUTELIER JP, 1990, J CLIN IMMUNOL, V10, P204, DOI 10.1007/BF00918653; COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; D'Acquisto F, 2017, DIALOGUES CLIN NEURO, V19, P9; De Vito P, 2011, THYROID, V21, P879, DOI 10.1089/thy.2010.0429; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Elenkov IJ, 2015, NEUROIMMUNOMODULAT, V12, P255; Futterman AD, 1994, PSYCHOSOMATIC MED; Gaspersz R, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0016-3; GLASER R, 1985, J BEHAV MED, V8, P249, DOI 10.1007/BF00870312; Gray EK, 2001, EMOTIONS WORK THEORY, P21; Gurok MG, 2018, PSYCHIAT CLIN PSYCH, P1; Heffner KL, 2014, ANN ALLERG ASTHMA IM, V113, P13, DOI 10.1016/j.anai.2014.03.008; Hendrick V, 1998, PSYCHIAT CLIN N AM, V21, P277, DOI 10.1016/S0193-953X(05)70005-8; Hyttel J, 1994, INT CLIN PSYCHOPHARM; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; KNAPP PH, 1992, PSYCHOSOM MED, V54, P133, DOI 10.1097/00006842-199203000-00002; Kostanjsak Lidija, 2017, Alcoholism and Psychiatry Research, V53, P33, DOI 10.20471/apr.2017.53.01.04; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lasselin J, 2016, CURR OPIN PHARMACOL, V29, P34, DOI 10.1016/j.coph.2016.05.003; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Liu Y, 2012, INT J RHEUM DIS, V15, P183, DOI 10.1111/j.1756-185X.2011.01673.x; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Mao RZ, 2018, J AFFECT DISORDERS, V237, P65, DOI 10.1016/j.jad.2018.04.115; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Marsland AL, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P761; Mihailova S, 2016, J NEUROIMMUNOL, V293, P123, DOI 10.1016/j.jneuroim.2016.03.005; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nieboer A, 2005, SOC INDIC RES, V73, P313, DOI 10.1007/s11205-004-0988-2; Nummenmaa L, 2018, BRIT J PHARM, V1; Park JE, 2005, J KOREAN MED SCI, V20, P215, DOI 10.3346/jkms.2005.20.2.215; Pini S, 2014, EUR NEUROPSYCHOPHARM, V24, pS477, DOI 10.1016/S0924-977X(14)70764-3; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; Russell JA, 2009, COGNITION EMOTION, V23, P1259, DOI 10.1080/02699930902809375; Segerstrom S. C., 2010, EUROPEAN HLTH PSYCHO, V12, P36; Segerstrom SC, 2000, ANN BEHAV MED, V22, P180, DOI 10.1007/BF02895112; SOLOMON WR, 1984, J ALLERGY CLIN IMMUN, V74, P449, DOI 10.1016/0091-6749(84)90376-2; Steibliene V, 2012, IMMUNOLOGY, V123, P584, DOI [10.1111/j.1365-2567.2007.02731.x, DOI 10.1111/J.1365-2567.2007.02731.X]; Tor P. C., 2007, SMJ Singapore Medical Journal, V48, P354; Troisi A, 2011, SOC NEUROSCI-UK, V6, P88, DOI 10.1080/17470919.2010.482786; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; van den Briel T, 2000, AM J CLIN NUTR, V72, P1179; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wawrzyniak AJ, 2011, JPN PSYCHOL RES, V53, P121, DOI 10.1111/j.1468-5884.2011.00466.x; Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962; Zachariae R, 2001, ALLERGY, V56, P734, DOI 10.1034/j.1398-9995.2001.056008734.x	60	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216232	10.1371/journal.pone.0216232	http://dx.doi.org/10.1371/journal.pone.0216232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150403	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100015
J	Royall, DR; Palmer, RF; Pavlik, V; Massman, P; Darby, E; Rodriguear, M; Ansari, AK; DeToledo, JC; Reddy, H; Wilms, H; Johnson, K; Perez, V; Fairchild, T; Knebl, J; O'Bryant, SE; Hall, JR; Johnson, L; Barber, RC; Mains, D; Alvarez, L; Cullum, M; Rosenberg, R; Williams, B; Quiceno, M; Reisch, J; Hynan, LS; Huebinger, R; Smith, J; Nguyen, T; Royall, D; Palmer, R; Polk, M; Stevens, A; Ory, M; Paydarfar, D; Bertelson, J; Woon, M; Ayres, G; Aguirre, A; Wilhelmsen, KC; Tilson, JL				Royall, Donald R.; Palmer, Raymond F.; Pavlik, Valory; Massman, Paul; Darby, Eveleen; Rodriguear, Monica; Ansari, Aisha Khaleeq; DeToledo, John C.; Reddy, Hemachandra; Wilms, Henrick; Johnson, Kim; Perez, Victoria; Fairchild, Thomas; Knebl, Janice; O'Bryant, Sid E.; Hall, James R.; Johnson, Leigh; Barber, Robert C.; Mains, Douglas; Alvarez, Lisa; Cullum, Munro; Rosenberg, Roger; Williams, Benjamin; Quiceno, Mary; Reisch, Joan; Hynan, Linda S.; Huebinger, Ryan; Smith, Janet; Trung Nguyen; Royall, Donald; Palmer, Raymond; Polk, Marsha; Stevens, Alan; Ory, Marcia; Paydarfar, David; Bertelson, John; Woon, Martin; Ayres, Gayle; Aguirre, Alyssa; Wilhelmsen, Kirk C.; Tilson, Jeffrey L.		ADNI; TARCC	Selection for depression-specific dementia cases with replication in two cohorts	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INSTRUMENTAL ACTIVITIES; MISSING DATA; VALIDATION; MILD; ASSOCIATION; PHENOTYPE; DIAGNOSIS; SCALES; STATE	The latent variable "delta" (for "dementia") provides an etiologically "agnostic" omnibus dementia severity metric capable of recognizing the dementing potential of any condition. Depressive symptoms are independent predictors of delta and are thereby implicated as "dementing". Serum resistin levels partially mediate the association between depressive symptoms and delta. We use a novel "off-diagonal" CHI SQ algorithm to demonstrate our ability to select individuals demented solely by depression's effect in both the Texas Alzheimer's Research and Care Consortium (TARCC) (N congruent to 3,500), and the Alzheimer's Disease Neuroimaging Initiative (ADNI (N congruent to 1,750), and demonstrate the higher resistin levels of such cases in TARCC. This approach can be adapted to any delta-related dementia risk factor or biomarker and used identify individuals who might revert back to non-demented states after its successful treatment.	[Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA; [Pavlik, Valory; Massman, Paul; Darby, Eveleen; Rodriguear, Monica; Ansari, Aisha Khaleeq] Baylor Coll Med, Houston, TX 77030 USA; [DeToledo, John C.; Reddy, Hemachandra; Wilms, Henrick; Johnson, Kim; Perez, Victoria] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79409 USA; [Fairchild, Thomas; Knebl, Janice; O'Bryant, Sid E.; Hall, James R.; Johnson, Leigh; Barber, Robert C.; Mains, Douglas; Alvarez, Lisa] Univ North Texas, Hlth Sci Ctr, Denton, TX 76203 USA; [Cullum, Munro; Rosenberg, Roger; Williams, Benjamin; Quiceno, Mary; Reisch, Joan; Hynan, Linda S.; Huebinger, Ryan; Smith, Janet; Trung Nguyen] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Royall, Donald; Palmer, Raymond; Polk, Marsha] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Stevens, Alan; Ory, Marcia] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; [Paydarfar, David; Bertelson, John; Woon, Martin; Ayres, Gayle; Aguirre, Alyssa] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Wilhelmsen, Kirk C.; Tilson, Jeffrey L.] Univ N Carolina, Chapel Hill, NC 27515 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; Baylor College of Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill	Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA.	royall@uthscsa.edu		Royall, Donald/0000-0001-6475-0300	Blue Skies of Texas comprehensive care retirement community (CCRC) through Alzheimer's Care and Research Center Foundation (Freedom House); Darrell K Royal Texas Alzheimer's Initiative; USAMRAA [11551963]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]	Blue Skies of Texas comprehensive care retirement community (CCRC) through Alzheimer's Care and Research Center Foundation (Freedom House); Darrell K Royal Texas Alzheimer's Initiative; USAMRAA; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense)	This analysis was funded by the Blue Skies of Texas comprehensive care retirement community (CCRC) through a grant from the Alzheimer's Care and Research Center Foundation (Freedom House). This project was supported in part by funding provided to the Texas Alzheimer's Research and Care Consortium by the Darrell K Royal Texas Alzheimer's Initiative, directed by the Texas Council on Alzheimer's Disease and Related Disorders. Dr. Royall is funded by USAMRAA GRANT11551963 to construct delta homologs for use in traumatic brain injury. Dr. Palmer has disclosed his co-invention of delta, its homologs and orthologs to UTHSCSA. Dr. Palmer is also funded by USAMRAA GRANT11551963. Some data used in preparation of this article were obtained from the ADNI database (adni.loni.usc.edu). ADNI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, ADNI investigators contributed to the design and implementation of ADNI and/or provided data. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Andrews SJ, 2019, ALZHEIMER DIS ASS DI; Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; Bishnoi RJ, 2015, J ALZHEIMERS DIS, V43, P37, DOI 10.3233/JAD-140042; Bollen K. A., 1993, TESTING STRUCTURAL E; Brendel M, 2018, J ALZHEIMERS DIS, V65, P793, DOI 10.3233/JAD-170387; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; BURKE WJ, 1989, J AM GERIATR SOC, V37, P856, DOI 10.1111/j.1532-5415.1989.tb02266.x; Degenhardt EK, 2016, PSYCHOSOMATICS, V57, P208, DOI 10.1016/j.psym.2015.12.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; Gavett BE, 2015, NEUROPSYCHOLOGY, V29, P344, DOI 10.1037/neu0000128; Goodglass H., 1983, BOSTON NAMING TEST; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Huang AR, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1726; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ismail Z, 2017, JAMA PSYCHIAT, V74, P58, DOI 10.1001/jamapsychiatry.2016.3162; John SE, 2016, NEUROPSYCHOLOGY, V30, P946, DOI 10.1037/neu0000315; Juva K, 1997, AGE AGEING, V26, P393, DOI 10.1093/ageing/26.5.393; Kizilarslanoglu MC, 2015, TURK J MED SCI, V45, P1040, DOI 10.3906/sag-1403-55; Koppara A, 2016, J ALZHEIMERS DIS, V49, P547, DOI 10.3233/JAD-150257; Landau SM, 2016, NEUROLOGY, V86, P1377, DOI 10.1212/WNL.0000000000002576; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAIXNER SM, 1995, AM J GERIAT PSYCHIAT, V3, P60, DOI 10.1097/00019442-199524310-00008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; O'Bryant SE, 2013, J ALZHEIMERS DIS, V34, P841, DOI 10.3233/JAD-122074; Palmer RF, 2016, J ALZHEIMERS DIS, V49, P521, DOI 10.3233/JAD-150254; Peh CX, 2017, J ALZHEIMERS DIS, V55, P823, DOI 10.3233/JAD-160575; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royall DR, 2019, J ALZHEIMERS DIS, V67, P67, DOI 10.3233/JAD-171053; Royall DR, 2018, J NEUROPSYCH CLIN N, V30, P202, DOI 10.1176/appi.neuropsych.17060110; Royall DR, 2017, J GERONTOL B-PSYCHOL, V72, P947, DOI 10.1093/geronb/gbw004; Royall DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175790; Royall Donald R, 2017, Alzheimers Dement (Amst), V6, P214, DOI 10.1016/j.dadm.2017.02.002; Royall DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172268; Royall DR, 2016, AGING-US, V8, P3241, DOI 10.18632/aging.101091; Royall Donald R, 2016, Alzheimers Dement (Amst), V3, P35, DOI 10.1016/j.dadm.2016.02.003; Royall DR, 2016, J ALZHEIMERS DIS, V49, P571, DOI 10.3233/JAD-150250; Royall DR, 2015, NEUROPSYCHOLOGY, V29, P683, DOI 10.1037/neu0000153; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Royall DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00369; Royall DR, 2013, ALZHEIMERS DEMENT, V9, P318, DOI 10.1016/j.jalz.2011.11.009; Royall DR, 2012, J ALZHEIMERS DIS, V30, P639, DOI 10.3233/JAD-2012-120055; Royall DR, 2018, ALZHEIMERS DEMENT, V14, pP649; Royall DR, 2016, J PREV ALZ DIS, V3, P283; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Teng E, 2010, DEMENT GERIATR COGN, V30, P189, DOI 10.1159/000313540; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P730, DOI 10.1016/j.jalz.2015.05.007; Wheaton B, 1977, SOCIOLOGY METHODOLOG; White LR, 2016, NEUROLOGY, V86, P1000, DOI 10.1212/WNL.0000000000002480; Witte MM, 2014, J NEUROPSYCH CLIN N, V26, P214, DOI 10.1176/appi.neuropsych.12120402	61	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216413	10.1371/journal.pone.0216413	http://dx.doi.org/10.1371/journal.pone.0216413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150419	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100020
J	Sellars, M; Clayton, JM; Detering, KM; Tong, A; Power, D; Morton, RL				Sellars, Marcus; Clayton, Josephine M.; Detering, Karen M.; Tong, Allison; Power, David; Morton, Rachael L.			Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis	PLOS ONE			English	Article							RENAL-DISEASE; DIALYSIS; DIRECTIVES; INTERVENTION; WITHDRAWAL; PATIENT; DEATH	Background Economic evaluations of advance care planning (ACP) in people with chronic kidney disease are scarce. However, past studies suggest ACP may reduce healthcare costs in other settings. We aimed to examine hospital costs and outcomes of a nurse-led ACP intervention compared with usual care in the last 12 months of life for older people with end-stage kidney disease managed with haemodialysis. Methods We simulated the natural history of decedents on dialysis, using hospital data, and modelled the effect of nurse-led ACP on end-of-life care. Outcomes were assessed in terms of patients' end-of-life treatment preferences being met or not, and costs included all hospitalbased care. Model inputs were obtained from a prospective ACP cohort study among dialysis patients; renal registries and the published literature. Cost-effectiveness of ACP was assessed by calculating an incremental cost-effectiveness ratio (ICER), expressed in dollars per additional case of end-of-life preferences being met. Robustness of model results was tested through sensitivity analyses. Results The mean cost of ACP was AUD$ 519 per patient. The mean hospital costs of care in last 12 months of life were $ 100,579 for those who received ACP versus $ 87,282 for those who did not. The proportion of patients in the model who received end-of-life care according to their preferences was higher in the ACP group compared with usual care (68% vs. 24%). The incremental cost per additional case of end-of-life preferences being met was $ 28,421. The greatest influence on the cost-effectiveness of ACP was the probability of dying in hospital following dialysis withdrawal, and costs of acute care. Conclusion Our model suggests nurse-led ACP leads to receipt of patient preferences for end-of-life care, but at an increased cost.	[Sellars, Marcus; Clayton, Josephine M.] Univ Sydney, Fac Med, Northern Clin Sch, Kolling Inst, Sydney, NSW, Australia; [Sellars, Marcus; Detering, Karen M.] Advance Care Planning Australia, Austin Hlth, Melbourne, Vic, Australia; [Clayton, Josephine M.] Greenwich Hosp, HammondCare Ctr Learning & Res Palliat Care, Sydney, NSW, Australia; [Detering, Karen M.] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic, Australia; [Tong, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Tong, Allison] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia; [Power, David] Austin Hlth, Dept Nephrol, Melbourne, Vic, Australia; [Morton, Rachael L.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Sydney	Sellars, M (corresponding author), Univ Sydney, Fac Med, Northern Clin Sch, Kolling Inst, Sydney, NSW, Australia.; Sellars, M (corresponding author), Advance Care Planning Australia, Austin Hlth, Melbourne, Vic, Australia.	marcus.sellars@austin.org.au	Morton, Rachael L/AAB-7420-2020	Morton, Rachael L/0000-0001-7834-0572; Clayton, Josephine/0000-0002-9856-5434; Tong, Allison/0000-0001-8973-9538; Sellars, Marcus/0000-0002-8299-0313	University of Sydney Postgraduate Award; Ramsay Health Care Foundation Top-Up Scholarship; Australian National Health and Medical Research Council Fellowship [1054216]; National Health and Medical Research Council Fellowship [1106716]	University of Sydney Postgraduate Award(University of Sydney); Ramsay Health Care Foundation Top-Up Scholarship; Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MS is supported by a University of Sydney Postgraduate Award and the Ramsay Health Care Foundation Top-Up Scholarship. RM is supported by an Australian National Health and Medical Research Council Fellowship (1054216). AT is supported by a National Health and Medical Research Council Fellowship (1106716). The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.	Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1023, DOI 10.2215/CJN.01050306; Davison SN, 2006, BRIT MED J, V333, P886, DOI 10.1136/bmj.38965.626250.55; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Dixon J, 2015, PALLIATIVE MED, V29, P869, DOI 10.1177/0269216315586659; Elliott BA, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4010017; Feely MA, 2016, CLIN J AM SOC NEPHRO, V11, P2204, DOI 10.2215/CJN.12131115; Findlay MD, 2016, NEPHROL DIAL TRANSPL, V31, P2041, DOI 10.1093/ndt/gfw074; Goff SL, 2015, CLIN J AM SOC NEPHRO, V10, P390, DOI 10.2215/CJN.07490714; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Houben CHM, 2014, J AM MED DIR ASSOC, V15, P477, DOI 10.1016/j.jamda.2014.01.008; Husereau Don, 2013, Cost Eff Resour Alloc, V11, P6, DOI 10.1186/1478-7547-11-6; Kirchhoff KT, 2012, J AM GERIATR SOC, V60, P946, DOI 10.1111/j.1532-5415.2012.03917.x; Klingler C, 2016, PALLIATIVE MED, V30, P423, DOI 10.1177/0269216315601346; Luckett T, 2014, AM J KIDNEY DIS, V63, P761, DOI 10.1053/j.ajkd.2013.12.007; McDonald S., ANZDATA REGISTRY REP; Morton RL, 2016, CLIN J AM SOC NEPHRO, V11, P2195, DOI 10.2215/CJN.11861115; Morton RL, 2016, CLIN J AM SOC NEPHRO; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; PETITTI DB, 2000, METAANALYSIS DECISIO; Sellars M, 2019, NEPHROLOGY, V24, P148, DOI 10.1111/nep.13230; Sellars M, 2018, AM J KIDNEY DIS, V71, P216, DOI 10.1053/j.ajkd.2017.07.021; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Song MK, 2017, PALLIATIVE MED, V31, P267, DOI 10.1177/0269216316652012; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sudore RL, 2018, J PAIN SYMPTOM MANAG, V55, P245, DOI 10.1016/j.jpainsymman.2017.08.025; Sudore RL, 2017, J PAIN SYMPTOM MANAG, V53, P821, DOI 10.1016/j.jpainsymman.2016.12.331; SWARTZ RD, 1993, J AM SOC NEPHROL, V3, P1623; Tamura MK, 2017, CLIN J AM SOC NEPHRO, V12, P435, DOI 10.2215/CJN.07510716; Weisbord SD, 2003, NEPHROL DIAL TRANSPL, V18, P1345, DOI 10.1093/ndt/gfg105; Wetmore JB, 2018, AM J KIDNEY DIS, V71, P831, DOI 10.1053/j.ajkd.2017.10.025	31	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217787	10.1371/journal.pone.0217787	http://dx.doi.org/10.1371/journal.pone.0217787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150504	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100108
J	Zhang, BB; Yang, J; Qin, ZF; Li, SS; Xu, JJ; Yao, ZH; Zhang, XJ; Gonzalez, FJ; Yao, XS				Zhang, Beibei; Yang, Jing; Qin, Zifei; Li, Shishi; Xu, Jinjin; Yao, Zhihong; Zhang, Xiaojian; Gonzalez, Frank J.; Yao, Xinsheng			Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BLOOD-BRAIN-BARRIER; REDUCED GLUCURONIDATION; CURCUMIN ANALOGS; IN-VITRO; IDENTIFICATION; METABOLITES; EXPRESSION; ENZYMES; MRP2	Demethoxycurcumin (DMC) is a safe and natural food-coloring additive, as well as an agent with several therapeutic properties. However, extensive glucuronidation in vivo has resulted in its poor bioavailability. In this study, we aimed to investigate the formation of DMC-O-glucuronides by uridine 5'-diphospho-glucuronosyltransferase 1A1 (UGT1A1) and its transport by breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in HeLa cells stably transfected with UGT1A1 (named HeLa1A1 cells). The chemical inhibitors Ko143 (a selective BCRP inhibitor) and MK571 (a pan-MRP inhibitor) both induced an obvious decrease in the excretion rate of DMC-O-glucuronides and a significant increase in intracellular DMC-O-glucuronide concentrations. Furthermore, BCRP knockdown resulted in a marked reduction in the level of excreted DMC-O-glucuronides (maximal 55.6%), whereas MRP1 and MRP4 silencing significantly decreased the levels of excreted DMC-O-glucuronides (a maximum of 42.9% for MRP1 and a maximum of 29.9% for MRP3), respectively. In contrast, neither the levels of excreted DMC-O-glucuronides nor the accumulation of DMC-O-glucuronides were significantly altered in the MRP4 knock-down HeLa cells. The BCRP, MRP1 and MRP3 transporters were identified as the most important contributors to the excretion of DMC-O-glucuronides. These results may significantly contribute to improving our understanding of mechanisms underlying the cellular disposition of DMC via UGT-mediated metabolism.	[Zhang, Beibei; Yang, Jing; Qin, Zifei; Zhang, Xiaojian] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Qin, Zifei; Li, Shishi; Xu, Jinjin; Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Zhengzhou University; Jinan University; Jinan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Qin, ZF (corresponding author), Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.; Qin, ZF; Yao, ZH (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China.; Yao, ZH (corresponding author), Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China.	qzf1989@163.com; yaozhihong_jnu@163.com	Yao, Zhihong/GQB-4386-2022	Yao, Zhihong/0000-0001-6946-2367; Qin, Zifei/0000-0001-8989-1986	National Major Scientific and Program of Introducing Talents of Discipline to Universities [B13038]; National Natural Science Foundation of China [81630097]; National Natural Science Foundation of Guangdong Province [2018A030310639, 2017A03031387]; Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University [YNQN2017200]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Major Scientific and Program of Introducing Talents of Discipline to Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Major Scientific and Program of Introducing Talents of Discipline to Universities (B13038) to XY, State Key Program of National Natural Science Foundation of China (81630097) to XY, National Natural Science Foundation of Guangdong Province (2017A03031387) to ZY, National Natural Science Foundation of Guangdong Province (2018A030310639) to ZQ and Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University (YNQN2017200) to BZ.; This study was supported by grants from the National Major Scientific and Program of Introducing Talents of Discipline to Universities (B13038), State Key Program of National Natural Science Foundation of China (81630097), National Natural Science Foundation of Guangdong Province (2017A03031387), National Natural Science Foundation of Guangdong Province (2018A030310639) and Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University (YNQN2017200).	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; Ahmad N, 2016, DRUG DELIV, V23, P2095, DOI 10.3109/10717544.2014.941076; Ahmed T, 2014, PHYTOTHER RES, V28, P517, DOI 10.1002/ptr.5030; Allen JD, 2002, MOL CANCER THER, V1, P417; Ampasavate C, 2010, PHYTOMEDICINE, V17, P506, DOI 10.1016/j.phymed.2009.09.004; Ansari M, 2012, PHARMACOGENOMICS J, V12, P386, DOI 10.1038/tpj.2011.17; Arshad L, 2017, FUTURE MED CHEM, V9, P605, DOI 10.4155/fmc-2016-0223; Asai A, 2000, LIFE SCI, V67, P2785, DOI 10.1016/S0024-3205(00)00868-7; Bamba Y, 2011, J NAT MED-TOKYO, V65, P583, DOI 10.1007/s11418-011-0507-0; Burapan S, 2017, J AGR FOOD CHEM, V65, P3306, DOI 10.1021/acs.jafc.7b00943; Cao Y, 2014, J CHROMATOGR B, V949, P70, DOI 10.1016/j.jchromb.2013.12.039; Dinkova-Kostova AT, 1999, CARCINOGENESIS, V20, P911, DOI 10.1093/carcin/20.5.911; Fahrmayr C, 2012, BRIT J PHARMACOL, V165, P1836, DOI 10.1111/j.1476-5381.2011.01672.x; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Ge SF, 2016, PHARM RES-DORDR, V33, P590, DOI 10.1007/s11095-015-1812-1; Hoehle SI, 2007, MOL NUTR FOOD RES, V51, P932, DOI 10.1002/mnfr.200600283; HOLDER GM, 1978, XENOBIOTICA, V8, P761, DOI 10.3109/00498257809069589; Hong XD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091983; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Jiang W, 2012, DRUG METAB DISPOS, V40, P336, DOI 10.1124/dmd.111.041467; Karibe T, 2018, DRUG METAB DISPOS, V46, P667, DOI 10.1124/dmd.117.078931; Kaur M, 2017, BRAIN RES, V1654, P9, DOI 10.1016/j.brainres.2016.10.020; Kocher A, 2015, J FUNCT FOODS, V14, P183, DOI 10.1016/j.jff.2015.01.045; Krishnakumar IM, 2015, J FUNCT FOODS, V14, P215, DOI 10.1016/j.jff.2015.01.049; Lee CA, 2015, DRUG METAB DISPOS, V43, P490, DOI 10.1124/dmd.114.062174; Li R, 2011, FOOD CHEM, V126, P1890, DOI 10.1016/j.foodchem.2010.12.014; Li SS, 2018, CHEM-BIOL INTERACT, V296, P45, DOI 10.1016/j.cbi.2018.09.001; Lin EPY, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.18.00043; Liu YQ, 2018, J PHARMACEUT BIOMED, V154, P31, DOI 10.1016/j.jpba.2018.03.014; Lu XY, 2015, MOL NUTR FOOD RES, V59, P634, DOI 10.1002/mnfr.201400493; Lv X, 2015, DRUG METAB PHARMACOK, V30, P358, DOI 10.1016/j.dmpk.2015.07.001; Maruo Y, 2003, CLIN GENET, V64, P420, DOI 10.1034/j.1399-0004.2003.00136.x; Qin ZF, 2018, FOOD FUNCT, V9, P1410, DOI 10.1039/c7fo01298e; Quan EX, 2015, DRUG METAB DISPOS, V43, P433, DOI 10.1124/dmd.114.061598; Schwabedissen HEUMZ, 2005, AM J PATHOL, V166, P39, DOI 10.1016/S0002-9440(10)62230-4; Sun H, 2015, J AGR FOOD CHEM, V63, P6001, DOI 10.1021/acs.jafc.5b00983; Teymouri M, 2018, J CELL PHYSIOL, V233, P124, DOI 10.1002/jcp.25749; Verma MK, 2013, DARU, V21, DOI 10.1186/2008-2231-21-11; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Vulsteke C, 2013, ANN ONCOL, V24, P1513, DOI 10.1093/annonc/mdt008; Wang L, 2018, XENOBIOTICA, V48, P357, DOI 10.1080/00498254.2017.1323139; Wang MF, 2016, MOL NUTR FOOD RES, V60, P1967, DOI 10.1002/mnfr.201500321; Wang XX, 2015, TOXICOL APPL PHARM, V289, P70, DOI 10.1016/j.taap.2015.09.003; Wu BJ, 2012, J PHARM SCI-US, V101, P381, DOI 10.1002/jps.22738; Xin H, 2015, J PHARM PHARMACOL, V67, P1673, DOI 10.1111/jphp.12483; Yang J, 2018, BIOFACTORS, V44, P558, DOI 10.1002/biof.1452; Zeng YC, 2007, DRUG METAB DISPOS, V35, P1564, DOI 10.1124/dmd.107.015008; Zhang XW, 2015, MOL PHARMACEUT, V12, P1268, DOI 10.1021/mp5008019; ZHANG Y, 2016, OXID MED CELL LONGEV, V16, DOI DOI 10.1155/2016/9045736	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217695	10.1371/journal.pone.0217695	http://dx.doi.org/10.1371/journal.pone.0217695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150474	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100090
J	Fu, X; Jia, TX; Zhang, XQ; Li, SL; Zhang, YL				Fu, Xiao; Jia, Tianxia; Zhang, Xueqi; Li, Shanlin; Zhang, Yonglin			Do street-level scene perceptions affect housing prices in Chinese megacities? An analysis using open access datasets and deep learning	PLOS ONE			English	Article							BUILT ENVIRONMENT; HEDONIC ANALYSIS; URBAN LANDSCAPE; VIEW; GREENERY; TREES; NEIGHBORHOODS; HEALTH; SKY; GUANGZHOU	Many studies have explored the relationship between housing prices and environmental characteristics using the hedonic price model (HPM). However, few studies have deeply examined the impact of scene perception near residential units on housing prices. This article used house purchasing records from FANacom and open access geolocation data (including massive street view pictures, point of interest (POI) data and road network data) and proposed a framework named "open-access-dataset-based hedonic price modeling (OADB-HPM)" for comprehensive analysis in Beijing and Shanghai, China. A state-of-the-art deep learning framework and massive Baidu street view panoramas were employed to visualize and quantify three major scene perception characteristics (greenery, sky and building view indexes, abbreviated GVI, SVI and BVI, respectively) at the street level. Then, the newly introduced scene perception characteristics were combined with other traditional characteristics in the HPM to calculate marginal prices, and the results for Beijing and Shanghai were explored and compared. The empirical results showed that the greenery and sky perceptual elements at the property level can significantly increase the housing price in Beijing (RMB 39,377 and 6011, respectively) and Shanghai (RMB 21,689 and 2763, respectively), indicating an objectively higher willingness by buyers to pay for houses that provide the ability to perceive natural elements in the surrounding environment. This study developed quantification tools to help decision makers and planners understand and analyze the interaction between residents and urban scene components.	[Fu, Xiao; Jia, Tianxia; Zhang, Xueqi; Zhang, Yonglin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Jia, Tianxia; Zhang, Xueqi; Zhang, Yonglin] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Li, Shanlin] Chinese Acad Sci, Natl Sci Lib, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Science Library, CAS	Zhang, YL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.; Zhang, YL (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.	ylzhang_rcees@foxmail.com		Zhang, Yonglin/0000-0001-5432-8800	National Key Research and Development Program of China [2016YFC0503605]	National Key Research and Development Program of China	All authors were funded by The National Key Research and Development Program of China (2016YFC0503605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair A, 2000, HOUSING STUD, V15, P699, DOI 10.1080/02673030050134565; [Anonymous], ICAL EC, V82, P34, DOI [10.1086/260169, DOI 10.1086/260169]; Asgarzadeh M, 2014, LANDSCAPE URBAN PLAN, V131, P36, DOI 10.1016/j.landurbplan.2014.07.011; Asgarzadeh M, 2012, LANDSCAPE URBAN PLAN, V107, P1, DOI 10.1016/j.landurbplan.2012.04.001; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bae C., 2003, TRANSPORT POLICY, V10, P85, DOI [10.1016/S0967-070X(02)00048-3, DOI 10.1016/S0967-070X(02)00048-3, 10.1016/s0967-070x(02)00048-3]; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Chen WY, 2008, CITIES, V25, P298, DOI 10.1016/j.cities.2008.06.002; Chen WY, 2018, GEOGR J, V184, P283, DOI 10.1111/geoj.12246; Chen WY, 2010, GEOGR J, V176, P227, DOI 10.1111/j.1475-4959.2010.00358.x; Cheng L, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6090265; Dong RC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071367; Dubey A, 2016, LECT NOTES COMPUT SC, V9905, P196, DOI 10.1007/978-3-319-46448-0_12; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Gebru T, 2017, P NATL ACAD SCI USA, V114, P13108, DOI 10.1073/pnas.1700035114; Gong FY, 2018, BUILD ENVIRON, V134, P155, DOI 10.1016/j.buildenv.2018.02.042; Gubbels JS, 2016, HEALTH PLACE, V40, P153, DOI 10.1016/j.healthplace.2016.06.002; HANEY WG, 1978, HUM ECOL, V6, P201, DOI 10.1007/BF00889095; He L, 2017, COMPUT ENVIRON URBAN, V66, P83, DOI 10.1016/j.compenvurbsys.2017.08.001; Hu TY, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020151; Hui ECM, 2007, BUILD ENVIRON, V42, P2333, DOI 10.1016/j.buildenv.2006.05.004; Jackson LE, 2003, LANDSCAPE URBAN PLAN, V64, P191, DOI 10.1016/S0169-2046(02)00230-X; Jim CY, 2007, GEOFORUM, V38, P414, DOI 10.1016/j.geoforum.2006.10.002; Jim CY, 2006, LANDSCAPE URBAN PLAN, V78, P422, DOI 10.1016/j.landurbplan.2005.12.003; Jim CY, 2009, LANDSCAPE URBAN PLAN, V91, P226, DOI 10.1016/j.landurbplan.2009.01.009; Joo Y, 2015, URBAN FOR URBAN GREE, V14, P1088, DOI 10.1016/j.ufug.2015.10.001; Klemm W, 2015, LANDSCAPE URBAN PLAN, V138, P87, DOI 10.1016/j.landurbplan.2015.02.009; Kong FH, 2006, LANDSCAPE URBAN PLAN, V78, P147, DOI 10.1016/j.landurbplan.2005.07.006; Lansford NH, 1995, J AGR RESOUR ECON, V20, P341; Li XJ, 2018, T GIS, V22, P1029, DOI 10.1111/tgis.12472; Li XJ, 2018, LANDSCAPE URBAN PLAN, V169, P81, DOI 10.1016/j.landurbplan.2017.08.011; Li XJ, 2016, URBAN FOR URBAN GREE, V18, P163, DOI 10.1016/j.ufug.2016.06.002; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P675, DOI 10.1016/j.ufug.2015.06.006; Liang JM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050411; Liu L, 2017, COMPUT ENVIRON URBAN, V65, P113, DOI 10.1016/j.compenvurbsys.2017.06.003; Liu RQ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061161; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Long Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171110; Lu Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081576; Lu Y, 2018, SOC SCI MED, V208, P41, DOI 10.1016/j.socscimed.2018.05.022; Luttik J, 2000, LANDSCAPE URBAN PLAN, V48, P161, DOI 10.1016/S0169-2046(00)00039-6; Lynch K., 1960, IMAGEN CITY; Mahan BL, 2000, LAND ECON, V76, P100, DOI 10.2307/3147260; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Mansfield C, 2005, J FOREST ECON, V11, P177, DOI 10.1016/j.jfe.2005.08.002; Tse RYC, 2002, URBAN STUD, V39, P1165, DOI 10.1080/00420980220135545; Tyrvainen L, 1997, LANDSCAPE URBAN PLAN, V37, P211, DOI 10.1016/S0169-2046(97)80005-9; Tyrvainen L, 2000, J ENVIRON ECON MANAG, V39, P205, DOI 10.1006/jeem.1999.1097; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Wen HZ, 2017, CITIES, V66, P72, DOI 10.1016/j.cities.2017.03.008; Wen HZ, 2014, HABITAT INT, V42, P155, DOI 10.1016/j.habitatint.2013.12.004; Wolf KL, 2005, J FOREST, V103, P396; Wu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164553; Xiao YX, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6110358; Yin L, 2015, APPL GEOGR, V63, P337, DOI 10.1016/j.apgeog.2015.07.010; Zeng LY, 2018, BUILD ENVIRON, V135, P74, DOI 10.1016/j.buildenv.2018.03.009; Zhang F, 2018, LANDSCAPE URBAN PLAN, V180, P148, DOI 10.1016/j.landurbplan.2018.08.020; Zhang F, 2018, COMPUT ENVIRON URBAN, V71, P153, DOI 10.1016/j.compenvurbsys.2018.05.005; Zhang YL, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7030104; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhao JZ, 2016, INT J SUST DEV WORLD, V23, P293, DOI 10.1080/13504509.2015.1119215; Zhou BL, 2019, INT J COMPUT VISION, V127, P302, DOI 10.1007/s11263-018-1140-0	62	29	30	10	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217505	10.1371/journal.pone.0217505	http://dx.doi.org/10.1371/journal.pone.0217505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145767	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500019
J	Meischl, T; Rasoul-Rockenschaub, S; Gyori, G; Sieghart, W; Reiberger, T; Trauner, M; Soliman, T; Berlakovich, G; Pinter, M				Meischl, Tobias; Rasoul-Rockenschaub, Susanne; Gyoeri, Georg; Sieghart, Wolfgang; Reiberger, Thomas; Trauner, Michael; Soliman, Thomas; Berlakovich, Gabriela; Pinter, Matthias			C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; GLASGOW PROGNOSTIC SCORE; POOR-PROGNOSIS; SURVIVAL; IMPACT; INFLAMMATION; BIOMARKER; CRITERIA	Background Serum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurrence of hepatocellular carcinoma (HCC) in patients treated with resection or non-surgical treatment. Here, we investigated the association of elevated CRP (>= 1 vs. < 1 mg/dL) with (i) recurrence of HCC and (ii) OS after liver transplantation (LT). Methods Adult HCC patients undergoing orthotopic deceased donor LT at the Medical University of Vienna between 1997 and 2014 were retrospectively analysed. Results Among 216 patients included, 132 (61.1%) were transplanted within the Milan criteria and forty-two patients (19.4%) had microvascular invasion on explant histology. Seventy patients (32.4%) showed elevated CRP (>= 1 mg/dL). On multivariate analysis, a CRP >= 1 mg/dL was an independent risk factor for HCC recurrence with a 5-year recurrence rate of 27.4% vs. 16.4% (HR 2.33; 95% CI 1.13-4.83; p = 0.022). OS was similar in patients with normal vs. elevated CRP levels. Conclusions Elevated serum CRP is associated with HCC recurrence after LT and may be a marker for more aggressive tumor biology. Future studies should evaluate whether patients with elevated pre-transplant CRP levels benefit from closer monitoring for HCC recurrence.	[Meischl, Tobias; Sieghart, Wolfgang; Reiberger, Thomas; Trauner, Michael; Pinter, Matthias] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Meischl, Tobias; Sieghart, Wolfgang; Pinter, Matthias] Med Univ Vienna, Liver Canc HCC Study Grp Vienna, Vienna, Austria; [Rasoul-Rockenschaub, Susanne; Gyoeri, Georg; Soliman, Thomas; Berlakovich, Gabriela] Med Univ Vienna, Dept Surg, Div Transplantat, Vienna, Austria; [Reiberger, Thomas] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Pinter, M (corresponding author), Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Pinter, M (corresponding author), Med Univ Vienna, Liver Canc HCC Study Grp Vienna, Vienna, Austria.	matthias.pinter@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019	Reiberger, Thomas/0000-0002-4590-3583; Meischl, Tobias/0000-0002-1716-9166; Trauner, Michael/0000-0002-1275-6425; Gyoeri, Georg/0000-0002-0863-2876				An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; Befeler AS, 2005, GASTROENTEROLOGY, V128, P1752, DOI 10.1053/j.gastro.2005.03.033; Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Fan WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119312; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Galle PR, 2018, J HEPATOLOGY; Graziadei I, 2016, WIEN KLIN WOCHENSCHR, V128, P679, DOI 10.1007/s00508-016-1046-1; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Howell JA, 2017, ONCOTARGET, V8, P36161, DOI 10.18632/oncotarget.15322; Hung HC, 2017, J HEPATO-BIL-PAN SCI, V24, P559, DOI 10.1002/jhbp.498; Imai N, 2013, CLIN TRANSL ONCOL, V15, P575, DOI 10.1007/s12094-012-0976-y; Ji F, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2189-1; Kim YK, 2015, TRANSPL P, V47, P686, DOI 10.1016/j.transproceed.2014.11.048; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Li MX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002133; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lue A, 2017, ONCOTARGET, V8, P103077, DOI 10.18632/oncotarget.21528; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2011, LIVER TRANSPLANT, V17, pS44, DOI 10.1002/lt.22365; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Mori S, 2014, HEPATO-GASTROENTEROL, V61, P2353, DOI 10.5754/hge13322; Na GH, 2014, WORLD J GASTROENTERO, V20, P6594, DOI 10.3748/wjg.v20.i21.6594; Nakanishi H, 2016, LIVER CANCER, V5, P257, DOI 10.1159/000449337; O'Dowd C, 2010, J THORAC ONCOL, V5, P988, DOI 10.1097/JTO.0b013e3181da78f9; Okamura Y, 2016, BRIT J SURG, V103, P891, DOI 10.1002/bjs.10123; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PENN I, 1991, SURGERY, V110, P726; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Polterauer S, 2010, INT J GYNECOL CANCER, V20, P1052, DOI 10.1111/IGC.0b013e3181e64bb1; Qi XS, 2016, ONCOTARGET, V7, P45283, DOI 10.18632/oncotarget.9942; Raj A, 2011, J HEPATOL, V55, P1063, DOI 10.1016/j.jhep.2011.01.052; Rebonato A, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/4164130; Shiba H, 2017, ONCOL LETT, V14, P293, DOI 10.3892/ol.2017.6104; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Sprinzl MF, 2018, LIVER CANCER, P1; Wang YJ, 2018, INT J SURG, V55, P73, DOI 10.1016/j.ijsu.2018.05.022; Xiao GQ, 2013, WORLD J GASTROENTERO, V19, P8398, DOI 10.3748/wjg.v19.i45.8398; Xiao W-K, 2014, BMC CANCER, P14, DOI [10.18632/oncotarget.9942, DOI 10.18632/ONCOTARGET.9942]; Yao FY, 2008, AM J TRANSPLANT, V8, P1982, DOI 10.1111/j.1600-6143.2008.02351.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216677	10.1371/journal.pone.0216677	http://dx.doi.org/10.1371/journal.pone.0216677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141535	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000018
J	Bleckmann, M; Schurig, M; Endres, M; Samuels, K; Gebauer, I; Konisch, N; van den Heuvel, J				Bleckmann, Maren; Schuerig, Margitta; Endres, Michelle; Samuels, Anke; Gebauer, Daniela; Konisch, Nadine; van den Heuvel, Joop			Identifying parameters to improve the reproducibility of transient gene expression in High Five cells	PLOS ONE			English	Article							INSECT CELLS; PROTEIN-PRODUCTION; BACULOVIRUS; TRANSFECTION; POLYETHYLENIMINE; VERSATILE; VECTORS; SF9; STABILITY; DELIVERY	Virus-free, transient gene expression (TGE) in High Five cells was recently presented as an efficient protein production method. However, published TGE protocols have not been standardized to a general protocol. Therefore, reproducibility and implementation of the method in other labs remains difficult. The aim of this study is to analyse the parameters determining the reproducibility of the TGE in insect cells. Here, we identified that using linear 40 kDa PEI instead of 25 kDa PEI was one of the most important aspects to improve TGE. Furthermore, DNA amount, DNA:PEI ratio, growth phase of the cells before transfection, passage number, the origin of the High-Five cell isolates and the type of cultivation medium were considered. Interestingly, a correlation of the passage number to the DNA content of single cells (ploidy) and to the transfection efficacy could be shown. The optimal conditions for critical parameters were used to establish a robust TGE method. Finally, we compared the achieved product yields in High Five cells using our improved TGE method with both the baculoviral expression system and TGE in the mammalian HEK293-6E cell line. In conclusion, the presented robust TGE protocol in High Five cells is easy to establish and produces ample amounts of high-quality recombinant protein, bridging the gap in expression level of this method to the well-established mammalian TGE in HEK293 cells as well as to the baculoviral expression vector system (BEVS).	[Bleckmann, Maren; Endres, Michelle] Rudolf Virchow Ctr, Dept Recombinant Prot Express Facil, Wurzburg, Bavaria, Germany; [Schuerig, Margitta; Samuels, Anke; Gebauer, Daniela; Konisch, Nadine; van den Heuvel, Joop] Helmholtz Ctr Infect Res, Dept Recombinant Prot Express, Braunschweig, Lower Saxony, Germany; [Bleckmann, Maren] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Dept Biotechnol, Braunschweig, Lower Saxony, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Bleckmann, M (corresponding author), Rudolf Virchow Ctr, Dept Recombinant Prot Express Facil, Wurzburg, Bavaria, Germany.; van den Heuvel, J (corresponding author), Helmholtz Ctr Infect Res, Dept Recombinant Prot Express, Braunschweig, Lower Saxony, Germany.; Bleckmann, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Dept Biotechnol, Braunschweig, Lower Saxony, Germany.	m.bleckmann@tu-bs.de; joop.vandenheuvel@helmholtz-hzi.de		Schubert, Maren/0000-0002-7041-9056; van den Heuvel, Joop/0000-0001-5085-4010	Protein Sample Production Facility (PSPF) of the Helmholtz Centre for Infection Research (HZI) in Braunschweig; HZI-Graduate School; Rudolf-Virchow-Centre	Protein Sample Production Facility (PSPF) of the Helmholtz Centre for Infection Research (HZI) in Braunschweig; HZI-Graduate School; Rudolf-Virchow-Centre	This work was supported by the Protein Sample Production Facility (PSPF) of the Helmholtz Centre for Infection Research (HZI) in Braunschweig. We also thank the HZI-Graduate School for supporting Margitta Schurig. In addition, we would like to thank the Rudolf-Virchow-Centre for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Aumiller JJ, 2012, GLYCOBIOLOGY, V22, P417, DOI 10.1093/glycob/cwr160; Backliwal G, 2008, BIOTECHNOL BIOENG, V99, P721, DOI 10.1002/bit.21596; Bleckmann M, 2016, BIOTECHNOL BIOENG, V113, P1975, DOI 10.1002/bit.25956; Bleckmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149424; Bleckmann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132898; Chambers A.C., 2018, CURR PROTOC PROTEIN, V91, DOI DOI 10.1042/BA20090130; Delafosse L, 2016, DATA BRIEF, V8, P456, DOI 10.1016/j.dib.2016.05.062; Delafosse L, 2016, J BIOTECHNOL, V227, P103, DOI 10.1016/j.jbiotec.2016.04.028; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Feshchenko E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-77; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g; Gabrielson NP, 2006, BIOMACROMOLECULES, V7, P2427, DOI 10.1021/bm060300u; Hitchman RB, 2010, BIOTECHNOL APPL BIOC, V56, P85, DOI 10.1042/BA20090130; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Jarman-Smith RF, 2002, BIOTECHNOL PROGR, V18, P623, DOI 10.1021/bp020028+; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Jorio H, 2006, BIOTECHNOL PROGR, V22, P319, DOI 10.1021/bp050218v; Kadlecova Z, 2012, MACROMOL BIOSCI, V12, P628, DOI 10.1002/mabi.201100404; Karste K, 2017, METHODS MOL BIOL, V1586, P313, DOI 10.1007/978-1-4939-6887-9_20; KURODA K, 1986, EMBO J, V5, P1359, DOI 10.1002/j.1460-2075.1986.tb04367.x; Lin CH, 2013, J BIOTECHNOL, V165, P11, DOI 10.1016/j.jbiotec.2013.02.007; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Lu HY, 2012, BIOENGINEERED, V3, P271, DOI 10.4161/bioe.20679; Lyons JA, 2016, CURR OPIN STRUC BIOL, V38, P137, DOI 10.1016/j.sbi.2016.06.011; Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]; Meyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068674; Monteiro F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00391; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Osz-Papai J, 2015, METHODS MOL BIOL, V1258, P181, DOI 10.1007/978-1-4939-2205-5_10; Palmberger D, 2013, BIOENGINEERED, V4, P78, DOI 10.4161/bioe.22327; Peixoto C, 2007, J BIOTECHNOL, V127, P452, DOI 10.1016/j.jbiotec.2006.08.002; Pelosse M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0447-6; Pijlman GP, 2004, BIOTECHNOL BIOENG, V87, P743, DOI 10.1002/bit.20178; Pijlman GP, 2003, J GEN VIROL, V84, P2669, DOI 10.1099/vir.0.19438-0; Puente-Massaguer E, 2018, APPL MICROBIOL BIOT, V102, P10495, DOI 10.1007/s00253-018-9423-5; Radner S, 2012, J STRUCT BIOL, V179, P46, DOI 10.1016/j.jsb.2012.04.013; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Scholz J, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0400-3; Shen X, 2015, J BIOTECHNOL, V216, P67, DOI 10.1016/j.jbiotec.2015.10.007; Shen X, 2014, J BIOTECHNOL, V171, P61, DOI 10.1016/j.jbiotec.2013.11.018; Stacey G, 1996, CYTOTECHNOLOGY, V20, P299, DOI 10.1007/BF00350409; Steele KH, 2017, BIOTECHNOL PROGR, V33, P1496, DOI 10.1002/btpr.2516; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Thompson CM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0152-x; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; ZHAO Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P434, DOI 10.1006/abbi.1993.1372	51	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217878	10.1371/journal.pone.0217878	http://dx.doi.org/10.1371/journal.pone.0217878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170233	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700076
J	Chaillon, A; Mehta, SR; Hoenigl, M; Solomon, SS; Vickerman, P; Hickman, M; Skaathun, B; Martin, NK				Chaillon, Antoine; Mehta, Sanjay R.; Hoenigl, Martin; Solomon, Sunil S.; Vickerman, Peter; Hickman, Matthew; Skaathun, Britt; Martin, Natasha K.			Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NATIONAL ASSOCIATION; CONSENSUS STATEMENT; INJECT DRUGS; TASK-FORCE; INFECTION; PART; EPIDEMIOLOGY; TRANSMISSION; POPULATION	Background HCV direct-acting antivirals (DAAs) are produced in India at low cost. However, concerns surrounding reinfection and budgetary impact limit treatment scale-up in India. We evaluate the cost-effectiveness and budgetary impact of HCV treatment in India, including reinfection. Methods A closed cohort Markov model of HCV disease progression, treatment, and reinfection was parameterized. We compared treatment by fibrosis stage (F2-F4 or FO-F4) to no treatment from a health care payer perspective. Costs (2017 USD$, based on India-specific data) and health utilities (in quality-adjusted life years, QALYs) were attached to each health state. We assumed DAAs with 90% sustained viral response at $900/treatment and 1%/year reinfection, varied in the sensitivity analysis from 0.1-15%. We deemed the intervention cost-effective if the incremental cost-effectiveness ratio (ICER) fell below India's per capita GDP ($1,709). We assessed the budgetary impact of treating all diagnosed individuals. Results HCV treatment for diagnosed F2-F4 individuals was cost-saving (net costs-$2,881 and net QALYs 3.18/person treated; negative ICER) compared to no treatment. HCV treatment remained cost-saving with reinfection rates of 15%/year. Treating all diagnosed individuals was likely cost-effective compared to delay until F2 (mean ICER $1,586/QALY gained, 67% of simulations falling under the $1,709 threshold) with 1%/year reinfection. For all scenarios, annual retesting for reinfection was more cost-effective than the current policy (one-time retest). Treating all diagnosed individuals and reinfections results in net costs of $445-1,334 million over 5 years (<0.25% of total health care expenditure over 5 years), and cost savings within 14 years. Conclusions HCV treatment was highly cost-effective in India, despite reinfection. Annual retesting for reinfection was cost-effective, supporting a policy change towards more frequent retesting. A comprehensive HCV treatment scale-up plan is warranted in India.	[Chaillon, Antoine; Mehta, Sanjay R.; Hoenigl, Martin; Skaathun, Britt; Martin, Natasha K.] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Mehta, Sanjay R.] San Diego Vet Affairs Med Ctr, Dept Med, La Jolla, CA USA; [Hoenigl, Martin] Med Univ Graz, Dept Med, Graz, Austria; [Solomon, Sunil S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Vickerman, Peter; Hickman, Matthew; Martin, Natasha K.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England	University of California System; University of California San Diego; Medical University of Graz; Johns Hopkins University; University of Bristol	Martin, NK (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA.; Martin, NK (corresponding author), Univ Bristol, Populat Hlth Sci, Bristol, Avon, England.	Natasha-martin@ucsd.edu	Hoenigl, Martin/E-8802-2010; chaillon, antoine/GNH-1623-2022; Chaillon, Antoine/GNH-6121-2022; Solomon, Sunil Suhas/P-6907-2019; Hickman, Matthew/Y-2400-2019	Hoenigl, Martin/0000-0002-1653-2824; Hickman, Matthew/0000-0001-9864-459X; Smith, Davey/0000-0003-3603-1733; Vickerman, Peter/0000-0002-8291-5890; Martin, Natasha/0000-0001-8344-1810	National Institute for Drug Abuse [R01 DA037773]; University of California San Diego Center for AIDS Research (CFAR), a National Institute of Health (NIH) [P30 AI036214]; NIH: NIAID; NIH: NIMH; NIH: NHLBI; NIH: NIA NIGMS; NIH: NIDDK; NIHR Health Protection Research Unit in Evaluation; NIH: NCI; NIH: NIDA; NIH: NICHD; NIMH [MH113477]; NIAID [AI106039];  [MH100974];  [DA037811]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, T32AI007384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037773] Funding Source: NIH RePORTER	National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of California San Diego Center for AIDS Research (CFAR), a National Institute of Health (NIH); NIH: NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH: NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH: NIA NIGMS; NIH: NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIHR Health Protection Research Unit in Evaluation; NIH: NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH: NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH: NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NKM and PV are supported by the National Institute for Drug Abuse [grant number R01 DA037773] and the University of California San Diego Center for AIDS Research (CFAR), a National Institute of Health (NIH) funded program [grant number P30 AI036214] which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA NIGMS, and NIDDK. MHo reports additional support from NIMH MH113477 and NIAID AI106039, and SRM is supported by MH100974, DA037811, and AI106039. The views expressed are those of the authors and not necessarily those of the National Institutes of Health. PV and MHi acknowledge support from NIHR Health Protection Research Unit in Evaluation. NIH: https://www.nih.gov/.CFAR: https://cfar.ucsd.edu/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD-IDSA, REC TEST MAN TREAT H; Aggarwal R, 2003, J HEPATOL, V38, P215, DOI 10.1016/S0168-8278(02)00382-3; Aggarwal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176503; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Arora Narendra K, 2012, WHO South East Asia J Public Health, V1, P189, DOI 10.4103/2224-3151.206931; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bickerstaff C, 2015, EXPERT REV PHARM OUT, V15, P787, DOI 10.1586/14737167.2015.1076337; Breban R, 2014, LANCET GLOB HEALTH, V2, pE541, DOI 10.1016/S2214-109X(14)70188-3; Chhatwal J, 2017, CLIN GASTROENTEROL H, V15, P827, DOI 10.1016/j.cgh.2016.09.015; Chhatwal J, 2016, PHARMACOECONOMICS, V34, P551, DOI 10.1007/s40273-015-0373-9; Chowdhury A, 2003, HEPATOLOGY, V37, P802, DOI 10.1053/jhep.2003.50157; Dandekar V, 2018, EC TIMES; DEPARTMENT OF HEALTH AND FAMILY WELFARE, 2016, STAND OP PROC MUKH M; Deuffic-Burban S, 2014, J HEPATOL, V61, P7, DOI 10.1016/j.jhep.2014.03.011; Ermis F, 2015, WORLD J HEPATOL, V7, P2100, DOI 10.4254/wjh.v7.i17.2100; Goel A, 2019, J GASTROEN HEPATOL, V34, P321, DOI 10.1111/jgh.14466; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hatzakis A, 2015, J VIRAL HEPATITIS, V22, P26, DOI 10.1111/jvh.12351; He T, 2017, ALIMENT PHARM THER, V46, P711, DOI 10.1111/apt.14271; Islam N, 2017, LANCET GASTROENTEROL, V2, P200, DOI 10.1016/S2468-1253(16)30182-0; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Lim AG, 2018, INT J EPIDEMIOL, V47, P550, DOI 10.1093/ije/dyx270; Marfatia S, 2015, VALUE HEALTH, V18, pA581, DOI 10.1016/j.jval.2015.09.1945; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Mukhopadhya A, 2008, J BIOSCIENCES, V33, P465, DOI 10.1007/s12038-008-0065-0; Murhekar MV, 2005, PUBLIC HEALTH, V119, P655, DOI 10.1016/j.puhe.2004.07.010; Nagral S, 2015, J CLIN EXP HEPATOL, V5, P329, DOI 10.1016/j.jceh.2015.11.001; National Health Accounts Technical Secretariat National Health Systems Resource Centre Ministry of Health and Family Welfare GoI, 2017, NAT HLTH ACC EST REP; Organization WH, 2014, CHOOS INT AR COST EF; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Puri P, 2016, J CLIN EXP HEPATOL, V6, P119, DOI 10.1016/j.jceh.2016.07.001; Puri P, 2014, J CLIN EXP HEPATOL, V4, P117, DOI 10.1016/j.jceh.2014.06.001; Puri P, 2014, J CLIN EXP HEPATOL, V4, P106, DOI 10.1016/j.jceh.2014.05.006; Rajasekaran M, 2003, PUBLIC HEALTH, V117, P208, DOI 10.1016/S0033-3506(03)00065-9; Reid Savanna, 2012, Indian J Community Med, V37, P89, DOI 10.4103/0970-0218.96093; Shanmugam K.R., 2011, EC RES INT, V2011, P1, DOI [10.1155/2011/191425, DOI 10.1155/2011/191425]; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006; Visconti AJ, 2013, J GASTROEN HEPATOL, V28, P707, DOI 10.1111/jgh.12041; WHO, 2017, GLOB HEP REP; WHO, GLOB HLTH SECT STRAT; World Health Organization, 2016, COMB HEP B C REACH E	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217964	10.1371/journal.pone.0217964	http://dx.doi.org/10.1371/journal.pone.0217964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170246	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700086
J	Dekerle, J; Greenhouse-Tucknott, A; Wrightson, JG; Schafer, L; Ansdell, P				Dekerle, Jeanne; Greenhouse-Tucknott, Aaron; Wrightson, James G.; Schafer, Lisa; Ansdell, Paul			Improving the measurement of TMS-assessed voluntary activation in the knee extensors	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; GROUP-III; METHODOLOGICAL ISSUES; NEUROMUSCULAR FATIGUE; STATISTICAL-METHODS; PERIPHERAL FATIGUE; MUSCLE AFFERENTS; EXCITABILITY; RELIABILITY	Purpose To test the accuracy, validity, reliability and sensitivity of an alternative method for the measure of TMS-assessed voluntary activation (VA(TMS)) in the knee extensors. Methods Ten healthy males (24 +/- 5 years) completed a neuromuscular assessment protocol before and after a fatiguing isometric exercise: two sets of five contractions (50%, 62.5%, 75%, 87.5%, 100% Maximal Voluntary Contraction; MVC) with superimposed TMS-evoked twitches for calculation of VATMs using either the first 5 stimulations (1x5C) or all 10 (2x5C). This was performed on two separate occasions (between-day reliability). Accuracy and validity were compared with a routinely used protocol [i.e. 50%, 75%, and 100% of MVC (1x3C) performed three times (3x3C)]. Results 95% confidence interval for estimated resting twitch, a key determinant of VA-rms, was similar between 1x5C, 2x5C, and 3x3C but improved by six-fold when compared to 1x3C (P<0.05). In a fresh state, potentiated twitch force was unchanged following 1x5C but decreased following 2x5C (P<0.05). A recovery was found post-exercise but was smaller for 1x5C compared to 2x5C (P<0.05), with no difference between the latter two (P>0.05). Absolute reliability was strong enough for both 1x5C and 2x5C to depict a true detectable change in the sample's VATMs following the fatiguing exercise (TEM < 3% at rest, <9% post-exercise) but 2x5C was marginally more sensitive to individual's changes from baseline. Conclusion Both 1x5C and 2x5C provide reliable measures of VA-rms. However, 1x5C may hold stronger internal validity. Both protocols allow detection of 'true' changes in sample's means but not individual scores following a fatiguing isometric exercise.	[Dekerle, Jeanne; Greenhouse-Tucknott, Aaron; Wrightson, James G.; Schafer, Lisa; Ansdell, Paul] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Fatigue & Exercise Tolerance Lab, Eastbourne, England; [Wrightson, James G.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Ansdell, Paul] Northumbria Univ, Fac Hlth & Life Sci, Dept Sport Exercise & Rehabil, Northumbria, England	University of Brighton; University of Calgary; Northumbria University	Dekerle, J (corresponding author), Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Fatigue & Exercise Tolerance Lab, Eastbourne, England.	j.dekerle@brighton.ac.uk	Dekerle, Jeanne/M-8367-2019; Ansdell, Paul/J-2618-2019	Dekerle, Jeanne/0000-0002-4482-4576; Ansdell, Paul/0000-0001-7542-1107; Wrightson, James/0000-0001-7106-7470				Adreani CM, 1997, J APPL PHYSIOL, V82, P1811, DOI 10.1152/jappl.1997.82.6.1811; Armitage P, 2002, STAT METHODS; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bachasson D, 2016, NEUROSCIENCE, V314, P125, DOI 10.1016/j.neuroscience.2015.11.056; Beaulieu LD, 2017, BRAIN STIMUL, V10, P196, DOI 10.1016/j.brs.2016.12.008; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clark BC, 2007, J ELECTROMYOGR KINES, V17, P90, DOI 10.1016/j.jelekin.2005.11.008; Dekerle J, 2019, EUR J APPL PHYSIOL, V119, P991, DOI 10.1007/s00421-019-04089-7; Folland JP, 2007, J ELECTROMYOGR KINES, V17, P317, DOI 10.1016/j.jelekin.2006.04.008; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodall S, 2018, EXP BRAIN RES, V236, P463, DOI 10.1007/s00221-017-5142-x; Goodall S, 2017, EUR J APPL PHYSIOL, V117, P687, DOI 10.1007/s00421-017-3561-9; Gruet M, 2014, EXP PHYSIOL, V99, P1053, DOI 10.1113/expphysiol.2014.078840; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; Hayes SG, 2005, J APPL PHYSIOL, V99, P1891, DOI 10.1152/japplphysiol.00629.2005; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hunter SK, 2006, J APPL PHYSIOL, V101, P1036, DOI 10.1152/japplphysiol.00103.2006; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; Kotan S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00363; Kufel TJ, 2002, MUSCLE NERVE, V25, P438, DOI 10.1002/mus.10047; LORING SH, 1992, J APPL PHYSIOL, V73, P516, DOI 10.1152/jappl.1992.73.2.516; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mira J, 2017, EUR J APPL PHYSIOL, V117, P1845, DOI 10.1007/s00421-017-3678-x; Otieno LA, 2019, J NEUROPHYSIOL, V121, P471, DOI 10.1152/jn.00628.2018; Sidhu SK, 2017, CLIN NEUROPHYSIOL, V128, P44, DOI 10.1016/j.clinph.2016.10.008; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Souron R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00519; Souron R, 2017, J APPL PHYSIOL, V122, P1504, DOI 10.1152/japplphysiol.00793.2016; Tamm AS, 2009, J BIOL RHYTHM, V24, P211, DOI 10.1177/0748730409334135; Taylor JL, 2009, J APPL PHYSIOL, V107, P357; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Thomas K, 2016, MED SCI SPORT EXER, V48, P1751, DOI 10.1249/MSS.0000000000000950; Thomas K, 2015, MED SCI SPORT EXER, V47, P537, DOI 10.1249/MSS.0000000000000448; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Todd G, 2016, J APPL PHYSIOL, V121, P678, DOI 10.1152/japplphysiol.00293.2016; Twomey R, 2017, MED SCI SPORT EXER, V49, P2422, DOI 10.1249/MSS.0000000000001371; Yue GH, 2000, MUSCLE NERVE, V23, P376, DOI 10.1002/(SICI)1097-4598(200003)23:3<376::AID-MUS9>3.3.CO;2-U	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216981	10.1371/journal.pone.0216981	http://dx.doi.org/10.1371/journal.pone.0216981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170180	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700013
J	Hayama, R; Sorci, M; Keating, JJ; Hecht, LM; Plawsky, JL; Belfort, G; Chait, BT; Rout, MP				Hayama, Ryo; Sorci, Mirco; Keating, John J.; Hecht, Lee M.; Plawsky, Joel L.; Belfort, Georges; Chait, Brian T.; Rout, Michael P.			Interactions of nuclear transport factors and surface-conjugated FG nucleoporins: Insights and limitations	PLOS ONE			English	Article							PHENYLALANINE-GLYCINE NUCLEOPORINS; MASS-TRANSPORT; IMPORTIN-BETA; KINETIC-ANALYSIS; QCM-D; BINDING; PROTEINS; REPEATS; TRANSLOCATION; FILMS	Protein-protein interactions are central to biological processes. In vitro methods to examine protein-protein interactions are generally categorized into two classes: in-solution and surface-based methods. Here, using the multivalent interactions between nucleocytoplasmic transport factors and intrinsically disordered FG repeat containing nuclear pore complex proteins as a model system, we examined the utility of three surface-based methods: atomic force microscopy, quartz crystal microbalance with dissipation, and surface plasmon resonance. Although results were comparable to those of previous reports, the apparent effect of mass transport limitations was demonstrated. Additional experiments with a loss-of-interaction FG repeat mutant variant demonstrated that the binding events that take place on surfaces can be unexpectedly complex, suggesting particular care must be exercised in interpretation of such data.	[Hayama, Ryo; Hecht, Lee M.; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10021 USA; [Sorci, Mirco; Keating, John J.; Plawsky, Joel L.; Belfort, Georges] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Sorci, Mirco; Keating, John J.; Plawsky, Joel L.; Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Chem, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rockefeller University	Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10021 USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.; Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Chem, 1230 York Ave, New York, NY 10021 USA.	belfog@rpi.edu; chait@mail.rockefeller.edu; rout@mail.rockefeller.edu			NIH [R01GM117212, P41GM109824, R01GM112108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112108, R01GM117212, P41GM109824, P41GM103314] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: BTC, MPR: NIH P41GM109824; MPR: NIH R01GM112108; MPR: NIH R01GM117212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; American Chemical Society, MACROMOLECULES; Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132; Ananth AN, 2018, ELIFE, V7, DOI 10.7554/eLife.31510; [Anonymous], 1993, COLLOIDS SURFACES B; [Anonymous], 1976, MEMBRANE SCI DESALIN; Aramburu IV, 2017, SEMIN CELL DEV BIOL, V68, P34, DOI 10.1016/j.semcdb.2017.06.026; Bayliss R, 2000, J STRUCT BIOL, V131, P240, DOI 10.1006/jsbi.2000.4297; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cardarelli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010475; Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q; Cho NJ, 2010, NAT PROTOC, V5, P1096, DOI 10.1038/nprot.2010.65; Christensen LLH, 1997, ANAL BIOCHEM, V249, P153, DOI 10.1006/abio.1997.2182; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dutta AK, 2007, LANGMUIR, V23, P3088, DOI 10.1021/la0624743; Eisele NB, 2013, BIOPHYS J, V105, P1860, DOI 10.1016/j.bpj.2013.09.006; Eisele NB, 2012, BIOMACROMOLECULES, V13, P2322, DOI 10.1021/bm300577s; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Fischer M, 2011, ANAL CHEM, V83, P1800, DOI 10.1021/ac103168q; Fisher PDE, 2018, ACS NANO, V12, P1508, DOI 10.1021/acsnano.7b08044; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grimaldi J, 2015, LANGMUIR, V31, P1005, DOI 10.1021/la503865b; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Gunawardena J, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-29; Hayama R, 2018, J BIOL CHEM, V293, P4555, DOI 10.1074/jbc.AC117.001649; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jovanovic-Talisman T, 2017, BIOPHYS J, V113, P6, DOI 10.1016/j.bpj.2017.05.024; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kapinos LE, 2014, BIOPHYS J, V106, P1751, DOI 10.1016/j.bpj.2014.02.021; Ketterer P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03313-w; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/nnano.2011.88, 10.1038/NNANO.2011.88]; Kubitscheck U, 2017, SEMIN CELL DEV BIOL, V68, P18, DOI 10.1016/j.semcdb.2017.06.016; Kusnezow W, 2006, PROTEOMICS, V6, P794, DOI 10.1002/pmic.200500149; Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Mol NJd, 2010, SURFACE PLASMON RESO, Vx; North American Membrane Society, J MEMBRANE SCI MEMBR; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Onischenko E, 2017, CELL, V171, P904, DOI 10.1016/j.cell.2017.09.033; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Raveh B, 2016, P NATL ACAD SCI USA, V113, pE2489, DOI 10.1073/pnas.1522663113; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Rotsch C, 1997, LANGMUIR, V13, P2825, DOI 10.1021/la960874s; Sakiyama Y, 2017, SEMIN CELL DEV BIOL, V68, P27, DOI 10.1016/j.semcdb.2017.05.021; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Sorci M, 2013, ANAL CHEM, V85, P6080, DOI 10.1021/ac400949t; Sparks S, 2018, STRUCTURE, V26, P477, DOI 10.1016/j.str.2018.01.010; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8; Tetenbaum-Novatt J, 2010, COLD SH Q B, V75, P567, DOI 10.1101/sqb.2010.75.033; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072; Wagner RS, 2015, BIOPHYS J, V108, P918, DOI 10.1016/j.bpj.2014.12.041; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wilczewski M, 2008, ORG BIOMOL CHEM, V6, P1114, DOI 10.1039/b716214f; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Zahn R, 2016, ELIFE, V5, DOI 10.7554/eLife.14119	87	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217897	10.1371/journal.pone.0217897	http://dx.doi.org/10.1371/journal.pone.0217897			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170242	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700078
J	Bartsch, VB; Niehaus, JK; Taylor-Blake, B; Zylka, MJ				Bartsch, Victoria Brings; Niehaus, Jesse K.; Taylor-Blake, Bonnie; Zylka, Mark J.			Enhanced histamine-induced itch in diacylglycerol kinase iota knockout mice	PLOS ONE			English	Article							MAST-CELL DEGRANULATION; SPARED NERVE INJURY; NEUROPATHIC PAIN; DORSAL-ROOT; SPINAL-CORD; RECEPTOR; MOUSE; MODEL; MECHANISMS; EXPRESSION	Subsets of small-diameter dorsal root ganglia (DRG) neurons detect pruritogenic (itch-causing) and algogenic (pain-causing) stimuli and can be activated or sensitized by chemical mediators. Many of these chemical mediators activate receptors that are coupled to lipid hydrolysis and diacylglycerol (DAG) production. Diacylglycerol kinase iota (DGKI) can phosphorylate DAG and is expressed at high levels in small-diameter mouse DRG neurons. Given the importance of these neurons in sensing pruritogenic and algogenic chemicals, we sought to determine if loss of DGKI impaired responses to itch-or pain-producing stimuli. Using male and female Dgki-knockout mice, we found that in vivo sensitivity to histamine-but not other pruritogens-was enhanced. In contrast, baseline pain sensitivity and pain sensitization following inflammatory or neuropathic injury were equivalent between wild type and Dgki(-/-) mice. In vitro calcium responses in DRG neurons to histamine was enhanced, while responses to algogenic ligands were unaffected by Dgki deletion. These data suggest Dgki regulates sensory neuron and behavioral responses to histamine, without affecting responses to other pruritogenic or algogenic agents.	[Bartsch, Victoria Brings; Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Niehaus, Jesse K.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.; Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022	Brings, Victoria/0000-0003-2325-6888; Niehaus, Jesse/0000-0002-6800-4134	National Institute of Neurological Disorders and Stroke [R01NS081127, F31NS098600, F31NS105397, T32NS007431, P30NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431, F31NS105397, R01NS081127, F31NS098600] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov/, grants R01NS081127 (MJZ), F31NS098600 (VBB), F31NS105397 (JKN), T32NS007431 (JKN), and P30NS045892 (MJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There !!!was no additional external funding received for this study.	Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Bartsch VB, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12570; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Carlos D, 2006, EUR J IMMUNOL, V36, P1494, DOI 10.1002/eji.200535464; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; EICHBERG J, 1992, ADV EXP MED BIOL, V318, P413; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hockley JRF, 2016, J NEUROSCI, V36, P2364, DOI 10.1523/JNEUROSCI.3369-15.2016; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu T, 2013, PFLUG ARCH EUR J PHY, V465, P1671, DOI 10.1007/s00424-013-1284-2; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Michael GJ, 1999, J NEUROSCI, V19, P1844; Moehring F, 2016, J PAIN, V17, P50, DOI 10.1016/j.jpain.2015.08.014; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; NISHIHARA I, 1995, BRAIN RES, V677, P138, DOI 10.1016/0006-8993(95)00133-B; Olenchock BA, 2006, IMPAIRED DEGRANULATI, V203, P1471, DOI [10.1084/jem.20052424, DOI 10.1084/JEM.20052424]; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Pingle S. C., 2007, V179, P155; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Rittiner JE, 2014, MOL PHARMACOL, V85, P800, DOI 10.1124/mol.113.091280; Sakuma M, 2014, BIOCHEM BIOPH RES CO, V445, P340, DOI 10.1016/j.bbrc.2014.01.197; Sasaki H, 2006, CELL TISSUE RES, V326, P35, DOI 10.1007/s00441-006-0219-z; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Voscopoulos C, 2010, BRIT J ANAESTH, V105, pI69, DOI 10.1093/bja/aeq323; WANG JJ, 1995, ANESTH ANALG, V80, P102, DOI 10.1097/00000539-199501000-00018; Wilkerson JL, 2016, BRIT J PHARMACOL, V173, P1678, DOI 10.1111/bph.13469; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wright BD, 2014, NEURON, V82, P836, DOI 10.1016/j.neuron.2014.04.006; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286	50	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217819	10.1371/journal.pone.0217819	http://dx.doi.org/10.1371/journal.pone.0217819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31167004	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800041
J	Ramanan, AV; Hampson, LV; Lythgoe, H; Jones, AP; Hardwick, B; Hind, H; Jacobs, B; Vasileiou, D; Wadsworth, I; Ambrose, N; Davidson, J; Ferguson, PJ; Herlin, T; Kavirayani, A; Killeen, OG; Compeyrot-Lacassagne, S; Laxer, RM; Roderick, M; Swart, JF; Hedrich, CM; Beresford, MW				Ramanan, A. V.; Hampson, L. V.; Lythgoe, H.; Jones, A. P.; Hardwick, B.; Hind, H.; Jacobs, B.; Vasileiou, D.; Wadsworth, I.; Ambrose, N.; Davidson, J.; Ferguson, P. J.; Herlin, T.; Kavirayani, A.; Killeen, O. G.; Compeyrot-Lacassagne, S.; Laxer, R. M.; Roderick, M.; Swart, J. F.; Hedrich, C. M.; Beresford, M. W.			Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO	PLOS ONE			English	Article							RECURRENT MULTIFOCAL OSTEOMYELITIS; CHRONIC NONBACTERIAL OSTEOMYELITIS; THERAPY	Introduction Chronic nonbacterial osteomyelitis (CNO) is a rare autoinflammatory bone disorder primarily affecting children and adolescents. It can lead to chronic pain, bony deformities and fractures. The pathophysiology of CNO is incompletely understood. Scientific evidence suggests dysregulated expression of pro-and anti-inflammatory cytokines to be centrally involved. Currently, treatment is largely based on retrospective observational studies and expert opinion. Treatment usually includes nonsteroidal anti-inflammatory drugs and/or glucocorticoids, followed by a range of drugs in unresponsive cases. While randomised clinical trials are lacking, retrospective and prospective non-controlled studies suggest effectiveness of TNF inhibitors and bisphosphonates. The objective of the Bayesian consensus meeting was to quantify prior expert opinion. Methods Twelve international CNO experts were randomly chosen to be invited to a Bayesian prior elicitation meeting. Results Results showed that a typical new patient treated with pamidronate would have an 84% chance of improvement in their pain score relative to baseline at 26 weeks and an 83% chance on adalimumab. Experts thought there was a 50% chance that a new typical patient would record a pain score of 28 mm (pamidronate) to 30mm (adalimumab) or better at 26 weeks. There was a modest trend in prior opinion to indicate an advantage of pamidronate vs adalimumab, with a 68% prior chance that pamidronate is superior to adalimumab by some margin. However, it is clear that there is considerable uncertainty about the precise relative merits of the two treatments. Conclusions The rarity of CNO leads to challenges in conducting randomised controlled trials with sufficient power to provide a definitive outcome. We address this using a Bayesian design, and here describe the process and outcome of the elicitation exercise to establish expert prior opinion. This opinion will be tested in the planned prospective CNO study. The process for establishing expert consensus opinion in CNO will be helpful for developing studies in other rare paediatric diseases.	[Ramanan, A. V.; Roderick, M.] Bristol Royal Hosp Children, Paediat Rheumatol, Bristol, Avon, England; [Ramanan, A. V.; Roderick, M.] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Hampson, L. V.] Novartis Pharma AG, Stat Methodol & Consulting, Basel, Switzerland; [Lythgoe, H.; Hedrich, C. M.; Beresford, M. W.] Univ Liverpool, Dept Womens & Childrens Hlth, Inst Translat Med, Liverpool, Merseyside, England; [Lythgoe, H.; Beresford, M. W.] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Rheumatol, Liverpool, Merseyside, England; [Jones, A. P.; Hardwick, B.; Hind, H.] Univ Liverpool, Clin Trials Res Ctr, Dept Biostat, Liverpool, Merseyside, England; [Jacobs, B.] Royal Natl Orthopaed Hosp, Paediat, London, England; [Vasileiou, D.; Wadsworth, I.] Univ Lancaster, Dept Math & Stat, Fylde Coll, Lancaster, England; [Ambrose, N.] Univ Coll Hosp, Rheumatol, London, England; [Davidson, J.] Royal Hosp Children, Paediat Rheumatol, Glasgow, Lanark, Scotland; [Ferguson, P. J.] Univ Iowa, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA USA; [Herlin, T.] Aarhus Univ, Dept Paediat, Aarhus, Denmark; [Kavirayani, A.] Oxford Univ Hosp NHS Fdn Trust, Paediat Rheumatol, Oxford, England; [Killeen, O. G.] Our Ladys Children Hosp, Natl Ctr Paediat Rheumatol, Dublin, Ireland; [Compeyrot-Lacassagne, S.] Great Ormond St Hosp Children NHS Fdn Trust, Rheumatol, London, England; [Laxer, R. M.] Univ Toronto, Dept Paediat, Hosp Sick Children, Toronto, ON, Canada; [Swart, J. F.] Univ Med Ctr Utrecht, Paediat Rheumatol, Utrecht, Netherlands	Bristol Royal Hospital For Children; University of Bristol; Novartis; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Lancaster University; University of London; University College London; University of Iowa; Aarhus University; Oxford University Hospitals NHS Foundation Trust; National Children's Research Centre (NCRC); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utrecht University; Utrecht University Medical Center	Ramanan, AV (corresponding author), Bristol Royal Hosp Children, Paediat Rheumatol, Bristol, Avon, England.; Ramanan, AV (corresponding author), Univ Bristol, Bristol Med Sch, Bristol, Avon, England.	avramanan@hotmail.com	Swart, Joost/AFF-8988-2022; KILLEEN, ORLA/AAJ-3993-2020; Hedrich, Christian/AAW-3958-2020; Beresford, Michael William/AAB-5261-2021; Kavirayani, Akhila/AAA-4746-2021; Hedrich, Christian/AAD-6855-2019; Jacobs, Benjamin/V-5547-2019	Beresford, Michael William/0000-0002-5400-9911; Jacobs, Benjamin/0000-0002-3704-749X; Lythgoe, Hanna/0000-0002-7162-7578; Wadsworth, Ian/0000-0001-6780-0254	Arthritis Research UK [21212]; Medical Research Council [MR/J014079/1, MR/M013510/1]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) from the National Institutes of Health (NIH) [R01AR059703]; MRC [MR/J014079/1, MR/M013510/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059703] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) from the National Institutes of Health (NIH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	AR, MWB, AJ, LH, HG, SL received funding from Arthritis Research UK (reference 21212) https://www.arthritisresearchuk.org/to conduct the consensus meeting. Neither sponsor or funder played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LVH's contribution to this work was made whilst she was an employee of Lancaster University and was funded by the Medical Research Council (grant MR/J014079/1). The contributions of DV and IW were funded by the Medical Research Council (IW grant MR/M013510/1; DV grant Arthritis Research UK  pound 21,010.36). PJF is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) from the National Institutes of Health (NIH) R01AR059703.	[Anonymous], R LANG ENV STAT COMP; Borzutzky A, 2012, PEDIATRICS, V130, pE1190, DOI 10.1542/peds.2011-3788; Brandt D, 2018, CLIN IMMUNOL, V196, P77, DOI 10.1016/j.clim.2018.04.011; Dallow N, 2018, PHARM STAT, V17, P301, DOI 10.1002/pst.1854; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Deutschmann A, 2005, PEDIATRICS, V116, P1231, DOI 10.1542/peds.2004-2206; Eleftheriou D, 2010, RHEUMATOLOGY, V49, P1505, DOI 10.1093/rheumatology/keq122; Girschick HJ, 2007, NAT CLIN PRACT RHEUM, V3, P733, DOI 10.1038/ncprheum0653; Gleeson H, 2008, J RHEUMATOL, V35, P707; Gosling, 2014, METHODS ELICITING EX; Hampson LV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120981; Hampson LV, 2014, STAT MED, V33, P4186, DOI 10.1002/sim.6225; Hofmann SR, 2015, CLIN IMMUNOL, V161, P300, DOI 10.1016/j.clim.2015.09.013; Hofmann SR, 2011, CLIN IMMUNOL, V141, P317, DOI 10.1016/j.clim.2011.08.012; Hofmann SR, 2017, CURR OSTEOPOROS REP, V15, P542, DOI 10.1007/s11914-017-0405-9; Hofmann SR, 2016, J RHEUMATOL, V43, P1956, DOI 10.3899/jrheum.160256; Hofmann SR, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00256; Hospach T, 2010, EUR J PEDIATR, V169, P1105, DOI 10.1007/s00431-010-1188-5; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Marangoni RG, 2010, SPINE, V35, pE253, DOI 10.1097/BRS.0b013e3181c09601; Miettunen PMH, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-2; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; O'Hagan A., SHELF SHEFFIELD ELIC; Roderick M, 2014, RHEUMATOLOGY, V53, P1973, DOI 10.1093/rheumatology/keu226; Schnabel A, 2016, RHEUMATOL INT, V36, P1737, DOI 10.1007/s00296-016-3572-6; Schnabel A, 2017, J RHEUMATOL, V44, P1058, DOI 10.3899/jrheum.161255; Simm PJ, 2008, J PEDIATR, V152, P571, DOI 10.1016/j.jpeds.2007.08.047; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; White IR, 2005, STAT MED, V24, P3805, DOI 10.1002/sim.2420; Zhao Y, 2018, ARTHRIT CARE RES, V70, P1228, DOI 10.1002/acr.23462	30	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0215739	10.1371/journal.pone.0215739	http://dx.doi.org/10.1371/journal.pone.0215739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166977	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800006
J	You, QH; Fang, N; Liu, LL; Yang, WJ; Zhang, L; Wang, YQ				You, Qinghui; Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li; Wang, Yeqiao			Effects of land use, topography, climate and socio-economic factors on geographical variation pattern of inland surface water quality in China	PLOS ONE			English	Article							DISSOLVED-OXYGEN; RIVER-BASIN; SIERRA-NEVADA; TEMPERATURE; COVER	The deterioration of water quality has become a primary environmental concern worldwide. Understanding the status of water quality and identifying the influencing factors are important for water resources management. However, reported analyses have mostly been conducted in small and focused areas. It is still unclear if factors driving spatial variation in water quality would be different in extended spatial scales. In this paper, we analyzed spatial pattern of inland surface water quality in China using a dataset with four water quality parameters (i.e., pH, DO, NH4+-N and CODMn) and the water quality level. We tested the effects of anthropogenic (i.e., land use and socio-economic) and natural (i.e., climatic and topographic) factors on spatial variation in water quality. The study concluded that the overall inland surface water quality in China was at level III (fair). Water quality level was strongly correlated with CODMn and NH4+-N concentration. In contrast to reported studies that suggested land use patterns were the determinants of inland surface water quality, this study revealed that both anthropogenic and natural factors played important roles in explaining spatial variation of inland surface water quality in China. Among the tested explanatory variables, mean elevation within watershed appeared as the best predictor for pH, while annual precipitation and mean air temperature were the most important explanatory variables for CODMn and DO, respectively. NH4+-N concentration and water quality level were most strongly correlated with the percent of forest cover in watershed. Compared to studies at smaller spatial scales, this study found different influencing factors of surface water quality, suggesting that factors may play different roles at different spatial scales of consideration. Therefore management policies and measures in water quality control must be established and implemented accordingly. Since currently adopted parameters for monitoring of inland surface water quality in China are largely influenced by natural variables, additional physicochemical and biological indicators are needed for a robust assessment of human impacts on water quality.	[You, Qinghui; Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Minist Educ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang, Jiangxi, Peoples R China; [You, Qinghui] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China; [Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Jiangxi Prov Key Lab Poyang Lake Comprehens Manag, Nanchang, Jiangxi, Peoples R China; [Wang, Yeqiao] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University; University of Rhode Island	Yang, WJ (corresponding author), Jiangxi Normal Univ, Minist Educ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang, Jiangxi, Peoples R China.; Yang, WJ (corresponding author), Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China.; Yang, WJ (corresponding author), Jiangxi Normal Univ, Jiangxi Prov Key Lab Poyang Lake Comprehens Manag, Nanchang, Jiangxi, Peoples R China.; Wang, YQ (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	yangwenjing@jxnu.edu.cn; yqwang@uri.edu			National Natural Science Foundation of China [41561097, 41701514]; Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation [JXS-EW-00]; Natural Science Foundation of Jiangxi Province [20142BAB213023, 20161BAB213074]; Education Department of Jiangxi Provincial Government [GJJ170199, GJJ150334]; Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education [PK2017004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Education Department of Jiangxi Provincial Government; Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education	This work was supported by National Natural Science Foundation of China (41561097, WY; 41701514, LZ), Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation (JXS-EW-00, YW), Natural Science Foundation of Jiangxi Province (20142BAB213023, WY; 20161BAB213074, LZ), Education Department of Jiangxi Provincial Government (GJJ170199, QY; GJJ150334, WY), and the Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education (PK2017004, WY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bu HM, 2014, ECOL INDIC, V41, P187, DOI 10.1016/j.ecolind.2014.02.003; BUTCHER JB, 1995, J ENVIRON ENG-ASCE, V121, P756, DOI 10.1061/(ASCE)0733-9372(1995)121:10(756); Caldwell P, 2015, HYDROL PROCESS, V29, P2196, DOI 10.1002/hyp.10358; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chapagain AK, 2008, WATER INT, V33, P19, DOI 10.1080/02508060801927812; Chen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102714; [陈静生 CHEN Jingsheng], 2006, [地学前缘, Earth science frontiers], V13, P74; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duncan R, 2014, LAND USE POLICY, V41, P378, DOI 10.1016/j.landusepol.2014.06.003; Dvornic A, 2011, ANN FACULTY ENG HUNE, V9, P79; Ficklin DL, 2013, WATER RESOUR RES, V49, P2765, DOI 10.1002/wrcr.20248; Fukushima T, 2000, HYDROL PROCESS, V14, P593, DOI [10.1002/(SICI)1099-1085(20000228)14:3<593::AID-HYP956>3.0.CO;2-O, 10.1002/(SICI)1099-1085(20000228)14:3&lt;593::AID-HYP956&gt;3.0.CO;2-O]; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; He HS, 2000, LANDSCAPE ECOL, V15, P591, DOI 10.1023/A:1008102521322; Jia K, 2014, GEOCARTO INT, V29, P941, DOI 10.1080/10106049.2014.894586; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kang JH, 2010, WATER RES, V44, P4143, DOI 10.1016/j.watres.2010.05.009; Kawabe M., 1997, J OCEANOGR, V53, P443; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Liu WZ, 2012, HYDROL PROCESS, V26, P570, DOI 10.1002/hyp.8157; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; Luce C, 2014, WATER RESOUR RES, V50, P3428, DOI 10.1002/2013WR014329; Manaspah R, 2006, OCEANOLOGIA, V48, P237; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; Ministry of Environmental Protection of the People''s Republic of China, 2012, STAND METH AN WAT WA; Morrice JA, 2008, ENVIRON MANAGE, V41, P347, DOI 10.1007/s00267-007-9055-5; National Water Quality Monitoring Council, 2002, NAT ENV METH IND; Nezlin NP, 2009, ESTUAR COAST SHELF S, V82, P139, DOI 10.1016/j.ecss.2009.01.004; Nie L, 2014, J JIANGXI NORMAL U N, V38, P429; Nielsen A, 2012, ECOL APPL, V22, P1187, DOI 10.1890/11-1831.1; Olaniran AO, 2008, J ENVIRON MONITOR, V10, P889, DOI 10.1039/b805055d; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; Sahu O, 2014, INT LETT NAT SCI, V13, P1, DOI 10.18052/www.scipress.com/ILNS.13.1; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; St-Hilaire A, 2016, CAN WATER RESOUR J, V41, P273, DOI 10.1080/07011784.2015.1010181; Tu J, 2011, APPL GEOGR, V31, P376, DOI 10.1016/j.apgeog.2010.08.001; WANG P, 2015, J JIANGXI NORMAL U N, V39, P435; Xing X, 2012, ENVIRON CHEM, V31, P804; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Ye L, 2009, ENVIRON GEOL, V58, P937, DOI 10.1007/s00254-008-1573-9; Zhao J, 2015, LANDSCAPE URBAN PLAN, V137, P20, DOI 10.1016/j.landurbplan.2014.12.010	46	12	13	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217840	10.1371/journal.pone.0217840	http://dx.doi.org/10.1371/journal.pone.0217840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31167003	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800043
J	Staudt, A; Freyer-Adam, J; Meyer, C; Bischof, G; John, U; Baumann, S				Staudt, Andreas; Freyer-Adam, Jennis; Meyer, Christian; Bischof, Gallus; John, Ulrich; Baumann, Sophie			Does prior recall of past week alcohol use affect screening results for at-risk drinking? Findings from a randomized study	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; GRADUATED-FREQUENCY; GENERAL-POPULATION; QUANTITY-FREQUENCY; SELF-REPORTS; TEST AUDIT; CONSUMPTION; PATTERNS; DIARY; PERFORMANCE	Underreporting of alcohol consumption is one of the major challenges in survey research including self-reports. The aim of this study was to test whether underreporting can be reduced by prompting respondents to first reflect on their drinking in the past week and then answer quantity-frequency based screening questions on their typical alcohol use. Data come from 2,379 adults (54% female; mean age = 31.8 years, SD = 11.4 years) consecutively recruited at a local registration office in northeastern Germany. Participants responded to an electronic, self-administered questionnaire on different health behaviors. They were randomized to receiving the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) either before or after the assessment of past week timeline follow-back questions. Logistic regression models were calculated predicting positive screening results for at-risk drinking. Potential interaction effects with gender, age and educational background were explored. Results show that the assessment of past week alcohol consumption prior to the assessment of the AUDIT-C reduced the odds of obtaining positive screening results (OR = 0.83; 95% CI = 0.70-0.99). There were no interaction effects with gender, age and educational background. As a secondary finding, participants reported consistently lower alcohol consumption in the alcohol measure that was administered later in the questionnaire. Preceding questions about alcohol consumption in the past week reduced the probability of positive screening results for at-risk drinking. Our findings suggest that prompting people to recall past week alcohol use prior to screening may not be a solution to reduce underreporting.	[Staudt, Andreas; Meyer, Christian; John, Ulrich; Baumann, Sophie] Univ Med Greifswald, Inst Social Med & Prevent, Greifswald, Germany; [Staudt, Andreas; Freyer-Adam, Jennis; Meyer, Christian; John, Ulrich; Baumann, Sophie] German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Freyer-Adam, Jennis] Univ Med Greifswald, Inst Med Psychol, Greifswald, Germany; [Bischof, Gallus] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Baumann, Sophie] Tech Univ Dresden, Fac Med, Inst & Policlin Occupat & Social Med, Dresden, Germany	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; University of Lubeck; Technische Universitat Dresden	Staudt, A (corresponding author), Univ Med Greifswald, Inst Social Med & Prevent, Greifswald, Germany.; Staudt, A (corresponding author), German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany.	andreas.staudt@uni-greifswald.de	Meyer, Christian/G-7448-2011	Meyer, Christian/0000-0003-4722-7109; Baumann, Sophie/0000-0002-7697-4923; Bischof, Gallus/0000-0003-0432-5497; Freyer-Adam, Jennis/0000-0002-4827-8760; Staudt, Andreas/0000-0001-9905-1999	German Research Foundation [SB 5858/2-1]; German Cancer Aid [108376, 109737, 110676, 110543, 111346]; German Federal Ministry of Education and Research [01EE1406F]; DFG (German Research Foundation) [393148499]; Open Access Publication Fund of the University of Greifswald	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG (German Research Foundation)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Greifswald	This study is part of the research project PRINT that was funded by the German Research Foundation (grant number: SB 5858/2-1 to SB). JFA was supported by the German Cancer Aid (grant numbers: 108376, 109737, 110676, 110543, 111346). CM was supported by the German Federal Ministry of Education and Research (grant number: 01EE1406F). We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499 to AS) and the Open Access Publication Fund of the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5774-1; Beatty JR, 2014, DRUG ALCOHOL DEPEN, V134, P280, DOI 10.1016/j.drugalcdep.2013.10.016; Bischof G, 2005, DRUG ALCOHOL DEPEN, V79, P373, DOI 10.1016/j.drugalcdep.2005.03.002; Boniface S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1297; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Bradburn Norman M., 2004, ASKING QUESTIONS; Bradley KA, 2011, J GEN INTERN MED, V26, P299, DOI 10.1007/s11606-010-1509-4; Bundesamt Statistisches, 2018, BILD BEV ERG MIKR 20; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chung A, 2016, REV COMMUN RES, V4, P1, DOI 10.12840/issn.2255-4165.2016.04.01.008; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Eysenck M. W., 2015, COGNITIVE PSYCHOL ST, DOI 10.4324/978131577800; Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI [10.1177/009145090403100304, DOI 10.1177/009145090403100304, DOI 10.1111/J.1360-0443.2005.01224.X]; Greenfield TK, 2008, ADDICTION, V103, P1082, DOI 10.1111/j.1360-0443.2008.02197.x; HARFORD TC, 1994, ADDICTION, V89, P421, DOI 10.1111/j.1360-0443.1994.tb00916.x; Heeb JL, 2005, ADDICT BEHAV, V30, P403, DOI 10.1016/j.addbeh.2004.04.022; Higgins-Biddle JC, 2018, AM J DRUG ALCOHOL AB, V44, P578, DOI 10.1080/00952990.2018.1456545; Knudsen AK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1533-8; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Kushnir V, 2014, J STUD ALCOHOL DRUGS, V75, P968, DOI 10.15288/jsad.2014.75.968; Livingston M, 2015, J STUD ALCOHOL DRUGS, V76, P158, DOI 10.15288/jsad.2015.76.158; McNeely J, 2016, ADDICTION, V111, P233, DOI 10.1111/add.13165; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2006, WHAT ISAT RISK HEAV; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rumpf HJ, 2002, ALCOHOL ALCOHOLISM, V37, P261, DOI 10.1093/alcalc/37.3.261; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Shakeshaft AP, 1999, ALCOHOL ALCOHOLISM, V34, P636, DOI 10.1093/alcalc/34.4.636; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; StataCorp, 2015, STAT STAT SOFTW REL; Statistisches Landesamt Mecklenburg-Vorpommern, 2019, ENTW EINW GREIFSW 19; Staudt A, 2018, DRUG ALCOHOL DEPEN, V191, P181, DOI 10.1016/j.drugalcdep.2018.06.031; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stockwell T, 2016, ADDICTION, V111, P1203, DOI 10.1111/add.13373; Stockwell T, 2014, ADDICTION, V109, P1657, DOI 10.1111/add.12609; Stockwell T, 2012, DRUG ALCOHOL REV, V31, P121, DOI 10.1111/j.1465-3362.2011.00416.x; Stockwell T, 2012, DRUG ALCOHOL REV, V31, P126, DOI 10.1111/j.1465-3362.2011.00342.x; Townshend JM, 2002, ALCOHOL ALCOHOLISM, V37, P187, DOI 10.1093/alcalc/37.2.187; Tyllesk?r T., 2009, INTERNET J EPIDEMIOL, V7, P1, DOI DOI 10.5580/1818; Universitat Greifswald, 2019, ZAHL DAT FAKT 2019; Utpala-Kumar R, 2010, DRUG ALCOHOL REV, V29, P28, DOI 10.1111/j.1465-3362.2009.00082.x	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217595	10.1371/journal.pone.0217595	http://dx.doi.org/10.1371/journal.pone.0217595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163053	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200023
J	Beltz, CW; Mobley, ML; Burke, IC				Beltz, Christopher W.; Mobley, Megan L.; Burke, Ingrid C.			Nitrogen addition pulse has minimal effect in big sagebrush (Artemisia tridentata) communities on the Pinedale Anticline, Wyoming (USA)	PLOS ONE			English	Article							TEMPORAL VARIATION; SOIL-NITROGEN; GAS EMISSIONS; ELEVATED CO2; GRASSLAND; PRECIPITATION; DYNAMICS; STEPPE; MINERALIZATION; DECOMPOSITION	Nitrogen additions are known to elicit variable responses in semi-arid ecosystems, with responses increasing with precipitation. The response of semi-arid ecosystems to nitrogen are important to understand due to their large spatial extent worldwide and the global trend of increasingly available nitrogen. In this study, we evaluated the impact of a single nitrogen addition pulse on a semi-arid big sagebrush (Artemisia tridentata) ecosystem in western Wyoming. This is important given that sagebrush ecosystems are poorly understood, despite their prevalence in the western US. In addition, large-scale nitrogen additions have begun on sagebrush landscapes in Wyoming in order to mitigate population declines in mule deer (Odocoileus hemionus). The study objectives were (1) to evaluate the effectiveness of a nitrogen fertilization pulse in increasing sagebrush biomass and forage quality, and (2) to assess effects of nitrogen addition on soil biogeochemistry and vegetation community structure. We fertilized 15 plots across 5 locations in western Wyoming using a single pulse of urea (5.5g N m(-2)). In addition, we immobilized available nitrogen through surface hay treatments (250g hay/m(2)). Nitrogen additions failed to increase growth of sagebrush, alter nitrogen content of sagebrush leaders, or alter greenhouse gas efflux from soils. The plant community also remained unchanged; total cover, species richness, and community composition were all unaffected by our treatment application. Over the two years of this study, we did not find indications of nitrogen limitation of ecosystem processes, despite a wet growing season in 2014. Thus, we have found a general lack of response to nitrogen in sagebrush ecosystems and no treatment effect of a single pulse of N to sagebrush biomass or forage quality.	[Beltz, Christopher W.; Burke, Ingrid C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Mobley, Megan L.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Yale University; Oregon State University	Beltz, CW (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	christopher.beltz@yale.edu	Mobley, Megan L/A-5402-2010; Mobley, Megan/AAF-3560-2020; Burke, Ingrid/A-1420-2009	Mobley, Megan L/0000-0002-6046-8380; Mobley, Megan/0000-0002-6046-8380; Burke, Ingrid/0000-0003-4717-6399; Beltz, Christopher/0000-0001-9605-0712	Wyoming Excellence Fund at the University of Wyoming; Yale University	Wyoming Excellence Fund at the University of Wyoming; Yale University	This research was funded by the Wyoming Excellence Fund at the University of Wyoming and by Yale University.	Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; BURKE IC, 1989, ECOLOGY, V70, P1115, DOI 10.2307/1941380; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Chen J, 2015, ECOSYSTEMS, V18, P867, DOI 10.1007/s10021-015-9868-7; Collins SL, 2017, GLOBAL CHANGE BIOL, V23, P1095, DOI 10.1111/gcb.13493; Connelly J.W., 2004, CONSERVATION ASSESSM; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Coskun D, 2016, J PLANT PHYSIOL, V203, P95, DOI 10.1016/j.jplph.2016.05.016; Dahlke J, 2015, 07SC0403657 WGFD SER; Daubenmire RF, 1959, PLANTS ENV TXB PLANT; Davies KW, 2012, RANGELAND ECOL MANAG, V65, P268, DOI 10.2111/REM-D-11-00146.1; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gomez-Casanovas N, 2016, GLOBAL CHANGE BIOL, V22, P1348, DOI 10.1111/gcb.13187; HART SC, 1993, SOIL BIOL BIOCHEM, V25, P431, DOI 10.1016/0038-0717(93)90068-M; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Korfanta NM, 2015, WILDLIFE SOC B, V39, P1, DOI 10.1002/wsb.519; LAUENROTH WK, 1978, OECOLOGIA, V36, P211, DOI 10.1007/BF00349810; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Length R., 2019, EMMEANS ESTIMATED MA; Lowe PN, 2002, J RANGE MANAGE, V55, P94, DOI 10.2307/4003269; Manier D.J., 2013, 20131098 US GEOL SUR, P170; McMurray JA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1487-3; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING DE; Mobley ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107775; Munn LC, 1998, SOILS WYOMING; Naftz DL, 2011, GEOCHEM T, V12, DOI 10.1186/1467-4866-12-4; National Oceanic and Atmospheric Administration, 1981 2010 CLIM NORM; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; Palmquist KA, 2016, ECOLOGY, V97, P2342, DOI 10.1002/ecy.1457; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; Samuel MJ, 1998, J RANGE MANAGE, V51, P408, DOI 10.2307/4003325; Sawyer H, 2017, GLOBAL CHANGE BIOL, V23, P4521, DOI 10.1111/gcb.13711; Schlaepfer DR, 2014, RANGELAND ECOL MANAG, V67, P344, DOI 10.2111/REM-D-13-00079.1; SEAGLE SW, 1993, BIOGEOCHEMISTRY, V22, P157, DOI 10.1007/BF00000645; SEASTEDT TR, 1992, CAN J BOT, V70, P384, DOI 10.1139/b92-052; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sobecki T.M., 2001, POTENTIAL US GRAZING; U.S. Department of the Interior Bureau of Land Management, 2011, WY100EA10303 US DEP; U.S. Department of the Interior Bureau of Land Management, 2011, FIND NO SIGN IMP DEC; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Walston LJ, 2009, ECOGRAPHY, V32, P943, DOI 10.1111/j.1600-0587.2009.05852.x; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012; WEST NE, 1989, N AM TERRESTRIAL VEG, P209; Yandjian L, 2011, J ARID ENVIRON, V75, P675, DOI 10.1016/j.jaridenv.2011.03.003	52	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0206563	10.1371/journal.pone.0206563	http://dx.doi.org/10.1371/journal.pone.0206563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150398	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100002
J	Cokal, D; Zimmerer, V; Turkington, D; Ferrier, N; Varley, R; Watson, S; Hinzen, W				Cokal, Derya; Zimmerer, Vitor; Turkington, Douglas; Ferrier, Nicol; Varley, Rosemary; Watson, Stuart; Hinzen, Wolfram			Disturbing the rhythm of thought: Speech pausing patterns in schizophrenia, with and without formal thought disorder	PLOS ONE			English	Article							LANGUAGE; PAUSES; PREDICTABILITY; IMPAIRMENT; BIOMARKER; DEFICITS; FLUENCY; LENGTH; WORDS	Everyday speech is produced with an intricate timing pattern and rhythm. Speech units follow each other with short interleaving pauses, which can be either bridged by fillers (erm, ah) or empty. Through their syntactic positions, pauses connect to the thoughts expressed. We investigated whether disturbances of thought in schizophrenia are manifest in patterns at this level of linguistic organization, whether these are seen in first degree relatives (FDR) and how specific they are to formal thought disorder (FTD). Spontaneous speech from 15 participants without FTD (SZ-FTD), 15 with FTD (SZ+ FTD), 15 FDRs and 15 neurotypical controls (NC) was obtained from a comic strip retelling task and rated for pauses subclassified by syntactic position and duration. SZ-FTD produced significantly more unfilled pauses than NC in utterance-initial positions and before embedded clauses. Unfilled pauses occurring within clausal units did not distinguish any groups. SZ-FTD also differed from SZ+ FTD in producing significantly more pauses before embedded clauses. SZ+ FTD differed from NC and FDR only in producing longer utterance-initial pauses. FDRs produced significantly fewer fillers than NC. Results reveal that the temporal organization of speech is an important window on disturbances of the thought process and how these relate to language.	[Cokal, Derya] Queen Mary Univ London, Sch Engn & Comp Sci, London, England; [Zimmerer, Vitor; Varley, Rosemary] UCL, Dept Language & Cognit, London, England; [Turkington, Douglas; Ferrier, Nicol; Watson, Stuart] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Turkington, Douglas; Ferrier, Nicol; Watson, Stuart] Northumberland Tyne & Wear NHS Fdn Trust, Newcastle, England; [Hinzen, Wolfram] ICREA, Barcelona, Spain; [Hinzen, Wolfram] Univ Pompeu Fabra, Dept Translat & Language Sci, Barcelona, Spain; [Hinzen, Wolfram] FIDMAG Germanes Hosp Res Fdn, Benito Menni Hosp, Barcelona, Spain	University of London; Queen Mary University London; University of London; University College London; Newcastle University - UK; ICREA; Pompeu Fabra University	Cokal, D (corresponding author), Queen Mary Univ London, Sch Engn & Comp Sci, London, England.	deryacokal@gmail.com	Hinzen, Wolfram/F-2333-2016; Cokal, Derya/AAB-8634-2021; COKAL, DERYA/ABH-2580-2020; watson, stuart/B-8728-2009	Hinzen, Wolfram/0000-0002-6159-4215; COKAL, DERYA/0000-0002-5653-1412; watson, stuart/0000-0002-2558-3367	Northumberland, Tyne and Wear NHS Mental Health Foundation Trust; Arts and Humanities Research Council [AH/L004070/1]; Ministerio de Economia y Competitividad, Spanish Government [FFI2016-77647-C2-1-P]; Generalitat de Catalunya [SGR-1265]; AHRC [AH/L004070/1] Funding Source: UKRI	Northumberland, Tyne and Wear NHS Mental Health Foundation Trust; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Ministerio de Economia y Competitividad, Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was supported by the Northumberland, Tyne and Wear NHS Mental Health Foundation Trust (including Research Capability Funding), the Arts and Humanities Research Council (AH/L004070/1 to W.H.), the Ministerio de Economia y Competitividad, Spanish Government (FFI2016-77647-C2-1-P to W.H.), and Generalitat de Catalunya (SGR-1265 to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert M, 1997, SCHIZOPHRENIA BULL, V23, P171, DOI 10.1093/schbul/23.2.171; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1315, DOI 10.1001/archpsyc.1979.01780120045006; Angelopoulou G, 2018, NEUROPSYCHOLOGIA, V114, P41, DOI 10.1016/j.neuropsychologia.2018.04.006; Ballard KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089864; BUTTERWORTH B, 1979, BRAIN LANG, V8, P133, DOI 10.1016/0093-934X(79)90046-4; Campione E, 2002, ISCA C P; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; CLEMMER EJ, 1980, J PSYCHOLINGUIST RES, V9, P161, DOI 10.1007/BF01067469; Cokal D, 2018, NPJ SCHIZOPHR, V4, DOI 10.1038/s41537-018-0061-9; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; CUESTA MJ, 1995, PSYCHIAT RES, V58, P227, DOI 10.1016/0165-1781(95)02712-6; Dibben CRM, 2009, PSYCHOL MED, V39, P381, DOI 10.1017/S0033291708003887; Engelhardt PE, 2010, MEM COGNITION, V38, P617, DOI 10.3758/MC.38.5.617; FERREIRA F, 1991, J MEM LANG, V30, P210, DOI 10.1016/0749-596X(91)90004-4; FRASER WI, 1986, BRIT J PSYCHIAT, V148, P275, DOI 10.1192/bjp.148.3.275; Goldman Eisler F., 1968, PSYCHOLINGUISTICS EX; GOLDMANEISLER F, 1958, Q J EXP PSYCHOL, V10, P96, DOI 10.1080/17470215808416261; GOLDMANEISLER F, 1958, LANG SPEECH, V1, P226, DOI 10.1177/002383095800100308; Hartsuiker RJ, 2010, EXP PSYCHOL, V57, P169, DOI 10.1027/1618-3169/a000021; Hinzen W, 2016, COGN NEUROPSYCHIATRY, V21, P281, DOI 10.1080/13546805.2016.1190703; Hinzen W, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00971; Howes C, 2017, COGSCI; Kircher TTJ, 2004, NEUROIMAGE, V21, P84, DOI 10.1016/j.neuroimage.2003.09.041; Lake JK, 2011, PSYCHON B REV, V18, P135, DOI 10.3758/s13423-010-0037-x; Levelt WJ, 1993, SPEAKING INTENTION A; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Mack JE, 2015, NEUROPSYCHOLOGIA, V77, P211, DOI 10.1016/j.neuropsychologia.2015.08.019; Mark H., 1983, STORYLINES PICTURE S; Matsumoto K., 2013, FRONT PSYCHIAT, V4; MORICE R, 1986, SCHIZOPHRENIA BULL, V12, P239, DOI 10.1093/schbul/12.2.239; MORICE RD, 1982, AUST NZ J PSYCHIAT, V16, P11, DOI 10.3109/00048678209161186; O'Leary DS, 2000, J NEUROPSYCH CLIN N, V12, P4, DOI 10.1176/jnp.12.1.4; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rapcan V, 2010, MED ENG PHYS, V32, P1074, DOI 10.1016/j.medengphy.2010.07.013; Rossi NF, 2011, RES DEV DISABIL, V32, P2957, DOI 10.1016/j.ridd.2011.05.006; Sevilla G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201545; Shriberg E., 2001, J INT PHON ASSOC, V31, P153, DOI [10.1017/S0025100301001128, DOI 10.1017/S0025100301001128]; SILVERMAN G, 1973, BRIT J PSYCHIAT, V122, P407, DOI 10.1192/bjp.122.4.407; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Teichmann M, 2013, BRAIN, V136, P3474, DOI 10.1093/brain/awt266; Toth L, 2018, CURR ALZHEIMER RES, V15, P130, DOI 10.2174/1567205014666171121114930; Zimmerer VC, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00017	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217404	10.1371/journal.pone.0217404	http://dx.doi.org/10.1371/journal.pone.0217404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150442	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100044
J	Ignasiak, NK; Ravi, DK; Orter, S; Nasab, SHH; Taylor, WR; Singh, NB				Ignasiak, Niklas Konig; Ravi, Deepak K.; Orter, Stefan; Nasab, Seyyed Hamed Hosseini; Taylor, William R.; Singh, Navrag B.			Does variability of footfall kinematics correlate with dynamic stability of the centre of mass during walking?	PLOS ONE			English	Article							LATERAL STABILIZATION; LOAD CARRIAGE; OLDER-ADULTS; GAIT; FALLS	A stable walking pattern is presumably essential to avoid falls. Stability of walking is most accurately determined by the short-term local dynamic stability (maximum Lyapunov exponent) of the body centre of mass. In many studies related to fall risk, however, variability of step width is considered to be indicative of the stability of the centre of mass during walking. However, other footfall parameters, in particular variability of stride time, have also been associated with increased risk for falling. Therefore, the aim of this study was to investigate the association between short-term local dynamic stability of the body centre of mass and different measures of footfall variability. Twenty subjects performed unperturbed walking trials on a treadmill and under increased (addition of 40% body weight) and decreased (harness system) demands to stabilise the body centre of mass. Association between stability of the centre of mass and footfall parameters was established using a structural equation model. Walking with additional body weight lead to greater instability of the centre of mass and increased stride time variability, however had no effect on step width variability. Supported walking in the harness system did not increase centre of mass stability further, however, led to a significant decrease of step width and increase in stride time variability. A structural equation model could only predict 8% of the variance of the centre of mass stability after variability of step width, stride time and stride length were included. A model which included only step width variability as exogenous variable, failed to predict centre of mass stability. Because of the failure to predict centre of mass stability in this study, it appears, that the stability of the centre of mass is controlled by more complex interaction of sagittal and frontal plane temporal and spatial footfall parameters, than those observed by standard variability measures. Anyway, this study does not support the application of step width variability as indicator for medio-lateral stability of the centre of mass during walking.	[Ignasiak, Niklas Konig; Ravi, Deepak K.; Orter, Stefan; Nasab, Seyyed Hamed Hosseini; Taylor, William R.; Singh, Navrag B.] Swiss Fed Inst Technol, Inst Biomech, Leopold Ruzicka Weg 4, Zurich, Switzerland; [Ignasiak, Niklas Konig] Chapman Univ, Dept Phys Therapy, Irvine, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Chapman University System; Chapman University	Taylor, WR (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Leopold Ruzicka Weg 4, Zurich, Switzerland.	bt@ethz.ch	Ravi, Deepak Kumar/S-3490-2019; Singh, Navrag/F-5305-2012; Ignasiak, Niklas/F-8617-2014; Taylor, William R./F-8692-2010; Nasab, Seyyed Hamed Hosseini/AAB-3461-2019	Ravi, Deepak Kumar/0000-0002-5015-8901; Singh, Navrag/0000-0001-8074-041X; Ignasiak, Niklas/0000-0001-9065-3344; Taylor, William R./0000-0003-4060-4098; Nasab, Seyyed Hamed Hosseini/0000-0002-3518-3316				Allet L, 2009, GAIT POSTURE, V29, P488, DOI 10.1016/j.gaitpost.2008.11.012; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Dragunas AC, 2016, J BIOMECH, V49, P2662, DOI 10.1016/j.jbiomech.2016.05.026; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Gates DH, 2007, J APPL PHYSIOL, V102, P965, DOI 10.1152/japplphysiol.00413.2006; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hamacher D, 2014, GAIT POSTURE, V40, P727, DOI 10.1016/j.gaitpost.2014.07.016; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hurt CP, 2010, GAIT POSTURE, V31, P461, DOI 10.1016/j.gaitpost.2010.02.001; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Konig N, 2016, NEUROSCI BIOBEHAV R, V68, P111, DOI 10.1016/j.neubiorev.2016.03.035; Konig N, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00319; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kyvelidou A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-22; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lhomond O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00318; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mortaza N, 2014, EUR J PHYS REHAB MED, V50, P677; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Qu XD, 2012, GAIT POSTURE, V36, P325, DOI 10.1016/j.gaitpost.2012.03.004; Qu XD, 2011, J BIOMECH, V44, P1259, DOI 10.1016/j.jbiomech.2011.02.016; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Reimann H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01271; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Stimpson KH, 2019, GAIT POSTURE, V70, P136, DOI 10.1016/j.gaitpost.2019.03.003; Timar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154654; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Wang Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0405; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217460	10.1371/journal.pone.0217460	http://dx.doi.org/10.1371/journal.pone.0217460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150452	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100053
J	Nair, M; Tripathi, S; Mazumdar, S; Mahajan, R; Harshana, A; Pereira, A; Jimenez, C; Halder, D; Burza, S				Nair, Mohit; Tripathi, Santanu; Mazumdar, Sumit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Jimenez, Carolina; Halder, Debasish; Burza, Sakib			Knowledge, attitudes, and practices related to antibiotic use in Paschim Bardhaman District: A survey of healthcare providers in West Bengal, India	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; MEDICAL-STUDENTS; NEW-DELHI; PERCEPTIONS; RESISTANCE; BELIEFS; PATIENT; ADULTS	Introduction Antibiotic misuse is widespread and contributes to antibiotic resistance, especially in less regulated health systems such as India. Although informal providers are involved with substantial segments of primary healthcare, their level of knowledge, attitudes, and practices is not well documented in the literature. Objectives This quantitative study systematically examines the knowledge, attitudes, and practices of informal and formal providers with respect to antibiotic use. Methods We surveyed a convenience sample of 384 participants (96 allopathic doctors, 96 nurses, 96 informal providers, and 96 pharmacy shopkeepers) over a period of 8 weeks from December to February using a validated questionnaire developed in Italy. Our team created an equivalent, composite KAP score for each respondent in the survey, which was subsequently compared between providers. We then performed a multivariate logistic regression analysis to estimate the odds of having a low composite score (<80) based on occupation by comparing allopathic doctors (referent category) with all other study participants. The model was adjusted for age (included as a continuous variable) and gender. Results Doctors scored highest in questions assessing knowledge (77.3%) and attitudes (87.3%), but performed poorly in practices (67.6%). Many doctors knew that antibiotics were not indicated for viral infections, but over 87% (n = 82) reported prescribing them in this situation. Nurses, pharmacy shopkeepers, and informal providers were more likely to perform poorly on the survey compared to allopathic doctors (OR: 10.4, 95% CI 5.4, 20.0, p<0.01). 30.8% (n = 118) of all providers relied on pharmaceutical company representatives as a major source of information about antibiotics. Conclusions Our findings indicate poor knowledge and awareness of antibiotic use and functions among informal health providers, and dissonance between knowledge and practices among allopathic doctors. The nexus between allopathic doctors, pharmaceutical company representatives, and informal health providers present promising avenues for future research and intervention.	[Nair, Mohit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Burza, Sakib] Medecins Sans Frontieres, New Delhi, India; [Tripathi, Santanu; Mazumdar, Sumit] Calcutta Sch Trop Med, Kolkata, India; [Jimenez, Carolina] Medecins Sans Frontieres, Barcelona, Spain; [Halder, Debasish] Pasch Bardhaman Hlth Dist, Bardhaman, W Bengal, India	Calcutta School of Tropical Medicine (CSTM); Doctors Without Borders	Burza, S (corresponding author), Medecins Sans Frontieres, New Delhi, India.	sakib.burza@barcelona.msf.org	Jimenez, Carolina/GYD-8755-2022	de Lima Pereira, Alan/0000-0001-7578-3626; Harshana, Amit Kumar Singh/0000-0003-1272-5087; Burza, Sakib/0000-0001-7886-8633; Mahajan, Raman/0000-0001-6788-2835	MSF fundraising activities	MSF fundraising activities	Funding for the study was provided through normal MSF fundraising activities. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; [Anonymous], 2016, ANT RES GLOB REP SUR; [Anonymous], 2017, CDC ENC SAF ANT PRES; [Anonymous], 2018, FACTS ANT RES; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Bashir A, 2012, JK PRACTITIONER, V17, P1; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Briggs GG., 2012, DRUGS PREGNANCY LACT; Centers for Disease Control and Prevention, 2017, ANT PRESCR US DOCT O; Chua KP, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5092; Das J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7384; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Davis ME, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040023; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P842, DOI 10.1093/jac/dkt440; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; George S, 2019, AIDS CARE, V31, P875, DOI 10.1080/09540121.2018.1549720; Hawkings NJ, 2007, J ANTIMICROB CHEMOTH, V59, P1155, DOI 10.1093/jac/dkm103; Hersh AL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0027; Khan AKA, 2013, J CLIN DIAGN RES, V7, P1613, DOI 10.7860/JCDR/2013/6290.3230; Kotwani A, 2016, INDIAN J PHARMACOL, V48, P365, DOI 10.4103/0253-7613.186208; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Krishna BY, 2015, IOSR J DENT MED SCI, V14, P2279; Lindberg BH, 2017, SCAND J PRIM HEALTH, V35, P178, DOI 10.1080/02813432.2017.1333301; Minen MT, 2010, MICROB DRUG RESIST, V16, P285, DOI 10.1089/mdr.2010.0009; Ministry of Health and Family Welfare (MoHFW) Government of Bangladesh, 2017, NATL ACTION PLAN ANT; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Norris P, 2013, ANTIBIOTICS-BASEL, V2, P465, DOI 10.3390/antibiotics2040465; Omaswa F, 2006, B WORLD HEALTH ORGAN, V84, P83, DOI 10.2471/BLT.05.027979; Padmanabha TS, 2016, INT J BASIC CLIN PHA, V5, P2432, DOI [10.18203/2319-2003.ijbcp20164100, DOI 10.18203/2319-2003.IJBCP20164100]; PULLA P, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I291; Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629; Sampath S., 2016, SCHOLARS J APPL MED, V4, P3294; Scaioli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122476; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Varghese Joe, 2010, Indian J Med Ethics, V7, P70; WHO, 2015, ANT RES MULT PUBL AW; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	41	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217818	10.1371/journal.pone.0217818	http://dx.doi.org/10.1371/journal.pone.0217818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150515	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000469759100117
J	Snider, JT; Sullivan, J; van Eijndhoven, E; Hansen, MK; Bellosillo, N; Neslusan, C; O'Brien, E; Riley, R; Seabury, S; Kasiske, BL				Snider, Julia Thornton; Sullivan, Jeffrey; van Eijndhoven, Emma; Hansen, Michael K.; Bellosillo, Nobel; Neslusan, Cheryl; O'Brien, Ellen; Riley, Ralph; Seabury, Seth; Kasiske, Bertram L.			Lifetime benefits of early detection and treatment of diabetic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TNF RECEPTORS 1; UNITED-STATES; HEALTH; RISK; PREVALENCE; MORTALITY; ADULTS; TRENDS; ESRD	Objectives Diabetic kidney disease (DKD) is a frequent complication of diabetes with potentially devastating consequences that may be prevented or delayed. This study aimed to estimate the health and economic benefit of earlier diagnosis and treatment of DKD. Methods Life expectancy and medical spending for people with diabetes were modeled using The Health Economics Medical Innovation Simulation (THEMIS). THEMIS uses data from the Health and Retirement Study to model cohorts of individuals over age 50 to project population-level lifetime health and economic outcomes. DKD status was imputed based on diagnoses and laboratory values in the National Health and Nutrition Examination Survey. We simulated the implementation of a new biomarker identifying people with diabetes at an elevated risk of DKD and DKD patients at risk of rapid progression. Results Compared to baseline, the prevalence of DKD declined 5.1% with a novel prognostic biomarker test, while the prevalence of diabetes with stage 5 chronic kidney disease declined 3.0%. Consequently, people with diabetes gained 0.2 years in life expectancy, while per-capita annual medical spending fell by 0.3%. The estimated cost was $12,796 per life-year gained and $25,842 per quality-adjusted life-year. Conclusions A biomarker test that allows earlier treatment reduces DKD prevalence and slows DKD progression, thereby increasing life expectancy among people with diabetes while raising healthcare spending by less than one percent.	[Snider, Julia Thornton; Sullivan, Jeffrey; van Eijndhoven, Emma; Seabury, Seth] Precis Hlth Econ, Los Angeles, CA 90025 USA; [Hansen, Michael K.] Janssen Res & Dev, Spring House, PA USA; [Bellosillo, Nobel] Janssen Diagnost, Raritan, NJ USA; [Neslusan, Cheryl; O'Brien, Ellen; Riley, Ralph] Janssen Global Serv, Raritan, NJ USA; [Kasiske, Bertram L.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	Johnson & Johnson; Janssen Pharmaceuticals; Hennepin County Medical Center	Snider, JT (corresponding author), Precis Hlth Econ, Los Angeles, CA 90025 USA.	julia.snider@precisionhealtheconomics.com			Janssen Diagnostics, LLC; Janssen	Janssen Diagnostics, LLC; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Financial support for this research was provided by Janssen Diagnostics, LLC, to Precision Health Economics (PHE). Dr. Snider, Mr. Sullivan, and Ms. van Eijndhoven are employees of PHE, which provides consulting services to life science firms. Dr. Snider holds equity in PHE. Dr. Kasiske and Dr. Seabury are consultants for PHE. Mr. Riley, Dr. Hansen, Dr. Neslusan, Dr. O'Brien, and Dr. Bellosillo are employees of Janssen, which provided financial support to PHE for this study. Janssen's website can be found here: https://www.janssen.com/us/.Janssen played a role in the study design, decision to publish, and review of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; AstraZeneca, 2017, STUD EV EFF DAP REN; Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Bhattacharya J., 2005, HLTH AFFAIRS S2, V24; Boehringer Ingelheim, 2018, EMPA KIDNEY STUD HEA; Carlsson AC, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0359-8; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Chernew M. E., 2005, HLTH AFFAIRS S2, V24; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Colombo M, 2019, DIABETOLOGIA, V62, P156, DOI 10.1007/s00125-018-4741-9; Congressional Budget Office (CBO), 2012, RAIS EXC TAX CIG EFF; Critselis E, 2018, NEPHROL DIAL TRANSPL, V33, P441, DOI 10.1093/ndt/gfx068; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Forsblom C, 2014, DIABETES CARE, V37, P2334, DOI 10.2337/dc14-0225; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Goldman Dana E., 2006, FORUM HLTH EC POLICY, V9; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Goldman DP, 2005, HEALTH AFFAIR, V24, pW5R5; Hayes A, 2016, VALUE HEALTH, V19, P36, DOI 10.1016/j.jval.2015.10.010; Hodes R. J., 2007, GROWING OLDER AM HLT; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Lakdawalla Darius N, 2005, Health Aff (Millwood), V24 Suppl 2, pW5R30; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Muehrer RJ, 2011, CLIN J AM SOC NEPHRO, V6, P489, DOI 10.2215/CJN.02550310; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; National Kidney Foundation, 2007, AM J KIDNEY DIS S2, V49; National Research Council, 2010, IMPR HLTH CAR COST P; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Ozieh MN, 2015, DIABETES RES CLIN PR, V109, P185, DOI 10.1016/j.diabres.2015.04.011; Paykov ME, 2015, KIDNEY INT, V87, P812, DOI 10.1038/ki.2014.330; Perkovic V, 2019, NEW ENGLAND J MED; Pontillo C, 2017, CLIN KIDNEY J, V10, P192, DOI 10.1093/ckj/sfx002; Radcliffe NJ, 2017, J DIABETES INVEST, V8, P6, DOI 10.1111/jdi.12533; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Shekelle PG, 2005, HLTH AFFAIRS S2, V24; Slabaugh SL, 2015, J MED ECON, V18, P106, DOI 10.3111/13696998.2014.979292; Stanton RC, 2014, AM J KIDNEY DIS, V63, pS3, DOI 10.1053/j.ajkd.2013.10.050; Szczech LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110535; U. S. Senate Committee on Health E Labor and Pensions, EX DIS PREV PUBL HLT; United States Renal Data System, 2015, ANN DAT REP 2015 EP; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wetmore J, 2017, DIABETES, V66, pA438; WHO, 2016, GLOB REP PSOR; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017	51	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217487	10.1371/journal.pone.0217487	http://dx.doi.org/10.1371/journal.pone.0217487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150444	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100056
J	Wazir, MRWN; Van Hiel, M; Mostaert, M; Deconinck, FJA; Pion, J; Lenoir, M				Wazir, Mohd Rozilee Wazir Norjali; Van Hiel, Maxim; Mostaert, Mireille; Deconinck, Frederik J. A.; Pion, Johan; Lenoir, Matthieu			Identification of elite performance characteristics in a small sample of taekwondo athletes	PLOS ONE			English	Article							MOTOR COORDINATION; PHYSIOLOGICAL PROFILES; TALENT IDENTIFICATION; PHYSICAL PERFORMANCE; HEIGHT VELOCITY; FITNESS; SPORT; PREDICTION; BOYS	Along with the increasing popularity of taekwondo, there is a need of evidence-based talent identification (TID) and development programs based upon profiles of future elite athletes. This study first aims to investigate the differences between elite and non-elite taekwondo athletes in anthropometry, physical performance and motor coordination. The second aim is to demonstrate the applicability of z-scores in TID research. A total of 98 Taekwondo athletes between 12 and 17 years old were tested using a generic test battery consisting of four anthropometrical (Height, Weight, Fat Percentage, BMI), six physical performance (Sit & Reach, Sprint 5m, Sprint 30m, Counter Movement Jump, Squat Jump, Endurance Shuttle Run) and three motor coordination tests (Moving Sideways, Jumping Sideways, Walking Backwards). Based on the individual success at international competition level, 18 were categorised as elite athletes and 80 were considered as non-elite. T-tests (step 1) on raw test scores and MANOVAs on z-scores (step 2) were conducted to examine differences between the elite and non-elite taekwondo athletes for anthropometry, physical performance and motor coordination tests. Finally, z-scores were reconverted to raw scores to demonstrate practical significance for coaches. Overall, elite taekwondo athletes score better compared to the non-elite group. The MANOVA analysis better scores for elites on fat percentage (-0.55 versus 0.12; p = 0.006), BMI (-0.37 versus 0,08; p = 0.067) sprint speed 30m (-0.48 versus 0.11; p = 0.029), counter movement jump (0.79 versus -0.18; p = 0.000), squat jump (0.42 versus -0.11; p = 0.041), moving sideways (0.79 versus -0.18; p = 0.000) and walking backwards (0.54 versus -0.12; p = 0.006). This study confirms our knowledge on physical profiles of elite taekwondo athletes and expands our knowledge to the domain of motor coordination. This study showed how the z-score method can be used to distinguish between elite and non-elite athletes, the former being low in number by definition.	[Wazir, Mohd Rozilee Wazir Norjali; Van Hiel, Maxim; Mostaert, Mireille; Deconinck, Frederik J. A.; Lenoir, Matthieu] Fac Med & Hlth Sci, Dept Movement & Sports Sci, Ghent, Belgium; [Wazir, Mohd Rozilee Wazir Norjali] Univ Putra Malaysia, Fac Educ Studies, Dept Sport Studies, Serdang, Selangor, Malaysia; [Pion, Johan] HAN Univ Appl Sci, Nijmegen, Netherlands	Ghent University; Universiti Putra Malaysia	Wazir, MRWN (corresponding author), Fac Med & Hlth Sci, Dept Movement & Sports Sci, Ghent, Belgium.; Wazir, MRWN (corresponding author), Univ Putra Malaysia, Fac Educ Studies, Dept Sport Studies, Serdang, Selangor, Malaysia.	Rozilee.Norjali@ugent.be	Deconinck, Frederik/H-1165-2016	Deconinck, Frederik/0000-0002-9064-9510; Norjali Wazir, Mohd Rozilee Wazir/0000-0001-5590-0725; Pion, Johan/0000-0002-2633-9120	Flemish Government	Flemish Government(European Commission)	The Flemish Sports Compass project was financially supported by the Flemish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Abdul Rashid, 2002, J Sports Sci Med, V1, P147; Ball N, 2011, J STRENGTH COND RES, V25, P2752, DOI 10.1519/JSC.0b013e31820d9f3f; Birrer RB, 1996, AM J SPORT MED, V24, pS72, DOI 10.1177/036354659602406S21; Bridge CA, 2014, SPORTS MED, V44, P713, DOI 10.1007/s40279-014-0159-9; Chiodo S, 2011, SCAND J MED SCI SPOR, V21, P111, DOI 10.1111/j.1600-0838.2009.01046.x; Choi H. H., 1999, TAEKWON DO KOREAN AR; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; COUNCIL OE, 1988, HDB EUR TESTS PHYS F; Fransen J, 2012, J SPORT SCI, V30, P379, DOI 10.1080/02640414.2011.642808; Pallares JG, 2012, J STRENGTH COND RES, V26, P794, DOI 10.1519/JSC.0b013e31824741e7; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Heller J, 1998, J SPORT SCI, V16, P243, DOI 10.1080/026404198366768; Kazemi M, 2006, J SPORT SCI MED, V5, P114; Kazemi Mohsen, 2010, J Can Chiropr Assoc, V54, P243; Krstulovic S, 2006, COLLEGIUM ANTROPOL, V30, P845; Malina RM, 2006, MED SCI SPORT EXER, V38, P1342, DOI 10.1249/01.mss.0000227321.61964.09; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; Markovic G, 2005, COLLEGIUM ANTROPOL, V29, P93; Matthys SPJ, 2013, J SPORT SCI, V31, P325, DOI 10.1080/02640414.2012.733819; Matthys SPJ, 2011, EUR J SPORT SCI, V11, P355, DOI 10.1080/17461391.2010.523850; Norjali R, 2017, ARCH BUDO, V13, P161; Novak A.R., 2017, J MOTOR LEARN DEV, V5, P227, DOI [DOI 10.1123/JMLD.2016-0028, 10.1123/jmld.2016-0028]; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Pieter W, 2009, 2 INT S TAEKW STUD, P247; Pieter W, 1997, SCI COACHING OLYMPIC; Pion J., 2014, ARCH BUDO; Pion J, 2015, EUR J SPORT SCI, V15, P357, DOI 10.1080/17461391.2014.944875; Pion JA, 2015, J STRENGTH COND RES, V29, P1480, DOI 10.1519/JSC.0000000000000778; Poliszczuk T, 2016, COORDINATION ABILITI, V202; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Sadowski J, 2012, ARCH BUDO, V8, P141, DOI 10.12659/AOB.883279; Sherar LB, 2005, J PEDIATR-US, V147, P508, DOI 10.1016/j.jpeds.2005.04.041; Storm R., 2011, International Journal of Sport Management and Marketing, V7, P104, DOI 10.1504/IJSMM.2010.029715; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Vandorpe B, 2012, J SCI MED SPORT, V15, P220, DOI 10.1016/j.jsams.2011.09.006; Vandorpe B, 2012, J SPORT SCI, V30, P497, DOI 10.1080/02640414.2012.654399; Wazir MRWN, 2018, ARCH BUDO, V14, P33; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041	38	20	20	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217358	10.1371/journal.pone.0217358	http://dx.doi.org/10.1371/journal.pone.0217358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150424	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100041
J	Yang, WY; Lee, Y; Lu, H; Chou, CH; Wang, CL				Yang, Wen-Yuan; Lee, Yuejia; Lu, Hsinyi; Chou, Chung-Hsi; Wang, Chinling			Analysis of gut microbiota and the effect of lauric acid against necrotic enteritis in Clostridium perfringens and Eimeria side-by-side challenge model	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; CAMPYLOBACTER-JEJUNI COLONIZATION; BACTERIAL METABOLIC PRODUCTS; BROILER-CHICKENS; PREDISPOSING FACTORS; TRACT; ENTEROCOLITIS; TRIGLYCERIDES; PATHOGENESIS; COCCIDIOSIS	Gut microbiota has been demonstrated to be involved in intestinal nutrition, defense, and immunity, as well as participating in disease progression. This study was to investigate gut microbiota changes in chickens challenged with netB-positive Clostridium perfringens strain (CP1) and/or the predisposing Eimeria species (Eimeria) and fed diets with fishmeal supplementation. In addition, the effects of lauric acid, a medium-chain fatty acid (MCFA), on necrotic enteritis (NE) reduction and modulation of microbiota were evaluated. The results demonstrated that microbial communities in the jejunum were distinct from those in the cecum, and the microbial community change was more significant in jejunum. Challenge of CP1 in conjunction with Eimeria significantly reduced species diversity in jejunal microbiota, but cecal microbiota remained stable. In the jejunum, CP1 challenge increased the abundance of the genera of Clostridium sensu stricto 1, Escherichia Shigella, and Weissella, but significantly decreased the population of Lactobacillus. Eimeria infection on its own was unable to promote NE, demonstrating decrements of Clostridium sensu stricto 1 and Lactobacillus. Co-infection with CP1 and Eimeria reproduced the majority of NE lesions with significant increment of Clostridium sensu stricto 1 and reduction in Lactobacillus. The advance of changes on these two taxa increased the severity of NE lesions. Further analyses of metagenomeSeq, STAMP, and LEfSe consistently showed significant overgrowth of Clostridium sensu stricto 1 was associated with NE. The supplementation of lauric acid did not reduce NE incidence and severity but decreased the relative abundance of Escherichia Shigella. In conclusion, significant overgrowth of C. perfringens as well as other Clostridium species in Clostridium sensu stricto 1 with the decrement of Lactobacillus in the jejunum is the featured microbiota correlated with NE. Controlling proliferation of Clostridium sensu stricto 1 and manipulation of Lactobacillus in the jejunum should be the strategy to prevent NE.	[Yang, Wen-Yuan; Lee, Yuejia; Lu, Hsinyi; Wang, Chinling] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Starkville, MS 39762 USA; [Chou, Chung-Hsi] Natl Taiwan Univ, Zoonoses Res Ctr, Taipei, Taiwan; [Chou, Chung-Hsi] Natl Taiwan Univ, Sch Vet Med, Taipei, Taiwan	Mississippi State University; National Taiwan University; National Taiwan University	Wang, CL (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Starkville, MS 39762 USA.	cw57@msstate.edu		Yang, Wenyuan/0000-0001-8259-1454	USDA CRIS [1014508]; USDA, National Institute of Food and Agriculture [1014508]; College of Veterinary Medicine, Mississippi State University	USDA CRIS(United States Department of Agriculture (USDA)); USDA, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); College of Veterinary Medicine, Mississippi State University	C. Wang received the financial support from USDA CRIS Project Accession Number 1014508 for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors would like to thank Dr. John F. Prescott (University of Guelph, Ontario, Canada) for providing netB positive C. perfringens strain CP1. This work was supported by the USDA, National Institute of Food and Agriculture (CRIS Project Accession Number 1014508) and the College of Veterinary Medicine, Mississippi State University.	Altieri C, 2009, INT J FOOD SCI TECH, V44, P359, DOI 10.1111/j.1365-2621.2008.01744.x; Antonissen G, 2016, AVIAN PATHOL, V45, P308, DOI 10.1080/03079457.2016.1152625; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Bertevello PL, 2012, JPEN-PARENTER ENTER, V36, P442, DOI 10.1177/0148607111421788; BRANTON SL, 1987, POULTRY SCI, V66, P1326, DOI 10.3382/ps.0661326; Caly DL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cooper KK, 2013, J VET DIAGN INVEST, V25, P314, DOI 10.1177/1040638713483468; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Dahiya JP, 2006, ANIM FEED SCI TECH, V129, P60, DOI 10.1016/j.anifeedsci.2005.12.003; de los Santos FS, 2008, POULTRY SCI, V87, P800, DOI 10.3382/ps.2007-00280; de los Santos FS, 2009, POULTRY SCI, V88, P61, DOI 10.3382/ps.2008-00228; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Dierick Noel, 2004, Commun Agric Appl Biol Sci, V69, P187; Dittmar E, 2008, EUR J PEDIATR, V167, P891, DOI 10.1007/s00431-007-0614-9; Du EC, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0079-7; Du EC, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0055-7; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng YN, 2010, VET MICROBIOL, V140, P116, DOI 10.1016/j.vetmic.2009.07.001; Fusco V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00155; Gaucher ML, 2015, POULTRY SCI, V94, P1791, DOI 10.3382/ps/pev142; Heida FH, 2016, CLIN INFECT DIS, V62, P863, DOI 10.1093/cid/ciw016; Hermans D, 2012, POULTRY SCI, V91, P1733, DOI 10.3382/ps.2011-02106; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hilmarsson H, 2006, POULTRY SCI, V85, P588, DOI 10.1093/ps/85.4.588; Jiang YF, 2009, AVIAN DIS, V53, P409, DOI 10.1637/8656-021109-Reg.1; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Lakshminarayanan B, 2013, J MED MICROBIOL, V62, P457, DOI 10.1099/jmm.0.052258-0; Li C, 2017, AVIAN DIS, V61, P178, DOI 10.1637/11507-093016-Reg.1; Li Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188634; Lin YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182426; Liu D, 2010, AVIAN PATHOL, V39, P17, DOI 10.1080/03079450903447404; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martin TG, 2009, VET MICROBIOL, V136, P202, DOI 10.1016/j.vetmic.2008.10.026; Mathis G, 2018, EFFECT ORGANIC ACIDS; Moore RJ, 2016, AVIAN PATHOL, V45, P275, DOI 10.1080/03079457.2016.1150587; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Mwangi WN, 2010, DEV COMP IMMUNOL, V34, P406, DOI 10.1016/j.dci.2009.11.009; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Prescott JF, 2016, AVIAN PATHOL, V45, P317, DOI 10.1080/03079457.2016.1141345; Prescott JF, 2016, AVIAN PATHOL, V45, P288, DOI 10.1080/03079457.2016.1139688; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Skrivanova E, 2005, LETT APPL MICROBIOL, V41, P77, DOI 10.1111/j.1472-765X.2005.01709.x; Sluis W. van der, 2000, World Poultry, V16, P42; Stackebrandt E, 1999, FEMS IMMUNOL MED MIC, V24, P253, DOI 10.1111/j.1574-695X.1999.tb01291.x; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; Van Immerseel F, 2004, APPL ENVIRON MICROB, V70, P3582, DOI 10.1128/AEM.70.6.3582-3587.2004; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Wade B., 2015, World Poultry, V31, P16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams RB, 2005, AVIAN PATHOL, V34, P159, DOI 10.1080/03079450500112195; Williams RB, 2003, PARASITOL RES, V90, P19, DOI 10.1007/s00436-002-0803-4; Wohlgemuth S, 2011, GUT MICROBES, V2, P159, DOI 10.4161/gmic.2.3.16104; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Xiao YP, 2017, POULTRY SCI, V96, P1387, DOI 10.3382/ps/pew372; Xu S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20059-z; Yan W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45308; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Yu Q, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00975-16, 10.1128/iai.00975-16]; Zeiger K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175693; Zentek J., 2011, Animal Health Research Reviews, V12, P83, DOI 10.1017/S1466252311000089; Zentek J, 2012, ARCH ANIM NUTR, V66, P14, DOI 10.1080/1745039X.2011.644916; Zhou HZ, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-016-0152-y	81	45	46	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0205784	10.1371/journal.pone.0205784	http://dx.doi.org/10.1371/journal.pone.0205784			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150394	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100001
J	Carvalho, F; Brown, KA; Waller, MP; Bunting, MJ; Boom, A; Leng, MJ				Carvalho, Fabio; Brown, Kerry A.; Waller, Martyn P.; Bunting, M. Jane; Boom, Arnoud; Leng, Melanie J.			A method for reconstructing temporal changes in vegetation functional trait composition using Holocene pollen assemblages	PLOS ONE			English	Article							RICH-FEN SYSTEMS; LITTER DECOMPOSITION RATES; PLANT-COMMUNITIES; QUANTITATIVE RECONSTRUCTION; LAND-COVER; DIVERSITY; ECOSYSTEMS; ENGLAND; CLIMATE; WALES	Methods of reconstructing changes in plant traits over long time scales are needed to understand the impact of changing environmental conditions on ecosystem processes and services. Although Holocene pollen have been extensively used to provide records of vegetation history, few studies have adopted a functional trait approach that is pertinent to changes in ecosystem processes. Here, for woody and herbaceous fen peatland communities, we use modern pollen and vegetation data combined with pollen records from Holocene deposits to reconstruct vegetation functional dynamics. The six traits chosen (measures of leaf area-to-mass ratio and leaf nutrient content) are known to modulate species' fitness and to vary with changes in ecosystem processes. We fitted linear mixed effects models between community weighted mean (CWM) trait values of the modern pollen and vegetation to determine whether traits assigned to pollen types could be used to reconstruct traits found in the vegetation from pollen assemblages. We used relative pollen productivity (RPP) correction factors in an attempt to improve this relationship. For traits showing the best fit between modern pollen and vegetation, we applied the model to dated Holocene pollen sequences from Fenland and Romney Marsh in eastern and southern England and reconstructed temporal changes in trait composition. RPP adjustment did not improve the linear relationship between modern pollen and vegetation. Leaf nutrient traits (leaf C and N) were generally more predictable from pollen data than mass-area traits. We show that inferences about biomass accumulation and decomposition rates can be made using Holocene trait reconstructions. While it is possible to reconstruct community-level trends for some leaf traits from pollen assemblages preserved in sedimentary archives in wetlands, we show the importance of testing methods in modern systems first and encourage further development of this approach to address issues concerning the pollen-plant abundance relationship and pollen source area.	[Carvalho, Fabio; Brown, Kerry A.; Waller, Martyn P.] Kingston Univ London, Dept Geog & Geol, Kingston Upon Thames, Surrey, England; [Bunting, M. Jane] Univ Hull, Sch Environm Sci, Kingston Upon Hull, N Humberside, England; [Boom, Arnoud] Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England; [Leng, Melanie J.] British Geol Survey, NERC Isotope Geosci Lab, Nottingham, England; [Leng, Melanie J.] Univ Nottingham, Sch Biosci, Ctr Environm Geochem, Loughborough, Leics, England	Kingston University; University of Hull; University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham	Carvalho, F (corresponding author), Kingston Univ London, Dept Geog & Geol, Kingston Upon Thames, Surrey, England.	fabiocgs@yahoo.com	Brown, Kerry/U-5082-2019; Carvalho, Fabio/AAB-5806-2020	Carvalho, Fabio/0000-0002-6305-5602; BROWN, KERRY/0000-0002-6342-8966; Boom, Arnoud/0000-0003-1299-691X	Faculty of Sciences, Engineering and Computing at Kingston University London	Faculty of Sciences, Engineering and Computing at Kingston University London	F.C. was funded through a PhD studentship from the Faculty of Sciences, Engineering and Computing at Kingston University London. Field work and laboratory analyses were supported by the Department of Geography and Geology at Kingston University London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alan Bowley and Craig Bellwood at Natural England and Debs Kershaw at the Norfolk Wildlife Trust for access to and information about Woodwalton Fen and Upton Broad, respectively. Jim Innes and Antony Long are thanked for giving us permission to use the data from Brookland. F.C. was funded through a PhD studentship from the Faculty of Sciences, Engineering and Computing at Kingston University London. Field work and laboratory analyses were supported by the Department of Geography and Geology at Kingston University London.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Birks HJB, 2014, VEG HIST ARCHAEOBOT, V23, P309, DOI 10.1007/s00334-013-0430-2; Brussel T, 2018, J VEG SCI, V29, P450, DOI 10.1111/jvs.12654; Bunting MJ, 2005, HOLOCENE, V15, P459, DOI 10.1191/0959683605hl821rr; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Davis BAS, 2015, VEG HIST ARCHAEOBOT, V24, P303, DOI 10.1007/s00334-014-0476-9; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dorrepaal E, 2005, J ECOL, V93, P817, DOI 10.1111/j.1365-2745.2005.01024.x; Dunn C, 2011, CARBON MANAG, V2, P289, DOI 10.4155/CMT.11.23; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Gaillard MJ, 2010, CLIM PAST, V6, P483, DOI 10.5194/cp-6-483-2010; Gaillard MJ, 2008, VEG HIST ARCHAEOBOT, V17, P415, DOI [10.1007/s00334-008-0170-x, 10.1007/s00334-008-0169-3]; Garnier E., 2016, PLANT FUNCTIONAL DIV, V1st, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Grant MJ, 2017, MICROPALEAEONTOLOGIC, P103; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hagemann U, 2015, SOIL BIOL BIOCHEM, V87, P10, DOI 10.1016/j.soilbio.2015.04.002; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Jeffers ES, 2015, QUATERNARY SCI REV, V112, P17, DOI 10.1016/j.quascirev.2014.12.018; Jeffers ES, 2015, J ECOL, V103, P459, DOI 10.1111/1365-2745.12365; Keddy PA, 2010, WETLAND ECOLOGY PRIN, Vxvi; Lacourse T, 2009, ECOLOGY, V90, P2149, DOI 10.1890/08-1136.1; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2013, J ECOL, V101, P4, DOI 10.1111/1365-2745.12031; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Marquer L, 2014, QUATERNARY SCI REV, V90, P199, DOI 10.1016/j.quascirev.2014.02.013; Mazier F, 2012, REV PALAEOBOT PALYNO, V187, P38, DOI 10.1016/j.revpalbo.2012.07.017; Moor H., 2017, Journal of Ecology (Oxford), V105, P1623, DOI 10.1111/1365-2745.12734; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pillar VD, 1999, J VEG SCI, V10, P631, DOI 10.2307/3237078; Pirzamanbein B, 2014, ECOL COMPLEX, V20, P127, DOI 10.1016/j.ecocom.2014.09.005; Prentice IC, 2009, CLIM PAST, V5, P297, DOI 10.5194/cp-5-297-2009; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; R Development Core Team, 2018, R LANG ENV STAT COMP; Reitalu T, 2015, J VEG SCI, V26, P911, DOI 10.1111/jvs.12300; Skiba MW, 2011, BIOCHEM SOC T, V39, P275, DOI 10.1042/BST0390275; Sokal R.R., 2012, BIOMETRY PRINCIPLES; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Sugita S, 2007, HOLOCENE, V17, P229, DOI 10.1177/0959683607075837; Sugita S, 2007, HOLOCENE, V17, P243, DOI 10.1177/0959683607075838; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vincens A, 2007, REV PALAEOBOT PALYNO, V145, P135, DOI 10.1016/j.revpalbo.2006.09.004; Waller M., 1994, E ANGLIAN ARCHAEOLOG, V70, P353; Waller M, 2017, REV PALAEOBOT PALYNO, V238, P15, DOI 10.1016/j.revpalbo.2016.11.007; Waller MP, 2005, REV PALAEOBOT PALYNO, V133, P179, DOI 10.1016/j.revpalbo.2004.10.001; Waller MP, 1999, QUATERNARY SCI REV, V18, P1419, DOI 10.1016/S0277-3791(98)00072-9; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; WHEELER BD, 1980, J ECOL, V68, P365, DOI 10.2307/2259411; WHEELER BD, 1980, J ECOL, V68, P761, DOI 10.2307/2259455; WHEELER BD, 1993, BIODIVERS CONSERV, V2, P490, DOI 10.1007/BF00056744; WHEELER BD, 1980, J ECOL, V68, P405, DOI 10.2307/2259413; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yu ZC, 2012, BIOGEOSCIENCES, V9, P4071, DOI 10.5194/bg-9-4071-2012	67	13	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216698	10.1371/journal.pone.0216698	http://dx.doi.org/10.1371/journal.pone.0216698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141538	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000469323000019
J	Oyeniran, AA; Bello, FA; Oluborode, B; Awowole, I; Loto, OM; Irinyenikan, TA; Fabamwo, AO; Olutayo, L; Ganatra, B; Guest, P; Fawole, B				Oyeniran, Agnes A.; Bello, Folasade A.; Oluborode, Babawale; Awowole, Ibraheem; Loto, Olabisi M.; Irinyenikan, Theresa A.; Fabamwo, Adetokunbo O.; Olutayo, Lanre; Ganatra, Bela; Guest, Philip; Fawole, Bukola			Narratives of women presenting with abortion complications in Southwestern Nigeria: A qualitative study	PLOS ONE			English	Article							SERVICES	Unsafe abortion continues to impact negatively on women's health in countries with restrictive abortion laws. It remains one of the leading causes of maternal mortality and morbidity. Paradoxically, modern contraceptive prevalence remains low and the unmet need for contraception continues to mirror unwanted pregnancy rates in many countries within subSaharan Africa. This qualitative study assessed women's knowledge; their expectation and experiences of the methods employed for abortion; and their health care-seeking decisions following a complicated abortion. Women who presented with abortion complications were purposively sampled from seven health facilities in south-west Nigeria. In-depth interviews were conducted by social scientists with the aid of a semi-structured interview guide. Coding schemes were developed and content analysis was performed with WEFTQDA software. Thirty-one women were interviewed. Misoprostol was used by 16 women; 15 women used other methods. About one-fifth of respondents were aged. 20 years; almost one-third were students. Common reasons for terminating a pregnancy were: " too young/still in school/ training"; "has enough number of children"; "last baby too young" and "still breastfeeding". Women had little knowledge about methods used. Friends, nurses or pharmacists were the commonest sources of information. Awareness about use of misoprostol for abortion among women was high. Women used misoprostol to initiate an abortion and were often disappointed if misoprostol did not complete the abortion process. Given its clandestine manner, women were financially exploited by the abortion providers and only presented to hospitals for post-abortion care as a last resort. Women's narratives of their abortion experience highlight the difficulties and risks women encounter to safeguard and protect their sexual and reproductive health. To reduce unsafe abortion therefore, urgent and synergized efforts are required to promote prompt access to family planning and post-abortion care services.	[Oyeniran, Agnes A.] Univ Ibadan, Dept Hlth Promot & Educ, Coll Med, Ibadan, Nigeria; [Bello, Folasade A.; Fawole, Bukola] Univ Ibadan, Dept Obstet & Gynaecol, Coll Med, Ibadan, Nigeria; [Oluborode, Babawale; Awowole, Ibraheem; Loto, Olabisi M.] Obafemi Awolowo Univ, Dept Obstet & Gynaecol, Ife, Nigeria; [Irinyenikan, Theresa A.] State Specialist Hosp, Dept Obstet & Gynaecol, Akure, Nigeria; [Fabamwo, Adetokunbo O.] Lagos State Univ, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria; [Olutayo, Lanre] Univ Ibadan, Dept Sociol, Fac Social Sci, Ibadan, Nigeria; [Ganatra, Bela] WHO, World Bank Special Programme Res Dev & Res Traini, UNICEF, UNFPA,UNDP, Geneva, Switzerland; [Guest, Philip] Inst Populat & Social Res, Bangkok, Thailand	University of Ibadan; University of Ibadan; Obafemi Awolowo University; Lagos State University; University of Ibadan; The World Bank; United Nations Population Fund; World Health Organization	Bello, FA (corresponding author), Univ Ibadan, Dept Obstet & Gynaecol, Coll Med, Ibadan, Nigeria.	dr.nikebello@yahoo.com		Bello, Folasade Adenike/0000-0002-3337-3335; Awowole, Ibraheem/0000-0001-7006-0824; Ganatra, Bela/0000-0002-4812-4577	World Health Organization	World Health Organization(World Health Organization)	The study was supported with a grant from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinma ED, 2012, SE ASIAN J TROP MED, V43, P471; Adinma ED, 2012, PRECONCEPTION POSTPA, P125; Adinma JIB, 2010, SE ASIAN J TROP MED, V41, P696; Adinma JI, 2010, INT J GYNECOL OBSTET, V111, P53, DOI 10.1016/j.ijgo.2010.06.003; Aniteye Patience, 2011, Afr J Reprod Health, V15, P47; [Anonymous], UNWANTED PREGNANCY I; Awoyemi BO, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0003-9; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Barot S, 2011, GUTTMACHER POLICY RE, V14, P24; Bello FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209415; Centre for Reproductive Rights, 2018, NIG AB PROV; Centre for Reproductive Rights, 1998, WOM REPR RIGHTS NIG; Emechebe C, 2016, SAUDI J HLTH SCI, V5, P34; Ganatra B, 2004, INFORMAL PROVIDERS A; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Government of the Federal Republic of Nigeria, 2015, MILL DEV GOALS END P; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Ilobinso LO, 2007, POLICY ABORTION NIGE; International Consortium, 2012, EM CONTR PILLS MED S; Kaluarachchi Athula, 2018, J Family Med Prim Care, V7, P1521, DOI 10.4103/jfmpc.jfmpc_188_18; Kumar R, 2013, AM J PUBLIC HEALTH, V103, P400, DOI 10.2105/AJPH.2012.301154; Lamina M A, 2015, Ghana Med J, V49, P187, DOI 10.4314/gmj.v49i3.10; Mya WW, 2016, RCOG WORLD C 2016; Okonofua FE, 2005, ACTA OBSTET GYN SCAN, V84, P270, DOI 10.1111/j.0001-6349.2005.00405.x; Omokhodion FO, 2017, AFR J REPROD HEALTH, V21, P114, DOI 10.29063/ajrh2017/v21i1.11; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Orisaremi TC, 2012, AFR SOCIOL REV, V16, P61; Oye-Adeniran BA, 2002, REPROD HEALTH MATTER, V10, P18, DOI 10.1016/S0968-8080(02)00024-1; Oye-Adeniran Boniface A, 2004, Afr J Reprod Health, V8, P103, DOI 10.2307/3583397; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Soe YY, 2016, RCOG WORLD C 2016; Tayo A, 2014, INT J MED MED SCI, V4, P47; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Warriner IK., 2006, PREVENTING UNSAFE AB; WHO, 2006, RED UNS AB; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2014, CLIN PRACT HDB SAF A	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217616	10.1371/journal.pone.0217616	http://dx.doi.org/10.1371/journal.pone.0217616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141550	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000067
J	Ferra, BT; Holec-Gasior, L; Gatkowska, J; Dziadek, B; Dzitko, K; Grazlewska, W; Lautenbach, D				Ferra, Bartlomiej Tomasz; Holec-Gasior, Lucyna; Gatkowska, Justyna; Dziadek, Bozena; Dzitko, Katarzyna; Grazlewska, Weronika; Lautenbach, Dariusz			The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IMMUNOGLOBULIN-G AVIDITY; INFECTION; SERODIAGNOSIS; DIAGNOSIS; SCHIZOPHRENIA; COMBINATION; EXPRESSION; PREGNANCY; PARASITES	This study presents an evaluation of four tetravalent recombinant chimeric proteins containing fragments of the Toxoplasma gondii antigens, SAG2, GRA1, ROP1 and AMA1, as potential replacements of a the soluble, whole-cell tachyzoite lysate (TLA) used in serological assays. Recombinant chimeric proteins (SAG2-GRA1-ROP1-AMA1N, AMA1N-SAG2-GRA1-ROP1, AMA1C-SAG2-GRA1-ROP1, and AMA1-SAG2-GRA1-ROP1) obtained by genetic engineering were tested for their reactivity with specific IgM and IgG antibodies from sera of experimentally infected mice and humans with T. gondii infection using an enzyme linked immunosorbent assay (ELISA). In total 192 serum samples from patients with acquired T. gondii infection and 137 sera from seronegative individuals were examined. The reactivity of chimeric antigens with antibodies generated during T. gondii invasion was measured and compared to the results obtained in assays based on whole-cell Toxoplasma antigen. Chimeric proteins proved effective in differentiation between T. gondii-infected and uninfected individuals (100% sensitivity and specificity in the IgG ELISAs) which shows their potential usefulness as a replacements for TLA in standardized commercial tests for the serodiagnosis of toxoplasmosis. In addition, the chimeric proteins were tested for use in avidity determination. Obtained results were comparable to those of the corresponding commercial assays, suggesting the utility of these proteins for avidity assessment. Furthermore, this study demonstrated that the AMA1-SAG2-GRA1-ROP1 chimeric protein has the potential to distinguish specific antibodies from serum samples of individuals with the early and chronic phase of T. gondii infection.	[Ferra, Bartlomiej Tomasz; Holec-Gasior, Lucyna; Grazlewska, Weronika] Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Gatkowska, Justyna; Dziadek, Bozena; Dzitko, Katarzyna] Univ Lodz, Fac Biol & Environm Protect, Dept Immunoparasitol, Lodz, Poland; [Lautenbach, Dariusz] Med Univ Gdansk, Dept Obstet, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; University of Lodz; Fahrenheit Universities; Medical University Gdansk	Ferra, BT (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland.	barferra@pg.edu.pl	Ferra, BartÅomiej/AAA-8476-2019	Ferra, BartÅomiej/0000-0003-2176-3966; Dziadek, Bozena/0000-0002-4942-7385; Holec-Gasior, Lucyna/0000-0001-5421-6905; Gatkowska, Justyna/0000-0002-0559-1706; Dzitko, Katarzyna/0000-0002-3265-0409; Grazlewska, Weronika/0000-0001-6420-4721	National Science Centre (Poland) [UMO-2015/17/B/NZ6/03480]	National Science Centre (Poland)	This work was financed by the National Science Centre (Poland), granted under the project No. UMO-2015/17/B/NZ6/03480 for the years 2016-2019, to LH-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise-Thomas P, 2001, PARASITOLOGY, V122, pS65, DOI 10.1017/S0031182000017339; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Beghetto E, 2005, J INFECT DIS, V191, P637, DOI 10.1086/427660; Beghetto E, 2003, J CLIN MICROBIOL, V41, P5414, DOI 10.1128/JCM.41.12.5414-5418.2003; Beghetto E, 2001, INT J PARASITOL, V31, P1659, DOI 10.1016/S0020-7519(01)00288-0; Beghetto E, 2006, J CLIN MICROBIOL, V44, P2133, DOI 10.1128/JCM.00237-06; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; Coppens I, 1999, EUR J CELL BIOL, V78, P463, DOI 10.1016/S0171-9335(99)80073-9; Costa JG, 2017, CLIN CHEM LAB MED, V55, P595, DOI 10.1515/cclm-2016-0331; Dai JF, 2013, EXP PARASITOL, V133, P95, DOI 10.1016/j.exppara.2012.10.016; Dai JF, 2012, CLIN VACCINE IMMUNOL, V19, P338, DOI 10.1128/CVI.05553-11; Drapala D, 2015, DIAGN MICR INFEC DIS, V82, P34, DOI 10.1016/j.diagmicrobio.2015.01.018; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Ferra B, 2015, PARASITOL RES, V114, P3291, DOI 10.1007/s00436-015-4552-6; Ferra B, 2015, PARASITOL INT, V64, P288, DOI 10.1016/j.parint.2015.03.004; Gatkowska J, 2006, EXP PARASITOL, V114, P220, DOI 10.1016/j.exppara.2006.03.011; Godwin R, 2012, VET REC, V171, P225, DOI 10.1136/vr.e5832; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hiszczynska-Sawicka E, 2003, PROTEIN EXPRES PURIF, V27, P150, DOI 10.1016/S1046-5928(02)00593-4; Holec L, 2007, CLIN VACCINE IMMUNOL, V14, P220, DOI 10.1128/CVI.00419-06; Holec-Gasior L, 2013, CLIN VACCINE IMMUNOL, V20, P1343, DOI 10.1128/CVI.00117-13; Holec-Gasior L, 2012, CLIN VACCINE IMMUNOL, V19, P1977, DOI 10.1128/CVI.00452-12; Holec-Gasior L, 2012, CLIN VACCINE IMMUNOL, V19, P57, DOI 10.1128/CVI.05433-11; Holec-Gasior L, 2010, POL J MICROBIOL, V59, P307; Holec-Gasior L, 2009, CLIN VACCINE IMMUNOL, V16, P510, DOI 10.1128/CVI.00341-08; Lalitha SG, 2016, J PHARM NEGAT RESULT, V7, P16, DOI 10.4103/0976-9234.177055; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; Lau YL, 2011, PARASITOL RES, V109, P871, DOI 10.1007/s00436-011-2315-6; Lecordier L, 2000, CLIN DIAGN LAB IMMUN, V7, P607, DOI 10.1128/CDLI.7.4.607-611.2000; Li SL, 2000, CLIN DIAGN LAB IMMUN, V7, P781, DOI 10.1128/CDLI.7.5.781-787.2000; Liu Q, 2017, EXP PARASITOL, V176, P89, DOI 10.1016/j.exppara.2017.03.001; MACEDO AG, 2013, BIOMED CENTRAL, V6, DOI DOI 10.1186/1756-3305-6-163; Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; PARMLEY SF, 1992, J CLIN MICROBIOL, V30, P1127, DOI 10.1128/JCM.30.5.1127-1133.1992; Paul M, 1999, CLIN DIAGN LAB IMMUN, V6, P514, DOI 10.1128/CDLI.6.4.514-518.1999; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Petersen E, 2005, J CLIN MICROBIOL, V43, P1570, DOI 10.1128/JCM.43.4.1570-1574.2005; Pietkiewicz H, 2007, PARASITOL RES, V100, P333, DOI 10.1007/s00436-006-0265-1; Poukchanski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070637; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rostami A, 2018, INFECTION, V46, P303, DOI 10.1007/s15010-017-1111-3; Sensini A, 2006, CLIN MICROBIOL INFEC, V12, P504, DOI 10.1111/j.1469-0691.2006.01444.x; Sensini Alessandra, 1996, Clin Microbiol Infect, V2, P25, DOI 10.1111/j.1469-0691.1996.tb00196.x; Soldati D, 1998, MOL BIOCHEM PARASIT, V96, P37, DOI 10.1016/S0166-6851(98)00090-5; Stommel EW, 2002, CRYPTOGENIC EPILEPSY, V42, P436, DOI [10.1046/j.1528-1157.2001.25500.x, DOI 10.1046/J.1528-1157.2001.25500.X]; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TENTER AM, 1991, PARASITOL RES, V77, P197, DOI 10.1007/BF00930858; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Webster JP, 2013, J EXP BIOL, V216, P99, DOI 10.1242/jeb.074716; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217866	10.1371/journal.pone.0217866	http://dx.doi.org/10.1371/journal.pone.0217866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170254	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700073
J	Franco-Santos, RM; Auel, H; Boersma, M; De Troch, M; Graeve, M; Meunier, CL; Niehoff, B				Franco-Santos, Rita M.; Auel, Holger; Boersma, Maarten; De Troch, Marleen; Graeve, Martin; Meunier, Cedric L.; Niehoff, Barbara			You are not always what you eat-Fatty acid bioconversion and lipid homeostasis in the larvae of the sand mason worm Lanice conchilega	PLOS ONE			English	Article							BIOCHEMICAL-COMPOSITION; NUTRITIONAL IMPORTANCE; CALANUS-FINMARCHICUS; TEMORA-LONGICORNIS; TROPHIC MARKERS; 1766 ANNELIDA; PALLAS; ZOOPLANKTON; GROWTH; DIET	The meroplanktonic larvae of benthic organisms are an important seasonal component of the zooplankton in temperate coastal waters. The larvae of the reef-building polychaete Lanice conchilega contribute up to 15% of the summer zooplankton biomass in the North Sea. Despite their importance for reef maintenance (which positively affects the benthic community), little is known about the trophic ecology of this meroplanktonic larva. Qualitative and quantitative estimates of carbon (C) transfer between trophic levels and of fatty acid (FA) specific assimilation, biosynthesis, and bioconversion can be obtained by compound-specific stable isotope analysis of FA. The present work tested the hypothesis that the concept of fatty acid trophic markers (FATM), widely used for studies on holoplankton with intermediate to high lipid contents, is also applicable to lipid-poor organisms such as meroplanktonic larvae. The incorporation of isotopically-enriched dietary C by L. conchilega larvae was traced, and lipid assimilation did not follow FA-specific relative availabilities in the diet. Furthermore, FAs that were unavailable in the diet, such as 22:5(n-3), were recorded in L. conchilega, suggesting their bioconversion by the larvae. The results indicate that L. conchilega larvae preferentially assimilate certain FAs and regulate their FA composition (lipid homeostasis) independently of that of their diet. Their quasi-homeostatic response to dietary FA availability could imply that the concept of FATM has limited application in lipid-poor organisms such as L. conchilega larvae.	[Franco-Santos, Rita M.; Auel, Holger; Boersma, Maarten] Univ Bremen, Marine Zool, Bremen, Germany; [Franco-Santos, Rita M.; Niehoff, Barbara] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany; [Franco-Santos, Rita M.; De Troch, Marleen] Univ Ghent, Marine Biol, Ghent, Belgium; [Boersma, Maarten; Meunier, Cedric L.] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Biol Anstalt Helgoland, Helgoland, Germany; [Graeve, Martin] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Ecol Chem, Bremerhaven, Germany	University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Franco-Santos, RM (corresponding author), Univ Bremen, Marine Zool, Bremen, Germany.; Franco-Santos, RM; Niehoff, B (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany.; Franco-Santos, RM (corresponding author), Univ Ghent, Marine Biol, Ghent, Belgium.	ritinhamf@hotmail.com; barbara.niehoff@awi.de	De Troch, Marleen/AAB-9809-2019; Franco-Santos, Rita M/G-8736-2014; Meunier, Cedric L/K-2792-2015; Boersma, Maarten/A-5475-2013; Graeve, Martin/B-5751-2017	De Troch, Marleen/0000-0002-6800-0299; Franco-Santos, Rita M/0000-0001-7846-3425; Meunier, Cedric L/0000-0002-4070-4286; Boersma, Maarten/0000-0003-1010-026X; Graeve, Martin/0000-0002-2294-1915	MARES Doctoral Programme on Marine Ecosystem Health and Conservation [2011-0016]; Ghent University (BOF-GOA project) [01G02617]; Bundesministerium fur Bildung und Forschung (BMBF) [01LN1702A]	MARES Doctoral Programme on Marine Ecosystem Health and Conservation; Ghent University (BOF-GOA project); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	RMF-S received a scholarship from the MARES Doctoral Programme on Marine Ecosystem Health and Conservation (www.mareseu.org) (Framework Agreement Number 2011-0016). MDT was supported by Ghent University (www.ugent.be) (BOF-GOA project 01G02617). CLM was supported by the Bundesministerium fur Bildung und Forschung (www.bmbf.de) (BMBF grant no. 01LN1702A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RMS, 2017, J EXP MAR BIOL ECOL, V489, P15, DOI 10.1016/j.jembe.2017.01.005; Antony Geetha, 2001, Indian Journal of Fisheries, V48, P41; Ben-David-Zaslow R, 2000, J EXP ZOOL, V287, P401, DOI 10.1002/1097-010X(20001101)287:6<401::AID-JEZ1>3.0.CO;2-4; BHAUD M, 1988, OPHELIA, V29, P141, DOI 10.1080/00785326.1988.10430825; BHAUD MR, 1990, J EXP MAR BIOL ECOL, V141, P31, DOI 10.1016/0022-0981(90)90155-6; Boissonnot L, 2016, J PLANKTON RES, V38, P1420, DOI 10.1093/plankt/fbw076; BRABER L, 1973, Netherlands Journal of Sea Research, V6, P163, DOI 10.1016/0077-7579(73)90011-2; Braeckman U, 2012, J SEA RES, V68, P6, DOI 10.1016/j.seares.2011.11.003; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Budge SM, 2011, J EXP BIOL, V214, P3790, DOI 10.1242/jeb.057596; Buhr K.-J., 1977, BIOL BENTHIC ORGANIS, P101, DOI [10.1016/b978, DOI 10.1016/B978]; BUHR KJ, 1976, MAR BIOL, V38, P373, DOI 10.1007/BF00391377; Callaway R, 2006, MAR ECOL PROG SER, V308, P49, DOI 10.3354/meps308049; Callaway R, 2003, HYDROBIOLOGIA, V503, P121, DOI 10.1023/B:HYDR.0000008494.20908.87; Clarke KR, 2015, PRIMER V7 USER MANUA; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/s0065-2881(03)46005-7; De Smet B, 2013, MAR BIOL, V160, P751, DOI 10.1007/s00227-012-2130-3; De Troch M, 2012, MAR ECOL PROG SER, V465, P53, DOI 10.3354/meps09920; DIEL S, 1992, MAR BIOL, V113, P21, DOI 10.1007/BF00367634; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; Franco-Santos RM, 2018, J PLANKTON RES, V40, P420, DOI 10.1093/plankt/fby016; Godet L, 2008, AMBIO, V37, P347, DOI 10.1579/07-A-317.1; GOSWAMI SC, 1981, INDIAN J MAR SCI, V10, P296; Graeve M, 2005, J EXP MAR BIOL ECOL, V317, P109, DOI 10.1016/j.jembe.2004.11.016; GRAEVE M, 1994, J EXP MAR BIOL ECOL, V182, P97, DOI 10.1016/0022-0981(94)90213-5; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Hagen W, 2001, MAR BIOL, V139, P95, DOI 10.1007/s002270000527; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; HARMS J, 1994, MAR ECOL PROG SER, V108, P107, DOI 10.3354/meps108107; HARMS J, 1991, J EXP MAR BIOL ECOL, V145, P233, DOI 10.1016/0022-0981(91)90178-Y; HICKEL W, 1975, HELGOLAND WISS MEER, V27, P254, DOI 10.1007/BF01611694; HIS E, 1988, AQUACULTURE, V69, P185, DOI 10.1016/0044-8486(88)90195-0; HOLLAND DL, 1975, J CONSEIL, V36, P162; Jeffreys RM, 2009, DEEP-SEA RES PT I, V56, P1816, DOI 10.1016/j.dsr.2009.05.001; JOHNSTON PV, 1985, ADV LIPID RES, V21, P103; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Kreibich T, 2011, J EXP MAR BIOL ECOL, V407, P182, DOI 10.1016/j.jembe.2011.06.013; LEE RF, 1975, COMP BIOCHEM PHYS B, V51, P263, DOI 10.1016/0305-0491(75)90003-6; LEE RF, 1974, J FISH RES BOARD CAN, V31, P1577, DOI 10.1139/f74-198; LEE RF, 1971, MAR BIOL, V9, P99, DOI 10.1007/BF00348249; LEE RF, 1974, MAR BIOL, V26, P313, DOI 10.1007/BF00391515; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li HY, 2014, MAR DRUGS, V12, P153, DOI 10.3390/md12010153; Lourenco S, 2017, FRONT PHYSIOL, V8, P1, DOI [10.3389/fphys.2017.00001, DOI 10.3389/FPHYS.2017.00001]; MANN R, 1985, J EXP MAR BIOL ECOL, V85, P211, DOI 10.1016/0022-0981(85)90159-5; Mansour MP, 2005, BIOCHEM SYST ECOL, V33, P659, DOI 10.1016/j.bse.2004.12.011; Meier-Augenstein W, 2002, ANAL CHIM ACTA, V465, P63, DOI 10.1016/S0003-2670(02)00194-0; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Muller-Navarra DC, 2006, ARCH HYDROBIOL, V167, P501, DOI 10.1127/0003-9136/2006/0167-0501; Orellana MC, 1996, BRYOZOANS SPACE TIME; Parsons TR, 1977, BIOL OCEANOGRAPHIC P, P40; Petersen B, 1999, MAR ECOL PROG SER, V178, P229, DOI 10.3354/meps178229; Pond DW, 2002, MAR ECOL PROG SER, V225, P219, DOI 10.3354/meps225219; R Core Team, 2018, R LANG ENV STAT COMP; Rabaut M, 2009, THESIS; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; REINHARDT SB, 1986, MAR BIOL, V91, P149, DOI 10.1007/BF00569431; Rix L, 2018, MAR ECOL PROG SER, V589, P85, DOI 10.3354/meps12443; Ropert M, 2000, OCEANOL ACTA, V23, P529, DOI 10.1016/S0399-1784(00)00143-2; Rotllant G, 2004, HELGOLAND MAR RES, V58, P206, DOI 10.1007/s10152-004-0186-2; SARGENT JR, 1988, HYDROBIOLOGIA, V167, P101, DOI 10.1007/BF00026297; Scott CL, 2000, POLAR BIOL, V23, P510, DOI 10.1007/s003000000114; Strasser M, 2001, HELGOLAND MAR RES, V55, P176, DOI 10.1007/s101520100081; Thatje S, 2004, J EXP MAR BIOL ECOL, V301, P159, DOI 10.1016/j.jembe.2003.09.019; Thor P, 2007, MAR ECOL PROG SER, V331, P131, DOI 10.3354/meps331131; Umezawa Y, 2018, MAR ECOL PROG SER, V592, P141, DOI 10.3354/meps12507; Van Hoey G., 2006, THESIS GHENT U BELGI; VAZQUEZ R, 1994, AQUACULTURE, V119, P273, DOI 10.1016/0044-8486(94)90182-1; Wang M, 2014, PROG OCEANOGR, V122, P153, DOI 10.1016/j.pocean.2014.01.003; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wegener G, 2012, ENVIRON MICROBIOL, V14, P1517, DOI 10.1111/j.1462-2920.2012.02739.x; WHYTE JNC, 1992, J EXP MAR BIOL ECOL, V163, P13, DOI 10.1016/0022-0981(92)90144-Y; Zuhlke R, 2001, J SEA RES, V46, P261, DOI 10.1016/S1385-1101(01)00091-0; Zuhlke Ruth, 1998, Senckenbergiana Maritima, V29, P131	76	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218015	10.1371/journal.pone.0218015	http://dx.doi.org/10.1371/journal.pone.0218015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170238	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700093
J	Horiike, R; Nakai, H; Itatani, T; Shirai, F; Konishi, K				Horiike, Ryo; Nakai, Hisao; Itatani, Tomoya; Shirai, Fumie; Konishi, Kaoru			Using GIS to simulate tsunami evacuation guidance signs for the hearing impaired	PLOS ONE			English	Article								The Nankai Trough in Japan has been identified as a geological feature that could cause extensive damage in the event of a major earthquake. In this study, we investigated the impact of effective guidance signs for hearing-impaired individuals requiring special care when escaping to a tsunami evacuation building (emergency evacuation location) using geographical information system (GIS) and viewshed analysis. We selected an area we considered would suffer severe damage following a major earthquake and tsunami; we identified difficulties in the provision of escape routes. Using GIS, we determined the time required for escape and tsunami arrival time if effective signs were installed; we undertook such analysis using the height data of buildings in the target area. With effectively installed guidance signs, the average required evacuation time was 36.88 minutes; without such signs (which is currently the case in the target area), the average time was 47.10 minutes: that would result in citizens getting caught by the tsunami. Installing effective guidance signs would allow hearing-impaired individuals to escape to an evacuation building before being hit by the tsunami.	[Horiike, Ryo] Hlth Policy Dept, Med Policy Sect, Kochi, Kochi, Japan; [Nakai, Hisao] Kanazawa Med Univ, Nursing Dept, Kanazawa, Ishikawa, Japan; [Itatani, Tomoya] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Doctoral Course, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Shirai, Fumie; Konishi, Kaoru] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan	Kanazawa Medical University; Kanazawa University; Osaka University	Horiike, R (corresponding author), Hlth Policy Dept, Med Policy Sect, Kochi, Kochi, Japan.	spi4949@gmail.com		Horiike, Ryo/0000-0001-9126-3727				Ai FL, 2016, SAFETY SCI, V90, P62, DOI 10.1016/j.ssci.2015.09.022; [Anonymous], 2018, KOUCH BOUS MAP; [Anonymous], 2012, KOCH KEN BAN DAI 2 D; [Anonymous], 2018, CHOUK HYOUK NIYOR JI; [Anonymous], 2013, KOCH TSUN HIN KEIK S; [Anonymous], 2015, KOCH TSUN HIN KEIK; [Anonymous], 2018, KOUCH SUIK JINK; [Anonymous], 2013, NANK TROUGH EARTHQ N; ashie Yasunobu, 2010, HIGH RESOLUTION NUME; Atsushi O, 2007, SEISAN KENKYU, V59, P295; Bradshaw Wayne, 2013, Aust Nurs J, V21, P32; Cabinet Office, SAIG YOUH; Cuckovi Z, 2016, J OPEN SOURCE SOFTW, V1, DOI [DOI 10.21105/JOSS.00032, 10.21105/joss.00032]; Fire and Disaster Management Agency, 1999, YUD OYOB YUD NI KAK; Fire and Disaster Management Agency, 2018, GAIK YA SYOUG GA RIY; Fujiwara Y., 2009, J JPN SOC CIV ENG A1, V65, P757; Geospatial Information Authority of Japan, FUND GEOSP DAT DOWNL; Global Open Data Index, PLAC OV; Hitoshi G, 2009, J JAPAN SOC CIV ENG, V53, P1311; Imamura F, 2009, J EARTHQ TSUNAMI, V3, P59, DOI 10.1142/S1793431109000457; Japan Tourism Agency, 2017, KANK RIKK SUISH KEIK; Japanese Federation of the Deaf, 2011, CHOUK SAIG ANP MAN; Klynman Y., 2007, WORLD DISASTERS REPO; Kwan MP, 2010, COMPUT ENVIRON URBAN, V34, P179, DOI 10.1016/j.compenvurbsys.2010.02.001; Lonergan C, 2015, NAT HAZARDS, V78, P41, DOI 10.1007/s11069-015-1696-8; Mamiooki Naoto T, 2009, J ARCH PLANN, V74, P1523; Manley M, 2012, EXPERT SYST APPL, V39, P8300, DOI 10.1016/j.eswa.2012.01.169; Ministry of Economy T and I, 2014, TSUN EV GUID SAF SIG; Ministry of Internal Affairs and Communications J, 2017, ACT PROM TSUN COUNT; Ministry of Land Infrastructure T and T, 2013, TSUN HIN WO SOUT SIT; Ministry of Land Infrastructure T and T, 2018, KOUK KOTS NO RYOK NI; Minoru A., QGIS2THREEJS PLUGIN; Nakai H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199252; Nippon Signs Association, 2014, GUID TSUN SIGNS; Shekhar S, 2012, INT J GEOGR INF SCI, V26, P2253, DOI 10.1080/13658816.2012.719624; Shinji Y, 2015, AIJ J TECHNOL DES, V21, P873; Tatsuki S, 2012, INT J JPN SOCIOL, V21, P12, DOI 10.1111/j.1475-6781.2012.01158.x; Thi N, 2012, INT J COMPT SCI ARTI, V2, P33; United Nations, SUST DEV GOALS; US Department of Commerce NO and AA, WHAT IS LIDAR; Wood N, 2016, INT J DISAST RISK RE, V18, P41, DOI 10.1016/j.ijdrr.2016.05.010; Yuling LIU MH, 2008, ANN DISAS PREY RES I, V49, P189	42	2	2	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217512	10.1371/journal.pone.0217512	http://dx.doi.org/10.1371/journal.pone.0217512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170210	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700038
J	Mirandola, D; Monaci, M; Miccinesi, G; Vannuzzi, A; Sgambati, E; Manetti, M; Marini, M				Mirandola, Daniela; Monaci, Marco; Miccinesi, Guido; Vannuzzi, Alessia; Sgambati, Eleonora; Manetti, Mirk; Marini, Mirca			Psychological well-being and quality of life in visually impaired baseball players: An Italian national survey	PLOS ONE			English	Article							ADAPTED PHYSICAL-ACTIVITY; PARTICIPATION; PEOPLE; HEALTH; IMPACT; RESILIENCE; VALIDATION; DISABILITY; SPORTS; BLIND	Italian baseball played by visually impaired and blind athletes is an adapted team sport which maintains the peculiar fast-moving features of this popular sport. It is also a mixed team game played together with sighted subjects. Here, we performed a national survey aimed at assessing the differences in psychological well-being (PWB) and quality of life (QoL) between visually impaired baseball players from Italian teams and non-players using a structured online questionnaire. Forty-three visually impaired baseball players and thirty-four visually impaired sedentary individuals completed a structured self-report survey including the validated 18-item Italian versions of the PWB (PWB-18) scale and the Short Form 12 (SF-12) questionnaire to assess the QoL. PWB-18 and SF-12 reference data from the Italian normally sighted population were also employed for comparison with the visually impaired baseball player group. Visually impaired baseball players reported better scores in all dimensions of the PWB-18 scale and significant higher scores in both physical and mental QoL evaluated by SF-12 than the non-player group. In addition, PWB-18 scale findings revealed significant differences between visually impaired baseball players and the reference normally sighted population consisting in lower scores for autonomy, environmental mastery, positive relations with others and purpose in life dimensions. Conversely, the mean scores for PWB-18 personal growth and self-acceptance dimensions were not significantly different between the two groups. The SF-12 questionnaire results demonstrated a significantly higher physical score in visually impaired players compared with the reference population. Instead, the SF-12 mental score of visually impaired athletes tended to be lower, though this difference was not statistically significant. Collectively, our findings suggest that the practice of Italian baseball may have a positive impact on PWB and QoL of visually impaired individuals.	[Mirandola, Daniela; Monaci, Marco; Vannuzzi, Alessia; Manetti, Mirk; Marini, Mirca] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy; [Miccinesi, Guido] Prevent & Res Inst ISPRO, Oncol Network, Florence, Italy; [Sgambati, Eleonora] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Florence; University of Molise	Marini, M (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	mirca.marini@unifi.it	Manetti, Mirko/AEH-9944-2022; miccinesi, guido/AAB-5476-2022	Manetti, Mirko/0000-0003-3956-8480; miccinesi, guido/0000-0002-7452-9594	Ministero dell'Istruzione, dell'Universita e della Ricerca (FFABR 2017)	Ministero dell'Istruzione, dell'Universita e della Ricerca (FFABR 2017)	This work was supported by research funds granted to Dr. M. Marini by Ministero dell'Istruzione, dell'Universita e della Ricerca (FFABR 2017). There was no additional external funding received for this study.	Alves AJ, 2016, WORLD J CARDIOL, V8, P575, DOI 10.4330/wjc.v8.i10.575; [Anonymous], INDAGINE BENESSERE O; Apolone G, 2001, QUESTIONARIO STATO S; Bujang MA, 2018, MALAYS J MED SCI, V25, P85, DOI 10.21315/mjms2018.25.6.9; Di Cagno A, 2013, RES DEV DISABIL, V34, P1204, DOI 10.1016/j.ridd.2012.11.010; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-50; FELCE D, 1995, RES DEV DISABIL, V16, P51, DOI 10.1016/0891-4222(94)00028-8; Fiorilli G, 2013, RES DEV DISABIL, V34, P3679, DOI 10.1016/j.ridd.2013.08.023; Hills Andrew P, 2015, Adv Food Nutr Res, V75, P77, DOI 10.1016/bs.afnr.2015.06.001; Jaarsma EA, 2014, ADAPT PHYS ACT Q, V31, P240, DOI [10.1123/apaq.2013-0119, 10.1123/2013-0119]; Kamelska AM, 2015, J HUM KINET, V48, P87, DOI 10.1515/hukin-2015-0095; Kamelska AM, 2015, PHYS CULT SPORT STUD, V67, P31, DOI 10.1515/pcssr-2015-0001; Kaplan Robert M, 2007, COPD, V4, P263, DOI 10.1080/15412550701480356; Karakaya IC, 2009, PERCEPT MOTOR SKILL, V108, P129, DOI 10.2466/PMS.108.1.129-136; Khorrami-Nejad Masoud, 2016, Med Hypothesis Discov Innov Ophthalmol, V5, P96; Kim J, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1435097; Lavalekar A, 2017, INDIAN J HLTH WELLBE, V8, P1083; Lee M, 2014, DISABIL HEALTH J, V7, P309, DOI 10.1016/j.dhjo.2014.02.004; Marini M, 2015, J SPORT MED PHYS FIT, V55, P1219; Marini M, 2011, J SPORT MED PHYS FIT, V51, P227; Marks DF, 2015, HLTH PSYCHOL THEORY; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; Miles L, 2007, NUTR BULL, V32, P314, DOI 10.1111/j.1467-3010.2007.00668.x; Mirandola D, 2018, SUPPORT CARE CANCER, V26, P329, DOI 10.1007/s00520-017-3930-2; Mirandola D, 2014, J PHYS ACT HEALTH, V11, P814, DOI 10.1123/jpah.2012-0119; Movahedi A, 2011, RES DEV DISABIL, V32, P58, DOI 10.1016/j.ridd.2010.08.013; Onutu Adela Hilda, 2017, Rom J Anaesth Intensive Care, V24, P21, DOI 10.21454/rjaic.7518.241.onu; Picardi A, 2012, RIV PSICHIATR, V47, P231, DOI 10.1708/1128.12446; Rayhan Rakib U, 2013, Appl Med Inform, V33, P12; Ruini C., 2003, RIV PSICHIATR, V38, P117, DOI DOI 10.1708/173.1864; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; Sagone E, 2014, PROCD SOC BEHV, V141, P881, DOI 10.1016/j.sbspro.2014.05.154; Sahlin KB, 2015, PM&R, V7, P1081, DOI 10.1016/j.pmrj.2015.03.019; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Varma R, 2006, OPHTHALMOLOGY, V113, P1846, DOI 10.1016/j.ophtha.2006.04.028; von Haaren B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00163; Vuletic G., 2016, J APPL HLTH SCI, V2, P101, DOI DOI 10.24141/1/2/2/3; WHO, 2010, VIS IMP BLINDN	38	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218124	10.1371/journal.pone.0218124	http://dx.doi.org/10.1371/journal.pone.0218124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170226	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700101
J	Ryu, SJ; Kim, DR; Song, IS; Shin, YU; Seong, M; Cho, H; Kang, MH				Ryu, So Jung; Kim, Du Roo; Song, In Seok; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho			The influence of low signal-to-noise ratio of axial length measurement on prediction of target refraction, achieved using IOLMaster	PLOS ONE			English	Article							PARTIAL COHERENCE INTERFEROMETRY; INTRAOCULAR-LENS POSITION; ANTERIOR-CHAMBER DEPTH; ULTRASOUND BIOMETRY; A-SCAN; CLINICAL FEASIBILITY; CATARACT-SURGERY; OPTICAL BIOMETRY; EYES; SEVERITY	Purpose To evaluate the influence of low signal-to-noise ratio (SNR) of axial length measurement, achieved using IOLMaster, on prediction of target refraction. Methods A total of 131 eyes of 131 patients who underwent phacoemulsification with posterior chamber lens implantation were enrolled. Preoperative axial length measurements were performed with the IOLMaster 500 (Carl Zeiss Meditec, Germany); preoperative SNR values were used to divide the eyes into three groups (Group 1; SNR <10, Group 2; 10 <= SNR <50, Group 3; 50 <= SNR <100). One month and 6 months after cataract surgery, the manifest refraction spherical equivalents (MRSE) were measured. The mean numeric errors (MNE), the mean of the difference between postoperative MRSE, and preoperative target refraction, using the various intraocular lens (IOL) formulas, were calculated and compared among the three groups. Results One month after cataract surgery, postoperative MRSE was more hyperopic than preoperative target refraction, calculated by the Haigis formula in group 1, and by the SRK/T formula in group 2. After 6 months, for all formulas in group 1, there were significantly hyperopic results (approximately 0.35 diopter). Upon comparison of MNE among the three groups, group 1 was statistically significantly different from the other groups by Haigis formula. Conclusions When the SNR values in biometry, using IOLMaster, are <10, careful attention should be given to determining IOL power, as postoperative spherical equivalents are more hyperopic than preoperative target refraction by IOL formula.	[Ryu, So Jung; Kim, Du Roo; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho] Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Du Roo; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho] Hanyang Univ, Dept Ophthalmol, Guri Hosp, Guri, South Korea; [Song, In Seok; Kang, Min Ho] Seoul Eye Clin, Seoul, South Korea; [Kang, Min Ho] Johns Hopkins Med Inst, Wilmer Eye Inst, Baltimore, MD 21205 USA	Hanyang University; Hanyang University; Johns Hopkins University; Johns Hopkins Medicine	Kang, MH (corresponding author), Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Kang, MH (corresponding author), Hanyang Univ, Dept Ophthalmol, Guri Hosp, Guri, South Korea.; Kang, MH (corresponding author), Johns Hopkins Med Inst, Wilmer Eye Inst, Baltimore, MD 21205 USA.	ocularimmunity@gmail.com	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985				Attas-Fox L, 2007, OPHTHALMOLOGY, V114, P1499, DOI 10.1016/j.ophtha.2006.10.053; Buckhurst PJ, 2009, BRIT J OPHTHALMOL, V93, P949, DOI 10.1136/bjo.2008.156554; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Connors R, 2002, J CATARACT REFR SURG, V28, P235, DOI 10.1016/S0886-3350(01)01179-8; Dietlein TS, 2005, J CATARACT REFR SURG, V31, P1006, DOI 10.1016/j.jcrs.2004.09.049; Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Eleftheriadis H, 2003, BRIT J OPHTHALMOL, V87, P960, DOI 10.1136/bjo.87.8.960; Findl O, 2003, J CATARACT REFR SURG, V29, P1950, DOI 10.1016/S0886-3350(03)00243-8; Freeman G, 2005, ACTA OPHTHALMOL SCAN, V83, P439, DOI 10.1111/j.1600-0420.2005.00473.x; Goyal R, 2003, ACTA OPHTHALMOL SCAN, V81, P331, DOI 10.1034/j.1600-0420.2003.00092.x; Haigis W, 2000, GRAEF ARCH CLIN EXP, V238, P765, DOI 10.1007/s004170000188; Hill W, 2008, J CATARACT REFR SURG, V34, P920, DOI 10.1016/j.jcrs.2008.02.021; Hirnschall N, 2011, J CATARACT REFR SURG, V37, P45, DOI 10.1016/j.jcrs.2010.07.023; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Kiss B, 2002, J CATARACT REFR SURG, V28, P224, DOI 10.1016/S0886-3350(01)01272-X; Kiss B, 2002, J CATARACT REFR SURG, V28, P230, DOI 10.1016/S0886-3350(01)01274-3; Koeppl C, 2005, J CATARACT REFR SURG, V31, P348, DOI 10.1016/j.jcrs.2004.04.063; Nemeth J, 2003, J CATARACT REFR SURG, V29, P85, DOI 10.1016/S0886-3350(02)01500-6; OLSEN T, 1992, J CATARACT REFR SURG, V18, P125, DOI 10.1016/S0886-3350(13)80917-0; Olsen T, 2005, J CATARACT REFR SURG, V31, P1345, DOI 10.1016/j.jcrs.2004.12.066; Packer M, 2002, J CATARACT REFR SURG, V28, P239, DOI 10.1016/S0886-3350(01)01259-7; Petternel V, 2004, J CATARACT REFR SURG, V30, P52, DOI 10.1016/S0886-3350(03)00556-X; Prinz A, 2006, J CATARACT REFR SURG, V32, P1161, DOI 10.1016/j.jcrs.2006.01.101; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Shammas HJ, 2010, J CATARACT REFR SURG, V36, P1474, DOI 10.1016/j.jcrs.2010.02.027; Stifter E, 2008, J CATARACT REFR SURG, V34, P749, DOI 10.1016/j.jcrs.2007.12.035; Suto C, 2007, J CATARACT REFR SURG, V33, P2062, DOI 10.1016/j.jcrs.2007.07.031; Tehrani M, 2003, J CATARACT REFR SURG, V29, P741, DOI 10.1016/S0886-3350(02)01740-6; Tehrani M, 2003, J CATARACT REFR SURG, V29, P747, DOI 10.1016/S0886-3350(02)01739-X; Wirtitsch MG, 2004, J CATARACT REFR SURG, V30, P45, DOI 10.1016/S0886-3350(03)00459-0	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217584	10.1371/journal.pone.0217584	http://dx.doi.org/10.1371/journal.pone.0217584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170196	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700043
J	Shamu, S; Kuwanda, L; Farirai, T; Guloba, G; Slabbery, J; Nkhwashu, N				Shamu, Simukai; Kuwanda, Locadiah; Farirai, Thato; Guloba, Geoffrey; Slabbery, Jean; Nkhwashu, Nkhensani			Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa	PLOS ONE			English	Article							HIV; ATTITUDES; MORTALITY; PEOPLE; CARE	South Africa ranks third among 22 high burden countries in the world. TB which remains a leading cause of death causes one in five adult deaths in South Africa. An in-depth understanding of knowledge, attitudes and practices of young people towards TB is required to implement meaningful interventions. We analysed young men and women (18-24 years)'s TB knowledge including TB/HIV coinfections, testing rates and factors associated with them. A cross sectional cluster-based household survey was conducted in two provinces. Participants completed computer-assisted self-interviews on TB knowledge, testing history and TB/HIV coinfections. A participant was regarded as knowledgeable of TB if s/he correctly answered the WHO-adopted TB knowledge questions. We built three multivariate regression models in Stata 13.0 to assess factors associated with knowing TB alone, testing alone and both knowing and testing for TB. 1955 participants were interviewed (89.9% response rate). Their median age was 20 years (IQR19-22). Sixteen percent (16.2%) of the participants were social grant recipients, 55% were enrolled in a school/college and 5% lived in substandard houses. A total of 72% had knowledge of TB, 21% underwent screening tests for TB and 14.7% knew and tested for TB. Factors associated with TB knowledge were being female, younger, a student, social grant recipient, not transacting sex and having positive attitudes towards people living with HIV (PLWH). Factors associated with TB testing were being a student, receiving a social grant, living in OR Tambo district, HIV knowledge and having a family member with TB history. Factors associated with both TB knowledge and testing were being female, a student, using the print media, living in OR Tambo district and having a family member with a TB history. The study demonstrates the importance of demographic factors (gender, economic status, family TB history, and location) and HIV factors in explaining TB knowledge and testing. We recommend extending community TB testing services to increase testing.	[Shamu, Simukai; Kuwanda, Locadiah; Farirai, Thato; Guloba, Geoffrey; Slabbery, Jean; Nkhwashu, Nkhensani] Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa; [Shamu, Simukai] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand	Shamu, S (corresponding author), Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa.; Shamu, S (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	shamuts@yahoo.com		Shamu, Simukai/0000-0002-2290-0515	KfW; South African National Department of Health; Foundation for professional Development	KfW; South African National Department of Health; Foundation for professional Development	The study was funded by KfW in collaboration with the South African National Department of Health and the Foundation for professional Development. There was no additional external funding received for this study.	Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Bati J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-734; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cramm JM, 2011, J PUBLIC HEALTH AFR, V2, P143, DOI 10.4081/jphia.2011.e34; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/518667; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Harris PA, 2012, BMC BIOINFORMATICS, V13, pA15, DOI DOI 10.1186/1471-2105-13-S12-A15; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HOSMER DW, 2000, WILEY PS TX, P1; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Johnson S, 2013, 3 NATL HIV COMMUNICA; Joint United Nations Programme on HIV AIDS, 2014, GLOB AIDS RESP PROGR; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Naidoo P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2951-y; National Department of Health, 2017, S AFR NAT STRAT PLAN; Nkuoh GN, 2013, J MIDWIFERY WOM HEAL, V58, P83, DOI 10.1111/j.1542-2011.2012.00208.x; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Sanac, 2017, S AFR NAT AIDS COUNC, V1, P1; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Shisana O., 2014, S AFRICAN NATL HIV P, V2012; StataCorp, 2019, STATA STAT SOFTWARE, DOI [10.2307/2234838, DOI 10.2307/2234838]; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tachfouti N, 2012, PAN AFR MED J, V12; Tasnim S, 2012, PULM MED, V2012, DOI 10.1155/2012/352850; Walzl G, 2005, T ROY SOC TROP MED H, V99, pS15, DOI 10.1016/j.trstmh.2005.06.006; WHO, 2009, GLOB TUB CONTR 2009; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2012, GLOB TUB REP 2012, P258; World Health Organization, 2015, WORLD HLTH ORG, V53, P1689; World Health Organization (WHO), 1994, FRAM EFF TUB CONTR	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217836	10.1371/journal.pone.0217836	http://dx.doi.org/10.1371/journal.pone.0217836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170200	Green Published, gold			2022-12-27	WOS:000470263700065
J	Dobra, A; Barnighausen, T; Vandormael, A; Tanser, F				Dobra, Adrian; Baernighausen, Till; Vandormael, Alain; Tanser, Frank			A method for statistical analysis of repeated residential movements to link human mobility and HIV acquisition	PLOS ONE			English	Article							GAUSSIAN GRAPHICAL MODELS; SOUTH-AFRICA; MIGRANT WOMEN; MIGRATION; RISK; POPULATION; PREVALENCE; POLICY; INFECTIONS; EPIDEMIC	We propose a method for analyzing repeated residential movements based on graphical loglinear models. This method allows an explicit representation of residential presence and absence patterns from several areas without defining mobility measures. We make use of our method to analyze data from one of the most comprehensive demographic surveillance sites in Africa that is characterized by high adult HIV prevalence, high levels of poverty and unemployment and frequent residential changes. Between 2004 and 2016, residential changes were recorded for 8,857 men over 35,500.01 person-years, and for 12,158 women over 57,945.35 person-years. These individuals were HIV negative at baseline. Over the study duration, there were a total of 806 HIV seroconversions in men, and 2,458 HIV seroconversions in women. Our method indicates that establishing a residence outside the rural study area is a strong predictor of HIV seroconversion in men (OR = 2.003, 95% CI = [1.718,2.332]), but not in women. Residing inside the rural study area in a single or in multiple locations is a less significant risk factor for HIV acquisition in both men and women compared to moving outside the rural study area.	[Dobra, Adrian] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Baernighausen, Till] Heidelberg Univ, HIGH, Fac Med, Heidelberg, Germany; [Baernighausen, Till] Heidelberg Univ, Univ Hosp, Heidelberg, Germany; [Baernighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Baernighausen, Till; Vandormael, Alain; Tanser, Frank] Africa Hlth Res Inst, Kwa Zulu, South Africa; [Vandormael, Alain; Tanser, Frank] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Tanser, Frank] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Tanser, Frank] UCL, Res Dept Infect & Populat Hlth, London, England	University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health; Africa Health Research Institute; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London	Dobra, A (corresponding author), Univ Washington, Dept Stat, Seattle, WA 98195 USA.	adobra@uw.edu	Tanser, Frank/ABE-8326-2021; Bärnighausen, Till/Y-2388-2019	dobra, adrian/0000-0001-7793-2197; Tanser, Frank/0000-0001-9797-0000	National Science Foundation [DMS/MPS-1737746]; Alexander von Humboldt Foundation through the Alexander von Humboldt Professorship; National Institute of Health [R01HD084233, R01AI124389]; South African Medical Research Council Flagship [MRC-RFA-UFSP-01-2013/UKZN HIVEPI]; UK Academy of Medical Sciences Newton Advanced Fellowship [NA150161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124389] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation through the Alexander von Humboldt Professorship(Alexander von Humboldt Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council Flagship; UK Academy of Medical Sciences Newton Advanced Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of AD was supported by the National Science Foundation Grant DMS/MPS-1737746 to University of Washington. The work of TB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professorship endowed by the German Federal Ministry of Education and Research. The work of FT was supported by National Institute of Health (R01HD084233 and R01AI124389) and South African Medical Research Council Flagship (MRC-RFA-UFSP-01-2013/UKZN HIVEPI) grants as well as a UK Academy of Medical Sciences Newton Advanced Fellowship (NA150161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglewicz P, 2016, AIDS, V30, P2099, DOI 10.1097/QAD.0000000000001150; Anglewicz P, 2012, DEMOGRAPHY, V49, P239, DOI 10.1007/s13524-011-0072-x; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Bishop YM., 2007, DISCRETE MULTIVARIAT; Butler A, 2005, AFR AFFAIRS, V104, P591, DOI 10.1093/afraf/adi036; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Cassels S, 2014, AIDS BEHAV, V18, P2302, DOI 10.1007/s10461-013-0665-z; Cassels S, 2014, DEMOGR RES, V31, P861, DOI 10.4054/DemRes.2014.31.28; Colebunders R, 2015, LANCET HIV, V2, pE223, DOI 10.1016/S2352-3018(15)00057-0; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Department of Health Republic of South Africa, 2010, S AFR ANT TREATM GUI; Dladla AN, 2001, SOC TRANSITION, V32, P79, DOI DOI 10.1080/21528586.2001.10419032; Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009; Dobra A, 2018, ANN APPL STAT, V12, P815, DOI 10.1214/18-AOAS1164; Dobra A, 2017, AIDS, V31, P137, DOI 10.1097/QAD.0000000000001292; Dobra A, 2011, J AM STAT ASSOC, V106, P1418, DOI 10.1198/jasa.2011.tm10465; Dobra A, 2011, ANN APPL STAT, V5, P969, DOI 10.1214/10-AOAS397; Drton M, 2017, ANNU REV STAT APPL, V4, P365, DOI 10.1146/annurev-statistics-060116-053803; Fienberg S.E., 1980, ANAL CROSS CLASSIFIE, V2nd ed.; Forsyth B, 2008, SAHARA J-J SOC ASP H, V5, P74, DOI 10.1080/17290376.2008.9724904; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Guerzhoy M, 2014, LECT NOTES COMPUT SC, V8436, P131, DOI 10.1007/978-3-319-06483-3_12; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hargrove J, 2008, S AFR J SCI, V104, P53; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; Jones B, 2005, STAT SCI, V20, P388, DOI 10.1214/088342305000000304; Lauritzen Steffen L., 1996, OXFORD STAT SCI SERI, V17; Lurie M, 1997, HLTH TRANSITION R S3, V7, P17; Lurie MN, 2006, J ETHN MIGR STUD, V32, P649, DOI 10.1080/13691830600610056; Lurie MN, 2014, HEALTH PSYCHOL BEHAV, V2, P34, DOI 10.1080/21642850.2013.866898; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; McGrath N, 2015, LANCET HIV, V2, pE252, DOI 10.1016/S2352-3018(15)00045-4; MOHAMMADI A., 2017, ISBA B, V4, P11; Moore H., 1994, AFRICAN STUDIES, V53, P137; Muhwava W, 2010, AFRICAN POPULATION S, V24, P259; Munyewende P, 2011, J PUBLIC HEALTH POL, V32, pS152, DOI 10.1057/jphp.2011.36; National Department of Health of South Africa, 2012, 2011 NAT ANT SENT HI; Nattrass, 2007, MORTAL COMBAT STRUGG; Posel D., 1993, APARTHEIDS GENESIS 1; Preston-Whyte E., 1993, S AFR J SOCIOL, V24, P63, DOI [10.1080/02580144.1993.10432905, DOI 10.1080/02580144.1993.10432905]; Putnam SH, 1989, ENVIRON PLANN A, V21, P27, DOI [10.1068/a210027, DOI 10.1068/A210027]; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; R Core Team, 2018, R LANG ENV STAT COMP; Rasmussen DA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey037; Raymer J, 2007, J ROY STAT SOC A STA, V170, P891, DOI 10.1111/j.1467-985X.2007.00490.x; Raymer J, 2013, J AM STAT ASSOC, V108, P801, DOI 10.1080/01621459.2013.789435; Shisana O, 2014, S AFRICAN NATL HIV P; Smith PWF, 2010, J R STAT SOC A STAT, V173, P733, DOI 10.1111/j.1467-985X.2009.00630.x; Statistics South Africa, 2004, MID POP EST; Strode A, 2010, SAMJ S AFR MED J, V100, P247, DOI 10.7196/SAMJ.3609; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2018, INT J EPIDEMIOL, V47, P537, DOI 10.1093/ije/dyx257; Tanser F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8012; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904; Tomita A, 2017, JAIDS-J ACQ IMM DEF, V75, P164, DOI 10.1097/qai.0000000000001349; Townsend L, 2014, AIDS BEHAV, V18, P2020, DOI 10.1007/s10461-014-0784-1; UNAIDS, 2014, UND FAST TRACK ACC A; Vandormael A, 2007, POLITIKON-UK, V34, P217, DOI 10.1080/02589340701725306; Vandormael A, 2018, INT J EPIDEMIOL, V47, P236, DOI 10.1093/ije/dyx134; Vandormael A, 2014, LANCET GLOB HEALTH, V2, pE209, DOI 10.1016/S2214-109X(14)70018-X; Vearey J, 2012, GLOB PUBLIC HEALTH, V7, P58, DOI [10.1080/17441692.2010.549494, 10.3402/gha.v4i0.5898]; Vearey J, 2010, HEALTH PLACE, V16, P694, DOI 10.1016/j.healthplace.2010.02.007; Vere-Jones D., 1988, B I INT STAT, V111, P119; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; Whittaker J., 1990, GRAPHICAL MODELS APP	77	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217284	10.1371/journal.pone.0217284	http://dx.doi.org/10.1371/journal.pone.0217284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166973	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800022
J	Nakamura, H; Fujii, K; Gupta, V; Hata, H; Koizumu, H; Hoshikawa, M; Naruki, S; Miyata, Y; Takahashi, I; Miyazawa, T; Sakai, H; Tsumoto, K; Takagi, M; Saji, H; Nishimura, T				Nakamura, Haruhiko; Fujii, Kiyonaga; Gupta, Vipul; Hata, Hiroko; Koizumu, Hirotaka; Hoshikawa, Masahiro; Naruki, Saeko; Miyata, Yuka; Takahashi, Ikuya; Miyazawa, Tomoyuki; Sakai, Hiroki; Tsumoto, Kouhei; Takagi, Masayuki; Saji, Hisashi; Nishimura, Toshihide			Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; NECROSIS-FACTOR RECEPTOR; PROGNOSTIC MARKERS; PROTEIN; DATABASE; PATHWAY; CANCER; CLASSIFICATION; TRANSCRIPTION; ORGANIZATION	Small-cell lung carcinoma (SCLC) and large-cell neuroendocrine lung carcinoma (LCNEC) are high-grade lung neuroendocrine tumors (NET). However, comparative protein expression within SCLC and LCNEC remains unclear. Here, protein expression profiles were obtained via mass spectrometry-based proteomic analysis. Weighted gene co-expression network analysis (WGCNA) identified co-expressed modules and hub genes. Of 34 identified modules, six were significant and selected for protein-protein interaction (PPI) network analysis and pathway enrichment. Within the six modules, the activation of cellular processes and complexes, such as alternative mRNA splicing, translation initiation, nucleosome remodeling and deacetylase (NuRD) complex, SWItch/Sucrose Non-Fermentable (SWI/SNF) superfamily-type complex, chromatin remodeling pathway, and mRNA metabolic processes, were significant to SCLC. Modules enriched in processes, including signal recognition particle (SRP)-dependent co-translational protein targeting to membrane, nuclear-transcribed mRNA catabolic process of nonsense-mediated decay (NMD), and cellular macromolecule catabolic process, were characteristically activated in LCNEC. Novel high-degree hub genes were identified for each module. Master and upstream regulators were predicted via causal network analysis. This study provides an understanding of the molecular differences in tumorigenesis and malignancy between SCLC and LCNEC and may help identify potential therapeutic targets.	[Nakamura, Haruhiko; Miyazawa, Tomoyuki; Sakai, Hiroki; Saji, Hisashi] St Marianna Univ, Dept Chest Surg, Sch Med, Kawasaki, Kanagawa, Japan; [Fujii, Kiyonaga; Nishimura, Toshihide] St Marianna Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan; [Gupta, Vipul] Syst Biol Inst, Tokyo, Japan; [Hata, Hiroko; Tsumoto, Kouhei] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo, Japan; [Koizumu, Hirotaka; Hoshikawa, Masahiro; Naruki, Saeko; Takagi, Masayuki] St Marianna Univ Hosp, Dept Pathol, Kawasaki, Kanagawa, Japan; [Miyata, Yuka; Takahashi, Ikuya] NISSHA Co, Corp Technol Res & Dev, Kyoto, Japan	Saint Marianna University; Saint Marianna University; University of Tokyo; Saint Marianna University	Nishimura, T (corresponding author), St Marianna Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan.	t-nisimura@marianna-u.ac.jp		Gupta, Vipul/0000-0003-3345-7288				Asamura H, 2006, J CLIN ONCOL, V24, P70, DOI 10.1200/JCO.2005.04.1202; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bo LJ, 2017, MED SCI MONITOR, V23, P4518, DOI 10.12659/MSM.902953; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Carvalho PC, 2016, NAT PROTOC, V11, P102, DOI 10.1038/nprot.2015.133; Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Derks JL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01838-2016; Deutsch EW, 2016, J PROTEOME RES, V15, P3961, DOI 10.1021/acs.jproteome.6b00392; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Esposti DD, 2016, ONCOTARGET, V7, P31862, DOI 10.18632/oncotarget.7364; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fehniger TE, 2010, J PROTEOME RES, V9, P1191, DOI 10.1021/pr1000237; Fujii K, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201800015; Giulietti M, 2017, CELL ONCOL, V40, P181, DOI 10.1007/s13402-017-0315-y; Giulietti M, 2016, CELL ONCOL, V39, P379, DOI 10.1007/s13402-016-0283-7; Guo X, 2017, CANCER GENE THER, V24, P333, DOI 10.1038/cgt.2017.23; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Huang H, 2017, J CANCER RES CLIN, V143, P2571, DOI 10.1007/s00432-017-2497-0; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karp P. D., 2017, BRIEF BIOINFORM; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kotlyar M, 2019, NUCLEIC ACIDS RES, V47, pD581, DOI 10.1093/nar/gky1037; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LaBaer J, GENES DEV EPOT, V11, P847; Lang S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00887; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lejeune F, 2017, BMB REP, V50, P175, DOI 10.5483/BMBRep.2017.50.4.015; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Liao XW, 2017, ONCOTARGETS THER, V10, P4493, DOI 10.2147/OTT.S142557; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26666-0; Liu XS, 2017, J CELL BIOCHEM, V118, P3953, DOI 10.1002/jcb.26050; Ma CH, 2017, INT J RHEUM DIS, V20, P971, DOI 10.1111/1756-185X.13063; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/00000478-200209000-00009; Nishimura T, 2014, TRANSL BIOINFORM, V6, P69, DOI 10.1007/978-94-017-9202-8_5; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Padmavathi G, 2018, CANCER LETT, V432, P260, DOI 10.1016/j.canlet.2018.06.017; Presson AP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-230; Prieto DaRue A, 2005, Biotechniques, VSuppl, P32; Rekhtman N, 2016, CLIN CANCER RES, V22, P3618, DOI 10.1158/1078-0432.CCR-15-2946; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2018, J CELL BIOCHEM, V119, P2102, DOI 10.1002/jcb.26372; Travis W, 2004, WHO CLASSIFICATION T; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wechsler DS, 1996, GENOMICS, V32, P466, DOI 10.1006/geno.1996.0144; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhou Y, 2019, BIOCHEM BIOPH RES CO, V508, P527, DOI 10.1016/j.bbrc.2018.11.157; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	70	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217105	10.1371/journal.pone.0217105	http://dx.doi.org/10.1371/journal.pone.0217105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166966	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800017
J	Medic, S; Anastassopoulou, C; Milosevic, V; Dragnic, N; Rajcevic, S; Ristic, M; Petrovic, V				Medic, Snezana; Anastassopoulou, Cleo; Milosevic, Vesna; Dragnic, Natasa; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir			Declining seroprevalence of hepatitis A in Vojvodina, Serbia	PLOS ONE			English	Article							VIRAL-HEPATITIS; EPIDEMIOLOGY	To assess the current hepatitis A virus (HAV) endemicity in the Autonomous Province of Vojvodina, Serbia, we examined the seroprevalence and susceptibility profiles of the general population. A serum bank of 3466 residual samples, collected in 2015-16 as per the specifications of the European Sero-Epidemiology Network 2 project (ESEN2), was tested for anti-HAV antibodies with an enzyme immunoassay. Relationships between anti-HAV positivity and demographic features of respondents were examined by univariable and multivariable analyses. Present-day HAV seroprevalence was compared with that obtained in 1978-79. Surveillance data for hepatitis A recorded between 2008 and 2017 were also analyzed. Age was the only demographic variable found to be independently associated with a HAV seropositive status. Seropositivity (17% overall vs. 79% in 1978-79) increased with age to a maximum of 90% in the elderly >= 60 years. Only 5% of subjects <30 years were seropositive, unlike the 44% of seropositives >= 30 years. The estimated age at midpoint of population immunity (AMPI) increased markedly from 14 years in the late 70s to 55 years in 2015-16. Meanwhile, disease incidence decreased noticeably in recent years (from 11 in 2008 to 2 per 100,000 population in 2017). In the ongoing pre-vaccine era, natural infection provides immunity for merely a third (31%) and two thirds (57%) of people in their 40s and 50s, respectively. Hence, the majority of people <= 40 years (94%) and middle-aged adults 40-49 years (69%) are susceptible to HAV. Older susceptible individuals, particularly those >= 50 years (24%), are prone to severe symptoms. Taken together, these changes reflect the epidemiological transition of Vojvodina and Serbia from high to very low HAV endemicity, thereby supporting the current national policy of immunization of only high-risk groups.	[Medic, Snezana; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir] Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia; [Medic, Snezana; Milosevic, Vesna; Dragnic, Natasa; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Anastassopoulou, Cleo] Univ Patras, Div Genet Cell & Dev Biol, Dept Biol, Patras, Greece; [Milosevic, Vesna] Inst Publ Hlth Vojvodina, Ctr Virol, Novi Sad, Serbia; [Dragnic, Natasa] Inst Publ Hlth Vojvodina, Ctr Informat & Biostat, Novi Sad, Serbia	University of Novi Sad; University of Patras	Medic, S (corresponding author), Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia.; Medic, S (corresponding author), Univ Novi Sad, Fac Med, Novi Sad, Serbia.	snezana.medic@izjzv.org.rs	Petrovic, Vladimir/L-7149-2018; Ristić, Mioljub/AFI-4237-2022; Anastassopoulou, Cleo/AAO-8539-2020; Ristić, Mioljub/AAF-3754-2022	Petrovic, Vladimir/0000-0002-2052-6232; Anastassopoulou, Cleo/0000-0001-7666-9198; N.Medic, Sneza/0000-0002-5778-9861	Institute of Public Health of Vojvodina	Institute of Public Health of Vojvodina	This study was supported by Institute of Public Health of Vojvodina (SM, VM, ND, SR, MR, VP).	[Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Beaute J, 2018, EUROSURVEILLANCE, V23, P11, DOI 10.2807/1560-7917.ES.2018.23.22.1700583; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Carrillo-Santisteve P, 2017, LANCET INFECT DIS, V17, pE306, DOI 10.1016/S1473-3099(17)30392-4; European Centre for Disease Prevention and Control, 2016, HEP A VIR EU EEA 197, DOI [10.2900/60930, DOI 10.2900/60930]; European Centre for Disease Prevention and Control, 2018, HEP A ANN EP REP 201; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Institute of Public Health of Serbia, 2018, ANN REP IMM REP SERB; Institute of Public Health of Vojvodina, 2018, ANN REPORT; Itani T, 2014, VACCINE, V32, P6067, DOI 10.1016/j.vaccine.2014.09.006; Jacobsen KH, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031716; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2009, GLOBAL PREVALENCE HE; Koroglu M, 2017, J INFECT PUBLIC HEAL, V10, P513, DOI 10.1016/j.jiph.2016.09.020; Kurkela S, 2012, EPIDEMIOL INFECT, V140, P2172, DOI 10.1017/S0950268812000015; Lanini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185428; Lazic G, 2015, FOOD ENVIRON VIROL, V7, P149, DOI 10.1007/s12560-015-9187-3; Lemon SM, 2018, J HEPATOL, V68, P167, DOI 10.1016/j.jhep.2017.08.034; Medic S, 2018, EPIDEMIOL INFECT, V146, P1593, DOI 10.1017/S0950268818001619; Mijuskovic P, 1978, Vojnosanit Pregl, V35, P405; Quaglio G, 2008, J MED VIROL, V80, P833, DOI 10.1002/jmv.21141; Ristic Mioljub, 2011, Med Pregl, V64, P570; Sane J, 2015, Euro Surveill, V20, DOI 10.2807/1560-7917.ES2015.20.4.21018; Seguljev Z, 1995, 8 K PREV MED JUG SA; Statistical Office of the Republic of Serbia, 2011, CNES POP HOUS DWELL; Statistical Office of the Republic of Serbia, 2017, DEM YB 2016; Tavoschi L, 2018, VACCINE, V36, P2501, DOI 10.1016/j.vaccine.2018.02.100; Vilibic-Cavlek T, 2011, HEPAT MON, V11, P997, DOI 10.5812/kowsar.1735143X.756; VUKOVIC BS, 1981, J HYG-CAMBRIDGE, V86, P105, DOI 10.1017/S0022172400068790; Wenzel JJ, 2014, FOOD ENVIRON VIROL, V6, P297, DOI 10.1007/s12560-014-9165-1	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217176	10.1371/journal.pone.0217176	http://dx.doi.org/10.1371/journal.pone.0217176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163046	Green Submitted, gold, Green Published			2022-12-27	WOS:000470086200008
J	Rangel, LT; Marden, J; Colston, S; Setubal, JC; Graf, J; Gogarten, JP				Rangel, Luiz Thiberio; Marden, Jeremiah; Colston, Sophie; Setubal, Joao Carlos; Graf, Joerg; Gogarten, Johann Peter			Identification and characterization of putative Aeromonas spp. T3SS effectors	PLOS ONE			English	Article							III SECRETION SYSTEM; HORIZONTAL GENE-TRANSFER; SALMONICIDA SUBSP SALMONICIDA; COMPLETE GENOME SEQUENCE; ADP-RIBOSYLATING TOXIN; TRAVELERS-DIARRHEA; BACTERIAL; PROTEIN; VIRULENCE; AEXT	The genetic determinants of bacterial pathogenicity are highly variable between species and strains. However, a factor that is commonly associated with virulent Gram-negative bacteria, including many Aeromonas spp., is the type 3 secretion system (T3SS), which is used to inject effector proteins into target eukaryotic cells. In this study, we developed a bioinformatics pipeline to identify T3SS effector proteins, applied this approach to the genomes of 105 Aeromonas strains isolated from environmental, mutualistic, or pathogenic contexts and evaluated the cytotoxicity of the identified effectors through their heterologous expression in yeast. The developed pipeline uses a two-step approach, where candidate Aeromonas gene families are initially selected using Hidden Markov Model (HMM) profile searches against the Virulence Factors DataBase (VFDB), followed by strict comparisons against positive and negative control datasets, greatly reducing the number of false positives. This approach identified 21 Aeromonas T3SS likely effector families, of which 8 represent known or characterized effectors, while the remaining 13 have not previously been described in Aeromonas. We experimentally validated our in silico findings by assessing the cytotoxicity of representative effectors in Saccharomyces cerevisiae BY4741, with 15 out of 21 assayed proteins eliciting a cytotoxic effect in yeast. The results of this study demonstrate the utility of our approach, combining a novel in silico search method with in vivo experimental validation, and will be useful in future research aimed at identifying and authenticating bacterial effector proteins from other genera.	[Rangel, Luiz Thiberio; Marden, Jeremiah; Colston, Sophie; Graf, Joerg; Gogarten, Johann Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Rangel, Luiz Thiberio; Setubal, Joao Carlos] Univ Sao Paulo, Interunidades Bioinformat, Sao Paulo, Brazil; [Rangel, Luiz Thiberio; Setubal, Joao Carlos] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Graf, Joerg; Gogarten, Johann Peter] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Rangel, Luiz Thiberio] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Colston, Sophie] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA	University of Connecticut; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Connecticut; Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Navy; Naval Research Laboratory	Graf, J; Gogarten, JP (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.; Graf, J; Gogarten, JP (corresponding author), Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA.	joerg.graf@uconn.edu; gogarten@uconn.edu	Setubal, Joao Carlos/C-7305-2012; Rangel, Luiz Thibério/AAA-4652-2021; Graf, Joerg/ABI-2447-2020	Setubal, Joao Carlos/0000-0001-9174-2816; Graf, Joerg/0000-0001-5320-2712; Gogarten, Johann Peter/0000-0001-6459-6518	JG Agricultural Research Service Agreement [58-1930-4-002]; United States Department of Agriculture JPG JG [1616514]; National Science Foundation JPG [1716046]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/17196-2, 2014/23975-0]; National Science Foundation LTR	JG Agricultural Research Service Agreement; United States Department of Agriculture JPG JG; National Science Foundation JPG; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation LTR	JG Agricultural Research Service Agreement 58-1930-4-002 United States Department of Agriculture JPG JG #1616514 National Science Foundation JPG #1716046 National Science Foundation LTR Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) awards 2012/17196-2 and 2014/23975-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Andam CP, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-47; Andam CP, 2010, P NATL ACAD SCI USA, V107, P10679, DOI 10.1073/pnas.1001418107; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bansal MS, 2015, BIOINFORMATICS, V31, P1211, DOI 10.1093/bioinformatics/btu806; Bansal MS, 2012, BIOINFORMATICS, V28, pI283, DOI 10.1093/bioinformatics/bts225; Beka L, 2018, MBIO, V9, DOI 10.1128/mBio.01328-18; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bomar L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00800-13; Braun M, 2002, J BACTERIOL, V184, P1851, DOI 10.1128/JB.184.7.1851-1858.2002; Brown Nat F, 2011, Mob Genet Elements, V1, P118; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chopra AK, 2009, J WATER HEALTH, V7, pS29, DOI 10.2166/wh.2009.053; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; CSH Protocols, 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.rec12315, DOI 10.1101/PDB.REC12315]; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Dacanay A, 2006, MICROBIOL-SGM, V152, P1847, DOI 10.1099/mic.0.28768-0; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; DONG X, 2015, PHYS REV B, V92, DOI DOI 10.1093/DATABASE/BAV064; Ebanks RO, 2006, MICROBIOL-SGM, V152, P1275, DOI 10.1099/mic.0.28485-0; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Eichinger V, 2016, NUCLEIC ACIDS RES, V44, pD669, DOI 10.1093/nar/gkv1269; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fehr D, 2006, MICROBIOL-SGM, V152, P2809, DOI 10.1099/mic.0.28889-0; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Gori K, 2016, MOL BIOL EVOL, V33, P1590, DOI 10.1093/molbev/msw038; Graf J, 1999, INFECT IMMUN, V67, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HANNINEN ML, 1995, J MED MICROBIOL, V42, P26, DOI 10.1099/00222615-42-1-26; Hiransuthikul N, 2005, CLIN INFECT DIS, V41, pE93, DOI 10.1086/497372; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Jones RM, 2012, CELL MICROBIOL, V14, P274, DOI 10.1111/j.1462-5822.2011.01717.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Lewis PO, 2016, SYST BIOL, V65, P1009, DOI 10.1093/sysbio/syw042; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; MacCannell D., 2016, Clinical Microbiology Newsletter, V38, P169; Mardeni JN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01569; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; Merda D, 2017, MOL ECOL, V26, P5939, DOI 10.1111/mec.14343; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Mulder Nicola, 2007, V396, P59; Naum M, 2009, MICROBIOL-SGM, V155, P3187, DOI 10.1099/mic.0.029892-0; Notti RQ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0004-2015; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Salomon D, 2010, JOVE-J VIS EXP, DOI [10.3791/1865, DOI 10.3791/1865]; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Silver AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016751; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Vila J, 2003, EMERG INFECT DIS, V9, P552, DOI 10.3201/eid0905.020451; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Wahli T, 2005, J FISH DIS, V28, P141, DOI 10.1111/j.1365-2761.2005.00608.x; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Williams D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-45; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150	95	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0214035	10.1371/journal.pone.0214035	http://dx.doi.org/10.1371/journal.pone.0214035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163020	Green Submitted, gold, Green Published			2022-12-27	WOS:000470086200002
J	von Hacht, JL; Erdmann, S; Niederstadt, L; Prasad, S; Wagener, A; Exner, S; Beindorff, N; Brenner, W; Grotzinger, C				von Hacht, Jan Lennart; Erdmann, Sarah; Niederstadt, Lars; Prasad, Sonal; Wagener, Asja; Exner, Samantha; Beindorff, Nicola; Brenner, Winfried; Groetzinger, Carsten			Increasing molar activity by HPLC purification improves Ga-68-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model	PLOS ONE			English	Article							STIMULATING HORMONE ANALOG; PET	Purpose Melanocortin receptor 1 (MC1R) is overexpressed in melanoma and may be a molecular target for imaging and peptide receptor radionuclide therapy. (68)Gallium (Ga-68) labeling of DOTA-conjugated peptides is an established procedure in the clinic for use in positron emission tomography (PET) imaging. Aim of this study was to compare a standard labeling protocol against the Ga-68-DOTA peptide purified from the excess of unlabeled peptide. Procedures The MC1R ligand DOTA-NAPamide was labeled with Ga-68 using a standard clinical protocol. Radioactive peptide was separated from the excess of unlabeled DOTA-NAPamide by HPLC. Immediately after the incubation of peptide and Ga-68 (95 degrees C, 15 min), the reaction was loaded on a C18 column and separated by a water/acetonitrile gradient, allowing fractionation in less than 20 minutes. Radiolabeled products were compared in biodistribution studies and PET imaging using nude mice bearing MC1R-expressing B16/F1 xenograft tumors. Results In biodistribution studies, non-purified Ga-68-DOTA-NAPamide did not show significant uptake in the tumor at 1 h post injection (0.78% IA/g). By the additional HPLC step, the molar activity was raised around 10,000-fold by completely removing unlabeled peptide. Application of this rapid purification strategy led to a more than 8-fold increase in tumor uptake (7.0% IA/g). The addition of various amounts of unlabeled DOTA-NAPamide to the purified product led to a blocking effect and decreased specific tumor uptake, similar to the result seen with non-purified radiopeptide. PET imaging was performed using the same tracer preparations. Purified Ga-68-DOTA-NAPamide, in comparison, showed superior tumor uptake. Conclusions We demonstrated that chromatographic separation of radiolabeled from excess unlabeled peptide is technically feasible and beneficial, even for short-lived isotopes such as Ga-68. Unlabeled peptide molecules compete with receptor binding sites in the target tissue. Purification of the radiopeptide therefore improved tumor uptake.	[von Hacht, Jan Lennart; Erdmann, Sarah; Niederstadt, Lars; Wagener, Asja; Exner, Samantha; Groetzinger, Carsten] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany; [Prasad, Sonal; Beindorff, Nicola; Brenner, Winfried] Charite Univ Med Berlin, BERIC, Berlin, Germany; [Prasad, Sonal; Brenner, Winfried] Charite Univ Med Berlin, Dept Nucl Med, Berlin, Germany; [Brenner, Winfried; Groetzinger, Carsten] German Canc Consortium DKTK, Berlin, Germany; [Groetzinger, Carsten] Charite Univ Med Berlin, Mol Canc Res Ctr MKFZ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Grotzinger, C (corresponding author), Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany.; Grotzinger, C (corresponding author), German Canc Consortium DKTK, Berlin, Germany.; Grotzinger, C (corresponding author), Charite Univ Med Berlin, Mol Canc Res Ctr MKFZ, Berlin, Germany.	carsten.groetzinger@charite.de	Grötzinger, Carsten/B-6938-2008	Grötzinger, Carsten/0000-0001-9872-3087; Brenner, Winfried/0000-0003-2478-6004; Prasad, Sonal/0000-0002-9126-855X; Beindorff, Nicola/0000-0001-9126-3356	InnoProfile program of the German Federal Ministry of Education and Research (BMBF) [03IPT614A]; Deutsche Forschungsgemeinschaft (DFG) [INST 335/454-1FUGG]; Sonnenfeld-Stiftung [20161123]	InnoProfile program of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sonnenfeld-Stiftung	This study was supported by grant 03IPT614A in the InnoProfile program of the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/) to CG, by grant INST 335/454-1FUGG from Deutsche Forschungsgemeinschaft (DFG; https://www.dfg.de/) to WB and by grant 20161123 from Sonnenfeld-Stiftung to Samantha Exner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2007, EUR J NUCL MED MOL I, V34, P982, DOI 10.1007/s00259-006-0317-x; BARD DR, 1990, BRIT J CANCER, V62, P919, DOI 10.1038/bjc.1990.409; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Brom M, 2011, MOL IMAGING, V10, P144, DOI 10.2310/7290.2010.00032; Brom M, 2010, EUR J NUCL MED MOL I, V37, P1345, DOI 10.1007/s00259-009-1363-y; Cheng Z, 2007, BIOCONJUGATE CHEM, V18, P765, DOI 10.1021/bc060306g; de Jong M, 1999, EUR J NUCL MED, V26, P693, DOI 10.1007/s002590050439; Exner S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00146; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Froidevaux S, 2004, J NUCL MED, V45, P116; Gladfelter P, 2017, MELANOMA RES, V27, P403, DOI 10.1097/CMR.0000000000000379; Katsifis A, 2006, APPL RADIAT ISOTOPES, V64, P27, DOI 10.1016/j.apradiso.2005.06.006; Lim SM, 2009, J NUCL MED, V50, P1638, DOI 10.2967/jnumed.109.065870; Notni J, 2016, J NUCL MED, V57, P1618, DOI 10.2967/jnumed.116.173948; Notni J, 2011, CHEM-EUR J, V17, P14718, DOI 10.1002/chem.201103503; Raposinho PD, 2010, BIOPOLYMERS, V94, P820, DOI 10.1002/bip.21490; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Schuhmacher J, 2005, J NUCL MED, V46, P691; SIEGRIST W, 1989, CANCER RES, V49, P6352; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Velikyan I, 2008, NUCL MED BIOL, V35, P529, DOI 10.1016/j.nucmedbio.2008.03.002	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217883	10.1371/journal.pone.0217883	http://dx.doi.org/10.1371/journal.pone.0217883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163066	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200042
J	Bundy, JL; Anderson, BR; Francescatto, L; Garrett, ME; Soldano, KL; Telen, MJ; Davis, EE; Ashley-Koch, AE				Bundy, Joseph L.; Anderson, Blair R.; Francescatto, Ludmila; Garrett, Melanie E.; Soldano, Karen L.; Telen, Marilyn J.; Davis, Erica E.; Ashley-Koch, Allison E.			RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-DISEASE; GENE; ASSOCIATION; INTERLEUKIN-6; NPHS1	Kidney failure occurs in 5-13% of individuals with sickle cell disease and is associated with early mortality. Two APOL1 alleles (G1 and G2) have been identified as risk factors for sickle cell disease nephropathy. Both risk alleles are prevalent in individuals with recent African ancestry and have been associated with nephropathic complications in other diseases. Despite the association of G1 and G2 with kidney dysfunction, the mechanisms by which these variants contribute to increased risk remain poorly understood. Previous work in zebrafish models suggest that the G2 risk allele functions as a dominant negative, whereas the G1 allele is a functional null. To understand better the cellular pathology attributed to APOL1 G2, we investigated the in vivo effects of the G2 risk variant on distinct cell types using RNA sequencing. We surveyed APOL1 G2 associated transcriptomic alterations in podocytes and vascular endothelial cells isolated from zebrafish larvae expressing cell-type specific reporters. Our analysis identified many transcripts (n = 7,523) showing differential expression between APOL1 G0 (human wild-type) and APOL1 G2 exposed podocytes. Conversely, relatively few transcripts (n = 107) were differentially expressed when comparing APOL1 G0 and APOL1 G2 exposed endothelial cells. Pathway analysis of differentially expressed transcripts in podocytes showed enrichment for autophagy associated terms such as " Lysosome" and " Phagosome", implicating these pathways in APOL1 G2 associated kidney dysfunction. This work provides insight into the molecular pathology of APOL1 G2 nephropathy which may offer new therapeutic strategies for multiple disease contexts such as sickle cell nephropathy.	[Bundy, Joseph L.; Anderson, Blair R.; Garrett, Melanie E.; Soldano, Karen L.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Bundy, Joseph L.; Telen, Marilyn J.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Francescatto, Ludmila; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA	Duke University; Duke University; Duke University	Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.; Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	allison.ashleykoch@duke.edu		Bundy, Joseph/0000-0002-7631-6197; Davis, Erica/0000-0002-2412-8397; Telen, Marilyn/0000-0003-3809-1780	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01) [DK110104]; National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32) [HL007057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110104] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01); National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01 #DK110104) to AEAK. JLB and LF were supported by a National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32 #HL007057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Chen TK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007199; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duchateau PN, 2001, J LIPID RES, V42, P620; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Granado D, 2017, J AM SOC NEPHROL, V28, P3226, DOI 10.1681/ASN.2016111220; Hashemi M, 2015, IRAN J KIDNEY DIS, V9, P25; Horibe H, 2015, NEPHROLOGY, V20, P273, DOI 10.1111/nep.12381; Hughson MD, 2018, KIDNEY INT REP, V3, P89, DOI 10.1016/j.ekir.2017.08.007; Jones SA, 2015, NEPHROL DIAL TRANSPL, V30, P564, DOI 10.1093/ndt/gfu233; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kormann R, 2017, BRIT J HAEMATOL, V179, P323, DOI 10.1111/bjh.14842; Kotb AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153768; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Neelofar K, 2017, J CELL BIOCHEM, V118, P1803, DOI 10.1002/jcb.25853; O'Toole JF, 2018, J AM SOC NEPHROL, V29, P869, DOI 10.1681/ASN.2016121322; Olabisi O, 2016, CLIN NEPHROL, V86, pS114, DOI 10.5414/CNP86S116; Olabisi OA, 2017, SEMIN NEPHROL, V37, P546, DOI 10.1016/j.semnephrol.2017.07.008; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sun ZJ, 2015, AM J TRANSPLANT, V15, P3229, DOI 10.1111/ajt.13378; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217042	10.1371/journal.pone.0217042	http://dx.doi.org/10.1371/journal.pone.0217042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158233	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700007
J	Ali, J; Roh, BH; Lee, S				Ali, Jehad; Roh, Byeong-hee; Lee, Seungwoon			QoS improvement with an optimum controller selection for software-defined networks	PLOS ONE			English	Article							DECISION	The software-defined networking (SDN) paradigm has simplified the management of computer networks by decoupling data and control planes. Moreover, the separation of the data and control planes has transitioned network complexity from traditional devices to controllers; therefore, controllers have become indispensable entities in SDN. Controllers have multiple features and direct the network from a central point and respond to updates to topological changes. However, the supportive capability of these features is strong in one controller but weak in another. Due to several controllers and each controller having a set of features, selecting an optimal SDN controller can be considered to be a multi-criteria decision-making (MCDM) problem. Herein, a two-step approach is proposed for SDN controller selection. First, the controllers are ranked with analytical network process (ANP) according to their qualitative features which influence the performance of these controllers and then a performance comparison is performed to check for the QoS improvement. The controller with a high-weight value from the feature-based comparison is quantitatively analysed by experimental analysis. The main contribution of this paper is checking the applicability of the ANP for controller selection in SDN considering its features and performance analysis in real-world Internet and Brite topologies. The simulation results show that the controller computed through the proposed approach outperforms the controller selected with existing approaches. The selection of an optimum controller with ANP results in a reduction of topology discovery time and delay in the normal and traffic load scenario. Similarly, an increase in throughput with a reasonable utilization of the central processing unit (CPU) is observed for the proposed controller.	[Ali, Jehad; Roh, Byeong-hee; Lee, Seungwoon] Ajou Univ, Comp Engn Dept, Suwon, South Korea	Ajou University	Roh, BH (corresponding author), Ajou Univ, Comp Engn Dept, Suwon, South Korea.	bhroh@ajou.ac.kr	Roh, Byeong-hee/V-4966-2018; Ali, Jehad/V-9707-2019	Ali, Jehad/0000-0002-0589-7924; Roh, Byeong-hee/0000-0003-2509-4210	Future Combat System Network Technology Research Center program of Defense Acquisition Program Administration; Agency for Defense Development [UD160070BD]	Future Combat System Network Technology Research Center program of Defense Acquisition Program Administration; Agency for Defense Development(Agency of Defense Development (ADD), Republic of Korea)	This work has been supported by the Future Combat System Network Technology Research Center program of Defense Acquisition Program Administration and Agency for Defense Development. (UD160070BD).	Abdelaziz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174715; Ali J, 2018, PERFORMANCE ANAL POX; Anderson D, 2017, IEEE MIL COMM C MILC; Belkadi O., 2017, INT J COMPUTER NETWO, V5, P239; Bholebawa IZ, 2018, WIRELESS PERS COMMUN, V98, P1679, DOI 10.1007/s11277-017-4939-z; Bispo P, 2017, 1NLEMALIONAL YOUNG E; Boateng P, 2015, INT J PROJ MANAG, V33, P1795, DOI 10.1016/j.ijproman.2015.08.007; Botta A, 2012, COMPUT NETW, V56, P3531, DOI 10.1016/j.comnet.2012.02.019; Brief OS, 2014, OPENFLOW ENABLE TRAN; Buyukozkan G, 2004, INT J GEN SYST, V33, P259, DOI 10.1080/03081070310001633581; Cai Z., 2010, MAESTRO SYSTEM SCALA; De Maesschalck S, 2003, PHOTONIC NETW COMMUN, V5, P203, DOI 10.1023/A:1023088418684; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Erickson D., 2013, P ACM SIGCOMM WORKSH; Famoriji OJ, 2017, WIREL COMMUN MOB COM, DOI 10.1155/2017/6083626; Farman H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180848; Freire P, 2014, QUAL INQ SOC JUSTICE, P1; Gonzalez-Escribano A., 2014, SYNTH LECT THEOR COM, V1, P1, DOI [10.2200/S00618ED1V01Y201412TCS001, DOI 10.2200/S00618ED1V01Y201412TCS001]; Gude N, 2008, ACM SIGCOMM COMP COM, V38, P105, DOI 10.1145/1384609.1384625; Huang J, 2018, IEEE T NETW SERV MAN, V15, P866, DOI 10.1109/TNSM.2018.2825358; Huang J, 2018, IEEE T CLOUD COMPUT, V6, P545, DOI 10.1109/TCC.2015.2491939; Ishizaka A., 2013, MULTICRITERIA DECISI, P1; Izard R, 2017, FLOODLIGHT WEB GUI; Jain S, 2013, ACM SIGCOMM COMP COM, V43, P3, DOI 10.1145/2534169.2486019; Kaur K., 2016, PERFORMANCE ANAL PYT; Khan AR, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/230708; Khondoker R, 2014, COMP APPL INF SYST W; Knight S, 2011, IEEE J SEL AREA COMM, V29, P1765, DOI 10.1109/JSAC.2011.111002; Lara A., 2014, IEEE COMMUNICATIONS, V16; Mamushiane L, 2018, 10 WIR DAYS C WD; Medina A, 2001, NINTH INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS, PROCEEDINGS, P346, DOI 10.1109/MASCOT.2001.948886; Mendoza GA, 2006, FOREST ECOL MANAG, V230, P1, DOI 10.1016/j.foreco.2006.03.023; Metzler J, 2013, 10 THINGS LOOK SDN C; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Raju V.R.S., 2018, P SCI GLOB INT C; Saaty T.L., 2001, DECISION MAKING DEPE; Saaty T. L., 1988, MATH MODELS DECISION, P109, DOI [DOI 10.1007/978-3-642-83555-1, DOI 10.1007/978-3-642-83555-1_5]; Saaty T. L., 2005, THEORY APPL ANAL NET; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Saino L., 2013, P 6 INT ICST C SIM T; Sakellaropoulou D., 2017, QUALITATIVE STUDY SD; Salman T, 2016, GLOBAL NEST J, V18, P1; Semenovykh A.A., 2018, INT J OPEN INFORM TE, V6, P2018; Shalimov A., 2013, P 9 CENTR E EUR SOFT; Shen GX, 2009, J OPT COMMUN NETW, V1, P176, DOI 10.1364/JOCN.1.000176; Shiva H, 2016, INT J INNOVATIVE RES, V4; Stancu AL, 2015, INT C TELECOMMUN MO, P223, DOI 10.1109/TELSKS.2015.7357774; Sun S, 2016, SCI REPORTS, V6; Tootoonchian A., 2012, P USENIX HOT ICE; Wang GD, 2018, IEEE T NETW SERV MAN, V15, P344, DOI 10.1109/TNSM.2017.2785660; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; Yousaf FZ, 2017, IEEE J SELECTED AREA, V35; Zhao Y., 2015, IEEE C NETW FUNCT VI	53	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217631	10.1371/journal.pone.0217631	http://dx.doi.org/10.1371/journal.pone.0217631			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150473	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100076
J	Horvath, D; Anderson, JV; Chao, WS; Zheng, PY; Buchwaldt, M; Parkin, IAP; Dorn, K				Horvath, David; Anderson, James, V; Chao, Wun S.; Zheng, Puying; Buchwaldt, Miles; Parkin, Isobel A. P.; Dorn, Kevin			Genes associated with chloroplasts and hormone-signaling, and transcription factors other than CBFs are associated with differential survival after low temperature treatments of Camelina sativa biotypes	PLOS ONE			English	Article							COLD RESPONSE PATHWAY; FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; NETWORK; STRESS; OVEREXPRESSION; EXPRESSION; TRAITS; PIF3	Winter annual biotypes of Camelina sativa regularly survive after winter conditions experienced in northern regions of the U.S., whereas summer annual biotypes do not. To determine potential molecular mechanisms associated with these biotype differences in survival after low temperature treatments, we examined genetic and transcript variations in both a winter (Joelle) and a summer- (CO46) biotype. It was determined that as few as one or two dominant genes may control differential survival after low temperature treatments. Of the 1797 genes that were differentially expressed in response to cold in both the winter and summer biotypes many COR genes were identified, indicating that the CBF regulon is functional in both. However, only 153 and 76 genes from Joelle and CO46, respectively, were either differentially expressed or not expressed at all in one biotype versus the other following cold acclimation. We hypothesize that these 229 genes play a significant role in, or are primarily responsive to, differences in survival after freezing between these two biotypes. Promoter analysis provided few clues as to the regulation or these genes; however, genes that were down-regulated specifically in the winter biotype Joelle were enriched with the sequence TGGCCCTCGCTCAC, which is over-represented among genes associated with chloroplasts in Arabidopsis. Additionally, several genes involved in auxin signaling were down-regulated specifically in Joelle. A transcription factor with strong similarity to MYB47, known to be up-regulated by salt, drought, and jasmonic acid, but not cold in Arabidopsis, was essentially off in the freezing sensitive biotype CO46, but was cold-induced in the winter biotype Joelle. Several other transcription factors genes including three with similarity to WRKY70, that may be involved in SA/JA-dependent responses, a HOMEOBOX 6 gene involved in ABA signaling, and two others (NUCLEAR FACTOR Y and CONSTANS-like 2) known to be implicated in photoperiodic flowering were also differentially expressed between the two biotypes.	[Horvath, David; Anderson, James, V; Chao, Wun S.] USDA ARS, Edward T Schafer Agr Res Ctr, Sunflower & Plant Biol Res Unit, Fargo, ND 58102 USA; [Zheng, Puying] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA; [Buchwaldt, Miles; Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK, Canada; [Dorn, Kevin] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); North Dakota State University Fargo; Agriculture & Agri Food Canada; Kansas State University	Horvath, D (corresponding author), USDA ARS, Edward T Schafer Agr Res Ctr, Sunflower & Plant Biol Res Unit, Fargo, ND 58102 USA.	David.horvath@ars.usda.gov	Parkin, Isobel/AAD-6625-2020; Dorn, Kevin/K-5667-2013	Dorn, Kevin/0000-0003-2722-6221; Parkin, Isobel/0000-0002-5807-9466; Anderson, James/0000-0002-1801-5767; Horvath, David/0000-0002-8458-7691	USDA-ARS CRIS [3060-21220-029-00-D]	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by USDA-ARS CRIS 3060-21220-029-00-D Novel Weed Management Solutions: Understanding Weed-Crop Interactions in Northern Climates.; This work was funded by USDA-ARS CRIS 3060-21220-029-00-D Novel Weed Management Solutions: Understanding Weed-Crop Interactions in Northern Climates. Significant technical contributions were provided by Wayne Sargent and Brant Bigger.	Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Anderson J. V., 2018, PLANT DIRECT, V2, P1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berti M, 2016, IND CROP PROD, V94, P690, DOI 10.1016/j.indcrop.2016.09.034; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Dong J, 2017, CURR BIOL, V27, P2420, DOI 10.1016/j.cub.2017.06.062; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gehan MA, 2015, PLANT J, V84, P682, DOI 10.1111/tpj.13027; Gesch RW, 2013, IND CROP PROD, V44, P718, DOI 10.1016/j.indcrop.2012.05.023; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang BC, 2017, P NATL ACAD SCI USA, V114, pE6695, DOI 10.1073/pnas.1706226114; Kagale S, 2016, PLANT J, V88, P879, DOI 10.1111/tpj.13302; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kole C, 2002, MOL BREEDING, V9, P201, DOI 10.1023/A:1019759512347; Le MQ, 2015, PLANT MOL BIOL, V87, P1, DOI 10.1007/s11103-014-0256-z; Ledger S, 2001, PLANT J, V26, P14; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Savitch LV, 2005, PLANT CELL PHYSIOL, V46, P1525, DOI 10.1093/pcp/pci165; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomashow MF, 2001, PHYSIOL PLANTARUM, V112, P171, DOI 10.1034/j.1399-3054.2001.1120204.x; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wilke BJ, 2008, J SCI FOOD AGR, V88, P551, DOI 10.1002/jsfa.3149; Yamasaki Y, 2016, PLANT SCI, V246, P80, DOI 10.1016/j.plantsci.2016.02.007; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zander M, 2012, MOL PLANT, V5, P831, DOI 10.1093/mp/ssr113; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217692	10.1371/journal.pone.0217692	http://dx.doi.org/10.1371/journal.pone.0217692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150478	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100089
J	Skalenius, M; Mattsson, CM; Dahlberg, P; Bergfeldt, L; Ravn-Fischer, A				Skalenius, Michael; Mattsson, C. Mikael; Dahlberg, Pia; Bergfeldt, Lennart; Ravn-Fischer, Annica			Performance and cardiac evaluation before and after a 3-week training camp for 400-meter sprinters - An observational, non-randomized study	PLOS ONE			English	Article							RECOMMENDATIONS; BLOOD; ASSOCIATION; ADAPTATIONS; PREVENTION; UPDATE; SYSTEM; TESTS; HEART	Objective To study the performance and cardiovascular function after a 3-week training camp in athletes competing in an anaerobically dominant sport. Methods Twenty-three competitive 400-m athletes were enrolled in this non-randomized study, 17 took part in a 3-week training camp in South-Africa (intervention), but one declined follow-up assessment, while 6 pursued in-door winter training in Sweden and served as controls. Electrocardiography, transthoracic echocardiography, blood test analyses, maximal exercise tolerance test, and a 300-m sprint test with lactate measurements ([La]peak) were performed before and after the training camp period. Results At baseline, there were no clinically significant pathological findings in any measurements. The training period resulted in improved 300m-sprint performance [n = 16; running time 36.71 (1.39) vs. 35.98 (1.13) s; p<0.01] and higher peak lactate values. Despite 48% more training sessions than performed on home ground (n = 6), myocardial biomarkers decreased significantly (NT-pro BNP -38%; p<0.05, troponin T -16%; p<0.05). Furthermore, resting heart rate (-7%; p<0.01) and left ventricular systolic and diastolic volumes decreased -6% (p<0.01) and -10% (p<0.05), respectively. Conclusions Intense physical activity at training camp improved the performance level, likely due to improved anaerobic capacity indicated by higher [La]peak. There were no clinically significant adverse cardiac changes after this period of predominantly anaerobic training.	[Skalenius, Michael; Dahlberg, Pia; Bergfeldt, Lennart; Ravn-Fischer, Annica] Sahlgrens Univ Hosp, Dept Mol & Clin Med Cardiol, Gothenburg, Sweden; [Mattsson, C. Mikael] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Mattsson, C. Mikael] Silicon Valley Exercise Analyt SVExA, Menlo Pk, CA USA; [Dahlberg, Pia; Bergfeldt, Lennart; Ravn-Fischer, Annica] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Region Vastra G, Sweden	Sahlgrenska University Hospital; Karolinska Institutet; Sahlgrenska University Hospital	Skalenius, M (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med Cardiol, Gothenburg, Sweden.	m.skalenius@gmail.com		Skalenius, Michael/0000-0002-0784-9643; Mattsson, C. Mikael/0000-0002-0642-4838				Aagaard P, 2012, MED SCI SPORT EXER, V44, P894, DOI 10.1249/MSS.0b013e31823cd051; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brauer KJ, 2003, KLIN ARBETSPROVET; Brudin L, 2014, CLIN PHYSIOL FUNCT I, V34, P297, DOI 10.1111/cpf.12097; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Eijsvogels TMH, 2016, PHYSIOL REV, V96, P99, DOI 10.1152/physrev.00029.2014; Ferro A, 2013, J STRENGTH COND RES, V27, P83, DOI 10.1519/JSC.0b013e31824f21c6; FRANK E, 1956, CIRCULATION, V13, P737, DOI 10.1161/01.CIR.13.5.737; Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4; Hanon C, 2011, J STRENGTH COND RES, V25, P2503, DOI 10.1519/JSC.0b013e3182001807; HIRVONEN J, 1992, CAN J SPORT SCI, V17, P141; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Michielsen ECHJ, 2008, SPORTS MED, V38, P425, DOI 10.2165/00007256-200838050-00005; Mujika Inigo, 2004, Sports Med, V34, P891, DOI 10.2165/00007256-200434130-00003; NORDENFELT I, 1985, CLIN PHYSIOL, V5, P161, DOI 10.1111/j.1475-097X.1985.tb00592.x; Pelliccia A, 2015, J ELECTROCARDIOL, V48, P385, DOI 10.1016/j.jelectrocard.2015.03.012; Periard JD, 2015, SCAND J MED SCI SPOR, V25, P20, DOI 10.1111/sms.12408; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Sawka MN, 2000, MED SCI SPORT EXER, V32, P332, DOI 10.1097/00005768-200002000-00012; Serra-Grima R, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2014.06.017; Sharma S, 1999, BRIT J SPORT MED, V33, P319, DOI 10.1136/bjsm.33.5.319; Sharma S, 2017, J AM COLL CARDIOL, V69, P1057, DOI 10.1016/j.jacc.2017.01.015; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Wheeler MT, 2010, ANN INTERN MED, V152, P276, DOI 10.7326/0003-4819-152-5-201003020-00005; Woo EJ, 1992, KOREAN CIRC J, V22, P248; Yamaji K, 1986, Br J Sports Med, V20, P62; Zouhal H, 2010, J STRENGTH COND RES, V24, P2309, DOI 10.1519/JSC.0b013e3181e31287	30	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217856	10.1371/journal.pone.0217856	http://dx.doi.org/10.1371/journal.pone.0217856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150507	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100120
J	Chiang, JT; Chang, FC; Lee, KW; Hsu, SY				Chiang, Jeng-Tung; Chang, Fong-Ching; Lee, Kun-Wei; Hsu, Szu-Yuan			Transitions in smartphone addiction proneness among children: The effect of gender and use patterns	PLOS ONE			English	Article							RISK; DEPRESSION; BEHAVIORS; INTERNET; ANXIETY; SLEEP	Objectives This study assessed the incidence of transitions in smartphone addiction proneness (SAP) among children and examined the effects of gender, use patterns (social networking sites (SNSs) use and smartphone gaming) and depression on smartphone addiction transitions. Methods A representative sample of 2,155 children from Taipei completed longitudinal surveys in both 2015 (5th grade) and 2016 (6th grade). Latent transition analysis (LTA) was used to characterize transitions in SAP and to examine the effects of gender, use patterns and depression on SAP transitions. Results LTA identified four latent statuses of SAP: about half of the children were in non-SAP status, one-fifth were in tolerance status, one-sixth were in withdrawal status, and one-seventh were in high-SAP status. Both boys and girls had a higher prevalence of high-SAP and tolerance in 6th grade than in 5th grade, whereas in both grades boys had a higher prevalence of high-SAP and withdrawal, and girls had a higher prevalence of non-SAP and tolerance. Controlling for parents' education, family structure, and household income, higher use of SNSs by children, increasing use of mobile gaming and higher levels of depression were individually associated with increased odds of being in one of the three SAP statuses other than non-SAP. When all three covariates were jointly entered into the model, usage of SNSs and depression remained significant predictors. Conclusion Both boys and girls tended to transition to tolerance or high-SAP statuses, while children's depression and their usage of SNSs increased the risk of smartphone addiction.	[Chiang, Jeng-Tung; Lee, Kun-Wei; Hsu, Szu-Yuan] Natl Chengchi Univ, Dept Stat, Taipei, Taiwan; [Chang, Fong-Ching] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Chengchi University; National Taiwan Normal University	Chang, FC (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	fongchingchang@ntnu.edu.tw			Taiwan Ministry of Science and Technology	Taiwan Ministry of Science and Technology	This work was supported by a research grant from the Taiwan Ministry of Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0163010; Boumosleh JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182239; Brambilla P, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-016-0324-x; Cha SS, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918755046; Chen BF, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1503-z; Cho KS, 2017, COMPUT HUM BEHAV, V66, P303, DOI 10.1016/j.chb.2016.09.063; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Christensen MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165331; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Elhai JD, 2017, J AFFECT DISORDERS, V207, P251, DOI 10.1016/j.jad.2016.08.030; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; Ihm J, 2018, J BEHAV ADDICT, V7, P473, DOI 10.1556/2006.7.2018.48; Khoury JM, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00073; Kim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097920; Kim R, 2015, J ADDICT NURS, V26, P81, DOI 10.1097/JAN.0000000000000074; Kuss DJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030311; Lanza ST, 2008, DEV PSYCHOL, V44, P446, DOI 10.1037/0012-1649.44.2.446; Lee EJ, 2018, J ADDICT NURS, V29, P244, DOI 10.1097/JAN.0000000000000254; Lee HJ, 2017, CLIN EXP VACCINE RES, V6, P22, DOI [10.7774/cevr.2017.6.1.22, 10.7774/cevr.2017.6.1.22.]; Lee H, 2017, J KOREAN MED SCI, V32, P1674, DOI 10.3346/jkms.2017.32.10.1674; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097838, 10.1371/journal.pone.0098312]; Lin Y, 2016, INT J GRID DISTRIB, V9, P25, DOI 10.14257/ijgdc.2016.9.6.03; Liu CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004068; Livingstone S., 2011, 2010 EU KIDS ONLINE; Lopez-Fernandez O, 2017, ADDICT BEHAV, V64, P275, DOI 10.1016/j.addbeh.2015.11.013; Mascheroni G., 2014, NET CHILDREN GO MOBI, V2nd; McDonald CC, 2019, HEALTH EDUC BEHAV, V46, P10, DOI 10.1177/1090198118788612; Mok JY, 2014, NEUROPSYCH DIS TREAT, V10, P817, DOI 10.2147/NDT.S59293; Moon JH, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0364-4; Ofcom, 2017, CHILDR PAR MED US AT; Panova T, 2018, J BEHAV ADDICT, V7, P252, DOI 10.1556/2006.7.2018.49; Petersen GL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205019; Petry NM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0610-0; Prasad S, 2018, INDIAN J PSYCHOL MED, V40, P468, DOI 10.4103/IJPSYM.IJPSYM_133_18; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Randler C, 2016, J BEHAV ADDICT, V5, P465, DOI 10.1556/2006.5.2016.056; Rikkers W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3058-1; Rumpf HJ, 2018, J BEHAV ADDICT, V7, P556, DOI 10.1556/2006.7.2018.59; Saxena R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117349; Staksrud E, 2013, COMPUT HUM BEHAV, V29, P40, DOI 10.1016/j.chb.2012.05.026; Tonacci A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55020037; Yang SY, 2018, J AM COLL HEALTH, V66, P693, DOI 10.1080/07448481.2018.1454930	42	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217235	10.1371/journal.pone.0217235	http://dx.doi.org/10.1371/journal.pone.0217235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145738	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500015
J	Reis, CMR; Matta-Machado, ATG; Amaral, JHL; Mambrini, JVD; Werneck, MAF; de Abreuid, MHNG				Rodrigues Reis, Clarice Magalhaes; Gonzaga Matta-Machado, Antonio Thomaz; Lara Amaral, Joao Henrique; de Melo Mambrini, Juliana Vaz; Furquim Werneck, Marcos Azeredo; Nogueira Guimaraes de Abreuid, Mauro Henrique			Understanding oral health care team performance in primary care: A mixed-method study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DENTAL-CARE; ALTRUISM; VALIDATION; EMPATHY; NEEDS	Objective This study aims to describe the primary care services carried out by Oral Health Teams (OHTs) in Brazil, and to understand the nuances that lead to different levels of OHT performance. Material & methods A mixed-methods study with a sequential explanatory design was developed. In the quantitative phase, secondary data from a national survey (PMAQ-AB) was used to describe the work of 12,403 OHTs. Item response theory (IRT) was applied, to evaluate the psychometric qualities of 20 oral health questions from PMAQ-AB and to identify the performance of OHT. The quantitative results guided the selection of the qualitative sample. An extreme case sampling strategy was used (opposite results). OHTs were selected from Belo Horizonte metropolitan region in Brazil using scores measured by IRT. Data were collected through semi-structured interviews. Data analysis was conducted using deductive and inductive thematic analysis. Results Quantitative results showed that there are OHT with high and low performance in Brazil. The IRT analysis showed that items related to prostheses and oral cancer tend to discriminate high-performance OHTs from other OHTs. Qualitative results deepened the understanding of accessing oral health services and found several access barriers, such as the insufficient number of OHTs for the population, and a very long waiting time for dental consultations other than urgency. The qualitative results confirmed that high-performance OHTs tend to emphasize oral cancer surveillance and deliver prostheses in PHC services. Conclusion Despite the expansion of oral health in PHC in Brazil in recent years, OHTs still face many challenges such as: access barriers; failures in prevention, early diagnosis and follow-up of oral cancer cases; and insufficient rehabilitation with prostheses.	[Rodrigues Reis, Clarice Magalhaes; Lara Amaral, Joao Henrique; Furquim Werneck, Marcos Azeredo; Nogueira Guimaraes de Abreuid, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Gonzaga Matta-Machado, Antonio Thomaz] Univ Fed Minas Gerais, Dept Social & Prevent Med, Belo Horizonte, MG, Brazil; [de Melo Mambrini, Juliana Vaz] Fiocruz MS, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	de Abreuid, MHNG (corresponding author), Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil.	maurohenriqueabreu@gmail.com	de Melo Mambrini, Juliana Vaz/AAO-9462-2021; Abreu, Mauro Henrique/G-6502-2012	Abreu, Mauro Henrique/0000-0001-8794-5725	National Council for Scientific and Technological Development (CNPq) Research Productivity Fellows (PQ) [307617/2015-7]; Ministry of Science and Technology; CNPq, Brazil [400965/2016-0]; Minas Gerais Research Foundation (FAPEMIG) [APQ-01218-15]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais	National Council for Scientific and Technological Development (CNPq) Research Productivity Fellows (PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais	MHNGA is National Council for Scientific and Technological Development (CNPq) Research Productivity Fellows (PQ) (307617/2015-7) since 2012. CMRR received a scholarship for 48 months, by the Ministry of Science and Technology, CNPq, Brazil (400965/2016-0). This study was also supported by Minas Gerais Research Foundation (FAPEMIG) (APQ-01218-15) and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. This study was also funded by the Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais. All the funding or sources of support received during this specific study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SAUDE MAIS PERTO VOC; Bhakta B, 2005, BMC MED EDUC, V5, P1, DOI [10.1186/1472-6920-5-1, DOI 10.1186/1472-6920-5-1]; Bourion-Bedes S, 2015, QUAL LIFE RES, V24, P287, DOI 10.1007/s11136-014-0772-y; Brasil, 2004, DIRETRIZES POLITICA; Brasil, 2005, PROJ SB BRAS 2003 CO; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004150.pub4; Burks DJ, 2012, SOC BEHAV PERSONAL, V40, P395, DOI 10.2224/sbp.2012.40.3.395; Burks DJ, 2012, MED EDUC, V46, P317, DOI 10.1111/j.1365-2923.2011.04159.x; Carnut L, 2011, CIENC SAUDE COLETIVA, V16, P3083, DOI 10.1590/S1413-81232011000800008; Creswell W. C., 2011, DESIGNING CONDUCTING; de Melo ACBV, 2011, REV BRAS CIENCIAS SA, V15, P309, DOI [10.4034/RBCS.2011.15.03.06, DOI 10.4034/RBCS.2011.15.03.06]; de Souza TMS, 2007, CAD SAUDE PUBLICA, V23, P2727, DOI 10.1590/S0102-311X2007001100020; Dos Anjos F, 2011, CIENC CUID SAUDE, V10, P601, DOI [DOI 10.4025/CIENCCUIDSAUDE.V10I3.10921, 10.4025/cienccuidsaude.v10i3.10921]; Gallagher JE, 2015, HEALTH POLICY, V119, P1565, DOI 10.1016/j.healthpol.2015.09.010; Cunha MAGD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001924; Gushi LL, 2008, REV SAUDE PUBL, V42, P480, DOI 10.1590/S0034-89102008005000015; Haggerty J, 2007, ANN FAM MED, V5, P336, DOI 10.1370/afm.682; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; Kornis George Edward Machado, 2011, Physis, V21, P197, DOI 10.1590/S0103-73312011000100012; Lourenco E do C, 2009, CIENC SAUDE COLETIVA, V14, P1367, DOI [10.1590/S1413-81232009000800009, DOI 10.1590/S1413-81232009000800009]; Mattos GCM, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0037; McGaghie WC, 2002, MED TEACH, V24, P374, DOI 10.1080/01421590220145734; Ministerio da Saude, 2012, INSTR AV EXT SAUD MA; Miotto MHM de B, 2015, REV BRAS PESQ SAUDE, V17, P121; Montero J, 2013, J DENT, V41, P493, DOI 10.1016/j.jdent.2013.01.006; Morris AJ, 2001, BRIT DENT J, V191, P660; Nascimento AC, 2013, INT DENT J, V63, P237, DOI 10.1111/idj.12039; Patton MQ, 2002, QUALITATIVE RES METH; Pyett PM, 2003, QUAL HEALTH RES, V13, P1170, DOI 10.1177/1049732303255686; dos Reis CMR, 2017, J PUBLIC HEALTH DENT, V77, P317, DOI 10.1111/jphd.12210; dos Reis CMR, 2015, INT J ENV RES PUB HE, V12, P667, DOI 10.3390/ijerph120100667; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Silverman S, 2010, J CANCER EDUC, V25, P279, DOI 10.1007/s13187-010-0045-6; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B., 1992, PRIMARY CARE CONCEPT; Starfield B., 2002, ATENCAO PRIMARIA EQU; Yen YY, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-1	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217738	10.1371/journal.pone.0217738	http://dx.doi.org/10.1371/journal.pone.0217738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145771	gold, Green Published, Green Submitted			2022-12-27	WOS:000469425500034
J	Nguiffo, DN; Wondji, CS; Wabo, JP; Mpoame, M				Nguiffo, Daniel Nguete; Wondji, Charles S.; Wabo, Josue Pone; Mpoame, Mbida			Microfilariae infestation of goliath frogs (Conraua goliath) from Cameroon	PLOS ONE			English	Article							PARASITES	The goliath frog (Conraua goliath) is endemic to Equatorial Guinea and Cameroon. It is an endangered species but little information is known about its parasites. To understand the impact of blood parasites on this species, we microscopically examined blood smears from 78 goliath frogs in February and November 2016 (dry and wet seasons) from six localities in Littoral Region of Cameroon, and we sequenced mitochondrial DNA from positive samples. Microfilariae were found in 33/78 (42.3%) goliath frogs at six locations. No other haemoparasite species was detected. Morphological characteristics of microfilariae were also described, and specimens from each frog species were similar. DNA sequencing data from the mitochondrial Cytochrome Oxidases sub unit I (COI) gene revealed a close relationship with Icosiella neglecta, a microfilaria documented in other European, Asian, and African frogs. However, sequences were sufficiently genetically distant (0.118) that they may define a new species of Icosiella. The infection burden of microfilariae varied by site, with season (65% in dry season to 23% in rainy season), and by sex, (male frogs had significantly higher parasite burdens than females (p < 0.0001)). However, this may have been confounded by size as the microfilaria intensity increased with frog weight (p < 0.0001), and males were larger than females. Microfilaria infection intensity varied from 1 to 120 per 50 mu l of blood. Microfilaria induced a significant increase (p < 0.05) in the number of white blood cells (WBC) counted compared to uninfected frogs, but there was no statistically significant variation in red blood cell (RBC) count, plasma cholesterol level (p = 0.210) or plasma glucose level (p = 0.100).	[Nguiffo, Daniel Nguete; Wabo, Josue Pone; Mpoame, Mbida] Univ Dschang, Dept Anim Biol, Fac Sci, Res Unit Biol & Appl Ecol, Dschang, Cameroon; [Nguiffo, Daniel Nguete; Wondji, Charles S.] Ctr Res Infect Dis, Yaounde, Cameroon; [Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Nguiffo, DN (corresponding author), Univ Dschang, Dept Anim Biol, Fac Sci, Res Unit Biol & Appl Ecol, Dschang, Cameroon.; Nguiffo, DN (corresponding author), Ctr Res Infect Dis, Yaounde, Cameroon.	danielnguete@yahoo.fr	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673				AHO JM, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P157; Al- Bayati O, 2009, IRAQI J VET SCI S1, V23; Allender Matthew C., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P463, DOI 10.1016/j.cvex.2008.03.006; Amiet J, 2004, IUCN 2013 IUCN RED L; ARIKAN H, 2014, N W J ZOOLOGY, V10; Baker D.G., 2008, FLYNNS PARASITES LAB; BARTA J R, 1984, Journal of Wildlife Diseases, V20, P180; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; BERNARD G, 2009, B GEORGIAN NATL ACAD, V3, P129; BLAUSTEIN AR, 1995, SCI AM, V272, P52, DOI 10.1038/scientificamerican0495-52; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Casiraghi M, 2001, PARASITOL RES, V87, P417, DOI 10.1007/s004360000368; Combes C, 1996, BIODIVERS CONSERV, V5, P953, DOI 10.1007/BF00054413; Daniel NN, 2015, GLOB ECOL CONSERV, V4, P146, DOI 10.1016/j.gecco.2015.06.009; Ferguson Laura V., 2012, Insects, V3, P410, DOI 10.3390/insects3020410; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Haroun EM, 1996, VET RES COMMUN, V20, P255, DOI 10.1007/BF00366923; Hemmingsen W, 2000, POLAR BIOL, V23, P368, DOI 10.1007/s003000050457; Klaphake Eric, 2009, Vet Clin North Am Exot Anim Pract, V12, P597, DOI 10.1016/j.cvex.2009.06.005; Kudo R., 1922, Transactions of the American Microscopical Society, V41, P59, DOI 10.2307/3221896; Lefoulon E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004233; MAFF, 1984, MANUAL VET INVESTIGA, V2, p[390, 162]; McKenzie VJ, 2008, J PARASITOL, V94, P824, DOI 10.1645/GE-1433.1; McKenzie VJ, 2007, BIOL CONSERV, V137, P102, DOI 10.1016/j.biocon.2007.01.019; Olivry J., 1986, ORSTOM MEMOIRES, V9, P1; Omonona A. O., 2011, Journal of Veterinary Medicine and Animal Health, V3, P14; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Reichenbach-Klinke H, 1965, SCIENCE, V150, P1143; ROESCHLAP, 1974, Z KLIN CHEM KLIN BIO, V12, P226; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	32	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217539	10.1371/journal.pone.0217539	http://dx.doi.org/10.1371/journal.pone.0217539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141563	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000469323000058
J	Martin-Cardona, A; Fernandez-Esparrach, G; Subtil, JC; Iglesias-Garcia, J; Garcia-Guix, M; Barroso, AB; Gimeno-Garcia, AZ; Esteban, JM; Balteiro, AP; Velasco-Guardado, A; Vazquez-Sequeiros, E; Loras, C; Martinez-Moreno, B; Castellot, A; Huertas, C; Martinez-Lapiedra, M; Sanchez-Yague, A; Teran, A; Morales-Alvarado, VJ; Betes, M; de la Iglesias, D; Sanchez-Montes, C; Lozano, MD; Larino-Noia, J; Gines, A; Tebe, C; Gornals, JB; Gallarreta, V; Aparicio, JR; Castellot, A				Martin-Cardona, A.; Fernandez-Esparrach, G.; Subtil, J. C.; Iglesias-Garcia, J.; Garcia-Guix, M.; Barturen Barroso, A.; Gimeno-Garcia, A. Z.; Esteban, J. M.; Pardo Balteiro, A.; Velasco-Guardado, A.; Vazquez-Sequeiros, E.; Loras, C.; Martinez-Moreno, B.; Castellot, A.; Huertas, C.; Martinez-Lapiedra, M.; Sanchez-Yague, A.; Teran, A.; Morales-Alvarado, V. J.; Betes, M.; de la Iglesias, D.; Sanchez-Montes, C.; Lozano, M. D.; Larino-Noia, J.; Gines, A.; Tebe, C.; Gornals, J. B.; Gallarreta, V; Aparicio, J. R.; Castellot, A.		Spanish Grp EUS-Guided TA Adrenal	EUS-guided tissue acquisition in the study of the adrenal glands: Results of a nationwide multicenter study	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; LUNG-CANCER; FDG-PET/CT; MASSES; BIOPSY; MANAGEMENT; DIAGNOSIS; BENIGN	Background There are limited data about the role of endoscopic ultrasound-guided tissue acquisition (EUS-TA), by fine needle aspiration (EUS-FNA) or biopsy (EUS-FNB), in the evaluation of the adrenal glands (AG). The primary aim was to assess the diagnostic yield and safety. The secondary aims were the malignancy predictors, and to create a predictive model of malignancy. Methods This was a retrospective nationwide study involving all Spanish hospitals experienced in EUS-TA of AGs. Inclusion period was from April-2003 to April-2016. Inclusion criteria: all consecutive cases that underwent EUS-TA of AGs. EUS and cytopathology findings were evaluated. Statistical analyses: diagnostic accuracy of echoendoscopist's suspicion using cytology by EUS-TA, as gold standard; multivariate logistic regression model to predict tumor malignancy. Results A total of 204 EUS-TA of AGs were evaluated. Primary tumor locations were lung70%, others19%, and unknown 11% AG samples were adequate for cytological diagnosis in 91%, and confirmed malignancy in 60%. Diagnostic accuracy of the endosonographer's suspicion was 68%. The most common technique was: a 22-G (65%) and cytological needle (75%) with suction -syringe (66%). No serious adverse events were described. The variables most associated with malignancy were size>30mm (OR2.27; 95%Cl, 1.16-4.05), heterogeneous echo pattern (OR2.11; 95%Cl, 1.1-3.9), variegated AG shape (OR2.46; 95%Cl, 1-6.24), and endosonographer suspicion (OR17.46; 95%Cl, 6.2-58.5). The best variables for a predictive multivariate logistic model of malignancy were age, sex, echo-pattern, and AG-shape. Conclusions EUS-TA of the AGs is a safe, minimally invasive procedure, allowing an excellent diagnostic yield. These results suggest the possibility of developing a pre-EUS procedure predictive malignancy model.	[Martin-Cardona, A.; Garcia-Guix, M.; Gornals, J. B.] Univ Barcelona, Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Endoscopy Unit,Dept Digest Dis, Barcelona, Spain; [Martin-Cardona, A.; Loras, C.] Hosp Univ Mittua Terrassa, CIBERehd, Fundacio Recerca Mittua Terrassa, Dept Digest Dis, Terrassa, Spain; [Fernandez-Esparrach, G.; Morales-Alvarado, V. J.; Sanchez-Montes, C.; Gines, A.] Univ Barcelona, CIBEREHD, DIBAPS, Endoscopy Unit,ICMDiM,Hosp Clin, Barcelona, Spain; [Subtil, J. C.; Betes, M.; Lozano, M. D.] Univ Navarra Clin, Endoscopy Unit, Pamplona, Spain; [Iglesias-Garcia, J.; de la Iglesias, D.; Larino-Noia, J.] Univ Hosp Santiago Compostela, Dept Gastroenterol & Hepatol, Santiago, Spain; [Barturen Barroso, A.] Hosp Univ Cruces, Dept Digest Dis, Bilbao, Spain; [Gimeno-Garcia, A. Z.] Hosp Univ Canarias, Dept Gastroenterol & Hepatol, Tenerife, Spain; [Esteban, J. M.] Hosp Clin San Carlos, Dept Digest Dis, Endoscopy Unit, Madrid, Spain; [Pardo Balteiro, A.] Hosp Univ Joan XXIII, Dept Digest Dis, Tarragona, Spain; [Velasco-Guardado, A.] Hosp Univ Salamanca, Inst Invest Biorned Salamanca IBSAL, Dept Digest Dis, Salamanca, Spain; [Vazquez-Sequeiros, E.] Hosp Ramon & Cajal, RYCIS, Gastroenterol & Hepatol Serv, Endoscopy Unit, Madrid, Spain; [Loras, C.; Gornals, J. B.] Univ Oberta Catalunya, Hlth Sci, Barcelona, Spain; [Martinez-Moreno, B.] Hosp Gen Univ Alicante, Dept Digest Dis, Alicante, Spain; [Castellot, A.] Hosp Insular Gran Canaria, Dept Digest Dis, Las Palmas Gran Canaria, Spain; [Huertas, C.] Hosp Dr Josep Trueta Girona, Dept Digest Dis, Girona, Spain; [Martinez-Lapiedra, M.] Inst Oncol Valenciano, Valencia, Spain; [Sanchez-Yague, A.] Hosp Costa Sol, Endoscopy Unit, Marbella, Spain; [Teran, A.] Hosp Univ Marques Valdecilla, Dept Digest Dis, Santander, Spain; [Tebe, C.] Inst Biomed Res Bellvitge, Biostat Unit, Barcelona, Spain; [Martin-Cardona, A.; Garcia-Guix, M.; Gornals, J. B.; Gallarreta, V] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain; [Fernandez-Esparrach, G.; Morales-Alvarado, V. J.; Sanchez-Montes, C.; Gines, A.] Hosp Clin Barcelona, Barcelona, Spain; [Subtil, J. C.; Lozano, M. D.] Clin Univ Navarra, Navarra, Spain; [Iglesias-Garcia, J.; de la Iglesias, D.; Larino-Noia, J.] Hosp Clin Univ Santiago Compostela, Santiago, Spain; [Barturen Barroso, A.] Hosp Univ Las Cruces, Baracaldo, Spain; [Gimeno-Garcia, A. Z.] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain; [Esteban, J. M.] Hosp Clin San Carlos, Madrid, Spain; [Pardo Balteiro, A.] Hosp Univ Joan XXIII, Tarragona, Spain; [Velasco-Guardado, A.] Hosp Univ Salamanca, Salamanca, Spain; [Vazquez-Sequeiros, E.] MD Anderson Madrid, Madrid, Spain; [Loras, C.] Hosp Univ Terrassa, Terrassa, Spain; [Martinez-Moreno, B.; Aparicio, J. R.] Hosp Gen Univ Alicante, Alicante, Spain; [Castellot, A.] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain; [Huertas, C.] Hosp Dr Josep Trueta Girona, Girona, Spain; [Martinez-Lapiedra, M.] Inst Oncol Valenciano, Valencia, Spain; [Sanchez-Yague, A.] Hosp Costa Sol, Marbella, Spain; [Teran, A.] Hosp Univ Marques Valdecilla, Santander, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario Cruces; Universidad de la Laguna; Hospital Clinico San Carlos; Hospital Universitario Ramon y Cajal; UOC Universitat Oberta de Catalunya; General University Hospital of Alicante; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Instituto Valenciano De Oncologia; Hospital Universitario Marques de Valdecilla (HUMV); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; Complexo Hospitalario Universitario de Santiago de Compostela; Universidad de la Laguna; Hospital Clinico San Carlos; University of Salamanca; University of Texas System; UTMD Anderson Cancer Center; Hospital Universitario Mutua Terrassa; General University Hospital of Alicante; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Instituto Valenciano De Oncologia; Hospital Universitario Marques de Valdecilla (HUMV)	Gornals, JB (corresponding author), Univ Barcelona, Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Endoscopy Unit,Dept Digest Dis, Barcelona, Spain.; Gornals, JB (corresponding author), Univ Oberta Catalunya, Hlth Sci, Barcelona, Spain.	jgornals@bellvitgehospi-tal.cat	de la Iglesia Garcia, Daniel/AAB-4152-2019; Guardado, Antonio Velasco/H-7237-2019; Tebé, Cristian/K-1991-2019; Esteban, Jose Miguel/ABA-1644-2020; de la Iglesia, Daniel/AAF-8955-2021; Lozano, Maria D/ABD-9613-2020; Morales Alvarado, Victor Jair/K-5427-2019	de la Iglesia Garcia, Daniel/0000-0002-1826-2282; Guardado, Antonio Velasco/0000-0002-9458-0602; Tebé, Cristian/0000-0003-2320-1385; Esteban, Jose Miguel/0000-0001-6644-960X; Lozano, Maria D/0000-0002-6796-9380; Gines, Angels/0000-0002-5979-6029; Morales Alvarado, Victor Jair/0000-0003-4379-2821; Fernandez-Esparrach/0000-0002-3378-3940; VAZQUEZ-SEQUEIROS, ENRIQUE/0000-0003-4372-3893; Martinez-Moreno, Belen/0000-0002-4025-6735; MARTIN-CARDONA, ALBERT/0000-0002-7090-0106; Gimeno-Garcia, Antonio Z/0000-0003-0670-6883				Akdamar MK, 2004, GASTROINTEST ENDOSC, V60, P1018, DOI 10.1016/S0016-5107(04)02218-7; Brady MJ, 2009, RADIOLOGY, V250, P523, DOI 10.1148/radiol.2502080219; BURT M, 1994, J THORAC CARDIOV SUR, V107, P584, DOI 10.1016/S0022-5223(94)70106-7; CHAPMAN GS, 1984, CANCER, V54, P1541, DOI 10.1002/1097-0142(19841015)54:8<1541::AID-CNCR2820540812>3.0.CO;2-N; DeWitt J, 2007, ENDOSCOPY, V39, P65, DOI 10.1055/s-2006-945042; Eloubeidi MA, 2004, GASTROINTEST ENDOSC, V59, P627, DOI 10.1016/S0016-5107(04)00296-2; Eloubeidi MA, 2010, GASTROINTEST ENDOSC, V71, P745, DOI 10.1016/j.gie.2009.10.022; GILLAMS A, 1992, CLIN RADIOL, V46, P18, DOI 10.1016/S0009-9260(05)80027-3; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Gupta N C, 2001, Clin Lung Cancer, V3, P59, DOI 10.3816/CLC.2001.n.019; Harisinghani MG, 2002, CLIN RADIOL, V57, P898, DOI 10.1053/crad.2002.1054; Haseganu Laura E, 2009, Gastrointest Endosc, V69, pe51, DOI 10.1016/j.gie.2008.09.035; Martinez Melissa, 2014, World J Nephrol, V3, P92, DOI 10.5527/wjn.v3.i3.92; MODY MK, 1995, J COMPUT ASSIST TOMO, V19, P434, DOI 10.1097/00004728-199505000-00017; Okada M, 2009, ANN NUCL MED, V23, P349, DOI 10.1007/s12149-009-0246-4; Patil R, 2016, ANN GASTROENTEROL, V29, P307, DOI 10.20524/aog.2016.0047; Porte HL, 1999, EUR J CARDIO-THORAC, V15, P597, DOI 10.1016/S1010-7940(99)00047-0; Schuurbiers OCJ, 2011, LUNG CANCER, V73, P310, DOI 10.1016/j.lungcan.2010.12.019; Serra K, 2017, REV ESP ENFERM DIG, V109, P378; Stelow EB, 2005, DIAGN CYTOPATHOL, V33, P26, DOI 10.1002/dc.20273; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Xu B, 2012, NEOPLASMA, V59, P92, DOI 10.4149/neo_2012_012	22	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216658	10.1371/journal.pone.0216658	http://dx.doi.org/10.1371/journal.pone.0216658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170163	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700007
J	Muttamba, W; Ssengooba, W; Kirenga, B; Sekibira, R; Walusimbi, S; Katamba, A; Joloba, M				Muttamba, Winters; Ssengooba, Willy; Kirenga, Bruce; Sekibira, Rogers; Walusimbi, Simon; Katamba, Achilles; Joloba, Moses			Health seeking behavior among individuals presenting with chronic cough at referral hospitals in Uganda; Missed opportunity for early tuberculosis diagnosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SERVICE DELAY; CARE; PATIENT	Background Tuberculosis (TB) is the 9th leading cause of death from a single infectious agent. Patients live in a complex health care system with both formal and informal providers, and it is important that a TB diagnosis is not missed at the first interaction with the health care system. In this study, we highlight the health seeking behavior of patients and missed opportunities for early TB diagnosis for which interventions could be instituted to ensure early TB diagnosis and prompt TB treatment initiation. Methods This study was nested in a cross-sectional study that assessed the accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the referral hospitals in Uganda. We documented the symptom profile of presumptive TB patients and assessed the health seeking behavior of those with chronic cough by calculating proportion of patients that visited each type of health facility and further calculated the odds of being TB positive given the type of health facility initially visited for consultation. Results A total of 1,863 presumptive TB patients were enrolled of which 979 (54.5%) were male, and 1795 (99.9%) had chronic cough. A total of 1352 (75.4%) had previously sought care for chronic cough, with 805 (59.6%) seeking care from a public health facility followed by private health facility (289; 21.4%). Up to 182 (13.5%) patients visited a drug store for chronic cough. Patients whose first contact was a private health facility were more likely to have a positive GeneXpert test (adjOR 1.4, 95% CI: 1.0-1.9; p = 0.047). Conclusions Chronic cough is a main symptom for many of the presumptive TB patients presenting at referral hospitals, with several patients having to visit the health system more than once before a TB diagnosis is made. This suggests the need for patients to be thoroughly evaluated at first interface with the health care system to ensure prompt diagnosis and treatment initiation. Improved TB diagnosis possibly with the GeneXpert test, at first contact with the health care system has potential to increase TB case finding and break the transmission cycle in the community.	[Muttamba, Winters; Ssengooba, Willy; Kirenga, Bruce; Sekibira, Rogers; Walusimbi, Simon] Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda; [Muttamba, Winters; Ssengooba, Willy; Joloba, Moses] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Muttamba, W; Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda.; Muttamba, W; Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	muttamba@gmail.com; willyssengooba@gmail.com	Ssengooba, Willy/ABE-2168-2020	Ssengooba, Willy/0000-0002-1643-110X	World Bank under the East African Public Health Laboratory Networking Project (EAPHLNP)	World Bank under the East African Public Health Laboratory Networking Project (EAPHLNP)	This study was conducted with funding from the World Bank under the East African Public Health Laboratory Networking Project (EAPHLNP). he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nugussie DA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6325484; Chanda-Kapata P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163975; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Liam CK, 1997, INT J TUBERC LUNG D, V1, P326; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Mistry N, 2017, J EPIDEMIOL GLOB HEA, V7, P241, DOI 10.1016/j.jegh.2017.08.001; Muttamba W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194741; Oola J, 2001, FACTORS INFLUENCING; Organization WH, 2017, GLOB TUB REP 2017; Organization WH, 2017, TUB PAT COST SURV HD; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Uganda Communication Council, 2017, ANN REPORT; Van Wyk SS, 2011, INT J TUBERC LUNG D, V15, P1069, DOI 10.5588/ijtld.10.0615; Xu B, 2005, INT J TUBERC LUNG D, V9, P784; Yimer SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-19	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217900	10.1371/journal.pone.0217900	http://dx.doi.org/10.1371/journal.pone.0217900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170234	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700079
J	Nuno, L; Guilera, G; Coenen, M; Rojo, E; Gomez-Benito, J; Barrios, M				Nuno, Laura; Guilera, Georgina; Coenen, Michaela; Rojo, Emilio; Gomez-Benito, Juana; Barrios, Maite			Functioning in schizophrenia from the perspective of psychologists: A worldwide study	PLOS ONE			English	Article							ICF CORE SET; COGNITIVE-BEHAVIORAL THERAPY; INTERNATIONAL CLASSIFICATION; NEGATIVE SYMPTOMS; SOCIAL-SKILLS; REMEDIATION; VALIDATION; GUIDELINES; DELPHI; TRAJECTORIES	Schizophrenia is a severe mental disorder associated with impairment in functioning. A multidisciplinary approach is essential to help individuals with this health condition, and psychological interventions are considered a priority. The International Classification of Functioning, Disability and Health (ICF) offers a theoretical framework for assessing functioning and disability. The ICF Core Sets for schizophrenia are a list of ICF categories describing the most common problems in functioning of persons affected by this health condition. This study aimed to explore the content validity of these ICF Core Sets and to identify the most common problems in people with schizophrenia from the perspective of psychologists. Psychologists with experience of schizophrenia treatment were recruited for a three-round Delphi study in order to gather their views regarding the problems commonly presented by these patients. A total of 175 psychologists from 46 countries covering the six WHO regions answered the first-round questionnaire, and 137 completed all three rounds. The 7,526 concepts extracted from first-round responses were linked to 412 ICF categories and 53 personal factors. Consensus (>= 75% agreement) was reached for 76 ICF categories and 28 personal factors. Seventy-three of the 97 ICF categories that form the Comprehensive ICF Core Set for schizophrenia achieved consensus, and only three categories that yielded consensus do not feature in this Core Set. These results support the content validity of these ICF Core Sets from the perspective of psychologists. This provides further evidence of the suitability of the ICF framework for describing functioning and disability in persons with schizophrenia.	[Nuno, Laura] Hosp Clin Barcelona, Clin Inst Neurosci ICN, Barcelona, Spain; [Nuno, Laura; Guilera, Georgina; Gomez-Benito, Juana; Barrios, Maite] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain; [Guilera, Georgina; Gomez-Benito, Juana; Barrios, Maite] Univ Barcelona, Inst Neurosci, Grp Measurement Invariance & Anal Change GEIMAC, Barcelona, Spain; [Coenen, Michaela] LMU, Inst Med Informat Proc Biometry & Epidemiol IBE, Res Unit Biopsychosocial Hlth, Munich, Germany; [Coenen, Michaela] Pettenkofer Sch Publ Hlth, Munich, Germany; [Coenen, Michaela] ICF Res Branch, Munich, Germany; [Rojo, Emilio] Sisters Hospitallers, Hosp Benito Menni CASM, St Boi De Llobregat, Spain; [Rojo, Emilio] Univ Int Catalunya, Dept Psychiat, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; University of Munich; Universitat Internacional de Catalunya (UIC)	Nuno, L (corresponding author), Hosp Clin Barcelona, Clin Inst Neurosci ICN, Barcelona, Spain.; Nuno, L (corresponding author), Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain.	nuno@clinic.cat	Rodes, Emilio Rojo/AAB-2913-2019; Gómez-Benito, Juana/I-2214-2015; Gómez-Benito, Juana/AAC-1856-2019; Barrios, Maite/J-5738-2013; Nuno Gomez, Laura/V-5488-2017; Guilera, Georgina/A-4253-2009	Gómez-Benito, Juana/0000-0002-4280-3106; Gómez-Benito, Juana/0000-0002-4280-3106; Barrios, Maite/0000-0003-1979-0818; Nuno Gomez, Laura/0000-0001-9014-956X; Guilera, Georgina/0000-0002-4941-2511	Spain's Ministry of Economy and Competitiveness [PSI2015-67984-R]; Agency for the Management of University and Research Grants of the Government of Catalonia [2017SGR1681]	Spain's Ministry of Economy and Competitiveness; Agency for the Management of University and Research Grants of the Government of Catalonia	This work was supported by Spain's Ministry of Economy and Competitiveness [grant PSI2015-67984-R], and by the Agency for the Management of University and Research Grants of the Government of Catalonia [grant 2017SGR1681]. J. Gomez-Benito was the author who received the funding. The grants financed the preparation of the materials in the five languages in which it was applied, the Qualtrics platform through which the data were collected, and the linguistic revision of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmed AO, 2018, J PSYCHIATR RES, V97, P8, DOI 10.1016/j.jpsychires.2017.11.004; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Andres AM, 2004, BRIT J MATH STAT PSY, V57, P1, DOI 10.1348/000711004849268; Becker S, 2010, PSYCHO-ONCOLOGY, V19, P594, DOI 10.1002/pon.1608; Best MW, 2017, EXPERT REV NEUROTHER, V17, P713, DOI 10.1080/14737175.2017.1331128; Bhalla IP, 2018, SCHIZOPHR RES, V201, P39, DOI 10.1016/j.schres.2018.04.035; Bowie CR, 2012, AM J PSYCHIAT, V169, P710, DOI 10.1176/appi.ajp.2012.11091337; Brissos S, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-18; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Brown CA, 2018, J CONSULT CLIN PSYCH, V86, DOI 10.1037/ccp0000257; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2019, DISABIL REHABIL, V41, P574, DOI 10.3109/09638288.2016.1145258; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100; Diaz-Caneja CM, 2018, EUR CHILD ADOLES PSY, V27, P1459, DOI 10.1007/s00787-018-1135-y; Geyh S, 2019, DISABIL REHABIL, V41, P1727, DOI 10.1080/09638288.2018.1445302; Geyh Szilvia, 2011, Am J Phys Med Rehabil, V90, pS79, DOI 10.1097/PHM.0b013e318230fb68; Goghari VM, 2017, PSYCHIAT RES, V251, P162, DOI 10.1016/j.psychres.2017.01.040; Gomez-Benito J, 2018, DISABIL REHABIL, V40, P2756, DOI 10.1080/09638288.2017.1356384; Granholm E, 2018, SCHIZOPHRENIA BULL, V44, P653, DOI 10.1093/schbul/sbx099; Grotkamp SL, 2012, AUST J REHABIL COUNS, V18, P1, DOI 10.1017/jrc.2012.4; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; ICF; World Health Organization, 2001, INTERNATIONAL CLASSI; Ira E, 2013, J PSYCHIATR NEUROSCI, V38, P366, DOI 10.1503/jpn.120178; Jablensky A, 2017, AUSTRALAS PSYCHIATRY, V25, P600, DOI 10.1177/1039856217726691; Kendall T, 2016, BRIT J PSYCHIAT, V208, P316, DOI 10.1192/bjp.bp.115.170324; Kendler KS, 2018, MOL PSYCHIATR, V23, P1076, DOI 10.1038/mp.2017.78; Kennedy L, 2017, COMMUNITY MENT HLT J, V53, P127, DOI 10.1007/s10597-016-0030-6; Kirchberger I, 2008, PSYCHOL HEALTH, V23, P639, DOI 10.1080/14768320701244076; Lee EE, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11776; Lincoln TM, 2012, J CONSULT CLIN PSYCH, V80, P674, DOI 10.1037/a0028665; MahMood Z, 2018, J PSYCHIATR RES, V102, P201, DOI 10.1016/j.jpsychires.2018.04.011; Matsuda Y, 2018, NEUROPSYCHOL REHABIL, V28, P387, DOI 10.1080/09602011.2016.1181555; Misiak B, 2018, MOL NEUROBIOL, V55, P5075, DOI 10.1007/s12035-017-0708-y; Moll VMK, 2016, PHYS THER, V96, P1262, DOI 10.2522/ptj.20150365; Mosolov SN, 2014, NEUROPSYCH DIS TREAT, V10, P167, DOI 10.2147/NDT.S46799; Norman R, 2017, CAN J PSYCHIAT, V62, P617, DOI 10.1177/0706743717719894; Nuno L, 2018, J PSYCHIATR RES, V103, P134, DOI 10.1016/j.jpsychires.2018.05.012; Penades R, 2013, BIOL PSYCHIAT, V73, P1015, DOI 10.1016/j.biopsych.2013.01.017; Poloni N, 2018, PSYCHOL RES BEHAV MA, V11, P123, DOI 10.2147/PRBM.S159571; RACE KEH, 1992, EVALUATION REV, V16, P171, DOI 10.1177/0193841X9201600204; Selb M, 2015, EUR J PHYS REHAB MED, V51, P105; Sevilla-Llewellyn-Jones J, 2018, SCHIZOPHR RES, V195, P86, DOI 10.1016/j.schres.2017.08.042; Torgalsboen AK, 2018, EUR PSYCHIAT, V52, P54, DOI 10.1016/j.eurpsy.2018.04.007; WHO, 2022, SCHIZ; Wolwer W, 2011, SCHIZOPHRENIA BULL, V37, pS63, DOI 10.1093/schbul/sbr071; Yen TH, 2014, DISABIL REHABIL, V36, P177, DOI 10.3109/09638288.2013.782359	47	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217936	10.1371/journal.pone.0217936	http://dx.doi.org/10.1371/journal.pone.0217936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170249	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700084
J	Supramaniam, A; Bielefeldt-Ohmann, H; Rudd, PA; Webster, J; Ferro, V; Herrero, LJ				Supramaniam, Aroon; Bielefeldt-Ohmann, Helle; Rudd, Penny A.; Webster, Julie; Ferro, Vito; Herrero, Lara J.			PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice	PLOS ONE			English	Article							RIVER VIRUS-VACCINE; TUMOR-GROWTH; ANGIOGENESIS; INHIBITOR; INFECTION; DISEASE; INFLAMMATION; HEPARANASE; DEFICIENT; AUSTRALIA	Recently the anti-viral effects of prophylactic treatment with the low-molecular-weight heparan sulfate mimetic PG545 in Ross River virus (RRV) infected mice were reported. We further investigated the related, transient pathophysiology of PG545 drug treatment in RRV-infected and mock-infected PG545-treated mice. PG545 treatment resulted in mild lethargy and piloerection, on days after the drug administration. Mice were treated with two or three doses of PG545 within a ten-day period and were subsequently culled at peak disease or at disease resolution. The treatment responses of the spleen and liver were assessed through histology, flow cytometry, gene arrays and serum biochemistry. Microscopy showed an expanded red pulp in the spleen following either two or three treatments with PG545. The red pulp expansion was further demonstrated by the proliferation of megakaryocytes and erythrocyte precursors within the spleen. In addition, flow cytometry and gene array analyses revealed a reduction of lymphocytes within the spleens of PG545-treated mice. Previously unreported, RRV-induced elevations of aspartate aminotransferase (AST) and alanine transaminase (ALT) enzymes and creatinine were also noted in the RRV-infected mice. However, PG545 only reduced AST and ALT levels but not the creatinine levels in infected mice during treatment. Mice treated with three doses of PG545 also showed hepatosplenomegaly and anaemia, which were reversed upon discontinuation of the treatment. In summary, this study demonstrates that dose and frequency related haemopoietic pathophysiology such as hepatosplenomegaly and anaemia, occurred in C57BL/6 mice treated with PG545. However, this effect was reversible once drug administration is terminated.	[Supramaniam, Aroon; Rudd, Penny A.; Webster, Julie; Herrero, Lara J.] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia; [Bielefeldt-Ohmann, Helle; Ferro, Vito] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Qld, Australia	Griffith University; University of Queensland; University of Queensland	Herrero, LJ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia.	l.herrero@griffith.edu.au	Ferro, Vito/A-4882-2010; Webster, Julie/N-6081-2015; Herrero, Lara/A-4628-2015	Ferro, Vito/0000-0003-3306-2550; Webster, Julie/0000-0003-2879-700X; Herrero, Lara/0000-0002-5661-9828	Australian National Health and Medical Research Council Career Development Award [105760]; NHMRC [1081954]	Australian National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	LJH is the recipient of the Australian National Health and Medical Research Council Career Development Award (ID: 105760) This study was supported by an NHMRC project grant number awarded to L.J.H (ID: 1081954).	Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125; Australian Government Department of Health, 1998, ARB AUSTR REG 1990 1; Australian Government Department of Health, NAT NOT DIS SURV SYS; Brennan TV, 2016, J CLIN INVEST, V126, P207, DOI 10.1172/JCI76566; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Cappellini MD, 2017, AM J HEMATOL, V92, P1068, DOI 10.1002/ajh.24820; Chen LM, 2018, CANCER DISCOV, V8, P1156, DOI 10.1158/2159-8290.CD-17-1033; Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; DREDGE K, 2017, J CLIN ONCOL S15, V35; Dredge K, 2018, BRIT J CANCER, V118, P1035, DOI 10.1038/s41416-018-0006-0; EACHO PI, 1985, FUND APPL TOXICOL, V5, P794, DOI 10.1016/0272-0590(85)90204-0; Elmore SA, 2006, TOXICOL PATHOL, V34, P648, DOI 10.1080/01926230600865523; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferro V, 2012, J MED CHEM, V55, P3804, DOI 10.1021/jm201708h; GARRATTY G, 1975, AM J MED, V58, P398, DOI 10.1016/0002-9343(75)90606-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Hammond E, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0363-5; Hamoud S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7357495; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Herrero LJ, 2015, J VIROL, V89, P8063, DOI 10.1128/JVI.00224-15; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; KAPLAN NM, 1986, AM J NEPHROL, V6, P1, DOI 10.1159/000167045; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Martin ME, 2004, FEBS LETT, V574, P187, DOI 10.1016/j.febslet.2004.08.010; Mirabella F, 2010, J IMMUNOL, V184, P3043, DOI 10.4049/jimmunol.0901364; Muhl H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00018; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Newsholme SJ, 2000, ELECTROPHORESIS, V21, P2122, DOI 10.1002/1522-2683(20000601)21:11<2122::AID-ELPS2122>3.0.CO;2-#; O'Brien PJ, 2002, LAB ANIM-UK, V36, P313, DOI 10.1258/002367702320162414; Ostapoff KT, 2013, MOL CANCER THER, V12, P1190, DOI 10.1158/1535-7163.MCT-12-1123; Pamir N, 2015, J BIOL CHEM, V290, P14656, DOI 10.1074/jbc.M115.645820; Petroianu Andy, 2011, Acta Med Port, V24 Suppl 4, P977; Russell RC, 2004, AUST J ENTOMOL, V43, P271, DOI 10.1111/j.1326-6756.2004.00436.x; Salama A, 2009, EXPERT OPIN DRUG SAF, V8, P73, DOI [10.1517/14740330802577351 , 10.1182/asheducation-2009.1.73, 10.1517/14740330802577351]; Sellars Maclean, 2011, World J Biol Chem, V2, P132, DOI 10.4331/wjbc.v2.i6.132; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Supramaniam A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.01959-17, 10.1128/AAC.01959-17]; Tall JA, 2014, J MED ENTOMOL, V51, P1097, DOI 10.1603/ME14007; Tanaka Y, 2004, J IMMUNOL, V172, P7848, DOI 10.4049/jimmunol.172.12.7848; Vallespinos M, 2011, J IMMUNOL, V186, P6726, DOI 10.4049/jimmunol.1002753; Watanabe Kazuto, 2003, J Toxicol Sci, V28, P123, DOI 10.2131/jts.28.123; Weibrecht K, 2010, J MED TOXICOL, V6, P294, DOI 10.1007/s13181-010-0075-9; Wressnigg N, 2015, CLIN VACCINE IMMUNOL, V22, P267, DOI 10.1128/CVI.00546-14; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030	50	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217998	10.1371/journal.pone.0217998	http://dx.doi.org/10.1371/journal.pone.0217998			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170255	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700090
J	Vissers, T; Koumakis, N; Hermes, M; Brown, AT; Schwarz-Linek, J; Dawson, A; Poon, WCK				Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.			Dynamical analysis of bacteria in microscopy movies	PLOS ONE			English	Article							ESCHERICHIA-COLI; ADHESION; BIOFILMS; CHEMOTAXIS; MOTILITY; FLOW	Recent advances in microscopy, computing power and image processing have enabled the analysis of ever larger datasets of movies of microorganisms to study their behaviour. However, techniques for analysing the dynamics of individual cells from such datasets are not yet widely available in the public domain. We recently demonstrated significant phenotypic heterogeneity in the adhesion of Escherichia coli bacteria to glass surfaces using a new method for the high-throughput analysis of video microscopy data. Here, we present an in-depth analysis of this method and its limitations, and make public our algorithms for following the positions and orientations of individual rod-shaped bacteria from time-series of 2D images to reconstruct their trajectories and characterise their dynamics. We demonstrate in detail how to use these algorithms to identify different types of adhesive dynamics within a clonal population of bacteria sedimenting onto a surface. The effects of measurement errors in cell positions and of limited trajectory durations on our results are discussed.	[Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.] Univ Edinburgh, SUPA, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.] Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [Hermes, Michiel] Univ Utrecht, Debye Inst Nanomat Sci, Soft Condensed Matter, Dept Phys, Princetonpl 5, NL-3584 CC Utrecht, Netherlands	University of Edinburgh; University of Edinburgh; Utrecht University	Vissers, T (corresponding author), Univ Edinburgh, SUPA, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.; Vissers, T (corresponding author), Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.	t.vissers@ed.ac.uk	Brown, Aidan T/M-4897-2017; Poon, Wilson/V-3495-2019; Poon, Wilson C K/B-5960-2013	Brown, Aidan T/0000-0002-6898-4021; Poon, Wilson/0000-0003-0760-7940; Poon, Wilson C K/0000-0003-0760-7940	FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC [623364]; Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC [654688]; ERC Advanced Grant [GA 340877-PHYSAPS]; EPSRC programme [EP/J007404/1]; National Physical Laboratory; SUPA; UK EPSRC [EP/S001255/1]; BBSRC [BB/R012415/1] Funding Source: UKRI; EPSRC [EP/S001255/1, EP/J007404/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/R012415/1] Funding Source: researchfish	FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC; Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC; ERC Advanced Grant(European Research Council (ERC)); EPSRC programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Physical Laboratory; SUPA; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided through FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC, 623364 (TV), Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC, 654688 (NK), ERC Advanced Grant GA 340877-PHYSAPS (TV, NK) and an EPSRC programme grant EP/J007404/1 (AD, WP, JSL). JSL was also funded by the National Physical Laboratory and SUPA. ATB received funding from UK EPSRC (EP/S001255/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 1990, BIOPHYS J, V58, P919, DOI 10.1016/S0006-3495(90)82436-X; Besseling TH, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/19/194109; Bianchi S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062705; Burov S, 2013, P NATL ACAD SCI USA, V110, P19689, DOI 10.1073/pnas.1319473110; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Chan J, 2010, POLLUT SCI TECHNOL A, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEWITT SK, 1962, GENETICS, V47, P577; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Duvernoy MC, 2017, BIORXIV; El-Kirat-Chatel S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01399; Leptos KC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198103; Ping LY, 2010, J MOL BIOL, V397, P906, DOI 10.1016/j.jmb.2010.02.008; Prakash B, 2003, CURR SCI INDIA, V85, P1299; Schlafer S, 2017, J MICROBIOL METH, V138, P50, DOI 10.1016/j.mimet.2016.03.002; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Schwarz-Linek J, 2016, COLLOID SURFACE B, V137, P2, DOI 10.1016/j.colsurfb.2015.07.048; Sharma S, 2016, LANGMUIR, V32, P5422, DOI 10.1021/acs.langmuir.6b00883; Sharma S, 2014, LANGMUIR, V30, P11147, DOI 10.1021/la502313y; Spengler C, 2017, NANOSCALE, V9, P10084, DOI 10.1039/c7nr02297b; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Vissers T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1170; Wang J, 2017, IEEE IMAGE PROC, P330; Weaver WM, 2014, CURR OPIN BIOTECH, V25, P114, DOI 10.1016/j.copbio.2013.09.005	29	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217823	10.1371/journal.pone.0217823	http://dx.doi.org/10.1371/journal.pone.0217823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170194	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700062
J	Han, SY; Ogawa, A; Osada, T; Suda, A; Tanaka, M; Nanjo, H; Shimo, Y; Hattori, N; Konishi, S				Han, Shuyan; Ogawa, Akitoshi; Osada, Takahiro; Suda, Akimitsu; Tanaka, Masaki; Nanjo, Hitoshi; Shimo, Yasushi; Hattori, Nobutaka; Konishi, Seiki			More subjects are required for ventrolateral than dorsolateral prefrontal TMS because of intolerability and potential drop-out	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; MEMORY-GUIDED SACCADES; COGNITIVE NEUROSCIENCE; MOTOR THRESHOLD; FRONTAL-CORTEX; SAFETY; DISRUPTION; PERTURBATION; CHRONOMETRY	Transcranial magnetic stimulation (TMS) of the human lateral prefrontal cortex, particularly the ventral region, often causes considerable discomfort to subjects. To date, in contrast to abundant literature on stimulations to the dorsolateral prefrontal cortex, the ventrolateral prefrontal cortex has been less frequently stimulated, partly because some subjects are intolerable of stimulation to the ventrolateral prefrontal cortex. To predict the additional number of subjects required for the stimulation of the dorsolateral and ventrolateral prefrontal cortices, 20 young healthy subjects reported two evaluation scores: the discomfort caused by TMS and the resulting intolerability to complete the TMS experiments. Single-pulse stimulation (SPS) or theta-burst stimulation (TBS) was administered to the lateral prefrontal cortex. The high-resolution extended 10-20 system was used to provide accurate estimation of the voxelwise scores. The discomfort ratings with the SPS and TBS were relatively higher in the ventrolateral prefrontal cortex than those in the dorsolateral prefrontal cortex. Both the SPS and TBS elicited maximal discomfort at the stimulation position F8. The SPS and TBS to F8 under the standard TMS protocols were intolerable for approximately one half (11 and 10, respectively) of the subjects. The intolerability was further calculated for all voxels in the lateral prefrontal cortex, which enabled us to estimate the additional number of subjects required for specific target areas. These results suggest that prior knowledge of subjects' discomfort during stimulation of the lateral prefrontal cortex can be of practical use in the experimental planning of the appropriate number of recruited subjects and provide the database for the probability of intolerability that can be used to predict the additional number of subjects.	[Han, Shuyan; Ogawa, Akitoshi; Osada, Takahiro; Suda, Akimitsu; Tanaka, Masaki; Nanjo, Hitoshi; Konishi, Seiki] Juntendo Univ, Dept Neurophysiol, Sch Med, Tokyo, Japan; [Suda, Akimitsu; Shimo, Yasushi; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Res Inst Dis Old Age, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Sportol Ctr, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Adv Res Inst Hlth Sci, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Konishi, S (corresponding author), Juntendo Univ, Dept Neurophysiol, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Res Inst Dis Old Age, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Sportol Ctr, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Adv Res Inst Hlth Sci, Sch Med, Tokyo, Japan.	skonishi@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Osada, Takahiro/GLU-9088-2022; Ogawa, Akitoshi/D-6287-2011; Ogawa, Akitoshi/AAB-6930-2020	Osada, Takahiro/0000-0002-3743-3200; Ogawa, Akitoshi/0000-0003-1247-445X	JSPS KAKENHI [16K16076]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI to A.O. (grant number 16K16076) and a grant from Takeda Science Foundation to S.K.	Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; Anderson BS, 2009, BRAIN STIMUL, V2, P88, DOI 10.1016/j.brs.2008.09.001; Arana AB, 2008, BRAIN STIMUL, V1, P44, DOI 10.1016/j.brs.2007.08.006; Basso D, 2010, NEUROPSYCHOLOGIA, V48, P3282, DOI 10.1016/j.neuropsychologia.2010.07.011; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Borckardt JJ, 2013, BRAIN STIMUL, V6, P925, DOI 10.1016/j.brs.2013.04.009; Cai WD, 2012, J NEUROSCI METH, V204, P238, DOI 10.1016/j.jneumeth.2011.11.020; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Chung SW, 2018, HUM BRAIN MAPP, V39, P783, DOI 10.1002/hbm.23882; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; De Dreu CKW, 2016, SOC COGN AFFECT NEUR, V11, P1236, DOI 10.1093/scan/nsw045; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Duecker F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073813; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Gogulski J, 2017, CEREB CORTEX, V27, P5343, DOI 10.1093/cercor/bhx219; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Grossheinrich N, 2009, BIOL PSYCHIAT, V65, P778, DOI 10.1016/j.biopsych.2008.10.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; Hartwright CE, 2016, HUM BRAIN MAPP, V37, P3502, DOI 10.1002/hbm.23255; Herwig U, 2010, NEUROSCI LETT, V471, P30, DOI 10.1016/j.neulet.2010.01.003; Holmes NP, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01989; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jimura K, 2014, NEUROSCIENCE, V274, P383, DOI 10.1016/j.neuroscience.2014.05.058; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahn I, 2005, J NEUROPHYSIOL, V94, P688, DOI 10.1152/jn.01335.2004; Loo CK, 2008, INT J NEUROPSYCHOPH, V11, P131, DOI 10.1017/S1461145707007717; Machii K, 2006, CLIN NEUROPHYSIOL, V117, P455, DOI 10.1016/j.clinph.2005.10.014; Maizey L, 2013, CLIN NEUROPHYSIOL, V124, P536, DOI 10.1016/j.clinph.2012.07.024; Meteyard L, 2018, J NEUROSCI METH, V299, P34, DOI 10.1016/j.jneumeth.2018.02.008; Miyashita Y., 2016, JUNTENDO MED J, V62, P6; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Mottaghy FM, 2003, NEUROIMAGE, V18, P565, DOI 10.1016/S1053-8119(03)00010-7; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Muri RM, 2000, NEUROPSYCHOLOGIA, V38, P1105, DOI 10.1016/S0028-3932(00)00030-0; Narayana S, 2015, J CHILD NEUROL, V30, P1111, DOI 10.1177/0883073814553274; Nyffeler T, 2004, EXP BRAIN RES, V154, P109, DOI 10.1007/s00221-003-1663-6; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Osada T, 2019, J NEUROSCI, V39, P2509, DOI 10.1523/JNEUROSCI.2244-18.2019; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Peterchev AV, 2017, BRAIN STIMUL, V10, P99, DOI 10.1016/j.brs.2016.09.007; Poreisz C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-54; Rahnev D, 2016, P NATL ACAD SCI USA, V113, P6059, DOI 10.1073/pnas.1522551113; Ro T, 1997, J COGNITIVE NEUROSCI, V9, P433, DOI 10.1162/jocn.1997.9.4.433; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sagliano L, 2016, SOC COGN AFFECT NEUR, V11, P1992, DOI 10.1093/scan/nsw105; Schabrun SM, 2018, PAIN MED, V19, P608, DOI 10.1093/pm/pnx099; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smalle EHM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14547-x; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Tame L, 2016, NEUROIMAGE, V138, P184, DOI 10.1016/j.neuroimage.2016.05.056; Tarapore PE, 2016, CLIN NEUROPHYSIOL, V127, P1895, DOI 10.1016/j.clinph.2015.11.042; Thapa T, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6207508; Thapa T, 2018, CLIN NEUROPHYSIOL, V129, P1090, DOI 10.1016/j.clinph.2018.01.060; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Ueno T, 2018, CEREB CORTEX, V28, P3035, DOI 10.1093/cercor/bhy131; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Watanabe T, 2015, J NEUROSCI, V35, P4813, DOI 10.1523/JNEUROSCI.3761-14.2015; Watanabe T, 2014, HUM BRAIN MAPP, V35, P1896, DOI 10.1002/hbm.22300; Yamasaki T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00208; Yi X, 2014, EXP BRAIN RES, V232, P545, DOI 10.1007/s00221-013-3763-2; Zhao D, 2018, CEREB CORTEX, V28, P3468, DOI 10.1093/cercor/bhx213	72	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217826	10.1371/journal.pone.0217826	http://dx.doi.org/10.1371/journal.pone.0217826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158248	gold, Green Published, Green Submitted			2022-12-27	WOS:000469915700028
J	Schindler, P; Helfen, A; Wildgruber, M; Heindel, W; Schulke, C; Masthoff, M				Schindler, Philipp; Helfen, Anne; Wildgruber, Moritz; Heindel, Walter; Schuelke, Christoph; Masthoff, Max			Intraosseous contrast administration for emergency computed tomography: A case-control study	PLOS ONE			English	Article							VASCULAR ACCESS; ANGIOGRAPHY; INFUSION	Objective The aim of the study was to evaluate the feasibility of intraosseous (i. o.) contrast media injection (CMI) for emergency computed tomography (CT) of severe trauma and the associated image quality compared to intravenous (i.v.) CMI. Materials and methods The authors retrospectively analysed objective (contrast-to-noise ratio (CNR)) and subjective (4-point Likert scale) image quality of CTs after i.o. (n = 4, mean age (y) 57.0 +/- 11.0) versus i.v. (n = 20, mean age (y) 58.8 +/- 4.4) CMI. All patients underwent a native head CT scan, a cerebral CT angiography (CTA) and CTA of the supra-aortic vasculature as well as a chest and abdominal CT scan in the venous phase; one patient with an i.o. access additionally received a CTA of the lower limbs. Electronic patient records have been reviewed to determine i.o. access related complications. Results Both groups were consistent in age, heart rate, scan parameters including the flow rate of the contrast agent, resulting in comparable radiation dose levels. The image noise and CNR had no significant difference between the two groups. Scoring the delineation of the main vessels after i.o. CMI showed no significant difference to the i.v. group. There were no CT or i.o. access related complications observed. Conclusion The i.o. access is a safe and suitable alternative for emergency CMI in CT. Using established protocols good to very good image quality can be achieved, comparable to i.v. CMI. We show for the first time, that i.o. CMI is also feasible for CTA imaging of the head and neck region as well as of pelvic and leg vessels.	[Schindler, Philipp; Helfen, Anne; Wildgruber, Moritz; Heindel, Walter; Schuelke, Christoph; Masthoff, Max] Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany	University of Munster	Schindler, P (corresponding author), Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany.	Philipp.Schindler@ukmuenster.de		Schindler, Philipp/0000-0002-8098-9853; Masthoff, Max/0000-0001-5338-9193				Ahrens KL, 2013, J EMERG MED, V45, P182, DOI 10.1016/j.jemermed.2012.11.091; Baadh AS, 2016, AM J ROENTGENOL, V207, P241, DOI 10.2214/AJR.15.15784; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Budach NM, 2017, EMERG RADIOL, V24, P105, DOI 10.1007/s10140-016-1438-6; Cambray EJ, 1997, PEDIATR RADIOL, V27, P892, DOI 10.1007/s002470050264; Cohen J, 2015, J EMERG MED, V49, P771, DOI 10.1016/j.jemermed.2014.06.036; Feuchtner GM, 2010, EUR J RADIOL, V75, pE51, DOI 10.1016/j.ejrad.2009.07.012; FISER DH, 1990, NEW ENGL J MED, V322, P1579; Fowler RL, 2008, ANN EMERG MED, V52, pS152, DOI 10.1016/j.annemergmed.2008.06.389; Fowler R, 2007, PREHOSP EMERG CARE, V11, P63, DOI 10.1080/10903120601021036; Geller E, 1999, PEDIATR EMERG CARE, V15, P328, DOI 10.1097/00006565-199910000-00007; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kleinman ME, 2010, PEDIATRICS, V126, pE1361, DOI 10.1542/peds.2010-2972D; ORLOWSKI JP, 1989, ANN EMERG MED, V18, P1062, DOI 10.1016/S0196-0644(89)80932-1; Petitpas F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1277-6; Schueller G, 2015, RADIOL MED, V120, P641, DOI 10.1007/s11547-015-0500-x; Winkler M, 2017, J CARDIOVASC COMPUT, V11, P203, DOI 10.1016/j.jcct.2017.03.001	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217629	10.1371/journal.pone.0217629	http://dx.doi.org/10.1371/journal.pone.0217629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150466	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100075
J	Stundl, A; Lucht, H; Shamekhi, J; Weber, M; Sedaghat, A; Mellert, F; Grube, E; Nickenig, G; Werner, N; Sinning, JM				Stundl, Anja; Lucht, Hannah; Shamekhi, Jasmin; Weber, Marcel; Sedaghat, Alexander; Mellert, Fritz; Grube, Eberhard; Nickenig, Georg; Werner, Nikos; Sinning, Jan-Malte			Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index)	PLOS ONE			English	Article							PARAVALVULAR LEAKAGE; REPLACEMENT; OUTCOMES; STENOSIS; IMPACT; MECHANISMS; SEVERITY	Aims More than mild paravalvular aortic regurgitation (pAR) negatively impacts prognosis after transcatheter aortic valve implantation (TAVI). "Newer generation" transcatheter heart valves (THVs) including Direct Flow Medical, Medtronic Evolut R, Boston Lotus, and Edwards SAPIEN 3 valve system promise to improve outcome by reducing the rate of TAVI-related issues such as pAR. Aim was to evaluate and compare the hemodynamic performance with AR index of "early" vs. "newer generation" THVs and its impact on outcome. Methods and results In 805 patients undergoing TAVI, the degree of pAR was assessed using imaging modalities (angiography, echocardiography) and hemodynamic measurements (aortic regurgitation index, ARI ratio). Severity of pAR and outcome were assessed according to the VARC-2 criteria. 805 patients underwent TAVI with use of the CoreValve (n = 400), SAPIEN XT (n = 48), Direct Flow Medical (n = 38), Evolut R (n = 114), Lotus (n = 104), or SAPIEN 3 (n = 101) prosthesis. TTE post TAVI revealed that a total of 7.3% of the patients showed moderate/severe pAR. The occurrence of greater than mild pAR occurred less frequently in patients treated with "newer generation" THVs (p<0.001): CoreValve (11.3%), SAPIEN XT (12.5%), Direct Flow Medical (5.3%), Evolut R (5.3%), Lotus (0.0%), and SAPIEN 3 (0.0%). The AR index was significantly higher (p<0.001) in patients receiving "newer generation" prostheses compared to those in whom "earlier generation" THVs were used. However, the ARI was only predictive of cumulative all-cause mortality at 1 and 3 years in "early generation", but not in "newer generation" THVs. In the overall cohort, 30-day and 1-year mortality was 4.8% and 20.1%, respectively. In patients treated with "newer generation" devices, the respective mortality rates remained substantially below those of patients treated with "earlier generation" THVs (30-day mortality: 2.5% vs. 6.7%, p<0.001; 1-year mortality: 11.2% vs. 27.2%, p<0.001). Conclusion TAVI with use of "newer generation" THVs showed significantly reduced pAR and improved outcomes compared to "early generation" devices that could at least in part be explained by more favorable hemodynamics	[Stundl, Anja; Lucht, Hannah; Shamekhi, Jasmin; Weber, Marcel; Sedaghat, Alexander; Grube, Eberhard; Nickenig, Georg; Werner, Nikos; Sinning, Jan-Malte] Univ Hosp Bonn, Dept Med 2, Heart Ctr Bonn, Bonn, Germany; [Mellert, Fritz] Univ Hosp Bonn, Heart Ctr Bonn, Dept Cardiothorac Surg, Bonn, Germany	University of Bonn; University of Bonn	Sinning, JM (corresponding author), Univ Hosp Bonn, Dept Med 2, Heart Ctr Bonn, Bonn, Germany.	jan-malte.sinning@ukbonn.de	Shamekhi, Jasmin/AAU-5430-2021	Weber, Marcel/0000-0003-4100-9522	Boston Scientific	Boston Scientific(Boston Scientific)	The present study was financed by a research grant from Boston Scientific, but no salaries for authors were paid. Despite the financial support, neither Boston Scientific nor any other company had any additional role in the research or results in any manner.	Bleiziffer S, 2012, J THORAC CARDIOV SUR, V143, P310, DOI 10.1016/j.jtcvs.2011.10.060; Buellesfeld L, 2011, J AM COLL CARDIOL, V57, P1650, DOI 10.1016/j.jacc.2010.11.044; Detaint D, 2009, JACC-CARDIOVASC INTE, V2, P821, DOI 10.1016/j.jcin.2009.07.003; Ewe SH, 2011, AM J CARDIOL, V108, P1470, DOI 10.1016/j.amjcard.2011.07.007; Grube E, 2017, J AM COLL CARDIOL, V70, P845, DOI 10.1016/j.jacc.2017.06.045; Gurvitch R, 2010, CIRCULATION, V122, P1319, DOI 10.1161/CIRCULATIONAHA.110.948877; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Koos R, 2011, INT J CARDIOL, V150, P142, DOI 10.1016/j.ijcard.2010.03.004; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; Meredith IT, 2014, J AM COLL CARDIOL, V64, P1339, DOI 10.1016/j.jacc.2014.05.067; Petronio AS, 2012, EUROINTERVENTION, V8, pQ18, DOI 10.4244/EIJV8SQA5; Sinning JM, 2016, JACC-CARDIOVASC INTE, V9, P700, DOI 10.1016/j.jcin.2015.12.271; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stahli BE, 2013, CARDIOVASC DIAGN THE, V3, P15, DOI 10.3978/j.issn.2223-3652.2013.02.01; Stundl A, 2016, EUROINTERVENTION, V11, P1140, DOI 10.4244/EIJY15M11_04; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Tofield A, 2013, EUR HEART J, V34, P2335; Vahanian A, 2016, EUROINTERVENTION, V12, pE235, DOI 10.4244/EIJV12I2A37; Vasa-Nicotera M, 2012, JACC-CARDIOVASC INTE, V5, P858, DOI 10.1016/j.jcin.2012.04.011	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217544	10.1371/journal.pone.0217544	http://dx.doi.org/10.1371/journal.pone.0217544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150455	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100064
J	Kiguen, AX; Marrama, M; Ruiz, S; Estofan, P; Venezuela, RF; Mosmann, JP; Monetti, MS; Rivero, V; Cuffini, CG				Ximena Kiguen, Ana; Marrama, Marcela; Ruiz, Susana; Estofan, Patricia; Fernando Venezuela, Raul; Paola Mosmann, Jessica; Soledad Monetti, Marina; Rivero, Virginia; Gabriela Cuffini, Cecilia			Prevalence, risk factors and molecular characterization of Chlamydia trachomatis in pregnant women from Cordoba, Argentina: A prospective study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Background Chlamydia trachomatis causes the most prevalent bacterial Sexual Transmitted Infection. In pregnant women, untreated chlamydial infections are associated with abortions, premature rupture of membranes, postpartum endometritis, low birth weight and transmission to the newborn. In Cordoba, Argentina, there is little knowledge about the prevalence of Chlamydia trachomatis in women in their third trimester of pregnancy, so, the aim of this study was to evaluate Chlamydia trachomatis prevalence and genotypes present in Cordovan pregnant women with different age and socioeconomic status. Methods and findings Design: prospective study. Settings: Women population from Cordoba city, Argentina. Population: Pregnant women having 35 to 37 weeks of gestation. Methods: Five hundred and nine cervical swabs were collected. Each sample was subjected to DNA extraction and PCR for Chlamydia trachomatis using primers NRO/NLO and CTP1/CTP2. Positives samples were sequenced to determine genotype. Main outcome measures: Demographic data of the patients were collected to detect a population at risk for this infection. Results A prevalence of 6.9% (35/509) for Chlamydia trachomatis infection was detected, with 32/295 and 3/214 from pregnant women with low or better economic resources respectively (p = 0,0001). Results showed a significantly increased rate of 11.6% (30/258) in women under 25 years compared with 2% (5/251) in patients over that age (p = 0,00003). Genotype E was the most prevalent. Conclusions With these results, we can say that pregnant women under 25 years old and low economic resources are one of the populations in which the screening programs of Chlamydia trachomatis should focus.	[Ximena Kiguen, Ana; Fernando Venezuela, Raul; Paola Mosmann, Jessica; Soledad Monetti, Marina; Gabriela Cuffini, Cecilia] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Doctor Jose Maria Vanella, Cordoba, Argentina; [Marrama, Marcela] Municipalidad Cordoba, Direcc Especialidades Med, Cordoba, Argentina; [Ruiz, Susana] Labs Lace Soc Anonima, Cordoba, Argentina; [Estofan, Patricia] CIGOR, Cordoba, Argentina; [Rivero, Virginia] Univ Nacl Cordoba, Ctr Invest Bioquim Clin & Inmunol CIBICI, CONICET, Dept Bioquim Clin,Fac Ciencias Quim, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Kiguen, AX (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Doctor Jose Maria Vanella, Cordoba, Argentina.	ximenakiguen@gmail.com	Mosmann, Jessica Paola/ABC-9690-2020	Mosmann, Jessica Paola/0000-0002-0839-6324; Venezuela, Raul Fernando/0000-0002-4325-8998	Fundacion Roemmers 2014; Secyt 2014 [Res Secyt UNC 203/2014. RHCD: 1565/2014]; Secyt 2016 [Res Secyt UNC 202/2016. RHCD: 1634/2016]	Fundacion Roemmers 2014; Secyt 2014; Secyt 2016	This study was supported by AXKiguen: Fundacion Roemmers 2014, AXKiguen: Secyt 2014 (Res Secyt UNC 203/2014. RHCD: 1565/2014), and AXKiguen: Secyt 2016 (Res Secyt UNC 202/2016. RHCD: 1634/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support was provided by Laboratorios LACE Sociedad Anonima (https://www.laboratoriolace.com.ar/) in the form of salary for Susana Ruiz, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Adachi K, 2016, BIOMED RES INT; Andersen B, 2006, SEX TRANSM DIS, V33, P407, DOI 10.1097/01.olq.0000200609.77577.3f; [Anonymous], 1994, EP INF VERS 7; Bilardi JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-505; Blatt AJ, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.027; Brunelle BW, 2006, INFECT IMMUN, V74, P578, DOI 10.1128/IAI.74.1.578-585.2006; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Cabeza J, 2015, SEX TRANSM INFECT, V91, P7, DOI 10.1136/sextrans-2014-051531; Crichton J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2069-7; Cuffini C, 2012, J MICROBIOL RES, V2, P114; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; de Borborema-Alfaia APB, 2013, BRAZ J INFECT DIS, V17, P545, DOI 10.1016/j.bjid.2013.01.014; de Vries R, 2006, VALUE HEALTH, V9, P1, DOI 10.1111/j.1524-4733.2006.00075.x; Eng T, 2003, HIDDEN EPIDEMIC CONF; Farinati A, 2008, REV PANAM INFECTOL, V10, P8; Gallo Vaulet Lucia, 2010, BMC Res Notes, V3, P34, DOI 10.1186/1756-0500-3-34; Gencay M, 2001, APMIS, V109, P636, DOI 10.1034/j.1600-0463.2001.d01-186.x; Head MG, 2015, J GLOB HEALTH, V5, P89, DOI 10.7189/jogh.05.020405; Kakar S, 2010, INDIAN J MED MICROBI, V28, P45, DOI 10.4103/0255-0857.58728; Lagergard T, 2010, EUR J CLIN MICROBIOL, V29, P609, DOI 10.1007/s10096-010-0887-1; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Lopez-Hurtado M, 2002, PERINATOL REPROD HUM, V16, P140; Lutter EI, 2010, INFECT IMMUN, V78, P3678, DOI 10.1128/IAI.00515-10; Monetti M., 2013, INT J VIROL MOL BIOL, V2, P1; Murray PR, 2006, MICROBIOLOGIA MED, P463; Nonato DR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.003; Ovalle A, 2012, REV CHIL INFECTOL, V29, P517, DOI 10.4067/S0716-10182012000600006; Schmidt R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141367; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vidwan NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034794; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; World Health Organization, 2016, ESTR MUND SECT SAL I; Zucotti Agostina, 2018, Rev Fac Cien Med Univ Nac Cordoba, V75, P183, DOI 10.31053/1853.0605.v75.n3.19810	34	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217245	10.1371/journal.pone.0217245	http://dx.doi.org/10.1371/journal.pone.0217245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150440	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100036
J	Krebs, E; Enns, B; Wang, L; Zang, X; Panagiotoglou, D; Rio, C; Dombrowski, J; Feaster, DJ; Golden, M; Granich, R; Marshall, B; Mehta, SH; Metsch, L; Schackman, BR; Strathdee, SA; Nosyk, B; Gebo, K; Kerr, T; Kirk, G; Montaner, J; Shoptaw, S; Small, W				Krebs, Emanuel; Enns, Benjamin; Wang, Linwei; Zang, Xiao; Panagiotoglou, Dimitra; Del Rio, Carlos; Dombrowski, Julia; Feaster, Daniel J.; Golden, Matthew; Granich, Reuben; Marshall, Brandon; Mehta, Shruti H.; Metsch, Lisa; Schackman, Bruce R.; Strathdee, Steffanie A.; Nosyk, Bohdan; Gebo, Kelly; Kerr, Thomas; Kirk, Gregory; Montaner, Julio; Shoptaw, Steven; Small, William		Localized HIV Modeling Study Grp	Developing a dynamic HIV transmission model for 6 US cities: An evidence synthesis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DECISION-ANALYTIC MODELS; HEALTH STATE UTILITIES; INJECTING DRUG-USERS; PLASMA VIRAL LOAD; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; HETEROSEXUAL TRANSMISSION; ECONOMIC EVALUATIONS	Background Dynamic HIV transmission models can provide evidence-based guidance on optimal combination implementation strategies to treat and prevent HIV/AIDS. However, these models can be extremely data intensive, and the availability of good-quality data characterizing regional microepidemics varies substantially within and across countries. We aim to provide a comprehensive and transparent description of an evidence synthesis process and reporting framework employed to populate and calibrate a dynamic, compartmental HIV transmission model for six US cities. Methods We executed a mixed-method evidence synthesis strategy to populate model parameters in six categories: (i) initial HIV-negative and HIV-infected populations; (ii) parameters used to calculate the probability of HIV transmission; (iii) screening, diagnosis, treatment and HIV disease progression; (iv) HIV prevention programs; (v) the costs of medical care; and (vi) health utility weights for each stage of HIV disease progression. We identified parameters that required city-specific data and stratification by gender, risk group and race/ethnicity a priori and sought out databases for primary analysis to augment our evidence synthesis. We ranked the quality of each parameter using context- and domain-specific criteria and verified sources and assumptions with our scientific advisory committee. Findings To inform the 1,667 parameters needed to populate our model, we synthesized evidence from 59 peer-reviewed publications and 24 public health and surveillance reports and executed primary analyses using 11 data sets. Of these 1,667 parameters, 1,517 (91%) were city-specific and 150 (9%) were common for all cities. Notably, 1,074 (64%), 201 (12%) and 312 (19%) parameters corresponded to categories (i), (ii) and (iii), respectively. Parameters ranked as best-to moderate-quality evidence comprised 39% of the common parameters and ranged from 56%-60% across cities for the city-specific parameters. We identified variation in parameter values across cities as well as within cities across risk and race/ethnic groups. Conclusions Better integration of modelling in decision making can be achieved by systematically reporting on the evidence synthesis process that is used to populate models, and by explicitly assessing the quality of data entered into the model. The effective communication of this process can help prioritize data collection of the most informative components of local HIV prevention and care services in order to reduce decision uncertainty and strengthen model conclusions.	[Krebs, Emanuel; Enns, Benjamin; Wang, Linwei; Zang, Xiao; Panagiotoglou, Dimitra; Nosyk, Bohdan] British Columbia Ctr Excellence HIV AIDS, Hlth Econ Res Unit, Vancouver, BC, Canada; [Zang, Xiao; Nosyk, Bohdan; Small, William] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Emory Ctr AIDS Res, Atlanta, GA 30322 USA; [Dombrowski, Julia; Golden, Matthew] Univ Washington, Dept Med, Div Allergy & Infect Dis Adjunct Epidemiol, Seattle, WA USA; [Feaster, Daniel J.] Univ Miami, Ctr Family Studies, Leonard M Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL USA; [Granich, Reuben] Int Assoc Providers AIDS Care, Washington, DC USA; [Marshall, Brandon] Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI USA; [Mehta, Shruti H.; Gebo, Kelly; Kirk, Gregory] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Metsch, Lisa] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Emory Ctr AIDS Res, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Kerr, Thomas] British Columbia Ctr Substance Use, Vancouver, BC, Canada; [Kerr, Thomas; Montaner, Julio] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Nosyk, Bohdan; Montaner, Julio; Small, William] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Shoptaw, Steven] Univ Calif Los Angeles, Sch Med, Ctr HIV Identificat Prevent & Treatment Serv, Los Angeles, CA 90024 USA	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Emory University; Rollins School Public Health; University of Washington; University of Washington Seattle; University of Miami; Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Cornell University; University of California System; University of California San Diego; Emory University; Rollins School Public Health; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nosyk, B (corresponding author), British Columbia Ctr Excellence HIV AIDS, Hlth Econ Res Unit, Vancouver, BC, Canada.; Nosyk, B (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	bnosyk@cfenet.ubc.ca	Enns, Benjamin/GYU-3276-2022; Gebo, Kelly/AHA-7533-2022; Golden, Matthew/AAE-4314-2020; Strathdee, Steffanie A/B-9042-2009	Enns, Benjamin/0000-0002-4865-1510; Gebo, Kelly/0000-0003-4010-398X; Krebs, Emanuel/0000-0002-6590-8728	National Institutes on Drug Abuse (NIDA) [R01-DA041747]; NIDA [DA12568, DA036297]; Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV [P30DA040500]; NIDA Method to Extend Research in Time (MERIT) award [R37-DA019829]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829, R01DA041747, P30DA040500] Funding Source: NIH RePORTER	National Institutes on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV; NIDA Method to Extend Research in Time (MERIT) award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes on Drug Abuse (NIDA), grant no. R01-DA041747 (BN), and received additional support from NIDA grants DA12568 and DA036297. BRS received additional support from the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (P30DA040500). SAS is supported by a NIDA Method to Extend Research in Time (MERIT) award (R37-DA019829). The funders had no direct role in the conduct of the analysis or the decision to submit the manuscript. NIDA - https://www.drugabuse.gov/. CHERISH - https://cherishresearch.org/.	Administration. DoHaMHVS, 2010, MAR VIT STAT ANN REP; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2017, GEORGIA HLTH NEWS; [Anonymous], 2019, HIV SURVEILL REP SPE; [Anonymous], 2018, HIV SURV REP 2017; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Baser O, 2011, AM J MANAG CARE, V17, pS6; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Bernard CL, 2016, ANN INTERN MED, V26, pM15; Blair JM, 2014, BEHAV CLIN CHARACTER; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Center for HIV Surveillance-Epidemiology and Evaluation-Department of Health and Mental Hygiene-Baltimore-MD, 2015, BALT CIT ANN HIV EP; Centers for Disease Control and Prevention, 2014, PUBL US DAT FIL DOC; Centers for Disease Control and Prevention, 2021, HIV SURVEILLANCE SUP; Centers for Disease Control and Prevention, 2015, 11 CDCP; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2015, SYR SERV PROGR PERS; Centers for Disease Control and Prevention, 2014, 15 CDCP; Centers for Disease Control and Prevention, 2013, 13 CDCP; Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S; Centers for Medicare and Medicaid Services, 2017, CLIN LAB FEE SCHED; Centers for Medicare and Medicaid Services, 2017, PHYS FEE SCHED SEARC; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; City of Baltimore, 2016, BALT CIT SYR EXCH PR; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Cleary S, 2009, HEALTH ECON, V19, P1166; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper NJ, 2007, HEALTH ECON, V16, P1277, DOI 10.1002/hec.1297; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; County of Los Angeles, 2011, 2010 ANN HIV SURV RE; Critchlow S, 2017, J MED ECON, V20, P129, DOI 10.1080/13696998.2016.1229671; Cuadros DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09464-y; DEGRUTTOLA V, 1989, J CLIN EPIDEMIOL, V42, P849, DOI 10.1016/0895-4356(89)90098-X; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001239; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Dombrowski JC, 2014, JAIDS-J ACQ IMM DEF, V67, P323, DOI 10.1097/QAI.0000000000000302; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P2604, DOI 10.1001/jama.2016.16739; Enns B, 2019, AIDS, V3; Evans E, 2015, ADDICTION, V110, P996, DOI 10.1111/add.12863; Florida Department of Health, 2018, ALL CAUS CRUD DEATH; Florida Department of Health, 2016, HIV SURV MIAM FL2015; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Fujimoto K, 2015, AM J PUBLIC HEALTH, V105, P1128, DOI 10.2105/AJPH.2014.302474; Gaines TL, 2016, AIDS CARE, V28, P554, DOI 10.1080/09540121.2015.1131968; Ganz ML, 2015, J MED ECON, V18, P366, DOI 10.3111/13696998.2014.1001848; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Georgia Department of Public Health, 2018, AG ADJ DEATH RAT 201; Georgia Department of Public Health. HIV, 2014, HIV AIDS EP PROGR HI; Goodreau SM, 2017, LANCET HIV, V4, pE311, DOI 10.1016/S2352-3018(17)30067-X; Granich RM, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60648-6; GRANT RM, 1987, J INFECT DIS, V156, P189, DOI 10.1093/infdis/156.1.189; Greenberg AE, 2015, JAIDS-J ACQ IMM DEF, V69, pS1, DOI 10.1097/QAI.0000000000000569; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hansen HB, 2013, J BEHAV HEALTH SER R, V40, P367, DOI 10.1007/s11414-013-9341-3; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Karnon J, 2011, PHARMACOECONOMICS, V29, P51, DOI 10.2165/11584610-000000000-00000; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Katz IT, 2017, LANCET HIV, V4, pE324, DOI 10.1016/S2352-3018(17)30086-3; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095735; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Los Angeles County Department of Public Health, 2013, MORT LOS ANG COUNT 2; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mangal TD, 2017, AIDS, V31, P1073, DOI 10.1097/QAD.0000000000001437; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; McCollister K, 2017, J SUBST ABUSE TREAT, V81, P25, DOI 10.1016/j.jsat.2017.07.008; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nachega JB, 2014, CLIN INFECT DIS, V59, pS21, DOI 10.1093/cid/ciu299; Neumann P. J., 2016, Cost-effectiveness in health and medicine; New York City Department of Health and Mental Hygiene, 2011, NEW YORK CIT HIV AID; New York City Department of Health and Mental Hygiene, 2011, SUMM VIT STAT 2010 C; New York State Department of Health AIDS Institute, 2014, COMPR HARM RED REV T; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Nosyk B, 2015, DRUG ALCOHOL DEPEN, V146, pe53, DOI DOI 10.1016/J.DRUGALCDEP.2014.09.516; Nosyk B, 2015, LANCET HIV, V2; Nosyk B, 2018, CLIN INFECT DIS, V66, P765, DOI 10.1093/cid/cix832; Nosyk B, 2017, LANCET HIV, V4, pE303, DOI 10.1016/S2352-3018(17)30045-0; Nosyk B, 2015, LANCET HIV, V2, pE393, DOI 10.1016/S2352-3018(15)00127-7; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paisley S, 2016, PHARMACOECONOMICS, V34, P597, DOI 10.1007/s40273-015-0372-x; Paisley S, 2010, INT J TECHNOL ASSESS, V26, P458, DOI 10.1017/S026646231000098X; Panagiotoglou D, 2017, AIDS BEHAV; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; PETERMAN TA, 1988, JAMA-J AM MED ASSOC, V259, P55, DOI 10.1001/jama.259.1.55; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Praditsitthikorn N, 2013, INFLUENZA OTHER RESP, V7, P59, DOI 10.1111/irv.12091; Public Health-Seattle and King County, HIV AIDS ANN Q REP 2; Public Health-Seattle & King County, 2017, HIV STD PROGR 2017; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rebeiro PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146119; Rodger A, 2014, 21 C RETR OPP INF 3; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Saloner B, 2017, MED CARE, V55, P669, DOI 10.1097/MLR.0000000000000727; SAMHSA, 2017, NUMB DATA CERT PHYS; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schiller-Fruthwirth IC, 2017, APPL HEALTH ECON HEA, V15, P333, DOI 10.1007/s40258-017-0312-3; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Song DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116694; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Substance Abuse and Mental Health Services Administration, 2020, TREATM EP DAT SET TE; Suen Sze-Chuan, 2017, J Theor Biol, V428, P1, DOI 10.1016/j.jtbi.2017.06.004; Sutton AJ, 2012, EPIDEMICS-NETH, V4, P48, DOI 10.1016/j.epidem.2011.12.001; Taylor DCA, 2010, PHARMACOECONOMICS, V28, P995, DOI 10.2165/11538660-000000000-00000; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Tookes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129360; Truven Health Analytics, 2018, RED BOOK AV WHOL PRI; Hoang VP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1368-8; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28; Wang L, 2019, LANCET HIV; Washington State Department of Health, 2011, AG ADJ MORT RAT; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; Wiseman V, 2016, HEALTH ECON, V25, P140, DOI 10.1002/hec.3299; World Health Organization, 2011, PREVENTION TREATMENT; Zang X, 2019, DEV CALIBRATIO UNPUB; Zang X, 2019, STRUCTURAL DESIGN DA; Zechmeister-Koss I, 2014, MED DECIS MAKING, V34, P288, DOI 10.1177/0272989X13509406	153	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217559	10.1371/journal.pone.0217559	http://dx.doi.org/10.1371/journal.pone.0217559			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145752	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500022
J	Rodriguez-Flores, EM; Mata-Espinosa, D; Barrios-Payan, J; Marquina-Castillo, B; Castanon-Arreola, M; Hernandez-Pando, R				Rodriguez-Flores, Eden M.; Mata-Espinosa, Dulce; Barrios-Payan, Jorge; Marquina-Castillo, Brenda; Castanon-Arreola, Mauricio; Hernandez-Pando, Rogelio			A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ANTITUBERCULOSIS AGENTS; INDUCED HEPATOTOXICITY; NATURAL-PRODUCTS; MILK THISTLE; SILIBININ; INHIBITION; ACTIVATION; EXPRESSION	For many years, tuberculosis (TB) has been a major public health problem worldwide. Advances for treatment and eradication have been very limited. Silymarin (Sm) is a natural product with antioxidant and hepatoprotective activities that has been proposed as a complementary medicine to reduce the liver injury produced by the conventional anti-TB chemotherapy. Sm also has immunoregulatory and microbicide properties. In this study, we determined the effect of Sm on the growth control of mycobacteria. In vitro studies showed that Sm and Silibinin (the principal active compound of Sm) have microbicidal activity against drug-sensitive and multidrug-resistant (MDR) mycobacteria, induce the production of protective cytokines from infected macrophages, and improve the growth control of mycobacteria (p <= 0.0001). Studies in vivo using a model of progressive pulmonary TB in BALB/c mice infected with drug-sensitive or MDR mycobacteria have shown that Sm induces significant expression of Th-1 cytokines such as IFN-gamma and IL-12 as well as TNF alpha, which produce significant therapeutic activity when administered alone and apparently have a synergistic effect with chemotherapy. These results suggest that Sm has a bactericidal effect and can contribute to the control and establishment of a T(H)1 protective immune response against mycobacterial infection. Thus, it seems that this flavonoid has a promising potential as adjuvant therapy in the treatment of TB.	[Rodriguez-Flores, Eden M.; Mata-Espinosa, Dulce; Barrios-Payan, Jorge; Marquina-Castillo, Brenda; Hernandez-Pando, Rogelio] Natl Inst Med Sci & Nutr Salvador Zubiran, Expt Pathol Sect, Dept Pathol, Mexico City, DF, Mexico; [Rodriguez-Flores, Eden M.; Castanon-Arreola, Mauricio] Autonomous Univ Mexico City, Genom Sci Program, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Hernandez-Pando, R (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Expt Pathol Sect, Dept Pathol, Mexico City, DF, Mexico.	rhdezpando@hotmail.com		Hernandez-Pando, Rogelio/0000-0003-1292-3833	National Council of Science and Technology (CONACYT); Rogelio Hernandez Pando [180990]	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Rogelio Hernandez Pando	This work was supported by the National Council of Science and Technology (CONACYT), grant Fon. Inst./58/2016 to Rogelio Hernandez Pando and No. 180990 to Mauricio Castanon-Arreola.	Abate G, 2016, IMMUNOTARGETS THER, V5, P37, DOI 10.2147/ITT.S81892; Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207; Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017; Bahmani M, 2015, J EVID-BASED INTEGR, V20, P292, DOI 10.1177/2156587215571116; Biedermann D, 2014, NAT PROD REP, V31, P1138, DOI 10.1039/c3np70122k; Bijak M, 2017, NUTRIENTS, V9; Bloom BR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2944; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Casas-Grajales Sael, 2015, World J Gastrointest Pharmacol Ther, V6, P59, DOI 10.4292/wjgpt.v6.i3.59; Chiang CY, 2013, INT J TUBERC LUNG D, V17, P714, DOI 10.5588/ijtld.12.0989; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; de Oliveira DR, IN VITRO ANTIMICROBI; Dooley KE, 2016, ADV DRUG DELIVER REV, V102, P116, DOI 10.1016/j.addr.2016.01.014; Eminzade S, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-18; Fordham JB, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/938712; Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231; Garcia A, 2012, EUR J MED CHEM, V49, P1, DOI 10.1016/j.ejmech.2011.12.029; Gharagozloo M, 2013, BASIC CLIN PHARMACOL, V113, P209, DOI 10.1111/bcpt.12088; Hackett ES, 2013, J VET INTERN MED, V27, P10, DOI 10.1111/jvim.12002; Hernandez Pando R, 1996, IMMUNOLOGY, V89, P26; Hoagland DT, 2016, ADV DRUG DELIVER REV, V102, P55, DOI 10.1016/j.addr.2016.04.026; Jahan S, 2015, J PAK MED ASSOC, V65, P620; Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141; Jiang RH, 2015, COMPLEMENT THER MED, V23, P544, DOI 10.1016/j.ctim.2015.06.006; Jnawali H., 2013, 1 2 LINE DRUGS DRUG; Kang HK, 2011, BIOTECHNOL J, V6, P1397, DOI 10.1002/biot.201000422; Kang JS, 2002, J PHARMACOL EXP THER, V302, P138, DOI 10.1124/jpet.302.1.138; Keni RS, 2015, EUR J MED CHEM, V100, P257, DOI 10.1016/j.ejmech.2015.06.017; Kim EJ, 2015, KOREAN J PHYSIOL PHA, V19, P211, DOI 10.4196/kjpp.2015.19.3.211; Kumar D, 2015, FUTURE MED CHEM, V7, P1981, DOI 10.4155/fmc.15.128; Lee DG, 2003, ARCH PHARM RES, V26, P597, DOI 10.1007/BF02976707; Lee H, 2016, J IND MICROBIOL BIOT, V43, P205, DOI 10.1007/s10295-015-1709-3; Lee JS, 2007, J CELL PHYSIOL, V210, P385, DOI 10.1002/jcp.20852; Lima MM, 2015, CURR CLIN PHARMACOL, V10, P242, DOI 10.2174/1574884708666131229124215; Luangchosiri C, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0861-7; Manna SK, 1999, J IMMUNOL, V163, P6800; Marjani M, 2016, IRAN J PHARM RES, V15, P247; Mascarello A, 2016, CURR PHARM DESIGN, V22, P1561, DOI 10.2174/1381612822666160112130539; Matteelli A, 2017, PRESSE MED, V46, pE13, DOI 10.1016/j.lpm.2017.01.015; Meeran SM, 2006, MOL CANCER THER, V5, P1660, DOI 10.1158/1535-7163.MCT-06-0095; Metushi I, 2016, BRIT J CLIN PHARMACO, V81, P1030, DOI 10.1111/bcp.12885; MIADONNA A, 1987, BRIT J CLIN PHARMACO, V24, P747, DOI 10.1111/j.1365-2125.1987.tb03241.x; Molina-Salinas GM, 2006, ARCH MED RES, V37, P45, DOI 10.1016/j.arcmed.2005.04.010; Nairz M, 2018, J TRACE ELEM MED BIO, V48, P118, DOI 10.1016/j.jtemb.2018.03.007; O'Donnell MR, 2016, INT J TUBERC LUNG D, V20, P430, DOI 10.5588/ijtld.15.0360; odany AT, 2016, F1000RES, P5, DOI [10.12688/f1000research.7403.1, DOI 10.12688/F1000RESEARCH.7403.1]; Oosthuizen C, 2017, J MED FOOD, DOI [10.1016/j.ctim.2015.06.006, DOI 10.1016/J.CTIM.2015.06.006]; Ordonez AA, 2014, CURR MOL MED, V14, P385, DOI 10.2174/1566524013666131118112431; Owatari MS, 2018, FISH SHELLFISH IMMUN, V82, P565, DOI 10.1016/j.fsi.2018.08.061; Papackova Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191353; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Parveen R, 2015, J PHARM BIOALLIED SC, V7, P321, DOI 10.4103/0975-7406.168037; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Rawal T, 2016, INDIAN J PHARM SCI, V78, P8, DOI 10.4103/0250-474X.180243; Rayasaml GV, 2015, TRENDS PHARMACOL SCI, V36, P506, DOI 10.1016/j.tips.2015.05.005; Rennie Robert P, 2012, Handb Exp Pharmacol, P45, DOI 10.1007/978-3-642-28951-4_4; Saller R, 2007, FORSCH KOMP KLAS NAT, V14, P70, DOI 10.1159/000100581; Salomon CE, 2012, CURR TOP MED CHEM, V12, P735; Senousy BE, 2010, NAT REV GASTRO HEPAT, V7, P543, DOI 10.1038/nrgastro.2010.134; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Singh M, 2012, HUM EXP TOXICOL, V31, P788, DOI 10.1177/0960327111433901; Sonika Ujjwal, 2012, Trop Gastroenterol, V33, P102; Surai PF, 2015, ANTIOXIDANTS-BASEL, V4, P204, DOI 10.3390/antiox4010204; Vaid M, 2013, BIOCHEM PHARMACOL, V85, P1066, DOI 10.1016/j.bcp.2013.01.026; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Vivekanandan L, 2018, BIOMED PHARMACOTHER, V108, P1303, DOI 10.1016/j.biopha.2018.09.133; Wang M, 2015, TUBERCULOSIS, V95, P364, DOI 10.1016/j.tube.2015.03.003; Wu JW, 2007, DRUG METAB DISPOS, V35, P1603, DOI 10.1124/dmd.107.014894; Wu SS, 2015, J GASTROEN HEPATOL, V30, P540, DOI 10.1111/jgh.12717; Zhang SM, 2016, J GASTROEN HEPATOL, V31, P409, DOI 10.1111/jgh.13070; Zumla A, 2016, LANCET INFECT DIS, V16, P396, DOI 10.1016/S1473-3099(16)00086-4; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	76	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217457	10.1371/journal.pone.0217457	http://dx.doi.org/10.1371/journal.pone.0217457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145751	Green Submitted, gold, Green Published			2022-12-27	WOS:000469425500018
J	Aloni, I; Markman, S; Ziv, Y				Aloni, Irith; Markman, Shai; Ziv, Yaron			Autumn temperatures at African wintering grounds affect body condition of two passerine species during spring migration	PLOS ONE			English	Article							BLACKCAPS SYLVIA-ATRICAPILLA; SWALLOWS HIRUNDO-RUSTICA; ENVIRONMENTAL-CONDITIONS; HABITAT QUALITY; BIRD MIGRATION; RAINFALL; ARRIVAL	Most papers on the physical condition of birds during spring migration focused on food availability preceding migratory take-off. Only a few studies examined the effect of climate conditions at the wintering grounds upon autumn arrival on bird physical condition later on. Here, we hypothesized that environmental conditions upon arrival at the wintering grounds, and not necessarily upon departure, have a crucial carry-over effect on bird spring migration. Using 29,000 observations of the lesser whitethroat, Sylvia curruca, and the eastern Bonelli's warbler, Phylloscopus orientalis, we found temperatures upon arrival at the African wintering grounds to be the only climatic variable correlated with birds' body state upon spring stopover in Israel, six months later. Two different mechanisms could explain these results. One possibility is that high temperatures create favorable conditions for insect activity, which allows rapid recovery from autumn migration and hence successful winter survival and maintenance. Another possible scenario is that harsh conditions, due to the heat and dry environment, cause high mortality, permitting survival of larger individuals which, then, enjoy reduced inter-and intra-specific competition. Whatever the mechanism is, our findings suggest that conditions upon autumn arrival, and not necessarily at the end of winter as traditionally thought, may have a major impact on migrating birds.	[Aloni, Irith; Ziv, Yaron] Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel; [Markman, Shai] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Haifa, Israel	Ben Gurion University; University of Haifa	Aloni, I (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel.	irital@post.bgu.ac.il		Aloni, Irith/0000-0002-7777-3365; Markman, Shai/0000-0002-0484-3801; Ziv, Yaron/0000-0002-6369-9803				Aloni I, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160755; Bairlein F, 2004, ADV ECOL RES, V35, P33, DOI 10.1016/S0065-2504(04)35002-6; Bairlein F, 2006, HDB BIRDS WORLD, V11, p[652, 695]; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; BirdLife International, 2017, SPEC FACTSH PHYLL OR; BirdLife International, 2016, SPEC FACTSH SYLV CUR; Cooper NW, 2015, ECOLOGY, V96, P1933, DOI 10.1890/14-1365.1; DICK WJA, 1979, ORNIS SCAND, V10, P117, DOI 10.2307/3676351; Evans KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034542; Finch T, 2014, BIODIVERS CONSERV, V23, P2427, DOI 10.1007/s10531-014-0731-5; FRUMKIN R, 1995, J ORNITHOL, V136, P127, DOI 10.1007/BF01651235; Gonzalez-Prieto AM, 2013, J ORNITHOL, V154, P1067, DOI 10.1007/s10336-013-0975-y; Goodenough AE, 2017, BIRD STUDY, V64, P433, DOI 10.1080/00063657.2017.1408566; Goodman SM, 1989, BIRDS EGYPT, P429; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Izhaki I, 1998, IBIS, V140, P234, DOI 10.1111/j.1474-919X.1998.tb04384.x; Jones PD, 2008, CLIMATIC RES UNIT CR; Karasov WH, 2004, PHYSIOL BIOCHEM ZOOL, V77, P149, DOI 10.1086/381465; Kiat Y, 2015, J ISRAELI RINGIN FAL, P7; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kutner M. H., 2004, APPL LINEAR REGRESSI; Moreau R., 1972, PALAEARCTIC AFRICAN; Ockendon N, 2014, J ORNITHOL, V155, P905, DOI 10.1007/s10336-014-1073-5; R Development Core Team, 2016, R LANG ENV STAT COMP; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2007, CLIM RES, V35, P123, DOI 10.3354/cr00719; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schlaich AE, 2016, J ANIM ECOL, V85, P1491, DOI 10.1111/1365-2656.12583; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Shirihai H., 2001, SYLVIA WARBLERS IDEN; Shirihai H., 1996, BIRDS ISRAEL; Sicurella B, 2016, POPUL ECOL, V58, P135, DOI 10.1007/s10144-015-0529-7; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Svensson L., 1992, IDENTIFICATION GUIDE; van den Brink B, 2000, OSTRICH, V71, P198, DOI 10.1080/00306525.2000.9639911; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Zduniak P, 2012, J ARID ENVIRON, V77, P32, DOI 10.1016/j.jaridenv.2011.09.002; Zwarts L., 2009, LIVING EDGE WETLAND	43	5	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217619	10.1371/journal.pone.0217619	http://dx.doi.org/10.1371/journal.pone.0217619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141573	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000069
J	da Costa, VG; Saivish, MV; Rodrigues, RL; Silva, RFD; Moreli, ML; Kruger, RH				da Costa, Vivaldo Gomes; Saivish, Marielena Vogel; Rodrigues, Roger Luiz; de Lima Silva, Rebeca Francielle; Moreli, Marcos Lazaro; Kruger, Ricardo Henrique			Molecular and serological surveys of canine distemper virus: A meta-analysis of cross-sectional studies	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; DOMESTIC DOGS; GENETIC-CHARACTERIZATION; HEMAGGLUTININ GENE; VIRAL PATHOGENS; WILD CARNIVORES; STRAY DOGS; PARVOVIRUS; EPIDEMIOLOGY	Background Canine morbillivirus (canine distemper virus, CDV) persists as a serious threat to the health of domestic dogs and wildlife. Although studies have been conducted on the frequency and risk factors associated with CDV infection, there are no comprehensive data on the current epidemiological magnitude in the domestic dog population at regional and national levels. Therefore, we conducted a cross-sectional study and included our results in a meta-analysis to summarize and combine available data on the frequency and potential risk factors associated with CDV infection. Methods For the cross-sectional study, biological samples from dogs suspected to have canine distemper (CD) were collected and screened for viral RNA. Briefly, the PRISMA protocol was used for the meta-analysis, and data analyses were performed using STATA IC 13.1 software. Results CDV RNA was detected in 34% (48/141) of dogs suspected to have CD. Following our meta-analysis, 53 studies were selected for a total of 11,527 dogs. Overall, the pooled frequency of CDV positivity based on molecular and serological results were 33% (95% CI: 23-43) and 46% (95% CI: 36-57), respectively. The pooled subgroup analyses of clinical signs, types of biological samples, diagnostic methods and dog lifestyle had a wide range of CDV positivity (range 8-75%). Free-ranging dogs (OR: 1.44, 95% CI: 1.05-1.97), dogs > 24 months old (OR: 1.83, 95% CI: 1.1-3) and unvaccinated dogs (OR: 2.92, 95% CI: 1.266.77) were found to be positively associated with CDV infection. In contrast, dogs < 12 months old (OR: 0.36, 95% CI: 0.20-0.64) and dogs with a complete anti-CDV vaccination (OR: 0.18, 95% CI: 0.05-0.59) had a negative association. Conclusion Considering the high frequency of CDV positivity associated with almost all the variables analyzed in dogs, it is necessary to immediately and continuously plan mitigation strategies to reduce the CDV prevalence, especially in determined endemic localities.	[da Costa, Vivaldo Gomes; Kruger, Ricardo Henrique] Univ Brasilia, Dept Cell Biol, Enzymol Lab, Brasilia, DF, Brazil; [da Costa, Vivaldo Gomes; Saivish, Marielena Vogel; Rodrigues, Roger Luiz; de Lima Silva, Rebeca Francielle; Moreli, Marcos Lazaro] Univ Fed Goias, Inst Hlth Sci, Virol Lab, Jatai, Go, Brazil	Universidade de Brasilia; Universidade Federal de Goias	da Costa, VG (corresponding author), Univ Brasilia, Dept Cell Biol, Enzymol Lab, Brasilia, DF, Brazil.; da Costa, VG; Moreli, ML (corresponding author), Univ Fed Goias, Inst Hlth Sci, Virol Lab, Jatai, Go, Brazil.	vivbiom@gmail.com; marcos_moreli@ufg.br	Moreli, Marcos Lazaro/AAC-9425-2019; Kruger, Ricardo/Y-9595-2019; Rodrigues, Roger Luiz/T-8461-2019; Gomes da Costa, Vivaldo/AIA-2425-2022	Gomes da Costa, Vivaldo/0000-0002-9359-0198; Kruger, Ricardo/0000-0002-8443-9402; Moreli, Marcos/0000-0002-9599-361X; Rodrigues, Roger Luiz/0000-0001-8042-4636; Silva, Rebeca Francielle de Lima/0000-0003-4637-211X; Saivish, Marielena Vogel/0000-0002-7627-621X	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPDF; CAPES	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was carried out as part of the doctoral thesis of VGC (Programa de Posgraduacao em Biotecnologia e Biodiversidade, UnB). VGC was supported by scholarships from Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES). In addition, funding for this study was financed in part by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), FAPDF and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jamett G, 2015, VET MICROBIOL, V178, P260, DOI 10.1016/j.vetmic.2015.05.012; Acosta-Jamett G, 2011, VET MICROBIOL, V152, P247, DOI 10.1016/j.vetmic.2011.05.008; Albrechtova K, 2011, VET PARASITOL, V182, P230, DOI 10.1016/j.vetpar.2011.05.042; Alcalde R., 2013, Brazilian Journal of Veterinary Research and Animal Science, V50, P74, DOI 10.11606/issn.2318-3659.v50i1p74-76; Alves CDBT, 2018, BRAZ J MICROBIOL, V49, P790, DOI 10.1016/j.bjm.2018.02.006; Amude AM, 2007, RES VET SCI, V82, P416, DOI 10.1016/j.rvsc.2006.08.008; An DJ, 2008, J VIROL METHODS, V147, P244, DOI 10.1016/j.jviromet.2007.09.006; Anis E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1027-2; APPEL M, 1973, AM J VET RES, V34, P1459; APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Ashmi JM, 2017, INDIAN J ANIM SCI, V87, P1062; Athanasiou LV, 2018, VIRAL IMMUNOL, V31, P272, DOI 10.1089/vim.2017.0101; Avizeh R, 2007, Pak J Biol Sci, V10, P3970, DOI 10.3923/pjbs.2007.3970.3972; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Barret T., 2010, DESK ENCY ANIMAL BAC, P221; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Belsare AV, 2014, TRANSBOUND EMERG DIS, V61, P78, DOI 10.1111/tbed.12265; Budaszewski RD, 2014, VIRUS RES, V180, P76, DOI 10.1016/j.virusres.2013.12.024; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Carvalho OV, 2012, ADV VIROL, V2012, DOI 10.1155/2012/163860; Castanheira P, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-91; Chen M, 2018, POL J VET SCI, V21, P623, DOI 10.24425/124301; Cho HS, 2005, J VET MED B, V52, P410, DOI 10.1111/j.1439-0450.2005.00886.x; Custilho JG, 2007, ARQ BRAS MED VET ZOO, V59, P654, DOI 10.1590/S0102-09352007000300016; Gizzi ABD, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-23; da Silva VCL, 2018, PERNAMBUCO, V12, P1, DOI [10.26605/medvet-v12n1-2136, DOI 10.26605/MEDVET-V12N1-2136]; Nava AFD, 2008, ECOHEALTH, V5, P513, DOI 10.1007/s10393-008-0207-8; Curi NHD, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0646-3; Curi NHD, 2010, BIODIVERS CONSERV, V19, P3513, DOI 10.1007/s10531-010-9911-0; Decaro N, 2016, VET MICROBIOL, V192, P21, DOI 10.1016/j.vetmic.2016.06.009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dezengrini Renata, 2007, Cienc. Rural, V37, P183, DOI 10.1590/S0103-84782007000100029; Di Francesco CE, 2012, J VET DIAGN INVEST, V24, P107, DOI 10.1177/1040638711425700; Diaz NM, 2016, PREV VET MED, V123, P128, DOI 10.1016/j.prevetmed.2015.11.016; Dong XY, 2015, IRAN J VET RES, V16, P172; Dowgier G, 2017, VET MICROBIOL, V204, P54, DOI 10.1016/j.vetmic.2017.04.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elia G, 2006, J VIROL METHODS, V136, P171, DOI 10.1016/j.jviromet.2006.05.004; Elia G, 2015, J VIROL METHODS, V213, P127, DOI 10.1016/j.jviromet.2014.12.004; Fischer CDB, 2016, INFECT GENET EVOL, V41, P135, DOI 10.1016/j.meegid.2016.03.029; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999; Fung HL, 2014, ACTA TROP, V135, P67, DOI 10.1016/j.actatropica.2014.03.010; Furtado MM, 2013, J WILDLIFE DIS, V49, P510, DOI 10.7589/2012-02-056; Garde Elena, 2013, Animals (Basel), V3, P843, DOI 10.3390/ani3030843; Gebara CMS, 2004, ARQ BRAS MED VET ZOO, V56, P480, DOI 10.1590/S0102-09352004000400009; Gencay A, 2004, REV MED VET-TOULOUSE, V155, P432; Gowtage-Sequeira S, 2009, J WILDLIFE DIS, V45, P1008, DOI 10.7589/0090-3558-45.4.1008; Greene C. E., 1984, Clinical microbiology and infectious diseases of the dog and cat, P386; Griot Christian, 2003, Animal Health Research Reviews, V4, P1, DOI 10.1079/AHRR20047; Hass R, 2008, ARQ BRAS MED VET ZOO, V60, P270, DOI 10.1590/S0102-09352008000100039; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Headley S. A., 2000, Brazilian Journal of Veterinary Research and Animal Science, V37, P136; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jin YP, 2017, ONCOTARGET, V8, P113910, DOI 10.18632/oncotarget.23042; Jozwik A, 2002, J VET MED B, V49, P413, DOI 10.1046/j.1439-0450.2002.00549.x; Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005; Ki O, 2017, SAUDI MED J, V2, P121; Kim D, 2006, J VET MED SCI, V68, P877, DOI 10.1292/jvms.68.877; Kim HH, 2018, J VET MED SCI, V80, P1424, DOI 10.1292/jvms.18-0012; Kim Y H, 2001, J Vet Sci, V2, P59; Latha D., 2007, Indian Journal of Biotechnology, V6, P35; Lavan R, 2015, J SMALL ANIM PRACT, V56, P572, DOI 10.1111/jsap.12389; Levy JK, 2008, J VET INTERN MED, V22, P60, DOI 10.1111/j.1939-1676.2007.0034.x; Li CQ, 2018, J VET MED SCI, V80, P1029, DOI 10.1292/jvms.17-0559; Licitra BN, 2014, VIRUSES-BASEL, V6, P3363, DOI 10.3390/v6083363; Lucio EC, 2014, SEMIN-CIENC AGRAR, V35, P1323, DOI 10.5433/1679-0359.2014v35n3p1323; Luo HQ, 2017, INDIAN J ANIM RES, V51, P159, DOI 10.18805/ijar.9553; Martinez-Gutierrez M, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0702-z; McRee A., 2014, Journal of the South African Veterinary Association, V85; Millan J, 2013, EMERG INFECT DIS, V19, P680, DOI 10.3201/eid1904.121143; Mira F, 2018, VET ITAL, V54, P225, DOI 10.12834/VetIt.1455.7862.2; Miranda C, 2016, J GEN VIROL, V97, P2043, DOI 10.1099/jgv.0.000540; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Muller A, 2011, J WILDLIFE DIS, V47, P725, DOI 10.7589/0090-3558-47.3.725; Negrao FJ, 2007, ARQ BRAS MED VET ZOO, V59, P253, DOI 10.1590/S0102-09352007000100042; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Posuwan N, 2010, ASIAN BIOMED, V4, P563, DOI 10.2478/abm-2010-0071; Pratelli A, 2011, VET J, V187, P290, DOI 10.1016/j.tvjl.2010.02.007; Romanutti C, 2016, J VIROL METHODS, V228, P79, DOI 10.1016/j.jviromet.2015.11.011; Saito TB, 2006, RES VET SCI, V80, P116, DOI 10.1016/j.rvsc.2005.03.002; Sepulveda MA, 2014, ECOHEALTH, V11, P409, DOI 10.1007/s10393-014-0917-z; Shin YJ, 2004, AUST VET J, V82, P83, DOI 10.1111/j.1751-0813.2004.tb14651.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Viana M, 2015, P NATL ACAD SCI USA, V112, P1464, DOI 10.1073/pnas.1411623112; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Ruden EL, 2012, NEUROPATH APPL NEURO, V38, P426, DOI 10.1111/j.1365-2990.2011.01218.x; Waner T, 2003, VET REC, V152, P588, DOI 10.1136/vr.152.19.588; Wang J, 2018, ARCH VIROL, V163, P3345, DOI 10.1007/s00705-018-3982-8; Woodroffe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030099; Zaccaria G, 2016, VIROLOGY, V490, P69, DOI 10.1016/j.virol.2016.01.007	93	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217594	10.1371/journal.pone.0217594	http://dx.doi.org/10.1371/journal.pone.0217594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141576	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000065
J	Felez-Nobrega, M; Bort-Roig, J; Dowd, KP; Wijndaele, K; Puig-Ribera, A				Felez-Nobrega, Mireia; Bort-Roig, Judit; Dowd, Kieran P.; Wijndaele, Katrien; Puig-Ribera, Anna			Validation study of the Spanish version of the Last-7-d Sedentary Time Questionnaire (SIT-Q-7d-Sp) in young adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; BEHAVIOR QUESTIONNAIRE; SITTING TIME; RELIABILITY; VALIDITY; ASSOCIATION; TELEVISION; MORTALITY	There are few valid instruments to assess domain-specific sedentary behaviours (SB) among Spanish-speaking populations. This study validated the original English version of the last 7 days SB questionnaire (SIT-Q-7d) into Spanish (Castilian). A total of 151 undergraduates (52% male, 21.19 +/- 2.57 yrs.) wore an activPAL(3M) (AP(3M)) for 7 days and subsequently completed the Spanish version of the SIT-Q-7d (SIT-Q-7d-Sp). A subsample of 30 participants (70% male, 22.89 +/- 1.54 yrs.) simultaneously wore the AP 3M and used a domain-log to register the context where the SB occurred. The SIT-Q-7d-Sp differed significantly from the AP 3M, overestimating sitting time by an average of 60.69 mins. d(-1) (all p< 0.016). No significant differences were observed between the two measures for weekend total sitting time. The SIT-Q-7d-Sp did not differ significantly from the AP(3M) + Log for meal, work, and transportation-based sitting time (all p> 0.016). However, screen-based and other leisure-based sitting activities were significantly overestimated (ranging from 94.68 mins. d(-1) to 234.08 mins. d(-)1, p< 0.001). The SIT-Q-7d-Sp appears to provide acceptable estimates of sitting time during transportation, occupational and meal-based domains. The SIT-Q-7d-Sp is not an appropriate measure of SB when examining total sitting time and leisure-based SB in young adults. For total sitting time and leisure-based SB, the use of objective measures is recommended.	[Felez-Nobrega, Mireia; Bort-Roig, Judit; Puig-Ribera, Anna] Cent Univ Catalonia, Univ Vic, Dept Phys Act & Sports Sci, Sport & Phys Act Res Grp, Barcelona, Spain; [Felez-Nobrega, Mireia; Bort-Roig, Judit; Puig-Ribera, Anna] Cent Univ Catalonia, Univ Vic, Dept Phys Act & Sports Sci, Ctr Hlth & Social Care Res, Barcelona, Spain; [Dowd, Kieran P.] Athlone Inst Technol, Dept Sport & Hlth Sci, Athlone, Westmeath, Ireland; [Wijndaele, Katrien] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Technological University of the Shannon: Midlands Midwest; University of Cambridge	Bort-Roig, J (corresponding author), Cent Univ Catalonia, Univ Vic, Dept Phys Act & Sports Sci, Sport & Phys Act Res Grp, Barcelona, Spain.; Bort-Roig, J (corresponding author), Cent Univ Catalonia, Univ Vic, Dept Phys Act & Sports Sci, Ctr Hlth & Social Care Res, Barcelona, Spain.	judit.bort@uvic.cat	Nobrega, Mireia Felez/ABG-8468-2020; Dowd, Kieran/L-5810-2016; Wijndaele, Katrien/H-5465-2013	Dowd, Kieran/0000-0002-1841-1604; Wijndaele, Katrien/0000-0003-2199-7981; Bort Roig, Judit/0000-0003-4622-4897	UK Medical Research Council [MC_UU_12015/3]; MRC [MC_UU_12015/7, MC_UU_12015/3] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KW was supported by the UK Medical Research Council (unit programme number MC_UU_12015/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Baumgartner T.A., 2016, MEASUREMENT EVALUATI; Busschaert C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0277-2; Byrom B, 2016, INT J OBESITY, V40, P1809, DOI 10.1038/ijo.2016.136; Chau JY, 2012, MED SCI SPORT EXER, V44, P118, DOI 10.1249/MSS.0b013e3182251060; Clark BK, 2013, MED SCI SPORT EXER, V45, P1198, DOI 10.1249/MSS.0b013e3182837f57; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dowd KP, 2012, PHYSIOL MEAS, V33, P1887, DOI 10.1088/0967-3334/33/11/1887; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Felez-Nobrega M, 2018, J SPORT SCI, V36, P2311, DOI 10.1080/02640414.2018.1451212; Felez-Nobrega M, 2017, EUR J PUBLIC HEALTH, V27, P741, DOI 10.1093/eurpub/ckx021; Gardiner PA, 2011, MED SCI SPORT EXER, V43, P2127, DOI 10.1249/MSS.0b013e31821b94f7; Gibson AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185143; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Jago R, 2007, HEALTH EDUC RES, V22, P438, DOI 10.1093/her/cyl107; Kelly P, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0351-4; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Ku PW, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1062-2; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Martinez CH, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-12; Martinez-Ramos E, 2018, PLOS ONE, V13, P1; Munguia-Izquierdo D, 2013, CLIN EXP RHEUMATOL, V31, pS22; Patterson R, 2018, EUR J EPIDEMIOL, V1, P1; Prince SA, 2017, PEERJ, V5, DOI 10.7717/peerj.4130; Puig-Ribera A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122474; Rey-Lopez JP, 2012, EUR J PUBLIC HEALTH, V22, P373, DOI 10.1093/eurpub/ckr040; Rogerson MC, 2016, HEART LUNG CIRC, V25, P829, DOI 10.1016/j.hlc.2016.03.006; Roman-Vinas B, 2010, EUR J SPORT SCI, V10, P297, DOI 10.1080/17461390903426667; Rosenberg DE, 2010, J PHYS ACT HEALTH, V7, P697, DOI 10.1123/jpah.7.6.697; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Wijndaele K, 2014, MED SCI SPORT EXER, V46, P1248, DOI 10.1249/MSS.0000000000000214; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217362	10.1371/journal.pone.0217362	http://dx.doi.org/10.1371/journal.pone.0217362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141542	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000054
J	Nagel, S; Uphoff, CC; Dirks, WG; Pommerenke, C; Meyer, C; Drexler, HG				Nagel, Stefan; Uphoff, Cord C.; Dirks, Wilhelm G.; Pommerenke, Claudia; Meyer, Corinna; Drexler, Hans G.			Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL	PLOS ONE			English	Article							B-CELL LYMPHOMA; DOWN-REGULATION; EXPRESSION; DIFFERENTIATION; SURVIVAL; RECEPTOR; PROLIFERATION; TRANSCRIPTION; PATHOGENESIS; INFECTION	NKL homeobox genes encode developmental transcription factors regulating basic processes in cell differentiation. According to their physiological expression pattern in early hematopoiesis and lymphopoiesis, particular members of this homeobox gene subclass constitute an NKL-code. B-cell specific NKL-code genes generate a regulatory network and their deregulation is implicated in B-cell lymphomagenesis. Epstein-Barr virus (EBV) infects B-cells and influences the activity of signalling pathways including JAK/STAT and several genes encoding developmental regulators. Therefore, EBV-infection impacts the pathogenesis and the outcome of B-cell malignancies including Hodgkin lymphoma and diffuse large B-cell lymphoma (DLBCL). Here, we isolated EBV-positive and EBV-negative subclones from the DLBCL derived cell line DOHH-2. These subclones served as models to investigate the role of EBV in deregulation of the B-cell specific NKL-code members HHEX, HLX, MSX1 and NKX6-3. We showed that the EBV-encoded factors LMP1 and LMP2A activated the expression of HLX via STAT3. HLX in turn repressed NKX6-3, SPIB and IL4R which normally mediate plasma cell differentiation. In addition, HLX repressed the pro-apoptotic factor BCL2L11/BIM and hence supported cell survival. Thus, EBV aberrantly activated HLX in DLBCL, thereby disturbing both B-cell differentiation and apoptosis. The results of our study appreciate the pathogenic role of EBV in NKL homeobox gene deregulation and B-cell malignancies.	[Nagel, Stefan; Uphoff, Cord C.; Dirks, Wilhelm G.; Pommerenke, Claudia; Meyer, Corinna; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de		Dirks, Wilhelm/0000-0001-9781-0998				Alanentalo T, 2006, GENE EXPR PATTERNS, V6, P162, DOI 10.1016/j.modgep.2005.06.012; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; CUOMO L, 1992, INT J CANCER, V51, P949, DOI 10.1002/ijc.2910510619; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Demetriades C, 2009, J VIROL, V83, P5269, DOI 10.1128/JVI.00097-09; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dijkstra D, 2017, J IMMUNOL, V198, P229, DOI 10.4049/jimmunol.1601144; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; El-Sharkawy A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00265; Garrido JL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-231; Guasparri L, 2008, BLOOD, V111, P3813, DOI 10.1182/blood-2007-03-080309; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Hannan JP, 2016, CURR PROTEIN PEPT SC, V17, P463, DOI 10.2174/1389203717666151201192124; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Incrocci R, 2017, VIROLOGY, V500, P96, DOI 10.1016/j.virol.2016.10.015; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; Kook SH, 2005, J BIOCHEM MOL BIOL, V38, P755; Kung CP, 2008, J VIROL, V82, P5486, DOI 10.1128/JVI.00125-08; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kuze T, 2000, JPN J CANCER RES, V91, P1233, DOI 10.1111/j.1349-7006.2000.tb00909.x; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Li XF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01052; Longnecker R., 2013, FIELDS VIROLOGY, V2, P1898; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mikhalkevich N, 2006, J IMMUNOL, V176, P1553, DOI 10.4049/jimmunol.176.3.1553; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Nagel Stefan, 2018, Oncotarget, V9, P37480, DOI 10.18632/oncotarget.26459; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205537; Nagel Stefan, 2018, Oncotarget, V9, P14338, DOI 10.18632/oncotarget.24512; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Nagy M, 2002, BRIT J HAEMATOL, V116, P429, DOI 10.1046/j.1365-2141.2002.03271.x; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Noujima-Harada M, 2017, CANCER SCI, V108, P1071, DOI 10.1111/cas.13213; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Pei YG, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006500; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Rosenthal A, 2017, BLOOD REV, V31, P37, DOI 10.1016/j.blre.2016.09.004; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Shannon-Lowe C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0271; Song S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02026; Styles CT, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001992; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Teng Y, 2007, EUR J CELL BIOL, V86, P581, DOI 10.1016/j.ejcb.2007.05.006; Tisi MC, 2016, LEUKEMIA LYMPHOMA, V57, P628, DOI 10.3109/10428194.2015.1072766; Uphoff CC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210404; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Vrzalikova K, 2011, BLOOD, V117, P5907, DOI 10.1182/blood-2010-09-307710; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; Wang L, 2017, ONCOGENE, V36, P2265, DOI 10.1038/onc.2016.380; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Yoon JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02901-y; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216898	10.1371/journal.pone.0216898	http://dx.doi.org/10.1371/journal.pone.0216898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141539	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000027
J	Rey, EG; Finkelstein, JL; Erickson, D				Rey, Elizabeth G.; Finkelstein, Julia L.; Erickson, David			Fluorescence lateral flow competitive protein binding assay for the assessment of serum folate concentrations	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; OPPORTUNITIES; PREVENTION	Folate is a micronutrient required for the production of new cells, making it a key factor in early fetal development and ensuring normal growth and maintenance of health. The increase in consumption of folate due to increased periconceptional supplementation and fortification of grains in many countries has led to a decrease in occurrence of folate deficiency and a class of birth defects called neural tube defects. However, an opportunity remains to further improve folate status of populations in areas with limited access to fortified foods and supplementation. Screening of women of reproductive age and other vulnerable populations for folate status would increase our understanding of the magnitude of the burden of folate deficiency and inform monitoring of public health programs. Current gold standard methods for folate assessment are time-intensive and require cold chain, sophisticated laboratory infrastructure, and highly-trained personnel. Our lateral flow assay is lowcost, easy to use, and allows a user to assess folate insufficiency at the point of care in less than 40 minutes. We evaluated the sensitivity and specificity of our assay in 24 human serum samples, including 8 samples with folate concentrations less than 10.0 nmol/L and 14 samples less than 13.4 nmol/L using the Immulite 2000 commercial assay as a reference standard. The sensitivity and specificity were found to be 93% (95% CI: 54.7-100.0) and 91% (95% CI: 80.0-100.0), respectively, when using our test to determine folate insufficiency based on a cutoff of 13.4 nmol/L. Our point-of-care diagnostic test for folate concentrations could inform screening and public health programs in at-risk populations.	[Rey, Elizabeth G.; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Finkelstein, Julia L.; Erickson, David] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Finkelstein, JL; Erickson, D (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	jfinkelstein@cornell.edu; de54@cornell.edu		Rey, Elizabeth/0000-0003-1445-9982	U.S. Department of Health & Human Services \ National Institutes of Health (NIH) - Indo-US [R03 EB 023190]; Cornell University Institute for Biotechnology Center for Advanced Technology Grant; National Science Foundation (NSF) [CBET-1343058]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB023190] Funding Source: NIH RePORTER	U.S. Department of Health & Human Services \ National Institutes of Health (NIH) - Indo-US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University Institute for Biotechnology Center for Advanced Technology Grant; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the funding support from the following: U.S. Department of Health & Human Services vertical bar National Institutes of Health (NIH) - Indo-US R03 EB 023190 [J.L.F.] https://www.nih.gov/ Cornell University Institute for Biotechnology Center for Advanced Technology Grant [J.L.F.] http://www.biotech.cornell.edu/cat/funding/cat-awards National Science Foundation (NSF) - CBET-1343058 [D.E.] https://www.nsf.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Laboratories, 2010, ARCH FOL ASS; Anagnostis P, 2013, INT J CLIN PRACT, V67, P225, DOI 10.1111/ijcp.12031; Bailey LB, BIOMARKERS NUTR DEV, DOI [10.3945/jn.114.206599, DOI 10.3945/JN.114.206599]; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; CDC, 2003, LAB PROC MAN FOL VIT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362; CHEN TS, 1979, J FOOD SCI, V44, P713, DOI 10.1111/j.1365-2621.1979.tb08483.x; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Farrell CJL, 2013, CLIN CHEM LAB MED, V51, P555, DOI 10.1515/cclm-2012-0639; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GIVAS JK, 1975, CLIN CHEM, V21, P427; Holm J, 2014, BBA-PROTEINS PROTEOM, V1844, P512, DOI 10.1016/j.bbapap.2013.12.009; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; HORNE DW, 1988, CLIN CHEM, V34, P2357; JENSEN EV, 1950, J BIOL CHEM, V185, P411; Jones ML, 2002, J NUTR, V132, P2690, DOI 10.1093/jn/132.9.2690; Lee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28237; Lu ZD, 2017, P NATL ACAD SCI USA, V114, P13513, DOI 10.1073/pnas.1711464114; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Pfeiffer CM, 2015, J NUTR, V145, P520, DOI 10.3945/jn.114.201210; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Qu Q, 2009, J MICROBIOL METH, V79, P121, DOI 10.1016/j.mimet.2009.07.015; Rey E G, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3906, DOI 10.1109/EMBC.2018.8513377; Rey EG, 2017, ANAL CHEM, V89, P5095, DOI 10.1021/acs.analchem.7b00638; Selhub J, 2016, BIOCHIMIE, V126, P71, DOI 10.1016/j.biochi.2016.04.010; Vemulapati S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13044-5; Vitale SG, 2016, OBSTET GYNECOL SURV, V71, P721, DOI 10.1097/OGX.0000000000000369; WALD N, 1991, LANCET, V338, P131; WAXMAN S, 1975, BRIT J HAEMATOL, V29, P23, DOI 10.1111/j.1365-2141.1975.tb01796.x; Waxman S, 1973, BLOOD, V42; WHO, 2012, STATE SCI ENDOCRINE, P1; World Health Organization, 2015, GUID OPT SER RED BLO, P38; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Zhang H-Y, 2008, NEURAL TUBE DEFECTS, DOI [10.1016/j.expneurol.2008.04.044, DOI 10.1016/J.EXPNEUROL.2008.04.044]	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217403	10.1371/journal.pone.0217403	http://dx.doi.org/10.1371/journal.pone.0217403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166978	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800026
J	Serrano, ME; Bartholome, O; Van den Ackerveken, P; Ferrara, A; Rogister, B; Plenevaux, A; Tirelli, E				Serrano, Maria Elisa; Bartholome, Odile; Van den Ackerveken, Priscilla; Ferrara, Andre; Rogister, Bernard; Plenevaux, Alain; Tirelli, Ezio			Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; SEX-DIFFERENCES; NEUROBEHAVIORAL COMORBIDITIES; IMPROVES COGNITION; ANTIEPILEPTIC DRUG; BINDING-SITE; WATER-MAZE; PLUS-MAZE	The Synaptic Vesicle Protein 2A (SV2A) is a transmembrane protein whose presence is reduced both in animal models and in patients with chronic epilepsy. Besides its implication in the epileptic process, the behavioural consequences of the changes in its expression remain unclear. The purpose of our research is to better understand the possible role(s) of this protein through the phenotype of cKO (Grik4 Cre+/-, SV2A lox/lox) mice, male and female, which present a specific decrease of SV2A expression levels in the hippocampal glutamatergic neurons but without any epileptic seizures. In this study, we compare the cKO mice with cHZ (Grik4 Cre+/-, SV2A lox/+) and WT (Grik4 Cre+/+, SV2A lox/lox) mice through a battery of tests, used to evaluate different features: the anxiety-related features (Elevated Plus Maze), the locomotor activity (Activity Chambers), the contextual fear-related memory (Contextual Fear Conditioning), and the spatial memory (Barnes Maze). Our results showed statistically significant differences in the habituation to a new environment, an increase in the anxiety levels and spatial memory deficit in the cHZ and cKO groups, compared to the WT group. No statistically significant differences due to the genotype appeared in the spontaneous locomotor activity or the fear-linked memory. However, sexual differences were observed in this last feature. These results highlight not only an important role of the SV2A protein in the cognitive and anxiety problems typically encountered in epileptic patients, but also a possible role in the symptomatology of other neurodegenerative diseases, such as the Alzheimer's disease.	[Serrano, Maria Elisa; Plenevaux, Alain] Univ Liege, GIGA CRC Vivo Imaging, Liege, Belgium; [Bartholome, Odile; Van den Ackerveken, Priscilla; Rogister, Bernard] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ferrara, Andre; Tirelli, Ezio] Univ Liege, Dept Psychol, Liege, Belgium; [Rogister, Bernard] Univ Liege, Acad Hosp, CHU, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Serrano, ME (corresponding author), Univ Liege, GIGA CRC Vivo Imaging, Liege, Belgium.	maelisaserranon@gmail.com	Rogister, Bernard/AAJ-9591-2020	Serrano Navacerrada, Maria Elisa/0000-0003-0880-6183; Plenevaux, Alain/0000-0003-3011-4984; Van Den Ackerveken, Priscilla/0000-0001-5913-6293	Action de Recherches Concertees (ARC) [13/17-07]; la Communaute Francaise de Belgique; FNRS	Action de Recherches Concertees (ARC); la Communaute Francaise de Belgique; FNRS(Fonds de la Recherche Scientifique - FNRS)	This work has been supported by Action de Recherches Concertees (ARC, grant number 13/17-07) (AP, MES, OB, BR), la Communaute Francaise de Belgique (BR) and by the FNRS (BR). AP is research director from Fonds De La Recherche Scientifique - FNRS Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Bakker A, 2015, NEUROIMAGE-CLIN, V7, P688, DOI 10.1016/j.nicl.2015.02.009; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bartholome O, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00148; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Berkiks I, 2019, PHYSIOL BEHAV, V199, P386, DOI 10.1016/j.physbeh.2018.11.037; Brabant C, 2007, PSYCHOPHARMACOLOGY, V190, P251, DOI 10.1007/s00213-006-0603-0; Bragina L, 2012, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00032; Celikyurt IK, 2012, LIFE SCI, V90, P185, DOI 10.1016/j.lfs.2011.11.003; Chaaya N, 2018, NEUROSCI BIOBEHAV R, V92, P43, DOI 10.1016/j.neubiorev.2018.05.013; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Charlier Y, 2013, BEHAV BRAIN RES, V253, P121, DOI 10.1016/j.bbr.2013.07.016; Chatzikonstantinou A, 2014, FRONT NEUROL NEUROSC, V34, P121, DOI 10.1159/000356435; Clary HMM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0445-9; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colon L, 2018, LEARN MEMORY, V25, P230, DOI 10.1101/lm.047159.117; Crevecoeur J, 2014, NEUROPATH APPL NEURO, V40, P191, DOI 10.1111/nan.12054; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dardou D, 2013, BRAIN RES, V1507, P61, DOI 10.1016/j.brainres.2013.02.041; Desgent S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042622; Devi L, 2013, NEUROBIOL LEARN MEM, V102, P7, DOI 10.1016/j.nlm.2013.02.001; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Ge YX, 2016, NEUROSCI LETT, V628, P194, DOI 10.1016/j.neulet.2016.06.043; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Helmstaedter C, 2017, SEIZURE-EUR J EPILEP, V49, P83, DOI 10.1016/j.seizure.2017.02.017; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Holler Y, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00058; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Izquierdo A, 2017, NEUROSCIENCE, V345, P12, DOI 10.1016/j.neuroscience.2016.03.021; Jacoby A, 2015, EPILEPSY BEHAV, V43, P149, DOI 10.1016/j.yebeh.2014.09.071; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Keiser AA, 2017, NEUROPSYCHOPHARMACOL, V42, P397, DOI 10.1038/npp.2016.174; Kesby JP, 2016, BEHAV BRAIN RES, V311, P131, DOI 10.1016/j.bbr.2016.05.034; Kesby JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140034; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Kleen J., 2012, JASPERS BASIC MECH E, Vfourth; Klein P, 2018, CLIN PHARMACOL-ADV A, V10, P1, DOI 10.2147/CPAA.S114072; Kochli DE, 2015, LEARN MEMORY, V22, P92, DOI 10.1101/lm.034918.114; Koh MT, 2018, SCHIZOPHR RES, V193, P119, DOI 10.1016/j.schres.2017.06.027; Korczyn AD, 2013, EPILEPSY BEHAV, V28, P283, DOI 10.1016/j.yebeh.2013.03.012; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Krabbe S, 2018, BIOL PSYCHIAT, V83, P800, DOI 10.1016/j.biopsych.2017.10.006; Lamberty Y, 2009, BEHAV BRAIN RES, V198, P329, DOI 10.1016/j.bbr.2008.11.005; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Magalhaes JC, 2015, CLIN PSYCHOPHARM NEU, V13, P83, DOI 10.9758/cpn.2015.13.1.83; Majak K, 2004, EPILEPSY BEHAV, V5, pS35, DOI 10.1016/j.yebeh.2003.11.012; McDonald CR, 2011, EPILEPSY BEHAV, V22, P69, DOI 10.1016/j.yebeh.2011.06.004; Menten-Dedoyart C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166525; Merz CJ, 2017, J NEUROSCI RES, V95, P93, DOI 10.1002/jnr.23811; Minjarez B, 2017, NEUROSCI BIOBEHAV R, V83, P373, DOI 10.1016/j.neubiorev.2017.10.016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Paul CM, 2009, BEHAV BRAIN RES, V203, P151, DOI 10.1016/j.bbr.2009.05.022; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; PITKANEN A, ANN N Y ACAD SCI, V911, P369; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roelofs K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0206; Rozeske RR, 2018, CURR OPIN NEUROBIOL, V52, P60, DOI 10.1016/j.conb.2018.04.017; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Savic I, 2014, EXP NEUROL, V259, P38, DOI 10.1016/j.expneurol.2014.04.009; Sen A, 2018, BRAIN, V141, P1592, DOI 10.1093/brain/awy022; Sendrowski K, 2013, PHARMACOL REP, V65, P555, DOI 10.1016/S1734-1140(13)71033-8; Serajee FJ, 2015, PEDIATR NEUROL, V52, P642, DOI 10.1016/j.pediatrneurol.2015.02.011; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Simone JJ, 2018, INT J DEV NEUROSCI, V69, P119, DOI 10.1016/j.ijdevneu.2018.07.011; Soukupova M, 2015, NEUROSCIENCE, V301, P246, DOI 10.1016/j.neuroscience.2015.06.013; Soukupova M, 2014, EXP NEUROL, V257, P39, DOI 10.1016/j.expneurol.2014.04.014; Toering ST, 2009, EPILEPSIA, V50, P1409, DOI 10.1111/j.1528-1167.2008.01955.x; Tokudome K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27420; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Venkatesan K, 2012, J NEUROSCI RES, V90, P2317, DOI 10.1002/jnr.23111; von Rosenstiel P, 2007, NEUROTHERAPEUTICS, V4, P84, DOI 10.1016/j.nurt.2006.11.004; Wiglusz MS, 2018, EPILEPSY BEHAV, V79, P1, DOI 10.1016/j.yebeh.2017.11.025; Wilson YM, 2009, LEARN MEMORY, V16, P357, DOI 10.1101/lm.1361509; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Zhang J, 2018, NEUROBIOL LEARN MEM	89	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217882	10.1371/journal.pone.0217882	http://dx.doi.org/10.1371/journal.pone.0217882			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166988	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800048
J	Yaney-Keller, A; Tomillo, PS; Marshall, JM; Paladino, FV				Yaney-Keller, Adam; Santidrian Tomillo, Pilar; Marshall, Jordan M.; Paladino, Frank V.			Using Unmanned Aerial Systems (UAS) to assay mangrove estuaries on the Pacific coast of Costa Rica	PLOS ONE			English	Article							LEAF-AREA INDEX; VEHICLE UAV; ABOVEGROUND BIOMASS; AVICENNIA-GERMINANS; VEGETATION INDEXES; CANOPY COVER; FOREST; IMAGERY; FIELD; NDVI	Mangrove forests, one of the world's most endangered ecosystems, are also some of the most difficult to access. This is especially true along the Pacific coast of Costa Rica, where 99% of the country's mangroves occur. Unmanned Aerial Systems (UAS), or drones, have become a convenient tool for natural area assessment, and offer a solution to the problems of remote mangrove monitoring. This study is the first to use UAS to analyze the structure of a mangrove forests within Central America. Our goals were to (1) determine the forest structure of two estuaries in northwestern Costa Rica through traditional ground measurements, (2) assess the accuracy of UAS measurements of canopy height and percent coverage and (3) determine whether the normalized difference vegetation index (NDVI) could discriminate between the most abundant mangrove species. We flew a UAS equipped with a single NDVI sensor during the peak wet (Sept-Nov) and dry (Jan-Feb) seasons. The structure and species composition of the estuaries showed a possible transition between the wet mangroves of southern Costa Rica and the drier northern mangroves. UAS-derived measurements at 100 cm/pixel resolution of percent canopy coverage and maximum and mean canopy height were not statistically different from ground measurements (p > 0.05). However, there were differences in mean canopy height at 10 cm/pixel resolution (p = 0.043), indicating diminished returns in accuracy as resolution becomes extremely fine. Mean NDVI values of Avicennia germinans (most abundant species) changed significantly between seasons (p < 0.001). Mean NDVI of Rhizophora racemosa (second most abundant species) was significantly different from A. germinans and dry forest dominant plots during the dry season (p < 0.001), demonstrating NDVI's capability of discriminating mangrove species. This study provides the first structural assessment of the studied estuaries and a framework for future studies of mangroves using UAS.	[Yaney-Keller, Adam; Marshall, Jordan M.; Paladino, Frank V.] Purdue Univ Ft Wayne, Ft Wayne, IN 46805 USA; [Santidrian Tomillo, Pilar; Paladino, Frank V.] Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Costa Rica		Yaney-Keller, A (corresponding author), Purdue Univ Ft Wayne, Ft Wayne, IN 46805 USA.	yaneam01@pfw.edu	Marshall, Jordan/AAF-9692-2021; Yaney-Keller, Adam/ABE-7576-2020; Santidrián Tomillo, Pilar/N-5406-2014; Marshall, Jordan/B-1934-2009	Santidrián Tomillo, Pilar/0000-0002-6895-7218; Marshall, Jordan/0000-0001-6024-3758; Paladino, Frank V./0000-0002-6452-0086; Yaney-Keller, Adam/0000-0003-1538-664X	Leatherback Trust; Fort Wayne Children's Zoo; Mary Margaret Stucky Testament Trust, under Purdue Fort Wayne Grant [8000078286]	Leatherback Trust; Fort Wayne Children's Zoo; Mary Margaret Stucky Testament Trust, under Purdue Fort Wayne Grant	Funding for this study was provided to FVP by The Leatherback Trust, (https://www.leatherback.org), Fort Wayne Children's Zoo, (https://kidszoo.org/), Mary Margaret Stucky Testament Trust, (https://www.manta.com/c/mr4rpd3/mary-margaret-stucky-testament-trust), under Purdue Fort Wayne Grant #8000078286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BM, 2015, FRONT ECOL ENVIRON, V13, P354, DOI 10.1890/15.WB.015; Andersen HE, 2006, CAN J REMOTE SENS, V32, P355, DOI 10.5589/m06-030; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; [Anonymous], 2000, ELEMENTS PHOTOGRAMME; Navarro JA, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11010077; Baena S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188714; Ballaria D, 2016, ISPRS INT ARCH PHOTO, P41, DOI DOI 10.5194/ISPRS-ARCHIVES-XLI-B1-1105-2016; Becker C, 2018, PHOTOGRAMM ENG REM S, V84, P287, DOI 10.14358/PERS.84.5.287; Cao JJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010089; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; Carreiras JMB, 2006, FOREST ECOL MANAG, V223, P45, DOI 10.1016/j.foreco.2005.10.056; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Conover W.J., 1999, PRACTICAL NONPARAMET, V350; Cordoba Munoz R, 1998, INVENTARIO HUMEDALES; Cortes J., 2014, REV BIOL TROPICAL S4, V62, P151; Cruzan MB, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600041; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dandois JP, 2010, REMOTE SENS-BASEL, V2, P1157, DOI 10.3390/rs2041157; Diaz BM, 2003, INT J REMOTE SENS, V24, P53, DOI 10.1080/01431160305012; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/NGEO1123, 10.1038/ngeo1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison A, 2010, IUCN RED LIST THREAT, DOI [10. 2305/IUCN. UK. 2010-2. RLTS. T178833A7621318. en, DOI 10.2305/IUCN.UK.2010-2.RLTS.T178833A7621318.EN]; Flores-de-Santiago F, 2013, WETL ECOL MANAG, V21, P193, DOI 10.1007/s11273-013-9290-x; Flores-De-Santiago F, 2012, MAR ECOL PROG SER, V444, P57, DOI 10.3354/meps09474; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Gross J, 2014, WETLANDS, V34, P55, DOI 10.1007/s13157-013-0482-1; Guo Q, 2017, INT J REMOTE SENS, V38, P2954, DOI 10.1080/01431161.2017.1285083; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Heenkenda MK, 2015, PHOTOGRAMM ENG REM S, V81, P471, DOI 10.14358/PERS.81.6.471; Huete AR, 1997, INT GEOSCI REMOTE SE, P1966, DOI 10.1109/IGARSS.1997.609169; Jensen JR, 1986, INTRO DIGITAL IMAGE, P379; Jiang ZY, 2006, REMOTE SENS ENVIRON, V101, P366, DOI 10.1016/j.rse.2006.01.003; JIMENEZ JA, 1985, REV BIOL TROP, V33, P25; Jimenez Jorge A., 2004, P136; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kauffman J. B., 2012, CIFOR Working Paper; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Kovacs JM, 2009, ENVIRON MONIT ASSESS, V157, P137, DOI 10.1007/s10661-008-0523-z; Kovacs JM, 2004, AQUAT BOT, V80, P13, DOI 10.1016/j.aquabot.2004.06.001; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Lee TM, 2009, ECOL ENG, V35, P487, DOI 10.1016/j.ecoleng.2008.01.007; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lewis RR, 2005, ECOL ENG, V24, P403, DOI 10.1016/j.ecoleng.2004.10.003; Li QS, 2017, INT ARCH PHOTOGRAMM, V42-2, P209, DOI 10.5194/isprs-archives-XLII-2-W6-209-2017; Lin H, 1991, GEOCARTO INT, V6, P13, DOI DOI 10.1080/10106049109354302; Lisein J, 2013, FORESTS, V4, P922, DOI 10.3390/f4040922; Liu XH, 2018, REMOTE SENS LETT, V9, P1040, DOI [10.1080/2150704X.2018.1504339, 10.1080/2150704x.2018.1504339]; Loria-Naranjo M., 2014, REV BIOL TROP, V62, P33, DOI [10.15517/rbt.v62i4.20030, DOI 10.15517/RBT.V62I4.20030]; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Manfreda S, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040641; Matese A, 2015, REMOTE SENS-BASEL, V7, P2971, DOI 10.3390/rs70302971; McKee KL, 1996, TREE PHYSIOL, V16, P883; Mendez-Alonzo R, 2008, BIOTROPICA, V40, P449, DOI 10.1111/j.1744-7429.2008.00397.x; Messinger M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080615; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myeong S., 2001, URBAN ECOSYST, V5, P243, DOI [DOI 10.1016/j.ufug.2017.05.012, 10.1023/A:1025687711588, DOI 10.1023/A:1025687711588]; Ota T, 2015, FORESTS, V6, P3882, DOI 10.3390/f6113882; Otero V, 2018, FOREST ECOL MANAG, V411, P35, DOI 10.1016/j.foreco.2017.12.049; Panagiotidis D, 2017, INT J REMOTE SENS, V38, P2392, DOI 10.1080/01431161.2016.1264028; Pereira JMC, 1995, EARSEL ADV REMOTE SE, V4, P14; Polania J., 1993, CONSERVATION SUSTAIN, P129; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Vo QT, 2013, REMOTE SENS-BASEL, V5, P183, DOI 10.3390/rs5010183; R Development Core Team, 2009, R LANG ENV STAT COMP; Rouse Jr J.W., 1974, P 3 EARTH RESOURCES, DOI DOI 10.1002/MRM.26868; Ruwaimana M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200288; Samper-Villarreal J, 2012, REV BIOL TROP, V60, P109; Satyanarayana B, 2011, INT J REMOTE SENS, V32, P1635, DOI 10.1080/01431160903586781; Savage NH, 2013, GEOSCI MODEL DEV, V6, P353, DOI 10.5194/gmd-6-353-2013; Smith AMS, 2009, CAN J REMOTE SENS, V35, P447, DOI 10.5589/m09-038; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; Sobrado MA, 1999, TREES-STRUCT FUNCT, V13, P125, DOI 10.1007/s004680050196; SOTO R, 1982, REV BIOL TROP, V30, P161; Tian JY, 2017, INT J APPL EARTH OBS, V61, P22, DOI 10.1016/j.jag.2017.05.002; Tomlinson PB, 2016, CAMBRIDGE TROPICAL B; Trout TJ, 2008, HORTSCIENCE, V43, P333, DOI 10.21273/HORTSCI.43.2.333; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; Unger M, 2009, LECT NOTES COMPUT SC, V5876, P1119, DOI 10.1007/978-3-642-10520-3_107; Wallace L, 2016, FORESTS, V7, DOI 10.3390/f7030062; Wang L, 2004, REMOTE SENS ENVIRON, V91, P432, DOI 10.1016/j.rse.2004.04.005; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Yu X, 2017, INT J REMOTE SENS, V38, P3101, DOI 10.1080/01431161.2016.1230291; Zahawi RA, 2015, BIOL CONSERV, V186, P287, DOI 10.1016/j.biocon.2015.03.031; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004	88	15	15	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217310	10.1371/journal.pone.0217310	http://dx.doi.org/10.1371/journal.pone.0217310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166979	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800024
J	Cho, KH; Huang, SM; Choi, CH; Chen, MJ; Chiang, HH; Buschbeck, RP; Farrher, E; Shah, NJ; Garipov, R; Chang, CP; Chang, H; Kuo, LW				Cho, Kuan-Hung; Huang, Sheng-Min; Choi, Chang-Hoon; Chen, Ming-Jye; Chiang, Hsuan-Han; Buschbeck, Richard P.; Farrher, Ezequiel; Shah, N. Jon; Garipov, Ruslan; Chang, Ching-Ping; Chang, Hsu; Kuo, Li-Wei			Development, integration and use of an ultra-high-strength gradient system on a human-size 3 T magnet for small animal MRI	PLOS ONE			English	Article							RAT-BRAIN; DIFFUSION TENSOR; SUSCEPTIBILITY	This study aims to integrate an ultra-high-strength gradient coil system on a clinical 3 T magnet and demonstrate its preclinical imaging capabilities. Dedicated phantoms were used to qualitatively and quantitatively assess the performance of the gradient system. Advanced MR imaging sequences, including diffusion tensor imaging (DTI) and quantitative susceptibility mapping (QSM), were implemented and executed on an ex vivo specimen as well as in vivo rats. The DTI and QSM results on the phantom agreed well with those in the literature. Furthermore, studies on ex vivo specimens have demonstrated the applicability of DTI and QSM on our system to probe microstructural changes in a mild traumatic brain injury rat model. The feasibility of in vivo rat DTI was also demonstrated. We showed that the inserted ultra-high-strength gradient coil was successfully integrated on a clinically used magnet. After careful tuning and calibration, we verified the accuracy and quantitative preclinical imaging capability of the integrated system in phantom and in vivo rat brain experiments. This study can be essential to establish dedicated animal MRI platform on clinical MRI scanners and facilitate translational studies at clinical settings.	[Cho, Kuan-Hung; Huang, Sheng-Min; Chen, Ming-Jye; Chiang, Hsuan-Han; Chang, Hsu; Kuo, Li-Wei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan; [Huang, Sheng-Min] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Choi, Chang-Hoon; Buschbeck, Richard P.; Farrher, Ezequiel; Shah, N. Jon] Forschungszentrum Julich, INM 4, Julich, Germany; [Shah, N. Jon] Forschungszentrum Julich, INM 11, Julich, Germany; [Shah, N. Jon] JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Garipov, Ruslan] MR Solut Ltd, Guildford, Surrey, England; [Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Li-Wei] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University; Chi Mei Hospital; National Taiwan University	Kuo, LW (corresponding author), Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan.; Kuo, LW (corresponding author), Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan.	lwkuo@nhri.org.tw	Huang, Sheng-Min/ABE-8722-2021; Choi, Chang-Hoon/S-9688-2019; Shah, N. Jon/H-5849-2013; Buschbeck, Richard P./G-5968-2017	Huang, Sheng-Min/0000-0003-2930-8562; Choi, Chang-Hoon/0000-0003-3569-0905; Shah, N. Jon/0000-0002-8151-6169; Cho, Kuan-Hung/0000-0001-9267-8342; Buschbeck, Richard P./0000-0001-8201-3937; Chang, Ching-Ping/0000-0003-0890-9414	Taiwan Ministry of Science and Technology [106-2221-E-400-002, 107-2911-I-400-502, 107-2321-B-400-005, 107-2221-E-400-001]; National Health Research Institutes [BN-107-PP-06, BN-107-SP-05]; Chi Mei Medical Center (Taiwan) grant [CMFHT 10504]; Taiwan Central Government S T grant [107-1901-01-19-02]; DAAD [57334221]	Taiwan Ministry of Science and Technology; National Health Research Institutes(National Health Research Institutes, Japan); Chi Mei Medical Center (Taiwan) grant; Taiwan Central Government S T grant; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the Taiwan Ministry of Science and Technology (106-2221-E-400-002, 107-2911-I-400-502, 107-2321-B-400-005, and 107-2221-E-400-001), the National Health Research Institutes (BN-107-PP-06 and BN-107-SP-05), Chi Mei Medical Center (Taiwan) grant (CMFHT 10504), and the Taiwan Central Government S & T grant (107-1901-01-19-02). C.-H.C. thanks DAAD (57334221) for travels. Ruslan Garipov is an employee of MR Solutions Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida GS, 2017, BRIT J CANCER, V117, P791, DOI 10.1038/bjc.2017.251; Aradi M, 2011, J NEURORADIOLOGY, V38, P90, DOI 10.1016/j.neurad.2009.11.003; Barral JK, 2010, MAGN RESON MED, V64, P1057, DOI 10.1002/mrm.22497; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brihuega-Moreno O, 2004, MAGN RESON MED, V51, P1048, DOI 10.1002/mrm.20044; Chen F, 2007, METHODS, V43, P12, DOI 10.1016/j.ymeth.2007.03.007; Chen MJ, 2018, JOINT ANN M ISMRM ES, P1755; Cho KH, 2009, J MAGN RESON IMAGING, V29, P1386, DOI 10.1002/jmri.21776; Chou W, 2018, MOL NEUROBIOL, V55, P8602, DOI 10.1007/s12035-018-1011-2; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deh K, 2019, MAGN RESON MED, V81, P1229, DOI 10.1002/mrm.27410; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Guzman R, 2000, J NEUROSCI METH, V97, P77, DOI 10.1016/S0165-0270(00)00172-2; Herrmann KH, 2012, MAGN RESON MATER PHY, V25, P233, DOI 10.1007/s10334-011-0284-5; Jones DK, 2018, NEUROIMAGE, V182, P8, DOI 10.1016/j.neuroimage.2018.05.047; Lee Y, 2019, MAGN RESON MED, V81, P454, DOI 10.1002/mrm.27421; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Mayer D, 2007, NEUROIMAGE, V35, P1077, DOI 10.1016/j.neuroimage.2007.01.006; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vavasour IM, 2019, J NEUROIMAGING, V29, P42, DOI 10.1111/jon.12559; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713	28	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217916	10.1371/journal.pone.0217916	http://dx.doi.org/10.1371/journal.pone.0217916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158259	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700034
J	Cumsille, P; Godoy, M; Gerdtzen, ZP; Conca, C				Cumsille, Patricio; Godoy, Matias; Gerdtzen, Ziomara P.; Conca, Carlos			Parameter estimation and mathematical modeling for the quantitative description of therapy failure due to drug resistance in gastrointestinal stromal tumor metastasis to the liver	PLOS ONE			English	Article							IDENTIFIABILITY	In this work we develop a general mathematical model and devise a practical identifiability approach for gastrointestinal stromal tumor (GIST) metastasis to the liver, with the aim of quantitatively describing therapy failure due to drug resistance. To this end, we have modeled metastatic growth and therapy failure produced by resistance to two standard treatments based on tyrosine kinase inhibitors (Imatinib and Sunitinib) that have been observed clinically in patients with GIST metastasis to the liver. The parameter identification problem is difficult to solve, since there are no general results on this issue for models based on ordinary differential equations (ODE) like the ones studied here. We propose a general modeling framework based on ODE for GIST metastatic growth and therapy failure due to drug resistance and analyzed five different model variants, using medical image observations (CT scans) from patients that exhibit drug resistance. The associated parameter estimation problem was solved using the Nelder-Mead simplex algorithm, by adding a regularization term to the objective function to address model instability, and assessing the agreement of either an absolute or proportional error in the objective function. We compared the goodness of fit to data for the proposed model variants, as well as evaluated both error forms in order to improve parameter estimation results. From the model variants analyzed, we identified the one that provides the best fit to all the available patient data sets, as well as the best assumption in computing the objective function (absolute or proportional error). This is the first work that reports mathematical models capable of capturing and quantitatively describing therapy failure due to drug resistance based on clinical images in a patient-specific manner.	[Cumsille, Patricio] Univ Bio Bio, Basic Sci Dept, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Grp Invest Tumor Angiogenesis GIANT, Chillan, Chile; [Cumsille, Patricio; Godoy, Matias; Gerdtzen, Ziomara P.; Conca, Carlos] Ctr Biotechnol & Bioengn CeBiB, Santiago, Chile; [Gerdtzen, Ziomara P.] Univ Chile, Dept Chem Engn Biotechnol & Mat, Santiago, Chile; [Conca, Carlos] Univ Chile, CNRS, UMI 2807, Dept Math Engn DIM, Santiago, Chile; [Conca, Carlos] Univ Chile, CNRS, UMI 2807, CMM, Santiago, Chile	Universidad del Bio-Bio; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile	Cumsille, P (corresponding author), Univ Bio Bio, Basic Sci Dept, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Grp Invest Tumor Angiogenesis GIANT, Chillan, Chile.; Cumsille, P (corresponding author), Ctr Biotechnol & Bioengn CeBiB, Santiago, Chile.	pcumsille@ubiobio.cl	Conca, Carlos/E-8985-2010; Cumsille, Patricio/AAE-7493-2020	Conca, Carlos/0000-0003-3891-0846; GODOY, Matias/0000-0003-1100-0340	Centre for Biotechnology and Bioengineering (CeBiB) [PIA-CONICYT FB-01]; Group of Investigation in Tumor Angiogenesis (GIANT) [DIUBB-GI 171709/VC, DIUBB 193409 3/R]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico [ID18I10308]	Centre for Biotechnology and Bioengineering (CeBiB); Group of Investigation in Tumor Angiogenesis (GIANT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico	Funding was provided by Centre for Biotechnology and Bioengineering (CeBiB), grant no. PIA-CONICYT FB-01, to PC, MG, ZG, and CC; Group of Investigation in Tumor Angiogenesis (GIANT), grant no. DIUBB-GI 171709/VC, and regular research project DIUBB 193409 3/R, to PC; and Fondo de Fomento al Desarrollo Cientifico y Tecnologico, grant no. ID18I10308 to ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks HI., 2009, MATH STAT ESTIMATION, P249, DOI [10.1007/978-90-481-2313-1_11, DOI 10.1007/978-90-481-2313-1_11]; Blay JY, 2011, CANCER TREAT REV, V37, P373, DOI 10.1016/j.ctrv.2010.11.003; Cumsille P, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0009-y; Engl HW, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123014; Greene H., 2003, ECONOMETRIC ANAL; Hartung N, 2014, J MATH BIOL, V68, P41, DOI 10.1007/s00285-013-0724-0; Lefebvre G, 2017, MATH MED BIOL, V34, P151, DOI 10.1093/imammb/dqw002; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Muller S, 2008, PARAMETER IDENTIFICA; Olufsen MS, 2013, J MATH BIOL, V67, P39, DOI 10.1007/s00285-012-0535-8; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Tanveer Adil M, 2016, EUR MED J ONCOL, V4, P113; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9	14	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217332	10.1371/journal.pone.0217332	http://dx.doi.org/10.1371/journal.pone.0217332			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145737	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500016
J	Harris, CM; Albaeni, A; Thorpe, RJ; Norris, KC; Abougergi, MS				Harris, Che Matthew; Albaeni, Aiham; Thorpe, Roland J.; Norris, Keith C.; Abougergi, Marwan S.			Racial factors and inpatient outcomes among patients with diabetes hospitalized with foot ulcers and foot infections, 2003-2014	PLOS ONE			English	Article							AMPUTATION RATES; DISPARITIES; MORTALITY; DISEASE; RACE; INSURANCE; IMPACT; RISK	Background In patients with diabetes, foot amputations among Black patients have been historically higher compared with White patients. Using the National Inpatient Sample database, we sought to determine if disparities in foot amputations and resource utilization have improved over time. We hypothesized there would be improvements and reduced differences in foot amputations between the two races as quality of care and access to healthcare has improved. Methods and findings Patients over 18 years old with a principal diagnosis of diabetic foot complications and secondary diagnosis of Diabetes Mellitus were selected. We compared the primary outcome of foot amputations between Black and White patients. Adjusted rates, odds ratios (aOR) and trends of foot amputations among Black and White patients were studied. Healthcare utilization was measured via length of hospital stay (LOS). Of 262,924 patients, 18% were Black. Following adjustment for confounders, major foot amputations decreased among Whites (1.5% in 2003 to 1.1% in 2014) and Blacks (2.1% in 2003 to 0.9% in 2014). On pooled analysis, Black patients had higher adjusted odds of major foot amputations in 2003-2004 [aOR 1.7; (1.16-2.57), p< 0.01]. Disparities in major foot amputations disappeared in 2013-2014 [aOR: 0.92 (0.58-1.44), p = 0.70]. Black patients had declining but persistently longer LOS (adjusted mean difference (aMD): 1.1 days (0.52-1.6) p< 0.01 in 2003-2004 and 0.46 days (0.18-0.73) p< 0.01 in 2013-2014). The main limitation of the study was that the NIS uses ICD-9 and ICD-10 CM codes, and hence prone to incorrect or missing codes. Conclusions Major foot amputations declined among Black and White patients hospitalized with Diabetic foot complications between 2003 and 2014. The observed difference for amputations in 2003-2004 was absent by 2013-2014. Future research to determine specific contributors for this reduction in health disparities is needed for ongoing improvements and sustainability.	[Harris, Che Matthew] Johns Hopkins Sch Med, Johns Hopkins Bayview Med Ctr, Dept Gen Internal Med, Div Hosp Med, Baltimore, MD 21205 USA; [Albaeni, Aiham] Univ Cent Florida, Dept Med, Ocala, FL USA; [Thorpe, Roland J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Norris, Keith C.] Univ Calif Los Angeles, Dept Internal Med, David Geffen Sch Med, Los Angeles, CA USA; [Abougergi, Marwan S.] Univ South Carolina, Sch Med, Dept Internal Med, Div Gastroenterol, Columbia, SC 29208 USA; [Abougergi, Marwan S.] Catalyst Med Consulting, Simpsonville, SC USA	Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of South Carolina System; University of South Carolina Columbia	Harris, CM (corresponding author), Johns Hopkins Sch Med, Johns Hopkins Bayview Med Ctr, Dept Gen Internal Med, Div Hosp Med, Baltimore, MD 21205 USA.	charri21@jhmi.edu		Norris, Keith/0000-0003-3071-0700	National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center;  [1R25HL126145-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL126145] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center. KN received Grant #1R25HL126145-01. No-The funders did not play a role in formulating the study or manuscript. NHLBI URL: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts.Catalyst Medical Consulting company did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of Marwan Abougergi's salary and/or research materials. Catalyst Medical Consulting company provided support in the form of salary for Marwan Abougergi but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007425; Ashry H R, 1998, J Foot Ankle Surg, V37, P186; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Brown DA, 2018, NEURO-ONCOLOGY, V20, P1374, DOI 10.1093/neuonc/noy102; Burton BN, 2018, J CARDIOTHOR VASC AN; Centers for Disease Control and Prevention, CDC REP FINDS LARG D; Chammas NK, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2879809; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dietrich I, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0680-z; Geiss LS, 2018, DIABETES CARE; Goldberg JB, 2012, J VASC SURG, V56, P1663, DOI 10.1016/j.jvs.2012.05.100; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hashimoto Robin E, 2014, Evid Based Spine Care J, V5, P74, DOI 10.1055/s-0034-1390027; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Hoffmann M, 2015, DIABETES VASC DIS RE, V12, P265, DOI 10.1177/1479164115579005; Hughes K, 2014, VASC ENDOVASC SURG, V48, P402, DOI 10.1177/1538574414543276; Hunt NA, 2011, PLAST RECONSTR SURG, V127, p289S, DOI 10.1097/PRS.0b013e3181fbe2a6; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kominski GF, 2017, ANNU REV PUBL HEALTH, V38, P489, DOI 10.1146/annurev-publhealth-031816-044555; Loehrer AP, 2016, ANN SURG, V263, P705, DOI 10.1097/SLA.0000000000001310; Mehtsun WT, 2017, HEALTH AFFAIR, V36, P1057, DOI 10.1377/hlthaff.2017.0061; Muhlestein WE, 2017, WORLD NEUROSURG, V104, P24, DOI 10.1016/j.wneu.2017.04.061; Newhall K, 2016, ANN VASC SURG, V30, P292, DOI 10.1016/j.avsg.2015.07.040; Noor S, 2017, DIABETES METAB SYND, V11, P149, DOI 10.1016/j.dsx.2016.06.023; Rice JB, 2013, DIABETES CARE; Rinkel WD, 2017, DIABETES RES CLIN PR, V132, P68, DOI 10.1016/j.diabres.2017.07.029; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Romano PS, SELECTING QUALITY RE; Skrepnek GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134914; Smedley BD, 2009, UNEQUAL TREATMENT CO; Suckow BD, 2016, ANN VASC SURG, V36, P208, DOI 10.1016/j.avsg.2016.03.035; Wukich DK, 2016, PLAST RECONSTR SURG, V138, p188S, DOI 10.1097/PRS.0000000000002713	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216832	10.1371/journal.pone.0216832	http://dx.doi.org/10.1371/journal.pone.0216832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141534	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000025
J	Holtkamp, C; Koos, B; Unterberg, M; Rahmel, T; Bergmann, L; Bazzi, Z; Bazzi, M; Bukhari, H; Adamzik, M; Rump, K				Holtkamp, Caroline; Koos, Bjoern; Unterberg, Matthias; Rahmel, Tim; Bergmann, Lars; Bazzi, Zainab; Bazzi, Maha; Bukhari, Hassan; Adamzik, Michael; Rump, Katharina			A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes	PLOS ONE			English	Article							DELIRIUM; ANESTHESIA; TERM; ACETYLCHOLINESTERASE; NEUROINFLAMMATION; PATHOPHYSIOLOGY; DYSFUNCTION; EXPRESSION; PATHWAYS; SYSTEM	Background Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model. Results We found that propofol indeed reduced the activity of AChE/BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro-or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27. Conclusion In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.	[Holtkamp, Caroline; Koos, Bjoern; Unterberg, Matthias; Rahmel, Tim; Bergmann, Lars; Bazzi, Zainab; Bazzi, Maha; Adamzik, Michael; Rump, Katharina] Ruhr Univ Bochum, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany; [Bukhari, Hassan] Ruhr Univ Bochum, Med Proteomctr MPC, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Rump, K (corresponding author), Ruhr Univ Bochum, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany.	katharina.k.rump@rub.de	Bukhari, Hassan/GZK-6477-2022; Rump, Katharina/AAJ-9090-2020; Rahmel, Tim/AAI-1566-2020; Adamzik, Michael/HGE-9286-2022	Bukhari, Hassan/0000-0003-3328-8234; Rump, Katharina/0000-0003-2220-519X; Rahmel, Tim/0000-0002-7039-6288; Unterberg, Matthias/0000-0002-1500-1984	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum and the Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum. (www.rub.de) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cascella M, 2018, MINERVA ANESTESIOL, V84, P246, DOI 10.23736/S0375-9393.17.12146-2; Cerejeira J, 2012, J AM GERIATR SOC, V60, P669, DOI 10.1111/j.1532-5415.2011.03883.x; Cerejeira J, 2011, AGE AGEING, V40, P621, DOI 10.1093/ageing/afr053; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Ferreira GK, 2012, NEUROCHEM INT, V61, P1370, DOI 10.1016/j.neuint.2012.09.017; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; Inoue N, 2018, EMBO REP, V19, DOI 10.15252/embr.201744860; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Ji MH, 2014, MOL NEUROBIOL, V50, P937, DOI 10.1007/s12035-014-8659-z; Koskderelioglu A, 2017, GERIATR GERONTOL INT, V17, P919, DOI 10.1111/ggi.12806; Lauzon MA, 2018, MOL CELL NEUROSCI, V88, P83, DOI 10.1016/j.mcn.2018.01.003; Maldonado JR, 2017, CRIT CARE CLIN, V33, P461, DOI 10.1016/j.ccc.2017.03.013; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Mei B, 2018, CLIN J PAIN, V34, P811, DOI 10.1097/AJP.0000000000000605; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Milanovic D, 2017, NEUROTOX RES, V32, P247, DOI 10.1007/s12640-017-9730-0; Mori K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087319; Nakaizumi K, 2018, J ALZHEIMERS DIS, V61, P1355, DOI [10.3233/JAD.170591, 10.3233/JAD-170591]; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Reddy Siddareddygari Velayudha, 2017, J Anaesthesiol Clin Pharmacol, V33, P291, DOI 10.4103/joacp.JOACP_180_16; Rump K, 2013, SHOCK, V40, P430, DOI 10.1097/SHK.0000000000000035; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sall JW, 2013, ANESTH ANALG, V117, P65, DOI 10.1213/ANE.0b013e318292f32e; Shaltiel G, 2013, BRAIN STRUCT FUNCT, V218, P59, DOI 10.1007/s00429-011-0376-z; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P622, DOI 10.1097/00000542-200703000-00026; Umholtz M, 2017, IMMUNOL INVEST, V46, P805, DOI 10.1080/08820139.2017.1373898; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WHITTAKER M, 1980, ANAESTHESIA, V35, P174, DOI 10.1111/j.1365-2044.1980.tb03800.x; Xu R, 2018, GENE, V657, P9, DOI 10.1016/j.gene.2018.03.010; Yadav R, 2017, NEUROSCIENCE, V349, P106, DOI 10.1016/j.neuroscience.2017.02.041; Zujalovic Benedikt, 2015, Case Rep Crit Care, V2015, P793015, DOI 10.1155/2015/793015	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217269	10.1371/journal.pone.0217269	http://dx.doi.org/10.1371/journal.pone.0217269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141559	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000047
J	Ma, H; Guo, XY; Ping, Y; Wang, BC; Yang, YH; Zhang, ZL; Zhou, JX				Ma, Hui; Guo, Xuyang; Ping, Yuan; Wang, Baocang; Yang, Yuehua; Zhang, Zhili; Zhou, Jingxian			PPCD: Privacy-preserving clinical decision with cloud support	PLOS ONE			English	Article							EFFICIENT; SECURE; SYSTEM; RISK	With the prosperity of machine learning and cloud computing, meaningful information can be mined from mass electronic medical data which help physicians make proper disease diagnosis for patients. However, using medical data and disease information of patients frequently raise privacy concerns. In this paper, based on single-layer perceptron, we propose a scheme of privacy-preserving clinical decision with cloud support (PPCD), which securely conducts disease model training and prediction for the patient. Each party learns nothing about the other's private information. In PPCD, a lightweight secure multiplication is presented and introduced to improve the model training. Security analysis and experimental results on real data confirm the high accuracy of disease prediction achieved by the proposed PPCD without the risk of privacy disclosure.	[Ma, Hui; Ping, Yuan; Wang, Baocang; Yang, Yuehua; Zhang, Zhili] Xuchang Univ, Sch Informat Engn, Xuchang, Henan, Peoples R China; [Guo, Xuyang] 1 Middle Sch Zhengzhou, Zhengzhou, Henan, Peoples R China; [Ping, Yuan; Zhou, Jingxian] Civil Aviat Univ China, Informat Technol Res Base Civil Aviat Adm China, Tianjin, Peoples R China; [Wang, Baocang] Xidian Univ, State Key Lab Integrated Serv Networks, Xian, Shaanxi, Peoples R China	Xuchang University; Civil Aviation University of China; Xidian University	Ping, Y; Wang, BC (corresponding author), Xuchang Univ, Sch Informat Engn, Xuchang, Henan, Peoples R China.; Ping, Y (corresponding author), Civil Aviat Univ China, Informat Technol Res Base Civil Aviat Adm China, Tianjin, Peoples R China.; Wang, BC (corresponding author), Xidian Univ, State Key Lab Integrated Serv Networks, Xian, Shaanxi, Peoples R China.	pyuan.lhn@xcu.edu.cn; bcwang79@aliyun.com			National Key R&D Program of China [2017YFB0802000]; National Natural Science Foundation of China [U1736111]; Plan For Scientific Innovation Talent of Henan Province [184100510012]; Program for Science & Technology Innovation Talents in Universities of He'nan Province [18HASTIT022]; Key Technologies R&D Program of He'nan Province [182102210123, 192102210295]; Foundation of He'nan Educational Committee [18A520047]; Foundation for University Key Teacher of He'nan Province [2016GGJS-141]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan For Scientific Innovation Talent of Henan Province; Program for Science & Technology Innovation Talents in Universities of He'nan Province; Key Technologies R&D Program of He'nan Province; Foundation of He'nan Educational Committee; Foundation for University Key Teacher of He'nan Province; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work is supported by the National Key R&D Program of China under Grants no. 2017YFB0802000 to BW, the National Natural Science Foundation of China under Grant no. U1736111 to BW, the Plan For Scientific Innovation Talent of Henan Province under Grand no. 184100510012 to BW, the Program for Science & Technology Innovation Talents in Universities of He'nan Province under Grant No. 18HASTIT022 to YP, Key Technologies R&D Program of He'nan Province under Grant No. 182102210123 to YP, the Foundation of He'nan Educational Committee under Grant No. 18A520047 to YP, the Foundation for University Key Teacher of He'nan Province under Grant No. 2016GGJS-141 to YP, Key Technologies R&D Program of He'nan Province (192102210295 to HM), and Innovation Scientists and Technicians Troop Construction Projects of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajemba PO, 2005, IEEE T INF TECHNOL B, V9, P276, DOI 10.1109/TITB.2005.847169; [Anonymous], [No title captured]; Anooj PK, 2012, J KING SAUD UNIV-COM, V24, P27, DOI 10.1016/j.jksuci.2011.09.002; Barakat NH, 2010, IEEE T INF TECHNOL B, V14, P1114, DOI 10.1109/TITB.2009.2039485; Foresti S., 2007, P 33 INT C VER LARG, P123; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Gao CZ, 2018, INFORM SCIENCES, V444, P72, DOI 10.1016/j.ins.2018.02.058; Huang CL, 2008, EXPERT SYST APPL, V34, P578, DOI 10.1016/j.eswa.2006.09.041; Jiang XQ, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-S1-S1; Kuo T.-T., 2018, MODELCHAIN DECENTRAL; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; Li P, 2017, FUTURE GENER COMP SY, V74, P76, DOI 10.1016/j.future.2017.02.006; Lichman M., UCI MACHINE LEARNING; Liu J, 2017, CCS'17: PROCEEDINGS OF THE 2017 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P619, DOI 10.1145/3133956.3134056; Liu XM, 2018, FUTURE GENER COMP SY, V78, P825, DOI 10.1016/j.future.2017.03.018; Liu XM, 2016, IEEE J BIOMED HEALTH, V20, P655, DOI 10.1109/JBHI.2015.2407157; Musen MA, 2014, J BIOMEDICAL INFORM, P698; Phan N, 2016, AAAI CONF ARTIF INTE, P1309; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Rahulamathavan Y, 2014, IEEE J BIOMED HEALTH, V18, P56, DOI 10.1109/JBHI.2013.2274899; Schurink CAM, 2005, LANCET INFECT DIS, V5, P305, DOI 10.1016/S1473-3099(05)70115-8; Taigel F, 2018, PRIVACY PRESERVING C, DOI [10.1007/s11573-017-0889-x, DOI 10.1007/S11573-017-0889-X]; Wang GX, 2015, INT CONF MACH LEARN, P1, DOI 10.1109/ICMLC.2015.7340888; Wang S, 2016, BIOINFORMATICS, V32, P211, DOI 10.1093/bioinformatics/btv563; Wang S, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-S1-S2; Wang WY, 2007, J CLIN ONCOL, V25, P1417, DOI 10.1200/JCO.2006.09.2452; Zhang C, 2018, FUTURE GENER COMP SY, V79, P16, DOI 10.1016/j.future.2017.09.002; Zhang X, 2018, SOFT COMPUT, DOI [10.1007/s00500-018-32-33-7, DOI 10.1007/S00500-018-32-33-7]; Zhao YA, 2015, J AM MED INFORM ASSN, V22, P100, DOI 10.1136/amiajnl-2014-003043; Zhu H, 2017, IEEE J BIOMED HEALTH, V21, P838, DOI 10.1109/JBHI.2016.2548248	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217349	10.1371/journal.pone.0217349	http://dx.doi.org/10.1371/journal.pone.0217349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141561	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000052
J	Ray, K; Banerjee, H; Dutta, S; Hazra, AK; Majumdar, K				Ray, Krishnendu; Banerjee, Hirak; Dutta, Sudarshan; Hazra, Alok Kumar; Majumdar, Kaushik			Macronutrients influence yield and oil quality of hybrid maize (Zea mays L.)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; NUTRITIONAL QUALITY; NITROGEN; POTASSIUM; PHOSPHORUS; PROTEIN; SEED; FERTILIZATION; PROFILE; GROWTH	In the present two-year study, an attempt was made to estimate the grain yield, grain nutrient uptake, and oil quality of three commonly grown maize (Zea mays L.) hybrids fertilized with varied levels of nitrogen (N), phosphorus (P) and potassium (K). Results obtained from both the experimental years indicated that application of 125% of recommended dose of fertilizer (RDF) recorded maximum grain yield (10.37 t ha -1; 124% higher than control). When compared with 100% RDF, grain yield reduction with nutrient omission was 44% for N omission, 17% for P omission, and 27% for K omission. Nitrogen uptake was increased with increasing NPK levels up to 150% RDF that was statistically at par (p. 0.01) with 125% RDF. Increasing trend in P and K uptake was observed with successive increase in NPK levels up to 125% RDF, above which it declined. The protein content was significantly higher in grains of var. P 3396 with 125% RDF. Nutrient management has significant (p. 0.01) role in the grain oil content. Saturated fatty acids (palmitic, stearic and arachidic acid) content decreased, and unsaturated fatty acid (oleic, linoleic and linolenic acid) increased with increasing NPK levels. The average oleic acid desaturation and linoleic acid desaturation ratios were increased with increasing NPK levels up to 100 and 125% RDF, respectively. However, average monounsaturated fatty acids (MUFA): poly-unsaturated fatty acids (PUFA), saturated: unsaturated as well as linoleic: linolenic acid ratios were increased on receiving 75% RDF, and beyond that it showed decreasing trend. The omission of K had the highest inhibitory effect on corn oil quality followed by N and P omission.	[Ray, Krishnendu] Sasya Shyamala Krishi Vigyan Kendra, Ramakrishna Mission Vivekananda Educ & Res Inst, Kolkata, W Bengal, India; [Banerjee, Hirak] Bidhan Chandra Krishi Viswavidyalaya, Reg Res Stn CSZ, Kakdwip, W Bengal, India; [Dutta, Sudarshan] Int Plant Nutr Inst, South Asia Program, Kolkata, W Bengal, India; [Dutta, Sudarshan; Majumdar, Kaushik] African Plant Nutr Inst, Benguerir, Morocco; [Hazra, Alok Kumar] Ramakrishna Mission Ashrama, IRDM Fac Ctr, Kolkata, W Bengal, India; [Majumdar, Kaushik] Int Plant Nutr Inst, Asia Africa & Middle East Program, Gurgaon, Haryana, India	Bidhan Chandra Agricultural University; Mohammed VI Polytechnic University	Dutta, S (corresponding author), Int Plant Nutr Inst, South Asia Program, Kolkata, W Bengal, India.; Dutta, S (corresponding author), African Plant Nutr Inst, Benguerir, Morocco.	sudarshandutta@gmail.com	; Ray, Krishnendu/H-8605-2018	MAJUMDAR, KAUSHIK/0000-0001-6931-8170; Ray, Krishnendu/0000-0001-6825-8129				Ahmad A, 2000, J AGRON CROP SCI, V185, P49, DOI 10.1046/j.1439-037X.2000.00401.x; Ahmad Alias, 2003, International Journal of Agriculture and Biology, V5, P632; Ahmad R., 1999, INT J AGRIC BIOL, V1, P325; Ali A, 2012, CHIL J AGR RES, V72, P564, DOI 10.4067/S0718-58392012000400016; Ali J., 2002, ASIAN J PLANT SCI, V1, P367; Alipatra A., 2017, THESIS; AOAC, 1960, OFF TENT METH AN; AOAC, 2000, OFFICIAL METHODS ANA, V17th; AOAC, 2016, OFFICIAL METHODS ANA, VII, P20; Ashraf M, 2006, J SCI FOOD AGR, V86, P871, DOI 10.1002/jsfa.2426; Aytac Z, 2017, J CHEM, P1; Bilgin O, 2010, CEREAL RES COMMUN, V38, P233, DOI 10.1556/CRC.38.2010.2.9; Blumenthal J., 2008, IMPORTANCE EFFECT NI; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Brady N.C., 1996, NATURE PROPERTIES SO; Chaudhary DP, 2012, INDIAN J AGR SCI, V82, P681; Chen YL, 2014, FIELD CROP RES, V159, P1, DOI 10.1016/j.fcr.2014.01.002; Ciampitti IA, 2013, AGRON J, V105, P783, DOI 10.2134/agronj2012.0467; Dag A, 2009, J SCI FOOD AGR, V89, P1871, DOI 10.1002/jsfa.3664; Dibaba D. H., 2013, Karnataka Journal of Agricultural Sciences, V26, P194; DUPONT J, 1990, J AM COLL NUTR, V9, P438, DOI 10.1080/07315724.1990.10720403; Echarte L, 2008, CROP SCI, V48, P656, DOI 10.2135/cropsci2007.06.0366; Fageria VD, 2001, J PLANT NUTR, V24, P1269, DOI 10.1081/PLN-100106981; FAOSTAT, 2017, STAT DAT DAT SETS FO; Genet T, 2004, J SCI FOOD AGR, V84, P1663, DOI 10.1002/jsfa.1856; Goffman FD, 2001, J AGR FOOD CHEM, V49, P4990, DOI 10.1021/jf010156y; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Haq MU, 2005, AGRON J, V97, P910, DOI 10.2134/agronj2004.0215; Iqbal S., 2013, Cercetari Agronomice in Moldova, V46, P39; Israel DW, 2007, CROP SCI, V47, P2036, DOI 10.2135/cropsci2006.11.0691; Jackson M.L, 1973, CONSTABLE CO, P38, DOI [DOI 10.1002/JPLN.19590850311, 10.1002/jpln.19590850311]; Jackson ML., 1963, SOIL CHEM ANAL; JELLUM MD, 1970, J AGR FOOD CHEM, V18, P365, DOI 10.1021/jf60169a032; Kaplan M, 2017, GRASAS ACEITES, V68, DOI 10.3989/gya.0222171; Khan M. B., 2003, International Journal of Agriculture and Biology, V5, P17; Kostik V., 2013, Journal of Hygienic Engineering and Design, V4, P112; Krueger K, 2013, CROP SCI, V53, P602, DOI 10.2135/cropsci2012.06.0372; Lambert RJ, 2000, SPECIALTY CORN, P154; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Mehta S, 2011, INDIAN J AGR SCI, V81, P50; Mengel K., 2006, PRINCIPLES PLANT NUT, V5th; Moreau RA, 2005, J AM OIL CHEM SOC, V82, P851, DOI 10.1007/s11746-005-1154-6; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Oikeh SO, 1998, CROP SCI, V38, P1056, DOI 10.2135/cropsci1998.0011183X003800040029x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Patra BC, 2000, INDIAN J AGR SCI, V70, P203; Pepo P, 2017, CEREAL RES COMMUN, V45, P699, DOI 10.1556/0806.45.2017.046; Pettigrew WT, 1999, AGRON J, V91, P962, DOI 10.2134/agronj1999.916962x; Prodhan HS, 2001, INDIAN J AGR SCI, V71, P55; Ray K, 2017, EXPT AGR, V52, P434; Rehman A, 2011, CHIL J AGR RES, V71, P586, DOI 10.4067/S0718-58392011000400014; Sadasivam S., 1996, BIOCH METHODS, P34; SALAMA AM, 1987, NOVENYTERMELES, V36, P191; Sanjeev P, 2014, J AM OIL CHEM SOC, V91, P1001, DOI 10.1007/s11746-014-2429-y; Sawan ZM, 2007, GRASAS ACEITES, V58, P243; Sawan Z. M., 2006, World Journal of Agricultural Sciences, V2, P56; Seebauer JR, 2004, PLANT PHYSIOL, V136, P4326, DOI 10.1104/pp.104.043778; Seo G. S., 1986, Korean Journal of Crop Science, V31, P24; Sharma N.K., 2012, ISRN AGRON, V2012, DOI [10.5402/2012/359673, DOI 10.5402/2012/359673]; STROMBERGER JA, 1994, J PLANT NUTR, V17, P19, DOI 10.1080/01904169409364707; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; THOMPSON DL, 1973, J AM OIL CHEM SOC, V50, P540, DOI 10.1007/BF02640529; TSAI CY, 1983, J SCI FOOD AGR, V34, P255, DOI 10.1002/jsfa.2740340309; Velasco L, 1998, GENET RESOUR CROP EV, V45, P371, DOI 10.1023/A:1008628624867; WELCH LF, 1969, AGRON J, V61, P890, DOI 10.2134/agronj1969.00021962006100060017x; Yin XinHua, 2016, American Journal of Plant Sciences, V7, P1975; Zheljazkov VD, 2012, IND CROP PROD, V36, P28, DOI 10.1016/j.indcrop.2011.08.002	67	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216939	10.1371/journal.pone.0216939	http://dx.doi.org/10.1371/journal.pone.0216939			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141543	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000030
J	Demitto, FO; Schmaltz, CAS; Sant'Anna, FM; Arriaga, MB; Andrade, BB; Rolla, VC				Demitto, Fernanda O.; Schmaltz, Carolina A. S.; Sant'Anna, Flavia M.; Arriaga, Maria B.; Andrade, Bruno B.; Rolla, Valeria C.			Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; RIO-DE-JANEIRO; CASE DEFINITIONS; TUBERCULOSIS; RIFAMPICIN; ACCESS; HAART	Background The implementation of antiretroviral (ARV) therapy caused a significant decrease in HIV-associated mortality worldwide. Nevertheless, mortality is still high among people living with HIV/AIDS and tuberculosis (TB). ARV-naive HIV patients coinfected with tuberculosis (TB) have more options to treat both diseases concomitantly. Nevertheless, some TB-HIV patients undertaking ARVs (ARV-experienced) are already failing the first line efavirenz-based regimen and seem to display different response to second line ARV therapy and exhibit other predictors of mortality. Methods We performed a retrospective cohort study including 273 patients diagnosed with TB-HIV and treated at a referral center in Rio de Janeiro, Brazil, between 2008 and 2016. Multivariate analysis and Cox regression models were used to evaluate the effectiveness of ARV therapy regimens (viral load [VL] <80 copies from the 4th to 10th months after TB therapy introduction) and to identify predictors of early mortality (100 days after TB therapy initiation) considering ARV-naive and ARV-experienced patients adjusting for sociodemographic, clinical and therapeutic covariates. Findings Survival analysis included 273 patients, out of whom 154 (56.4%) were ARV-naive and 119 (43.6%) were ARV-experienced. Seven deaths occurred within 6 months of anti-TB treatment, 4 in ARV-naive and 3 in ARV-experienced patients. Multivariate analysis revealed that in ARV-naive patients, the chance of death was substantially higher in patients who developed immune reconstitution inflammatory syndrome during the study follow up (HR = 40.6, p<0.01). For ARV-experienced patients, similar analyses failed to identify factors significantly associated with mortality. Variables independently associated with treatment failure for the ARV-naive group were previous TB (adjusted OR [aOR] = 6.1 p = 0.03) and alcohol abuse (aOR = 3.7 p = 0.01). For ARV-experienced patients, a ritonavir boosted. Protease Inhibitor-based regimen resulted in a 2.6 times higher risk of treatment failure compared to the use of efavirenz based ARV regimens (p = 0.03) and High baseline HIV VL (p = 0.03) were predictors of treatment failure. Conclusions Risk factors for mortality and ARV failure were different for ARV-naive and ARV-experienced patients. The latter patient group should be targeted for trials with less toxic and rifampicin-compatible drugs to improve TB-HIV treatment outcomes and prevent death.	[Demitto, Fernanda O.; Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Programa Posgrad Pesquisa Clin Doencas Infecciosa, Rio De Janeiro, Brazil; [Schmaltz, Carolina A. S.; Sant'Anna, Flavia M.; Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Micobacterioses LAPCLIN TB, Rio De Janeiro, Brazil; [Arriaga, Maria B.; Andrade, Bruno B.] Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Andrade, Bruno B.] EBMSP, Salvador, BA, Brazil; [Andrade, Bruno B.] Laureate Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil; [Andrade, Bruno B.] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Andrade, Bruno B.] Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, Nashville, TN 37232 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Salvador (UNIFACS); University of Cape Town; Vanderbilt University	Andrade, BB (corresponding author), Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), EBMSP, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Laureate Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.; Andrade, BB (corresponding author), Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, Nashville, TN 37232 USA.	bruno.andrade@bahia.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Andrade, Bruno/AAI-2248-2020	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; de Oliveira Demitto Tamogami, Fernanda/0000-0002-0939-9615; Andrade, Bruno/0000-0001-6833-3811; Arriaga Gutierrez, Maria Belen/0000-0001-6883-8422	Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime) [113/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]; FIOCRUZ; National Institutes of Health [U01AI115940]; Fundacao de Amparo a Pesquisa da Bahia (FAPESB); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115940] Funding Source: NIH RePORTER	Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of V.C.R. was supported by the Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime; agreement 113/2013). Fernanda Demitto was also supported as a post graduate student by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (finance code: 001). The work from BBA was supported by intramural research program from FIOCRUZ and from the National Institutes of Health (U01AI115940). MBA received a fellowship from the Fundacao de Amparo a Pesquisa da Bahia (FAPESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud Michael, 2018, ADV TB CRYPTOCOCCAL; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulanger C, 2017, MED CORRECTOS DOSIS; Brasil. Ministerio da Saude, 2009, NOT TECN MUD TRAT TU; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; da Silva TP, 2017, BMC INFECT DIS, P17, DOI [10.1186/s1287901727006, DOI 10.1186/S1287901727006]; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Greco DB, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000279705.24428.a3; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P459, DOI 10.1016/S1473-3099(14)70711-X; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Johnson LF, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002468; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Ministerio da saude, 2008, GUIA TRAT REC TER AN; Ministerio da Saude, 2012, 4212012CQVDDSTAIDSHV; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Rolla VC, 2006, CLIN DRUG INVEST, V26, P469, DOI 10.2165/00044011-200626080-00005; Sant'Anna FM, 2009, BRAZ J INFECT DIS, V13, P362, DOI 10.1590/S1413-86702009000500010; Schmaltz C. A. S., 2014, Journal of AIDS and Clinical Research, V5, P358; Serra FC, 2007, BRAZ J INFECT DIS, V11, P462, DOI 10.1590/S1413-86702007000500004; Schmaltz CAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045704; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Walker NF, 2015, HIV AIDS-RES PALLIAT, V7, P49, DOI 10.2147/HIV.S42328; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization,, 2008, NEW LAB DIAGN TOOLS	26	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217014	10.1371/journal.pone.0217014	http://dx.doi.org/10.1371/journal.pone.0217014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170171	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700014
J	Takagi, J; Singh-Babak, SD; Lohse, MB; Dalal, CK; Johnson, AD				Takagi, Julie; Singh-Babak, Sheena D.; Lohse, Matthew B.; Dalal, Chiraj K.; Johnson, Alexander D.			Candida albicans white and opaque cells exhibit distinct spectra of organ colonization in mouse models of infection	PLOS ONE			English	Article							EXPRESSION; MISEXPRESSION; EPIDEMIOLOGY; TRANSITION; REGULATOR; SURVIVAL; GROWTH; PHASE	Candida albicans, a species of fungi, can thrive in diverse niches of its mammalian hosts; it is a normal resident of the GI tract and mucosal surfaces but it can also enter the bloodstream and colonize internal organs causing serious disease. The ability of C. albicans to thrive in these different host environments has been attributed, at least in part, to its ability to assume different morphological forms. In this work, we examine one such morphological change known as white-opaque switching. White cells are the default state of C. albicans, and most animal studies have been carried out exclusively with white cells. Here, we compared the proliferation of white and opaque cells in two murine models of infection and also monitored, using specially constructed strains, switching between the two states in the host. We found that white cells outcompeted opaque cells in many niches; however, we show for the first time that in some organs (specifically, the heart and spleen), opaque cells competed favorably with white cells and, when injected on their own, could colonize these organs. In environments where the introduced white cells outcompeted the introduced opaque cells, we observed high rates of opaque-to-white switching. We did not observe white-to-opaque switching in any of the niches we examined.	[Takagi, Julie; Singh-Babak, Sheena D.; Lohse, Matthew B.; Dalal, Chiraj K.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Takagi, Julie] MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT)	Dalal, CK; Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	chirajdalal.ucsf@gmail.com; ajohnson@cgl.ucsf.edu		Dalal, Chiraj/0000-0002-3624-8409; Singh, Sheena/0000-0002-0991-0989	NIH [R01AI049187]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grant R01AI049187 (A.D.J.). More information about the funders is available here: http://grantome.com/grant/NIH/R01-AI049187-17.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JM, 2001, FEMS MICROBIOL LETT, V204, P323, DOI 10.1111/j.1574-6968.2001.tb10905.x; Baker S, 2007, OVERVIEW GENUS ASPER, P3, DOI [10.1201/9781420008517.sec1, DOI 10.1201/9781420008517.SEC1]; Bohm L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006699; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Ene IV, 2016, MBIO, V7, DOI [10.1128/mBio.01269-16, 10.1128/mbio.01269-16]; Geiger J, 2004, INFECT IMMUN, V72, P667, DOI 10.1128/IAI.72.2.667-677.2004; Hernday AD, 2013, MOL MICROBIOL, V90, P22, DOI 10.1111/mmi.12329; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Huang GH, 2012, VIRULENCE, V3, P251, DOI 10.4161/viru.20010; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Huang G, 2009, CURR BIOL, V19, P330, DOI 10.1016/j.cub.2009.01.018; KOLOTILA MP, 1990, INFECT IMMUN, V58, P1174, DOI 10.1128/IAI.58.5.1174-1179.1990; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Kvaal CA, 1997, INFECT IMMUN, V65, P4468, DOI 10.1128/IAI.65.11.4468-4475.1997; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Lohse MB, 2016, G3-GENES GENOM GENET, V6, P721, DOI 10.1534/g3.115.024885; Lohse MB, 2009, CURR OPIN MICROBIOL, V12, P650, DOI 10.1016/j.mib.2009.09.010; Lohse MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001473; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Morschhauser J, 2010, MED MICROBIOL IMMUN, V199, P165, DOI 10.1007/s00430-010-0147-0; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Odds FC, 2000, MICROBIOL-SGM, V146, P1881, DOI 10.1099/00221287-146-8-1881; Odds FC., 1988, CANDIDA CANDIDOSIS; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Porman AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003369; Pujol C, 2004, EUKARYOT CELL, V3, P1015, DOI 10.1128/EC.3.4.1015-1027.2004; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RIKKERINK EHA, 1988, J BACTERIOL, V170, P895, DOI 10.1128/jb.170.2.895-899.1988; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sasse C, 2013, EUKARYOT CELL, V12, P50, DOI 10.1128/EC.00266-12; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; Solis NV, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00774-17; Soll DR, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.22993; Soll DR, 2009, FEMS YEAST RES, V9, P973, DOI 10.1111/j.1567-1364.2009.00562.x; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; Soll DR, 2004, BIOESSAYS, V26, P10, DOI 10.1002/bies.10379; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; VANDEVENTER AJM, 1995, J CLIN MICROBIOL, V33, P625, DOI 10.1128/JCM.33.3.625-628.1995; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	47	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218037	10.1371/journal.pone.0218037	http://dx.doi.org/10.1371/journal.pone.0218037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170229	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700097
J	Taniuchi, K; Furihata, M; Naganuma, S; Sakaguchi, M; Saibara, T				Taniuchi, Keisuke; Furihata, Mutsuo; Naganuma, Seiji; Sakaguchi, Masahiko; Saibara, Toshiji			Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; POOR-PROGNOSIS; OPEN-LABEL; PROMOTES; GEMCITABINE; INVASIVENESS; RESECTION; INVASION; MULTICENTER; FOLFIRINOX	We previously reported that overexpression of PODXL, BCL7B, and ARHGEF4 in pancreatic cancer tissue is correlated with pancreatic cancer-related survival. The aim of this study was to investigate the use of PODXL, BCL7B, ARHGEF4, and the integrin family member ITGB1 as useful markers for the prognosis of postoperative pancreatic cancer patients in comparison with tumor size and the tumor node metastasis (TNM) staging system. Immunohistochemistry was performed using an anti-ITGB1 antibody on 102 samples of pancreatic cancer tissue surgically resected at the University of Kochi Medical School Hospital and the Matsuyama Shimin Hospital. Univariate Cox proportional hazards regression analysis showed that TNM stage and overexpression of PODXL, BCL7B, and ITGB1 were correlated with postoperative survival. However, tumor size was not significantly associated with postoperative prognosis of pancreatic cancer compared to these features. Multivariate Cox proportional hazards regression analysis showed that the overexpression of both PODXL and ITGB1 and overexpression of both BCL7B and ITGB1 increased the hazard ratio (6.27, 95% confidence interval [CI] 2.58-15.21; and 3.93, 95% CI 1.74-8.91, respectively) compared to that of TNM stage (IIA and IIB vs. III and IV; 3.05, 95% CI 1.25-7.42). These results imply that the combination of PODXL with ITGB1 and the combination of BCL7B with ITGB1 accurately predicted the postoperative outcomes of pancreatic cancer patients, and they were superior compared to the TNM staging system. The combination of PODXL with ITGB1 would be particularly useful, as it was the most highly correlated with postoperative outcomes. Importantly, the present results are useful to determine which adjuvant therapy should be selected.	[Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Nankoku, Kochi, Japan; [Furihata, Mutsuo; Naganuma, Seiji] Kochi Univ, Kochi Med Sch, Dept Pathol, Nankoku, Kochi, Japan; [Sakaguchi, Masahiko] Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol, Nankoku, Kochi, Japan; [Sakaguchi, Masahiko] Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan	Kochi University; Kochi University; Kochi University; Kochi University; Kanagawa Prefectural Cancer Center	Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan.; Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Nankoku, Kochi, Japan.	ktaniuchi@kochi-u.ac.jp			 [24591013];  [15K14396];  [17K09463]	; ; 	This research was supported by the Grants-in-Aid for Scientific Research (KAKENHI; 24591013, 15K14396, and 17K09463 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Arao S, 2000, PANCREAS, V20, P129, DOI 10.1097/00006676-200003000-00004; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Japan Pancreatic Society, 2003, CLASS PANCR CARC; Khushman M, 2015, PANCREATOLOGY, V15, P667, DOI 10.1016/j.pan.2015.08.010; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Marchegiani G, 2017, ANN SURG, V266, P142, DOI 10.1097/SLA.0000000000001837; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Morganti AG, 2014, INT J RADIAT ONCOL, V90, P911, DOI 10.1016/j.ijrobp.2014.07.024; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Philip Philip A, 2009, Gastrointest Cancer Res, V3, P37; Royall NA, 2015, TRANSL CANCER RES, V4, P641, DOI 10.3978/j.issn.2218-676X.2015.11.04; Shaul YD, 2016, NUCLEIC ACIDS RES, V44, pD560, DOI 10.1093/nar/gkv1337; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Sobin LH, 2009, TNM CLASSIFICATION M, P132; Taniuchi K, 2018, INT J ONCOL, V53, P2224, DOI 10.3892/ijo.2018.4549; Taniuchi K, 2018, AM J CANCER RES, V8, P387; Taniuchi K, 2016, CANCER SCI, V107, P1430, DOI 10.1111/cas.13018; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Tsuboi M, 2016, PANCREATOLOGY, V16, P905, DOI 10.1016/j.pan.2016.07.002; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Van den Broeck A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-68; Xu JB, 2017, ONCOTARGET, V8, P81419, DOI 10.18632/oncotarget.19082	30	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217920	10.1371/journal.pone.0217920	http://dx.doi.org/10.1371/journal.pone.0217920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166991	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800052
J	Hawkes, VC; Gerwing, TG				Hawkes, Virgil C.; Gerwing, Travis G.			Wildlife usage indicates increased similarity between reclaimed upland habitat and mature boreal forest in the Athabasca Oil Sands Region of Alberta, Canada	PLOS ONE			English	Article							LANDSCAPES; FRAGMENTATION; BIOINDICATORS; RECLAMATION; SELECTION; SOILS; BATS	While there is no denying that oil sands development in the Athabasca Oil Sands Region (AOSR) has large impacts upon the habitat it disturbs, developers are legally required to return this land to "an equivalent land capability." While still early in the process of reclamation, land undergoing reclamation offers an opportunity to study factors influencing reclamation success, as well as how reclaimed ecosystems function. As such, an Early Successional Wildlife Dynamics (ESWD) program was created to study how wildlife return to and use reclaimed upland boreal habitat in the AOSR. Wildlife data comprising 182 taxa of mammals, birds, and amphibians, collected between 2011 and 2017 and from five oil sands leases, were compared from multiple habitat types (burned [BRN], cleared [CLR], compensation lakes [COMP], logged [LOG], mature forest [MF], and reclaimed sites [REC]). Overall, similarity of wildlife communities in REC and MF plots varied greatly, even at 33 years since reclamation (31-62% with an average of 52%). However, an average community similarity of 52% so early in the successional process suggests that current reclamation efforts are progressing towards increased similarity compared to mature forest plots. Conversely, our data suggest that REC plots are recovering differently than plots impacted by natural (BRN) or other anthropogenic disturbances (LOG), which is likely due to differences associated with soil reconstruction and development on reclaimed plots. Regardless of the developmental trajectory of reclaimed habitats, progression towards increased wildlife community similarity at REC and MF plots is apparent in our data. While there is no expectation that reclaimed upland habitats will resemble or function identically to naturally occurring boreal forest, the degree of similarity observed in our study suggests that comparable ecological functionality is possible, increasing the probability that oil sands operators will be able to fulfill their regulatory requirements and duty to reclaim regarding wildlife and wildlife habitat.	[Hawkes, Virgil C.; Gerwing, Travis G.] LGL Ltd Environm Res Associates, Sidney, BC, Canada; [Gerwing, Travis G.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Gerwing, Travis G.] Univ British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Victoria; University of British Columbia	Hawkes, VC (corresponding author), LGL Ltd Environm Res Associates, Sidney, BC, Canada.	vhawkes@lgl.com	Gerwing, Travis/AAU-6569-2020	Gerwing, Travis/0000-0002-4433-1843	Canadian Natural Resources Limited; Horizon Oil Sands [806448]; Shell Canada Energy [UA54615]; Suncor Energy Services Inc. [POs 4501376479, 4502047284, 45022884647]; Fort Hills Energy [PO 4502244761]	Canadian Natural Resources Limited; Horizon Oil Sands; Shell Canada Energy; Suncor Energy Services Inc.; Fort Hills Energy	This project was completed under contract to Canadian Natural Resources Limited, Horizon Oil Sands (Contract #806448); Shell Canada Energy (Agreement Number UA54615), Suncor Energy Services Inc. (POs 4501376479, 4502047284, and 45022884647) and Fort Hills Energy (PO 4502244761) to LGL Limited environmental research associates. Some data (i.e., those collected on Syncrude's Mildred Lake Lease) used in this report were obtained under contract to the Cumulative Environmental Management Association (CEMA) in 2010, 2011, and 2012. These data used with permission. LGL provided support in the form of salaries for authors [VCH, and TGG] and field technicians, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AE. Alberta Energy, 2018, OIL SANDS; Alberta Environment, 2010, GUID RECL FOR VEG AT, V2nd ed.; Allen EW, 2008, J ENVIRON ENG SCI, V7, P123, DOI 10.1139/S07-038; Andersen AN, 1999, J INSECT CONSERV, V3, P61; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Asif N, 2018, POLLUTION, V4, P111, DOI 10.22059/poll.2017.237440.296; Audet P, 2015, CAN J FOREST RES, V45, P364, DOI 10.1139/cjfr-2014-0330; Beckingham JD, 1996, FIELD GUIDE ECOSITES, V5; BERGERON Y, 1989, VEGETATIO, V79, P51, DOI 10.1007/BF00044848; Burger Joanna, 2006, Environmental Bioindicators, V1, P136, DOI 10.1080/15555270600701540; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Charchuk C, 2018, FOREST ECOL MANAG, V407, P9, DOI 10.1016/j.foreco.2017.10.033; Chase Mary K., 2005, U S Forest Service General Technical Report PSW, V191, P130; Chen HYH, 2018, J APPL ECOL, V55, P926, DOI 10.1111/1365-2664.13018; Choi YD, 2008, ECOSCIENCE, V15, P53, DOI 10.2980/1195-6860(2008)15[53:ERFFSI]2.0.CO;2; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; COGBILL CV, 1985, CAN J FOREST RES, V15, P252, DOI 10.1139/x85-043; Cristescu B, 2016, ENVIRON CONSERV, V43, P327, DOI 10.1017/S0376892916000217; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feinsinger P., 2001, DESIGNING FIELD STUD; Foster KR, 2017, RESTOR ECOL, V25, P532, DOI 10.1111/rec.12478; Giesy JP, 2010, P NATL ACAD SCI USA, V107, P951, DOI 10.1073/pnas.0912880107; Gosselin P., 2010, ENV HLTH IMPACTS CAN; Hammond JHE, 2018, J INSECT CONSERV, P1; Hawkes VC, 2013, EA3248 LGL CEMA RWG; Hawkes VC, 2012, MINE CLOSURE 2012, P717; Hawkes VC, 2014, YEAR 2 2013 2014 ANN; Hawkes VC, 2018, REGIONAL EARLY UNPUB; Johnson EA, 2008, ANN NY ACAD SCI, V1134, P120, DOI 10.1196/annals.1439.007; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Keim JL, 2019, J ANIMAL ECOLOGY; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, P1; Martiniakova M, 2012, J ENVIRON SCI HEAL A, V47, P1202, DOI 10.1080/10934529.2012.672062; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Moreno Claudia E., 2007, International Journal of Environment and Health, V1, P71, DOI 10.1504/IJENVH.2007.012225; Padoa-Schioppa E, 2006, ECOL INDIC, V6, P83, DOI 10.1016/j.ecolind.2005.08.006; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Pezya J-P, 2018, ECOLOGICAL INDICATOR, V91, P2320; Pickard D, 2013, LONG TERM PLOT NETWO; Pinno BD, 2015, FORESTS, V6, P2109, DOI 10.3390/f6062109; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Ralph C. J, 1995, PSWGTR149 USDA FOR S, V187, P149; Robataille R, 2010, EARLY SUCCESSI UNPUB; Rogers VV, 2002, TOXICOL SCI, V66, P347, DOI 10.1093/toxsci/66.2.347; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108; Rowland SM, 2009, J ENVIRON QUAL, V38, P1580, DOI 10.2134/jeq2008.0317; Salafsky N., 2001, ADAPTIVE MANAGEMENT; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Scopel LC, 2017, CANADIAN J FISHERIES, P1; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Stefani F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20783-6; Sullivan RM, 1997, J MAMMAL, V78, P798, DOI 10.2307/1382937; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, J EXPT MARINE BIOL E, V250, P97; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	63	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217556	10.1371/journal.pone.0217556	http://dx.doi.org/10.1371/journal.pone.0217556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163043	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200017
J	Wojcik, E; Szostek, M				Wojcik, Ewa; Szostek, Malgorzata			Assessment of genome stability in various breeds of cattle	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGE; COMMON FRAGILE SITE; CHROMOSOME FRAGILITY; MOLECULAR-MECHANISMS; INSTABILITY; LOCALIZATION; SCE; COWS; SEX; IDENTIFICATION	Chromosomal instability is a type of genome instability involving changes in genetic information at the chromosomal level. The basic tests used to identify this form of instability are sister chromatid exchange (SCE) tests and identification of fragile sites (FS). SCE is the process by which sister chromatids become fragmented as a result of DNA strand breakage and reassembly, followed by exchange of these fragments. FS can be observed in the form of breaks, gaps or constrictions on chromosomes, which often result from multiple nucleotide repeats in DNA that are difficult to replicate. The research material was the peripheral blood of ten breeds of cattle raised in Poland, including four native breeds covered by a genetic resources conservation programme, i.e. Polish Red, Polish Red-and-White, White-Backed, and Polish Black-and-White, as well as Polish Holstein-Friesian, Simmental, Montbeliarde, Jersey, Limousine and Danish Red. Two tests were performed on chromosomes obtained from in vitro cultures: SCE and FS. The average frequency of SCE was 5.08 +/- 1.31, while the incidence of FS was 3.45 +/- 0.94. Differences in the incidence of SCE and FS were observed between breeds. The least damage was observed in the Polish Red and White-Backed breeds, and the most in Polish Holstein-Friesians. The most damage was observed in the interstitial part of the chromosomes. Age was shown to significantly affect the incidence of SCE and FS. Younger cows showed less damage than older ones (SCE: 4.84 +/- 1.25; 5.34 +/- 1.24; FS: 3.10 +/- 0.88, 3.80 +/- 0.92).	[Wojcik, Ewa; Szostek, Malgorzata] Siedlce Univ Nat Sci & Humanities, Inst Bioengn & Anim Breeding, Siedlce, Poland		Wojcik, E (corresponding author), Siedlce Univ Nat Sci & Humanities, Inst Bioengn & Anim Breeding, Siedlce, Poland.	ewa.wojcik@uph.edu.pl		Wojcik, Ewa/0000-0002-9446-7132				Albarella S, 2009, MUTAGENESIS, V24, P471, DOI 10.1093/mutage/gep030; Ali A, 2008, J GENET, V87, P219, DOI 10.1007/s12041-008-0035-1; Ansari HA, 1999, CYTOGENET CELL GENET, V87, P134, DOI 10.1159/000015380; Arias E, 2000, HEREDITAS, V133, P263, DOI 10.1111/j.1601-5223.2000.00263.x; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Blagoev KB, 2010, AGING-US, V2, P727, DOI 10.18632/aging.100206; CATALAN J, 1995, MUTAT RES-FUND MOL M, V331, P205, DOI 10.1016/0027-5107(95)00077-V; Ciotola F, 2005, VET RES COMMUN, V29, P359, DOI 10.1007/s11259-005-0081-6; Conrad S, 2011, CELL CYCLE, V10, P222, DOI 10.4161/cc.10.2.14639; Danielak-Czech B, 2004, J ANIM FEED SCI, V13, P257, DOI 10.22358/jafs/67410/2004; Danielak-Czech B., 2012, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V30, P18; Danielak-Czech B., 2011, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V29, P28, DOI 10.2478/v10083-011-0015-4; Dezfouli SMA, 2012, IRAN J VET RES, V13, P161; Di Berardino D, 2001, CYTOGENET CELL GENET, V92, P284; Di Meo GP, 2008, CYTOGENET GENOME RES, V120, P127, DOI 10.1159/000118751; Di Meo GP, 2011, MUTAGENESIS, V26, P269, DOI 10.1093/mutage/geq082; DIBERARDINO D, 1983, CARYOLOGIA, V36, P285, DOI 10.1080/00087114.1983.10797668; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; Garrick DJ, 2015, CYTOGENETICS CHROMOS, P103; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Genualdo V, 2012, J APPL GENET, V53, P221, DOI 10.1007/s13353-012-0092-2; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; HUSUM B, 1986, HEREDITAS, V105, P17, DOI 10.1111/j.1601-5223.1986.tb00635.x; IANNUZZI L, 1991, HEREDITAS, V114, P201, DOI 10.1111/j.1601-5223.1991.tb00325.x; IANNUZZI L, 1991, CARYOLOGIA, V44, P145, DOI 10.1080/00087114.1991.10797179; Iannuzzi L, 1996, CHROMOSOME RES, V4, P448, DOI 10.1007/BF02265052; Iannuzzi L, 2004, MUTAGENESIS, V19, P355, DOI 10.1093/mutage/geh041; Iannuzzi L, 2007, ITAL J ANIM SCI, V6, P713, DOI DOI 10.4081/IJAS.2007.1S.23; Khatun MR, 2011, ASIAN J ANIM VET ADV, V6, P117, DOI 10.3923/ajava.2011.117.125; Kuchta-Gladysz M, 2016, FOLIA BIOL-KRAKOW, V64, P89, DOI 10.3409/fb64_2.89; Kuchta-Gladysz M, 2015, CAN J ANIM SCI, V95, P543, DOI 10.4141/CJAS-2015-073; Kumar A, 2014, INDIAN J DAIRY SCI, V67, P1; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; LAZUTKA JR, 1994, MUTAT RES, V306, P173, DOI 10.1016/0027-5107(94)90028-0; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEIBENGUTH F, 1986, Archivos de Zootecnia, V35, P301; Litwinczuk Z, 2012, ANN ANIM SCI, V12, P423; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Nagasawa H, 2017, RADIAT RES, V187, P259, DOI 10.1667/RR14679.1; Neja W., 2013, Journal of Central European Agriculture, V14, P91, DOI 10.5513/JCEA01/14.1.1161; Nicodemo D, 2008, CYTOGENET GENOME RES, V120, P178, DOI 10.1159/000118760; Nicolae I., 2009, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V42, P64; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Peretti V, 2007, MUTAGENESIS, V22, P317, DOI 10.1093/mutage/gem019; Peretti V, 2005, ITAL J ANIM SCI, V4, P97; Peretti V, 2006, HEREDITAS, V143, P113, DOI 10.1111/j.2006.0018-0661.01937.x; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Prasanthi GS, 2004, INTAS POLIVET, V5, P87; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RangelFigueiredo MT, 1995, HEREDITAS, V123, P25, DOI 10.1111/j.1601-5223.1995.t01-1-00025.x; RIGGS PK, 1993, CYTOGENET CELL GENET, V62, P110, DOI 10.1159/000133452; Rodriguez V, 2002, GENET SEL EVOL, V34, P649, DOI [10.1051/gse:2002029, 10.1186/1297-9686-34-6-649]; Rodriguez-Reyes R, 2003, MUTAGENESIS, V18, P65, DOI 10.1093/mutage/18.1.65; RONNE M, 1995, HEREDITAS, V122, P153, DOI 10.1111/j.1601-5223.1995.00153.x; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Schoket B, 1999, MUTAT RES-FUND MOL M, V424, P143, DOI 10.1016/S0027-5107(99)00015-9; Seppa N., 1998, SCI NEWS, V154, P317; SINHA AK, 1985, CELL BIOL TOXICOL, V1, P333, DOI 10.1007/BF00118198; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sram RJ, 1999, MUTAT RES-FUND MOL M, V428, P203, DOI 10.1016/S1383-5742(99)00048-4; Stults DM, 2014, METHODS MOL BIOL, V1105, P439, DOI 10.1007/978-1-62703-739-6_32; VIJH RK, 1992, INDIAN J ANIM SCI, V62, P473; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Wnuk M, 2011, MECH AGEING DEV, V132, P257, DOI 10.1016/j.mad.2011.04.009; Wojcik E, 2014, BRIT POULTRY SCI, V55, P435, DOI 10.1080/00071668.2014.929637; Wojcik E, 2013, POULTRY SCI, V92, P84, DOI 10.3382/ps.2012-02564; Wojcik E, 2012, POULTRY SCI, V91, P2424, DOI 10.3382/ps.2012-02327; Wojcik E, 2018, CAN J ANIM SCI, V98, P818, DOI 10.1139/cjas-2017-0078; Wojcik E, 2013, FOLIA BIOL-KRAKOW, V61, P199, DOI 10.3409/fb61_3-4.199; Wojcik E, 2012, FOLIA BIOL-KRAKOW, V60, P141, DOI 10.3409/fb60_3-4.141-146; Wojcik E, 2012, CAN J ANIM SCI, V92, P49, DOI 10.4141/CJAS2011-112; Wojcik E, 2011, ARCH TIERZUCHT, V54, P107, DOI 10.5194/aab-54-107-2011; WOLFF S, 1974, CHROMOSOMA, V48, P341, DOI 10.1007/BF00290991; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	83	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217799	10.1371/journal.pone.0217799	http://dx.doi.org/10.1371/journal.pone.0217799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163060	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200036
J	Nielsen, LG; Rimvall, MK; Clemmensen, L; Munkholm, AA; Elberling, H; Olsen, EM; Rask, CU; Skovgaard, AM; Jeppesen, P				Nielsen, Louise G.; Rimvall, Martin K.; Clemmensen, Lars; Munkholm, Anj A.; Elberling, Hanne; Olsen, Else Marie; Rask, Charlotte Ulrikka; Skovgaard, Anne Mette; Jeppesen, Pia			The predictive validity of the Strengths and Difficulties Questionnaire in preschool age to identify mental disorders in preadolescence	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; HEALTH PROBLEMS; CHILD; SDQ; ADOLESCENTS; POPULATION; TEACHER; SCREEN; SAMPLE; COHORT	The Strengths and Difficulties Questionnaire (SDQ) is a brief, widely used instrument to screen for mental health problems in children and adolescents. The SDQ predictive algorithms developed for the SDQ, synthesize information from multiple informants regarding psychiatric symptoms and their impact on daily life. This study aimed to explore the validity of the SDQ predictive algorithms used in preschool age to predict mental disorders in preadolescence. The study population comprises 1176 children from the Copenhagen Child Cohort 2000 (CCC2000) assessed at age 5-7 years by the SDQ and reassessed at 11-12 years with the Development and Well Being Assessment (DAWBA) for evaluation of ICD-10 mental disorders. Odds Ratios (ORs), sensitivities, specificities, positive predictive values (PPVs) and negative predictive values (NPVs) were calculated for the SDQ predictive algorithms regarding ICD-10 diagnoses of hyperkinetic-inattentive-, behavioural-and emotional disorders. Significant ORs ranging from 2.3-36.5 were found for the SDQ predictive algorithms in relation to the corresponding diagnoses. The highest ORs were found for hyperkinetic and inattentive disorders, and the lowest for emotional disorders. Sensitivities ranging from 4.5-47.4, specificities ranging from 83.0-99.5, PPVs ranging from 5.0-45.5 and NPVs ranging from 90.6-99.0 were found for the SDQ predictive algorithms in relation to the diagnoses. The results support that the SDQ predictive algorithms are useful for screening at preschool-age to identify children at an increased risk of mental disorders in preadolescence. However, early screening with the SDQ predictive algorithms cannot stand alone, and repeated assessments of children are needed to identify, especially internalizing, mental health problems.	[Nielsen, Louise G.; Rimvall, Martin K.; Munkholm, Anj A.; Elberling, Hanne; Jeppesen, Pia] Mental Hlth Serv Capital Reg Denmark, Child & Adolescent Mental Hlth Ctr, Gentofte, Denmark; [Nielsen, Louise G.; Rimvall, Martin K.; Elberling, Hanne; Jeppesen, Pia] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Clemmensen, Lars] Reg Southern Denmark, Mental Hlth Serv, Ctr Telepsychiat, Odense, Denmark; [Clemmensen, Lars] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Munkholm, Anj A.] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Paediat & Adolescent Med, Copenhagen, Denmark; [Olsen, Else Marie] Capital Reg Denmark, Ctr Clin Res & Dis Prevent, Frederiksberg Hosp, Copenhagen, Denmark; [Olsen, Else Marie; Skovgaard, Anne Mette] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Rask, Charlotte Ulrikka] Psychiat Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Aarhus, Denmark; [Rask, Charlotte Ulrikka] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Skovgaard, Anne Mette] Univ Southern Denmark, Fac Hlth Sci, Natl Inst Publ Hlth, Odense, Denmark	University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark	Nielsen, LG (corresponding author), Mental Hlth Serv Capital Reg Denmark, Child & Adolescent Mental Hlth Ctr, Gentofte, Denmark.; Nielsen, LG (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.	louise.gunhard.nielsen.01@region.dk	Jeppesen, Pia/L-6716-2016; Rimvall, Martin Køster/AAJ-1488-2021	Jeppesen, Pia/0000-0003-2471-2929; Rimvall, Martin Køster/0000-0003-2627-5523; Clemmensen, Lars/0000-0002-1750-4649; Skovgaard, Anne Mette/0000-0002-8793-8303; Olsen, Else Marie/0000-0002-7240-9767	Lundbeckfonden [R197-2016-1730]; Trygfonden; Mental Health Services, Capital Region of Denmark	Lundbeckfonden(Lundbeckfonden); Trygfonden; Mental Health Services, Capital Region of Denmark	LGN received Grant number: R197-2016-1730 from Commercial Company: Lundbeckfonden, https://www.lundbeckfonden.com.AMS received funding from Commercial Company: Lundbeckfonden, https://www.lundbeckfonden.com.AMS received funding from Commercial Company: Trygfonden, https://www.trygfonden.dk.PJ received funding from Commercial Company: Mental Health Services, Capital Region of Denmark, https://www.regionh.dk/forskning-og-innovation/Sider/default.aspx.The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Arango C, 2018, LANCET PSYCHIAT, V5, P591, DOI 10.1016/S2215-0366(18)30057-9; Becker A, 2015, EUR CHILD ADOLES PSY, V24, P715, DOI 10.1007/s00787-014-0640-x; Brondbo Per Hakan, 2011, Child Adolesc Psychiatry Ment Health, V5, P32, DOI 10.1186/1753-2000-5-32; Caye A, 2016, JAMA PSYCHIAT, V73, P705, DOI 10.1001/jamapsychiatry.2016.0383; Close C, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0187-3; Copeland WE, 2013, J CHILD PSYCHOL PSYC, V54, P791, DOI 10.1111/jcpp.12062; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920; DOHRENWEND BP, 1990, SOC PSYCH PSYCH EPID, V25, P41; Elberling H, 2010, EUR CHILD ADOLES PSY, V19, P725, DOI 10.1007/s00787-010-0110-z; Fleitlich B, 2001, BRIT MED J, V323, P599, DOI 10.1136/bmj.323.7313.599; Glowinski AL, 2003, J CHILD PSYCHOL PSYC, V44, P988, DOI 10.1111/1469-7610.00183; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2004, EUR CHILD ADOLES PSY, V13, P25, DOI 10.1007/s00787-004-2005-3; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Heiervang E, 2008, J CHILD PSYCHOL PSYC, V49, P678, DOI 10.1111/j.1469-7610.2008.01882.x; Jeppesen P, 2015, J CHILD PSYCHOL PSYC, V56, P558, DOI 10.1111/jcpp.12319; Mathai J, 2004, AUST NZ J PSYCHIAT, V38, P639, DOI 10.1111/j.1440-1614.2004.01428.x; Maughan B, 2009, RUTTERS CHILD ADOLES, P160; Merikangas KR, 2009, DIAL CLIN NEUROSC, V11, P1; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; O'Connor C, 2018, EUR CHILD ADOLES PSY, V27, P289, DOI 10.1007/s00787-017-1044-5; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Olsen EM, 2007, PAEDIATR PERINAT EP, V21, P418, DOI 10.1111/j.1365-3016.2007.00851.x; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Raven D, 2017, EPIDEMIOL PSYCH SCI, V26, P177, DOI 10.1017/S2045796016000226; Rimvall MK, 2014, EUR CHILD ADOLES PSY, V23, P1051, DOI 10.1007/s00787-014-0546-7; Sawyer ACP, 2014, AUST NZ J PSYCHIAT, V48, P554, DOI 10.1177/0004867413514491; Skovgaard AM, 2005, SCAND J PUBLIC HEALT, V33, P197, DOI 10.1080/14034940510005662; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Van Lieshout RJ, 2015, PEDIATRICS, V135, P452, DOI 10.1542/peds.2014-3143; Verhulst FC, 1997, ACTA PSYCHIAT SCAND, V96, P75, DOI 10.1111/j.1600-0447.1997.tb09909.x; Vostanis P, 2006, CURR OPIN PSYCHIATR, V19, P367, DOI 10.1097/01.yco.0000228755.72366.05	40	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217707	10.1371/journal.pone.0217707	http://dx.doi.org/10.1371/journal.pone.0217707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158249	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700022
J	Ruckbeil, MV; Hilgers, RD; Heussen, N				Rueckbeil, Marcia Viviane; Hilgers, Ralf-Dieter; Heussen, Nicole			Randomization in survival studies: An evaluation method that takes into account selection and chronological bias	PLOS ONE			English	Article							CLINICAL-TRIALS; TEST DECISIONS; IMPACT	The random allocation of patients to treatments is a crucial step in the design and conduct of a randomized controlled trial. For this purpose, a variety of randomization procedures is available. In the case of imperfect blinding, the extent to which a randomization procedure forces balanced group sizes throughout the allocation process affects the predictability of allocations. As a result, some randomization procedures perform superior with respect to selection bias, whereas others are less susceptible to chronological bias. The choice of a suitable randomization procedure therefore depends on the expected risk for selection and chronological bias within the particular study in question. To enable a sound comparison of different randomization procedures, we introduce a model for the combined effect of selection and chronological bias in randomized studies with a survival outcome. We present an evaluation method to quantify the influence of bias on the test decision of the log-rank test in a randomized parallel group trial with a survival outcome. The effect of selection and chronological bias and the dependence on the study setting are illustrated in a sensitivity analysis. We conclude with a case study to showcase the application of our model for comparing different randomization procedures in consideration of the expected type I error probability.	[Rueckbeil, Marcia Viviane; Hilgers, Ralf-Dieter; Heussen, Nicole] Rhein Westfal TH Aachen, Dept Med Stat, Aachen, Germany; [Heussen, Nicole] Sigmund Freud Private Univ, Ctr Biostat & Epidemiol, Vienna, Austria	RWTH Aachen University	Ruckbeil, MV (corresponding author), Rhein Westfal TH Aachen, Dept Med Stat, Aachen, Germany.	mrueckbeil@ukaachen.de	Rückbeil, Marcia/P-1821-2018; Heussen, Nicole/Q-5309-2019; Hilgers, Ralf-Dieter/C-7090-2013	Rückbeil, Marcia/0000-0003-0277-1282; Heussen, Nicole/0000-0002-6134-7206; Hilgers, Ralf-Dieter/0000-0002-5945-1119	European Union [FP7 HEALTH 2013-602552]	European Union(European Commission)	MVR, RDH and NH have received funding from the European Union's 7th Framework Programme for research, technological development and demonstration under the grant agreement number FP7 HEALTH 2013-602552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger VW, 2016, STAT MED, V35, P685, DOI 10.1002/sim.6637; Berger VW, 2005, BIOMETRICAL J, V47, P119, DOI 10.1002/bimj.200410106; Berger VW, 2003, STAT MED, V22, P3017, DOI 10.1002/sim.1538; Berger VW, 2005, STAT PRACTICE; BLACKWELL D, 1957, ANN MATH STAT, V28, P449, DOI 10.1214/aoms/1177706973; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Canadian Task Force on the periodic Health Examination, 1979, PER HLTH EX, V121, P1193; Chen YP, 1999, STOCH MODEL, V15, P953; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Collett D, 2003, CHAPMAN HALL CRC TEX; COX DR, 1972, J R STAT SOC B, V34, P187; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; EMBURY SH, 1977, WESTERN J MED, V126, P267; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Hilgers RD, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0428-z; Hopper AN, 2007, POSTGRAD MED J, V83, P777, DOI 10.1136/pgmj.2007.057190; ICH Topic E8, 1998, GEN CONS CLIN TRIALS; International Council on harmonisation of technical requirements for pharmaceuticals for human use (ICH), 1998, STAT PRINC CLIN TRIA; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; Kennes LN, 2011, STAT MED, V30, P2573, DOI 10.1002/sim.4279; Langer S., 2014, MODIFIED DISTRIBUTIO; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MATTS JP, 1978, J CHRON DIS, V31, P725, DOI 10.1016/0021-9681(78)90057-7; Nunan D, 2018, BMJ EVID-BASED MED, V23, P20, DOI 10.1136/ebmed-2017-110882; PROSCHAN M, 1994, STAT SINICA, V4, P219; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenberger WF, 2015, WILEY SERIES PROBABI; Ruckbeil MV, 2017, STAT MED, V36, P2656, DOI 10.1002/sim.7299; Schindler D, 2016, RANDOMIZER RANDOMIZA; SCHOENFELD D, 1981, BIOMETRIKA, V68, P316, DOI 10.1093/biomet/68.1.316; Senn SS, 2008, STAT PRACTICE; Senn S, 2013, STAT MED, V32, P1439, DOI 10.1002/sim.5713; SOARES JF, 1983, COMMUN STAT-THEOR M, V12, P2017, DOI 10.1080/03610928308828586; Spencer EA, 2017, CATALOGUE BIAS; Tamm M, 2014, METHOD INFORM MED, V53, P501, DOI 10.3414/ME14-01-0048; Tamm M, 2012, METHOD INFORM MED, V51, P138, DOI 10.3414/ME11-01-0043; Uschner D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192065	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217946	10.1371/journal.pone.0217946	http://dx.doi.org/10.1371/journal.pone.0217946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158260	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700036
J	Semites, K; Kolilekas, L; Vamvakaris, I; Gkogkou, C; Filippousis, P; Gaga, M; Zervas, E				Semites, Konstantinos; Kolilekas, Lykourgos; Vamvakaris, Ioannis; Gkogkou, Charalampos; Filippousis, Petros; Gaga, Mina; Zervas, Eleftherios			Introducing transbronchial cryobiopsies in diagnosing diffuse parenchymal lung diseases in Greece: Implementing training into clinical practice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BIOPSY; YIELD; STATEMENT; SAFETY; STANDARDIZATION; COMPLICATIONS; GUIDELINES	Introduction Diffuse parenchymal lung diseases (DPLD) constitute a heterogeneous group of disorders, sometimes requiring surgical lung biopsies (SLB) to obtain a definite diagnosis. Transbronchial cryobiopsy (TBCB) is a new promising interventional bronchoscopic method of obtaining lung tissue that is gaining ground against SLB. Methods Fifty consecutive patients with indeterminate DPLD (definite/possible UIP excluded), after expert panel review referral, were retrospectively analyzed from January 2016 to August 2018. Patients underwent TBCB under deep sedation with endotracheal intubation and spontaneous breathing at a single, tertiary-care, reference hospital. Results A total of 110 TBCBs (2.7 per patient, range 1 to 4) were performed. Frequent complications included mild pneumothorax in 5 patients (10%), requiring only oxygen supplementation, and bleeding in 31 patients (62%) that was mild in 19 patients and moderate in 12 patients. No serious bleeding was observed. There was zero mortality and no serious adverse events. Adequate samples for diagnostic purposes were obtained in 46 patients (92%) and pathologic histologic diagnosis was reached in 40 patients (80%). The most frequent histopathological patterns were organizing pneumonia (OP) (25%) and non-specific interstitial pneumonia (NSIP) (15%). After an expert panel review of all cases a final diagnosis was achieved in 38 patients, corresponding to a diagnostic yield of 76% for TBCB. Conclusion Our single center cohort demonstrates that establishing TBCBs as a new technique is safe and feasible after proper training in specialized centers, resulting in low complication rates and adequate diagnostic yields.	[Semites, Konstantinos; Kolilekas, Lykourgos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Resp Med Dept, Athens, Greece; [Semites, Konstantinos; Kolilekas, Lykourgos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Asthma Ctr, Athens, Greece; [Semites, Konstantinos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Cent Bronchoscopy Unit, Athens, Greece; [Vamvakaris, Ioannis] Athens Chest Hosp Sotiria, Pathol Dept, Athens, Greece; [Gkogkou, Charalampos] HistoBioDiag Lab, Pathol Dept, Athens, Greece; [Filippousis, Petros] Athens Chest Hosp Sotiria, Dept Med Imaging & Intervent Radiol, Athens, Greece		Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Resp Med Dept, Athens, Greece.; Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Asthma Ctr, Athens, Greece.; Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Cent Bronchoscopy Unit, Athens, Greece.	lefzervas@yahoo.gr	Gaga, Mina/AAP-8348-2020	Zervas, Eleftherios/0000-0001-7436-4550				Aragaki-Nakahodo AA, 2017, RESP MED, V131, P65, DOI 10.1016/j.rmed.2017.08.003; Babiak A, 2009, RESPIRATION, V78, P203, DOI 10.1159/000203987; Bango-Alvarez Antonio, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00148-2016; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Berbescu EA, 2006, CHEST, V129, P1126, DOI 10.1378/chest.129.5.1126; Bondue B, 2017, PULM MED, V2017, DOI 10.1155/2017/6794343; Casoni GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086716; Colby TV, 2017, ARCH PATHOL LAB MED, V141, P891, DOI 10.5858/arpa.2016-0233-RA; DiBardino DM, 2017, ANN AM THORAC SOC, V14, P851, DOI 10.1513/AnnalsATS.201610-829OC; Drakopanagiotakis F, 2011, CHEST, V139, P893, DOI 10.1378/chest.10-0883; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Ganganah O, 2016, RESPIROLOGY, V21, P834, DOI 10.1111/resp.12770; Griff S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-171; Hagmeyer L, 2016, CLIN RESPIR J, V10, P589, DOI 10.1111/crj.12261; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Hernandez-Gonzalez F, 2015, ARCH BRONCONEUMOL, V51, P261, DOI 10.1016/j.arbres.2014.09.009; Hetzel J, 2018, RESPIRATION, V95, P188, DOI 10.1159/000484055; Hohberger LA, 2014, RESPIRATION, V88, P521, DOI 10.1159/000368616; Huang Steven K, 2008, Expert Opin Med Diagn, V2, P183, DOI 10.1517/17530059.2.2.183; Hutchinson JP, 2016, EUR RESPIR J, V48, P1453, DOI 10.1183/13993003.00378-2016; Iftikhar IH, 2017, ANN AM THORAC SOC, V14, P1197, DOI 10.1513/AnnalsATS.201701-086SR; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Kronborg-White S, 2017, EUR CLIN RESPIR J, V4, P1, DOI 10.1080/20018525.2016.1274099; Kropski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078674; Lentz RJ, 2017, J THORAC DIS, V9, P2186, DOI 10.21037/jtd.2017.06.96; Lynch DA, 2018, LANCET RESP MED, V6, P138, DOI 10.1016/S2213-2600(17)30433-2; Marcoa R, 2017, REV PORT PNEUMOL, V23, P296, DOI 10.1016/j.rppnen.2017.07.002; MILMAN N, 1994, RESP MED, V88, P749, DOI 10.1016/S0954-6111(05)80197-0; MOLIN LJ, 1994, ANN THORAC SURG, V58, P1595, DOI 10.1016/0003-4975(94)91638-1; Pajares V, 2014, RESPIROLOGY, V19, P900, DOI 10.1111/resp.12322; Poletti V, 2016, CURR OPIN PULM MED, V22, P289, DOI 10.1097/MCP.0000000000000272; Poletti V, 2015, RESPIRATION, V90, P275, DOI 10.1159/000439313; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raj R, 2016, AM J RESP CRIT CARE, V193, P1082, DOI 10.1164/rccm.201512-2488ED; Raparia K, 2016, ARCH PATHOL LAB MED, V140, P1281, DOI 10.5858/arpa.2016-0258-SA; Ravaglia C, 2017, RESPIRATION, V93, P285, DOI 10.1159/000456671; Ravaglia C, 2016, RESPIRATION, V91, P215, DOI 10.1159/000444089; Riario Sforza Gian Galeazzo, 2017, Clin Mol Allergy, V15, P6, DOI 10.1186/s12948-017-0062-7; Sharp C, 2017, CHEST, V151, P512, DOI 10.1016/j.chest.2016.10.060; Thomeer M, 2001, EUR RESPIR J, V32, P114, DOI DOI 10.1016/S1010-7940(01)00915-0; Tomassetti S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-96; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217554	10.1371/journal.pone.0217554	http://dx.doi.org/10.1371/journal.pone.0217554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158264	gold, Green Submitted, Green Published			2022-12-27	WOS:000469915700020
J	Foster, KL; Kern, KD; Chambers, TM; Lupo, PJ; Kamdar, KY; Scheurer, ME; Brown, AL				Foster, Kayla L.; Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.			Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis	PLOS ONE			English	Article							BODY-MASS INDEX; ADULT SURVIVORS; CHILDHOOD-CANCER; UNITED-STATES; OBESITY; CHILDREN; PREVALENCE; OVERWEIGHT; PREDICTORS; ADOLESCENTS	Background As survival rates for childhood acute lymphoblastic leukemia (ALL) continue to improve, there is growing concern over the chronic health conditions that survivors face. Given that survivors of childhood ALL are at increased risk of cardiovascular complications and obesity, we sought to characterize BMI trends from diagnosis through early survivorship in a multi-ethnic, contemporary cohort of childhood ALL patients and determine if early weight change was predictive of long-term weight status. Methods The study population consisted of ALL patients aged 2-15 years at diagnosis who were treated with chemotherapy alone at Texas Children's Hospital. Each patient had BMI z-scores collected at diagnosis, 30-days post-diagnosis, and annually for five years. Linear regression models were estimated to evaluate the association between: 1) BMI z-score change in the first 30 days and BMI z-scores at five-years post-diagnosis; and 2) BMI zscore change in the first year post-diagnosis and BMI z-scores at five-years post-diagnosis. Results This retrospective cohort study included longitudinal data from 121 eligible patients. The mean BMI z-scores for the population increased significantly (p-value< 0.001) from baseline (mean = 0.25) to 30 days post-diagnosis (mean = 1.17) before plateauing after one year post-diagnosis (mean = 0.99). Baseline BMI z-scores were statistically significant predictors to five year BMI z-scores (p < 0.001). Independent of baseline BMI z-score and other clinical factors, the BMI z-score at one year post-diagnosis was significantly associated with BMI z-score at five-years post-diagnosis (beta = 0.63, p < 0.001), while BMI z-score at 30 days postdiagnosis was not (beta = 0.10, p = 0.23). Conclusion Our results suggest that weight gain within the first year after diagnosis is more strongly associated with long-term BMI than early weight gain (within 30 days). If confirmed, this information may help identify a window of time during therapy when ALL patients would benefit most from weight management directed interventions.	[Foster, Kayla L.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.] Baylor Coll Med, Houston, TX 77030 USA; [Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.] Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA	St Jude Children's Research Hospital; Baylor College of Medicine; Texas Children's Cancer Center	Brown, AL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Brown, AL (corresponding author), Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA.	Austin.Brown@bcm.edu	Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; Scheurer, Michael/0000-0002-8379-6088	National Institutes of Health National Cancer Institute [K07 CA218362]; Leukemia & Lymphoma Society Translational Research Program [6314-11]; Leukemia Research Foundation Hollis Brownstein Research Grants Program; St. Baldrick's Foundation Consortium Grant; NATIONAL CANCER INSTITUTE [K07CA218362] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Leukemia Research Foundation Hollis Brownstein Research Grants Program; St. Baldrick's Foundation Consortium Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health National Cancer Institute (K07 CA218362 to A.L.B.); Leukemia & Lymphoma Society Translational Research Program (6314-11 to K.Y.K.); Leukemia Research Foundation Hollis Brownstein Research Grants Program (to A.L.B); St. Baldrick's Foundation Consortium Grant (to P.J.L). The funders listed had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Belle FN, 2018, CANCER-AM CANCER SOC, V124, P3576, DOI 10.1002/cncr.31599; Brown AL, 2016, J PEDIAT HEMATOL ONC, V38, P429, DOI 10.1097/MPH.0000000000000555; Browne EK, 2018, CANCER-AM CANCER SOC, V124, P4248, DOI 10.1002/cncr.31736; Butturini AM, 2007, J CLIN ONCOL, V25, P2063, DOI 10.1200/JCO.2006.07.7792; Chow EJ, 2007, CANCER-AM CANCER SOC, V110, P2313, DOI 10.1002/cncr.23050; Collins L, 2010, J PEDIAT HEMATOL ONC, V32, pE304, DOI 10.1097/MPH.0b013e3181ece2bb; Dores GM, 2012, BLOOD, V119, P34, DOI 10.1182/blood-2011-04-347872; Esbenshade AJ, 2013, PEDIATR BLOOD CANCER, V60, P1287, DOI 10.1002/pbc.24489; Esbenshade AJ, 2011, PEDIATR BLOOD CANCER, V56, P372, DOI 10.1002/pbc.22782; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Irizarry KA, 2014, PEDIATR ANN, V43, P210, DOI 10.3928/00904481-20140825-07; Jansen H, 2009, SUPPORT CARE CANCER, V17, P103, DOI 10.1007/s00520-008-0531-0; Love E, 2011, PEDIATR BLOOD CANCER, V57, P1204, DOI 10.1002/pbc.23010; Ness KK, 2015, BLOOD, V125, P3411, DOI 10.1182/blood-2015-01-621680; Ness KK, 2009, CANCER-AM CANCER SOC, V115, P1984, DOI 10.1002/cncr.24209; Nottage KA, 2014, BRIT J HAEMATOL, V165, P364, DOI 10.1111/bjh.12754; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Orgel E, 2016, AM J CLIN NUTR, V103, P808, DOI 10.3945/ajcn.115.124586; Pakakasama S, 2010, INT J HEMATOL, V91, P850, DOI 10.1007/s12185-010-0594-9; Prevention CfDCa, 2010, 2000 CDC GROWTH CHAR; Prevention CfDCa, 2011, OV OB; Razzouk BI, 2007, J CLIN ONCOL, V25, P1183, DOI 10.1200/JCO.2006.07.8709; Reilly JJ, 2001, J CLIN ENDOCR METAB, V86, P3742, DOI 10.1210/jc.86.8.3742; Sklar CA, 2000, MED PEDIATR ONCOL, V35, P91, DOI 10.1002/1096-911X(200008)35:2<91::AID-MPO1>3.0.CO;2-G; United States Cancer Statistics, 2017, 1999 2014 INC MORT W; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Withycombe JS, 2009, PEDIATR BLOOD CANCER, V53, P1249, DOI 10.1002/pbc.22237; Zhang F. F., 2015, PEDIAT BLOOD CANC; Zhang FF, 2014, PEDIATR BLOOD CANCER, V61, P1263, DOI 10.1002/pbc.24960; Zhang FF, 2014, PEDIATRICS, V133, pE704, DOI 10.1542/peds.2013-3332	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							0217932	10.1371/journal.pone.0217932	http://dx.doi.org/10.1371/journal.pone.0217932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150521	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100129
J	Ksenofontov, AL; Fedorova, NV; Badun, GA; Serebryakova, MV; Nikitin, NA; Evtushenko, EA; Chernysheva, MG; Bogacheva, EN; Dobrov, EN; Baratova, LA; Atabekov, JG; Karpova, OV				Ksenofontov, Alexander L.; Fedorova, Natalia, V; Badun, Gennady A.; Serebryakova, Marina, V; Nikitin, Nikolai A.; Evtushenko, Ekaterina A.; Chernysheva, Maria G.; Bogacheva, Elena N.; Dobrov, Eugeny N.; Baratova, Ludmila A.; Atabekov, Joseph G.; Karpova, Olga, V			Surface characterization of the thermal remodeling helical plant virus	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; POTATO-VIRUS; COAT PROTEIN; SPHERICAL-PARTICLES; SPATIAL-ORGANIZATION; TRITIUM PLANIGRAPHY; BACTERIORHODOPSIN; TRANSITION; VIRIONS; VACCINE	Previously, we have reported that spherical particles (SPs) are formed by the thermal remodeling of rigid helical virions of native tobacco mosaic virus (TMV) at 94 degrees C. SPs have remarkable features: stability, unique adsorption properties and immunostimulation potential. Here we performed a comparative study of the amino acid composition of the SPs and virions surface to characterize their properties and take an important step to understanding the structure of SPs. The results of tritium planigraphy showed that thermal transformation of TMV leads to a significant increase in tritium label incorporation into the following sites of SPs protein: 41-71 .a. and 93-122 a.a. At the same time, there was a decrease in tritium label incorporation into the N- and C-terminal region (1-15 a.a., 142-158 a.a). The use of complementary physico-chemical methods allowed us to carry out a detailed structural analysis of the surface and to determine the most likely surface areas of SPs. The obtained data make it possible to consider viral protein thermal rearrangements, and to open new opportunities for biologically active complex design using information about SPs surface amino acid composition and methods of non-specific adsorption and bioconjugation.	[Ksenofontov, Alexander L.; Fedorova, Natalia, V; Serebryakova, Marina, V; Dobrov, Eugeny N.; Baratova, Ludmila A.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Badun, Gennady A.; Chernysheva, Maria G.] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Nikitin, Nikolai A.; Evtushenko, Ekaterina A.; Atabekov, Joseph G.; Karpova, Olga, V] Lomonosov Moscow State Univ, Dept Virol, Moscow, Russia; [Bogacheva, Elena N.] Russian Acad Sci, Semenov Inst Chem Phys, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences	Ksenofontov, AL (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.; Nikitin, NA (corresponding author), Lomonosov Moscow State Univ, Dept Virol, Moscow, Russia.	ksenofon@belozersky.msu.ru; nikitin@mail.bio.msu.ru	Chernysheva, Maria G/L-5404-2018; Badun, Gennadii A/D-3492-2015; Ksenofontov, Alexander L/D-6747-2012; Evtushenko, Ekaterina A./H-6989-2013; Ksenofontov, Alexander/AAH-1774-2021; Karpova, Olga V/H-2475-2013; Serebryakova, Marina/E-2986-2012; Chernysheva, Maria G./J-2945-2013; Nikitin, Nikolai/D-6520-2013	Chernysheva, Maria G/0000-0001-5040-9937; Badun, Gennadii A/0000-0002-9792-8432; Ksenofontov, Alexander L/0000-0003-1585-7907; Evtushenko, Ekaterina A./0000-0002-0679-6818; Ksenofontov, Alexander/0000-0003-1585-7907; Karpova, Olga V/0000-0002-0605-9033; Serebryakova, Marina/0000-0002-5402-8215; Chernysheva, Maria G./0000-0001-5040-9937; Nikitin, Nikolai/0000-0001-9626-2336	Russian Science Foundation [18-1400044]; Russian Foundation for Basic Research (RFBR) [RFBR-18-04-00525-a]; Russian Science Foundation [18-14-00044] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported in part by Russian Science Foundation project No. 18-1400044, https://grant.rscf.ru, (N.A.N., E.A.E., J.G.A, O.V.K); Russian Foundation for Basic Research (RFBR) project No. RFBR-18-04-00525-a, https://kias.rfbr.ru, (A.L.K., N.V.F., G.A.B., E.N.B., E.N.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 1997, P NATL ACAD SCI USA, V94, P12892, DOI 10.1073/pnas.94.24.12892; Atabekov JG, 2016, MOSCOW U BIOL SCI B, V70, P177, DOI [10.3103/s0096392515040045, DOI 10.3103/S0096392515040045]; Atabekov J, 2011, J GEN VIROL, V92, P453, DOI 10.1099/vir.0.024356-0; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Bruckman MA, 2016, J CONTROL RELEASE, V231, P103, DOI 10.1016/j.jconrel.2016.02.045; Dobrov EN, 2003, EUR J BIOCHEM, V270, P3300, DOI 10.1046/j.1432-1033.2003.03680.x; Dobrov EN, 2014, J BIOMOL STRUCT DYN, V32, P701, DOI 10.1080/07391102.2013.788983; Fraenkel-Conrat H, 1999, PHILOS T ROY SOC B, V354, P583, DOI 10.1098/rstb.1999.0409; Gol'danskii V I, 1982, Mol Biol (Mosk), V16, P528; GOLDANSKII VI, 1988, J MOL BIOL, V201, P567, DOI 10.1016/0022-2836(88)90638-9; Karpova O, 2012, J GEN VIROL, V93, P400, DOI 10.1099/vir.0.036293-0; Kondakova O. A., 2017, Sel'skokhozyaistvennaya Biologiya, P731, DOI 10.15389/agrobiology.2017.4.731rus; Kordyukova LV, 2001, BIOSCIENCE REP, V21, P711, DOI 10.1023/A:1015572321508; Ksenofontov AL, 2018, J BIOMOL STRUCT DYN, V36, P1728, DOI 10.1080/07391102.2017.1333457; Ksenofontov AL, 2016, J BIOMOL STRUCT DYN, V34, P250, DOI 10.1080/07391102.2015.1022604; Ksenofontov AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067830; Lukashina E, 2012, MOL PLANT PATHOL, V13, P38, DOI 10.1111/j.1364-3703.2011.00725.x; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; Nikitin NA, 2018, DATA BRIEF, V21, P1504, DOI 10.1016/j.dib.2018.10.102; Nikitin NA, 2018, DATA BRIEF, V21, P742, DOI 10.1016/j.dib.2018.10.030; Nikitin NA, 2018, REGUL TOXICOL PHARM, V97, P127, DOI 10.1016/j.yrtph.2018.06.010; Nikitin N. A., 2016, Moscow University Biological Sciences Bulletin, V71, P128, DOI 10.3103/S0096392516030081; Nikitin N, 2016, FEBS LETT, V590, P1543, DOI 10.1002/1873-3468.12184; Nikitin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142415; Nikitin N, 2013, MICROSC MICROANAL, V19, P808, DOI 10.1017/S1431927613000597; Shishkov A, 2011, FEBS J, V278, P4905, DOI 10.1111/j.1742-4658.2011.08392.x; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shishkov AV, 2002, BIOELECTROCHEMISTRY, V56, P147, DOI 10.1016/S1567-5394(02)00018-X; Trifonova EA, 2016, MOSCOW U BIOL SCI B, V70, P194, DOI [10.3103/s0096392515040094, DOI 10.3103/S0096392515040094]; Trifonova E, 2014, J BIOMOL STRUCT DYN, V32, P1193, DOI 10.1080/07391102.2013.816868; Trifonova EA, 2017, ANTIVIR RES, V144, P27, DOI 10.1016/j.antiviral.2017.05.006; Trofimova L, 2016, CURR ANAL CHEM, V12, P349, DOI 10.2174/1573411011666151006220356; TSETLIN VI, 1988, EUR J BIOCHEM, V178, P123, DOI 10.1111/j.1432-1033.1988.tb14437.x; TSUGITA A, 1982, EUR J BIOCHEM, V124, P585, DOI 10.1111/j.1432-1033.1982.tb06634.x	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216905	10.1371/journal.pone.0216905	http://dx.doi.org/10.1371/journal.pone.0216905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150411	gold, Green Published			2022-12-27	WOS:000469759100026
J	Lee, GB; Woo, H; Lee, SY; Cheon, SM; Kim, JW				Lee, Geum-Bong; Woo, Hyunhee; Lee, Su-Yoon; Cheon, Sang-Myung; Kim, Jae Woo			The burden of care and the understanding of disease in Parkinson's disease	PLOS ONE			English	Article							PATIENT EDUCATION-PROGRAM; QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; CAREGIVER BURDEN; KNOWLEDGE; ATTITUDES	Background and objective Education of disease plays an important role in management of Parkinson's disease (PD). However, little is known about the link between the understanding of disease and the burden of care. This study was carried out to find the correlation between the burden of care and the understanding of disease in caregivers for PD patients. Methods Non-demented patients with PD and their caregivers participated in structured interviews. Understanding of patients and caregivers was evaluated through newly-devised questions. The caregiver burden inventory was used to assess the burden of care. Results A total of 142 pairs of patients and their caregivers were recruited. A correlation analysis showed that the burden of care was positively associated with low understanding of the disease by the caregiver. Daily care time and female patients were revealed to be independently associated with the burden of care through a multivariate analysis. Further analyses were performed in the caregiver group according to relationship with patients. The spouse group showed an increased burden of care and poor understanding compared to the offspring group. A multivariate analysis revealed that daily care time and understanding were independent predictors for the burden of care in the spouse group. There was no significant association in the offspring group. Conclusion The burden of care was associated with higher daily caregiving time and female gender of the patient, and was significantly increased in the spouse of the patient. In the spouse group, better understanding of the caregiver correlated with less burden of care.	[Lee, Geum-Bong; Cheon, Sang-Myung; Kim, Jae Woo] Dong A Univ, Dept Neurol, Sch Med, Busan, South Korea; [Woo, Hyunhee] Dongju Coll, Dept Nursing, Busan, South Korea; [Lee, Su-Yoon] Pohang S Hosp, Dept Neurol, Pohang, South Korea	Dong A University	Cheon, SM (corresponding author), Dong A Univ, Dept Neurol, Sch Med, Busan, South Korea.	smcheon@dau.ac.kr			Dong-A University Research Fund	Dong-A University Research Fund	This study was supported by Dong-A University Research Fund to SMC. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	A'Campo LEI, 2011, INT J CLIN PRACT, V65, P1173, DOI 10.1111/j.1742-1241.2011.02765.x; A'Campo LEI, 2010, PARKINSONISM RELAT D, V16, P89, DOI 10.1016/j.parkreldis.2009.07.009; Baik JS, 2017, J MOV DISORD, V10, P109, DOI 10.14802/jmd.17053; Bhidayasiri R, 2014, NEUROLOGY, V82, P2238, DOI 10.1212/WNL.0000000000000515; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cheon SM, 2008, PARKINSONISM RELAT D, V14, P286, DOI 10.1016/j.parkreldis.2007.09.002; Dahodwala N, 2018, NEUROLOGY, V90, pE48, DOI 10.1212/WNL.0000000000004764; Gallagher DA, 2010, MOVEMENT DISORD, V25, P2493, DOI 10.1002/mds.23394; Grun D, 2016, J AM MED DIR ASSOC, V17, P626, DOI 10.1016/j.jamda.2016.03.004; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jitkritsadakul O, 2017, J NEUROL SCI, V374, P69, DOI 10.1016/j.jns.2016.12.063; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Macht M, 2007, PATIENT EDUC COUNS, V65, P245, DOI 10.1016/j.pec.2006.08.005; Martinez-Martin P, 2012, EXPERT REV PHARM OUT, V12, P221, DOI [10.1586/erp.11.106, 10.1586/ERP.11.106]; Mosley PE, 2017, J GERIATR PSYCH NEUR, V30, P235, DOI 10.1177/0891988717720302; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Pan S, 2014, J CROSS-CULT GERONTO, V29, P339, DOI 10.1007/s10823-014-9233-x; Santos-Garcia D, 2013, J NEUROL SCI, V332, P136, DOI 10.1016/j.jns.2013.07.005; Shin H, 2012, EUR NEUROL, V67, P292, DOI 10.1159/000335577; Terayama H, 2018, PSYCHOGERIATRICS, V18, P327, DOI 10.1111/psyg.12337; Walton E., 2003, J FAMILY SOCIAL WORK, V7, P1	21	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217581	10.1371/journal.pone.0217581	http://dx.doi.org/10.1371/journal.pone.0217581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150470	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100069
J	Parigi, A; Porter, C; Cermak, M; Pitchers, WR; Dworkin, I				Parigi, Abhijna; Porter, Cody; Cermak, Megan; Pitchers, William R.; Dworkin, Ian			The behavioral repertoire of Drosophila melanogaster in the presence of two predator species that differ in hunting mode	PLOS ONE			English	Article							JUMPING SPIDERS; TENODERA-ARIDIFOLIA; FORAGING BEHAVIOR; PRAYING-MANTIS; ARANEAE; PREY; SALTICIDAE; ECOLOGY; RISK; COMMUNITIES	The fruit fly, Drosophila melanogaster, has proven to be an excellent model organism for genetic, genomic and neurobiological studies. However, relatively little is known about the natural history of D. melanogaster. In particular, neither the natural predators faced by wild populations of D. melanogaster, nor the anti-predatory behaviors they may employ to escape and avoid their enemies have been documented. Here we observe and describe the influence of two predators that differ in their mode of hunting: zebra jumping spiders, Salticus scenicus (active hunters) and Chinese praying mantids, Tenodera sinensis (ambush predators) on the behavioral repertoire of Drosophila melanogaster. We documented three particularly interesting behaviors: abdominal lifting, stopping, and retreat-which were performed at higher frequency by D. melanogaster in the presence of predators. While mantids had only a modest influence on the locomotory activity of D. melanogaster, we observed a significant increase in the overall activity of D. melanogaster in the presence of jumping spiders. Finally, we observed considerable among-individual behavioral variation in response to both predators.	[Parigi, Abhijna; Pitchers, William R.; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Parigi, Abhijna; Porter, Cody; Cermak, Megan; Dworkin, Ian] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Parigi, Abhijna; Pitchers, William R.; Dworkin, Ian] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Parigi, Abhijna] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Porter, Cody] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Cermak, Megan] Nationwide Childrens Hosp, Columbus, OH USA; [Pitchers, William R.] Univ Melbourne, Microbiol Diagnost Unit, Publ Hlth Lab, Melbourne, Vic, Australia; [Dworkin, Ian] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Michigan State University; Michigan State University; Michigan State University; University of California System; University of California Davis; University of Wyoming; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Melbourne; McMaster University	Parigi, A (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	abhijna.parigi@gmail.com		Dworkin, Ian/0000-0002-2874-287X	BEACON via the National Science Foundation [DBI-0939454]	BEACON via the National Science Foundation	The funding was awarded to ID by BEACON via the National Science Foundation under Cooperative Agreement No. DBI-0939454. https://nsf. gov/; https://www3.beacon-center.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAN GC, 1993, ANIM BEHAV, V46, P233, DOI 10.1006/anbe.1993.1185; Bakeman R., 1997, OBSERVING INTERACTIO; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Brown GE, 1999, ANIM BEHAV, V58, P469, DOI 10.1006/anbe.1999.1173; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; Ceccarelli FS, 2008, J ARACHNOL, V36, P344, DOI 10.1636/CSt07-114.1; Chabaud MA, 2009, CURR BIOL, V19, P1654, DOI 10.1016/j.cub.2009.08.017; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; DILL LM, 1975, CAN J ZOOL, V53, P1284, DOI 10.1139/z75-153; Edmunds M., 1974, DEFENCE ANIMALS; ESCALANTE A, 1990, BIOTROPICA, V22, P48, DOI 10.2307/2388718; FITZGIBBON CD, 1988, BEHAV ECOL SOCIOBIOL, V23, P69, DOI 10.1007/BF00299889; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; FORSTER LM, 1979, NEW ZEAL J ZOOL, V6, P79, DOI 10.1080/03014223.1979.10428351; FREED AN, 1984, J ZOOL, V203, P49; Gosline AK, 2008, AQUAT ECOL, V42, P693, DOI 10.1007/s10452-007-9138-7; Harland DP, 1999, J ZOOL, V247, P357, DOI 10.1111/j.1469-7998.1999.tb00998.x; Harrington B., 2004, INKSCAPE; Herberholz J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00125; HILL D, 1988, J WILDLIFE MANAGE, V52, P446, DOI 10.2307/3801588; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; HORNER NV, 1988, J ARACHNOL, V16, P260; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; IWASAKI T, 1990, J ETHOL, V8, P75, DOI 10.1007/BF02350277; Iwasaki Taku, 1998, Entomological Science, V1, P529; Jackson CH, 2011, J STAT SOFTW, V38, P1; JACKSON RR, 1982, J EXP BIOL, V97, P441; JACKSON RR, 1982, ZOOL J LINN SOC-LOND, V76, P293, DOI 10.1111/j.1096-3642.1982.tb02185.x; Jensen P, 2014, ANNU REV ANIM BIOSCI, V2, P85, DOI 10.1146/annurev-animal-022513-114135; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; LAND MF, 1971, J EXP BIOL, V54, P119; Langerhans R. Brian, 2007, P177, DOI 10.1007/978-3-540-46046-6_10; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Lefranc A, 2001, CR ACAD SCI III-VIE, V324, P219, DOI 10.1016/S0764-4469(00)01297-X; Levine JD, 2004, CURR OPIN CELL BIOL, V16, P210, DOI 10.1016/j.ceb.2004.02.009; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mercier JL, 1997, BEHAV PROCESS, V41, P39, DOI 10.1016/S0376-6357(97)00026-0; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Okuyama T, 2007, APPL ENTOMOL ZOOL, V42, P663, DOI 10.1303/aez.2007.663; Polak M, 1998, P ROY SOC B-BIOL SCI, V265, P2197, DOI 10.1098/rspb.1998.0559; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; PRETE FR, 1990, J INSECT PHYSIOL, V36, P561, DOI 10.1016/0022-1910(90)90024-A; Prete FR, 1991, PRAYING MANTIDS 93 1, P93; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Sansom A, 2009, BEHAV ECOL, V20, P1168, DOI 10.1093/beheco/arp110; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHROTH KE, 1991, ORNIS SCAND, V22, P249, DOI 10.2307/3676598; SPIETH HT, 1952, B AM MUS NAT HIST, V99, P401; Wilfert L, 2014, MOL ECOL, V23, P2093, DOI 10.1111/mec.12709; Wong BBM, 2005, BEHAV ECOL SOCIOBIOL, V58, P345, DOI 10.1007/s00265-005-0955-1; WORTHEN WB, 1989, ECOL ENTOMOL, V14, P117, DOI 10.1111/j.1365-2311.1989.tb00761.x; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103	65	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216860	10.1371/journal.pone.0216860	http://dx.doi.org/10.1371/journal.pone.0216860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150415	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100025
J	Lino, VTS; Rodrigues, NCP; Andrade, MKD; Reis, IND; Lopes, LAE; Atie, S				Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; de Noronha Andrade, Monica Kramer; de Carvalho Reis, Ines Nascimento; Elias Lopes, Lucilia Almeida; Atie, Soraya			Association between visual problems, insufficient emotional support and urinary incontinence with disability in elderly people living in a poor district in Rio de Janeiro, Brazil: A six-year follow-up study	PLOS ONE			English	Article							METROPOLITAN BELO-HORIZONTE; MENTAL-STATE-EXAMINATION; MINAS-GERAIS STATE; OLDER-ADULTS; FUNCTIONAL DISABILITY; SOCIAL SUPPORT; RISK-FACTORS; INCIDENT DISABILITY; GENDER-DIFFERENCES; HEALTH	Introduction Disability follows the rapid rate of population ageing, imposing a huge burden on society. Functional assessment in older people can identify predictors of disability. Objective Analyze the incidence and the risk factors for disability in activities of daily living (ADL) and instrumental activities of daily living (IADL) in older adults over six years. Methods Six year-follow up study initiated in 2010. The baseline non-probabilistic sample consisted of 180 independent community dwelling individuals aged 60 and over. The procedures comprised an interview with sociodemographic data, questions about falls, urinary incontinence, self-rated health, and assessment of ADL, IADL, mobility, depression, vision, hearing, cognition, nutrition, grip strength and social support. The second research was carried out by telephone and assessed ADL and IADL. Logistic regression models calculated the odds of disability in ADL and IADL according to the age, sex and all other variables. Results At six-year follow-up, 118 participants were still alive (65.6%), 31 died (17%) and other 31 were missed (17%). The incidence of disability to performADL and IADL were 25.4% and 32.3%, respectively. The regression logistic models revealed thaturinary incontinence (OR = 3.2; P = 0.03) and insufficient emotional support (OR = 3.8; P = 0.04) were associated with ADL disability, while visual problems (OR: 2.9; P = 0.03) and insufficient emotional support (OR: 5.6; P = 0.01) were associated with IADL disability. Conclusion The current study has identified that insufficient emotional support, visual problems and urinary incontinence are associated with disability in older adults. The routine assessment of these problems in the primary care clinics enable the implementation of strategies aimed at reducing or postponing disability. Educating patients and families will also enable better choices to reduce the risk of functional decline.	[Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; de Noronha Andrade, Monica Kramer; de Carvalho Reis, Ines Nascimento; Elias Lopes, Lucilia Almeida; Atie, Soraya] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Lino, VTS (corresponding author), Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil.	valerialino@ensp.fiocruz.br	Lino, Valeria/ADI-4254-2022	Saraiva Lino, Valeria Teresa/0000-0002-3087-5778	Rio de Janeiro's Municipal Health Secretariat [ENSP-043-PPE-14-2-12]	Rio de Janeiro's Municipal Health Secretariat	This research was funded by Rio de Janeiro's Municipal Health Secretariat, grant number: ENSP-043-PPE-14-2-12. The grant in this research was aimed only at paying scholarships to the field work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Navarro S, 2012, J GERONTOL A-BIOL, V67, P1266, DOI 10.1093/gerona/gls152; Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Balzi D, 2010, AGE AGEING, V39, P92, DOI 10.1093/ageing/afp209; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bravo FV, 2012, ARQUIVOS BRASILEIROS, V75, P4; Carvalho M, 2012, INTEGRATED TERRITORY; Cherry N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-379; Rosa TEDC, 2007, CAD SAUDE PUBLICA, V23, P2982, DOI 10.1590/S0102-311X2007001200019; de Souza ER, 2008, CIENC SAUDE COLETIVA, V13, P1153, DOI 10.1590/S1413-81232008000400011; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; den Ouden MEM, 2013, EXP GERONTOL, V48, P437, DOI 10.1016/j.exger.2013.02.002; Eisenberger NI, 2013, CURR OPIN NEUROBIOL, V23, P407, DOI 10.1016/j.conb.2013.01.006; Erekson EA, 2015, FEMALE PELVIC MED RE, V21, P170, DOI 10.1097/SPV.0000000000000136; Figueiredo CS, 2013, BRAZ J PHYS THER, V17, P297, DOI 10.1590/S1413-35552012005000094; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; Giacomin KC, 2008, CAD SAUDE PUBLICA, V24, P1260, DOI 10.1590/S0102-311X2008000600007; Griep R., 2003, CONFIABILIDADE VALID; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; IBGE, 2015, IND DES SUST GIN DIS; IBGE, 2010, 2010 POP CENS DIS PE; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lino VTS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071712; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Mangione C., 2000, COMPREHENSIVE GERIAT, P285; McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177; Moreira PL, 2016, ARCH GERONTOL GERIAT, V66, P140, DOI 10.1016/j.archger.2016.05.013; Nagarkar A, 2017, ARCH GERONTOL GERIAT, V69, P151, DOI 10.1016/j.archger.2016.11.015; Okabe T, 2017, GERIATR GERONTOL INT, V17, P1096, DOI 10.1111/ggi.12834; Parahyba MI, 2009, AM J PUBLIC HEALTH, V99, P81, DOI 10.2105/AJPH.2007.130708; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Saarela M., 2018, ARTIFINTELL MED 1003; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Lino VTS, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00086715; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tas U, 2007, BRIT J GEN PRACT, V57, P319; Teo N, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.04.015; Torres JL, 2014, CAD SAUDE PUBLICA, V30, P1018, DOI 10.1590/0102-311X00102013; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127; WINPEPI J A., 2009, PEPI FOR WINDOWS COM; World Health Organization, 2001, ICF INT CLASFUNCT	52	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217456	10.1371/journal.pone.0217456	http://dx.doi.org/10.1371/journal.pone.0217456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150450	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100052
J	Shrivastava, R; Power, F; Tanwir, F; Feine, J; Emami, E				Shrivastava, Richa; Power, Frances; Tanwir, Farzeen; Feine, Jocelyne; Emami, Elham			University-based initiatives towards better access to oral health care for rural and remote populations: A scoping review	PLOS ONE			English	Review							DENTAL-CARE; PLACEMENT PROGRAM; EDUCATION-PROGRAM; SERVICE; COMMUNITY; STUDENTS; CHILDREN; DELIVERY; SCHOOL; PERSPECTIVES	This scoping review maps a wide array of literature to identify academic programs that have been developed to enhance oral health care for rural and remote populations and to provide an overview of their outcomes. Arksey and O'Malley's 5-stage scoping review framework has steered this review. We conducted a literature search with defined eligibility criteria through electronic databases, websites of academic records, professional and rural oral health care organizations as well as grey literature spanning the time interval from the late 1960s to May 2017. The charted data was classified, analyzed and reported using a thematic approach. A total of 72 citations (67 publications and seven websites) were selected for the final review. The review identified 62 universities with program initiatives towards improving access to oral health care in rural and remote communities. These initiatives were classified into three categories: training and education of dental and allied health students and professionals, education and training of rural and remote community members and oral health care services. The programs were successful in terms of dental students' positive perception about rural practice and their enhanced competencies, students' increased adoption of rural practices, non-dental health care providers' improved oral health knowledge and self-efficacy, rural oral health and oral health services' improvement, as well as cost-effectiveness compared to other strategies. The results of our review suggest that these innovative programs were effective in improving access to oral health care in rural and remote regions and may serve as models for other academic institutions that have not yet implemented such programs.	[Shrivastava, Richa] Univ Montreal, Fac Dent, Montreal, PQ, Canada; [Power, Frances; Tanwir, Farzeen; Feine, Jocelyne; Emami, Elham] McGill Univ, Fac Dent, Montreal, PQ, Canada	Universite de Montreal; McGill University	Emami, E (corresponding author), McGill Univ, Fac Dent, Montreal, PQ, Canada.	elham.emami@mcgill.ca		Shrivastava, Richa/0000-0002-8370-4147	Canadian Institute of Health Research Clinician Scientist Award	Canadian Institute of Health Research Clinician Scientist Award	We are grateful to Natalie Clairoux, Librarian, Universite de Montreal for her contribution in developing the search strategy. Dr. Elham Emami is supported by a Canadian Institute of Health Research Clinician Scientist Award.	Abuzar MA, 2009, EUR J DENT EDUC, V13, P233, DOI 10.1111/j.1600-0579.2009.00581.x; Abuzar MA, 2016, J PUBLIC HEALTH RES, V5, P27, DOI 10.4081/jphr.2016.668; ANDERSEN RM, 2009, J DENT EDUC S, V73, pS31; Anderson V R, 2015, N Z Dent J, V111, P6; [Anonymous], 2016, SAN CAR MOB DENT HEA; [Anonymous], 2015, BEST PRACT OR HLTH P; [Anonymous], 2014, SCOTT DENT POSTGR TR; Arevalo O, 2010, J PUBLIC HEALTH DENT, V70, P28, DOI 10.1111/j.1752-7325.2009.00140.x; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Asawa Kailash, 2015, Rocz Panstw Zakl Hig, V66, P275; Barnett T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009341; Bazen Jennifer J, 2007, Rural Remote Health, V7, P703; BENTLEY JM, 1983, AM J PUBLIC HEALTH, V73, P500, DOI 10.2105/AJPH.73.5.500; Benzian H., 2015, CHALLENGE ORAL DIS C; Bernabe Eduardo, 2006, J Dent Educ, V70, P875; Bhayat A, 2011, J DENT EDUC, V75, P1482; Branson Bonnie G, 2007, J Allied Health, V36, pe47; Bulgarelli Alexandre Favero, 2012, Indian J Dent Res, V23, P498, DOI 10.4103/0970-9290.104957; Burger A D, 1997, J Dent Hyg, V71, P117; Cane R, 2007, AUST J RURAL HEALTH, V15, P257, DOI 10.1111/j.1440-1584.2007.00898.x; Chandrashekar Byalakere Rudraiah, 2014, Indian J Public Health, V58, P235, DOI 10.4103/0019-557X.146278; Davidson PL, 2009, J DENT EDUC, V73, pS108; Dawkins E, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-19; Dijkers M., 2015, KT UPDATE, V4, P1; Elkind A, 2005, BRIT DENT J, V198, P233, DOI 10.1038/sj.bdj.4812092; Emami E, 2016, RURAL REMOTE HEALTH, V16; Emami E, 2008, CAN J RURAL MED, V13, P36; Emami E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013807; Emami E, 2014, CAN J RURAL MED, V19, P63; FELDMAN CA, 1988, J PUBLIC HEALTH DENT, V48, P201, DOI 10.1111/j.1752-7325.1988.tb03199.x; Fricton James, 2009, Dent Clin North Am, V53, P537, DOI 10.1016/j.cden.2009.03.005; FRIEDMAN JA, 2009, J DENT EDUC S, V73, pS16; Friedman JA, 2009, J DENT ED S, V73, pS73; Glassman Paul, 2012, J Calif Dent Assoc, V40, P569; Goel P, 2014, J CLIN DIAGN RES, V8, pZC6, DOI 10.7860/JCDR/2014/8351.4534; Gonsalves WC, 2004, FAM MED, V36, P544; Harrison RL, 2006, CAN J PUBLIC HEALTH, V97, P237, DOI 10.1007/BF03405594; HEISE AL, 1973, HEALTH SERV REP, V88, P591, DOI 10.2307/4594861; Hunter ML, 2007, EUR J DENT EDUC, V11, P10, DOI 10.1111/j.1600-0579.2007.00433.x; Ibiyemi O, 2013, RURAL REMOTE HEALTH, V13; Johnson G, 2013, EUR J DENT EDUC, V17, P229, DOI 10.1111/eje.12043; Johnson G, 2013, EUR J DENT EDUC, V17, pe100, DOI 10.1111/j.1600-0579.2012.00768.x; Johnson GE, 2011, RURAL REMOTE HEALTH, V11; Johnson George, 2012, Eur J Dent, V6, P235; Kaakko T, 2002, J PUBLIC HEALTH DENT, V62, P45, DOI 10.1111/j.1752-7325.2002.tb03420.x; Kastner M, 2016, J CLIN EPIDEMIOL, V73, P43, DOI 10.1016/j.jclinepi.2015.11.022; Kruger Estie, 2005, Aust J Rural Health, V13, P321, DOI 10.1111/j.1440-1584.2005.00724.x; Kruger E, 2010, INT DENT J, V60, P129, DOI 10.1922/IDJ_2351Kruger06; KURTZMAN C, 1974, J PUBLIC HEALTH DENT, V34, P74, DOI 10.1111/j.1752-7325.1974.tb00681.x; Kuthy RA, 2009, J DENT ED S, V73, pS9; Kuthy RA, 2009, J DENT EDUC, V73, pS331; Lalloo R, 2013, J DENT EDUC, V77, P1193; Lalloo R, 2013, AUST J RURAL HEALTH, V21, P158, DOI 10.1111/ajr.12027; Lalloo R, 2013, AUST NZ J PUBL HEAL, V37, P47, DOI 10.1111/1753-6405.12009; Lo ECM, 2005, HONG KONG DENT J; Macnab AJ, 2008, RURAL REMOTE HEALTH, V8; Macnab A, 2012, HEALTH PROMOT INT, V27, P63, DOI 10.1093/heapro/dar039; Martinez-Mier Esperanza A, 2011, Educ Health (Abingdon), V24, P259; McFarland KK, 2010, J DENT EDUC, V74, P830; McMillan W B, 1975, J Public Health Dent, V35, P260, DOI 10.1111/j.1752-7325.1975.tb01018.x; Mofidi M, 2002, J PUBLIC HEALTH DENT, V62, P102, DOI 10.1111/j.1752-7325.2002.tb03429.x; Mouradian Wendy E, 2003, J Dent Educ, V67, P886; Naidu A, 2014, RURAL REMOTE HEALTH, V14; Nayar P, 2014, J DENT EDUC, V78, P1139; Ogunbodede E O, 2015, Adv Dent Res, V27, P18, DOI 10.1177/0022034515575538; Okeigbemen SA, 2016, J DENT SPECIALITIES, V4, P5; Okeigbemen SA, 2015, J INT SOC PREV COMMU, V5, P118, DOI 10.4103/2231-0762.172951; Orpin Peter, 2005, Rural Remote Health, V5, P412; Pacza T, 2001, Aust J Rural Health, V9, P105, DOI 10.1046/j.1440-1584.2001.00294.x; Parker EJ, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/496236; Parker Eleanor J, 2005, Rural Remote Health, V5, P254; Parlani Swapnil, 2011, Indian J Dent Res, V22, P367, DOI 10.4103/0970-9290.87054; Poche Centre for Indigenous Health- 5 Year strategy, 2016, 5 YEAR STRAT STRET P; PODSHADLEY A G, 1969, Journal of Public Health Dentistry, V29, P27, DOI 10.1111/j.1752-7325.1969.tb01433.x; Richards L, 2002, AUST DENT J, V47, P254, DOI 10.1111/j.1834-7819.2002.tb00338.x; Schoo AM, 2008, RURAL REMOTE HEALTH, V8; Shannon CK, 2016, J DENT EDUC, V80, P1180; Sharifian N, 2015, J CAN DENT ASSOC, V81; Shrestha A, 2008, RURAL REMOTE HEALTH, V8; Shreve W B Jr, 1989, J Community Health, V14, P53, DOI 10.1007/BF01324439; Singh A, 2013, INT DENT J, V63, P225, DOI 10.1111/idj.12035; Skillman SM, 2010, J PUBLIC HEALTH DENT, V70, pS49, DOI 10.1111/j.1752-7325.2010.00178.x; Skinner John C, 2009, N S W Public Health Bull, V20, P56, DOI 10.1071/NB08065; Smith Carlos S, 2006, J Dent Educ, V70, P398; Summerfelt FF, 2011, J DENT EDUC, V75, P733; Tandon S, 2012, J ORAL HLTH COMM DEN, V6, P56; Vargas CM, 2002, J AM DENT ASSOC, V133, P1672, DOI 10.14219/jada.archive.2002.0120; Vashishtha V, 2015, J INDIAN ASS PUBLIC, V13, P324, DOI [10.4103/2319-5932.165284, DOI 10.4103/2319-5932.165284]; Vashisth S, 2012, CONTEMP CLIN DENT, V3, P164, DOI 10.4103/0976-237X.101076; Verma A, 2016, RURAL REMOTE HEALTH, V16; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2009, MON GEOGR DISTR HLTH; Woronuk John I, 2004, J Can Dent Assoc, V70, P233	93	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217658	10.1371/journal.pone.0217658	http://dx.doi.org/10.1371/journal.pone.0217658			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150463	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100082
J	Hebeisen, M; Scherer, A; Micheroli, R; Nissen, MJ; Tamborrini, G; Moller, B; Zufferey, P; Exer, P; Ciurea, A				Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J.; Tamborrini, Giorgio; Moller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian			Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis	PLOS ONE			English	Article							NECROSIS-FACTOR INHIBITORS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; TREATMENT RESPONSE; DISEASE-ACTIVITY; COMEDICATION; PREDICTORS; RETENTION; CRITERIA; DANBIO	Objectives To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. Methods Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondyloarthritis in the Swiss Clinical Quality Management cohort were included in this study if a first TNF inhibitor on standard dosage was started after recruitment and if a baseline visit was available. Drug maintenance up to drug discontinuation or dose escalation was compared between TNF inhibitors with multiple adjusted Cox proportional hazards models and multiple imputation for missing baseline covariate data. Results A total of 966 patients were included (adalimumab 344, etanercept 237, golimumab 214, infliximab 171). Patients on certolizumab (n = 18) were excluded. Patients starting golimumab had lower disease activity as well as better physical function and quality of life in comparison to patients starting another drug. A higher proportion of patients starting infliximab had a history of extra-articular manifestations. Drug dosage was more often escalated during follow-up in patients treated with infliximab than with subcutaneously administered agents. However, no significant differences in time up to drug discontinuation or dose escalation were observed in multiple adjusted analyses if treatment was initiated after 2009, when all 4 TNF inhibitors were available: hazard ratio for infliximab versus etanercept 1.16 (95% confidence interval 0.80; 1.67), p = 0.44, for golimumab versus etanercept 0.80 (0.58; 1.10), p = 0.17 and for adalimumab versus etanercept 0.93 (0.69; 1.26), p = 0.66. Conclusion In axial spondyloarthritis, drug survival with standard doses of different TNF inhibitors is comparable.	[Hebeisen, Monika; Micheroli, Raphael; Ciurea, Adrian] Univ Zurich, Dept Rheumatol, Zurich, Switzerland; [Hebeisen, Monika; Scherer, Almut] SCQM Fdn, Stat Grp, Zurich, Switzerland; [Nissen, Michael J.] Univ Hosp Geneva, Div Rheumatol, Geneva, Switzerland; [Tamborrini, Giorgio] Private Ctr Sonog & Rheumatol, Basel, Switzerland; [Moller, Burkhard] Inselspital Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Zufferey, Pascal] CHU Vaudois, Div Rheumatol, Lausanne, Switzerland; [Exer, Pascale] Praxis Rheuma Basel, Basel, Switzerland	University of Zurich; University of Geneva; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ciurea, A (corresponding author), Univ Zurich, Dept Rheumatol, Zurich, Switzerland.	adrian.ciurea@usz.ch		Ciurea, Adrian/0000-0002-7870-7132; Micheroli, Raphael/0000-0002-8918-7304	Swiss Society of Rheumatology; AbbVie; Celgene; iQone; Eli Lilly; Merck Sharp Dohme; Novartis; Pfizer; Roche; Sandoz; Sanofi Genzyme; UCB; Bristol-Myers-Squibb; Janssen-Cilag; Arco Foundation, Switzerland; Swiss Balgrist Society, Switzerland	Swiss Society of Rheumatology; AbbVie(AbbVie); Celgene(Bristol-Myers SquibbCelgene Corporation); iQone; Eli Lilly(Eli Lilly); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Sandoz(Novartis); Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); UCB(UCB Pharma SA); Bristol-Myers-Squibb(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Arco Foundation, Switzerland; Swiss Balgrist Society, Switzerland	The SCQM Foundation is supported by the Swiss Society of Rheumatology and by AbbVie, Celgene, iQone, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sandoz, Sanofi Genzyme, UCB. It has also been supported by Bristol-Myers-Squibb and Janssen-Cilag and has received project-based financial supports from the Arco Foundation, Switzerland, as well as from the Swiss Balgrist Society, Switzerland. This study was supported by Pfizer through an investigator-initiated research grant to SCQM. The grant provider had no role in the study design or in the collection, analysis, or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication. Publication of this article was not contingent upon approval by the grant donor.	Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Ciurea A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0969-2; Ciurea A, 2013, ARTHRITIS RHEUM-US, V65, P3096, DOI 10.1002/art.38140; de Vries MK, 2007, ANN RHEUM DIS, V66, P1252, DOI 10.1136/ard.2007.072397; Fabbroni M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/862969; Favalli EG, 2017, ARTHRIT CARE RES, V69, P867, DOI 10.1002/acr.23090; Glintborg B, 2014, RHEUMATOLOGY, V53, P2100, DOI 10.1093/rheumatology/keu252; Glintborg B, 2010, ANN RHEUM DIS, V69, P2002, DOI 10.1136/ard.2009.124446; Heinonen AV, 2015, J RHEUMATOL, V42, P2339, DOI 10.3899/jrheum.150389; Kang JH, 2014, J KOREAN MED SCI, V29, P1205, DOI 10.3346/jkms.2014.29.9.1205; Landewe RBM, 2015, ANN RHEUM DIS, V74, P951, DOI 10.1136/annrheumdis-2014-206758; Lie E, 2015, ANN RHEUM DIS, V74, P970, DOI 10.1136/annrheumdis-2014-206616; Molnar C, 2018, ANN RHEUM DIS, V77, P63, DOI 10.1136/annrheumdis-2017-211544; Neovius M, 2015, ANN RHEUM DIS, V74, P354, DOI 10.1136/annrheumdis-2013-204128; Nissen MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2141, DOI 10.1002/art.39691; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Scire CA, 2013, CLIN EXP RHEUMATOL, V31, P857; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yahya F, 2018, RHEUMATOLOGY, V57, P619, DOI 10.1093/rheumatology/kex457	22	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216746	10.1371/journal.pone.0216746	http://dx.doi.org/10.1371/journal.pone.0216746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145730	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500005
J	Gastaldi, G; Gomes, D; Schneiter, P; Montet, X; Tappy, L; Clements, S; Negro, F				Gastaldi, Giacomo; Gomes, Diana; Schneiter, Philippe; Montet, Xavier; Tappy, Luc; Clements, Sophie; Negro, Francesco			Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TYPE-2 DIABETES-MELLITUS; CHRONIC LIVER-DISEASE; QUALITY-OF-LIFE; VIRUS-INFECTION; ADIPOSE-TISSUE; EXTRAHEPATIC MANIFESTATIONS; RECEPTOR SUBSTRATE-1; SELENOPROTEIN P; GROWTH-FACTOR	Background and aims Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 diabetes and its complications. Although HCV infects mainly hepatocytes, it may impair insulin sensitivity at the level of uninfected extrahepatic tissues (muscles and adipose tissue). The aim of this study was to assess whether an interferon-free, antiviral therapy may improve HCV-associated hepatic vs. peripheral insulin sensitivity. Methods In a single-arm exploratory trial, 17 non-diabetic, lean chronic hepatitis C patients without significant fibrosis were enrolled, and 12 completed the study. Patients were treated with a combination of sofosbuvir/ledipasvir and ribavirin for 12 weeks, and were submitted to a 2 step euglycemic hyperinsulinemic clamp with tracers, together with indirect calorimetry measurement, to measure insulin sensitivity before and after 6 weeks of antivirals. A panel of 27 metabolically active cytokines was analyzed at baseline and after therapy-induced viral suppression. Results Clamp analysis performed in 12 patients who achieved complete viral suppression after 6 weeks of therapy showed a significant improvement of the peripheral insulin sensitivity (13.1% [4.6-36.7], p = 0.003), whereas no difference was observed neither in the endogenous glucose production, in lipolysis suppression nor in substrate oxidation. A distinct subset of hepatokines, potentially involved in liver-to-periphery crosstalk, was modified by the antiviral therapy. Conclusion Pharmacological inhibition of HCV improves peripheral (but not hepatic) insulin sensitivity in non-diabetic, lean individuals with chronic hepatitis C without significant fibrosis.	[Gastaldi, Giacomo] Geneva Univ Hosp, Div Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland; [Gomes, Diana] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Schneiter, Philippe; Tappy, Luc] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Montet, Xavier] Geneva Univ Hosp, Div Radiol, Geneva, Switzerland; [Clements, Sophie; Negro, Francesco] Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland; [Negro, Francesco] Geneva Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Lausanne; University of Geneva; University of Geneva; University of Geneva	Negro, F (corresponding author), Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland.; Negro, F (corresponding author), Geneva Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland.	Francesco.negro@hcuge.ch	Montet, Xavier/GMW-9003-2022; Gastaldi, Giacomo/AAV-8187-2021; gastaldi, giacomo/AAF-9948-2020	gastaldi, giacomo/0000-0001-6327-7451; Gomes, Diana/0000-0002-9342-2557	Gilead Sciences, Inc. Foster City, CA, US; Swiss National Science Foundation [314730-166609]; FLAGS Foundation; Fondation pour la Recherche sur le Diabete, Geneva, Switzerland	Gilead Sciences, Inc. Foster City, CA, US(Gilead Sciences); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FLAGS Foundation; Fondation pour la Recherche sur le Diabete, Geneva, Switzerland	This work was supported by: (FN) Gilead Sciences, Inc. Foster City, CA, US, https://www.gilead.com/; Swiss National Science Foundation (314730-166609 to F.N.), http://www.snf.ch/en/Pages/default.aspx; FLAGS Foundation and the Fondation pour la Recherche sur le Diabete, Geneva, Switzerland, http://www.fondation-diabete.ch/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Gilead Sciences, Inc. Foster City, CA, US, the Swiss National Science Foundation (314730-166609 to F.N.), the FLAGS Foundation and the Fondation pour la Recherche sur le Diabete, Geneva, Switzerland. We thank Dr Nicolas Liaudet (Bioimaging Core Facility, Faculty of Medicine, Geneva) for his help and advice, Dr Annarita Farina (Department of Internal Medicine, Faculty of Medicine, Geneva) for the support provided with the multiplex assays, and the Clinical Research Center, University Hospital of Geneva for its contribution. We gratefully acknowledge the patients who participated in the study.	Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Aghemo A, 2012, HEPATOLOGY, V56, P1681, DOI 10.1002/hep.25867; Ali SA, 2016, CLIN RES HEPATOL GAS, V40, P465, DOI 10.1016/j.clinre.2015.12.003; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Brenachot X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02074-2; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Butt AA, 2019, GASTROENTEROLOGY, V156, P987, DOI 10.1053/j.gastro.2018.11.022; Cacoub P, 2018, J VIRAL HEPATITIS, V25, P811, DOI 10.1111/jvh.12881; Cacoub P, 2018, GUT, V67, P2025, DOI 10.1136/gutjnl-2018-316234; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Dawood AA, 2017, DIABETES METAB J, V41, P316, DOI 10.4093/dmj.2017.41.4.316; Ebert T, 2009, METABOLISM, V58, P547, DOI 10.1016/j.metabol.2008.11.016; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fabrizio C, 2017, CLIN MICROBIOL INFEC, V23, P342, DOI 10.1016/j.cmi.2016.09.021; Feng RN, 2014, DIABETES RES CLIN PR, V106, P88, DOI 10.1016/j.diabres.2014.07.026; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Garcia-Alvarez M, 2011, CYTOKINE, V54, P244, DOI 10.1016/j.cyto.2011.03.001; GOODPASTER BH, J APPL PHYSL, V89, P104; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Gouthamchandra K, 2014, J GEN VIROL, V95, P1654, DOI 10.1099/vir.0.062430-0; HARGREAVES M, 1991, J APPL PHYSIOL, V70, P194, DOI 10.1152/jappl.1991.70.1.194; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Himoto T, 2013, NUTR RES, V33, P27, DOI 10.1016/j.nutres.2012.11.007; Hoyer D, 2011, DIABETOLOGIA, V54, P2795, DOI 10.1007/s00125-011-2275-5; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Hum J, 2017, DIABETES CARE, V40, P1173, DOI 10.2337/dc17-0485; Jacques C, 2012, J BIOL CHEM, V287, P15100, DOI 10.1074/jbc.M112.350215; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kaishima T, 2018, HEPATOL RES, V48, P509, DOI 10.1111/hepr.13053; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2007, AM J GASTROENTEROL, V102, P570, DOI 10.1111/j.1572-0241.2006.01038.x; KELLEY DE, 1991, AM J CLIN NUTR, V54, P509, DOI 10.1093/ajcn/54.3.509; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Kukla M, 2010, J VIRAL HEPATITIS, V17, P661, DOI 10.1111/j.1365-2893.2009.01224.x; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lin YJ, 2017, LIVER INT, V37, P179, DOI 10.1111/liv.13194; Liu WM, 2016, ARCH IMMUNOL THER EX, V64, P371, DOI 10.1007/s00005-016-0395-9; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10227; Mahale P, 2018, GUT, V67, P553, DOI 10.1136/gutjnl-2017-313983; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Milner KL, 2014, J VIRAL HEPATITIS, V21, P325, DOI 10.1111/jvh.12143; Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; Nakamura I, 2018, HEPATOL RES, V48, P855, DOI 10.1111/hepr.13186; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Pavone P, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.030; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Schlevogt B, 2017, Z GASTROENTEROL, V55, P848, DOI 10.1055/s-0043-112656; Schneiter P, 1999, METABOLISM, V48, P1260, DOI 10.1016/S0026-0495(99)90265-2; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Wang CS, 2003, AM J EPIDEMIOL, V158, P1154, DOI 10.1093/aje/kwg259; Wasmuth HE, 2008, J HEPATOL, V48, P208, DOI 10.1016/j.jhep.2007.09.008; WHO, 2017, WHO PUBLISHES LIST B; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1599, DOI 10.1053/j.gastro.2016.02.039; Younossi ZM, 2019, LIVER INT, V39, P54, DOI 10.1111/liv.13900; Zanchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109134	74	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217751	10.1371/journal.pone.0217751	http://dx.doi.org/10.1371/journal.pone.0217751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170218	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700052
J	Groarke, JM; Hogan, MJ				Groarke, Jenny M.; Hogan, Michael J.			Listening to self-chosen music regulates induced negative affect for both younger and older adults	PLOS ONE			English	Article							EMOTION RECOGNITION; RELAXING MUSIC; RESPONSES; STRESS; RELAXATION; EXPRESSION; ATTENTION	The current study evaluated the efficacy of self-chosen music listening for the function of affect regulation comparing effects in younger and older adults. Forty younger (18-30 years, M= 19.75, SD = 2.57, 14 males) and forty older (60-81 years, M= 68.48, SD = 6.07, 21 males) adults visited the laboratory and were randomised to either the intervention (10 minutes of listening to self-chosen music) or the active control condition (10 minutes of listening to an experimenter-chosen radio documentary). Negative affect (NA) was induced in all participants using a speech preparation and mental arithmetic task, followed by the intervention/control condition. Measures of self-reported affect were taken at baseline, post induction and post-intervention. Controlling for baseline affect and reactivity to the NA induction, in comparison with the active control group the music listening group demonstrated greater reduction in NA. Supporting developmental theories of positive ageing, analyses also found significant main effects for age, with older adults experiencing greater reduction of NA than younger adults, regardless of condition. Results of the current study provide preliminary insights into the effects of self-chosen music on induced NA, however, additional experimental control conditions comparing self-chosen and experimenter-chosen music with self-chosen and experimenter-chosen active controls are needed to fully understand music listening effects for affect regulation.	[Groarke, Jenny M.] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Hogan, Michael J.] Natl Univ Ireland, Sch Psychol, Galway, Ireland	Queens University Belfast; Ollscoil na Gaillimhe-University of Galway	Groarke, JM (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.	j.groarke@qub.ac.uk	Groarke, Jenny/M-8055-2019; Campailla, Jasmin/AAK-2420-2021; Hogan, Michael/AAW-6943-2021	Groarke, Jenny/0000-0001-6370-7116; 	Irish Research Council [GOIP/2013/876]	Irish Research Council(Irish Research Council for Science, Engineering and Technology)	JMG was awarded a Government of Ireland Postgraduate Scholarship from the Irish Research Council (GOIP/2013/876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltazar M, 2017, MUSIC SCI; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Birkett MA, 2011, JOVE-J VIS EXP, DOI 10.3791/3238; Burns J, 1999, APPL PSYCHOPHYS BIOF, V24, P197, DOI 10.1023/A:1023488614364; Burns JL, 2002, J MUSIC THER, V39, P101, DOI 10.1093/jmt/39.2.101; Carstensen LL, 2003, ANN NY ACAD SCI, V1000, P152, DOI 10.1196/annals.1280.008; CARSTENSEN LL, 1995, CURR DIR PSYCHOL SCI, V4, P151, DOI 10.1111/1467-8721.ep11512261; CARVER CS, 1982, PSYCHOL BULL, V92, P111, DOI 10.1037/0033-2909.92.1.111; Chafin S, 2004, BRIT J HEALTH PSYCH, VXX, P1; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; DeNora T, 1999, POETICS, V27, P31, DOI 10.1016/S0304-422X(99)00017-0; Gerra G, 1998, INT J PSYCHOPHYSIOL, V28, P99, DOI 10.1016/S0167-8760(97)00071-8; Groarke JM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00516; Groarke JM, 2016, PSYCHOL MUSIC, V44, P769, DOI 10.1177/0305735615591844; Iwanaga M, 1999, J MUSIC THER, V36, P26, DOI 10.1093/jmt/36.1.26; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2011, MUSIC SCI, V15, P174, DOI 10.1177/1029864911401169; JUSLIN Patrik N., 2001, MUSIC EMOTION THEORY, P309; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Krause A, 2014, J BROADCAST ELECTRON, V58, P306, DOI 10.1080/08838151.2014.906437; Krause AE, 2017, PSYCHOL MUSIC, V45, P355, DOI 10.1177/0305735616664214; Labbe E, 2007, APPL PSYCHOPHYS BIOF, V32, P163, DOI 10.1007/s10484-007-9043-9; Laukka P., 2007, J HAPPINESS STUD, V8, P215, DOI [DOI 10.1007/S10902-006-9024-3, 10.1007/s10902-006-9024-3]; Laukka P, 2007, MOTIV EMOTION, V31, P182, DOI 10.1007/s11031-007-9063-z; Liljestrom S, 2013, PSYCHOL MUSIC, V41, P579, DOI 10.1177/0305735612440615; Lima CF, 2011, COGNITION EMOTION, V25, P585, DOI 10.1080/02699931.2010.502449; Lonsdale AJ, 2011, BRIT J PSYCHOL, V102, P108, DOI 10.1348/000712610X506831; Lundqvist LO, 2009, PSYCHOL MUSIC, V37, P61, DOI 10.1177/0305735607086048; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Matsumoto J, 2002, JPN J EDUC PSYCHOL, V50, P23, DOI 10.5926/jjep1953.50.1_23; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Radstaak M, 2014, PSYCHOSOM MED, V76, P529, DOI 10.1097/PSY.0000000000000094; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rocke C, 2009, PSYCHOL AGING, V24, P863, DOI 10.1037/a0016276; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schafer T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151634; Schafer T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00511; Schafer T, 2009, PSYCHOL MUSIC, V37, P279, DOI 10.1177/0305735608097247; Scheufele PM, 2000, J BEHAV MED, V23, P207, DOI 10.1023/A:1005542121935; Sharman L, 2015, FRONT HUM NEUROSCI, V9, P960; Sleigh MJ, 2014, MUSIC PERCEPT, V31, P303, DOI 10.1525/MP.2014.31.4.303; SLOBODA J. A., 2001, MUSIC SCI, V5, P9, DOI [10.1177/102986490100500102, DOI 10.1177/102986490100500102]; Thoma MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070156; van Goethem A, 2011, MUSIC SCI, V15, P208, DOI 10.1177/1029864911401174; Vieillard S, 2012, EXP AGING RES, V38, P422, DOI 10.1080/0361073X.2012.699371	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218017	10.1371/journal.pone.0218017	http://dx.doi.org/10.1371/journal.pone.0218017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170224	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700094
J	Peidl, A; Perbal, B; Leask, A				Peidl, Alexander; Perbal, Bernard; Leask, Andrew			Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SKIN FIBROSIS; TISSUE; PROTEINS; SCLERODERMA; DIFFERENTIATION; INHIBITION; REGULATOR; PHENOTYPE; ADHESION	The role of the microenvironment in driving connective tissue disease is being increasingly appreciated. Matricellular proteins of the CCN family are signaling modifiers that are secreted by cells into the extracellular matrix microenvironment where they have profound, context-dependent effects on organ development, homeostasis and disease. Indeed, CCN proteins are emergent targets for therapeutic intervention. Recent evidence suggests that, in vivo, CCN3 has effects opposing CCN2. Moreover, when CCN3 expression is high, CCN2 expression is low. That is, they appear to be regulated in a yin/yang fashion, leading to the hypothesis that the CCN2:CCN3 ratio is important to control tissue homeostasis. To begin to test the hypothesis that alterations in CCN2:CCN3 expression might be important in skin biology in vivo, we evaluated the relative ex vivo effects of the profibrotic protein TGFbetal on dermal fibroblasts on protein and RNA expression of CCN3 and CCN2, as well as the related protein CCN1. We also used signal transduction inhibitors to begin to identify the signal transduction pathways controlling the ability of fibroblasts to respond to TGFbetal. As anticipated, CCN1 and CCN2 protein and mRNA were induced by TGFbetal in human dermal fibroblasts. This induction was blocked by TAK1, FAK, YAP1 and MEK inhibition. Conversely, TGFbetal suppressed CCN3 mRNA expression in a fashion insensitive to FAK, MEK, TAK1 or YAP1 inhibition. Unexpectedly, CCN3 protein was not detected in human dermal fibroblasts basally. These data suggest that, in dermal fibroblasts, the pro fibrotic protein TGFbetal has a divergent effect on CCN3 relative to CCN2 and CCN1, both at the mRNA and protein level. Given that the major source in skin in vivo of CCN proteins are fibroblasts, our data are consistent that alterations in CCN2/CCN1: CCN3 ratios in response to profibrotic agents such as TGFbetal may play a role in connective tissue pathologies including fibrosis.	[Peidl, Alexander] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Perbal, Bernard] Univ Cote Azur, CNRS, GREDEG, Nice, France; [Leask, Andrew] Univ Western Ontario, Dept Dent, London, ON, Canada	Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Western University (University of Western Ontario)	Leask, A (corresponding author), Univ Western Ontario, Dept Dent, London, ON, Canada.	aleask@uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015		Arthritis Society; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Bone and Joint Institute MSc fellowship	Arthritis Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bone and Joint Institute MSc fellowship	We have received funding support (to AL) from The Arthritis Society, the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council. AP was the recipient of a Bone and Joint Institute MSc fellowship. The URLs are: http://cihr-irsc.gc.ca/; https://www.canada.ca/en/science-engineering-research. html; https://www.arthritis.ca/; http://boneandjoint.uwo.ca/.The funders had no say in the study design, data collection/analysis, decision to publish or preparation of the manuscript.	Allanore Y, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.2; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Cipriani P, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0754-7; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Futakuchi A, 2018, INVEST OPHTH VIS SCI, V59, P3069, DOI 10.1167/iovs.18-24258; Gibault F, 2016, CURR MED CHEM, V23, P1171, DOI 10.2174/0929867323666160316125048; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang CY, 2012, CONNECT TISSUE RES, V53, P187, DOI 10.3109/03008207.2011.642035; Hutchenreuther J, 2018, MATRIX BIOL, V74, P52, DOI 10.1016/j.matbio.2018.06.003; Hutchenreuther J, 2018, J CELL COMMUN SIGNAL, V12, P113, DOI 10.1007/s12079-017-0419-1; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI 10.1359/JBMR.080615; Kuk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123689; Kurundkar AR, 2016, FASEB J, V30, P2135, DOI 10.1096/fj.201500173; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2013, ADV WOUND CARE, V2, P160, DOI 10.1089/wound.2012.0365; Leask A, 2013, EXPERT OPIN THER TAR, V17, P1067, DOI 10.1517/14728222.2013.812074; Li S, 2018, AM J PHYSIOL-LUNG C, V315, pL241, DOI 10.1152/ajplung.00093.2018; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Makino K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1356-3; Murphy-Marshman H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186740; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P625, DOI 10.1007/s12079-018-0491-1; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P3, DOI 10.1007/s12079-018-0455-5; Petrosino JM, 2018, FASEB J; Raghu G, 2016, EUR RESPIR J, V47, P1481, DOI 10.1183/13993003.01030-2015; Rebolledo DL, 2019, MATRIX BIOL, V82, P20, DOI 10.1016/j.matbio.2019.01.002; Riser BL, 2015, J CELL COMMUN SIGNAL, V9, P327, DOI 10.1007/s12079-015-0309-3; Riser BL, 2014, AM J PATHOL, V184, P2908, DOI 10.1016/j.ajpath.2014.07.009; Riser BL, 2010, J CELL COMMUN SIGNAL, V4, P39, DOI 10.1007/s12079-010-0085-z; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Scholz G, 1996, MOL CELL BIOL, V16, P481; Schulz JN, 2018, MATRIX BIOL, V68-69, P522, DOI 10.1016/j.matbio.2018.01.025; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thompson K, 2014, J CELL COMMUN SIGNAL, V8, P59, DOI 10.1007/s12079-014-0229-7; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Roeyen CRC, 2008, KIDNEY INT, V73, P86, DOI 10.1038/sj.ki.5002584; Walraven M, 2018, MATRIX BIOL, V71-72, P205, DOI 10.1016/j.matbio.2018.02.020; Wang C, 2016, AM J CANCER RES, V6, P27; Xu SW, 2012, RHEUMATOLOGY, V51, P2146, DOI 10.1093/rheumatology/kes234; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	54	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218178	10.1371/journal.pone.0218178	http://dx.doi.org/10.1371/journal.pone.0218178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170244	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700103
J	Marsoner, K; Voetsch, A; Lierzer, C; Sodeck, GH; Fruhwald, S; Dapunt, O; Mischinger, HJ; Kornprat, P				Marsoner, Katharina; Voetsch, Andreas; Lierzer, Christoph; Sodeck, Gottfried H.; Fruhwald, Sonja; Dapunt, Otto; Mischinger, Hans Joerg; Kornprat, Peter			Gastrointestinal complications following on-pump cardiac surgery-A propensity matched analysis	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; BLOOD-FLOW; DETERMINANTS; PREDICTORS	Background Gastrointestinal complications following on-pump cardiac surgery are orphan but serious risk factors for postoperative morbidity and mortality. We aimed to assess incidence, perioperative risk factors, treatment modalities and outcomes. Material and methods A university medical center audit comprised 4883 consecutive patients (median age 69 [interquartile range IQR 60-76] years, 33% female, median logistic EuroScore 5 [IQR 3-11]) undergoing all types of cardiac surgery including surgery on the thoracic aorta; patients undergoing repair of congenital heart disease, implantation of assist devices or cardiac transplantation were excluded. Coronary artery disease was the leading indication for on-pump cardiac surgery (60%), patients undergoing cardiac surgery under urgency or emergency setting were included in analysis. We identified a total of 142 patients with gastrointestinal complications. To identify intra-and postoperative predictors for gastrointestinal complications, we applied a 1: 1 propensity score matching procedure based on a logistic regression model. Results Overall, 30-day mortality for the entire cohort was 5.4%; the incidence of gastrointestinal complications was 2.9% and median time to complication 8 days (IQR 4-12). Acute pancreatitis (n = 41), paralytic ileus (n = 14) and acute cholecystitis (n = 18) were the leading pathologies. Mesenteric ischemia and gastrointestinal bleeding accounted for 16 vs. 18 cases, respectively. While 72 patients (51%) could be managed conservatively, 27 patients required endoscopic/radiological (19%) or surgical intervention (43/142 patients, 30%); overall 30-day mortality was 12.1% (p<0.001). Propensity score matching identified prolonged skin-to-skin times (p = 0.026; Odds Ratio OR 1.003, 95% Confidence Interval CI 1.000-1.007) and extended on-pump periods (p = 0.010; OR 1.006, 95% CI 1.001-1.011) as significant perioperative risk factors. Comment Prolonged skin-to-skin times and extended on-pump periods are important perioperative risk factors regardless of preoperative risk factors.	[Marsoner, Katharina; Lierzer, Christoph; Mischinger, Hans Joerg; Kornprat, Peter] Med Univ Graz, Dept Gen Surg, Graz, Austria; [Voetsch, Andreas; Dapunt, Otto] Med Univ Graz, Dept Cardiac Surg, Graz, Austria; [Voetsch, Andreas] Paracelsus Med Univ, Dept Cardiac Surg, Salzburg, Austria; [Sodeck, Gottfried H.] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Fruhwald, Sonja] Med Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University; Medical University of Vienna; Medical University of Graz	Kornprat, P (corresponding author), Med Univ Graz, Dept Gen Surg, Graz, Austria.	peter.kornprat@medunigraz.at	, Kornprat/AAH-6353-2019; Vötsch, Andreas/N-5953-2014	Vötsch, Andreas/0000-0001-6841-4208				Abbas SH, 2018, DIGEST SURG, V35, P171, DOI 10.1159/000477780; Byhahn C, 2001, WORLD J SURG, V25, P1140, DOI 10.1007/BF03215861; Chaudhry R, 2017, J CARDIOTHOR VASC AN, V31, P1268, DOI 10.1053/j.jvca.2017.04.013; CHRISTENSON JT, 1994, THORAC CARDIOV SURG, V42, P152, DOI 10.1055/s-2007-1016478; Chung JW, 2013, YONSEI MED J, V54, P154, DOI 10.3349/ymj.2013.54.1.154; D'Ancona G, 2003, TEX HEART I J, V30, P280; FERNANDEZDELCASTILLO C, 1991, NEW ENGL J MED, V325, P382; Filsoufi F, 2007, ANN SURG, V246, P323, DOI 10.1097/SLA.0b013e3180603010; Guillaume A, 2017, SHOCK, V47, P296, DOI 10.1097/SHK.0000000000000720; HUDDY SPJ, 1991, BRIT J SURG, V78, P293, DOI 10.1002/bjs.1800780309; Mangi AA, 2005, ANN SURG, V241, P895, DOI 10.1097/01.sla.0000164173.05762.32; Mayson Sarah E, 2007, Cardiol Rev, V15, P231, DOI 10.1097/CRD.0b013e31813e62bb; MONETA GL, 1985, AM J SURG, V149, P648, DOI 10.1016/S0002-9610(85)80148-3; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nilsson J, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-156; OHRI SK, 1994, ANN THORAC SURG, V57, P1193, DOI 10.1016/0003-4975(94)91355-2; Ohri SK, 2006, PERFUSION-UK, V21, P215, DOI 10.1191/0267659106pf871oa; Poirier B, 2003, J CAN CHIR, V36, P176; Rodriguez R, 2010, J CARDIAC SURG, V25, P188, DOI 10.1111/j.1540-8191.2009.00985.x; Sever K, 2014, ANGIOLOGY, V65, P425, DOI 10.1177/0003319713482357; TAO WK, 1995, J THORAC CARDIOV SUR, V110, P819, DOI 10.1016/S0022-5223(95)70116-8; Viana FF, 2013, ANZ J SURG, V83, P651, DOI 10.1111/ans.12134; Zacharias A, 2000, TEX HEART I J, V27, P93	23	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217874	10.1371/journal.pone.0217874	http://dx.doi.org/10.1371/journal.pone.0217874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166962	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800047
J	Heiferman, MJ; Fawzi, AA				Heiferman, Michael J.; Fawzi, Amani A.			Progression of subclinical choroidal neovascularization in age-related macular degeneration	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; VISUAL-ACUITY; EYES; CHORIOCAPILLARIS; PREVALENCE; ATROPHY; DRUSEN	Purpose To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD). Methods This study included a total of 34 patients with unilateral neovascular AMD who were evaluated prospectively using OCTA to detect subclinical CNV in their fellow eye. Eyes with baseline subclinical CNV were followed with serial OCTA for a minimum of one year (15.2 +/- 3.27 months) to monitor the development of exudation. Results Of the 34 fellow eyes studied, five were found to have baseline subclinical CNV. One of the five cases of baseline subclinical CNV converted to exudative AMD during the follow up period. The average surface area of baseline subclinical CNV on OCTA was 0.131 +/- 0.096 mm(2) which progressed to 0.136 +/- 0.104 mm(2) at the final follow up (P = 0.539). Geographic atrophy grew at a rate of 0.82 +/- 1.20mm(2)/year in four eyes without subclinical CNV and 0.02mm(2)/year in one eye with subclinical CNV. Conclusion and importance The rate of conversion to exudative AMD in eyes with subclinical CNV of 20% in our study is similar to previous reports and suggests the importance of vigilance in these eyes. The lower growth rate of geographic atrophy may suggest a protective effect of subclinical CNV that deserves further study.	[Heiferman, Michael J.; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	National Institutes of Health [AAF - 1DP3DK108248]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by AAF - 1DP3DK108248, National Institutes of Health (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Amissah-Arthur KN, 2012, EYE, V26, P394, DOI 10.1038/eye.2011.335; Capuano V, 2017, AM J OPHTHALMOL, V182, P45, DOI 10.1016/j.ajo.2017.07.009; Carnevali A, 2016, AM J OPHTHALMOL, V169, P189, DOI 10.1016/j.ajo.2016.06.042; Chew EY, 2014, JAMA OPHTHALMOL, V132, P272, DOI 10.1001/jamaophthalmol.2013.6636; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dias JRD, 2018, OPHTHALMOLOGY, V125, P255, DOI 10.1016/j.ophtha.2017.08.030; Fayed A. E., 2018, PREVALENCE SUBCLINIC; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Hanutsaha P, 1998, OPHTHALMOLOGY, V105, P1632, DOI 10.1016/S0161-6420(98)99030-3; Lamoureux EL, 2011, BRIT J OPHTHALMOL, V95, P666, DOI 10.1136/bjo.2010.185207; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nesper PL, 2017, AM J OPHTHALMOL, V174, P42, DOI 10.1016/j.ajo.2016.10.005; Palejwala NV, 2015, RETINA-J RET VIT DIS, V35, P2204, DOI 10.1097/IAE.0000000000000867; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sunness JS, 1999, OPHTHALMOLOGY, V106, P1768, DOI 10.1016/S0161-6420(99)90340-8; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Yanagi Y, 2018, JAMA OPHTHALMOL, V136, P905, DOI 10.1001/jamaophthalmol.2018.2154; Yanagi Y, 2017, INVEST OPHTH VIS SCI, V58, P3488, DOI 10.1167/iovs.16-21167	24	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217805	10.1371/journal.pone.0217805	http://dx.doi.org/10.1371/journal.pone.0217805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163067	Green Submitted, Green Published, gold			2022-12-27	WOS:000470086200037
J	Kaczensky, P; Khaliun, S; Payne, J; Boldgiv, B; Buuveibaatar, B; Walzer, C				Kaczensky, Petra; Khaliun, Sanchir; Payne, John; Boldgiv, Bazartseren; Buuveibaatar, Bayarbaatar; Walzer, Chris			Through the eye of a Gobi khulan - Application of camera collars for ecological research of far-ranging species in remote and highly variable ecosystems	PLOS ONE			English	Article							EQUUS-HEMIONUS; SELECTION; DYNAMICS; BEHAVIOR	The Mongolian Gobi-Eastern Steppe Ecosystem is one of the largest remaining natural drylands and home to a unique assemblage of migratory ungulates. Connectivity and integrity of this ecosystem are at risk if increasing human activities are not carefully planned and regulated. The Gobi part supports the largest remaining population of the Asiatic wild ass (Equus hemionus; locally called "khulan"). Individual khulan roam over areas of thousands of square kilometers and the scale of their movements is among the largest described for terrestrial mammals, making them particularly difficult to monitor. Although GPS satellite telemetry makes it possible to track animals in near-real time and remote sensing provides environmental data at the landscape scale, remotely collected data also harbors the risk of missing important abiotic or biotic environmental variables or life history events. We tested the potential of animal born camera systems ("camera collars") to improve our understanding of the drivers and limitations of khulan movements. Deployment of a camera collar on an adult khulan mare resulted in 7,881 images over a one-year period. Over half of the images showed other khulan and 1,630 images showed enough of the collared khulan to classify the behaviour of the animals seen into several main categories. These khulan images provided us with: i) new insights into important life history events and grouping dynamics, ii) allowed us to calculate time budgets for many more animals than the collared khulan alone, and iii) provided us with a training dataset for calibrating data from accelerometer and tilt sensors in the collar. The images also allowed to document khulan behaviour near infrastructure and to obtain a day-time encounter rate between a specific khulan with semi-nomadic herders and their livestock. Lastly, the images allowed us to ground truth the availability of water by: i) confirming waterpoints predicted from other analyses, ii) detecting new waterpoints, and iii) compare precipitation records for rain and snow from landscape scale climate products with those documented by the camera collar. We discuss the added value of deploying camera collars on a subset of animals in remote, highly variable ecosystems for research and conservation.	[Kaczensky, Petra] Norwegian Inst Nat Res, Trondheim, Norway; [Kaczensky, Petra; Payne, John; Walzer, Chris] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria; [Khaliun, Sanchir; Boldgiv, Bazartseren] Natl Univ Mongolia, Ecol Grp, Dept Biol, Ulaanbaatar, Mongolia; [Payne, John; Buuveibaatar, Bayarbaatar; Walzer, Chris] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongolia	Norwegian Institute Nature Research; University of Veterinary Medicine Vienna; National University of Mongolia	Kaczensky, P (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.; Kaczensky, P (corresponding author), Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria.	petra.kaczensky@nina.no	Buuveibaatar, Bayarbaatar/AAY-9092-2020; Boldgiv, Bazartseren/I-4754-2013; Bayarbaatar, Buuveibaatar/AAS-5963-2020	Boldgiv, Bazartseren/0000-0003-0015-8142; Sanchir, Khaliun/0000-0002-8964-1642; Walzer, Chris/0000-0002-0437-5147; Kaczensky, Petra/0000-0001-5428-1176; Bayarbaatar, Buuveibaatar/0000-0003-1803-0745	Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through Austrian Science Fund (FWF) [P24231]; Norwegian Research Council TOPPFORSK project [251112]; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology	Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Norwegian Research Council TOPPFORSK project; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology	Funding for the camera collar and part of the analysis was provided by the Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through matching funds in context with the Austrian Science Fund (FWF) grant P24231. Manuscript preparation for PK was supported by the Norwegian Research Council TOPPFORSK project 251112. SK and BBo of NUM were supported by the Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology. Capture and collaring of the khulan happened within the framework of the Oyu Tolgoi LLC Core Biodiversity Monitoring Program, implemented by the Wildlife Conservation Society through a cooperative agreement with Sustainability East Asia LLC. Apart from the roles described, the funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bannikov AG, 1981, THE ASIAN WILD ASS; Batsaikhan N, 2014, CONSERV BIOL, V28, P1736, DOI 10.1111/cobi.12297; Battersby SE, 2013, STORY MAPS CLASSROOM, P62; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2013, CONSERV BIOL, V27, P679, DOI 10.1111/cobi.12100; Brockman CJ, 2017, WILDLIFE SOC B, V41, P88, DOI 10.1002/wsb.733; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Buuveibaatar B, 2017, ORYX, V51, P639, DOI 10.1017/S0030605316000417; Buuveibaatar B, 2016, BIOL CONSERV, V203, P168, DOI 10.1016/j.biocon.2016.09.013; Caravaggi A, 2017, REMOTE SENS ECOL CON, V3, P109, DOI 10.1002/rse2.48; DeMars CA, 2013, ECOL EVOL, V3, P4149, DOI 10.1002/ece3.785; Dietz AJ, 2015, REMOTE SENS LETT, V6, P844, DOI 10.1080/2150704X.2015.1084551; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Gerritsmann H, 2016, J WILDLIFE DIS, V52, P642, DOI 10.7589/2015-07-198; Hughey LF, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0005; Kaczensky P., 2010, Erforschung Biologischer Ressourcen der Mongolei, V11, P291; Kaczensky P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.EN]; Kaczensky P., 2006, MONGOLIA DISCUSSION; Kaczensky P, 2019, EXPLORATION BIOL RES, V14; Kaczensky Petra, 2015, Open Ecology Journal, V8, P92; Kaczensky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028057; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kroschel M, 2017, ANIMAL BIOTELEMETRY, V5, P10, DOI [10.1186/s40317-017-0125-z, DOI 10.1186/S40317-017-0125-Z]; Linnell JDC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002483; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; Lyftingsmo E, 2016, THESIS; Milner-Gulland EJ, 2011, ANIMAL MIGRATIONS A; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Mosser AA, 2014, J ANIM ECOL, V83, P916, DOI 10.1111/1365-2656.12187; Nandintsetseg D, 2016, BIOL CONSERV, V204, P313, DOI 10.1016/j.biocon.2016.10.021; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Rubenstein DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138645; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; St-Louis A, 2017, BEHAVIOUR, V154, P357, DOI 10.1163/1568539X-00003425; Strand O, 2015, MIDT I FLOKKEN; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson ID, 2015, CAN J ZOOL, V93, P87, DOI 10.1139/cjz-2014-0140; Thompson ID, 2012, WILDLIFE SOC B, V36, P365, DOI 10.1002/wsb.130; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; von Wehrden H, 2009, PHYTOCOENOLOGIA, V39, P331, DOI 10.1127/0340-269X/2009/0039-0331; Walzer C, 2007, MONGOLIAN J BIOL SCI, V4, P19; Wang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146725; Watanabe YY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2376; Wilson RP, 2014, FRONT ECOL ENVIRON, V12, P582, DOI 10.1890/140068; Wingard J., 2018, SILENT STEPPE II MON, DOI [10.13140/RG.2.2.18957.03049, DOI 10.13140/RG.2.2.18957.03049]; Wingard J., 2014, UNEPCMSCOP11DOC2332; Zhirnov LV, 1986, THE GREAT GOBI PARK	52	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217772	10.1371/journal.pone.0217772	http://dx.doi.org/10.1371/journal.pone.0217772			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163047	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200034
J	Wakie, TT; Yee, WL; Neven, LG; Kumar, S				Wakie, Tewodros T.; Yee, Wee L.; Neven, Lisa G.; Kumar, Sunil			Modeling the abundance of two Rhagoletis fly (Diptera: Tephritidae) pests in Washington State, USA	PLOS ONE			English	Article							CHERRY FRUIT-FLY; HOST-PLANT USE; APPLE MAGGOT; POMONELLA DIPTERA; RELATIVE-HUMIDITY; SOIL-MOISTURE; UNITED-STATES; HETEROGENEITY; ESTABLISHMENT; TEMPERATURE	Well-adapted and abundant insect pests can negatively affect agricultural production. We modeled the abundance of two Rhagoletis fly (Diptera: Tephritidae) pests, apple maggot fly, Rhagoletis pomonella (Walsh), and western cherry fruit fly, Rhagoletis indifferens Curran, in Washington State (WA), U. S. A. using biologically relevant environmental variables. We tested the hypothesis that abundance of the two species is influenced by different environmental variables, based on the fact that these two species evolved in different environments, have different host plants, and that R. pomonella is an introduced pest in WA while R. indifferens is native. We collected data on fly and host plant abundance at 61 randomly selected sites across WA in 2015 and 2016. We obtained land-cover, climate, and elevation data from online sources and used these data to derive relevant landscape variables and modeled fly abundance using generalized linear models. For R. pomonella, relatively high winter mean minimum temperature, low elevation, and developed land-cover were the top variables positively related to fly abundance. In contrast, for R. indifferens, the top variables related to greater fly abundance were high Hargreaves climatic moisture and annual heat-moisture deficits (indication of drier habitats), high host plant abundance, and developed land-cover. Our results identify key environmental variables driving Rhagoletis fly abundance in WA and can be used for understanding adaptation of insects to non-native and native habitats and for assisting fly quarantine and management decisions.	[Wakie, Tewodros T.; Yee, Wee L.; Neven, Lisa G.] USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA; [Kumar, Sunil] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	Wakie, TT (corresponding author), USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA.	Tewodros.wakie@ars.usda.gov	Kumar, Sunil/A-6730-2009	Neven, Lisa/0000-0003-2391-5652; Wakie, Tewodros/0000-0002-5760-0053	Washington Tree Fruit Research Commission through a grant from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program [58-5352-1-301]	Washington Tree Fruit Research Commission through a grant from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program	L.N., W.Y., and S.K. received funding from the Washington Tree Fruit Research Commission (https://www.treefruitresearch.com/), agreement number 58-5352-1-301, through a grant originating from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2018, CLIM ITH; [Anonymous], W CHERRY FRUIT FLY R; [Anonymous], 2018, CLIM HUDS; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Corcos D, 2017, INSECT CONSERV DIVER, V10, P462, DOI 10.1111/icad.12249; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DEAN R W, 1973, Search Agriculture (Geneva New York), V3, P1; Eastwell KC, 2005, FIELD GUIDE SWEET CH; Eide PM, 1949, WASHINGTON STATE AGR, V72, P1; ESRI, 2016, ARCGIS DESKT VERS 10; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Frick K.E., 1954, WASHINGTON AGR EXPT, V13, P1; Goedickemeier I., 1997, Coenoses, V12, P43; Grez AA, 2014, AGR FOREST ENTOMOL, V16, P382, DOI 10.1111/afe.12068; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); HARGREAVES GH, 1994, J IRRIG DRAIN ENG, V120, P1132, DOI 10.1061/(ASCE)0733-9437(1994)120:6(1132); Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hood GR, 2013, ANN ENTOMOL SOC AM, V106, P59, DOI 10.1603/AN12074; IPPC, 2017, 30 IPPC ISPM FAO UN; JENKS GF, 1971, ANN ASSOC AM GEOGR, V61, P217, DOI 10.1111/j.1467-8306.1971.tb00779.x; JONES SC, 1955, J ECON ENTOMOL, V48, P616, DOI 10.1093/jee/48.5.616; Kumar S, 2009, BIODIVERS CONSERV, V18, P739, DOI 10.1007/s10531-008-9536-8; Kumar S, 2016, J ECON ENTOMOL, V109, P2043, DOI 10.1093/jee/tow166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Lino LO, 2016, J AGR FOOD CHEM, V64, P4029, DOI 10.1021/acs.jafc.6b00104; Lyons C. P., 1995, TREES SHRUBS FLOWERS; Manosathiyadevan M., 2017, SUSTAINABLE AGR FOOD, P57, DOI DOI 10.1007/978-981-10-6647-4_4; Maxwell SA, 2014, AGR FOREST ENTOMOL, V16, P33, DOI 10.1111/afe.12029; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; McClintock T.C., 1967, OREG HIST QUART, V68, P153; McHugh TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13767; NASS, 2017, VAL WASH 2016 AGR PR, P1; NEILSON WTA, 1964, CAN ENTOMOL, V96, P810, DOI 10.4039/Ent96810-5; NEILSON WTA, 1971, J ECON ENTOMOL, V64, P648, DOI 10.1093/jee/64.3.648; Raghuvanshi Avadhesh Kumar, 2012, Journal of Plant Protection Research, V52, P264, DOI 10.2478/v10045-012-0042-3; Reich RM, 2014, FOREST SCI, V60, P308, DOI 10.5849/forsci.12-092; Schurich JA, 2014, J AM MOSQUITO CONTR, V30, P7, DOI 10.2987/13-6373.1; Senger S.E., 2007, THESIS; Sidder AM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1396; Sim SB, 2017, J ECON ENTOMOL, V110, P2599, DOI 10.1093/jee/tox248; Smith JJ, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P187; Team RC., 2013, R LANG ENV STAT COMP; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TROTTIER R, 1979, CAN ENTOMOL, V111, P975, DOI 10.4039/Ent111975-8; USGS, 2012, 100 MET RES EL US; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Western Regional Climate Center, 2018, CLIM SUMM; WSDA, 2017, 2017 IND CHERR WORKS; WSDA, 2018, PROP RUL CR 102 DEC, P1; Yee WL, 2017, CAN ENTOMOL, V149, P241, DOI 10.4039/tce.2016.49; Yee W. L., 2017, USDA COMPENDIUM FRUI; Yee WL, 2018, ENVIRON ENTOMOL, V47, P457, DOI 10.1093/ee/nvx209; Yee WL, 2015, PAN-PAC ENTOMOL, V91, P39, DOI 10.3956/2014-91.1.039; Yee WL, 2013, CAN ENTOMOL, V145, P317, DOI 10.4039/tce.2013.7; Yee WL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.12401; Yee WL, 2008, PAN-PAC ENTOMOL, V84, P179, DOI 10.3956/2007-49.1; Yee WL, 2008, PAN-PAC ENTOMOL, V84, P163, DOI 10.3956/2007-48.1; Yee WL, 2005, J ENTOMOL SCI, V40, P158, DOI 10.18474/0749-8004-40.2.158; Zhang Y, 2008, COLD REG SCI TECHNOL, V52, P355, DOI 10.1016/j.coldregions.2007.07.001	64	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217071	10.1371/journal.pone.0217071	http://dx.doi.org/10.1371/journal.pone.0217071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158239	gold, Green Submitted, Green Published			2022-12-27	WOS:000469915700009
J	Borys, AM; Seweryn, M; Golabek, T; Belch, L; Klimkowska, A; Toton-zuranskal, J; Machlowska, J; Chlosta, P; Okon, K; Wolkow, PP				Borys, Agnieszka M.; Seweryn, Michel; Golabek, Tomasz; Belch, Lukasz; Klimkowska, Agnieszka; Toton-zuranskal, Justyna; Machlowska, Julita; Chlosta, Piotr; Okon, Krzysztof; Wolkow, Pawel P.			Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes	PLOS ONE			English	Article							MOUSE MODEL; PROTEIN; METASTASIS; PROGNOSIS; TARGET; TUMORS; PAX2	Renal carcinoma is the 20th most common cancer worldwide. Clear cell renal cell carcinoma is the most frequent type of renal cancer. Even in patients diagnosed at an early stage, characteristics of disease progression remain heterogeneous. Up-to-date molecular classifications stratify the ccRCC samples into two clusters. We analyzed gene expression in 23 T1 or T3 ccRCC samples. Unsupervised clustering divided this group into three clusters, two of them contained pure T1 or T3 samples while one contained a mixed group. We defined a group of 36 genes that discriminate the mixed cluster. This gene set could be associated with tumor classification into a higher stage and it contained significant number of genes coding for molecular transporters, channel and transmembrane proteins. External data from TCGA used to test our findings confirmed that the expression levels of those 36 genes varied significantly between T1 and T3 tumors. In conclusion, we found a clustering pattern of gene expression, informative for heterogeneity among T1 and T3 tumors of clear cell renal cell carcinoma.	[Borys, Agnieszka M.; Seweryn, Michel; Toton-zuranskal, Justyna; Machlowska, Julita; Wolkow, Pawel P.] Jagiellonian Univ, Med Fac, Ctr Med Genom OMICRON, Med Coll, Krakow, Poland; [Golabek, Tomasz; Belch, Lukasz; Chlosta, Piotr] Jagiellonian Univ, Med Fac, Chair & Dept Urol, Med Coll, Krakow, Poland; [Klimkowska, Agnieszka; Okon, Krzysztof] Jagiellonian Univ, Med Fac, Chair Pathomorphol, Med Coll, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Wolkow, PP (corresponding author), Jagiellonian Univ, Med Fac, Ctr Med Genom OMICRON, Med Coll, Krakow, Poland.	pawel.wolkow@uj.edu.pl	Okon, Krzysztof/D-1345-2011; Wolkow, Pawel/AAI-4222-2021; Totoń-Żurańska, Justyna/AAM-9149-2021; Borys, Agnieszka/AAL-9208-2021	Okon, Krzysztof/0000-0002-1921-5007; Wolkow, Pawel/0000-0002-9322-5545; Totoń-Żurańska, Justyna/0000-0001-5970-238X; Seweryn, Michal/0000-0002-9090-3435; Machlowska, Julita/0000-0001-9951-9248	Jagiellonian University Medical College [K/ZDS/005737]; Ohio Supercomputer Center [PAS0885-2]; PLGrid Infrastructure	Jagiellonian University Medical College; Ohio Supercomputer Center; PLGrid Infrastructure	This work was supported by Statutory Funds No. K/ZDS/005737, Jagiellonian University Medical College, www.uj.edu.pl, to PW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work used the HPC resources provided by the Ohio Supercomputer Center (GRANT #: PAS0885-2). This research was supported in part by PLGrid Infrastructure.	Amin M.B., 2010, AJCC CANC STAGING MA; Astudillo L, 2016, BIOCHIMIE, V125, P267, DOI 10.1016/j.biochi.2015.11.009; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brannon A Rose, 2010, Genes Cancer, V1, P152; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Doberstein K, 2011, CARCINOGENESIS, V32, P1713, DOI 10.1093/carcin/bgr195; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Hueber PA, 2008, CANCER LETT, V265, P148, DOI 10.1016/j.canlet.2008.02.016; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Javorhazy A, 2016, J CANCER RES CLIN, V142, P1947, DOI 10.1007/s00432-016-2207-3; Kaminska K, 2015, UROL ONCOL-SEMIN ORI, V33, P476, DOI 10.1016/j.urolonc.2015.07.010; Kirschner KM, 2014, J BIOL CHEM, V289, P24452, DOI 10.1074/jbc.M114.564336; Klatt MG, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1204504; Klatte T, 2008, J UROLOGY, V179, P1719, DOI 10.1016/j.juro.2008.01.018; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Larrinaga G, 2010, REGUL PEPTIDES, V165, P218, DOI 10.1016/j.regpep.2010.07.170; Lin D, 2016, CELL CYCLE, V15, P2414, DOI 10.1080/15384101.2016.1148843; Liu Q, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S7; Lochhead P, 2012, EUR J CANCER, V48, P3405, DOI 10.1016/j.ejca.2012.06.021; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; Morrissey JJ, 2013, J UROLOGY, V189, P1913, DOI 10.1016/j.juro.2012.11.034; Ning XH, 2016, ONCOL LETT, V11, P4095, DOI 10.3892/ol.2016.4504; Packer LM, 2007, INT J CANCER, V121, P784, DOI 10.1002/ijc.22725; Papadopoulos EI, 2015, CLIN BIOCHEM, V48, P590, DOI 10.1016/j.clinbiochem.2015.02.007; Paule B, 2000, J CLIN PATHOL, V53, P388, DOI 10.1136/jcp.53.5.388; Pietrzak M, 2016, TEST-SPAIN, V25, P654, DOI 10.1007/s11749-016-0489-z; Quaas A, 2015, WORLD J UROL, V33, P1561, DOI 10.1007/s00345-014-1463-6; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Ridge CA, 2014, SEMIN INTERVENT RAD, V31, P3, DOI 10.1055/s-0033-1363837; Sanders Edward, 2015, Oncoscience, V2, P151; Sen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048770; Shantha Kumara Hmc, 2015, Oncoscience, V2, P607; Shoji T, 2009, ATHEROSCLEROSIS, V207, P579, DOI 10.1016/j.atherosclerosis.2009.05.023; Sircar K, 2013, CHIN J CANCER, V32, P303, DOI 10.5732/cjc.012.10136; Steffens S, 2014, EUR J CANCER, V50, P739, DOI 10.1016/j.ejca.2013.11.020; Sun Y, 2014, MOL CELL BIOL, V34, P2409, DOI 10.1128/MCB.00104-14; Takahashi M, 2003, ONCOGENE, V22, P6810, DOI 10.1038/sj.onc.1206869; Takemura Y, 2010, PEDIATR NEPHROL, V25, P1349, DOI 10.1007/s00467-010-1463-8; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Wang L, 2013, ANAL CELL PATHOL, V36, P93, DOI [10.1155/2013/790698, 10.3233/ACP-130084]; Williamson SR, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.01.001; Yang J, 2013, EUR J CANCER, V49, P1479, DOI 10.1016/j.ejca.2012.10.027; Zand B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv426; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	52	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216793	10.1371/journal.pone.0216793	http://dx.doi.org/10.1371/journal.pone.0216793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150395	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100023
J	Mendes, SR; Martins, RC; Mambrini, JVM; Matta-Machado, ATG; Mattos, GCM; Gallagher, JE; Abreu, MHNG				Mendes, Suellen R.; Martins, Renata C.; Mambrini, Juliana V. M.; Matta-Machado, Antonio Thomaz G.; Mattos, Grazielle C. M.; Gallagher, Jennifer E.; Abreu, Mauro H. N. G.			Using Item Response Theory to evaluate the psychometric characteristics of questions in a Brazilian programme and the performance of dental teams in primary care	PLOS ONE			English	Article							ORAL-HEALTH; QUALITY	Objectives First, to assess the psychometric properties of key questions included in a public sector evaluation of primary dental care in Brazil; and second, to evaluate the performance of dental teams in relation to these items. Methods Secondary analysis of a national primary care dataset monitoring quality and access to dental care. Data were collected through face-to-face interviews with representatives of dental teams participating in the 'National Programme for Improving Access and Quality of Primary Care'. Twenty-three mandatory questions about the dentists' reported delivery of dental procedures were included in the analysis. Item Response Theory (IRT) modelling was applied to measure the psychometric properties of the instrument-level of difficulty and discrimination parameter of each item-and then to estimate dental team performance scores based on these parameters. Based on IRT, possible scores ranged from -4 to + 4. Results Three of the 23 mandatory items were removed due to poor internal consistency, resulting in a scale of 20 items for assessing dental team performance. The results showed variation in procedures delivered by the dental teams; whilst more than a half of the procedures were executed by at least 80% of the dental teams, those relating to dentures (partial/total) and frenectomy (lingual/labial) were performed by less than 30%. Amongst the 20 items included in the model, those related to partial/total dentures and oral cancer follow-up presented higher levels of difficulty and were less frequently provided. The items relating to the treatment of deciduous teeth and access to the dental pulp of permanent teeth had the highest discrimination parameters and, consequently, greater weight in the performance's score estimation; therefore, dental teams that did not perform these items had the lowest performance scores. In the present study, dental team performance scores ranged from -3.66 to +1.87 with a mean/median of -0.06/+0.01. Conclusion The findings suggest that whilst the items within the instrument demonstrated some potential to discriminate between poor and very poor teams, they were ineffective in discriminating between poor and good teams. Whilst Brazilian dental teams perform many mandatory procedures, variation in the nature of their delivery of care requires further investigation to enhance service provision to the population.	[Mendes, Suellen R.] Univ Fed Minas Gerais, Fac Dent, Grad Program Dent, Belo Horizonte, MG, Brazil; [Martins, Renata C.; Abreu, Mauro H. N. G.] Univ Fed Minas Gerais, Fac Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Mambrini, Juliana V. M.] Fiocruz MS, Rene Rachou Inst, Belo Horizonte, MG, Brazil; [Matta-Machado, Antonio Thomaz G.] Univ Fed Minas Gerais, Fac Med, Dept Prevent & Social Med, Belo Horizonte, MG, Brazil; [Mattos, Grazielle C. M.; Gallagher, Jennifer E.] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Host Microbiome Interact, London, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; University of London; King's College London	Abreu, MHNG (corresponding author), Univ Fed Minas Gerais, Fac Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil.	maurohenriqueabreu@gmail.com	de Melo Mambrini, Juliana Vaz/AAO-9462-2021; Abreu, Mauro Henrique/G-6502-2012; Martins, Renata/AAL-7123-2020	Abreu, Mauro Henrique/0000-0001-8794-5725; Martins, Renata/0000-0002-8911-0040	Brazilian research agency: Coordination of Superior Level Staff Improvement (CAPES, in Portuguese: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Brazilian research agency: Brazilian National Council for Scientific and Technological Development (CNPq, in Portuguese: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Brazilian research agency: Research Support Foundation of the State of Minas Gerais (FAPEMIG, in Portuguese: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	Brazilian research agency: Coordination of Superior Level Staff Improvement (CAPES, in Portuguese: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Brazilian research agency: Brazilian National Council for Scientific and Technological Development (CNPq, in Portuguese: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Brazilian research agency: Research Support Foundation of the State of Minas Gerais (FAPEMIG, in Portuguese: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	The authors would like to thank the financial support of the Brazilian research agencies: Coordination of Superior Level Staff Improvement (CAPES, in Portuguese: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), The Brazilian National Council for Scientific and Technological Development (CNPq, in Portuguese: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), and Research Support Foundation of the State of Minas Gerais (FAPEMIG, in Portuguese: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) and also Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bhakta Bipin, 2005, BMC Med Educ, V5, P9, DOI 10.1186/1472-6920-5-9; Bourion-Bedes S, 2015, QUAL LIFE RES, V24, P287, DOI 10.1007/s11136-014-0772-y; Brasil. Ministerio da Saude. Secretaria de Atencao Saude. Departamento de Atencao Basica, 2015, VERS PREL NOT MET CE; Cascaes AM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/s1679-49742018000100015, 10.5123/S1679-49742018000100015]; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Gallagher JE, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0037-z; Cunha MAGM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4536707; Gordon RA, 2015, J MARRIAGE FAM, V77, P147, DOI 10.1111/jomf.12157; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Hassona Y, 2016, J CANCER EDUC, V31, P285, DOI 10.1007/s13187-015-0823-2; Hays RD, 2000, MED CARE, V38, P28; Mendes SR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121480; Ministerio da Saude, 2013, PROGR NAC MELH AC QU; Ministerio da Saude (BR), 2012, HIGIENE MAOS PROFISS; Nascimento AC, 2013, INT DENT J, V63, P237, DOI 10.1111/idj.12039; Neves RG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300008, 10.5123/s1679-49742018000300008]; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Peres MA, 2013, REV SAUDE PUBLICA S3, V47, P1; Pucca Junior Gilberto Alfredo, 2009, Braz. oral res., V23, P9, DOI 10.1590/S1806-83242009000500003; Reeve C, 2015, EVAL PROGRAM PLANN, V53, P91, DOI 10.1016/j.evalprogplan.2015.08.006; Rizopoulos D, 2006, J STAT SOFTW, V17; dos Reis CMR, 2017, J PUBLIC HEALTH DENT, V77, P317, DOI 10.1111/jphd.12210; dos Reis CMR, 2015, INT J ENV RES PUB HE, V12, P667, DOI 10.3390/ijerph120100667; sage.saude.gov.br, 2018, BRAZ SUPP SIT STRAT; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Saurman E, 2016, J HEALTH SERV RES PO, V21, P36, DOI 10.1177/1355819615600001; Scherer CI, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005961; Shaw C., 2003, WHAT IS EVIDENCE SCH; Sun XY, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4384-7; van der Waal Isaac, 2013, Med Oral Patol Oral Cir Bucal, V18, pe33; World Dental Federation-FDI, FDI ICHOM PRESENT ST; Yang Frances M, 2014, Shanghai Arch Psychiatry, V26, P171, DOI 10.3969/j.issn.1002-0829.2014.03.010	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217249	10.1371/journal.pone.0217249	http://dx.doi.org/10.1371/journal.pone.0217249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150438	Green Published, gold			2022-12-27	WOS:000469759100037
J	Russo, LX; Scott, A; Sivey, P; Dias, J				Russo, Leticia Xander; Scott, Anthony; Sivey, Peter; Dias, Joilson			Primary care physicians and infant mortality: Evidence from Brazil	PLOS ONE			English	Article							FAMILY-HEALTH-PROGRAM; CHILDHOOD MORTALITY; NEONATAL-MORTALITY; MIDDLE-INCOME; IMPACT; SYSTEMS; DETERMINANTS; SANITATION; EXPANSION; COUNTRIES	Primary health care has been recognized as a critical strategy for improving population health in developing countries. This paper investigates the effect of primary care physicians on the infant mortality rate in Brazil using a dynamic panel data approach. This method accounts for the endogeneity problem and the persistence of infant mortality over time. The empirical analysis uses an eight-year panel of municipalities between 2005 and 2012. The results indicate that primary care physician supply contributed to the decline of infant mortality in Brazil. An increase of one primary care physician per 10,000 population was associated with 7.08 fewer infant deaths per 10,000 live births. This suggests that, in addition to other determinants, primary care physicians can play an important role in accounting for the reduction of infant mortality rates.	[Russo, Leticia Xander; Dias, Joilson] Univ Estadual Maringa, Dept Econ, Maringa, Parana, Brazil; [Scott, Anthony] Univ Melbourne, Melbourne Inst Appl Econ & Social Res, Melbourne, Vic, Australia; [Sivey, Peter] RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia	Universidade Estadual de Maringa; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Scott, A (corresponding author), Univ Melbourne, Melbourne Inst Appl Econ & Social Res, Melbourne, Vic, Australia.	a.scott@unimelb.edu.au	Russo, Leticia X/H-4485-2017; Scott, Anthony/E-6636-2010	Russo, Leticia X/0000-0001-9592-8212; Scott, Anthony/0000-0002-2851-5378; Sivey, Peter/0000-0002-3703-615X	Coordination of Improvement of Higher Level Personnel (CAPES), Ministry of Education of Brazil	Coordination of Improvement of Higher Level Personnel (CAPES), Ministry of Education of Brazil	Funded by Coordination of Improvement of Higher Level Personnel (CAPES), Ministry of Education of Brazil.	Aakvik A, 2006, J HEALTH ECON, V25, P1139, DOI 10.1016/j.jhealeco.2006.04.001; Andrade MV, 2009, EST EC, V39, P31; [Anonymous], 1978, WHO DECL ALM AT INT; [Anonymous], 2016, 28 IPEA; [Anonymous], 2017, WHO WHO DAT; [Anonymous], 2015, WHO MILL DEV GOALS R; ANS, NAT REG AG PRIV HLTH; Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Arellano M, 1991, REV ECON STUD, V58, P20; Arulampalam W, 2006, 2488IZA; Barros FC, 2010, AM J PUBLIC HEALTH, V100, P1877, DOI 10.2105/AJPH.2010.196816; Basu S, 2019, JAMA INT MED; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Cambota JN, 2015, PESQUISA PLANEJAMENT, V45, P24; Fontes LFC, 2018, HEALTH ECON, V27, P1284, DOI 10.1002/hec.3775; de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113; do Nascimento RM, 2012, CAD SAUDE PUBLICA, V28, P559, DOI 10.1590/S0102-311X2012000300016; Escorel S, 2007, REV PANAM SALUD PUBL, V21, P164; Ezeh OK, 2014, INT J ENV RES PUB HE, V11, P9256, DOI 10.3390/ijerph110909256; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Feres BCJ, 2017, 1729 HEDG WP U YORK; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Gamper-Rabindran S, 2010, J DEV ECON, V92, P188, DOI 10.1016/j.jdeveco.2009.02.006; Menicucci TMG, 2009, CAD SAUDE PUBLICA, V25, P1620, DOI 10.1590/S0102-311X2009000700021; Guanais FC, 2013, AM J PUBLIC HEALTH, V103, P2000, DOI 10.2105/AJPH.2013.301452; Guimarães Maria José Bezerra, 2003, Cad. Saúde Pública, V19, P1413, DOI 10.1590/S0102-311X2003000500020; Kassouf AL, 2005, REV EC SOCIOL RURAL, V43; MacDorman MF, 2009, PUBLIC HEALTH REP, V124, P670, DOI 10.1177/003335490912400509; Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Macinko J, 2007, SOC SCI MED, V65, P2070, DOI 10.1016/j.socscimed.2007.06.028; Macinko J, 2015, NEW ENGL J MED, V373, P1278, DOI 10.1056/NEJMc1509056; Macinko J, 2011, AM J PUBLIC HEALTH, V101, P1963, DOI 10.2105/AJPH.2010.198887; Macinko J, 2010, HEALTH AFFAIR, V29, P2149, DOI 10.1377/hlthaff.2010.0251; Macinko J, 2009, J AMBUL CARE MANAG, V32, P150, DOI 10.1097/JAC.0b013e3181994221; Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829; Mishra P, 2009, J HEALTH ECON, V28, P855, DOI 10.1016/j.jhealeco.2009.05.004; O'Hare B, 2013, J ROY SOC MED, V106, P408, DOI 10.1177/0141076813489680; Preston SH, 1975, POPULATION STUDIES, V29; Rasella D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002570; Rasella Davide, 2014, BMJ, V349, pg4014, DOI 10.1136/bmj.g4014; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Rasella D, 2010, PEDIATRICS, V126, pE534, DOI 10.1542/peds.2009-3197; Ribeiro AM, 2009, REV SAUDE PUBL, V43, P246, DOI 10.1590/S0034-89102009005000004; Rocha R, 2010, HEALTH ECON, V19, P126, DOI 10.1002/hec.1607; Roodman D., 2009, OXFORD B ECON STAT, V71, P23; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Saparolli ECL, 2007, ACTA PAUL ENFERM, V20, P7; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078; Sousa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074772; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; de Andrade CLT, 2007, CAD SAUDE PUBLICA, V23, P1207, DOI 10.1590/S0102-311X2007000500022; UNICEF W, 2009, DIARRH WHY CHILDR AR; Van de Poel E, 2009, DEMOGRAPHY, V46, P827, DOI 10.1353/dem.0.0074; Volpe FM, 2009, REV PANAM SALUD PUBL, V26, P478, DOI 10.1590/S1020-49892009001200002; Windmeijer F, 2005, J ECONOMETRICS, V126, P25, DOI 10.1016/j.jeconom.2004.02.005; Wooldridge Jr M, 2001, ECONOMETRIC ANAL CRO	61	13	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217614	10.1371/journal.pone.0217614	http://dx.doi.org/10.1371/journal.pone.0217614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150468	Green Published, Green Accepted, gold			2022-12-27	WOS:000469759100072
J	Sandfort, TGM; Dominguez, K; Kayange, N; Ogendo, A; Panchia, R; Chen, YQ; Chege, W; Cummings, V; Guo, X; Hamilton, EL; Stirratt, M; Eshleman, SH				Sandfort, Theo G. M.; Dominguez, Karen; Kayange, Noel; Ogendo, Arthur; Panchia, Ravindre; Chen, Ying Q.; Chege, Wairimu; Cummings, Vanessa; Guo, Xu; Hamilton, Erica L.; Stirratt, Michael; Eshleman, Susan H.			HIV testing and the HIV care continuum among sub-Saharan African men who have sex with men and transgender women screened for participation in HPTN 075	PLOS ONE			English	Article							KEY POPULATIONS; HIGH PREVALENCE; INFECTION; RISK; INTERVENTIONS; STIGMA; PREVENTION; GAY; MSM; EPIDEMIOLOGY	Throughout the world, men who have sex with men (MSM) are at increased risk for HIV infection compared to heterosexual men. Little is known about awareness of HIV infection and other gaps in the HIV care continuum for MSM, especially in sub-Saharan Africa (SSA). This information is urgently needed to address the HIV epidemic in this population. This study assessed gaps in the HIV care continuum among persons screened for participation in a multi-country prospective study that evaluated the feasibility of recruiting and retaining MSM for HIV prevention studies in SSA (HIV Prevention Trials Network (HPTN) 075, conducted in four cities in Kenya, Malawi, and South Africa). Participants were recruited using site-specific strategies, that included outreach and informal networks. Transgender women (TW) were eligible to participate. During screening, 601 MSM and TW were tested for HIV infection and asked about prior HIV testing, HIV status, engagement in care, and HIV treatment. Viral load testing and retrospective antiretroviral (ARV) drug testing were performed for HIV-infected participants. Most participants (92.2%) had a prior HIV test; 42.1% were last tested >6 months earlier. HIV prevalence was 30.4%. HIV infection was associated with older age and identifying as female or transgender; 43.7% of the HIV-infected participants were newly diagnosed, especially younger persons and persons with a less recent HIV test. Almost a third of previously-diagnosed participants were not linked to care. Most participants (88.7%) in care were on ARV treatment (ART). Only about one-quarter of all HIV-infected participants were virally suppressed. These findings demonstrate substantial prevalence of undiagnosed HIV infection and sub-optimal HIV care engagement among MSM and TW in SSA. Increased HIV testing frequency and better linkage to care represent critical steps in preventing further HIV transmission in this population. Once in care, gaps in the HIV care continuum appear less critical.	[Sandfort, Theo G. M.] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA; [Dominguez, Karen] UCT Med Sch, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Kayange, Noel] Johns Hopkins Med Coll, Blantyre, Malawi; [Ogendo, Arthur] Kenya Med Res Inst KEMRI CDC, Kisumu, Kenya; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto HPTN CRS, Soweto, South Africa; [Chen, Ying Q.; Guo, Xu] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Chege, Wairimu] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cummings, Vanessa; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hamilton, Erica L.] FHI, Sci Facilitat Dept, Durham, NC USA; [Stirratt, Michael] NIMH, Div AIDS Res, Bethesda, MD 20892 USA	Columbia University; University of Cape Town; Kenya Medical Research Institute; University of Witwatersrand; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sandfort, TGM (corresponding author), Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA.	tgs2001@cumc.columbia.edu	Sandfort, Theo/D-1796-2011	Sandfort, Theo/0000-0002-4986-1739; Chen, Ying Qing/0000-0002-2726-3391; Hamilton, Erica L./0000-0003-1174-9263	National Institute of Allergy and Infectious Diseases; National Institute of Mental Health of the National Institutes of Health [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health [P30 MH43520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069518, UM1AI068617, UM1AI068613, UM1AI069453, UM1AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases and the National Institute of Mental Health of the National Institutes of Health under award number UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institute of Mental Health. Sandfort received additional support from the National Institute of Mental Health, P30 MH43520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bowring AL, 2016, AIDS BEHAV, V20, P2243, DOI 10.1007/s10461-015-1281-x; Cao BL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7997; Carroll A, 2017, STATE SPONSORED HOMO; Cock J, 2003, WOMEN STUD INT FORUM, V26, P35, DOI 10.1016/S0277-5395(02)00353-9; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Crowell TA, 2019, ANN EPIDEMIOL, V31, P11, DOI 10.1016/j.annepidem.2018.12.004; Djomand G, 2014, CURR OPIN HIV AIDS, V9, P506, DOI 10.1097/COH.0000000000000090; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Fogel JM, 2019, AIDS BEHAV, V23, P289, DOI 10.1007/s10461-018-2231-1; Freeland R, 2018, AIDS BEHAV, V22, P1614, DOI 10.1007/s10461-017-1975-3; Gelmon L, 2009, KENYA HIV PREVENTION; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hakim A, 2017, SEX TRANSM DIS, V44, P565, DOI 10.1097/OLQ.0000000000000655; Hergenrather KC, 2016, AIDS EDUC PREV, V28, P252, DOI 10.1521/aeap.2016.28.3.252; Hoad Neville Wallace, 2005, SEX POLITICS S AFRIC; Keane J, 2017, AIDS BEHAV, V21, P1745, DOI 10.1007/s10461-016-1532-5; Kellerman S, 2012, EPIDEMIOLOGY HIV EPI; Keshinro B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21270; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kohut A, 2013, GLOBAL DIVIDE HOMOSE, P4; Krishnaratne S, 2016, LANCET HIV, V3, pE307, DOI 10.1016/S2352-3018(16)30038-8; Kunzweiler CP, 2017, JAIDS-J ACQ IMM DEF, V76, P241, DOI 10.1097/QAI.0000000000001512; Laar A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0129-z; Lane T, 2016, JAIDS-J ACQ IMM DEF, V73, P609, DOI 10.1097/QAI.0000000000001162; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Logie CH, 2017, J INT AIDS SOC, V20, DOI [10.7448/IAS.20.01/21422, 10.7448/IAS.20.1.21385, 10.7448/IAS.20.1.21422]; Lyons CE, 2017, JAIDS-J ACQ IMM DEF, V74, pS52, DOI 10.1097/qai.0000000000001209; Maleke K, 2019, GLOB HEALTH PROMOT, V26, P6, DOI 10.1177/1757975917737509; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Mmbaga EJ, 2018, JAIDS-J ACQ IMM DEF, V77, P243, DOI [10.1097/qai.0000000000001593, 10.1097/QAI.0000000000001593]; Mumtaz GR, 2013, SEX TRANSM INFECT, V89, P49, DOI 10.1136/sextrans-2012-050844; Poteat T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002422; Poteat T, 2016, GLOB PUBLIC HEALTH, V11, P835, DOI 10.1080/17441692.2015.1134615; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Reid G, 2010, SOC DYNAMICS, V36, P38, DOI 10.1080/02533950903561221; Reisner SL, 2016, CURR OPIN ENDOCRINOL, V23, P198, DOI 10.1097/MED.0000000000000229; Reisner SL, 2014, ARCH SEX BEHAV, V43, P1503, DOI 10.1007/s10508-014-0314-2; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Sandfort TGM, 2018, ARCH SEX BEHAV, V47, P2481, DOI 10.1007/s10508-018-1168-9; Sandfort TGM, 2015, AIDS BEHAV, V19, P561, DOI 10.1007/s10461-014-0843-7; Sandfort TGM, 2015, AIDS BEHAV, V19, P2270, DOI 10.1007/s10461-015-1067-1; Sevelius JM, 2016, GLOB PUBLIC HEALTH, V11, P1060, DOI 10.1080/17441692.2016.1154085; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stahlman S, 2016, J INT AIDS SOC, V19, P5, DOI 10.7448/IAS.19.3.20774; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; Thoreson R, 2011, NOWHERE TURN BLACKMA; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; Wirtz AL, 2017, LANCET HIV, V4, pE260, DOI 10.1016/S2352-3018(17)30042-5; Zhang YF, 2018, AIDS, V32, P1301, DOI 10.1097/QAD.0000000000001839	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217501	10.1371/journal.pone.0217501	http://dx.doi.org/10.1371/journal.pone.0217501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150447	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100060
J	Zhong, ZM; Zhang, GY; Zhang, HR				Zhong, Zhiming; Zhang, Guangyu; Zhang, Haorui			Impact of diurnal unsymmetrical warming on soil respiration in an agroecological system of the Lhasa region	PLOS ONE			English	Article							ALPINE MEADOW; TIBETAN PLATEAU; GROWING-SEASON; CLIMATIC FACTORS; INCREASED PRECIPITATION; ECOSYSTEM RESPIRATION; MICROBIAL BIOMASS; NITROGEN ADDITION; VEGETATION INDEX; PLANT-PRODUCTION	Purpose The impact of diurnal unsymmetrical rise in temperature on soil respiration (Rs) is not fully understood; thus, we explored such a warming influence on Rs in an agroecological system of the Lhasa. Materials and methods A field warming experiment (C: control; DW: daytime warming; NW: nighttime warming; DW +NW: daytime plus nighttime warming) was carried out in a naked barley ecological system. Results and discussion The DW, NW and DW+ NW treatments dramatically increased soil temperature and decreased soil moisture but did not markedly modify R-s. The effects of DW and NW on soil respiration sensitivity (Q(10)) during the daytime and nighttime were different; they had no effects on daytime Q(10) of R-s, but a significant inhibitory effect on nighttime Q(10) of R-s. Conclusions A diurnal unsymmetrical rise in temperature brought about different results for the Q(10) of Rs but did not cause changes in Rs under different experimental treatments in agroecological systems of the Lhasa.	[Zhong, Zhiming; Zhang, Guangyu; Zhang, Haorui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosystem Network Observat & Modeling, Beijing, Peoples R China; [Zhang, Guangyu; Zhang, Haorui] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HR (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosystem Network Observat & Modeling, Beijing, Peoples R China.; Zhang, HR (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhanghr.18s@igsnrr.ac.cn			National Natural Science Foundation of China [31370458, 31600432, 41571042]; National Key R&D Program of China [2017YFA0604801, 2016YFC0502005]; Youth Innovation Research Team Project [LENOM2016Q0002]; Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2018RC202]; Tibet Science and Technology Major Projects of the Pratacultural Industry [XZ201901NA03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Youth Innovation Research Team Project; Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences; Tibet Science and Technology Major Projects of the Pratacultural Industry	The research was sponsored by the National Natural Science Foundation of China [31370458, 31600432, 41571042], National Key R&D Program of China [2017YFA0604801, 2016YFC0502005], Youth Innovation Research Team Project [LENOM2016Q0002], the Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2018RC202] and the Tibet Science and Technology Major Projects of the Pratacultural Industry [XZ201901NA03]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai E, 2013, NEW PHYTOL, V199, P441, DOI 10.1111/nph.12252; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Chen J, 2016, AGR FOREST METEOROL, V220, P21, DOI 10.1016/j.agrformet.2016.01.010; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Feng JG, 2017, ATMOS ENVIRON, V150, P181, DOI 10.1016/j.atmosenv.2016.11.060; Fu G., 2010, ACTA ECOL SIN, V30, P264, DOI [10.1016/j.chnaes.2010.08.007, DOI 10.1016/J.CHNAES.2010.08.007]; Fu G, 2019, SCI TOTAL ENVIRON, V650, P2666, DOI 10.1016/j.scitotenv.2018.09.384; Fu G, 2018, AGR FOREST METEOROL, V249, P11, DOI 10.1016/j.agrformet.2017.11.017; Fu G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16645-2; [付刚 Fu Gang], 2017, [生态环境学报, Ecology and Environmental Sciences], V26, P49; Fu G, 2017, APPL SOIL ECOL, V114, P99, DOI 10.1016/j.apsoil.2017.03.008; Fu G, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2387-8; Fu G, 2016, J PLANT GROWTH REGUL, V35, P974, DOI 10.1007/s00344-016-9595-0; Fu G, 2016, CAN J REMOTE SENS, V42, P16, DOI 10.1080/07038992.2016.1131115; Fu G, 2015, J MT SCI-ENGL, V12, P935, DOI 10.1007/s11629-014-3035-z; Fu G, 2015, J PLANT GROWTH REGUL, V34, P57, DOI 10.1007/s00344-014-9442-0; Fu G, 2014, POL J ECOL, V62, P17, DOI 10.3161/104.062.0103; Fu G, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073505; Fu G, 2013, J MT SCI-ENGL, V10, P455, DOI 10.1007/s11629-013-2360-y; Fu G, 2012, APPL SOIL ECOL, V61, P158, DOI 10.1016/j.apsoil.2012.05.002; Fu G, 2012, EUR J SOIL BIOL, V52, P27, DOI 10.1016/j.ejsobi.2012.05.004; HARVEY LDD, 1995, NATURE, V377, P15, DOI 10.1038/377015a0; IPCC, 2018, SUMMARY POLICYMAKERS; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Landman W, 2010, S AFR GEOGR J, V92, P86, DOI 10.1080/03736245.2010.480842; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Pan SF, 2015, J GEOGR SCI, V25, P1027, DOI 10.1007/s11442-015-1217-4; Peng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102265; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shen ZX, 2016, POL J ECOL, V64, P125, DOI 10.3161/15052249PJE2015.64.1.011; Shen ZX, 2015, APPL SOIL ECOL, V90, P35, DOI 10.1016/j.apsoil.2015.01.015; Shen ZX, 2014, REMOTE SENS-BASEL, V6, P6765, DOI 10.3390/rs6086765; Wan JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148072; Wang J, 2013, BIOL TRACE ELEM RES, V156, P367, DOI 10.1007/s12011-013-9822-5; Wang SH, 2015, POL J ECOL, V63, P424, DOI 10.3161/15052249PJE2015.63.3.012; Wang X, 2014, GLOBAL CHANGE BIOL, V20, P3229, DOI 10.1111/gcb.12620; Wu JS, 2018, REMOTE SENS LETT, V9, P150, DOI [10.1080/2150704X.2017.1407045, 10.1080/2150704x.2017.1407045]; Yang G.H., 1996, PRODUCTIVITY LAND RE, P44; Yu CQ, 2019, SCI TOTAL ENVIRON, V647, P1490, DOI 10.1016/j.scitotenv.2018.08.111; Yu Cheng-Qun, 2014, ScientificWorldJournal, V2014, P152576, DOI 10.1155/2014/152576; Yu CQ, 2019, SCI TOTAL ENVIRON, V655, P814, DOI 10.1016/j.scitotenv.2018.11.309; Zhang XZ, 2015, APPL SOIL ECOL, V87, P32, DOI 10.1016/j.apsoil.2014.11.012; Zhang XZ, 2000, AGR FOREST METEOROL, V102, P207, DOI 10.1016/S0168-1923(00)00093-9; Zhong ZM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1761-0; [周玉科 Zhou Yuke], 2017, [地理与地理信息科学, Geography and Geo-information Science], V33, P64	51	2	2	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217575	10.1371/journal.pone.0217575	http://dx.doi.org/10.1371/journal.pone.0217575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141568	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000063
J	Fermaut, M; Fauconnier, A; Brossard, A; Razafimamonjy, J; Fritel, X; Serfaty, A				Fermaut, Marion; Fauconnier, Arnaud; Brossard, Aurelie; Razafimamonjy, Jimmy; Fritel, Xavier; Serfaty, Annie			Detection of complicated ectopic pregnancies in the hospital discharge database: A validation study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; ACCURACY; SYSTEM; HEALTH; CANCER; ERRORS	Objective Complicated ectopic pregnancies with severe bleeding (CEPSB) are life-threatening situations and should be considered maternal near-miss cases. Previous studies have found an association between severe maternal morbidity secondary to CEPSB and substandard care. Almost all women with CEPSB are hospitalized, generating administrative and medical records. The objective of this study was to propose a method to measure the validity of the hospital discharge database (HDD) to detect CEPSB among hospital stays in two gynecological units. Methods We included all hospital stays of women who were 18-45 years old and hospitalized for acute pelvic pain or/and metrorrhagia in the two hospitals. The HDD was compared to medical data (gold standard). Two algorithms constructed from the International Classification of Disease (ICD-10) and Common Classification of Medical Procedures (CCAM), were applied to the HDD: a "predefined algorithm" according to coding guidelines and a "pragmatic algorithm" based on coding practices. Sensitivity, specificity and positive likelihood-ratios were calculated. False negatives and positives were analyzed to describe coding practices. Results Among 370 hospital stays included, 52 were classified as CEPSB cases. The "predefined algorithm" gave a sensitivity of 23.1% (95% CI: 11.6-34.5) and a specificity of 99.1% (95% CI: 98.0-100.0) to identify CEPSB. The "pragmatic algorithm" gave a sensitivity of 63.5% (95% CI: 50.4-76.5) and a specificity of 94.7% (95% CI: 92.2-97.5) to identify CEPSB. Coding errors (77.6%) were due to misuse of diagnosis codes and because complications were not coded. Conclusion HDD is not reliable enough to detect CEPSB due to incorrect coding practices. However, it could be an ideal tool to monitor quality of care if a culture in data quality assessment is developed to improve quality of medical information.	[Fermaut, Marion; Fauconnier, Arnaud] Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynecol & Obstet, Poissy, France; [Fermaut, Marion; Fauconnier, Arnaud; Serfaty, Annie] UVSQ, EA 7285, Res Unit Risk & Safety Clin Med Women & Perinatal, Montigny Le Bretonneux, France; [Brossard, Aurelie; Fritel, Xavier] Univ Hosp Ctr Poitiers, Dept Gynecol & Obstet, Poitiers, France; [Razafimamonjy, Jimmy] Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Med Informat, Poissy, France; [Fritel, Xavier] Univ Hosp Ctr Poitiers, INSERM, CIC 1402, Poitiers, France; [Serfaty, Annie] Eastern Parisian Univ Hosp, AP HP, Dept Med Informat, Paris, France; [Serfaty, Annie] Reg Agcy Hlth Paris Reg Direct Hlth Promot & Ineq, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP)	Serfaty, A (corresponding author), UVSQ, EA 7285, Res Unit Risk & Safety Clin Med Women & Perinatal, Montigny Le Bretonneux, France.; Serfaty, A (corresponding author), Eastern Parisian Univ Hosp, AP HP, Dept Med Informat, Paris, France.; Serfaty, A (corresponding author), Reg Agcy Hlth Paris Reg Direct Hlth Promot & Ineq, Paris, France.	annieserfatydr@yahoo.fr	FRITEL, Xavier/K-8566-2012	FRITEL, Xavier/0000-0002-4987-8127; SERFATY, Annie/0000-0002-3973-5210	Woman's Health Research Institute (France)	Woman's Health Research Institute (France)	This work was supported by the Woman's Health Research Institute (France) for conducting the research.	Allanson ER, 2016, BJOG-INT J OBSTET GY, V123, P2037, DOI 10.1111/1471-0528.14246; American College of Obstetricians and Gynecologists' Committee on Practice BulletinsGynecology, 2018, Obstet Gynecol, V131, pe91, DOI 10.1097/AOG.0000000000002560; [Anonymous], 2016, BJOG, V123, pe15, DOI 10.1111/1471-0528.14189; Baldi I, 2008, J CLIN EPIDEMIOL, V61, P373, DOI 10.1016/j.jclinepi.2007.05.017; Bhattacharya AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211265; Bouyer J, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, pS8; Chantry AA, 2012, REV EPIDEMIOL SANTE, V60, P177, DOI 10.1016/j.respe.2011.11.003; Chantry AA, 2011, J CLIN EPIDEMIOL, V64, P1014, DOI 10.1016/j.jclinepi.2010.11.015; Coste J, 2004, HUM REPROD, V19, P2014, DOI 10.1093/humrep/deh399; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Couris CM, 2004, REV EPIDEMIOL SANTE, V52, P151, DOI 10.1016/S0398-7620(04)99036-0; DUSSAUCY A, 1994, REV EPIDEMIOL SANTE, V42, P345; Grimes DA, 2006, AM J OBSTET GYNECOL, V194, P92, DOI 10.1016/j.ajog.2005.06.070; Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300; HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; LOMBRAIL P, 1994, REV EPIDEMIOL SANTE, V42, P334; Mavrelos D, ULTRASOUND OBSTET GY, V42, P102; Ministry of Health, 2012, B OFFICIEL, P126; Ministry of Health, 1991, J OFFICIEL REPUBLIQU; Ministry of Health, 2004, J OFFICIEL REPUBLIQU, P14277; Misset B, 2008, CRIT CARE, V12, DOI 10.1186/cc6969; Quan H, 2004, J CLIN EPIDEMIOL, V57, P366, DOI 10.1016/j.jclinepi.2003.01.002; Serfaty A, 2017, REV EPIDEMIOL SANTE, V65, pS209, DOI 10.1016/j.respe.2017.06.002; Serfaty A, 2014, LANCET, V384, P1672, DOI 10.1016/S0140-6736(14)62032-8; Serfaty A, 2011, EUR J PUBLIC HEALTH, V21, P504, DOI 10.1093/eurpub/ckq101; van Mello NM, 2012, FERTIL STERIL, V97, P623, DOI 10.1016/j.fertnstert.2011.12.021; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217674	10.1371/journal.pone.0217674	http://dx.doi.org/10.1371/journal.pone.0217674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166967	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800034
J	Nah, K; Magpantay, FMG; Bede-Fazekas, A; Rost, G; Trajer, AJ; Wu, XT; Zhang, X; Wu, JH				Nah, Kyeongah; Magpantay, Felicia Maria G.; Bede-Fazekas, Akos; Rost, Gergely; Trajer, Attila Janos; Wu, Xiaotian; Zhang, Xue; Wu, Jianhong			Assessing systemic and non-systemic transmission risk of tick-borne encephalitis virus in Hungary	PLOS ONE			English	Article							SEASONAL POPULATION-DYNAMICS; IXODES-RICINUS TICKS; LYME-DISEASE; INFECTION; BORRELIOSIS; PATHOGENS; EUROPE; EPIDEMIOLOGY; INFESTATION; TEMPERATURE	Estimating the tick-borne encephalitis (TBE) infection risk under substantial uncertainties of the vector abundance, environmental condition and human-tick interaction is important for evidence-informed public health intervention strategies. Estimating this risk is computationally challenging since the data we observe, i.e., the human incidence of TBE, is only the final outcome of the tick-host transmission and tick-human contact processes. The challenge also increases since the complex TBE virus (TBEV) transmission cycle involves the non-systemic route of transmission between co-feeding ticks. Here, we describe the hidden Markov transition process, using a novel TBEV transmission-human case reporting cascade model that couples the susceptible-infected compartmental model describing the TBEV transmission dynamics among ticks, animal hosts and humans, with the stochastic observation process of human TBE reporting given infection. By fitting human incidence data in Hungary to the transmission model, we estimate key parameters relevant to the tick-host interaction and tick-human transmission. We then use the parametrized cascade model to assess the transmission potential of TBEV in the enzootic cycle with respect to the climate change, and to evaluate the contribution of non-systemic transmission. We show that the TBEV transmission potential in the enzootic cycle has been increasing along with the increased temperature though the TBE human incidence has dropped since 1990s, emphasizing the importance of persistent public health interventions. By demonstrating that non-systemic transmission pathway is a significant factor in the transmission of TBEV in Hungary, we conclude that the risk of TBE infection will be highly underestimated if the non-systemic transmission route is neglected in the risk assessment.	[Nah, Kyeongah; Wu, Jianhong] York Univ, Dept Math & Stat, Toronto, ON, Canada; [Magpantay, Felicia Maria G.] Queens Univ, Dept Math & Stat, Kingston, ON, Canada; [Bede-Fazekas, Akos] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Bede-Fazekas, Akos] MTA Ctr Ecol Res, GINOP Sustainable Ecosyst Grp, Tihany, Hungary; [Rost, Gergely] Univ Oxford, Wolfson Ctr Math Biol, Oxford, England; [Rost, Gergely] Univ Szeged, Bolyai Inst, Szeged, Hungary; [Trajer, Attila Janos] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Trajer, Attila Janos] Univ Pannonia, Inst Environm Engn, Veszprem, Hungary; [Wu, Xiaotian] Shanghai Maritime Univ, Coll Arts & Sci, Shanghai, Peoples R China; [Zhang, Xue] Northeastern Univ, Dept Math, Shenyang, Liaoning, Peoples R China	York University - Canada; Queens University - Canada; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Oxford; Szeged University; University of Pannonia; University of Pannonia; Shanghai Maritime University; Northeastern University - China	Wu, JH (corresponding author), York Univ, Dept Math & Stat, Toronto, ON, Canada.	wujh@mathstat.yorku.ca	Wu, Jian/AAU-5221-2020; Trájer, Attila J/GVS-3713-2022; Bede-Fazekas, Ákos/J-1636-2012; Rost, Gergely/L-9376-2016; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Trájer, Attila J/0000-0003-3248-6474; Bede-Fazekas, Ákos/0000-0002-2905-338X; Rost, Gergely/0000-0001-9476-3284; Wu, Jian/0000-0002-3394-1507; Nah, Kyeongah/0000-0002-7708-1019	GlaxoSmithKline SA [HO-17-18014]; Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary) [GINOP-2.3.2-15-2016-00019]; National Natural Science Foundation of China [11701072, 11501358]; Natural Sciences and Engineering Research Council of Canada [105588-2011]	GlaxoSmithKline SA(GlaxoSmithKline); Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is part of the project entitled "Estimating risk of tick-borne encephalitis with changes in climate, habitation and recreational activities" which received funding from GlaxoSmithKline SA (HO-17-18014 (K.N., X.Z., J.W.) https://www.gsk.com.GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The project was also supported by Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary) (GINOP-2.3.2-15-2016-00019 [A.B., A.T.] http://www.kormany.hu/en/ministry-for-national-economy), National Natural Science Foundation of China (11701072 [X.Z.]), 11501358 (X.W.) http://www.nsfc.gov.cn/english/site_1/index.html and Natural Sciences and Engineering Research Council of Canada (105588-2011 [J.W.]) http://www.nserc-crsng.gc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2009, EN DEL FUT, P16; Balogh Z, 2010, J VIROL METHODS, V163, P481, DOI 10.1016/j.jviromet.2009.10.003; Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430; Bolzoni L, 2012, INT J PARASITOL, V42, P373, DOI 10.1016/j.ijpara.2012.02.006; Brockmann SO, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.15.17-00336; Campbell JA, 1948, THESIS; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00090; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Donoso-Mantke O., 2011, FLAVIVIRUS ENCEPHALI; DUSBABEK F, 1995, MED VET ENTOMOL, V9, P133, DOI 10.1111/j.1365-2915.1995.tb00169.x; ECDC, 2020, IX RIC FACTSH EXP; Egyed L, 2012, TICKS TICK-BORNE DIS, V3, P90, DOI 10.1016/j.ttbdis.2012.01.002; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; European Centre for Disease Prevention and Control, 2018, ANN EP REP 2015 TICK; European Centre for Disease Prevention and Control, FACTSH TICK BORN ENC; Ferenczi E, 2005, NATO SCI SER I LIFE, V370, P43; Ghosh M, 2004, B MATH BIOL, V66, P1659, DOI 10.1016/j.bulm.2004.03.007; GRAY JS, 1981, B ENTOMOL RES, V71, P533, DOI 10.1017/S0007485300008543; Greenfield B.P.J., 2011, Bioscience Horizons, V4, P140; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; Harrison A, 2012, PARASITOLOGY, V139, P1605, DOI 10.1017/S0031182012000893; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Khasnatinov MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158105; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; LABUDA M, 1993, MED VET ENTOMOL, V7, P339, DOI 10.1111/j.1365-2915.1993.tb00702.x; Magpantay FMG, 2016, PARASITOLOGY, V143, P835, DOI 10.1017/S0031182015000979; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; MATUSCHKA FR, 1991, AM J TROP MED HYG, V44, P100, DOI 10.4269/ajtmh.1991.44.100; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Mogl C, 2011, ACTA ZOOL BULGAR, V63, P301; MOLNAR E, 1982, Geographia Medica, V12, P78; Nonaka E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011745; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 1997, PARASITOLOGY, V115, P591, DOI 10.1017/S0031182097001868; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Pettersson JHO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-102; PRETZMAN.G, 1964, ZENTBL BAKTERIOLOG P, V194, P431; Qviller L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-179; R Core Team, 2018, R LANG ENV STAT COMP; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; REHACEK J, 1962, ACTA VIROL, V6, P220; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Sikutova S, 2009, VET MICROBIOL, V135, P267, DOI 10.1016/j.vetmic.2008.09.082; Sixl W, 1971, EINFLUSS TEMPERATUR; Sonenshine D. E., 1994, ECOLOGICAL DYNAMICS; Trajer A, 2014, INT J ENVIRON HEAL R, V24, P226, DOI 10.1080/09603123.2013.807329; Trajer A, 2013, ANN AGR ENV MED, V20, P245; Voordouw MJ, 2015, PARASITOLOGY, V142, P290, DOI 10.1017/S0031182014001486; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wu XT, 2013, J THEOR BIOL, V319, P50, DOI 10.1016/j.jtbi.2012.11.014; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zhang X, 2017, J BIOL SYST, V25, P657, DOI 10.1142/S0218339017400083; Zoldi V, 2015, ECOHEALTH, V12, P174, DOI 10.1007/s10393-014-0969-0; Zoldi V, 2015, INFECT DIS-NOR, V47, P178, DOI 10.3109/00365548.2014.975743; Zoldi V, 2013, VECTOR-BORNE ZOONOT, V13, P256, DOI 10.1089/vbz.2011.0905; ZOLOTOV PE, 1981, PARAZITOLOGIYA+, V15, P469	69	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217206	10.1371/journal.pone.0217206	http://dx.doi.org/10.1371/journal.pone.0217206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163042	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000470086200009
J	Pees, M; Schmidt, V; Papp, T; Gellert, A; Abbas, M; Starck, M; Neul, A; Marschang, RE				Pees, Michael; Schmidt, Volker; Papp, Tibor; Gellert, Akos; Abbas, Maha; Starck, Matthias; Neul, Annkatrin; Marschang, Rachel E.			Three genetically distinct ferlaviruses have varying effects on infected corn snakes (Pantherophis guttatus)	PLOS ONE			English	Article							PARAMYXOVIRUS FUSION; OPHIDIAN PARAMYXOVIRUS; DIFFUSION CAPACITY; PROTEIN-STRUCTURE; SEQUENCE; PREDICTION; LIZARDS; ACTIVATION; EXPRESSION; PNEUMONIA	Ferlaviruses are important pathogens in snakes and other reptiles. They cause respiratory and neurological disease in infected animals and can cause severe disease outbreaks. Isolates from this genus can be divided into four genogroups-A, B, and C, as well as a more distantly related sister group, "tortoise". Sequences from large portions (5.3 kb) of the genomes of a variety of ferlavirus isolates from genogroups A, B, and C, including the genes coding the surface glycoproteins F and HN as well as the L protein were determined and compared. In silico analyses of the glycoproteins of genogroup A, B, and C isolates were carried out. Three isolates representing these three genogroups were used in transmission studies with corn snakes (Pantherophis guttatus), and clinical signs, gross and histopathology, electronmicroscopic changes in the lungs, and isolation of bacteria from the lungs were evaluated. Analysis of the sequences supported the previous categorization of ferlaviruses into four genogroups, and criteria for definition of ferlavirus genogroups and species were established based on sequence identities (80% resp. 90%). Analysis of the ferlavirus glycoprotein models showed parallels to corresponding regions of other paramyxoviruses. The transmission studies showed clear differences in the pathogenicities of the three virus isolates used. The genogroup B isolate was the most and the group A virus the least pathogenic. Reasons for these differences were not clear based on the differences in the putative structures of their respective glycoproteins, although e.g. residue and consequential structure variation of an extended cleavage site or changes in electrostatic charges at enzyme binding sites could play a role. The presence of bacteria in the lungs of the infected animals also clearly corresponded to increased pathogenicity. This study contributes to knowledge about the structure and phylogeny of ferlaviruses and lucidly demonstrates differences in pathogenicity between strains of different genogroups.	[Pees, Michael; Schmidt, Volker; Neul, Annkatrin] Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Leipzig, Germany; [Papp, Tibor; Gellert, Akos] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, Budapest, Hungary; [Abbas, Maha] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany; [Starck, Matthias] LMU Munchen, Bioctr, Dept Biol 2, Munich, Germany; [Marschang, Rachel E.] Laboklin, Bad Kissingen, Germany; [Abbas, Maha] Al Qasim Green Univ, Dept Biotechnol, Coll Biotechnol, Hilla, Iraq	Leipzig University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University Hohenheim; University of Munich; Al Qasim Green University	Pees, M (corresponding author), Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Leipzig, Germany.	pees@uni-leipzig.de	Papp, Tibor/A-6437-2011; Schmidt, Volker/I-7708-2019; Starck, Matthias/K-5713-2014	Papp, Tibor/0000-0002-6402-3864; Schmidt, Volker/0000-0002-6001-9542; Gellert, Akos/0000-0002-1455-8879; Starck, Matthias/0000-0001-7882-9482; Marschang, Rachel/0000-0002-0578-8963; abbas, maha/0000-0001-9313-3192; Pees, Michael/0000-0002-7244-9697	German Research Foundation (DFG) [PE 877/2-2]; Bolyai Research Fellowship of the Hungarian Academy of Sciences [BO/00569/15]	German Research Foundation (DFG)(German Research Foundation (DFG)); Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The work was supported by a grant from the German Research Foundation (DFG, PE 877/2-2 to MP), and the Bolyai Research Fellowship of the Hungarian Academy of Sciences (BO/00569/15 to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Maha Diekan, 2012, Journal of Herpetological Medicine and Surgery, V22, P86, DOI 10.5818/1529-9651-22.3.86; Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Ahne W, 1999, VIRUS RES, V63, P65, DOI 10.1016/S0168-1702(99)00059-3; Ahne W, 1991, 2ND P INT S VIR LOW, P203; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; CLARK HF, 1979, J GEN VIROL, V44, P405, DOI 10.1099/0022-1317-44-2-405; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Essbauer S, 2001, J VET MED B, V48, P403, DOI 10.1046/j.1439-0450.2001.00473.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrando RE, 2003, J ALLERGY CLIN IMMUN, V112, P1243, DOI 10.1016/j.jaci.2003.09.038; FOELSCH DW, 1976, TIERAERZTL PRAX, V4, P527; Franke J, 2006, ARCH VIROL, V151, P449, DOI 10.1007/s00705-005-0663-1; Franke J, 2001, VIRUS RES, V80, P67, DOI 10.1016/S0168-1702(01)00353-7; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyndman TH, 2013, VET MICROBIOL, V165, P200, DOI 10.1016/j.vetmic.2013.04.002; International Committee on Taxonomy of Viruses, VIRUS TAXONOMY; JACOBSON E, 1980, J AM VET MED ASSOC, V177, P796; Jacobson Elliott R., 2007, P395, DOI 10.1201/9781420004038.ch9; Jacobson ER, 2001, J VET DIAGN INVEST, V13, P143, DOI 10.1177/104063870101300208; JACOBSON ER, 1992, J ZOO WILDLIFE MED, V23, P318; Jacobson ER, 1997, VET PATHOL, V34, P450, DOI 10.1177/030098589703400509; Junqueira de Azevedo ILM, 2001, ARCH VIROL, V146, P51, DOI 10.1007/s007050170190; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kindermann J, 2001, ARCH VIROL, V146, P1021, DOI 10.1007/s007050170133; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurath G, 2004, J VIROL, V78, P2045, DOI 10.1128/JVI.78.4.2045-2056.2004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luque LE, 2007, J VIROL, V81, P3130, DOI 10.1128/JVI.02464-06; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2009, VIRUS RES, V144, P272, DOI 10.1016/j.virusres.2009.05.011; Marschang RE, 2002, J ZOO WILDLIFE MED, V33, P317, DOI 10.1638/1042-7260(2002)033[0317:PARIIW]2.0.CO;2; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI [10.1093/bioinformatics/btn575, 10.1093/bioinformatics/btp666]; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Neul A, 2017, AM J VET RES, V78, P482, DOI 10.2460/ajvr.78.4.482; Papp T., 2010, Journal of Herpetological Medicine and Surgery, V20, P64, DOI 10.5818/1529-9651-20.2.64; Papp T, 2013, VET MICROBIOL, V162, P195, DOI 10.1016/j.vetmic.2012.08.010; Papp T, 2010, VET MICROBIOL, V144, P466, DOI 10.1016/j.vetmic.2010.02.002; Pees M, 2016, VET MICROBIOL, V182, P213, DOI 10.1016/j.vetmic.2015.11.024; PERRY SF, 1981, MIKROSKOPIE, V38, P278; Plenz B, 2015, VET REC, V176, P285, DOI 10.1136/vr.102580; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Schmidt V, 2013, VET REC, V172, DOI 10.1136/vr.100972; Schrodinger L, 2016, SCHRODINGER SUITE; Starck JM, 2017, J COMP PATHOL, V156, P419, DOI 10.1016/j.jcpa.2017.02.001; Starck JM, 2015, J COMP PATHOL, V153, P333, DOI 10.1016/j.jcpa.2015.07.004; Starck JM, 2012, ZOOLOGY, V115, P245, DOI [10.1016/j.zool.2012.02.003, 10.1016/j.zoo1,2012.02.003]; Terrell Scott P., 2007, P219; Tian S, 2009, BIOCHEM INSIGHTS, V2, P9, DOI 10.4137/BCI.S2049; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Wang L.-F., 2011, VIRUS TAXONOMY CLASS; Welch BD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003534; West G, 2001, J ZOO WILDLIFE MED, V32, P360, DOI 10.1638/1042-7260(2001)032[0360:MIABSP]2.0.CO;2; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Woo PCY, 2014, J CLIN MICROBIOL, V52, P3614, DOI 10.1128/JCM.01653-14; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108	70	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217164	10.1371/journal.pone.0217164	http://dx.doi.org/10.1371/journal.pone.0217164			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163032	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000470086200007
J	Shamali, M; Konradsen, H; Stas, L; Ostergaard, B				Shamali, Mahdi; Konradsen, Hanne; Stas, Lara; Ostergaard, Birte			Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-CARE; IMPACT	Background Social support, family functioning and family health are essential elements in the treatment of heart failure, yet most heart failure studies focus on the pharmacological interventions. This study aimed to examine whether perceived social support from nurses is associated with better family functioning of patients with heart failure and their nearest relatives and to examine whether family health mediates this relationship. Methods and findings A sample of 312 patients with heart failure and 312 of their nearest relatives were included in the study. The Family Functioning, Health and Social Support questionnaire was used to collect the data. Dyadic data were analysed by the Actor-Partner Interdependence Mediation Model with distinguishable dyads using structural equation modelling. Patients and nearest relatives who perceived more social support had a higher level of family health and functioned better within the family. One partner effect was found, indicating that the higher the level of family health of the nearest relative, the better the family functioning of the patient (p <0.001). Family health partially (in the patient) and completely (in the nearest relative) mediated the association between social support and family functioning. Conclusion This study indicated that patients with heart failure and their nearest relatives who perceived more social support from nurses were more likely to have high level of family health and function better within the family. The interdependent relationships found in our study highlight a dyadic and family-oriented approach to improve family functioning in patients with heart failure.	[Shamali, Mahdi; Ostergaard, Birte] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Konradsen, Hanne] Herlev & Gentofte Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark; [Konradsen, Hanne] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Konradsen, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Stas, Lara] Univ Ghent, Dept Data Anal, Ghent, Belgium; [Ostergaard, Birte] Univ Southern Denmark, OPEN, Odense, Denmark	University of Southern Denmark; Karolinska Institutet; University of Copenhagen; Ghent University; University of Southern Denmark	Shamali, M (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	mshamali@health.sdu.dk	Shamali, Mahdi/A-2087-2017	Shamali, Mahdi/0000-0001-7628-0887; Konradsen, Hanne/0000-0002-7477-125X; Ostergaard, Birte/0000-0002-9094-8123; Stas, Lara/0000-0003-1567-2881	Novo Nordisk Foundation [NNF17OC0027968]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was funded by the Novo Nordisk Foundation (http://novonordiskfonden.dk) under grant Number NNF17OC0027968.	Al-Rawashdeh SY, 2017, WESTERN J NURS RES, V39, P492, DOI 10.1177/0193945916672647; Astedt-Kurki P, 2004, J ADV NURS, V48, P115, DOI 10.1111/j.1365-2648.2004.03178.x; Astedt-Kurki P, 2009, INT J NURS STUD, V46, P350, DOI 10.1016/j.ijnurstu.2008.01.008; Buck HG, 2015, J PALLIAT MED, V18, P1026, DOI 10.1089/jpm.2015.0086; Cameron J, 2017, J CLIN NURS, V26, P4804, DOI 10.1111/jocn.13836; Campbell L., 2015, ENCY CLIN PSYCHOL, P1, DOI [10.1002/9781118625392.wbecp467, DOI 10.1002/9781118625392.WBECP467]; Chung ML, 2009, J PSYCHOSOM RES, V67, P29, DOI 10.1016/j.jpsychores.2009.01.009; Dalteg T, 2016, J FAM NURS, V22, P368, DOI 10.1177/1074840716656815; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dunbar SB, 2008, J CARDIOVASC NURS, V23, P258, DOI 10.1097/01.JCN.0000305093.20012.b8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fritz MS, 2008, BEHAV RES METHODS, V40, P55, DOI 10.3758/BRM.40.1.55; Hasanpour-Dehkordi A, 2016, APPL NURS RES, V31, P165, DOI 10.1016/j.apnr.2016.03.005; Hautsalo K, 2013, J CLIN NURS, V22, P2953, DOI 10.1111/j.1365-2702.2012.04335.x; Kenny DA, 1999, PERS RELATIONSHIP, V6, P433, DOI 10.1111/j.1475-6811.1999.tb00202.x; Kenny DA, 2010, J FAM PSYCHOL, V24, P359, DOI 10.1037/a0019651; Ledermann T, 2011, STRUCT EQU MODELING, V18, P595, DOI 10.1080/10705511.2011.607099; Luttik ML, 2007, J CARDIOVASC NURS, V22, P131, DOI 10.1097/00005082-200703000-00010; Mansourian BP, 2009, GLOBAL PERSPECTIVES, VI; Molloy GJ, 2005, EUR J HEART FAIL, V7, P592, DOI 10.1016/j.ejheart.2004.07.008; Ostergaard B, 2018, SCAND J CARING SCI, V32, P554, DOI 10.1111/scs.12479; Paavilainen Eija, 2006, Eur J Cardiovasc Nurs, V5, P54, DOI 10.1016/j.ejcnurse.2005.10.002; Pedersen S, 2005, J FAM PSYCHOL, V19, P404, DOI 10.1037/0893-3200.19.3.404; Pischke CR, 2007, EUR J HEART FAIL, V9, P928, DOI 10.1016/j.ejheart.2007.05.009; Riegel B, 2011, NAT REV CARDIOL, V8, P644, DOI 10.1038/nrcardio.2011.95; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Shamali M, 2018, SCAND J CARING SCI, V32, P1247, DOI 10.1111/scs.12541; Tarkka MT, 2003, J CLIN NURS, V12, P736, DOI 10.1046/j.1365-2702.2003.00771.x; Vellone E, 2014, J FAM NURS, V20, P120, DOI 10.1177/1074840713510205	31	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217970	10.1371/journal.pone.0217970	http://dx.doi.org/10.1371/journal.pone.0217970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163068	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200049
J	Zheng, XL; Zhang, Y; Yue, P; Liu, L; Wang, C; Zhou, KY; Hua, YM; Wu, G; Li, YF				Zheng, Xiaolan; Zhang, Yi; Yue, Peng; Liu, Lei; Wang, Chuan; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei			Diagnostic significance of circulating miRNAs in systemic lupus erythematosus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DIFFERENTIAL-DIAGNOSIS; CLINICAL-SIGNIFICANCE; PLASMA MIR-21; ANTI-DSDNA; MICRORNAS; EXPRESSION; BIOMARKERS; PATHOGENESIS; SENSITIVITY	Background In recent years, many studies focused on the association between the microRNAs (miRNAs) and the risk of systemic lupus erythematosus (SLE), especially miRNA-21 (miR-21). We aimed to investigate the role of circulating miRNAs, especially the miR-21, as a biomarker in detecting SLE. Methods We searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and China National Knowledge Infrastructure through Mar 3th, 2019. We performed this meta-analysis in a fixed/random-effect model using Meta-disc 1.4 and STATA 15.1. Results A total of 17 relevant studies were eligible to analyze pooled accuracy. The overall performance of total mixed miRNAs (TmiRs) detection was: pooled sensitivity, 0.71 (95% confidence interval [CI], 0.69 to 0.72); pooled specificity, 0.81 (95% CI, 0.79 to 0.83); and area under the summary receiver operating characteristic curves value (SROC), 0.8797. The miR-21 detection was: pooled sensitivity, 0.68 (95% CI, 0.62 to 0.74); pooled specificity, 0.77 (95% CI, 0.69 to 0.84); and SROC, 0.8281. The meta-regression analysis showed that the type of samples was the sources of heterogeneity. The subgroup analysis suggested that detection in plasma group had the largest AUC of SROC in all the subgroups: pooled sensitivity, 0.8 (95% CI, 0.78 to 0.82); pooled specificity, 0.83 (95% CI, 0.8 to 0.86); and SROC, 0.9068. Conclusions Our meta-analysis demonstrated that circulating miRNAs might be potential novel biomarkers for detecting SLE, especially miR-21. Moreover, plasma is recommended as the clinical specimen for diagnostic detection.	[Zheng, Xiaolan; Zhang, Yi; Yue, Peng; Liu, Lei; Wang, Chuan; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China; [Zheng, Xiaolan; Zhang, Yi; Yue, Peng; Liu, Lei; Wang, Chuan; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Women & Childrens Dis & Birth Defects, Chengdu, Sichuan, Peoples R China; [Zheng, Xiaolan; Yue, Peng; Liu, Lei] Sichuan Univ, West China Med Sch, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, YF (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China.; Li, YF (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Women & Childrens Dis & Birth Defects, Chengdu, Sichuan, Peoples R China.	liyfwcsh@scu.edu.cn		zheng, xiaolan/0000-0001-5971-4284	National Natural Science Foundation of China [81700360, 81741025, 81570369, 81571515]; Technology Project of Sichuan Province of China [2018JY0603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Project of Sichuan Province of China	This work was supported by National Natural Science Foundation of China 81700360 to Yifei Li, National Natural Science Foundation of China 81741025 to Kaiyu Zhou, National Natural Science Foundation of China 81570369 to Kaiyu Zhou, National Natural Science Foundation of China 81571515 to Yimin Hua, and Technology Project of Sichuan Province of China 2018JY0603 to Yi Zhang.	Amr KS, 2016, RHEUMATOL INT, V36, P1617, DOI 10.1007/s00296-016-3550-z; Chen JQ, 2016, AUTOIMMUN REV, V15, P1171, DOI 10.1016/j.autrev.2016.09.003; Dai ZW, 2018, CLIN RHEUMATOL, V37, P2999, DOI 10.1007/s10067-018-4189-9; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Faurschou M, 2006, J RHEUMATOL, V33, P1563; Firooz N, 2011, LUPUS, V20, P588, DOI 10.1177/0961203310393378; Flechsig A, 2017, CLIN EXP RHEUMATOL, V35, P598; Gholaminejad A, 2018, J NEPHROL, V31, P813, DOI 10.1007/s40620-018-0511-5; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guo GQ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1739-5; Guo SM, 2016, INT J CLIN EXP MED, V9, P2905; Heidenreich U, 2009, LUPUS, V18, P1276, DOI 10.1177/0961203309345753; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Honarpisheh M, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/4126106; Husakova M, 2016, BIOMED PAP, V160, P327, DOI 10.5507/bp.2016.004; Jin FF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02381; Kaul A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.39; Khoshmirsafa M, 2019, INT J RHEUM DIS, V22, P458, DOI 10.1111/1756-185X.13410; Kim BS, 2016, HLA, V88, P187, DOI 10.1111/tan.12874; Kim HA, 2017, CLIN RHEUMATOL, V36, P2479, DOI 10.1007/s10067-017-3792-5; Kim HA, 2012, J RHEUMATOL, V39, P728, DOI 10.3899/jrheum.111044; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Le X, 2017, CURR OPIN RHEUMATOL, V29, P450, DOI 10.1097/BOR.0000000000000420; Leffers HCB, 2019, AUTOIMMUN REV, V18, P382, DOI 10.1016/j.autrev.2018.11.005; Li HS, 2017, EUR REV MED PHARMACO, V21, P4790; Long H, 2018, CANCER LETT, V428, P90, DOI 10.1016/j.canlet.2018.04.016; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Motawi TK, 2016, CHEM-BIOL INTERACT, V260, P110, DOI 10.1016/j.cbi.2016.11.001; Navarro-Quiroz E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166202; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Phuti A, 2018, RHEUMATOL INT, V38, P1601, DOI 10.1007/s00296-018-4017-1; Qu B, 2015, INT J MOL SCI, V16, P9557, DOI 10.3390/ijms16059557; Ribas J, 2012, NUCLEIC ACIDS RES, V40, P6821, DOI 10.1093/nar/gks308; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sciascia S, 2012, J THROMB HAEMOST, V10, P2512, DOI 10.1111/jth.12014; Sekar D, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0752-z; Sharaf-Eldin WE, 2017, J NEUROL SCI, V383, P188, DOI 10.1016/j.jns.2017.11.014; Shumnalieva R, 2018, ACTA REUMATOL PORT, V43, P217; Stagakis E, 2011, ANN RHEUM DIS, V70, P1496, DOI 10.1136/ard.2010.139857; Stypinska B, 2015, INT J MOL SCI, V16, P24194, DOI 10.3390/ijms161024194; Tang ZM, 2014, J CLIN LAB ANAL, V28, P446, DOI 10.1002/jcla.21708; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vahed SZ, 2018, BIOIMPACTS, V8, P177, DOI 10.15171/bi.2018.20; Wang WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12644; Wang X, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1618-8; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wichainun R, 2013, ASIAN PAC J ALLERGY, V31, P292, DOI 10.12932/AP0272.31.4.2013; Yan HL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006825; Yao Q, 2019, CURR OPIN CHEM BIOL, V51, P11, DOI 10.1016/j.cbpa.2019.01.024; Yurkovich M, 2014, ARTHRIT CARE RES, V66, P608, DOI 10.1002/acr.22173; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zeng L, 2018, CLIN IMMUNOL, V196, P103, DOI 10.1016/j.clim.2018.10.004; Zhang HD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01473; Zhang Y, 2018, EUR REV MED PHARMACO, V22, P3118, DOI 10.26355/eurrev_201805_15070; Zheng W, 2018, ONCOL LETT, V16, P2777, DOI 10.3892/ol.2018.8972; Zhu YF, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.900667	61	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217523	10.1371/journal.pone.0217523	http://dx.doi.org/10.1371/journal.pone.0217523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163082	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200016
J	Dahms, I; Bailey-Hall, E; Sylvester, E; Parenteau, A; Yu, SG; Karagiannis, A; Roos, F; Wilson, J				Dahms, Irina; Bailey-Hall, Eileen; Sylvester, Erin; Parenteau, Audrey; Yu, Shiguang; Karagiannis, Alexios; Roos, Franz; Wilson, Jon			Safety of a novel feed ingredient, Algal Oil containing EPA and DHA, in a gestation-lactation-growth feeding study in Beagle dogs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ETHYL-ESTER; FISH OILS; PLASMA; OMEGA-3-FATTY-ACIDS; BLOOD	An Algal Oil Containing EPA and DHA (AOCED) at similar to 50% was developed as a sustainable source of omega-3 fatty acids. AOCED was incorporated into extruded dry foods for dogs at 0, 0.75%, 1.5% and 3.0% levels (equivalent to 0, 7.5, 15 and 30 g/kg diet) on dry matter basis at the expense of chicken fat and fed to healthy female Beagle dogs starting at mating and throughout gestation and lactation. The offspring were fed their maternal corresponding diets for 26 weeks after weaning. AOCED-enriched diets were well tolerated by dogs in both generations and did not affect their overall health, physiological parameters, food consumption, body weights and body weight gains. There were no changes in hematology, clinical chemistry, and coagulation parameters in both generations of dogs fed the AOCED diets when compared to those in the control group. Plasma levels of DHA and EPA increased significantly and generally dose-dependently in both generations. The study demonstrated the safety of AOCED in dogs during gestation, lactation, and growth periods at dietary levels up to 3.0wt%, equivalent to 30 g/kg diet. AOCED's bioavailability as a source of DHA and EPA in dogs was demonstrated by the increased plasma concentrations of these nutritional lipids.	[Dahms, Irina; Karagiannis, Alexios; Roos, Franz] DSM Nutr Prod, Kaiseraugst, Switzerland; [Bailey-Hall, Eileen; Sylvester, Erin; Yu, Shiguang; Wilson, Jon] DSM Nutr Prod, Columbia, MD USA; [Parenteau, Audrey] Citoxlab North Amer, Laval, PQ, Canada	DSM NV; DSM NV	Dahms, I (corresponding author), DSM Nutr Prod, Kaiseraugst, Switzerland.	irina.dahms@dsm.com						Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Bauer JE, 2011, JAVMA-J AM VET MED A, V239, P1441, DOI 10.2460/javma.239.11.1441; BROWN SA, 1999, COMPENDIUM CONTINU S, V21, P11, DOI DOI 10.1111/J.1939-1676.1998.TB02148.X; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; CARLSON SE, 1992, LIPIDS, V27, P901, DOI 10.1007/BF02535870; CARLSON SE, 1992, J PEDIATR-US, V120, pS159, DOI 10.1016/S0022-3476(05)81251-X; CRAWFORD MA, 1993, AM J CLIN NUTR, V57, P703; Dahms I, 2016, PROSTAG LEUKOTR ESS, V113, P1, DOI 10.1016/j.plefa.2016.08.001; Dahms I, 2016, FOOD CHEM TOXICOL, V92, P50, DOI 10.1016/j.fct.2016.03.024; Fedorova-Dahms I, 2011, FOOD CHEM TOXICOL, V49, P70, DOI 10.1016/j.fct.2010.09.033; Freeman LM, 2006, J VET INTERN MED, V20, P1116, DOI 10.1892/0891-6640(2006)20[1116:EODMID]2.0.CO;2; Freeman LM, 1998, J VET INTERN MED, V12, P440, DOI 10.1111/j.1939-1676.1998.tb02148.x; Hall JA, 1999, AM J VET RES, V60, P319; Hall JA, 1996, COMP CONT EDUC PRACT, V18, P879; HARRIS WS, 1989, J LIPID RES, V30, P785; HOLUB BJ, 1987, ATHEROSCLEROSIS, V66, P11, DOI 10.1016/0021-9150(87)90174-2; Laurent G, 2008, CARDIOVASC RES, V77, P89, DOI 10.1093/cvr/cvm024; Lenox CE, 2013, J VET INTERN MED, V27, P217, DOI 10.1111/jvim.12033; Logas Dawn, 1994, Vet Dermatol, V5, P99, DOI 10.1111/j.1365-3164.1994.tb00020.x; MARSEN TA, 1992, PROSTAG LEUKOTR ESS, V46, P191, DOI 10.1016/0952-3278(92)90069-U; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; National Research Council (NRC), 2006, NUTR REQ DOGS CATS, P81; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Pinheiro J, R PACKAGE VERSION; R Development Core Team, 2009, R LANG ENV STAT COMP; Raatz SK, 2012, NUTR RES, V32, P1, DOI 10.1016/j.nutres.2011.12.006; SALEM N, 1989, ADV PROSTAG THROMB L, V19, P618; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Sargent JR, 1999, P NUTR SOC, V58, P377, DOI 10.1017/S0029665199001366	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217794	10.1371/journal.pone.0217794	http://dx.doi.org/10.1371/journal.pone.0217794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158258	Green Submitted, gold, Green Published			2022-12-27	WOS:000469915700027
J	Kazim, N; Adhikari, A; Davie, J				Kazim, Noor; Adhikari, Abhinav; Davie, Judith			The transcription elongation factor TCEA3 promotes the activity of the myogenic regulatory factors	PLOS ONE			English	Article							ANNEXIN A1; MOUSE; DIFFERENTIATION; EXPRESSION; APOPTOSIS; TARGET; GENES; MYOD; CELL	The transcription elongation factor TFIIS is encoded by a three member gene family in vertebrates. Here we show that one member of this family, TCEA3, is upregulated during skeletal muscle differentiation and acts to promote gene activation by the myogenic regulatory family of transcription factors, which includes MyoD and myogenin. We show that myogenin is a direct regulator of Tcea3. Myogenin binds to the Tcea3 promoter and is required to recruit RNA polymerase II. TCEA3 can bind to both myogenin and MyoD and is co-recruited with the MRFs to promoters dependent on the MRFs. Depletion of myogenin inhibits the recruitment of TCEA3, suggesting that the interaction of TCEA3 with the MRFs serves to aid in recruitment to target promoters. Like TFIIS, we show that TCEA3 interacts with RNA polymerase II. TCEA3 travels with the elongating RNA polymerase II in the coding region of genes and depletions of TCEA3 inhibit the recruitment of RNA polymerase II to promoters. In proliferating cells, TCEA3 expressed at low levels and is present in both the nucleus and cytoplasm. However, upon differentiation, TCEA3 is upregulated and transported exclusively to the nucleus. Thus, our data show that TCEA3 is a required co-factor for MRF driven gene expression during myogenesis.	[Kazim, Noor; Adhikari, Abhinav; Davie, Judith] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Kazim, Noor; Adhikari, Abhinav; Davie, Judith] Southern Illinois Univ, Sch Med, Simmons Canc Inst, Carbondale, IL 62901 USA; [Kazim, Noor] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Cornell University	Davie, J (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	jdavie@siumed.edu	Adhikari, Abhinav/J-5224-2019; Kazim, Noor/AAJ-4824-2021	Adhikari, Abhinav/0000-0002-9228-480X; Kazim, Noor/0000-0001-7313-0875	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [RAR068622]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health, grant no. RAR068622 (to JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Cha Y, 2013, GENE EXPRESSION, V16, P25, DOI 10.3727/105221613X13776146743343; Cha Y, 2013, CELL SIGNAL, V25, P1245, DOI 10.1016/j.cellsig.2013.01.016; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Ge Y, 2019, J CELL PHYSIOL, V234, P10554, DOI 10.1002/jcp.27726; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Kablar B, 2000, HISTOL HISTOPATHOL, V15, P649, DOI 10.14670/HH-15.649; Labhart P, 1998, GENOMICS, V52, P278, DOI 10.1006/geno.1998.5449; Li J, 2015, MED SCI MONITOR, V21, P3241, DOI 10.12659/MSM.895860; Liao JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23542; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Park KS, 2013, STEM CELLS, V31, P282, DOI 10.1002/stem.1284; Shimasaki NB, 2000, J BIOL CHEM, V275, P36541, DOI 10.1074/jbc.M005834200; Yang TM, 2018, EXP CELL RES, V370, P551, DOI 10.1016/j.yexcr.2018.07.020; You S, 2018, AM J CANCER RES, V8, P2076; Zhu Y, 2017, BIOCHEM BIOPH RES CO, V484, P827, DOI 10.1016/j.bbrc.2017.01.182	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217680	10.1371/journal.pone.0217680	http://dx.doi.org/10.1371/journal.pone.0217680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158246	gold, Green Published, Green Submitted			2022-12-27	WOS:000469915700021
J	Keyel, AC; Timm, OE; Backenson, PB; Prussing, C; Quinones, S; McDonough, KA; Vuille, M; Conn, JE; Armstrong, PM; Andreadis, TG; Kramer, LD				Keyel, Alexander C.; Timm, Oliver Elison; Backenson, P. Bryon; Prussing, Catharine; Quinones, Sarah; McDonough, Kathleen A.; Vuille, Mathias; Conn, Jan E.; Armstrong, Philip M.; Andreadis, Theodore G.; Kramer, Laura D.			Seasonal temperatures and hydrological conditions improve the prediction of West Nile virus infection rates in Culex mosquitoes and human case counts in New York and Connecticut	PLOS ONE			English	Article							UNITED-STATES; PIPIENS DIPTERA; SUFFOLK COUNTY; OVIPOSITION PREFERENCES; TRANSMISSION DYNAMICS; FEATURE-SELECTION; RISK-ASSESSMENT; BRIDGE VECTOR; LAND-COVER; CULICIDAE	West Nile virus (WNV; Flaviviridae: Flavivirus) is a widely distributed arthropod-borne virus that has negatively affected human health and animal populations. WNV infection rates of mosquitoes and human cases have been shown to be correlated with climate. However, previous studies have been conducted at a variety of spatial and temporal scales, and the scale-dependence of these relationships has been understudied. We tested the hypothesis that climate variables are important to understand these relationships at all spatial scales. We analyzed the influence of climate on WNV infection rate of mosquitoes and number of human cases in New York and Connecticut using Random Forests, a machine learning technique. During model development, 66 climate-related variables based on temperature, precipitation and soil moisture were tested for predictive skill. We also included 20-21 non-climatic variables to account for known environmental effects (e.g., land cover and human population), surveillance related information (e.g., relative mosquito abundance), and to assess the potential explanatory power of other relevant factors (e.g., presence of wastewater treatment plants). Random forest models were used to identify the most important climate variables for explaining spatial-temporal variation in mosquito infection rates (abbreviated as MLE). The results of the cross-validation support our hypothesis that climate variables improve the predictive skill for MLE at county-and trap-scales and for human cases at the county-scale. Of the climate-related variables selected, mean minimum temperature from July-September was selected in all analyses, and soil moisture was selected for the mosquito county-scale analysis. Models demonstrated predictive skill, but still over-and under-estimated WNV MLE and numbers of human cases. Models at fine spatial scales had lower absolute errors but had greater errors relative to the mean infection rates.	[Keyel, Alexander C.; McDonough, Kathleen A.; Conn, Jan E.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12203 USA; [Keyel, Alexander C.; Timm, Oliver Elison; Quinones, Sarah; Vuille, Mathias] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Backenson, P. Bryon] New York State Dept Hlth, Bur Communicable Dis Control, Albany, NY USA; [Prussing, Catharine; McDonough, Kathleen A.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Armstrong, Philip M.; Andreadis, Theodore G.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, Dept Environm Sci, New Haven, CT 06504 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Connecticut Agricultural Experiment Station	Keyel, AC (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12203 USA.; Keyel, AC (corresponding author), SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA.	akeyel@albany.edu	Armstrong, Philip/GWU-8253-2022; Vuille, Mathias/O-8128-2019; Vuille, Mathias/S-3906-2019; Prussing, Catharine/AAB-4546-2019	Vuille, Mathias/0000-0002-9736-4518; Prussing, Catharine/0000-0001-6425-6839; Keyel, Alexander C./0000-0001-5256-6274; Conn, Jan/0000-0002-5301-7020	Centers for Disease Control and Prevention [1U01CK000509-01]; University at Albany Vice President for Research Office	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University at Albany Vice President for Research Office	This publication was supported by cooperative agreement 1U01CK000509-01, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. Initial funding supporting this collaboration was provided by the University at Albany Vice President for Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137; Bernard KA, 2001, VIRAL IMMUNOL, V14, P319, DOI 10.1089/08828240152716574; Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO; BirdLife International, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22705874A94039098.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22705874A94039098.EN]; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown H, 2008, VECTOR-BORNE ZOONOT, V8, P197, DOI 10.1089/vbz.2007.0154; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Carpenter S. J., 1955, MOSQUITOES N AM N ME; CDC, 2017, FIN CUM MAPS DAT 199; CDC, 2017, SPEC DEAD BIRDS WHIC; Census Bureau U. S, 2010, 2010 CENS COUNT CONN; CHIANG CL, 1962, AM J HYG, V75, P377, DOI 10.1093/oxfordjournals.aje.a120259; Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021; Clark MP, 2006, J HYDROMETEOROL, V7, P3, DOI 10.1175/JHM474.1; Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113; Connecticut Agricultural Experimental Station, 2018, CONN MOSQ TRAP DAT T; Connecticut State Department of Public Health, 2018, W NIL VIR STAT; Darsie R.F.J., 1981, IDENTIFICATION GEOGR; DeFelice NB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006047; DeFelice NB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14592; DeGroote JP, 2012, VECTOR-BORNE ZOONOT, V12, P657, DOI 10.1089/vbz.2011.0786; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; EPA, 2013, EPA FAC REG SERV FRS; Farnsworth George L., 2005, U S Forest Service General Technical Report PSW, V191, P736; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Gates MC, 2009, PREV VET MED, V89, P134, DOI 10.1016/j.prevetmed.2008.12.004; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; George TL, 2015, P NATL ACAD SCI USA, V112, P14290, DOI 10.1073/pnas.1507747112; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Jackson BT, 2005, J AM MOSQUITO CONTR, V21, P360, DOI 10.2987/8756-971X(2006)21[360:OPOCRA]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2005, AM J TROP MED HYG, V73, P1031, DOI 10.4269/ajtmh.2005.73.1031; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Kostyukov M. A., 1986, MED PARAZITOL MOSK, V6, P76; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lampman RL, 1996, J AM MOSQUITO CONTR, V12, P23; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Little E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1720-1; Liu A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-67; Manore CA, 2014, PLOS CURR, V6; Means R, 1979, NY STATE MUS B A, V430, P1; Means RG., 1987, NEW YORK STATE MUSEU, V430B, P1; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Mongoh MN, 2008, TROP ANIM HEALTH PRO, V40, P69, DOI 10.1007/s11250-007-9055-8; Montgomery RR, 2017, CLIN EXP IMMUNOL, V187, P26, DOI 10.1111/cei.12863; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Myer MH, 2019, SCI TOTAL ENVIRON, V650, P2818, DOI 10.1016/j.scitotenv.2018.09.397; Myer MH, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1854; New York State Department of Health, 2018, NEW YORK MOSQ TRAP D; Newman AJ, 2015, J HYDROMETEOROL, V16, P2481, DOI 10.1175/JHM-D-15-0026.1; Nilsson R, 2007, J MACH LEARN RES, V8, P589; Niu GY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015139; NYSDOH, 2018, COMM DIS ANN REP REL; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078; Paz S, 2008, ECOHEALTH, V5, P40, DOI 10.1007/s10393-007-0150-0; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pimentel RS, 2015, STAT PROBABIL LETT, V96, P61, DOI 10.1016/j.spl.2014.09.002; Python Software Foundation, 2016, PYTH LANG REF VERS 2; R Development Core Team, 2009, R LANG ENV STAT COMP; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; REITER P, 1983, MOSQ NEWS, V43, P496; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; Root JJ, 2006, AM J TROP MED HYG, V75, P697, DOI 10.4269/ajtmh.2006.75.697; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2011, J MED ENTOMOL, V48, P867, DOI 10.1603/ME10269; Simpson JE, 2012, P ROY SOC LOND B BIO, V279; Spielman A, 2001, ANN NY ACAD SCI, V951, P220; Stojanovich CJ, 1961, ILLUSTRATED KEY COMM; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; Tonjes DJ, 2008, J VECTOR ECOL, V33, P293, DOI 10.3376/1081-1710-33.2.293; Trawinski PR, 2008, VECTOR-BORNE ZOONOT, V8, P505, DOI 10.1089/vbz.2007.0202; Trawinski PR, 2010, VECTOR-BORNE ZOONOT, V10, P515, DOI 10.1089/vbz.2008.0063; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Vitart F, 2017, B AM METEOROL SOC, V98, P163, DOI 10.1175/BAMS-D-16-0017.1; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; WALTER SD, 1980, AM J EPIDEMIOL, V112, P124, DOI 10.1093/oxfordjournals.aje.a112961; WHITTAKER J, 1984, J R STAT SOC C-APPL, V33, P52; Williams AP, 2017, J GEOPHYS RES-ATMOS, V122, P10888, DOI 10.1002/2017JD027523; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Xia YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016048; Young SG, 2013, APPL GEOGR, V45, P241, DOI 10.1016/j.apgeog.2013.09.022	118	17	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217854	10.1371/journal.pone.0217854	http://dx.doi.org/10.1371/journal.pone.0217854			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158250	gold, Green Published, Green Submitted			2022-12-27	WOS:000469915700030
J	Hussein, NR; Balatay, AA; Saleem, ZSM; Hassan, SM; Assafi, MS; Sheikhan, RS; Amedi, FR; Hafzullah, SS; Hafzullah, MS; Xedr, AM; Zebary, MT; Aqrawi, HA				Hussein, Nawfal R.; Balatay, Amer A.; Saleem, Zana S. M.; Hassan, Shiraz M.; Assafi, Mande S.; Sheikhan, Ramzy Sh; Amedi, Farasheen R.; Hafzullah, Shivan S.; Hafzullah, Mahmood S.; Xedr, Abdulkareem M.; Zebary, Mohamed T.; Aqrawi, Hindreen A.			A clinical study of cutaneous leishmaniasis in a new focus in the Kurdistan region, Iraq	PLOS ONE			English	Article								Leishmaniasis is caused by protozoan parasites of the genus Leishmania and is a major health problem in various parts of the world. Cutaneous leishmaniasis (CL) occurs, among others, in unpredictable outbreaks after wars and disasters. After the last war in Iraq, the collapse of the health system led to the spread of infectious diseases, including CL. Between September 2016 and November 2017, all patients with confirmed CL having one or more skin lesion(s) were referred to a regional health center in Musol City within the Rabeea District. During this period, 1539 patients visited the clinic. A total of 190 patients were excluded from the study because of poor follow-up. The treatment success rate was 97.7% (1319/1349). Statistically significant associations were found between number of lesions and treatment failure (p = 0.0018; OR = 1.4430; CI = 1.1466-1.8161), number of doses and number of lesions (Pearson's correlation coefficient = 0.095; p = 0.001), and the lack of municipality services and number of doses used for the treatment (p = 0.008; OR = 1.0629; CI = 1.0158-1.1122). To conclude, the highest number of patients with CL in the city of Musol was recorded after the war in Iraq. The treatment success rate was high, which reflected the strict treatment and follow-up program. An urgent plan is needed to stop the spread of infection.	[Hussein, Nawfal R.] Univ Zakho, Coll Med, Zakho, Kurdistan Regio, Iraq; [Balatay, Amer A.] Univ Duhok, Coll Pharm, Duhok, Iraq; [Saleem, Zana S. M.; Hassan, Shiraz M.] Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq; [Assafi, Mande S.] Univ Duhok, Coll Sci, Dept Biol, Duhok, Iraq; [Sheikhan, Ramzy Sh; Hafzullah, Shivan S.; Hafzullah, Mahmood S.; Xedr, Abdulkareem M.; Zebary, Mohamed T.; Aqrawi, Hindreen A.] Azadi Hosp, Infect Dis Unit, Directorate Hlth, Duhok, Iraq; [Amedi, Farasheen R.] Duhok Cent Lab, Dept Pathol, Duhok, Iraq	University of Duhok; University of Duhok; University of Duhok	Hussein, NR (corresponding author), Univ Zakho, Coll Med, Zakho, Kurdistan Regio, Iraq.	nawfal.hussein@yahoo.com		assafi, Mahde/0000-0002-4863-282X; Hussein, Nawfal/0000-0002-7813-9198	International Organization of Migration (IOM) - Duhok Suboffice - Medical Department	International Organization of Migration (IOM) - Duhok Suboffice - Medical Department	The role of the International Organization of Migration (IOM) - Duhok Suboffice - Medical Department should be acknowledged for supporting both the Rabeea medical team and researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004835; Alam E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004426; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; de Vries HJC, 2015, AM J CLIN DERMATOL, V16, P99, DOI 10.1007/s40257-015-0114-z; Fakoorziba MR, 2012, INT J INFECT DIS, V16, pE158, DOI 10.1016/j.ijid.2012.05.689; Hashiguchi Y, 2018, ACTA TROP, V177, P135, DOI 10.1016/j.actatropica.2017.09.028; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Kobets T, 2012, PLOS NEGLECT TROP D, V6, P1; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Machado P, 2002, CLIN INFECT DIS, V34, pE69, DOI 10.1086/340526; Munir M, 2002, GUIDELINES TREATMENT; Norouzinezhad F, 2016, ASIAN PAC J TROP BIO, V6, P614, DOI 10.1016/j.apjtb.2016.05.005; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Salam N, 2014, PLOS NEGLECT TROP D, V8, P1	14	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217683	10.1371/journal.pone.0217683	http://dx.doi.org/10.1371/journal.pone.0217683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150485	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100085
J	Wiatrowska, K; Komisarek, J				Wiatrowska, Katarzyna; Komisarek, Jolanta			Role of the light fraction of soil organic matter in trace elements binding	PLOS ONE			English	Article							METALLURGICAL FALLOUT; METAL ENRICHMENT; ARABLE SOILS; HEAVY-METALS; COPPER; CARBON; CADMIUM; ZINC; PB; BIOAVAILABILITY	The light fraction of soil organic matter (LF) has a rapid turnover and may be potentially metal-enriched, but the interaction between this pool of organic matter and trace elements has not been well studied. The present study aimed to investigate changes in LF content and its effect on heavy metals distribution and extractability in long-term contaminated soil by smelting activity. An incubation experiment was conducted on a surface horizon of Brunic Arenosol sampled from the previously-existing sanitary zone of Gtogow smelter, for 450 days. The contaminated soil was divided into three combinations: with the addition of either triticate straw (at the dose of 4.5 Mg ha(-1)) or pig manure (at the dose of 40 Mg ha(-1)) or without any "foreign" organic materials (nil). The LF (rho > 1.7 g cm(-3)) occurred to be metal-enriched and despite its low content (5.49%-nil, 7.18-straw and 7.29%-manure combination) in the bulk soil, it was observed that initially Cd, Cu, Pb and Zn stock reached 16.2%, 11.9%, 18.0% and 32.3%, respectively. Incubation conditions where mineralization processes dominate led to a decrease in the LF share by about 12.6% in nil and 31.4-39.8% in the combinations with organic amendments. In consequence, the DOC (dissolved organic carbon) concentration doubled and metal distribution had changed. The increase in water-soluble (F1) fraction was observed for all metals, additionally for Cu, Pb, Zn in exchangeable fraction (F2) and in carbonate bound (F3) fraction for Cd and Zn. These results support the view that changes in the LF content may play a key role in controlling trace metals mobility, especially in long-term contaminated soil.	[Wiatrowska, Katarzyna; Komisarek, Jolanta] Poznan Univ Life Sci, Dept Soil Sci & Land Reclamat, Poznan, Poland	Poznan University of Life Sciences	Wiatrowska, K (corresponding author), Poznan Univ Life Sci, Dept Soil Sci & Land Reclamat, Poznan, Poland.	kawiatr@up.poznan.pl		Komisarek, Jolanta/0000-0002-2986-0229; Wiatrowska, Katarzyna/0000-0002-5467-7952	Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022 [005/RID/2018/19];  [N N305 371 638]	Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022; 	Grant No. N N305 371 638; The work was founded by the Polish Ministry of Science and Higher Education and the publication was co-financed within the framework of Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022, Project No. 005/RID/2018/19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 14841999 PNE; Balabane M, 1999, ENVIRON POLLUT, V105, P45, DOI 10.1016/S0269-7491(98)00209-7; Balabane M, 2002, SOIL BIOL BIOCHEM, V34, P1513, DOI 10.1016/S0038-0717(02)00066-4; Beckett P. H. T., 1989, Advances in Soil Science, V9, P143; Berardi R, 1998, WASTE MANAGE, V17, P535, DOI 10.1016/S0956-053X(97)10061-7; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Chen W, 2015, ENVIRON SCI TECHNOL, V49, P2052, DOI 10.1021/es5049495; Chen Y, 2006, NATO SCI S SS IV EAR, V69, P275; Chlopecka A, 1996, J ENVIRON QUAL, V25, P69, DOI 10.2134/jeq1996.00472425002500010009x; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; DALAL RC, 1986, AUST J SOIL RES, V24, P293, DOI 10.1071/SR9860293; Du HH, 2018, ENVIRON POLLUT, V243, P444, DOI 10.1016/j.envpol.2018.08.087; Du HH, 2016, ENVIRON POLLUT, V218, P168, DOI 10.1016/j.envpol.2016.08.022; Dumat C, 2006, ENVIRON POLLUT, V142, P521, DOI 10.1016/j.envpol.2005.10.027; FAO. IUSS Working Group WRB, 2015, WORLD SOIL RESOURCES, V106; Gregorich E., 1993, SOIL SAMPLING METHOD, P397; Gregorich EG, 2006, SOIL SCI SOC AM J, V70, P975, DOI 10.2136/sssaj2005.0116; Grzebisz W, 2001, POL J ENVIRON STUD, V10, P269; Guo XJ, 2015, J SOIL SEDIMENT, V15, P1473, DOI 10.1007/s11368-015-1113-7; Hammer D, 2002, J ENVIRON QUAL, V31, P1561, DOI 10.2134/jeq2002.1561; Hu SH, 2016, J SOIL SEDIMENT, V16, P327, DOI 10.1007/s11368-015-1226-z; Jenkinson D. S., SOIL SCI, V197, P298; Kabala C., 2006, Polish Journal of Environmental Studies, V15, P90; Kabala C, 2001, J ENVIRON QUAL, V30, P485, DOI 10.2134/jeq2001.302485x; Kabata-Pendias A., 1992, TRACE ELEMENT SOILS; Kabata-Pendias A., 1995, BIBLIOTEKA MONITORIN, P28; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Komisarek J, 2009, POL J ENVIRON STUD, V18, P1029; Labanowski J, 2007, ENVIRON POLLUT, V149, P59, DOI 10.1016/j.envpol.2006.12.019; Li ZB, 1997, ENVIRON POLLUT, V95, P227, DOI 10.1016/S0269-7491(96)00074-7; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; Liu BL, 2017, SCI TOTAL ENVIRON, V609, P822, DOI 10.1016/j.scitotenv.2017.07.215; MA QL, 1997, J ENVIRON QUAL, V26, P259; Magid J, 2010, EUR J SOIL SCI, V61, P539, DOI 10.1111/j.1365-2389.2010.01247.x; McBride M. B., 1989, Advances in Soil Science, V10, P1; Mohamed I, 2010, J SOIL SEDIMENT, V10, P973, DOI 10.1007/s11368-010-0199-1; Muller T, 2004, SOIL BIOL BIOCHEM, V36, P877, DOI 10.1016/S0038-0717(04)00047-1; Oades JM, 1995, DAHL WS ENV, V16, P293; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Przewocka M., 2011, INZYNIERIA SRODOWISK, V144, P103; Sherene T., 2009, NAT ENV POLLUT TECHN, V8, P817; Shi WJ, 2018, ECOTOX ENVIRON SAFE, V154, P59, DOI 10.1016/j.ecoenv.2018.02.013; Song B, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-3; Soriano-Disla JM, 2008, FRESEN ENVIRON BULL, V17, P1839; Szwed M, 2010, NAT HAZARD EARTH SYS, V10, P1725, DOI 10.5194/nhess-10-1725-2010; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Tiller K. G., 1989, Advances in Soil Science, V9, P113; Wiatrowska K, 2013, FRESEN ENVIRON BULL, V22, P3424; Wiatrowska K, 2011, FRESEN ENVIRON BULL, V20, P2193; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Zhou T, 2018, ENVIRON POLLUT, V232, P514, DOI 10.1016/j.envpol.2017.09.081	51	8	9	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217077	10.1371/journal.pone.0217077	http://dx.doi.org/10.1371/journal.pone.0217077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145729	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500010
J	Deshpande, NG; Saxena, J; Pesaresi, TG; Carrell, CD; Ashby, GB; Liao, MK; Freeman, LR				Deshpande, Nikita Girish; Saxena, Juhi; Pesaresi, Tristan G.; Carrell, Casey Dylan; Ashby, Grayson Breneman; Liao, Min-Ken; Freeman, Linnea Ruth			High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats	PLOS ONE			English	Article							HIGH SATURATED FAT; INDUCED DYSBIOSIS; CHOLESTEROL DIET; OBESITY; BRAIN; SUGAR; IMPAIRMENT; MECHANISMS; EXPOSURE; MARKERS	As the global population ages, and rates of dementia rise, understanding lifestyle factors that play a role in the development and acceleration of cognitive decline is vital to creating therapies and recommendations to improve quality of later life. Obesity has been shown to increase risk for dementia. However, the specific mechanisms for obesity-induced cognitive decline remain unclear. One potential contributor to diet-induced cognitive changes is neuroinflammation. Furthermore, a source of diet-induced inflammation to potentially increase neuroinflammation is via gut dysbiosis. We hypothesized that a high fat diet would cause gut microbe dysbiosis, and subsequently: neuroinflammation and cognitive decline. Using 7-month old male Sprague Dawley rats, this study examined whether 8 weeks on a high fat diet could impact performance on the water radial arm maze, gut microbe diversity and abundance, and microgliosis. We found that a high fat diet altered gut microbe populations compared to a low fat, control diet. However, we did not observe any significant differences between dietary groups on maze performance (a measure of spatial working memory) or microgliosis. Our data reveal a significant change to the gut microbiome without subsequent effects to neuroinflammation (as measured by microglia characterization and counts in the cortex, hippocampus, and hypothalamus) or cognitive performance under the parameters of our study. However, future studies that explore duration of the diet, composition of the diet, age of animal model, and strain of animal model, must be explored.	[Deshpande, Nikita Girish; Saxena, Juhi; Pesaresi, Tristan G.; Freeman, Linnea Ruth] Furman Univ, Neurosci, Greenville, SC 29613 USA; [Carrell, Casey Dylan; Ashby, Grayson Breneman; Liao, Min-Ken; Freeman, Linnea Ruth] Furman Univ, Dept Biol, 3300 Poinsett Highway, Greenville, SC 29613 USA		Freeman, LR (corresponding author), Furman Univ, Neurosci, Greenville, SC 29613 USA.; Freeman, LR (corresponding author), Furman Univ, Dept Biol, 3300 Poinsett Highway, Greenville, SC 29613 USA.	linnea.freeman@furman.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103499 (LRF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilharz JE, 2018, MOL PSYCHIATR, V23, P351, DOI 10.1038/mp.2017.38; Beilharz JE, 2016, BEHAV BRAIN RES, V306, P1, DOI 10.1016/j.bbr.2016.03.018; Beilharz JE, 2016, BRAIN BEHAV IMMUN, V57, P304, DOI 10.1016/j.bbi.2016.07.151; Beilharz JE, 2015, NUTRIENTS, V7, P6719, DOI 10.3390/nu7085307; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Borre YE, 2014, ADV EXP MED BIOL, V817, P373, DOI 10.1007/978-1-4939-0897-4_17; Bruce-Keller AJ, 2016, BIOL PSYCHIAT, V80, pE5, DOI 10.1016/j.biopsych.2015.11.006; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cope EC, 2018, J NEUROSCI, V38, P8889, DOI 10.1523/JNEUROSCI.0789-18.2018; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Dorfman MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14556; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; Freeman LR, 2011, NUTR NEUROSCI, V14, P32, DOI 10.1179/174313211X12966635733358; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; Hargrave SL, 2016, BEHAV NEUROSCI, V130, P123, DOI 10.1037/bne0000110; Khan MZH, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7869080; Ledreux A, 2016, BEHAV BRAIN RES, V312, P294, DOI 10.1016/j.bbr.2016.06.012; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Magnusson KR, 2015, NEUROSCIENCE, V300, P128, DOI 10.1016/j.neuroscience.2015.05.016; Marques C, 2016, BIOL PSYCHIAT, V80, pE3, DOI 10.1016/j.biopsych.2015.10.027; McNeilly AD, 2012, DIABETOLOGIA, V55, P3061, DOI 10.1007/s00125-012-2686-y; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x; Myles IA, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-61; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P2; Singh-Manoux A, 2018, ALZHEIMERS DEMENT, V14, P178, DOI 10.1016/j.jalz.2017.06.2637; Smith P J, 2016, J Prev Alzheimers Dis, V3, P53; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217553	10.1371/journal.pone.0217553	http://dx.doi.org/10.1371/journal.pone.0217553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141574	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000061
J	Hamaoka, M; Kobayashi, T; Tanaka, Y; Mashima, H; Ohdan, H				Hamaoka, Michinori; Kobayashi, Tsuyoshi; Tanaka, Yuka; Mashima, Hiroaki; Ohdan, Hideki			Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study	PLOS ONE			English	Article							MICROVASCULAR INVASION; LIVER-TRANSPLANTATION; VENOUS INVASION; POOR-PROGNOSIS; EXPRESSION; BIOMARKER; RECURRENCE; ENUMERATION; PREDICTORS; RESECTION	The utility of glypican-3 (GPC3) expression for the detection of circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC) patients has not been elucidated. The aim of this study was to identify associations between the presence of GPC3-positive CTCs and clinicopathological factors of these patients, furthermore, to evaluate whether CTC can predict microscopic portal vein invasion (mPVI). This study was done on 85 patients who underwent hepatectomy as the first-line treatment and whose preoperative imaging showed no evidence of macroscopic PVI and distant metastases. Peripheral blood was collected from all patients immediately before surgery. Cells were purified initially by density gradient centrifugation followed by immunomagnetic positive enrichment based upon the expression of GPC3. The numbers of CTCs contained in the enriched samples were enumerated via flow cytometry. Protocol validation using HepG2 cells spiked into 8.0 mL of blood from a healthy volunteer indicated that we were able to recover 12.1% of the tumor cells. A median number of 3 CTCs (range: 0-27) was detected in the 8.0 mL of peripheral blood of the 85 analyzed HCC patients. Thirty-three patients had CTCs >= 5, and these patients had a higher incidence of mPVI (p < 0.001), a lower disease-free survival (p = 0.015), and a lower overall survival (p = 0.047) than those with CTCs < 5. Multivariate analysis identified CTCs >= 5 as an independent predictor of mPVI (p < 0.001). In conclusion, preoperative GPC3-positive CTCs >= 5 was a risk factor of mPVI and poor prognosis, and therefore may be a useful biomarker for HCC patient outcomes.	[Hamaoka, Michinori; Kobayashi, Tsuyoshi; Tanaka, Yuka; Mashima, Hiroaki; Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan	Hiroshima University	Kobayashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.	tsukoba@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019	Ohdan, Hideki/0000-0002-9066-1288; Kobayashi, Tsuyoshi/0000-0001-7364-1798	JSPS KAKENHI [15K10166]; Japan Agency for Medical Research and Development [JP17fk0210207]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) under Grant Number 15K10166 (2015-2018) to TK, and Japan Agency for Medical Research and Development under Grant Number JP17fk0210207 to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ES, 2010, CLIN LIVER DIS, V14, P687, DOI 10.1016/j.cld.2010.10.001; de Boer CJ, 1999, J PATHOL, V188, P201, DOI 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8; Dent BM, 2016, INT J CANCER, V138, P206, DOI 10.1002/ijc.29680; Eguchi S, 2010, WORLD J SURG, V34, P1034, DOI 10.1007/s00268-010-0424-5; Fan ST, 2011, ANN SURG, V254, P569, DOI 10.1097/SLA.0b013e3182300a1d; Fu SJ, 2013, SURGERY, V154, P536, DOI 10.1016/j.surg.2013.02.014; Hemming AW, 2001, ANN SURG, V233, P652, DOI 10.1097/00000658-200105000-00009; Kaibori M, 2010, J SURG ONCOL, V102, P462, DOI 10.1002/jso.21631; Kelley RK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1195-z; Li J, 2016, ONCOTARGET, V7, P2646, DOI 10.18632/oncotarget.6104; Libbrecht L, 2006, AM J SURG PATHOL, V30, P1405, DOI 10.1097/01.pas.0000213323.97294.9a; Liu HH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013170; MOLDENHAUER G, 1987, BRIT J CANCER, V56, P714, DOI 10.1038/bjc.1987.276; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Schulze K, 2013, INT J CANCER, V133, P2165, DOI 10.1002/ijc.28230; Shah SA, 2006, J AM COLL SURGEONS, V202, P275, DOI 10.1016/j.jamcollsurg.2005.10.005; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Shimada S, 2017, WORLD J SURG, V41, P2087, DOI 10.1007/s00268-017-3964-0; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; Tanaka T, 1997, HEPATOLOGY, V26, P283, DOI 10.1002/hep.510260205; Toyosaka A, 1996, HPB Surg, V10, P97, DOI 10.1155/1996/75210; Tsai TJ, 2000, SURGERY, V127, P603, DOI 10.1067/msy.2000.105498; von Felden J, 2017, ONCOTARGET, V8, P89978, DOI 10.18632/oncotarget.21208; Xu W, 2011, CLIN CANCER RES, V17, P3783, DOI 10.1158/1078-0432.CCR-10-0498; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yorita K, 2011, LIVER INT, V31, P120, DOI 10.1111/j.1478-3231.2010.02359.x; Zhang W, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011402	31	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217586	10.1371/journal.pone.0217586	http://dx.doi.org/10.1371/journal.pone.0217586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141571	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000064
J	Ning, K; Ding, CJ; Huang, QJ; Zhang, WX; Yang, CC; Liang, DJ; Fan, RT; Su, XH				Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Yang, Chengchao; Liang, Dejun; Fan, Ruting; Su, Xiaohua			Transcriptome profiling revealed diverse gene expression patterns in poplar (Populus x euramericana) under different planting densities	PLOS ONE			English	Article							NITROGEN ASSIMILATION; GLUTAMINE-SYNTHETASE; BIOMASS PRODUCTION; YIELD; AUXIN; MAIZE; LIGHT; DEFENSE; GROWTH; RESISTANCE	Certain plant genotypes can achieve optimal growth under appropriate environmental conditions. Under high planting density conditions, plants undergo competition for uptake and utilization of light and nutrients. However, the relationship between whole-genome expression patterns and the planting density in perennial woody plants remains unknown. In this study, whole-genome RNA sequencing of poplar (Populus x euramericana) was carried out at three different sampling heights to determine gene expression patterns under high (HD) and low (LD) planting densities. As a result, 4,004 differentially expressed genes (DEGs) were detected between HD and LD, of which 2,300, 701, and 1,003 were detected at the three positions, upper, middle and bottom, respectively. Function annotation results further revealed that a large number of the DEGs were involved in distinct biological functions. There were significant changes in the expression of metabolism-related and stimulusrelated genes in response to planting density. There were 37 DEGs that were found at all three positions and were subsequently screened. Several DEGs related to plant light responses and photosynthesis were observed at different positions. Meanwhile, numbers of genes related to auxin/indole-3-acetic acid, and carbon and nitrogen metabolism were also revealed, displaying overall trends of upregulation under HD. These findings provide a basis for identifying candidate genes related to planting density and could increase our molecular understanding of the effect of planting density on gene expression.	[Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Su, Xiaohua] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Su, Xiaohua] State Forestry & Grassland Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China; [Yang, Chengchao; Liang, Dejun] Liaoning Prov Inst Poplar, Gaizhou, Liaoning, Peoples R China; [Fan, Ruting] Annoroad Gene Technol Co Ltd, Beijing, Peoples R China; [Su, Xiaohua] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Su, XH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.; Su, XH (corresponding author), State Forestry & Grassland Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China.; Su, XH (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	suxh@caf.ac.cn	fan, ru/GYQ-7323-2022; Ning, Kun/GWQ-4538-2022	Ning, Kun/0000-0002-9086-128X; yang, chengchao/0000-0001-9765-987X	National Key Research and Development program of China [2016YFD0600401]	National Key Research and Development program of China	This work was supported by the National Key Research and Development program of China [Grant No. 2016YFD0600401 to XS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah HM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0555-5; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Benomar L, 2012, TREES-STRUCT FUNCT, V26, P939, DOI 10.1007/s00468-011-0671-6; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Chen ChuanYong, 2010, Acta Agronomica Sinica, V36, P871, DOI 10.3724/SP.J.1006.2010.00871; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cominelli E, 2009, CELL RES, V19, P1231, DOI 10.1038/cr.2009.123; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Estrada-Campuzano G, 2008, EUR J AGRON, V28, P597, DOI 10.1016/j.eja.2008.01.003; GERAKIS PA, 1980, AGR METEOROL, V21, P129, DOI 10.1016/0002-1571(80)90059-X; Gonzalez-Grandio E, 2013, PLANT CELL, V25, P834, DOI 10.1105/tpc.112.108480; Grassini P, 2011, FIELD CROP RES, V120, P142, DOI 10.1016/j.fcr.2010.09.012; Guo D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02001; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hecht VL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00944; Jansson G, 2017, SCAND J FOREST RES, V32, P273, DOI 10.1080/02827581.2016.1242770; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Johnson DM, 2005, AM J BOT, V92, P1425, DOI 10.3732/ajb.92.9.1425; Kang M, 2015, BIOGEOSCIENCES, V12, P4245, DOI 10.5194/bg-12-4245-2015; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Karve AA, 2012, NEW PHYTOL, V196, P726, DOI 10.1111/j.1469-8137.2012.04288.x; Khan S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00532; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; Ku LX, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0483-x; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; Li HW, 2010, EUR J AGRON, V33, P267, DOI 10.1016/j.eja.2010.07.002; Liu HZ, 2008, PLANT MOL BIOL, V68, P17, DOI 10.1007/s11103-008-9349-x; Lockhart J, 2013, PLANT CELL, V25, P1483, DOI 10.1105/tpc.113.250510; Lutter R, 2017, SCAND J FOREST RES, V32, P688, DOI 10.1080/02827581.2017.1278784; Mao K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00480; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Raey Y, 2009, NEW ZEAL J CROP HORT, V37, P141, DOI 10.1080/01140670909510259; Ren BZ, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1445-9; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Roig-Villanova I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00236; Ryu H, 2015, J PLANT BIOL, V58, P147, DOI 10.1007/s12374-015-0103-z; Sanchez-Rodriguez E, 2011, J PLANT PHYSIOL, V168, P816, DOI 10.1016/j.jplph.2010.11.018; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; St Pierre S, 2011, PLANT GENOME-US, V4, P47, DOI 10.3835/plantgenome2010.08.0020; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Suga M, 2016, CURR OPIN STRUC BIOL, V39, P46, DOI 10.1016/j.sbi.2016.04.004; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tian Q, 2001, J PLANT GROWTH REGUL, V20, P274, DOI 10.1007/s003440010022; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tun TN, 2018, SCAND J FOREST RES, V33, P464, DOI 10.1080/02827581.2018.1457711; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Ittersum MK, 2013, FIELD CROP RES, V143, P1, DOI 10.1016/j.fcr.2012.12.012; Vanselow C, 2009, BBA-BIOENERGETICS, V1787, P46, DOI 10.1016/j.bbabio.2008.10.004; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang NY, 2015, PLANT PHYSIOL, V168, P575, DOI 10.1104/pp.15.00025; Zhao HS, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0720-9; Zhao SQ, 2013, MOL PLANT, V6, P174, DOI 10.1093/mp/sss064	68	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217066	10.1371/journal.pone.0217066	http://dx.doi.org/10.1371/journal.pone.0217066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141527	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000038
J	Rai, P; Bharati, M; Subba, A; Saha, D				Rai, Priyanka; Bharati, Minu; Subba, Abhisekh; Saha, Dhiraj			Insecticide resistance mapping in the vector of lymphatic filariasis, Culex quinquefasciatus Say from northern region of West Bengal, India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PYRETHROID RESISTANCE; CARBAMATE RESISTANCE; AEDES-AEGYPTI; HARRIS COUNTY; MECHANISMS; MOSQUITOS; DIPTERA; CULICIDAE; ORGANOPHOSPHATE	Culex quinquefasciatus is a vector of lymphatic filariasis and vector control strategies normally involve the use of synthetic insecticides targeted against them. Extensive and uncontrolled use of these synthetic insecticides has led to the development of insecticide resistance in the mosquito vectors. In this context, to study the resistance status of Cx. quinquefasciatus, field populations were collected from three districts of Northern part of West Bengal and tested against insecticides ( 5% malathion, 0.05% deltamethrin, 0.05% lambdacyhalothrin, 0.75% permethrin, 0.1% propoxur, 4% DDT and Temephos). Qualitative and quantitative enzyme assay was also conducted in order to find the role of detoxifying enzymes behind the development of insecticide resistance. This study revealed the presence of widespread resistance amongst the field populations of Cx. quinquefasciatus throughout the studied regions. Moreover, the result of native PAGE and biochemical enzyme assay may be linked to some extent in the involvement of the detoxifying enzymes in conferring resistance against insecticides in most of the tested Cx. quinquefasciatus populations. The present study involving the survey of resistance status may be of immense help during the implementation of vector control strategies throughout this region.	[Rai, Priyanka; Bharati, Minu; Subba, Abhisekh; Saha, Dhiraj] Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, Raja Rammohanpur, W Bengal, India	University of North Bengal	Saha, D (corresponding author), Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, Raja Rammohanpur, W Bengal, India.	dhirajsaha.nbu@gmail.com	Saha, Dhiraj/AEB-7986-2022	Saha, Dhiraj/0000-0002-2309-4068	University Grants Commission (UGC), New Delhi, India [2061630607, 19/06/2016 (ii) EU-V]	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	The first author expresses sincere gratitude to University Grants Commission (UGC), New Delhi, India for providing financial assistance through Junior Research Fellowship (JRF) award letter Sr. no. 2061630607, Ref no.: 19/06/2016 (ii) EU-V, Dated 23/01/2017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 2006, PESTICIDES THEIR APP; [Anonymous], 2014, ADV ENTOMOL, DOI DOI 10.4236/ae.2014.23019; Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030; Balabanidou V, 2018, CURR OPIN INSECT SCI, V27, P68, DOI 10.1016/j.cois.2018.03.001; Bharati M., 2017, VECTOR BORNE DIS TRE, P1; Bharati M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203207; Bharati M, 2018, ACTA TROP, V187, P78, DOI 10.1016/j.actatropica.2018.07.004; BISSET JA, 1990, B ENTOMOL RES, V80, P245, DOI 10.1017/S0007485300050434; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; CARVALHO VM, 2003, GENET MOL BIOL, V26, P195, DOI DOI 10.1590/S1415-47572003000200013; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Delannay C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199615; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Gordon JR, 2012, J ECON ENTOMOL, V105, P971, DOI 10.1603/EC11224; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes J.D., 1988, GLUTATHIONE CONJUGAT, P3150; HEMINGWAY J, 1990, MED VET ENTOMOL, V4, P275, DOI 10.1111/j.1365-2915.1990.tb00440.x; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; KARUNARATNE SHPP, 1993, BIOCHEM J, V294, P575, DOI 10.1042/bj2940575; Kudom AA, 2015, ACTA TROP, V150, P122, DOI 10.1016/j.actatropica.2015.07.009; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NVBDCP, 2018, FIL MAGN DIS; Pietrantonio PV, 2000, J VECTOR ECOL, V25, P74; Rai P, 2018, VECTOR BORNE DIS TRE, VII, P1; Skovmand O, 2018, MED RES ARCH, V6, DOI [10.18103/mra.v6i4.1773, DOI 10.18103/MRA.V6I4.1773]; Stark PM, 2017, J VECTOR ECOL, V42, P279, DOI 10.1111/jvec.12268; Sudomo M, 2010, ADV PARASIT, V72, P205, DOI 10.1016/S0065-308X(10)72008-X; Thavaselvam D., 1993, Indian Journal of Malariology, V30, P75; Tyagi BK., 2015, INT J MOSQ RES, V50, P50; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; WHO, TEST PROC INREMO; World Health Organization, 2005, GUIDELINES LAB FIELD; Yadouleton A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0638-3	43	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217706	10.1371/journal.pone.0217706	http://dx.doi.org/10.1371/journal.pone.0217706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141548	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000075
J	Li, J; Yang, ZY; Wang, ZX; Xu, Y; Luo, SB; Yu, XL; Liu, J; Zhou, Y; Tong, WB; Zeng, PB				Li, Jing; Yang, Zeyuan; Wang, Zhixuan; Xu, Yong; Luo, Shuibin; Yu, Xuelan; Liu, Juan; Zhou, Yan; Tong, Wenbin; Zeng, Peibin			The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010-2017: A retrospective study	PLOS ONE			English	Article							HUMAN ENTEROVIRUSES; SICHUAN PROVINCE; GENETIC-ANALYSIS; ASSOCIATION; DIAGNOSIS; FEATURES; CLIMATE	Hand, foot, and mouth disease (HFMD) is well recognized as one of the major threats to children's health globally. The increasing complexity of the etiology of HFMD still challenges disease control in China. There is little surveillance of the molecular epidemiological characteristics of the enteroviruses (EVs) that cause HFMD in Neijiang city or the Sichuan Basin area in Southwest China. In this study, demographic and epidemiological information for 14,928 probable HFMD cases was extracted and analyzed to describe the epidemic features of HFMD in Neijiang city from Jan 2010 to Dec 2017. The swab samples of select probable HFMD cases from 2012 to 2017 were tested by reverse transcription (RT) real-time PCR to identify the serotype distribution of EVs, and 110 randomly selected RT-real-time PCR positive samples were then amplified and analyzed for the VP1 or VP4 regions of EVs to further analyze the phylogenetic characteristics of the circulating strains in this area. The eight-year average annual incidence was 49.82 per 100,000 in Neijiang. The incidence rates varied between 19.51 and 70.73 per 100,000, demonstrating peaks of incidence in even-number years (2012, 2014 and 2016). The median age of the probable cases was 27 months and the interquartile range (25th to 75th percentile) of ages for the probable HFMD cases was between 14 and 42 months. The male-to-female ratio of the probable HFMD cases was 1.47:1, and scattered children were the major population classification (81.7%). Two epidemic peaks were observed: one major peak between April and July and the other lesser peak between October and December. Of 6513 probable cases tested with RT-realtime PCR, 4015 (61.6%) were positive for enterovirus with the serotype distribution as follows: EV71+, 30.1% (n = 1210); CV-A16+, 28.7% (n = 1154) and a sole pan-enterovirus+, 41.1% (n = 1651). A total of 91 cases (82.7%, 91/110) were successfully amplified and underwent phylogenetic analysis: all EV71+ cases were C4a serotype (n = 23/30); all CV Al 6+ cases were B2b serotype (n = 24/30); of 42 sole pan-enterovirus+ samples, 20 were CV-A6, 14 were CV-A10 and the rest within this group were CV-A4 (n = 4), CV-A8 (n = 2), CV-A9 (n = 1) and CV-B3 (n = 1). Our findings provide important evidence that aids the improvement of strategies for vaccination against HFMD and comprehensive disease control in China.	[Li, Jing; Wang, Zhixuan; Xu, Yong; Luo, Shuibin; Yu, Xuelan; Liu, Juan; Zhou, Yan] Neijiang Ctr Dis Control & Prevent, Neijiang, Sichuan, Peoples R China; [Yang, Zeyuan; Zeng, Peibin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Yang, Zeyuan; Zeng, Peibin] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China; [Tong, Wenbin] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zeng, PB (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Zeng, PB (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.	zengpeibin@live.cn			key research and development projects, Department of Science and Technology, Sichuan province [2018SZ0212]	key research and development projects, Department of Science and Technology, Sichuan province	The study was supported by the key research and development projects, Department of Science and Technology, Sichuan province (Grant No. 2018SZ0212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Goksugur Nadir, 2010, N Engl J Med, V362, pe49, DOI 10.1056/NEJMicm0910628; Gui JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139109; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Li Y, 2017, J MED VIROL, V89, P1749, DOI 10.1002/jmv.24847; Liao JQ, 2016, SCI TOTAL ENVIRON, V563, P152, DOI 10.1016/j.scitotenv.2016.03.159; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; LIU Y, 2014, J TRANSL MED, V12; Lu J, 2014, CLIN MICROBIOL INFEC, V20, pO442, DOI 10.1111/1469-0691.12468; Momoki TS, 2009, JPN J INFECT DIS, V62, P471; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qi L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020270; Song C, 2019, SCI TOTAL ENVIRON, V648, P550, DOI 10.1016/j.scitotenv.2018.08.114; Tan XJ, 2015, ARCH VIROL, V160, P1097, DOI 10.1007/s00705-015-2340-3; Tao J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45630; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050343; Van Boeckel TP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25248; Wang H, 2015, INT J INFECT DIS, V34, P66, DOI 10.1016/j.ijid.2015.03.007; Xiao X, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3762-x; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yin F, 2016, SCI REP-UK, V6, DOI 10.1038/srep27305; Zeng P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179328; Zha J, 2015, J MED VIROL, V87, P2000, DOI 10.1002/jmv.24272	27	9	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217474	10.1371/journal.pone.0217474	http://dx.doi.org/10.1371/journal.pone.0217474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170178	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700034
J	Weinroth, MD; Britton, BC; McCullough, KR; Martin, JN; Geornaras, I; Knight, R; Belk, KE; Metcalf, JL				Weinroth, Margaret D.; Britton, Brianna C.; McCullough, Kathryn R.; Martin, Jennifer N.; Geornaras, Ifigenia; Knight, Rob; Belk, Keith E.; Metcalf, Jessica L.			Ground beef microbiome changes with antimicrobial decontamination interventions and product storage	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LACTIC-ACID; BACTERIAL SPOILAGE; SODIUM-SULFATE; SULFURIC-ACID; MEAT; CONTAMINATION; SALMONELLA; TEMPERATURE; REDUCTION	Ground beef makes up more than half of the beef consumed in the U.S. market. Although numerous studies have been conducted on microbial safety and shelf life of ground beef limited work has been done using a culture-independent approach. While past studies have allowed for the evaluation of a few organisms of interest, there is limited work on the microbial community associated with fresh ground beef. In order to have a more complete picture of the microbial ecology of the product, a culture-independent approach utilizing 16S rRNA gene amplicon sequencing was used. The objectives of this study were to characterize the fresh ground beef microbiome and the effect that antimicrobial interventions and antioxidants, applied to beef trim before grinding, and product storage have on community composition using 16S rRNA gene amplicon sequencing. Beef trimmings were treated with antimicrobials and an antioxidant. Samples were ground, loafed, and overwrapped before being packaged in modified-atmosphere packaging. Samples were in dark storage for 21 days followed by five days in retail display. Periodically during storage, samples were collected for microbiological analysis and DNA isolation. Due to low microbial biomass, only 52 of 210 samples were included in the final analysis. These samples represented two antimicrobial treatments (peroxyacetic acid, and a sulfuric acid and sodium sulfate blend) and a control, from day-15 of dark storage and day-5 of retail display. As sample age increased, so did the number of raw reads (P < 0.001) and aerobic plate counts (P < 0.001), which were correlated (r = 0.94, P = 0.017). Across all samples, lactic acid bacteria were most abundant followed by Enterobacteriaceae; several rare taxa were also identified (namely Geobacillus, Thermus, and Sporosarcina). Antimicrobial treatment altered the bacterial alpha (P < 0.001) and beta (P = 0.001) diversity, while storage day altered alpha (P = 0.001) diversity. Enterobacteriaceae relative abundance differed (P < 0.05) among treatments and was highest in control samples. In addition to confirming previously described dominant microbial differences in culture-dependent results, these data identified genera not typically associated with ground beef and allowed for study of shifts in the entire microbiome and not just a subset of indicator organisms.	[Weinroth, Margaret D.; Martin, Jennifer N.; Geornaras, Ifigenia; Belk, Keith E.; Metcalf, Jessica L.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Britton, Brianna C.] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [McCullough, Kathryn R.] North Amer Meat Inst, Washington, DC USA; [Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	Colorado State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Metcalf, JL (corresponding author), Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA.	Jessica.Metcalf@colostate.edu	Geornaras, Ifigenia/S-3828-2017	Knight, Rob/0000-0002-0975-9019; Weinroth, Margaret/0000-0001-8351-395X; Geornaras, Ifigenia/0000-0002-2384-2628				Ali NH, 2010, J INFECT DEV COUNTR, V4, P382, DOI 10.3855/jidc.599; ANDERSON ME, 1990, J FOOD SAFETY, V10, P181, DOI 10.1111/j.1745-4565.1989.tb00019.x; Arthur TM, 2004, J FOOD PROTECT, V67, P658, DOI 10.4315/0362-028X-67.4.658; Borch E, 1996, INT J FOOD MICROBIOL, V33, P103, DOI 10.1016/0168-1605(96)01135-X; Brooks JC, 2008, J FOOD PROTECT, V71, P293, DOI 10.4315/0362-028X-71.2.293; Brown MH, 2000, INT J FOOD MICROBIOL, V62, P7, DOI 10.1016/S0168-1605(00)00408-6; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHURCH N, 1994, TRENDS FOOD SCI TECH, V5, P345, DOI 10.1016/0924-2244(94)90211-9; Close D., 2014, RABOBANK AGFOCUS; Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doulgeraki AI, 2010, FOOD MICROBIOL, V27, P1028, DOI 10.1016/j.fm.2010.07.004; Earth Microbiome Project, 2018, 16S ILL AMPL SEQ; Economic Research Service, 2018, Q RED MEAT POULTR EG; Ercolini D, 2006, APPL ENVIRON MICROB, V72, P4663, DOI 10.1128/AEM.00468-06; Griffiths E, 2004, J BACTERIOL, V186, P3097, DOI 10.1128/JB.186.10.3097-3107.2004; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Holzapfel WH, 1998, GRAM POSTIVE BACTERI, P35; Karre L, 2013, MEAT SCI, V94, P220, DOI 10.1016/j.meatsci.2013.01.007; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koutsoumanis K, 2006, APPL ENVIRON MICROB, V72, P124, DOI 10.1128/AEM.72.1.124-134.2006; Laufer AS, 2015, EPIDEMIOL INFECT, V143, P2003, DOI 10.1017/S0950268814003112; Lavieri N, 2014, MEAT SCI, V97, P534, DOI 10.1016/j.meatsci.2014.02.014; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; NASSOS PS, 1983, APPL ENVIRON MICROB, V46, P894, DOI 10.1128/AEM.46.4.894-900.1983; Nissen H, 2000, INT J FOOD MICROBIOL, V59, P211, DOI 10.1016/S0168-1605(00)00373-1; Nychas G. J. E., 2005, Improving the safety of fresh meat, P461, DOI 10.1533/9781845691028.2.461; Osman KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29932-3; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rajkovic A, 2010, INT J FOOD MICROBIOL, V141, pS29, DOI 10.1016/j.ijfoodmicro.2009.12.019; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ransom J. R., 2003, Food Protection Trends, V23, P24; Scott-Bullard BR, 2017, J FOOD PROTECT, V80, P1987, DOI 10.4315/0362-028X.JFP-17-022; Stanbridge L. H., 1998, MICROBIOLOGY MEAT PO, P175; USDA-FSIS, 2012, SHIG TOX PROD ESCH C; USDA- FSIS, 2018, PATH RED SALM CAMP P; Wheeler TL, 2014, MEAT SCI, V98, P372, DOI 10.1016/j.meatsci.2014.06.026; Yang XA, 2017, J FOOD PROTECT, V80, P809, DOI 10.4315/0362-028X.JFP-16-317; Yoon Lee, 2009, GENUS 8 SPOROSARCINA, P377; Zeigler DR, 2014, MICROBIOL-SGM, V160, P1, DOI 10.1099/mic.0.071696-0	44	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217947	10.1371/journal.pone.0217947	http://dx.doi.org/10.1371/journal.pone.0217947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166992	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800053
J	He, MJ; Yao, YW; Li, YN; Yang, M; Li, Y; Wu, B; Yu, DZ				He, Meijun; Yao, Yiwei; Li, Yanni; Yang, Meng; Li, Yu; Wu, Bin; Yu, Dazhao			Comprehensive transcriptome analysis reveals genes potentially involved in isoflavone biosynthesis in Pueraria thomsonii Benth	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; PROTEIN; EXPRESSION; CLASSIFICATION; INHIBITION; MICRORNAS; ACCURACY; PROGRAM; MIRNAS	Pueraria thomsonii Benth is an important medicinal plant. Transcriptome sequencing, unigene assembly, the annotation of transcripts and the study of gene expression profiles play vital roles in gene function research. However, the full-length transcriptome of P. thomsonii remains unknown. Here, we obtained 44,339 nonredundant transcripts of P. thomsonii by using the PacBio RS II Isoform and Illumina sequencing platforms, of which 43,195 were annotated genes. Compared with the expression levels in the plant roots, those of transcripts with a vertical bar fold change vertical bar >= 4 and FDR < 0.01 in the leaves or stems were assigned as differentially expressed transcripts (DETs). In total, we found 9,225 DETs, 32 of which came from structural genes that were potentially involved in isoflavone biosynthesis. The expression profiles of 8 structural genes from the RNA-Seq data were validated by qRT-PCR. We identified 437 transcription factors (TFs) that were positively or negatively correlated with at least 1 of the structural genes involved in isoflavone biosynthesis using Pearson correlation coefficients (r) (r > 0.8 or r < -0.8). We also identified a total of 32 microRNAs (miRNAs), which targeted 805 transcripts. These miRNAs caused enriched function in 'ATP binding', 'defense response', 'ADP binding', and 'signal transduction'. Interestingly, MIR156a potentially promoted isoflavone biosynthesis by repressing SBP, and MIR319 promoted isoflavone biosynthesis by repressing TCP and HB-HD-ZIP. Finally, we identified 2,690 alternative splicing events, including that of the structural genes of trans-cinnamate 4-mono-oxygenase and pullulanase, which are potentially involved in the biosynthesis of isoflavone and starch, respectively, and of three TFs potentially involved in isoflavone biosynthesis. Together, these results provide us with comprehensive insight into the gene expression and regulation of P. thomsonii.	[He, Meijun; Yu, Dazhao] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [He, Meijun; Li, Yu] Hubei Acad Agr Sci, Inst Chinese Med Mat, Enshi, Peoples R China; [Yao, Yiwei; Li, Yanni; Yang, Meng; Wu, Bin] Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing, Peoples R China; [Yao, Yiwei; Li, Yanni; Yang, Meng; Wu, Bin] Peking Union Med Coll, Beijing, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, DZ (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.; Wu, B (corresponding author), Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing, Peoples R China.; Wu, B (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	bwu@implad.ac.cn; dazhaoyu@china.com		Wu, Bin/0000-0001-5042-8345	Natural Science Foundation of China [81274015]; Research and development of science and technology project of Enshi [XYJ2017000305]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and development of science and technology project of Enshi	This work was supported by Natural Science Foundation of China (81274015) to Bin Wu (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and Research and development of science and technology project of Enshi (XYJ2017000305) to Meijun He (http://kjj.enshi.gov.cn/2017/1026/595024.shtml).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamancos GP, 2015, RNA, V21, P1521, DOI 10.1261/rna.051557.115; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2005, CHINESE PHARMACOPOEI, P203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chu SS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006770; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Deng Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092476; Du G, 2010, J CHROMATOGR A, V1217, P705, DOI 10.1016/j.chroma.2009.12.017; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Gong P, 2017, EXP THER MED, V14, P4431, DOI 10.3892/etm.2017.5049; Gordon SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132628; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Han RC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00426; He L, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100257; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00861; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00793; Li J, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.31; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Lin RC, 1996, ALCOHOL CLIN EXP RES, V20, P659, DOI 10.1111/j.1530-0277.1996.tb01668.x; Liu XQ, 2013, PLANT BIOTECHNOL REP, V7, P445, DOI 10.1007/s11816-013-0283-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Qu JZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30411-y; Reddy CK, 2017, INT J BIOL MACROMOL, V105, P354, DOI 10.1016/j.ijbiomac.2017.07.052; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Wang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066417, 10.1371/journal.pone.0068894]; Wang X, 2017, PLANT J, V90, P535, DOI 10.1111/tpj.13510; Wang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00387; Wu B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2151-7; Wu B, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034588, 10.1371/journal.pone.0044385]; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Yang X, 2017, CURR MOL MED, V17, P488, DOI 10.2174/1566524018666171219101142; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014	45	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217593	10.1371/journal.pone.0217593	http://dx.doi.org/10.1371/journal.pone.0217593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163077	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200022
J	Oldenburg, M; Jensen, HJ				Oldenburg, Marcus; Jensen, Hans-Joachim			Stress and strain among merchant seafarers differs across the three voyage episodes of port stay, river passage and sea passage	PLOS ONE			English	Article							SLEEP; EXPERIENCE; SAFETY; WORK; LIFE	Background A sea voyage is characterized by a variety of work requirements for the ship's crew, basically reflected in three voyage episodes: port stay, river passage and sea passage. The primary aim of this study was to compare stress and strain amongst a sample of merchant seafarers across these three voyage episodes. Methods In a cross-sectional maritime field study, 323 sailors on 22 container ships were biometrically surveyed and completed a questionnaire. In addition, a survey of energy expenditure and heart rate (variability) was carried out in parallel with 236 participants with the Sense-Wear armband monitor and the RS 800 polar watch. Results Port stay and sea passage each accounted for the largest proportion of the ships' journeys, each at around 40%. The study participants rated port stay with 37.8% as the voyage episode with the highest strain, followed by the river passage (24.8%) and then the sea passage (13.0%). The working time during the sea passage was on average shorter than during port stay or the river passage (p<0.001)-as a result, seafarers had more spare time to spend on leisure and sleep. Total energy turnover and, by trend, work energy turnover were notably at the lowest during the sea passage. In particular, the crew had a significantly lower heart rate during the sea passage than during the other two voyage episodes (p = 0.001). Furthermore, there was no difference in the seafarers' heart rate variability between the voyage episodes. Conclusion In the present study, it becomes clear that an accumulation of psychophysical stress takes place during port stay and leads to a subjectively and objectively higher strain level. In contrast, seafarers are more likely to recover during the sea passage. This knowledge should be used to offer ships' crews targeted health measures, in particular during the sea passage.	[Oldenburg, Marcus; Jensen, Hans-Joachim] Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med Hamburg ZfAM, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Oldenburg, M (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med Hamburg ZfAM, Hamburg, Germany.	marcus.oldenburg@bgv.hamburg.de			Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg	Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg	This study was funded by the Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg. Both authors received funding. The funder has no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report or the decision to submit the paper for publication.	Ambrosino D, 2004, TRANSPORT RES A-POL, V38, P81, DOI 10.1016/j.tra.2003.09.002; [Anonymous], 2017, 1007512017 ISO; [Anonymous], 2015, CONNECTING YOU CREW; Arafat MT, 2009, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION 2008, VOL 2, P3; BG BAU, 2018, ERG FACH BEGR DAUERL; Carotenuto A, 2012, INT MARIT HEALTH, V63, P188; Carter Tim, 2005, Travel Med Infect Dis, V3, P61, DOI 10.1016/j.tmaid.2004.09.005; Cezar-Vaz MR, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.1347.2837; Comperatore CA, 2005, AVIAT SPACE ENVIR MD, V76, pB108; Doyle N, 2016, INT ARCH OCC ENV HEA, V89, P199, DOI 10.1007/s00420-015-1063-9; Eagles AN, 2016, J SPORT MED PHYS FIT, V56, P565; Fan JJ, 2016, PAPERS LANGUAGE TEST, P2; Forsell K, 2017, INT ARCH OCC ENV HEA, V90, P161, DOI 10.1007/s00420-016-1180-0; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Gruwez A, 2017, INT J MED INFORM, V102, P87, DOI 10.1016/j.ijmedinf.2017.03.008; Haka M, 2011, INT MARIT HEALTH, V62, P20; Jepsen JR, 2015, INT MARIT HEALTH, V66, P106, DOI 10.5603/IMH.2015.0024; Karan C., 2016, GUIDELINES MARINE IN; Kunte M, 2017, INDIAN J PSYCHOL MED, V39, P590, DOI 10.4103/0253-7176.217022; Lodde B, 2008, INT MARIT HEALTH, V59, P53; Manfredini F, 2007, G Ital Med Lav Ergon, V29, P722; McVeigh J, 2019, MAR POLICY, V99, P283, DOI 10.1016/j.marpol.2018.10.012; Oldenburg M, 2012, OCCUP ENVIRON MED, V69, P685, DOI 10.1136/oemed-2011-100619; Oldenburg M, 2010, J OCCUP HEALTH, V52, P249, DOI 10.1539/joh.K10004; Oldenburg M, 2009, INT J PUBLIC HEALTH, V54, P96, DOI 10.1007/s00038-009-7067-z; Papachristou A, 2015, WMU J MARIT AFF, V14, P159, DOI 10.1007/s13437-015-0085-1; Pauksztat B, 2017, MARIT POLICY MANAG, V44, P899, DOI 10.1080/03088839.2017.1371347; Pitta F, 2006, EUR RESPIR J, V27, P1040, DOI 10.1183/09031936.06.00064105; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7; Ross J., 2006, PRACTICAL ASSESSMENT, V11, P2; Sampson Helen, 2003, Int Marit Health, V54, P58; Simkuva H, 2016, OPTIMIZATION WORK RE; Sliskovic A., 2017, MARITIME PSYCHOL RES, P99, DOI DOI 10.1007/978-3-319-45430-6_5; Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204; Teo STT, 2013, J NURS MANAGE, V21, P878, DOI 10.1111/jonm.12120	36	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217904	10.1371/journal.pone.0217904	http://dx.doi.org/10.1371/journal.pone.0217904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163071	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200045
J	Ryoo, SM; Ahn, R; Shin, TG; Jo, YH; Chung, SP; Beom, JH; Choi, SH; Yoon, YH; Ko, BS; Lee, HJ; Suh, GJ; Kim, WY; Park, YS; Kim, K; Shin, JH; Lee, SW; Kang, GH; Lim, TH; Choi, HS				Ryoo, Seung Mok; Ahn, Ryeok; Shin, Tae Gun; Jo, You Hwan; Chung, Sung Phil; Beom, Jin Ho; Choi, Sung-Hyuk; Yoon, Young-Hoon; Ko, Byuk Sung; Lee, Hui Jai; Suh, Gil Joon; Kim, Won Young; Park, Yoo Seok; Kim, Kyuseok; Shin, Jong Hwan; Lee, Sung Woo; Kang, Gu Hyun; Lim, Tae Ho; Choi, Han Sung		Korean Shock Soc KoSS Investigator	Lactate normalization within 6 hours of bundle therapy and 24 hours of delayed achievement were associated with 28-day mortality in septic shock patients	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; CLEARANCE; DEFINITIONS	This study evaluated the prognostic ability of lactate normalization achieved within 6 and 24 h from septic shock recognition. Data from a septic shock registry from October 2015 to February 2017 were reviewed. The study included 2,102 eligible septic shock patients to analyze the prognostic ability of lactate normalization, defined as a follow-up lactate level <2 mmol/L within six hours of bundle therapy and within 24 hours of delayed normalization. The primary outcome was 28-day mortality. The overall 28-day mortality rate was 21.4%. The rates of lactate normalization within 6 and 24 h were significantly higher in the survivor groups than in the non-survivor group (42.4% vs. 23.4% and 60.2% vs. 31.2%; P<0.001, respectively). Multivariate logistic regression analysis showed that both 6-and 24-h lactate normalization were independent predictors (odds ratio [ OR] 0.58, 95% confidence interval [ CI] 0.45-0.75, p<0.001 and OR 0.42, 95% CI 0.33-0.54, p<0.001, respectively). When we could not achieve the lactate normalization, the sensitivity, specificity, positive, and negative predictive value to predict mortality were 76.6%, 42.4%, 26.5% and 87.0% respectively for 6-h normalization, and 68.8%, 60.2%, 32.0% and 87.7% respectively for 24-h normalization. Besides 6-h lactate normalization, 24-h delayed lactate normalization was associated with decreasing mortality in septic shock patients. Lactate normalization may have a role in early risk stratification and as a therapeutic target.	[Ryoo, Seung Mok; Kim, Won Young] Univ Ulsan, Asan Med Ctr, Dept Emergency Med, Coll Med, Seoul, South Korea; [Ahn, Ryeok] Univ Ulsan, Ulsan Univ Hosp, Dept Emergency Med, Coll Med, Ulsan, South Korea; [Shin, Tae Gun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea; [Jo, You Hwan] Seoul Natl Univ, Dept Emergency Med, Bundang Hosp, Seongnam, South Korea; [Chung, Sung Phil; Beom, Jin Ho] Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Choi, Sung-Hyuk; Yoon, Young-Hoon] Korea Univ, Guro Hosp, Dept Emergency Med, Med Ctr, Seoul, South Korea; [Ko, Byuk Sung] Hanyang Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Lee, Hui Jai] Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul, South Korea; [Suh, Gil Joon] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, WY (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Emergency Med, Coll Med, Seoul, South Korea.	wonpia73@naver.com	Shin, Tae Gun/GSD-5866-2022; YOON, Young-Hoon/ABA-8810-2020	Yoon, Young-Hoon/0000-0002-1916-2080; Ryoo, Seung Mok/0000-0002-2436-3311; Choi, Sung-Hyuk/0000-0002-6686-6937	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2018-0409]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This study was supported by a grant (2018-0409) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [http://ails.amc.seoul.kr/ailsk/main.do].The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Hernandez G, 2019, JAMA-J AM MED ASSOC, V321, P654, DOI 10.1001/jama.2019.0071; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Jung C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030374; Kim JS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120554; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lyu Xiaochun, 2015, Zhonghua Yi Xue Za Zhi, V95, P496; Masyuk M, 2019, INTENS CARE MED, V45, P55, DOI 10.1007/s00134-018-5475-3; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Ryoo SM, 2018, AM J MED SCI, V356, P97, DOI 10.1016/j.amjms.2018.05.002; Scott HF, 2016, J PEDIATR-US, V170, P149, DOI 10.1016/j.jpeds.2015.11.071; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sterling SA, 2015, CLIN EXP EMERG MED, V2, P197, DOI 10.15441/ceem.15.025; Tian Huan-huan, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P42; Yu Bin, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P578, DOI 10.3760/cma.j.issn.2095-4352.2013.10.002; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405; Zhang ZH, 2014, J THORAC DIS, V6, P995, DOI 10.3978/j.issn.2072-1439.2014.07.01	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217857	10.1371/journal.pone.0217857	http://dx.doi.org/10.1371/journal.pone.0217857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158247	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700031
J	Arteni, AA; LaFountain, AM; Alexandre, MTA; Fradot, M; Mendes-Pinto, MM; Sahel, JA; Picaud, S; Franke, HA; Robert, B; Pascal, AA				Arteni, Ana-Andreea; LaFountain, Amy M.; Alexandre, Maxime T. A.; Fradot, Mathias; Mendes-Pinto, Maria M.; Sahel, Jose-Alain; Picaud, Serge; Franke, Harry A.; Robert, Bruno; Pascal, Andrew A.			Carotenoid composition and conformation in retinal oil droplets of the domestic chicken	PLOS ONE			English	Article								Carotenoid-containing oil droplets in the avian retina act as cut-off filters to enhance colour discrimination. We report a confocal resonance Raman investigation of the oil droplets of the domestic chicken, Gallus gallus domesticus. We show that all carotenoids present are in a constrained conformation, implying a locus in specific lipid binding sites. In addition, we provide proof of a recent conclusion that all carotenoid-containing droplets contain a mixture of all carotenoids present, rather than only a subset of them-a conclusion that diverges from the previously-held view. Our results have implications for the mechanism(s) giving rise to these carotenoid mixtures in the differently-coloured droplets.	[Arteni, Ana-Andreea; Alexandre, Maxime T. A.; Mendes-Pinto, Maria M.; Robert, Bruno; Pascal, Andrew A.] Univ Paris Saclay, CNRS, CEA, I2BC, Gif Sur Yvette, France; [LaFountain, Amy M.; Franke, Harry A.] Univ Connecticut, Dept Chem, U-60, Storrs, CT USA; [Fradot, Mathias; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Inst Vis, CNRS, INSERM, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pascal, AA (corresponding author), Univ Paris Saclay, CNRS, CEA, I2BC, Gif Sur Yvette, France.	andrew.pascal@i2bc.paris-saclay.fr	Pinto, Maria Manuela Mendes/M-2804-2013; Robert, Bruno/D-1264-2012; Arteni, Ana Andreea/AAK-8561-2020; pascal, andrew/B-6186-2014; Picaud, Serge/H-4012-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew/0000-0002-1844-6065; ARTENI, Ana Andreea/0000-0001-6462-905X; Mendes Pinto, Maria Manuela/0000-0001-7541-7335; Picaud, Serge/0000-0002-0548-5145	European Research Council through the Advanced Grant PHOTPROT [267333]; French Agence Nationale de la Recherche through contract BIOPHYSMEMBPROT [ANR-07-CEX-009-0]; French Agence Nationale de la Recherche through contract CYANOPROTECT (Blanc SVSE 8 2011); CEA interdisciplinary program Technology for Health (MEDIASPEC project); French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05]	European Research Council through the Advanced Grant PHOTPROT; French Agence Nationale de la Recherche through contract BIOPHYSMEMBPROT; French Agence Nationale de la Recherche through contract CYANOPROTECT (Blanc SVSE 8 2011); CEA interdisciplinary program Technology for Health (MEDIASPEC project); French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the European Research Council (http://erc.europa.eu) through the Advanced Grant PHOTPROT (contract No. 267333, to BR); the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) through contracts BIOPHYSMEMBPROT (contract No. ANR-07-CEX-009-0, to BR) and CYANOPROTECT (Blanc SVSE 8 2011, to BR); the CEA (http://www.cea.fr) interdisciplinary program Technology for Health (MEDIASPEC project, to BR); and The French Infrastructure for Integrated Structural Biology (FRISBI; http://frisbi.eu) ANR-10-INBS-05 (to BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhosale P, 2007, BIOCHEMISTRY-US, V46, P9050, DOI 10.1021/bi700558f; BOWMAKER JK, 1977, VISION RES, V17, P755, DOI 10.1016/0042-6989(77)90117-1; Christensen RL, 2004, ARCH BIOCHEM BIOPHYS, V430, P30, DOI 10.1016/j.abb.2004.02.026; Cobbs C, 2013, MOL PHYLOGENET EVOL, V68, P221, DOI 10.1016/j.ympev.2013.03.012; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hill G.E., 2006, BIRD COLOURATION FUN; Ho JM, 2017, P NATL ACAD SCI USA, V114, pE5513, DOI 10.1073/pnas.1614857114; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Osorio D, 1999, J EXP BIOL, V202, P2951; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Subramanian B, 2015, ANALYST, V140, P7423, DOI [10.1039/C5AN01261A, 10.1039/c5an01261a]; Toomey MB, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00097; Toomey MB, 2016, ELIFE, V5, DOI 10.7554/eLife.15675; Toomey MB, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0563; Toomey MB, 2009, FUNCT ECOL, V23, P321, DOI 10.1111/j.1365-2435.2008.01498.x; Wilby D, 2017, J EXP BIOL, V220, P1997, DOI 10.1242/jeb.152918	19	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217418	10.1371/journal.pone.0217418	http://dx.doi.org/10.1371/journal.pone.0217418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150434	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100047
J	Ekakoro, JE; Caldwell, M; Strand, EB; Okafor, CC				Ekakoro, John E.; Caldwell, Marc; Strand, Elizabeth B.; Okafor, Chika C.			Perceptions of Tennessee cattle producers regarding the Veterinary Feed Directive	PLOS ONE			English	Article							ANTIMICROBIAL USE; RESISTANCE; ANIMALS; PRODUCTIVITY; HEALTH	Since January 1, 2017, the United States Food and Drug Administration (FDA) has fully implemented the Veterinary Feed Directive (VFD) final rule aimed at facilitating the judicious use of medically important antimicrobials in food-producing animals. The objective of this study was to identify the common perceptions of Tennessee (TN) cattle producers regarding the VFD. We used a combination of focus groups and survey questionnaires to explore TN cattle producers' perceptions regarding the VFD. Preliminary findings from seven focus groups of 62 producers were used in the development of the questionnaire sent both online and in-print to rest of cattle producers in TN. The beef focus group participants perceived the VFD: to be a top-down policy; to have led to unregulated access to in-feed antimicrobials; a regulation that has limited the producers' ability to prevent disease and leading to economic losses; to negatively affect small producers; and to be affected by challenges related to prescription writing and disposal of un-used medicines. The dairy focus group participants perceived the VFD as unnecessary and burdensome, to have affected small producers, and introduced additional costs. Among the survey questionnaire respondents, 35 (15.4%) beef producers and 6 (13.6%) dairy producers respectively were not familiar at all with the VFD. Forty-eight (21.1%) beef producers and 11 (25%) dairy producers were slightly familiar with VFD. Gender was significantly associated (P = 0.02) with the beef producers' belief in the usefulness of the VFD. Similarly, for dairy producers, herd size was significantly associated (P = 0.002) with their perceptions regarding the usefulness of the VFD. The findings of this study could inform future VFD policy review processes. More awareness regarding the VFD and its benefits is needed among both beef and dairy producers in TN.	[Ekakoro, John E.; Strand, Elizabeth B.; Okafor, Chika C.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Caldwell, Marc] Univ Tennessee, Coll Vet Med, Dept Large Anim Clin Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Okafor, CC (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	okaforch@utk.edu		Ekakoro, John Eddie/0000-0002-8148-753X; Okafor, Chika/0000-0002-2895-8347	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2016-36100-04715]; Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture [2016-36100-04715, 12-2209]	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture	This research received major funding from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (Award number: 2016-36100-04715) and supplemented funding from the Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture (Project number: 12-2209; Award number: 2016-36100-04715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Aidara-Kane A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0294-9; [Anonymous], 2017, FRONT MICROBIOL, DOI DOI 10.3389/FMICB.2017.02124; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Ciesinski L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191660; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Coyne LA, 2014, VET REC, V175, P593, DOI 10.1136/vr.102686; Debski B, 2016, POL J VET SCI, V19, P917, DOI 10.1515/pjvs-2016-0113; Dohoo IR, 2003, VET EPIDEMIOLOGIC RE; Duane S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008894; Ekakoro John E, 2018, Vet Med Int, V2018, P1836836, DOI 10.1155/2018/1836836; Ekakoro JE, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1731-6; FDA, FACT SHEET VET FEED; FDA, CVM RESP VFD QUEST; FDA, 2012, GUID IND 209 JUD US; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Laxminarayan R, EC COSTS WITHDRAWING; Lee T., 2017, KANSAS AGR EXPT STAT, P1, DOI [10.4148/2378-5977.1341, DOI 10.4148/2378-5977.1341]; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; May AM, 2018, KYKLOS, V71, P162, DOI 10.1111/kykl.12166; May AM, 2014, CONTEMP ECON POLICY, V32, P111, DOI 10.1111/coep.12004; McEwen SA, 2017, WHO GUIDELINES USE M; McEwen SA, 2018, LANCET PLANET HEALTH, V2, pE279, DOI 10.1016/S2542-5196(18)30138-4; Olsen R., 2008, ENCY SURVEY RES METH, P809, DOI DOI 10.4135/9781412963947; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Speksnijder D., 2017, ANTIBIOTIC USE FARM; Speksnijder DC, 2018, ANIM FRONT, V8, P4, DOI 10.1093/af/vfy006; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; The Dairy Alliance, 2017, 2017 TENN DAIR FACTS; The Pew Charitable trusts, 2018, TRENDS US ANT US; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turnidge J, 2005, LANCET, V365, P548; Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3; van Duijkeren E, 2014, J ANTIMICROB CHEMOTH, V69, P2022, DOI 10.1093/jac/dku123; Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066; World Organization for Animal Health, OIE STAND GUID RES A; World Organization for Animal Health (OIE), OIE LIST ANT AG VET	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217773	10.1371/journal.pone.0217773	http://dx.doi.org/10.1371/journal.pone.0217773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150500	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100103
J	Sarker, S; Lim, UT				Sarker, Souvic; Lim, Un Taek			Development and fecundity performance of Grapholita molesta and Grapholita dimorpha (Lepidoptera: Tortricidae) on different immature fruits	PLOS ONE			English	Article							HOST-PLANT QUALITY; MOTH LEPIDOPTERA; SEX-PHEROMONE; APPLE; LARVAE; PEACH; PARAMETERS; SHOOTS; BEETLE	Both Grapholita molesta (Busck) and Grapholita dimorpha Komai (Lepidoptera: Tortricidae) are important pests of pome and stone fruits. Mature fruits of peach and plum have been tested as food sources for G. molesta, but no studies have examined the suitability of immature fruits, which are the fruit stage more likely to be available for the spring populations of both G. molesta and G. dimorpha. Thus, we evaluated immature fruits of peach, plum, and apple as food sources by assessing their effects on biological and behavioral attributes of these moths in the laboratory. Immature fruits were collected in May and June of 2016 and again in 2017. The first-instar larvae of G. molesta preferred either peach or plum, which showed exit rates of mature larvae of 81.0 and 100.0% for the two fruits, respectively. On peach, development time was shorter, and fecundity was lower than plum. However, G. dimorpha preferred plum and apple, showing the lowest fruit-boring rate and lowest mature larval exit rate on peach, from which only one female moth emerged but produced no eggs. In conclusion, it seems that at the immature fruit stage, plum and apple are better food sources for both G. molesta and G. dimorpha than is peach.	[Sarker, Souvic; Lim, Un Taek] Andong Natl Univ, Dept Plant Med, Andong, South Korea	Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	utlim@andong.ac.kr		Lim, Un Taek/0000-0002-6704-0627; Sarker, Souvic/0000-0001-6346-9656	R&D Program for Forest Science Technology by Korea Forest Service (Korea Forestry Promotion Institute) [2017064A00-1720-AB02]	R&D Program for Forest Science Technology by Korea Forest Service (Korea Forestry Promotion Institute)	This study was carried out with the support of R&D Program for Forest Science Technology (Project No. 2017064A00-1720-AB02) provided by Korea Forest Service (Korea Forestry Promotion Institute).	Atachi P., 2000, WALP INSECT SCI APPL, V20, P117, DOI [10.1017/S1742758400018750, DOI 10.1017/S1742758400018750]; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Beljaev E.A., 2005, Far Eastern Entomologist, V155, P1; Bellerose S, 2007, CAN ENTOMOL, V139, P292, DOI 10.4039/N06-058; BRANSON TF, 1982, ENTOMOL EXP APPL, V31, P303, DOI 10.1111/j.1570-7458.1982.tb03149.x; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; CHEW FS, 1980, OECOLOGIA, V46, P347, DOI 10.1007/BF00346263; Du J, 2015, ENVIRON ENTOMOL, V44, P1522, DOI 10.1093/ee/nvv124; Il'ichev AL, 2007, J APPL ENTOMOL, V131, P368, DOI 10.1111/j.1439-0418.2007.01201.x; Ishihara M, 2006, ENVIRON ENTOMOL, V35, P524, DOI 10.1603/0046-225X-35.2.524; Jung CR, 2014, GENOMICS, V103, P308, DOI 10.1016/j.ygeno.2014.02.009; Jung CR, 2013, J ASIA-PAC ENTOMOL, V16, P189, DOI 10.1016/j.aspen.2013.01.008; Jung Chung Ryul, 2012, Korean Journal of Applied Entomology, V51, P479, DOI 10.5656/KSAE.2012.10.0.049; KOMAI F, 1979, APPL ENTOMOL ZOOL, V14, P133, DOI 10.1303/aez.14.133; Komai Furumi, 1999, Entomologica Scandinavica Supplement, V55, P1; Leskey TC, 2001, J CHEM ECOL, V27, P1, DOI 10.1023/A:1005667430877; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Masante-Roca I, 2007, ENTOMOL EXP APPL, V122, P239, DOI 10.1111/j.1570-7458.2006.00510.x; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; MORRIS R. F., 1954, CANADIAN JOUR ZOOL, V32, P283, DOI 10.1139/z54-027; Murakami Y, 2005, APPL ENTOMOL ZOOL, V40, P521, DOI 10.1303/aez.2005.521; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Myers CT, 2006, J ECON ENTOMOL, V99, P1299, DOI 10.1603/0022-0493-99.4.1299; Myers CT, 2006, J ECON ENTOMOL, V99, P349, DOI 10.1603/0022-0493-99.2.349; Myers CT, 2006, J ENTOMOL SCI, V41, P65, DOI 10.18474/0749-8004-41.1.65; Najar-Rodriguez A, 2013, PHYSIOL ENTOMOL, V38, P63, DOI 10.1111/phen.12003; Naseri B, 2009, ENTOMOL SCI, V12, P147, DOI 10.1111/j.1479-8298.2009.00310.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; OKU T, 1988, Bulletin of the Fruit Tree Research Station Series C (Morioka), P49; Park K.-T., 1986, Korean Journal of Plant Protection, V25, P77; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; Singh A.K., 1997, Indian Journal of Entomology, V59, P209; Timm AE, 2008, ANN ENTOMOL SOC AM, V101, P197, DOI 10.1603/0013-8746(2008)101[197:PGSOGM]2.0.CO;2; Tremblay E., 1990, ENTOMOLOGIA APPL, P170; Walter AJ, 2010, BIOL INVASIONS, V12, P1133, DOI 10.1007/s10530-009-9531-3; WILLS RBH, 1983, J SCI FOOD AGR, V34, P1383, DOI 10.1002/jsfa.2740341211; Yan S., 1999, FOR PEST DIS, V18, P15; Yoshizawa E., 2008, PLANT PROT JAPAN, V62, P556; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang WX, 2010, ECOLOGY, V91, P2070, DOI 10.1890/09-0979.1; 최경희, 2009, [Korean Journal of Applied Entomology, 한국응용곤충학회지], V48, P417	41	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217492	10.1371/journal.pone.0217492	http://dx.doi.org/10.1371/journal.pone.0217492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150441	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100058
J	Pan, FD; Zhang, L; Ou, YH; Zhang, XN				Pan, Fada; Zhang, Li; Ou, Yuhong; Zhang, Xinni			The audio-visual integration effect on music emotion: Behavioral and physiological evidence	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; CROSSMODAL BINDING; SPEECH-PERCEPTION; VISUAL-ATTENTION; TIME-COURSE; RESPONSES; VOICE; BRAIN; INFORMATION; CONFLICT	Previous research has indicated that, compared to audio-only presentation, audio-visual congruent presentation can lead to a more intense emotional response. In the present study, we investigated the audio-visual integration effect on emotions elicited by positive or negative music and the role of visual information presentation durations. The participants were presented with audio-only condition, audio-visual congruent condition, and audiovisual incongruent condition and then required to judge the intensity of emotional experience elicited by the music. Their emotional responses to the music were measured using self-ratings and physiological aspects, including heart rate, skin temperature, EMG root mean square and prefrontal EEG. Relative to the audio-only presentation, the audio-visual congruent presentation led to a more intense emotional response. More importantly, the audiovisual integration occurred both in the positive music and in the negative music. Furthermore, the audio-visual integration effect was larger for positive music than for negative music; meanwhile the audio-visual integration effect was strongest with the visual information presented within 80s for negative music, which indicated that this integration effect was more likely to occur in the negative music. These results suggest that when the music was positive, the effect of audio-visual integration was greater. When the music was negative, the modulation effect of the presentation durations of visual information on the music induced emotion was more significant.	[Pan, Fada; Zhang, Li; Ou, Yuhong; Zhang, Xinni] Nantong Univ, Sch Educ Sci, Nantong, Peoples R China	Nantong University	Pan, FD (corresponding author), Nantong Univ, Sch Educ Sci, Nantong, Peoples R China.	psyc_lee2015@126.com	Campailla, Jasmin/AAK-2420-2021		Social Sciences Foundation of Jiangsu Province, China [14SHC006]; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China [C-a/2013/01/003]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18_2389]	Social Sciences Foundation of Jiangsu Province, China; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China; Postgraduate Research & Practice Innovation Program of Jiangsu Province	Fada Pan was supported by Grant number: 14SHC006, The Social Sciences Foundation of Jiangsu Province, China. http://jspopss.jschina.com.cn/; and Grant number: C-a/2013/01/003, The Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China. http://www.jssghb.cn/.Li Zhang was supported by Grant number: KYCX18_2389, Postgraduate Research & Practice Innovation Program of Jiangsu Province. http://jyt.jiangsu.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Brett-Green BA, 2008, BRAIN RES, V1242, P283, DOI 10.1016/j.brainres.2008.03.090; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Chapados C, 2008, COGNITION, V108, P639, DOI 10.1016/j.cognition.2008.05.008; Chen MC, 2013, BRAIN INJURY, V27, P75, DOI 10.3109/02699052.2012.722255; Chen XH, 2016, INT J PSYCHOPHYSIOL, V106, P14, DOI 10.1016/j.ijpsycho.2016.05.009; Conrey B, 2006, J ACOUST SOC AM, V119, P4065, DOI 10.1121/1.2195091; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gao YL, 2014, NEUROREPORT, V25, P668, DOI 10.1097/WNR.0000000000000155; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Platz F, 2012, MUSIC PERCEPT, V30, P71, DOI 10.1525/MP.2012.30.1.71; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Santangelo V, 2010, NEUROIMAGE, V49, P2717, DOI 10.1016/j.neuroimage.2009.10.061; Senkowski D, 2005, EXP BRAIN RES, V166, P411, DOI 10.1007/s00221-005-2381-z; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Tang XY, 2016, NEUROSCI BIOBEHAV R, V61, P208, DOI 10.1016/j.neubiorev.2015.11.002; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vines BW, 2011, COGNITION, V118, P157, DOI 10.1016/j.cognition.2010.11.010; Vuoskoski J. K., 2016, PSYCHOMUSICOLOGY MUS, V26, P179, DOI DOI 10.1037/PMU0000142; Vuoskoski JK, 2014, ATTEN PERCEPT PSYCHO, V76, P591, DOI 10.3758/s13414-013-0582-2; Watson R, 2014, J NEUROSCI, V34, P6813, DOI 10.1523/JNEUROSCI.4478-13.2014; Weijkamp J, 2017, PSYCHOL MUSIC, V45, P204, DOI 10.1177/0305735616654216; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Yu HT, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P1965, DOI 10.1109/ICMA.2016.7558867; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	47	14	14	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217040	10.1371/journal.pone.0217040	http://dx.doi.org/10.1371/journal.pone.0217040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145745	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500009
J	Bessat, M; Dewair, A				Bessat, Mohamed; Dewair, Amira			Assessment of the inhibitory effects of disinfectants on the embryonation of Ascaridia columbae eggs	PLOS ONE			English	Article							SUUM EGGS; INACTIVATION; LUMBRICOIDES; PRESSURE; IODINE; FECES; SOIL	This study was set out with the aim of assessing the effects of the most commonly available commercial disinfectants on embryogenesis of A. columbae eggs. In addition to the distilled water treatment as a control group, four disinfectants were tested that included formalin, povidone iodide, TH4, and Virkon-S, in three independent experiments. In the first experiment, an overnight incubation with the working concentration of disinfectants resulted in significant inhibition of 80%, 85%, and 98% of embryonic development at day 9 post-treatment with formalin, povidone iodide, and TH4, respectively. This inhibition was continued through days 12 and 15 with the three tested disinfectants. Virkon-S did not affect embryogenesis with larval development comparable to that of the control group. In the second more dissected experiment, contact times of 10, 20, 30, and 60 minutes were set out for each disinfectant with embryogenesis inhibition results echoed that of the first experiment, with all disinfectants but Virkon-S inhibited larval development in significant proportions of eggs. Again, Virkon-S was very neutral in its effect on embryogenesis. When pigeon fecal matters were mixed with eggs and were subjected to disinfectants, discrepancies to results of the first two experiments were observed with only formalin inhibited embryogenesis in considerable proportion of eggs. Thus, and with the exception of Virkon-S, disinfectants tested at levels similar to those applicable in poultry in-houses and farms exhibited potent ovicidal activities on free eggs. To our knowledge, this is the first study involving the application of the commonly used in-poultry houses disinfectants to inactivate or delay the embryogenesis of bird Ascarids. The future perspective will potentially involve the in-field applications of the efficient disinfectants to eliminate or reduce the dissemination of infections with bird Ascarids in the chicken, turkey, pigeons, and other poultry houses.	[Bessat, Mohamed; Dewair, Amira] Alexandria Univ, Dept Parasitol, Fac Vet Med, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Bessat, M (corresponding author), Alexandria Univ, Dept Parasitol, Fac Vet Med, Alexandria, Egypt.	mohamed.bessat@alexu.edu.eg	bessat, mohamed/W-6396-2019	bessat, mohamed/0000-0002-4583-1604	Vmerge FP7 grant from EU [613996]	Vmerge FP7 grant from EU	The study was in-part supported financially by the Vmerge FP7 grant (613996) from EU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT J, 1976, PARASITOLOGY, V73, P109, DOI 10.1017/S0031182000051374; Boado E., 1992, Revista Cubana de Ciencia Avicola, V19, P74; Brownell SA, 2006, APPL ENVIRON MICROB, V72, P2178, DOI 10.1128/AEM.72.3.2178-2184.2006; Butkus MA, 2011, APPL ENVIRON MICROB, V77, P363, DOI 10.1128/AEM.01675-10; Feachem RG, 1983, SANITATION DIS HLTH, Vxxvii; GASPARINI R, 1995, EUR J EPIDEMIOL, V11, P193, DOI 10.1007/BF01719487; Hernandez A, 2000, J HOSP INFECT, V46, P203, DOI 10.1053/jhin.2000.0818; Labare MP, 2013, AM J INFECT CONTROL, V41, P360, DOI 10.1016/j.ajic.2012.05.013; Mandarino-Pereira A, 2010, VET PARASITOL, V170, P176, DOI 10.1016/j.vetpar.2010.02.007; McMullin P, 2004, APOCKET GUIDE POULTR, DOI [10.1016/j.ajic.2012.05.013, DOI 10.1016/J.AJIC.2012.05.013]; MELENDEZ RD, 1979, J PARASITOL, V65, P85, DOI 10.2307/3280207; Msoffe PLMM, 2010, AFRJAGRICRES, V5, P564; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; Oh KS, 2016, KOREAN J PARASITOL, V54, P103, DOI 10.3347/kjp.2016.54.1.103; Pecson BM, 2005, ENVIRON SCI TECHNOL, V39, P7909, DOI 10.1021/es050659a; RAO TB, 2006, ZOOS PRINT J, V21, P2377; Rosypal AC, 2007, VET PARASITOL, V145, P86, DOI 10.1016/j.vetpar.2006.11.001; Sari BK B., 2008, B VET I PULAWY, V52, P20; SINNIAH B, 1982, PARASITOLOGY, V84, P167, DOI 10.1017/S0031182000051763; Soulsby EJL., 1968, HELMINTHS ARTHROPODS; Soulsby EJL, 1983, HELMINTHS ARTHROPODS, Vxix; Taylor M. A., 2015, VET PARASITOL; Thomas Divyamol, 2014, Journal of Parasitic Diseases, V38, P174, DOI 10.1007/s12639-012-0217-x; Tietz Marques Sandra Marcia, 2007, Parasitologia Latinoamericana, V62, P183; vd Burg W P, 1987, Tijdschr Diergeneeskd, V112, P769; WATTAL C, 1985, J PARASITOL, V71, P518, DOI 10.2307/3281551; WEHR EE, 1964, J PARASITOL, V50, P131, DOI 10.2307/3276047; Yu YM, 2014, KOREAN J PARASITOL, V52, P111, DOI 10.3347/kjp.2014.52.1.111; ZAMAN V, 1967, T ROY SOC TROP MED H, V61, P443, DOI 10.1016/0035-9203(67)90026-0	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217551	10.1371/journal.pone.0217551	http://dx.doi.org/10.1371/journal.pone.0217551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141572	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000060
J	Nuss, H; Altazan, A; Zabaleta, J; Sothern, M; Redman, L				Nuss, Henry; Altazan, Abby; Zabaleta, Jovanny; Sothern, Melinda; Redman, Leanne			Maternal pre-pregnancy weight status modifies the influence of PUFAs and inflammatory biomarkers in breastmilk on infant growth	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; DEPRESSIVE SYMPTOMS; ADIPOSE-TISSUE; BODY-WEIGHT; TNF-ALPHA; OBESITY; PREGNANCY; LEPTIN; MARKERS	Background Human breastmilk contains pro- and anti-inflammatory compounds and hormones that can influence infant growth. However, little is known about the specific interrelationships between these compounds and whether their effects on infant growth may be influenced by pre-pregnancy weight status. Objective The purpose of this novel, prospective cohort study was to assess the interrelationships between pro- inflammatory cytokines (TNF-alpha, IL-6), hormones (insulin, leptin) and PUFAs (n-6, n-3) in blood and breastmilk in early postpartum between women with normal BMI (Group 1, n = 18; 18.5<BMI <= 24.9 kg/m(2)) and with overweight/obesity (Group 2, n = 15; BMI >= 25.0 kg/m(2)) befor e pregnancy to determine if these components correlated to infant growth measures at age 4-8 weeks. Methods Participants were robustly phenotyped along with their infants at 4-8 weeks postpartum. TNF-alpha, IL-6, insulin, leptin, and n-3 and n-6 PUFAs measured in blood and breastmilk and compared between pre-pregnancy BMI groups and with infant weight, length, head circumference and % fat mass. Results Group 1 women had higher serum leptin (p< 0.01) and breastmilk leptin (p< 0.001) compared to Group 2. Other inflammatory markers, hormones, and total n-6, n-3 and n-6/n-3 ratio PUFAs were similar between pre-pregnancy BMI groups. No relationships were observed between whey inflammatory markers, hormones, PUFAs and growth measures in infants born to Group 2 women. However, TNF-alpha was positively related and, IL-6, leptin, insulin, total n-6, n-3 and n-6/n-3 PUFAs in whey breastmilk were negatively correlated to infant growth measures in infants born to Group 1 women (p< 0.01). Conclusions Pro-inflammatory qualities of breastmilk were associated with infant growth measures regardless of maternal pre-pregnancy BMI. However, infants born to women with overweight or obesity demonstrated less responsive growth to breastmilk contents. More studies are needed to assess longitudinal effects of this impact.	[Nuss, Henry; Sothern, Melinda] Louisiana State Univ Hlth, Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA; [Altazan, Abby; Sothern, Melinda; Redman, Leanne] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Zabaleta, Jovanny; Sothern, Melinda] Louisiana State Univ Hlth, Sch Med, Dept Pediat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Nuss, H (corresponding author), Louisiana State Univ Hlth, Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA.	hnussj@lsuhsc.edu			Louisiana/Pennington Nutrition Obesity Research Center [P30DK072476]; Lifestyle Interventions for Expectant Moms (LIFE-Moms); National Institutes of Health through the NIDDK [U01 DK094418, U01 DK094463, U01 DK094416, 5U01 DK094466]; National Heart, Lung, and Blood Institute [U01 HL114344, U01 HL114377]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD072834]; National Center for Complementary and Integrative Health; National Institutes of Health Office of Research in Women's Health; Office of Behavioral and Social Science Research; Indian Health Service; Intramural Research Program of the NIDDK; Louisiana Clinical and Translational Science Center [U54 GM104940];  [P30 DK089503];  [U24 DK097153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, U24DK097153, U01DK094466, U01DK094416, P30DK072476, U01DK094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Louisiana/Pennington Nutrition Obesity Research Center; Lifestyle Interventions for Expectant Moms (LIFE-Moms); National Institutes of Health through the NIDDK; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary and Integrative Health; National Institutes of Health Office of Research in Women's Health; Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Health Service(United States Department of Health & Human Services); Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Louisiana Clinical and Translational Science Center; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Louisiana/Pennington Nutrition Obesity Research Center (P30DK072476) (HN, AA), the Lifestyle Interventions for Expectant Moms (LIFE-Moms), supported by the National Institutes of Health through the NIDDK (U01 DK094418 [LR; Expecting Success], U01 DK094463, U01 DK094416, 5U01 DK094466), the National Heart, Lung, and Blood Institute (U01 HL114344, U01 HL114377), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01 HD072834), the National Center for Complementary and Integrative Health, the National Institutes of Health Office of Research in Women's Health, the Office of Behavioral and Social Science Research, the Indian Health Service, and the Intramural Research Program of the NIDDK (HN, LR). The study was supported by cores and services including biostatistics by Louisiana Clinical and Translational Science Center (U54 GM104940) and the lipid analyses at the University of Michigan, supported by grant P30 DK089503 and U24 DK097153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Andreas NJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010778; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackmore ER, 2014, J PSYCHOSOM OBST GYN, V35, P8, DOI 10.3109/0167482X.2013.868879; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosviel R, 2017, FREE RADICAL BIO MED, V103, P146, DOI 10.1016/j.freeradbiomed.2016.12.018; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Calder PC, 2013, P NUTR SOC, V72, P326, DOI 10.1017/S0029665113001031; Cao YL, 2008, DIABETES RES CLIN PR, V79, P214, DOI 10.1016/j.diabres.2007.08.030; Chan D, 2018, INT J OBESITY, V42, P36, DOI 10.1038/ijo.2017.189; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Eriksson B, 2010, BRIT J NUTR, V103, P50, DOI 10.1017/S0007114509991371; Fields DA, 2017, PEDIATR OBES, V12, P78, DOI 10.1111/ijpo.12182; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Fields DA, 2016, OBESITY, V24, P1213, DOI 10.1002/oby.21519; Flock MR, 2014, PROSTAG LEUKOTR ESS, V91, P161, DOI 10.1016/j.plefa.2014.07.006; Fujimori M, 2017, BIOFACTORS, V43, P243, DOI 10.1002/biof.1339; Gomes RM, 2018, J NUTR BIOCHEM, V61, P24, DOI 10.1016/j.jnutbio.2018.07.006; Hales Craig M, 2017, NCHS Data Brief, P1; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Huang YS, 2011, MOL CELL BIOCHEM, V358, P85, DOI 10.1007/s11010-011-0924-0; Kramer MS, 2012, EPIDEMIOLOGY, V23, P790, DOI 10.1097/EDE.0b013e31826cc0e9; Lindholm ES, 2013, PROSTAG LEUKOTR ESS, V88, P211, DOI 10.1016/j.plefa.2012.11.007; Mastroeni MF, 2017, PUBLIC HEALTH NUTR, V20, P2537, DOI [10.1017/s1368980017001239, 10.1017/S1368980017001239]; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panagos PG, 2016, J PERINATOL, V36, P284, DOI 10.1038/jp.2015.199; Perichart-Perera O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180874; Rudolph MC, 2017, INT J OBESITY, V41, P510, DOI 10.1038/ijo.2016.211; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schuster S, 2011, PEDIATR RES, V70, P633, DOI 10.1203/PDR.0b013e31823214ea; Sergeant S, 2016, EUR J PHARMACOL, V785, P77, DOI 10.1016/j.ejphar.2016.04.020; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Simpson W, 2016, REV BRAS PSIQUIATR, V38, P190, DOI 10.1590/1516-4446-2015-1899; Skinner AC, 2016, OBESITY, V24, P1116, DOI 10.1002/oby.21497; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Sutton EF, 2017, OBSTET GYNECOL, V129, P554, DOI 10.1097/AOG.0000000000001900; Vahamiko S, 2013, BRIT J NUTR, V110, P1098, DOI 10.1017/S0007114513000214; Vaidya H, 2018, PEDIATR OBES, V13, P285, DOI 10.1111/ijpo.12215; Vidakovic AJ, 2016, AM J CLIN NUTR, V103, P1017, DOI 10.3945/ajcn.115.112847; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Young BE, 2018, PEDIATR OBES, V13, P598, DOI 10.1111/ijpo.12394; Young BE, 2017, MATERN CHILD HLTH J, V21, P1367, DOI 10.1007/s10995-016-2243-2	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217085	10.1371/journal.pone.0217085	http://dx.doi.org/10.1371/journal.pone.0217085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141526	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000040
J	Pontes, TA; Barbosa, AD; Silva, RD; Melo, MR; Silva, RO				Pontes, T. A.; Barbosa, A. D.; Silva, R. D.; Melo-Junior, M. R.; Silva, R. O.			Osteopenia-osteoporosis discrimination in postmenopausal women by H-1 NMR-based metabonomics	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SPECTROSCOPY; DIAGNOSIS; CANCER; PLASMA; SERUM	This is a report on how H-1 NMR-based metabonomics was employed to discriminate osteopenia from osteoporosis in postmenopausal women, identifying the main metabolites associated to the separation between the groups. The Assays were performed using seventyeight samples, being twenty-eight healthy volunteers, twenty-six osteopenia patients and twenty-four osteoporosis patients. PCA, LDA, PLS-DA and OPLS-DA formalisms were used. PCA discriminated the samples from healthy volunteers from diseased patient samples. Osteopenia-osteoporosis discrimination was only obtained using Analysis Discriminants formalisms, as LDA, PLS-DA and OPLS-DA. The metabonomics model using LDA formalism presented 88.0% accuracy, 88.5% specificity and 88.0% sensitivity. Cross-Validation, however, presented some problems as the accuracy of modeling decreased. LOOCV resulted in 78.0% accuracy. The OPLS-DA based model was better: R2Y and Q2 values equal to 0.871 (p< 0.001) and 0.415 (p< 0.001). LDA and OPLS-DA indicated the important spectral regions for discrimination, making possible to assign the metabolites involved in the skeletal system homeostasis, as follows: VLDL, LDL, leucine, isoleucine, allantoin, taurine and unsaturated lipids. These results indicate that H-1 NMR-based metabonomics can be used as a diagnosis tool to discriminate osteoporosis from osteopenia using a single serum sample.	[Pontes, T. A.; Barbosa, A. D.; Melo-Junior, M. R.] Univ Fed Pernambuco, Biol Appl Hlth Postgrad Program, LIKA, Ave Prof Luis Freire S-N,Cidade Univ, Recife, PE, Brazil; [Silva, R. D.; Silva, R. O.] Univ Fed Pernambuco, Fundamental Chem Dept, CCEN, Chem Postgrad Program, Ave Jornalista Anibal Fernandes S-N,Cidade Univ, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Pontes, TA (corresponding author), Univ Fed Pernambuco, Biol Appl Hlth Postgrad Program, LIKA, Ave Prof Luis Freire S-N,Cidade Univ, Recife, PE, Brazil.	tiagoarrudatg@gmail.com	Silva, Ricardo Oliveira/ABF-2093-2021; Silva, Ricardo O/A-9461-2013	Silva, Ricardo Oliveira/0000-0001-8090-7320; Silva, Ricardo O/0000-0001-8090-7320; Pontes, Tiago/0000-0002-1080-7460	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR) [APQ-0765-1.06/14]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR)	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to T. A. Pontes and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR) (APQ-0765-1.06/14) to R. O. Silva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista AD, 2018, WORLD J HEPATOL, V10, P105, DOI 10.4254/wjh.v10.i1.105; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106559; Chubb SAP, 2015, J CLIN ENDOCR METAB, V100, P90, DOI 10.1210/jc.2014-2646; da Silva RA, 2018, MOL CELL ENDOCRINOL, V478, P151, DOI 10.1016/j.mce.2018.08.008; Dixon SJ, 2000, DRUG DEVELOP RES, V49, P187, DOI 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F; Duarte IF, 2012, PROG NUCL MAG RES SP, V62, P51, DOI 10.1016/j.pnmrs.2011.11.002; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Gouveia LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182196; Hanaa HA, 2009, REP OPIN, V1, DOI [10.7537/marsroj010609.05, DOI 10.7537/MARSROJ010609.05]; IOF, 2018, OST MUSC DIS; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; Liu YR, 2014, MOL CELL ENDOCRINOL, V387, P19, DOI 10.1016/j.mce.2014.02.007; Long Wei-Fu, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P843; Lv HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122018; Ma B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054965; Maritz FJ, 2001, ARTERIOSCL THROM VAS, V21, P1636, DOI 10.1161/hq1001.097781; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Parhami F, 2000, ARTERIOSCL THROM VAS, V20, P2346, DOI 10.1161/01.ATV.20.11.2346; Poiana C, 2013, BONE RES, V1, P275, DOI 10.4248/BR201303004; Prentice RL, 2014, SEMIN REPROD MED, V32, P419, DOI 10.1055/s-0034-1384624; Qiao Y, 2016, NEUROSCI LETT, V617, P270, DOI 10.1016/j.neulet.2016.02.031; Rosen, 2000, ENDOTEXT; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; Varga F, 1997, CALCIFIED TISSUE INT, V61, P404, DOI 10.1007/s002239900356; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vasikaran Samuel D, 2014, Clin Biochem Rev, V35, P237; Xue LM, 2011, INT J MOL SCI, V12, P7635, DOI 10.3390/ijms12117635; You L, 2011, ACTA PHARMACOL SIN, V32, P1498, DOI 10.1038/aps.2011.135	34	19	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217348	10.1371/journal.pone.0217348	http://dx.doi.org/10.1371/journal.pone.0217348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141566	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000051
J	van Zyl, FJ; Marais, J; Nieuwoudt, M; Niesler, TR				van Zyl, Floris J.; Marais, Johan; Nieuwoudt, Martin; Niesler, Thomas R.			Computer simulation and physical phantom models for estimating the dielectric properties of rhinoceros tissue	PLOS ONE			English	Article								In vivo and ex vivo sensors have the potential to aid tracking and anti-poaching endeavours and provide new insights into rhinoceros physiology and environment. However, the propagation of electromagnetic signals in rhinoceros tissue is currently not known. We present simulation and agar models of the rhinoceros that allow the investigation of electromagnetic propagation by in vivo and ex vivo devices without the need for surgery. Since the dielectric properties of rhinoceros tissue have not been documented, the conductivity and permittivity of the skin, fat, muscle, blood and other organs are first approximated by means of a meta-analysis that includes animals with similar physical properties. Subsequently, we develop anatomical models that include dermal layers, internal organs and a skeleton. We also develop a flank model that serves as an approximation of the anatomical model in certain situations. These models are used to determine the viability of communication between an in vivo device and an ex vivo device attached to the hind leg of the animal. Two types of antenna (microstrip- fed planar elliptical monopole antenna and printed inverted-F antenna) and three feasible implant locations (back, neck and chest) are considered. In addition to the computer models, phantom recipes using salt, sugar and agar are developed to match the dielectric properties of each tissue type at the industrial, scientific and medical (ISM) frequencies of 403MHz, 910MHz and 2.4GHz. The average error between the measured and theoretically predicted dielectric values was 6.22% over all recipes and 4.49% for the 2.4 GHz recipe specifically. When considering the predicted efficiency of the transmitting and receiving antennas, an agreement of 67.38% was demonstrated between the computer simulations and laboratory measurements using the agar rhinoceros flank models. Computer simulations using the anatomical model of the rhinoceros indicate that the chest is the optimal implant location and that best signal propagation is achieved using the planar inverted-F antenna (PIFA). Using this configuration, the simulations indicate that communication between the implant and an ex vivo device attached to the hind leg is challenging but possible. Furthermore, we find that the inclusion of factors such as the density and temperature of the phantom materials were found to be critical to the achievement of good agreement between practice and simulation.	[van Zyl, Floris J.; Niesler, Thomas R.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa; [Marais, Johan] Univ Pretoria, Fac Vet Sci, Pretoria, Gauteng, South Africa; [Nieuwoudt, Martin] Stellenbosch Univ, IBE, Stellenbosch, Western Cape, South Africa	Stellenbosch University; University of Pretoria; Stellenbosch University	Niesler, TR (corresponding author), Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa.	trn@sun.ac.za		Nieuwoudt, Martin/0000-0002-6354-799X	South African National Research Foundation (NRF); South African Centre for Epidemiological Modelling and Analysis (SACEMA)	South African National Research Foundation (NRF)(National Research Foundation - South Africa); South African Centre for Epidemiological Modelling and Analysis (SACEMA)	The work was supported in part by grants from the South African National Research Foundation (NRF) and the South African Centre for Epidemiological Modelling and Analysis (SACEMA). National Research Foundation (NRF): www.nrf.ac.za; South African Centre for Epidemiological Modelling and Analysis (SACEMA): www.sacema.org.The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearcraft W, 1958, EPIDERMAL STRUCTURES, V182, P196; Dabbagh A, 2014, ULTRASONIC IMAGING, V36, P291, DOI 10.1177/0161734614526372; Duan Q, 2014, MED PHYS, V41, DOI 10.1118/1.4895823; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Huang J., 2016, SENSORS, V16, P1; International Rhino Foundation, 2016, RHIN FACT SHEET; MALMBERG CG, 1956, J RES NAT BUR STAND, V56, P1, DOI 10.6028/jres.056.001; SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118; TOMASELL.VP, 1973, BIOPOLYMERS, V12, P353, DOI 10.1002/bip.1973.360120212	10	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216595	10.1371/journal.pone.0216595	http://dx.doi.org/10.1371/journal.pone.0216595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141536	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000017
J	Gonzalez-Rodriguez, R; Campbell, E; Naumov, A				Gonzalez-Rodriguez, Roberto; Campbell, Elizabeth; Naumov, Anton			Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing	PLOS ONE			English	Article							IRON-OXIDE; CONTRAST AGENTS; SYNERGISTIC ENHANCEMENT; CONTROLLED-RELEASE; DOXORUBICIN; GADOLINIUM; DESIGN; SIZE; INTERNALIZATION; ACCUMULATION	Graphene Oxide (GO) has recently attracted substantial attention in biomedical field as an effective platform for biological sensing, tissue scaffolds and in vitro fluorescence imaging. However, the targeting modality and the capability of its in vivo detection have not been explored. To enhance the functionality of GO, we combine it with superparamagnetic iron oxide nanoparticles (Fe3O4 NPs) serving as a biocompatible magnetic drug delivery addends and magnetic resonance contrast agent for MRI. Synthesized GO-Fe3O4 conjugates have an average size of 260 nm and show low cytotoxicity comparable to that of GO. Fe3O4 nanoparticles provide superparamagnetic properties for magnetic targeted drug delivery allowing simple manipulation by the magnetic field and magnetic resonance imaging with high r2/r1 relaxivity ratios of similar to 10.7. GO-Fe3O4 retains pH-sensing capabilities of GO used in this work to detect cancer versus healthy environments in vitro and exhibits fluorescence in the visible for bioimaging. As a drug delivery platform GO-Fe3O4 shows successful fluorescence-tracked transport of hydrophobic doxorubicin non-covalently conjugated to GO with substantial loading and 2.5-fold improved efficacy. As a result, we propose GO-Fe3O4 nanoparticles as a novel multifunctional magnetic targeted platform for high efficacy drug delivery traced in vitro by GO fluorescence and in vivo via MRI capable of optical cancer detection.	[Gonzalez-Rodriguez, Roberto; Campbell, Elizabeth; Naumov, Anton] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA	Texas Christian University	Gonzalez-Rodriguez, R (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.	r.ganzalezrodriguez@tcu.edu		Naumov, Anton/0000-0001-6427-7277; Gonzalez Rodriguez, Roberto/0000-0001-6849-1799	INFOR (Initiative for Oncology Research Grant); TCU Invests in Scholarship grant	INFOR (Initiative for Oncology Research Grant); TCU Invests in Scholarship grant	This work was supported with INFOR (Initiative for Oncology Research Grant), and TCU Invests in Scholarship grant.	Ahmad T, 2011, J NANOSCI NANOTECHNO, V11, P5645, DOI 10.1166/jnn.2011.4502; Ahmed MSU, 2017, INT J NANOMED, V12, P6973, DOI 10.2147/IJN.S139011; Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Allier C, 2017, CYTOM PART A, V91A, P433, DOI 10.1002/cyto.a.23079; Balcioglu M, 2013, J MATER CHEM B, V1, P6187, DOI 10.1039/c3tb20992j; Bjornerud A, 2002, MAGNET RESON MED, V47, P461, DOI 10.1002/mrm.10066; Campbell E., 2018, SCI REPORTS; Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f; Cormode DP, 2011, BIOCONJUGATE CHEM, V22, P353, DOI 10.1021/bc1003179; Eiblmaier M, 2008, J NUCL MED, V49, P1472, DOI 10.2967/jnumed.108.052316; Espinosa A, 2016, ACS NANO, V10, P2436, DOI 10.1021/acsnano.5b07249; Galande C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00085; GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y; Goncalves G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06735; Gossuin Y, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/15/155706; Granitzer P, 2015, NANOSCALE, V7, P20220, DOI 10.1039/c5nr05232g; Granitzer P, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-413; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guo L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23091-1; Hasan MT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06107-0; Hope TA, 2012, RADIOLOGY, V264, P423, DOI 10.1148/radiol.12112453; Hu FQ, 2012, NANOSCALE, V4, P6235, DOI 10.1039/c2nr31865b; Hu W, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4796602; Huang A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40772; Huang J, 2013, ACS APPL MATER INTER, V5, P4632, DOI 10.1021/am400713j; Hurley KR, 2013, CHEM MATER, V25, P1968, DOI 10.1021/cm400711h; Ishikawa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21273; Jarockyte G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081193; Jiang B, 2017, GENES DIS, V4, P25, DOI 10.1016/j.gendis.2017.02.003; Jiao TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12451; Justin R, 2016, CARBON, V97, P54, DOI 10.1016/j.carbon.2015.06.070; Justino CIL, 2017, TRAC-TREND ANAL CHEM, V91, P53, DOI 10.1016/j.trac.2017.04.003; Kim BH, 2011, J AM CHEM SOC, V133, P12624, DOI 10.1021/ja203340u; Larsen EKU, 2009, ACS NANO, V3, P1947, DOI 10.1021/nn900330m; Lee CS, 2017, EUR J MED CHEM, V142, P416, DOI 10.1016/j.ejmech.2017.08.063; Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180; Li HJ, 2016, P NATL ACAD SCI USA, V113, P4164, DOI 10.1073/pnas.1522080113; Liu Z, 2014, SMALL, V10, P2429, DOI 10.1002/smll.201303909; Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612; Lu YJ, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8040193; Luo HN, 2017, J APPL PHYS, V122, DOI 10.1063/1.4991967; Ma XX, 2012, NANO RES, V5, P199, DOI 10.1007/s12274-012-0200-y; Wettstein CM, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4953172; Matsumoto Y., 2015, CARBON N Y, V87, P463, DOI DOI 10.1016/J.CARB0N.2015.02.032; Mkhoyan KA, 2009, NANO LETT, V9, P1058, DOI 10.1021/nl8034256; Montes-Navajas P, 2013, LANGMUIR, V29, P13443, DOI 10.1021/la4029904; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; Papageorgiou DG, 2017, PROG MATER SCI, V90, P75, DOI 10.1016/j.pmatsci.2017.07.004; Paquet C, 2011, ACS NANO, V5, P3104, DOI 10.1021/nn2002272; Perazella MA, 2008, CURR DRUG SAF, V3, P67, DOI 10.2174/157488608783333989; Pereira C, 2015, J MATER CHEM B, V3, P6261, DOI 10.1039/c5tb00789e; Qin J, 2007, ADV MATER, V19, P1874, DOI [10.1002/adma.200602326, 10.1002/adma.200790066]; Rogosnitzky M, 2016, BIOMETALS, V29, P365, DOI 10.1007/s10534-016-9931-7; Ruan YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21682; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x; Shadjou N, 2018, BIOENGINEERED, V9, P38, DOI 10.1080/21655979.2017.1373539; Shang JZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00792; Shang L, 2017, RSC ADV, V7, P47715, DOI 10.1039/c7ra08348c; Shen ZY, 2017, MOL PHARMACEUT, V14, P1352, DOI 10.1021/acs.molpharmaceut.6b00839; Shi CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8449; Shi Y, 2013, BIOMACROMOLECULES, V14, P1826, DOI 10.1021/bm400234c; Shibata H, 2015, DRUG DEV IND PHARM, V41, P1376, DOI 10.3109/03639045.2014.954582; Shin DS, 2017, RSC ADV, V7, P13979, DOI 10.1039/c7ra00114b; Singh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42771; Tong S, 2017, ACS NANO, V11, P6808, DOI 10.1021/acsnano.7b01762; Tong S, 2010, NANO LETT, V10, P4607, DOI 10.1021/nl102623x; Tukmachev D, 2015, NANOSCALE, V7, P3954, DOI 10.1039/c4nr05791k; Tuoek J, 2014, ACS NANO, V8, P7571, DOI [10.1021/m501836x, DOI 10.1021/M501836X]; van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008; Yan H, 2014, ACS APPL MATER INTER, V6, P9871, DOI 10.1021/am502377n; Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k; Yathindranath V, 2013, LANGMUIR, V29, P10850, DOI 10.1021/la402007d; Zhang F, 2012, BIOCHEM BIOPH RES CO, V425, P886, DOI 10.1016/j.bbrc.2012.07.168; Zhang HZ, 2016, J COLLOID INTERF SCI, V471, P94, DOI 10.1016/j.jcis.2016.03.015; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11129; Zhang ZY, 2015, SMALL, V11, P3000, DOI 10.1002/smll.201403459; Zhou T, 2014, BIOMATERIALS, V35, P4185, DOI 10.1016/j.biomaterials.2014.01.044; Zhou ZJ, 2014, ACS NANO, V8, P7976, DOI 10.1021/nn5038652; Zhu XL, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/36/365103	82	58	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217072	10.1371/journal.pone.0217072	http://dx.doi.org/10.1371/journal.pone.0217072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170197	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700017
J	Perneger, TV; Hannouche, D; Miozzari, HH; Lubbeke, A				Perneger, Thomas V.; Hannouche, Didier; Miozzari, Hermes H.; Lubbeke, Anne			Symptoms of osteoarthritis influence mental and physical health differently before and after joint replacement surgery: A prospective study	PLOS ONE			English	Article							REPORTED OUTCOME MEASURES; TOTAL HIP-REPLACEMENT; QUALITY-OF-LIFE; RESPONSE SHIFT; KNEE; IMPLEMENTATION; ARTHROPLASTY; REGISTRIES; WOMAC	Background Patient-reported outcomes are increasingly used in evaluations of joint replacement surgery, but it is unclear if symptoms of osteoarthritis (i.e., pain and dysfunction) influence health perceptions similarly before and after surgery. Methods In this prospective study based on a hospital-based arthroplasty registry, patients with primary total hip or knee arthroplasty (THA, N = 990, and TKA, N = 907) completed the WOMAC Pain and Function scales, and the SF12 Physical and Mental Component Scores (PCS and MCS), before surgery and one year later. Associations between WOMAC and SF12 scales were examined using mixed linear regression models. Results All patient-reported outcomes improved following total joint arthroplasty, but the associations between symptom scales and global health perceptions were altered. Mental health scores at a given level of pain or function were lower after surgery than before, by about 4-5 points, a clinically meaningful and statistically significant difference. In contrast, the associations between WOMAC scales and the PCS remained stable. These findings were observed in both cohorts of patients. Conclusions After total joint arthroplasty, mental health scores were lower than would have been expected given the symptomatic improvement. This suggests that relationships between patient-reported outcomes are context-dependent, and that care should be exerted when interpreting changes in patient-reported outcomes over time.	[Perneger, Thomas V.] Geneva Univ Hosp, Div Clin Epidemiol, Geneva, Switzerland; [Hannouche, Didier; Miozzari, Hermes H.; Lubbeke, Anne] Geneva Univ Hosp, Div Orthoped Surg & Traumatol, Geneva, Switzerland	University of Geneva; University of Geneva	Perneger, TV (corresponding author), Geneva Univ Hosp, Div Clin Epidemiol, Geneva, Switzerland.	Thomas.Perneger@hcuge.ch		Hannouche, Didier/0000-0003-2060-2394				American Society of Anesthesiologists (ASA), 2014, ASA PHYS STAT CLASS; Ayers DC, 2017, J AM ACAD ORTHOP SUR, V25, pS48, DOI 10.5435/JAAOS-D-16-00631; Ayers DC, 2013, CLIN ORTHOP RELAT R, V471, P3409, DOI 10.1007/s11999-013-3224-z; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BURTON KE, 1979, ANN RHEUM DIS, V38, P471, DOI 10.1136/ard.38.5.471; Busija L, 2011, ARTHRIT CARE RES, V63, pS383, DOI 10.1002/acr.20541; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cullati S, 2014, SOCIOL HEALTH ILL, V36, P1077, DOI 10.1111/1467-9566.12156; Franklin PD, 2014, J BONE JOINT SURG AM, V96A, P104, DOI 10.2106/JBJS.N.00328; Karrholm J, 2017, ANN REPORT 2016; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Lubbeke A, 2018, HEALTH POLICY, V122, P548, DOI 10.1016/j.healthpol.2018.03.010; Nemes S, 2015, QUAL LIFE RES, V24, P2963, DOI 10.1007/s11136-015-1020-9; Ostendorf M, 2004, J BONE JOINT SURG BR, V86B, P801, DOI 10.1302/0301-620X.86B6.14950; Palazzo C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-53; Perneger T, 2019, QUAL LIFE RES, V28, P503, DOI 10.1007/s11136-018-2018-x; Pickard AS, 2017, MED CARE, V55, P979, DOI 10.1097/MLR.0000000000000802; Razmjou H, 2006, J BONE JOINT SURG AM, V88A, P2590, DOI 10.2106/JBJS.F.00283; Razmjou H, 2009, J CLIN EPIDEMIOL, V62, P91, DOI 10.1016/j.jclinepi.2008.08.004; SooHoo NF, 2015, J ARTHROPLASTY, V30, P176, DOI 10.1016/j.arth.2014.09.026; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Ubel PA, 2010, QUAL LIFE RES, V19, P465, DOI 10.1007/s11136-010-9592-x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whitehouse SL, 2003, J BONE JOINT SURG BR, V85B, P706, DOI 10.1302/0301-620X.85B5.13681; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Zahiri CA, 1998, J ARTHROPLASTY, V13, P890, DOI 10.1016/S0883-5403(98)90195-4	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217912	10.1371/journal.pone.0217912	http://dx.doi.org/10.1371/journal.pone.0217912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170228	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700080
J	Suzuki, A; Yamasaki, T; Hasebe, R; Horiuchi, M				Suzuki, Akio; Yamasaki, Takeshi; Hasebe, Rie; Horiuchi, Motohiro			Enhancement of binding avidity by bivalent binding enables PrPSc-specific detection by anti-PrP monoclonal antibody 132	PLOS ONE			English	Article							MOUSE NEUROBLASTOMA-CELLS; SCRAPIE PRION PROTEIN; ABNORMAL ISOFORM; CONFORMATIONAL TRANSITION; INFECTED CELLS; VIRUS; PANEL	Anti-prion protein (PrP) monoclonal antibody 132, which recognizes mouse PrP amino acids 119-127, enables us to reliably detect abnormal isoform prion protein (PrPSc) in cells or frozen tissue sections by immunofluorescence assay, although treatment with guanidinium salts is a prerequisite. Despite the benefit of this mAb, the mechanism of PrPSc-specific detection remains unclear. Therefore, to address this mechanism, we analyzed the reactivities of mono- and bivalent mAb 132 to recombinant mouse PrP (rMoPrP) by enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR). In ELISA, binding of the monovalent form was significantly weaker than that of the bivalent form, indicating that bivalent binding confers a higher binding stability to mAb 132. Compared with other anti-PrP mAbs tested, the reactivity of bivalent mAb 132 was easily affected by a decrease in antigen concentration. The binding kinetics of mAb 132 assessed by SPR were consistent with the results of ELISA. The dissociation constant of the monovalent form was approximately 260 times higher than that of the bivalent form, suggesting that monovalent binding is less stable than bivalent binding. Furthermore, the amount of mAb 132 that bound to rMoPrP decreased if the antigen density was too low to allow bivalent binding. If two cellular PrP (PrPC) are close enough to allow bivalent binding, mAb 132 binds to PrPC. These results indicate that weak monovalent binding to monomeric PrPC diminishes PrPC signals to background level, whereas after exposure of the epitope, mAb 132 binds stably to oligomeric PrPSc in a bivalent manner.	[Suzuki, Akio; Yamasaki, Takeshi; Horiuchi, Motohiro] Hokkaido Univ, Grad Sch Infect Dis, Fac Vet Med, Lab Vet Hyg,Kita Ku, Sapporo, Hokkaido, Japan; [Hasebe, Rie] Hokkaido Univ, Inst Genet Med, Biomed Anim Res Lab, Kita Ku, Sapporo, Hokkaido, Japan; [Horiuchi, Motohiro] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Horiuchi, M (corresponding author), Hokkaido Univ, Grad Sch Infect Dis, Fac Vet Med, Lab Vet Hyg,Kita Ku, Sapporo, Hokkaido, Japan.; Horiuchi, M (corresponding author), Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ, Kita Ku, Sapporo, Hokkaido, Japan.	horiuchi@vetmed.hokudai.ac.jp		HASEBE, Rie/0000-0003-2009-0595	JSPS KAKENHI [JP 15H02475, JP 16K15033]; Program for Leading Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [F01]; Ministry of Health, Labour and Welfare of Japan [H29-Shokuhin-Ippan-004]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Leading Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Science Research (A) (JSPS KAKENHI Grant Number JP 15H02475 to MH) and a Grant-in-Aid for challenging Exploratory Research (JSPS KAKENHI Grant Number JP 16K15033 to MH), and a grant from the Program for Leading Graduate Schools (F01 to MH) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by grants for TSE research (H29-Shokuhin-Ippan-004 to MH) from the Ministry of Health, Labour and Welfare of Japan.	Cutler TA, 2009, J MOL BIOL, V386, P854, DOI 10.1016/j.jmb.2008.10.090; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072; Garrido G, 2011, CANCER BIOL THER, V11, P373, DOI 10.4161/cbt.11.4.14097; Harms BD, 2012, METHOD ENZYMOL, V502, P67, DOI 10.1016/B978-0-12-416039-2.00004-5; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Holscher C, 1998, J VIROL, V72, P1153; Horiuchi M, 1997, J VET MED SCI, V59, P133, DOI 10.1292/jvms.59.133; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Masujin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058013; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; OLSON WC, 1989, MOL IMMUNOL, V26, P129, DOI 10.1016/0161-5890(89)90094-1; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Saijo E, 2016, J VIROL, V90, P4905, DOI 10.1128/JVI.00088-16; Sakai K, 2013, J VIROL, V87, P13433, DOI 10.1128/JVI.02072-13; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shan ZF, 2016, PRION, V10, P305, DOI 10.1080/19336896.2016.1189053; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Tanaka M, 2016, J GEN VIROL, V97, P2030, DOI 10.1099/jgv.0.000514; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; WEISS E, 1994, J BIOTECHNOL, V33, P43, DOI 10.1016/0168-1656(94)90097-3; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yamasaki T, 2018, J VIROL, V92, DOI 10.1128/JVI.01457-17; Yamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106516; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217944	10.1371/journal.pone.0217944	http://dx.doi.org/10.1371/journal.pone.0217944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170247	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700085
J	Yu, K; Rodriguez, MD; Paul, Z; Gordon, E; Rice, K; Triplett, EW; Keller-Wood, M; Wood, CE				Yu, Kevin; Rodriguez, Michelle D.; Paul, Zubin; Gordon, Elizabeth; Rice, Kelly; Triplett, Eric W.; Keller-Wood, Maureen; Wood, Charles E.			Proof of principle: Physiological transfer of small numbers of bacteria from mother to fetus in late-gestation pregnant sheep	PLOS ONE			English	Article							BREAST-MILK; FETAL; MICROBIOTA; INFANT	Fetal development is thought to proceed in a sterile environment. Recent reports of the presence of bacterial DNA in human placenta, the transfer of live bacteria from mother to fetus after hypoxia in the pregnant sheep, and the presence of bacteria in the meconium of newborn infants have suggested that the fetus might be exposed to bacteria in utero. The present experiments were designed to test the hypothesis that small numbers of bacteria introduced into the maternal bloodstream (too few to induce fever or changes in maternal food consumption), can be found in the fetus days later. We injected 100 colony forming units of green-, red- and far red- fluorescent protein (GFP, RFP, FRFP) expressing S. aureus into late-gestation pregnant sheep intravenously. Five to 7 days later, the animals were euthanized and tissues collected for analysis of GFP. The inoculations did not cause any fever or other measurable behavioral response in the ewes, but did result in the appearance of GFP DNA, and protein in various tissues within the fetuses. Immunohistochemical analysis reveals GFP protein-containing bacteria that appear to be mostly contained within other cells. We were unable to recover any live GFP-expressing bacteria from the fetal tissues. We conclude that S. aureus, and perhaps other bacteria, gain access to the fetus, although it is not clear from these experiments that they survive in the fetus. It is possible that these low inocula and their progeny were effectively cleared by the fetal immune system.	[Yu, Kevin; Paul, Zubin; Gordon, Elizabeth; Wood, Charles E.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Rodriguez, Michelle D.; Rice, Kelly; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Keller-Wood, Maureen] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wood, CE (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	woodc@ufl.edu		Keller-Wood, Maureen/0000-0002-1443-9212	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD33053]; National Institute of Allergy and Infectious Diseases [AI120195]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the following grants: HD33053 (CEW) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov), AI120195 (CEW and ET) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov).None of the sponsors or funders played any role in the study design, data collection or analysis, decision to publish, or in preparation of this manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ahmed S, 2015, AM J REPROD IMMUNOL, V73, P232, DOI 10.1111/aji.12299; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; Ardissone A. N., 2014, PLOS ONE, V9; Brocklehurst P, 1999, BRIT MED J, V318, P548, DOI 10.1136/bmj.318.7183.548; Burton GJ, 1997, REV MED VIROL, V7, P219, DOI 10.1002/(SICI)1099-1654(199712)7:4<219::AID-RMV205>3.0.CO;2-E; Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007; Chang EI, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12741; Chang EI, 2016, J PHYSIOL-LONDON, V594, P1295, DOI 10.1113/JP271066; Clawson AB, 1928, AMERICAN JOURNAL OF, V85, P20; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; ESCHERICH T, 1989, REV INFECT DIS, V11, P352; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; HAY FC, 1971, CLIN EXP IMMUNOL, V9, P355; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Purinton SC, 2002, J PHYSIOL-LONDON, V544, P919, DOI 10.1113/jphysiol.2002.025635; Rabaglino MB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1001; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Rodriguez MD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02491; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Tissier H., 1900, RECHERCHES FLORE INT; Zar JH., 1999, BIOSTAT ANAL, V663rd; Zarate MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06789-6; Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217211	10.1371/journal.pone.0217211	http://dx.doi.org/10.1371/journal.pone.0217211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170184	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700021
J	Mpimbaza, A; Nayiga, S; Ndeezi, G; Rosenthal, PJ; Karamagi, C; Katahoire, A				Mpimbaza, Arthur; Nayiga, Susan; Ndeezi, Grace; Rosenthal, Philip J.; Karamagi, Charles; Katahoire, Anne			Understanding the context of delays in seeking appropriate care for children with symptoms of severe malaria in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RAPID DIAGNOSTIC-TESTS; PRIVATE-SECTOR; FEBRILE CHILDREN; HEALTH SYSTEMS; DRUG SHOPS; COMBINATION TREATMENT; QUALITATIVE RESEARCH; ILLNESS; MANAGEMENT	Introduction A large proportion of children with uncomplicated malaria receive appropriate treatment late, contributing to progression of illness to severe disease. We explored contexts of caregiver delays in seeking appropriate care for children with severe malaria. Methods This qualitative study was conducted at the Children's Ward of Jinja Hospital, where children with severe malaria were hospitalized. A total of 22in-depth interviews were conducted with caregivers of children hospitalized with severe malaria. Issues explored were formulated based on the Partners for Applied Social Sciences (PASS) model, focusing on facilitators and barriersto caregivers'promptseeking and accessing ofappropriate care. The data were coded deductively using ATLAS. ti (version 7.5). Codes were then grouped into families based on emerging themes. Results Caregivers' rating of initial symptoms as mild illness lead to delays in response. Use of home initiated interventions with presumably ineffective herbs or medicines was common, leading to further delay. When care was sought outside the home, drug shops were preferred over public health facilities for reasons of convenience. Drug shops often provided sub-optimal care, and thus contributed to delays in access to appropriate care. Public facilities were often a last resort when illness was perceived to be progressing to severe disease. Further delays occurred at health facilities due to inadequate referral systems. Conclusion Communities living in endemic areas need to be sensitized about the significance of fever, even if mild, as an indicator of malaria. Additionally, amidst ongoing efforts at bringing antimalarial treatment services closer to communities, the value of drug shops as providers ofrationalantimalarialtreatment needs to be reviewed.	[Mpimbaza, Arthur; Katahoire, Anne] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Nayiga, Susan] Infect Dis Res Collaborat, Kampala, Uganda; [Ndeezi, Grace; Karamagi, Charles] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda; [Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Karamagi, Charles] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Dept Med, Kampala, Uganda	Makerere University; Makerere University; University of California System; University of California San Francisco; Makerere University	Mpimbaza, A (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	arthurwakg@yahoo.com			NIH Fogarty International Center; University of California Global Health Institute GloCal Health Fellowship [TW009343]; Training in Malaria Research in Uganda program [TW007375]	NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute GloCal Health Fellowship; Training in Malaria Research in Uganda program	This research was supported by two training awards from the NIH Fogarty International Center, the University of California Global Health Institute GloCal Health Fellowship (TW009343) and the Training in Malaria Research in Uganda program (TW007375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansah EK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1019; Awor P, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2950; Awor P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0798-9; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Bartoloni A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.026; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bedford KJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100038; Benavides S., 2013, ANAL TANZANIAS ADDO; Bennett A, 2017, LANCET GLOB HEALTH, V5, pE418, DOI 10.1016/s2214-109x(17)30076-1; Bloom G, 2008, SOC SCI MED, V66, P2067, DOI 10.1016/j.socscimed.2008.01.032; Bruxvoort K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0602-x; Buchner DL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209641; Bukirwa H, 2008, TROP MED INT HEALTH, V13, P1143, DOI 10.1111/j.1365-3156.2008.02119.x; Camponovo F, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1650-6; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Doherty JE, 2015, HEALTH POLICY PLANN, V30, pi93, DOI 10.1093/heapol/czu111; Embrey M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164332; Ewing VL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1559-0; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hanson K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1829-5; Hutchinson E, 2018, SOC SCI MED, V211, P123, DOI 10.1016/j.socscimed.2018.05.039; Hutchinson E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000067; Kabaghe AN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2066-7; Kamat VR, 2006, SOC SCI MED, V62, P2945, DOI 10.1016/j.socscimed.2005.11.042; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kassam R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2813-7; Kassam R, 2015, ACTA TROP, V152, P252, DOI 10.1016/j.actatropica.2015.07.028; Katahoire AR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2129-z; Kaula H, 2015, MALARIA J, V16, P219, DOI [10.1186/s12936-017-1824-x, DOI 10.1186/S12936-017-1824-X]; Kedenge SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054371; Kitutu Freddy Eric, 2017, BMJ Glob Health, V2, pe000334, DOI 10.1136/bmjgh-2017-000334; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Korenromp E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1461-9; Liu J, 2016, B WORLD HEALTH ORGAN, V94, P267, DOI 10.2471/BLT.15.154666; Lungu EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189940; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Maloney K, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1658-y; Mangham-Jefferies L, 2014, SOC SCI MED, V104, P98, DOI 10.1016/j.socscimed.2013.12.024; Mbonye AK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1723-1; Michael D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1819-7; Ministry of Health, 2014, UG HOSP HLTH CTR 4 C; Mpanya G, 2013, MALARIA J, V16, P94, DOI [10.1186/s12936-016-1659-x, DOI 10.1186/S12936-016-1659-X]; Mpimbaza A, 2017, AM J TROP MED HYG, V97, P1513, DOI 10.4269/ajtmh.17-0056; Muela Ribera J., 2012, MALARIA REPORTS, V2; Musuva A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2089-0; Mutebi F, 2018, ACTA TROP, V177, P81, DOI 10.1016/j.actatropica.2017.10.003; Mwandama D, 2016, MALAWI MED J, V28, P150, DOI 10.4314/mmj.v28i4.1; National Drug Authority, 2017, PUBL NOT LIC PHARM D; Nayiga S, 2014, EVALUATION-US, V20, P471, DOI 10.1177/1356389014551484; Newton PN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1818-8; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2; Opiyo N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009926.pub2; Phanalasy S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1769-0; Phok S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1800-5; Pierce H, 2016, POPUL RES POLICY REV, V35, P581, DOI 10.1007/s11113-016-9396-y; Poyer S, 2015, TROP MED INT HEALTH, V20, P744, DOI 10.1111/tmi.12491; Rosapep L, 2017, HEALTH POLICY PLANN, V32, P527, DOI 10.1093/heapol/czw155; Rutebemberwa E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1529-9; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Stauffer W, 2003, CLIN INFECT DIS, V37, P1340, DOI 10.1086/379074; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Tabuti JRS, 2008, J ETHNOPHARMACOL, V116, P33, DOI 10.1016/j.jep.2007.10.036; Talisuna AO, 2013, EPIDEMIOLOGICAL PROF; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Tawiah T, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0090-2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tougher S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1814-z; Uganda Bureau of Statistics (UBOS), 2016, UG NAT HOUS SURV 201; Uganda Bureau of Statistics (UBOS) and ICF, 2016, UG DEM HLTH SURV 201; Visser T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173093; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Wafula FN, 2010, INT J QUAL HEALTH C, V22, P316, DOI 10.1093/intqhc/mzq022; Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916; Wang LT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2454-7; Webster P, 2017, LANCET, V390, P15, DOI 10.1016/S0140-6736(17)31722-1; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007; World Health Organization, 2016, WHO GLOB TECHN STRAT; World Health Orgnaization, 2017, WORLD MALARIA REPORT, DOI [10.4269/ajtmh.17-0056, DOI 10.4269/AJTMH.17-0056]; Zinsou C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1808-x; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	89	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217262	10.1371/journal.pone.0217262	http://dx.doi.org/10.1371/journal.pone.0217262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166968	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800021
J	Panmanee, W; Su, SC; Schurr, MJ; Lau, GW; Zhu, XT; Ren, ZW; McDaniel, CT; Lu, LJ; Ohman, DE; Muruve, DA; Panos, RJ; Ye, HD; Thompson, TB; Tseng, BS; Hassett, DJ				Panmanee, Warunya; Su, Shengchang; Schurr, Michael J.; Lau, Gee W.; Zhu, Xiaoting; Ren, Zhaowei; McDaniel, Cameron T.; Lu, Long J.; Ohman, Dennis E.; Muruve, Daniel A.; Panos, Ralph J.; Ye, Hongwei D.; Thompson, Thomas B.; Tseng, Boo Shan; Hassett, Daniel J.			The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a Delta mucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; ELECTRON-PARAMAGNETIC-RESONANCE; HYDROGEN-PEROXIDE; S-NITROSYLATION; ALGINATE BIOSYNTHESIS; OXYGEN LIMITATION; MUCOID CONVERSION; NITRATE REDUCTASE; GENE-EXPRESSION; REGULATED GENES	Mucoid mucA22 Pseudomonas aeruginosa (PA) is an opportunistic lung pathogen of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients that is highly sensitive to acidified nitrite (A-NO2-). In this study, we first screened PA mutant strains for sensitivity or resistance to 20 mM A-NO2- under anaerobic conditions that represent the chronic stages of the aforementioned diseases. Mutants found to be sensitive to A-NO2- included PA0964 (pmpR, PQS biosynthesis), PA4455 (probable ABC transporter permease), katA (major catalase, KatA) and rhlR (quorum sensing regulator). In contrast, mutants lacking PA0450 (a putative phosphate transporter) and PA1505 (moaA2) were A-NO2- resistant. However, we were puzzled when we discovered that mucA22 mutant bacteria, a frequently isolated mucA allele in CF and to a lesser extent COPD, were more sensitive to A-NO2- than a truncated Delta mucA deletion (Delta 157-194) mutant in planktonic and biofilm culture, as well as during a chronic murine lung infection. Subsequent transcriptional profiling of anaerobic, ANO(2)(-) -treated bacteria revealed restoration of near wild-type transcript levels of protective NO2- and nitric oxide (NO) reductase (nirS and norCB, respectively) in the Delta mucA mutant in	[Panmanee, Warunya; Su, Shengchang; McDaniel, Cameron T.; Thompson, Thomas B.; Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Schurr, Michael J.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Lau, Gee W.] Univ Illinois, Coll Vet Med, Urbana, IL USA; [Zhu, Xiaoting; Ren, Zhaowei; Lu, Long J.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Ctr, Richmond, VA 23298 USA; [Ohman, Dennis E.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Panos, Ralph J.] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH USA; [Panos, Ralph J.] Univ Cincinnati, Coll Med, Dept Med, Pulm Crit Care & Sleep Div, Cincinnati, OH USA; [Ye, Hongwei D.] Marshall Univ, Dept Biochem & Microbiol, Huntington, WV USA; [Tseng, Boo Shan] Univ Nevada Las Vegas, Dept Life Sci, Las Vegas, NV USA	University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Urbana-Champaign; Cincinnati Children's Hospital Medical Center; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; University of Calgary; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Marshall University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hassett, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Daniel.Hassett@UC.Edu	Schurr, Michael/I-2481-2013; Tseng, Boo Shan/M-6279-2018; Schurr, Michael/AAX-6596-2020; Lau, Gee W/H-4073-2018	Schurr, Michael/0000-0003-2585-0477; Tseng, Boo Shan/0000-0001-7563-0232; Yu, Hongwei/0000-0002-8546-0158	Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US) [5I01BX000845-03]	Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US)	This study was funded by the Merit Award from the Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US) (5I01BX000845-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgent MA, 2012, FREE RADICAL BIO MED, V53, P951, DOI 10.1016/j.freeradbiomed.2012.06.003; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Borrero-de Acuna JM, 2015, J BACTERIOL, V197, P3066, DOI 10.1128/JB.00415-15; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Boucher JC, 1997, MICROBIOL-UK, V143, P3473, DOI 10.1099/00221287-143-11-3473; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Corradi M, 2010, AM J RESP CRIT CARE, V181, P3, DOI 10.1164/rccm.200908-1279ED; Crespo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14051-2; Crespo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00688; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dotsch J, 2002, EUR ARCH OTO-RHINO-L, V259, P222, DOI 10.1007/s00405-001-0436-8; Field TR, 2005, EUR J CLIN MICROBIOL, V24, P677, DOI 10.1007/s10096-005-0031-9; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Frisk A, 2004, INFECT IMMUN, V72, P5433, DOI 10.1128/IAI.72.9.5433-5438.2004; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; GODFREY C, 1987, BIOCHEM J, V243, P241, DOI 10.1042/bj2430241; GODFREY C, 1984, BIOCHEM J, V224, P601, DOI 10.1042/bj2240601; GOLDBERG JB, 1993, J BACTERIOL, V175, P1303, DOI 10.1128/JB.175.5.1303-1308.1993; GOLDBERG JB, 1984, J BACTERIOL, V158, P1115, DOI 10.1128/JB.158.3.1115-1121.1984; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grasemann H, 1998, ARCH DIS CHILD, V78, P49, DOI 10.1136/adc.78.1.49; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hasegawa N, 2001, BIOCHEM BIOPH RES CO, V288, P1223, DOI 10.1006/bbrc.2001.5919; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hassett DJ, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P87; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hayashi NR, 1998, BBA-GEN SUBJECTS, V1381, P347, DOI 10.1016/S0304-4165(98)00045-2; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jassem Ewa, 1996, Medycyna Doswiadczalna i Mikrobiologia, V48, P49; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Koskenkorva T, 2008, ARCH MICROBIOL, V189, P385, DOI 10.1007/s00203-007-0329-3; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Liang HH, 2008, J BACTERIOL, V190, P6217, DOI 10.1128/JB.00428-08; Liu J, 2007, RESPIRATION, V74, P617, DOI 10.1159/000106379; Lizewski SE, 2004, J BACTERIOL, V186, P5672, DOI 10.1128/JB.186.17.5672-5684.2004; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Ma S, 1998, J BACTERIOL, V180, P956, DOI 10.1128/JB.180.4.956-968.1998; Major TA, 2010, ANTIMICROB AGENTS CH, V54, P4671, DOI 10.1128/AAC.00379-10; Maniatis T., 1982, MOL CLONING; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; McDaniel C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00291; McGrath LT, 1999, THORAX, V54, P518, DOI 10.1136/thx.54.6.518; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; OCHSNER UA, 1994, J BACTERIOL, V176, P2044, DOI 10.1128/jb.176.7.2044-2054.1994; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Roche N, 2007, REV MAL RESPIR, V24, P803, DOI 10.1016/S0761-8425(07)91159-6; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Silo-Suh LA, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomea.00153-15, 10.1128/genomeA.00153-15]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stapley R, 2012, BIOCHEM J, V446, P499, DOI 10.1042/BJ20120675; Storey DG, 1997, INFECT IMMUN, V65, P4061, DOI 10.1128/IAI.65.10.4061-4067.1997; Su S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091813; Su SC, 2012, EXPERT OPIN THER TAR, V16, P859, DOI 10.1517/14728222.2012.708025; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Wang D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00376-15; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Worlitzsch D, 1998, EUR RESPIR J, V11, P377, DOI 10.1183/09031936.98.11020377; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Yorgey P, 2001, MOL MICROBIOL, V41, P1063, DOI 10.1046/j.1365-2958.2001.02580.x; Zhang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041202	108	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216401	10.1371/journal.pone.0216401	http://dx.doi.org/10.1371/journal.pone.0216401			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158231	Green Published, gold			2022-12-27	WOS:000469915700002
J	Pfister, PB; de Bruin, ED; Bastiaenen, CHG; Maurer, B; Knols, RH				Pfister, Pierrette Baschung; de Bruin, Eling D.; Bastiaenen, Caroline H. G.; Maurer, Britta; Knols, Ruud H.			Reliability and validity of the German version of the Myositis Activities Profile (MAP) in patients with inflammatory myopathy	PLOS ONE			English	Article							CULTURAL-ADAPTATION; POLYMYOSITIS; ADULT; QUESTIONNAIRE; EPIDEMIOLOGY; TRANSLATION; VALIDATION	The Myositis Activity Profile (MAP) is the only disease-specific questionnaire to assess limitations in activities of daily living (ADL) in patients with inflammatory myopathy (IM). Because a German version does not currently exist, this study's aim was to translate the MAP and assess reliability and construct validity of the new version. Therefore, a cross-cultural adaptation was performed following international guidelines. Forty-eight patients with IM completed the German-MAP, twice within two weeks. They were also assessed using the Health Assessment Questionnaire (HAQ), 36-Item Short Form Survey (SF36), Manual Muscle Test (MMT8), Quantitative Muscle Testing (QMT) and Functional Index (FI-2). For discriminant validity, 48 age-and gender-matched healthy controls completed the German-MAP. Reliability was assessed using weighted kappa (K-w). Correlations between the MAP and the HAQ, the physical (PCM) and mental (MCS) component scores of SF36 and the MMT8 and QMT muscle tests were assessed using Spearman correlation analysis. Discriminative validity was assessed by calculating the Area under the Curve (AUC). The German-MAP showed substantial reliability for the four subscales (K-w: 0.65-0.71) and moderate to substantial reliability for the single items (K-w: 0.57-0.77). The MAP showed good construct validity (high correlations with HAQ and PCM, moderate with FI-2, QMT and MMT8 and poor with MCS and pain) and acceptable discrimination for three subscales and two single items (AUC: 0.65-0.79). In conclusion, the German-MAP appears to be a reliable and valid questionnaire to assess ADL-limitations in patients with IM. Further research is required, both to substantiate these results and to evaluate responsiveness.	[Pfister, Pierrette Baschung; Knols, Ruud H.] Univ Hosp Zurich, Directorate Res & Educ, Physiotherapy Occupat Therapy Res Ctr, Zurich, Switzerland; [Pfister, Pierrette Baschung; Bastiaenen, Caroline H. G.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden; [Bastiaenen, Caroline H. G.] Maastricht Univ, Dept Epidemiol, Caphri Res Inst, Res Line Functioning & Rehabil, Maastricht, Netherlands; [Maurer, Britta] Univ Hosp Zurich, Div Rheumatol, Zurich, Switzerland; [Maurer, Britta] Univ Hosp Zurich, Lab Syst Autoimmune Dis, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet; Maastricht University; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	de Bruin, ED (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden.	eling.debruin@hest.ethz.ch	de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385				Alexanderson H, 2006, ARTHRIT RHEUM-ARTHR, V55, P114, DOI 10.1002/art.21715; Alexanderson H, 2002, J RHEUMATOL, V29, P2386; Alexanderson H, 2012, J RHEUMATOL, V39, P2134, DOI 10.3899/jrheum.120504; Alkotob ML, 2006, CHEST, V130, P176, DOI 10.1378/chest.130.1.176; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bernatsky S, 2011, J RHEUMATOL, V38, P885, DOI 10.3899/jrheum.101083; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; de Vet HC, 2011, MEASUREMENT MED PRAC; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Furst DE, 2012, MUSCLE NERVE, V45, P676, DOI 10.1002/mus.23302; Greenberg SA, 2008, SEMIN NEUROL, V28, P241, DOI 10.1055/s-2008-1062267; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hosmer D. W., 2013, APPL LOGISTIC REGRES; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Munro, 1997, STAT METHODS HLTH CA; Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532; Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Vincze M, 2012, BEST PRACT RES CL RH, V26, P25, DOI 10.1016/j.berh.2012.01.013; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217173	10.1371/journal.pone.0217173	http://dx.doi.org/10.1371/journal.pone.0217173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158240	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000469915700010
J	Badiea, EA; Sayed, AA; Maged, M; Fouad, WM; Seid, MM; Esmat, AY				Badiea, Elham A.; Sayed, Ahmed A.; Maged, Mohamad; Fouad, Walid M.; Seid, Mahmoud M.; Esmat, Amr Y.			A novel thermostable and halophilic thioredoxin reductase from the Red Sea Atlantis II hot brine pool	PLOS ONE			English	Article							MAMMALIAN THIOREDOXIN; SALT BRIDGES; SYSTEM; IDENTIFICATION; PROTEINS; PURIFICATION; ACID; DIVERSITY; SEQUENCES; ALIGNMENT	The highly extreme conditions of the lower convective layer in the Atlantis II (ATII) Deep brine pool of the Red Sea make it an ideal environment for the search for novel enzymes that can function under extreme conditions. In the current study, we isolated a novel sequence of a thioredoxin reductase (TrxR) enzyme from the metagenomic dataset established from the microbial community that resides in the lower convective layer of Atlantis II. The gene was cloned, expressed and characterized for redox activity, halophilicity, and thermal stability. The isolated thioredoxin reductase (ATII-TrxR) was found to belong to the high-molecular-weight class of thioredoxin reductases. A search for conserved domains revealed the presence of an extra domain (Crp) in the enzyme sequence. Characterization studies of ATII-TrxR revealed that the enzyme was halophilic (maintained activity at 4 M NaCl), thermophilic (optimum temperature was 65 degrees C) and thermostable (60% of its activity was retained at 70 degrees C). Additionally, the enzyme utilized NADH in addition to NADPH as an electron donor. In conclusion, a novel thermostable and halophilic thioredoxin reductase has been isolated with a unique sequence that adapts to the harsh conditions of the brine pools making this protein a good candidate for biological research and industrial applications.	[Badiea, Elham A.; Sayed, Ahmed A.; Seid, Mahmoud M.; Esmat, Amr Y.] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt; [Badiea, Elham A.; Fouad, Walid M.] Amer Univ Cairo, Sch Sci & Engn, Dept Biol, New Cairo, Egypt; [Sayed, Ahmed A.] Children Canc Hosp, Cairo, Egypt; [Maged, Mohamad] October Univ Modern Sci & Arts, Fac Biotechnol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); American University Cairo; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA)	Esmat, AY (corresponding author), Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt.	amryesmat@yahoo.com	Fouad, Walid/AAO-5236-2020; Said, Mahmoud/AAJ-6553-2020; Maged, Mohamed/AAY-9724-2021; Maged, Mohamad/AAE-4190-2021	Maged, Mohamad/0000-0001-6967-9793; Esmat, Amr/0000-0002-6360-2354				Adel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32704; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrei AS, 2012, FEMS MICROBIOL LETT, V330, P1, DOI 10.1111/j.1574-6968.2012.02526.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Behzad H, 2016, GENE, V576, P717, DOI 10.1016/j.gene.2015.10.034; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brown DM, 1996, MOL BIOCHEM PARASIT, V83, P211, DOI 10.1016/S0166-6851(96)02776-4; Cha MK, 1995, BIOCHEM BIOPH RES CO, V217, P900, DOI 10.1006/bbrc.1995.2856; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; COHEN G, 1993, J BACTERIOL, V175, P5159, DOI 10.1128/JB.175.16.5159-5167.1993; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DasSarma S, 2015, CURR OPIN MICROBIOL, V25, P120, DOI 10.1016/j.mib.2015.05.009; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Gamal M M., 2014, THESIS; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gomes E, 2016, FUNG BIOL-US, P459, DOI 10.1007/978-3-319-27951-0_21; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kashima Y, 2003, ARCH BIOCHEM BIOPHYS, V418, P179, DOI 10.1016/j.abb.2003.08.002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacey BM, 2006, BIOCHEM BIOPH RES CO, V346, P629, DOI 10.1016/j.bbrc.2006.05.095; Lam KN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01196; Laurila TE, 2015, GEOCHEM GEOPHY GEOSY, V16, P4449, DOI 10.1002/2015GC006010; Lee CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084597; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Mick E, 2014, NAT BIOTECHNOL, V32, P750, DOI 10.1038/nbt.2962; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mohamed YM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03358; Ngugi DK, 2015, ISME J, V9, P396, DOI 10.1038/ismej.2014.137; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Oren A, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P81; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2010, GEOLOGY, V38, P843, DOI 10.1130/G31052.1; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Saccoccia F, 2014, CURR PROTEIN PEPT SC, V15, P621, DOI 10.2174/1389203715666140530091910; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayed A, 2014, J BIOL CHEM, V289, P1675, DOI 10.1074/jbc.M113.493429; Seo HJ, 2010, J MICROBIOL, V48, P637, DOI 10.1007/s12275-010-0283-7; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; SILVA OF, 2012, BMC BIOINFORMATICS, V13, P124, DOI DOI 10.1186/1471-2105-13-124; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Watabe S, 1999, EUR J BIOCHEM, V264, P74, DOI 10.1046/j.1432-1327.1999.00578.x; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMS CH, EUROPEAN J BIOCH, V267, P6110; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Zhao SR, 2016, PARASITOL RES, V115, P3219, DOI 10.1007/s00436-016-5084-4	63	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217565	10.1371/journal.pone.0217565	http://dx.doi.org/10.1371/journal.pone.0217565			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150456	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100067
J	Holgado, D; Zabala, M; Sanabria, D				Holgado, Darias; Zabala, Mikel; Sanabria, Daniel			No evidence of the effect of cognitive load on self-paced cycling performance	PLOS ONE			English	Article							DUAL-TASK INTERFERENCE; PHYSICAL PERFORMANCE; EXECUTIVE FUNCTION; ATTENTIONAL FOCUS; WORKING-MEMORY; EXERCISE; SPORT; INHIBITION; FATIGUE; BRAIN	Objectives To test the hypothesis that cognitive load (low vs. high load) during a 20 min self-paced cycling exercise affects physical performance. Design A pre-registered (https://osf.io/qept5/), randomized, within-subject design experiment. Methods 28 trained and experienced male cyclists completed a 20 min self-paced cycling time-trial exercise in two separate sessions, corresponding to two working memory load conditions: 1-back or 2-back. We measured power output, heart rate, RPE and mental fatigue. Results Bayes analyses revealed extreme evidence for the 2-back task being more demanding than the 1-back task, both in terms of accuracy (BF10 = 4490) and reaction time (BF = 1316). The data only showed anecdotal evidence for the alternative hypothesis for the power output (BF10 = 1.52), moderate evidence for the null hypothesis for the heart rate (BF10 = 0.172), anecdotal evidence for RPE (BF10 = 0.72) and anecdotal evidence for mental fatigue (BF10 = 0.588). Conclusions Our data seem to challenge the idea that self-paced exercise is regulated by top-down processing, given that we did not show clear evidence of exercise impairment (at the physical, physiological and subjective levels) in the high cognitive load condition task with respect to the low working memory load condition. The involvement of top-down processing in self-pacing the physical effort, however, cannot be totally discarded. Factors like the duration of the physical and cognitive tasks, the potential influence of dual-tasking, and the participants' level of expertise, should be taken into account in future attempts to investigate the role of top-down processing in self-paced exercise.	[Holgado, Darias; Zabala, Mikel] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Holgado, Darias; Sanabria, Daniel] Univ Granada, Mind Brain & Behav Res Ctr, Dept Expt Psychol, Granada, Spain	University of Granada; University of Granada	Holgado, D (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.; Holgado, D (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr, Dept Expt Psychol, Granada, Spain.	dariashn@ugr.es	Zabala, Mikel/AAE-8977-2021; Holgado, Darias/I-3101-2015; Sanabria, Daniel/C-3409-2012	Holgado, Darias/0000-0003-3211-8006; Sanabria, Daniel/0000-0002-4164-7607	Ministerio de Economia, Industria y Competitividad [PSI2016-75956-P]; Ministerio de Educacion, Cultura y Deporte [FPU14/06229]	Ministerio de Economia, Industria y Competitividad; Ministerio de Educacion, Cultura y Deporte	This project was supported by grant PSI2016-75956-P from Ministerio de Economia, Industria y Competitividad, awarded to DS and MZ, and grant FPU14/06229 from Ministerio de Educacion, Cultura y Deporte, awarded to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; Blakely MJ, 2016, IISE T OCCUP ERG HUM, V4, P104, DOI 10.1080/21577323.2015.1055864; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brick N, 2015, PSYCHOL SPORT EXERC, V19, P1, DOI 10.1016/j.psychsport.2015.02.003; Brick N, 2014, INT REV SPORT EXER P, V7, P106, DOI 10.1080/1750984X.2014.885554; Brick NE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00159; Caramia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185825; Ciria LF, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13326; Ciria LF, 2018, NEUROIMAGE, V181, P203, DOI 10.1016/j.neuroimage.2018.07.009; Daniels GL, 2003, BIOL PSYCHOL, V63, P163, DOI 10.1016/S0301-0511(03)00024-3; Darling KA, 2014, EXP BRAIN RES, V232, P1367, DOI 10.1007/s00221-014-3855-7; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Edwards AM, 2013, SPORTS MED, V43, P1057, DOI 10.1007/s40279-013-0091-4; Epling SL, 2016, EXP BRAIN RES, V234, P2979, DOI 10.1007/s00221-016-4700-y; Holgado D, 2018, J SCI MED SPORT, V21, P654, DOI 10.1016/j.jsams.2017.10.032; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Luque-Casado A, 2016, MED SCI SPORT EXER, V48, P887, DOI 10.1249/MSS.0000000000000857; Malcolm BR, 2018, J NEUROPHYSIOL, V120, P2246, DOI 10.1152/jn.00079.2018; Martin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159907; McMorris T, 2018, PHYSIOL BEHAV, V188, P103, DOI 10.1016/j.physbeh.2018.01.029; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pageaux B, 2018, PROG BRAIN RES, V240, P291, DOI 10.1016/bs.pbr.2018.10.004; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H., 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; Schneider S, 2010, MED SCI SPORT EXER, V42, P600, DOI 10.1249/MSS.0b013e3181b76ac8; Tempest GD, 2017, BRAIN COGNITION, V113, P133, DOI 10.1016/j.bandc.2017.02.001; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; Vera J, 2018, J SPORT SCI, V36, P2521, DOI 10.1080/02640414.2018.1466848; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Verhoeven K, 2011, EUR J PAIN, V15, P866, DOI 10.1016/j.ejpain.2011.01.009; Walsh V, 2014, CURR BIOL, V24, pR859, DOI 10.1016/j.cub.2014.08.003; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	41	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217825	10.1371/journal.pone.0217825	http://dx.doi.org/10.1371/journal.pone.0217825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150517	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100118
J	Armstrong, MJ; Alliance, S; Taylor, A; Corsentino, P; Galvin, JE				Armstrong, Melissa J.; Alliance, Slande; Taylor, Angela; Corsentino, Pamela; Galvin, James E.			End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers	PLOS ONE			English	Article							PALLIATIVE CARE; BODY DEMENTIA; MANAGEMENT; DIAGNOSIS; SURVIVAL; DISEASE; RESIDENTS; MORTALITY; PEOPLE; NEEDS	Background Dementia caregivers describe knowing what to expect as an unmet need and many are unaware that dementia can be a terminal condition. Dementia with Lewy bodies (DLB) is a common neurodegenerative dementia with unique features which may affect the end of life (EOL). Given the paucity of data on EOL experiences in dementia and unique aspects of DLB affecting EOL, we investigated EOL experiences as reported by caregivers of individuals with DLB. Method We conducted telephone interviews with caregivers and family members of individuals who died with DLB in the last 5 years using a semi-structured questionnaire to identify and describe EOL experiences. We used a qualitative descriptive approach to analyze interview transcripts and identify common themes. Results Thirty individuals participated in interviews. Key themes included lack of knowledge regarding what to expect, end-of-life time course (including end-of-life symptoms, declines after hospitalization and falls, and varied EOL trajectories), advance care planning, lack of family understanding, hospice, views regarding right-to-die, medications at the end of life, approaching end of life, the death experience, and activities that enhanced end of life. Lack of communication between health care teams and families and difficulty predicting death timing were two frequently expressed challenges. Conclusions Study results emphasize the need for improved EOL counseling in DLB, recognition of EOL symptoms, earlier hospice involvement, tailoring EOL care to DLB-specific needs, and clinician-family communication. Suggestions for patient and family education are provided. Further research should confirm predictors of approaching EOL in DLB, identify strategies to improve physician recognition of EOL, and develop tools to aid communication and quality EOL care.	[Armstrong, Melissa J.; Alliance, Slande] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Armstrong, Melissa J.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Taylor, Angela; Corsentino, Pamela] Lewy Body Dementia Assoc, Lilburn, GA USA; [Galvin, James E.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Comprehens Ctr Brain Hlth, Boca Raton, FL 33431 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; Florida Atlantic University	Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.; Armstrong, MJ (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.	melissa.armstrong@neurology.ufl.edu	Galvin, James/AAM-7492-2021	Armstrong, Melissa/0000-0002-2163-1907; Alliance, Slande/0000-0003-1290-8422	ARHQ K08 career development award [K08HS24159]; 1Florida ADRC pilot grant [AG047266]; Michael J. Fox Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS100610, R01NS088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG057681, R01AG054425, R01AG056531, R01AG056610, R01AG040211] Funding Source: NIH RePORTER	ARHQ K08 career development award; 1Florida ADRC pilot grant; Michael J. Fox Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MJA is supported by an ARHQ K08 career development award (K08HS24159), a 1Florida ADRC (AG047266) pilot grant, and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. Staff from the LBDA participated in data collection, analysis, and preparation of the manuscript. MJA previously received research support from the Michael J. Fox Foundation. MJA receives royalties from the publication of the book Parkinson's Disease: Improving Patient Care. MJA receives compensation from the American Academy of Neurology for work as an evidence-based medicine methodology consultant and has participated as faculty in the annual meeting of the American Academy of Neurology and for Medscape CME. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Armstrong MJ, 2019, J AM GERIATR SOC, V67, P67, DOI 10.1111/jgs.15608; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Biola H, 2007, J AM GERIATR SOC, V55, P846, DOI 10.1111/j.1532-5415.2007.01179.x; Bostrom F, 2007, ALZ DIS ASSOC DIS, V21, P150, DOI 10.1097/WAD.0b013e318065c4a9; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; de Beaufort ID, 2016, J NEUROL, V263, P1463, DOI 10.1007/s00415-016-8095-2; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; Dionne-Odom JN, 2019, PALLIAT SUPPORT CARE, V17, P643, DOI 10.1017/S1478951519000154; Erel M, 2017, ANN PALLIAT MED, V6, P365, DOI 10.21037/apm.2017.06.13; Galvin JE, 2010, PARKINSONISM RELAT D, V16, P388, DOI 10.1016/j.parkreldis.2010.03.007; Galvin JE, 2010, ALZ DIS ASSOC DIS, V24, P177, DOI 10.1097/WAD.0b013e3181c72b5d; Garcia-Ptacek S, 2016, J AM GERIATR SOC, V64, pE137, DOI 10.1111/jgs.14421; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hennings J, 2010, REV CLIN GERONTOL, V20, P114, DOI 10.1017/S0959259810000092; Jennings LA, 2015, J AM GERIATR SOC, V63, P282, DOI 10.1111/jgs.13251; Klapwijk MS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-99; Lee RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179355; Lewis LF, 2014, QUAL HEALTH RES, V24, P1221, DOI 10.1177/1049732314545888; MCKEITH I, 1992, BRIT MED J, V305, P673, DOI 10.1136/bmj.305.6855.673; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Millenaar JK, 2016, INT J GERIATR PSYCH, V31, P1261, DOI 10.1002/gps.4502; Mitchell SL, 2015, NEW ENGL J MED, V372, P2533, DOI [10.1056/NEJMcp1412652, 10.1056/NEJMc1509349]; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Moscovich M, 2017, PARKINSONISM RELAT D, V41, P99, DOI 10.1016/j.parkreldis.2017.05.022; Price A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017504; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sanders AE, 2017, NEUROLOGY, V88, P1951, DOI 10.1212/WNL.0000000000003917; Toles M, 2018, J AM MED DIR ASSOC, V19, P879, DOI 10.1016/j.jamda.2018.05.015; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; van der Steen JT, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-105; Vandervoort A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091130; Walker Z, 2000, INT J GERIATR PSYCH, V15, P267, DOI 10.1002/(SICI)1099-1166(200003)15:3<267::AID-GPS107>3.0.CO;2-7; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	37	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217039	10.1371/journal.pone.0217039	http://dx.doi.org/10.1371/journal.pone.0217039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145749	gold, Green Published, Green Submitted			2022-12-27	WOS:000469425500008
J	Brunie, A; Callahan, RL; Godwin, CL; Bajpai, J; OlaOlorun, FM				Brunie, Aurelie; Callahan, Rebecca L.; Godwin, Christine L.; Bajpai, Jyoti; OlaOlorun, Funmilola M.			User preferences for a contraceptive microarray patch in India and Nigeria: Qualitative research on what women want	PLOS ONE			English	Article							MICRONEEDLE PATCHES; VACCINATION	Background A new contraceptive microarray patch (MAP) for women is in development. Input on this method from potential end-users early in the product development process is important to guide design decisions. This paper presents the qualitative component of a broader study exploring initial acceptability of the MAP and selected product features. The qualitative research was intended to identify product features that are most salient to end-users and to contextualize preferences around them with subsequent research planned to assess quantitatively the relative importance of those features. Methods We conducted 16 focus group discussions and 20 in-depth interviews with women and 20 IDIs with family planning providers in New Delhi, India, and Ibadan, Nigeria. Input from the MAP developer served to identify plausible features of the MAP to include in the focus group discussions and in-depth interviews. Interviews were audio-recorded, transcribed into English, coded, and analyzed to examine key dimensions of MAP features. Results Many participants viewed the MAP as potentially easy to use. Interest in self-application after learning correct use was high, especially in India. Participants favored formulations affording protection from pregnancy for three or six months, if not longer. Interest in a shorter-acting MAP was particularly low in Nigeria. Non-desirable MAP features included a potential localized skin rash and pain at application. Views on patch size and location of application were related to the potential for rash and pain, with a desire to permit discreet use and minimize pain. Results indicate that the side effect profile, effectiveness, and pricing are also important factors for acceptability and uptake of a future product. Conclusion Study findings indicate that a contraceptive MAP is of potential interest to women and that specific MAP attributes will be important to acceptability.	[Brunie, Aurelie] Hlth Serv Res, Washington, DC 20001 USA; [Callahan, Rebecca L.] Contracept Technol Innovat, Durham, NC USA; [OlaOlorun, Funmilola M.] Univ Ibadan, Coll Med, Ibadan, Nigeria	University of Ibadan	Brunie, A (corresponding author), Hlth Serv Res, Washington, DC 20001 USA.	abrunie@fhi360.org	OlaOlorun, Funmilola/ABN-6506-2022	OlaOlorun, Funmilola/0000-0001-5544-2875; Brunie, Aurelie/0000-0002-9515-1420	American people through the U.S. Agency for International Development (USAID) [AID-OAA-A-15-00045]; National Institute of Child Health and Human Development (NICHD)	American people through the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study is made possible by the generous support of the American people through the U.S. Agency for International Development (USAID), provided to FHI 360 through cooperative agreement number AID-OAA-A-15-00045, co-funded by an Interagency Agreement with the National Institute of Child Health and Human Development (NICHD). The contents are the responsibility of FHI 360 and do not necessarily reflect the views of USAID, NICHD or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya J, 2017, BIOMATERIALS, V128, P1, DOI 10.1016/j.biomaterials.2017.02.040; Arya J, 2016, J CONTROL RELEASE, V240, P135, DOI 10.1016/j.jconrel.2015.11.019; Bhatnagar S, 2017, J CONTROL RELEASE, V260, P164, DOI 10.1016/j.jconrel.2017.05.029; Burke HM, 2018, LANCET GLOB HEALTH, V6, pE568, DOI 10.1016/S2214-109X(18)30061-5; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Darroch JacquelineE., 2011, CONTRACEPTIVE TECHNO; Guest G., 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Guttmacher Institute, 2017, FACT SHEET ADD IT IN; International Institute for Population Sciences (IIPS), 2017, IND FACT SHEET 2017; Li JW, 2017, CURR MED CHEM, V24, P2413, DOI 10.2174/0929867324666170526124053; McCrudden MTC, 2015, EXP DERMATOL, V24, P561, DOI 10.1111/exd.12723; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Owen D., 2018, BUZZ MICRONEEDLE PAT; Performance Monitoring & Accountability 2020 (PMA2020), 2018, PMA2018 NIG FAM PLAN; Prausnitz MR, 2017, ANNU REV CHEM BIOMOL, V8, P177, DOI 10.1146/annurev-chembioeng-060816-101514; Rouphael NG, 2017, LANCET, V390, P649, DOI 10.1016/S0140-6736(17)30575-5	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216797	10.1371/journal.pone.0216797	http://dx.doi.org/10.1371/journal.pone.0216797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170173	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700009
J	Duan, LM; Luo, XQ; Ruan, L; Gu, MH				Duan, Liming; Luo, Xueqing; Ruan, Lang; Gu, Minghui			Novel method of boundary-free mesh parameterization	PLOS ONE			English	Article								Unless the targeted mesh is developable, metric distortion is inevitable during the process of surface mesh parameterization, thus one important objective of all involved parametric studies is to reduce the metric distortion. In order to further reduce area and angle distortion, a novel method of boundary-free mesh parameterization is presented in the paper. Firstly, the initial boundary-fixed conformal parameterization from 3D surface mesh patch to a plane is performed in the method. Then, based on the initial parameterization, the iterations of boundary-free quasi-harmonic parameterization are developed, where the tensor field is updated in each iterative step and the principal curvature direction is utilized to terminate the iteration. The solution of the novel method is convenient to calculate since it involves a series of linear systems. In our novel parameterization method, lower metric distortion and considerable efficiency have been obtained in experiments.	[Duan, Liming; Luo, Xueqing; Ruan, Lang; Gu, Minghui] Chongqing Univ, Educ Minist China, ICT Res Ctr, Key Lab Optoelect Technol & Syst, Chongqing, Peoples R China; [Duan, Liming; Luo, Xueqing; Ruan, Lang; Gu, Minghui] Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China; [Duan, Liming; Luo, Xueqing; Ruan, Lang; Gu, Minghui] Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University	Duan, LM (corresponding author), Chongqing Univ, Educ Minist China, ICT Res Ctr, Key Lab Optoelect Technol & Syst, Chongqing, Peoples R China.; Duan, LM (corresponding author), Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China.; Duan, LM (corresponding author), Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China.	duanliming163@163.com			National Key Instrument and Equipment Development Projects. China [2013YQ030629]	National Key Instrument and Equipment Development Projects. China	The work was supported by the National Key Instrument and Equipment Development Projects. China (Grant NO.2013YQ030629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Cao JJ, 2010, J ZHEJIANG U-SCI C, V11, P187, DOI 10.1631/jzus.C0910460; Choi GPT, 2018, ADV COMPUT MATH, V44, P87, DOI 10.1007/s10444-017-9536-x; Choi GPT, 2016, SIAM J IMAGING SCI, V9, P1582, DOI 10.1137/15M1037561; Claici S, 2017, COMPUT GRAPH FORUM, V36, P37, DOI 10.1111/cgf.13243; Desbrun M, 2002, COMPUT GRAPH FORUM, V21, P209, DOI 10.1111/1467-8659.00580; Dong AH, 2007, STUD COMPUT INTELL, P185; Fan Dian, 2015, Journal of Computer Aided Design & Computer Graphics, V27, P559; Floater MS, 2005, MATH VIS, P157, DOI 10.1007/3-540-26808-1_9; Gary Pui-Tung C, 2016, FAST SPHERICAL QUASI; Guo Feng-Hua, 2016, Journal of Software, V27, P112, DOI 10.13328/j.cnki.jos.004919; Ho KT, 2016, ADV COMPUT MATH, V42, P279, DOI 10.1007/s10444-015-9424-1; Hormann Kai, 2007, SIGGRAPH 2007 COURSE; Ka Chun L, 2017, COMMUNICATIONS MATH, V15, P2027; Kovalsky SZ, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2897824.2925920; Lam KC, 2015, MED IMAGE ANAL, V25, P45, DOI 10.1016/j.media.2015.04.006; Lee Y, 2002, COMPUT GRAPH-UK, V26, P677, DOI 10.1016/S0097-8493(02)00123-1; Liu LG, 2008, COMPUT GRAPH FORUM, V27, P1495, DOI 10.1111/j.1467-8659.2008.01290.x; Lui LM, 2015, J SCI COMPUT, V63, P573, DOI 10.1007/s10915-014-9903-4; Lui LM, 2014, SIAM J IMAGING SCI, V7, P391, DOI 10.1137/120900186; Mullen P, 2008, COMPUT GRAPH FORUM, V27, P1487, DOI 10.1111/j.1467-8659.2008.01289.x; Noam A, 2013, ACM T GRAPHIC, V32; Peng C, 2016, COMPUT GRAPH-UK, V59, P107, DOI 10.1016/j.cag.2016.06.001; Pinkall U., 1993, EXP MATH, V2, P15, DOI DOI 10.1080/10586458.1993.10504266; Pui Tung C, 2015, SIAM J IMAGING SCI, V8, DOI [10.1137/130935434, DOI 10.1137/130935434]; Rabinovich M, 2017, ACM T GRAPHIC, V36, DOI 10.1145/2983621; Rusinkiewicz S, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P486, DOI 10.1109/TDPVT.2004.1335277; Sheffer A, 2005, ACM T GRAPHIC, V24, P311, DOI 10.1145/1061347.1061354; Sheffer A, 2002, VIS 2002: IEEE VISUALIZATION 2002, PROCEEDINGS, P291, DOI 10.1109/VISUAL.2002.1183787; Sheffer A, 2001, ENG COMPUT-GERMANY, V17, P326, DOI 10.1007/PL00013391; Sheffer A, 2006, FOUND TRENDS COMPUT, V2, P1, DOI 10.1561/0600000011; Shiqing L, 2007, APPL RES COMPUTERS, V24, P107; Ng TC, 2014, J SCI COMPUT, V60, P249, DOI 10.1007/s10915-013-9791-z; Vaitkus M, 2015, SPRING C COMP GRAPH; Wang CCL, 2002, COMPUT AIDED DESIGN, V34, P823, DOI 10.1016/S0010-4485(01)00150-6; Xin H, 2018, IEEE T VIS COMPUT GR, V99, P1; Yaron L, 2012, WEIZMANN I SCI; Zayer R, 2005, INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDINGS, P276, DOI 10.1109/SMI.2005.17; Zayer R, 2005, S GEOM PROC, P91; Zayer R., 2007, EUROGRAPHICS S GEOME, P135, DOI DOI 10.1145/571647.571651	41	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217537	10.1371/journal.pone.0217537	http://dx.doi.org/10.1371/journal.pone.0217537			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170192	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700040
J	Jung, JS; Park, SJ; Kim, EY; Na, KS; Kim, YJ; Kim, KG				Jung, Jun Su; Park, Sung Jin; Kim, Eun Young; Na, Kyoung-Sae; Kim, Young Jae; Kim, Kwang Gi			Prediction models for high risk of suicide in Korean adolescents using machine learning techniques	PLOS ONE			English	Article							BEHAVIORS; IDEATION; THOUGHTS	Objective Suicide in adolescents is a major problem worldwide and previous history of suicide ideation and attempt represents the strongest predictors of future suicidal behavior. The aim of this study was to develop prediction model to identify Korean adolescents of high risk suicide (= who have history of suicide ideation/attempt in previous year) using machine learning techniques. Methods A nationally representative dataset of Korea Youth Risk Behavior Web-based Survey (KYRBWS) was used (n = 59,984 of middle and high school students in 2017). The classification process was performed using machine learning techniques such as logistic regression (LR), random forest (RF), support vector machine (SVM), artificial neural network (ANN), and extreme gradient boosting (XGB). Results A total of 7,443 adolescents (12.4%) had a previous history of suicidal ideation/attempt. In the multivariable analysis, sadness (odds ratio [OR], 6.41; 95% confidence interval [95% CI], 6.08-6.87), violence (OR, 2.32; 95% CI, 2.01-2.67), substance use (OR, 1.93; 95% CI, 1.52-2.45), and stress (OR, 1.63; 95% CI, 1.40-1.86) were associated factors. Taking into account 26 variables as predictors, the accuracy of models of machine learning techniques to predict the high-risk suicidal was comparable with that of LR; the accuracy was best in XGB (79.0%), followed by SVM (78.7%), LR (77.9%), RF (77.8%), and ANN (77.5%). Conclusions The machine leaning techniques showed comparable performance with LR to classify adolescents who have previous history of suicidal ideation/attempt. This model will hopefully serve as a foundation for decreasing future suicides as it enables early identification of adolescents at risk of suicide and modification of risk factors.	[Jung, Jun Su] Gachon Univ, Sch Med, Coll Med, Incheon, South Korea; [Park, Sung Jin; Kim, Young Jae; Kim, Kwang Gi] Gachon Univ, Coll Med, Dept Biomed Engn, Incheon, South Korea; [Kim, Eun Young] Korea Natl Open Univ, Dept Informat & Stat, Seoul, South Korea; [Kim, Eun Young] Gachon Univ, Coll Med, Dept Radiol, Gil Med Ctr, Incheon, South Korea; [Na, Kyoung-Sae] Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea	Gachon University; Gachon University; Korea National Open University; Gachon University; Gachon University	Kim, KG (corresponding author), Gachon Univ, Coll Med, Dept Biomed Engn, Incheon, South Korea.; Kim, EY (corresponding author), Korea Natl Open Univ, Dept Informat & Stat, Seoul, South Korea.; Kim, EY (corresponding author), Gachon Univ, Coll Med, Dept Radiol, Gil Med Ctr, Incheon, South Korea.	oneshot0229@gmail.com; kimkg@gachon.ac.kr	Na, Kyoung-Sae/W-1317-2019	Na, Kyoung-Sae/0000-0002-0148-9827; Kim, Young Jae/0000-0003-0443-0051; Kim, Eun Young/0000-0002-2101-7982	MD-PhD research through the Korea Research-Driven Hospital [2018-5287]; Future Innovation Challenges through the Gachon University [2018-0669]	MD-PhD research through the Korea Research-Driven Hospital; Future Innovation Challenges through the Gachon University	This research was supported by MD-PhD research through the Korea Research-Driven Hospital (grant 2018-5287) and Future Innovation Challenges through the Gachon University (grant 2018-0669).	Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Burke TA, 2019, J AFFECT DISORDERS, V245, P869, DOI 10.1016/j.jad.2018.11.073; Byeon KH, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018046; Choi SB, 2018, J AFFECT DISORDERS, V231, P8, DOI 10.1016/j.jad.2018.01.019; Choi SB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4491-5; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Jordan P, 2018, GEN HOSP PSYCHIAT, V51, P106, DOI 10.1016/j.genhosppsych.2018.02.002; Kim YJ, 2018, CRISIS, V39, P4, DOI 10.1027/0227-5910/a000438; McArdle JJ, 2014, CONTEMPORARY ISSUES; Oh J, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00192; Passos IC, 2016, J AFFECT DISORDERS, V193, P109, DOI 10.1016/j.jad.2015.12.066	12	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217639	10.1371/journal.pone.0217639	http://dx.doi.org/10.1371/journal.pone.0217639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170212	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700045
J	Qin, L; Xie, YD; Zhang, XG; Wu, SX; Xu, WM; Zuo, T				Qin Lang; Xie Yidong; Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao			ETA-mediated anti-TNF-alpha therapy ameliorates the phenotype of PCOS model induced by letrozole	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; GENE-EXPRESSION; INFLAMMATION; ETANERCEPT; RECEPTOR; ANDROGENS	Chronic inflammation is a typical characteristic of polycystic ovary syndrome (PCOS), in which, tumor necrosis factor (TNF)-alpha plays an important role. We investigated whether anti-TNF-alpha therapy can alleviate the core phenotypes of PCOS. In pubertal female Wistar rats, release pellets of letrozole (LET) were administered continuously for 90 days to induce PCOS-like phenotypes, followed by treatment with etanercept (ETA), a TNF-alpha inhibitor. ETA significantly inhibited increases in body weight and androgen, TNF-alpha, and MCP-1 levels, excessive recruitment of lipid droplets, altered levels of pre-adipose differentiation markers, and abnormal development of follicles. In addition, TNF-alpha and testosterone (T) levels in the rat sera were significantly positively correlated. Further experiments were performed to investigate the relationship between TNF-alpha and androgen. Persistent exposure of the RAW 264.7 cell line to low doses of testosterone significantly enhanced TNF-alpha expression and activated the NF-KB signaling pathway, which were blocked by ETA. Furthermore, treatment with TNF-alpha promoted the production of testosterone in KGN granulosa cells by reducing CYP19A1 expression, whereas ETA treatment blocked this process. In conclusion, anti-TNF-alpha therapy with ETA may be an efficient method to alleviate PCOS, whose underlying mechanism may be associated with its ability to reduce excessive androgen levels.	[Qin Lang; Xie Yidong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Reprod Med Ctr, Chengdu, Sichuan, Peoples R China; [Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao] Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Sichuan, Peoples R China; [Zhang Xueguang; Xu Wenming; Zuo Tao] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China; [Wu Sixian] Sichuan Univ, West China Sch Pharm, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University; Sichuan University; Sichuan University	Xu, WM; Zuo, T (corresponding author), Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Sichuan, Peoples R China.; Xu, WM; Zuo, T (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China.	xuwenming1973@163.com; zuotaoxy@163.com		Xu, wenming/0000-0002-3686-229X; Wu, Sixian/0000-0001-9396-9635	Science and Technology Support Project of Science and Technology Bureau of Sichuan Province [2016FZ0061]; Sichuan Province Science and Technology Support Project [2016-16ZC1659]	Science and Technology Support Project of Science and Technology Bureau of Sichuan Province; Sichuan Province Science and Technology Support Project	This work was supported by the Science and Technology Support Project of Science and Technology Bureau of Sichuan Province (grant number 2016FZ0061) to LQ. This work was also supported by Sichuan Province Science and Technology Support Project (2016-16ZC1659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytan AN, 2016, GYNECOL ENDOCRINOL, V32, P709, DOI 10.3109/09513590.2016.1155208; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Comim FV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080416; Debelec-Butuner B, 2014, MOL CARCINOGEN, V53, P85, DOI 10.1002/mc.21948; Delfino FJ, 2003, MOL CELL ENDOCRINOL, V201, P1, DOI 10.1016/S0303-7207(03)00005-4; Dewailly D, 2014, HUM REPROD UPDATE, V20, P334, DOI 10.1093/humupd/dmt061; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164021; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Goodarzi MO, 2015, J STEROID BIOCHEM, V145, P213, DOI 10.1016/j.jsbmb.2014.06.003; Joham AE, 2015, J WOMENS HEALTH, V24, P299, DOI 10.1089/jwh.2014.5000; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Liao CH, 2012, STEROIDS, V77, P756, DOI 10.1016/j.steroids.2012.03.014; Liu MM, 2015, CLIN ENDOCRINOL, V83, P913, DOI 10.1111/cen.12951; Maliqueo M, 2013, ENDOCRINOLOGY, V154, P434, DOI 10.1210/en.2012-1693; Marotte H, 2014, EXPERT OPIN BIOL TH, V14, P569, DOI 10.1517/14712598.2014.896334; Morisset AS, 2013, J MATERN-FETAL NEO M, V26, P513, DOI 10.3109/14767058.2012.735725; Morooka N, 2016, BIOCHEM BIOPH RES CO, V477, P895, DOI 10.1016/j.bbrc.2016.06.155; Ojeda-Ojeda M, 2013, CURR PHARM DESIGN, V19, P5775, DOI 10.2174/1381612811319320012; Prizant H, 2014, J ENDOCRINOL, V222, pR141, DOI 10.1530/JOE-14-0296; Repaci A, 2011, MOL CELL ENDOCRINOL, V335, P30, DOI 10.1016/j.mce.2010.08.002; Scott LJ, 2014, DRUGS, V74, P1379, DOI 10.1007/s40265-014-0258-9; Shannon M, 2012, J MIDWIFERY WOM HEAL, V57, P221, DOI 10.1111/j.1542-2011.2012.00161.x; Sinagra E, 2013, EUR J INTERN MED, V24, P385, DOI 10.1016/j.ejim.2012.12.015; Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Tannus S, 2015, WOMENS HEALTH, V11, P901, DOI 10.2217/whe.15.40; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Walters KA, 2015, REPRODUCTION, V149, pR193, DOI 10.1530/REP-14-0517; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Yu J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/670743; Zuo T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8589318	35	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217495	10.1371/journal.pone.0217495	http://dx.doi.org/10.1371/journal.pone.0217495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170164	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700037
J	Tuzun, F; Ozkan, H; Cetinkaya, M; Yucesoy, E; Kurum, O; Cebeci, B; Cakmak, E; Ozkutuk, A; Keskinoglu, P; Baysal, B; Kumral, A; Duman, N				Tuzun, Funda; Ozkan, Hasan; Cetinkaya, Merih; Yucesoy, Ebru; Kurum, Ozge; Cebeci, Burcu; Cakmak, Ertan; Ozkutuk, Aydan; Keskinoglu, Pembe; Baysal, Bora; Kumral, Abdullah; Duman, Nuray			Is European Medicines Agency (EMA) sepsis criteria accurate for neonatal sepsis diagnosis or do we need new criteria?	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; MANAGEMENT; BACTERIAL	Background Currently, there is a lack of clear definition for neonatal sepsis. The Pediatric Committee of the European Medicines Agency (EMA) developed consensus criteria to ensure a standardization for neonatal sepsis definition. However, there is no evidence supporting the accuracy of the EMA sepsis criteria in neonatal sepsis diagnosis. The main objective of this study was to evaluate the diagnostic accuracy of EMA sepsis criteria for proven neonatal sepsis. Methods A multicenter prospective cohort study was conducted from October 2015 to November 2018. Infants with a gestational age over 34th weeks, diagnosed with clinical sepsis and received antibiotics according to the EMA criteria or experienced neonatologists' opinion were included. Blood culture or multiplex real time-PCR or 16S-rRNA positive infants were accepted as "proven sepsis". The predictive performance of EMA criteria for proven sepsis was evaluated by sensitivity, specificity, accuracy, and area under the curve measures of receiver operator characteristic curves. Data-mining methods were used for further analysis. Results Among the 245 included infants, the EMA criteria were positive in 97 infants (39.6%), while proven sepsis was diagnosed in 113 infants (46.1%). The sensitivity, specificity, and accuracy of the EMA criteria for proven sepsis were 44.2% (95%CI: 34.9-53.9), 64.4% (95%CI: 55.6-72.5), 55.1% (95%CI: 46.6-59.4) respectively. None of the clinical and laboratory parameters had sufficient performance individually in terms of sensitivity, specificity and accuracy measures. The diagnostic performance was similar when different clinical findings were added to the EMA sepsis criteria or assessment of the score was interpreted in different ways. Conclusions Results highlighted that clinician opinion and standard laboratory tests are limited in the neonatal sepsis diagnosis. The EMA criteria also did not efficiently meet the diagnostic accuracy measures for neonatal sepsis. A predictive sepsis definition and rapid bedside point-of care tests are urgently needed.	[Tuzun, Funda; Ozkan, Hasan; Baysal, Bora; Kumral, Abdullah; Duman, Nuray] Dokuz Eylul Univ, Fac Med, Dept Pediat, Div Neonatol, Izmir, Turkey; [Cetinkaya, Merih; Kurum, Ozge; Cebeci, Burcu] Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat, Div Neonatol, Istanbul, Turkey; [Yucesoy, Ebru] Urfa Matern & Children Hosp, Dept Pediat, Div Neonatol, Urfa, Turkey; [Cakmak, Ertan; Ozkutuk, Aydan] Dokuz Eylul Univ, Fac Med, Dept Clin Microbiol, Izmir, Turkey; [Keskinoglu, Pembe] Dokuz Eylul Univ, Fac Med, Dept Biostat & Bioinformat, Izmir, Turkey; [Baysal, Bora] Buca Matern & Children Hosp, Dept Pediat, Div Neonatol, Izmir, Turkey	Dokuz Eylul University; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Dokuz Eylul University; Dokuz Eylul University	Ozkan, H (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Pediat, Div Neonatol, Izmir, Turkey.	hozkandeu@gmail.com	Bagdiken, Ebru Ycesoy/AAB-3946-2021; Özkan, Hasan/P-6128-2019; ozkutuk, aydan/AAD-5501-2019; Baysal, Bora/AFR-7500-2022; Cebeci, Burcu/GRN-8407-2022; Çakmak, Ertan/AAE-5419-2019; Cetinkaya, Merih/AFP-9671-2022; keskinoglu, pembe/H-1864-2013	Özkan, Hasan/0000-0003-2542-7441; Baysal, Bora/0000-0002-3825-858X; Cebeci, Burcu/0000-0003-1886-8126; 	Scientific and Technological Research Council of Turkey (TUBITAK) [115S355]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) by Project number 115S355 (HO), www.tubitak.gov.tr.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antillon M, 2018, J INFECT DIS, V218, pS255, DOI 10.1093/infdis/jiy471; Benitz WE, 2015, J PEDIATR-US, V166, P1070, DOI 10.1016/j.jpeds.2014.12.023; Brocklehurst P, 2011, NEW ENGL J MED, V365, P1201, DOI 10.1056/NEJMoa1100441; Clinical Laboratory Standards Institute (CLSI), M47A CLSI; European Medicines Agency (EMA), 2010, EXP M NEON PAED SEPS; Fernandez-Cruz A, 2013, J CLIN MICROBIOL, V51, P1130, DOI 10.1128/JCM.02882-12; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Kasper DC, 2013, NEONATOLOGY, V103, P268, DOI 10.1159/000346365; Klingenberg C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00285; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Liang L, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00277; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Lutsar I, 2014, EUR J PEDIATR, V173, P997, DOI 10.1007/s00431-014-2279-5; Meem Mahbuba, 2011, J Glob Health, V1, P201; Ohlin A, 2012, NEONATOLOGY, V101, P241, DOI 10.1159/000334655; Pammi M, 2011, PEDIATRICS, V128, pE973, DOI 10.1542/peds.2011-1208; Puopolo KM, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2894; Puopolo KM, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2896; Shane AL, 2017, LANCET, V390, P1770, DOI 10.1016/S0140-6736(17)31002-4; Straub J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187688; Wynn JL, 2018, PEDIATR RES, V83, P13, DOI 10.1038/pr.2017.224; Wynn JL, 2016, CURR OPIN PEDIATR, V28, P135, DOI 10.1097/MOP.0000000000000315	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218002	10.1371/journal.pone.0218002	http://dx.doi.org/10.1371/journal.pone.0218002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170237	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700091
J	Chung, YS; Choi, JY; Yoo, MS; Seong, JH; Choi, BS; Kang, C				Chung, Yoon-Seok; Choi, Ju-Yeon; Yoo, Myoung-Su; Seong, Jae Hyun; Choi, Byeong-Sun; Kang, Chun			Phylogenetic transmission clusters among newly diagnosed antiretroviral drug-naive patients with human immunodeficiency virus-1 in Korea: A study from 1999 to 2012	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC-VARIATION; RESISTANT HIV-1; NATIONAL-SURVEY; SEX; MEN; POPULATION; DIVERSITY; EMERGENCE; EVOLUTION	Population-level phylogenetic patterns reflect both transmission dynamics and genetic changes, which accumulate because of selection or drift. In this study, we determined whether a longitudinally sampled dataset derived from human immunodeficiency virus (HIV)-1-infected individuals over a 14-year period (1999-2012) could shed light on the transmission processes involved in the initiation of the HIV-1 epidemic in Korea. In total, 927 sequences were acquired from 1999 to 2012; each sequence was acquired from an individual patient who had not received treatment. Sequences were used for drug resistance and phylogenetic analyses. Phylogenetic and other analyses were conducted using MEGA version 6.06 based on the GTR G+I parameter model and SAS. Of the 927 samples, 863 (93.1%) were classified as subtype B and 64 were classified as other subtypes. Phylogenetic analysis demonstrated that 104 of 927 patient samples (11.2%) were grouped into 37 clusters. Being part of a transmission cluster was significantly associated with subtype-B viruses, infection via sexual contact, and the infection of young males. Of all clusters, three (similar to 8.1%) that comprised 10 individual samples (22.2% of 45 individuals) included at least one member with total transmitted drug resistance (TDR). In summary, HIV transmission cluster analyses can integrate laboratory data with behavioral data to enable the identification of key transmission patterns to develop tailored interventions aimed at interrupting transmission chains.	[Chung, Yoon-Seok; Choi, Ju-Yeon; Kang, Chun] Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control & Infect Dis, Cheongju, South Korea; [Yoo, Myoung-Su; Seong, Jae Hyun; Choi, Byeong-Sun] Korea Ctr Dis Control & Prevent, Div Viral Dis Res, Ctr Res Infect Dis, Natl Inst Hlth, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH)	Kang, C (corresponding author), Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control & Infect Dis, Cheongju, South Korea.	kangchun@korea.kr	Chung, Yoon-Seok/GQA-3042-2022	Chung, Yoon-Seok/0000-0003-4562-5533	STI Prevention Study [4800-4842-304-210]; Korea Centers for Disease Control and Prevention	STI Prevention Study; Korea Centers for Disease Control and Prevention	This study was supported by a grant for the AIDS and STI Prevention Study (grant number 4800-4842-304-210) from the Korea Centers for Disease Control and Prevention.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abubakar YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080487; Alpsar D, 2013, MED MICROBIOL IMMUN, V202, P251, DOI 10.1007/s00430-012-0285-7; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Bao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114764; Bielejec F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-133; Bolivar H, 2009, JAIDS-J ACQ IMM DEF, V52, P659, DOI 10.1097/QAI.0b013e3181b72539; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Chan PA, 2014, INFECT GENET EVOL, V28, P358, DOI 10.1016/j.meegid.2014.03.027; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093130; Chen YJ, 2012, JAIDS-J ACQ IMM DEF, V59, P438, DOI 10.1097/QAI.0b013e3182454ea3; Chen YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091104; Chijiwa K, 1999, MICROBIOL IMMUNOL, V43, P271, DOI 10.1111/j.1348-0421.1999.tb02403.x; Choi JY, 2008, JAIDS-J ACQ IMM DEF, V49, P237, DOI 10.1097/QAI.0b013e318188a919; Ciccozzi M, 2013, AIDS RES HUM RETROV, V29, P404, DOI [10.1089/AID.2012.0209, 10.1089/aid.2012.0209]; Cohen J, 2015, SCIENCE, V348, P1188, DOI 10.1126/science.348.6240.1188; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Pina-Araujo IIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096201; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Fabeni L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135325; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gui T, 2016, CURR HIV RES, V14, P148, DOI 10.2174/1570162X13666150929094555; Hattori J, 2016, JAIDS-J ACQ IMM DEF, V71, P367, DOI 10.1097/QAI.0000000000000861; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Huang SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128266; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jiao Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0689-7; Kim GJ, 2008, JAIDS-J ACQ IMM DEF, V48, P127, DOI 10.1097/QAI.0b013e31816b6ae6; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Kim JY, 2011, CLIN MICROBIOL INFEC, V17, P1155, DOI 10.1111/j.1469-0691.2010.03392.x; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Kusagawa S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00196-15; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li Xi, 2014, Trust and Trustworthy Computing. 7th International Conference, TRUST 2014. Proceedings: LNCS 8564, P1, DOI 10.1007/978-3-319-08593-7_1; Lubelchek RJ, 2015, JAIDS-J ACQ IMM DEF, V68, P46, DOI 10.1097/QAI.0000000000000404; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067286; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Shiino T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102633; Takebe Y, 2014, J VIROL, V88, P9864, DOI 10.1128/JVI.01354-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wu JJ, 2015, AIDS RES HUM RETROV, V31, P926, DOI [10.1089/AID.2015.0107, 10.1089/aid.2015.0107]; Zhang WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099693	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217817	10.1371/journal.pone.0217817	http://dx.doi.org/10.1371/journal.pone.0217817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166970	gold, Green Submitted, Green Published			2022-12-27	WOS:000470087800040
J	Peng, LY; Cui, ZQ; Wu, ZM; Fu, BD; Yi, PF; Shen, HQ				Peng, Lu-Yuan; Cui, Zhen-Qiang; Wu, Zong-Mei; Fu, Ben-Dong; Yi, Peng-Fei; Shen, Hai-Qing			RNA-seq profiles of chicken type II pneumocyte in response to Escherichia coli infection	PLOS ONE			English	Article							NF-KAPPA-B; SALMONELLA-INDUCED APOPTOSIS; ALVEOLAR EPITHELIAL-CELLS; T-CELLS; VIRULENCE; ANTIGEN; DIFFERENTIATION; INFLAMMATION; INHIBITION; SEQUENCE	Avian pathogenic Escherichia coli (APEC) causes great economic loss to the poultry industry worldwide. Chicken type II pneumocytes (CP II cells) secrete surfactants and modulate lung immunity to decrease the infection of the invading pathogen. Nevertheless, the pathogenesis of CP II cells to APEC infection remains poorly understood. Therefore, we conducted global gene expression profiling of CP II cells after APEC-O78 infection to explore the host-pathogen interaction. The differentially expressed genes of CP II cells to APEC infection were characterized by RNA-seq with EB-seq algorithm. In consequence, the mRNA of 18996 genes was identified, and CP II cells responded to APEC infection with marked changes in the expression of 1390 genes. Among them, there are 803 down-regulated mRNAs and 587 upregulated mRNAs. The KEGG prediction and Gene Ontology terms analysis revealed that the major enriched pathways were related to NF-kappa B signaling pathway, apoptosis pathway, tight junction, and cytokine-cytokine receptor interaction and other pathways. We adopted qRT-PCR to verify the validity of the selected gene expression. The fold induction of qPCR was similar to the RNA-seq results. These results provide a better understanding of the pathogenesis of APEC, especially apoptosis pathway involved in APEC infection.	[Peng, Lu-Yuan; Cui, Zhen-Qiang; Wu, Zong-Mei; Fu, Ben-Dong; Yi, Peng-Fei; Shen, Hai-Qing] Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China	Jilin University	Fu, BD; Shen, HQ (corresponding author), Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China.	fubendong96@163.com; 510055813@qq.com			National Natural Science Foundation of China [31372470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 31372470).	Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; Bjornstad S, 2014, NEONATOLOGY, V105, P112, DOI 10.1159/000355346; Carneiro NVQ, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920170831; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Dou XH, 2016, GENE, V576, P244, DOI 10.1016/j.gene.2015.10.012; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Frode-Saleh TS, 2000, INFLAMM RES, V49, P330, DOI 10.1007/PL00000213; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gao QX, 2012, VET MICROBIOL, V160, P395, DOI 10.1016/j.vetmic.2012.06.009; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Green SR, 2010, BRIT J CANCER, V103, P1391, DOI 10.1038/sj.bjc.6605922; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Johnson JR, 2006, MICROBES INFECT, V8, P1702, DOI 10.1016/j.micinf.2006.02.007; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kamble NM, 2016, VET IMMUNOL IMMUNOP, V169, P96, DOI 10.1016/j.vetimm.2015.11.002; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Lai JL, 2017, INFLAMMATION, V40, P1, DOI 10.1007/s10753-016-0447-7; Lavric M, 2008, VET MICROBIOL, V126, P111, DOI 10.1016/j.vetmic.2007.06.011; Li PC, 2011, BIOCHEM BIOPH RES CO, V409, P142, DOI 10.1016/j.bbrc.2011.04.131; Liang CJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/305149; Liang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145001; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Oliveira A, 2009, J APPL MICROBIOL, V106, P1919, DOI 10.1111/j.1365-2672.2009.04145.x; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Qin M, 2014, IMMUNOPHARM IMMUNOT, V36, P251, DOI 10.3109/08923973.2013.861481; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Remppis A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/194896; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Salmond RJ, 2002, EUR J IMMUNOL, V32, P1737, DOI 10.1002/1521-4141(200206)32:6<1737::AID-IMMU1737>3.0.CO;2-J; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Scott O, 2019, J ALLERGY CLIN IMMUN, V143, P1688, DOI 10.1016/j.jaci.2019.03.016; Sun HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1850-4; Szmolka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127708; Varasteh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138975; Vasanthakumar A, 2017, CELL REP, V20, P2906, DOI 10.1016/j.celrep.2017.08.068; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilbur JS, 2015, INFECT IMMUN, V83, P1139, DOI 10.1128/IAI.02876-14; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Zhang LY, 2014, VET IMMUNOL IMMUNOP, V159, P50, DOI 10.1016/j.vetimm.2014.02.005	45	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217438	10.1371/journal.pone.0217438	http://dx.doi.org/10.1371/journal.pone.0217438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166969	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800028
J	Puig-Divi, A; Escalona-Marfil, C; Padulles-Riu, JM; Busquets, A; Padulles-Chando, X; Marcos-Ruiz, D				Puig-Divi, Albert; Escalona-Marfil, Carles; Maria Padulles-Riu, Josep; Busquets, Albert; Padulles-Chando, Xavier; Marcos-Ruiz, Daniel			Validity and reliability of the Kinovea program in obtaining angles and distances using coordinates in 4 perspectives	PLOS ONE			English	Article							LOW-COST; CONCURRENT VALIDITY; ANALYSIS SOFTWARE; VIDEO ANALYSIS; WALKING; MOTION; QUANTIFICATION; PARTICIPANTS; VALIDATION; CHILDREN	An objective analysis of the human movement can help both clinical assessment and sports performance. Kinovea is a free 2D motion analysis software that can be used to measure kinematic parameters. This low-cost technology has been used in sports sciences, as well as in the clinical and research fields. One interesting tool is that it can measure an object (or person) passing in front of the camera, taking into account the perspective between the camera and the recorded object. Although it has been validated as a tool to assess time-related variables, few studies assessed its validity compared to a Gold Standard; furthermore, its reliability in different perspectives has not been previously assessed. The main objective of this study is to determine the validity of the Kinovea software compared to AutoCAD, and its intra and inter-rater reliability in obtaining coordinates data; a second objective is to compare their results at 4 different perspectives (90 degrees, 75 degrees, 60 degrees and 45 degrees) and to assess the inter and intra rater reliability at each perspective. For this purpose, a wire structure figure in the shape of a human lower limb was designed and measured in AutoCAD; it was then recorded during a pendular motion with a video-camera placed at distance of 5 m and analyzed with Kinovea in the 4 perspectives (90 degrees, 75 degrees, 60 degrees and 45 degrees). Each frame was examined by three observers who made two attempts. A multiple approach was applied involving the analysis of the systematic error, with a two-way ANOVA 2x4; the relative reliability with Intraclass Correlation Coefficient (ICC) and the Coefficient of Variance (CV) (95% confidence interval); and the absolute reliability with the Standard Error (SE). The results indicate that the Kinovea software is a valid and reliable tool that is able to measure accurately at distances up to 5 m from the object and at an angle range of 90 degrees-45 degrees. Nevertheless, for optimum results an angle of 90 degrees is suggested.	[Puig-Divi, Albert] Ramon Llull Univ, Blanquerna Sch Hlth Sci, Barcelona, Catalunya, Spain; [Escalona-Marfil, Carles] Univ Cent Catalunya, Fac Ciencies Salut Manresa, Univ Vic, Catalunya, Barcelona, Spain; [Escalona-Marfil, Carles; Marcos-Ruiz, Daniel] Univ Girona, Dept Phys Therapy, EUSES, Catalunya, Girona, Spain; [Maria Padulles-Riu, Josep; Busquets, Albert; Padulles-Chando, Xavier] Natl Inst Phys Educ Catalonia INEFC, Barcelona, Catalunya, Spain	Universitat Ramon Llull; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat de Girona	Escalona-Marfil, C (corresponding author), Univ Cent Catalunya, Fac Ciencies Salut Manresa, Univ Vic, Catalunya, Barcelona, Spain.; Escalona-Marfil, C (corresponding author), Univ Girona, Dept Phys Therapy, EUSES, Catalunya, Girona, Spain.	cescalona@umanresa.cat	Busquets, Albert/I-5544-2015; Padullés, Josep M/AAB-2723-2019; Escalona Marfil, Carles/P-1982-2017	Busquets, Albert/0000-0002-8879-1577; Padullés, Josep M/0000-0002-0531-7459; Escalona Marfil, Carles/0000-0003-3028-9557; Puig-Divi, Albert/0000-0002-1778-0803				Aguilar LM, 2015, 2015 CHILEAN Conference on Electrical, Electronics Engineering, Information and Communication Technologies (CHILECON), P205, DOI 10.1109/Chilecon.2015.7400376; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Balsalobre-Fernandez C, 2014, J STRENGTH COND RES, V28, P528, DOI 10.1519/JSC.0b013e318299a52e; Baude M, 2015, BIOMED RES INT, V2015, P1; Damsted C, 2015, GAIT POSTURE, V42, P32, DOI 10.1016/j.gaitpost.2015.01.029; Damsted C, 2015, INT J SPORTS PHYS TH, V10, P147; Dias JA, 2011, J STRENGTH COND RES, V25, P2034, DOI 10.1519/JSC.0b013e3181e73f6e; Ditroilo M, 2011, J SPORT SCI, V29, P1675, DOI 10.1080/02640414.2011.614270; Elnahhas A, 2014, TRENDS APPL SCI RES, V9, P503, DOI DOI 10.3923/tasr.2014.503.511; Eltoukhy M, 2012, IJSER, V3, P1; Candido PEF, 2012, WORK, V41, P2506, DOI 10.3233/WOR-2012-0490-2506; Grigore V, 2015, 4TH INTERNATIONAL CONGRESS OF PHYSICAL EDUCATION, SPORT AND KINETOTHERAPY (ICPESK 2014), P125; Hernandez-Gervilla O, 2016, APUNTS-MED ESPORT, V51, P115, DOI 10.1016/j.apunts.7016.03.001; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Ismail SI, 2014, PROCEDIA ENGINEER, V72, P186, DOI 10.1016/j.proeng.2014.06.031; Krishnan C, 2015, J BIOMECH, V48, P544, DOI 10.1016/j.jbiomech.2014.11.048; Maas JC, 2014, CLIN REHABIL, V28, P1025, DOI 10.1177/0269215514542355; Macleod CA, 2014, MED ENG PHYS, V36, P541, DOI 10.1016/j.medengphy.2013.11.011; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Moral-Munoz JA, 2015, J STRENGTH COND RES, V29, P2661, DOI 10.1519/JSC.0000000000000896; Norris Beth S., 2011, Physiotherapy Theory and Practice, V27, P521, DOI 10.3109/09593985.2010.533745; Northeast L, 2018, GAIT POSTURE, V64, P114, DOI 10.1016/j.gaitpost.2018.06.001; Nuzzo JL, 2011, J STRENGTH COND RES, V25, P2580, DOI 10.1519/JSC.0b013e3181fee650; Olper L, 2011, PHYS THER, V91, P566, DOI 10.2522/ptj.20100156; Padulo J, 2015, BIOL SPORT, V32, P53, DOI 10.5604/20831862.1127282; Pontes LF, 2015, EUR J ORTHODONT, V37, P435, DOI 10.1093/ejo/cju055; Potop V, 2014, ELEARN SOFTW EDUC, P177; Potov V, 2015, 4TH INTERNATIONAL CONGRESS OF PHYSICAL EDUCATION, SPORT AND KINETOTHERAPY (ICPESK 2014), P477; Quieregatto PR, 2014, ACTA CIR BRAS, V29, P688, DOI 10.1590/S0102-8650201400160010; Suarez GR, 2016, VIREF-REV EDUC FIS, V5, P1; Ramos-Ortega J, 2014, CLIN J SPORT MED, V24, P251, DOI 10.1097/JSM.0000000000000027; Rebolledo Uribe JP, 2012, REV FAC ODONTOL U AN, V24, P76; Rozan M, 2016, J HUM KINET, V50, P115, DOI 10.1515/hukin-2015-0148; Sanudo B, 2016, J STRENGTH COND RES, V30, P2934, DOI 10.1519/JSC.0000000000000563; Thewlis D, 2013, J APPL BIOMECH, V29, P112, DOI 10.1123/jab.29.1.112; Torralba Jordán Miguel Angel, 2016, CPD, V16, P69; Torres-Luque G, 2015, INT J PERF ANAL SPOR, V15, P1135, DOI 10.1080/24748668.2015.11868857; Ugbolue UC, 2013, GAIT POSTURE, V38, P483, DOI 10.1016/j.gaitpost.2013.01.018; Valdivia C., 2013, INT J SOFT COMPUT EN, V3, P359; Vitorio R, 2012, GAIT POSTURE, V35, P175, DOI 10.1016/j.gaitpost.2011.09.002; Webber SC, 2010, PHYS THER, V90, P1165, DOI 10.2522/ptj.20090394; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Youssef AR, 2016, INT J PHYSIOTHER, V3, P326, DOI 10.15621/ijphy/2016/v3i3/100838	43	91	91	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216448	10.1371/journal.pone.0216448	http://dx.doi.org/10.1371/journal.pone.0216448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166989	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800009
J	Yamaguchi, A; Yamamoto, Y				Yamaguchi, Atsuko; Yamamoto, Yasunori			Split4Blank: Maintaining consistency while improving efficiency of loading RDF data with blank nodes	PLOS ONE			English	Article								In life sciences, accompanied by the rapid growth of sequencing technology and the advancement of research, vast amounts of data are being generated. It is known that as the size of Resource Description Framework (RDF) datasets increases, the more efficient loading to triple stores is crucial. For example, UniProt's RDF version contains 44 billion triples as of December 2018. PubChem also has an RDF dataset with 137 billion triples. As data sizes become extremely large, loading them to a triple store consumes time. To improve the efficiency of this task, parallel loading has been recommended for several stores. However, with parallel loading, dataset consistency must be considered if the dataset contains blank nodes. By definition, blank nodes do not have global identifiers; thus, pairs of identical blank nodes in the original dataset are recognized as different if they reside in separate files after the dataset is split for parallel loading. To address this issue, we propose the Split4Blank tool, which splits a dataset into multiple files under the condition that identical blank nodes are not separated. The proposed tool uses connected component and multiprocessor scheduling algorithms and satisfies the above condition. Furthermore, to confirm the effectiveness of the proposed approach, we applied Split4Blank to two life sciences RDF datasets. In addition, we generated synthetic RDF datasets to evaluate scalability based on the properties of various graphs, such as a scale-free and random graph.	[Yamaguchi, Atsuko; Yamamoto, Yasunori] Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Kashiwa, Chiba, Japan	Research Organization of Information & Systems (ROIS)	Yamaguchi, A (corresponding author), Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Kashiwa, Chiba, Japan.	atsuko@dbcls.rois.ac.jp		Yamaguchi, Atsuko/0000-0001-7538-5337	NBDC; National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	NBDC; National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	NBDC (https://biosciencedbc.jp/en/) financially supported our work and there is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST).	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beckett D, RDF 1 1 N TRIPLES; Beckett D, RDF 1 1 TURTLE; Chen R, 2011, APPL MECH MAT, V145, P460, DOI [10.4028/www.scientific.net/AMM.145.460, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.145.460]; Cheung KH, 2005, BIOINFORMATICS, V21, pI85, DOI 10.1093/bioinformatics/bti1026; Cyganiak R., RDF 1 1 CONCEPTS ABS; Gandon F., RDF 1 1 XML SYNTAX; Garey M.R., 1979, COMPUTERS INTRACTABI; GRAHAM RL, 1969, SIAM J APPL MATH, V17, P416, DOI 10.1137/0117039; Hayes P.J., RDF 1 1 SEMANTICS; Hey T., 2009, 4 PARADIGM DATA INTE; HOCHBAUM DS, 1987, J ACM, V34, P144, DOI 10.1145/7531.7535; Hogan A, 2014, J WEB SEMANT, V27-28, P42, DOI 10.1016/j.websem.2014.06.004; Kumar R., 2015, TOPC, V2, p14:1, DOI DOI 10.1145/2809814; Lam HYK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S4; Mallea A, 2011, LECT NOTES COMPUT SC, V7031, P421, DOI 10.1007/978-3-642-25073-6_27; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; O'Driscoll A, 2015, J BIOMED INFORM, V54, P58, DOI 10.1016/j.jbi.2015.01.008; Stolpe A, 2017, SEMANT WEB, V8, P1001, DOI 10.3233/SW-160250; Yamamoto Yasunori, 2011, Database (Oxford), V2011, pbar013, DOI 10.1093/database/bar013	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217852	10.1371/journal.pone.0217852	http://dx.doi.org/10.1371/journal.pone.0217852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163073	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200041
J	Jasoliya, M; Sacca, F; Sahdeo, S; Chedin, F; Pane, C; Morra, VB; Filla, A; Pook, M; Cortopassi, G				Jasoliya, Mittal; Sacca, Francesco; Sahdeo, Sunil; Chedin, Frederic; Pane, Chiara; Morra, Vincenzo Brescia; Filla, Alessandro; Pook, Mark; Cortopassi, Gino			Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia	PLOS ONE			English	Article							MITOCHONDRIAL BIOGENESIS; EPIGENETIC CHANGES; R-LOOPS; DEFICIENCY; REPEATS; GENE; MODELS; CELLS; MICE	Friedreich's Ataxia (FA) is an inherited neurodegenerative disorder resulting from decreased expression of the mitochondrial protein frataxin, for which there is no approved therapy. High throughput screening of clinically used drugs identified Dimethyl fumarate (DMF) as protective in FA patient cells. Here we demonstrate that DMF significantly increases frataxin gene (FXN) expression in FA cell model, FA mouse model and in DMF treated humans. DMF also rescues mitochondrial biogenesis deficiency in FA-patient derived cell model. We further examined the mechanism of DMF's frataxin induction in FA patient cells. It has been shown that transcription-inhibitory R-loops form at GAA expansion mutations, thus decreasing FXN expression. In FA patient cells, we demonstrate that DMF significantly increases transcription initiation. As a potential consequence, we observe significant reduction in both R-loop formation and transcriptional pausing thereby significantly increasing FXN expression. Lastly, DMF dosed Multiple Sclerosis (MS) patients showed significant increase in FXN expression by similar to 85%. Since inherited deficiency in FXN is the primary cause of FA, and DMF is demonstrated to increase FXN expression in humans, DMF could be considered for Friedreich's therapy.	[Jasoliya, Mittal; Sahdeo, Sunil; Cortopassi, Gino] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Sacca, Francesco; Pane, Chiara; Morra, Vincenzo Brescia; Filla, Alessandro] Univ Federico II, Dept Neurosci Odontostomatol & Reprod Sci, Naples, Italy; [Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Pook, Mark] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Uxbridge, Middx, England	University of California System; University of California Davis; University of Naples Federico II; University of California System; University of California Davis; Brunel University	Cortopassi, G (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu		Pane, Chiara/0000-0002-3459-2644; Chedin, Frederic/0000-0002-1306-5335	FARA (Friedreich's ataxia Research Alliance); NIH [NS-077777]	FARA (Friedreich's ataxia Research Alliance); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the FARA (Friedreich's ataxia Research Alliance) and the NIH NS-077777, and a gift from the Packer-Wentz foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A part of Sunil Sahdeo and Mittal Jasoliya's salaries were supported by these grants.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Albano Lilian Maria José, 2002, Arq. Bras. Cardiol., V78, P448, DOI 10.1590/S0066-782X2002000500002; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; Cory SA, 2017, P NATL ACAD SCI USA; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hayashi G, 2017, HUM MOL GENET, V26, P2864, DOI 10.1093/hmg/ddx167; Indelicato E, 2018, EXPERT OPIN ORPHAN D, V6, P57, DOI 10.1080/21678707.2018.1409109; Jasoliya MJ, 2017, HUM MOL GENET, V26, P2627, DOI 10.1093/hmg/ddx141; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Li YJ, 2015, HUM MOL GENET, V24, P6932, DOI 10.1093/hmg/ddv397; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Oglesbee D, 2013, CLIN CHEM CLINCHEM; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sacca F, 2013, J NEUROL, V260, P1116, DOI 10.1007/s00415-012-6770-5; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Sahdeo S, 2014, HUM MOL GENET, V23, P6848, DOI 10.1093/hmg/ddu408; Sandi C, 2013, GENET RES INT, V2013, DOI 10.1155/2013/852080; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Strawser C, 2017, EXPERT REV NEUROTHER, V17, P895, DOI 10.1080/14737175.2017.1356721; Tai G, 2018, NEUROLOGIA NEUROCHIR; Venci JV, 2013, ANN PHARMACOTHER, V47, P1697, DOI 10.1177/1060028013509232	32	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217776	10.1371/journal.pone.0217776	http://dx.doi.org/10.1371/journal.pone.0217776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158268	Green Submitted, Green Published, gold			2022-12-27	WOS:000469915700025
J	Hultin, E; Muhr, LSA; Lagheden, C; Dillner, J				Hultin, Emilie; Muhr, Laila Sara Arroyo; Lagheden, Camilla; Dillner, Joakim			HPV transcription in skin tumors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-DNA; TRANSPLANT RECIPIENTS; CANCER; BETAPAPILLOMAVIRUSES; PREVALENCE; HEAD	Background Although more than 95% of viral sequences found in skin tumors typically belong to human papillomaviruses (HPVs), HPV transcription has so far not been detected. As current technology allows very deep transcriptome sequencing, we examined skin tumors and precursor lesions for HPV transcription. Method Fresh frozen biopsies from 12 skin specimens (11/12 were positive for HPV DNA) were subjected to total RNA sequencing. The cervical cancer cell line CaSki was included as a positive control for HPV transcription. Results HPV RNA was detected and confirmed in 1/12 skin lesions at a median depth of 66 million reads per sample. One specimen was positive for HPV 110 transcripts mapping to E6, E7, E2/E4 and L2 open reading frames, as well as to a spliced E1<^>E4 transcript. Conclusion In conclusion, the study revealed that a minority of skin lesions contains HPV transcripts and that HPV DNA detection does not predict HPV transcriptional activity.	[Hultin, Emilie; Muhr, Laila Sara Arroyo; Lagheden, Camilla; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Dillner, Joakim] Karolinska Univ Hosp, Karolinska Univ Lab, Clin Pathol Cytol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Hultin, E (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	Emilie.Hultin@ki.se		Hultin, Emilie/0000-0003-2169-0840; Arroyo Muhr, Laila Sara/0000-0003-2498-5206	Swedish Cancer Society [CAN 2017/459]; Swedish Research Council [2017-01841_3]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Cancer Society (author: JD, grant number: CAN 2017/459, url: https://www.cancerfonden.se) and by the Swedish Research Council (author: JD, grant number: 2017-01841_3, url: https://www.vr.se).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ALP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-262; Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Arroyo LS, 2013, J CLIN VIROL, V58, P437, DOI 10.1016/j.jcv.2013.07.013; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bzhalava D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05807; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Chen JM, 2014, VIROLOGY, V462, P14, DOI 10.1016/j.virol.2014.05.026; de Jong SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01222; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Ekstrom J, 2013, VIROLOGY, V447, P300, DOI 10.1016/j.virol.2013.09.010; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Ganzenmueller T, 2012, INT J CANCER, V131, pE1173, DOI 10.1002/ijc.27581; Graham SV, 2017, VIRUS RES, V231, P83, DOI 10.1016/j.virusres.2016.11.016; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hortlund M, 2017, INT J CANCER, V140, P1091, DOI 10.1002/ijc.30531; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2017, INT J CANCER, V141, P2498, DOI 10.1002/ijc.31017; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pfister H, 1997, CLIN DERMATOL, V15, P335, DOI 10.1016/S0738-081X(96)00162-9; Plasmeijer EI, 2009, CANCER RES, V69, P8926, DOI 10.1158/0008-5472.CAN-09-1186; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Walboomers JMM, 1997, J PATHOL, V181, P253, DOI 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217942	10.1371/journal.pone.0217942	http://dx.doi.org/10.1371/journal.pone.0217942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150522	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100130
J	Lorenz, TK; Cheng, H; Heiman, JR				Lorenz, Tierney K.; Cheng, Hu; Heiman, Julia R.			Neural correlates of emotion processing comparing antidepressants and exogenous oxytocin in postpartum depressed women: An exploratory study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; AMYGDALA RESPONSE; MATERNAL BRAIN; SEXUAL DYSFUNCTION; GESTATIONAL STRESS; SSRI TREATMENT; PREGNANCY; PLASTICITY; SEROTONIN; INFANT	Despite common use of antidepressants to treat postpartum depression, little is known about the impact of antidepressant use on postpartum brain activity. Additionally, although oxytocin has been investigated as a potential treatment for postpartum depression, the interaction between antidepressants and exogenous oxytocin on brain activity is unknown. We explored postpartum depressed women's neural activation in areas identified as important to emotion and reward processing and potentially, antidepressant response: the amygdala, nucleus accumbens and ventral tegmental area. We conducted a secondary analysis of a functional imaging study of response to sexual, crying infant and smiling infant images in 23 postpartum depressed women with infants under six months (11 women taking antidepressants, 12 unmedicated). Participants were randomized to receive a single dose of oxytocin or placebo nasal spray. There was significantly higher amygdala activation to sexual stimuli than either neutral or infant-related stimuli among women taking antidepressants or receiving oxytocin nasal spray. Among unmedicated women receiving placebo, amygdala activation was similar across stimuli types. There were no significant effects of antidepressants nor oxytocin nasal spray on reward area processing (i.e., in the nucleus accumbens or ventral tegmental area). Among postpartum women who remain depressed, there may be significant interactions between the effects of antidepressant use and exogenous oxytocin on neural activity associated with processing emotional information. Observed effect sizes were moderate to large, strongly suggesting the need for further replication with a larger sample.	[Lorenz, Tierney K.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Lorenz, Tierney K.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Cheng, Hu; Heiman, Julia R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Indiana University System; Indiana University Bloomington	Heiman, JR (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jheiman@indiana.edu	Lorenz, Tierney/ABB-8558-2021; Cheng, Hu/AAS-3076-2021; Lorenz, Tierney/AAF-2531-2020	Lorenz, Tierney/0000-0002-4999-1584; 	National Institutes of Health [NIMH R21MH082925, NICHD T32HD049336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by National Institutes of Health grants NIMH R21MH082925 (JRH; Co-PI) and NICHD T32HD049336 (TKL; trainee), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; Borrow AP, 2012, HORM BEHAV, V61, P266, DOI 10.1016/j.yhbeh.2011.11.001; Briceno EM, 2013, PSYCHOL MED, V43, P1433, DOI 10.1017/S0033291712002176; Brown RSE, 2015, J NEUROENDOCRINOL, V27, P708, DOI 10.1111/jne.12297; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Carceller H, 2018, NEUROSCIENCE, V386, P205, DOI 10.1016/j.neuroscience.2018.06.041; Carter CS, 2014, ANNU REV PSYCHOL, V65, P17, DOI 10.1146/annurev-psych-010213-115110; Chase HW, 2014, SOC COGN AFFECT NEUR, V9, P1069, DOI 10.1093/scan/nst083; Clarici A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00426; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cox EQ, 2015, PSYCHONEUROENDOCRINO, V55, P164, DOI 10.1016/j.psyneuen.2015.02.009; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; Galbally M, 2018, PSYCHONEUROENDOCRINO, V90, P1, DOI 10.1016/j.psyneuen.2018.01.004; Gemmel M, 2016, NEUROSCIENCE, V327, P32, DOI 10.1016/j.neuroscience.2016.03.068; Godlewska BR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.130; Godlewska BR, 2012, PSYCHOL MED, V42, P2609, DOI 10.1017/S0033291712000591; Godlewska B, 2017, BIOL PSYCHIAT, V81, pS57, DOI 10.1016/j.biopsych.2017.02.148; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Graf H, 2014, PHARMACOL BIOCHEM BE, V121, P138, DOI 10.1016/j.pbb.2013.12.003; Gregory R, 2015, HORM BEHAV, V69, P82, DOI 10.1016/j.yhbeh.2014.12.009; Gu V, 2015, BIRTH; Haim A, 2017, BRAIN BEHAV IMMUN, V59, P67, DOI 10.1016/j.bbi.2016.09.026; Haim A, 2016, HORM BEHAV, V77, P124, DOI 10.1016/j.yhbeh.2015.05.005; Hillerer KM, 2011, ENDOCRINOLOGY, V152, P3930, DOI 10.1210/en.2011-1091; Joshi SH, 2016, BIOL PSYCHIAT, V79, P282, DOI 10.1016/j.biopsych.2015.02.029; Julian MM, 2017, ARCH WOMEN MENT HLTH, P1; Keers R, 2010, INT REV PSYCHIATR, V22, P485, DOI 10.3109/09540261.2010.496448; Kim K, 2016, J AFFECT DISORDERS, V191, P222, DOI 10.1016/j.jad.2015.11.050; Kim P, 2016, HORM BEHAV, V77, P113, DOI 10.1016/j.yhbeh.2015.08.001; Kim P, 2011, J CHILD PSYCHOL PSYC, V52, P907, DOI 10.1111/j.1469-7610.2011.02406.x; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kim S, 2016, NEW DIR CHILD ADOLES, V153, P59, DOI 10.1002/cad.20170; Kim S, 2014, BRAIN RES, V1580, P219, DOI 10.1016/j.brainres.2013.11.009; Klimes-Dougan B, 2018, PROG NEURO-PSYCHOPH, V81, P194, DOI 10.1016/j.pnpbp.2017.10.015; Kokras N, 2017, J NEUROSCI RES, V95, P731, DOI 10.1002/jnr.23861; Kroll-Desrosiers AR, 2017, DEPRESS ANXIETY, V34, P137, DOI 10.1002/da.22599; Lang P. J., 2005, INT AFFECTIVE PICTUR; Langevin JP, 2016, BIOL PSYCHIAT, V79, pE82, DOI 10.1016/j.biopsych.2015.09.003; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Leuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089912; Levy F, 2016, ANN ENDOCRINOL-PARIS, V77, P114, DOI 10.1016/j.ando.2016.04.002; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Macoveanu J, 2014, BRAIN RES, V1556, P19, DOI 10.1016/j.brainres.2014.02.003; Mah BL, 2017, CHILD PSYCHIAT HUM D, V48, P308, DOI 10.1007/s10578-016-0642-7; Mah BL, 2016, HARVARD REV PSYCHIAT, V24, P1, DOI 10.1097/HRP.0000000000000093; Mah BL, 2013, PROG NEURO-PSYCHOPH, V40, P267, DOI 10.1016/j.pnpbp.2012.10.005; Massey SH, 2016, DEPRESS ANXIETY, V33, P316, DOI 10.1002/da.22467; McDonald E, 2017, MIDWIFERY, V55, P60, DOI 10.1016/j.midw.2017.09.002; McQuaid RJ, 2014, NEUROSCI BIOBEHAV R, V45, P305, DOI 10.1016/j.neubiorev.2014.07.005; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mottolese R, 2014, P NATL ACAD SCI USA, V111, P8637, DOI 10.1073/pnas.1319810111; Outhred T, 2014, J PSYCHIATR NEUROSCI, V39, P267, DOI 10.1503/jpn.130118; Ozsoy S, 2009, PSYCHIAT RES, V169, P249, DOI 10.1016/j.psychres.2008.06.034; Pawluski JL, 2017, TRENDS NEUROSCI, V40, P106, DOI 10.1016/j.tins.2016.11.009; Pawluski JL, 2016, HORM BEHAV, V77, P86, DOI 10.1016/j.yhbeh.2015.06.004; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Pratt M, 2015, DEPRESS ANXIETY, V32, P635, DOI 10.1002/da.22392; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rantala MJ, 2017, BEHAV IMMUNITY DEPRE; Rupp HA, 2014, SOC COGN AFFECT NEUR, V9, P48, DOI 10.1093/scan/nss100; Rupp HA, 2013, HORM BEHAV, V63, P114, DOI 10.1016/j.yhbeh.2012.10.007; Rupp HA, 2009, ARCH SEX BEHAV, V38, P417, DOI 10.1007/s10508-008-9402-5; Sabihi S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00258; Scantamburlo G, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.08.007; Serretti A, 2009, J CLIN PSYCHOPHARM, V29, P259, DOI 10.1097/JCP.0b013e3181a5233f; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Uvnas-Moberg K, 1999, PSYCHOPHARMACOLOGY, V142, P95, DOI 10.1007/s002130050867; Walsh EC, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00547; Wang T, 2018, BEHAV BRAIN RES, V336, P236, DOI 10.1016/j.bbr.2017.09.012; Williams LM, 2015, NEUROPSYCHOPHARMACOL, V40, P2398, DOI 10.1038/npp.2015.89; Wonch KE, 2016, SOC NEUROSCI-UK, V11, P600, DOI 10.1080/17470919.2015.1131193; Yang JC, 2008, J SEX MED, V5, P602, DOI 10.1111/j.1743-6109.2007.00737.x; Yang JC, 2012, PSYCHIAT INVEST, V9, P379, DOI 10.4306/pi.2012.9.4.379; Yip SH, 2019, CELL REP, V26, P1787, DOI 10.1016/j.celrep.2019.01.067; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zelkowitz P, 2014, HORM BEHAV, V66, P351, DOI 10.1016/j.yhbeh.2014.06.014	83	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217764	10.1371/journal.pone.0217764	http://dx.doi.org/10.1371/journal.pone.0217764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150502	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100101
J	Spaggiari, D; Desfontaine, V; Cruchon, S; Guinchard, S; Vocat, A; Blattes, E; Pitteloud, J; Ciullini, L; Bardinet, C; Ivanyuk, A; Makarov, V; Ryabova, O; Buclin, T; Cole, ST; Decosterd, LA				Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Vocat, Anthony; Blattes, Emilyne; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Makarov, Vadim; Ryabova, Olga; Buclin, Thierry; Cole, Stewart T.; Decosterd, Laurent A.			Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma	PLOS ONE			English	Article							QUANTITATIVE ANALYTICAL PROCEDURES; CHROMATOGRAPHY-MASS-SPECTROMETRY; MYCOBACTERIUM-TUBERCULOSIS; SFSTP PROPOSAL; COMBINATION THERAPY; STRATEGIES; BENZOTHIAZINONES; HARMONIZATION; IDENTIFICATION; BIOANALYSIS	The emergence of Mycobacterium tuberculosis strains resistant to current first-line antibiotic regimens constitutes a major global health threat. New treatments against multidrug-resistant tuberculosis (MDR-TB) are thus eagerly needed in particular in countries with a high MDR-TB prevalence. In this context, macozinone (PBTZ169), a promising drug candidate with an unique mode of action and highly potent in vitro tuberculocidal properties against MDR Mycobacterium strains, has now reached the clinical phase and has been notably tested in healthy male volunteers in Switzerland. To that endeavor, a multiplex UHPLC-MS/MS method has been developed for the sensitive and accurate human plasma levels determination of PBTZ169 along with five metabolites retaining in vitro anti-TB activity. Plasma protein precipitation with methanol was carried out as a simplified sample clean-up procedure followed by direct injection of the undiluted supernatant for the bioanalysis of the six analytes within 5 min, using 1.8 mu m reversed-phase chromatography coupled to triple quadrupole mass spectrometry employing electrospray ionization in the positive mode. Stable isotopically-labelled PBTZ169 was used as internal standard (ISTD), while metabolites could be reliably quantified using two unlabeled chemical analogues selected as ISTD from a large in-house analogous compounds library. The overall methodology was fully validated according to current recommendations (FDA, EMEA) for bioanalytical methods, which include selectivity, carryover, qualitative and quantitative matrix effect, extraction recovery, process efficiency, trueness, precision, accuracy profiles, method and instrument detection limits, integrity to dilution, anticoagulant comparison and short-and long-term stabilities. Stability studies on the reduced metabolite H-2-PBTZ169 have shown no significant impact on the actual PBTZ169 concentrations determined with the proposed assay. This simplified, rapid, sensitive and robust methodology has been applied to the bioanalysis of human plasma samples collected within the frame of a phase I clinical study in healthy volunteers receiving PBTZ169.	[Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Buclin, Thierry; Decosterd, Laurent A.] Univ Hosp Lausanne, Dept Labs, Lab & Serv Clin Pharmacol, Lausanne, Switzerland; [Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Buclin, Thierry; Decosterd, Laurent A.] Univ Lausanne, Lausanne, Switzerland; [Vocat, Anthony; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland; [Blattes, Emilyne; Makarov, Vadim; Cole, Stewart T.] Innovat Med TB IM4TB, Lausanne, Switzerland; [Makarov, Vadim; Ryabova, Olga] Fundamentals Biotechnol RAS, Fed Res Ctr, Moscow, Russia; [Spaggiari, Deny] Debiopharm Int SA, Lausanne, Switzerland; [Cole, Stewart T.] Pasteur Inst, Paris, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Research Center of Biotechnology RAS; Debiopharm; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Decosterd, LA (corresponding author), Univ Hosp Lausanne, Dept Labs, Lab & Serv Clin Pharmacol, Lausanne, Switzerland.; Decosterd, LA (corresponding author), Univ Lausanne, Lausanne, Switzerland.	laurentarthur.decosterd@chuv.ch	Riabova, Olga/K-6030-2015; Makarov, Vadim/HGB-7756-2022; Buclin, Thierry/P-1640-2014; Makarov, Vadim/AAE-5483-2021; Decosterd, Laurent/E-8494-2019	Riabova, Olga/0000-0002-3794-6495; Makarov, Vadim/0000-0001-8746-2694; Buclin, Thierry/0000-0003-0639-5536; Makarov, Vadim/0000-0001-8746-2694; Decosterd, Laurent/0000-0002-9840-1325	Bill and Melinda Gates Foundation through the im4TB [OPP1164837]; Swiss National Science Foundation (SNF) [SNF 324730-165956]; REQUIP grant SNF [326000-121314/1]	Bill and Melinda Gates Foundation through the im4TB; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); REQUIP grant SNF	This research program is supported by the Bill and Melinda Gates Foundation (grant OPP1164837) through the study sponsor im4TB (EB). Support for this work and part of the salaries of DS were also provided by a grant from the Swiss National Science Foundation (SNF) No SNF 324730-165956 to LAD. This analytical project performed at the Laboratory of Clinical Pharmacology also benefits from the REQUIP grant SNF No 326000-121314/1 to LAD and from a donation of the Loterie Romande for the acquisition of LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AB SCIEX PUBLICATION; [Anonymous], GLOB TUB REP; Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO;2-S; Bylda C, 2014, ANALYST, V139, P2265, DOI 10.1039/c4an00094c; Chetty S, 2017, BIOORG MED CHEM LETT, V27, P370, DOI 10.1016/j.bmcl.2016.11.084; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; De Nicolo A, 2017, BIOANALYSIS, V9, P1093, DOI 10.4155/bio-2017-0059; EMEA, 2011, GUID BIOAN METH VAL; Feinberg M, 2007, J CHROMATOGR A, V1158, P174, DOI 10.1016/j.chroma.2007.02.021; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hoagland DT, 2016, ADV DRUG DELIVER REV, V102, P55, DOI 10.1016/j.addr.2016.04.026; Hoffman D, 2007, PHARM RES, V24, P1157, DOI 10.1007/s11095-007-9242-3; Hubert P, 1999, ANAL CHIM ACTA, V391, P135, DOI 10.1016/S0003-2670(99)00106-3; Hubert P, 2004, J PHARMACEUT BIOMED, V36, P579, DOI 10.1016/j.jpba.2004.07.027; Hubert P, 2008, J PHARMACEUT BIOMED, V48, P760, DOI 10.1016/j.jpba.2008.07.018; Hubert P, 2007, J PHARMACEUT BIOMED, V45, P70, DOI 10.1016/j.jpba.2007.06.013; Hubert P, 2007, J PHARMACEUT BIOMED, V45, P82, DOI 10.1016/j.jpba.2007.06.032; Kloss F, 2014, ANGEW CHEM INT EDIT, V56, P2187; Law RA, 2016, TN10494EN0816S THERM; Lechartier B, 2015, ANTIMICROB AGENTS CH, V59, P4457, DOI 10.1128/AAC.00395-15; Lechartier B, 2012, ANTIMICROB AGENTS CH, V56, P5790, DOI 10.1128/AAC.01476-12; Lupien A, 2018, ANTIMICROB AGENTS CH; Lv K, 2017, ACS MED CHEM LETT, V8, P636, DOI 10.1021/acsmedchemlett.7b00106; Makarov V, 2015, ANTIMICROB AGENTS CH, V59, P4446, DOI 10.1128/AAC.00778-15; Makarov V, 2014, EMBO MOL MED, V6, P372, DOI 10.1002/emmm.201303575; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; Panuwet P, 2016, CRIT REV ANAL CHEM, V46, P93, DOI 10.1080/10408347.2014.980775; Parra NPT, 2014, 59914089EN AG TECHN; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Peters FT, 2012, ANAL BIOANAL CHEM, V403, P2155, DOI 10.1007/s00216-012-6035-2; Richter A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31316-6; Rozet E, 2007, J CHROMATOGR A, V1158, P126, DOI 10.1016/j.chroma.2007.03.102; Rozet E, 2007, J CHROMATOGR A, V1158, P111, DOI 10.1016/j.chroma.2007.03.111; Sheehan T.L., 2015, SPECTROSCOPY-US, V13, P16; Singh V, 2017, DRUG DISCOV TODAY, V22, P503, DOI 10.1016/j.drudis.2016.09.010; Spaggiari D, 2017, C PRINT SOC SUISS ME; Stepanova ES, 2018, PHARM CHEM J+, V52, P248, DOI 10.1007/s11094-018-1801-x; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Taylor PJ, 2005, CLIN BIOCHEM, V38, P328, DOI 10.1016/j.clinbiochem.2004.11.007; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; US Department of Health and Human Services Food and Drug Administration, GUID IND BIOAN METH; US Food and Drug Administration, 2016, GUID IND SAF TEST DR; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Wells G., 2011, 59907651EN AG TECHN; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217139	10.1371/journal.pone.0217139	http://dx.doi.org/10.1371/journal.pone.0217139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150423	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100032
J	Wu, LF; Fan, JL				Wu, Lifeng; Fan, Junliang			Comparison of neuron-based, kernel-based, tree-based and curve-based machine learning models for predicting daily reference evapotranspiration	PLOS ONE			English	Article							SUPPORT-VECTOR-MACHINE; GLOBAL SOLAR-RADIATION; LIMITED CLIMATIC DATA; ARPS DECLINE MODEL; EMPIRICAL EQUATIONS; REGRESSION; NETWORK; ANFIS; TEMPERATURE; SVM	Accurately predicting reference evapotranspiration (ET0) with limited climatic data is crucial for irrigation scheduling design and agricultural water management. This study evaluated eight machine learning models in four categories, i.e. neuron-based (MLP, GRNN and ANFIS), kernel-based (SVM, KNEA), tree-based (M5Tree, XGBoost) and curve-based (MARS) models, for predicting daily ET0 with maximum/maximum temperature and precipitation data during 2001-2015 from 14 stations in various climatic regions of China, i.e., arid desert of northwest China (NWC), semi-arid steppe of Inner Mongolia (IM), Qinghai-Tibetan Plateau (QTP), (semi-)humid cold-temperate northeast China (NEC), semi-humid warm-temperate north China (NC), humid subtropical central China (CC) and humid tropical south China (SC). The results showed machine learning models using only temperature data obtained satisfactory daily ET0 estimates (on average R-2 = 0.829, RMSE = 0.718 mm day(-1), NRMSE = 0.250 and MAE = 0.508 mm day(-1)). The prediction accuracy was improved by 7.6% across China when information of precipitation was further considered, particularly in (sub) tropical humid regions (by 9.7% in CC and 12.4% in SC). The kernel-based SVM, KNEA and curve-based MARS models generally outperformed the others in terms of prediction accuracy, with the best performance by KNEA in NWC and IM, by SVM in QTP, CC and SC, and very similar performance by them in NEC and NC. SVM (1.9%), MLP (2.0%), MARS (2.6%) and KNEA (6.4%) showed relatively small average increases in RMSE during testing compared with training RMSE. SVM is highly recommended for predicting daily ET0 across China in light of best accuracy and stability, while KNEA and MARS are also promising powerful models.	[Wu, Lifeng] Nanchang Inst Technol, Sch Hydraul & Ecol Engn, Nanchang, Jiangxi, Peoples R China; [Fan, Junliang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China	Nanchang Institute Technology; Northwest A&F University - China	Fan, JL (corresponding author), Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China.	nwwfjl@163.com	Fan, Junliang/E-2534-2017	Fan, Junliang/0000-0002-7687-9109; Wu, Lifeng/0000-0002-1210-5411	Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS) [FIRI2018-01]; National Natural Science Foundation of China [51709144]	Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS, FIRI2018-01), the National Natural Science Foundation of China (No. 51709144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SS, 2015, J HYDROL, V527, P184, DOI 10.1016/j.jhydrol.2015.04.073; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Antonopoulos VZ, 2017, COMPUT ELECTRON AGR, V132, P86, DOI 10.1016/j.compag.2016.11.011; Baba APA, 2013, HYDROL RES, V44, P131, DOI 10.2166/nh.2012.074; Fan JL, 2019, RENEW SUST ENERG REV, V105, P168, DOI 10.1016/j.rser.2019.01.040; Fan JL, 2019, RENEW SUST ENERG REV, V100, P186, DOI 10.1016/j.rser.2018.10.018; Fan JL, 2018, AGR FOREST METEOROL, V263, P225, DOI 10.1016/j.agrformet.2018.08.019; Fan JL, 2018, ENERG CONVERS MANAGE, V164, P102, DOI 10.1016/j.enconman.2018.02.087; Fan JL, 2016, J HYDROL, V542, P923, DOI 10.1016/j.jhydrol.2016.09.060; Fan JL, 2014, J HYDROL, V519, P1120, DOI 10.1016/j.jhydrol.2014.08.039; Feng Y, 2017, AGR WATER MANAGE, V193, P163, DOI 10.1016/j.agwat.2017.08.003; Feng Y, 2017, COMPUT ELECTRON AGR, V136, P71, DOI 10.1016/j.compag.2017.01.027; Feng Y, 2016, J HYDROL, V536, P376, DOI 10.1016/j.jhydrol.2016.02.053; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gocic M, 2015, COMPUT ELECTRON AGR, V113, P164, DOI 10.1016/j.compag.2015.02.010; Guo XH, 2011, HYDROL RES, V42, P268, DOI 10.2166/nh.2011.072; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hassan MA, 2017, APPL ENERG, V203, P897, DOI 10.1016/j.apenergy.2017.06.104; He T., 2015, XGBOOST EXTREME GRAD, V1, P1; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jovic S, 2018, COMPUT ELECTRON AGR, V150, P1, DOI 10.1016/j.compag.2018.04.003; Karbasi M, 2018, WATER RESOUR MANAG, V32, P1035, DOI 10.1007/s11269-017-1853-9; Karimi S, 2017, INT J CLIMATOL, V37, P3238, DOI 10.1002/joc.4911; Keshtegar B, 2018, WATER RESOUR MANAG, V32, P1101, DOI 10.1007/s11269-017-1857-5; Kisi O, 2008, HYDROL PROCESS, V22, P2449, DOI 10.1002/hyp.6837; Kisi O, 2016, THEOR APPL CLIMATOL, V126, P413, DOI 10.1007/s00704-015-1582-z; Kisi O, 2016, AGR WATER MANAGE, V169, P162, DOI 10.1016/j.agwat.2016.02.026; Kisi O, 2015, J HYDROL, V528, P312, DOI 10.1016/j.jhydrol.2015.06.052; Kisi O, 2014, WATER RESOUR MANAG, V28, P4045, DOI 10.1007/s11269-014-0726-8; Landeras G, 2008, AGR WATER MANAGE, V95, P553, DOI 10.1016/j.agwat.2007.12.011; Ma X, 2019, APPL MATH MODEL, V70, P402, DOI 10.1016/j.apm.2019.01.039; Ma X, 2019, J GREY SYST-UK, V31, P1; Ma X, 2018, NEURAL COMPUT APPL, V29, P579, DOI 10.1007/s00521-016-2721-x; Ma X, 2017, J GREY SYST-UK, V29, P122; Mehdizadeh S, 2017, COMPUT ELECTRON AGR, V139, P103, DOI 10.1016/j.compag.2017.05.002; Pal M, 2009, HYDROL PROCESS, V23, P1437, DOI 10.1002/hyp.7266; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rahimikhoob A, 2014, WATER RESOUR MANAG, V28, P657, DOI 10.1007/s11269-013-0506-x; Sanikhani H, 2019, THEOR APPL CLIMATOL, V135, P449, DOI 10.1007/s00704-018-2390-z; Shiri J, 2018, J HYDROL, V561, P737, DOI 10.1016/j.jhydrol.2018.04.042; Shiri J, 2017, AGR WATER MANAGE, V188, P101, DOI 10.1016/j.agwat.2017.04.009; Shiri J, 2014, COMPUT ELECTRON AGR, V108, P230, DOI 10.1016/j.compag.2014.08.007; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Tabari H, 2013, IRRIGATION SCI, V31, P107, DOI 10.1007/s00271-011-0295-z; Tabari H, 2012, J HYDROL, V444, P78, DOI 10.1016/j.jhydrol.2012.04.007; Trabert W., 1896, METEOROL Z, V13, P261; Traore S, 2016, AGR WATER MANAGE, V163, P363, DOI 10.1016/j.agwat.2015.10.009; Vapnik V, 2003, NATURE STAT LEARNING; Wang LC, 2017, INT J CLIMATOL, V37, P1076, DOI 10.1002/joc.5064; Wang LC, 2017, J HYDROL, V544, P407, DOI 10.1016/j.jhydrol.2016.11.059; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; Wang XK, 2019, ADV AGRON, V153, P121, DOI 10.1016/bs.agron.2018.08.003; Wang Y., 1997, P POST PAP EUR C MAC; Wen XH, 2015, WATER RESOUR MANAG, V29, P3195, DOI 10.1007/s11269-015-0990-2; Wu LF, 2019, ENERG CONVERS MANAGE, V183, P280, DOI 10.1016/j.enconman.2018.12.103; Yao N, 2018, SCI TOTAL ENVIRON, V616, P73, DOI 10.1016/j.scitotenv.2017.10.327; Yin ZL, 2017, HYDROL RES, V48, P1177, DOI 10.2166/nh.2016.205; Zhao S., 1983, ACTA GEOGRAPH SIN, V38, P1	59	37	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217520	10.1371/journal.pone.0217520	http://dx.doi.org/10.1371/journal.pone.0217520			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150448	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100062
J	He, S; Joseph, N; Luo, X; Raston, CL				He, Shan; Joseph, Nikita; Luo, Xuan; Raston, Colin L.			Vortex fluidic mediated food processing	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PROTEIN HYDROLYSATE; MILK; ENCAPSULATION; OPTIMIZATION; STABILITY; CURCUMIN	The high heat and mass transfer, and controlled mechanoenergy, in angled vortex fluidics has been applied in chemical and material sciences and allied fields, but its utility in food processing remains largely unexplored. Herein we report three models of food processing incorporating such vortex fluidics, including enzymatic hydrolysis, raw milk pasteurization and encapsulation. The processing times of enzymatic hydrolysis was reduced from about 2-3 hours to 20 minutes, with the processing time of raw milk pasteurization reduced from 30 to 10 minutes, and an encapsulated particle size reduced approximately 10-fold, from micro meters to hundreds of nanometers. These findings highlight exciting possibilities, in exploiting the value of vortex fluidic mediated processing in the food industry.	[He, Shan] Guangzhou Univ, Sch Chem & Chem Engn, Dept Food Sci, Guangzhou, Guangdong, Peoples R China; [He, Shan; Joseph, Nikita; Luo, Xuan; Raston, Colin L.] Flinders Univ S Australia, Coll Sci & Engn, Flinders Inst NanoScale Sci & Technol, Bedford Pk, SA, Australia	Guangzhou University; Flinders University South Australia	He, S (corresponding author), Guangzhou Univ, Sch Chem & Chem Engn, Dept Food Sci, Guangzhou, Guangdong, Peoples R China.; He, S; Raston, CL (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Flinders Inst NanoScale Sci & Technol, Bedford Pk, SA, Australia.	he0091@gmail.com; colin.raston@flinders.edu.au		Luo, Xuan/0000-0002-8811-3143	Australian Research Council (ARC) [DP170100453]	Australian Research Council (ARC)(Australian Research Council)	The authors acknowledge support from the Australian Research Council (ARC Discovery Grant DP170100453) and Flinders Analytical Facility for MALDI measurements, and acknowledge the provision of in kind by Bd farm Paris Creek PTY LTD (9/7 Paris Creek Rd, Paris Creek SA 5201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamsi KA, 2018, J DAIRY SCI, V101, P47, DOI 10.3168/jds.2017-13194; Awad S, 2016, J DAIRY SCI, V99, P8499, DOI 10.3168/jds.2015-10626; Betoret E, 2015, TRENDS FOOD SCI TECH, V46, P1, DOI 10.1016/j.tifs.2015.07.006; Britton J, 2016, ANGEW CHEM INT EDIT, V55, P11387, DOI 10.1002/anie.201604014; Britton J, 2015, CHEM-EUR J, V21, P10660, DOI 10.1002/chem.201501785; Britton J, 2014, RSC ADV, V4, P49850, DOI 10.1039/C4RA10317C; Chemat F, 2017, INNOV FOOD SCI EMERG, V41, P357, DOI 10.1016/j.ifset.2017.04.016; He S, 2019, LWT-FOOD SCI TECHNOL, V103, P88, DOI 10.1016/j.lwt.2018.12.066; He S, 2015, J FOOD SCI, V80, pE108, DOI 10.1111/1750-3841.12684; He S, 2012, INT J FOOD SCI TECH, V47, P2397, DOI 10.1111/j.1365-2621.2012.03115.x; Honary S, 2014, PHARM DEV TECHNOL, V19, P987, DOI 10.3109/10837450.2013.846375; Kaur K, 2015, J MOL LIQ, V209, P62, DOI 10.1016/j.molliq.2015.05.018; Liu G, 2016, BIOPROC BIOSYST ENG, V39, P133, DOI 10.1007/s00449-015-1497-1; Luo X, 2016, ACS SUSTAIN CHEM ENG, V4, P3905, DOI 10.1021/acssuschemeng.6b00756; Majumdar S., 2017, ANGEW CHEM, V129, P2336, DOI DOI 10.1002/ange.201610821; Ming Y, 2015, INT J BIOL MACROMOL, V79, P201, DOI [10.1016/j.ijbiomac.2015.04.057, DOI 10.1016/J.IJBIOMAC.2015.04.057]; Shoabargh S, 2014, J IND ENG CHEM, V20, P3150, DOI 10.1016/j.jiec.2013.11.058; Valle BCS, 2015, AQUACULT NUTR, V21, P105, DOI 10.1111/anu.12149; Wu Y, 2017, INT J FOOD PROP, V20, P3295, DOI 10.1080/10942912.2017.1286505; Zhang YD, 2014, FOOD CONTROL, V36, P238, DOI 10.1016/j.foodcont.2013.08.012; Zhang Z, 2017, ANGEW CHEM, V129, P9518, DOI DOI 10.1002/ANGE.201608673	21	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216816	10.1371/journal.pone.0216816	http://dx.doi.org/10.1371/journal.pone.0216816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145727	gold, Green Published, Green Submitted			2022-12-27	WOS:000469425500006
J	Kaplinski, M; Taylor, D; Mitchell, LE; Hammond, DA; Goldmuntz, E; Agopian, AJ; Newburger, J; Seidman, C; Chung, W; Gelb, B; Romano-Adesman, A; Brueckner, M; Porter, G; Kim, R; Giardini, A				Kaplinski, Michelle; Taylor, Deanne; Mitchell, Laura E.; Hammond, Dorothy A.; Goldmuntz, Elizabeth; Agopian, A. J.; Newburger, Jane; Seidman, Christine; Chung, Wendy; Gelb, Bruce; Romano-Adesman, Angela; Brueckner, Martina; Porter, George; Kim, Richard; Giardini, Alessandro		Pediat Cardic Genomics Consortium	The association of elevated maternal genetic risk scores for hypertension, type 2 diabetes and obesity and having a child with a congenital heart defect	PLOS ONE			English	Article							BLOOD-PRESSURE; DISEASE; PREGNANCY; PREVALENCE; VARIANTS; WEIGHT	Background Maternal hypertension, type 2 diabetes (T2D) and obesity are associated with an increased risk of having offspring with conotruncal heart defects (CTDs). Prior studies have identified sets of single nucleotide polymorphisms (SNPs) that are associated with risk for each of these three adult phenotypes. We hypothesized that these same SNPs are associated with maternal risk of CTDs in offspring. Methods and results We evaluated the parents of children with a CTD ascertained from the Children's Hospital of Philadelphia (n = 466) and by the Pediatric Cardiac Genomic Consortium (n = 255). We used a family-based design to assess the association between CTDs and the maternal genotype for individual hypertension, T2D, and obesity- related SNPs and found no association between CTDs and the maternal genotype for any individual SNP. In addition, we calculated genetic risk scores (GRS) for hypertension, T2D, and obesity using previously published GRS formulas. When comparing the GRS of mothers to fathers, there were no statistically significant differences in the mean for the combined GRS or the GRS for each individual condition. However, when we categorized the mothers and fathers of cases with CTDs as having high (> 95th percentile) or low (>= 95 th percentile) scores, compared to fathers, mothers had almost two times the odds of having a high GRS for hypertension (OR 1.7, 95% CI 1.0, 2.8) and T2D (OR 1.8, 95% CI 1.1, 3.1). Conclusions Our results support a link between maternal genetic risk for hypertension/T2D and CTDs in their offspring. These associations might be independent of maternal phenotype at conception.	[Kaplinski, Michelle; Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Dept Pediat, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Taylor, Deanne; Hammond, Dorothy A.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Taylor, Deanne; Goldmuntz, Elizabeth] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mitchell, Laura E.; Agopian, A. J.] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Agopian, AJ (corresponding author), UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	a.j.agopian@uth.tmc.edu	Taylor, Deanne/AAY-6296-2020	Taylor, Deanne/0000-0002-3302-4610; Kaplinski, Michelle/0000-0001-8680-2626	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454]; National Heart, Lung, and Blood Institute; Pediatric Cardiac Genomics Consortium [P50-HL74731, U01-HL098188, U01HL131003, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162, U01-HL-09003]; National Human Genome Research Institute [U54HG006504]; National Center for Research Resources [M01-RR-000240, RR024134]; National Center for Advancing Translational Sciences [UL1TR000003]; American Heart Association [16GRNT29660001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098162, U01HL131003, U01HL098147] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pediatric Cardiac Genomics Consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, EG, LEM, AJ, DT [grant number P01HD070454] (https://www.nichd.nih.gov).The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by The National Heart, Lung, and Blood Institute, including the Pediatric Cardiac Genomics Consortium, EG, LEM, AJ [grant numbers P50-HL74731, U01-HL098188, U01HL131003, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162, U01-HL-09003] (https://www.nhlbi.nih.gov).The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by The National Human Genome Research Institute, EG [grant number U54HG006504] (https://www.genome.gov).The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by The National Center for Research Resources, EG [grant numbers M01-RR-000240, RR024134; now the National Center for Advancing Translational Sciences, grant number UL1TR000003] (https://ncats.nih.gov).The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by The American Heart Association, AJ [16GRNT29660001] (https://research.americanheart.org/ris/template.jsp; jsessionid=jVQlUrw8VmQkIJKuQYwEt2rh. aharispa1?pid=ris. extlogin&_requestid=809250). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001449; Agopian AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096057; Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Alwan S, 2005, BIRTH DEFECTS RES A, V73, P123, DOI 10.1002/bdra.20102; Balsells M, 2012, DIABETES-METAB RES, V28, P252, DOI 10.1002/dmrr.1304; Boyd HA, 2017, CIRCULATION, V136, P39, DOI 10.1161/CIRCULATIONAHA.116.024600; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Brite J, 2014, INT J OBESITY, V38, P878, DOI 10.1038/ijo.2013.244; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; Committee W, 2013, CIRC RES, V112, P698, DOI [10.1161/CIRCRESAHA.111.300297, DOI 10.1161/CIRCRESAHA.111.300297]; Debrus S, 1996, HUM GENET, V97, P138, DOI 10.1007/BF02265254; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Goldmuntz E., 2000, DEV CARDIOVASC MED, P355, DOI 10.1007/978-1-4615-4517-0_22; Hobbs CA, 2006, J MED GENET, V43, P162, DOI 10.1136/jmg.2005.032656; Howey R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-149; Leirgul E, 2016, OBSTET GYNECOL, V128, P1116, DOI 10.1097/AOG.0000000000001694; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lindheimer MD, 2010, J AM SOC HYPERTENS, V4, P68, DOI 10.1016/j.jash.2010.03.002; Liu Si-jing, 2013, Industrial Engineering Journal, V16, P128, DOI 10.3969/j.issn.1007-7375.2013.06.021; Liu XC, 2015, INT J EPIDEMIOL, V44, P884, DOI 10.1093/ije/dyv107; Llurba E, 2014, EUR HEART J, V35, P701, DOI 10.1093/eurheartj/eht389; Maloyan A, 2013, PHYSIOL GENOMICS, V45, P889, DOI 10.1152/physiolgenomics.00050.2013; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NORA JJ, 1970, TERATOLOGY, V3, P325, DOI 10.1002/tera.1420030408; Oyen N, 2016, CIRCULATION, V133, P2243, DOI 10.1161/CIRCULATIONAHA.115.017465; Peyvandi S, 2014, AM J MED GENET A, V164, P1490, DOI 10.1002/ajmg.a.36500; Ramakrishnan A, 2015, PEDIATR CARDIOL, V36, P1442, DOI 10.1007/s00246-015-1182-9; Roberts VHJ, 2015, PHYSIOLOGY, V30, P224, DOI 10.1152/physiol.00021.2014; Seely EW, 2014, CIRCULATION, V129, P1254, DOI 10.1161/CIRCULATIONAHA.113.003904; Smedts HPM, 2012, NUTR METAB CARDIOVAS, V22, P477, DOI 10.1016/j.numecd.2010.07.016; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tyrrell J, 2016, JAMA-J AM MED ASSOC, V315, P1129, DOI 10.1001/jama.2016.1975; van Beynum IM, 2007, QJM-INT J MED, V100, P743, DOI 10.1093/qjmed/hcm094; van der Linde D, 2011, J AM COLL CARDIOL, V58-21, P2241, DOI DOI 10.1016/J.JACC.2011.08.025; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Wolf JB, 2011, GENETICS, V189, P1069, DOI 10.1534/genetics.111.130591; Xuan C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07311	40	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216477	10.1371/journal.pone.0216477	http://dx.doi.org/10.1371/journal.pone.0216477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141530	Green Submitted, gold, Green Published			2022-12-27	WOS:000469323000013
J	Somma, F; Stoia, V; Serra, N; D'Angelo, R; Gatta, G; Fiore, F				Somma, Francesco; Stoia, Vincenzo; Serra, Nicola; D'Angelo, Roberto; Gatta, Gianluca; Fiore, Francesco			Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; MICROSPHERES; CANCER; TERM; SORAFENIB; BRACHYTHERAPY; DESIGN; SAFETY	Purpose Portal vein thrombosis (PVT) is generally recognized as a prognostic factor in HCC. Our purpose is to assess and compare the survival of patients with PVT and without PVT, after Y-90 Trans-Arterial Radio-Embolization (TARE) of unresectable HCC, unresponsive to other loco-regional treatments. Materials and methods Between November 2005 and November 2012, Y-90 resin-based TARE was performed in an IRB-approved prospective protocol, on 89 patients with unresectable HCC. 33/89 patients had PVT, the remaining 56 were resistant-to-cTACE or underwent TARE as a downstaging therapy. All patients were studied with Multi-Detector Computed Tomography (MDCT), angiography, 99m Tc-MAA-scintigraphy and liver biopsy. Gastro-duodenal artery was embolized in most cases. Proton-Pump Inhibitors were administered to prevent gastritis and ulcers..2 test with Yates correction and log rank test were used to compare the two proportions and Kaplan-Meier survival curves, respectively. Results The average activity administered was 1.7 +/- 0.4 GBq. After the treatment, CTCAE grade 2 adverse events occurred in 46% (41/89) patients: in particular, fever and abdominal pain were found in 25 and 16 patients, respectively. No major side-effect was observed. According to mRECIST criteria, partial response or complete response was found in 70% of patient three months after the treatment, and in 90.5% nine months after the treatment. No significant difference was found in survival of patients with PVT compared to those without PVT (p-value = 0.672). A complete regression of PVT was observed in almost half patients (13/27, 48.1%). Conclusions Portal vein invasion does not affect survival in advanced stage HCC-patients undergoing TARE using Y-90 resin-based microspheres. Y90 procedure is associated with regression of portal vein tumor thrombus.	[Somma, Francesco; Stoia, Vincenzo; Serra, Nicola; D'Angelo, Roberto; Gatta, Gianluca; Fiore, Francesco] Ist Nazl Tumori IRCCS Fdn G Pascale, Dipartimento Radiol Interventist, Naples, Italy	IRCCS Fondazione Pascale	Somma, F (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Dipartimento Radiol Interventist, Naples, Italy.	fra1585@hotmail.it	Somma, Francesco/AAA-9462-2021; , vincenzo/AAY-6364-2021	, vincenzo/0000-0002-8919-861X; GATTA, Gianluca/0000-0003-0874-8294; Somma, Francesco/0000-0002-8193-3050				Barbier L, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/791013; BREEDIS C, 1954, AM J PATHOL, V30, P969; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Carr BI, 2016, ONCOLOGY-BASEL, V90, P215, DOI 10.1159/000444394; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chow P, 2017, P AN M AM SOC CLIN, V35, P4002, DOI DOI 10.1200/JC0.201735.15.3UPPL.4002; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Clayton D, 1993, STAT MODELS EPIDEMIO, p[27, 146]; Costentin CE, 2017, LIVER CANCER, V6, P360, DOI 10.1159/000481315; D'Avola D, 2009, HEPATO-GASTROENTEROL, V56, P1683; Dai QS, 2014, MOL CLIN ONCOL, V2, P1047, DOI 10.3892/mco.2014.391; FARMER DG, 1994, ANN SURG, V219, P236, DOI 10.1097/00000658-199403000-00003; Fiore F, 2014, ENDOCRINE; Gondolesi GE, 2004, ANN SURG, V239, P142, DOI 10.1097/01.sla.0000109022.32391.eb; Hilgard P, 2010, HEPATOLOGY, V52, P1741, DOI 10.1002/hep.23944; Ho S, 1997, BRIT J RADIOL, V70, P823, DOI 10.1259/bjr.70.836.9486047; Ho S, 1996, EUR J NUCL MED, V23, P947, DOI 10.1007/BF01084369; Jeong SW, 2013, GUT LIVER, V7, P696, DOI 10.5009/gnl.2013.7.6.696; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kennedy AS, 2006, INT J RADIAT ONCOL, V65, P412, DOI 10.1016/j.ijrobp.2005.12.051; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Lau WY, 2013, ONCOLOGY-BASEL, V84, P311, DOI 10.1159/000348325; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lewandowski RJ, 2009, AM J TRANSPLANT, V9, P1920, DOI 10.1111/j.1600-6143.2009.02695.x; Lewandowski RJ, 2007, CARDIOVASC INTER RAD, V30, P571, DOI 10.1007/s00270-007-9064-z; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Liapi E, 2007, J CLIN ONCOL, V25, P978, DOI 10.1200/JCO.2006.09.8657; Liu DM, 2005, J VASC INTERV RADIOL, V16, P911, DOI 10.1097/01.RVI.0000164324.79242.B2; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2012, CURR TREAT OPTION ON, V13, P403, DOI 10.1007/s11864-012-0200-x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; Pirisi M, 1998, J CANCER RES CLIN, V124, P397, DOI 10.1007/s004320050189; Salem R, 2002, J VASC INTERV RADIOL, V13, pS223, DOI 10.1016/S1051-0443(07)61790-4; Salem R, 2007, TECH VASC INTERV RAD, V10, P12, DOI 10.1053/j.tvir.2007.08.001; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; SOKAL RR, 1995, BIOMETRY PRINCIPLES, P724; Somma F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129573; Syha R, 2012, EUR J GASTROEN HEPAT, V24, P1325, DOI 10.1097/MEG.0b013e32835724bc; Vilgrain V, 2017, J HEPATOL, V66, pS85, DOI 10.1016/S0168-8278(17)30436-1	57	20	21	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216935	10.1371/journal.pone.0216935	http://dx.doi.org/10.1371/journal.pone.0216935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141552	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000029
J	Arora, R; Kumar, SN; Sudarshan, S; Fairoze, MN; Kaur, M; Sharma, A; Girdhar, Y; Sreesujatha, RM; Devatkal, SK; Ahlawat, S; Vijh, RK; Manjunatha, SS				Arora, Reena; Kumar, Naveen S.; Sudarshan, S.; Fairoze, Mohamed Nadeem; Kaur, Mandeep; Sharma, Anju; Girdhar, Yashila; Sreesujatha, R. M.; Devatkal, Suresh K.; Ahlawat, Sonika; Vijh, Ramesh Kumar; Manjunatha, S. S.			Transcriptome profiling of longissimus thoracis muscles identifies highly connected differentially expressed genes in meat type sheep of India	PLOS ONE			English	Article							TENDERNESS; RYANODINE; PROTEINS; RNA; FAT; NETWORK; QUALITY; TRAITS; TISSUE; ACIDS	This study describes the muscle transcriptome profile of Bandur breed, a consumer favoured, meat type sheep of India. The transcriptome was compared to the less desirable, unregistered local sheep population, in order to understand the molecular factors related to muscle traits in Indian sheep breeds. Bandur sheep have tender muscles and higher backfat thickness than local sheep. The longissimus thoracis transcriptome profiles of Bandur and local sheep were obtained using RNA sequencing (RNA Seq). The animals were male, non-castrated, with uniform age and reared under similar environment, as well as management conditions. We could identify 568 significantly up-regulated and 538 significantly down-regulated genes in Bandur sheep (p<0.05). Among these, 181 up-regulated and 142 down-regulated genes in Bandur sheep, with a fold change >= 1.5, were considered for further analysis. Significant Gene Ontology terms for the up-regulated dataset in Bandur sheep included transporter activity, substrate specific transmembrane, lipid and fatty acid binding. The down-regulated activities in Bandur sheep were mainly related to RNA degradation, regulation of ERK1 and ERK2 cascades and innate immune response. The MAPK signaling pathway, Adipocytokine signaling pathway and PPAR signaling pathway were enriched for Bandur sheep. The highly connected genes identified by network analysis were CNOT2, CNOT6, HSPB1, HSPA6, MAP3K14 and PPARD, which may be important regulators of energy metabolism, cellular stress and fatty acid metabolism in the skeletal muscles. These key genes affect the CCR4-NOT complex, PPAR and MAPK signaling pathways. The highly connected genes identified in this study, form interesting candidates for further research on muscle traits in Bandur sheep.	[Arora, Reena; Kaur, Mandeep; Sharma, Anju; Girdhar, Yashila; Ahlawat, Sonika; Vijh, Ramesh Kumar] ICAR Natl Bur Anim Genet Resources, Kernel, Haryana, India; [Kumar, Naveen S.; Sudarshan, S.; Fairoze, Mohamed Nadeem; Sreesujatha, R. M.; Manjunatha, S. S.] Karnataka Vet Anim & Fisheries Sci Univ, Bangalore, Karnataka, India; [Devatkal, Suresh K.] ICAR Natl Res Ctr Meat, Hyderabad, Telangana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Meat	Arora, R (corresponding author), ICAR Natl Bur Anim Genet Resources, Kernel, Haryana, India.	rejagati@gmail.com	Ahlawat, Sonika/AAW-9905-2020; ARORA, REENA/AAK-6892-2021; Arora, Reena/AAR-2240-2021		Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India	Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India	This work was supported by the Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India, and not by any external funding.	Acharya R.M., 1982, 30 UN FAO; An QM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060160; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], [No title captured]; BAHS-Basic Animal Husbandry and Fisheries Statistics, 2017, AHS SER, V18, P1; Berton MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3232-y; Bhatia S, 2005, ASIAN AUSTRAL J ANIM, V18, P1387, DOI 10.5713/ajas.2005.1387; Bongiorni S, 2016, ANIM GENET, V47, P273, DOI 10.1111/age.12418; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brocker Chad, 2010, Hum Genomics, V4, P411; Cassar-Malek Isabelle, 2016, ScientificWorldJournal, V2016, P2185323, DOI 10.1155/2016/2185323; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; DANI NP, 1985, INDIAN J ANIM SCI, V55, P1094; de Huidobro FR, 2005, MEAT SCI, V69, P527, DOI 10.1016/j.meatsci.2004.09.008; Ferguson DM, 2014, ANIM PROD SCI, V54, P464, DOI 10.1071/AN13088; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Guillemin N, 2011, ANIMAL, V5, P885, DOI 10.1017/S1751731110002612; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Hocquette JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-135; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; KAUFFMAN RG, 1986, MEAT SCI, V18, P307, DOI 10.1016/0309-1740(86)90020-3; KEETON JT, 1983, J FOOD SCI, V48, P878, DOI 10.1111/j.1365-2621.1983.tb14921.x; Kim NK, 2011, J AGR FOOD CHEM, V59, P5657, DOI 10.1021/jf200217j; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Kumar NS, 2017, INDIAN J ANIM RES, V2, P1; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Ogawa Y, 2000, TRENDS CARDIOVAS MED, V10, P65, DOI 10.1016/S1050-1738(00)00050-5; Paiao FG, 2013, GENET MOL RES, V12, P3017, DOI 10.4238/2013.August.20.3; Picard B, 2014, J AGR FOOD CHEM, V62, P9808, DOI 10.1021/jf501528s; REDDY KS, 1982, INDIAN VET J, V59, P217; Renand G, 2001, MEAT SCI, V59, P49, DOI 10.1016/S0309-1740(01)00051-1; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SARWAR G, 1993, J CHROMATOGR-BIOMED, V615, P1, DOI 10.1016/0378-4347(93)80286-D; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soam SK, 2008, PARTICIPATORY SOCIOE, P1; Sohn EJ, 2015, CELL PHYSIOL BIOCHEM, V37, P1881, DOI 10.1159/000438549; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Sun LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33586; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YH, 2015, ANIM GENET, V46, P655, DOI 10.1111/age.12338; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; Xu QL, 2011, CZECH J ANIM SCI, V56, P1, DOI 10.17221/231/2009-CJAS	60	12	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217461	10.1371/journal.pone.0217461	http://dx.doi.org/10.1371/journal.pone.0217461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170190	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700031
J	Cui, HL; Zhang, YA; Shi, XL; Gong, FF; Xiong, X; Kang, XP; Xing, GM; Li, S				Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen			The numerical classification and grading standards of daylily (Hemerocallis) flower color	PLOS ONE			English	Article							ANTIOXIDANT	This study collected 183 Hemerocallis varieties to conduct numerical classification of flower color and provide valuable baseline data and foundational theory for normalization and precision of Hemerocallis. The color CIELab phenotypes were collected via colorimeter (CR-10 Plus), which separately measured three sepal and petal parts (throat, eye and limb). The colors of experimental samples were artificially named by the Royal Horticultural Society Colour Chart (RHSCC). All the data were analyzed using R software. The results showed that the throat was predominantly green-yellow, light yellow and yellow; green-yellow accounted for the largest proportion of sepals (67.76%) and petals (69.40%). The eye was more abundant, and there were significant differences between sepals and petals. The limb was clustered into five color groups (orange, yellow, pink, red and purple); the yellow group had the most varieties for both sepals and petals, containing 57.38% and 55.74%, respectively. Both sepals and petals had significant differences (p<0.0001) in color (LE), redness (a*) and color angle (h) for the throat, eye and limb. However, the difference in CIELab phenotypes between the eye and limb were not significant. According to "Dual Classification", the color classification standard was proposed as a 3-level standard. The color of sepal and petal consistency served as the first standard, and the color of limb was the second standard. The color pattern types of pure, gradual change, watermark and eye spot, served as the third standard. It has been proposed that all the 183 experimental varieties were divided into two categories, five groups and finally four types. This study provides a classification basis and reference for numeric and standardized color phenotype description for Hemerocallis.	[Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen] Shanxi Agr Univ, Coll Hort, Taigu, Peoples R China; [Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen] Facil Hort Enginering & Technol Ctr Shanxi Prov, Taigu, Peoples R China	Shanxi Agricultural University	Xing, GM; Li, S (corresponding author), Shanxi Agr Univ, Coll Hort, Taigu, Peoples R China.; Xing, GM; Li, S (corresponding author), Facil Hort Enginering & Technol Ctr Shanxi Prov, Taigu, Peoples R China.	xingguoming@163.com; saulisen@163.com			Research Fund for the Doctoral Program of Higher Education of China [20131403110005]; Shanxi Scholarship Council of China [2015-065]; Basic Theory Innovation Project of Shanxi Agricultural University [K4614144]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Scholarship Council of China; Basic Theory Innovation Project of Shanxi Agricultural University	This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (20131403110005 to GX), Shanxi Scholarship Council of China (2015-065 to SL), and Basic Theory Innovation Project of Shanxi Agricultural University (K4614144 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHS, 2017, ONL DAYL CULT DIS; Brugliera F, 1999, PLANT J, V19, P441, DOI 10.1046/j.1365-313X.1999.00539.x; Chen J., 1998, ACTA SEDIMENTOL SIN, V16, P5; Chen X. Q., 1997, ACTA PHYTOTAXONOMICA, V35, P311; Du E, 2005, J NW SCI TECHNOLOGY, V10, P85; Fernandes L, 2017, J FOOD COMPOS ANAL, V60, P38, DOI 10.1016/j.jfca.2017.03.017; Fu MR, 2009, FOOD CHEM, V114, P1192, DOI 10.1016/j.foodchem.2008.10.072; GONNET JF, 1993, J HORTIC SCI, V68, P499, DOI 10.1080/00221589.1993.11516378; Graca VC, 2016, IND CROP PROD, V87, P363, DOI 10.1016/j.indcrop.2016.04.058; Hong Yan, 2012, Acta Horticulturae Sinica, V39, P1330; Hsu YW, 2011, FOOD CHEM, V129, P1813, DOI 10.1016/j.foodchem.2011.05.116; Huang X., 2013, THESIS; Kong H., 2001, ACTA BOT BOREAL, V02, P373; Li S., 2016, J SHANXI AGR U, V09, P619, DOI [10.13842/j.cnki.issn1671-8151.2016.09.003, DOI 10.13842/J.CNKI.ISSN1671-8151.2016.09.003]; Liu W, 2017, FOOD RES INT, V102, P493, DOI 10.1016/j.foodres.2017.09.015; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Rodriguez-Enriquez MJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls055; Saito H, 2003, SCI HORTIC-AMSTERDAM, V97, P185, DOI 10.1016/S0304-4238(02)00150-4; Stout A., 1941, HERBERTIA, P95; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tremblay RR, 2017, J PLANT PHYSIOL, V212, P1, DOI 10.1016/j.jplph.2017.01.006; Wang F, 2017, ACTA HORTICULTURAE S, V06, P1125; Wang X., 2014, HEMEROCALLIS, V1st Edn; Xiong Z.T., 1996, ACTA PHYTOTAXON SIN, V34, P586; Zhu H., 2008, THESIS	27	12	18	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216460	10.1371/journal.pone.0216460	http://dx.doi.org/10.1371/journal.pone.0216460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170177	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700005
J	Lantos, T; Nyari, TA; McNally, RJQ				Lantos, Tamas; Nyari, Tibor Andras; McNally, Richard J. Q.			Seasonal variation of mortality from external causes in Hungary between 1995 and 2014	PLOS ONE			English	Article							SUICIDE MORTALITY; REGRESSION; PATTERNS; EUROPE	Objective To analyze trends in external mortality in Hungary between 1995 and 2014 by sex. Methods Data on the numbers of deaths due to external causes were obtained from the published nationwide population register. Negative binomial regression was applied to investigate the yearly trends in external-cause mortality rates. Cyclic trends were investigated using the Walter-Elwood method. Results Suicide and accidents accounted for approximately 84% of the all-external-cause of deaths in Hungary. Annual suicide, unintentional falls and traffic accidents mortality declined significantly (p-value for annual trend: p < 0.001) from 30.5 (95% CI: 29.5-31.5) to 15.8 (15.1-16.5), from 31.2 (30.2-32.2) to 12.2 (11.7-12.8) and from 17.2 (16.4-18) to 5.4 (5-5.8) per 100 000 persons per year, respectively, during the study period. A significant declining trend in annual mortality was also found for assault, cold/heating-related accidents and accidents caused by electric current. However, the declining trend for drowning-related accidents was significant only for males. Significant winter-peak seasonality was found in the mortality rates from accidental falls, cold/heat-related accidents, other accidents caused by submersion/obstruction and other causes. Seasonal trends with a peak from June to July were observed in death rates from suicide/self-harm, accidental drowning/submersion and accidents caused by electric current. A significant seasonal variation with a peak in September was revealed in the mortality due to traffic accidents. Conclusions This Hungarian study suggests that there was a significant seasonal effect on almost all kinds of deaths from external causes between 1995 and 2014. Environmental effects are involved in the aetiology of suicide and accidents.	[Lantos, Tamas; Nyari, Tibor Andras] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary; [McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Royal Victoria Infirm, Newcastle, England	Szeged University; Newcastle University - UK	Nyari, TA (corresponding author), Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary.	nyari.tibar@med.u-szeged.hu	Lantos, Tamás/T-5614-2019; Lantos, Tamás/HHZ-9053-2022	Lantos, Tamás/0000-0002-5081-7313; Lantos, Tamás/0000-0002-5081-7313; McNally, Richard/0000-0001-6685-6467; Nyari, Tibor/0000-0001-8900-6641	 [EFOP-3.6.1-16-2016-00008]		This research was supported by EFOP-3.6.1-16-2016-00008 (TL, TNy), https://www.palyazat.gov.hu.There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2002, CATEGORICAL DATA ANA, V2nd ed., DOI [10.1002/0471249688.ch6, DOI 10.1002/0471249688.CH6]; Association of Public Health Epidemiologists in Ontario, STAND RAT; Balint L, 2016, J AFFECT DISORDERS, V190, P777, DOI 10.1016/j.jad.2015.11.011; Bitter I, 2012, INT REV PSYCHIATR, V24, P307, DOI 10.3109/09540261.2012.694856; Bramness JG, 2015, AM J EPIDEMIOL, V182, P244, DOI 10.1093/aje/kwv064; Bridges FS, 2005, PERCEPT MOTOR SKILL, V100, P920, DOI 10.2466/pms.100.3c.920-924; Bulajic-Kopjar M, 2000, Inj Prev, V6, P16, DOI 10.1136/ip.6.1.16; Casey P, 2012, J AFFECT DISORDERS, V136, P862, DOI 10.1016/j.jad.2011.09.020; Christodoulou C, 2012, ACTA PSYCHIAT SCAND, V125, P127, DOI 10.1111/j.1600-0447.2011.01750.x; EDWARDS JH, 1961, ANN HUM GENET, V25, P83, DOI 10.1111/j.1469-1809.1961.tb01501.x; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; Fountoulakis KN, 2016, ANN GEN PSYCHIATR, V15, DOI 10.1186/s12991-016-0106-2; French Institute for Demographic Studies MPI for DR, HUM CAUS OF DEATH DA; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Holopainen J, 2013, ENVIRON HEALTH PREV, V18, P494, DOI 10.1007/s12199-013-0348-4; Hungarian Central Statistical Office, DISS DAT; Hungarian Central Statistical Office, 1996, DEM YB 1995 2014; Korhonen N, 2011, INJURY, V42, P885, DOI 10.1016/j.injury.2010.08.033; Lester D, 2003, PERCEPT MOTOR SKILL, V96, P421, DOI 10.2466/PMS.96.2.421-422; Luy M, 2003, POPUL DEV REV, V29, P647, DOI 10.1111/j.1728-4457.2003.00647.x; Majdan M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008672; Makris GD, 2013, ACTA PSYCHIAT SCAND, V127, P117, DOI 10.1111/j.1600-0447.2012.01891.x; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Partonen T, 2004, J AFFECT DISORDERS, V81, P133, DOI 10.1016/S0165-0327(03)00137-X; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Preti A, 2002, ACTA NEUROPSYCHIATR, V14, P17, DOI 10.1034/j.1601-5215.2002.140103.x; Radun I, 2006, CHRONOBIOL INT, V23, P1053, DOI 10.1080/07420520600921096; Rau R, 2007, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-44902-7; Remund A, 2018, DEMOGRAPHY, V55, P957, DOI 10.1007/s13524-018-0680-9; Rihmer Z, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-21; Rihmer Zoltan, 2012, Neuropsychopharmacol Hung, V14, P245; Rocchi MBL, 2007, J AFFECT DISORDERS, V100, P129, DOI 10.1016/j.jad.2006.10.003; ROGER JH, 1977, BIOMETRIKA, V64, P152, DOI 10.2307/2335789; Sebestyen B, 2010, WORLD J BIOL PSYCHIA, V11, P579, DOI 10.3109/15622970903397722; Stevens JA, 2007, ACCIDENT ANAL PREV, V39, P1239, DOI 10.1016/j.aap.2007.03.011; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; TRUDEAU R, 1997, HLTH REP, V9, P43; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Voracek M, 2007, PSYCHOL REP, V100, P810, DOI 10.2466/PR0.100.3.810-814; WALTER SD, 1975, BRIT J PREV SOC MED, V29, P18; WALTER SD, 1977, BRIT J PREV SOC MED, V31, P137; WEHRUNG DA, 1970, BRIT J PREV SOC MED, V24, P24; World Health Organization, EUR MORT DAT; Zonda T, 2005, CRISIS, V26, P34, DOI 10.1027/0227-5910.26.1.34	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217979	10.1371/journal.pone.0217979	http://dx.doi.org/10.1371/journal.pone.0217979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170243	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700088
J	Liu, QW; Li, H; You, LK; Li, T; Li, LL; Zhou, PK; Bo, XC; Chen, HB; Chen, XH; Hu, Y				Liu, Qiaowei; Li, Hao; You, Lukuan; Li, Tao; Li, Lingling; Zhou, Pingkun; Bo, Xiaochen; Chen, Hebing; Chen, Xiaohua; Hu, Yi			Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by alpha-particles radiation	PLOS ONE			English	Article							ADENOSINE DEAMINASES; GENE AMPLIFICATION; READ ALIGNMENT; CANCER; SITES; PROMOTES; ADAR1; RADON	Adenosine (A) to inosine (I) RNA editing is the most prevalent RNA editing mechanism in humans and plays critical roles in tumorigenesis. However, the effects of radiation on RNA editing were poorly understood, and a deeper understanding of the radiation-induced cancer is imperative. Here, we analyzed BEP2D (a human bronchial epithelial cell line) and radiation-induced malignantly transformed cell lines with next generation sequencing. By performing an integrated analysis of A-to-I RNA editing, we found that single-nucleotide variants (SNVs) might induce the downregulation of ADAR2 enzymes, and further caused the abnormal occurrence of RNA editing in malignantly transformed cell lines. These editing events were significantly enriched in differentially expressed genes between normal cell line and malignantly transformed cell lines. In addition, oncogenes CTNNB1 and FN1 were highly edited and significantly overexpressed in malignantly transformed cell lines, thus may be responsible for the lung cancer progression. Our work provides a systematic analysis of RNA editing from cell lines derived from human bronchial epithelial cells with high-throughput RNA sequencing and DNA sequencing. Moreover, these results provide further evidence for RNA editing as an important tumorigenesis mechanism.	[Liu, Qiaowei; Li, Hao; You, Lukuan; Li, Tao; Li, Lingling; Hu, Yi] Chinese PLA, Med Sch, Beijing, Peoples R China; [Liu, Qiaowei; You, Lukuan; Li, Tao; Li, Lingling; Hu, Yi] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China; [Liu, Qiaowei; Zhou, Pingkun; Bo, Xiaochen; Chen, Hebing; Chen, Xiaohua] Beijing Inst Radiat Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Hu, Y (corresponding author), Chinese PLA, Med Sch, Beijing, Peoples R China.; Hu, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China.; Chen, HB; Chen, XH (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	chb-1012@163.com; chenxh0676@sina.com; huyi0401@aliyun.com	Zhou, Ping-Kun/AAF-3536-2019; Zhou, Ping-Kun/GSJ-3972-2022	Zhou, Ping-Kun/0000-0001-7666-1209; Chen, Hebing/0000-0003-4102-356X; Li, Tao/0000-0002-9038-4794	Innovation Project of People's Liberation Army [16CXZ042, AWS14C002]	Innovation Project of People's Liberation Army	This work was supported by the Innovation Project of People's Liberation Army no. 16CXZ042 to Yi Hu and the Logistics Research Project of People's Liberation Army grant no. AWS14C002 to Xiaohua Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camero S, 2019, J CANCER RES CLIN, V145, P137, DOI 10.1007/s00432-018-2774-6; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Choi JR, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e207; Choi JR, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0095-2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferri GM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061294; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; John D, 2017, BRIEF BIOINFORM, V18, P993, DOI 10.1093/bib/bbw087; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JC, 2016, MODERN PATHOL, V29, P1335, DOI 10.1038/modpathol.2016.137; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Lino AD, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.572; Liu CY, 2014, BIOMED REP, V2, P525, DOI 10.3892/br.2014.268; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nath N, 2018, HEALTH PHYS, V115, P151, DOI 10.1097/HP.0000000000000880; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Piao CQ, 2001, RADIAT RES, V155, P263, DOI 10.1667/0033-7587(2001)155[0263:GAAMII]2.0.CO;2; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Reiko S, 2012, GASTROENTEROLOGY, V142, P572, DOI [10.1053/j.gastro.2011.11.041, DOI 10.1053/J.GASTRO.2011.11.041]; Samet JM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S4; Schroeder MP, 2014, BIOINFORMATICS, V30, pI549, DOI 10.1093/bioinformatics/btu467; Sui JL, 2004, RADIAT ENVIRON BIOPH, V43, P257, DOI 10.1007/s00411-004-0268-1; Sui JL, 2002, B ACAD MILITARY MED, V2, P86; Sun JF, 2002, INT J RADIAT BIOL, V78, P773, DOI 10.1080/09553000210141441; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogeltanz-Holm N, 2018, J ENVIRON RADIOACTIV, V192, P26, DOI 10.1016/j.jenvrad.2018.05.017; Weaver DA, 1997, CARCINOGENESIS, V18, P1251, DOI 10.1093/carcin/18.6.1251; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; WILLEY JC, 1991, CANCER RES, V51, P5370; Wu JJ, 2016, CARCINOGENESIS, V37, P511, DOI 10.1093/carcin/bgw029; Yang F, 2017, AGING-US, V9, P2316, DOI 10.18632/aging.101323; Zhan S, 2018, ONCOLOGIST; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhao YL, 2001, RADIAT RES, V155, P230, DOI 10.1667/0033-7587(2001)155[0230:MORINT]2.0.CO;2	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0213047	10.1371/journal.pone.0213047	http://dx.doi.org/10.1371/journal.pone.0213047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158229	gold, Green Published, Green Submitted			2022-12-27	WOS:000469915700001
J	Brondani, JE; Comim, FV; Flores, LM; Martini, LA; Premaor, MO				Brondani, Juliana E.; Comim, Fabio, V; Flores, Liziane M.; Martini, Ligia Araujo; Premaor, Melissa O.			Fruit and vegetable intake and bones: A systematic review and meta-analysis	PLOS ONE			English	Review							GRAIN DIETARY PATTERN; MINERAL DENSITY; TURNOVER MARKERS; OXIDATIVE STRESS; ELDERLY-MEN; HEALTH; FRACTURES; WOMEN; RISK; CONSUMPTION	Background Although intake of fruits and vegetables seemed to have a protective effect on bone metabolism, its effect on fractures remains uncertain. Methods A systematic review of randomized controlled trials (RCTs) and cohort studies (PROS-PERO: CRD42016041462) was performed. RCTs and cohort studies that evaluated the combined intake of fruits and vegetables in men and women aged over 50 years were included. We considered fractures as a primary outcome measure. Changes in bone markers were considered as secondary outcomes. The search strategy included the following descriptors: fruit, vegetables, vegetable products, bone and bones, bone fractures, postmenopausal osteoporosis, and osteoporosis. PubMed, Embase, and Cochrane Library were the databases used. The appraisal of the studies was performed by two independent reviewers, and discussed and agreed upon by both examiners. The data extracted from the RCTs and cohort studies were summarized separately. The risks of fractures were combined across studies using random models. Bone resorption marker (CTx) was summarized with standardized mean differences. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) method was used to evaluate the strength of recommendations. Results Of the 1,192 studies screened, 13 articles were included in the systematic review and 10 were included in the pooled analysis (6 cohort studies and 4 RCTs). The six cohort studies included in the meta-analysis included a population of 225,062. The pooled hazard ratio (HR) (95% confidence interval (CI)) of the hip in five studies was 0.92 (0.87, 0.98). Its heterogeneity was moderate (I-2 = 55.7%, p = 0.060), GRADE (circle plus circle plus circle plus O). Two cohort studies evaluated the risk of any fracture; the HR was 0.90 (95% CI: 0.86-0.96), with aheterogeneity of 24.9% (p = 0.249, GRADE (circle plus circle plus circle plus O)). There was no association between the bone resorption marker CTx and 3 months of fruit and vegetable intake evaluated by four RCTs, GRADE ((sic)(sic)O O). Conclusion There was an association between the increase of at least one serving of fruits and vegetables per day and decreases in the risk of fractures. The level of evidence for this association is moderate.	[Brondani, Juliana E.; Comim, Fabio, V; Premaor, Melissa O.] Univ Fed Santa Maria, Hlth Sci Ctr, Posgrad Farmacol, Santa Maria, RS, Brazil; [Flores, Liziane M.] Univ Fed Santa Maria, Hlth Sci Ctr, Dept Saude Colet, Santa Maria, RS, Brazil; [Martini, Ligia Araujo] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade de Sao Paulo	Premaor, MO (corresponding author), Univ Fed Santa Maria, Hlth Sci Ctr, Posgrad Farmacol, Santa Maria, RS, Brazil.	mopremaor@bol.com.br	Brondani, Juliana E/G-8032-2018; Brondani, Juliana Ebling/AAB-4403-2019; Premaor, Melissa/K-7401-2016; Comim, Fabio Vasconcellos/L-1298-2015; Maahs Flores, Liziane/M-4043-2014	Brondani, Juliana Ebling/0000-0001-5478-6633; Premaor, Melissa/0000-0002-0770-9202; Comim, Fabio Vasconcellos/0000-0002-2726-233X; Maahs Flores, Liziane/0000-0003-2110-2471; Araujo Martini, Ligia/0000-0001-8409-2907	Coordination of Higher Level Personnel (CAPES), Brazil; Federal University of Santa Maria (UFSM)	Coordination of Higher Level Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Federal University of Santa Maria (UFSM)	JEB received grants from The Coordination of Higher Level Personnel (CAPES), Brazil, regarding her Ph.D. thesis. The Federal University of Santa Maria (UFSM) is the sponsor of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005780; [Anonymous], 2016, N Engl J Med, V374, P1797, DOI 10.1056/NEJMx160008; [Anonymous], 2012, J Z AUDITORIA REGION; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Benetou V, 2011, EUR J CLIN NUTR, V65, P132, DOI 10.1038/ejcn.2010.226; Benetou V, 2016, J BONE MINER RES, V31, P1743, DOI 10.1002/jbmr.2850; Bonjour JP, 2013, J AM COLL NUTR, V32, P251, DOI 10.1080/07315724.2013.816604; Briot K, 2017, OSTEOPOROSIS INT, V28, P3301, DOI 10.1007/s00198-017-4189-7; Byberg L, 2015, FRUIT VEGETABLE INTA; Caroli A, 2011, J DAIRY SCI, V94, P5249, DOI 10.3168/jds.2011-4578; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; De Jonge EAL, 2015, EUROPEAN J EPIDEMIOL, V30, P761; de Jonge EAL, 2018, EUR J NUTR, V57, P61, DOI 10.1007/s00394-016-1297-7; de Jonge EAL, 2017, AM J CLIN NUTR, V105, P203, DOI 10.3945/ajcn.116.139196; Domazetovic V, 2017, CLIN CASES MINER BON, V14, P209, DOI 10.11138/ccmbm/2017.14.1.209; Dominguez-Avila JA, PHYTOCHEMICALS BIOAC; Ebrahimof S, 2009, EFFECTS INCREASING F; Fung TT, 2015, OSTEOPOROSIS INT, V26, P1825, DOI 10.1007/s00198-015-3081-6; Group GW, GRADE GRAD REC ASS D; Gunn CA, 2015, INCREASED INTAKE SEL; Hamidi M, 2011, OSTEOPOROSIS INT, V22, P1681, DOI 10.1007/s00198-010-1510-0; Harasym J, 2014, NUTRITION, V30, P511, DOI 10.1016/j.nut.2013.08.019; Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.036; Hu D, 2014, STROKE, V45, P1613, DOI 10.1161/STROKEAHA.114.004836; Ilha TASH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26312-9; Kaptoge S, 2003, OSTEOPOROSIS INT, V14, P418, DOI 10.1007/s00198-003-1391-6; Langsetmo L, 2011, AM J CLIN NUTR, V93, P192, DOI 10.3945/ajcn.110.002956; Liu ZM, 2015, J AM MED DIR ASSOC, V16, P309, DOI 10.1016/j.jamda.2014.11.001; Luo SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19783; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; Macdonald HM, 2008, EFFECT POTASSIUM CIT; McNaughton SA, 2011, J NUTR, V141, P1516, DOI 10.3945/jn.111.138271; McTiernan A, 2009, LOW FAT INCREASED FR; McTiernan A, 2009, AM J CLIN NUTR, V89, P1864, DOI 10.3945/ajcn.2008.26956; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Neville CE, 2014, EFFECT INCREASED FRU; Organization WWH, 2003, DIET NUTR PREV CHRON; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Requena G, 2014, CALCIFIED TISSUE INT, V94, P580, DOI 10.1007/s00223-014-9850-y; Samieri C, 2013, OSTEOPOROSIS INT, V24, P1295, DOI 10.1007/s00198-012-2132-5; Cabral HWS, 2016, REV ASSOC MED BRAS, V62, P368, DOI 10.1590/1806-9282.62.04.368; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Shin S, 2015, EUR J CLIN NUTR, V69, P442, DOI 10.1038/ejcn.2014.231; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Szulc P, 2017, OSTEOPOROSIS INT, V28, P2541, DOI 10.1007/s00198-017-4082-4; Szulc P, 2012, CLIN BIOCHEM, V45, P907, DOI 10.1016/j.clinbiochem.2012.01.022; Tucker KL, 2002, AM J CLIN NUTR, V76, P245, DOI 10.1093/ajcn/76.1.245; Tucker KL, 1999, AM J CLIN NUTR, V69, P727; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Weaver CM, 2019, PRIMER METABOLIC BON; Weaver CMH, PRIMER; Wells GA, 2015, NEWCASTLE OTTAWA SCA, DOI DOI 10.13105/WJMA.V5.I4.80; Zhu FM, 2018, CRIT REV FOOD SCI, V58, P1260, DOI 10.1080/10408398.2016.1251390	56	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217223	10.1371/journal.pone.0217223	http://dx.doi.org/10.1371/journal.pone.0217223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150426	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100035
J	Curry, AS; McPherson, DT; Barlow, AM; Pensa, NW; Reddy, MS; Bellis, SL				Curry, Andrew S.; McPherson, David T.; Barlow, Abby M.; Pensa, Nicholas W.; Reddy, Michael S.; Bellis, Susan L.			Addition of an oligoglutamate domain to bone morphogenic protein 2 confers binding to hydroxyapatite materials and induces osteoblastic signaling	PLOS ONE			English	Article							COLLAGEN-MIMETIC PEPTIDE; BIOACTIVE PEPTIDES; SERUM-PROTEINS; ILIAC CREST; GRAFT; RENATURATION; SUBSTITUTES; DELIVERY; CELLS; SITE	Nonautologous bone grafts have limited osteoinductive potential and thus there is substantial interest in reconstituting these graft materials with osteogenic factors such as bone morphogenic protein 2 (BMP2). However, one limitation of this approach is that BMP2 is typically weakly bound to the graft, which can lead to side effects associated with BMP2 dissemination. In the current study we added a hydroxyapatite (HA)-binding domain onto BMP2 to increase coupling to the graft surface. A sequence consisting of eight glutamate residues (E8) was inserted into the C-terminus of BMP2, and the recombinant protein (rBMP2-E8) was expressed in E. coli. Compared with rBMP2, rBMP2-E8 displayed markedly enhanced binding to HA disks and was better retained on the disks following exposure to vigorous wash steps. Furthermore, rBMP2-E8 was purified using a heparin column, and evaluated for its capacity to stimulate osteoblastic cell signaling. Treatment of SAOS2 cells with rBMP2-E8 induced SMAD 1/5 activation, confirming that the protein retains activity. Collectively these results suggest that the E8 domain serves as an effective tool for improving rBMP2 coupling to graft materials. The increased retention of rBMP2-E8 on the graft surface is expected to prolong BMP2' s osteoinductive activity within the graft site, while simultaneously reducing off-target effects.	[Curry, Andrew S.; Pensa, Nicholas W.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [McPherson, David T.; Barlow, Abby M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Reddy, Michael S.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.; Reddy, MS (corresponding author), Univ Calif San Francisco, Sch Dent, San Francisco, CA 94115 USA.	michael.reddy@ucsf.edu; bellis@uab.edu		Bellis, Susan/0000-0002-5071-527X	National Institutes of Health [R01 DE024670, NRSA F31 DE028164-01]; National Institutes of Health Dental Academic Research Training Program [T32 DE017607]; National Aeronautics and Space Administration (ASGC) [NNX15AJ18H]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024670, F31DE028164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Dental Academic Research Training Program; National Aeronautics and Space Administration (ASGC); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by National Institutes of Health grant R01 DE024670 (S.L.B., M.S.R.). Andrew Curry was supported by the National Institutes of Health Dental Academic Research Training Program T32 DE017607, and Nick Pensa was supported Predoctoral Fellowships from National Aeronautics and Space Administration (ASGC #NNX15AJ18H) and National Institutes of Health (NRSA F31 DE028164-01).	Bain JL, 2015, TISSUE ENG PT A, V21, P2426, DOI [10.1089/ten.TEA.2015.0160, 10.1089/ten.tea.2015.0160]; Bain JL, 2014, INT J ORAL MAX IMPL, V29, P1437, DOI 10.11607/jomi.3759; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Bhatt RA, 2012, HAND CLIN, V28, P457, DOI 10.1016/j.hcl.2012.08.001; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Culpepper BK, 2014, J BIOMED MATER RES A, V102, P1008, DOI 10.1002/jbm.a.34766; Culpepper BK, 2013, BIOMATERIALS, V34, P1506, DOI 10.1016/j.biomaterials.2012.10.046; Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020; FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006; Fisher DM, 2013, CURR STEM CELL RES T, V8, P260; Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Grabowski G, 2013, J AM ACAD ORTHOP SUR, V21, P51, DOI 10.5435/JAAOS-21-01-51; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x; Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053; Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.teb.2015.0357, 10.1089/ten.TEB.2015.0357]; Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R; Kim HS, 2017, MAX PLAST RECONSTR S, V39, DOI 10.1186/s40902-017-0138-9; Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114; Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025; Marino JT, 2010, ORTHOP CLIN N AM, V41, P15, DOI 10.1016/j.ocl.2009.08.003; Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Pensa NW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213592; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salem D, 2016, J PERIODONTOL, V87, P872, DOI 10.1902/jop.2016.150512; Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006; Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031; Shimer AL, 2009, INJURY, V40, P32; Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060; Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906; von Einem S, 2010, PROTEIN EXPRES PURIF, V73, P65, DOI 10.1016/j.pep.2010.03.009; Zhang YH, 2011, PROTEIN EXPRES PURIF, V75, P155, DOI 10.1016/j.pep.2010.07.014	47	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217766	10.1371/journal.pone.0217766	http://dx.doi.org/10.1371/journal.pone.0217766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150531	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100102
J	Guan, JH; Hsieh, F; Koehl, P				Guan, Jiahui; Hsieh, Fushing; Koehl, Patrice			DCG plus plus : A data-driven metric for geometric pattern recognition	PLOS ONE			English	Article							STRUCTURE DEFINITION; HARMONIC-ANALYSIS; CONNECTIVITY; DIFFUSIONS; MODEL; TOOL	Clustering large and complex data sets whose partitions may adopt arbitrary shapes remains a difficult challenge. Part of this challenge comes from the difficulty in defining a similarity measure between the data points that captures the underlying geometry of those data points. In this paper, we propose an algorithm, DCG++ that generates such a similarity measure that is data-driven and ultrametric. DCG++ uses Markov Chain Random Walks to capture the intrinsic geometry of data, scans possible scales, and combines all this information using a simple procedure that is shown to generate an ultrametric. We validate the effectiveness of this similarity measure within the context of clustering on synthetic data with complex geometry, on a real-world data set containing segmented audio records of frog calls described by mel-frequency cepstral coefficients, as well as on an image segmentation problem. The experimental results show a significant improvement on performance with the DCG-based ultrametric compared to using an empirical distance measure.	[Guan, Jiahui; Hsieh, Fushing] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koehl, P (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.; Koehl, P (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	koehl@cs.ucdavis.edu	Koehl, Patrice/K-5708-2013	Koehl, Patrice/0000-0002-0908-068X				Anderberg M. R., 1973, CLUSTER ANAL APPL; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Bader D.A., 2012, 10 DIMACS IMPLEMENTA; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Carlsson G, 2014, ACTA NUMER, V23, P289, DOI 10.1017/S0962492914000051; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Cole EM, 2014, GLOB ECOL CONSERV, V1, P60, DOI 10.1016/j.gecco.2014.06.002; Colonna JG, 2016, LECT NOTES ARTIF INT, V9956, P198, DOI 10.1007/978-3-319-46307-0_13; DONATH WE, 1973, IBM J RES DEV, V17, P420, DOI 10.1147/rd.175.0420; FIEDLER M, 1973, CZECH MATH J, V23, P298; Fischer B, 2004, ADV NEUR IN, V16, P89; Fischer B, 2003, IEEE T PATTERN ANAL, V25, P513, DOI 10.1109/TPAMI.2003.1190577; FORTUIN CM, 1972, PHYSICA, V57, P536, DOI 10.1016/0031-8914(72)90045-6; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Franti P, 2016, LECT NOTES COMPUT SC, V10029, P207, DOI 10.1007/978-3-319-49055-7_19; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Fukunaga K., 2013, INTRO STAT PATTERN R; Fushing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056259; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Hartuv E, 2000, INFORM PROCESS LETT, V76, P175, DOI 10.1016/S0020-0190(00)00142-3; Horn D, 2002, ADV NEUR IN, V14, P769; Horn D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018702; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Jain AK, 2005, LECT NOTES COMPUT SC, V3776, P1, DOI 10.1145/1083091.1083101; LANCZOS C, 1950, J RES NAT BUR STAND, V45, P255, DOI 10.6028/jres.045.026; Lawson C. L., 1979, ACM Transactions on Mathematical Software, V5, P324, DOI [10.1145/355841.355847, 10.1145/355841.355848]; Lehoucq R.B., 1998, ARPACK USERS GUIDE S; Li DW, 2018, NEURAL NETWORKS, V105, P447, DOI 10.1016/j.neunet.2018.06.003; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; MATULA DW, 1972, SIAM J APPL MATH, V22, P459, DOI 10.1137/0122040; Matula DW., 1977, CLASSIFICATION CLUST; Nadler B, 2006, ADV NEURAL INFORM PR, V19, P1117; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Singh Gurjeet, 2007, EUR S POINT BAS GRAP, DOI [10.2312/SPBG/SPBG07/091-100, DOI 10.2312/SPBG/SPBG07/091-100]; STRASSEN V, 1969, NUMER MATH, V13, P354, DOI 10.1007/BF02165411; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang F, 2015, DATA MIN KNOWL DISC, V29, P534, DOI 10.1007/s10618-014-0356-z; Weinstein M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066117; WU Z, 1993, IEEE T PATTERN ANAL, V15, P1101, DOI 10.1109/34.244673; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; ZAHN CT, 1971, IEEE T COMPUT, VC 20, P68, DOI 10.1109/T-C.1971.223083; Zelnik-Manor L., 2005, ADV NEURAL INFORM PR, V17, P1601	55	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217838	10.1371/journal.pone.0217838	http://dx.doi.org/10.1371/journal.pone.0217838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170208	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700066
J	Ukke, GG; Diriba, K				Ukke, Gebresilasea Gendisha; Diriba, Ketema			Prevalence and factors associated with neonatal hypothermia on admission to neonatal intensive care units in Southwest Ethiopia - A cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS; MORTALITY; NEWBORNS	Introduction Neonatal hypothermia is one of the main underlying factors associated with neonatal deaths. Objective The objective of this study was to assess the prevalence and factors associated with neonatal hypothermia on admission to neonatal intensive care units in Southwest Ethiopia. Methods Institution-based cross-sectional study design was employed between February to September 2017 at intensive care units of Arba Minch and Jinka General Hospitals. All neonates admitted to the two neonatal intensive care units during the study period were included in the study. Data were collected by four nurses who were working in the units of the hospitals through semi-structured pre-tested questionnaire and checklist. Multi-variable logistic regression was used to analyze the relationship between the dependent and independent variables using odds ratio with a confidence interval of 95% and a p-value of 0.05. Results The prevalence of neonatal hypothermia on admission to the neonatal intensive care units in this study area was 50.3%. Admission weight below 2500 gm. (AOR = 3.61, 95% CI: 2.10, 6.18), delay in initiation of breastfeeding (AOR = 2.42, 95% CI: 1.45, 4.02), early bathing (AOR = 2.63, 95% CI: 1.23, 5.63), admissions during cold season (AOR = 1.72, 95% CI: 1.04, 2.84), and presence of obstetrical complication(s) during pregnancy/labor (AOR = 2.46, 95% CI: 1.07, 5.66) were factors significantly associated with hypothermia on admission to the neonatal intensive care units. Conclusions The prevalence of neonatal hypothermia on admission to the intensive care units was high. There is a need to create awareness among the community members about the dangers of early bathing and late initiation of breastfeeding. It is also important to give attention to the newborns of mothers with obstetric complications, low-birth-weight babies and babies delivered during the cold season.	[Ukke, Gebresilasea Gendisha] Arba Minch Univ, Dept Midwifery, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Diriba, Ketema] Arba Minch Univ, Dept Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Ukke, GG (corresponding author), Arba Minch Univ, Dept Midwifery, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	gebretecno@gmail.com	UKKE, GEBRESILASEA GENDISHA/AAX-4268-2021	UKKE, GEBRESILASEA GENDISHA/0000-0003-0932-1276	Arba Minch University [GOV/AMU/TH.1.1, CMHS/MID/02/09]	Arba Minch University	GGU received the grant, grant number: GOV/AMU/TH.1.1./CMHS/MID/02/09, name of the funder: Arba Minch University, www.amu.edu.et.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei G., 2007, INCIDENCE RISK FACTO; Bergstrom A, 2005, ACTA PAEDIATR, V94, P1462, DOI 10.1080/080352505100366750; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P29, DOI 10.4314/ejhs.v24i0.4S; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Carlo W., 2011, NELSON TXB PEDIAT, P538; Ebrahim E., 2015, GEN MED OPEN ACCESS, P2015; Gordon A, 1999, NEONATOLOGY PATHOPHY; Guha DK, 1998, NEONATOLOGY PRINCIPL, P253; Kambarami R, 2002, CENTRAL AFRICAN J ME, V49, P103; Knobel RB, 2014, NEWBORN INFANT NURS, V14, P72, DOI 10.1053/j.nainr.2014.03.002; Lunze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092006; Lunze K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-24; Manji K, 2003, NEONATAL HYPOTHERMIA; Moore ER, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub4; Mullany LC, 2010, SEMINARS PERINATOLOG; Mullany LC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-43; Nayeri F, 2006, IRAN J PUBLIC HEALTH, V35, P48; Nimbalkar SM, 2014, J PERINATOL, V34, P364, DOI 10.1038/jp.2014.15; Ogunlesi TA, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-40; Ogunlesi TA, 2009, J PERINAT MED, V37, P180, DOI 10.1515/JPM.2009.014; Onalo R, 2013, NIGER J CLIN PRACT, V16, P129, DOI 10.4103/1119-3077.110120; Srivastava Smita, 2014, Indian J Public Health, V58, P22, DOI 10.4103/0019-557X.128160; Wondimeneh B., 2016, NEONATAL HYPOTHERMIA; World Health Organization. Maternal and Newborn Health/Safe Motherhood, 1997, THERM PROT NEWB PRAC; Zayeri F, 2005, SAUDI MED J, V26, P1367	25	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218020	10.1371/journal.pone.0218020	http://dx.doi.org/10.1371/journal.pone.0218020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170252	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700095
J	Fechner, C; Greiner, M; Heseker, H; Lindtner, O				Fechner, Carolin; Greiner, Matthias; Heseker, Helmut; Lindtner, Oliver			Dietary exposure assessment of aluminium and cadmium from cocoa in relation to cocoa origin	PLOS ONE			English	Article							TRACE-ELEMENTS; CACAO BEANS; FOOD; SOIL; CHOCOLATE; LEAD; FRACTIONATION; POWDER	Cocoa contains aluminium and cadmium as environmental contaminants while concentrations are supposed to be country of origin-related. Integrating origin in dietary exposure assessment could refine calculations. Averages or higher percentiles of concentrations in cocoa powder from German Food Monitoring (GFM) and cocoa consumption from the German National Nutrition Survey II (NVS II) were combined in standard scenarios. Additional origin-related scenarios used concentration data grouped into origin A (lower concentrations) and origin B (higher concentrations) as plausible origin information was rare. The most conservative standard scenario resulted in the highest intake estimates for aluminium and cadmium with 0.152 mg/week/kg BW and 0.363 mu g/week/kg BW and covered the origin influence calculated in origin-related scenarios. Having plausible origin information would help to refine exposure assessment as it is exemplarily shown here that origin-related lower intake estimates are possible. Using the Eurostat database and the Mintel Global New Product Database (GNPD) generated more origin information for products available on the German market. For Germany, cocoa beans, cocoa powder and cocoa mass were mainly sourced in Cote d'Ivoire, while the Netherlands was the main distributor. Packages of cocoa powders were sourced from different origins.	[Fechner, Carolin; Greiner, Matthias; Lindtner, Oliver] German Fed Inst Risk Assessment, Exposure, Berlin, Germany; [Greiner, Matthias] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany; [Heseker, Helmut] Paderborn Univ, Dept Sports & Hlth, Paderborn, North Rhine Wes, Germany; [Fechner, Carolin] Norwegian Inst Publ Hlth, Norwegian Sci Comm Food & Environm, Oslo, Norway	Federal Institute for Risk Assessment; University of Veterinary Medicine Hannover, Foundation; University of Paderborn; Norwegian Institute of Public Health (NIPH)	Fechner, C (corresponding author), German Fed Inst Risk Assessment, Exposure, Berlin, Germany.; Fechner, C (corresponding author), Norwegian Inst Publ Hlth, Norwegian Sci Comm Food & Environm, Oslo, Norway.	fechner.carolin@gmail.com		Fechner, Carolin/0000-0002-6586-8826				Abt E, 2018, FOOD ADDIT CONTAM B, V11, P92, DOI 10.1080/19393210.2017.1420700; Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; [Anonymous], 2018, GLOB NEW PROD DAT GN; Arnich N, 2012, FOOD CHEM TOXICOL, V50, P2432, DOI 10.1016/j.fct.2012.04.016; Bertoldi D, 2016, FOOD CONTROL, V65, P46, DOI 10.1016/j.foodcont.2016.01.013; Blume K, 2010, ARZTEMANGEL KRANKENH, P1; Boateng DO., 2014, INT J ADV AGR RES, V2, P89; Brombach C, 2006, ERNAHRUNGS UMSCHAU, V53, P4; BVL Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit, 2012, BER LEB HEIT 2012 MO, P3; BVL Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit, 2018, MON PROGR; Chavez E, 2015, SCI TOTAL ENVIRON, V533, P205, DOI 10.1016/j.scitotenv.2015.06.106; D'Elia G., 2011, Annali della Facolta di Medicina Veterinaria, Universita di Parma, V31, P65; Duku MH, 2011, RENEW SUST ENERG REV, V15, P3539, DOI 10.1016/j.rser.2011.05.010; European Food Safety Authority, 2012, EFSA J, V10, DOI [10.2903/j.efsa.2012.2551, 10.2903/j.efsa.2012.2831]; FAO, 2017, STAT FOOD AGR LEV FO, P1; Fechner C, 2020, J EXPO SCI ENV EPID, V30, P492, DOI 10.1038/s41370-019-0117-6; Fold N., 2001, J ECON GEOGR, V1, P405, DOI DOI 10.1093/JEG/1.4.405; Frankowski M, 2013, J ENVIRON MANAGE, V127, P1, DOI 10.1016/j.jenvman.2013.04.033; Frey HC, 2002, RISK ANAL, V22, P553; Heinemeyer G, 2015, GUIDANCE DOCUMENT UN; Husband C, 2009, ALUMINUM IND W CENTR; ICCO, 2017, ANN REP 2014 2015; ICCO International Cocoa Organization, 2008, ANN REP 2006 07; Kaplinsky R., 2004, UN C TRAD DEV UNCTAD; Krems C, 2006, ERNAHRUNGS-UMSCHAU, V53, P44; Kruszewski B, 2018, J FOOD COMPOS ANAL, V66, P127, DOI 10.1016/j.jfca.2017.12.012; Lindtner O, 2013, TOTAL DIET STUDIES, P521; Lo Dico GM, 2018, FOOD CHEM, V245, P1163, DOI 10.1016/j.foodchem.2017.11.052; Mora ML, 2006, SOIL USE MANAGE, V22, P95, DOI 10.1111/j.1475-2743.2006.00011.x; Mounicou S, 2003, FOOD ADDIT CONTAM A, V20, P343, DOI 10.1080/0265203031000077888; Muller M, 1998, FOOD CHEM, V61, P419, DOI 10.1016/S0308-8146(97)00085-X; Nordlokken M, 2015, SCI TOTAL ENVIRON, V502, P391, DOI 10.1016/j.scitotenv.2014.09.038; Ofori-Frimpong K, 1999, GHANA J AGR SCI, V32, P101; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Porter SD, 2016, REG ENVIRON CHANGE, V16, P2279, DOI 10.1007/s10113-015-0783-4; Sarvan I, 2017, BUNDESGESUNDHEITSBLA, V60, P689, DOI 10.1007/s00103-017-2566-1; Schneider K, 2014, FOOD ADDIT CONTAM A, V31, P1052, DOI 10.1080/19440049.2014.905875; Schwarz MA, 2014, FOOD ADDIT CONTAM A, V31, P688, DOI 10.1080/19440049.2013.878041; Sieke C, 2008, DEUT LEBENSM-RUNDSCH, V104, P271; Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P38, DOI 10.1186/2190-4715-23-38; Uras U, 2012, J ANAL APPL PYROL, V98, P207, DOI 10.1016/j.jaap.2012.08.007; Vitola V., 2016, Rural Sustainability Research, V35, P19, DOI 10.1515/plua-2016-0003; Yaman M, 2006, ENVIRON MONIT ASSESS, V115, P279, DOI 10.1007/s10661-006-6554-4; Yanus RL, 2014, TALANTA, V119, P1, DOI 10.1016/j.talanta.2013.10.048	45	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217990	10.1371/journal.pone.0217990	http://dx.doi.org/10.1371/journal.pone.0217990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166999	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800056
J	Madrazo-Moya, CF; Cancino-Munoz, I; Cuevas-Cordoba, B; Gonzalez-Covarrubias, V; Barbosa-Amezcua, M; Soberon, X; Muniz-Salazar, R; Martinez-Guarneros, A; Backer, C; Zarrabal-Meza, J; Sampieri-Ramirez, C; Enciso-Moreno, A; Lauzardo, M; Comas, I; Zenteno-Cuevas, R				Francisco Madrazo-Moya, Carlos; Cancino-Munoz, Irving; Cuevas-Cordoba, Betzaida; Gonzalez-Covarrubias, Vanessa; Barbosa-Amezcua, Martin; Soberon, Xavier; Muniz-Salazar, Raquel; Martinez-Guarneros, Armando; Backer, Claudia; Zarrabal-Meza, Jose; Sampieri-Ramirez, Clara; Enciso-Moreno, Antonio; Lauzardo, Michael; Comas, Inaki; Zenteno-Cuevas, Roberto			Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico	PLOS ONE			English	Article							MGIT 960 SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; MUTATIONS; SUSCEPTIBILITY; PYRAZINAMIDE; VERACRUZ; RIFAMPIN; STRAINS; INDIA	Background Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic region in Mexico. Methods WGS analysis was performed in 81 tuberculosis positive clinical isolates with a known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were identified for each isolate; drug resistant genotypes were predicted and compared with the phenotypic profile. Genotypes and transmission clusters based on genetic distances were also characterized. Findings Prediction by WGS analysis of resistance against isoniazid, rifampicin, ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively. Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, enabling classification of eight and two clinical isolates as pre- and extreme drug-resistant cases, respectively. Lastly, four lineages were identified in the population (L1, L2, L3 and L4). The most frequent of these was L4, which included 90% (77) of the isolates. Six transmission clusters were identified; the most frequent was TC6, which included 13 isolates with a L4.1.1 and a predominantly multidrug-resistant condition. Conclusions The results illustrate the utility of WGS for establishing the potential for prediction of resistance against first and second line drugs in isolates of tuberculosis from the region. They also demonstrate the feasibility of this procedure for use as a tool to support the epidemiological surveillance of drug-and multidrug-resistant tuberculosis.	[Francisco Madrazo-Moya, Carlos; Sampieri-Ramirez, Clara; Zenteno-Cuevas, Roberto] Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico; [Francisco Madrazo-Moya, Carlos; Zenteno-Cuevas, Roberto] Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico; [Cancino-Munoz, Irving; Comas, Inaki] CSIC, Biomed Inst Valencia IBV, Valencia, Spain; [Cuevas-Cordoba, Betzaida; Gonzalez-Covarrubias, Vanessa; Barbosa-Amezcua, Martin; Soberon, Xavier] Inst Nacl Med Genom, Lab Farmacogenom, Mexico City, DF, Mexico; [Muniz-Salazar, Raquel] Univ Autonoma Baja Calif, Lab Epidemiol & Ecol & Mol, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Martinez-Guarneros, Armando; Backer, Claudia] Inst Nacl Diagnost & Referencia Epidemiol, Lab Micobacterias, Mexico City, DF, Mexico; [Zarrabal-Meza, Jose] Secretaria Salud, Lab Estatal Salud Publ, Xalapa, Veracruz, Mexico; [Enciso-Moreno, Antonio] IMSS, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico; [Lauzardo, Michael] Univ Florida, Coll Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Comas, Inaki] CIBER Epidemiol & Publ Hlth, Madrid, Spain	Universidad Veracruzana; Universidad Veracruzana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Instituto Nacional de Medicina Genomica; Universidad Autonoma de Baja California; State University System of Florida; University of Florida; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Zenteno-Cuevas, R (corresponding author), Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.; Zenteno-Cuevas, R (corresponding author), Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico.	robzencue@gmail.com	GUARNEROS, JOSE ARMANDO MARTINEZ/I-7475-2019; ZENTENO-CUEVAS, ROBERTO/A-7152-2012; Cancino-Muñoz, Irving/AAJ-2761-2020; Comas, Iñaki/AAA-1155-2019; Cuevas-Córdoba, Betzaida/C-4103-2014; Gonzalez-Covarrubias, Vanessa/AAG-3675-2020	ZENTENO-CUEVAS, ROBERTO/0000-0001-9597-127X; Cancino-Muñoz, Irving/0000-0002-5261-1634; Comas, Iñaki/0000-0001-5504-9408; Cuevas-Córdoba, Betzaida/0000-0002-6528-9998; Madrazo Moya, Carlos Francisco/0000-0002-1131-481X; Muniz-Salazar, Raquel/0000-0001-5528-7772; Sampieri, Clara Luz/0000-0001-7495-426X; Martinez-Guarneros, Armando/0000-0003-4042-9680	CONACyT-Problemas nacionales grant [2015-01-147]; GACD-FONCICYT Conacyt [264693];  [I-COOP-2017-COOPB2032]	CONACyT-Problemas nacionales grant; GACD-FONCICYT Conacyt; 	CFM-M was a CONACYT fellow of the Maestria en Ciencias de la Salud of the Instituto de Ciencias de la Salud Universidad Veracruzana. RZC and IC were partially funded by I-COOP-2017-COOPB2032. RMS was funded by CONACyT-Problemas nacionales grant no. 2015-01-147. XS was funded by GACD-FONCICYT Conacyt No. 264693.	Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117771; Aung HL, 2016, J GLOB ANTIMICROB RE, V6, P113, DOI 10.1016/j.jgar.2016.04.008; Castellanos-Joya M., 2014, ACTUAL SITUATION TUB; Chatterjee A, 2017, TUBERCULOSIS, V107, P63, DOI 10.1016/j.tube.2017.08.002; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Coll F, 2018, NAT GENET, V50, P307, DOI 10.1038/s41588-017-0029-0; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cuevas-Cordoba B, 2015, ANTIMICROB AGENTS CH, V59, P5455, DOI 10.1128/AAC.00117-15; Cuevas-Cordoba B, 2013, INFECT GENET EVOL, V19, P330, DOI 10.1016/j.meegid.2012.12.013; Cuevas-Cordoba B, 2013, J MICROBIOL IMMUNOL, V46, P30, DOI 10.1016/j.jmii.2012.08.020; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Flores-Lopez CA, 2017, INFECT GENET EVOL, V55, P378, DOI 10.1016/j.meegid.2016.07.001; Flores-Trevino S, 2014, SALUD PUBLICA MEXICO, V56, P63; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mahomed S, 2017, TUBERCULOSIS, V107, P137, DOI 10.1016/j.tube.2017.09.005; Manson AL, 2017, CLIN INFECT DIS, V64, P1494, DOI 10.1093/cid/cix169; Juarez-Eusebio DM, 2017, INFECT GENET EVOL, V55, P384, DOI 10.1016/j.meegid.2016.09.012; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Miotto P, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01599-17, 10.1128/JCM.01599-17]; Perez-Navarro LM, 2011, GAC MED MEX, V147, P219; Munro-Rojas D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193626; Pan American Health Organization, 2018, TUB AM 2018; Papaventsis D, 2017, CLIN MICROBIOL INFEC, V23, P61, DOI 10.1016/j.cmi.2016.09.008; Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Senghore M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184510; Serra A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37411-y; Shea J, 2017, J CLIN MICROBIOL, V55, P1871, DOI 10.1128/JCM.00298-17; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Stop TB Partnership W, 2016, GLOB PLAN STOP TB 20, V2020, P1; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; The CRyPTIC Consortium and the 100 000 Genomes Project, 2018, NEW ENGL J MED; Trauer J., 2016, THESIS U MELBOURNE; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2017, CLIN MICROBIOL INFEC, V23, P161, DOI 10.1016/j.cmi.2016.10.014; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Witney AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0598-2; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; World Health Organization, 2017, GLOB TUB REP, V2017, P1; Zenteno-Cuevas R, 2009, MEM I OSWALDO CRUZ, V104, P468, DOI 10.1590/S0074-02762009000300012; Zenteno-Cuevas R, 2015, INT J ANTIMICROB AG, V45, P671, DOI 10.1016/j.ijantimicag.2015.02.006; Zenteno-Cuevas R, 2015, APMIS, V123, P116, DOI 10.1111/apm.12312; Zenteno-Cuevas R, 2012, CAN J MICROBIOL, V58, P318, DOI [10.1139/W11-127, 10.1139/w11-127]; Zenteno-Cuevas R, 2011, REV SOC BRAS MED TRO, V44, P282, DOI 10.1590/S0037-86822011005000034; Zhang Y, 2015, INT J TUBERC LUNG D, P1276	56	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0213046	10.1371/journal.pone.0213046	http://dx.doi.org/10.1371/journal.pone.0213046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166945	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800001
J	Heiss, AG; Antolin, F; Azorin, MB; Biederer, B; Erlach, R; Gail, N; Griebl, M; Linke, R; Lochner, M; Marinova, E; Oberndorfer, D; Stika, HP; Valamoti, SM				Heiss, Andreas G.; Antolin, Ferran; Azorin, Marian Berihuete; Biederer, Benedikt; Erlach, Rudolf; Gail, Niki; Griebl, Monika; Linke, Robert; Lochner, Michaela; Marinova, Elena; Oberndorfer, Daniel; Stika, Hans-Peter; Valamoti, Soultana Maria			The Hoard of the Rings. "Odd" annular bread-like objects as a case study for cereal-product diversity at the Late Bronze Age hillfort site of Stillfried (Lower Austria)	PLOS ONE			English	Article							TEMPERATURE; PYROLYSIS; FOOD; MICROSTRUCTURE; ARCHAEOLOGY; BAKING	Cereals, in addition to being a major ingredient in daily meals, also play a role in the preparation of foodstuffs for ritual purposes. This paper deals with finds that may correspond to such ritual preparations retrieved from the hillfort site of Stillfried an der March. The site, spreading across an area of ca. 23 ha, held a very important position among settlements of Late Urnfield period (particularly during the 10th-9thc. BCE), acting as a central place where large scale storage of grain as well as textile and metal production took place under the control of local elites. Three incomplete ring-shaped charred organic objects, found together with 14 rings and ring fragments made of clay were discovered in a secondary filled silo pit, excavated among a total of about 100 pits of this kind at the site. The overall good state of preservation of the organic ring fragments suggests that they were deposited intact on the bottom of the pit and covered well so that no re-deposition or damage occurred. This could be indicate their intentional placement in this position. Light and scanning electron microscopy revealed that the charred organic rings are cereal products containing hulled barley and a wheat species. Indications that the objects were shaped from a wet cereal mixture and had been subsequently dried without baking are discussed, as well as the possible significance of the find assemblage. The annular objects are put in context with the contemporary cereal spectrum as well as other cereal preparations from Stillfried, outlining their different chaines operatoires for handling cereal food.	[Heiss, Andreas G.; Gail, Niki; Oberndorfer, Daniel] Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria; [Antolin, Ferran] Univ Basel, Integrat Prehist & Archaeol Sci IPAS IPNA, Basel, Switzerland; [Azorin, Marian Berihuete; Stika, Hans-Peter] Univ Hohenheim, Inst Bot 210, Stuttgart, Germany; [Biederer, Benedikt; Griebl, Monika; Lochner, Michaela] Austrian Acad Sci OAW, Inst Oriental & European Archaeol OREA, Vienna, Austria; [Erlach, Rudolf] Univ Appl Arts Vienna, Inst Art & Technol, Vienna, Austria; [Linke, Robert] Fed Monuments Author Austria BDA, Referat Nat Wissensch Lab, Vienna, Austria; [Marinova, Elena] State Off Cultural Heritage Baden Wurttemberg, Lab Archaeobot, Gaienhofen Hemmenhofen, Germany; [Valamoti, Soultana Maria] Aristotle Univ Thessaloniki, Lira Lab, Dept Archaeol, Sch Hist & Archaeol, Thessaloniki, Greece; [Valamoti, Soultana Maria] Aristotle Univ Thessaloniki, Ctr Interdisciplinary Res & Innovat CIRI AUTH, Thessaloniki, Greece	Austrian Academy of Sciences; University of Basel; University Hohenheim; Austrian Academy of Sciences; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Heiss, AG (corresponding author), Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria.	andreas.heiss@oeai.at	Berihuete Azorín, Marian/H-9833-2015; Heiss, Andreas/K-5393-2013; Marinova, Elena/E-9935-2010; Antolin, Ferran/I-1489-2015	Berihuete Azorín, Marian/0000-0002-6248-1562; Heiss, Andreas/0000-0002-2989-7259; Marinova, Elena/0000-0003-3793-3317; Antolin, Ferran/0000-0002-0533-5788	ERC-CoG-2015 [GA 682529]; backaldrin - The Kornspitz Company; Austrian Science Fund [FWF P28005]; Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?" [P 28005]; European Research Council within European Union's Horizon 2020 Research and Innovation Program [682529]	ERC-CoG-2015; backaldrin - The Kornspitz Company; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?"; European Research Council within European Union's Horizon 2020 Research and Innovation Program	AGH, HPS, MBA, SMV, FA were supported by: ERC-CoG-2015, GA 682529 (PI: SMV) https://cordis.europa.eu/project/rcn/202606/factsheet/en.AGH was supported by: backaldrin - The Kornspitz Company https://www.backaldrin.com/.ML, MG, BB were supported by: Austrian Science Fund FWF P28005 (PI: ML) https://www.fwf. ac. at/. Evaluation of the archaeological context is funded by the Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?" (P 28005, PI Michaela Lochner, 2015-2019), based at OAW-OREA. Analysis of the bread-like objects was partly funded by the European Research Council within the framework of the project 'PLANTCULT': Identifying the Food Cultures of Ancient Europe, under the European Union's Horizon 2020 Research and Innovation Program (Grant Agreement No. 682529, Consolidator Grant 2016-2021. PI Soultana Maria Valamoti). Radiocarbon dating of the annular objects (sample ST 12050.4 B/Beta-486379) was funded by backaldrin - The Kornspitz Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg A, 1990, TRIERER Z, V53, P225; Adams W.Y., 1991, ARCHAEOLOGICAL TYPOL; [Anonymous], 2009, GEBACK MOCKBA MMI IV; [Anonymous], 2017, MAHL SCHALPR MITT CO; [Anonymous], [No title captured]; [Anonymous], 2017, BALKAN DIALOGUES NEG; Antolin F, 2016, JB ARCHAOL SCHWEIZ, V99, P143, DOI DOI 10.5281/3888318.894128; Antolin F, 2018, JAHR AG ARCH AK VEG; Arnold P, 2005, BANDKERAMIKER 1 STEI, P99; Arranz-Otaegui A, 2017, QUATERN INT, V457, P60, DOI 10.1016/j.quaint.2016.06.030; Arranz-Otaegui A, 2018, P NATL ACAD SCI USA, V115, P7925, DOI 10.1073/pnas.1801071115; Auerbock CF, 2009, AUSSEER FASCHING ETH; Bahn P., 2005, ARCHAEOLOGY KEY CONC, P18; Bahn PaulG., 2016, ARCHAEOLOGY THEORIES; Balinska M, 2008, BAGEL SURPRISING HIS; Balme J., 2007, ENCY ARCHAEOLOGY, V1-3, P508; Berihuete Azorin M., FRESH OVEN EXPT TRIT; Boateng AA, 2007, FUEL, V86, P735, DOI 10.1016/j.fuel.2006.08.024; Braun T, 1995, FOOD IN ANTIQUITY, P25; Brock F, 2018, RADIOCARBON, V60, P35, DOI 10.1017/RDC.2017.68; BUCHANAN KJ, 1980, EUR POLYM J, V16, P309, DOI 10.1016/0014-3057(80)90074-9; Cafarelli B, 2014, J FOOD ENG, V124, P64, DOI 10.1016/j.jfoodeng.2013.10.002; Campbell G.M., 2008, PROVING BAKING, P337, DOI [10.1016/B978-1-891127-59-5.50037-7, DOI 10.1016/B978-1-891127-59-5.50037-7]; Cappers R.T.J., 2016, DIGITAL ATLAS TRADIT DIGITAL ATLAS TRADIT; Cappers RTJ., 2018, DIGITAL ATLAS TRADIT; Carretero LG, 2017, VEG HIST ARCHAEOBOT, V26, P415, DOI 10.1007/s00334-017-0602-6; Cash JR, 2013, CHARITY REMEMBRANCE; Chevalier A, 2014, PLANTS PEOPLE CHOICE; Chevalier A., 2014, PLANTS PEOPLE CHOICE, P3, DOI DOI 10.2307/J.CTVH1DWFP; Ciaraldi, 1998, ACCORDIA RES PAP, V7, P75; Cohn-Sherbok D., 2005, JUDAISM HIST BELIEF; College S., 1988, SCANNING ELECT MICRO, P225; Cronyn J.M., 1990, ELEMENTS ARCHAEOLOGI; Crowther A, 2012, ARCHAEOL ANTHROP SCI, V4, P221, DOI 10.1007/s12520-012-0097-0; Cruz-Garcia G.S., 2014, PLANTS PEOPLE CHOICE, P42; Das Beilke-Voigt I., 2007, OPFER ARCHAOLOGISCHE; Davison S., 2008, CONSERVATION RESTORA; Dee MW, 2011, RADIOCARBON, V53, P705, DOI 10.1017/S0033822200039151; DELLACASA N, 1984, FOLKLORE, V95, P30, DOI 10.1080/0015587X.1984.9716294; Di Giovine MA, 2014, HERIT CULT INDENT, P77; Dickson C., 1987, CIRCAEA, V4, P95; Dietler M., 1997, FOOD STATUS QUEST IN, P87; Domenech-Carbo A, 2014, J SOLID STATE ELECTR, V18, P399, DOI 10.1007/s10008-013-2232-y; Falcone PM, 2005, J FOOD SCI, V70, pE265, DOI 10.1111/j.1365-2621.2005.tb07182.x; Felgenhauer F., 1980, FORSCHUNGEN STILLFRI, V4, P177; Fu P, 2011, BIORESOURCE TECHNOL, V102, P8211, DOI 10.1016/j.biortech.2011.05.083; Fuller D.Q., 2006, MILLET ATLAS SOME ID; Fuller DQ, 2018, ARCHAEOL INT, V21, P109, DOI 10.5334/ai-391; Fuller DQ., 2014, ANCIENT PLANTS PEOPL, P174; Galanidou-Balphousia E., 1999, PONTIAN FOLKLORE 4 S; Gale R., 2000, PLANTS ARCHAEOLOGY; Gansicke S, 2003, J AM INST CONSERV, V42, P193, DOI 10.2307/3180070; Garnsey P., 1999, FOOD SOC CLASSICAL A; Garrow D, 2012, ARCHAEOL DIALOG, V19, P85, DOI 10.1017/S1380203812000141; Gassner G., 1989, MIKROSKOPISCHE UNTER; Greenwood C T, 1967, Adv Carbohydr Chem Biochem, V22, P483; Griebl M, SPEICHERGRUBEN SPATU; Griebl M, 2017, BEITRAGE ZUM TAG NIE, P195; Griebl M., 2008, ARCHAOLOGIE OSTERREI, V19, P13; Griebl M, 2015, ARCHAEOLOGIA AUSTRIA, V99, P179; GRIEBL M., 2013, KOLLOQUIEN VOR FRUHG, V19, P327; Hahn H., 1996, MIKROSKOPISCHE DIAGN; Hansson A.-M., 1994, LAB ARKEOL, V7, P5; Hansson A-M, 1996, LABORATIV ARKEOLOGI, V9, P61; Hansson A-M., 1994, LAB ARKEOL, V7, P21; Hansson Ann-Marie, 2014, PLANTS PEOPLE CHOICE, V1, P311; Hastorf C., 2016, SOCIAL ARCHAEOLOGY F; Hayden Brian, 1997, FOOD STATUS QUEST IN, P127; Heiss AG, 2007, UNTERSUCHUNG LATENEZ, V2006, P70; Heiss AG., 2014, PLANTS PEOPLE CHOICE, P343; Heiss AG, 2008, OPFERBROTE ARCHAOBOT; Heiss AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182401; Heiss AG, 2015, J ARCHAEOL SCI, V55, P71, DOI 10.1016/j.jas.2014.12.014; Hellerschmid I, 2015, ARCHAEOL AUSTRIACA, P203, DOI 10.1553/archaeologia99s203; Himmelstein P, 1977, J AM INT CONSERV, V17, P37, DOI 10.1179/019713677806029211; Hofmann E., 1924, SITZUNGSBERICHTE MN, V133, P379; Horie V, 2010, ACRYLIC POLYM MAT CO, P153; JOHNSON JS, 1994, J FIELD ARCHAEOL, V21, P221, DOI 10.1179/009346994791547661; Jones G, 2000, VEG HIST ARCHAEOBOT, V9, P133, DOI 10.1007/BF01299798; Kohler-Schneider M, 2003, VEG HIST ARCHAEOBOT, V12, P105, DOI 10.1007/s00334-003-0010-y; Kohler-Schneider M., 1999, ARCHAOLOGIE OSTERREI, V10, P64; Kohler-Schneider M., 2001, VERKOHLTE KULTUR WIL; Koob, 1984, STUDIES CONSERVATI S, V29, P103, DOI DOI 10.1179/SIC.1984.29.SUPPLEMENT-1.103; Koob S.P., 1984, ADHESIVES CONSOLIDAN, P98; KORBERGROHNE U, 1980, FLORA, V170, P189; Kozub D, 2000, HELICON FOCUS 7 0 1; Kroll H, 2016, ARCHAOBOTANIK FEUDVA; Kubiak-Martens L, 2015, VEG HIST ARCHAEOBOT, V24, P47, DOI 10.1007/s00334-014-0485-8; Kuhn E., 2013, THESIS; Lannoy S., 2002, PAIN, P119; Lemke H., 2004, AUFKLARUNG KRITIK, V11, P117; Levi-Strauss C., 1965, FOOD HIST, V2, P7, DOI [10.1484/j.Food.2.300271, DOI 10.1484/J.FOOD.2.300271]; Linke R., 2019, BDA00061SB0002ARSENA; Linke R., 2019, BDA00061SB0001ARSENA; LUND D, 1984, CRC CR REV FOOD SCI, V20, P249, DOI 10.1080/10408398409527391; Lundstrom-Baudais K., 2002, MOUDRE BROYER INTERP, V1, P181; Maier U, 2001, BOT PEDOLOGISCHE UNT; Marchylo B. A., 2001, CEREALS PROCESSING T, P109, DOI [10.1533/ 9781855736283.2.109, DOI 10.1533/9781855736283.2.109]; Martinez Straumann S., 2004, JUNGSTEINZEITLICHE S, P277; Mayeske B. J., 1972, THESIS; Mesnil M, 2002, BREAD OVEN HEARTHS P, P101; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO, V1; Metheny K.B., 2015, ARCHAEOLOGY FOOD ENC, VVolume 1, P70; Miedaner T, 2012, UNTERSCHATZTE GETREI; Miller D., 1982, SYMBOLIC STRUCTURAL, P17; Mintz SW, 2002, ANNU REV ANTHROPOL, V31, P99, DOI 10.1146/annurev.anthro.32.032702.131011; Mondal A, 2008, J FOOD ENG, V86, P465, DOI 10.1016/j.jfoodeng.2007.11.014; Montanari M., 2017, FAME ABBONDANZA STOR; Montoya J, 2016, J ANAL APPL PYROL, V122, P106, DOI 10.1016/j.jaap.2016.10.010; Morehart CT, 2015, J ARCHAEOL METHOD TH, V22, P483, DOI 10.1007/s10816-013-9183-6; Netolitzky F., 1914, SITZUNGSBERICHTE MN, V123, P725; Odegaard N., 2007, HUMAN REMAINS GUIDE, P77; OUDEMANS TFM, 1991, J ANAL APPL PYROL, V20, P197, DOI 10.1016/0165-2370(91)80073-H; Palmer Carol, 2002, Acta Palaeobotanica, V42, P195; PEACOCK E, 1991, J FIELD ARCHAEOL, V18, P345, DOI 10.1179/009346991791548645; Peto A, 2013, J ARCHAEOL SCI, V40, P58, DOI 10.1016/j.jas.2012.08.027; Phelan W.H., 1971, B AM GROUP INT I CON, V11, P58; Pleterski A., 2015, REKONSTRUKTION MITTE, P123; Popova T., 2016, SE EUROPE ANATOLIA P; Popovtschak M, URNENFELDERKUL UNPUB; Primavera M, 2019, ARCHAEOL ANTHROP SCI, V11, P1273, DOI 10.1007/s12520-018-0605-y; Pucher E., 2018, BEITRAGE ARCHAOZOOLO, V11, P71; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasband W., 2006, IMAGEJ; Razavi P., 2013, REZEPT BILD BRONZEZE, P72; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rivers S, 2003, CONSERVATION FURNITU; Rodgers B. A., 2004, ARCHAEOLOGISTS MANUA; Saleem Q, 2005, J FOOD ENG, V68, P19, DOI 10.1016/j.jfoodeng.2004.05.020; Samuel D., 1994, THESIS; SCHIERER I., 1987, ARCHAEOLOGICA AUSTRI, V71, P29; Schmidt L., 1966, VOLKSKUNDE NIEDEROST; Schneider M., 1991, ACTA INTERDISCIPLINA, P295; Seibel W., 2005, WARENKUNDE GETREIDE; Seifert O, 2004, PANIS ANGELORUM BROT; Sherratt AG., 1991, PALEOECOLOGIA ARQUEO, P221; Simit Roth A., 2012, GASTRONOMICA, V12, P31, DOI [10.1525/gfc.2012.12.4.31, DOI 10.1525/GFC.2012.12.4.31]; Sperber L., 2017, STUDIEN SPATBRONZEZE; Stapel A., 1999, BRONZEZEITLICHE DEPO; Stika H.-P., 2013, OXFORD HDB EUROPEAN, P348, DOI DOI 10.1093/OXFORDHB/9780199572861.013.0019; Stika H-P., 2013, SIEDLUNGEN LTEREN BR, P189; Stillfried Felgenhauer F., 1996, FORSCHUNGEN STILLFRI, V9, P9; Szilvassy J, 1991, Anthropol Anz, V49, P303; Teper J.H., 2011, BPGA, V30, P131; Valamoti SM, 2019, J ARCHAEOL SCI, V104, P97, DOI 10.1016/j.jas.2018.11.004; Valamoti SM, 2011, ARCHAEOL ANTHROP SCI, V3, P19, DOI 10.1007/s12520-011-0058-z; Valamoti SM, 2017, ANTIQUITY, V91, DOI 10.15184/aqy.2017.130; Valamoti SM, 2008, VEG HIST ARCHAEOBOT, V17, pS265, DOI 10.1007/s00334-008-0190-6; vonGroller-Mildensee M., 1902, ROMISCHE LIMES OSTER, V3, P31; Wagner GE., 1988, CURRENT PALEOETHNOBO, P17; Wahren M, 1990, FUNDE AUSGRABUNGEN B, V22, P13; Wahren M., 1990, TRIERER Z, V53, P195; Wahren M., 1984, ARCHAOLOGIE SCHWEIZ, V7, P2, DOI 10.5169/seals-6409; Wang S, 2011, J CEREAL SCI, V54, P203, DOI 10.1016/j.jcs.2011.05.004; WANG SS, 1991, J FOOD SCI, V56, P121, DOI 10.1111/j.1365-2621.1991.tb07990.x; Weikart S., 2002, THESIS; Wilkins J., 2005, HLTH ANTIQUITY, P136; WINTON A. L., 1932, STRUCTURE COMPOSITIO; Wollstonecroft MM, 2011, ARCHAEOL ANTHROP SCI, V3, P141, DOI 10.1007/s12520-011-0062-3; Zapata Pena L., 2014, PLANTS PEOPLE CHOICE, P15; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	161	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216907	10.1371/journal.pone.0216907	http://dx.doi.org/10.1371/journal.pone.0216907			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166950	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000470087800014
J	van Minde, MRC; Blanchette, LMG; Raat, H; Steegers, EAP; de Kroon, MLA				van Minde, Minke R. C.; Blanchette, Lyne M. G.; Raat, Hein; Steegers, Eric A. P.; de Kroon, Marlou L. A.			Reducing growth and developmental problems in children: Development of an innovative postnatal risk assessment	PLOS ONE			English	Article							ADVERSE BIRTH OUTCOMES; LOW SOCIOECONOMIC-STATUS; WEIGHT-GAIN; CATCH-UP; POPULATION; HEALTH; BORN; NEIGHBORHOODS; CHECKLIST; BEHAVIOR	Introduction Globally, awareness of the relevance of both medical and non-medical risk factors influencing growth and development of children has been increasing. The aim of our study was to develop an innovative postnatal risk assessment to be used by the Preventive Child Healthcare (PCHC) to identify at an early stage children at risk for growth (catch-up growth, overweight and obesity) and developmental problems (such as motor, cognitive, psychosocial and language/speech problems). Methods We used the first four steps of the Intervention Mapping process. Step 1: Review of the literature and focus group discussions. Step 2: Identification of program objectives on how to develop and implement a risk assessment in PCHC daily practice. Step 3: Application of the ASE model to initiate behavioral change in the target group. Step 4: Development of the postnatal R4U and a program plan for the implementation in PCHC organizations. Results Subsequently in 2015, the 41 item postnatal R4U (the postnatal Rotterdam Reproduction Risk Reduction checklist) was developed according to steps one until four of the Intervention Mapping process and was implemented in four PCHC organizations. Conclusions It was feasible to design and implement a postnatal risk assessment identifying both medical and non-medical risks for growth and developmental problems, using the Intervention Mapping process.	[van Minde, Minke R. C.; Steegers, Eric A. P.] Erasmus Univ, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Med Ctr, Rotterdam, Netherlands; [van Minde, Minke R. C.; Raat, Hein; de Kroon, Marlou L. A.] Erasmus Univ, Dept Publ Hlth, Div Child & Youth, Med Ctr, Rotterdam, Netherlands; [Blanchette, Lyne M. G.] Municipal City Rotterdam, Dept Social Dev, Rotterdam, Netherlands; [de Kroon, Marlou L. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	van Minde, MRC (corresponding author), Erasmus Univ, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Med Ctr, Rotterdam, Netherlands.; van Minde, MRC (corresponding author), Erasmus Univ, Dept Publ Hlth, Div Child & Youth, Med Ctr, Rotterdam, Netherlands.	m.vanminde@erasmusmc.nl	de Kroon, Marlou MLA/M-4040-2014	van Minde, Minke/0000-0003-3316-336X; de Kroon, Marlou/0000-0003-1730-4994	Dutch government, Ministry of Welfare and Sports (VWS) [323911]	Dutch government, Ministry of Welfare and Sports (VWS)	The HP4All-2 program has been funded by the Dutch government, Ministry of Welfare and Sports (VWS), grant 323911 to EAPS. The study sponsor had no role in the study design, writing the report and the decision to submit the report for publication.	Arpi E, 2013, DEV MED CHILD NEUROL, V55, P788, DOI 10.1111/dmcn.12142; Bartholomew Eldridge L.K., 2016, PLANNING HLTH PROMOT; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; BRUG J, 1995, APPETITE, V25, P285, DOI 10.1006/appe.1995.0062; cie- de Winter, 2013, RAPP STEV FUND EV BA; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; de Waal CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041302; DEVRIES H, 1995, J APPL SOC PSYCHOL, V25, P237; Dua T, 2016, LANCET GLOB HEALTH, V4, pE887, DOI 10.1016/S2214-109X(16)30218-2; Dunger DB, 2006, MOL CELL ENDOCRINOL, V254, P140, DOI 10.1016/j.mce.2006.04.003; Fishbein, 2010, PREDICTION CHANGE HL; Garba RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174438; Heppe DHM, 2013, PEDIATR RES, V73, P120, DOI 10.1038/pr.2012.145; Holmbeck GN, 2009, J PEDIATR PSYCHOL, V34, P691, DOI 10.1093/jpepsy/jsp046; Kerstjens JM, 2013, OBSTET GYNECOL, V121, P727, DOI 10.1097/AOG.0b013e3182860c52; Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x; Moore GF, 2017, SSM-POPUL HLTH, V3, P132, DOI 10.1016/j.ssmph.2016.12.005; Morandi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049919; Pereira SMP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011044; Polk S, 2016, PUBLIC HEALTH NUTR, V19, P1777, DOI 10.1017/S1368980015003201; Posthumus AG, 2016, MIDWIFERY, V38, P78, DOI 10.1016/j.midw.2015.11.006; Potijk MR, 2015, EUR CHILD ADOLES PSY, V24, P787, DOI 10.1007/s00787-014-0623-y; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Razaz N, 2016, ARCH DIS CHILD-FETAL, V101, pF114, DOI 10.1136/archdischild-2015-308458; Scholte RS, 2015, J HEALTH ECON, V39, P17, DOI 10.1016/j.jhealeco.2014.10.002; Schouten MCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165641; Sittig JS, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-91; Staal IIE, 2015, PREV MED, V81, P236, DOI 10.1016/j.ypmed.2015.09.003; Steegers-Theunissen RPM, 2015, REPROD FERT DEVELOP, V27, P712, DOI 10.1071/RD14386; Taal HR, 2013, OBESITY, V21, P1261, DOI 10.1002/oby.20116; van der Kooy J, 2011, OBSTET GYNECOL, V118, P1037, DOI 10.1097/AOG.0b013e3182319737; van Stel HF, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-71; van Veen MJ, 2015, MIDWIFERY, V31, P147, DOI 10.1016/j.midw.2014.08.002; Vos AA, 2015, INT J INTEGR CARE, V15; Vos AA, 2014, ACTA OBSTET GYN SCAN, V93, P727, DOI 10.1111/aogs.12430; Waelput AJM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1425-2; Weigl M, 2017, OCCUP MED-OXFORD, V67, P7, DOI 10.1093/occmed/kqw151; Wells NM, 2010, AM J PUBLIC HEALTH, V100, P2507, DOI 10.2105/AJPH.2009.184291; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR; Zeitlin J, 2013, J EPIDEMIOL COMMUN H, V67, P983, DOI 10.1136/jech-2013-203291; Zimmerman E, 2018, J SPEECH LANG HEAR R, V61, P53, DOI 10.1044/2017_JSLHR-L-16-0150	44	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217261	10.1371/journal.pone.0217261	http://dx.doi.org/10.1371/journal.pone.0217261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166964	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800020
J	Zar, G; Smith, JG; Smith, ML; Andersson, B; Nilsson, J				Zar, Gustav; Smith, J. Gustav; Smith, Maya Landenhed; Andersson, Bodil; Nilsson, Johan			Whole-genome sequencing based on formalin-fixed paraffin-embedded endomyocardial biopsies for genetic studies on outcomes after heart transplantation	PLOS ONE			English	Article							DNA METHYLATION; INTERNATIONAL SOCIETY; FRAMEWORK; ACCURATE; REGISTRY	Background Whole-genome sequencing (WGS) of heart transplant recipient-and donor-derived cardiac biopsies may facilitate organ matching, graft failure prediction, and immunotolerance research. The objective of this study was to determine the feasibility of WGS based on formalin-fixed paraffin-embedded endomyocardial biopsies. Methods and results The study included serial donor-and recipient samples from patients who had undergone heart transplantation at Skane University Hospital, Lund, Sweden, between 1988 and 2009. DNA extraction and WGS were conducted. Additional WGS sequencing quality metrics and coverage were obtained with the Genome Analysis Toolkit (GATK). 455 endomyocardial samples from 37 heart transplant recipients were acquired from routine rejection monitoring and stored as formalin-fixed paraffin-embedded samples. They were analyzed after 3-26 years of storage. DNA was extracted from 114 samples and WGS was run on 85 samples. DNA extraction yielded 313 ng (IQR 96-601) for all samples. A coverage of 11.3x (IQR 9.0-15.9) was recorded for all WGS samples. Three samples stored for > 25 years yielded a coverage of > 25x. Data were generated for 1.7 billion reads per sample (IQR 1.42.7). A Transition/Transversion (TiTv) ratio of 2.09 +/- 0.05 was calculated for all WGS samples. No associations were found among storage time, DNA yield, or sequencing quality metrics. Conclusions The present study demonstrated the feasibility of whole-genome sequencing based on endomyocardial biopsies. This process could enable large-scale retrospective genomic studies using stored histopathological samples.	[Zar, Gustav; Smith, Maya Landenhed; Nilsson, Johan] Lund Univ, Dept Clin Sci Lund, Cardiothorac Surg, Lund, Sweden; [Zar, Gustav; Smith, J. Gustav; Smith, Maya Landenhed; Andersson, Bodil; Nilsson, Johan] Skane Univ Hosp, Lund, Sweden; [Smith, J. Gustav] Lund Univ, Dept Clin Sci, Cardiol, Lund, Sweden; [Smith, J. Gustav] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Andersson, Bodil] Lund Univ, Dept Clin Sci Lund, Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Lund, Cardiothorac Surg, Lund, Sweden.; Nilsson, J (corresponding author), Skane Univ Hosp, Lund, Sweden.	johan.nilsson@med.lu.se	Nilsson, Johan/A-4742-2011	Nilsson, Johan/0000-0001-6860-6090; Zar, Gustav/0000-0002-5791-6496	Swedish Heart-Lung Foundation; Swedish Society of Medicine; Anna-Lisa and Sven Eric Lundgrens Foundation; Crafoord Foundation; Region Skane Research Funds	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; Anna-Lisa and Sven Eric Lundgrens Foundation; Crafoord Foundation; Region Skane Research Funds	This study was funded by the Swedish Heart-Lung Foundation, the Swedish Society of Medicine, a government grant for clinical research, Region Skane Research Funds, Donation Funds from Skane University Hospital, the Anna-Lisa and Sven Eric Lundgrens Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Baudhuin LM, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001844; Bonnet E, 2018, PLOS ONE, V13, pR1, DOI [10.1186/gb-2011-12-1-r1, DOI 10.1186/GB-2011-12-1-R1]; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Carrick DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127353; Crespo-Leiro MG, 2008, AM J TRANSPLANT, V8, P1031, DOI 10.1111/j.1600-6143.2008.02196.x; Dallol A, 2011, METHODS MOL BIOL, V724, P191, DOI 10.1007/978-1-61779-055-3_13; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Illumina, 2014, SEQ COV CALC METH HU, P1; KapaBiosystems, 2016, KAPA HUM GEN DNA QUA, P1; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Moran B, 2017, ONCOTARGET, V8, P48126, DOI 10.18632/oncotarget.18296; Peters FS, 2016, J HEART LUNG TRANSPL, V35, P843, DOI 10.1016/j.healun.2016.02.007; Robbe P, 2018, GENET MED, V20, P1196, DOI 10.1038/gim.2017.241; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217747	10.1371/journal.pone.0217747	http://dx.doi.org/10.1371/journal.pone.0217747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166960	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800037
J	Spensieri, V; Cerutti, R; Presaghi, F; Amendola, S; Crozier, WR				Spensieri, Valentina; Cerutti, Rita; Presaghi, Fabio; Amendola, Simone; Crozier, W. Ray			Italian validation of the Children's Shyness Questionnaire: Exploring associations between shyness and psychosocial functioning	PLOS ONE			English	Article							INTERNET ADDICTION; PEER ATTACHMENT; SELF-ESTEEM; INDIVIDUAL-DIFFERENCES; BEHAVIORAL-INHIBITION; SOCIAL WITHDRAWAL; YOUNG-ADULTS; INVENTORY; TEMPERAMENT; ADJUSTMENT	Background In recent years, researchers have begun to explore the implications of shyness for the psychosocial wellbeing of children and adolescents, exploring its association with internalizing problems. Research in an Italian context is hindered by the lack of a validated self-report measure of shyness. We report two studies aimed to assess the psychometric properties of an Italian translation of the Children's Shyness Questionnaire (CSQ-it) and investigate its correlations with convergent and divergent constructs. The first study aimed to examine associations between CSQ-it and self-report measures of anxiety and somatic symptoms and attachment with parents and peers. The second study aimed to investigate its relations to internet addiction. Methods The self-report measures were completed by 550 participants in the first study and 131 participants in the second study. Parents provided information on their child's problems. Psychometric properties were assessed by Cronbach's alpha in both studies and by exploratory and confirmatory factor analysis in Study 1. The relations between shyness and measures of internalizing problems and attachments were analyzed by correlational methods. In Study 2 a moderated mediation model tested the hypothesis that the relationship between shyness and internet addiction is mediated by somatic symptoms and that shyness moderates the relationship between somatic symptoms and internet addiction. Results The reliability and validity of the Italian Version of the Children's Shyness Questionnaire were satisfactory. Results from confirmatory factor analyses confirmed the single-factor model of the questionnaire previously identified in North American and Chinese studies. There were significant correlations between shyness, anxious and somatic symptomatology, impaired psychosocial functioning and specific components of attachment relationships. In Study 2 the indirect effect of shyness on internet addiction through somatic symptoms was significant as well as significantly moderated for high shyness scores but not for low levels of shyness. Conclusion To our knowledge this is the first study that explored the psychometric proprieties of the Children's Shyness Questionnaire in the Italian context. Findings demonstrated that this self-reported measure of shyness has sound psychometric properties and can be used as a sensitive and appropriate instrument for the assessment of shyness in children and adolescents.	[Spensieri, Valentina; Cerutti, Rita; Amendola, Simone] Sapienza Univ, Dept Dynam & Clin Psychol, Rome, Italy; [Presaghi, Fabio] Sapienza Univ, Dept Psychol Dev & Social Proc, Rome, Italy; [Crozier, W. Ray] Cardiff Univ, Sch Social Sci, Cardiff, S Glam, Wales	Sapienza University Rome; Sapienza University Rome; Cardiff University	Spensieri, V (corresponding author), Sapienza Univ, Dept Dynam & Clin Psychol, Rome, Italy.	valentina.spensieri@uniroma1.it	Presaghi, Fabio/N-1590-2019; Amendola, Simone/AAY-6051-2021; Crozier, Raymond/AAH-1585-2019	Presaghi, Fabio/0000-0001-7880-6715; Amendola, Simone/0000-0002-1950-4351; SPENSIERI, VALENTINA/0000-0001-5413-3528				ALDEN LE, 1995, BEHAV RES THER, V33, P497, DOI 10.1016/0005-7967(94)00088-2; American Psychological Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2001, PLAY OBSERVATION SCA; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Baiocco R, 2009, PSICOL CLIN SVILUPP, V13, P355, DOI 10.1449/30135; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; BELL IR, 1990, PSYCHOSOM MED, V52, P517, DOI 10.1097/00006842-199009000-00004; Biederman J, 2001, AM J PSYCHIAT, V158, P1673, DOI 10.1176/appi.ajp.158.10.1673; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Boccia Artieri G, 2004, COMUNICAZIONE LUOGHI; Booth-LaForce C, 2008, DEV PSYCHOL, V44, P1298, DOI 10.1037/a0012954; Bowlby J., 1973, ATTACHMENT LOSS, V2; Bowlby J, 1969, ATTACHMENT LOSS SEPA; BRUCH MA, 1989, J PERS SOC PSYCHOL, V57, P904, DOI 10.1037/0022-3514.57.5.904; Casale S, 2011, INT J PSYCHOL, V46, P288, DOI 10.1080/00207594.2010.541256; Cerruti R, 2017, CLIN NEUROPSYCHIATR, V14, P374; Cerutti R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171867; Cerutti R, 2016, HEADACHE, V56, P1161, DOI 10.1111/head.12840; Chak K, 2004, CYBERPSYCHOL BEHAV, V7, P559, DOI 10.1089/cpb.2004.7.559; Chan SM, 2012, ASIA-PAC PSYCHIAT, V4, P233, DOI 10.1111/j.1758-5872.2012.00179.x; CHEEK JM, 1981, J PERS SOC PSYCHOL, V41, P330, DOI 10.1037/0022-3514.41.2.330; Chung JYY, 2000, CAN J BEHAV SCI, V32, P49, DOI 10.1037/h0087100; Coplan R.J., 2010, DEV SHYNESS SOCIAL W, P3; Coplan RJ, 2004, DEV PSYCHOL, V40, P244, DOI 10.1037/0012-1649.40.2.244; Coplan RJ, 2008, J ABNORM CHILD PSYCH, V36, P359, DOI 10.1007/s10802-007-9183-7; Coplan RJ, 2013, DEV PSYCHOL, V49, P861, DOI 10.1037/a0028861; Crozier W. R., 2002, BODY SHAME CONCEPTUA, P205; CROZIER WR, 1995, BRIT J EDUC PSYCHOL, V65, P85, DOI 10.1111/j.2044-8279.1995.tb01133.x; Crozier WR, 2001, SHYNESS DEV CONSOLID; Crozier WR, 2005, PERSONALITY INDIVIDU, V38, P81047; De Acutis S, 2009, PSICHIATRIA INFANZIA, V76, P608; Di Lorenzo M., 2013, PSICHIATRIA E PSICOT, V32, P101; Ding XC, 2014, PERS INDIV DIFFER, V68, P183, DOI 10.1016/j.paid.2014.04.027; Edelmann R.J., 1987, PSYCHOL EMBARRASSMEN; Essex MJ, 2010, AM J PSYCHIAT, V167, P40, DOI 10.1176/appi.ajp.2009.07010051; Findlay LC, 2008, CAN J BEHAV SCI, V40, P153, DOI 10.1037/0008-400X.40.3.153; Findlay LC, 2009, INT J BEHAV DEV, V33, P47, DOI 10.1177/0165025408098017; Fordham K, 1999, J CHILD PSYCHOL PSYC, V40, P757, DOI 10.1111/1469-7610.00491; Guidetti V, 2015, CEPHALALGIA, V35, P204; Gullone E, 2005, CLIN PSYCHOL PSYCHOT, V12, P67, DOI 10.1002/cpp.433; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Henderson HA, 2015, NEUROPSYCHOPHARMACOL, V40, P207, DOI 10.1038/npp.2014.189; Henriksen RE, 2009, SCHOOL PSYCHOL INT, V30, P148, DOI 10.1177/0143034309104149; Huan VS, 2014, J PSYCHOL, V148, P699, DOI 10.1080/00223980.2013.825229; Hughes K, 2010, SCHOOL PSYCHOL QUART, V25, P213, DOI 10.1037/a0022070; Jones KM., 2014, PSYCHOLOGY, V5, P244, DOI [10.4236/psych.2014.53035., DOI 10.4236/PSYCH.2014.53035, 10.4236/psych.2014.53035]; Kagan J, 1999, DEV PSYCHOPATHOL, V11, P209, DOI 10.1017/S0954579499002023; Kagan J., 2004, LONG SHADOW TEMPERAM; Kennedy JH, 2004, PSYCHOL SCHOOLS, V41, P247, DOI 10.1002/pits.10153; Kingsbury M, 2013, SOC DEV, V22, P126, DOI 10.1111/sode.12003; Kokkinos CM, 2016, SOC PSYCHOL EDUC, V19, P117, DOI 10.1007/s11218-015-9317-7; Larose S, 2001, Attach Hum Dev, V3, P96; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Masi G, 2003, CHILD PSYCHIAT HUM D, V33, P245, DOI 10.1023/A:1021408714741; Miller Jessie L, 2008, Eat Behav, V9, P352, DOI 10.1016/j.eatbeh.2008.01.001; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; Ogliari A, 2006, J ANXIETY DISORD, V20, P760, DOI 10.1016/j.janxdis.2005.11.004; Park SK, 2008, ADOLESCENCE, V43, P895; Piko BF, 2016, EUR J PEDIATR, V175, P785, DOI 10.1007/s00431-016-2709-7; Pontes HM, 2014, J BEHAV ADDICT, V3, P107, DOI 10.1556/JBA.3.2014.2.4; Revelle W., 2016, PROCEDURES PERSONALI; Roberts LD, 2000, SHYNESS DEV CONSOLID, P121, DOI DOI 10.4324/9780203183427; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; ROTHBART MK, 1994, J ABNORM PSYCHOL, V103, P55, DOI 10.1037/0021-843X.103.1.55; RUBIN KH, 1995, DEV PSYCHOPATHOL, V7, P751, DOI 10.1017/S0954579400006829; Rubin KH., 2002, HDB PARENTING, P383; San Martini P., 2009, GIORNALE ITALIANO PS, V36, P199, DOI [10.1421/29288, DOI 10.1421/29288]; Scaini S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00242; SCHMIDT LA, 1995, PERS INDIV DIFFER, V19, P455, DOI 10.1016/0191-8869(95)00083-I; Schwartz CE, 1999, J AM ACAD CHILD PSY, V38, P1008, DOI 10.1097/00004583-199908000-00017; Sette S, 2014, INFANT CHILD DEV, V23, P323, DOI 10.1002/icd.1859; Spangler G, 1998, INT J BEHAV DEV, V22, P681, DOI 10.1080/016502598384126; Spensieri V, 2016, J BEHAV ADDICT, V5, P58; Spooner AL, 2005, MERRILL PALMER QUART, V51, P437, DOI 10.1353/mpq.2005.0028; STEMBERGER T, 1995, J ABNORM PSYCHOL, V104, P526, DOI 10.1037/0021-843X.104.3.526; Team RC., 2013, R LANG ENV STAT COMP; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; Walker LS, 2005, HEALTH PSYCHOL, V24, P364, DOI 10.1037/0278-6133.24.4.364; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; WALKER LS, 1991, J ABNORM CHILD PSYCH, V19, P379, DOI 10.1007/BF00919084; Walker LS, 2009, J PEDIATR PSYCHOL, V34, P430, DOI 10.1093/jpepsy/jsn093; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019660; Young KS., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Zhang Z, 2018, PRACTICAL STAT POWER	84	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217722	10.1371/journal.pone.0217722	http://dx.doi.org/10.1371/journal.pone.0217722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163051	Green Submitted, gold, Green Published			2022-12-27	WOS:000470086200030
J	Agbemabiese, CA; Nakagomi, T; Damanka, SA; Dennis, FE; Laney, BL; Armah, GE; Nakagomi, O				Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Damanka, Susan Afua; Dennis, Francis Ekow; Laney, Belinda Larteley; Armah, George Enyimah; Nakagomi, Osamu			Sub-genotype phylogeny of the non-G, non-P genes of genotype 2 Rotavirus A strains	PLOS ONE			English	Article							EQUINE-LIKE; REASSORTANT ROTAVIRUS; ACUTE GASTROENTERITIS; MOLECULAR CHARACTERIZATION; GENOME CHARACTERIZATION; DS-1-LIKE; CHILDREN; EMERGENCE; EVOLUTION; JAPAN	Recent increase in the detection of unusual G1P[8], G3P[8], G8P[8], and G9P[4] Rotavirus A (RVA) strains bearing the DS-1-like constellation of the non-G, non-P genes (hereafter referred to as the genotype 2 backbone) requires better understanding of their evolutionary relationship. However, within a genotype, there is lack of a consensus lineage designation framework and a set of common sequences that can serve as references. Phylogenetic analyses were carried out on over 8,500 RVA genotype 2 genes systematically retrieved from the rotavirus database within the NCBI Virus Variation Resource. In line with previous designations, using pairwise comparison of cogent nucleotide sequences and stringent bootstrap support, reference lineages were defined. This study proposes a lineage framework and provides a dataset ranging from 34 to 145 sequences for each genotype 2 gene for orderly lineage designation of global genotype 2 genes of RVAs detected in human and animals. The framework identified five to 31 lineages depending on the gene. The least number of lineages (five to seven) were observed in genotypes A2 (NSP1), T2 (NSP3) and H2 (NSP5) which are limited to human RVA whereas the most number of lineages (31) was observed in genotype E2 (NSP4). Sharing of the same lineage constellations of the genotype 2 backbone genes between recently-emerging, unusual G1P[8], G3P[8], G8P[8] and G9P[4] reassortants and many contemporary G2P[4] strains provided strong support to the hypothesis that unusual genotype 2 strains originated primarily from reassortment events in the recent past involving contemporary G2P[4] strains as one parent and ordinary genotype 1 strains or animal RVA strains as the other. The lineage framework with selected reference sequences will help researchers to identify the lineage to which a given genotype 2 strain belongs, and trace the evolutionary history of common and unusual genotype 2 strains in circulation.	[Agbemabiese, Chantal Ama; Damanka, Susan Afua; Dennis, Francis Ekow; Laney, Belinda Larteley; Armah, George Enyimah] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana; [Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Epidemiol, Nagasaki, Japan	University of Ghana; Nagasaki University	Agbemabiese, CA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana.; Agbemabiese, CA (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Epidemiol, Nagasaki, Japan.	chagbem@gmail.com		Agbemabiese, Chantal/0000-0003-1862-9408				Agbemabiese CA, 2015, J GEN VIROL, V96, P2219, DOI 10.1099/vir.0.000174; Agbemabiese CA, 2017, MICROBIOL IMMUNOL, V61, P328, DOI 10.1111/1348-0421.12501; Agbemabiese CA, 2016, INFECT GENET EVOL, V45, P122, DOI 10.1016/j.meegid.2016.08.024; Agbemabiese CA, 2015, INFECT GENET EVOL, V35, P184, DOI 10.1016/j.meegid.2015.07.033; Aida S, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00168; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Do LP, 2015, MICROBIOL IMMUNOL, V59, P605, DOI 10.1111/1348-0421.12323; Doan YH, 2017, INFECT GENET EVOL, V54, P417, DOI 10.1016/j.meegid.2017.07.025; Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065; Heylen E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14658; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Ianiro G, 2018, INFECT GENET EVOL, V64, P57, DOI 10.1016/j.meegid.2018.06.017; Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kikuchi W, 2018, ARCH VIROL, V163, P791, DOI 10.1007/s00705-017-3668-7; Komoto S, 2018, J MED VIROL, V90, P890, DOI 10.1002/jmv.25016; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Kondo K., 2014, JAPAN EMERG INFECT D, V23, P968; Lewis J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01284-14; Luchs A, 2019, J GEN VIROL, V100, P7, DOI 10.1099/jgv.0.001171; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Nakagomi T, 2017, ARCH VIROL, V162, P213, DOI 10.1007/s00705-016-3103-5; Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Perkins C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01341-17; Pietsch C, 2018, INFECT GENET EVOL, V57, P46, DOI 10.1016/j.meegid.2017.11.007; Pradhan GN, 2016, J GEN VIROL, V97, P3139, DOI 10.1099/jgv.0.000650; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tacharoenmuang R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165826; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran T N Hoa, 2013, Trop Med Health, V41, P13, DOI 10.2149/tmh.2012-29; Yamamoto D, 2017, New Microbes New Infect, V18, P54, DOI 10.1016/j.nmni.2017.04.001; Yamamoto SP, 2015, J MED VIROL, V87, P1311, DOI 10.1002/jmv.24121; Yodmeeklin A, 2018, ARCH VIROL, V163, P2165, DOI 10.1007/s00705-018-3848-0	50	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217422	10.1371/journal.pone.0217422	http://dx.doi.org/10.1371/journal.pone.0217422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150425	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100049
J	Duranti, S; Mancabelli, L; Mancino, W; Anzalone, R; Longhi, G; Statello, R; Carnevali, L; Sgoifo, A; Bernasconi, S; Turroni, F; Ventura, M				Duranti, Sabrina; Mancabelli, Leonardo; Mancino, Walter; Anzalone, Rosaria; Longhi, Giulia; Statello, Rosario; Carnevali, Luca; Sgoifo, Andrea; Bernasconi, Sergio; Turroni, Francesca; Ventura, Marco			Exploring the effects of COLOSTRONONI on the mammalian gut microbiota composition	PLOS ONE			English	Article							MORINDA-CITRIFOLIA NONI; BOVINE COLOSTRUM; TNF-ALPHA; CELLS; CONSTITUENTS; THERAPY; FRUIT; JUICE	COLOSTRONONI is a dietary supplement consisting of bovine colostrum and Morinda citrifolia fruit (Noni). In this study, we tested the capability of COLOSTRONONI to influence gut microbiota composition using an in vivo evaluation in rats. Furthermore, we analyzed the effect of COLOSTRONONI on the systemic inflammatory responses as well as on the gut permeability of the animals. Altogether, our analyses supported the concept of COLOSTRONONI as a natural food supplement that doesn't affect (neither negatively nor positively) gut microbiota homeostasis in healthy conditions. Moreover, COLOSTRONONI highlighted a lower effect in the expression of genes coding for IL-10, Il-12 and TNF-alpha response allowing us to hypothesize an immunomodulatory activity of this dietary supplement.	[Duranti, Sabrina; Mancabelli, Leonardo; Mancino, Walter; Turroni, Francesca; Ventura, Marco] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy; [Anzalone, Rosaria; Longhi, Giulia] GenProbio Srl Parma, Parma, Italy; [Statello, Rosario; Carnevali, Luca; Sgoifo, Andrea] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Stress Physiol Lab, Parma, Italy; [Sgoifo, Andrea; Bernasconi, Sergio; Turroni, Francesca; Ventura, Marco] Univ Parma, Microbiome Res Hub, Parma, Italy	University of Parma; University of Parma; University of Parma	Ventura, M (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy.; Ventura, M (corresponding author), Univ Parma, Microbiome Res Hub, Parma, Italy.	marco.ventura@unipr.it	Duranti, Sabrina/AAI-7916-2020; Sgoifo, Andrea/AAC-6278-2022; Mancabelli, Leonardo/AAV-5147-2021; Turroni, Francesca/K-9660-2016; ventura, marco/M-8230-2015; Bernasconi, Sergio/AAA-9419-2021; Carnevali, Luca/E-5322-2017	Duranti, Sabrina/0000-0002-7724-5669; Sgoifo, Andrea/0000-0002-9428-6198; Mancabelli, Leonardo/0000-0002-1744-2214; Turroni, Francesca/0000-0001-5363-0231; Carnevali, Luca/0000-0001-9053-7976; Statello, Rosario/0000-0002-0644-2454	GenProbio srl	GenProbio srl	GenProbio srl supports the Laboratory of Probiogenomics. The funder provided support in the form of salaries for R.A. and G.L. and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Assi R, 2017, ARAB J CHEM, V10, P691, DOI 10.1016/j.arabjc.2015.06.018; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardani D, 2014, Minerva Gastroenterol Dietol, V60, P71; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferrario C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01749; Filipescu IE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202929; Furusawa E, 2003, PHYTOTHER RES, V17, P1158, DOI 10.1002/ptr.1307; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gorska S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37613; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Kamiya K, 2004, J AGR FOOD CHEM, V52, P5843, DOI 10.1021/jf040114k; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Leppkes M, 2014, INT IMMUNOL, V26, P509, DOI 10.1093/intimm/dxu051; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Pakkanen R, 1997, INT DAIRY J, V7, P285, DOI 10.1016/S0958-6946(97)00022-8; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rathe M, 2014, NUTR REV, V72, P237, DOI 10.1111/nure.12089; Saludes JP, 2002, PHYTOTHER RES, V16, P683, DOI 10.1002/ptr.1003; Shen YJ, 2017, AM J PHYSIOL-GASTR L, V312, pG123, DOI 10.1152/ajpgi.00316.2016; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Sponseller JK, 2015, J INFECT DIS, V211, P1334, DOI 10.1093/infdis/jiu605; Uruakpa FO, 2002, NUTR RES, V22, P755, DOI 10.1016/S0271-5317(02)00373-1; Yang J, 2007, FOOD CHEM, V102, P302, DOI 10.1016/j.foodchem.2006.05.020; Zin ZM, 2006, FOOD CHEM, V94, P169, DOI 10.1016/j.foodchem.2004.08.048	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217609	10.1371/journal.pone.0217609	http://dx.doi.org/10.1371/journal.pone.0217609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150516	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100070
J	Nagoshi, RN; Dhanani, I; Asokan, R; Mahadevaswamy, HM; Kalleshwaraswamy, CM; Sharanabasappa; Meagher, RL				Nagoshi, Rodney N.; Dhanani, Isabel; Asokan, R.; Mahadevaswamy, H. M.; Kalleshwaraswamy, Chicknayakanahalli M.; Sharanabasappa; Meagher, Robert L.			Genetic characterization of fall armyworm infesting South Africa and India indicate recent introduction from a common source population	PLOS ONE			English	Article							SMITH LEPIDOPTERA-NOCTUIDAE; HOST STRAINS; UNITED-STATES; MIGRATION; IDENTIFICATION; DIVERGENCE; PATTERNS; MEXICO; TEXAS	The invasion of the Western Hemisphere native fall armyworm (Spodoptera frugiperda; J. E. Smith) (Lepidoptera: Noctuidae) into the Eastern Hemisphere has been notable for the rapidity and geographical breadth of new detections. In the year following the first discovery in western sub-Saharan Africa in 2016, infestations have been documented in most sub-Saharan maize growing regions and has now expanded beyond Africa with populations recently reported in India. These observations could indicate a remarkable capacity for rapid establishment and long-distance dissemination. However, while fall armyworm does exhibit extended migration in North America where it annually traverses thousands of kilometers, this behavior is known to be dependent on highly favorable wind patterns and so can't be assumed to occur in all locations. An alternative possibility is that the species has long been present in Africa, and perhaps the rest of the hemisphere, but was undetected until the enhanced monitoring that resulted after its initial discovery. Determining whether the fall armyworm in the Eastern Hemisphere is newly arrived or long pre-existing is important for assessing the risks of significant economic impacts, as the former indicates a change in pest composition while the latter does not. This study examined this issue by comparing collections from two geographically distant locations, South Africa and India. Sequence comparisons were used to quantify differences between the South Africa and India collections, assess the likelihood of their sharing a common source population, and their possible relationship with previously characterized fall armyworm from other regions of Africa. The results indicate genetic homogeneity between the South African and Indian fall armyworm populations tested and substantial similarities between these and collections from eastern Africa. The implications of these findings on fall armyworm population behavior and composition are discussed.	[Nagoshi, Rodney N.; Meagher, Robert L.] USDA, Ctr Med Agr & Vet Entomol, ARS, Gainesville, FL 32608 USA; [Dhanani, Isabel] Plant Hlth Diagnost Serv, DAFF, Stellenbosch, South Africa; [Asokan, R.; Mahadevaswamy, H. M.; Kalleshwaraswamy, Chicknayakanahalli M.] Indian Inst Hort Res, Div Biotechnol, Hessaraghatta Lake PO, Bangalore, Karnataka, India; [Sharanabasappa] Univ Agr & Hort Sci, Dept Entomol, Shivamogga, Karnataka, India	United States Department of Agriculture (USDA); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Nagoshi, RN (corresponding author), USDA, Ctr Med Agr & Vet Entomol, ARS, Gainesville, FL 32608 USA.	rodney.nagoshi@ars.usda.gov	, Kalleshwaraswamy/Z-2891-2019	Meagher, Robert/0000-0003-2769-1043	United States Department of Agriculture Agricultural Research Service (CRIS) [6615-22000-016-00D]; National Institute of Food and Agriculture [2011-67003-30209]; Agricultural Research Service of the United States Department of Agriculture, USAID; United States Department of Agriculture National Institutes for Food and Agriculture [2011-67003-30209]	United States Department of Agriculture Agricultural Research Service (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Agricultural Research Service of the United States Department of Agriculture, USAID(United States Agency for International Development (USAID)); United States Department of Agriculture National Institutes for Food and Agriculture	R.N.N. and R.L.M. received funding from the United States Department of Agriculture Agricultural Research Service (CRIS # 6615-22000-016-00D, https://www.ars.usda.gov/) and the National Institute of Food and Agriculture (2011-67003-30209, https://nifa.usda.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. J.M.G. Thomas for technical assistance and together with Dr. D. Dixon for comments about the manuscript. Support came from the Agricultural Research Service of the United States Department of Agriculture, USAID, and the United States Department of Agriculture National Institutes for Food and Agriculture (2011-67003-30209). The use of trade, firm, or corporation names in this publication is for the information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable.	Cock MJW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04238-y; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Ganiger PC, 2018, CURR SCI INDIA, V115, P621, DOI 10.18520/cs/v115/i4/621-623; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052594; Jacobs A, 2018, AFR ENTOMOL, V26, P45, DOI 10.4001/003.026.0045; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2016, INSECT MOL BIOL, V25, P324, DOI 10.1111/imb.12223; Nagoshi RN, 2006, ENVIRON ENTOMOL, V35, P561, DOI 10.1603/0046-225X-35.2.561; Nagoshi RN, 2004, FLA ENTOMOL, V87, P440, DOI 10.1653/0015-4040(2004)087[0440:BADOTT]2.0.CO;2; Nagoshi RN, 2017, J EC ENTOMOL; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208966; Nagoshi RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21954-1; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175076; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2012, ANN ENTOMOL SOC AM, V105, P351, DOI 10.1603/AN11138; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Otim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194571; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; Rosenberg J., 1999, AEROBIOLOGIA, V15, P167; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Sharanabasappa Kalleshwaraswamy CM, 2018, PEST MANAGE HORTIC E, V24, P23; Shylesha A. N., 2018, Journal of Biological Control, V32, P145, DOI 10.18311/jbc/2018/21707; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Srinivasan R, 2018, CURR SCI INDIA, V114, P27, DOI 10.18520/cs/v114/i01/27-28; Swamy H.M. Mahadeva, 2018, Indian Journal of Entomology, V80, P544, DOI 10.5958/0974-8172.2018.00239.0; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x	43	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217755	10.1371/journal.pone.0217755	http://dx.doi.org/10.1371/journal.pone.0217755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150493	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100098
J	Hedman, L; Manley, D; van Ham, M				Hedman, Lina; Manley, David; van Ham, Maarten			Using sibling data to explore the impact of neighbourhood histories and childhood family context on income from work	PLOS ONE			English	Article							INTERGENERATIONAL TRANSMISSION; CONCENTRATED DISADVANTAGE; EXPOSURE; POVERTY; CHILDREN; OUTCOMES; RISK; INEQUALITY; EDUCATION; MOBILITY	Previous research has reported evidence of intergenerational transmissions of neighbourhood status and social and economic outcomes later in life. Research also shows neighbourhood effects on adult incomes of both childhood and adult neighbourhood experiences. However, these estimates of neighbourhood effects may be biased because confounding factors originating from the childhood family context. It is likely that part of the neighbourhood effects observed for adults, are actually lingering effects of the family in which someone grew up. This study uses a sibling design to disentangle family and neighbourhood effects on income, with contextual sibling pairs used as a control group. The sibling design helps us to separate the effects of childhood family and neighbourhood context from adult neighbourhood experiences. Using data from Swedish population registers, including the full Swedish population, we show that the neighbourhood effect on income from both child-hood and adult neighbourhood experiences, is biased upwards by the influence of the child-hood family context. Ultimately, we conclude that there is a neighbourhood effect on income from adult neighbourhood experiences, but that the childhood neighbourhood effect is actually a childhood family context effect. We find that there is a long lasting effect of the family context on income later in life, and that this effect is strong regardless the individual neighbourhood pathway later in life.	[Hedman, Lina] Uppsala Univ Reg Gavleborg, Ctr Res & Dev, Gavle, Sweden; [Hedman, Lina] Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden; [Hedman, Lina; Manley, David; van Ham, Maarten] Delft Univ Technol, Fac Architecture & Built Environm, Dept Urbanism, Delft, Netherlands; [Manley, David] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [van Ham, Maarten] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland	Uppsala University; Delft University of Technology; University of Bristol; University of St Andrews	van Ham, M (corresponding author), Delft Univ Technol, Fac Architecture & Built Environm, Dept Urbanism, Delft, Netherlands.; van Ham, M (corresponding author), Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland.	m.vanham@tudelft.nl	van Ham, Maarten/AAA-6263-2020	van Ham, Maarten/0000-0002-2106-0702	European Research Council under the European Union [615159]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 615159 (ERC Consolidator Grant DEPRIVEDHOODS, Socio-spatial inequality, deprived neighbourhoods, and neighbourhood effects by M. van Ham), https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson D, 1998, J HUM RESOUR, V33, P915, DOI 10.2307/146403; Andersson EK, 2015, URBAN STUD, V52, P2117, DOI 10.1177/0042098014542487; Anger S, 2010, J POPUL ECON, V23, P1255, DOI 10.1007/s00148-009-0298-8; Bjorklund A, 2010, BE J ECON ANAL POLI, V10; Bjorklund Anders., 2009, OXFORD HDB EC INEQUA; Black SE, 2011, HBK ECON, V4, P1487, DOI 10.1016/S0169-7218(11)02414-2; Black SE, 2005, Q J ECON, V120, P669, DOI 10.1162/0033553053970179; Bolster A, 2007, J ECON GEOGR, V7, P1, DOI 10.1093/jeg/lbl013; Brannstrom L., 2005, HOUS THEORY SOC, V22, P169, DOI DOI 10.1080/14036090510011586; Card D., 1999, HDB LABOR EC A, P1761, DOI [DOI 10.1016/S1573-4463(99)03010-2, 10.1016/S1573-4463(99)03010-2]; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; D'Addio Anna Cristina, 2007, EMPLOYMENT MIGRATION, V52; de Vuijst E, 2017, ENVIRON PLANN A, V49, P2135, DOI 10.1177/0308518X17715638; Duncan GJ, 2001, DEMOGRAPHY, V38, P437, DOI 10.1353/dem.2001.0026; Galster G, 2001, URBAN STUD, V38, P2111, DOI 10.1080/00420980120087072; Galster GC, 2017, GEOGR ANN B, V98, P145; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Galster G, 2007, HOUSING STUD, V22, P723, DOI 10.1080/02673030701474669; Galster G, 2017, RSF-RUS SAGE J SOC S, V3, P1, DOI 10.7758/RSF.2017.3.2.01; Galster G, 2017, HOUS POLICY DEBATE, V27, P584, DOI 10.1080/10511482.2016.1254098; Ginther D, 2000, J HUM RESOUR, V35, P603, DOI 10.2307/146365; Glass TA, 2016, SOC SCI MED, V166, P244, DOI 10.1016/j.socscimed.2016.01.001; Gronqvist E, 2017, J HUM RESOUR, V52, P887, DOI 10.3368/jhr.52.4.0115-6882R1; Gustafsson B, 2017, POPUL SPACE PLACE, V23, DOI 10.1002/psp.2028; Hedman L, 2015, J ECON GEOGR, V15, P195, DOI 10.1093/jeg/lbt042; Kwan M-P, 2008, GEOGR ANAL, V30, P191; Lindahl L, 2011, J ECON INEQUAL, V9, P207, DOI 10.1007/s10888-010-9144-1; Manley D, 2017, 11335 IZA; Mason PL, 2007, IND RELAT, V46, P51, DOI 10.1111/j.1468-232X.2007.00457.x; McLanahan S., 1994, GROWING SINGLE PAREN; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Nicoletti C, 2013, ECONOMICA, V80, P197, DOI 10.1111/ecca.12010; Oreopoulos P, 2003, Q J ECON, V118, P1533, DOI 10.1162/003355303322552865; Page ME, 2003, J LABOR ECON, V21, P831, DOI 10.1086/377021; Petrovic A, 2018, ANN AM ASSOC GEOGR, V108, P1057, DOI 10.1080/24694452.2017.1411245; Plotnick RD, 1999, SOC SCI QUART, V80, P1; Raaum O, 2006, ECON J, V116, P200, DOI 10.1111/j.1468-0297.2006.01053.x; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Sharkey P, 2008, AM J SOCIOL, V113, P931, DOI 10.1086/522804; Sharkey P, 2014, ANNU REV SOCIOL, V40, P559, DOI 10.1146/annurev-soc-071913-043350; Sharkey P, 2011, AM J SOCIOL, V116, P1934, DOI 10.1086/660009; Sharkey Patrick., 2013, URBAN NEIGHBORHOODS; Small ML, 2012, NEIGHBOURHOOD EFFECT, P57, DOI [10.1007/978- 94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2]; Solon G, 2000, REV ECON STAT, V82, P383, DOI 10.1162/003465300558885; van Ham M, 2014, T I BRIT GEOGR, V39, P402, DOI 10.1111/tran.12040; van Ham M, 2010, J ECON GEOGR, V10, P257, DOI 10.1093/jeg/lbp017; Vartanian TP, 2007, HOUSING STUD, V22, P833, DOI 10.1080/02673030701474792; Vartanian TP, 2005, SOC SERV REV, V79, P60, DOI 10.1086/426718; Wheaton B, 2003, AM SOCIOL REV, V68, P680, DOI 10.2307/1519758; Wodtke GT, 2013, DEMOGRAPHY, V50, P1765, DOI 10.1007/s13524-013-0219-z; Wodtke GT, 2011, AM SOCIOL REV, V76, P713, DOI 10.1177/0003122411420816	52	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217635	10.1371/journal.pone.0217635	http://dx.doi.org/10.1371/journal.pone.0217635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145761	Green Published, gold			2022-12-27	WOS:000469425500029
J	Khatab, K; Raheem, MA; Sartorius, B; Ismail, M				Khatab, Khaled; Raheem, Maruf A.; Sartorius, Benn; Ismail, Mubarak			Prevalence and risk factors for child labour and violence against children in Egypt using Bayesian geospatial modelling with multiple imputation	PLOS ONE			English	Article							MISSING-DATA	Background The incidence of child labour, especially across developing nations, is of global concern. The use of children in employment in developing economies constitutes a major threat to the societies, and concerted efforts are made by the relevant stakeholders towards addressing some of the factors and issues responsible. Significant risk factors include socio-demographic and economic factors such as poverty, neglect, lack of adequate care, exposure of children to various grades of violence, parental education status, gender, place of residence, household size, residence type or size, wealth index, parental survivorship and household size. Egypt is the largest country in Africa by population. Although UNCIF 2017 reported that the worst forms of child labour in Egypt are concentrated in domestic work, forced begging and commercial sexual exploitation, the situation has received little attention. There are still very few studies initiated specifically to look at child labour in domestic service in Egypt and those that exist have been limited in the scope of their methodology. Geographical coverage and research for child labour in Egypt is also limited, as are accurate statistics and data. There was, therefore, a strong case for looking again at the domestic child labour phenomenon in Egypt, especially after the Demographic Health Survey (DHS) released the first data about child labour in Egypt in 2014. This study builds on the few findings of earlier work, and broadens coverage by including advanced methods and geographical effects of this problem. Objectives This study focuses on identifying socio-demographic, economic and geospatial factors associated with child labour participation. Methods We used the 2014 Egypt Demographic and Health Survey (EDHS) from the Ministry of Health and Population in Egypt, with the record of 20,560 never-married children aged 5-17 years engaging in economic activities, in and out of their home. The data focused on demographic and socio-economic characteristics of household members. Multivariate Bayesian geo-additive models were employed to examine the demographical and socio-economic factors for children working less than 16 hrs; between 16 and less 45 hrs; and over 45 hrs weekly. Results The results showed that at least 31.6% of the children in the age group from 5-10 were working, 68.5% of children aged 11-17 years were engaged in child labour for a wage, and 44.7% of the children in the age group from 5-10 were engaged in hazardous work. From the multivariate Bayesian geo-additive models, female children (with male children as reference category) working at least 16 hrs (OR: 1.3; with 95% CI: 1.2-1.5) were more likely to be engaged in child labour than girls working 16 to 45 hrs (OR: 1; 95% CI: 0.3-1.5). Children born to women without formal education, in non-hazardous jobs, irrespective of the hours spent at work, were more likely to be involved in child labour (52.9%, 56.8%, 62.4%) compared to children of mothers with some level of education. Finally, children who have experienced psychological aggression and physical punishment are more likely to be used as child labour than those without such experience across the job types and hours spent. North-eastern Egypt has a higher likelihood of child labour than most other regions, while children who live in the Delta are more engaged in hazardous work. Conclusion This study revealed a significant influence of socio-demographic and economic factors on child labour and violence against children in Egypt. Poverty, neglect, lack of adequate care and exposure of children to various grades of violence are major drivers of child labour across the country. The spatial effect suggests the need to give more attention to some areas that have high rates of child labour, such as the Nile Delta, Upper Egypt, and Northeastern Egypt.	[Khatab, Khaled; Ismail, Mubarak] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England; [Raheem, Maruf A.] Sheffield Hallam Univ, Dept Engn & Math, Sheffield, S Yorkshire, England; [Sartorius, Benn] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England	Sheffield Hallam University; Sheffield Hallam University; University of London; London School of Hygiene & Tropical Medicine	Khatab, K (corresponding author), Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England.	k.khatab@shu.ac.uk	Raheem, Maruf Ariyo/GLN-5963-2022	Raheem, Maruf Ariyo/0000-0002-7229-703X; Khatab, Professor.Dr. Khaled/0000-0002-8755-3964				[Anonymous], 2017, UND TRENDS CHILD LAB; Bank W, 2015, WORLD DEV ID DAT CAT; Benova L, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0111-5; Binder DA, 1996, P SECT SURV RES METH; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; BREZGER A, 2005, BAYESX SOFTWARE BAYE; CAPMAS, 2014, CAIRO POST; Cattle BA, 2011, STAT MED, V30, P2736, DOI 10.1002/sim.4314; Egypt CBo, 2012, ANN REP 2011 2012; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Graham J.W., 2012, HDB PSYCHOL, V2; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; Huebler F., 2008, SEM CHILD LAB ED YOU; ILO and Central Agency for Public Mobilization and Statistics (CAPMAS), 2012, WORK CHILDR EG RES 2; Khatab K., 2011, Asian Pacific Journal of Tropical Disease, V1, P169, DOI 10.1016/S2222-1808(11)60022-4; Khatab K, 2008, TECHNICAL REPORTS, V21; Khatab K, 2013, ADV TECHNIQUES MODEL; Khatab K, 2012, ROYAL STAT SOC AM AS, V9, P32; Khatab K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159173; Khatab K, 2010, AM J TROP MED HYG, V82, P653, DOI 10.4269/ajtmh.2010.09-0501; Khatab K, 2009, AM J TROP MED HYG, V81, P116, DOI 10.4269/ajtmh.2009.81.116; Kneib T, 2007, ASTA-ADV STAT ANAL, V91, P225, DOI 10.1007/s10182-007-0033-2; Lin TH, 2010, QUAL QUANT, V44, P277, DOI 10.1007/s11135-008-9196-5; McGoldrick, 1991, INT J LAW FAMILY, V5, P132, DOI DOI 10.1093/LAWFAM/5.2.132; McLachlan GJ, 1997, EM ALGORITHM EXTENSI; Ministry of Health and Population Cairo EE-ZaAC, 2014, DEM HLTH SURV EG; Ross-Larson CMaB, 2004, HUMAN DEV REPORT; Rubin DB, 2003, STAT NEERL, V57, P3, DOI 10.1111/1467-9574.00217; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Statistics CAfPMa, 2013, MOST IMP RES INC EXP; Statistics UIf, 2017, SUMM REP 2015 UIS IN; UNICEF G, 2015, MULT IND CLUST SURV, DOI [10.12669/pjms.316.8181, DOI 10.12669/PJMS.316.8181]; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yuan YC, 2000, P 25 ANN SAS US GROU; Zhang P, 2003, INT STAT REV, V71, P581	38	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0212715	10.1371/journal.pone.0212715	http://dx.doi.org/10.1371/journal.pone.0212715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145743	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000469425500003
J	Chandler, TL; White, HM				Chandler, Tawny L.; White, Heather M.			Glucose metabolism is differentially altered by choline and methionine in bovine neonatal hepatocytes	PLOS ONE			English	Article							RUMEN-PROTECTED CHOLINE; MESSENGER-RNA EXPRESSION; DAIRY-COWS; PYRUVATE-CARBOXYLASE; FATTY LIVER; TRANSITION PERIOD; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLUCONEOGENESIS; FEED RESTRICTION	Choline and methionine serve essential roles in the liver that may interact with glucose metabolism. Our objectives were to quantify glucose export, cellular glycogen, and expression of genes controlling oxidation and gluconeogenesis in primary bovine neonatal hepatocytes exposed to increasing concentrations of choline chloride (CC) and D, L-methionine (DLM) with or without fatty acids (FA). Primary hepatocytes isolated from 3 Holstein calves were maintained as monolayer cultures for 24 h before treatment with CC (61, 128, 2028, 4528 mu mol/L) and DLM (16, 30, 100, 300 mu mol/L) with or without a 1 mmol/L FA cocktail in a factorial design. After 24 h, media was harvested to quantify glucose, beta-hydroxybutyrate (BHB), and cells harvested to quantify glycogen, DNA, and gene expression. No interactions between CC and DLM were detected. The potential two-way interaction between CC or DLM and FA was partitioned into three contrasts when P <= 0.20: linear without FA, linear with FA, difference of slope. Fatty acids did not affect glucose or cellular glycogen but increased pyruvate carboxylase (PC), cytosolic and mitochondrial phosphoenolpyruvate carboxykinase (PEPCKc, PEPCKm), and glucose-6-phosphatase (G6PC) expression. Increasing CC decreased glucose but increased cellular glycogen. Expression of PC and PEPCKc was increased by CC during FA treatment. Increasing DLM did not affect metabolites or PC expression, although PEPCKc was marginally decreased. Methionine did not affect G6PC, while CC had a marginal quadratic effect on G6PC. Oxidative and gluconeogenic enzymes appear to respond to FA in primary bovine neonatal hepatocytes. Increased PC and PEPCKc by CC during FA treatment suggest increased gluconeogenic capacity. Changes in G6PC may have shifted glucose-6-phosphate towards cellular glycogen; however, subsequent examination of G6PC protein is needed. Unaltered PC and marginally decreased PEPCKc suggest increased oxidative capacity with DLM, although BHB export was unaltered. The differential regulation supports unique effects of CC and DLM within bovine hepatocytes.	[Chandler, Tawny L.; White, Heather M.] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	White, HM (corresponding author), Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu		Chandler, Tawny/0000-0001-6299-9436	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY [MSN169422]	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	This research was supported by funding provided through the Real Science Initiative Grant by Balchem Corporation (MSN169422), New Hampton, NY (http://www.balchem.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Andersen JB, 2002, J VET MED A, V49, P65, DOI 10.1046/j.1439-0442.2002.jv417.x; ARMENTANO LE, 1991, J DAIRY SCI, V74, P132, DOI 10.3168/jds.S0022-0302(91)78153-8; ARMENTANO LE, 1994, J DAIRY SCI, V77, P2809, DOI 10.3168/jds.S0022-0302(94)77221-0; Artegoitia VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103412; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; BALLARD FJ, 1965, COMP BIOCHEM PHYSIOL, V14, P437, DOI 10.1016/0010-406X(65)90218-5; BALLARD FJ, 1969, FED PROC, V28, P218; Barritt GJ, 1985, PYRUVATE CARBOXYLASE, P147; Batistel F, 2017, J DAIRY SCI, V100, P7455, DOI 10.3168/jds.2017-12689; Berry MN, 1991, LAB TECHNIQUES BIOCH, P121; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; Blum JW, 1999, J DAIRY SCI, V82, P1991, DOI 10.3168/jds.S0022-0302(99)75435-4; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; CadornigaValino C, 1997, J DAIRY SCI, V80, P646, DOI 10.3168/jds.S0022-0302(97)75983-6; Chandler TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171080; DONKIN SS, 1994, AM J PHYSIOL, V266, pR1229, DOI 10.1152/ajpregu.1994.266.4.R1229; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; DONKIN SS, 1995, J ANIM SCI, V73, P546; Donkin SS, 1997, J ANIM SCI, V75, P3082; DRACKLEY JK, 1992, J DAIRY SCI, V75, P1622, DOI 10.3168/jds.S0022-0302(92)77919-3; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Duske K, 2003, J DAIRY SCI, V86, P1722, DOI [10.3168/jds.S0022-0302(03)73758-8, DOI 10.3168/JDS.S0022-0302(03)73758-8]; Elek P, 2013, ACTA VET HUNG, V61, P59, DOI 10.1556/AVet.2012.053; Elek R, 2008, ANIMAL, V2, P1595, DOI 10.1017/S1751731108002917; Freitas I, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9307064; GALLAGHER CH, 1959, BIOCHEM J, V72, P575, DOI 10.1042/bj0720575; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hartwell JR, 2001, J DAIRY SCI, V84, P490, DOI 10.3168/jds.S0022-0302(01)74499-2; HOWARTH RE, 1968, J DAIRY SCI, V51, P1270, DOI 10.3168/jds.S0022-0302(68)87170-X; HUNTER SV, 1967, J NUTR, V92, P133, DOI 10.1093/jn/92.1.133; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kohlmeier M., 2015, NUTRIENT METABOLISM, P265, DOI [DOI 10.1016/B978-0-12-387784-0.00008-0, 10.1016/B978-0-12-387784-0.00008-0]; Larsen M, 2013, ANIMAL, V7, P1640, DOI 10.1017/S1751731113001171; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; MILLS SE, 1986, J DAIRY SCI, V69, P362, DOI 10.3168/jds.S0022-0302(86)80414-3; MUNCK A, 1964, ARCH BIOCHEM BIOPHYS, V107, P504, DOI 10.1016/0003-9861(64)90308-X; NADKARNI GB, 1960, J BIOL CHEM, V235, P420; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Oksbjerg N, 2000, ANIM SCI, V71, P81, DOI 10.1017/S1357729800054916; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Overton TR, 1999, J ANIM SCI, V77, P1940; Piepenbrink MS, 2003, J DAIRY SCI, V86, P1722, DOI 10.3168/jds.S0022-0302(03)73758-8; Preynat A, 2010, J DAIRY SCI, V93, P2130, DOI 10.3168/jds.2009-2796; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rukkwamsuk T, 1999, J DAIRY SCI, V82, P500, DOI 10.3168/jds.S0022-0302(99)75260-4; Soty M, 2016, J PROTEOME RES, V15, P1342, DOI 10.1021/acs.jproteome.6b00110; Strang BD, 1998, J DAIRY SCI, V81, P728, DOI 10.3168/jds.S0022-0302(98)75629-2; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Velez JC, 2005, J DAIRY SCI, V88, P2938, DOI 10.3168/jds.S0022-0302(05)72974-X; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277; White HM, 2012, J DAIRY SCI, V95, P1249, DOI 10.3168/jds.2011-4644; White HM, 2011, J DAIRY SCI, V94, P3428, DOI 10.3168/jds.2010-3960; White HM, 2011, J ANIM SCI, V89, P1763, DOI 10.2527/jas.2010-3407; White HM, 2015, ANIMALS-BASEL, V5, P793, DOI 10.3390/ani5030384; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; XUE GP, 1985, BIOCHEM INT, V11, P381; Zenobi MG, 2018, J DAIRY SCI, V101, P5902, DOI 10.3168/jds.2017-13973; Zenobi MG, 2018, J DAIRY SCI, V101, P1088, DOI 10.3168/jds.2017-13327; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P1766, DOI 10.1073/pnas.90.5.1766; ZHANG J, 1995, BIOCHEM J, V306, P205, DOI 10.1042/bj3060205; Zhang Q, 2016, J DAIRY SCI, V99, P8451, DOI 10.3168/jds.2016-11312; Zhang Q, 2016, J DAIRY SCI, V99, P3908, DOI 10.3168/jds.2015-10312; Zhang Q, 2015, J DAIRY SCI, V98, P8698, DOI 10.3168/jds.2015-9590; Zhang QH, 2014, FASEB J, V28; Zhou Z, 2016, J DAIRY SCI, V99, P8716, DOI 10.3168/jds.2015-10525; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	84	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217160	10.1371/journal.pone.0217160	http://dx.doi.org/10.1371/journal.pone.0217160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141525	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000041
J	Mella, VSA; McArthur, C; Krockenberger, MB; Frend, R; Crowther, MS				Mella, Valentina S. A.; McArthur, Clare; Krockenberger, Mark B.; Frend, Robert; Crowther, Mathew S.			Needing a drink: Rainfall and temperature drive the use of free water by a threatened arboreal folivore	PLOS ONE			English	Article							KOALA PHASCOLARCTOS-CINEREUS; FIELD METABOLIC-RATE; CLIMATE-CHANGE; FOLIAR CHEMISTRY; FOOD-CONSUMPTION; HABITAT; QUEENSLAND; AUSTRALIA; DROUGHT; RANGE	Arboreal folivores are particularly vulnerable to the impacts of extreme climate change-driven heatwaves and droughts as they rely on leaf moisture to maintain hydration. During these increasingly frequent and intense weather events, leaf water content may not be enough to meet their moisture requirements, potentially leading to large-scale mortality due to dehydration. Water supplementation could be critical for the conservation of these animals. We tested artificial water stations for a threatened arboreal folivore, the koala (Phascolarctos cinereus), as a potential mitigation measure during hot and dry weather in New South Wales, Australia. We provided ground and tree drinkers to koalas and investigated changes in use with season, environmental conditions and foliar moisture. Our study provides first evidence of the regular use of free water by koalas. Koalas used supplemented water extensively throughout the year, even during cooler months. Time spent drinking varied with season and depended on days since last rain and temperature. The more days without rain, the more time koalas spent drinking. When temperature was high, visits to water stations were more frequent, indicating that in hot weather koalas need regular access to free water. Our results suggest that future changes in rainfall regimes and temperature in Australia have the potential to critically affect koala populations. Our conclusions can be applied to many other arboreal folivorous mammals worldwide which rely on leaves for their nutritional and water requirements. Artificial water stations may facilitate the resilience of vulnerable arboreal folivores during heat and drought events and may help mitigate the effects of climate change.	[Mella, Valentina S. A.; McArthur, Clare; Frend, Robert; Crowther, Mathew S.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Krockenberger, Mark B.] Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Krockenberger, Mark B.] Univ Sydney, Marie Bashir Inst Emerging Infect Dis & Biosecur, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Mella, VSA (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	valentina.mella@sydney.edu.au	Crowther, Mathew/M-7406-2013; Mella, Valentina/AAE-5346-2020	Crowther, Mathew/0000-0001-8968-1161; Mella, Valentina/0000-0001-5577-2487; McArthur, Clare/0000-0002-7867-414X	Australian Research Council Linkage grant [LP140100279]; NSW Office of Environment and Heritage	Australian Research Council Linkage grant(Australian Research Council); NSW Office of Environment and Heritage	The research was partially funded by the Australian Research Council Linkage grant LP140100279 to Mathew Crowther with Shenhua Watermark (http://www.shenhuawatermark.com/) and the NSW Office of Environment and Heritage (https://www.environment.nsw.gov.au/) as Linkage partners in the form of salary for Valentina Simona Alice Mella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Beale PK, 2018, BIOL REV, V93, P674, DOI 10.1111/brv.12364; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Boland DJ, 2006, FOREST TREES AUSTR; BOM, 2018, LAT WEATH OBS GUNN A; Booth G. D., 1994, IDENTIFYING PROXY SE; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Briscoe NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0235; Clifton Irene Delma, 2007, Australian Mammalogy, V29, P85; Clifton Irene Delma, 2010, Australian Mammalogy, V32, P157, DOI 10.1071/AM10015; Craine JM, 2010, GLOBAL CHANGE BIOL, V16, P2901, DOI 10.1111/j.1365-2486.2009.02060.x; Crowther MS, 2014, ECOGRAPHY, V37, P336, DOI 10.1111/j.1600-0587.2013.00413.x; Dargan JR, 2019, ANIM CONSERV, V22, P543, DOI 10.1111/acv.12487; Davies N, 2014, BIOL CONSERV, V172, P80, DOI 10.1016/j.biocon.2014.02.004; Davies NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079136; DEGABRIELE R, 1979, J COMP PHYSIOL, V134, P293, DOI 10.1007/BF00709996; Degabriele R., 1978, P163; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; DUFF GA, 1994, FUNCT ECOL, V8, P502, DOI 10.2307/2390075; Dunham AE, 2011, GLOBAL CHANGE BIOL, V17, P219, DOI 10.1111/j.1365-2486.2010.02205.x; Ellis W., 2010, Australian Zoologist, V35, P369; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; EVERY KR, 1986, WILDLIFE RES, V13, P517; Fensham RJ, 1999, J APPL ECOL, V36, P1035, DOI 10.1046/j.1365-2664.1999.00460.x; Fernandez CM, 2019, VET MICROBIOL, V231, P264, DOI 10.1016/j.vetmic.2019.02.020; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Green K, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P239; Higgins DP, 2005, J COMP PATHOL, V133, P164, DOI 10.1016/j.jcpa.2005.04.005; Hughes L, 1996, GLOBAL ECOL BIOGEOGR, V5, P23, DOI 10.2307/2997467; Hughes TP, 2018, ECOLOGY, V99, P501, DOI 10.1002/ecy.2092; HUME ID, 1993, AUST J ZOOL, V41, P379, DOI 10.1071/ZO9930379; Jackson S., 2015, HDB MAMMALS WORLD, V5, P400; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jobbins SE, 2012, AUST J ZOOL, V60, P1, DOI 10.1071/ZO12013; Kanowski J, 2001, AUSTRAL ECOL, V26, P165, DOI 10.1046/j.1442-9993.2001.01103.x; KNIGHT MH, 1989, S AFR J WILDL RES, V19, P42; Krockenberger AK, 2012, OECOLOGIA, V168, P889, DOI 10.1007/s00442-011-2146-2; Lawler IR, 1997, OECOLOGIA, V109, P59, DOI 10.1007/s004420050058; Lunney D., 2012, KOALAS CLIMATE CHANG, P150, DOI DOI 10.7882/FS.2012.0221016/J.VETMIC.2013.02.026; Lunney D, 2014, WILDLIFE RES, V41, P22, DOI 10.1071/WR13054; Lunney D, 2009, WILDLIFE RES, V36, P262, DOI 10.1071/WR08079; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Martin R. W., 2008, MAMMALS AUSTR, P198; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Mella VSA, 2018, AUST MAMMAL, V40, P103, DOI 10.1071/AM16049; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2015, ANIM PROD SCI, V55, P272, DOI 10.1071/AN14487; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Pahl L.I., 1990, P123; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; PHILLIPS B, 1990, KOALAS LITTLE AUSTR; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Pratt A, 1937, CALL KOALA; Reckless HJ, 2017, WILDLIFE RES, V44, P458, DOI 10.1071/WR16163; Roden JS, 1996, GLOBAL CHANGE BIOL, V2, P115, DOI 10.1111/j.1365-2486.1996.tb00056.x; Seabrook L, 2014, DIVERS DISTRIB, V20, P95, DOI 10.1111/ddi.12152; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Speight N, 2019, AUST MAMMAL, V41, P92, DOI [10.1071/am17038, 10.1071/AM17038]; Sullivan BJ, 2003, WILDLIFE RES, V30, P583, DOI 10.1071/WR02036; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; WOODWARD FI, 1991, GLOBAL ECOL BIOGEOGR, V1, P7, DOI 10.2307/2997540; Wu H., 2018, INFLUENCE LEAF CHEM; Wu Huiying, 2012, Australian Zoologist, V36, P93	71	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216964	10.1371/journal.pone.0216964	http://dx.doi.org/10.1371/journal.pone.0216964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141564	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000033
J	Arshad, R; Sohail, MF; Sarwar, HS; Saeed, H; Ali, I; Akhtar, S; Hussain, SZ; Afzal, I; Jahan, S; Anees-ur-Rehman; Shahnaz, G				Arshad, Rabia; Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib; Saeed, Hamid; Ali, Imran; Akhtar, Sohail; Hussain, Syed Zajif; Afzal, Iqra; Jahan, Sarwat; Anees-ur-Rehman; Shahnaz, Gul			ZnO-NPs embedded biodegradable thiolated bandage for postoperative surgical site infection: In vitro and in vivo evaluation	PLOS ONE			English	Article							RISK-FACTORS; CHITOSAN NANOPARTICLES; DRUG-RELEASE; MECHANISMS; POLYMERS; MUCIN	Post-operative surgical site infections (SSI) present a serious threat and may lead to complications. Currently available dressings for SSI lack mucoadhesion, safety, efficacy and most importantly patient compliance. We aimed to address these concerns by developing a bioactive thiolated chitosan-alginate bandage embedded with zinc oxide nanoparticles (ZnO-NPs) for localized topical treatment of SSI. The FTIR, XRD, DSC and TGA of bandage confirmed the compatibility of ingredients and modifications made. The porosity, swelling index and lysozyme degradation showed good properties for wound healing and biodegradation. Moreover, in-vitro antibacterial activity showed higher bactericidal effect as compared to ZnO-NPs free bandage. In-vivo wound healing in murine model showed significant improved tissue generation and speedy wound healing as compared to positive and negative controls. Over all, thiolated bandage showed potential as an advanced therapeutic agent for treating surgical site infections, meeting the required features of an ideal surgical dressing.	[Arshad, Rabia; Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib; Afzal, Iqra; Anees-ur-Rehman; Shahnaz, Gul] Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad, Pakistan; [Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib] Riphah Int Univ, RIPS, Lahore Campus, Lahore, Pakistan; [Saeed, Hamid] Univ Punjab, Univ Coll Pharm, Lahore, Pakistan; [Ali, Imran] Islamia Univ, Univ Coll Agr & Environm Sci, Dept Entomol, Bahawalpur, Pakistan; [Akhtar, Sohail] Victoria Hosp, Bahawalpur, Pakistan; [Hussain, Syed Zajif] LUMS, SBA SSE, Dept Chem & Chem Engn, Lahore, Pakistan; [Jahan, Sarwat] Quaid I Azam Univ, Dept Anim Sci, Islamabad, Pakistan; [Anees-ur-Rehman] USM, Sch Pharmaceut Sci, George Town, Malaysia	Quaid I Azam University; University of Punjab; Lahore University of Management Sciences; Quaid I Azam University; Universiti Sains Malaysia	Sohail, MF; Shahnaz, G (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad, Pakistan.; Sohail, MF (corresponding author), Riphah Int Univ, RIPS, Lahore Campus, Lahore, Pakistan.	farmacist.pk@gmail.com; gshahnaz@qau.edu.pk	Shahnaz, Gul/I-7041-2019; Hussain, Syed Zajif/AAZ-3250-2021	Shahnaz, Gul/0000-0003-0736-2277; Hussain, Syed Zajif/0000-0002-3834-6061; Sohail, Farhan/0000-0002-3970-5003; Arshad, Rabia/0000-0001-7654-3456; ur Rehman, Anees/0000-0002-6502-8464				Afzal I, 2019, NANOMEDICINE; Alfonso-Sanchez JL, 2017, CAN J SURG, V60, P155, DOI 10.1503/cjs.017916; Amna Sirelkhatim DM, 2015, REV ZINC OXIDE NANOP; Anitha A, 2011, CARBOHYD POLYM, V83, P66, DOI 10.1016/j.carbpol.2010.07.028; [Anonymous], INT J MED MED SCI; [Anonymous], AAPS PHARMSCITECH; Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034; Asija R., 2013, J DRUG DISCOVERY THE, V1; Azoury SC, 2015, CHRONIC WOUND CARE M, V2, P137, DOI 10.2147/CWCMR.S62514; Ball R., 2012, BIOMATERIALS; Begam T, 2003, J APPL POLYM SCI, V89, P779, DOI 10.1002/app.12270; Bernkop-Schnurch A, 2005, ADV DRUG DELIVER REV, V57, P1569, DOI 10.1016/j.addr.2005.07.002; Boateng J, 2015, J PHARM SCI-US, V104, P3653, DOI 10.1002/jps.24610; Carbinatto FM, 2014, ASIAN J PHARM SCI, V9, P27, DOI 10.1016/j.ajps.2013.12.002; Catanzano Ovidio D R, 2017, CARBOHYDRATE POLYM; Cherng J.-H., 2018, STRATEGIES NATURAL P; Chhabra H, 2016, RSC ADV, V6, P1428, DOI 10.1039/c5ra21821g; Davis FM, 2016, J VASC SURG, V64, P870, DOI 10.1016/j.jvs.2016.07.017; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031; Doillon CJ, 1987, J BIOMATER APPL, V2, P562, DOI [10.1177/088532828700200404, DOI 10.1177/088532828700200404]; Dragostin Oana Maria S SK, 2016, NEW ANTIMICROBIAL CH; Fernandez-Flores A, 2016, J CUTAN PATHOL, V43, P1005, DOI 10.1111/cup.12782; Florman S, 2001, CLIN INFECT DIS; Gopikrishnan R, 2010, NANO-MICRO LETT, V2, P31, DOI 10.1007/BF03353614; GU JM, 1988, CRC CR REV THER DRUG, V5, P21; Hassan S, 2017, NANO TODAY, V15, P91, DOI 10.1016/j.nantod.2017.06.008; Herning Linn Kira Kolsrud, 2009, THESIS; Hira S, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00945; Idrees A, 2014, ACTA POL PHARM, V71, P287; Iqbal J, 2012, EUR J PHARM BIOPHARM, V80, P95, DOI 10.1016/j.ejpb.2011.09.010; Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v; Kumar PTS, 2013, PHARM RES-DORDR, V30, P523, DOI 10.1007/s11095-012-0898-y; Lee Seung Moon, 2016, Biomater Res, V20, P15, DOI 10.1186/s40824-016-0063-5; Mishra Renuka P N, 2012, REV MINERAL GEOCHEM, V23, P177; Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015; Mohandas Annapoorna, 2015, Int J Nanomedicine, V10 Suppl 1, P53, DOI 10.2147/IJN.S79981; Naz Kiran S G, 2016, AAPS PHARM SCI TECH; Nimesh S, 2006, INT J PHARMACEUT, V323, P146, DOI 10.1016/j.ijpharm.2006.05.065; PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1; Ribeiro Maximiano P., 2009, THESIS; Roy S., 2016, ASIAN J BIOMEDICAL P, V6; Saboktakin MR., 2010, J PHARM ED RES, V1, P62; Safferling K, 2013, J CELL BIOL, V203, P691, DOI 10.1083/jcb.201212020; Saremi S, 2011, INT J NANOMED, V6, P119, DOI 10.2147/IJN.S15500; Siddiqi KS, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2532-3; Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001; Sohail MF, 2016, J MATER CHEM B, V4, P6240, DOI 10.1039/c6tb01348a; Sriamornsak P, 2008, CARBOHYD POLYM, V74, P458, DOI 10.1016/j.carbpol.2008.03.022; Yu J, 2011, J PHYS C SERIES	50	39	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217079	10.1371/journal.pone.0217079	http://dx.doi.org/10.1371/journal.pone.0217079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170179	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700018
J	Edwards, KL; Miller, MA; Carlstead, K; Brown, JL				Edwards, Katie L.; Miller, Michele A.; Carlstead, Kathy; Brown, Janine L.			Relationships between housing and management factors and clinical health events in elephants in North American zoos	PLOS ONE			English	Article							LOXODONTA-AFRICANA; SERUM PROLACTIN; ANIMAL-WELFARE; ENRICHMENT; MAXIMUS; DISEASE; CORTISOL; BEHAVIOR; PIG; STEREOTYPIES	Elephants experience a number of health issues that can contribute to their well-being and survival. In managed populations, housing conditions and management practices can influence individual health, so potential risk factors associated with morbidity or mortality should be identified to ensure the best possible standards of care. The goal of this study was to determine if the number of clinical events experienced could be a useful welfare indicator in zoo elephants, and to determine factors associated with key pathologies. We used an epidemiological approach to investigate how intrinsic (species, sex, age) and extrinsic (housing, management) factors were associated with both the total number of clinical events, and each of the four most prevalent pathology types (gastrointestinal issues, skin lesions, lameness, foot lesions), over a 12-month period. The study included 220 (127 African; 93 Asian) elephants housed at 61 facilities across North America. More than 1100 clinical events were identified. Species and sex differences were apparent in the types of pathology encountered, and unsurprisingly, the number of clinical events was positively correlated with age. Factors relating to housing (percent time with indoor/outdoor choice, space experience inside, number of unique environments an elephant was housed in, percent time on soft substrate) and management (enrichment diversity, spread of feeding opportunities) were also related to the number of clinical events. However, relationships were often counter to our initial hypotheses, highlighting caution in assuming cause and effect from correlational analyses such as these. Other welfare indicators such as serum and fecal glucocorticoids and serum prolactin were also associated with health status, being higher or more variable in individuals with a greater number of events. This approach provides insight into housing and management factors related to the health of these species in zoos, and in some cases, may reflect management changes that have already been made to mitigate existing or anticipated health concerns.	[Edwards, Katie L.; Carlstead, Kathy; Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Miller, Michele A.] Stellenbosch Univ, Nat Res Fdn Ctr Excellence Biomed TB Res, South African Med Res Council,Ctr TB Res, Dept Sci & Technol,Div Mol Biol & Human Genet,Fac, Cape Town, South Africa	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; South African Medical Research Council; Stellenbosch University	Edwards, KL (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.	edwardskl@si.edu	Miller, Michele/ABA-1332-2020; Edwards, Katie/K-5559-2015	Miller, Michele/0000-0002-5883-6076; Edwards, Katie/0000-0001-6736-1183	Institute of Museum and Library Services [LG-25-10-0033-10]; Morris Animal Foundation [D15Z0-403]	Institute of Museum and Library Services; Morris Animal Foundation	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Funding support was also provided by a Morris Animal Foundation Training Fellowship Grant (https://www.morrisanimalfoundation.org/) to KLE (Grant number: D15Z0-403). Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park and Conservation Biology Institute (KLE, JLB); Honolulu Zoo (KC); Palm Beach Zoo (MAM). The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZA, 2018, AZA STAND EL MAN CAR; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bechert U, 2008, J ZOO WILDLIFE MED, V39, P188, DOI 10.1638/2007-0139R.1; Bedore M. P., 1982, ELEPHANT, V2, P3, DOI DOI 10.22237/ELEPHANT/1521731887; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Brown JL, 1997, ZOO BIOL, V16, P149, DOI 10.1002/(SICI)1098-2361(1997)16:2<149::AID-ZOO5>3.0.CO;2-A; BROWN JL, 2016, PLOS ONE, V11; Carlstead K, 2005, ZOO BIOL, V24, P215, DOI 10.1002/zoo.20050; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Chadwick CL, 2017, ANIM WELFARE, V26, P461, DOI 10.7120/09627286.26.4.461; Clauss M, 2007, EUR J WILDLIFE RES, V53, P68, DOI 10.1007/s10344-006-0064-0; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Csuti B, 2001, ELEPHANTS FOOT PREVE; D'Agata M, 2009, MEAT SCI, V83, P691, DOI 10.1016/j.meatsci.2009.08.005; Das B. K., 2002, Indian Journal of Pediatrics, V69, P663; de Boer SF, 2017, NEUROSCI BIOBEHAV R, V74, P401, DOI 10.1016/j.neubiorev.2016.07.008; Dierenfeld Ellen S., 2006, P57, DOI 10.1002/9780470344484.ch6; Dow TL, 2012, REPROD FERT DEVELOP, V24, P1019, DOI 10.1071/RD11302; DUNLAP KD, 1995, PHYSIOL ZOOL, V68, P608, DOI 10.1086/physzool.68.4.30166347; Edwards KL, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coy077; Edwards KL, 2016, GEN COMP ENDOCR, V225, P104, DOI 10.1016/j.ygcen.2015.09.011; El-Khateeb EA, 2011, INT J DERMATOL, V50, P693, DOI 10.1111/j.1365-4632.2010.04752.x; Elsherif NA, 2015, J DERMATOL DERMATOL, V19, P104, DOI 10.1016/j.jdds.2015.03.002; Fagan D. A., 2001, Zoologische Garten, V71, P281; Fazio JM, 2016, ASSESSMENT ADRENAL A; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fernandez LT, 2008, ZOO BIOL, V27, P200, DOI 10.1002/zoo.20180; Foitzik K, 2009, J INVEST DERMATOL, V129, P1071, DOI 10.1038/jid.2008.348; Fowler M, 2006, BIOL MED SURG ELEPHA; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; French F, 2014, P 50 CONV ART INT SI; Gage L, 2001, ELEPHANT'S FOOT, P117; Ganswindt A, 2010, WILDLIFE BIOL, V16, P323, DOI 10.2981/09-081; Gillis-Germitsch N, 2017, ZOO BIOL, V36, P40, DOI 10.1002/zoo.21341; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Godagama W. K., 1999, Ceylon Journal of Science, Biological Sciences, V27, P47; Gold JR, 2012, J VET INTERN MED, V26, P654, DOI 10.1111/j.1939-1676.2012.00910.x; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144276; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152490; Grindrod JAE, 2001, ANIM WELFARE, V10, P53; Guy JH, 2002, LIVEST PROD SCI, V75, P233, DOI 10.1016/S0301-6226(01)00327-X; Harris M., 2008, WELFARE HOUSING HUSB; Haspeslagh M, 2013, ANIM WELFARE, V22, P437, DOI 10.7120/09627286.22.4.437; Hatt J. -M., 2006, International Zoo Yearbook, V40, P88, DOI 10.1111/j.1748-1090.2006.00088.x; Henderson JV, 2001, ANIM WELFARE, V10, P73; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150331; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153301; Kapur G, 2004, J TROP PEDIATRICS, V50, P37, DOI 10.1093/tropej/50.1.37; Karlen J, 2015, PEDIATRICS, V135, pE1450, DOI 10.1542/peds.2014-2561; Kaufman G, 2009, AN ELEPHANT IN THE R, P69; Kim YS, 2014, WORLD J GASTROENTERO, V20, P10577, DOI 10.3748/wjg.v20.i30.10577; Knierim U, 2006, NJAS-WAGEN J LIFE SC, V54, P133, DOI 10.1016/S1573-5214(06)80017-5; Kottwitz J, 2016, J ZOO WILDLIFE MED, V47, P301, DOI 10.1638/2015-0195.1; Leach MC, 2008, ANIM WELFARE, V17, P171; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LOBIE PE, 1993, J ENDOCRINOL, V139, P371, DOI 10.1677/joe.0.1390371; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Magda S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0438-1; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Maslow JN, 2015, VET PATHOL, V52, P437, DOI 10.1177/0300985814568357; MCCAIN G A, 1989, Journal of Rheumatology, V16, P154; Meehan CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158124; Meehan CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146703; Mikota S.K., 1994, W BLOOMFIELD; Mikota Susan K., 2006, P211, DOI 10.1002/9780470344484.ch15; Miller David, 2015, Veterinary Medicine International, P614690, DOI 10.1155/2015/614690; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Montgomery DC., 2012, INTRO LINEAR REGRESS, V4th; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; NEECK G, 1990, J RHEUMATOL, V17, P24; Nielsen AMW, 2012, J ZOO WILDLIFE MED, V43, P744, DOI 10.1638/2011-0059R2.1; ORTON RK, 1985, EQUINE VET J, V17, P386, DOI 10.1111/j.2042-3306.1985.tb02530.x; PAHUJA DN, 1981, SCIENCE, V214, P1038, DOI 10.1126/science.7302575; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; PILLAI NP, 1981, EUR J PHARMACOL, V72, P11; Powell David M., 2016, Zoo Biology, V35, P298, DOI 10.1002/zoo.21289; Prado-Oviedo NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154750; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramanathan A, 2008, J ZOO WILDLIFE MED, V39, P148, DOI 10.1638/2007-0008R1.1; RAMSEY DH, 1972, J ENDOCRINOL, V53, P453, DOI 10.1677/joe.0.0530453; Ruis M, 2004, P 38 ISAE C HELS FIN; Samuelson MM, 2017, J APPL ANIM WELF SCI, V20, P75, DOI 10.1080/10888705.2016.1246362; SCHAPIRO SJ, 1994, ANIM WELFARE, V3, P25; Schoeman JP, 2007, JAVMA-J AM VET MED A, V231, P1534, DOI 10.2460/javma.231.10.1534; SCHOEN RT, 1989, AM J MED, V86, P449, DOI 10.1016/0002-9343(89)90344-6; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Ullrey DE., 1997, ELEPHANTS NUTR DIETA; von Houwald F., 1998, EAZWV SCI M, V2, P323; von Houwald FF, 2001, FOOT PROBLEMS INDIAN; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; West G., 2006, BIOL MED SURG ELEPHA; Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wiedner EB, 2012, J ZOO WILDLIFE MED, V43, P125, DOI 10.1638/2011-0088.1; Williams E, 2018, ANIM WELFARE, V27, P235, DOI 10.7120/09627286.27.3.235; Wyss F, 2014, ANIM WELFARE, V23, P57, DOI 10.7120/09627286.23.1.057; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792	108	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217774	10.1371/journal.pone.0217774	http://dx.doi.org/10.1371/journal.pone.0217774			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170219	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700055
J	Ren, JW; Zhao, QQ; Liu, B; Chen, CH				Ren, Jianwei; Zhao, Qingqing; Liu, Bo; Chen, Chunhua			Selection of pallet management strategies from the perspective of supply chain cost with Anylogic software	PLOS ONE			English	Article							SYSTEM	Pallet is a very important innovation in logistics industry. Pallets are so widely used that we can find them in nearly every logistical operation scenario. In order to manage pallets efficiently, researchers have developed several pallet management strategies (PMS). The most common and widely accepted PMS includes extensive management of pallets (EMP), transfer of pallet's ownership (TPO), and pallet rent (PR). This paper addresses mainly on how to help pallet managers choose a certain kind of PMS from the perspective of supply chain cost. Firstly, cost models of three kinds of PMS are presented. Secondly, all parameters involved in the models are valued based on data that is collected from industry survey. The results show that the cost of PR is constantly lower than EMP, and also lower than TPO when the operation period is no more than 37 months. Finally, the effect of several important parameters on the cost is studied by sensitivity analysis. The selection strategies of PMS are proposed based on the results.	[Ren, Jianwei; Zhao, Qingqing] Inner Mongolia Univ, Transportat Inst, Hohhot, Inner Mongolia, Peoples R China; [Ren, Jianwei] Inner Mongolia Univ, Sch Math Sci, Hohhot, Inner Mongolia, Peoples R China; [Ren, Jianwei] Univ Plymouth, Sch Business, Plymouth, Devon, England; [Liu, Bo] Univ Sci & Technol, Sch Mech Engn, Beijing, Peoples R China; [Chen, Chunhua] Jiangxi Univ Finance & Econ, Sch Business Adm, Nanchang, Jiangxi, Peoples R China; [Chen, Chunhua] Agr Bank China, Inner Mongolia Branch, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University; Inner Mongolia University; University of Plymouth; University of Science & Technology Beijing; Jiangxi University of Finance & Economics; Agricultural Bank of China	Chen, CH (corresponding author), Jiangxi Univ Finance & Econ, Sch Business Adm, Nanchang, Jiangxi, Peoples R China.; Chen, CH (corresponding author), Agr Bank China, Inner Mongolia Branch, Hohhot, Inner Mongolia, Peoples R China.	nmgchenchunhua@126.com			National Natural Science Foundation of China [71862026]; China Postdoctoral Science Foundation [2018T110209]; Inner Mongolia Natural Science Foundation of China [2018MS07006]; State Scholarship Found of China Scholarship Council [201808155025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Inner Mongolia Natural Science Foundation of China; State Scholarship Found of China Scholarship Council	This paper was supported by the National Natural Science Foundation of China (71862026, http://www.nsfc.gov.cn/), China Postdoctoral Science Foundation (2018T110209, http://jj.chinapostdoctor.org.cn), Inner Mongolia Natural Science Foundation of China (2018MS07006, http://www.nmkjt.gov.cn), and State Scholarship Found of China Scholarship Council (201808155025, https://www.csc.edu.cn/).Jianwei Ren received these awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Inner Mongolia Branch of Agricultural Bank of China provided support in the form of salaries for Chunhua Chen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], [No title captured]; Auguston K.A., 1991, MOD MATER HANDL, V46, P76; Bengtsson J, 2015, PROC CIRP, V29, P414, DOI 10.1016/j.procir.2015.02.045; Brindley C., 2014, PALLET ENTERPRI 0801, V8, P18; Buehlmann U, 2009, J CLEAN PROD, V17, P271, DOI 10.1016/j.jclepro.2008.06.002; Carrano AL, 2015, INT J PROD ECON, V164, P258, DOI 10.1016/j.ijpe.2014.09.037; Doungpattra N, 2012, PACKAG TECHNOL SCI, V25, P311, DOI 10.1002/pts.976; Elia V, 2015, INT J PROD ECON, V170, P730, DOI 10.1016/j.ijpe.2015.05.030; Gnimpieba DR, 2015, PROCEDIA COMPUT SCI, V56, P550, DOI 10.1016/j.procs.2015.07.251; Gnoni MG, 2011, IN C IND ENG ENG MAN, P1228, DOI 10.1109/IEEM.2011.6118111; Gnoni MG, 2010, INT J RF TECHNOL-RES, V2, P1, DOI 10.3233/RFT-2010-001; Kim T, 2014, TRANSPORT RES E-LOG, V64, P12, DOI 10.1016/j.tre.2014.01.011; KYUNG YUNBEOM, 2017, [The Journal of International Trade & Commerce, 무역연구], V13, P675; Li Jianhui, 2018, Int J Endocrinol, V2018, P5689030, DOI 10.1155/2018/5689030; Mckerrow D., 1996, LOGIST INF MANAG, V9, P39; Mosqueda A., 2009, PALLET ENTERPRISE, V7, P38; Mosqueda A., 2009, PALLET ENTERPRISE, V38, P32; Ni L., 2015, J INFORM COMPUT SCI, V12, P2635, DOI DOI 10.12733/JICS20105800; Raballand G, 2007, WORLD ECON, V30, P685, DOI 10.1111/j.1467-9701.2007.01009.x; Ray CD, 2006, FOREST PROD J, V56, P52; Ren JW, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814017748013; [任建伟 Ren Jianwei], 2014, [系统工程理论与实践, Systems Engineering-Theory & Practice], V34, P1788; Ren JL, 2017, INT J INF SYST SERV, V9, P1, DOI 10.4018/IJISSS.2017040101; Roy D, 2016, TRANSPORT RES E-LOG, V93, P358, DOI 10.1016/j.tre.2016.06.005; Tornese F, 2018, J CLEAN PROD, V172, P155, DOI 10.1016/j.jclepro.2017.10.054; Tornese F, 2016, J CLEAN PROD, V126, P630, DOI 10.1016/j.jclepro.2016.03.009; Trebilcock B., 2010, MOD MAT HANDL, V9, P24; Witt C.E., 1999, MATER HANDL ENG, V54, P47; Wu J, 2016, ADV MECH ENG, V8, P1; Wu QY, 2003, LOGIST MAT HANDL, V2, P1; Zhao N., 2011, ELECT ENG CONTROL, VVolume 98, P367, DOI [10.1007/978-3-642-21765-4_46, DOI 10.1007/978-3-642-21765-4_46]; Zhou K, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/5691735; Zhou Kang, 2015, Control and Decision, V30, P2009, DOI 10.13195/j.kzyjc.2014.1459; [周康 Zhou Kang], 2014, [北京交通大学学报. 自然科学版, Journal of Beijing Jiaotong University], V38, P22; Zlatanovska B, 2018, TEM J, V7, P465, DOI 10.18421/TEM72-31	35	10	11	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217995	10.1371/journal.pone.0217995	http://dx.doi.org/10.1371/journal.pone.0217995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170248	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700089
J	Stenchly, K; Feldt, T; Weiss, D; Andriamparany, JN; Buerkert, A				Stenchly, Kathrin; Feldt, Tobias; Weiss, David; Andriamparany, Jessica N.; Buerkert, Andreas			The explanatory power of silent comics: An assessment in the context of knowledge transfer and agricultural extension to rural communities in southwestern Madagascar	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; CLIMATE-CHANGE; FUNCTIONAL DIVERSITY; TECHNOLOGY ADOPTION; EDIBLE YAM; ADAPTATION; INTENSIFICATION; DIOSCOREACEAE; COMMUNICATION; PRODUCTIVITY	The distribution of silent comic illustrations can facilitate the communication and transfer of scientific recommendations about sustainable land management (SLM) to local communities in countries where many people are illiterate. However, since there are cross-cultural differences in "visual languages", visualization styles need to be carefully selected as well as locals' comprehension of the illustrated recommendation evaluated systematically. Three agricultural recommendations were chosen for comic-style illustrations, distributed to six communities in the Mahafaly region of southwestern Madagascar and evaluated using a three-step, interdependent approach. The silent comics illustrated (i) composting of manure and its application to improve soil fertility; (ii) cautious utilization of succulent silver thicket as supplementary forage; and (iii) sustainable harvesting practices of wild yam. Results revealed that general understandability strongly depended on the community that was surveyed and on the environmental subject that was illustrated. We found a strong relationship between the general understandability of comics and the divergence that exist in communities' socio-economic structure. Education level was an important factor that explained a better understanding of respondents for the comic illustrating compost production, but not for comics that illustrated sustainable usage of silver thicket and wild yam harvest. Willingness to follow the recommended practice was impaired when respondents valued no change to the improved technique compared to the common one. Effects of respondents' socio-economic characteristics on the implementation of the recommended practice could not be clarified within this study due to the small subset of data. Based on the evaluation of recurring comments made by respondents and interviewers, we conclude that comics can be a useful communication tool to increase locals' awareness and comprehension for SLM practices. This, however, requires that drawing details used to facilitate farmers' ability to adopt a point-of-view inside the comic story are used thoughtfully as they might interfere with the central message.	[Stenchly, Kathrin; Andriamparany, Jessica N.; Buerkert, Andreas] Univ Kassel, Fac Organ Agr Sci, Organ Plant Prod & Agroecosyst Res Trop & Subtrop, Witzenhausen, Germany; [Feldt, Tobias] Univ Kassel, Fac Organ Agr Sci, AHTS, Witzenhausen, Germany; [Andriamparany, Jessica N.] Univ Kassel, Fac Organ Agr Sci, Tropenzentrum, Ctr Int Rural Dev, Witzenhausen, Germany	Universitat Kassel; Universitat Kassel; Universitat Kassel	Feldt, T (corresponding author), Univ Kassel, Fac Organ Agr Sci, AHTS, Witzenhausen, Germany.	tropanimals@uni-kassel.de	Stenchly, Kathrin/R-1265-2018	Stenchly, Kathrin/0000-0001-8215-510X; Buerkert, Dr. Andreas/0000-0003-1329-1559; Feldt, Tobias/0000-0001-7062-3199	German Federal Ministry of Education and Research (BMBF) [FKZ: 01LL0914C]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was part of the SuLaMa project funded by the German Federal Ministry of Education and Research (BMBF, FKZ: 01LL0914C). The funder provided support in the form of salaries for authors [TF, DW, JNA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler S, 2013, PRAGMATICS, V23, P389; Adler S, 2011, J PRAGMATICS, V43, P2278, DOI 10.1016/j.pragma.2010.11.012; Ahlers F, 2016, FUTURE MANAGEMENT GR, P286; Aker JC, 2016, AGR ECON-BLACKWELL, V47, P35, DOI 10.1111/agec.12301; Aker JC, 2011, AGR ECON-BLACKWELL, V42, P631, DOI 10.1111/j.1574-0862.2011.00545.x; Andriamparany J.N, 2015, THESIS; Andriamparany JN, J ETHNOBIOL ETHNOMED, V10, DOI [10.1186/1746-4269-10, DOI 10.1186/1746-4269-10]; ANGAP, 1999, ET EL PLAN AM GEST N; Antsonantenainarivony O., 2017, THESIS; Asadullah MN, 2009, APPL ECON, V41, P17, DOI 10.1080/00036840601019125; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayala J, 1998, QUELLE RECHERCHE DEV; Brouwer H., 1995, VISUAL SOCIOLOGY, V10, P15, DOI [10.1080/14725869508583746, DOI 10.1080/14725869508583746]; Burnham K.P., 2007, MODEL SELECTION MULT; Bust PD, 2008, SAFETY SCI, V46, P585, DOI 10.1016/j.ssci.2007.06.026; Campo PC, 2010, ENVIRON MODELL SOFTW, V25, P1302, DOI 10.1016/j.envsoft.2010.01.005; Castella JC, 2009, J ENVIRON MANAGE, V90, P1313, DOI 10.1016/j.jenvman.2008.07.010; Chen C, 2004, TRANSPORT RES F-TRAF, V7, P351, DOI 10.1016/j.trf.2004.10.003; Clark M., 2012, GLOBAL MAJORITY E J, V3, P61; Colverson KE, CLOSING GENDER GAP A, P9; Cooper TL, 2016, PREV VET MED, V128, P135, DOI 10.1016/j.prevetmed.2016.04.008; Coral Guerra CS, 2014, THESIS; Davidson D, 2001, COGNITION EMOTION, V15, P1, DOI 10.1080/0269993004200105; Dietz T, 2017, ED AFRICA RECENT DYN; Esham M, 2013, MITIG ADAPT STRAT GL, V18, P535, DOI 10.1007/s11027-012-9374-6; Farhadi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048903; Feldt T., 2017, MAKING SENSE RES SUS, P235; Feldt T., 2015, THESIS; Feldt T, 2017, J ARID ENVIRON, V144, P81, DOI 10.1016/j.jaridenv.2017.03.009; Feldt T, 2016, PASTORALISM, V6, DOI 10.1186/s13570-016-0052-2; Feng X, 2009, 2009 INTERNATIONAL CONFERENCE ON BUSINESS INTELLIGENCE AND FINANCIAL ENGINEERING, PROCEEDINGS, P514, DOI 10.1109/BIFE.2009.122; Fisher M., 2009, 739 IND STUD PROJ; Foster AD, 1996, AM ECON REV, V86, P931; Franz NK, 2009, FARMERS LEARN IMPROV; Fraslin J-H, 2002, AFRIQUE CONT TRIMEST, V202-203, P75; Fuglesang A., 1973, APPL COMMUNICATION D; Fuglesang A., 1982, UNDERSTANDING IDEAS; Giam XL, 2016, METHODS ECOL EVOL, V7, P388, DOI 10.1111/2041-210X.12492; Goetter JF, 2016, INT J COMMONS, V10, P617, DOI 10.18352/ijc.743; Gravoso RS, 2000, J APPL COMMUN, V84, DOI [10.4148/1051-0834.2154, DOI 10.4148/1051-0834.2154]; Hanisch S., 2015, IMPROVING CROPPING S; Harris PL, 1998, INTERSUBJECTIVE COMM, P336; Holt AR, 2016, SCI TOTAL ENVIRON, V573, P1422, DOI 10.1016/j.scitotenv.2016.07.139; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Jensen M., 2011, ENV NATURAL RESOURCE, V1, P92, DOI DOI 10.5539/ENRR.V1N1P92; Jost C, 2016, CLIM DEV, V8, P133, DOI 10.1080/17565529.2015.1050978; Kalipeni E, 1996, J Soc Dev Afr, V11, P53; Kone D, 2007, WATER RES, V41, P4397, DOI 10.1016/j.watres.2007.06.024; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lefevre P., 2014, TOOLS ANAL GRAPHIC N; MANGAN J, 1978, ECTJ-EDUC COMMUN TEC, V26, P245; Maredia MK, 2018, INFORM TECHNOL DEV, V24, P429, DOI 10.1080/02681102.2017.1312245; Mase AS, 2017, CLIM RISK MANAG, V15, P8, DOI 10.1016/j.crm.2016.11.004; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McBean G, 1980, ILLUSTRATIONS DEV MA, P6; McDermott T J, 1989, J Biocommun, V16, P20; McNicol S., 2016, CRITICAL LITERACY IN, P31; Meinzen-Dick R, 2010, 00973 IFPRI; Mertz O, 2009, ENVIRON MANAGE, V43, P743, DOI 10.1007/s00267-008-9259-3; Minten B, 2008, WORLD DEV, V36, P797, DOI 10.1016/j.worlddev.2007.05.004; Minten B, 2013, AGR ECON-BLACKWELL, V44, P629, DOI 10.1111/agec.12078; Moser CM, 2006, AGR ECON-BLACKWELL, V35, P373, DOI 10.1111/j.1574-0862.2006.00169.x; Moser CM, LABOR LIQUIDITY LEAR, DOI [10.2139/ssrn.328662, DOI 10.2139/SSRN.328662]; Motavalli P, 2013, INT SOIL WATER CONSE, V1, P1; Ndiritu SW, 2014, FOOD POLICY, V49, P117, DOI 10.1016/j.foodpol.2014.06.010; Norman DA, 1994, THINGS THAT MAKE US; Oladele O. I., 2008, Journal of International Agricultural and Extension Education, V15, P55; Osnes B, 2013, RENEW ENERG, V49, P185, DOI 10.1016/j.renene.2012.01.036; Pannoux S., COHESION SOCIALE MOD; Perez-Escamilla R, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.000513; Peterman A, 2010, 01003 IFPRI, P1482; PETTERSSON R, 1982, ECTJ-EDUC COMMUN TEC, V30, P43; Postema B., 2014, J GRAPHIC NOVELS COM, V5, P311, DOI DOI 10.1080/21504857.2014.943541; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravoavy Randrianasolo JLR, 2015, THESIS; Reimer A, 2014, J SOIL WATER CONSERV, V69, p57A, DOI 10.2489/jswc.69.2.57A; Reimers M, 2013, AM J AGR ECON, V95, P131, DOI 10.1093/ajae/aas118; Rollin D., 1997, AGR DEV, V16, P57; ROSENZWEIG MR, 1995, AM ECON REV, V85, P153; Roser M., 2018, LITERACY; Segall MS, 1966, SOC PERCEPT, V1966, P1; Stifel D, 2008, AGR ECON-BLACKWELL, V39, P1, DOI 10.1111/j.1574-0862.2008.00310.x; Theriault V, 2017, WORLD DEV, V92, P177, DOI 10.1016/j.worlddev.2016.12.003; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Truelove HB, 2015, GLOBAL ENVIRON CHANG, V31, P85, DOI 10.1016/j.gloenvcha.2014.12.010; UNICEF, MAD STAT; Van Campenhout B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169557; Van Crowder L, 1998, KNOWLEDGE INFORM FOO; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Weiss D., 2017, THESIS; Wesselow M, 2018, GEOGR J, V184, P298, DOI 10.1111/geoj.12248; Wilkin Paul, 2009, Kew Bulletin, V64, P461, DOI 10.1007/s12225-009-9126-2; Wilkin Paul, 2008, Kew Bulletin, V63, P113, DOI 10.1007/s12225-007-9000-z	93	1	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217843	10.1371/journal.pone.0217843	http://dx.doi.org/10.1371/journal.pone.0217843			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170209	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700068
J	Zhao, R; Wang, Q; Hu, XX; Nie, TY; Yang, XY; Li, CR; Lu, X; Wang, XK; Jiang, JD; Pang, J; You, XF				Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu			Microdialysis combined with liquid chromatography-tandem mass spectrometry for the quantitation of gemifloxacin and its application to a muscle penetration study in healthy and MRSA-infected rats	PLOS ONE			English	Article							PHARMACOKINETICS; PHARMACODYNAMICS; LUNG; SUSCEPTIBILITY; GATIFLOXACIN; MOXIFLOXACIN; EFFICACY; FUTURE; TISSUE	Pharmacological efficacy is based on the drug concentration in target tissues, which usually cannot be represented by the plasma concentration. The purpose of this study was to compare the pharmacokinetic characteristics of gemifloxacin in plasma and skeletal muscle and evaluate its tissue penetration in both healthy and MRSA (methicillin-resistant Staphylococcus aureus)-infected rats. A microdialysis (MD) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to determine free gemifloxacin concentrations in rat plasma and skeletal muscle simultaneously. The in vivo recoveries of MD were 23.21% +/- 3.42% for skeletal muscle and 20.62% +/- 3.19% for plasma, and were concentration independent. We provided evidence that the method developed here meets FDA requirements. Additionally, this method was successfully applied to the determination of free gemifloxacin in rats. Muscle and blood dialysates were collected after an 18 mg/kg intravenous bolus dose. The mean areas under the concentration-time curves (AUCs) from 0 to 9 h for skeletal muscle and plasma were 3641.50 +/- 915.65 h*ng/mL and 7068.32 +/- 1964.19 h*ng/mL in MRSA-infected rats and 3774.72 +/- 700.36 h*ng/mL and 6927.49 +/- 1714.86 h*ng/mL in healthy rats, respectively. There was no significant difference (P>0.05) in gemifloxacin exposure between healthy rats and MRSA-infected rats for plasma or muscle. The low ratio of AUC(0-9) muscle to AUC(0-9) plasma suggested lower drug exposure in skeletal muscle than in plasma for both healthy and MRSA-infected rats. Our study suggested that the administration of gemifloxacin according to drug levels in plasma to treat local infection is unreasonable and might result in an inadequate dose regimen.	[Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Chinese Acad Med Sci, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China; [Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Chinese Acad Med Sci, Dept Pharmacol, Inst Med Biotechnol, Beijing, Peoples R China; [Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pang, J; You, XF (corresponding author), Chinese Acad Med Sci, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.; Pang, J; You, XF (corresponding author), Chinese Acad Med Sci, Dept Pharmacol, Inst Med Biotechnol, Beijing, Peoples R China.	pangjing.pangjing@163.com; xuefuyou@imb.pumc.edu.cn			National Natural Science Foundation of China [81621064, 81361138020]; Beijing Science and Technology Projects [Z141102004414065, Z151100000315029]; CAMS Initiative for Innovative Medicine [2016-I2M-3-014, 2017-I2M-1-012, 2016-I2M-2-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Projects; CAMS Initiative for Innovative Medicine	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 81621064 and 81361138020 received by XFY), Beijing Science and Technology Projects (http://kw.beijing.gov.cn/, Z141102004414065 and Z151100000315029 received by XFY), CAMS Initiative for Innovative Medicine (http://www.pumc.edu.cn/%/E9%A6%96%E9%A1%B5% 2016-I2M-3-014 received by XFY, 2017-I2M-1-012 received by JP, and 2016-I2M-2-002 received by XW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose PG, 2006, PHARMACOTHERAPY, V26, P129, DOI 10.1592/phco.2006.26.1.129; Araki Harumi, 2002, Drug Metab Pharmacokinet, V17, P237, DOI 10.2133/dmpk.17.237; Azeredo FJ, 2014, CLIN PHARMACOKINET, V53, P205, DOI 10.1007/s40262-014-0131-8; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Bernardi PM, 2017, J PHARMACEUT BIOMED, V134, P340, DOI 10.1016/j.jpba.2016.10.023; Brunner M, 1999, ANTIMICROB AGENTS CH, V43, P1307, DOI 10.1128/AAC.43.5.1307; Bush K, 2000, CURR OPIN CHEM BIOL, V4, P433, DOI 10.1016/S1367-5931(00)00106-X; Chaurasia CS, 2007, J CLIN PHARMACOL, V47, P589, DOI 10.1177/0091270006299091; Clinical and Laboratory Standards Institute Wayne PA, 2012, M07A10 CLIN LAB STAN, P27; de Araujo BV, 2013, J CHROMATOGR B, V919, P62, DOI 10.1016/j.jchromb.2013.01.006; de Carvalho JF, 2017, ACTA CIR BRAS, V32, P46, DOI 10.1590/s0102-865020170106; FDA, 2013, GUID IND BIOAN METH; Fulzele SV, 2007, TOXICOLOGY, V237, P77, DOI 10.1016/j.tox.2007.05.005; Hutschala D, 2008, INTENS CARE MED, V34, P1827, DOI 10.1007/s00134-008-1122-8; Islinger F, 2004, ANTIMICROB AGENTS CH, V48, P4246, DOI 10.1128/AAC.48.11.4246-4249.2004; Jin HE, 2013, XENOBIOTICA, V43, P355, DOI 10.3109/00498254.2012.720740; Kaiser M, 2011, J CHROMATOGR B, V879, P3639, DOI 10.1016/j.jchromb.2011.09.011; Labreche MJ, 2012, AM J HEALTH-SYST PH, V69, P1863, DOI 10.2146/ajhp110464; Marino A, 2016, INT J ANTIMICROB AG, V48, P395, DOI 10.1016/j.ijantimicag.2016.06.026; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Muller M, 1999, ANTIMICROB AGENTS CH, V43, P2345, DOI 10.1128/AAC.43.10.2345; Nix DE, 2004, ANTIMICROB AGENTS CH, V48, P3419, DOI 10.1128/AAC.48.9.3419-3424.2004; Ramji JV, 2001, DRUG METAB DISPOS, V29, P435; Roberts DJ, 2008, EXPERT OPIN DRUG MET, V4, P1245, DOI 10.1517/17425255.4.10.1245 ; Roberts JA, 2012, BRIT J CLIN PHARMACO, V73, P27, DOI 10.1111/j.1365-2125.2011.04080.x; Saravolatz LD, 2003, CLIN INFECT DIS, V37, P1210, DOI 10.1086/378809; Segreti J, 2012, J OCUL PHARMACOL TH, V28, P3, DOI 10.1089/jop.2011.0072; Tasso L, 2008, INT J PHARMACEUT, V358, P96, DOI 10.1016/j.ijpharm.2008.02.023; Wagdy HA, 2019, TURK J PHARM SCI, V16, P8, DOI 10.4274/tjps.04934	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217573	10.1371/journal.pone.0217573	http://dx.doi.org/10.1371/journal.pone.0217573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170198	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700042
J	Sifunda, S; Peltzer, K; Rodriguez, VJ; Mandell, LN; Lee, TK; Ramlagan, S; Alcaide, ML; Weiss, SM; Jones, DL				Sifunda, Sibusiso; Peltzer, Karl; Rodriguez, Violeta J.; Mandell, Lissa N.; Lee, Tae Kyoung; Ramlagan, Shandir; Alcaide, Maria L.; Weiss, Stephen M.; Jones, Deborah L.			Impact of male partner involvement on mother-to-child transmission of HIV and HIV-free survival among HIV-exposed infants in rural South Africa: Results from a two phase randomised controlled trial	PLOS ONE			English	Article							PREVENTION; PARTICIPATION; PROTOCOL; SCALE	Background The Sub-Saharan Africa region still remains the epicentre of the global HIV/AIDS epidemic. With regards to new paediatric HIV infections, almost 90% of new HIV infections are among children (aged 0-14 years), largely through mother to child transmission. Male Partner Involvement in Prevention of Mother to Child Transmission programmes is now strongly advocated as being key in improving infant outcomes. This study describes the role of Male Partner Involvement on infant HIV infection and mortality survival in the first year among HIV-exposed infants born from HIV positive mothers. Methods This study was a two-phase, two condition (intervention or control) longitudinal study as part of a clinic-randomized Prevention of Mother to Child Transmission controlled trial. For Phase 1, female participants were recruited without their male partners. In Phase 2, both female and male participants were enrolled in the study as couples in order to encourage active Male Partner Involvement during pregnancy. Participants had two assessments pre-natally (8-24 weeks and 32 weeks) and three assessments postnatally (6 weeks, 6 months, and 12 months) Results About 1424 women were eligible for recruitment into the study and 18 eligible women declined to participate. All women had a partner; 54% were unmarried, 26% were cohabiting, and 20% were married. Just over half (55%) of the women had been diagnosed with HIV during the current pregnancy. Phase 1 had significantly more HIV-infected infants than Phase 2 at 12-months postpartum (aOR = 4.55 [1.38, 15.07]). Increased depressive symptoms were associated with infant HIV infection at 12-months (aOR = 1.06 [1.01, 1.10]). Phase 1 also had a significantly greater proportion of dead and HIV-infected infants than Phase 2 at 12-months (aOR = 1.98 [1.33, 2.94]). Conclusion Male partner involvement in antenatal care is critical in ensuring infant survival and HIV infection among children born to HIV-positive mothers. This study highlights the high risk of ante-and-post natal depression and underscores the need of screening for depression during pregnancy.	[Sifunda, Sibusiso; Peltzer, Karl; Ramlagan, Shandir] Human Sci Res Council, Social Aspects Publ Hlth SAPH Res Programme, Pretoria, South Africa; [Peltzer, Karl] Univ Limpopo, Dept Res & Innovat, Sovenga, South Africa; [Rodriguez, Violeta J.; Mandell, Lissa N.; Weiss, Stephen M.; Jones, Deborah L.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Rodriguez, Violeta J.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Rodriguez, Violeta J.] Natl Acad Sci Engn & Med, Washington, DC USA; [Lee, Tae Kyoung] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Alcaide, Maria L.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA	Human Sciences Research Council-South Africa; University of Limpopo; University of Miami; University System of Georgia; University of Georgia; National Academies of Sciences, Engineering & Medicine; University of Miami; University of Miami	Sifunda, S (corresponding author), Human Sci Res Council, Social Aspects Publ Hlth SAPH Res Programme, Pretoria, South Africa.	SSifunda@hsrc.ac.za	Rodriguez, Violeta J/I-6290-2019; Lee, Tae Kyoung/AAE-7907-2021; Peltzer, Karl/Q-7334-2019	Rodriguez, Violeta J/0000-0001-8543-2061; Peltzer, Karl/0000-0002-5980-0876; Sifunda, Sibusiso/0000-0002-8766-7240; Alcaide, Maria/0000-0003-4648-0145; Mandell, Lissa/0000-0003-1180-1711	NIH [R01HD078187]; University of Miami Miller School of Medicine Center for AIDS Research - NIH [P30AI073961]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Miller School of Medicine Center for AIDS Research - NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from NIH, R01HD078187 to DLJ, and with the support of the University of Miami Miller School of Medicine Center for AIDS Research, funded by an NIH grant, P30AI073961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2008, J EDUC BEHAV STAT, V33, P416, DOI 10.3102/1076998607306081; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Aluisio AR, 2016, JAIDS-J ACQ IMM DEF, V73, P169, DOI 10.1097/QAI.0000000000001038; Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; Asparouhov T., 2010, MPLUS WEB NOTES; Besada D, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.33507; Beyene GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3217-3; Cox J. L, 2017, BRIT J PSYCHIAT, V150, P782; Cuco RMM, 2015, SAHARA J-J SOC ASP H, V12, P87, DOI 10.1080/17290376.2015.1123643; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Falnes EF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-21; Jones D, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-417; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Lawrie TA, 1998, S AFR MED J, V88, P1340; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Matseke MG, 2017, J SOC BEHAV HLTH SCI, P11; Matseke MG, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111333; McKenna A., 2017, SCREENING COMMON PER; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Musheke M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-97; Muthen L. K., 2014, MPLUS VERSION 7 4; Nesane K, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.929; Otamere H., 2011, JPCS, P22; Peltzer K, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0187-2; Rodriguez VJ, 2017, SAHARA J-J SOC ASP H, V14, P38, DOI 10.1080/17290376.2017.1375425; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Takah NF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018207; Tilahun M, 2015, MATER RENEW SUSTAIN, V4, DOI 10.1007/s40243-015-0044-y; UNAIDS, 2018, FACT SHEET LAT GLOB; Vermeulen E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0853-8; WHO, 2012, MAL INV PREV MOTH TO	33	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217467	10.1371/journal.pone.0217467	http://dx.doi.org/10.1371/journal.pone.0217467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166984	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800030
J	Chang, CL; Hsu, SYT				Chang, Chia Lin; Hsu, Sheau Yu Teddy			Development of chimeric and bifunctional antagonists for CLR/RAMP receptors	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CGRP RECEPTOR; CALCITONIN-RECEPTOR; ADRENOMEDULLIN-RAMP2 SYSTEM; THERAPEUTIC TARGET; CANCER CURRENT; GROWTH-FACTOR; KEY RESIDUE; ALPHA-CGRP; IN-VITRO	CGRP, adrenomedullin (ADM), and adrenomedullin 2 (ADM2) family peptides are important neuropeptides and hormones for the regulation of neurotransmission, vasotone, cardiovascular morphogenesis, vascular integrity, and feto-placental development. These peptides signal through CLR/RAMP1, 2 and 3 receptor complexes. CLR/RAMP1, or CGRP receptor, antagonists have been developed for the treatment of migraine headache and osteoarthritis pain; whereas CLR/RAMP2, or ADM receptor, antagonists are being developed for the treatment of tumor growth/metastasis. Based on the finding that an acylated chimeric ADM/ADM2 analog potently stimulates CLR/RAMP1 and 2 signaling, we hypothesized that the binding domain of this analog could have potent inhibitory activity on CLR/RAMP receptors. Consistent with this hypothesis, we showed that acylated truncated ADM/ADM2 analogs of 27-31 residues exhibit potent antagonistic activity toward CLR/RAMP1 and 2. On the other hand, nonacylated analogs have minimal activity. Further truncation at the junctional region of these chimeric analogs led to the generation of CLR/RAMP1-selective antagonists. A 17-amino-acid analog (Antagonist 2-4) showed 100-fold selectivity for CLR/RAMP1 and was >100-fold more potent than the classic CGRP receptor antagonist CGRP8-37. In addition, we showed (1) a lysine residue in the Antagonist 2-4 is important for enhancing the antagonistic activity, (2) an analog consisted of an ADM sequence motif and a 12-amino-acid binding domain of CGRP exhibits potent CLR/RAMP1-inhibitory activity, and (3) a chimeric analog consisted of a somatostatin analog and an ADM antagonist exhibits dual activities on somatostatin and CLR/RAMP receptors. Because the blockage of CLR/RAMP signaling prevents migraine pain and suppresses tumor growth/metastasis, further studies of these analogs, which presumably have better access to the tumor microenvironment and nerve endings at the trigeminal ganglion and synovial joints as compared to antibody-based therapies, may lead to the development of better anti-CGRP therapy and alternative antiangiogenesis therapy. Likewise, the use of bifunctional somatostatin-ADM antagonist analogs could be a promising strategy for the treatment of high-grade neuroendocrine tumors by targeting an antiangiogenesis agent to the neuroendocrine tumor microenvironment.	[Chang, Chia Lin] Chang Gung Univ, Dept Obstet & Gynecol, Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan; [Hsu, Sheau Yu Teddy] Adepthera LLC, San Jose, CA 95035 USA	Chang Gung Memorial Hospital; Chang Gung University	Hsu, SYT (corresponding author), Adepthera LLC, San Jose, CA 95035 USA.	SYT.HSU@adepthera.com			Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards [1R43HD078056-01A1, 1R41HD082698-01]; National Heart, Lung, and Blood Institute SBIR award [1R43HL127808-01]; Adepthera LLC	Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards; National Heart, Lung, and Blood Institute SBIR award; Adepthera LLC	This study was partly supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards (1R43HD078056-01A1 and 1R41HD082698-01, SYTH), National Heart, Lung, and Blood Institute SBIR award (1R43HL127808-01, SYTH), and Adepthera LLC. The funders provided support in the form of salaries for SYTH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0864-8; Aiyar N, 2001, J PHARMACOL EXP THER, V296, P768; Albertin G, 2010, INT J MOL MED, V26, P289, DOI 10.3892/ijmm_00000464; Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Benschop RJ, 2014, OSTEOARTHR CARTILAGE, V22, P578, DOI 10.1016/j.joca.2014.01.009; Berenguer-Daize C, 2013, CLIN CANCER RES, V19, P6138, DOI 10.1158/1078-0432.CCR-13-0691; Bigal ME, 2015, BRIT J CLIN PHARMACO, V79, P886, DOI 10.1111/bcp.12591; Boeglin D, 2007, J MED CHEM, V50, P1401, DOI 10.1021/jm061343w; Boulanger Y, 1996, INT J PEPT PROT RES, V47, P477; Bradley J, 2009, METHODS MOL BIOL, V552, P171, DOI 10.1007/978-1-60327-317-6_12; BREEZE AL, 1991, BIOCHEMISTRY-US, V30, P575, DOI 10.1021/bi00216a036; Bullock CM, 2014, ARTHRITIS RHEUMATOL, V66, P2188, DOI 10.1002/art.38656; Carpenter KA, 2001, BIOCHEMISTRY-US, V40, P8317, DOI 10.1021/bi0102860; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; CHOY M, 2018, P & T, V43, P462; Conner AC, 2002, BIOCHEM SOC T, V30, P451, DOI 10.1042/bst0300451; Conteduca V, 2014, CRIT REV ONCOL HEMAT, V92, P11, DOI 10.1016/j.critrevonc.2014.05.008; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Cornish J, 2001, J ENDOCRINOL, V170, P251, DOI 10.1677/joe.0.1700251; D'Angelillo RM, 2014, TUMORI, V100, P249, DOI 10.1700/1578.17192; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Deen M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0807-1; DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; Dong YL, 2003, MOL HUM REPROD, V9, P481, DOI 10.1093/molehr/gag058; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Durham PL, 2010, CNS DRUGS, V24, P539, DOI 10.2165/11534920-000000000-00000; Edvinsson L, 2008, BRIT J PHARMACOL, V155, P967, DOI 10.1038/bjp.2008.346; Edvinsson L, 2008, LANCET, V372, P2089, DOI 10.1016/S0140-6736(08)61710-9; Erdener SE, 2014, BRIT J PHARMACOL, V171, P4575, DOI 10.1111/bph.12651; Feistel S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-93; Fernandez AP, 2010, ENDOCRINOLOGY, V151, P4908, DOI 10.1210/en.2010-0121; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Hendrikse ER, 2019, CEPHALALGIA, V39, P403, DOI 10.1177/0333102418765787; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Howitt SG, 2003, BRIT J PHARMACOL, V138, P325, DOI 10.1038/sj.bjp.0705040; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Jacobs B, 2016, NEUROSCIENCE, V338, P130, DOI 10.1016/j.neuroscience.2016.06.012; Jin Y, 2018, OSTEOARTHR CARTILAGE, V26, P1609, DOI 10.1016/j.joca.2018.08.019; Jin Y, 2016, OSTEOARTHR CARTILAGE, V24, pS50, DOI 10.1016/j.joca.2016.01.114; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Khalfaoui-Bendriss G, 2015, ONCOTARGET, V6, P7536, DOI 10.18632/oncotarget.3167; KITAMURA K, 1994, FEBS LETT, V341, P288, DOI 10.1016/0014-5793(94)80474-5; Korner C, 2014, PEPTIDES, V62, P49, DOI 10.1016/j.peptides.2014.09.022; Koyama T, 2015, J ATHEROSCLER THROMB, V22, P647, DOI 10.5551/jat.29967; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lang M, 2006, J MED CHEM, V49, P616, DOI 10.1021/jm050613s; Larrayoz IM, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0339-2; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Li CC, 2015, BRIT J CLIN PHARMACO, V79, P831, DOI 10.1111/bcp.12547; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Lv Y, 2016, J BIOL CHEM, V291, P23390, DOI 10.1074/jbc.M116.735563; Ma WY, 2006, P NATL ACAD SCI USA, V103, P16027, DOI 10.1073/pnas.0602488103; Maas D, 2013, PROCEEDINGS OF THE 2013 38TH ANNUAL IEEE CONFERENCE ON LOCAL COMPUTER NETWORKS WORKSHOPS (LCN WORKSHOPS), P203, DOI 10.1109/LCNW.2013.6758520; MAGGI CA, 1995, PROG NEUROBIOL, V45, P1, DOI 10.1016/0301-0082(94)E0017-B; Marinoni E, 2011, EUR J OBSTET GYN R B, V154, P146, DOI 10.1016/j.ejogrb.2010.10.013; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Michibata H, 1998, KIDNEY INT, V53, P979, DOI 10.1111/j.1523-1755.1998.00855.x; Michot B, 2015, EUR J PAIN, V19, P281, DOI 10.1002/ejp.616; Minatani A, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0460-4; Miranda LP, 2008, J MED CHEM, V51, P7889, DOI 10.1021/jm8009298; Moore EL, 2012, BRIT J PHARMACOL, V166, P66, DOI 10.1111/j.1476-5381.2011.01633.x; Muff R, 1998, FEBS LETT, V441, P366, DOI 10.1016/S0014-5793(98)01587-7; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Negro A, 2012, EXPERT OPIN INV DRUG, V21, P807, DOI 10.1517/13543784.2012.681044; Nouguerede E, 2013, CANCER MED-US, V2, P196, DOI 10.1002/cam4.51; Ochoa-Callejero L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17573-x; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Poyner DR, 1998, BRIT J PHARMACOL, V124, P1659, DOI 10.1038/sj.bjp.0702032; Qian SJ, 2005, CHINESE J ASTRON AST, V5, P27, DOI 10.1088/1009-9271/5/1/004; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Rist B, 1998, J MED CHEM, V41, P117, DOI 10.1021/jm970533r; Roehrkasse AM, 2018, J BIOL CHEM, V293, P15840, DOI 10.1074/jbc.RA118.005062; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; ROVERO P, 1992, PEPTIDES, V13, P1025, DOI 10.1016/0196-9781(92)90067-D; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Russo AF, 2015, BRIT J CLIN PHARMACO, V80, P403, DOI 10.1111/bcp.12686; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Schou WS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0741-2; Schuster NM, 2016, NAT REV NEUROL, V12, P635, DOI 10.1038/nrneurol.2016.143; Shi LC, 2016, J PHARMACOL EXP THER, V356, P223, DOI 10.1124/jpet.115.227793; Smith DD, 2003, J MED CHEM, V46, P2427, DOI 10.1021/jm020507f; Smith RS, 2009, AM J PHYSIOL-HEART C, V297, pH1040, DOI 10.1152/ajpheart.00404.2009; Storer RJ, 2004, BRIT J PHARMACOL, V142, P1171, DOI 10.1038/sj.bjp.0705807; Takano S, 2017, J PAIN RES, V10, P1099, DOI 10.2147/JPR.S135939; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taniguchi A, 2015, INT J CLIN EXP PATHO, V8, P12967; Taylor CK, 2007, CHEM BIOL DRUG DES, V70, P216, DOI 10.1111/j.1747-0285.2007.00558.x; Taylor CK, 2006, J PHARMACOL EXP THER, V319, P749, DOI 10.1124/jpet.106.108316; Tepper SJ, 2018, HEADACHE, V58, P238, DOI 10.1111/head.13379; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Thakur MK, 2018, CLIN GENITOURIN CANC, V16, pE695, DOI 10.1016/j.clgc.2018.01.019; Tsatsaris V, 2002, J CLIN ENDOCR METAB, V87, P4383, DOI 10.1210/jc.2002-020138; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Tsuchiya K, 2010, INT J ONCOL, V36, P1379, DOI 10.3892/ijo_00000622; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Verheggen R, 2002, BRIT J PHARMACOL, V136, P120, DOI 10.1038/sj.bjp.0704682; Walsh DA, 2015, BRIT J CLIN PHARMACO, V80, P965, DOI 10.1111/bcp.12669; Wang BC, 2017, J THERM SCI TECH-JPN, V12, DOI 10.1299/jtst.2017jtst0008; Wang DM, 2011, BEHAV BRAIN RES, V221, P83, DOI 10.1016/j.bbr.2011.02.046; Wang LJ, 2014, INT J CANCER, V134, P2041, DOI 10.1002/ijc.28542; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Watkins HA, 2013, BRIT J PHARMACOL, V170, P1308, DOI 10.1111/bph.12072; Williams ET, 2018, ANGEW CHEM INT EDIT, V57, P11640, DOI 10.1002/anie.201805208; Woolley MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0589; Yu DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077824; Zeller J, 2008, BRIT J PHARMACOL, V155, P1093, DOI 10.1038/bjp.2008.334; Zeng X, 2014, EUR J PAIN, V18, P1323, DOI 10.1002/j.1532-2149.2014.493.x; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010	117	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216996	10.1371/journal.pone.0216996	http://dx.doi.org/10.1371/journal.pone.0216996			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150417	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100028
J	Cheng, YW; Chang, YC; Chen, YL; Chen, RC; Chou, CT				Cheng, Yi-Wen; Chang, Ya-Chien; Chen, Yao-Li; Chen, Ran-Chou; Chou, Chen-Te			Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; LIVER FIBROSIS; PORTAL-HYPERTENSION; DIAGNOSTIC PERFORMANCE; NONINVASIVE ASSESSMENT; ESOPHAGEAL-VARICES; REPEATABILITY; SIZE	Aim The aim of this study was to investigate the relationship between spleen stiffness value, splenic volume and the liver fibrosis stages. Materials and methods This retrospective study was approved by the institutional review board of our institute. We enrolled 109 patients that had undergone abdominal MR imaging and histopathological examination. The preoperative MR imaging, MR elastography and laboratory data were reviewed. Liver stiffness and spleen stiffness were determined with MR elastography, and splenic volume was calculated. Liver fibrosis stage was determined using surgical pathology. Results The correlation coefficient between the liver stiffness and the fibrosis stage was r = 0.72 and r = 0.62 when the passive driver was on right chest wall and the left chest wall, respectively. The correlation coefficient between the spleen stiffness and the fibrosis stage was r = 0.63 and r = 0.18 when the passive driver was on the left chest wall and the right chest wall, respectively. The correlation coefficient between the splenic volume and the fibrosis stage was r = 0.31. The diagnostic performance of spleen stiffness was similar to liver stiffness in prediction of advanced liver fibrosis. The combination of spleen stiffness and liver stiffness provided greater sensitivity in prediction of advanced fibrosis than spleen or liver stiffness alone, but no significant difference was found. Conclusion According to our study, the spleen stiffness value was useful in staging liver fibrosis. The combination of spleen stiffness and liver stiffness could provide higher diagnostic sensitivity than liver stiffness alone in prediction of advanced fibrosis.	[Cheng, Yi-Wen; Chen, Ran-Chou] Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chang, Ya-Chien; Chou, Chen-Te] Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Chou, Chen-Te] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chou, Chen-Te] Dayeh Univ, Coll Biotechnol & Bioresources, Dept Mol Biotechnol, Changhua, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Da Yeh University	Chou, CT (corresponding author), Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan.; Chou, CT (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Chou, CT (corresponding author), Dayeh Univ, Coll Biotechnol & Bioresources, Dept Mol Biotechnol, Changhua, Taiwan.	96888@cch.org.tw		Chou, Chen-Te/0000-0003-1879-8105				Bensamoun SF, 2008, J MAGN RESON IMAGING, V28, P1287, DOI 10.1002/jmri.21523; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chang W, 2016, RADIOLOGY, V280, P88, DOI 10.1148/radiol.2016150397; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Hirsch S, 2014, J MAGN RESON IMAGING, V39, P298, DOI 10.1002/jmri.24165; Ichikawa S, 2017, J MAGN RESON IMAGING, V46, P375, DOI 10.1002/jmri.25551; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291, DOI 10.2463/mrms.11.291; Kim D, 2013, RADIOLOGY, V268, P411, DOI 10.1148/radiol.13121193; Lee YJ, 2014, J MAGN RESON IMAGING, V39, P326, DOI 10.1002/jmri.24147; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Mannelli L, 2010, AM J ROENTGENOL, V195, P387, DOI 10.2214/AJR.09.3390; Mariappan YK, 2009, MAGN RESON MED, V61, P678, DOI 10.1002/mrm.21885; Morisaka H, 2018, J MAGN RESON IMAGING, V47, P1268, DOI 10.1002/jmri.25868; Morisaka H, 2017, J MAGN RESON IMAGING, V45, P1163, DOI 10.1002/jmri.25425; Morisaka H, 2015, J MAGN RESON IMAGING, V41, P117, DOI 10.1002/jmri.24505; Nedredal GI, 2011, J MAGN RESON IMAGING, V34, P79, DOI 10.1002/jmri.22610; Runge JH, 2014, ABDOM IMAGING, V39, P283, DOI 10.1007/s00261-013-0063-z; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shi Y, 2014, RADIOLOGY, V273, P88, DOI 10.1148/radiol.14132592; Shin SU, 2014, RADIOLOGY, V272, P143, DOI 10.1148/radiol.14130916; Simon TG, 2015, J HEPATOL, V62, P18, DOI 10.1016/j.jhep.2014.08.013; Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046; Sporea I, 2010, WORLD J GASTROENTERO, V16, P4832, DOI 10.3748/wjg.v16.i38.4832; Sun HY, 2014, J MAGN RESON IMAGING, V39, P559, DOI 10.1002/jmri.24186; Takuma Y, 2017, CLIN GASTROENTEROL H, V15, P1782, DOI 10.1016/j.cgh.2016.10.041; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; TARAO K, 1989, HEPATOLOGY, V9, P589, DOI 10.1002/hep.1840090413; Wagner M, 2018, J MAGN RESON IMAGING, V48, P1091, DOI 10.1002/jmri.26026; Yin M, 2013, J MAGN RESON IMAGING, V38, P809, DOI 10.1002/jmri.24049; Yin M, 2011, AM J ROENTGENOL, V197, P64, DOI 10.2214/AJR.10.5989	33	7	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217876	10.1371/journal.pone.0217876	http://dx.doi.org/10.1371/journal.pone.0217876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150508	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100124
J	Gong, H; Wu, WQ; Xu, JJ; Yu, DN; Qiao, B; Liu, H; Yang, B; Li, YZ; Ling, Y; Kuang, HB				Gong, Han; Wu, Weiqi; Xu, Jingjie; Yu, Dainan; Qiao, Bo; Liu, Hui; Yang, Bei; Li, Yuezhen; Ling, Yan; Kuang, Haibin			Flutamide ameliorates uterine decidualization and angiogenesis in the mouse hyperandrogenemia model during mid-pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; POLYCYSTIC-OVARY-SYNDROME; EXPRESSION; PROLIFERATION; DEFECTS	Background/Aim Patients with polycystic ovary syndrome (PCOS), characterized by anovulation, hyperandrogenemia and polycystic ovaries, are still vulnerable to undergo recurrent pregnancy loss and premature labor even though the ovulatory process is pharmacologically recovered. However, its potential mechanism remains unknown. Thus, our aim was to investigate the effect and mechanism of hyperandrogenemia and flutamide (a non-steroidal anti-androgen) on the embryo implantation and pregnancy during mid-pregnancy. Methods We used a mouse model in which PCOS-like hyperandrogenemia was induced by subcutaneous injection of testosterone propionate. In this model, we observed the effect of hyperandrogenemia and flutamide on the decidualization, angiogenesis and uNK cells by methods of immunohistochemistry, quantitative PCR, western blotting and Dolichos biflorus agglutinin (DBA) lectin staining. Results Testosterone and flutamide treatment did not significantly influence the numbers of implanted embryo compared with the control group. However, different doses of testosterone significantly increased the ratio of resorbed/implanted embryo, decreased the level of prl8a2 mRNA and cyclin D3 protein, inhibited the uterine angiogenesis and reduced the numbers of uNK cells, but combined treatment with flutamide markedly decreased the resorbed embryos, increased expressions of prl8a2 mRNA and cyclin D3 protein and angiogenesis and numbers of uNK cells. Conclusion Flutamide treatment can efficiently ameliorate the hyperandrogenemia-induced the disorders in aspects of decidualization, angiogenesis and uNK cells, which further improve the poor endometrial receptivity in PCOS patients.	[Gong, Han; Wu, Weiqi; Xu, Jingjie; Yu, Dainan; Qiao, Bo; Liu, Hui; Yang, Bei; Kuang, Haibin] Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Gong, Han] Sichuan Univ, West China Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China; [Li, Yuezhen; Kuang, Haibin] Nanchang Univ, Med Expt Teaching Ctr, Jiangxi Prov Key Lab Reprod Physiol & Pathol, Nanchang, Jiangxi, Peoples R China; [Ling, Yan] Jiangxi Prov Peoples Hosp, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Sichuan University; Nanchang University	Kuang, HB (corresponding author), Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China.; Kuang, HB (corresponding author), Nanchang Univ, Med Expt Teaching Ctr, Jiangxi Prov Key Lab Reprod Physiol & Pathol, Nanchang, Jiangxi, Peoples R China.; Ling, Y (corresponding author), Jiangxi Prov Peoples Hosp, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China.	lingyan1205@163.com; kuanghaibin@ncu.edu.cn		Kuang, haibin/0000-0003-4711-5449	National Natural Science Foundation of China [81860283, 81671486, 81270668, 31260248]; 555 project of Jiangxi Province Gan Po Excellence	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 555 project of Jiangxi Province Gan Po Excellence	This work was supported by the National Natural Science Foundation of China (81860283, 81671486, 81270668 and 31260248 to HK) and The 555 project of Jiangxi Province Gan Po Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khalifah RA, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0105-4; Auble B, 2013, J PEDIATR ADOL GYNEC, V26, P234, DOI 10.1016/j.jpag.2013.03.007; Bilinski MJ, 2008, REPROD BIOMED ONLINE, V16, P218, DOI 10.1016/S1472-6483(10)60577-9; Cermik D, 2003, J CLIN ENDOCR METAB, V88, P238, DOI 10.1210/jc.2002-021072; Degaki KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052037; Dosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021; Dragamestianos C, 2018, GYNECOL OBSTET INVES, P1; Freis A, 2017, ARCH GYNECOL OBSTET, V295, P1005, DOI 10.1007/s00404-017-4295-y; Fu XF, 2018, CELL PHYSIOL BIOCHEM, V48, P670, DOI 10.1159/000491894; Gibson DA, 2015, HUM REPROD, V30, P1290, DOI 10.1093/humrep/dev067; Gong H, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0290-1; Hugar AL, 2017, ENDOCR METAB IMMUNE, V17, P317, DOI 10.2174/1871530317666170912153934; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Kuang HB, 2010, J MOL HISTOL, V41, P1, DOI 10.1007/s10735-010-9256-8; Mokhtar HM, 2014, INT J CLIN EXP PATHO, V7, P1967; Patel S, 2018, J STEROID BIOCHEM, V182, P27, DOI 10.1016/j.jsbmb.2018.04.008; Ratsep MT, 2015, REPRODUCTION, V149, pR91, DOI 10.1530/REP-14-0271; Rahman MA, 2006, DEV BIOL, V290, P105, DOI 10.1016/j.ydbio.2005.11.016; Roe Andrea Hsu, 2011, Rev Obstet Gynecol, V4, P45; Spanos N, 2012, OBESITY FACTS, V5, P495, DOI 10.1159/000341579; Sroga JM, 2012, ENDOCRINOLOGY, V153, P5575, DOI 10.1210/en.2012-1528; Tal R, 2015, SEMIN REPROD MED, V33, P195, DOI 10.1055/s-0035-1552582; Tanbo T, 2018, ACTA OBSTET GYN SCAN, V97, P1162, DOI 10.1111/aogs.13395; Zhang YH, 2017, EBIOMEDICINE, V18, P157, DOI 10.1016/j.ebiom.2017.03.023; Zhao DM, 2018, MOL MED REP, V17, P414, DOI 10.3892/mmr.2017.7890; Zong T, 2015, J HAZARD MATER, V297, P25, DOI 10.1016/j.jhazmat.2015.04.065; Zou WY, 2016, ACUPUNCT MED, V34, P114, DOI 10.1136/acupmed-2015-010788	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217095	10.1371/journal.pone.0217095	http://dx.doi.org/10.1371/journal.pone.0217095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150416	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100030
J	Nowack, S; Bauch, CT; Anand, M				Nowack, Shane; Bauch, Chris T.; Anand, Madhur			A local optimization framework for addressing conservation conflicts in mosaic ecosystems	PLOS ONE			English	Article							LAND-USE; FOREST EXPANSION; ATLANTIC FOREST; BIODIVERSITY CONSERVATION; ARAUCARIA FOREST; NATURAL FOREST; GRASSLAND; FRAGMENTATION; INFORMATION; MANAGEMENT	An effective strategy to resolve conservation conflicts on lands outside of nature reserves is to consider the spatial arrangement of agricultural and native vegetation parcels such that the ecological value of the landscape is improved without reducing the amount of land used for agricultural production. Global optimization methods have been used to identify the best spatial arrangement of land parcels for a given project goal, but these methods are not designed to provide pathways to reach the optimum from the initial landscape. Here we describe how local search algorithms can be used to develop land parcel rearrangement pathways to obtain a landscape that sustains greater species richness than the initial landscape without changing the amount of land used for agricultural production. To demonstrate how the local optimization framework can be applied, an ecological setting based on a forest-grassland mosaic ecosystem in Rio Grande do Sul, Brazil was constructed. Plant samples collected from this region were used to construct species area curves. Multiple locally optimal solutions that improved the modeled species richness of the landscape almost to globally optimal levels were identified. To support the results, the algorithm was also applied to a 306,250 ha forest-grassland region of Rio Grande do Sul. The case study results suggested that conservation polices solely based on landowners satisfying a legal reserve percentage on their property should be revised to consider landscape-level connectivity. Providing multiple possible solutions for landscape configurations using local optimization methods may improve managerial flexibility for decision-makers, compared to global optimization approaches providing a single solution. Furthermore, the algorithm details the parcel exchange pathways that are required to reach the optimal land state. We conclude that local and global optimization approaches can be used in combination to improve land use decision-making for conservation, in mosaic ecosystems as well as other terrestrial ecosystems.	[Nowack, Shane; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada	University of Guelph; University of Waterloo	Nowack, S (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	spnowack@gmail.com		Nowack, Shane/0000-0002-8265-6366	James S. McDonnell Foundation Complex Systems Scholar Award; Natural Sciences and Engineering Research Council of Canada; NSERC Discovery Grants; James S. McDonnell Complex Systems Scholar Award	James S. McDonnell Foundation Complex Systems Scholar Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Complex Systems Scholar Award	This research was supported by a James S. McDonnell Foundation Complex Systems Scholar Award to MA, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to MA and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Gerhard Overbeck and his students at Universidade Federal do Rio Grande do Sul, Brazil, for collecting samples in Aparados da Serra National Park and sharing the corresponding data. Permission to sample in the area of the National Park was granted by the ICMBio (Instituto Chico Mendes de Conservac [comma] ao da Biodiversidade), which administrates the National Park. This research was supported by NSERC Discovery Grants to MA and CTB and a James S. McDonnell Complex Systems Scholar Award to MA.	Adams W., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Aguiar L., 1986, IHERINGIA BOT, V34, P3; Aguilar J, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0136580; Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; Cao K, 2013, STOCH ENV RES RISK A, V27, P1133, DOI 10.1007/s00477-012-0649-y; Carothers NL, 2000, REAL ANAL; Chopard B., 1998, CELLULAR AUTOMATA MO; Cordeiro JLP., 2009, CAMPOS SULINOS CONSE, P285; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Duarte LDS, 2006, AUSTRAL ECOL, V31, P520, DOI 10.1111/j.1442-9993.2006.01602.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faith DP, 1996, BIODIVERS CONSERV, V5, P431, DOI 10.1007/BF00056389; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Forman RT., 1995, LAND MOSAICS ECOLOGY; Furst C, 2012, J ENVIRON PLANN MAN, V55, P855, DOI 10.1080/09640568.2011.630067; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Hasenack H., 2006, MAPEAMENTO COBERTURA; Henderson KA, 2016, P NATL ACAD SCI USA, V113, P14552, DOI 10.1073/pnas.1604987113; Henderson KA, 2016, SUSTAIN SCI, V11, P321, DOI 10.1007/s11625-015-0319-3; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Kelley C.T., 1999, ITERATIVE METHODS OP; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Kumm Karl-Ivar, 2004, Journal for Nature Conservation (Jena), V12, P213, DOI 10.1016/j.jnc.2004.07.001; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Matte ALL, 2015, AUSTRAL ECOL, V40, P21, DOI 10.1111/aec.12178; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Matthews KB, 1999, COMPUT ELECTRON AGR, V23, P9, DOI 10.1016/S0168-1699(99)00005-8; Moilanen A, 2005, AM NAT, V165, P695, DOI 10.1086/430011; Moilanen A, 2009, SPATIAL CONSERVATION; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N., 1997, Nature's services: societal dependence on natural ecosystems., P255; Natuhara Y, 1999, ECOL RES, V14, P105, DOI 10.1046/j.1440-1703.1999.00287.x; Overbeck G. E., 2006, Braz. J. Biol., V66, P1073, DOI 10.1590/S1519-69842006000600015; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Prugh T., 2000, LOCAL POLITICS GLOBA; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues C, 2007, IEEE PART ACC CONF, P713; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schindler S, 2013, ECOL INDIC, V31, P41, DOI 10.1016/j.ecolind.2012.04.012; Silva LCR, 2011, ECOSYSTEMS, V14, P1354, DOI 10.1007/s10021-011-9486-y; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Venema HD, 2005, EUR J OPER RES, V164, P423, DOI 10.1016/j.ejor.2003.11.011; Virkkala R, 2004, ECOGRAPHY, V27, P273, DOI 10.1111/j.0906-7590.2004.03810.x; Westphal MI, 2003, CONSERV BIOL, V17, P327, DOI 10.1046/j.1523-1739.2003.01594.x	57	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217812	10.1371/journal.pone.0217812	http://dx.doi.org/10.1371/journal.pone.0217812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150510	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100116
J	Patil, DN; Patil, SA; Sistla, S; Jadhav, JP				Patil, Devashree N.; Patil, Sushama A.; Sistla, Srinivas; Jadhav, Jyoti P.			Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; IN-VITRO; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; ANTIOXIDANT PROPERTIES; SERUM-ALBUMIN; BINDING; DRUG; ANTICHOLINESTERASE; GALANTAMINE	Among neurodegenerative diseases, Alzheimer's disease (AD) is one of the most grievous disease. The oldest cholinergic hypothesis is used to elevate the level of cognitive impairment and acetylcholinesterase (AChE) comprises the major targeted enzyme in AD. Thus, acetylcholinesterase inhibitors (AChEI) constitutes the essential remedy for the treatment of AD. The study aims to evaluate the interactions between natural molecules and AChE by Surface Plasmon Resonance (SPR). The molecules like alkaloids, polyphenols and substrates of AChE have been considered for the study with a major emphasis on affinity and kinetics. To better understand the activity of small molecules, the investigation is supported by both experimental and theoretical approach such as fluorescence, Circular Dichroism (CD) and molecular docking studies. Amongst the screened ones tannic acid showed promising results compared with others. The methodology followed here have highlighted many molecules with a higher affinity towards AChE and these findings may take lead molecules generated in preclinical studies to treat neurodegenerative diseases. Additionally, we suggest a unique signature for the heterogeneous analyte model using competitive experiments for analyzing simultanous interactions of both the analytes.	[Patil, Devashree N.; Patil, Sushama A.; Jadhav, Jyoti P.] Shivaji Univ, Dept Biotechnol, Kolhapur, MS, India; [Sistla, Srinivas] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA USA	Shivaji University; Virginia Commonwealth University	Jadhav, JP (corresponding author), Shivaji Univ, Dept Biotechnol, Kolhapur, MS, India.	jpjbiochem@gmail.com	Sistla, Srinivas/H-3335-2019	Sistla, Srinivas/0000-0003-3693-8597; Patil, Devashree/0000-0003-1131-9482	 [DST/INSPIRE Fellowship/2017/IF170648]		This research was supported by DST/INSPIRE Fellowship/2017/IF170648, to DNP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewusi E.A., 2012, AFRICAN J PHARM THER, V1, P78; Afshari AR, 2016, ADV PHARMACOL SCI, V2016, DOI 10.1155/2016/8964849; Balkis A., 2015, Journal of Agricultural Science (Toronto), V7, P26; Berg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026039; Bhullar KS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/891748; Commenges AD, 2016, EUR J EPIDEMIOL, V16, P357, DOI [10.1023/A:1007614613771, DOI 10.1023/A:1007614613771]; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; D'Onofrio G, 2017, CURR DRUG TARGETS, V18, P1487, DOI 10.2174/1389450117666161102121553; Deka P., 2017, INT RES J PHARM, V8, P5, DOI [10.7897/2230-8407.08565, DOI 10.7897/2230-8407.08565]; Di Bari Maria, 2017, Central Nervous System Agents in Medicinal Chemistry, V17, P109, DOI 10.2174/1871524916666160822115133; Diehl A, 2006, INT J CLIN PHARM TH, V44, P614; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Elgorashi EE, 2004, PLANTA MED, V70, P260, DOI 10.1055/s-2004-818919; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fabini E, 2018, J PHARMACEUT BIOMED, V155, P177, DOI 10.1016/j.jpba.2018.03.060; Fathi E., 2012, AFR J BIOCH RES, V6, P8; Gao Y, 2012, ANAL METHODS-UK, V4, P3718, DOI 10.1039/c2ay25780g; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Garcia-Morales G, 2015, ARCH PHARM RES, V38, P1369, DOI 10.1007/s12272-015-0587-6; Gasca CA, 2017, FOOD CHEM TOXICOL, V109, P996, DOI 10.1016/j.fct.2017.02.032; Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c; Giacobini E, 2004, PHARMACOL RES, V50, P433, DOI 10.1016/j.phrs.2003.11.017; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hasnat MA, 2013, MOLECULES, V18, P6663, DOI 10.3390/molecules18066663; Heinrich M, 2004, J ETHNOPHARMACOL, V92, P147, DOI 10.1016/j.jep.2004.02.012; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Iannello C, 2014, FITOTERAPIA, V92, P163, DOI 10.1016/j.fitote.2013.11.005; Jensen KP, 2018, CNS DRUGS, V32, P981, DOI 10.1007/s40263-018-0572-y; Karlsson R, 2000, ANAL BIOCHEM, V278, P1, DOI 10.1006/abio.1999.4406; Khan MTH, 2009, CHEM-BIOL INTERACT, V181, P383, DOI 10.1016/j.cbi.2009.06.024; Kim Se Young, 2014, Natural Product Sciences, V20, P191; Konrath EL, 2013, J PHARM PHARMACOL, V65, P1701, DOI 10.1111/jphp.12090; Kostelnik A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2532764; Kumar M., 2014, MINI REV RIP, V4, P8; Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036; MANAVALAN P, 1985, BIOCHIM BIOPHYS ACTA, V829, P365, DOI 10.1016/0167-4838(85)90246-8; Mann K, 2006, PSYCHOPHARMACOLOGY, V184, P115, DOI 10.1007/s00213-005-0243-9; MESA RA, 2012, INT J ALZHEIMERS DIS, V120, DOI DOI 10.1155/2012/728983; Milkani E, 2011, ANAL BIOCHEM, V408, P212, DOI 10.1016/j.ab.2010.09.009; Mukherjee PK, 2007, PHYTOMEDICINE, V14, P289, DOI 10.1016/j.phymed.2007.02.002; Mulla T, 2018, INT J BIOL MACROMOL, V109, P399, DOI 10.1016/j.ijbiomac.2017.12.074; Niu B, 2017, ONCOTARGET, V8, P57149, DOI 10.18632/oncotarget.19169; Oboh G, 2017, METAB BRAIN DIS, V32, P629, DOI 10.1007/s11011-017-9951-1; Odontuya G, 2016, MONG J CHEM, V17, P42; Patil S, 2014, J AGR FOOD CHEM, V62, P11594, DOI 10.1021/jf5039585; Murray AP, 2013, CURR NEUROPHARMACOL, V11, P388, DOI 10.2174/1570159X11311040004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinho BR, 2013, J PHARM PHARMACOL, V65, P1681, DOI 10.1111/jphp.12081; Rodriguez-Franco MI, 2006, J MED CHEM, V49, P459, DOI 10.1021/jm050746d; Roseiroa LB, 2012, NUTR AGING, V1, P99, DOI DOI 10.3233/NUA-2012-0006; Rosenberry TL, 2008, CHEM-BIOL INTERACT, V175, P235, DOI 10.1016/j.cbi.2008.06.002; Sarikaya SBO, 2015, J ENZYM INHIB MED CH, V30, P761, DOI 10.3109/14756366.2014.965700; Stravalaci M, 2016, J BIOMOL SCREEN, V21, P749, DOI 10.1177/1087057116637563; Suganthy N., 2009, INT J BIOMED PHARM S, V3, P87; Surwase SV, 2016, ENZYME MICROB TECH, V82, P110, DOI 10.1016/j.enzmictec.2015.09.002; Szwajgier D, 2014, POL J FOOD NUTR SCI, V64, P59, DOI 10.2478/v10222-012-0089-x; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Tuntland T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00174; Upadhyay A, 2011, CHEMOSPHERE, V85, P1095, DOI 10.1016/j.chemosphere.2011.07.041; Uriarte-Pueyo I, 2011, CURR MED CHEM, V18, P5289, DOI 10.2174/092986711798184325; Verhoeff Nicolaas Paul L G, 2005, Expert Rev Neurother, V5, P277, DOI 10.1586/14737175.5.2.277; Xiang J, 2009, PROG NAT SCI-MATER, V19, P1721, DOI 10.1016/j.pnsc.2009.07.010; Zhang FM, 2015, BIOSENSORS-BASEL, V5, P500, DOI 10.3390/bios5030500	63	10	10	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0215291	10.1371/journal.pone.0215291	http://dx.doi.org/10.1371/journal.pone.0215291			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150404	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100011
J	Patinha, D; Carvalho, C; Abreu, C; Cunha, OM; Mota, MC; Afonso, J; Albino-Teixeira, A; Diniz, C; Morato, M				Patinha, Daniela; Carvalho, Carla; Abreu, Carla; Cunha, Olga M.; Mota, Mariana C.; Afonso, Joana; Albino-Teixeira, Antonio; Diniz, Carmen; Morato, Manuela			Diabetes downregulates renal adenosine A(2A) receptors in an experimental model of hypertension	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; CHRONIC KIDNEY-DISEASE; CHLORIDE SECRETION; GENE-EXPRESSION; A(1) RECEPTORS; IMAGE-ANALYSIS; RAT; ACTIVATION; HYPERFILTRATION; NEPHROPATHY	Studies on diabetic nephropathy rarely take into account that the co-existence of diabetes and hypertension is frequent and further aggravates the prognosis of renal dysfunction. Adenosine can activate four subtypes of adenosine receptors (A(1), A(2A), A(2B) and A(3)) and has been implicated in diabetic nephropathy. However, it is not known if, in hypertensive conditions, diabetes alters the presence/distribution profile of renal adenosine receptors. The aim of this work was to describe the presence/distribution profile of the four adenosine receptors in six renal structures (superficial/deep glomeruli, proximal/distal tubules, loop of Henle, collecting tubule) of the hypertensive kidney and to evaluate whether it is altered by diabetes. Immunoreactivities against the adenosine receptors were analyzed in six renal structures from spontaneously hypertensive rats (SHR, the control group) and from SHR rats with diabetes induced by streptozotocyin (SHR-STZ group). Data showed, for the first time, that all adenosine receptors were present in the kidney of SHR rats, although the distribution pattern was specific for each adenosine receptor subtype. Also, induction of diabetes in the SHR was associated with downregulation of adenosine A(2A) receptors, which might be relevant for the development of hypertensive diabetic nephropathy. This study highlights the adenosine A(2A) receptors as a potential target to explore to prevent and/or treat early diabetes-induced hyperfiltration, at least in hypertensive conditions.	[Patinha, Daniela; Afonso, Joana; Albino-Teixeira, Antonio] Univ Porto, Fac Med, Dept Biomed, Pharmacol & Therapeut Unit, Porto, Portugal; [Carvalho, Carla; Abreu, Carla; Cunha, Olga M.; Mota, Mariana C.; Diniz, Carmen; Morato, Manuela] Univ Porto, Fac Pharm, Dept Drug Sci, LAQV REQUIMTE,Lab Pharmacol, Porto, Portugal; [Afonso, Joana; Albino-Teixeira, Antonio] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Diniz, C; Morato, M (corresponding author), Univ Porto, Fac Pharm, Dept Drug Sci, LAQV REQUIMTE,Lab Pharmacol, Porto, Portugal.	cdiniz@ff.up.pt; mmorato@ff.up.pt	Morato, Manuela/D-7563-2013; , CDiniz/D-6293-2013; Abreu, Carla/AAY-7760-2020	Morato, Manuela/0000-0002-9509-0613; , CDiniz/0000-0003-4668-9360; Abreu, Carla/0000-0003-2026-9595; Patinha, Daniela/0000-0003-1150-0046	Portuguese Foundation for Science and Technology (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Factores de Competitividade (POFC-COMPETE) [PTDC/SAU-FCF/67764/2006, UID/QUI/50006/2013 - POCI/01/0145/FEDER/007265]; FCT [SFRH/BD/43187/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Factores de Competitividade (POFC-COMPETE); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank the financial support from the Portuguese Foundation for Science and Technology (FCT, https://www.fct.pt/), Fundo Europeu de Desenvolvimento Regional (FEDER), and Programa Operacional Factores de Competitividade (POFC-COMPETE): projects PTDC/SAU-FCF/67764/2006 and UID/QUI/50006/2013 - POCI/01/0145/FEDER/007265. DP thanks FCT for the PhD fellowship SFRH/BD/43187/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas D., 2021, IDF DIABETES ATLAS, V10th edn; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Bell TD, 2009, KIDNEY INT, V75, P769, DOI 10.1038/ki.2009.18; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; CHURCHILL PC, 1985, J PHARMACOL EXP THER, V232, P589; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Diniz C., 2010, MICROSCOPY SCI TECHN, V2; Dousdampanis P, 2014, HEMODIAL INT, V18, P730, DOI 10.1111/hdi.12159; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Dubey RK, 2005, HYPERTENSION, V46, P628, DOI 10.1161/01.HYP.0000178464.63393.88; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Guirado R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00669; Hansen PB, 2005, J PHARMACOL EXP THER, V315, P1150, DOI 10.1124/jpet.105.091017; Imai G, 2003, HYPERTENS RES, V26, P339, DOI 10.1291/hypres.26.339; JACKSON EK, 1991, ANNU REV PHARMACOL, V31, P1; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kang HS, 2001, AM J PHYSIOL-RENAL, V281, pF1141, DOI 10.1152/ajprenal.2001.281.6.F1141; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kost CK, 2000, J PHARMACOL EXP THER, V292, P752; Kretschmar C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147430; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Laforest S, 2018, HISTOCHEM CELL BIOL, V149, P209, DOI 10.1007/s00418-018-1635-3; Leal S, 2008, MICROSC RES TECHNIQ, V71, P703, DOI 10.1002/jemt.20609; Leal S, 2006, ANAL BIOCHEM, V357, P137, DOI 10.1016/j.ab.2006.07.017; Lee J, 2013, AM J PATHOL, V183, P1488, DOI 10.1016/j.ajpath.2013.07.010; Lu Z, 2018, COMPUT METH PROG BIO, V155, P179, DOI 10.1016/j.cmpb.2017.12.014; Ma HP, 1996, AM J PHYSIOL-RENAL, V270, pF798, DOI 10.1152/ajprenal.1996.270.5.F798; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Mozaffari MS, 2000, CAN J PHYSIOL PHARM, V78, P428, DOI 10.1139/cjpp-78-5-428; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; OLIVERA A, 1989, KIDNEY INT, V35, P1300, DOI 10.1038/ki.1989.126; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Palm F, 2001, UPSALA J MED SCI, V106, P175, DOI 10.3109/2000-1967-147; Patinha D, 2014, LIFE SCI, V108, P71, DOI 10.1016/j.lfs.2014.05.011; Patinha D, 2014, UPSALA J MED SCI, V119, P10, DOI 10.3109/03009734.2013.851748; Patinha D, 2013, AM J PHYSIOL-RENAL, V304, pF614, DOI 10.1152/ajprenal.00285.2012; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Quezada C, 2013, CURR DRUG TARGETS, V14, P490; Rajagopal M, 2010, HYPERTENSION, V55, P1123, DOI 10.1161/HYPERTENSIONAHA.109.143404; Reshkin SJ, 2000, J MEMBRANE BIOL, V178, P103, DOI 10.1007/s002320010018; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Smith JA, 2001, BIOCHEM PHARMACOL, V61, P237, DOI 10.1016/S0006-2952(00)00532-3; Sousa-Oliveira A, 2018, HISTOCHEM CELL BIOL; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; Szczepanska-Konkel M, 2003, J PHYSIOL PHARMACOL, V54, P109; Thakur S, 2010, J BIOL CHEM, V285, P40104, DOI 10.1074/jbc.M110.184606; Tomohiro T, 2007, LIFE SCI, V80, P1364, DOI 10.1016/j.lfs.2006.11.054; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; Valladares D, 2008, BIOCHEM BIOPH RES CO, V366, P180, DOI 10.1016/j.bbrc.2007.11.113; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Vallon Volker, 2009, Handb Exp Pharmacol, P443, DOI 10.1007/978-3-540-89615-9_15; Vitzthum H, 2004, KIDNEY INT, V65, P1180, DOI 10.1111/j.1523-1755.2004.00490.x; WEAVER DR, 1992, AM J PHYSIOL, V263, pF991, DOI 10.1152/ajprenal.1992.263.6.F991; Wengert M, 2005, INT J BIOCHEM CELL B, V37, P155, DOI 10.1016/j.biocel.2004.06.006; WHO, 2016, GLOB REP PSOR; Wilcox CS, 1999, J AM SOC NEPHROL, V10, P714; Wilkinson PF, 2016, ANN CLIN LAB SCI, V46, P339; YAMAGUCHI S, 1995, HYPERTENSION, V26, P1181, DOI 10.1161/01.HYP.26.6.1181; Zhao ZH, 2002, KIDNEY INT, V61, P1276, DOI 10.1046/j.1523-1755.2002.00256.x; Zizzo MG, 2009, LIFE SCI, V84, P772, DOI 10.1016/j.lfs.2009.03.006	65	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217552	10.1371/journal.pone.0217552	http://dx.doi.org/10.1371/journal.pone.0217552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150459	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100065
J	Zhu, ZJ; Li, QX; Li, P; Xun, XJ; Zheng, LY; Ning, DD; Su, M				Zhu, Zhijun; Li, Qingxuan; Li, Ping; Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming			Surface charge controlled nucleoli selective staining with nanoscale carbon dots	PLOS ONE			English	Article							GRAPHENE QUANTUM DOTS; HIGHLY LUMINESCENT; REAL-TIME; C-DOTS; DELIVERY; ACID; MECHANISM; NANODOTS; CELLS; GREEN	Organelle selective imaging can reveal structural and functional characters of cells undergoing external stimuli, and is considered critical in revealing biological fundamentals, designing targeted delivery system, and screening potential drugs and therapeutics. This paper describes the nucleoli targeting ability of nanoscale carbon dots (including nanodiamond) that are hydrothermally made with controlled surface charges. The surface charges of carbon dots are controlled in the range of -17.9 to -2.84 mV by changing the molar ratio of two precursors, citric acid (CA) and ethylenediamine (EDA). All carbon dots samples show strong fluorescence under wide excitation wavelength, and samples with both negative and positve charges show strong fluorescent contrast from stained nucleoli. The nucleoli selective imaging of live cell has been confirmed with Hoechst staining and nucleoli specific staining (SYTO RNA-select green), and is explained as surface charge heterogeneity on carbon dots. Carbon dots with both negative and positive charges have better ability to penetrate cell and nucleus membranes, and the charge heterogeneity helps carbon dots to bind preferentially to nucleoli, where the electrostatic environment is favored.	[Zhu, Zhijun; Li, Qingxuan; Li, Ping; Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Wenzhou Med Univ, Wenzhou Inst Biomat & Engn, Wenzhou, Zhejiang, Peoples R China; [Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Chinese Acad Sci, Ningbo, Zhejiang, Peoples R China; [Li, Ping] Ningde Normal Univ, Sch Chem & Mat, Ningde, Fujian, Peoples R China	Northeastern University; Wenzhou Medical University; Chinese Academy of Sciences; Ningde Normal University	Su, M (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.; Su, M (corresponding author), Wenzhou Med Univ, Wenzhou Inst Biomat & Engn, Wenzhou, Zhejiang, Peoples R China.; Su, M (corresponding author), Chinese Acad Sci, Ningbo, Zhejiang, Peoples R China.	m.su@northeastern.edu	Zhu, Zhijun/E-5394-2016		National Institute of Health [1DP2EB016572]; Ningde Normal University [2016Q46]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ningde Normal University	This project was supported by a Director's New Innovator Award from National Institute of Health (no. 1DP2EB016572) to MS, a Young Teacher Specific Project from Ningde Normal University (no. 2016Q46) to PL.	Barbosa CDDS, 2015, CHEM-EUR J, V21, P5055, DOI 10.1002/chem.201406330; Bhunia SK, 2016, CHEMBIOCHEM, V17, P614, DOI 10.1002/cbic.201500694; Cao L, 2007, J AM CHEM SOC, V129, P11318, DOI 10.1021/ja073527l; Du FY, 2017, BIOMATERIALS, V121, P109, DOI 10.1016/j.biomaterials.2016.07.008; Feng T, 2016, ACS NANO, V10, P4410, DOI 10.1021/acsnano.6b00043; Fowley C, 2012, CHEM COMMUN, V48, P9361, DOI 10.1039/c2cc34962k; Gupta V, 2011, J AM CHEM SOC, V133, P9960, DOI 10.1021/ja2036749; He H, 2016, ACS APPL MATER INTER, V8, P28529, DOI 10.1021/acsami.6b10737; Hola K, 2014, NANO TODAY, V9, P590, DOI 10.1016/j.nantod.2014.09.004; Hu F, 2016, ORG BIOMOL CHEM, V14, P9931, DOI 10.1039/c6ob01414c; Hu LM, 2014, CARBON, V67, P508, DOI 10.1016/j.carbon.2013.10.023; Huang P, 2012, ADV MATER, V24, P5104, DOI 10.1002/adma.201200650; Jiang D., 2016, PLOS ONE, V10; Jiang K, 2015, ANGEW CHEM INT EDIT, V54, P5360, DOI 10.1002/anie.201501193; Jung YK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18807; Kim J, 2013, BIOMATERIALS, V34, P7168, DOI 10.1016/j.biomaterials.2013.05.072; Kong B, 2012, ADV MATER, V24, P5844, DOI 10.1002/adma.201202599; Kong WQ, 2014, J MATER CHEM B, V2, P5077, DOI 10.1039/c4tb00579a; LeCroy GE, 2014, ACS NANO, V8, P4522, DOI 10.1021/nn406628s; Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e; Liu WJ, 2016, J MATER CHEM B, V4, P5772, DOI 10.1039/c6tb00976j; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31100; Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; Mewada A, 2014, J MATER CHEM B, V2, P698, DOI 10.1039/c3tb21436b; Mosquera J, 2018, ACCOUNTS CHEM RES, V51, P2305, DOI 10.1021/acs.accounts.8b00292; Pierrat P, 2015, BIOMATERIALS, V51, P290, DOI 10.1016/j.biomaterials.2015.02.017; Qu KG, 2013, CHEM-EUR J, V19, P7243, DOI 10.1002/chem.201300042; Saini AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34807; Salinas-Castillo A, 2013, CHEM COMMUN, V49, P1103, DOI 10.1039/c2cc36450f; Senthilnathan N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11293-y; Sharma V, 2017, J MATER CHEM B, V5, P8904, DOI 10.1039/c7tb02484c; Shen R, 2010, J AM CHEM SOC, V132, P8627, DOI 10.1021/ja1002668; Song YB, 2015, J MATER CHEM C, V3, P5976, DOI 10.1039/c5tc00813a; Tao HQ, 2012, SMALL, V8, P281, DOI 10.1002/smll.201101706; Vazquez-Gonzalez M, 2017, ACS NANO, V11, P3247, DOI 10.1021/acsnano.7b00352; Wang CI, 2013, ANAL CHEM, V85, P3263, DOI 10.1021/ac303613d; Wang F, 2011, ADV FUNCT MATER, V21, P1027, DOI 10.1002/adfm.201002279; Wang L, 2017, BIOMATERIALS, V145, P192, DOI 10.1016/j.biomaterials.2017.08.039; Wang L, 2014, LANGMUIR, V30, P14270, DOI 10.1021/la5031813; Wang SS, 2017, BIOMATERIALS, V141, P29, DOI 10.1016/j.biomaterials.2017.05.040; Wang XJ, 2017, ACS APPL MATER INTER, V9, P17799, DOI 10.1021/acsami.7b04576; Wu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21170; Yan FY, 2014, SENSOR ACTUAT B-CHEM, V192, P488, DOI 10.1016/j.snb.2013.11.041; Yang GM, 2012, ADV FUNCT MATER, V22, P736, DOI 10.1002/adfm.201101764; Yang ST, 2009, J AM CHEM SOC, V131, P11308, DOI 10.1021/ja904843x; Yang Y, 2014, SENSOR ACTUAT B-CHEM, V199, P121, DOI 10.1016/j.snb.2014.03.064; Zeng QH, 2016, J MATER CHEM B, V4, P5119, DOI 10.1039/c6tb01259k; Zhu H, 2016, ACCOUNTS CHEM RES, V49, P2115, DOI 10.1021/acs.accounts.6b00292; Zhu SJ, 2015, NANO RES, V8, P355, DOI 10.1007/s12274-014-0644-3	50	16	16	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216230	10.1371/journal.pone.0216230	http://dx.doi.org/10.1371/journal.pone.0216230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150413	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100014
J	Tharabenjasin, P; Pabalan, N; Jarjanazi, H				Tharabenjasin, Phuntila; Pabalan, Noel; Jarjanazi, Hamdi			Association of the ACTN3 R577X (rs1815739) polymorphism with elite power sports: A meta-analysis	PLOS ONE			English	Article							ALPHA-ACTININ-3 DEFICIENCY; MUSCLE POWER; POLYGENIC PROFILE; ATHLETE STATUS; GENOTYPE; PERFORMANCE; GENE; PHENOTYPES; ACE; STRENGTH	Objective The special status accorded to elite athletes stems from their uncommon genetic potential to excel in world-class power sports (PS). Genetic polymorphisms have been reported to influence elite PS status. Reports of associations between the alpha-actinin-3 gene (ACTN3) R577X polymorphism and PS have been inconsistent. In light of new published studies, we perform a meta-analysis to further explore the roles of this polymorphism in PS performance among elite athletes. Methods Multi-database literature search yielded 44 studies from 38 articles. Pooled odds ratios (ORs) and 95% confidence intervals (Cis) were used in estimating associations (significance threshold was set at P-a <= 0.05) using the allele-genotype model (R and X alleles, RX genotype). Outlier analysis was used to examine its impact on association and heterogeneity outcomes. Subgroup analysis was race (Western and Asian) and gender (male/female)-based. Interaction tests were applied to differential outcomes between the subgroups, P-values of which were Bonferroni corrected (P-interaction (BC)). Tests for sensitivity and publication bias were performed. Results Significant overall R allele effects (OR 1.21, 95% CI 1.07-1.37, P-a = 0.002) were confirmed in the Western subgroup (OR 1.11, 95% CI 1.01-1.22, P-a = 0.02) and with outlier treatment (ORs 1.12-1.20, 95% CIs 1.02-1.30, P-a < 10(-5)-0.01). This treatment resulted in acquired significance of the RX effect in Asian athletes (OR 1.91, 95% CI 1.25-2.92, P-a = 0.003). Gender analysis dichotomized the RX genotype and R allele effects as significantly higher in male (OR 1.14, 95% CI 1.02-1.28, P-a = 0.02) and female (OR 1.58, 95% CI 1.21-2.06, P-a = 0.0009) athletes, respectively, when compared with controls. Significant R female association was improved with a test of interaction (P-interaction (BC) = 0.03). The overall, Asian and female outcomes were robust. The R allele results were more robust than the RX genotype outcomes. No evidence of publication bias was found. Conclusions In this meta-analysis, we present clear associations between the R allele/RX genotype in the ACTN3 polymorphism and elite power athlete status. Significant effects of the R allele (overall analysis, Western and female subgroups) and RX genotype (Asians and males) were for the most part, results of outlier treatment. Interaction analysis improved the female outcome. These robust findings were free of publication bias.	[Tharabenjasin, Phuntila; Pabalan, Noel] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani, Thailand; [Jarjanazi, Hamdi] Ontario Minist Environm Conservat & Pk, Environm Monitoring & Reporting Branch, Toronto, ON, Canada	Chulabhorn Research Institute; Thammasat University	Pabalan, N (corresponding author), Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani, Thailand.	noelpabalan@mail.com						Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Ahmetov II, 2015, ADV CLIN CHEM, V70, P247, DOI 10.1016/bs.acc.2015.03.003; Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berman Y, 2010, PHYSIOLOGY, V25, P250, DOI 10.1152/physiol.00008.2010; Berthold MR, 2010, TEXTS COMPUT SCI, P1, DOI 10.1007/978-1-84882-260-3_1; Bouchard C, 2015, BRIT J SPORT MED, V49, P1492, DOI 10.1136/bjsports-2015-095294; Broos S, 2015, EUR J APPL PHYSIOL, V115, P1637, DOI 10.1007/s00421-015-3144-6; Celikkaya H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00023; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Delmonico MJ, 2007, J GERONTOL A-BIOL, V62, P206, DOI 10.1093/gerona/62.2.206; Delmonico MJ, 2008, J GERONTOL A-BIOL, V63, P1227, DOI 10.1093/gerona/63.11.1227; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egorova ES, 2014, J SPORT SCI, V32, P1286, DOI 10.1080/02640414.2014.898853; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Eynon N, 2014, J SCI MED SPORT, V17, P102, DOI 10.1016/j.jsams.2013.02.005; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Eynon N, 2013, J SCI MED SPORT, V16, P135, DOI 10.1016/j.jsams.2012.05.004; Eynon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043132; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Eynon N, 2010, METABOLISM, V59, P861, DOI 10.1016/j.metabol.2009.10.003; Fuku N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166605; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Garatachea N, 2014, INT J SPORT PHYSIOL, V9, P226, DOI [10.1123/ijspp.2012-0331, 10.1123/IJSPP.2012-0331]; Garatachea N, 2013, AGE, V35, P207, DOI 10.1007/s11357-011-9327-0; Garatachea N, 2012, EUR J APPL PHYSIOL, V112, P2409, DOI 10.1007/s00421-011-2217-4; Garton FC, 2018, AM J HUM GENET, V102, P845, DOI 10.1016/j.ajhg.2018.03.009; Gineviciene V, 2016, BIOL SPORT, V33, P199, DOI 10.5604/20831862.1201051; Gineviciene V, 2011, MEDICINA-LITHUANIA, V47, P284, DOI 10.3390/medicina47050040; Grenda A, 2014, J HUM KINET, V42, P127, DOI 10.2478/hukin-2014-0067; Hanson ED, 2010, INT J SPORTS MED, V31, P834, DOI 10.1055/s-0030-1263116; He HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083103; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Jacques M, 2019, NUTR ENHANCED SPORTS; Juffer P, 2009, INT J SPORTS MED, V30, P387, DOI 10.1055/s-0028-1105931; Kikuchi Naoki, 2015, J Exerc Nutrition Biochem, V19, P157, DOI 10.5717/jenb.2015.15093001; Kikuchi N, 2013, INT J SPORT PHYSIOL, V8, P57, DOI 10.1123/ijspp.8.1.57; Kothari ST, 2011, INT J HUM GENET, V11, P149, DOI 10.1080/09723757.2011.11886137; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee FXZ, 2016, BBA-MOL CELL RES, V1863, P686, DOI 10.1016/j.bbamcr.2016.01.013; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lorenz DS, 2013, SPORTS HEALTH, V5, P542, DOI 10.1177/1941738113479763; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MANTEL N, 1959, J NATL CANCER I, V22, P719; Massidda M, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0008-x; McCauley T, 2009, EXP PHYSIOL, V94, P81, DOI 10.1113/expphysiol.2008.043075; Mikami E, 2014, INT J SPORTS MED, V35, P172, DOI 10.1055/s-0033-1347171; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Nikolakopoulou A, 2014, EVID-BASED MENT HEAL, V17, P53, DOI 10.1136/eb-2014-101795; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North K, 2008, TWIN RES HUM GENET, V11, P384, DOI 10.1375/twin.11.4.384; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Papadimitriou ID, 2008, INT J SPORTS MED, V29, P352, DOI 10.1055/s-2007-965339; Peplonska B, 2017, SCAND J MED SCI SPOR, V27, P788, DOI 10.1111/sms.12687; Pereira A, 2013, AGE, V35, P1949, DOI 10.1007/s11357-012-9461-3; Pickering C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00015; Pickering C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01080; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; Roth S M, 2000, J Nutr Health Aging, V4, P143; Roth SM, 2012, MED SCI SPORT EXER, V44, P809, DOI 10.1249/MSS.0b013e31824f28b6; Ruiz JR, 2013, SCAND J MED SCI SPOR, V23, pe162, DOI 10.1111/sms.12045; Ruiz JR, 2011, SCAND J MED SCI SPOR, V21, pE34, DOI 10.1111/j.1600-0838.2010.01134.x; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Santiago C, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.039172; Santiago C, 2010, SCAND J MED SCI SPOR, V20, P771, DOI 10.1111/j.1600-0838.2009.01017.x; Santiago C, 2010, SCAND J MED SCI SPOR, V20, pE188, DOI 10.1111/j.1600-0838.2009.00943.x; SEDGWICK P, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.H1435; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Walsh S, 2008, J APPL PHYSIOL, V105, P1486, DOI 10.1152/japplphysiol.90856.2008; Wang G, 2014, GENETICS; Wang G, 2016, MED SPORT SCI, V61, P55, DOI 10.1159/000445241; Wang G, 2013, MED SCI SPORT EXER, V45, P892, DOI 10.1249/MSS.0b013e31827c501f; Weyerstrass J, 2018, J SCI MED SPORT, V21, P213, DOI 10.1016/j.jsams.2017.06.012; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang RY, 2017, J STRENGTH COND RES, V31, P1107, DOI 10.1519/JSC.0000000000001558	85	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217390	10.1371/journal.pone.0217390	http://dx.doi.org/10.1371/journal.pone.0217390			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145768	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500017
J	Bedri, SK; Nilsson, OB; Fink, K; Manberg, A; Hamsten, C; Ayoglu, B; Manouchehrinia, A; Nilsson, P; Olsson, T; Hillert, J; Gronlund, H; Glaser, A				Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manberg, Anna; Hamsten, Carl; Ayoglu, Burcu; Manouchehrinia, Ali; Nilsson, Peter; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna			Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; NATALIZUMAB; EXPRESSION; CLONING; KINASE	Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affinity proteomics technology to identify potential biomarkers which could ultimately be used to as facilitate treatment decisions. We profiled the intra-individual changes in the levels of 59 target proteins using an antibody suspension bead array in serial plasma samples from 44 MS patients during treatment with natalizumab followed by fingolimod. Nine proteins showed decreasing plasma levels during natalizumab treatment, with PEBP1 and RTN3 displaying the most significant changes. Protein levels remained stable during fingolimod treatment for both proteins. The decreasing PEBP1 levels during natalizumab treatment could be validated using ELISA and replicated in an independent cohort. These results support the use of this technology as a high throughput method of identifying potentially useful biomarkers of MS treatment.	[Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manouchehrinia, Ali; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manouchehrinia, Ali; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Nilsson, Ola B.] Advice Foretagsassistans & Stockholm AB, TCER AB, Stockholm, Sweden; [Fink, Katharina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Manberg, Anna; Ayoglu, Burcu; Nilsson, Peter] KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Affin Prote, SciLifeLab, Stockholm, Sweden; [Hamsten, Carl] Karolinska Inst, Dept Med, Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; SciLifeLab; Karolinska Institutet	Bedri, SK (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Bedri, SK (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	sahl.bedri@ki.se	Manouchehrinia, Ali/AAD-4898-2022	Manouchehrinia, Ali/0000-0003-4857-5762; /0000-0001-7843-2960; Bedri, Sahl Khalid/0000-0002-7750-5723; Olsson, Tomas/0000-0002-2938-1877	Sanofi Genzyme [GZ-2014-11150]; Swedish Research Council [K2014-61X-11220-20-4]	Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	JH received funding from Sanofi Genzyme [(grant number GZ-2014-11150] and the Swedish Research Council [grant number K2014-61X-11220-20-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2014, BASIC IMMUNOLOGY FUN, pix; Ayoglu B, 2014, EMBO MOL MED, V6, P918, DOI 10.15252/emmm.201303724; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bystrom S, 2014, J PROTEOME RES, V13, P4607, DOI 10.1021/pr500609e; Chiurchiu V, NEUROMOLECULAR MED, P3; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Deng M, 2013, INCREASED EXPRESSION, V1, DOI [10.1074/jbc.M113.480079, DOI 10.1074/JBC.M113.480079]; Drobin Kimi, 2013, Methods Mol Biol, V1023, P137, DOI 10.1007/978-1-4614-7209-4_8; Forsberg L, ECTRIMS2016; Frisell T, 2016, MULT SCLER J, V22, P85, DOI 10.1177/1352458515579216; Haggmark A, 2014, ANN CLIN TRANSL NEUR, V1, P544, DOI 10.1002/acn3.83; Haggmark A, 2013, PROTEOMICS, V13, P2256, DOI 10.1002/pmic.201200580; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Heath JE, 2010, NEUROPATHOLOGY, V30, P574, DOI 10.1111/j.1440-1789.2010.01107.x; Holmen C, 2011, MULT SCLER J, V17, P708, DOI 10.1177/1352458510394701; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Iaffaldano P, 2015, BRAIN, V138, DOI 10.1093/brain/awv260; Kuznetsova A., 2012, LMERTEST TESTS RANDO; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lundstrom W, 2014, MULT SCLER J, V20, P1727, DOI 10.1177/1352458514532700; Maki M, 2002, J NEUROPATH EXP NEUR, V61, P176, DOI 10.1093/jnen/61.2.176; Moreira EF, 1999, GENOMICS, V58, P73, DOI 10.1006/geno.1999.5807; Neiman M, 2011, J PROTEOME RES, V10, P4925, DOI 10.1021/pr200286c; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Pabarcus MK, 2005, PROTEIN EXPRES PURIF, V44, P39, DOI 10.1016/j.pep.2005.04.013; Pollard K. S., 2005, BIOINFORMATICS COMPU, DOI DOI 10.1007/0-387-29362-0_23; Prosperini L, 2017, J NEUROL, V264, P284, DOI 10.1007/s00415-016-8343-5; Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Sevastou I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157754; Sundqvist E, 2012, GENES IMMUN, V13, P14, DOI 10.1038/gene.2011.42; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Tsugu Y, 1998, EUR J NEUROL, V5, P561, DOI 10.1046/j.1468-1331.1998.560561.x; Tykhomyrov AA, 2016, NEUROPHYSIOLOGY+, V48, P54, DOI 10.1007/s11062-016-9568-8; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vostry Michal, 2010, EJIFCC, V20, P162; World Health Organization (WHO), 2008, ATL MULT SCLER RES W; Wu YM, 2009, ACTA MED OKAYAMA, V63, P305; Yamout BI, 2018, SEMIN NEUROL, V38, P212, DOI 10.1055/s-0038-1649502; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04389-0	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217208	10.1371/journal.pone.0217208	http://dx.doi.org/10.1371/journal.pone.0217208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141529	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000044
J	Bleck, D; Ma, L; Erdene-Bymbadoo, L; Brinks, R; Schneider, M; Tian, L; Pongratz, G				Bleck, Dennis; Ma, Li; Erdene-Bymbadoo, Lkham; Brinks, Ralph; Schneider, Matthias; Tian, Li; Pongratz, Georg			Introduction and validation of a new semi-automated method to determine sympathetic fiber density in target tissues	PLOS ONE			English	Article							MOLECULE HB-GAM; NERVOUS-SYSTEM; NEURITE OUTGROWTH; HEPARAN-SULFATE; INNERVATION; EXPRESSION; MORPHOLOGY; RESISTANT; NEURONS; GLANDS	In recent years, the role of sympathetic nervous fibers in chronic inflammation has become increasingly evident. At the onset of inflammation, sympathetic activity is increased in the affected tissue. However, sympathetic fibers are largely absent from chronically inflamed tissue. Apparently, there is a very dynamic relationship between sympathetic innervation and the immune system in areas of inflammation, and hence a rapid and easy method for quantification of nerve fiber density of target organs is of great value to answer potential research questions. Currently, nervous fiber densities are either determined by tedious manual counting, which is not suitable for high throughput approaches, or by expensive automated processes relying on specialized software and high-end microscopy equipment. Usually, tyrosine hydroxylase (TH) is used as the marker for sympathetic fibers. In order to overcome the current quantification bottleneck with a cost-efficient alternative, an automated process was established and compared to the classic manual approach of counting TH-positive sympathetic fibers. Since TH is not exclusively expressed on sympathetic fibers, but also in a number of catecholamine-producing cells, a prerequisite for automated determination of fiber densities is to reliably distinct between cells and fibers. Therefore, an additional staining using peripherin exclusively expressed in nervous fibers as a secondary marker was established. Using this novel approach, we studied the spleens from a syndecan-3 knockout (SDC3KO) mouse line, and demonstrated equal results on SNS fiber density for both manual and automated counts (Manual counts: wildtype: 22.57 +/-11.72 fibers per mm(2); ko: 31.95 +/-18.85 fibers per mm(2); p = 0.05; Automated counts: wildtype: 31.6 +/-18.98 fibers per mm(2); ko: 45.49 +/-19.65 fibers per mm(2); p = 0.02). In conclusion, this new and simple method can be used as a high-throughput approach to reliably and quickly estimate SNS nerve fiber density in target tissues.	[Bleck, Dennis; Erdene-Bymbadoo, Lkham; Brinks, Ralph; Schneider, Matthias; Pongratz, Georg] Heinrich Heine Univ, Fac Med, Univ Hosp Dusseldorf, Hiller Res Ctr Rheumatol, Dusseldorf, Germany; [Ma, Li; Tian, Li] Univ Helsinki, HiLIFE, Neurosci Ctr, Helsinki, Finland; [Tian, Li] Univ Tartu, Fac Med, Dept Physiol, Inst Biomed & Translat Med, Tartu, Estonia	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Helsinki; University of Tartu	Pongratz, G (corresponding author), Heinrich Heine Univ, Fac Med, Univ Hosp Dusseldorf, Hiller Res Ctr Rheumatol, Dusseldorf, Germany.; Tian, L (corresponding author), Univ Helsinki, HiLIFE, Neurosci Ctr, Helsinki, Finland.; Tian, L (corresponding author), Univ Tartu, Fac Med, Dept Physiol, Inst Biomed & Translat Med, Tartu, Estonia.	li.tian@helsinki.fi; Georg.Pongratz@med.uni-duesseldorf.de	Pongratz, Georg/F-5472-2016; Tian, Li/P-2950-2015	Pongratz, Georg/0000-0002-2185-8458; Tian, Li/0000-0003-0222-7076	Deutsche Forschungsgemeinschaft (DFG) [PO801/9-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	GP received Grant number PO801/9-1 from the Deutsche Forschungsgemeinschaft (DFG), http://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 2015, ANAT CELL BIOL, V48, P36, DOI 10.5115/acb.2015.48.1.36; AUER RN, 1994, J NEUROSCI METH, V51, P229, DOI 10.1016/0165-0270(94)90015-9; Avenali L, 2014, J NEUROSCI, V34, P14506, DOI 10.1523/JNEUROSCI.1801-14.2014; Bahey NG, 2017, NEUROSCIENCE, V358, P261, DOI 10.1016/j.neuroscience.2017.06.061; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Chow LTC, 2001, ANAT RECORD, V264, P169, DOI 10.1002/ar.1158; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Ewen S, 2013, CURR HYPERTENS REP, V15, P370, DOI 10.1007/s11906-013-0365-0; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Freeman K, 2014, J NEUROSCI METH, V221, P48, DOI 10.1016/j.jneumeth.2013.09.005; Frykman G K, 1979, J Med Syst, V3, P81, DOI 10.1007/BF02225467; HENTGES F, 1994, CLIN EXP IMMUNOL, V97, P3; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Hoover DB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01712; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Kimura K, 2012, CIRC RES, V110, P325, DOI 10.1161/CIRCRESAHA.111.257253; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Li HY, 2014, SPINE, V39, P2119, DOI 10.1097/BRS.0000000000000647; LOVELAND BE, 1981, INT J IMMUNOPHARMACO, V3, P45, DOI 10.1016/0192-0561(81)90044-8; MADDEN K S, 1989, Brain Behavior and Immunity, V3, P72, DOI 10.1016/0889-1591(89)90007-X; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Moszkowicz D, 2012, DIS COLON RECTUM, V55, P473, DOI 10.1097/DCR.0b013e318245190e; Murray K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182416; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NAKANO K, 1984, J NUTR SCI VITAMINOL, V30, P163, DOI 10.3177/jnsv.30.163; Paveliev M, 2008, NEUROREPORT, V19, P1397, DOI 10.1097/WNR.0b013e32830d1486; Pongratz G, 2013, NAT REV RHEUMATOL, V9, P117, DOI 10.1038/nrrheum.2012.181; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1994, DEV BRAIN RES, V79, P157, DOI 10.1016/0165-3806(94)90121-X; REDER A, 1989, Brain Behavior and Immunity, V3, P110, DOI 10.1016/0889-1591(89)90011-1; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Schwartz PJ, 2011, HEART FAIL REV, V16, P101, DOI 10.1007/s10741-010-9179-1; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Straub RH, 2008, ARTHRITIS RHEUM, V58, P3450, DOI 10.1002/art.24030; Tsuboi Tetsuhiro, 2004, Nagoya J Med Sci, V67, P25; VANLENNEP EW, 1979, J MORPHOL, V159, P205, DOI 10.1002/jmor.1051590204; Zhang DY, 2014, CARDIOL CLIN, V32, P33, DOI 10.1016/j.ccl.2013.09.010; Zheng Q, 2010, NEUROSCIENCE, V171, P1032, DOI 10.1016/j.neuroscience.2010.09.060	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217475	10.1371/journal.pone.0217475	http://dx.doi.org/10.1371/journal.pone.0217475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141555	Green Submitted, gold, Green Published			2022-12-27	WOS:000469323000056
J	Soares, AP; Oliveira, H; Ferreira, M; Comesana, M; Macedo, AF; Ferre, P; Acuna-Farina, C; Hernandez-Cabrera, J; Fraga, I				Soares, Ana Paula; Oliveira, Helena; Ferreira, Marisa; Comesana, Montserrat; Macedo, Antonio Filipe; Ferre, Pilar; Acuna-Farina, Carlos; Hernandez-Cabrera, Juan; Fraga, Isabel			Lexico-syntactic interactions during the processing of temporally ambiguous L2 relative clauses: An eye-tracking study with intermediate and advanced Portuguese-English bilinguals	PLOS ONE			English	Article							WORD RECOGNITION; SENTENCE CONTEXT; COGNATE-STATUS; INFORMATION; REPRESENTATIONS; ACTIVATION; SPANISH; PROFICIENCY; ATTACHMENT; MOVEMENTS	There is extensive evidence showing that bilinguals activate the lexical and the syntactic representations of both languages in a nonselective way. However, the extent to which the lexical and the syntactic levels of representations interact during second language (L2) sentence processing and how those interactions are modulated by L2 proficiency remain unclear. This paper aimed to directly address these issues by using an online technique (eye-tracking) that is highly sensitive to the lexical and syntactic processes involved in sentence reading. To that purpose, native-speakers of European Portuguese (EP) learning English as L2 at intermediate and advanced levels of proficiency were asked to silently read temporally ambiguous L2 relative clause (RC) sentences disambiguated with a High-Attachment (HA) or Low-Attachment (LA) strategy while their eye-movements were monitored. Since EP and English native speakers differ in the way they process and comprehend this syntactic structure (EP: HA, English: LA), HA preferences were used as a marker of L1 RC syntax interference. Additionally, the cognate status of the complex NP that preceded the RC was manipulated to further analyze how the lexical co-activation of both languages would also affect the syntactic representations of the non-target (L1) language. Results showed cognate facilitation in early and late reading time measures regardless of L2 proficiency, and also that the cognate status of the complex NP impacted L2 reading performance, particularly at lower levels of L2 proficiency. These findings provide compelling evidence for a bilingual reading system that seems to be highly dynamic and interactive not only within each level of processing, but, importantly, across levels of representation. They also suggested that, as the level of L2 proficiency increases, L1 RC syntax interference becomes stronger, in a syntactic parser that seems to operate in a more integrated and nonselective way, with both strategies being equally available to guide L2 reading comprehension. Results are discussed attending to the current models of bilingual syntactic processing.	[Soares, Ana Paula; Oliveira, Helena; Comesana, Montserrat] Univ Minho, Sch Psychol, CIPsi, Human Cognit Lab, Braga, Portugal; [Ferreira, Marisa; Macedo, Antonio Filipe] Linnaeus Univ, Dept Med & Optometry, Kalmar, Sweden; [Macedo, Antonio Filipe] Univ Minho, Vis Rehabil Lab, Ctr Phys & Optometry, Braga, Portugal; [Ferre, Pilar] Univ Rovira & Virgili, Psycholinguist Res Grp, Tarragona, Spain; [Acuna-Farina, Carlos; Fraga, Isabel] Univ Santiago Compostela, Cognit Proc & Behav Res Grp, Santiago de Compostela, Spain; [Hernandez-Cabrera, Juan] Univ La Laguna, Dept Psychobiol & Methodol Behav Sci, Tenerife, Spain	Universidade do Minho; Linnaeus University; Universidade do Minho; Universitat Rovira i Virgili; Universidade de Santiago de Compostela; Universidad de la Laguna	Soares, AP (corresponding author), Univ Minho, Sch Psychol, CIPsi, Human Cognit Lab, Braga, Portugal.	asoares@psi.uminho.pt	Macedo, Antonio/I-8108-2013; Hernández-Cabrera, Juan/H-8309-2015; Carou, Isabel Fraga/B-6532-2016; Oliveira, Helena Mendes/P-1620-2019; Soares, Ana Paula/H-3794-2011; COMESANA, MONTSERRAT/H-3785-2011	Macedo, Antonio/0000-0003-3436-2010; Hernández-Cabrera, Juan/0000-0001-6731-5670; Carou, Isabel Fraga/0000-0001-9346-6560; Oliveira, Helena Mendes/0000-0003-0644-5302; Soares, Ana Paula/0000-0002-4047-3799; COMESANA, MONTSERRAT/0000-0003-2547-7684	University of Minho [PSI/01662]; Portuguese Foundation for Science and Technology; Portuguese Ministry of Science, Technology and Higher Education through national funds; FEDER through COMPETE2020 under the PT2020 Partnership [POCI-01-0145-FEDER-007653]; Portuguese Foundation for Science and Technology [EXPL/MHC-PCN/0859/2013]; Portuguese Ministry of Science; Spanish Ministry of Economy and Competitiveness [UID/PSI/01662/2013, PSI2015-65116-P]; Fundação para a Ciência e a Tecnologia [EXPL/MHC-PCN/0859/2013] Funding Source: FCT	University of Minho; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science, Technology and Higher Education through national funds; FEDER through COMPETE2020 under the PT2020 Partnership; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundação para a Ciência e a Tecnologia	This study was conducted at Psychology Research Centre (PSI/01662), University of Minho, and supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Science, Technology and Higher Education through national funds, and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007653). It was also supported by the grant EXPL/MHC-PCN/0859/2013 from the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Science (https://www.fct.pt/apoios/) and from the grants UID/PSI/01662/2013 and PSI2015-65116-P from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernolet S, 2007, J EXP PSYCHOL LEARN, V33, P931, DOI 10.1037/0278-7393.33.5.931; Bernolet S, 2013, COGNITION, V127, P287, DOI 10.1016/j.cognition.2013.02.005; Bernolet S, 2009, COGNITION, V112, P300, DOI 10.1016/j.cognition.2009.05.013; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Bultena S, 2014, Q J EXP PSYCHOL, V67, P1214, DOI 10.1080/17470218.2013.853090; Cai ZGG, 2011, J MEM LANG, V65, P431, DOI 10.1016/j.jml.2011.05.003; Carreiras M, 1999, MEM COGNITION, V27, P826, DOI 10.3758/BF03198535; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Clifton Charles Jr., 2007, P341, DOI 10.1016/B978-008044980-7/50017-3; Comesana M, 2015, J EXP PSYCHOL LEARN, V41, P614, DOI 10.1037/xlm0000065; CUETOS F, 1988, COGNITION, V30, P73, DOI 10.1016/0010-0277(88)90004-2; Davis CJ, 2005, BEHAV RES METHODS, V37, P65, DOI 10.3758/BF03206399; Dekydtspotter L, 2014, LINGUIST APPROACH BI, V4, P131, DOI 10.1075/lab.4.2.01dek; Desmet T, 2006, J MEM LANG, V54, P610, DOI 10.1016/j.jml.2005.12.007; Desmet T, 2006, LANG COGNITIVE PROC, V21, P453, DOI 10.1080/01690960400023485; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Dussias P.E., 2003, STUD SECOND LANG ACQ, V25, P529, DOI [10.1017/S0272263103000238, DOI 10.1017/S0272263103000238, 10.1017.S0272263103000238]; Dussias PE, 2007, BILING-LANG COGN, V10, P101, DOI 10.1017/S1366728906002847; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Felser C, 2003, APPL PSYCHOLINGUIST, V24, P453, DOI 10.1017/S0142716403000237; FernSSndez E.M., 2003, BILINGUAL SENTENCE P; Fontes ABAD, 2011, BILING-LANG COGN, V14, P360, DOI 10.1017/S1366728910000374; Frazier L., 1996, CONSTRUAL; Frenck-Mestre C., 1997, P GALA 1997 C LANG A, P474; Grosjean F., 2010, BILINGUAL; Guasch M, 2013, BEHAV RES METHODS, V45, P765, DOI 10.3758/s13428-012-0296-8; Hartsuiker RJ, 2004, PSYCHOL SCI, V15, P409, DOI 10.1111/j.0956-7976.2004.00693.x; Hartsuiker RJ, 2008, ACTA PSYCHOL, V128, P479, DOI 10.1016/j.actpsy.2007.08.005; Hopp H, 2017, LINGUIST APPROACH BI, V7, P96, DOI 10.1075/lab.14027.hop; Hopp H, 2014, LANG ACQUIS, V21, P250, DOI 10.1080/10489223.2014.892943; Kootstra GJ, 2016, BILING-LANG COGN, V19, P710, DOI 10.1017/S1366728916000420; Kroll JF, 2015, ANNU REV LINGUIST, V1, P377, DOI 10.1146/annurev-linguist-030514-124937; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Li P, 2014, BILING-LANG COGN, V17, P673, DOI 10.1017/S1366728913000606; Libben MR, 2009, J EXP PSYCHOL LEARN, V35, P381, DOI 10.1037/a0014875; Loebell H, 2003, LINGUISTICS, V41, P791, DOI 10.1515/ling.2003.026; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MacWhinney B., 2005, HDB BILINGUALISM PSY, P49, DOI DOI 10.1075/TILAR.22.15MAC; MacWhinney B., 1997, TUTORIALS BILINGUALI, P113; McDonald JL, 2006, J MEM LANG, V55, P381, DOI 10.1016/j.jml.2006.06.006; Papadopoulou D., 2003, STUD SECOND LANG ACQ, V25, P501, DOI [10.1017/S0272263103000214, DOI 10.1017/S0272263103000214]; Pivneva I, 2014, J EXP PSYCHOL LEARN, V40, P787, DOI 10.1037/a0035583; POLLATSEK A, 1995, J EXP PSYCHOL LEARN, V21, P785, DOI 10.1037/0278-7393.21.3.785; Raaijmakers JGW, 2003, CAN J EXP PSYCHOL, V57, P141, DOI 10.1037/h0087421; Raaijmakers JGW, 1999, J MEM LANG, V41, P416, DOI 10.1006/jmla.1999.2650; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Schoonbaert S, 2007, J MEM LANG, V56, P153, DOI 10.1016/j.jml.2006.10.002; Schwartz AI, 2006, J MEM LANG, V55, P197, DOI 10.1016/j.jml.2006.03.004; Shin JA, 2009, COGNITION, V112, P175, DOI 10.1016/j.cognition.2009.03.011; Soares AP, 2018, PSICOLOGICA, V39, P164, DOI 10.2478/psicolj-2018-0008; Soares AP, 2018, BEHAV RES METHODS, V50, P1461, DOI 10.3758/s13428-018-1058-z; Soares AP, 2015, Q J EXP PSYCHOL, V68, P680, DOI 10.1080/17470218.2014.964271; Soares AP, 2010, PSICOTHEMA, V22, P691; Soares AP, 2014, 9 M PORT ASS EXP PSY; Sorace A, 2011, LINGUIST APPROACH BI, V1, P2, DOI 10.1075/lab.1.1.01sor; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; Van Assche E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00174; Van Assche E, 2013, STUD SECOND LANG ACQ, V35, P237, DOI 10.1017/S0272263112000873; Van Assche E, 2011, J MEM LANG, V64, P88, DOI 10.1016/j.jml.2010.08.006; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Witzel J, 2012, APPL PSYCHOLINGUIST, V33, P419, DOI 10.1017/S0142716411000427	61	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216779	10.1371/journal.pone.0216779	http://dx.doi.org/10.1371/journal.pone.0216779			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141531	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000023
J	Li, M; Havelaar, AH; Hoffmann, S; Hald, T; Kirk, MD; Torgerson, PR; Devieesschauwer, B				Li, Min; Havelaar, Arie H.; Hoffmann, Sandra; Hald, Tine; Kirk, Martyn D.; Torgerson, Paul R.; Devieesschauwer, Brecht			Global disease burden of pathogens in animal source foods, 2010	PLOS ONE			English	Article							CHILDREN; NUTRITION; HEALTH	Animal source foods (ASF) such as dairy, eggs, fish and meat are an important source of high-quality nutrients. Lack of ASF in diets can result in developmental disorders including stunting, anemia, poor cognitive and motor development. ASF are more effective in preventing stunting than other foods and promoting ASF consumption in low- and middle-income countries could help improve health, particularly among pregnant women and young children. Production and consumption of ASF are, however, also associated with potential food safety risks. Strengthening of food control systems, informed by quantitative assessments of the disease burden associated with ASF is necessary to meet global nutrition goals. We present the human disease burden associated with 13 pathogens (bacteria and parasites) in ASF, based on an analysis of global burden of foodborne disease (FBD) estimates of the WHO Foodborne Disease Burden Epidemiology Reference Group (FERG). The FBD burden of these pathogens was combined with estimates of the proportion of disease transmitted by eight main groups of ASF. Uncertainty in all estimates was accounted for by Monte Carlo simulation. In 2010, the global burden of ASF was 168 (95% uncertainty interval (UI 137-219) Disability Adjusted Life Years (DALYs) per 100,000 population, which is approximately 35% of the estimated total burden of FBD. Main pathogens contributing to this burden included non-typhoidal Salmonella enterica, Taenia solium, and Campylobacterspp. The proportion of FBD burden associated with ASF varied considerably between subregions and between countries within subregions. Likewise, the contribution of different pathogens and ASF groups varied strongly between subregions. Pathogens with a localized distribution included T. solium and fishborne trematodes. Pathogens with a global distribution included non-typhoidal S. enterica, Campylobacterspp., Toxoplasma gondii, and Mycobacterium bovis. Control methods exist for many hazards associated with ASF, and their implementation is linked to economic development and effective food safety systems.	[Li, Min; Havelaar, Arie H.] Univ Florida, Inst Sustainable Food Syst, Feed Future Innovat Lab Livestock Syst, Emerging Pathogens Inst,Dept Anim Sci, Gainesville, FL 32611 USA; [Hoffmann, Sandra] USDA, Econ Res Serv, Washington, DC USA; [Hald, Tine] Danish Tech Univ, Unit Genom Epidemiol, Lyngby, Denmark; [Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland; [Devieesschauwer, Brecht] Sciensano, Dept Epidemiol & Publ Hlth, Brussels, Belgium; [Devieesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Technical University of Denmark; Australian National University; University of Zurich; Sciensano; Ghent University	Havelaar, AH (corresponding author), Univ Florida, Inst Sustainable Food Syst, Feed Future Innovat Lab Livestock Syst, Emerging Pathogens Inst,Dept Anim Sci, Gainesville, FL 32611 USA.	ariehavelaar@ufl.edu	Havelaar, Arie H./P-8495-2014; Hald, Tine/B-5477-2016; Torgerson, Paul R/M-4447-2013	Havelaar, Arie H./0000-0002-6456-5460; Hald, Tine/0000-0002-1115-9792; Torgerson, Paul R/0000-0003-4277-9983; Kirk, Martyn/0000-0001-5432-5984; Hoffmann, Sandra/0000-0003-2537-8731	World Bank; intramural research program of the U.S. Department of Agriculture, Economic Research Service; National Health and Medical Research Council, Australia [GNT1145997]	World Bank(The World Bank India); intramural research program of the U.S. Department of Agriculture, Economic Research Service; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was in part funded by a grant from the World Bank (https://www.worldbank.org/) to the University of Florida. In addition, this research was supported in part by the intramural research program of the U.S. Department of Agriculture, Economic Research Service. MDK is supported by a Career Development Fellowship (GNT1145997) from the National Health and Medical Research Council, Australia (https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour C, 2016, CLIN INFECT DIS, V63, P1171, DOI 10.1093/cid/ciw542; [Anonymous], INFL FOOD ENV HLTH D; Bank World, 2017, RED IN WAT SUPPL SAN; Batz MB, 2005, EMERG INFECT DIS, V11, P993, DOI 10.3201/eid1107.040634; Chan M, 2014, LANCET, V384, P1910, DOI 10.1016/S0140-6736(14)62037-7; Devleesschauwer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142498; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Enahoro D, 2018, GLOB FOOD SECUR-AGR, V19, P1, DOI 10.1016/j.gfs.2018.08.002; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FAO, 2016, STAT FOOD SEC NUTR W; FAO, 2007, FOOD SAF RISK AN GUI; FAO/WHO, 2014, 2 INT C NUTR FRAM AC; FAO WHO, 2014, 2 INT C NUTR DECL NU; Hald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145839; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Hoffmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183641; Iannotti LL, 2017, AM J CLIN NUTR, V106, P1482, DOI 10.3945/ajcn.117.160515; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Platts-Mills JA, 2018, LANCET GLOB HEALTH, V6, pE1309, DOI [10.1016/s2214-109x(18)30349-8, 10.1016/S2214-109X(18)30349-8]; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; R Core Team, 2018, R LANG ENV STAT COMP; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Troeger C, 2018, LANCET GLOB HEALTH, V6, pE255, DOI 10.1016/S2214-109X(18)30045-7; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	30	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216545	10.1371/journal.pone.0216545	http://dx.doi.org/10.1371/journal.pone.0216545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170162	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000470263700006
J	Roberts, H; Boktor, SW; Waller, K; Daar, ZS; Boscarino, JA; Dubin, PH; Suryaprasad, A; Moorman, AC				Roberts, Henry; Boktor, Sameh W.; Waller, Kirsten; Daar, Zahra S.; Boscarino, Joseph A.; Dubin, Perry H.; Suryaprasad, Anil; Moorman, Anne C.			Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015	PLOS ONE			English	Article							VIRAL-HEPATITIS; UNITED-STATES; HEALTH; PREVALENCE; CARE; EPIDEMIOLOGY	Context In Pennsylvania, reporting of viral hepatitis B (HBV) and viral hepatitis C (HCV) infections to CDC has been mandated since 2002. Underreporting of HBV and HCV infections has long been identified as a problem. Few reports have described the accuracy of state surveillance case registries for recording clinically-confirmed cases of HBV and HCV infections, or the characteristics of populations associated with lower rates of reporting. Objective The primary objective of the current study is to estimate the proportion of HBV and HCV infections that went unreported to the Pennsylvania Department of Health (PDoH), among patients in the Geisinger Health System of Pennsylvania. As a secondary objective, we study the association between underreporting of HBV and HCV infections to PDoH, and the select patient characteristics of interest: sex, age group, race/ethnicity, rural status, and year of initial diagnosis. Design Per medical record review, the study population was limited to Geisinger Health System patients, residing in Pennsylvania, who were diagnosed with a chronic HBV and/or HCV infection, between 2001 and 2015. Geisinger Health System patient medical records were matched to surveillance records of confirmed cases reported to the Pennsylvania Department of Health (PDoH). To quantify the extent that underreporting occurred among the Geisinger Health System study participants, we calculated the proportion of study participants that were not reported to PDoH as confirmed cases of HBV or HCV infections. An analysis of adjusted prevalence ratio estimates was conducted to study the association between underreporting of HBV and HCV infections to PDoH, and the select patient characteristics of interest. Results Geisinger Health System patients living with HBV were reported to PDoH 88.4% (152 of 172) of the time; patients living with HCV were reported to PDoH 94.6% (2,257 of 2,386) of the time; and patients who were co-infected with both viruses were reported to PDoH 72.0% (18 of 25) of the time. Patients living with HCV had an increased likelihood of being reported if they were: less than or equal to age 30 vs ages 65+ {PR = 1.2, [95`)/X1, (1.1, 1.3)]}, and if they received their initial diagnosis of HCV during the 2010-2015 time period vs the 19901999 time period {PR = 1.08, [95`)/X1, (1.05, 1.12)]}. Conclusion The findings in this study are promising, and suggests that PDoH has largely been successful with tracking and monitoring viral hepatitis B and C infections, among persons that were tested for HBV and/or HCV. Additional efforts should be placed on decreasing underreporting rates of HCV infections among seniors (ages 65 and over), and persons who are co infected with HBV and HCV.	[Roberts, Henry; Dubin, Perry H.; Suryaprasad, Anil; Moorman, Anne C.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Boktor, Sameh W.; Waller, Kirsten] Penn Dept Hlth, Harrisburg, PA 17108 USA; [Daar, Zahra S.; Boscarino, Joseph A.] Geisinger Hlth Syst, Danville, PA USA; [Dubin, Perry H.] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Suryaprasad, Anil] Mayo Clin, Radiat & Oncol, Jacksonville, FL 32224 USA	Centers for Disease Control & Prevention - USA; Geisinger Health System; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic	Roberts, H (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	hroberts@yahoo.com	Boktor, Sameh W./Y-7236-2019	Boktor, Sameh W./0000-0001-9651-7706; Boscarino, Joseph/0000-0002-9965-6805	CDC; Gilead Sciences; CDC Foundation; AbbVie; Genentech; Janssen Pharmaceuticals, Inc.; Vertex Pharmaceuticals; Bristol- Myers Squibb; CDC Epidemiology Elective Program	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Gilead Sciences(Gilead Sciences); CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AbbVie(AbbVie); Genentech(Roche HoldingGenentech); Janssen Pharmaceuticals, Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Bristol- Myers Squibb(Bristol-Myers Squibb); CDC Epidemiology Elective Program	Centers for Disease Control and Prevention (CDC), and Pennsylvania Department of Health co-authors do not have any financial interests or relationships to disclose. Henry Ford Health System receives funding for CHeCS from the CDC and from Gilead Sciences. CHeCS was previously funded through May 2016 by the CDC Foundation, which received grants from AbbVie; Genentech, A Member of the Roche Group; Gilead Sciences; Janssen Pharmaceuticals, Inc. and Vertex Pharmaceuticals; past partial funders include Bristol- Myers Squibb. Granting corporations do not have access to CHeCS data and do not contribute to data analysis or writing of manuscripts. This research was also funded by the CDC Epidemiology Elective Program for its support of co-author Perry Dubin.	ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Brass V, 2009, J HEPATOL, V51, P423, DOI 10.1016/j.jhep.2009.06.003; CDC, 2014, VIR HEP SURV US; CDC, CAS DEF PUBL HLTH SU; Centers for Disease Control and Prevention, NAT EL DIS SURV SYST; Centers for Disease Control and Prevention, NAT EL TRANSM SURV S; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Crockett SD, 2005, ANN CLIN MICROBIOL A; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Hagan H, 2002, J URBAN HEALTH, V79, P579, DOI 10.1093/jurban/79.4.579; Ingram DD, 2012, VITAL HLTH STAT, V2, P1; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Kirkey K, 2013, MMWR-MORBID MORTAL W, V62, P99; Klevens RM, 2014, AM J PUBLIC HEALTH, V104, P482, DOI 10.2105/AJPH.2013.301601; Klevens RM, 2009, EMERG INFECT DIS, V15, P1499, DOI 10.3201/eid1509.081050; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; PDOH, REPORTING OF CASES B; Ramsey S, 2019, JAMA ONCOLOGY; Roberts H, 2016, HEPATOLOGY, V63, P388, DOI 10.1002/hep.28109; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Underwood J. Michael, 2012, Morbidity and Mortality Weekly Report, V61, P1; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217455	10.1371/journal.pone.0217455	http://dx.doi.org/10.1371/journal.pone.0217455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170165	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700030
J	Sundbakk, LM; Wood, M; Gran, JM; Nordeng, H				Sundbakk, Lene Maria; Wood, Mollie; Gran, Jon Michael; Nordeng, Hedvig			Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							PREGNANT-WOMEN; BRAIN-DEVELOPMENT; PROPENSITY SCORE; DIAZEPAM; POPULATION; MEDICATION; PROFILE; DRUGS; BIAS	Many women experience anxiety or sleep disorders during pregnancy and require pharmacological treatment with benzodiazepines (BZDs) or z-hypnotics. Limited information is currently available on how prenatal exposure to these medications affects behavioral problems in children over the long term. Therefore, from a public health perspective, this issue is highly important. The present study aimed to determine whether prenatal exposure to BZDs and z-hypnotics affected externalizing and internalizing behavior problems in children at age 5 years. This study was based on The Norwegian Mother and Child Cohort Study and The Medical Birth Registry of Norway. The final study population included data for 36 401 children, from questionnaires completed by the mothers throughout the 5-year follow up. Children's behaviors were measured at age 5, based on parental responses to The Child Behavior Checklist. Children T-scores of 63 or above were considered to indicate clinically relevant behavior problems. We applied inverse probability of treatment weighting (IPTW) and log-binomial regression models to estimate risk ratios (RRs) and bootstrapped 95% confidence intervals (CIs) with censoring weights to account for loss during follow-up. Several sensitivity analyses were performed to assess the robustness of the main results. The final sample included 273 (0.75%) children that were exposed to BZDs and/or z-hypnotics during pregnancy. The main, IPTW and censoring weighted analyses showed that prenatal exposure to BZD and/or z-hypnotics increased the risks of internalizing behavioral problems (RR: 1.35, 95% CI: 0.73-2.49) and externalizing behavioral problems (RR: 1.51, 95% CI: 0.86-2.64). However, based on sensitivity analyses, we concluded that the risks of displaying externalizing and internalizing problems at 5 years of age did not significantly increase after prenatal exposure to BZDs and/or z-hypnotics. Instead, the sensitivity analyses suggested that residual confounding and selection bias might explain the increased risks observed in the main analyses.	[Sundbakk, Lene Maria; Wood, Mollie; Nordeng, Hedvig] Univ Oslo, Fac Math & Nat Sci, Dept Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Sundbakk, Lene Maria; Wood, Mollie; Nordeng, Hedvig] Univ Oslo, Fac Math & Nat Sci, PharmaTox Strateg Initiat, Oslo, Norway; [Wood, Mollie] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gran, Jon Michael] Univ Oslo, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Nordeng, Hedvig] Norwegian Inst Publ Hlth, Dept Child Dev & Hlth, Oslo, Norway	University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Norwegian Institute of Public Health (NIPH)	Sundbakk, LM (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway.; Sundbakk, LM (corresponding author), Univ Oslo, Fac Math & Nat Sci, PharmaTox Strateg Initiat, Oslo, Norway.	l.m.sundbakk@farmasi.uio.no			Ministry of Health and Care Services; Ministry of Education and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [U01 NS 04753701, U01 NS 047537-06A1]; HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy" [639377]; PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway	Ministry of Health and Care Services; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy"; PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway	The Norwegian Mother and Child Cohort Study (MoBa) is supported by the Ministry of Health and Care Services and the Ministry of Education and Research https://www.regjeringen.no/en/id4/, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 U01 NS 04753701 and grant no.2 U01 NS 047537-06A1). Primary investigator of MoBa is Center director Per Magnus, Center for Fertility and Health, Norway (www.fhi.no/en/more/research-centres/Centre-for-fertility-and-health/employees/per-magnus/).This study was funded by HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy" (grant no. 639377). LMS and MW are funded by the PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; [Anonymous], 1996, BRUK BENZODIAZEPINER; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Brandlistuen RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181042; Bromley RL, 2017, SEIZURE-EUR J EPILEP, V44, P225, DOI 10.1016/j.seizure.2016.10.006; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dennis CL, 2017, BRIT J PSYCHIAT, V210, P315, DOI 10.1192/bjp.bp.116.187179; DESALVIA MA, 1990, DEV PHARMACOL THERAP, V15, P173; Flower R., 2016, RANG DALES PHARM; GAI N, 1982, PSYCHOPHARMACOLOGY, V78, P225, DOI 10.1007/BF00428155; Gidai J, 2008, TOXICOL IND HEALTH, V24, P61, DOI 10.1177/0748233708089016; GUERREMILLO M, 1979, EUR J CLIN PHARMACOL, V15, P171, DOI 10.1007/BF00563101; Hanley GE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-242; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KELLOGG C, 1980, SCIENCE, V207, P205, DOI 10.1126/science.7350658; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Lash TL., 2009, APPL QUANTITATIVE BI; Leite W., 2016, PRACTICAL PROPENSITY; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2016, SURVEY ANAL COMPLEX, DOI [10.1016/j.jfma.2016.08.004, DOI 10.1016/J.JFMA.2016.08.004]; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; MANDELLI M, 1975, CLIN PHARMACOL THER, V17, P564; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordeng H., 2016, DRUG UTILIZATION RES; Novik TS, 1999, EUR CHILD ADOLES PSY, V8, P247, DOI 10.1007/s007870050098; Oerbeck B, 2017, J ATTEN DISORD, DOI [10.1177/1087054212696265, DOI 10.1177/1087054212696265]; Organization WH, 2012, THE ANATOMICAL THERA; R Core Team, 2018, R LANG ENV STAT COMP; Radojcic MR, 2017, NEUROTOXICOL TERATOL, V61, P58, DOI 10.1016/j.ntt.2017.02.005; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Riska BS, 2014, EUR J CLIN PHARMACOL, V70, P1367, DOI 10.1007/s00228-014-1744-4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SCHLUMPF M, 1989, NEUROTOXICOLOGY, V10, P501; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; STIKA L, 1990, PHARM WEEKBLAD, V12, P252; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; VanderWeele TJ, 2007, AM J EPIDEMIOL, V166, P1096, DOI 10.1093/aje/kwm179; VIGGEDAL G, 1993, J CHILD PSYCHOL PSYC, V34, P295, DOI 10.1111/j.1469-7610.1993.tb00993.x; Wood ME, 2018, PHARMACOEPIDEM DR S, V27, P140, DOI 10.1002/pds.4336; Wu C, 2015, METAB BRAIN DIS, V30, P367, DOI 10.1007/s11011-014-9560-1; Zachrisson HD, 2013, CHILD DEV, V84, P1152, DOI 10.1111/cdev.12040	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217830	10.1371/journal.pone.0217830	http://dx.doi.org/10.1371/journal.pone.0217830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170221	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700063
J	Voets, M; Mollersen, K; Bongo, LA				Voets, Mike; Mollersen, Kajsa; Bongo, Lars Ailo			Reproduction study using public data of: Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs	PLOS ONE			English	Article								We have attempted to reproduce the results in Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs, published in JAMA 2016; 316(22), using publicly available data sets. We re-implemented the main method in the original study since the source code is not available. The original study used non-public fundus images from EyePACS and three hospitals in India for training. We used a different EyePACS data set from Kaggle. The original study used the benchmark data set Messidor-2 to evaluate the algorithm's performance. We used another distribution of the Messidor-2 data set, since the original data set is no longer available. In the original study, ophthalmologists re-graded all images for diabetic retinopathy, macular edema, and image gradability. We have one diabetic retinopathy grade per image for our data sets, and we assessed image gradability ourselves. We were not able to reproduce the original study's results with publicly available data. Our algorithm's area under the receiver operating characteristic curve (AUC) of 0.951 (95% CI, 0.947-0.956) on the Kaggle EyePACS test set and 0.853 (95% CI, 0.835-0.871) on Messidor-2 did not come close to the reported AUC of 0.99 on both test sets in the original study. This may be caused by the use of a single grade per image, or different data. This study shows the challenges of reproducing deep learning method results, and the need for more replication and reproduction studies to validate deep learning methods, especially for medical image analysis. Our source code and instructions are available at: https://github.com/mikevoets/jama16-retina-replication.	[Voets, Mike; Bongo, Lars Ailo] UiT Arctic Univ Norway, Dept Comp Sci, Tromso, Norway; [Mollersen, Kajsa] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Bongo, LA (corresponding author), UiT Arctic Univ Norway, Dept Comp Sci, Tromso, Norway.	lars.ailo.bongo@uit.no		Bongo, Lars/0000-0002-7544-2482; Voets, Mike/0000-0001-9582-8799	UiT The Arctic University of Norway	UiT The Arctic University of Norway	The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2016, ABRAMOFF MESSIDOR 2; Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; [Anonymous], 2016, NATURE, V533, P437, DOI 10.1038/533437a; [Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; [Anonymous], 2015, DIABETIC RETINOPATHY; [Anonymous], 2018, B MATH BIOL, V80, P3069, DOI [10.1007/s11538-018-0501-8, DOI 10.1007/S11538-018-0501-8]; Caruana R, 2001, ADV NEUR IN, V13, P402; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Dean  J., 2012, ADV NEURAL INFORM PR, P1223; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Editorial, 2017, ELIFE, V6; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hutson M., 2018, MISSING DATA HINDER; Ioffe S, 2015, ARXIV150203167CSLG; Kaggle, 2015, DIAB RET DET DAT; Krause J, 2017, ARXIV171001711CSCV; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Quellec G, 2008, IEEE T MED IMAGING, V27, P1230, DOI 10.1109/TMI.2008.920619; Rakhlin A., 2017, BIORXIV; Raman R, EYE; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Szegedy C., 2015, ARXIV151200567CSCV; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Voets M, 2018, ARXIV180304337V1CSCV; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5	27	42	43	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217541	10.1371/journal.pone.0217541	http://dx.doi.org/10.1371/journal.pone.0217541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170223	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700041
J	Byun, YS; Kim, SE; Paik, JS; Yang, SW				Byun, Yong-Soo; Kim, Sung-Eun; Paik, Ji-Sun; Yang, Suk-Woo			Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia	PLOS ONE			English	Article							BOTULINUM-TOXIN; GANGLION-CELLS; SHEDDING LIGHT; MECHANISM; DISEASE	We evaluated whether the pupillary light reflex is altered in benign essential blepharospasm patients. Twenty-three patients with benign essential blepharospasm, 47 with reflex blepharospasm, and 29 dry eye disease controls were included. Pupillary light reflex-related parameters were measured under mesopic (10 lux) and photopic illuminance (200 lux) using an infrared pupillometer. Additionally, we assessed photophobia grade, eyelid function, and dry eye disease-related parameters. There were no differences in age, sex predominance, or dry eye disease-related parameters among the three groups, or in photophobia grade and eyelid function between benign essential blepharospasm and reflex groups. Constriction velocity and maximum constriction velocity in the mesopic condition were significantly greater in the benign essential blepharospasm group (3.26 +/- 0.56 and 5.27 +/- 0.90 mm/s) than in reflex (2.86 +/- 0.62 and 4.59 +/- 1.00 mm/s) or dry eye disease groups (2.96 +/- 0.46 and 4.72 +/- 0.67 mm/s). Constriction velocity and maximum constriction velocity in the mesopic condition positively correlated with photophobia grade (r = 0.525 and 0.617, P = 0.025 and 0.006) in the benign essential blepharospasm group. Pupillary light reflex may be related to the pathophysiology of benign essential blepharospasm with photophobia. Further studies are required to reveal connections among pupillary light reflex, photophobia, and focal dystonia in benign essential blepharospasm patients with photophobia.	[Byun, Yong-Soo; Kim, Sung-Eun; Paik, Ji-Sun; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Yang, SW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	yswoph@catholic.ac.kr		Yang, Suk-Woo/0000-0003-3984-9506; Byun, Yong-Soo/0000-0002-7264-0723	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01054947]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	BYS was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01054947) (URL: https://ernd.nrf.re.kr).The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RL, 1998, OPHTHALMIC PLAST REC, V14, P305, DOI 10.1097/00002341-199809000-00002; Blackburn MK, 2009, OPHTHALMOLOGY, V116, P997, DOI 10.1016/j.ophtha.2008.12.031; Bussa M, 2015, ACTA ANAESTH SCAND, V59, P685, DOI 10.1111/aas.12489; Conte A, 2017, MOV DISORD CLIN PRAC, V4, P733, DOI 10.1002/mdc3.12499; Coscarelli JM, 2010, SEMIN OPHTHALMOL, V25, P104, DOI 10.3109/08820538.2010.488564; Defazio G, 2017, PARKINSONISM RELAT D, V40, P64, DOI 10.1016/j.parkreldis.2017.04.014; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Ferrazzano G, 2015, J NEUROL NEUROSUR PS, V86, P336, DOI 10.1136/jnnp-2014-307821; FISHER CM, 1963, NEUROLOGY, V13, P77, DOI 10.1212/WNL.13.1.77; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; GRANDAS F, 1988, J NEUROL NEUROSUR PS, V51, P767, DOI 10.1136/jnnp.51.6.767; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hyon Joon Young, 2014, Korean J Ophthalmol, V28, P197, DOI 10.3341/kjo.2014.28.3.197; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Judd RA, 2007, NEURO-OPHTHALMOLOGY, V31, P49, DOI 10.1080/01658100701247646; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; LEMP MA, 1970, ARCH OPHTHALMOL-CHIC, V83, P89, DOI 10.1001/archopht.1970.00990030091017; Liang H, 2015, INVEST OPHTH VIS SCI, V56, P3218, DOI 10.1167/iovs.15-16499; Lu R, 2014, AM J OPHTHALMOL, V157, P591, DOI 10.1016/j.ajo.2013.11.014; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; McCann JD, 1999, OPHTHALMIC PLAST REC, V15, P384, DOI 10.1097/00002341-199911000-00003; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Park DI, 2013, ACTA OPHTHALMOL, V91, pe108, DOI 10.1111/aos.12002; Peckham EL, 2011, EUR J NEUROL, V18, P382, DOI 10.1111/j.1468-1331.2010.03161.x; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Valls-Sole J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00045; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yoon Jin Sook, 2009, Korean J Ophthalmol, V23, P137, DOI 10.3341/kjo.2009.23.3.137	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217924	10.1371/journal.pone.0217924	http://dx.doi.org/10.1371/journal.pone.0217924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163059	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200046
J	Loughlin, AM; Lin, N; Abler, V; Carroll, B				Loughlin, Anita M.; Lin, Nancy; Abler, Victor; Carroll, Benjamin			Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States	PLOS ONE			English	Article							BASAL INSULIN; SCHIZOPHRENIA; TOLERABILITY; EXENATIDE; RISK	Background Tardive dyskinesia (TD) is a movement disorder resulting from treatment with typical and atypical antipsychotics. An estimated 16-50% of patients treated with antipsychotics have TD, but this number may be underestimated. The objectives of this study were to build an algorithm for use in electronic health records (EHRs) for the detection and characterization of TD patients, and to estimate the prevalence of TD in a population of patients exposed to antipsychotic medications. Methods This retrospective observational study included patients identified in the Optum EHR Database who received a new or refill prescription for an antipsychotic medication between January 2011 and December 2015 (follow-up through June 2016). TD mentions were identified in the natural language-processed clinical notes, and an algorithm was built to classify the likelihood that the mention represented documentation of a TD diagnosis as probable, possible, unlikely, or negative. The final TD population comprised a subgroup identified using this algorithm, with >= 1 probable TD mention (highly likely TD). Results 164,417 patients were identified for the antipsychotic population, with1,314 comprising the final TD population. Conservatively, the estimated average annual prevalence of TD in patients receiving antipsychotics was 0.8% of the antipsychotic user population. The average annual prevalence may be as high as 1.9% per antipsychotic user per year, allowing for a more-inclusive algorithm using both probable and possible TD. Most TD patients were prescribed atypical antipsychotics (1049/1314, 79.8%). Schizophrenia (601/1314, 45.7%), and paranoid and schizophrenia-like disorders (277/1314, 21.1%) were more prevalent in the TD population compared with the entire antipsychotic drug cohort (13,308/164,417; 8.1% and 19,359/164,417; 11.8%, respectively). Conclusions Despite a lower TD prevalence than previously estimated and the predominant use of atypical antipsychotics, identified TD patients appear to have a substantial comorbidity burden that requires special treatment and management consideration.	[Loughlin, Anita M.; Lin, Nancy] Optum, Boston, MA USA; [Abler, Victor; Carroll, Benjamin] Teva Pharmaceut, Frazer, PA 19355 USA	Optum	Carroll, B (corresponding author), Teva Pharmaceut, Frazer, PA 19355 USA.	Benjamin.carroll02@tevapharm.com			Teva Pharmaceuticals, Petach Tikva, Israel	Teva Pharmaceuticals, Petach Tikva, Israel	This manuscript was funded by Teva Pharmaceuticals, Petach Tikva, Israel. The funder provided support in the form of salaries for authors VA and BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Kristen Hokenson, PhD (Chameleon Communications International with funding from Teva Pharmaceutical Industries) for editorial assistance in the preparation of this report, and Yuqing Gao, Yuan Fan, Michael Doherty, and Synne Wing from Optum for analytic and management support of the project.	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; American Psychiatric Association, 1979, TARD DYSK TASK FORC; [Anonymous], 2017, INGREZZATM VALB CAPS; Aquino Camila Catherine H, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS113, DOI 10.1016/S1353-8020(13)70028-2; BALDESSARINI RJ, 1980, AM J PSYCHIAT, V137, P753; Bhidayasiri R, 2011, POSTGRAD MED J, V87, P132, DOI 10.1136/pgmj.2010.103234; Caroff SN, 2011, NEUROL CLIN, V29, P127, DOI 10.1016/j.ncl.2010.10.002; Domino ME, 2008, PSYCHIAT SERV, V59, P507, DOI 10.1176/ps.2008.59.5.507; GILBERT PL, 1995, ARCH GEN PSYCHIAT, V52, P173; Jankelowitz SK, 2013, NEUROPSYCH DIS TREAT, V9, P1371, DOI 10.2147/NDT.S30767; Leo Raphael J., 2000, Prim Care Companion J Clin Psychiatry, V2, P194; Lerner PP, 2015, PSYCHIAT CLIN NEUROS, V69, P321, DOI 10.1111/pcn.12270; Loughlin Anita M, 2018, Diabetes Spectr, V31, P129, DOI 10.2337/ds16-0081; Loughlin AM, 2018, DIABETES OBES METAB, V20, P898, DOI 10.1111/dom.13175; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Maher AR., 2012, J MANAGE CARE PHARM, V18, pS1, DOI [DOI 10.18553/JMCP.2012.18.S5-B.1, DOI 10.18553/jmcp.2012.18.S5-B.1, 10.18553/jmcp.2012.18.s5-b.1]; Nunes AP, 2017, DIABETES THER, V8, P1349, DOI 10.1007/s13300-017-0314-z; Nunes AP, 2017, DIABETES OBES METAB, V19, P1425, DOI 10.1111/dom.13000; Rummel-Kluge C, 2012, SCHIZOPHRENIA BULL, V38, P167, DOI 10.1093/schbul/sbq042; Sariah AE, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0240-9; SCHOOLER NR, 1991, SCHIZOPHRENIA BULL, V17, P311, DOI 10.1093/schbul/17.2.311; Seeger JS., 2018, INT C PHARM THER RIS; Tarsy D, 2006, MOVEMENT DISORD, V21, P589, DOI 10.1002/mds.20823; Waln O, 2013, TREMOR OTHER HYPERK, V3; Woods SW, 2010, J CLIN PSYCHIAT, V71, P463, DOI 10.4088/JCP.07m03890yel; Zutshi D, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8MS3R8C	26	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0216044	10.1371/journal.pone.0216044	http://dx.doi.org/10.1371/journal.pone.0216044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163035	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200005
J	Chaurasiya, SP; Pravana, NK; Khanal, V; Giri, D				Chaurasiya, Surendra Prasad; Pravana, Nilesh Kumar; Khanal, Vishnu; Giri, Dhiraj			Two thirds of the most disadvantaged Dalit population of Nepal still do not deliver in health facilities despite impressive success in maternal health	PLOS ONE			English	Article							CARE; BIRTH	Introduction The gains in maternal and child health in Nepal was impressive in the last two decade but success was unevenly distributed. The Dalits of Nepal are the most disadvantaged caste group and have benefitted least from the advances in maternal health service. This study investigated the rate of and factors associated with the institutional delivery among the Dalit women of the Mahottari, Nepal. Materials and methods A cross-sectional study was conducted during July-December 2014 using a structured questionnaire. A total of 328 mothers who had their childbirth within one year were interviewed. Descriptive statistics followed by binary and multivariable logistic regression analyses were computed to find the association of key variables with institutional delivery. Results In this study, only 30% of the mother had institutional delivery. Fifty eight percent mothers had no any birth preparedness and complication readiness. Four or more antenatal visits (Adjusted Odds Ratio (AOR): 3.54, CI: 1.82-6.90), birth preparedness (AOR: 3.15, CI: 1.61-6.18), planned pregnancy (AOR: 2.63, CI: 1.37-5.06) and receiving advice from health staffs (AOR: 3.96, CI: 2.00-7.86) and mother's autonomy (AOR: 2.25, CI: 1.03-4.49) were associated with child birth at the health facility. Conclusion This study indicated that birth preparedness, ANC visit frequency, planning of pregnancy, advice for institutional delivery and mother's autonomy were significantly associated with health facility delivery. Less than one-third mothers had institutional delivery and reasons were feeling of un-necessary, far distance, lack of transportation and associated cost; and birth preparedness is also low. Hence, promotion of birth preparedness, uptake of ANC service, proper counselling for institutional delivery, promoting women autonomy and strengthening women to have planned pregnancy were some recommendation to promote institutional delivery for such disadvantage community.	[Chaurasiya, Surendra Prasad; Pravana, Nilesh Kumar] Tribhuvan Univ, Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal; [Khanal, Vishnu] Nepal Dev Soc, Bharatpur, Nepal; [Giri, Dhiraj] Kathmandu Univ, Dept Nat Sci, Kathmandu, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal; Kathmandu University	Chaurasiya, SP (corresponding author), Tribhuvan Univ, Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	spchaurasiya@gmail.com	Khanal, Vishnu/AAE-5948-2020	Khanal, Vishnu/0000-0002-3863-9913				AbouZahr Carla, 2015, HLTH 2015 MDGS MILLE; Ajit Pradhan, 2010, NEPAL MATERNAL MORTA; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Belda SS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0837-8; Burgard S, 2004, SOC SCI MED, V59, P1127, DOI 10.1016/j.socscimed.2004.01.006; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Choulagai B, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-49; Dahal RK., 2013, INT J MATERN CHILD H, V1, P30; Daniel W. W., 2005, BIOSTATISTIC FDN ANA; Dhakal Sulochana E. v. T, 2011, SKILLED CARE BIRTH R; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Gabriel SA, 2009, BE J ECON ANAL POLI, V9, DOI 10.1186/1471-2393-9-34; Government of Nepal, 2011, DISTR HLTH OFF MAH D; Government of Nepal Ministry of Health and Population D. o. H. S. Family Health Division, 2006, NAT SAF MOTH NEWB HL; Government of Nepal N. P. C, 2013, NEP MILL DEV GOALS P; Karkee R., 2013, WHY WOMEN DO NOT UTI; Karkee R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004372; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Karki Sujan, 2013, MATERNAL CHILD HLTH; Khanal V, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-14; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Magadi M, 2000, SOC BIOL, V47, P164; Ministry of Health and Population, 2011, ANN REP DEP HLTH SER; Ministry of Health and Population, NEP DEM HLTH SURV 20; Ministry of Health and Population Government of Nepal, 2010, NEP HLTH SECT PROGR; Pradhan A, 2007, TRENDS DEMOGRAPHIC R; RTI International, 2008, EQ AN HLTH CAR UT OU; Sudesh Raj Sharma A. K. P, 2014, FACTORS ASS PLACE DE; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217337	10.1371/journal.pone.0217337	http://dx.doi.org/10.1371/journal.pone.0217337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158238	Green Submitted, Green Published, gold			2022-12-27	WOS:000469915700011
J	De Marco, F; Willer, K; Gromann, LB; Andrejewski, J; Hellbach, K; Bahr, A; Dmochewitz, M; Koehler, T; Maack, HI; Pfeiffer, F; Herzen, J				De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Hellbach, Katharina; Baehr, Andrea; Dmochewitz, Michaels; Koehler, Thomas; Maack, Hanns-Ingo; Pfeiffer, Franz; Herzen, Julia			Contrast-to-noise ratios and thickness-normalized, ventilation-dependent signal levels in dark-field and conventional in vivo thorax radiographs of two pigs	PLOS ONE			English	Article							X-RAY; MECHANICAL VENTILATION; VISIBILITY-CONTRAST; DIAGNOSIS; LUNG; VISUALIZATION	Lung tissue causes significant small-angle X-ray scattering, which can be visualized with grating-based X-ray dark-field imaging. Structural lung diseases alter alveolar microstructure, which often causes a dark-field signal decrease. The imaging method provides benefits for diagnosis of such diseases in small-animal models, and was successfully used on porcine and human lungs in a fringe-scanning setup. Micro-and macroscopic changes occur in the lung during breathing, but their individual effects on the dark-field signal are unknown. However, this information is important for quantitative medical evaluation of dark-field thorax radiographs. To estimate the effect of these changes on the dark-field signal during a clinical examination, we acquired in vivo dark-field chest radiographs of two pigs at three ventilation pressures. Pigs were used due to the high degree of similarity between porcine and human lungs. To analyze lung expansion separately, we acquired CT scans of both pigs at comparable posture and ventilation pressures. Segmentation, masking, and forward-projection of the CT datasets yielded maps of lung thickness and logarithmic lung attenuation signal in registration with the dark-field radiographs. Upon correlating this data, we discovered approximately linear relationships between the logarithmic dark-field signal and both projected quantities for all scans. Increasing ventilation pressure strongly decreased dark-field extinction coefficients, whereas the ratio of lung dark-field and attenuation signal changed only slightly. Furthermore, we investigated ratios of dark-field and attenuation noise levels at realistic signal levels via calculations and phantom measurements. Dark-field contrast-tonoise ratio (CNR) per lung height was 5 to 10% of the same quantity in attenuation. We conclude that better CNR performance in the dark-field modality is typically due to greater anatomical noise in the conventional radiograph. Given the high physiological similarity of human and porcine lungs, the presented thickness-normalized, ventilation-dependent values allow estimation of dark-field activity of human lungs of variable size and inspiration, which facilitates the design of suitable clinical imaging setups.	[De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Chair Biomed Phys, Garching, Germany; [De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Sch BioMed Engn, Garching, Germany; [Hellbach, Katharina] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Baehr, Andrea; Dmochewitz, Michaels] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Koehler, Thomas] Philips GmbH Innovat Technol, Res Labs, Hamburg, Germany; [Koehler, Thomas; Pfeiffer, Franz] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Maack, Hanns-Ingo] Philips Med Syst DMC GmbH, Hamburg, Germany; [Pfeiffer, Franz] Tech Univ Munich, Sch Med, Dept Diagnost & Intervent Radiol, Munich, Germany; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; University of Munich; Philips; Philips Research; Technical University of Munich; Philips; Philips Healthcare; Technical University of Munich; Technical University of Munich	De Marco, F (corresponding author), Tech Univ Munich, Chair Biomed Phys, Garching, Germany.	fabio.de.marco@tum.de		De Marco, Fabio/0000-0002-3561-7305; Koehler, Thomas/0000-0002-1986-0057	Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program; European Research Council [AdG 695045]; Deutsche Forschungsgemeinschaft [DFG EXC-158]	Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program to FP, the European Research Council (AdG 695045), and the Deutsche Forschungsgemeinschaft (DFG EXC-158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bachche S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07032-y; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Endrizzi M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/50/505102; Gromann LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05101-w; Hauke C, 2018, MED PHYS, V45, P2565, DOI 10.1002/mp.12889; Hellbach K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20985-y; Hellbach K, 2015, INVEST RADIOL, V50, P430, DOI 10.1097/RLI.0000000000000147; Horn F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19482-z; Judge EP, 2014, AM J RESP CELL MOL, V51, P334, DOI 10.1165/rcmb.2013-0453TR; Koehler T, 2015, MED PHYS, V42, P1959, DOI 10.1118/1.4914420; Kottler C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2723064; Krause C, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4975826; Lynch SK, 2011, APPL OPTICS, V50, P4310, DOI 10.1364/AO.50.004310; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; McLaughlin RA, 2014, PHYSIOLOGY, V29, P369, DOI 10.1152/physiol.00002.2014; Meinel FG, 2014, INVEST RADIOL, V49, P653, DOI 10.1097/RLI.0000000000000067; Michel T, 2013, PHYS MED BIOL, V58, P2713, DOI 10.1088/0031-9155/58/8/2713; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Namati E, 2013, BIOMED OPT EXPRESS, V4, P2492, DOI 10.1364/BOE.4.002492; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Pelzer G, 2016, MED PHYS, V43, P2774, DOI 10.1118/1.4948671; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Pfeiffer F, 2012, AIP CONF PROC, V1466, P2, DOI 10.1063/1.4742261; Prade F, 2015, CEMENT CONCRETE RES, V74, P19, DOI 10.1016/j.cemconres.2015.04.003; Proschek P, 2011, DIAGNOSTISCHE INTERV, P503, DOI [10.1007/978-3-540-87668-7, DOI 10.1007/978-3-540-87668-7]; Punnoose J, 2016, MED PHYS, V43, P4711, DOI 10.1118/1.4955438; Revol V, 2013, NDT&E INT, V58, P64, DOI 10.1016/j.ndteint.2013.04.012; Revol V, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3465334; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Scherer K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00489-x; Scherer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130776; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schleede S, 2012, P NATL ACAD SCI USA, V109, P17880, DOI 10.1073/pnas.1206684109; Seifert M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38030-3; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Vignero J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206302; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willer K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204565; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Yaroshenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24269; Yaroshenko A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17492; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890; Yashiro W, 2015, OPT EXPRESS, V23, P23462, DOI 10.1364/OE.23.023462	46	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217858	10.1371/journal.pone.0217858	http://dx.doi.org/10.1371/journal.pone.0217858			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158251	Green Published, gold			2022-12-27	WOS:000469915700032
J	Elamin, F; Abdelazeem, N; Salah, I; Mirghani, Y; Wong, F				Elamin, Fadil; Abdelazeem, Nihal; Salah, Isra; Mirghani, Yousra; Wong, Ferranti			A randomized clinical trial comparing Hall vs conventional technique in placing preformed metal crowns from Sudan	PLOS ONE			English	Article							STAINLESS-STEEL CROWNS; PRIMARY MOLARS; PEDIATRIC DENTISTS; CARIES; RESTORATIONS; MANAGEMENT; SURVIVAL; OUTCOMES; SUCCESS; MEMORY	Despite the high success rates of preformed metal crowns (PMCs) in children no randomized clinical trials compare methods of placement and none describe its use in Africa. Our aim was to compare survival and cost-effectiveness of PMCs placed by conventional techniques (CT) and biological Hall techniques (HT) using a prospective randomized control trial in a general dental practice from Khartoum. One hundred and nine and 103 PMCs were placed in randomly selected children (5-8years) with 1-2 carious primary molars using HT and CT respectively and followed for 2 years. Socioeconomic status, periodontal health, occlusion, anxiety, and procedure time were compared using student t-test. Kaplan-Meier survival rates and incremental cost effectiveness ratio (ICER) were compared between CT and HT. CT and HT groups were similar for age, gender, socio-economic status. Survival rates were high (over 90%) for both study arms and not statistically different (p> 0.05). Anxiety scores were significantly higher in CT arm after 12 months compared to HT (p<0.001). Clinically, gingival and plaque indices were similar between groups (p> 0.05) but occlusions were raised in nearly all subjects in the HT arm (p<0.05). Periodontal health improved, and occlusions adjusted over time in both arms. There were 3 (2.7%) and 6 (5.8%) minor failures, 7 (6.4%) and 6 (5.8%) major failures in HT and CT arms respectively. Mean procedure time was lower in HT (9.1 min) than CT (33.9 min); p<0.001. Mean PMC cost was US$ 2.45 and US$ 7.81 for HT and CT respectively. The ICER was US$ 136.56 more for each PMC placed by CT per life year. We show that PMCs have high survival outcomes in disadvantaged populations similar to results from developed countries. As HT can be carried out by less experienced dental operators and therapists, this biological approach provides a promising cost-effective option to manage caries in developing countries with limited resources.	[Elamin, Fadil; Wong, Ferranti] Queen Mary Univ London, Inst Dent, Barts & London Sch Med & Dent, London, England; [Elamin, Fadil; Abdelazeem, Nihal; Salah, Isra; Mirghani, Yousra] Khartoum Ctr Res & Med Training, Khartoum, Sudan	University of London; Queen Mary University London	Elamin, F (corresponding author), Queen Mary Univ London, Inst Dent, Barts & London Sch Med & Dent, London, England.; Elamin, F (corresponding author), Khartoum Ctr Res & Med Training, Khartoum, Sudan.	fadilelamin@yahoo.co.uk						[Anonymous], 2011, POV PROF NO STAT SUD; Atieh M, 2008, INT J PAEDIATR DENT, V18, P325, DOI 10.1111/j.1365-263X.2007.00900.x; Banihani A, 2018, INT J PAEDIATR DENT, V28, P12, DOI 10.1111/ipd.12314; Buchanan H, 2002, Int J Paediatr Dent, V12, P47, DOI 10.1046/j.0960-7439 .2001.00322.x; Chadwick Barbara L, 2007, Prim Dent Care, V14, P140, DOI 10.1308/135576107782144351; Chen E, 1999, J CONSULT CLIN PSYCH, V67, P481, DOI 10.1037/0022-006X.67.4.481; Chisini LA, 2018, INT J PAEDIATR DENT, V28, P123, DOI 10.1111/ipd.12346; Curzon MEJ, 1996, KENNEDYS PAEDIAT OPE; Dawson LR, 2018, ASDC J DENT CHILD, V48, P420; DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147; Enderlein G., 1985, BIOMETRICAL J, V27, P634; Erdemci ZY, PEDIAT DENT, V36, P286; ERIKSSON A-L, 1988, Proceedings of the Finnish Dental Society, V84, P95; Halawany HS, 2017, SAUDI DENT J, V29, P66, DOI 10.1016/j.sdentj.2017.03.001; Hesse D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1270-z; Holmes R D, 2005, Int J Paediatr Dent, V15, P169, DOI 10.1111/j.1365-263X.2005.00633.x; Hutcheson C, 2012, PEDIATR DENT, V34, P460; Innes NPT, 2011, J DENT RES, V90, P1405, DOI 10.1177/0022034511422064; Innes Nicola P, 2007, BMC Oral Health, V7, P18, DOI 10.1186/1472-6831-7-18; Innes NPT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005512.pub3; Innes NPT, 2006, BRIT DENT J, V200, P451, DOI 10.1038/sj.bdj.4813466; Jeffcoat M, 1993, Int Dent J, V43, P415; Kara NB, 2014, INT J PAEDIATR DENT, V24, P303, DOI 10.1111/ipd.12074; Kim J, 2013, CLIN ORTHOP SURG, V5, P235, DOI 10.4055/cios.2013.5.3.235; Kindelan SA, 2008, INT J PAEDIATR DENT, V18, P20, DOI 10.1111/j.1365-263X.2008.00935.x; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LOE H, 1972, SCAND J DENT RES, V80, P1; Ludwig KH, 2014, J AM DENT ASSOC, V145, P1248, DOI 10.14219/jada.2014.89; Maggs-Rapport F L, 2000, Int J Paediatr Dent, V10, P133; Mahiepala NA, 2015, EUR J PAEDIATR DENT, V16, P159; Milsom KM, 2006, INT J HEALTH PROMOT, V44, P141, DOI 10.1080/14635240.2006.10708087; Nash DA, 2014, COMMUNITY DENT ORAL, V42, P1, DOI 10.1111/cdoe.12052; Papathanasiou a G, 1990, PEDIAT DENT, V16, P282; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Ram Diana, 2003, Pediatr Dent, V25, P582; Rennie D, 2001, JAMA-J AM MED ASSOC, V285, P2006, DOI 10.1001/jama.285.15.2006; Roberts A, 2018, BRIT DENT J, V224, P48, DOI 10.1038/sj.bdj.2018.4; Roberts JF, 2005, BRIT DENT J, V198, P427, DOI 10.1038/sj.bdj.4812197; Rocha EM, 2009, PAIN RES MANAG, V14, P233, DOI 10.1155/2009/535941; Santamaria RM, 2014, J DENT RES, V93, P1062, DOI 10.1177/0022034514550717; Santamaria RM, 2017, CARIES RES, V51, P605, DOI 10.1159/000477855; Schuler IM, 2014, J DENT, V42, P1396, DOI 10.1016/j.jdent.2014.06.009; Schwendicke F, 2019, J DENT RES, V98, P61, DOI 10.1177/0022034518799742; Schwendicke F, 2016, INT ENDOD J, V49, P817, DOI 10.1111/iej.12537; Threlfall AG, 2005, BRIT DENT J, V199, P453, DOI 10.1038/sj.bdj.4812746; Tickle M, 2007, BRIT DENT J, V203, DOI 10.1038/bdj.2007.570; Tseveenjav B, 2018, INT J PAEDIATR DENT, V28, P249, DOI 10.1111/ipd.12348; van der Zee V, 2010, EUR ARCH PAEDIATR DE, V11, P225, DOI 10.1007/BF03262751; Wong F S, 1990, J Int Assoc Dent Child, V20, P11	49	16	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217740	10.1371/journal.pone.0217740	http://dx.doi.org/10.1371/journal.pone.0217740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158253	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700023
J	Rodriguez-Osorio, I; Mena, A; Meijide, H; Morano, L; Delgado, M; Cid, P; Margusino, L; Pedreira, JD; Castro, A				Rodriguez-Osorio, Iria; Mena, Alvaro; Meijide, Hector; Morano, Luis; Delgado, Manuel; Cid, Purificacion; Margusino, Luis; Pedreira, Jose Domingo; Castro, Angeles			Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; COST-EFFECTIVENESS; THERAPY; LEDIPASVIR/SOFOSBUVIR; EPIDEMIOLOGY; INFECTION; AGENTS; RISK	Background Direct-acting antivirals (DAAs) are effective in patients aged >= 65 years. However, little is known about the effects of DAAs on survival, liver decompensation and development of hepatocellular carcinoma (HCC). Objective To compare the incidence of liver-related events and mortality between patients aged. 65 and < 65 years. Methods Prospective study comparing patients aged >= 65 and < 65 years treated with DAAs. The incidence of liver-related events and mortality, and HCC was compared between age groups. Results Five hundred patients (120 aged >= 65 and 380 aged < 65 years) were included. The incidence of liver-related events was 2.62 per 100 patient-years (py) in older and 1.41/100 py in younger patients. All-cause mortality was 3.89 and 1.27/100 py in older and younger patients, respectively. The respective liver-related mortality rates were 1.12 and 0.31/100 py. In patients with cirrhosis (stage F4), all-cause mortality (P = 0.283) and liver-related mortality (P = 0.254) did not differ between groups. All five liver-related deaths were related to multifocal HCC. The incidence of HCC was 1.91 and 1.43 per 100 py in the older and younger groups, respectively (P = 0.747). The diagnosis of HCC was 8 months after the end of treatment. Conclusions The incidence of liver-related events and liver-related mortality was low in older people treated with DAAs and was similar to that in younger patients. The extra mortality in people aged >= 65 years treated with DAAs seems to be secondary to non-liver-related causes. These results support the utilization of DAAs in patients aged >= 65 years.	[Rodriguez-Osorio, Iria; Mena, Alvaro; Meijide, Hector; Delgado, Manuel; Cid, Purificacion; Margusino, Luis; Pedreira, Jose Domingo; Castro, Angeles] Univ Coruna UDC, CHUAC, Grp Virol Clin, Inst Invest Biomed A Coruna INIBIC,Sergas, La Coruna, Spain; [Rodriguez-Osorio, Iria; Mena, Alvaro; Castro, Angeles] CHUAC, Serv Med Interna, Unidad Enfermedades Infecciosas, Sergas, La Coruna, Spain; [Meijide, Hector] Hosp Quironsalud, Serv Med Interna, La Coruna, Spain; [Morano, Luis] Complexo Hosp Univ Vigo, Hosp Alvaro Cunqueiro, Serv Med Interna, Unidad Patol Infecciosa, Vigo, Spain; [Delgado, Manuel] CHUAC, Serv Aparato Digest, Sergas, La Coruna, Spain; [Cid, Purificacion; Margusino, Luis] CHUAC, Serv Farm, Sergas, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; quironsalud Group; Complexo Hospitalario Universitario de Vigo; Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Mena, A (corresponding author), Univ Coruna UDC, CHUAC, Grp Virol Clin, Inst Invest Biomed A Coruna INIBIC,Sergas, La Coruna, Spain.; Mena, A (corresponding author), CHUAC, Serv Med Interna, Unidad Enfermedades Infecciosas, Sergas, La Coruna, Spain.	alvaro.mena.de.cea@sergas.es		Morano Amado, Luis Enrique/0000-0002-0560-3260; Mena, Alvaro/0000-0002-9165-6798; CID-SILVA, PURIFICACION/0000-0002-3227-8002	Fondo de Investigacion Sanitaria [JR17/00028]; Fundacion Profesor Novoa Santos, A Coruna	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Profesor Novoa Santos, A Coruna	This work was supported in part by grants from Fondo de Investigacion Sanitaria (JR17/00028), and Fundacion Profesor Novoa Santos, A Coruna.	Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Backus LI, 2019, HEPATOLOGY, V69, P487, DOI 10.1002/hep.29408; El-Serag HB, 2016, J VIRAL HEPATITIS, V23, P687, DOI 10.1111/jvh.12533; Fabrizio C, 2017, DIGEST LIVER DIS, V49, P1036, DOI 10.1016/j.dld.2017.05.019; Facciorusso A, 2018, J GASTROEN HEPATOL, V33, P942, DOI 10.1111/jgh.14008; Guo H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184160; He T, 2017, ALIMENT PHARM THER, V46, P711, DOI 10.1111/apt.14271; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Kondili LA, 2017, HEPATOLOGY, V66, P1814, DOI 10.1002/hep.29399; Kozbial K, 2016, J HEPATOL, V65, P856, DOI 10.1016/j.jhep.2016.06.009; Lens S, 2017, AM J GASTROENTEROL, V112, P1400, DOI 10.1038/ajg.2017.157; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; Rodriguez-Osorio I, 2017, J CLIN VIROL, V88, P58, DOI 10.1016/j.jcv.2017.01.003; Saab S, 2016, HEPATOLOGY, V63, P1112, DOI 10.1002/hep.28425; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vespasiani-Gentilucci U, 2015, WORLD J GASTROENTERO, V21, P7412, DOI 10.3748/wjg.v21.i24.7412; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yang JD, 2016, J HEPATOL, V65, P859, DOI 10.1016/j.jhep.2016.06.023	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217052	10.1371/journal.pone.0217052	http://dx.doi.org/10.1371/journal.pone.0217052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158237	gold, Green Published, Green Submitted			2022-12-27	WOS:000469915700008
J	Azevedo, AS; Sousa, IM; Fernandes, RM; Azevedo, NF; Almeida, C				Azevedo, Andreia S.; Sousa, Inds M.; Fernandes, Ricardo M.; Azevedo, Nuno F.; Almeida, Carina			Optimizing locked nucleic acid/2 '-O-methyl-RNA fluorescence in situ hybridization (LNA/2 ' OMe-FISH) procedure for bacterial detection	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBES; RESPONSE-SURFACE METHODOLOGY; PNA-FISH; ESCHERICHIA-COLI; PHYLOGENETIC IDENTIFICATION; HIGHLY EFFICIENT; MESSENGER-RNA; ACID; DNA	Despite the successful application of LNA/2'OMe-FISH procedures for bacteria detection, there is a lack of knowledge on the properties that affect hybridization. Such information is crucial for the rational design of protocols. Hence, this work aimed to evaluate the effect of three essential factors on the LNA/2'OMe hybridization step-hybridization temperature, NaCl concentration and type and concentration of denaturant (formamide, ethylene carbonate and urea). This optimization was performed for 3 Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa and Citrobacter freundii) and 2 Gram-positive bacteria (Enterococcus faecalis and Staphylococcus epidermidis), employing the response surface methodology and a Eubacteria probe. In general, it was observed that a high NaCl concentration is beneficial (from 2 M to 5 M), regardless of the denaturant used. Urea, formamide and ethylene carbonate are suitable denaturants for LNA/2'OMe-FISH applications; but urea provides higher fluorescence intensities among the different bacteria, especially for gram-positive bacteria and for P. aeruginosa. However, a unique optimal protocol was not found for all tested bacteria. Despite this, the results indicate that a hybridization solution with 2 M of urea and 4 M of NaCl would be a proper starting point. Furthermore, a hybridization temperature around 62 degrees C, for 14 bp probes with LNA monomers at every third position of 2'OMe and 64% of GC content, should be use in initial optimization of new LNA/2'OMe-FISH protocols.	[Azevedo, Andreia S.; Fernandes, Ricardo M.; Almeida, Carina] Univ Minho, CEB Ctr Biol Engn, Braga, Portugal; [Azevedo, Andreia S.; Sousa, Inds M.; Fernandes, Ricardo M.; Azevedo, Nuno F.; Almeida, Carina] Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Porto, Portugal; [Azevedo, Andreia S.] Univ Porto, i3S, Porto, Portugal; [Azevedo, Andreia S.] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Porto, Portugal; [Fernandes, Ricardo M.; Almeida, Carina] IP Natl Inst Agrarian & Vet Res, INIAV, Rua Lagidos, Vairao, Vila Do Conde, Portugal	Universidade do Minho; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV)	Almeida, C (corresponding author), Univ Minho, CEB Ctr Biol Engn, Braga, Portugal.; Almeida, C (corresponding author), Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Porto, Portugal.; Almeida, C (corresponding author), IP Natl Inst Agrarian & Vet Res, INIAV, Rua Lagidos, Vairao, Vila Do Conde, Portugal.	carina.almeida@iniav.pt	Azevedo, Nuno/I-4915-2013	Almeida, Carina/0000-0002-0175-1119; Azevedo, Andreia Sofia/0000-0002-0521-2841; Azevedo, Nuno/0000-0001-5864-3250	European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [POCI-01-0145-FEDER-006939, UID/EQU/00511/2013, POCI-01-0145-FEDER-006684, UID/BIO/04469]; national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES [POCI-01-0145-FEDER-006939, UID/EQU/00511/2013, POCI-01-0145-FEDER-006684, UID/BIO/04469]; European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte [NORTE-01-0145-FEDER-000004]; FCT - Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/121601/2016, SFRH/BD/118860/2016]; FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678, POCI-01-0145-FEDER-030431]; FCT - Fundacao para a Ciencia e a Tecnologia, I.P. [PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678, POCI-01-0145-FEDER-030431]	European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES; European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT - Fundacao para a Ciencia e a Tecnologia, I.P.	This work was financially supported by project POCI-01-0145-FEDER-006939 (Laboratory for Process Engineering, Environment, Biotechnology and Energy - UID/EQU/00511/2013), POCI-01-0145-FEDER-006684 (Center of Biological Engineering - UID/BIO/04469) funded by European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), and by national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES; NORTE-01-0145-FEDER-000004 - BioTecNorte operation, funded by the European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; Post-Doctoral Fellowship SFRH/BPD/121601/2016 (Andreia S. Azevedo) and PhD Fellowship SFRH/BD/118860/2016 (Ricardo M. Fernandes) supported by national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Project PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678 (Coded-FISH) and Project POCI-01-0145-FEDER-030431 (CLASInVivo), funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, I.P.	Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; Amann R, 2001, CURR OPIN BIOTECH, V12, P231, DOI 10.1016/S0958-1669(00)00204-4; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Arora Amit, 2008, Nucleic Acids Symp Ser (Oxf), P417, DOI 10.1093/nass/nrn212; Azevedo AS, 2015, BIOCHEM ENG J, V104, P64, DOI 10.1016/j.bej.2015.04.024; Barrero-Canosa J, 2017, ENVIRON MICROBIOL, V19, P70, DOI 10.1111/1462-2920.13432; Behrens S, 2003, APPL ENVIRON MICROB, V69, P4935, DOI 10.1128/AEM.69.8.4935-4941.2003; Berndt A, 1996, ACTA HISTOCHEM, V98, P79, DOI 10.1016/S0065-1281(96)80053-5; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bond PL, 2001, MICROBIAL ECOL, V41, P149; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Carr EL, 2005, J MICROBIOL METH, V61, P47, DOI 10.1016/j.mimet.2004.10.023; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Cerqueira L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-101; Danilevich VN, 2008, CHEM ENG TECHNOL, V31, P904, DOI 10.1002/ceat.200800024; Fontenete S, 2017, METHODS MOL BIOL, V1616, P137, DOI 10.1007/978-1-4939-7037-7_8; Fontenete S, 2016, APPL MICROBIOL BIOT, V100, P5897, DOI 10.1007/s00253-016-7429-4; Fontenete S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148353; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; Griffin TJ, 1998, ANAL BIOCHEM, V260, P56, DOI 10.1006/abio.1998.2686; Haruta S, 2017, MICROBES ENVIRON, V32, P142, DOI 10.1264/jsme2.ME16186; Hoshino T, 2008, APPL ENVIRON MICROB, V74, P5068, DOI 10.1128/AEM.00208-08; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Lambert D, 2012, BIOCHEMISTRY-US, V51, P9014, DOI 10.1021/bi301103j; Lima JF, 2018, BMC MOL BIOL, V19, DOI 10.1186/s12867-018-0107-6; Lopes SP, 2017, BIOTECHNOL BIOENG, V114, P355, DOI 10.1002/bit.26085; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; Mendes L, 2016, MICROBIOL RES, V192, P185, DOI 10.1016/j.micres.2016.07.002; Moreno PMD, 2018, MOL THER-NUCL ACIDS, V11, P393, DOI 10.1016/j.omtn.2018.03.009; Myers R.H., 1995, RESPONSE SURFACE MET; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Priyakumar UD, 2009, J AM CHEM SOC, V131, P17759, DOI 10.1021/ja905795v; Rocha R, 2016, J BIOTECHNOL, V226, P1, DOI 10.1016/j.jbiotec.2016.03.047; Santos RS, 2017, LWT-FOOD SCI TECHNOL, V80, P27, DOI 10.1016/j.lwt.2017.01.077; Santos RS, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.46; Santos RS, 2014, J BIOTECHNOL, V187, P16, DOI 10.1016/j.jbiotec.2014.06.023; Silahtaroglu A, 2004, CYTOGENET GENOME RES, V107, P32, DOI 10.1159/000079569; Silvia F, 2015, APPL MICROBIOL BIOT, V99, P3961, DOI 10.1007/s00253-015-6389-4; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; Tang YZ, 2005, APPL ENVIRON MICROB, V71, P8157, DOI 10.1128/AEM.71.12.8157-8164.2005; Thomsen R, 2005, RNA, V11, P1745, DOI 10.1261/rna.2139705; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Volpi EV, 2017, SPRINGER PROTOC HAND, P135, DOI 10.1007/978-3-662-52959-1_12; Wagner M, 1998, FEMS MICROBIOL LETT, V160, P159, DOI 10.1016/S0378-1097(97)00570-3; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Yamaguchi T, 2015, SYST APPL MICROBIOL, V38, P400, DOI 10.1016/j.syapm.2015.06.007; Yilmaz LS, 2006, APPL ENVIRON MICROB, V72, P733, DOI 10.1128/AEM.72.1.733-744.2006; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217689	10.1371/journal.pone.0217689	http://dx.doi.org/10.1371/journal.pone.0217689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150460	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100087
J	Kraft, AJ; Robinson, DT; Evans, IS; Rooney, RC				Kraft, Adam J.; Robinson, Derek T.; Evans, Ian S.; Rooney, Rebecca C.			Concordance in wetland physicochemical conditions, vegetation, and surrounding land cover is robust to data extraction approach	PLOS ONE			English	Article							PRAIRIE WETLANDS; MANTEL TEST; SPATIAL AUTOCORRELATION; WATER-QUALITY; CATCHMENTS; CULTIVATION; MACROPHYTES; INDICATORS; DIVERSITY; ECOSYSTEM	Concordance among wetland physicochemical conditions, vegetation, and surrounding land cover may result from the influence of land cover on the sources of plant propagules, on physicochemical conditions, and their subsequent determination of growing conditions. Alternatively, concordance may result if differences in climate, soils, and species pools are spatially confounded with differences in human population density and land conversion. Further, we expect that land cover within catchment boundaries will be more predictive than land cover in symmetrical buffers if runoff is a major pathway. We measured concordance between land cover, wetland vegetation and physicochemical conditions in 48 prairie pothole wetlands, controlling for inter-wetland distance. We contrasted land-cover data collected over a four-year period by multiple extraction approaches including topographically-delineated catchments and nested 30 m to 5,000 m radius buffers. After factoring out inter-wetland distance, physiochemical conditions were significantly concordant with land cover. Vegetation was not significantly concordant with land cover, though it was strongly and significantly concordant with physicochemical conditions. More, concordance was as strong when land cover was extracted from buffers <500 m in radius as from catchments, indicating the mechanism responsible is not topographically constrained. We conclude that local landscape structure does not directly influence wetland vegetation composition, but rather that vegetation depends on 1) physicochemical conditions in the wetland that are affected by surrounding land cover and on 2) regional factors such as the vegetation species pool and geographic gradients in climate, soil type, and land use.	[Kraft, Adam J.; Rooney, Rebecca C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Robinson, Derek T.; Evans, Ian S.] Univ Waterloo, Dept Geog & Environm Management, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Rooney, RC (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.	rrooney@uwaterloo.ca	Robinson, Derek/B-6076-2011	Robinson, Derek/0000-0002-4293-1095; Rooney, Rebecca/0000-0002-3956-7210	Alberta Innovates [2094A]	Alberta Innovates	RCR received award 2094A from Alberta Innovates (https://albertainnovates.ca/).Funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAFC, 2013, ANN CROP INV 2011; AAFC, 2013, ANN CROP INV 2012; AAFC, 2015, ANN CROP INV 2014; AEP, 2014, ALB MERG WETL INV; Agriculture and Agri-Food Canada (AAFC), 2013, ANN CROP INV 2013; Akasaka M, 2010, FRESHWATER BIOL, V55, P909, DOI 10.1111/j.1365-2427.2009.02334.x; [Anonymous], 2012, INT J ADV RES COMPUT; BARKO JW, 1982, CAN J BOT, V60, P877, DOI 10.1139/b82-113; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bremer DJ, 2001, AGRON J, V93, P338, DOI 10.2134/agronj2001.932338x; Capers RS, 2010, FRESHWATER BIOL, V55, P952, DOI 10.1111/j.1365-2427.2009.02328.x; Cronk J.K., 2001, WETLAND PLANTS BIOL; Downing D. J., 2006, PUBLICATIONS, VT/852; Dutilleul P, 2000, J AGRIC BIOL ENVIR S, V5, P131, DOI 10.2307/1400528; ESRI, 2011, ARCPAD 10 0; ESRI (Environmental Systems Resource Institute), 2015, ARCMAP 10 3 1; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisette T, 2014, INT GEOSCI REMOTE SE, P5095, DOI 10.1109/IGARSS.2014.6947643; Freeland JA, 1999, WETLANDS, V19, P56, DOI 10.1007/BF03161733; Galatowitsch SM, 2000, ENVIRON MONIT ASSESS, V60, P121, DOI 10.1023/A:1006159028274; Gleason RA, 1998, GREAT PLAINS RES, V8, P97; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hayashi M, 1998, J HYDROL, V207, P56, DOI 10.1016/S0022-1694(98)00099-7; Hayashi M, 2016, WETLANDS, V36, pS237, DOI 10.1007/s13157-016-0797-9; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; Howard RJ, 1999, AM J BOT, V86, P785, DOI 10.2307/2656700; JACKSON DA, 1989, CAN J ZOOL, V67, P766, DOI 10.1139/z89-108; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kraft AJ, 2016, THESIS; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Lopez RD, 2002, LANDSCAPE ECOL, V17, P43, DOI 10.1023/A:1015203802047; Lougheed VL, 2001, CAN J FISH AQUAT SCI, V58, P1603, DOI 10.1139/cjfas-58-8-1603; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; MARTIN DB, 1987, WATER AIR SOIL POLL, V34, P45; Martinez C, 2010, INT J REMOTE SENS, V31, P6239, DOI 10.1080/01431160903403060; McCauley LA, 2014, WETLANDS, V34, P1123, DOI 10.1007/s13157-014-0571-9; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mikulyuk A, 2011, CAN J FISH AQUAT SCI, V68, P1778, DOI [10.1139/F2011-095, 10.1139/f2011-095]; Moss E.H., 1983, FLORA ALBERTA; Novikmec M, 2016, HYDROBIOLOGIA, V774, P155, DOI 10.1007/s10750-015-2514-8; Queen's Printer for Ontario, 2014, ONTARIO WETLAND EVAL; Rooney RC, 2015, J BIOGEOGR, V42, P439, DOI 10.1111/jbi.12400; Rooney RC, 2012, LANDSCAPE ECOL, V27, P1321, DOI 10.1007/s10980-012-9784-6; Rooney RC, 2011, LANDSCAPE ECOL, V26, P1023, DOI 10.1007/s10980-011-9629-8; Shaw DA, 2012, HYDROL PROCESS, V26, P3147, DOI 10.1002/hyp.8390; Stewart R. E., 1971, RESOURCE PUBLICATION, V92; Tanner CC, 2001, WATER SCI TECHNOL, V44, P9, DOI 10.2166/wst.2001.0804; Tavernia BG, 2010, LANDSCAPE ECOL, V25, P1085, DOI 10.1007/s10980-010-9482-1; Team RC., 2013, R LANG ENV STAT COMP; van der Kamp G, 1999, HYDROLOG SCI J, V44, P387, DOI 10.1080/02626669909492234; Werner KJ, 2002, WETLANDS, V22, P451, DOI 10.1672/0277-5212(2002)022[0451:HSMSMA]2.0.CO;2; Yang P, 2014, ENVIRON MODELL SOFTW, V58, P48, DOI 10.1016/j.envsoft.2014.04.005; Zobel M, 2001, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0022549, DOI 10.1002/9780470015902.A0022549]	60	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216343	10.1371/journal.pone.0216343	http://dx.doi.org/10.1371/journal.pone.0216343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150421	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100019
J	Nakayama, C; Sato, O; Sugita, M; Nakayama, T; Kuroda, Y; Orui, M; Iwasa, H; Yasumura, S; Rudd, RE				Nakayama, Chihiro; Sato, Osamu; Sugita, Minoru; Nakayama, Takeo; Kuroda, Yujiro; Orui, Masatsugu; Iwasa, Hajime; Yasumura, Seiji; Rudd, Rima E.			Lingering health-related anxiety about radiation among Fukushima residents as correlated with media information following the accident at Fukushima Daiichi Nuclear Power Plant	PLOS ONE			English	Article							SOCIAL AMPLIFICATION; RISK; JAPAN; CHERNOBYL; LITERACY; DISTRESS	Following the March 2011 accident at Fukushima Daiichi Nuclear Power Plant, many residents of Fukushima have faced anxieties about the health impacts of radiation exposure. Considering that source of information may influence resident anxiety, this study aimed to elucidate the correlation between the two. In addition, a health literacy query was included to examine a possible relationship between anxiety and health literacy skills. A mail survey was conducted in August 2016 among 2000 residents of Fukushima Prefecture aged 20 to 79 years. Survey items included questions about current health anxieties caused by radiation, trusted sources of information about radiation, and media used to obtain information on radiation. The survey valid response rate was 43.4%. Results of multiple linear regression analysis revealed that anxiety was significantly higher for the groups indicating "trust in citizen groups" and "use of internet sites." Anxiety was significantly lower for the groups indicating "trust in government ministries," "trust in local government," and "use of local broadcast television." Also anxiety was significantly lower for groups with higher health literacy. It was found that the significant relationship to anxiety varies depending on the sources of trust and media used. There is a possibility that this was caused by the difference between the contents of each information and media reports. In preparation for any future nuclear accident, government may consider action to improve the media literacy of residents. In addition, improving health literacy of both the recipient and the sender of information can improve access to information and thereby safeguard the health and well-being of the public.	[Nakayama, Chihiro; Kuroda, Yujiro; Orui, Masatsugu; Iwasa, Hajime; Yasumura, Seiji] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan; [Sato, Osamu] Fukushima Coll, Childrens Dept, Welf Fac, Fukushima, Japan; [Sugita, Minoru] Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Tokyo, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Rudd, Rima E.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Fukushima Medical University; Toho University; Kyoto University; Harvard University; Harvard T.H. Chan School of Public Health	Nakayama, C (corresponding author), Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan.	nakac@fmu.ac.jp	Iwasa, Hajime/AFQ-6399-2022; NAKAYAMA, Takeo/HCH-0537-2022	Nakayama, Chihiro/0000-0002-0049-9628; Nakayama, Takeo/0000-0002-7918-6252; Kuroda, Yujiro/0000-0003-0587-5423	 [15K08810]		This work was supported by Grant-in-Aid for Scientific Research (C) (No. 15K08810, SY, TN, MS, and OS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, J RISK RES, DOI [10.1080/136698700376699, DOI 10.1080/136698700376699]; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Dordevic M, 2016, LECT NOTES COMPUT SC, V9844, P442, DOI 10.1007/978-3-319-45234-0_40; Endo K., 2013, JAPAN SCI SUPPORT FD, V1, P15; Friedman SM, 2011, B ATOM SCI, V67, P55, DOI 10.1177/0096340211421587; Fukasawa M, 2017, SSM-POPUL HLTH, V3, P740, DOI 10.1016/j.ssmph.2017.09.002; HANDFORD HA, 1986, J AM ACAD CHILD PSY, V25, P409, DOI 10.1016/S0002-7138(09)60264-8; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; HOBBS R., 2009, J MEDIA LITERACY ED, V1, P1; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Ishikawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12712; Kanda R, 2014, JAPAN HLTH PHYS SOC, V49, P77, DOI [10.5453/jhps.49.68, DOI 10.5453/JHPS.49.68]; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kuroda Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071463; Maeda M., 2018, Journal of the National Institute of Public Health, V67, P50; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Nakagawa K, 2016, RAYONNEMENTS IONISAN, P18; Ochi S., 2017, ASIA PACIFIC J PUB S, V29, p83S, DOI [10.1177/1010539516681841, DOI 10.1177/1010539516681841]; Ohmori M., 2016, Annals of the ICRP, V45, P33, DOI 10.1177/0146645316666757; Perko T, 2015, MASS COMMUNICATION J, V5, P1, DOI [DOI 10.4172/2165-7912.1000252, 10.4172/2165-7912.1000252]; Perko T, 2016, INTEGR ENVIRON ASSES, V12, P683, DOI 10.1002/ieam.1832; RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x; Rubin GJ, 2012, BRIT J PSYCHIAT, V201, P400, DOI 10.1192/bjp.bp.112.111575; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Science Council of Japan Committee on Clinical Medicine Housyasen bougo risk management bunka-kai, 2017, HOUK KOD HOUS HIB EI; Shin H, 2017, ENERG ENVIRON-UK, V28, P518, DOI 10.1177/0958305X17706179; Shineha R., 2017, RESILIENCE NEW PARAD, P111, DOI DOI 10.1007/978-3-319-58768-4; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Tanaka K., 2012, EIZOU MEDIA GAKKAISI, V66, P891; Tateno S., 2013, J SCI COMMUNICATION, V12, P1; Thoman E, 2004, AM BEHAV SCI, V48, P18, DOI 10.1177/0002764204267246; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Uno K., 2013, TEISENRYOU HOUSYASEN, P140; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; Vyncke B, 2017, RISK ANAL, V37, P570, DOI 10.1111/risa.12618; Yasumura S., 2014, PUBLIC HLTH NUCL DIS, P401	39	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217285	10.1371/journal.pone.0217285	http://dx.doi.org/10.1371/journal.pone.0217285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150483	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100038
J	Quanjel, TCC; Spreeuwenberg, MD; Struijs, JN; Baan, CA; Ruwaard, D				Quanjel, Tessa C. C.; Spreeuwenberg, Marieke D.; Struijs, Jeroen N.; Baan, Caroline A.; Ruwaard, Dirk			Substituting hospital-based outpatient cardiology care: The impact on quality, health and costs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUADRUPLE AIM CARE; OUTREACH CLINICS; GENERAL-PRACTICE; SPECIALISTS; SYSTEMS; TRIPLE	Background Many Western countries face the challenge of providing high-quality care while keeping the healthcare system accessible and affordable. In an attempt to deal with this challenge a new healthcare delivery model called primary care plus (PC+) was introduced in the Netherlands. Within the PC+ model, medical specialists perform consultations in a primary care setting. PC+ aims to support the general practitioners in gatekeeping and prevent unnecessary referrals to hospital care. The aim of this study was to examine the effects of a cardiology PC+ intervention on the Triple Aim outcomes, which were operationalized by patient-perceived quality of care, health-related quality of life (HRQoL) outcomes, and healthcare costs per patient. Methods This is a quantitative study with a longitudinal observational design. The study population consisted of patients, with non-acute and low-complexity cardiology-related health complaints, who were referred to the PC+ centre (intervention group) or hospital-based outpatient care (control group; care-as-usual). Patient-perceived quality of care and HRQoL (EQ-5D-5L, EQ-VAS and SF-12) were measured through questionnaires at three different time points. Healthcare costs per patient were obtained from administrative healthcare data and patients were followed for nine months. Chi-square tests, independent t-tests and multilevel linear models were used to analyse the data. Results The patient-perceived quality of care was significantly higher within the intervention group for 26 out of 27 items. HRQoL outcomes did significantly increase in both groups (P < 0.05) but there was no significant interaction between group and time. At baseline and also at three, six and nine months' follow-up the healthcare costs per patient were significantly lower for patients in the intervention group (P<0.001). Conclusions While this study showed no improvements on HRQoL outcomes, PC+ seemed to be promising as it results in improved quality of care as experienced by patients and lower healthcare costs per patient.	[Quanjel, Tessa C. C.; Spreeuwenberg, Marieke D.; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Hlth Serv Res, Maastricht, Netherlands; [Spreeuwenberg, Marieke D.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [Struijs, Jeroen N.; Baan, Caroline A.] Natl Inst Publ Hlth & Environm, Prevent & Hlth Serv, Dept Qual Care & Hlth Econ, Ctr Nutr, Bilthoven, Netherlands; [Struijs, Jeroen N.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Baan, Caroline A.] Univ Tilburg, Sci Ctr Transformat Care & Welf Tranzo, Tilburg, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tilburg University	Quanjel, TCC (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Hlth Serv Res, Maastricht, Netherlands.	t.quanjel@maastrichtuniversity.nl	Struijs, Jeroen/AAQ-9872-2020; Struijs, Jeroen/AAX-6827-2020; Struijs, Jeroen/AAA-8057-2022	Struijs, Jeroen/0000-0002-7493-6720; Ruwaard, Dirk/0000-0003-4887-8413; Quanjel, Tessa/0000-0001-6103-363X	Province of Limburg, the Netherlands; cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'); CZ; VGZ	Province of Limburg, the Netherlands(Netherlands Government); cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'); CZ; VGZ	We received funding from non-commercial companies, namely from the non-commercial private health insurers CZ and VGZ and the Province of Limburg, the Netherlands. The insurers funded this project via the cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'). VEZN is a cooperative for project funding, focused on regional projects which aim to keep healthcare sustainable and affordable. The funding sources of this study have been checked and approved by the Medical Research and Ethics Committee. They approved that there were no competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OPEN DATA NEDERLANDS; Atun R, 2004, WHAT ARE ADVANTAGES; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bond M, 2000, J EPIDEMIOL COMMUN H, V54, P149, DOI 10.1136/jech.54.2.149; Bowling A, 2001, BRIT J GEN PRACT, V51, P264; Bowling A, 1997, J EPIDEMIOL COMMUN H, V51, P52, DOI 10.1136/jech.51.1.52; Gruen RL, 2003, COCHRANE DB SYST REV, P1; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Kessler R, 2011, AM J PREV MED, V40, P637, DOI 10.1016/j.amepre.2011.02.023; Kringos DS, 2013, HEALTH AFFAIR, V32, P686, DOI 10.1377/hlthaff.2012.1242; Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65; Ma X., 2010, INT ENCYCLOP ED, V3, P757, DOI [10.1016/B978-0-08-044894-7.01611-0, DOI 10.1016/B978-0-08-044894-7.01611-0]; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Maris E, 1998, PSYCHOL METHODS, V3, P309, DOI 10.1037/1082-989X.3.3.309; Meuwissen LE, 2008, CONSUMER QUALITY IND; Ministerie van Volksgezondheid Welzijn en Sport, 2013, OND MED SPEC ZORG 20; Ministerie van Volksgezondheid Welzijn en Sport, 2013, OND 1 LIJN 2014 MET; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Ovretveit J, 2017, INT J QUAL HEALTH C, V29, P874, DOI 10.1093/intqhc/mzx108; Peiro S, 2015, EUR J PUBLIC HEALTH, V25, P1, DOI 10.1093/eurpub/cku223; Porter ME, 2013, HARVARD BUS REV, V91, P50; Powell John, 2002, J Health Serv Res Policy, V7, P177, DOI 10.1258/135581902760082490; Quanjel TCC, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0734-5; Quanjel TCC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2580-x; Sandager M, 2016, J PATIENT EXP, V3, P63; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Schulpen GJC, 2003, ANN RHEUM DIS, V62, P159, DOI 10.1136/ard.62.2.159; Schut FT, 2017, HEALTH POLICY, V121, P126, DOI 10.1016/j.healthpol.2016.11.002; Sibbald B, 2008, J HEALTH SERV RES PO, V13, P233, DOI 10.1258/jhsrp.2008.008049; Sikka R, 2015, BMJ QUAL SAF, V24, P608, DOI 10.1136/bmjqs-2015-004160; Steenbakkers M., 2014, NIEUWE KIJK GEZONDHE; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; van Hoof SJM, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0498-8; van Hoof SJM, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2446; van Poucke A, 2018, WIE DOET MET WIE TIJ; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Vlek JFM, 2003, BRIT J GEN PRACT, V53, P108; WHO, 2008, PHARMAFORUM 0121; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Wiering B, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2582-8; Winpenny EM, 2017, J HEALTH SERV RES PO, V22, P53, DOI 10.1177/1355819616648982; Zarbailov N, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0653-x	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217923	10.1371/journal.pone.0217923	http://dx.doi.org/10.1371/journal.pone.0217923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150520	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100128
J	Auwal, SM; Abidin, NZ; Zarei, M; Tan, CP; Saari, N				Auwal, Shehu Muhammad; Abidin, Najib Zainal; Zarei, Mohammad; Tan, Chin Ping; Saari, Nazamid			Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; BIOACTIVE PEPTIDES; ANTIHYPERTENSIVE PEPTIDES; ANTIOXIDANT ACTIVITIES; PURIFICATION; COMPONENTS; PRODUCTS	Stone fish is an under-utilized sea cucumber with many health benefits. Hydrolysates with strong ACE-inhibitory effects were generated from stone fish protein under the optimum conditions of hydrolysis using bromelain and fractionated based on hydrophobicity and isoelectric properties of the constituent peptides. Five novel peptide sequences with molecular weight (mw) < 1000 daltons (Da) were identified using LC-MS/MS. The peptides including Ala-Leu-Gly-Pro-Gln-Phe-Tyr (794.44 Da), Lys-Val-Pro-Pro-Lys-Ala (638.88 Da), Leu-Ala-Pro-Pro-Thr-Met (628.85 Da), Glu-Val-Leu-lle-Gln (600.77 Da) and Glu-His-Pro-Val-Leu (593.74 Da) were evaluated for ACE-inhibitory activity and showed IC50 values of 0.012 mM, 0.980 mM, 1.310 mM, 1.440 mM and 1.680 mM, respectively. The ACE-inhibitory effects of the peptides were further verified using molecular docking study. The docking results demonstrated that the peptides exhibit their effect mainly via hydrogen and electrostatic bond interactions with ACE. These findings provide evidence about stone fish as a valuable source of raw materials for the manufacture of antihypertensive peptides that can be incorporated to enhance therapeutic relevance and commercial significance of formulated functional foods.	[Auwal, Shehu Muhammad; Abidin, Najib Zainal; Saari, Nazamid] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia; [Auwal, Shehu Muhammad] Bayero Univ, Fac Basic Med Sci, Dept Biochem, Kano, Nigeria; [Zarei, Mohammad] Univ Teknol MARA, Fac Sci Appl, Sch Ind Technol, Dept Food Sci & Technol, Shah Alam, Selangor, Malaysia; [Tan, Chin Ping] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Technol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Bayero University; Universiti Teknologi MARA; Universiti Putra Malaysia	Saari, N (corresponding author), Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia.	nazamid@upm.edu.my	Tan, Chin-Ping/A-8130-2008; Auwal, Shehu/GYQ-5993-2022; Zarei, Mohammad/B-8556-2014	Tan, Chin-Ping/0000-0003-4177-4072; Zarei, Mohammad/0000-0003-1573-347X	 [02-01-04-SF 2309]		This work was supported by Grant No. 02-01-04-SF 2309; https://ernd.mosti.gov.my.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhedi O, 2018, FOOD CHEM, V239, P453, DOI 10.1016/j.foodchem.2017.06.112; Aluko RE, 2015, CURR OPIN FOOD SCI, V4, P44, DOI 10.1016/j.cofs.2015.05.002; Asoodeh A, 2016, J FOOD DRUG ANAL, V24, P332, DOI 10.1016/j.jfda.2015.11.010; Auwal SM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4765463; Auwal SM, 2017, MAR DRUGS, V15, DOI 10.3390/md15040104; Bordbar S, 2011, MAR DRUGS, V9, P1761, DOI 10.3390/md9101761; Chay SY, 2018, FOOD FUNCT, V9, P1657, DOI [10.1039/c7fo01769c, 10.1039/C7FO01769C]; CHEUNG HS, 1980, J BIOL CHEM, V255, P401; Chowdhuri AK, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2013, VOL 8A; Ngo DH, 2016, PROCESS BIOCHEM, V51, P1622, DOI 10.1016/j.procbio.2016.07.006; Daskaya-Dikmen C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040316; Datta A, 2016, J BIOL CHEM, V291, P13301, DOI 10.1074/jbc.M116.719575; DEDDISH PA, 1994, P NATL ACAD SCI USA, V91, P7807, DOI 10.1073/pnas.91.16.7807; Rocha GF, 2017, FOOD CHEM, V237, P350, DOI 10.1016/j.foodchem.2017.05.112; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghanbari R, 2015, INT J MOL SCI, V16, P28870, DOI 10.3390/ijms161226140; Girgih AT, 2014, J AGR FOOD CHEM, V62, P4135, DOI 10.1021/jf5002606; Hartmann R, 2007, CURR OPIN BIOTECH, V18, P163, DOI 10.1016/j.copbio.2007.01.013; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hu FJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0904-3; Ibrahim HR, 2017, J ADV RES, V8, P63, DOI 10.1016/j.jare.2016.12.002; Iwaniak A, 2014, COMPR REV FOOD SCI F, V13, P114, DOI 10.1111/1541-4337.12051; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Jimsheena VK, 2009, ANAL CHEM, V81, P9388, DOI 10.1021/ac901775h; Kim SK, 2013, MARINE BIOMATERIALS: CHARACTERIZATION, ISOLATION AND APPLICATIONS, P1, DOI 10.1201/b14723; Kim SK, 2001, J AGR FOOD CHEM, V49, P2992, DOI 10.1021/jf001119u; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; Lee JK, 2012, ADV FOOD NUTR RES, V65, P47, DOI 10.1016/B978-0-12-416003-3.00004-4; Lee SY, 2017, FOOD CHEM, V228, P506, DOI 10.1016/j.foodchem.2017.02.039; Li Y, 2012, J AGR FOOD CHEM, V60, P1320, DOI 10.1021/jf204118n; Li Y, 2016, MAR DRUGS, V14, DOI 10.3390/md14060110; Manoharan Sivananthan, 2017, Afr J Tradit Complement Altern Med, V14, P383, DOI 10.21010/ajtcam.v14i2.39; Meena J, 2018, INDIAN J TRADIT KNOW, V17, P162; Meresa A., 2017, CLIN EXP PHARM INTER, V7, P1, DOI [DOI 10.4172/2161-1459.1000228, 10.4172/2161-1459.1000228]; Moayedi A, 2017, APPL BIOCHEM BIOTECH, V181, P48, DOI 10.1007/s12010-016-2198-1; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nollet L. M. L., 2012, HDB ANAL ACTIVE COMP; Norris R., 2013, BIOACTIVE FOOD PEPTI, P45, DOI [10.1146/annurev-food-022814-015520, DOI 10.5772/32009]; Pan DD, 2012, FOOD CHEM, V130, P121, DOI 10.1016/j.foodchem.2011.07.011; Pihlanto-Leppala A, 1998, INT DAIRY J, V8, P325, DOI 10.1016/S0958-6946(98)00048-X; Qiao LS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122099; Amado IR, 2014, MAR DRUGS, V12, P1390, DOI 10.3390/md12031390; Schrodinger Software Team, 2015, PROT PREP GUID SCHRO; Segura-Campos M, 2011, FOOD REV INT, V27, P213, DOI 10.1080/87559129.2011.563395; Sheih IC, 2009, FOOD CHEM, V115, P279, DOI 10.1016/j.foodchem.2008.12.019; Shi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111188; Shrikant Sharma, 2011, International Journal BIOAutomation, V15, P223; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Sun LX, 2017, MAR DRUGS, V15, DOI 10.3390/md15020029; Udenigwe CC, 2012, J FOOD SCI, V77, pR11, DOI 10.1111/j.1750-3841.2011.02455.x; Viator JA, 2004, LASER SURG MED, P9; Wang XQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9746720; Wu YQ, 2017, PROTEOMICS IN FOOD SCIENCE: FROM FARM TO FORK, P17, DOI 10.1016/B978-0-12-804007-2.00002-3; Yea CS, 2014, FOOD FUNCT, V5, P1007, DOI 10.1039/c3fo60667h; Yousr M, 2015, INT J MOL SCI, V16, P29161, DOI 10.3390/ijms161226155; Zarei M, 2015, IND CROP PROD, V76, P112, DOI 10.1016/j.indcrop.2015.06.040; Zhu CZ, 2013, J AGR FOOD CHEM, V61, P1265, DOI 10.1021/jf3044764	57	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0197644	10.1371/journal.pone.0197644	http://dx.doi.org/10.1371/journal.pone.0197644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145747	Green Submitted, Green Published, gold			2022-12-27	WOS:000469425500001
J	Jones, GD; James, DC; Thacker, M; Perry, R; Green, DA				Jones, Gareth D.; James, Darren C.; Thacker, Michael; Perry, Rhian; Green, David A.			Gait-initiation onset estimation during sit-to-walk: Recommended methods suitable for healthy individuals and ambulatory community-dwelling stroke survivors	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; PARKINSON-DISEASE; ELDERLY SUBJECTS; OLDER-ADULTS; TEST-RETEST; STAND TASK; MOVEMENT; VARIABILITY; COORDINATION; RELIABILITY	Background Gait-initiation onset (GI-onset) during sit-to-walk (STW) is commonly defined by mediolateral ground-reaction-force (xGRF) rising and crossing a threshold pre-determined from sitto-stand peak xGRF. However, after stroke this method [xGRFthresh] lacks validity due to impaired STW performance. Instead, methodologies based upon instance of swing-limb maximum-vertical-GRF [vGRFmaxSWING], maximum-xGRF [xGRFmax], and swing-limb heel-off [firstHEELoff] can be applied, although their validity is unclear. Therefore, we determined these methodologies' validity by revealing the shortest transition-time (seat-off-GIonset), their utility in routinely estimating GI-onset, and whether they exhibited satisfactory intra-subject reliability. Methods Twenty community-dwelling stroke (60 (SD 14) years), and twenty-one age-matched healthy volunteers (63 (13) years) performed 5 standardised STW trials with 2 force-plates and optical motion-tracking. Transition-time differences across-methods were assessed using Friedman tests with post-hoc pairwise-comparisons. Within-method single-measure intra-subject reliability was determined using ICC3,1 and standard errors of measurement (SEMs). Results In the healthy group, median xGRFthresh transition-time was significantly shorter than xGRFmax (0.183s). In both the healthy and stroke groups, xGRFthresh transition-times (0.027s, 0.695s respectively) and vGRFmaxSWING (0.080s, 0.522s) were significantly shorter than firstHEELoff (0.293s, 1.085s) (p< 0.001 in all cases). GI-onset failed to be estimated in 48% of stroke trials using xGRFthresh. Intra-subject variability was relatively high but was comparable across all estimation methods. Conclusion The firstHEELoff method yielded significantly longer transition-times. The xGRFthresh method failed to routinely produce an estimation of GI-onset estimation. Thus, with all methods exhibiting low, yet comparable intra-subject repeatability, averaged xGRFmax or vGRFmaxSWING repeated-measures are recommended to estimate GI-onset for both healthy and community-dwelling stroke individuals.	[Jones, Gareth D.; Thacker, Michael; Green, David A.] Kings Coll London, CHAPS, London, England; [Jones, Gareth D.; Perry, Rhian] Guys & St Thomas NHS Fdn Trust, Physiotherapy Dept, London, England; [James, Darren C.] London South Bank Univ, Sch Appl Sci, Sport & Exercise Sci Res Ctr, London, England; [Thacker, Michael] London South Bank Univ, Sch Hlth & Social Care, London, England; [Green, David A.] European Space Agcy, European Astronaut Ctr, Directorate Human Spaceflight & Robot Explorat Pr, Cologne, Germany; [Green, David A.] KBRwyle GmbH, Cologne, Germany	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; London South Bank University; London South Bank University; European Space Agency	James, DC (corresponding author), London South Bank Univ, Sch Appl Sci, Sport & Exercise Sci Res Ctr, London, England.	jamesd6@lsbu.ac.uk	Jones, Gareth D/AAQ-5189-2020; Jones, Gareth D/I-3250-2015	Jones, Gareth D/0000-0001-5516-9418; Thacker, Michael/0000-0002-9034-1137; James, Darren/0000-0001-6833-6019	Private Physiotherapy Educational Foundation [233]; National Institute for Health Research Clinical Research Network (NIHR CRN)	Private Physiotherapy Educational Foundation; National Institute for Health Research Clinical Research Network (NIHR CRN)	GDJ and MT received funding support from the trustees of the Private Physiotherapy Educational Foundation, http://ppef.org.uk/grants-awards/(award no. 233), and the National Institute for Health Research Clinical Research Network (NIHR CRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GAIT POSTURE; Bland JM, 1996, BRIT MED J, V313, P744; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; BRENIERE Y, 1987, J MOTOR BEHAV, V19, P62, DOI 10.1080/00222895.1987.10735400; Brunt D, 2005, GAIT POSTURE, V21, P297, DOI 10.1016/j.gaitpost.2004.03.003; Buckley T, 2009, J BIOMECH, V42, P2318, DOI 10.1016/j.jbiomech.2009.06.023; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Choi Y, 2013, J PHYS THER SCI, V25, P431, DOI 10.1589/jpts.25.431; Collen F M, 1991, Int Disabil Stud, V13, P50; Corriveau H, 2001, ARCH PHYS MED REHAB, V82, P80, DOI 10.1053/apmr.2001.18678; Corriveau H, 2000, ARCH PHYS MED REHAB, V81, P45, DOI 10.1053/apmr.2000.0810045; Dehail P, 2007, CLIN BIOMECH, V22, P1096, DOI 10.1016/j.clinbiomech.2007.07.015; Dion L, 2003, NEUROREHAB NEURAL RE, V17, P83, DOI 10.1177/0888439003017002002; Frykberg GE, 2009, ARCH PHYS MED REHAB, V90, P1009, DOI 10.1016/j.apmr.2008.12.023; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Jackson TA, 2013, AGE AGEING, V42, P689, DOI 10.1093/ageing/aft145; Jones GD, 2016, JOVE-J VIS EXP, DOI 10.3791/54323; Jones GD, 2016, GAIT POSTURE, V48, P226, DOI 10.1016/j.gaitpost.2016.06.005; Kerr A, 2004, CLIN BIOMECH, V19, P385, DOI 10.1016/j.clinbiomech.2003.12.012; Kerr A, 2007, GAIT POSTURE, V26, P11, DOI 10.1016/j.gaitpost.2006.07.004; Kerr A, 2017, GAIT POSTURE, V52, P233, DOI 10.1016/j.gaitpost.2016.11.046; Kouta M, 2006, J PHYS THER SCI, V18, P201, DOI [DOI 10.1589/JPTS.18.201, 10.1589/jpts.18.201]; Ledebt A, 1998, EXP BRAIN RES, V120, P9, DOI 10.1007/s002210050372; Lin CC, 2016, J NEUROL PHYS THER, V40, P40, DOI 10.1097/NPT.0000000000000112; Looney MA, 2000, MEAS PHYS ED EXERC S, V4, P73, DOI DOI 10.1207/S15327841MPEE0402_3; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Malouin F, 2003, CLIN REHABIL, V17, P674, DOI 10.1191/0269215503cr663oa; Martin K, 2011, GAIT POSTURE, V34, P374, DOI 10.1016/j.gaitpost.2011.06.004; Martin M, 2002, PHYS THER, V82, P566, DOI 10.1093/ptj/82.6.566; Meher I, 2004, J AM GERIATR SOC, V52, P1255, DOI 10.1111/j.1532-5415.2004.52353.x; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Park S, 2009, J MECH SCI TECHNOL, V23, P204, DOI 10.1007/s12206-008-0812-z; Patchay S, 2002, MOVEMENT DISORD, V17, P317, DOI 10.1002/mds.10074; Pereira MP, 2015, J PHYS THER SCI, V27, P1113, DOI 10.1589/jpts.27.1113; SCHENKMAN, 1990, PHYS THER, V70, P54; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Sentinel Stroke National Audit Programme, 2019, MOV DIAL STROK CAR 6; Sethi A, 2013, CLIN BIOMECH, V28, P134, DOI 10.1016/j.clinbiomech.2012.11.006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Townsend N, 2012, CORONARY HEART DIS S; VANDERLINDEN DW, 1994, ARCH PHYS MED REHAB, V75, P653, DOI 10.1016/0003-9993(94)90188-0; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wilson C, 2008, SPORT BIOMECH, V7, P2, DOI 10.1080/14763140701682983; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	53	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217563	10.1371/journal.pone.0217563	http://dx.doi.org/10.1371/journal.pone.0217563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141570	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000469323000062
J	Silva, WS; McFadyen, B; Kehayia, E; Azevedo, N; Fung, J; Lamontagne, A				Silva, Wagner Souza; McFadyen, Bradford; Kehayia, Eva; Azevedo, Nancy; Fung, Joyce; Lamontagne, Anouk			Phone messages affect the detection of approaching pedestrians in healthy young and older adults immersed in a virtual community environment	PLOS ONE			English	Article							DUAL-TASK INTERFERENCE; OBSTACLE AVOIDANCE; CROSSING BEHAVIOR; WORKING-MEMORY; WALKING; DISTRACTION; PERFORMANCE; CIRCUMVENTION; INJURIES; TALKING	Background Mobile phones are increasingly associated with accidents while walking. Little is known, however, about the impact of phone messaging on the actual perception of other pedestrians. This study aimed to investigate the extent to which the detection of approaching pedestrians is affected by the sensory modality (text or audio) of phone messages in young vs. older adults. Methods Eighteen healthy young (24 +/- 2.9 years) and 15 older adults (68 +/- 4.2 years) performed a phone message deciphering task, an obstacle detection task, and a dual-task condition combining both tasks. Participants were tested while seated and viewing a virtual subway station (VE) in a helmet mounted display. As they were passively moved within the VE one of three virtual pedestrians randomly approached them from the center (0 degrees), right (+40 degrees) or left (+40 degrees). When present, phone message conditions were delivered at obstacle movement onset and presented either as (1) text messages on the screen of a virtual phone or (2) audio messages delivered through earphones. Participants were instructed to press a joystick button as soon as they detected the approaching virtual pedestrian and to report the message content at the end of the trials. Results Young and older participants showed delayed obstacle detection times with vs. without text messages. Older adults further showed reduced accuracy of message report for texts compared to audio messages. In both groups, audio messages yielded no difference in obstacle detection time or accuracy of message report compared to the no message condition. Conclusions Findings indicate that text messages prolong the detection of approaching pedestrians, suggesting that they compromise safe ambulation in community environments. Older adults, who show larger deteriorations on the obstacle detection and message deciphering tasks, may be at even greater risk of collision. Audio messages could be a safer alternative for onthe-go communication.	[Silva, Wagner Souza; Kehayia, Eva; Fung, Joyce; Lamontagne, Anouk] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Silva, Wagner Souza; Kehayia, Eva; Azevedo, Nancy; Fung, Joyce; Lamontagne, Anouk] Jewish Rehabil Hosp CISSS Laval, Feil & Oberfeld Res Ctr, Res Site CRIR, Laval, PQ, Canada; [McFadyen, Bradford] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [McFadyen, Bradford] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada	McGill University; Centre Integre de Sante et de Services Sociaux de Laval; Laval University	Silva, WS (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.; Silva, WS (corresponding author), Jewish Rehabil Hosp CISSS Laval, Feil & Oberfeld Res Ctr, Res Site CRIR, Laval, PQ, Canada.	wagner.souzasilva@mail.mcgill.ca		H. De Souza Silva, Wagner/0000-0003-3982-5475; McFadyen, Bradford/0000-0003-1992-4927	Natural Science and Engineering Research Council [RGPIN-2016-04471]; CNPq; Fonds de la recherche du Quebec - Sante	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fonds de la recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This project was supported by the Natural Science and Engineering Research Council (RGPIN-2016-04471 to AL). WSS is the recipient of a Science Without Borders Scholarship from CNPq and AL is supported by a Research Scientist Award from the Fonds de la recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Boulanger M, 2017, 2017 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION (ICVR); Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Conci M, 2009, LECT NOTES COMPUT SC, V5726, P63, DOI 10.1007/978-3-642-03655-2_7; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; Fitch GM, 2015, J SAFETY RES, V54, P105, DOI 10.1016/j.jsr.2015.06.008; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Gerin-Lajoie M, 2008, GAIT POSTURE, V27, P239, DOI 10.1016/j.gaitpost.2007.03.015; Gerin-Lajoie M, 2006, GAIT POSTURE, V24, P364, DOI 10.1016/j.gaitpost.2005.11.001; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Hegeman J, 2012, GAIT POSTURE, V36, P236, DOI 10.1016/j.gaitpost.2012.02.024; Hinton DC, 2018, GAIT POSTURE, V59, P168, DOI 10.1016/j.gaitpost.2017.10.011; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Krasovsky T, 2017, GAIT POSTURE, V52, P354, DOI 10.1016/j.gaitpost.2016.12.027; Krasovsky T, 2018, PHYS THERAPY; Krasovsky T, 2017, IEEE 2017 2017 INT C, P1, DOI [10.1109/ICVR.2017.8007506, DOI 10.1109/ICVR.2017.8007506]; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; Licence S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133281; Lim J, 2015, GAIT POSTURE, V42, P466, DOI 10.1016/j.gaitpost.2015.07.060; Nanhoe-Mahabier W, 2012, MOVEMENT DISORD, V27, P574, DOI 10.1002/mds.24935; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Nasreddine Ziad S, 2012, Neurology, V78, P765, DOI 10.1212/01.wnl.0000413072.54070.a3; Neider MB, 2011, PSYCHOL AGING, V26, P260, DOI 10.1037/a0021566; Newman XP, 2017, J NEUROSCI, V37, P3378, DOI 10.1523/JNEUROSCI.3512-16.2017; Ogourtsova T, 2018, NEUROREHAB NEURAL RE, V32, P46, DOI 10.1177/1545968317751677; Plummer P, 2015, GAIT POSTURE, V41, P46, DOI 10.1016/j.gaitpost.2014.08.007; Ren J, 2013, GERIATR GERONTOL INT, V13, P19, DOI 10.1111/j.1447-0594.2012.00914.x; Sabourin L., 2016, P 2016 ANN C CAN LIN; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Shumway-Cook A, 2003, J AM GERIATR SOC, V51, P393, DOI 10.1046/j.1532-5415.2003.51114.x; Silva WS, 2018, GAIT POSTURE, V61, P294, DOI 10.1016/j.gaitpost.2018.01.028; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Souza Silva W, 2019, GERONTOLOGY, V65, DOI [10.1159/000499067, DOI 10.1159/000499067]; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thompson LL, 2013, INJURY PREV, V19, P232, DOI 10.1136/injuryprev-2012-040601; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Wahn B, 2017, ADV COGN PSYCHOL, V13, P83, DOI 10.5709/acp-0209-2; Weerdesteyn V, 2003, J MOTOR BEHAV, V35, P53, DOI 10.1080/00222890309602121; Zhou J, 2014, BEHAV INFORM TECHNOL, V33, P552, DOI 10.1080/0144929X.2013.780637	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217062	10.1371/journal.pone.0217062	http://dx.doi.org/10.1371/journal.pone.0217062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141549	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000037
J	Hanley, SM; Watt, SE; Coventry, W				Hanley, Sarah M.; Watt, Susan E.; Coventry, William			Taking a break: The effect of taking a vacation from Facebook and Instagram on subjective well-being	PLOS ONE			English	Article							SOCIAL NETWORK SITES; COLLEGE-STUDENTS; ENVY; DISCONTINUANCE; SATISFACTION; ASSOCIATION; VALIDATION; DEPRESSION; IMPACT; OTHERS	Social Networking Sites (SNS) such as Facebook and Instagram have relocated a large portion of people's social lives online, but can be intrusive and create social disturbances. Many people therefore consider taking an "SNS vacation." We investigated the effects of a one week vacation from both Facebook and Instagram on subjective well-being, and whether this would vary for passive or active SNS users. Usage amount was measured objectively, using RescueTime software, to circumvent issues of self-report. Usage style was identified at pre-test, and SNS users with a more active or more passive usage style were assigned in equal numbers to the conditions of one-week SNS vacation (n = 40) or no SNS vacation (n = 38). Subjective well-being (life satisfaction, positive affect, and negative affect) was measured before and after the vacation period. At pre-test, more active SNS use was found to correlate positively with life satisfaction and positive affect, whereas more passive SNS use correlated positively with life satisfaction, but not positive affect. Surprisingly, at post-test the SNS vacation resulted in lower positive affect for active users and had no significant effects for passive users. This result is contrary to popular expectation, and indicates that SNS usage can be beneficial for active users. We suggest that SNS users should be educated in the benefits of an active usage style and that future research should consider the possibility of SNS addiction among more active users.	[Hanley, Sarah M.; Watt, Susan E.; Coventry, William] Univ New England, Sch Psychol & Behav Sci, Armidale, NSW, Australia	University of New England	Hanley, SM (corresponding author), Univ New England, Sch Psychol & Behav Sci, Armidale, NSW, Australia.	shanley@myune.edu.au	; Watt, Sue/K-2476-2016	Hanley, Sarah/0000-0001-8308-9204; Watt, Sue/0000-0001-7938-7444; Coventry, William/0000-0003-0864-5463				[Anonymous], 2018, LEADING COUNTRIES BA; Appel H, 2015, J SOC CLIN PSYCHOL, V34, P277, DOI 10.1521/jscp.2015.34.4.277; Burke M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1909; Chen W, 2016, COMPUT HUM BEHAV, V64, P507, DOI 10.1016/j.chb.2016.04.038; Cho IH, 2015, QUAL QUANT, V49, P1531, DOI 10.1007/s11135-015-0225-x; Chou HTG, 2012, CYBERPSYCH BEH SOC N, V15, P117, DOI 10.1089/cyber.2011.0324; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; Ding Q, 2017, PERS INDIV DIFFER, V113, P142, DOI 10.1016/j.paid.2017.03.027; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Feinstein BA, 2013, PSYCHOL POP MEDIA CU, V2, P161, DOI 10.1037/a0033111; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gerson J, 2017, PERS INDIV DIFFER, V117, P81, DOI 10.1016/j.paid.2017.05.034; Haferkamp N, 2011, CYBERPSYCH BEH SOC N, V14, P309, DOI 10.1089/cyber.2010.0120; Hinsch C, 2013, J CONSUM BEHAV, V12, P496, DOI 10.1002/cb.1453; Hormes JM, 2014, ADDICTION, V109, P2079, DOI 10.1111/add.12713; Iran Open Data, 2018, MOST POP ONL STOR GR; Krasnova H, 2013, 11 INT C WIRTSH; Lee SY, 2014, COMPUT HUM BEHAV, V32, P253, DOI 10.1016/j.chb.2013.12.009; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; Pagani M, 2011, PSYCHOL MARKET, V28, P441, DOI 10.1002/mar.20395; Ritsner M, 2005, QUAL LIFE RES, V14, P1693, DOI 10.1007/s11136-005-2816-9; Sagioglou C, 2014, COMPUT HUM BEHAV, V35, P359, DOI 10.1016/j.chb.2014.03.003; Schoenebeck SY, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P773, DOI 10.1145/2556288.2556983; Tandoc EC, 2015, COMPUT HUM BEHAV, V43, P139, DOI 10.1016/j.chb.2014.10.053; Tromholt M, 2016, CYBERPSYCH BEH SOC N, V19, P661, DOI 10.1089/cyber.2016.0259; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Vanman EJ, 2018, J SOC PSYCHOL, V158, P496, DOI 10.1080/00224545.2018.1453467; Verduyn P, 2017, SOC ISS POLICY REV, V11, P274, DOI 10.1111/sipr.12033; Verduyn P, 2015, J EXP PSYCHOL GEN, V144, P480, DOI 10.1037/xge0000057; Vigil TR, 2015, MEDIA COMMUN, V3, P5, DOI 10.17645/mac.v3i1.199; Wang JL, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00771; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; York C, 2015, COMMUN RES REP, V32, P54, DOI 10.1080/08824096.2014.989975	34	19	19	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217743	10.1371/journal.pone.0217743	http://dx.doi.org/10.1371/journal.pone.0217743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170206	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700051
J	Rasmussen, CL; Palarea-Albaladejo, J; Korshoj, M; Gupta, N; Nabe-Nielsen, K; Holtermann, A; Jorgensen, MB				Rasmussen, Charlotte Lund; Palarea-Albaladejo, Javier; Korshoj, Mette; Gupta, Nidhi; Nabe-Nielsen, Kirsten; Holtermann, Andreas; Jorgensen, Marie Birk			Is high aerobic workload at work associated with leisure time physical activity and sedentary behaviour among blue-collar workers? A compositional data analysis based on accelerometer data	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; 20-YEAR INCIDENCE; R-PACKAGE; FITNESS; RISK; VALIDITY; ADULTS; MOVEMENT	Objective This study aimed to investigate the hypothesized negative association between duration of work time spent at a high relative aerobic workload and leisure time movement behaviours among blue-collar workers. Methods This was a cross-sectional study based on heart rate and accelerometer data from 803 blue-collar workers (447 men and 356 women). Relative aerobic workload was measured as percentage of heart rate reserve during work (%HRR). Leisure time movement behaviours were expressed in terms of leisure time spent in sedentary and active behaviours in uninterrupted bouts (i.e. <10 min, >= 10-30 min and >30 min). Compositional regression and isotemporal substitution models were used to assess the association between the predominance of work time spent at >= 40%HRR and leisure time spent in sedentary and active bouts. All analyses were stratified by sex. Results For men, there was no statistically significant association between the predominance of work time spent at >= 40%HRR and leisure time movement behaviours. Among women, the predominance of >= 40%HRR at work was negatively associated with relative leisure time spent in >= 10 min bouts of active behaviour ((beta) over cap =-0.21, p = 0.02) and a theoretical 15 min reallocation of work time from <40%HRR to >= 40%HRR was estimated to decrease active behaviour by 6 min during leisure time. Conclusion Our result highlights the need for considering work-related barriers for an active leisure time in high-risk populations. Longitudinal studies are warranted to disentangle the relationship between physically demanding work characteristics and leisure time movement behaviours in such populations.	[Rasmussen, Charlotte Lund; Korshoj, Mette; Gupta, Nidhi; Nabe-Nielsen, Kirsten; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Rasmussen, Charlotte Lund; Nabe-Nielsen, Kirsten] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Holtermann, Andreas] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Jorgensen, Marie Birk] Univ Copenhagen, Dept Forens Sci, Copenhagen, Denmark	National Research Centre for the Working Environment; University of Copenhagen; James Hutton Institute; University of Southern Denmark; University of Copenhagen	Rasmussen, CL (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.; Rasmussen, CL (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark.	CLR@nrcwe.dk	Palarea-Albaladejo, Javier/J-5591-2013; Rasmussen, Charlotte Lund/AAP-7065-2020	Palarea-Albaladejo, Javier/0000-0003-0162-669X; Rasmussen, Charlotte Lund/0000-0003-2193-5019; Jorgensen, Marie Birk/0000-0002-1479-2622; Korshoj, Mette/0000-0001-8422-9969	Danish government (Satspulje); Danish Working Environment Research Fund [20175100213]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS [MTM2015-65016-C2-1(2)-R]	Danish government (Satspulje); Danish Working Environment Research Fund; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS	The work was supported by a grant from the Danish government (Satspulje) and by The Danish Working Environment Research Fund (grant number 20175100213). J. Palarea-Albaladejo was partly supported by the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) and by the Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS MTM2015-65016-C2-1(2)-R.	Aitchson J., 1986, STAT ANAL COMPOSITIO; Allesoe K, 2015, EUR J PREV CARDIOL, V22, P1601, DOI 10.1177/2047487314554866; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2018, PHYS ACT GUID ADV CO; Arias OE, 2015, J OCCUP ENVIRON MED, V57, P73, DOI 10.1097/JOM.0000000000000303; Astrand PO., 1986, TXB WORK PHYSL, P391; BALL K, 2015, INT J BEHAV NUTR PHY, V12; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Blafoss R, 2019, SCAND J PUBLIC HEALT, V47, P383, DOI 10.1177/1403494818765894; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brighenti-Zogg S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154073; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chu AHY, 2013, PREV MED, V57, pS14, DOI 10.1016/j.ypmed.2012.12.011; Clays E, 2014, AM J EPIDEMIOL, V179, P559, DOI 10.1093/aje/kwt294; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Coenen P, 2018, BRIT J SPORT MED, V52, P1320, DOI 10.1136/bjsports-2017-098540; Efron B., 2003, INTRO BOOTSTRAP; Ekblom-Bak E, 2016, EUR J PREV CARDIOL, V23, P967, DOI 10.1177/2047487315619734; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; Ferrario MM, 2018, HEART, V104, P1165, DOI 10.1136/heartjnl-2017-312594; Fletcher GF, 2018, J AM COLL CARDIOL, V72, P1622, DOI 10.1016/j.jacc.2018.08.2141; Gupta N, 2018, MED SCI SPORT EXER, V50, P2150, DOI 10.1249/MSS.0000000000001680; Gupta N, 2014, INT J ENV RES PUB HE, V11, P5333, DOI 10.3390/ijerph110505333; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Howley ET, 2001, MED SCI SPORT EXER, V33, pS364, DOI 10.1097/00005768-200106001-00005; Hron K, 2012, J APPL STAT, V39, P1115, DOI 10.1080/02664763.2011.644268; Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051; Hu GC, 2014, ASIA-PAC J PUBLIC HE, V26, P604, DOI 10.1177/1010539512471966; Ilmarinen J, 1992, INT J IND ERGON, V10, P53, DOI [10.1016/0169-8141(92)90048-5, DOI 10.1016/0169-8141(92)90048-5]; JORGENSEN MB, 2013, BMC MUSCULOSKEL DIS, V14, P1; Karlqvist L, 2003, EUR J APPL PHYSIOL, V89, P536, DOI 10.1007/s00421-003-0832-4; Karvonen MJ, 1957, ANN MED EXPER FENN, V35, P1; Korshoj M, 2013, ERGONOMICS, V56, P935, DOI 10.1080/00140139.2013.782427; Krause N, 2015, SCAND J WORK ENV HEA, V41, P124, DOI 10.5271/sjweh.3476; Krause N, 2010, SCAND J WORK ENV HEA, V36, P349, DOI 10.5271/sjweh.3077; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Lagersted-Olsen J, 2016, SCAND J WORK ENV HEA, V42, P528, DOI 10.5271/sjweh.3591; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Loprinzi PD, 2013, AM J HEALTH PROMOT, V27, P143, DOI 10.4278/ajhp.110916-QUAN-348; Lunde LK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040356; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; McArdle W.D., 2007, EXERCISE PHYSL ENERG; Mehdi Riazi A., 2016, ROUTLEDGE ENCY RES M, DOI DOI 10.4324/9781315656762; Palarea-Albaladejo J, 2008, COMPUT GEOSCI-UK, V34, P902, DOI 10.1016/j.cageo.2007.09.015; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Palarea-Albaladejo J, 2014, J CHEMOMETR, V28, P585, DOI 10.1002/cem.2621; Pawlowsky-Glahn V., 2015, MODELLING ANAL COMPO, DOI DOI 10.1002/9781119003144; Pawlowsky-Glahn V, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535526; Pedisic Z, 2017, KINESIOLOGY, V49, P252; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rasmussen CL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071306; Savinainen M, 2004, ERGONOMICS, V47, P1087, DOI 10.1080/00140130410001686357; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stefelova N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102248; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Tomaz SA, 2016, EUR J SPORT SCI, V16, P149, DOI 10.1080/17461391.2014.987323; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; Vasankari V, 2017, EUR J PREV CARDIOL, V24, P1311, DOI 10.1177/2047487317711048; Wang AL, 2016, SCAND J WORK ENV HEA, V42, P423, DOI 10.5271/sjweh.3580; Wellburn S, 2016, MED SCI SPORT EXER, V48, P641, DOI 10.1249/MSS.0000000000000816; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P694, DOI 10.1123/jpah.2013-0463; Wu HC, 2005, ERGONOMICS, V48, P668, DOI 10.1080/00140130500070871	69	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217024	10.1371/journal.pone.0217024	http://dx.doi.org/10.1371/journal.pone.0217024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170169	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700015
J	Smith, MR; Veneklaas, E; Polania, J; Rao, IM; Beebe, SE; Merchant, A				Smith, Millicent R.; Veneklaas, Erik; Polania, Jose; Rao, Idupulapati M.; Beebe, Stephen E.; Merchant, Andrew			Field drought conditions impact yield but not nutritional quality of the seed in common bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; RESPONSES; STRESS; VARIABILITY; PHOSPHORUS; RESISTANCE; SELECTION; NITROGEN; GENES; GRAIN	Drought substantially limits seed yield of common bean (Phaseolus vulgaris L.) in the tropics. Understanding the interaction of drought on yield and the nutrient concentration of the seed is vital in order to supply nutrition to the millions of consumers who rely on common bean as a staple crop. Nevertheless, the impact of drought on common bean for both yield and nutrient concentration has not yet been concurrently investigated in a field environment. Using 10 bred lines developed by CIAT and its partners for their improved adaptation to drought and phosphorus deficiency, this study characterised the impact of drought on yield and nutrient concentration for leaf and seed tissue of common bean grown in the field. Drought significantly reduced leaf area (by 50%), harvest index (by 60%), yield (by similar to 70%), seed weight (by similar to 25%) and enriched carbon isotope abundance (delta C-13) in the seed. Within the soluble leaf fraction, drought significantly decreased the concentration of mineral nutrients and amino acids, whereas no negative effect on the concentration of nutrients and amino acids was detected within the seed. Genotypic variation in nutrient concentration in both the leaf and seed tissue was identified and should be explored further to identify traits that may confer tolerance to abiotic stress.	[Smith, Millicent R.; Merchant, Andrew] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney Inst Agr, Sydney, NSW, Australia; [Veneklaas, Erik] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Polania, Jose; Rao, Idupulapati M.; Beebe, Stephen E.] CIAT, Cali, Colombia; [Smith, Millicent R.] Int Crops Res Inst Semi Arid Trop, Patancheru, Telangana, India; [Rao, Idupulapati M.] ARS, Natl Ctr Agr Utilizat Res, Plant Polymer Res Unit, USDA, Peoria, IL USA	University of Sydney; University of Western Australia; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); United States Department of Agriculture (USDA)	Smith, MR (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney Inst Agr, Sydney, NSW, Australia.; Smith, MR (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru, Telangana, India.	millicent.smith@cgiar.org	Merchant, Andrew/AAQ-4592-2021; Smith, Millicent/AAB-5602-2020; Merchant, Andrew/C-8689-2011; Veneklaas, Erik J/C-8907-2009; Polania, Jose/Q-2745-2017	Merchant, Andrew/0000-0001-8979-6786; Smith, Millicent/0000-0003-1749-2884; Merchant, Andrew/0000-0001-8979-6786; Veneklaas, Erik J/0000-0002-7030-4056; Polania, Jose/0000-0002-1186-0503	Australian Postgraduate Award; ARC Future Fellowship Scheme; ARC Industrial Transformation Hub [IT140100013]; CGIAR Research Program on Grain Legumes through funds from USAID; USAID	Australian Postgraduate Award(Australian Government); ARC Future Fellowship Scheme(Australian Research Council); ARC Industrial Transformation Hub(Australian Research Council); CGIAR Research Program on Grain Legumes through funds from USAID(CGIAR); USAID(United States Agency for International Development (USAID))	M.R. Smith was the recipient of an Australian Postgraduate Award. A. Merchant was supported by the ARC Future Fellowship Scheme and ARC Industrial Transformation Hub (IT140100013). This work was also partially supported by the CGIAR Research Program on Grain Legumes through funds from USAID.	Andersson MS, 2017, AFRICAN J FOOD AGR N, V17, P11906; Assefa T, 2013, FIELD CROP RES, V148, P24, DOI 10.1016/j.fcr.2013.04.008; Beebe S., 2012, PLANT BREEDING REVIE, V36; Beebe Stephen, 2000, Food and Nutrition Bulletin, V21, P387; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Beebe SE, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00035; Behboudian MH, 2001, J SCI FOOD AGR, V81, P1288, DOI 10.1002/jsfa.939; Blum A, 1996, PLANT GROWTH REGUL, V20, P135, DOI 10.1007/BF00024010; Boyer JS, 2007, J EXP BOT, V58, P267, DOI 10.1093/jxb/erl177; Boyer JS, 2010, J EXP BOT, V61, P3493, DOI 10.1093/jxb/erq231; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Daryanto S, 2017, AGR WATER MANAGE, V179, P18, DOI 10.1016/j.agwat.2016.04.022; Dumschott K, 2017, PHYTOCHEMISTRY, V144, P243, DOI 10.1016/j.phytochem.2017.09.019; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; FAO, 2017, DAT PULS DRY MATT BA; Food and Agriculture Organisation (FAO), 2003, FOOD EN METH AN CONV; Gous PW, 2015, J I BREWING, V121, P19, DOI 10.1002/jib.187; Gyori Z, 1998, J AGR FOOD CHEM, V46, P3087, DOI 10.1021/jf980060c; Haas JD, 2016, J NUTR, V146, P1586, DOI 10.3945/jn.115.224741; He MZ, 2014, NEW PHYTOL, V204, P924, DOI 10.1111/nph.12952; Liu ZQ, 2013, J CHROMATOGR B, V912, P8, DOI 10.1016/j.jchromb.2012.10.040; Lockhart E, 2016, FUNCT PLANT BIOL, V43, P1149, DOI 10.1071/FP16022; Maillard A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00317; McClean PE, 2011, FUNCT PLANT BIOL, V38, P927, DOI 10.1071/FP11102; Merchant A, 2006, PHYTOCHEMISTRY, V67, P402, DOI 10.1016/j.phytochem.2005.11.027; Merchant A, 2011, FUNCT PLANT BIOL, V38, P934, DOI 10.1071/FP11105; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Pang JY, 2011, PLANT SOIL, V348, P299, DOI 10.1007/s11104-011-0904-x; Passioura J, 2007, J EXP BOT, V58, P113, DOI 10.1093/jxb/erl212; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Polania J, 2017, THEORETICAL EXPT PLA, DOI [10.1104/pp.16.01790, DOI 10.1104/PP.16.01790]; Polania J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00296; Polania J, 2016, EUR J AGRON, V79, P66, DOI 10.1016/j.eja.2016.05.014; Polania J, 2016, EUPHYTICA, V210, P17, DOI 10.1007/s10681-016-1691-5; Polania JA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00660; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Rao IM, 2017, J AGR SCI-CAMBRIDGE, V155, P857, DOI 10.1017/S0021859616000915; Singh S.P., 1981, ANN REP BEAN IMPROV, V25, P92; Tardieu F, 1998, J EXP BOT, V49, P419, DOI 10.1093/jexbot/49.suppl_1.419	44	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217099	10.1371/journal.pone.0217099	http://dx.doi.org/10.1371/journal.pone.0217099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170187	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700019
J	Waserstein, G; Parting, C; Cohen, D; Schettler, P; Kinkead, B; Rapaport, MH				Waserstein, Gabriella; Parting, Clyde; Cohen, Debra; Schettler, Pamela; Kinkead, Becky; Rapaport, Mark Hyman			The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBSYNDROMAL DEPRESSIVE SYMPTOMS; FUNCTIONAL SOMATIC SYNDROMES; SATISFACTION QUESTIONNAIRE; HEALTH; METAANALYSIS; ASSOCIATION; IMPAIRMENT; ENJOYMENT; ANXIETY	In 2008, the NIH launched an undiagnosed diseases program to investigate difficult to diagnose, and typically, multi-system diseases. The objective of this study was to evaluate the presence of psychiatric symptoms or psychiatric diagnoses in a cohort of patients seeking care at the Emory Special Diagnostic Service clinic. We hypothesized that psychiatric symptoms would be prevalent and associated with trauma exposure, and a decreased quality of life and functioning. This is a cross-sectional, retrospective analysis of 247 patients seen between February 7, 2014 and May 31, 2017. The sources for data included the Emory Health History Questionnaire (HHQ) that had the work and social adjustment and quality of life enjoyment and satisfaction questionnaire short form (QLSQ) embedded in it; medical records, and the comprehensive standardized special diagnostic clinic forms. Primary outcomes were presence of any psychiatric symptom, based on report of the symptom on the HHQ or medical record, or presence of a confirmed preexisting psychiatric disorder. Seventy-two percent of patients had at least one psychiatric symptom while 24.3% of patients had a pre-existing psychiatric diagnosis. Patients with any psychiatric symptom had significantly diminished Q-LES-Q scores (45.27 +/- 18.63) versus patients with no psychiatric symptoms (62.01 +/- 21.57, t = 5.60, df = 225, p<0.0001) and they had significantly greater functional disability. Patients with a psychiatric disorder also had significantly diminished Q-LES-Q scores (45.16 17.28) versus those without a psychiatric diagnosis (51.85 21.54, t = 2.11, df = 225, p = 0.036) but did not have significantly increased functional impairment. Both patients with psychiatric symptoms and ones with psychiatric disorders had an increased prevalence of trauma. Psychiatric symptoms are prevalent in patients evaluated for undiagnosed disorders. The presence of any psychiatric symptom, with or without a formal psychiatric diagnosis, significantly decreases quality of life and functioning. This suggests that assessment for psychiatric symptoms should be part of the evaluation of individuals with undiagnosed disorders and may have important diagnostic and treatment implications.	[Waserstein, Gabriella] Emory Univ, Sch Med, Atlanta, GA USA; [Parting, Clyde; Cohen, Debra] Emory Univ, Sch Med, Dept Med, Emory Special Diagnost Serv Clin, Atlanta, GA USA; [Schettler, Pamela; Kinkead, Becky; Rapaport, Mark Hyman] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Rapaport, MH (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA.	mrapapo@emory.edu						Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; Association AP, 2013, DSM 5 DIAGNOSTIC AND; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Bloss CS, 2015, GENET MED, V17, P995, DOI 10.1038/gim.2015.21; Bobevski I, 2016, PSYCHOSOM MED, V78, P13, DOI 10.1097/PSY.0000000000000252; Bonvanie IJ, 2017, BRIT J PSYCHOL, V108, P318, DOI 10.1111/bjop.12198; Carson A, 2011, J NEUROL NEUROSUR PS, V82, P810, DOI 10.1136/jnnp.2010.220640; Creed FH, 2013, INT J BEHAV MED, V20, P194, DOI 10.1007/s12529-012-9257-y; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; De Hert M, 2018, DIALOGUES CLIN NEURO, V20, P31; Druss Benjamin G, 2011, Synth Proj Res Synth Rep, P1; Eikelboom EM, 2016, J PSYCHOSOM RES, V88, P60, DOI 10.1016/j.jpsychores.2016.07.001; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gahl WA, 2012, DIS MODEL MECH, V5, P3, DOI 10.1242/dmm.009258; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; HOLM S, 1979, SCAND J STAT, V6, P65; Howland RH, 2008, PSYCHOTHER PSYCHOSOM, V77, P384, DOI 10.1159/000151519; Jiang W, 2011, DEPRESSION HEART DIS; Joustra ML, 2015, J PSYCHOSOM RES, V79, P94, DOI 10.1016/j.jpsychores.2015.05.004; Judd LL, 1996, AM J PSYCHIAT, V153, P1411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Momsen AH, 2016, PUBLIC HEALTH, V133, P75, DOI 10.1016/j.puhe.2015.10.018; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Nettleton S, 2006, SOC SCI MED, V62, P1167, DOI 10.1016/j.socscimed.2005.07.030; Nettleton S., 2004, SOCIAL THEORY HLTH, V2, P47, DOI DOI 10.1057/PALGRAVE.STH.8700013; Palmer CGS, 2018, J GENET COUNS, V27, P1087, DOI 10.1007/s10897-018-0228-6; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Penning BWJH, 2018, METABOLIC SYNDROME P, V20; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rapaport MH, 1998, J AFFECT DISORDERS, V48, P227, DOI 10.1016/S0165-0327(97)00196-1; Rapaport MH, 2002, AM J PSYCHIAT, V159, P637, DOI 10.1176/appi.ajp.159.4.637; Schechter D, 2007, PSYCHIAT RES, V152, P45, DOI 10.1016/j.psychres.2006.09.008; Spillmann RC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0623-3; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Stevanovic D, 2011, J PSYCHIATR MENT HLT, V18, P744, DOI 10.1111/j.1365-2850.2011.01735.x; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; van Dessel N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011142.pub2; Weiss K, 2018, RAMBAM MAIMONIDES ME, V9, DOI 10.5041/RMMJ.10341; Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216937	10.1371/journal.pone.0216937	http://dx.doi.org/10.1371/journal.pone.0216937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170170	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700011
J	Halvorsen, CJ; Chen, YC				Halvorsen, Cal J.; Chen, Yu-Chih			The diversity of interest in later-life entrepreneurship: Results from a nationally representative survey of Americans aged 50 to 70	PLOS ONE			English	Article							PROPORTIONAL ODDS MODELS; SELF-EMPLOYMENT; LIQUIDITY CONSTRAINTS; HOUSEHOLD WEALTH; HEALTH-INSURANCE; OLDER-ADULTS; GENDER; GENERATIVITY; PERCEPTIONS; TRANSITIONS	While older entrepreneurs are more likely to be male, white, and have higher levels of human, social, and financial capital, we know less about interest in later-life entrepreneurship. This study estimates entrepreneurial interest in a nationally representative sample of Americans aged 50 to 70 using partial proportional odds modeling. We estimate that more than 31 million older Americans have some interest in entrepreneurship and reveal key predictors of this interest (e.g., younger age). Importantly, the findings indicate that a more diverse group of older adults are interested in entrepreneurship than have become entrepreneurs, suggesting the need for additional research on the potential disparities between entrepreneurial interest and action in later life.	[Halvorsen, Cal J.] Boston Coll, Sch Social Work, Chestnut Hill, MA 02167 USA; [Chen, Yu-Chih] Washington Univ, Brown Sch Social Work, St Louis, MO 63110 USA	Boston College; Washington University (WUSTL)	Halvorsen, CJ (corresponding author), Boston Coll, Sch Social Work, Chestnut Hill, MA 02167 USA.	cal.halvorsen@bc.edu	Chen, Yu-Chih/J-9529-2019	Chen, Yu-Chih/0000-0002-5678-5850; Halvorsen, Cal J./0000-0002-9184-633X				Acs Z, 2016, SMALL BUS ECON, V47, P35, DOI 10.1007/s11187-016-9712-2; Anderson MP, 2016, 13 AM DONT USE INTER; [Anonymous], 2016, J MATH SOCIOL, V40, P7, DOI [10.1080/0022250X.2015.1112384, DOI 10.1080/0022250X.2015.1112384]; [Anonymous], 2011, ENC ENTR CREAT JOBS; [Anonymous], 1998, MEANING SOCIAL ENTRE; [Anonymous], 2011, ENC CAR CHOIC PURP P; Becker SG., 1993, HUMAN CAPITAL THEORE, P15, DOI [DOI 10.7208/CHICAGO/9780226041223.001.0001, 10.7208/chicago/9780226041223.001.0001]; Beckhusen JB, 2014, 267 US CENS BUR; Blumberg LJ, 2014, AFFORDABLE CARE ACT, V24; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Bygrave W.D., 1992, ENTREP THEORY PRACT, V16, P13, DOI [DOI 10.1177/104225879201600203, 10.1177/104225879201600203]; Cahill K., 2013, 463 US BUR LAB STAT; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Craemer T, 2009, SOC SCI RES, V38, P668, DOI 10.1016/j.ssresearch.2009.03.006; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Erikson E. H., 1963, CHILDHOOD SOC; Ewing Marion Kauffman Foundation, 2017, 2017 KAUFFM IND STAR; Ewing Marion Kauffman Foundation, 2016, CAN SOC INS UNL ENTR; Fairlie RW, 2012, REV INCOME WEALTH, V58, P279, DOI 10.1111/j.1475-4991.2011.00491.x; Fairlie RW, 2011, J HEALTH ECON, V30, P146, DOI 10.1016/j.jhealeco.2010.09.003; Fasbender U, 2016, WORK AGING RETIRE, V2, P12, DOI 10.1093/workar/wav015; Gonzales E, 2017, RES AGING, V39, P1100, DOI 10.1177/0164027516664569; Gupta VK, 2009, ENTREP THEORY PRACT, V33, P397, DOI 10.1111/j.1540-6520.2009.00296.x; Haapanen M, 2009, APPL ECON, V41, P2449, DOI 10.1080/00036840802360278; Haltiwanger J, 2013, REV ECON STAT, V95, P347, DOI 10.1162/REST_a_00288; Halvorsen CJ, 2017, WORK AGING RETIRE, V3, P313, DOI 10.1093/workar/waw031; Halvorsen CJ, 2013, GENERATIONS, V37, P33; Hatfield I., 2015, SELF EMPLOYMENT EURO; Henrekson M, 2014, P NATL ACAD SCI USA, V111, P1760, DOI 10.1073/pnas.1307204111; Hochguertel S., 2010, 7 NETW STUD PENS AG; Hurst E, 2004, J POLIT ECON, V112, P319, DOI 10.1086/381478; Kalton G., 2003, J OFF STAT, V19, P81; Kautonen T, 2017, J BUS VENTURING, V32, P318, DOI 10.1016/j.jbusvent.2017.02.005; Kautonen T, 2014, SMALL BUS ECON, V42, P579, DOI 10.1007/s11187-013-9489-5; Kennedy P, 2008, GUIDE ECONOMETRICS; Kenny B, 2018, INT J ENTREP BEHAV R, V24, P234, DOI 10.1108/IJEBR-01-2017-0004; Kollinger P, 2006, SMALL BUS ECON, V27, P59, DOI 10.1007/s11187-006-0019-6; Lewis KV, 2013, J SMALL BUS ENTERP D, V20, P399, DOI 10.1108/14626001311326798; Lochner K, 1999, HEALTH PLACE, V5, P259, DOI 10.1016/S1353-8292(99)00016-7; Maalaoui Adnan, 2013, International Journal of Entrepreneurship and Small Business, V20, P148; Millan JM, 2014, INT ENTREP MANAG J, V10, P187, DOI 10.1007/s11365-011-0184-1; McNamara TK, 2011, J GERONTOL B-PSYCHOL, V66, P490, DOI 10.1093/geronb/gbr055; MetLife Foundation, 2005, NEW FAC WORK SURV; MetLife Foundation, 2008, ENC CAR SURV; Miller D, 2007, STRATEG ORGAN, V5, P177, DOI 10.1177/1476127007077558; Minniti M, 2007, SMALL BUS ECON, V28, P223, DOI 10.1007/s11187-006-9017-y; Minola T, 2016, SMALL BUS ECON, V46, P187, DOI 10.1007/s11187-015-9685-6; MorBarak ME, 1995, INT J AGING HUM DEV, V41, P325, DOI 10.2190/VGTG-EPK6-Q4BH-Q67Q; Morrow-Howell N, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx018; Moulton JG, 2016, SOC FORCES, V94, P1539, DOI 10.1093/sf/sow026; Ng TWH, 2015, WORK AGING RETIRE, V1, P64, DOI 10.1093/workar/wau003; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Pierre Azoulay, 2018, 24489 NBER; Pitt-Catsouphes Marcie, 2017, PALGRAVE HDB AGE DIV, P195, DOI DOI 10.1037/PAG0000191; Schaper, 2004, J ENTERPRISING CULTU, V12, P147, DOI [10.1142/s0218495804000087, DOI 10.1142/S0218495804000087]; Shinnar RS, 2012, ENTREP THEORY PRACT, V36, P465, DOI 10.1111/j.1540-6520.2012.00509.x; Tareque IS, 2016, GENDER GAP REMAINS L; U.S. Census Bureau, 2017, ANN EST RES POP SEX; U.S. Census Bureau, 2018, ANN EST RES POP SING; U. S. Department of Labor Bureau of Labor Statistics, 2015, CIV LAB FORC PART RA; United States Census Bureau, US POP GROWTH REG; US Census Bureau, 2016, ED ATTA US 2014; Weller C. E., 2015, WHAT DATA OLDER HOUS; Weller CE, 2018, GERONTOLOGIST, V58, P308, DOI 10.1093/geront/gnw145; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Wilmoth D., 2016, ASCENT SENIOR ENTREP; Wilmoth D., 2017, RETREAT RURAL ENTREP; Wilson F, 2009, J DEV ENTREP, V14, P105, DOI 10.1142/S1084946709001247; Winter N., 2018, SURVWGT STATA MODULE; Zacher H, 2012, AGEING SOC, V32, P673, DOI 10.1017/S0144686X11000547; Zhao H, 2005, J APPL PSYCHOL, V90, P1265, DOI 10.1037/0021-9010.90.6.1265; Zissimopoulos JM, 2007, 200704 AARP PUBL POL; Zissimopoulos JM, 2009, RES AGING, V31, P89, DOI 10.1177/0164027508324642; Zissiniopoulos JM, 2007, LABOUR ECON, V14, P269, DOI 10.1016/j.labeco.2005.08.002	75	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217971	10.1371/journal.pone.0217971	http://dx.doi.org/10.1371/journal.pone.0217971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166994	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800054
J	Chong, SY; Chittleborough, CR; Gregory, T; Lynch, J; Mittinty, M; Smithers, LG				Chong, Shiau Yun; Chittleborough, Catherine Ruth; Gregory, Tess; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye			The controlled direct effect of temperament at 2-3 years on cognitive and academic outcomes at 6-7 years	PLOS ONE			English	Article							EFFORTFUL CONTROL; SELF-REGULATION; CHILDRENS; ACHIEVEMENT; SKILLS; PREDICTORS; PERFORMANCE; PRESCHOOL; BEHAVIOR; RATINGS	There is widespread interest in temperament and its impact upon cognitive and academic outcomes. Parents adjust their parenting according to their child's temperament, however, few studies have accounted for parenting while estimating the association between temperament and academic outcomes. We examined the associations between temperament (2-3 years) and cognitive and academic outcomes (6-7 years) when mediation by parenting practices (4-5 years) was held constant, by estimating the controlled direct effect. Participants were from the Longitudinal Study of Australian Children (n = 5107). Cognitive abilities were measured by the Peabody Picture Vocabulary Test (verbal) and the Matrix Reasoning test (non-verbal). Literacy and numeracy were reported by teachers using the Academic Rating Scale. Mothers reported children's temperament using the Short Temperament Scale for Toddlers (subscales: reactivity, approach, and persistence). Parenting practices included items about engagement in activities with children. Marginal structural models with inverse probability of treatment weights were used to estimate the controlled direct effect of temperament, when setting parenting to the mean. All temperament subscales were associated with cognitive abilities, with persistence showing the largest associations with verbal (PPVT; beta = 0.58; 95%CI 0.27, 0.89) and non-verbal (Matrix Reasoning: beta = 0.19; 0.02, 0.34) abilities. Higher persistence was associated with better literacy (beta = 0.08; 0.03, 0.13) and numeracy (beta = 0.08; 0.03, 0.13), and higher reactivity with lower literacy (beta = -0.08; -0.11, -0.05) and numeracy (beta = -0.07; -0.10, -0.04). There was little evidence that temperamental approach influenced literacy or numeracy. Overall, temperament had small associations with cognitive and academic outcomes after accounting for parenting and confounders.	[Chong, Shiau Yun; Chittleborough, Catherine Ruth; Gregory, Tess; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Chittleborough, Catherine Ruth; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye] Robinson Res Inst, Adelaide, SA, Australia; [Gregory, Tess] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Lynch, John] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England	University of Adelaide; Robinson Research Institute; Telethon Kids Institute; University of Western Australia; University of Bristol	Smithers, LG (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.; Smithers, LG (corresponding author), Robinson Res Inst, Adelaide, SA, Australia.	lisa.smithers@adelaide.edu.au	Chittleborough, Catherine/A-7436-2011; Smithers, Lisa/D-1605-2009	Chittleborough, Catherine/0000-0003-3196-7137; Smithers, Lisa/0000-0002-6585-7836; Gregory, Tess/0000-0003-4799-6258	University of Adelaide International Scholarship; Fraser Mustard Centre PhD Scholarship; Australia Fellowship from the National Health and Medical Research Council of Australia [70120]; Australia Fellowship	University of Adelaide International Scholarship; Fraser Mustard Centre PhD Scholarship; Australia Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship	Dr Chong was funded by a University of Adelaide International Scholarship and a Fraser Mustard Centre PhD Scholarship. During this work, Professor Lynch was supported by an Australia Fellowship from the National Health and Medical Research Council of Australia (70120). Associate Professor Smithers and Dr Mittinty were also supported by funds from the Australia Fellowship awarded to Prof Lynch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association (APA), 2009, APA CONC DICT PSYCH; [Anonymous], TEMPERAMENT CHILDHOO; [Anonymous], 2005, 1 LSAC; Baker CN, 2015, J EDUC PSYCHOL, V107, P805, DOI 10.1037/edu0000008; Banerjee PN, 2007, INFANT BEHAV DEV, V30, P479, DOI 10.1016/j.infbeh.2006.12.001; Bierman KL, 2014, CHILD DEV, V85, P140, DOI 10.1111/cdev.12117; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blair C, 2015, ANNU REV PSYCHOL, V66, P711, DOI 10.1146/annurev-psych-010814-015221; Byford M, 2012, INT J EPIDEMIOL, V41, P263, DOI 10.1093/ije/dyr188; CAREY WB, 1977, PEDIATRICS, V60, P621; Cheng SY, 2010, J EPIDEMIOL, V20, pS452, DOI 10.2188/jea.JE20090177; Childs G, 2001, BRIT J EDUC PSYCHOL, V71, P303, DOI 10.1348/000709901158532; Dixon WE, 2006, INFANT BEHAV DEV, V29, P342, DOI 10.1016/j.infbeh.2006.01.002; Dixon WE, 2003, INFANT CHILD DEV, V12, P177, DOI 10.1002/icd.283; Dunn L.M., 2009, PEABODY PICTURE VOCA; FULLARD W, 1984, J PEDIATR PSYCHOL, V9, P205, DOI 10.1093/jpepsy/9.2.205; GREENBERG MT, 1995, DEV PSYCHOPATHOL, V7, P117, DOI 10.1017/S0954579400006374; Heckman JJ, 2001, AM ECON REV, V91, P145, DOI 10.1257/aer.91.2.145; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Hernan MA, 2018, CASUAL INFERENCE; Hughes K, 2010, SCHOOL PSYCHOL QUART, V25, P213, DOI 10.1037/a0022070; KEOGH BK, 1982, CIBA F SYMP, V89, P269; LERNER JV, 1985, J CHILD PSYCHOL PSYC, V26, P125, DOI 10.1111/j.1469-7610.1985.tb01633.x; Lipsey M. W., 2012, TRANSLATING STAT REP; MACCOBY EE, 1984, DEV PSYCHOL, V20, P459, DOI 10.1037/0012-1649.20.3.459; MacKenzie MJ, 2013, PEDIATRICS, V132, pE1118, DOI 10.1542/peds.2013-1227; Martin R.P., 1985, J PSYCHOEDUC ASSESS, V3, P131, DOI [DOI 10.1177/073428298500300204, 10.1177/073428298500300204]; National Center for Education Statistics, 2002, 2002135 NCES; Nix RL, 2013, EARLY EDUC DEV, V24, P1000, DOI 10.1080/10409289.2013.825565; PALISIN H, 1986, DEV PSYCHOL, V22, P766, DOI 10.1037/0012-1649.22.6.766; PRIOR M, 1987, INT J BEHAV DEV, V10, P121, DOI 10.1177/016502548701000108; Prior M, 2008, INFANT BEHAV DEV, V31, P270, DOI 10.1016/j.infbeh.2007.11.001; Rabiner D, 2000, J AM ACAD CHILD PSY, V39, P859, DOI 10.1097/00004583-200007000-00014; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Rock D.A., 2002, EARLY CHILDHOOD LONG; Rothman S, 2005, 2 AUSTR I FAM STUD; Rudasill KM, 2010, J SCHOOL PSYCHOL, V48, P113, DOI 10.1016/j.jsp.2009.11.002; Salley BJ, 2007, MERRILL PALMER QUART, V53, P131; Sanson A., 2011, WILEY BLACKWELL HDB, P227, DOI [DOI 10.1002/9781444390933, DOI 10.1002/9781444390933.CH12]; Sawyer ACP, 2015, CHILD CARE HLTH DEV, V41, P744, DOI 10.1111/cch.12208; Smithers LG, 2018, NAT HUM BEHAV, V2, P867, DOI 10.1038/s41562-018-0461-x; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Valiente C, 2010, J EDUC PSYCHOL, V102, P550, DOI 10.1037/a0018992; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20; VanderWeele TJ, 2010, EPIDEMIOLOGY, V21, P540, DOI 10.1097/EDE.0b013e3181df191c; Vassallo S, 2013, AUSTR TEMPERAMENT PR; VAUGHN BE, 1987, DEV PSYCHOL, V23, P152, DOI 10.1037/0012-1649.23.1.152; WACHS TD, 1983, INT J BEHAV DEV, V6, P135, DOI 10.1177/016502548300600202; WEBSTERSTRATTON C, 1982, J CLIN CHILD PSYCHOL, V11, P123, DOI 10.1207/s15374424jccp1102_5; Wechsler D, 1974, WECHSLER INTELLIGENC; West J., 2000, AM KINDERGARTNERS FI	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0204189	10.1371/journal.pone.0204189	http://dx.doi.org/10.1371/journal.pone.0204189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163023	Green Submitted, Green Published, gold			2022-12-27	WOS:000470086200001
J	Tarca, AL; Romero, R; Benshalom-Tirosh, N; Than, NG; Gudicha, DW; Done, B; Pacora, P; Chaiworapongsa, T; Panaitescu, B; Tirosh, D; Gomez-Lopez, N; Draghici, S; Hassan, SS; Erez, O				Tarca, Adi L.; Romero, Roberto; Benshalom-Tirosh, Neta; Than, Nandor Gabor; Gudicha, Dereje W.; Done, Bogdan; Pacora, Percy; Chaiworapongsa, Tinnakorn; Panaitescu, Bogdan; Tirosh, Dan; Gomez-Lopez, Nardhy; Draghici, Sorin; Hassan, Sonia S.; Erez, Offer			The prediction of early preeclampsia: Results from a longitudinal proteomics study	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; PLACENTAL GROWTH-FACTOR; LATE-ONSET PREECLAMPSIA; FOR-GESTATIONAL-AGE; ANTI-ANGIOGENIC FACTORS; MATERNAL PLASMA-CONCENTRATIONS; HUMAN CHORIONIC-GONADOTROPIN; HIGH-DIMENSIONAL BIOLOGY; FREE BETA-HCG; SERUM PAPP-A	Objectives To identify maternal plasma protein markers for early preeclampsia (delivery <34 weeks of gestation) and to determine whether the prediction performance is affected by disease severity and presence of placental lesions consistent with maternal vascular malperfusion (MVM) among cases. Study design This longitudinal case-control study included 90 patients with a normal pregnancy and 33 patients with early preeclampsia. Two to six maternal plasma samples were collected throughout gestation from each woman. The abundance of 1,125 proteins was measured using high-affinity aptamer-based proteomic assays, and data were modeled using linear mixed-effects models. After data transformation into multiples of the mean values for gestational age, parsimonious linear discriminant analysis risk models were fit for each gestational-age interval (8-16, 16.1-22, 22.1-28, 28.1-32 weeks). Proteomic profiles of early preeclampsia cases were also compared to those of a combined set of controls and late preeclampsia cases (n = 76) reported previously. Prediction performance was estimated via bootstrap. Results We found that 1) multi-protein models at 16.1-22 weeks of gestation predicted early preeclampsia with a sensitivity of 71% at a false-positive rate (FPR) of 10%. High abundance of matrix metalloproteinase-7 and glycoprotein IIbIIIa complex were the most reliable predictors at this gestational age; 2) at 22.1-28 weeks of gestation, lower abundance of placental growth factor (PlGF) and vascular endothelial growth factor A, isoform 121 (VEGF-121), as well as elevated sialic acid binding immunoglobulin-like lectin 6 (siglec-6) and activin-A, were the best predictors of the subsequent development of early preeclampsia (81% sensitivity, FPR = 10%); 3) at 28.1-32 weeks of gestation, the sensitivity of multi-protein models was 85% (FPR = 10%) with the best predictors being activated leukocyte cell adhesion molecule, siglec-6, and VEGF-121; 4) the increase in siglec-6, activin-A, and VEGF-121 at 22.1-28 weeks of gestation differentiated women who subsequently developed early preeclampsia from those who had a normal pregnancy or developed late preeclampsia (sensitivity 77%, FPR = 10%); 5) the sensitivity of risk models was higher for early preeclampsia with placental MVM lesions than for the entire early preeclampsia group (90% versus 71% at 16.1-22 weeks; 87% versus 81% at 22.1-28 weeks; and 90% versus 85% at 28.1-32 weeks, all FPR = 10%); and 6) the sensitivity of prediction models was higher for severe early preeclampsia than for the entire early preeclampsia group (84% versus 71% at 16.1-22 weeks). Conclusion We have presented herein a catalogue of proteome changes in maternal plasma proteome that precede the diagnosis of preeclampsia and can distinguish among early and late phenotypes. The sensitivity of maternal plasma protein models for early preeclampsia is higher in women with underlying vascular placental disease and in those with a severe phenotype.	[Tarca, Adi L.; Romero, Roberto; Benshalom-Tirosh, Neta; Gudicha, Dereje W.; Done, Bogdan; Pacora, Percy; Chaiworapongsa, Tinnakorn; Panaitescu, Bogdan; Tirosh, Dan; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Erez, Offer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,NICHD,US DHHS, Bethesda, MD 20892 USA; [Tarca, Adi L.; Romero, Roberto; Benshalom-Tirosh, Neta; Gudicha, Dereje W.; Done, Bogdan; Pacora, Percy; Chaiworapongsa, Tinnakorn; Panaitescu, Bogdan; Tirosh, Dan; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Erez, Offer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,NICHD,US DHHS, Detroit, MI 48201 USA; [Tarca, Adi L.; Benshalom-Tirosh, Neta; Gudicha, Dereje W.; Pacora, Percy; Chaiworapongsa, Tinnakorn; Panaitescu, Bogdan; Tirosh, Dan; Gomez-Lopez, Nardhy; Draghici, Sorin; Hassan, Sonia S.; Erez, Offer] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Tarca, Adi L.; Draghici, Sorin] Wayne State Univ, Coll Engn, Dept Comp Sci, Detroit, MI USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Than, Nandor Gabor] Hungarian Acad Sci, Inst Enzymol, Syst Biol Reprod Res Grp, Res Ctr Nat Sci, Budapest, Hungary; [Than, Nandor Gabor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Than, Nandor Gabor] Semmelweis Univ, Matern Clin, Kutvolgyi Clin Block, Budapest, Hungary; [Gomez-Lopez, Nardhy] Wayne State Univ, CS Mott Ctr Human Growth & Dev, Detroit, MI USA; [Gomez-Lopez, Nardhy] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Erez, Offer] Ben Gurion Univ Negev, Matern Dept D, Div Obstet & Gynecol, Soroka Univ Med Ctr,Sch Med,Fac Hlth Sci, Beer Sheva, Israel	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Michigan State University; Wayne State University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Semmelweis University; Wayne State University; Wayne State University; Wayne State University; Ben Gurion University; Soroka Medical Center	Tarca, AL; Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,NICHD,US DHHS, Bethesda, MD 20892 USA.; Tarca, AL; Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,NICHD,US DHHS, Detroit, MI 48201 USA.	atarca@med.wayne.edu; prbchiefstaff@med.wayne.edu	Draghici, Sorin/B-3074-2013; Benshalom-Tirosh, Neta/AAE-9455-2021; Than, Nandor G/N-1442-2016; Tirosh, Dan/Q-4677-2016; Romero, Roberto/A-5268-2019	Draghici, Sorin/0000-0002-0786-8377; Benshalom-Tirosh, Neta/0000-0003-1627-0200; Tirosh, Dan/0000-0002-7570-2272; Tarca, Adi Laurentiu/0000-0003-1712-7588; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Huma; NICHD/NIH/DHHS [HHSN275201300006C]; Perinatal Initiative of the Wayne State University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Huma; NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Perinatal Initiative of the Wayne State University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported, in part, by the Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with federal funds from NICHD/NIH/DHHS under contract no. HHSN275201300006C. ALT was also supported by the Perinatal Initiative of the Wayne State University School of Medicine.	ACOG American College of Obstetricians and Gynecologists, 2016, AM COLL OBST GYN PRA; Aggarwal PK, 2012, J HUM HYPERTENS, V26, P236, DOI 10.1038/jhh.2011.29; Aghaeepour N, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.208; Akolekar R, 2016, ULTRASOUND OBST GYN, V48, P618, DOI 10.1002/uog.17288; Akolekar R, 2016, ULTRASOUND OBST GYN, V48, P624, DOI 10.1002/uog.17295; Akolekar R, 2013, FETAL DIAGN THER, V33, P8, DOI 10.1159/000341264; Akolekar R, 2009, PRENATAL DIAG, V29, P753, DOI 10.1002/pd.2279; Allen RE, 2014, EUR J OBSTET GYN R B, V182, P194, DOI 10.1016/j.ejogrb.2014.09.027; Anand S, 2016, J LIPID RES, V57, P687, DOI 10.1194/jlr.P064451; Anand S, 2015, BIOMARK MED, V9, P563, DOI 10.2217/bmm.15.21; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Antsaklis P, 2011, J MATERN-FETAL NEO M, V24, P465, DOI 10.3109/14767058.2010.501124; Ashar-Patel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11639-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audibert F, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.014; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Aupont JE, 2016, ULTRASOUND OBST GYN, V48, P631, DOI 10.1002/uog.17229; Austdal M, 2015, INT J MOL SCI, V16, P21520, DOI 10.3390/ijms160921520; Ay E, 2005, AUST NZ J OBSTET GYN, V45, P283, DOI 10.1111/j.1479-828X.2005.00412.x; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; Baig S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-40; Bakalis SP, 2012, J MATERN-FETAL NEO M, V25, P2475, DOI 10.3109/14767058.2012.717127; Baker PN, 2009, EXPERT REV PROTEOMIC, V6, P107, DOI 10.1586/EPR.09.5; Baschat AA, 2015, ULTRASOUND OBST GYN, V45, P119, DOI 10.1002/uog.14770; Baschat AA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.018; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumann MU, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.069; Benton SJ, 2016, PLACENTA, P1; Blankley RT, 2009, BJOG-INT J OBSTET GY, V116, P1473, DOI 10.1111/j.1471-0528.2009.02283.x; Blankley RT, 2010, REPROD SCI, V17, P247, DOI 10.1177/1933719109351320; Bobrow CS, 2002, AM J OBSTET GYNECOL, V186, P283, DOI 10.1067/mob.2002.119777; Bokslag A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.015; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown SHJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163972; Brunelli VB, 2015, BJOG-INT J OBSTET GY, V122, P904, DOI 10.1111/1471-0528.13334; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Carty DM, 2013, J HUM HYPERTENS, V27, P211, DOI 10.1038/jhh.2012.30; Centlow M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458748; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chaiworapongsa T, 2013, J PERINAT MED, V41, P485, DOI 10.1515/jpm-2013-0082; Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016; Chen GX, 2011, PROTEOM CLIN APPL, V5, P300, DOI 10.1002/prca.201000100; Christensen M, 2017, ACTA OBSTET GYN SCAN, V96, P1084, DOI 10.1111/aogs.13173; Chung JY, 2004, J CLIN ENDOCR METAB, V89, P2484, DOI 10.1210/jc.2003-031580; Cim N, 2016, J MATERN-FETAL NEO M, P1; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Colombo EF, 2016, J INTEGR DES PROCESS, V20, P3, DOI 10.3233/jid-2016-0019; Conde-Agudelo A, 2015, BJOG-INT J OBSTET GY, V122, P41, DOI 10.1111/1471-0528.13096; Conde-Agudelo A, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P221, DOI 10.1016/B978-0-12-407866-6.00011-0; Conde-Agudelo A, 2014, AM J OBSTET GYNECOL, V211, P583, DOI 10.1016/j.ajog.2014.07.047; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Crispi F, 2006, AM J OBSTET GYNECOL, V195, P201, DOI 10.1016/j.ajog.2006.01.014; Crovetto F, 2016, ULTRASOUND OBST GYN, V48, P340, DOI 10.1002/uog.15879; Crovetto F, 2015, PRENATAL DIAG, V35, P183, DOI 10.1002/pd.4519; Dai X, 2017, J CELL BIOCHEM, P1; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Davutoglu EA, 2018, J MATERN-FETAL NEO M, V31, P1976, DOI 10.1080/14767058.2017.1333098; Dayarian A, 2015, BIOINFORMATICS, V31, P462, DOI 10.1093/bioinformatics/btu490; de Groot CJM, 2007, PROTEOM CLIN APPL, V1, P325, DOI 10.1002/prca.200600911; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Edlow AG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.023; Ekin A, 2015, J OBSTET GYNAECOL RE, V41, P23, DOI 10.1111/jog.12484; Elangbam CS, 1997, VET PATHOL, V34, P61, DOI 10.1177/030098589703400113; Epiney M, 2012, J PROTEOMICS, V75, P1771, DOI 10.1016/j.jprot.2011.12.021; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181468; Espinoza J, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.002; Familiari A, 2016, ACTA OBSTET GYN SCAN, V95, P1313, DOI 10.1111/aogs.13012; Feng YL, 2012, GYNECOL OBSTET INVES, V73, P252, DOI 10.1159/000334820; Foidart JM, 2010, ULTRASOUND OBST GYN, V35, P680, DOI 10.1002/uog.7621; Founds S, 2015, INT J MOL SCI, V16, P27208, DOI 10.3390/ijms161126023; Gallo DM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.016; Gandley RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157608; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034; Gharesi-Fard B, 2010, PLACENTA, V31, P121, DOI 10.1016/j.placenta.2009.11.004; Goetzinger KR, 2012, PRENATAL DIAG, V32, P1002, DOI 10.1002/pd.3949; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Greco E, 2012, FETAL DIAGN THER, V31, P154, DOI 10.1159/000335686; Groom KM, 2018, AM J OBSTET GYNECOL, V218, pS829, DOI 10.1016/j.ajog.2017.11.565; Guizani M, 2017, FETAL DIAGN THER, P1; Gulec UK, 2013, J MATERN-FETAL NEO M, V26, P1228, DOI 10.3109/14767058.2013.776533; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hamamura K, 2016, ANN CLIN BIOCHEM, V53, P85, DOI 10.1177/0004563215583697; Hernandez-Nunez J, 2015, INT J WOMENS HEALTH, V7, P385, DOI 10.2147/IJWH.S79577; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hsu TY, 2015, TAIWAN J OBSTET GYNE, V54, P499, DOI 10.1016/j.tjog.2014.01.007; Iacobelli S, 2017, J REPROD IMMUNOL, V123, P12, DOI 10.1016/j.jri.2017.08.005; JANES SL, 1994, CLIN SCI, V86, P731, DOI 10.1042/cs0860731; Jelin AC, 2010, J MATERN-FETAL NEO M, V23, P389, DOI [10.1080/14767050903168416, 10.3109/14767050903168416]; Jin H, 2008, ANAL CHIM ACTA, V629, P158, DOI 10.1016/j.aca.2008.09.015; Jin XH, 2017, BBA-PROTEINS PROTEOM, V1865, P1207, DOI 10.1016/j.bbapap.2017.07.003; Johnson M, 2012, Pregnancy Hypertens, V2, P202, DOI 10.1016/j.preghy.2012.04.047; Jokimaa V, 1998, PLACENTA, V19, P157, DOI 10.1016/S0143-4004(98)90004-2; Jokimaa VIS, 2000, AM J OBSTET GYNECOL, V183, P1495, DOI 10.1067/mob.2000.107320; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P493, DOI 10.1002/uog.5332; Karagiannis G, 2011, FETAL DIAGN THER, V29, P148, DOI 10.1159/000321694; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P253, DOI 10.1007/s00795-003-0223-2; Kayode GA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1061-2; Kedia K, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.004; Khalil A, 2016, ULTRASOUND OBST GYN, V47, P74, DOI 10.1002/uog.15729; Khodzhaeva ZS, 2016, J MATERN-FETAL NEO M, V29, P2980, DOI 10.3109/14767058.2015.1111332; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Kim SM, 2016, PROTEOMICS, V16, P1581, DOI 10.1002/pmic.201500381; Kim SM, 2016, J MATERN-FETAL NEO M, V29, P2414, DOI 10.3109/14767058.2015.1094049; Kim YM, 2015, J MATERN-FETAL NEO M, V28, P2001, DOI 10.3109/14767058.2014.976198; Kim YN, 2007, PROTEOM CLIN APPL, V1, P1625, DOI 10.1002/prca.200700034; Klein J, 2014, EXPERT REV PROTEOMIC, V11, P75, DOI 10.1586/14789450.2014.872564; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kolialexi A, 2017, EXPERT REV PROTEOMIC, V14, P269, DOI 10.1080/14789450.2017.1291345; Kolialexi A, 2017, EXPERT REV PROTEOMIC, V14, P113, DOI 10.1080/14789450.2017.1275574; Kolialexi A, 2015, PROTEOM CLIN APPL, V9, P501, DOI 10.1002/prca.201400092; Kolialexi A, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/121848; Kolla V, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/305964; Kononikhin AS, 2016, J PROTEOMICS, V149, P38, DOI 10.1016/j.jprot.2016.04.024; Korzeniewski SJ, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.015; Koster MPH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/857108; Kovo M, 2012, PRENATAL DIAG, V32, P632, DOI 10.1002/pd.3872; Kuc S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098540; Kuc S, 2011, OBSTET GYNECOL SURV, V66, P225, DOI 10.1097/OGX.0b013e3182227027; Kurtoglu E, 2016, J MATERN-FETAL NEO M, V29, P1987, DOI 10.3109/14767058.2015.1072157; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lai J, 2013, FETAL DIAGN THER, V33, P149, DOI 10.1159/000343220; Law KP, 2015, INT J MOL SCI, V16, P10952, DOI 10.3390/ijms160510952; Lee SM, 2011, J PERINAT MED, V39, P391, DOI [10.1515/JPM.2011.028, 10.1515/jpm.2011.028]; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lindheimer MD, 2007, HYPERTENSION, V50, P35, DOI 10.1161/HYPERTENSIONAHA.107.089045; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Liu C, 2011, PLACENTA, V32, P168, DOI 10.1016/j.placenta.2010.11.007; Llurba E, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/275613; Lu Q, 2016, J OBSTET GYNAECOL RE, V42, P1111, DOI 10.1111/jog.13037; Luo Q, 2017, J PERINAT MED, V45, P809, DOI 10.1515/jpm-2016-0249; Luo SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178549; Lynch AM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.001; Ma KD, 2014, CELL BIOCHEM BIOPHYS, V69, P247, DOI 10.1007/s12013-013-9792-4; Madazli R, 2005, INT J GYNECOL OBSTET, V89, P251, DOI 10.1016/j.ijgo.2005.02.008; Madazli R, 2014, ARCH GYNECOL OBSTET, V290, P53, DOI 10.1007/s00404-014-3176-x; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Mary S, 2017, J PROTEOME RES, V16, P1050, DOI 10.1021/acs.jproteome.6b00955; Mastrodima S, 2016, ULTRASOUND OBST GYN, V48, P613, DOI 10.1002/uog.17289; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKenzie ME, 2003, BLOOD COAGUL FIBRIN, V14, P249, DOI 10.1097/01.mbc.0000046182.72384.ab; Melchiorre K, 2008, ULTRASOUND OBST GYN, V32, P133, DOI 10.1002/uog.5400; Melchiorre K, 2009, ULTRASOUND OBST GYN, V33, P524, DOI 10.1002/uog.6368; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Mor O, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.020; Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195; Myers Jenny, 2004, J Obstet Gynaecol, V24, P873, DOI 10.1080/01443610400018791; Myers JE, 2013, HYPERTENSION, V61, P1281, DOI 10.1161/HYPERTENSIONAHA.113.01168; Nejatizadeh A, 2008, BIOCHEM GENET, V46, P451, DOI 10.1007/s10528-008-9163-9; Nelson DB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.010; O'Gorman N, 2016, WOMENS HEALTH, V12, P199, DOI 10.2217/whe.15.95; O'Gorman N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.034; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Park HJ, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-35; Park JS, 2008, REPROD SCI, V15, P457, DOI 10.1177/1933719108316909; Parra-Cordero M, 2014, ULTRASOUND OBST GYN, V43, P291, DOI 10.1002/uog.12465; Parra-Cordero M, 2013, ULTRASOUND OBST GYN, V41, P538, DOI 10.1002/uog.12264; Parry S, 2017, AM J OBSTET GYNECOL, P30749; Perales A, 2017, ULTRASOUND OBST GYN, V50, P373, DOI 10.1002/uog.17373; Poon LCY, 2009, ULTRASOUND OBST GYN, V34, P497, DOI 10.1002/uog.7439; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LCY, 2009, ULTRASOUND OBST GYN, V34, P142, DOI 10.1002/uog.6452; Poon LCY, 2010, PRENATAL DIAG, V30, P216, DOI 10.1002/pd.2440; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Qi WH, 2017, MINERVA MED, V108, P389, DOI 10.23736/S0026-4806.17.05080-7; Qian YF, 2017, MOL MED REP, V16, P2620, DOI 10.3892/mmr.2017.6881; Quezada MS, 2015, ULTRASOUND OBST GYN, V45, P101, DOI 10.1002/uog.14666; Rana Sarosh, 2012, PLoS One, V7, pe48259, DOI 10.1371/journal.pone.0048259; Rasanen J, 2010, J PROTEOME RES, V9, P4274, DOI 10.1021/pr100198m; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Reister F, 2006, J PERINAT MED, V34, P272, DOI 10.1515/JPM.2006.052; Rocha RS, 2017, J PERINAT MED; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2002, J CLIN ENDOCR METAB, V87, P2431, DOI 10.1210/jc.87.6.2431; ROMERO R, 1988, SEMIN PERINATOL, V12, P302; Romero R, 2017, AM J OBSTET GYNECOL, V217; Romero R., 1996, PRENAT NEONAT MED, V1, P8; Romero R, 2017, J MATERN-FETAL NEO M, P1; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2006, AM J OBSTET GYNECOL, V195, P360, DOI 10.1016/j.ajog.2006.06.077; Romero R, 2018, J PERINAT MED, V46, P613, DOI 10.1515/jpm-2018-0055; Roux DTL, 2000, BLOOD, V96, P1399, DOI 10.1182/blood.V96.4.1399.h8001399_1399_1408; Scazzocchio E, 2017, ULTRASOUND OBST GYN, V49, P188, DOI 10.1002/uog.15982; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Seidler AL, 2018, AM J OBSTET GYNECOL, V219, P117, DOI 10.1016/j.ajog.2018.03.018; Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMoa1704559, 10.1056/NEJMc1713798]; Seravalli V, 2016, J PERINAT MED, V44, P543, DOI 10.1515/jpm-2015-0324; Shin JK, 2011, GYNECOL OBSTET INVES, V71, P151, DOI 10.1159/000315162; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sober S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13336; Soto E, 2012, J MATERN-FETAL NEO M, V25, P498, DOI 10.3109/14767058.2011.591461; Spencer K, 2008, ULTRASOUND OBST GYN, V31, P147, DOI 10.1002/uog.5163; Spencer K, 2000, PRENATAL DIAG, V20, P652; Spencer K, 2006, ULTRASOUND OBST GYN, V27, P658, DOI 10.1002/uog.2676; Spencer K, 2005, PRENATAL DIAG, V25, P949, DOI 10.1002/pd.1251; SPENCER K, 1992, LANCET, V339, P1480, DOI 10.1016/0140-6736(92)92073-O; Stampalija T, 2013, J MATERN-FETAL NEO M, V26, P1359, DOI 10.3109/14767058.2013.784256; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Stout MJ, 2013, PLACENTA, V34, P14, DOI 10.1016/j.placenta.2012.10.013; Stubert J, 2014, J PERINAT MED, V42, P617, DOI 10.1515/jpm-2013-0285; Sun LZ, 2007, GYNECOL OBSTET INVES, V64, P17, DOI 10.1159/000098399; Szabo S, 2013, VIRCHOWS ARCH, V463, P445, DOI 10.1007/s00428-013-1426-0; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tarca AL, 2013, SYST BIOMED, V1, P217; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Than N, 2017, REPROD SCI, V24, p278A; Than NG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01661; Tobinaga CM, 2014, ACTA OBSTET GYN SCAN, V93, P469, DOI 10.1111/aogs.12366; Tomer A, 2004, J BIOL REG HOMEOS AG, V18, P172; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Trudell AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173461; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; Tsiakkas A, 2016, ULTRASOUND OBST GYN, V47, P472, DOI 10.1002/uog.15816; Tsiakkas A, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.016; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Vascotto C, 2007, J PROTEOME RES, V6, P160, DOI 10.1021/pr060315z; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Ventura W, 2015, PRENATAL DIAG, V35, P294, DOI 10.1002/pd.4542; Verlohren S, 2014, ULTRASOUND OBST GYN, V44, P293, DOI 10.1002/uog.13310; Vettraino IM, 1996, PLACENTA, V17, P557, DOI 10.1016/S0143-4004(96)80072-5; Villa PM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-110; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Wataganara T, 2017, J PERINAT MED, V45, P895, DOI 10.1515/jpm-2017-0093; Watanabe H, 2004, PROTEOMICS, V4, P537, DOI 10.1002/pmic.200300565; Webster RP, 2007, PROTEOM CLIN APPL, V1, P1147, DOI 10.1002/prca.200700128; Webster RP, 2007, PROTEOM CLIN APPL, V1, P446, DOI 10.1002/prca.200600745; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Whitehead CL, 2016, PRENATAL DIAG, V36, P997, DOI 10.1002/pd.4934; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yang JI, 2015, J KOREAN MED SCI, V30, P770, DOI 10.3346/jkms.2015.30.6.770; Yerlikaya G, 2016, ULTRASOUND OBST GYN, V48, P607, DOI 10.1002/uog.17290; Yliniemi A, 2015, CLIN MED INSIGHTS-RE, V9, P13, DOI 10.4137/CMRH.S21865; Yong HEJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128230; Yu J, 2011, ULTRASOUND OBST GYN, V37, P528, DOI 10.1002/uog.8800	262	46	47	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217273	10.1371/journal.pone.0217273	http://dx.doi.org/10.1371/journal.pone.0217273			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163045	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000470086200011
J	Cameron, L; Suarez, DC; Cornwell, K				Cameron, Lisa; Suarez, Diana Contreras; Cornwell, Katy			Understanding the determinants of maternal mortality: An observational study using the Indonesian Population Census	PLOS ONE			English	Article							SAFE MOTHERHOOD; OBSTETRIC CARE; HEALTH-CARE; BIRTH; BANGLADESH; DISTANCE; SERVICES; MATLAB; POOR; TOO	Background For countries to contribute to Sustainable Development Goal 3.1 of reducing the global maternal mortality ratio (MMR) to less than 70 per 100,000 live births by 2030, identifying the drivers of maternal mortality is critically important. The ability of countries to identify the key drivers is however hampered by the lack of data sources with sufficient observations of maternal death to allow a rigorous analysis of its determinants. This paper overcomes this problem by utilising census data. In the context of Indonesia, we merge individual-level data on pregnancy-related deaths and households' socio-economic status from the 2010 Indonesian population census with detailed data on the availability and quality of local health services from the Village Census. We use these data to test the hypothesis that health service access and quality are important determinants of maternal death and explain the differences between high maternal mortality and low maternal mortality provinces. Methods The 2010 Indonesian Population Census identifies 8075 pregnancy-related deaths and 5,866,791 live births. Multilevel logistic regression is used to analyse the impacts of demographic characteristics and the existence of, distance to and quality of health services on the likelihood of maternal death. Decomposition analysis quantifies the extent to which the difference in maternal mortality ratios between high and low performing provinces can be explained by demographic and health service characteristics. Findings Health service access and characteristics account for 23% (CI: 17.2% to 28.5%) of the difference in maternal mortality ratios between high and low-performing provinces. The most important contributors are the number of doctors working at the community health centre (8.6%), the number of doctors in the village (6.9%) and distance to the nearest hospital (5.9%). Distance to health clinics and the number of midwives at community health centres and village health posts are not significant contributors, nor is socio-economic status. If the same level of access to doctors and hospitals in lower maternal mortality Java-Bali was provided to the higher maternal mortality Outer Islands of Indonesia, our model predicts 44 deaths would be averted per 100,000 pregnancies. Conclusion Indonesia has employed a strategy over the past several decades of increasing the supply of midwives as a way of decreasing maternal mortality. While there is evidence of reductions in maternal mortality continuing to accrue from the provision of midwife services at village health posts, our findings suggest that further reductions in maternal mortality in Indonesia may require a change of focus to increasing the supply of doctors and access to hospitals. If data on maternal death is collected in a subsequent census, future research using two waves of census data would prove a useful validation of the results found here. Similar research using census data from other countries is also likely to be fruitful.	[Cameron, Lisa; Suarez, Diana Contreras] Univ Melbourne, Melbourne Inst Appl Econ & Social Res, Melbourne, Vic, Australia; [Cornwell, Katy] Monash Univ, Ctr Dev Econ & Sustainabil, Clayton, Vic, Australia; [Cornwell, Katy] World Vis Australia, Burwood East, Vic, Australia	University of Melbourne; Monash University	Cameron, L (corresponding author), Univ Melbourne, Melbourne Inst Appl Econ & Social Res, Melbourne, Vic, Australia.	lisa.cameron@unimelb.edu.au		Contreras Suarez, Diana/0000-0003-0991-7029; Cameron, Lisa/0000-0002-7539-2198	Australian Department of Foreign Affairs and Trade through the Australia-Indonesia Partnership for Gender Equality and Women's Empowerment (MAMPU) program [MAMPU-MONASH-2014-1]	Australian Department of Foreign Affairs and Trade through the Australia-Indonesia Partnership for Gender Equality and Women's Empowerment (MAMPU) program	An initial version of the paper was supported by funding from the Australian Department of Foreign Affairs and Trade through the Australia-Indonesia Partnership for Gender Equality and Women's Empowerment (MAMPU) program (MAMPU-MONASH-2014-1 to LC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are the authors' alone and are not necessarily the views of the Australian Government, MAMPU or other partner organisations.	Achadi EL, 2014, 91325 WORLD BANK HLT; Achadi E, 2007, TROP MED INT HEALTH, V12, P1490, DOI 10.1111/j.1365-3156.2007.01957.x; Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Akbar A, 2012, Pregnancy Hypertens, V2, P184, DOI 10.1016/j.preghy.2012.04.019; Akbar A, 2012, Pregnancy Hypertens, V2, P183, DOI 10.1016/j.preghy.2012.04.018; Badriah F., 2014, J NURS CARE, V3, P198; Baird J, 2011, SOC SCI MED, V72, P1948, DOI 10.1016/j.socscimed.2010.04.038; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bulatao RA, 2003, TROP MED INT HEALTH, V8, P710, DOI 10.1046/j.1365-3156.2003.01083.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Conway KS, 2006, HEALTH ECON, V15, P461, DOI 10.1002/hec.1097; Etuk SJ, 2000, ACTA TROP, V75, P29, DOI 10.1016/S0001-706X(99)00088-1; Frankenberg E, 2009, STUD FAMILY PLANN, V40, P27, DOI 10.1111/j.1728-4465.2009.00184.x; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Garenne Michel, 2008, Popul Health Metr, V6, P4, DOI 10.1186/1478-7954-6-4; Goldenberg Robert L, 2015, Matern Health Neonatol Perinatol, V1, P3, DOI 10.1186/s40748-014-0004-z; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Hanson C, 2015, LANCET GLOB HEALTH, V3, pE387, DOI 10.1016/S2214-109X(15)00048-0; Hartanto W, 2012, PAA APA WORKSH DAT Q; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hatt L, 2007, B WORLD HEALTH ORGAN, V85, P774, DOI 10.2471/BLT.06.033472; Heywood P, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-3; Hussein J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019898; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Koblinsky M., 2003, REDUCING MATERNAL MO; KOBLINSKY MA, 1994, HEALTH POLICY PLANN, V9, P252, DOI 10.1093/heapol/9.3.252; Kosen S., 2014, UNIVERSAL MATERNAL H; Kumar S, 2014, APPL ECON, V46, P4091, DOI 10.1080/00036846.2014.950836; Lan CW, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1492-4; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; Mawarti Y, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1326-4; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Midhet F, 1998, SOC SCI MED, V46, P1587, DOI 10.1016/S0277-9536(97)10137-X; Nababan HY, 2018, INT J WOMENS HEALTH, V10, P11, DOI 10.2147/IJWH.S144828; National Academy of Sciences, 2013, RED MAT NEON MORT IN; National Research Council, 2013, RED MAT NEON MORT IN; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Rokx C, 2010, HLTH FINANCING INDON; Ronsmans C, 2009, B WORLD HEALTH ORGAN, V87, P416, DOI 10.2471/BLT.08.051581; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Scott S, 2013, TROP MED INT HEALTH, V18, P1193, DOI 10.1111/tmi.12175; Scott S, 2009, TROP MED INT HEALTH, V14, P1523, DOI 10.1111/j.1365-3156.2009.02402.x; Shiffman J, 2003, SOC SCI MED, V56, P1197, DOI 10.1016/S0277-9536(02)00119-3; Shrestha S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093029; Soemantri S, WORKSH TRAIN SP 2010; Statistics Indonesia National Population and Family Planning Board Ministry of Health of the Republic of Indonesia and ICF International, 2013, IND DEM HLTH SURV 20; Stover J, 2010, MATERN CHILD HLTH J, V14, P687, DOI 10.1007/s10995-009-0505-y; Sustainable Development Goals, 2015, GOAL 3 1 ENSURE HLTH; Taguchi N, 2003, PREGNANCY HYPERTENS, V2, P183; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tinker A, 1993, MAKING MOTHERHOOD SA; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; WHO UNICEF, 2013, TRENDS MAT MORT 1990	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217386	10.1371/journal.pone.0217386	http://dx.doi.org/10.1371/journal.pone.0217386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158243	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700014
J	Penningroth, SL; Scott, WD				Penningroth, Suzanna L.; Scott, Walter D.			Age-related differences in the goals and concerns that motivate real-life prospective memory tasks	PLOS ONE			English	Article							AVOIDANCE MOTIVATION; ORIENTATION; INTENTIONS; ADULTHOOD; SELECTION; YOUNG; COMPENSATION; OPTIMIZATION; PERSONALITY; RETRIEVAL	Prospective memory tasks are tasks that one must remember to perform in the future, such as keeping a dentist appointment or locking the door when leaving home. There has been little research to date on the question of what motivates real-life prospective memory tasks, and this is true both generally and within the subfield of aging and prospective memory. In the current study, we investigated whether the prospective memory tasks of younger and older adults were motivated by different personal goals and concerns, a question that has not been addressed in past research. Participants completed a questionnaire on current prospective memory tasks and the higher level goals and concerns that motivated these tasks. In general, younger and older adults reported prospective memory tasks motivated by different goals and concerns that reflected different social age systems or developmental tasks. Specifically, younger adults were more likely to report prospective memory tasks related to goals for education, profession, property, self, and leisure, and related to concerns about education and profession. In contrast, older adults were more likely to report prospective memory tasks related to concerns about world issues and war/terrorism. We also examined prospective memory task motivation more generally as approach motivation (goal-relatedness) and avoidance motivation (concern-relatedness). Both measures showed a gender by age group interaction. That is, older males showed especially low approach motivation and especially high avoidance motivation for their real-life prospective memory tasks. We suggest that a new approach to prospective memory research that incorporates motivational influences would enhance the ecological validity of prospective memory and aging research and may inform more effective memory interventions.	[Penningroth, Suzanna L.; Scott, Walter D.] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Washington State University	Penningroth, SL (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	s.penningroth@wsu.edu						Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; CANTOR N, 1991, J PERS, V59, P425, DOI 10.1111/j.1467-6494.1991.tb00255.x; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; Cook GI, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00278; CROSS S, 1991, HUM DEV, V34, P230, DOI 10.1159/000277058; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; Ebner NC, 2006, PSYCHOL AGING, V21, P664, DOI 10.1037/0882-7974.21.4.664; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 1997, J PERS SOC PSYCHOL, V73, P171, DOI 10.1037/0022-3514.73.1.171; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P3; Elliot AJ, 2010, J PERS, V78, P865, DOI 10.1111/j.1467-6494.2010.00636.x; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Emmons R. A., 1996, PSYCHOL ACTION LINKI, P313; Emmons RA, GOAL CONCEPTS PERSON, P7; Evans CD, 2009, PSYCHOL WOMEN QUART, V33, P235, DOI 10.1111/j.1471-6402.2009.01493.x; Fishbach A, 2004, J EXP SOC PSYCHOL, V40, P723, DOI 10.1016/j.jesp.2004.04.001; Freeman JE, 2003, INT J PSYCHOL, V38, P215, DOI 10.1080/00207590344000141; Freund AM, 2002, J PERS SOC PSYCHOL, V82, P642, DOI 10.1037//0022-3514.82.4.642; Gilbert SJ, 2015, Q J EXP PSYCHOL, V68, P971, DOI 10.1080/17470218.2014.972963; Gollwitzer P. M., 2008, PROSPECTIVE MEMORY C, P433; Gollwitzer P.M., 1996, PSYCHOL ACTION LINKI; Hagestad G. O., 1985, HDB AGING SOCIAL SCI, P35; Havighurst RJ, 1948, DEV TASKS ED, V3rd; Heckhausen J, 1997, DEV PSYCHOL, V33, P176, DOI 10.1037/0012-1649.33.1.176; Heimerdinger SR, 2008, HUM PERFORM, V21, P383, DOI 10.1080/08959280802347155; Helson R, 2002, J RES PERS, V36, P287, DOI 10.1016/S0092-6566(02)00010-7; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Higgins ET., 1996, PSYCHOL ACTION LINKI, P91; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Ihle A, 2012, AGING NEUROPSYCHOL C, V19, P84, DOI 10.1080/13825585.2011.629288; Kliegel M., 2008, PROSPECTIVE MEMORY C; Kliegel M., 2002, PSYCHOL BEITR, V44, P303; Kruglanski A.W., 1996, PSYCHOL ACTION LINKI, P599; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; Kvavilashvili Lia., 1996, PROSPECTIVE MEMORY T, P23; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Maylor EA, 2001, PSYCHON B REV, V8, P162, DOI 10.3758/BF03196153; Maylor EA, 2010, Q J EXP PSYCHOL, V63, P442, DOI 10.1080/17470210903469872; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Murty VP, 2011, LEARN MEMORY, V18, P712, DOI 10.1101/lm.023549.111; NURMI JE, 1992, PSYCHOL AGING, V7, P194, DOI 10.1037/0882-7974.7.2.194; NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6; NURMI JE, 1992, INT J BEHAV DEV, V15, P487, DOI 10.1177/016502549201500404; Ogilvie DM, 2001, BASIC APPL SOC PSYCH, V23, P207, DOI 10.1207/153248301750433768; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Penningroth S.L., 2007, PSYCHOL MOTIVATION, p(pp. 115; Penningroth SL, 2005, MEMORY, V13, P711, DOI 10.1080/09658210444000359; Penningroth SL, 2012, PSYCHOL OF MEMORY, P255; Penningroth SL, 2013, APPL COGNITIVE PSYCH, V27, P655, DOI 10.1002/acp.2945; Penningroth SL, 2012, INT J AGING HUM DEV, V74, P87, DOI 10.2190/AG.74.2.a; Phillips L. H., 2008, PROSPECTIVE MEMORY C, P161; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Saajanaho M, 2016, J GERONTOL B-PSYCHOL, V71, P1, DOI 10.1093/geronb/gbu094; Schnitzspahn K, 2018, PSYCHOL RES; Schnitzspahn KM, 2016, MEMORY, V24, P444, DOI 10.1080/09658211.2015.1018276; Shah JY, 2003, J PERS SOC PSYCHOL, V84, P1109, DOI 10.1037/0022-3514.84.6.1109; Sheeran P, 2005, PERS SOC PSYCHOL B, V31, P87, DOI 10.1177/0146167204271308; United States Census Bureau, 2011, STAT COUNT QUICK FAC; Uttl B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193806	68	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216888	10.1371/journal.pone.0216888	http://dx.doi.org/10.1371/journal.pone.0216888			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158234	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700003
J	Artuso, C; Palladino, P				Artuso, Caterina; Palladino, Paola			Long-term memory effects on working memory updating development	PLOS ONE			English	Article							BINDING; INHIBITION; SIMILARITY; COMPONENTS; KNOWLEDGE; CHILDREN	Long-term memory (LTM) associations appear as important to cognition as single memory contents. Previous studies on updating development have focused on cognitive processes and components, whereas our investigation examines how contents, associated with different LTM strength (strong or weak), might be differentially updated at different ages. To this end, we manipulated association strength of information given at encoding, in order to focus on updating pre-existing LTM associations; specifically, associations for letters. In particular, we controlled for letters usage frequency at the sub-lexical level. We used a task where we dissociated inhibition online (i.e., RTs for updating and controlling inhibition from the same set) and offline (i.e., RTs for controlling inhibition from previously updated sets). Mixed-effect analyses were conducted and showed a substantial behavioural cost when strong associations had to be dismantled online (i.e., longer RTs), compared to weak ones; here, in primary school age children. Interestingly, this effect was independent of age; in fact, children from 7-8 to 9-10 years were comparably sensitive to the strength of LTM associations in updating. However, older children were more effective in offline inhibitory control.	[Artuso, Caterina] Univ Urbino, Urbino, Italy; [Palladino, Paola] Univ Pavia, Pavia, Italy	University of Urbino; University of Pavia	Artuso, C (corresponding author), Univ Urbino, Urbino, Italy.	caterina.artuso@uniurb.it		Palladino, Paola/0000-0002-4131-911X; Artuso, Caterina/0000-0001-6938-3693	Blue Sky Research (BRS)	Blue Sky Research (BRS)	This work was supported by Blue Sky Research (BRS) 2017 Established Investigator awarded to PP. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Artuso C, 2018, MEM COGNITION, V46, P285, DOI 10.3758/s13421-017-0764-6; Artuso C, 2016, LEARN INDIVID DIFFER, V52, P53, DOI 10.1016/j.lindif.2016.10.008; Artuso C, 2016, COGN PROCESS, V17, P49, DOI 10.1007/s10339-015-0735-4; Artuso C, 2014, BRIT J PSYCHOL, V105, P226, DOI 10.1111/bjop.12024; Artuso C, 2011, ACTA PSYCHOL, V136, P363, DOI 10.1016/j.actpsy.2011.01.001; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bathelt J, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12579; Belacchi C, 2011, BRIT J DEV PSYCHOL, V29, P942, DOI 10.1111/j.2044-835X.2011.02030.x; Boujut A, 2016, MEMORY, V24, P1231, DOI 10.1080/09658211.2015.1091893; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Carriedo N, 2016, DEV PSYCHOL, V52, P666, DOI 10.1037/dev0000091; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2017, PSYCHON B REV, V24, P1158, DOI 10.3758/s13423-016-1191-6; Cowan N, 2014, J EXP PSYCHOL GEN, V143, P1806, DOI 10.1037/a0036814; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Mauro T., 1993, LESSICO FREQUENZA IT; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037/0278-7393.25.1.84; GATHERCOLE SE, 1994, J MEM LANG, V33, P672, DOI 10.1006/jmla.1994.1032; Hale S, 1997, DEV PSYCHOL, V33, P364, DOI 10.1037/0012-1649.33.2.364; Hulme C, 2003, J MEM LANG, V49, P500, DOI 10.1016/S0749-596X(03)00096-2; Lendinez C, 2014, Q J EXP PSYCHOL, V67, P16, DOI 10.1080/17470218.2013.793375; Lendinez C, 2011, MEM COGNITION, V39, P675, DOI 10.3758/s13421-010-0047-y; Lewis-Peacock JA, 2018, ANN NY ACAD SCI, V1424, P33, DOI 10.1111/nyas.13714; Linares R, 2016, J EXP CHILD PSYCHOL, V147, P39, DOI 10.1016/j.jecp.2016.02.009; Majerus S, 2003, BRIT J DEV PSYCHOL, V21, P303, DOI 10.1348/026151003765264101; Monnier C, 2011, BRIT J DEV PSYCHOL, V29, P929, DOI 10.1111/j.2044-835X.2010.02024.x; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; NAIRNE JS, 1990, MEM COGNITION, V18, P251, DOI 10.3758/BF03213879; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Oberauer K, 2005, J EXP PSYCHOL GEN, V134, P368, DOI 10.1037/0096-3445.134.3.368; Palladino P, 2001, MEM COGNITION, V29, P344, DOI 10.3758/BF03194929; Saint-Aubin J, 2005, PSYCHON B REV, V12, P171, DOI 10.3758/BF03196364; Schmiedek F, 2009, J EXP PSYCHOL LEARN, V35, P1089, DOI 10.1037/a0015730; Schneider W, 2000, COGNITIVE DEV, V15, P115, DOI 10.1016/S0885-2014(00)00024-1; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Taylor H. A., 2014, LECT NOTES COMPUTER, V8684, P14, DOI DOI 10.1007/978-3-319-11215-2_2; Thurstone L. L., 1963, PMA BATTERIA ATTITUD	42	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217697	10.1371/journal.pone.0217697	http://dx.doi.org/10.1371/journal.pone.0217697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150475	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100091
J	Umar, A; Ameh, CA; Muriithi, F; Mathai, M				Umar, Aminu; Ameh, Charles A.; Muriithi, Francis; Mathai, Matthews			Early warning systems in obstetrics: A systematic literature review	PLOS ONE			English	Review							VALIDATION; TOOL	Introduction Several versions of Early Warning Systems (EWS) are used in obstetrics to detect and treat early clinical deterioration to avert morbidity and mortality. EWS can potentially be useful to improve the quality of care and reduce the risk of maternal mortality in resource-limited settings. We conducted a systematic literature review of published obstetric early warning systems, define their predictive accuracy for morbidity and mortality, and their effectiveness in triggering corrective actions and improving health outcomes. Methods We systematically searched for primary research articles on obstetric EWS published in peer-reviewed journals between January 1997 and March 2018 in Medline, CINAHL, SCOPUS, Science Direct, and Science Citation Index. We also searched reference lists of relevant articles and websites of professional societies. We included studies that assessed the predictive accuracy of EWS to detect clinical deterioration, or/and their effectiveness in improving clinical outcomes in obstetric inpatients. We excluded studies with a paediatric or non-obstetric adult population. Cross-sectional and qualitative studies were also excluded. We performed a narrative synthesis since the outcomes reported were heterogeneous. Results A total of 381 papers were identified, 17 of which met the inclusion criteria. Eleven of the included studies evaluated the predictive accuracy of EWS for obstetric morbidity and mortality, 5 studies assessed the effectiveness of EWS in improving clinical outcomes, while one study addressed both. Sixteen published EWS versions were reviewed, 14 of which included five basic clinical observations (pulse rate, respiratory rate, temperature, blood pressure, and consciousness level). The obstetric EWS identified had very high median (inter-quartile range) sensitivity-89% (72% to 97%) and specificity-85% (67% to 98%) but low median (inter-quartile range) positive predictive values-41% (25% to 74%) for predicting morbidity or ICU admission. Obstetric EWS had a very high accuracy in predicting death (AUROC > 0.80) among critically ill obstetric patients. Obstetric EWS improves the frequency of routine vital sign observation, reduces the interval between the recording of specifically defined abnormal clinical observations and corrective clinical actions, and can potentially reduce the severity of obstetric morbidity. Conclusion Obstetric EWS are effective in predicting severe morbidity (in general obstetric population) and mortality (in critically ill obstetric patients). EWS can contribute to improved quality of care, prevent progressive obstetric morbidity and improve health outcomes. There is limited evidence of the effectiveness of EWS in reducing maternal death across all settings. Clinical parameters in most obstetric EWS versions are routinely collected in resource-limited settings, therefore implementing EWS may be feasible in such settings.	[Umar, Aminu; Ameh, Charles A.; Mathai, Matthews] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England; [Muriithi, Francis] Blackpool Teaching Hosp Natl Hlth Serv Fdn Trust, Blackpool, England	Liverpool School of Tropical Medicine	Ameh, CA (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England.	Charles.Ameh@lstmed.ac.uk	Ameh, Charles Anawo/I-9872-2019; Mathai, Matthews/F-8605-2017	Ameh, Charles Anawo/0000-0002-2341-7605; MURIITHI, FRANCIS GITHAE/0000-0002-2314-5611; Mathai, Matthews/0000-0002-7352-9330	Nigerian Petroleum Trust Development Fund (PTDF)	Nigerian Petroleum Trust Development Fund (PTDF)	No specific funding was provided for this review, but the review was undertaking as part of the doctoral thesis of the first author, sponsored by the Nigerian Petroleum Trust Development Fund (PTDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Austin DM, 2014, AUST NZ J OBSTET GYN, V54, P152, DOI 10.1111/ajo.12160; Betesh J, 2013, OBSTET EARLY WARNING; Carle C, 2013, ANAESTHESIA, V68, P354, DOI 10.1111/anae.12180; Edwards SE, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.007; Friedman AM, 2015, OBSTET GYN CLIN N AM, V42, P289, DOI 10.1016/j.ogc.2015.01.006; Hedriana HL, 2016, INT J GYNECOL OBSTET, V132, P337, DOI 10.1016/j.ijgo.2015.07.036; Isaacs RA, 2014, ANAESTHESIA, V69, P687, DOI 10.1111/anae.12708; Khan KS., 2001, 4 CRD, V2, DOI 1900640201; Lappen JR, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.040; Machiyama K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013903; Maguire PJ, 2016, INT J GYNECOL OBSTET, V133, P121, DOI 10.1016/j.ijgo.2015.09.014; Maguire PJ, 2015, AM J OBSTET GYNECOL, V213, P748, DOI 10.1016/j.ajog.2015.06.059; Maguire PJ, 2015, INT J GYNECOL OBSTET, DOI [10.1016/j.ijgo.2014.11, DOI 10.1016/J.IJGO.2014.11]; McClure JH, 2011, BRIT J ANAESTH, V107, P127, DOI 10.1093/bja/aer192; Merriel A, 2017, INT J GYNECOL OBSTET, V136, P175, DOI 10.1002/ijgo.12028; Moher D., 2009, J CHINESE INTEGRATIV; Morgan R.L, 1997, EARLY WARNING SCORIN; Nathan HL, 2018, PREGNANCY HYPERTENS, V12, P183, DOI 10.1016/j.preghy.2017.11.003; Paternina-Caicedo A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.103; Payne BA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001589; Popay J., 2006, PROD ESRC METHODS PR; Ryan HM, 2017, J OBSTET GYNAECOL CA, V39, P728, DOI 10.1016/j.jogc.2017.01.028; Sheikh S, 2017, J PAK MED ASS; Shields LE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.154; Singh A, 2016, EUR J OBSTET GYN R B, V207, P11, DOI 10.1016/j.ejogrb.2016.09.014; Singh S, 2012, ANAESTHESIA, V67, P12, DOI 10.1111/j.1365-2044.2011.06896.x; Smith GB, 2013, RESUSCITATION, DOI [10.1016/j.resuscitation.2012.12, DOI 10.1016/J.RESUSCITATION.2012.12]; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Wheeler I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059830; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	33	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217864	10.1371/journal.pone.0217864	http://dx.doi.org/10.1371/journal.pone.0217864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150513	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000469759100121
J	Vetter, SY; Privalov, M; Beisemann, N; Swartman, B; Keil, H; Kirsch, J; Grutzner, PA; Franke, J				Vetter, Sven Y.; Privalov, Maxim; Beisemann, Nils; Swartman, Benedict; Keil, Holger; Kirsch, Joachim; Gruetzner, Paul Alfred; Franke, Jochen			Influence of ankle joint position on angles and distances of the ankle mortise using intraoperative cone beam CT: A cadaveric study	PLOS ONE			English	Article							TIBIOFIBULAR SYNDESMOSIS; COMPUTED-TOMOGRAPHY; FOOT; FRACTURES; ISO-C-3D; ALIGNMENT; FIXATION; SURGERY; IMPACT; CARE	Background The precise anatomical reduction of the ankle mortise is crucial for the clinical outcome in unstable syndesmotic injuries. Intraoperative cone beam computed tomography (CT), in addition to two-dimensional fluoroscopy, provides detailed information about the reduction and implant placement. The aim of this study was to analyze the influence of the joint position on the fibula position in the incisural notch and to determine the inter-and intraindividual anatomical differences in the intact ankle joints. Methods A total of 20 fresh-frozen lower legs disarticulated in the knee joint of 10 individuals were included. The measurements were performed using a cone beam CT. The distances and angles were measured in the standard imaging planes. The mean values of distances and angles were compared during the different joint positions: 10 degrees dorsiflexion, 0 degrees neutral position and 20 degrees plantar flexion. Results The influence of the joint position was on average as follows: The anterior tibiofibular distance was 3.68 mm in 10 degrees dorsiflexion, 3.66 mm (0 degrees neutral position) and 3.59 mm (20 degrees plantar flexion). The posterior tibiofibular distance measured 7.82mm, 7.76mm and 7.82mm. The rotation of the fibula measured ten millimeters proximal the joint line was 1.2 degrees, 1.3 degrees and 1.05 degrees. The fibular rotation determined 4mm was 9.3 degrees, 9.4 degrees and 9.4 degrees. On average, the following intraindividual variations were observed: superior tibiotalar clear space of 0.27mm and 0.15mm medial; and anterior tibiofibular distance of 0.42mm, 0.38mm posterior and 0.24mm in the incisural notch. The proximal angle of the fibular rotation was 0.2 degrees and distal 0.4 degrees. The interindividual variations of the angles and distances exceeded the intraindividual values partly by 3 to 4 fold. Conclusions Within the scope of this study neither the tibiofibular distance, nor the tibiofibular angle changed significantly through the different joint positions. The intraindividual differences were little while the interindividual variations of the parameters were distinctive.	[Vetter, Sven Y.; Privalov, Maxim; Beisemann, Nils; Swartman, Benedict; Keil, Holger; Gruetzner, Paul Alfred; Franke, Jochen] Heidelberg Univ Hosp, BG Trauma Ctr Ludwigshafen, Ludwigshafen, Germany; [Kirsch, Joachim] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Franke, J (corresponding author), Heidelberg Univ Hosp, BG Trauma Ctr Ludwigshafen, Ludwigshafen, Germany.	jochen.franke@bgu-ludwigshafen.de	Keil, Holger/AAE-1264-2020	Keil, Holger/0000-0002-5006-8420; Franke, Jochen/0000-0003-3755-7948				Atesok K, 2007, INJURY, V38, P1163, DOI 10.1016/j.injury.2007.06.014; Barg A, 2018, FOOT ANKLE INT, V39, P376, DOI 10.1177/1071100717740330; Belatti DA, 2014, FOOT ANKLE INT, V35, P334, DOI 10.1177/1071100713519777; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; DESOUZA LJ, 1985, J BONE JOINT SURG AM, V67A, P1066, DOI 10.2106/00004623-198567070-00010; Elgafy H, 2010, SKELETAL RADIOL, V39, P559, DOI 10.1007/s00256-009-0809-4; Franke J, 2013, UNFALLCHIRURG, V116, P185, DOI 10.1007/s00113-013-2359-4; Franke J, 2011, TRAUMA BERUFSKRANKH, V13, P160, DOI 10.1007/s10039-011-1750-z; Franke J, 2012, J BONE JOINT SURG AM, V94A, P1386, DOI 10.2106/JBJS.K.01122; Geerling J, 2009, J TRAUMA, V66, P768, DOI 10.1097/TA.0b013e31816275c7; Grifka J., 2011, ORTHOPADIE UNFALLCHI, VXIII; Hermans JJ, 2010, J ANAT, V217, P633, DOI 10.1111/j.1469-7580.2010.01302.x; Kendoff D, 2009, J TRAUMA, V66, P232, DOI 10.1097/TA.0b013e31815ede5d; Kuo CC, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-131; Lintz F, 2017, FOOT ANKLE INT, V38, P684, DOI 10.1177/1071100717690806; Lintz Francois, 2012, Foot Ankle Surg, V18, P9, DOI 10.1016/j.fas.2011.01.003; Moon SW, 2014, J ORTHOP SCI, V19, P125, DOI 10.1007/s00776-013-0475-1; Nault ML, 2017, FOOT ANKLE INT, V38, P215, DOI 10.1177/1071100716674309; RAMSEY PL, 1976, J BONE JOINT SURG AM, V58, P356, DOI 10.2106/00004623-197658030-00010; Richter M, 2005, J ORTHOP TRAUMA, V19, P259, DOI 10.1097/01.bot.0000151822.10254.db; Richter M, 2009, J ORTHOP TRAUMA, V23, P213, DOI 10.1097/BOT.0b013e31819867f6; Rubberdt A, 2006, UNFALLCHIRURG, V109, P112, DOI 10.1007/s00113-005-1015-z; Scharf H-P, 2011, ORTHOPADIE UNFALLCHI, VXIV; Stephan D, 2014, COMPUT METHOD BIOMEC, V17, P1635, DOI 10.1080/10255842.2012.759564; Summers HD, 2013, J ORTHOP TRAUMA, V27, P196, DOI 10.1097/BOT.0b013e3182694766; Thakore RV, 2015, DISABIL REHABIL, V37, P417, DOI 10.3109/09638288.2014.923525; Thordarson DB, 1997, J BONE JOINT SURG AM, V79A, P1809, DOI 10.2106/00004623-199712000-00006; Tochigi Y, 2006, FOOT ANKLE INT, V27, P82, DOI 10.1177/107110070602700202; Vetter S., 2013, ORTHOP UNFALLCHIR UP, V7, P467, DOI [10.1055/s-0032-1324884, DOI 10.1055/S-0032-1324884]; Vetter SY, 2016, FOOT ANKLE INT, V37, P977, DOI 10.1177/1071100716650532; XENOS JS, 1995, J BONE JOINT SURG AM, V77A, P847, DOI 10.2106/00004623-199506000-00005; Zwaag H, 2015, ADV COMPUT TOMOGR, V4, P9, DOI [10.4236/act.2015.41002, DOI 10.4236/ACT.2015.41002]	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217737	10.1371/journal.pone.0217737	http://dx.doi.org/10.1371/journal.pone.0217737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150469	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100093
J	Kamathewatta, KI; Bushell, RN; Young, ND; Stevenson, MA; Billman-Jacobe, H; Browning, GF; Marenda, MS				Kamathewatta, Kanishka Indiwari; Bushell, Rhys Nathan; Young, Neil David; Stevenson, Mark Anthony; Billman-Jacobe, Helen; Browning, Glenn Francis; Marenda, Marc Serge			Exploration of antibiotic resistance risks in a veterinary teaching hospital with Oxford Nanopore long read sequencing	PLOS ONE			English	Article							GENES; PREVALENCE; INTEGRONS; BACTERIA; COMPLEX; DESIGN	The Oxford Nanopore MinION DNA sequencing device can produce large amounts of long sequences, typically several kilobases, within a few hours. This long read capacity was exploited to detect antimicrobial resistance genes (ARGs) in a large veterinary teaching hospital environment, and to assess their taxonomic origin, genetic organisation and association with mobilisation markers concurrently. Samples were collected on eight occasions between November 2016 and May 2017 (inclusive) in a longitudinal study. Nanopore sequencing was performed on total DNA extracted from the samples after a minimal enrichment step in broth. Many ARGs present in the veterinary hospital environment could potentially confer resistance to antimicrobials widely used in treating infections of companion animals, including aminoglycosides, extended-spectrum beta-lactams, sulphonamides, macrolides, and tetracyclines. High-risk ARGs, defined here as single or multiple ARGs associated with pathogenic bacterial species or with mobile genetic elements, were shared between the intensive care unit (ICU) patient cages, a dedicated laundry trolley and a floor cleaning mop-bucket. By contrast, a floor surface from an office corridor without animal contact and located outside the veterinary hospital did not contain such high-risk ARGs. Relative abundances of high-risk ARGs and co-localisation of these genes on the same sequence read were higher in the laundry trolley and mop bucket samples, compared to the ICU cages, suggesting that amplification of ARGs is likely to occur in the collection points for hospital waste. These findings have prompted the implementation of targeted intervention measures in the veterinary hospital to mitigate the risks of transferring clinically important ARGs between sites and to improve biosecurity practices in the facility.	[Kamathewatta, Kanishka Indiwari; Bushell, Rhys Nathan; Young, Neil David; Marenda, Marc Serge] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Werribee, Vic, Australia; [Stevenson, Mark Anthony; Billman-Jacobe, Helen; Browning, Glenn Francis] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Marenda, MS (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Werribee, Vic, Australia.	mmarenda@unimelb.edu.au	Young, Neil David/AAU-4572-2020; Browning, Glenn/P-4459-2014	Young, Neil David/0000-0001-8756-229X; Browning, Glenn/0000-0002-0903-2469; MARENDA, MARC/0000-0001-6778-1110				Benedict KM, 2008, JAVMA-J AM VET MED A, V233, P767, DOI 10.2460/javma.233.5.767; Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; Cusco A, 2017, USING MINION CHARACT, DOI [10.1101/167015, DOI 10.1101/167015]; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hayashi H, 2004, MICROBIOL IMMUNOL, V48, P1, DOI 10.1111/j.1348-0421.2004.tb03481.x; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunt M, 2013, PYTHON3 SCRIPTS MANI; Ito R, 2017, MBIO, V8, DOI 10.1128/mBio.00749-17; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kraken Wood D., 2014, KRAKEN TAXONOMIC SEQ; Krueger F., 2017, TRIM GALORE; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Leggett R. M., 2017, BIORXIV, DOI [10.1101/180406, DOI 10.1101/180406]; Leggett RM, 2017, J EXP BOT, V68, P5419, DOI 10.1093/jxb/erx289; Legione AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194881; Li CH, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0140-7; Li H, 2016, TOOLKIT PROCESSING S; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Luby E, 2016, J ENVIRON QUAL, V45, P441, DOI 10.2134/jeq2015.07.0367; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Marx V, 2015, NAT METHODS, V12, P1015, DOI 10.1038/nmeth.3625; Mendonca N, 2009, DIAGN MICR INFEC DIS, V63, P334, DOI 10.1016/j.diagmicrobio.2008.11.005; Moura A, 2012, RES MICROBIOL, V163, P92, DOI 10.1016/j.resmic.2011.10.010; Noyes NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24645; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Pitta DW, 2016, FOODBORNE PATHOG DIS, V13, P296, DOI 10.1089/fpd.2015.2092; Rodriguez-Martinez JM, 2013, J ANTIMICROB CHEMOTH, V68, P68, DOI 10.1093/jac/dks377; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seemann T., 2017, ABRICATE MASS SCREEN; Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29681; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Thijs S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00494; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; van der Helm E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1328; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Walsh TR, 1998, ANTIMICROB AGENTS CH, V42, P436; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Wang FH, 2014, ENVIRON SCI TECHNOL, V48, P9079, DOI 10.1021/es502615e; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; Wichmann F, 2014, MBIO, V5, DOI 10.1128/mBio.01017-13; Wick R., 2017, FAST5 TO FASTQ SIMPL; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]; Yuan JY, 2012, J ANTIMICROB CHEMOTH, V67, P1655, DOI 10.1093/jac/dks086; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarnayova M, 2005, ANTIMICROB AGENTS CH, V49, P3066, DOI 10.1128/AAC.49.7.3066-3069.2005; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	66	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217600	10.1371/journal.pone.0217600	http://dx.doi.org/10.1371/journal.pone.0217600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145757	Green Published, gold			2022-12-27	WOS:000469425500025
J	Moreno-Peral, P; Conejo-Ceron, S; Fernandez, A; Martin-Perez, C; Fernandez-Alonso, C; Rodriguez-Bayon, A; Ballesta-Rodriguez, MI; Aiarzaguena, JM; Monton-Franco, C; King, M; Nazareth, I; Bellon, JA				Moreno-Peral, Patricia; Conejo-Ceron, Sonia; Fernandez, Anna; Martin-Perez, Carlos; Fernandez-Alonso, Carmen; Rodriguez-Bayon, Antonina; Isabel Ballesta-Rodriguez, Maria; Maria Aiarzaguena, Jose; Monton-Franco, Carmen; King, Michael; Nazareth, Irwin; Angel Bellon, Juan			Family physicians' views on participating in prevention of major depression. The predictD-EVAL qualitative study	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH-CARE; ALGORITHM; ONSET; INTERVENTIONS; VALIDATION; RISK	Background The predictD intervention, a multicomponent intervention delivered by family physicians (FPs), reduced the incidence of major depression by 21% versus the control group and was cost-effective. A qualitative methodology was proposed to identify the mechanisms of action of these complex interventions. Purpose To seek the opinions of these FPs on the potential successful components of the predictD intervention for the primary prevention of depression in primary care and to identify areas for improvement. Method Qualitative study with FPs who delivered the predictD intervention at 35 urban primary care centres in seven Spanish cities. Face-to-face semi-structured interviews adopting a phenomenological approach. The data was triangulated by three investigators using thematic analysis and respondent validation was carried out. Results Sixty-seven FPs were interviewed and they indicated strategies used to perform the predictD intervention, including specific communication skills such as empathy and the activation of patient resources. They perceived barriers such as lack of time and facilitators such as prior acquaintance with patients. FPs recognized the positive consequences of the intervention for FPs, patients and the doctor-patient relationship. They also identified strategies for future versions and implementations of the predictD intervention. Conclusions The FPs who carried out the predictD intervention identified factors potentially associated with successful prevention using this program and others that could be improved. Their opinions about the predictD intervention will enable development of a more effective and acceptable version and its implementation in different primary health care settings.	[Moreno-Peral, Patricia; Conejo-Ceron, Sonia; Angel Bellon, Juan] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Moreno-Peral, Patricia; Conejo-Ceron, Sonia; Angel Bellon, Juan] Dist Sanitario Malaga Guadalhorce, Malaga, Spain; [Moreno-Peral, Patricia; Conejo-Ceron, Sonia; Angel Bellon, Juan] Red Invest Actividades Prevent & Promoc Salud red, Barcelona, Spain; [Fernandez, Anna] Fundacio St Joan Deu, Parc Sanitari St Joan Deu, Barcelona, Spain; [Fernandez, Anna] Ctr Invest Biomed Red Epidemiol & Salud Publ, CIBERESP, Barcelona, Spain; [Martin-Perez, Carlos] Serv Andaluz Salud, Ctr Salud Marquesado, Granada, Spain; [Fernandez-Alonso, Carmen] Reg Hlth Management Valladolid, Serv Assistance Programs, Valladolid, Spain; [Rodriguez-Bayon, Antonina] Serv Andaluz Salud, Ctr Salud San Jose, Jaen, Spain; [Isabel Ballesta-Rodriguez, Maria] Serv Andaluz Salud, Ctr Salud Federico Castillo, Jaen, Spain; [Maria Aiarzaguena, Jose] Osakidetza, Primary Care Res Unit, Ctr Salud San Ignacio, Bilbao, Spain; [Monton-Franco, Carmen] Ctr Salud Casablanca, Zaragoza, Spain; [Monton-Franco, Carmen] IIS Aragon, Aragonese Inst Hlth Sci, Zaragoza, Spain; [Monton-Franco, Carmen] Univ Zaragoza, Dept Med & Psiquiatria, Zaragoza, Spain; [King, Michael] UCL, Fac Brain Sci, Div Psychiat, London, England; [King, Michael] UCL, PRIMENT Clin Trials Unit, London, England; [Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England; [Angel Bellon, Juan] Serv Andaluz Salud, Ctr Salud El Palo, Malaga, Spain; [Angel Bellon, Juan] Univ Malaga, Dept Salud Publ & Psiquiatria, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Zaragoza; University of London; University College London; University of London; University College London; University of London; University College London; Universidad de Malaga	Moreno-Peral, P (corresponding author), Inst Invest Biomed Malaga IBIMA, Malaga, Spain.; Moreno-Peral, P (corresponding author), Dist Sanitario Malaga Guadalhorce, Malaga, Spain.; Moreno-Peral, P (corresponding author), Red Invest Actividades Prevent & Promoc Salud red, Barcelona, Spain.	predictmalaga@hotmail.com	Conejo-CerÃn, Sonia/ABH-2992-2020; Moreno-Peral, Patricia/I-3594-2012; PRISMA, Grupo/AAI-6753-2021	Moreno-Peral, Patricia/0000-0003-4130-9090; Conejo Ceron, Sonia/0000-0002-1357-2281	Spanish Ministry of Health; Institute of Health Carlos III; European Regional Development Fund "Una manera de hacer Europa" [PI12/02755]; Andalusian Council of Health [0583/2012]; Prevention and Health Promotion Research Network 'redIAPP' [RD16/0007]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); European Regional Development Fund "Una manera de hacer Europa"; Andalusian Council of Health; Prevention and Health Promotion Research Network 'redIAPP'	This study was supported by the Spanish Ministry of Health, the Institute of Health Carlos III, and the European Regional Development Fund "Una manera de hacer Europa" (grant FIS reference: PI12/02755) (www.isciii.es) and the Andalusian Council of Health (grant reference: 0583/2012); as well as the Prevention and Health Promotion Research Network 'redIAPP' (RD16/0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellon JA, 2007, FAM PRACT, V24, P562, DOI 10.1093/fampra/cmm059; Bellon JA, 2016, ANN INTERN MED, V164, P656, DOI 10.7326/M14-2653; Bellon JA, 2015, PREV MED, V76, pS22, DOI 10.1016/j.ypmed.2014.11.003; Bellon JA, 2011, PSYCHOL MED, V41, P2075, DOI 10.1017/S0033291711000468; Bellon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092008; Bellon JA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-171; Borkan J, 2010, HEALTH AFFAIR, V29, P1432, DOI 10.1377/hlthaff.2010.0023; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Conejo-Ceron S, 2017, ANN FAM MED, V15, P262, DOI 10.1370/afm.2031; Damman OC, 2018, PATIENT EDUC COUNS, V101, P1410, DOI 10.1016/j.pec.2018.03.015; De Waal MWM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-5; Doherty W J, 1986, Fam Med, V18, P153; Dowrick CF, 2000, BRIT J GEN PRACT, V50, P361; Dwamena F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003267.pub2; England MJ, 2015, PSYCHOSOCIAL INTERVE; Fernandez A, 2018, AUST NZ J PSYCHIAT, V52, P47, DOI 10.1177/0004867417704506; Fernandez A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1005-y; Guest G., 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hinchey SA, 2011, J GEN INTERN MED, V26, P588, DOI 10.1007/s11606-010-1620-6; Husk K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0269-6; Karmali KN, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006887.pub4; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Lasser KE, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-49; McDaniel S., 2004, FAMILY ORIENTED PRIM, V2; Moreno-Peral P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125004; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Nigatu YT, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0971-x; Pope C., 2020, QUALITATIVE RES HLTH; Pryor K, 2018, NEW ENGL J MED, V378, P1761, DOI 10.1056/NEJMp1716272; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Saldivia S, 2014, REV MED CHILE, V142, P323, DOI 10.4067/S0034-98872014000300006; Salvador-Carulla L, 2010, J MENT HEALTH POLICY, V13, P73; Saulsberry A, 2013, J CAN ACAD CHILD ADO, V22, P106; Stewart M., 2013, PATIENT CTR MED TRAN; Stuart MR, 1993, 15 MINUTE HOUR APPL; Van Voorhees BW, 2008, ANN FAM MED, V6, P503, DOI 10.1370/afm.887; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; Wang JL, 2014, J EPIDEMIOL COMMUN H, V68, P418, DOI 10.1136/jech-2013-202845	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217621	10.1371/journal.pone.0217621	http://dx.doi.org/10.1371/journal.pone.0217621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145762	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500027
J	Yabe, SG; Nishida, J; Fukuda, S; Takeda, F; Nasiro, K; Yasuda, K; Iwasaki, N; Okochi, H				Yabe, Shigeharu G.; Nishida, Junko; Fukuda, Satsuki; Takeda, Fujie; Nasiro, Kiyoko; Yasuda, Kazuki; Iwasaki, Naoko; Okochi, Hitoshi			Expression of mutant mRNA and protein in pancreatic cells derived from MODY3-iPS cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; LOSS-OF-FUNCTION; TRANSCRIPTION FACTORS; BETA-CELLS; MUTATIONS; GENE; DECAY; HNF-1-ALPHA; INDUCTION	Maturity-onset diabetes of the young (MODY) is a heterozygous monogenic diabetes; more than 14 disease genes have been identified. However, the pathogenesis of MODY is not fully understood because the patients' pancreatic beta cells are inaccessible. To elucidate the pathology of MODY, we established MODY3 patient-derived iPS (MODY3-iPS) cells using non-integrating Sendai virus (SeV) vector and examined the mutant mRNA and protein of HNF1A (Hepatocyte Nuclear factor 1A) after pancreatic lineage differentiation. Our patient had a cytosine insertion in the HNF1A gene (P291fsinsC) causing frameshift and making a premature termination codon (PTC). We confirmed these MODY3-iPS cells possessed the characteristics of pluripotent stem cells. After we differentiated them into pancreatic beta cells, transcripts of HNF1A gene were cloned and sequenced. We found that P291fsinsC mutant transcripts were much less frequent than wild ones, but they increased after adding cycloheximide (CHX) to the medium. These results suggested that mutant mRNA was destroyed by nonsense-mediated mRNA decay (NMD). Moreover, we were not able to detect any band of mutant proteins in pancreatic lineage cells which were differentiated from MODY3-iPSCs by western blot (WB) analysis. A scarcity of the truncated form of mutant protein may indicate that MODY3 might be caused by a haplo-insufficiency effect rather than a dominant negative manner.	[Yabe, Shigeharu G.; Nishida, Junko; Fukuda, Satsuki; Takeda, Fujie; Nasiro, Kiyoko; Okochi, Hitoshi] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Metab Disorders, Tokyo, Japan; [Iwasaki, Naoko] Tokyo Womens Med Univ, Inst Med Genet, Diabet Ctr, Inst Geriatr, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University	Yabe, SG; Okochi, H (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan.	syabe@ri.ncgm.go.jp; hokochi@ri.ncgm.go.jp			National Center for Global Health and Medicine [27A1201, 29A1016]; MEXT [22510214]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the National Center for Global Health and Medicine (27A1201) to HO and (29A1016) to SGY. This work was also partially supported by a Grant-in-Aid (22510214) for Scientific Research from the MEXT to N.I.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Braverman-Gross C, 2018, STEM CELL RES, V31, P16, DOI 10.1016/j.scr.2018.06.013; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gu N, 2004, BIOCHEM BIOPH RES CO, V325, P308, DOI 10.1016/j.bbrc.2004.10.027; Gu N, 2006, BIOCHEM BIOPH RES CO, V346, P1016, DOI 10.1016/j.bbrc.2006.06.010; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Okita K, 1999, BIOCHEM BIOPH RES CO, V263, P566, DOI 10.1006/bbrc.1999.1412; Owen KR, 2018, CURR OPIN GENET DEV, V50, P103, DOI 10.1016/j.gde.2018.04.006; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sujjitjoon J., 2008, THAI J GENETICS, V1, P93; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Teo AKK, 2016, STEM CELL REP, V6, P357, DOI 10.1016/j.stemcr.2016.01.007; Timsit J, 2016, CAN J DIABETES, V40, P455, DOI 10.1016/j.jcjd.2015.12.005; Tomura H, 1999, J BIOL CHEM, V274, P12975, DOI 10.1074/jbc.274.19.12975; Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107; Vaxillaire M, 1999, J BIOL CHEM, V274, P35639, DOI 10.1074/jbc.274.50.35639; Vethe H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04979-w; Yabe SG, 2019, INT J DEV BIOL; Yabe SG, 2019, REGEN THER, V10, P69, DOI 10.1016/j.reth.2018.11.003; Yabe SG, 2017, J DIABETES, V9, P168, DOI 10.1111/1753-0407.12400; Yabe SG, 2015, J DIABETES INVEST, V6, P543, DOI 10.1111/jdi.12334; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang Q, 1999, BIOCHEM BIOPH RES CO, V266, P196, DOI 10.1006/bbrc.1999.1747; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217110	10.1371/journal.pone.0217110	http://dx.doi.org/10.1371/journal.pone.0217110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145732	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500012
J	Krysztofiak, H; Mlynczak, M; Malek, LA; Folga, A; Braksator, W				Krysztofiak, Hubert; Mlynczak, Marcel; Malek, Lukasz A.; Folga, Andrzej; Braksator, Wojciech			Left ventricular mass is underestimated in overweight children because of incorrect body size variable chosen for normalization	PLOS ONE			English	Article							CARDIAC GEOMETRY; BLOOD-PRESSURE; SURFACE AREA; OBESITY; HYPERTROPHY; ADOLESCENTS; IMPACT; ADULTS; ASSOCIATION; LIMITATIONS	Background Left ventricular mass normalization for body size is recommended, but a question remains: what is the best body size variable for this normalization-body surface area, height or lean body mass computed based on a predictive equation? Since body surface area and computed lean body mass are derivatives of body mass, normalizing for them may result in underestimation of left ventricular mass in overweight children. The aim of this study is to indicate which of the body size variables normalize left ventricular mass without underestimating it in overweight children. Methods Left ventricular mass assessed by echocardiography, height and body mass were collected for 464 healthy boys, 5-18 years old. Lean body mass and body surface area were calculated. Left ventricular mass z-scores computed based on reference data, developed for height, body surface area and lean body mass, were compared between overweight and non- overweight children. The next step was a comparison of paired samples of expected left ventricular mass, estimated for each normalizing variable based on two allometric equations-the first developed for overweight children, the second for children of normal body mass. Results The mean of left ventricular mass z-scores is higher in overweight children compared to non-overweight children for normative data based on height (0.36 vs. 0.00) and lower for normative data based on body surface area (-0.64 vs. 0.00). Left ventricular mass estimated normalizing for height, based on the equation for overweight children, is higher in overweight children (128.12 vs. 118.40); however, masses estimated normalizing for body surface area and lean body mass, based on equations for overweight children, are lower in overweight children (109.71 vs. 122.08 and 118.46 vs. 120.56, respectively). Conclusion Normalization for body surface area and for computed lean body mass, but not for height, underestimates left ventricular mass in overweight children.	[Krysztofiak, Hubert] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Krysztofiak, Hubert; Folga, Andrzej] Natl Ctr Sports Med, Warsaw, Poland; [Mlynczak, Marcel] Warsaw Univ Technol, Inst Metrol & Biomed Engn, Fac Mechatron, Warsaw, Poland; [Malek, Lukasz A.] Jozef Pilsudski Univ Phys Educ, Fac Rehabil, Warsaw, Poland; [Braksator, Wojciech] Med Univ Warsaw, Med Fac 2, Dept Sports Cardiol & Noninvas Cardiovasc Imaging, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology; Jozef Pilsudski University Physical Education in Warsaw; Medical University of Warsaw	Krysztofiak, H (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.; Krysztofiak, H (corresponding author), Natl Ctr Sports Med, Warsaw, Poland.	hkrysztofiak@imdik.pan.pl	Młyńczak, Marcel/L-1509-2016; Krysztofiak, Hubert/L-8083-2019; Braksator, Wojciech/N-2197-2018	Młyńczak, Marcel/0000-0001-8549-7973; Krysztofiak, Hubert/0000-0003-4567-1433; Braksator, Wojciech/0000-0003-2201-4887; Malek, Lukasz/0000-0002-9586-0163				Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Braley KT, 2017, ECHOCARDIOGR-J CARD, V34, P1029, DOI 10.1111/echo.13565; Cantinotti M, 2014, J AM SOC ECHOCARDIOG, V27, P339, DOI 10.1016/j.echo.2013.12.002; Chinali M, 2006, J AM COLL CARDIOL, V47, P2267, DOI 10.1016/j.jacc.2006.03.004; Chirinos JA, 2010, HYPERTENSION, V56, P91, DOI 10.1161/HYPERTENSIONAHA.110.150250; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dai S, 2009, AM J PREV MED, V37, pS97, DOI 10.1016/j.amepre.2009.04.011; Dallaire F, 2015, PEDIATR CARDIOL, V36, P667, DOI 10.1007/s00246-014-1063-7; DANIELS SR, 1995, CIRCULATION, V92, P3249, DOI 10.1161/01.CIR.92.11.3249; de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Devuyst O, 2014, PERITON DIALYSIS INT, V34, P685, DOI 10.3747/pdi.2014.00272; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Foster BJ, 2016, J AM SOC ECHOCARDIOG, V29, P441, DOI 10.1016/j.echo.2015.12.011; Foster BJ, 2013, J AM SOC ECHOCARDIOG, V26, P410, DOI 10.1016/j.echo.2012.11.018; Foster BJ, 2012, ANN HUM BIOL, V39, P171, DOI 10.3109/03014460.2012.681800; GEORGESON L, 2017, BMJ OPEN SPORT EXERC, V3, DOI DOI 10.1136/BMJSEM-2017; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Ippisch HM, 2008, J AM COLL CARDIOL, V51, P1342, DOI 10.1016/j.jacc.2007.12.029; Janz KF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e63; Jing L, 2017, J CARDIOVASC MAGN R, V19, P1, DOI [10.1186/s12968-016-0318-2, DOI 10.1186/s12968-016-0318-2]; Kharod AM, 2014, PEDIATR CARDIOL, V35, P353, DOI 10.1007/s00246-013-0782-5; Kinoshita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140573; Kuch B, 2001, J HYPERTENS, V19, P135, DOI 10.1097/00004872-200101000-00018; Lopez L, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006979; Mahgerefteh J, 2016, PEDIATR CARDIOL, V37, P993, DOI 10.1007/s00246-016-1380-0; Majonga ED, 2017, INT J CARDIOL, V248, P409, DOI 10.1016/j.ijcard.2017.06.109; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mangner N, 2014, JACC-CARDIOVASC IMAG, V7, P1198, DOI 10.1016/j.jcmg.2014.08.006; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mawad W, 2013, J AM SOC ECHOCARDIOG, V26, P29, DOI 10.1016/j.echo.2012.09.021; Movahed MR, 2009, OBESITY, V17, P606, DOI 10.1038/oby.2008.563; Movahed MR, 2011, ECHOCARDIOGR-J CARD, V28, P150, DOI 10.1111/j.1540-8175.2010.01289.x; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Pressler A, 2012, EUR J PREV CARDIOL, V19, P1194, DOI 10.1177/1741826711422455; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Stiefel EC, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116629368; Whalley GA, 2004, J AM COLL CARDIOL, V44, P892, DOI 10.1016/j.jacc.2004.04.051; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Woodiwiss AJ, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0539-z	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217637	10.1371/journal.pone.0217637	http://dx.doi.org/10.1371/journal.pone.0217637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141818	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000070
J	Baiocchi, M; Friedberg, R; Rosenman, E; Amuyunzu-Nyamongo, M; Oguda, G; Otieno, D; Sarnquist, C				Baiocchi, Michael; Friedberg, Rina; Rosenman, Evan; Amuyunzu-Nyamongo, Mary; Oguda, Gabriel; Otieno, Dorothy; Sarnquist, Clea			Prevalence and risk factors for sexual assault among class 6 female students in unplanned settlements of Nairobi, Kenya: Baseline analysis from the IMPower & Sources of Strength cluster randomized controlled trial	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SELF-EFFICACY; BYSTANDER BEHAVIOR; PREVENTION; WOMEN; EMPOWERMENT	Background Gender-based violence (GBV) is a crucial global health problem among all age groups, including adolescents. This study describes incidences of GBV, as well as factors associated with sexual assault, among female adolescents in class six living in urban informal settlements in Nairobi, Kenya. Methods Study participants were interviewed using a structured survey instrument focusing on experiences of GBV, including emotional, physical, and sexual violence, and corresponding perpetrators, as well as gender attitudes, alcohol use, self-efficacy, and previous sexual experiences. Summary statistics and clustered bootstrap confidence intervals were calculated for social behaviors and violence rates. Stepwise logistic regression identified variables associated with an adolescent's experience of sexual assault. Findings In this population 7.2% of adolescent girls reported being raped in the prior twelve months, with 11-1% of these rape victims reporting over five experiences. Among the 21.3% who report having had a boyfriend, 38-1% reported emotional, physical, and/or sexual intimate partner violence (IPV). Boyfriends were identified most often as perpetrators, accounting for 46.3% of reported lifetime rapes. Previous experience of physical (p = <0.001) or emotional (p<0.001) IPV and home violence (p<0.001) were risk factors for being raped, while high self-efficacy (p<0.001) was a protective factor. Interpretation Sexual assault and GBV are major challenges in this highly-disadvantaged population. Novel prevention efforts are needed for this age group, as prevention is often targeted at older adolescents. Prevention efforts should focus on assaults by perpetrators known to adolescents, especially boyfriends, and may need to account for the adolescents' previous experience of, and exposure to, violence.	[Baiocchi, Michael] Stanford Prevent Res Ctr, Palo Alto, CA USA; [Baiocchi, Michael; Friedberg, Rina; Rosenman, Evan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Amuyunzu-Nyamongo, Mary; Oguda, Gabriel; Otieno, Dorothy] Africa Inst Hlth & Dev, Nairobi, Kenya; [Sarnquist, Clea] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Sarnquist, C (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	cleas@stanford.edu			What Works to Prevent Violence Innovation Grant through the South African Medical Research Council [52069]; National Defense Science and Engineering Graduate (NDSEG) Fellowship via Department of Defense, Air Force Office of Scientific Research [32 CFR 168a]	What Works to Prevent Violence Innovation Grant through the South African Medical Research Council; National Defense Science and Engineering Graduate (NDSEG) Fellowship via Department of Defense, Air Force Office of Scientific Research	This work was supported by the What Works to Prevent Violence Innovation Grant (#52069) through the South African Medical Research Council (http://www.hpcsa.co.za/) to MB, CS and the National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a via Department of Defense, Air Force Office of Scientific Research (https://ndseg.asee.org/) to RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2014, LANCET, V383, P1648, DOI 10.1016/S0140-6736(13)62243-6; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Austin MJM, 2016, VIOLENCE AGAINST WOM, V22, P90, DOI 10.1177/1077801215597790; Baiocchi M, 2017, PREV SCI, V18, P818, DOI 10.1007/s11121-016-0701-0; Barth J, 2013, INT J PUBLIC HEALTH, V58, P469, DOI 10.1007/s00038-012-0426-1; Carlson J, 2015, VIOLENCE AGAINST WOM, V21, P1406, DOI 10.1177/1077801215594888; Ellsberg M, 2015, LANCET, V385, P1555, DOI 10.1016/S0140-6736(14)61703-7; Fisher RA, 1935, DESIGN EXPT; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hovsepian SL, 2010, HEALTH EDUC BEHAV, V37, P65, DOI 10.1177/1090198108327730; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; McMahon S, 2015, AM J COMMUN PSYCHOL, V56, P46, DOI 10.1007/s10464-015-9740-0; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Orchowski LM, 2008, PSYCHOL WOMEN QUART, V32, P204, DOI 10.1111/j.1471-6402.2008.00425.x; OZER EM, 1990, J PERS SOC PSYCHOL, V58, P472, DOI 10.1037/0022-3514.58.3.472; Rosenman E, 2018, ANAL METHODS IMPOWER; Russell M, 2014, PREV SCI, V15, P283, DOI 10.1007/s11121-013-0405-7; Sarnquist C, A PROTOCOL FOR A CLU; Sarnquist C, 2014, PEDIATRICS, V133, pE1226, DOI 10.1542/peds.2013-3414; Shamu S, 2016, INT HEALTH, V8, P18, DOI 10.1093/inthealth/ihv068; United Nations Children's Fund (UNICEF), 2012, VIOL CHILDR KEN FIND; United Nations Report, 2016, WORLD CITIES REPORT; Vyas S, 2016, INT J PUBLIC HEALTH, V61, P971, DOI 10.1007/s00038-016-0876-y; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Zapp D, 2021, J INTERPERS VIOLENCE, V36, pNP2324, DOI 10.1177/0886260518762449	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0213359	10.1371/journal.pone.0213359	http://dx.doi.org/10.1371/journal.pone.0213359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170151	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700003
J	Torrecilla, JL; Quijano-Sanchez, L; Liberatore, F; Lopez-Ossorio, JJ; Gonzalez-Alvarez, JL				Torrecilla, Jose L.; Quijano-Sanchez, Lara; Liberatore, Federico; Lopez-Ossorio, Juan J.; Gonzalez-Alvarez, Jose L.			Evolution and study of a copycat effect in intimate partner homicides: A lesson from Spanish femicides	PLOS ONE			English	Article							MEDIA; VIOLENCE; SUICIDES; BEHAVIOR; IMPACT; WOMEN; RISK	Objectives This paper focuses on the issue of intimate partner violence and, specifically, on the distribution of femicides over time and the existence of copycat effects. This is the subject of an ongoing debate often triggered by the social alarm following multiple intimate partner homicides (IPHs) occurring in a short span of time. The aim of this research is to study the evolution of IPHs and provide a far-reaching answer by rigorously analyzing and searching for patterns in data on femicides. Methods The study analyzes an official dataset, provided by the system VioGen of the Secretarla de Estado de Seguridad (Spanish State Secretariat for Security), including all the femicides occurred in Spain in 2007-2017. A statistical methodology to identify temporal interdependencies in count time series is proposed and applied to the dataset. The same methodology can be applied to other contexts. Results There has been a decreasing trend in the number of femicides per year. No interdependencies among the temporal distribution of femicides are observed. Therefore, according to data, the existence of copycat effect in femicides cannot be claimed. Conclusions Around 2011 there was a clear change in the average number of femicides which has not picked up. Results allow for an informed answer to the debate on copycat effect in Spanish femicides. The planning of femicides prevention activities should not be a reaction to a perceived increase in their occurrence. As a copycat effect is not detected in the studied time period, there is no evidence supporting the need to censor media reports on femicides.	[Torrecilla, Jose L.; Quijano-Sanchez, Lara; Liberatore, Federico] Univ Carlos III Madrid, UC3M BS Inst Financial Big Data, Madrid, Spain; [Torrecilla, Jose L.] Univ Autonoma Madrid, Dept Math, Madrid, Spain; [Quijano-Sanchez, Lara] Univ Autonoma Madrid, Dept Comp Sci, Madrid, Spain; [Liberatore, Federico] Univ Complutense Madrid, Fac Math, Dept Stat & Operat Res, Madrid, Spain; [Lopez-Ossorio, Juan J.; Gonzalez-Alvarez, Jose L.] Minist Interior, Secretaria Estado Seguridad, Gabinete Coordinac & Estudios, Madrid, Spain	Universidad Carlos III de Madrid; Autonomous University of Madrid; Autonomous University of Madrid; Complutense University of Madrid	Quijano-Sanchez, L (corresponding author), Univ Carlos III Madrid, UC3M BS Inst Financial Big Data, Madrid, Spain.; Quijano-Sanchez, L (corresponding author), Univ Autonoma Madrid, Dept Comp Sci, Madrid, Spain.	lara.quijano@uam.es	Álvarez, José Luis González/AAP-7883-2020; Quijano-Sanchez, Lara/Y-3960-2019; Torrecilla, José Luis/L-2688-2013	Quijano-Sanchez, Lara/0000-0002-9389-2380; Torrecilla, José Luis/0000-0003-3719-5190; LIBERATORE, FEDERICO/0000-0001-9900-5108	Spanish Grant [MTM2016-78751-P]; Government of Spain [MTM2015-65803-R]; Government of Madrid [S2013/ICE-2845]	Spanish Grant(Spanish Government); Government of Spain(Spanish Government); Government of Madrid	The work by Torrecilla has been partially supported by Spanish Grant MTM2016-78751-P. The research of Liberatore has been supported by the Government of Spain, grant MTM2015-65803-R, and by the Government of Madrid, grant S2013/ICE-2845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All financial supports are gratefully acknowledged.	Abad JG, 2017, MUJERES ASESINADAS V; Alvarez P., 2017, OJO CLINICO CONTRA L; Alvarez P., 2017, SOLO 12 MEDIDAS PACT; [Anonymous], VIOL WOM GLOB HLTH P; Arendt F, 2017, SUICIDOL ONLINE-SOL, V8; Bhatia A., 2012, WHAT DOES RANDOMNESS; Caballero F., 2017, MADRID CREARA COMITE; Carbone-Lopez K, 2012, J QUANT CRIMINOL, V28, P319, DOI 10.1007/s10940-011-9143-9; Catala-Minana A, 2014, J INTERPERS VIOLENCE, V29, P2652, DOI 10.1177/0886260513517301; Chadee D, 2017, PSYCHOL POP MEDIA CU, V6, P142, DOI 10.1037/ppm0000088; Cheng Q, 2018, J AFFECT DISORDERS, V227, P643, DOI 10.1016/j.jad.2017.11.007; Cheng QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108724; Coleman Loren., 2004, COPYCAT EFFECT MEDIA; Dufort M, 2015, EUR J PUBLIC HEALTH, V25, P413, DOI 10.1093/eurpub/cku198; Farnham N., 2017, CAN COPYCAT EFFECT B; Frye V, 2008, AM J PUBLIC HEALTH, V98, P1473, DOI 10.2105/AJPH.2007.112813; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Gonzalez JL, 2018, ANU PSICOL JURID, V28, P28, DOI 10.5093/apj2018a2; Gould MS, 2017, MASS SHOOTINGS AND M; Helfgott JB, 2015, AGGRESS VIOLENT BEH, V22, P46, DOI 10.1016/j.avb.2015.02.002; Hinkley D.V., 1970, INFERENCE CHANGE POI; Igartua JJ, 2002, CULT EDUC, V14, P17, DOI [10.1174/, DOI 10.1174/]; Ji NJ, 2014, J AFFECT DISORDERS, V156, P56, DOI 10.1016/j.jad.2013.11.015; JONAS K, 1992, BRIT J SOC PSYCHOL, V31, P295, DOI 10.1111/j.2044-8309.1992.tb00974.x; Lopez-Ossorio JJ, 2017, INT J CLIN HLTH PSYC, V17, P107, DOI 10.1016/j.ijchp.2016.12.001; King DM, 2017, VIOLENCE VICTIMS, V32, P1014, DOI 10.1891/0886-6708.VV-D-16-00039; Kingman J., 1993, POISSON PROCESSES; Laanpere M, 2013, EUR J PUBLIC HEALTH, V23, P688, DOI 10.1093/eurpub/cks144; Liesenfeld R, 2017, J APPL ECONOMET, V32, P600, DOI 10.1002/jae.2534; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Loeffler C, 2017, J QUANTITATIVE CRIMI, P1; Lorente M., 2010, COMO INFORM VIOLENCI, P16; MALAMUTH NM, 1986, J SOC ISSUES, V42, P75, DOI 10.1111/j.1540-4560.1986.tb00243.x; Marzabal Manresa I., 2015, FEMINICIDIOS PAREJA, DOI [10.1093/eurpub/ckp086, DOI 10.1093/EURPUB/CKP086]; Meindl JN, 2017, AM J PUBLIC HEALTH, V107, P368, DOI 10.2105/AJPH.2016.303611; Vicente JMM, 2016, ANU PSICOL JURID, V26, P130, DOI 10.1016/j.apj.2016.04.005; Niederkrotenthaler T, 2017, MEDIA SUICIDE INT PE; Ornstein JT, 2017, J QUANT CRIMINOL, V33, P65, DOI 10.1007/s10940-016-9281-1; PHILLIPS DP, 1982, AM J SOCIOL, V87, P1340, DOI 10.1086/227596; Pirkis J, 2007, SUICIDE LIFE-THREAT, V37, P278, DOI 10.1521/suli.2007.37.3.278; Poelmans J, 2011, APPL SOFT COMPUT, V11, P3870, DOI 10.1016/j.asoc.2011.02.026; R Development Core Team, 2009, R LANG ENV STAT COMP; Sidhu SS, 2017, J AM ACAD CHILD PSY, V56, P3, DOI 10.1016/j.jaac.2016.10.004; Siegal, 1956, NONPARAMETRIC STAT B; Stack S, 1996, SUICIDE LIFE-THREAT, V26, P132; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Sudak HS, 2005, ACAD PSYCHIATR, V29, P495, DOI 10.1176/appi.ap.29.5.495; Szekely GJ, 2013, J STAT PLAN INFER, V143, P1249, DOI 10.1016/j.jspi.2013.03.018; TERUELO FERNANDEZ, 2011, REV ESPANOLA INVESTI, P1; Toledo, 2014, MEDIA GENDER BASED M; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117259; Turanovic JJ, 2015, J QUANT CRIMINOL, V31, P183, DOI 10.1007/s10940-014-9230-9; Ueda M, 2014, INT J EPIDEMIOL, V43, P623, DOI 10.1093/ije/dyu056; Vives-Cases C, 2009, EUR J PUBLIC HEALTH, V19, P592, DOI 10.1093/eurpub/ckp086; Vives-Cases C, 2014, EUR J PUBLIC HEALTH, V24, P605, DOI 10.1093/eurpub/ckt127; Weldon L., 2002, PROTEST POLICY PROBL; Winfield N, 2018, WASH POST; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V	58	4	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217914	10.1371/journal.pone.0217914	http://dx.doi.org/10.1371/journal.pone.0217914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170250	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000470263700081
J	Adedini, SA; Omisakin, OA; Somefun, OD				Adedini, Sunday A.; Omisakin, Olusola Akintoye; Somefun, Oluwaseyi Dolapo			Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa	PLOS ONE			English	Article							UNMET NEED; FERTILITY; MORTALITY; PREGNANCIES; COUNTRIES; DEMAND; POOR	Background Method-specific contraceptive prevalence varies widely globally, as huge variations exist in the use of different types of contraception, with short-term methods being the most common methods in sub-Saharan Africa (SSA). Evidence is scanty on the trends, patterns and determinants of long-acting reversible contraceptive (LARC) methods in SSA. This study aimed to address this knowledge gap. Methods Using a pseudo longitudinal research design and descriptive and inferential statistics, we analysed Demographic and Health Survey data of eight countries selected on the basis of contraceptive prevalence rates across SSA. Multinomial logistic regression modelling was used to tease out the predictors of the uptake of LARC methods in the selected countries. Results Findings exhibit a steady but slow upward trend in LARC methods across selected countries, as a marginal increase was recorded in LARC uptake over a 10-year period in many of the selected countries. Results established significant predictors of LARC methods uptake, including fertility-related characteristics, age, level of education, work status, wealth index and exposure to mass media. This study underscored the need to address various barriers to the uptake of LARC methods in SSA. It is recommended that governments at different levels undertake to cover the costs of LARC methods in order to increase access and uptake.	[Adedini, Sunday A.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa; [Adedini, Sunday A.; Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa; [Adedini, Sunday A.; Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Sch Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa; [Omisakin, Olusola Akintoye] Fed Univ, Demog & Social Stat Dept, Birnin Kebbi, Nigeria	South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Adedini, SA (corresponding author), Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.; Adedini, SA (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa.; Adedini, SA (corresponding author), Univ Witwatersrand, Sch Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa.	sunday.adedini@gmail.com	Adedini, Sunday/AAM-6790-2021; Adedini, Sunday/GZM-8362-2022	Adedini, Sunday/0000-0003-0378-1941; 				Adebowale SA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-40; Adedini SA, 2015, J HEALTH POPUL NUTR, V33, P187; Adeyanju O., 2017, NIGERIAN URBAN REPRO; Akinyemi A, 2015, GLOBAL HEALTH ACTION, V8, P45, DOI 10.3402/gha.v8.29745; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2015, TRENDS CONTR US WORL; Babalola S, 2015, DEMOGR RES, V33, P211, DOI 10.4054/DemRes.2015.33.8; Bongaarts J, 2017, POPUL DEV REV, V43, P39, DOI 10.1111/j.1728-4457.2016.00164.x; Choi Y, 2015, GLOBAL HEALTH ACTION, V8, P3, DOI 10.3402/gha.v8.29734; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Ezeh AC, 2009, PHILOS T R SOC B, V364, P2991, DOI 10.1098/rstb.2009.0166; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; Fekadu H, 2017, J WOMENS HLTH CARE, V6, P2167; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; Gribble J, 2008, POPULATION REFERENCE, P8; Gyimah SO, 2012, J RELIG HEALTH, V51, P1359, DOI 10.1007/s10943-011-9478-4; Hasselback L, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2316-y; Imasiku ENS, 2014, J BIOSOC SCI, V46, P294, DOI 10.1017/S0021932013000357; Lipetz C, 2009, J FAM PLAN REPROD H, V35, P75, DOI 10.1783/147118909787931555; Masquelier B, 2018, LANCET GLOB HEALTH, V6, pE1087, DOI [10.1016/S2214-109X(18)30353-X, 10.1016/s2214-109x(18)30353-x]; Mbizvo MT, 2014, BEST PRACT RES CL OB, V28, P931, DOI 10.1016/j.bpobgyn.2014.04.014; Ngo TD, 2017, MATERN CHILD HLTH J, V21, P1734, DOI 10.1007/s10995-016-2014-0; Ochako R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0314-6; Okigbo C, 2017, WORLD MED HEALTH POL, V9, P65, DOI 10.1002/wmh3.215; Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120; Oye-Adeniran Boniface A, 2006, Afr J Reprod Health, V10, P90; Payne JB, 2016, J MIDWIFERY WOM HEAL, V61, P482, DOI 10.1111/jmwh.12425; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Shoupe D, 2016, CONTRACEP REPROD MED, V1, DOI 10.1186/s40834-016-0011-8; Singh S., 2014, ADD COSTS BEN INV SE; Skiles MP, 2015, INT PERSPECT SEX R H, V41, P20, DOI 10.1363/4102015; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Stoddard A, 2011, DRUGS, V71, P969, DOI 10.2165/11591290-000000000-00000; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0382-2; United Nations, 2015, 241 ESAPWP UN; Waggoner MR, 2012, J CHILD ADOL PS NURS, V25, P96, DOI 10.1111/j.1744-6171.2012.00326.x	41	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217574	10.1371/journal.pone.0217574	http://dx.doi.org/10.1371/journal.pone.0217574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163050	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200019
J	Ho, KF; Ho, CH; Chung, MH				Ho, Kuei-Fang; Ho, Cheng-Hsun; Chung, Min-Huey			Theoretical integration of user satisfaction and technology acceptance of the nursing process information system	PLOS ONE			English	Article							MODEL; HEALTH; QUALITY; SUCCESS	Background The nursing process system (NPS) is used to establish the nursing process involving assessment, diagnosis, planning, intervention, and evaluation in solving the health problems of patients. Objectives The factors influencing the use of the NPS by nurses were analyzed based on user satisfaction and technology acceptance within the 3Q (service quality, information quality, and system quality) model. Methods In this cross-sectional quantitative study, the valid responses of 222 nurses to a questionnaire were obtained; these nurses worked at eight hospitals affiliated with public organizations in Taiwan. Structural equation modeling was used to analyze information quality, system quality, service quality, user satisfaction, perceived usefulness, perceived ease of use, perceived enjoyment, behavioral attitude, and intention after the nurses had used the NPS system for more than 1 month. Results Information quality, service quality, and system quality influenced user satisfaction. User satisfaction affected perceived usefulness, perceived ease of use, and perceived enjoyment and had the highest explanatory power (R-2 = 0.75). Furthermore, perceived usefulness, perceived ease of use, and perceived enjoyment influenced behavioral attitude and intention to use the system. The proposed model explained 53% of the variance in the intention to use the NPS. Conclusions The relationships between the variables of the 3Q model were successfully used to examine the intention of nurses toward using the NPS. Using the findings of this study, designers and programmers can comprehensively understand the perceptions of nurses and further improve the performance of the NPS.	[Ho, Kuei-Fang; Chung, Min-Huey] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Ho, Cheng-Hsun] Natl Taipei Univ, Grad Inst Informat Management, New Taipei, Taiwan; [Chung, Min-Huey] Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, New Taipei, Taiwan	Taipei Medical University; National Taipei University; Taipei Medical University; Shuang Ho Hospital	Chung, MH (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Chung, MH (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, New Taipei, Taiwan.	minhuey300@tmu.edu.tw						Aggelidis VP, 2009, INT J MED INFORM, V78, P115, DOI 10.1016/j.ijmedinf.2008.06.006; Awang Z., 2012, RES METHODOLOGY DATA; BenMessaoud C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016395; Chang IC, 2012, GOV INFORM Q, V29, P235, DOI 10.1016/j.giq.2011.07.006; Chen RF, 2012, INT J MED INFORM, V81, P810, DOI 10.1016/j.ijmedinf.2012.05.003; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dabholkar Pratibha A., 1996, INT J RES MARK, V13, P29, DOI DOI 10.1016/0167-8116(95)00027-5; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748; Farzandipour M, 2016, INTENTION CONTINUING, V8, P3385, DOI [10.19082/3385, DOI 10.19082/3385]; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928; Ho KF., 2009, BUILDING KNOWLEDGE B; Hsiao JL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-16; Hsiao JL, 2011, J NURS RES, V19, P150, DOI 10.1097/JNR.0b013e31821cbb25; Hsu HH, 2017, CIN-COMPUT INFORM NU, V35, P315, DOI 10.1097/CIN.0000000000000313; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hussey P, 2015, NURSE LEAD, V13, P52, DOI 10.1016/j.mnl.2015.07.002; Koo C, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1574; Kuo KM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-88; Lei P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-436; Lin HC, 2017, CIN-COMPUT INFORM NU, V35, P91, DOI 10.1097/CIN.0000000000000293; Lu CH, 2012, CIN-COMPUT INFORM NU, V30, P257, DOI 10.1097/NCN.0b013e318224b4cf; Marsh HW, 1998, MULTIVAR BEHAV RES, V33, P181, DOI 10.1207/s15327906mbr3302_1; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Or CKL, 2011, J AM MED INFORM ASSN, V18, P51, DOI 10.1136/jamia.2010.007336; Socklow PS, 2014, APPL NURS RES, V27, P25, DOI 10.1016/j.apnr.2013.10.005; Tao Donghua, 2009, AMIA Annu Symp Proc, V2009, P629; Tao Donghua, 2008, AMIA Annu Symp Proc, P717; Topaz M, 2016, INT J NURS STUD, V64, P25, DOI 10.1016/j.ijnurstu.2016.09.013; Tsai HH, 2016, STUD HEALTH TECHNOL, V225, P846, DOI 10.3233/978-1-61499-658-3-846; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Wixom BH, 2005, INFORM SYST RES, V16, P85, DOI 10.1287/isre.1050.0042; Wu JH, 2008, INT J QUAL HEALTH C, V20, P123, DOI 10.1093/intqhc/mzm074; Xu JJ, 2013, MIS QUART, V37, P777, DOI 10.25300/MISQ/2013/37.3.05; Yu P, 2009, INT J MED INFORM, V78, P219, DOI 10.1016/j.ijmedinf.2008.07.006; Zadvinskis IM, 2014, INT J MED INFORM, V83, P89, DOI 10.1016/j.ijmedinf.2013.11.001	38	15	15	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217622	10.1371/journal.pone.0217622	http://dx.doi.org/10.1371/journal.pone.0217622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163076	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200025
J	Suh, Y; Park, Y; Kang, D				Suh, Yongyoon; Park, Yongtae; Kang, Daekook			Evaluating mobile services using integrated weighting approach and fuzzy VIKOR	PLOS ONE			English	Article							GROUP DECISION-MAKING; EVIDENTIAL REASONING APPROACH; CUSTOMER SATISFACTION; ATTRIBUTE WEIGHTS; USER INTERFACES; SHANNON ENTROPY; MCDM METHODS; SELECTION; DEMATEL; ADOPTION	Mobile services' rapid evolution and development has meant that their evaluation has become a more and more pressing issue, and from both the practical and theoretical standpoints. The significant previous work in the field of multiple-criteria decision-making based evaluation of mobile services has some practical limitations that should be noted. First, there has been insufficient research that has utilized both objective and subjective weighting. Second, the investigations that have employed Vise Kriterijumska Optimizacija I Kompromisno Resenje (VIKOR), a well known practical tool for use in multi-criteria decision making, did not consider the fuzzy environment. In order to fill these gaps in the literature, the present study developed fuzzy VIKOR for use with an integrated weighting approach that combines subjective and objective weighting to account for mobile services' various characteristics and, thereby, evaluate their quality. For subjective weighting, Decision Making Trial and Evaluation Laboratory (DEMATEL) was employed for simple determination of the weighting and causal relationships. For objective weighting of evaluation criteria, Shannon entropy was utilized. This study has a unique contribution in that it reflects the special circumstances of the mobile service evaluation that have not been considered in the previous studies. Especially, in this study, not only the subjective weighting method but also the objective weighting method are used for more accurate importance weight of evaluation criteria. In the novelty aspect, this is the first study trying to utilize fuzzy VIKOR in concert with a novel combined subjective/objective weighting method in order to integrate objective decision-matrix-derived information with subjective decision-maker preferences. Additionally, a supplemental, empirical mobile-service-evaluation case study was conducted that enables researchers and practitioners to better understand the overall, practical evaluation process. Validation of the case study results by comparison with other, representative multiple-criteria decision-making methods verified the proposed method's robustness.	[Suh, Yongyoon] Pukyong Natl Univ, Dept Safety Engn, Busan, South Korea; [Park, Yongtae] Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea; [Kang, Daekook] Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea	Pukyong National University; Seoul National University (SNU); Inje University	Kang, D (corresponding author), Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea.	dkkang@inje.ac.kr			National Research Foundation (NRF) of Korea Grant - Korean Government (MOE) [NRF-2019R1G1A1006073]	National Research Foundation (NRF) of Korea Grant - Korean Government (MOE)	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MOE) (NRF-2019R1G1A1006073).	Acuna-Carvajal F, 2019, EXPERT SYST APPL, V122, P351, DOI 10.1016/j.eswa.2019.01.030; Alnanih R, 2013, PROCEDIA COMPUT SCI, V21, P390, DOI 10.1016/j.procs.2013.09.051; Asan U, 2018, APPL SOFT COMPUT, V66, P34, DOI 10.1016/j.asoc.2018.01.018; AZAD N., 2013, MANAGEMENT SCI LETT, V3, P1161; Barnes SJ, 2002, INT J INFORM MANAGE, V22, P91, DOI 10.1016/S0268-4012(01)00047-0; Baykasoglu A, 2017, EXPERT SYST APPL, V70, P37, DOI 10.1016/j.eswa.2016.11.001; Blechar J, 2006, EUR J INFORM SYST, V15, P285, DOI 10.1057/palgrave.ejis.3000618; Bowers CP, 2013, INT J HUM-COMPUT ST, V71, P1103, DOI 10.1016/j.ijhcs.2013.08.017; Browne K, 2012, ENTERTAIN COMPUT, V3, P1, DOI 10.1016/j.entcom.2011.06.001; Buyukozkan G, 2008, MATH COMPUT SIMULAT, V77, P464, DOI 10.1016/j.matcom.2007.11.015; Buyukozkan G, 2009, COMPUT STAND INTER, V31, P144, DOI 10.1016/j.csi.2007.11.006; Chang TH, 2014, INFORM SCIENCES, V271, P196, DOI 10.1016/j.ins.2014.02.118; Chen C, 2011, PROCEDIA ENVIRON SCI, V10, P262, DOI 10.1016/j.proenv.2011.09.043; Chen PT, 2010, TECHNOL FORECAST SOC, V77, P678, DOI 10.1016/j.techfore.2009.11.007; Chen S-H, 2008, 2008 INT C MACH LEAR; Chen VYC, 2011, APPL SOFT COMPUT, V11, P265, DOI 10.1016/j.asoc.2009.11.017; Chin KS, 2015, COMPUT IND ENG, V87, P150, DOI 10.1016/j.cie.2015.04.016; Chincholle D, 2002, INT C MOB HUM COMP I; Chong JL, 2011, INT J MOB COMMUN, V9, P1, DOI 10.1504/IJMC.2011.037952; Chou SY, 2008, EUR J OPER RES, V189, P132, DOI 10.1016/j.ejor.2007.05.006; Chou Y-C, 2011, APPL SOFT COMPUTING; Cui L, 2019, J BUS RES, V98, P450, DOI 10.1016/j.jbusres.2018.03.031; Deng H, 2000, COMPUT OPER RES, V27, P963, DOI 10.1016/S0305-0548(99)00069-6; Dijkstra J, 2014, TRANSP RES PROC, V2, P141, DOI 10.1016/j.trpro.2014.09.018; Dincer H, 2013, KYBERNETES, V42, P1072, DOI 10.1108/K-02-2013-0021; Dong MG, 2015, EXPERT SYST APPL, V42, P7846, DOI 10.1016/j.eswa.2015.06.007; Efe B, 2016, APPL SOFT COMPUT, V38, P106, DOI 10.1016/j.asoc.2015.09.037; Fu C, 2015, COMPUT IND ENG, V81, P109, DOI 10.1016/j.cie.2014.12.031; Gou XJ, 2017, INFORM SCIENCES, V388, P225, DOI 10.1016/j.ins.2017.01.033; Gul M, 2019, J SAFETY RES, V69, P135, DOI 10.1016/j.jsr.2019.03.005; Tzeng GH, 2007, EXPERT SYST APPL, V32, P1028, DOI 10.1016/j.eswa.2006.02.004; Hill SR, 2010, INT J MOB COMMUN, V8, P150, DOI 10.1504/IJMC.2010.031445; Itoh N, 2005, INT C SER, DOI [10.1016/j.ics.2005.07.090, DOI 10.1016/J.ICS.2005.07.090]; Jeng DJF, 2012, MANAGE DECIS, V50, P1570, DOI 10.1108/00251741211266697; Kang D, 2016, APPL SOFT COMPUT, V42, P53, DOI 10.1016/j.asoc.2016.01.017; Kang D, 2014, EXPERT SYST APPL, V41, P1041, DOI 10.1016/j.eswa.2013.07.101; Khademi-Zare H, 2010, TELECOMMUN POLICY, V34, P747, DOI 10.1016/j.telpol.2010.10.001; Kim CS, 2010, SERV BUS, V4, P253, DOI 10.1007/s11628-009-0088-0; Kim J, 2014, SERV BUS, V8, P1, DOI 10.1007/s11628-013-0184-z; Kim Y, 2013, APPL MATH MODEL, V37, P9419, DOI 10.1016/j.apm.2013.04.040; Lee HC, 2018, RENEW SUST ENERG REV, V92, P883, DOI 10.1016/j.rser.2018.05.007; Lee PTW, 2012, EXPERT SYST APPL, V39, P5649, DOI 10.1016/j.eswa.2011.11.052; Li XX, 2011, PROCEDIA ENGINEER, V26, DOI 10.1016/j.proeng.2011.11.2410; Li YF, 2019, APPL SOFT COMPUT, V79, P268, DOI 10.1016/j.asoc.2019.03.048; Lin CL, 2016, APPL SOFT COMPUT, V48, P385, DOI 10.1016/j.asoc.2016.05.035; Liu S, 2016, EXPERT SYST APPL, V55, P37, DOI 10.1016/j.eswa.2016.01.059; Lu MT, 2015, SERV BUS, V9, P541, DOI 10.1007/s11628-014-0239-9; Mohsen O, 2017, SAFETY SCI, V92, P160, DOI 10.1016/j.ssci.2016.10.006; Mokhtarian M, 2012, APPL SOFT COMPUT, DOI [10.1016/j.asoc.2011.12.003, DOI 10.1016/J.ASOC.2011.12.003]; Moreno M, 2012, PROCEEDINGS OF THE 4, V14, P74; Narayanamoorthy S, 2019, EXPERT SYST APPL, V121, P28, DOI 10.1016/j.eswa.2018.12.015; Nikou S, 2013, TELECOMMUN POLICY, V37, P915, DOI 10.1016/j.telpol.2012.09.007; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Opricovic S, 1998, THESIS FACULTY CIVIL; Pagani M, 2004, J INTERACT MARK, V18, P46, DOI 10.1002/dir.20011; Ploskas N, 2019, FUZZY SET SYST, V377, P1, DOI 10.1016/j.fss.2019.01.012; Qi JY, 2012, INFORM TECHNOL MANAG, V13, P281, DOI 10.1007/s10799-012-0132-y; Quang NH, 2013, APPL SOFT COMPUTING; Quezada LE, 2018, COMPUT IND ENG, V118, P170, DOI 10.1016/j.cie.2018.02.020; Rao RV, 2008, MATER DESIGN, V29, P1949, DOI 10.1016/j.matdes.2008.04.019; Ren ZL, 2017, INFORM SCIENCES, V388, P1, DOI 10.1016/j.ins.2017.01.024; Shahraki AR, 2011, INDIAN J SCI TECHNOL, V4, P1763; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shemshadi A, 2011, EXPERT SYST APPL, V38, P12160, DOI 10.1016/j.eswa.2011.03.027; Shieh LF, 2014, TECHNOL FORECAST SOC, V87, P80, DOI 10.1016/j.techfore.2013.11.004; Song ML, 2017, COMPUT IND ENG, V112, P99, DOI 10.1016/j.cie.2017.07.023; Suh Y, 2012, INT J MOB COMMUN, V10, P1, DOI 10.1504/IJMC.2012.044520; Teng WC, 2009, TELECOMMUN POLICY, V33, P628, DOI 10.1016/j.telpol.2009.07.002; Tian GD, 2019, J CLEAN PROD, V220, P1088, DOI 10.1016/j.jclepro.2019.01.086; Tian GD, 2017, J CLEAN PROD, V164, P1363, DOI 10.1016/j.jclepro.2017.07.028; Wan SP, 2015, INFORM SCIENCES, V316, P329, DOI 10.1016/j.ins.2015.04.019; Wang H, 2019, J CLEAN PROD, V208, P199, DOI 10.1016/j.jclepro.2018.10.131; Wang Q, 2015, J AIR TRANSP MANAG, V42, P55, DOI 10.1016/j.jairtraman.2014.08.003; Wang TC, 2009, EXPERT SYST APPL, V36, P8980, DOI 10.1016/j.eswa.2008.11.035; Wu SS, 2018, SUSTAIN CITIES SOC, V41, P443, DOI 10.1016/j.scs.2018.05.052; Yoon C, 2015, INFORM TECHNOL MANAG, V16, P139, DOI 10.1007/s10799-014-0202-4; Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5; Zeng SZ, 2019, INFORM SCIENCES, V488, P76, DOI 10.1016/j.ins.2019.03.018; Zhang HH, 2019, INFORM SCIENCES, V481, P491, DOI 10.1016/j.ins.2018.12.071; Zhou T, 2012, INFORM TECHNOL MANAG, V13, P27, DOI 10.1007/s10799-011-0111-8; Zhu B, 2014, EUR J OPER RES, V239, P794, DOI 10.1016/j.ejor.2014.06.019; Zitnick CL, 2004, P 20 C UNC ART INT	82	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217786	10.1371/journal.pone.0217786	http://dx.doi.org/10.1371/journal.pone.0217786			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163061	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200035
J	Esplugas, R; Arenas, M; Serra, N; Belles, M; Bonet, M; Gascon, M; Vallve, JC; Linares, V				Esplugas, Roser; Arenas, Meritxell; Serra, Noemi; Belles, Montserrat; Bonet, Marta; Gascon, Marina; Vallve, Joan-Cartes; Linares, Victoria			Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a,-155,-221 and-222 in blood of women with breast cancer	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIRCULATING MICRORNAS; POTENTIAL BIOMARKER; ALTERED EXPRESSION; ARTERY; MIR-146A; RNAS; MIR-221/222; SUPPRESSION; RISK	Breast cancer (BC) is one of the most important neoplasias among women. Many patients receive radiotherapy (RT), which involves radiation exposure of the thoracic zone, including the heart and blood vessels, leading to the development of cardiovascular disease (CVD) as a long-term side effect. The severity of CVD-related pathologies leads research on assessing novel CVD biomarkers as diagnostic, prognostic or therapeutic agents. Currently, the possible candidates include blood microRNAs (miRNAs). Previous studies have supported a role for miRNA-146a, -155, -221, and -222 in the progression of CVD. Our purpose was to evaluate the RT-induced modulation of the expression of these miRNAs in the blood of women with BC. Pre-RT control and post-RT blood samples were collected, and after miRNA isolation and reverse transcription, the levels of the selected miRNAs were measured by real-time PCR. Our results showed that miRNA-155 exhibited the lowest expression, while miRNA-222 exhibited the highest expression, followed by miRNA-221. The expression of each individual miRNA was positively correlated with that of the others both pre-RT control and post-RT and inversely correlated with age before RT. Furthermore, RT promoted the overexpression of the selected miRNAs. Their levels were also affected by CVD-linked clinical parameters, treatment and BC side. Modulation of the expression of the selected miRNAs together with other risk factors might be associated with the development of future cardiovascular pathologies. Further confirmatory studies are needed to assess their potential as possible biomarkers in the progression of or as therapeutic targets for RT-induced CVD in BC patients.	[Esplugas, Roser; Belles, Montserrat; Linares, Victoria] Rovira & Virgili Univ, IISPV, Sch Med, Physiol Unit, Reus, Spain; [Esplugas, Roser; Serra, Noemi; Belles, Montserrat; Linares, Victoria] Rovira & Virgili Univ, IISPV, Sch Med, Lab Toxicol & Environm Hlth, Reus, Spain; [Arenas, Meritxell; Bonet, Marta] Rovira & Virgili Univ, IISPV, St Joan Univ Hosp, Radiat Oncol Dept, Reus, Spain; [Gascon, Marina] Miguel Servet Univ Hosp, Radiat Oncol Unit, Zaragoza, Spain; [Vallve, Joan-Cartes] Rovira & Virgili Univ, IISPV, St Joan Univ Hosp, Res Unit Lipids & Atherosclerosis, Reus, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Miguel Servet University Hospital; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Vallve, JC (corresponding author), Rovira & Virgili Univ, IISPV, St Joan Univ Hosp, Res Unit Lipids & Atherosclerosis, Reus, Spain.	jc.vallve@urv.cat	Arenas, Meritxell/HCG-8786-2022; Vallvé, Joan-Carles/T-6742-2019; Bonet, Marta/AAO-6276-2021	Arenas, Meritxell/0000-0003-0815-2570; Vallvé, Joan-Carles/0000-0001-8711-9618; Bonet, Marta/0000-0002-6417-0514; Serra, Noemi/0000-0002-2277-351X	Instituto de Salud Carlos III [PI 10/02547, PI030786]; Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBER-DEM); Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBER-DEM); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by grants from the Instituto de Salud Carlos III (PI 10/02547, PI030786), Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBER-DEM) and Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni-Fabbroni M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4020-7; Arenas M, 2016, CLIN TRANSL ONCOL, V18, P582, DOI 10.1007/s12094-015-1401-0; Arenas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188633; Baldeon RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115209; Bildirici AE, 2018, BIOMARKERS, V23, P670, DOI 10.1080/1354750X.2018.1474260; Bots WTC, 2017, HEAD NECK-J SCI SPEC, V39, P1122, DOI 10.1002/hed.24733; Celic T, 2017, CURR VASC PHARMACOL, V15, P40, DOI 10.2174/1570161114666160914175149; Chamorro-Jorganes A, 2013, PHARMACOL RES, V75, P15, DOI 10.1016/j.phrs.2013.04.002; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Chen X YX, 2013, ONCOLOGIST, V18, P7; Cheng HS, 2017, CIRC RES, V121, P354, DOI 10.1161/CIRCRESAHA.116.310529; Cheng YJ, 2017, J AM HEART ASSOC, V6, P5; Costantino S, 2018, INT J CARDIOL, V250, P207, DOI 10.1016/j.ijcard.2017.09.188; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; de Lucia C, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00074; Decandia F, 2018, IRISH J MED SCI, V187, P39, DOI 10.1007/s11845-017-1617-9; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Di Stefano V, 2011, VASC PHARMACOL, V55, P111, DOI 10.1016/j.vph.2011.08.001; Dlouha D, 2017, PHYSIOL RES, V66, pS21, DOI 10.33549/physiolres.933588; Dragomir M, 2018, CANCER BIOL MED, V15, P103, DOI 10.20892/j.issn.2095-3941.2018.0006; Economou EK, 2015, ATHEROSCLEROSIS, V241, P624, DOI 10.1016/j.atherosclerosis.2015.06.037; Eposito F, 2018, EUROPEAN J HEART FAI; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gacon J, 2018, KARDIOL POL, V76, P362, DOI 10.5603/KP.a2017.0243; Gangwar RS, 2018, AM J HYPERTENS, V31, P150, DOI 10.1093/ajh/hpx197; Gezer U, 2014, ONCOL LETT, V8, P845, DOI 10.3892/ol.2014.2188; Guo M, 2010, IMMUNOL CELL BIOL, V88, P555, DOI 10.1038/icb.2010.16; Huang H, 2016, CIVIL ENGINEERING AND URBAN PLANNING IV, P961; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Jia QW, 2017, CELL PHYSIOL BIOCHEM, V42, P808, DOI 10.1159/000478071; Jiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05026; Khosrow-Khavar F, 2017, ANN ONCOL, V28, P487, DOI 10.1093/annonc/mdw673; Kijima T, 2017, ONCOL REP, V37, P23, DOI 10.3892/or.2016.5267; Kim CS, 2018, RAD THERAPY BREAST C; Koelwyn GJ LN, 2016, ONCOLOGIST, V21, P9; Koroleva IA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1380, DOI 10.1134/S0006297917110165; Liu GA, 2010, TOHOKU J EXP MED, V222, P187, DOI 10.1620/tjem.222.187; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Long HD LY, 2016, ONCOLOGIST, V21, P8; Malla B, 2017, INT J RADIAT ONCOL, V98, P982, DOI 10.1016/j.ijrobp.2017.03.031; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Obi N, 2018, BREAST, V38, P75, DOI 10.1016/j.breast.2017.12.006; Oner T, 2017, J GENET, V96, P251, DOI 10.1007/s12041-017-0768-9; Palumbo I, 2016, BREAST, V25, P45, DOI 10.1016/j.breast.2015.10.004; Prades J, 2017, RADIOTHER ONCOL, V123, P22, DOI 10.1016/j.radonc.2017.01.014; Quan XH, 2018, CELL PHYSIOL BIOCHEM, V45, P226, DOI 10.1159/000486769; Raghunathan D, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0658-x; Ramkaran P, 2014, CELL BIOCHEM BIOPHYS, V68, P259, DOI 10.1007/s12013-013-9704-7; Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586; Rigaud VOC, 2017, ONCOTARGET, V8, P6994, DOI 10.18632/oncotarget.14355; Roos CTG, 2018, RADIOTHER ONCOL, V126, P170, DOI 10.1016/j.radonc.2017.10.009; Schaapveld M, 2018, BRIT J CANC; Simionescu N, 2014, MOL BIOL REP, V41, P5765, DOI 10.1007/s11033-014-3449-2; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skytta T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0436-2; Sochor M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-448; Strain T, 2018, J SPORT SCI, V36, P732, DOI 10.1080/02640414.2017.1339904; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Templin T, 2011, INT J RADIAT ONCOL, V80, P549, DOI 10.1016/j.ijrobp.2010.12.061; Turer CB, 2018, CIRCULATION, V137, P1256, DOI 10.1161/CIRCULATIONAHA.118.032531; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wang R, 2015, BIOCHEM BIOPH RES CO, V464, P574, DOI 10.1016/j.bbrc.2015.07.010; Wang Y, 2011, INT J RADIAT ONCOL, V81, P839, DOI 10.1016/j.ijrobp.2010.09.048; Xie XX, 2014, ONCOL REP, V31, P2195, DOI 10.3892/or.2014.3058; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yang ZZ, 2017, THERANOSTICS, V7, P3106, DOI 10.7150/thno.19016; Yao R, 2011, CELL MOL IMMUNOL, V8, P486, DOI 10.1038/cmi.2011.22; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; Zagar TM, 2016, NAT REV CLIN ONCOL, V13, P172, DOI 10.1038/nrclinonc.2015.171; Zhang CZ, 2011, INT J RADIAT ONCOL, V80, P240, DOI 10.1016/j.ijrobp.2010.12.049	72	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217443	10.1371/journal.pone.0217443	http://dx.doi.org/10.1371/journal.pone.0217443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150454	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100051
J	Khlebus, E; Kutsenko, V; Meshkov, A; Ershova, A; Kiseleva, A; Shevtsov, A; Shcherbakova, N; Zharikova, A; Lankin, V; Tikhaze, A; Chazova, I; Yarovaya, E; Drapkina, O; Boytsov, S				Khlebus, Eleonora; Kutsenko, Vladimir; Meshkov, Alexey; Ershova, Alexandra; Kiseleva, Anna; Shevtsov, Anton; Shcherbakova, Natalia; Zharikova, Anastasiia; Lankin, Vadim; Tikhaze, Alla; Chazova, Irina; Yarovaya, Elena; Drapkina, Oksana; Boytsov, Sergey			Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; PLASMA-LEVELS; SEQUENCE ALIGNMENT; LIPID-LEVELS; POLYMORPHISMS; MUTATIONS; RISK; CHOLESTEROL	Oxidatively modified low-density lipoproteins (oxLDL) play an important role in the occurrence and progression of atherosclerosis. To identify the genetic factors influencing the oxLDL levels, we have genotyped 776 DNA samples of Russian individuals for 196,725 single-nucleotide polymorphisms (SNPs) using the Cardio-MetaboChip (Illumina, USA) and conducted genome-wide association study (GWAS). Fourteen common variants in the locus including APOB gene were significantly associated with the oxLDL levels (P < 2.18 x 10(-7)). These variants explained only 6% of the variation in the oxLDL levels. Then, we assessed the contribution of rare coding variants of APOB gene to the oxLDL levels. Individuals with the extreme oxLDL levels (48 with the lowest and 48 with the highest values) were selected for targeted sequencing of the region including APOB gene. To evaluate the contribution of the SNPs to the oxLDL levels we used various statistical methods for the association analysis of rare variants: WST, SKAT, and SKAT-O. We revealed that both synonymous and nonsynonymous SNPs affected the oxLDL levels. For the joint analysis of the rare and common variants, we conducted the SKAT-C testing and found a group of 15 SNPs significantly associated with the oxLDL levels (P = 2.14 x 10(-9)). Our results indicate that the oxLDL levels depend on both common and rare variants of the APOB gene.	[Khlebus, Eleonora; Kutsenko, Vladimir; Meshkov, Alexey; Ershova, Alexandra; Kiseleva, Anna; Shcherbakova, Natalia; Zharikova, Anastasiia; Drapkina, Oksana] Minist Healthcare Russian Federat, Fed State Inst, Natl Med Res Ctr Prevent Med, Moscow, Russia; [Khlebus, Eleonora] Moscow Inst Phys & Technol, Moscow, Russia; [Kutsenko, Vladimir; Shevtsov, Anton; Yarovaya, Elena] Lomonosov Moscow State Univ, Moscow, Russia; [Lankin, Vadim; Tikhaze, Alla; Chazova, Irina; Boytsov, Sergey] Minist Healthcare Russian Federat, Fed State Budget Org, Natl Med Res Ctr Cardiol, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; Moscow Institute of Physics & Technology; Lomonosov Moscow State University; National Medical Research Center of Cardiology	Khlebus, E (corresponding author), Minist Healthcare Russian Federat, Fed State Inst, Natl Med Res Ctr Prevent Med, Moscow, Russia.; Khlebus, E (corresponding author), Moscow Inst Phys & Technol, Moscow, Russia.	eleonora.khlebus@phystech.edu	Meshkov, Alexey N/K-1056-2017; Chazova, Irina/B-8688-2017; Shcherbakova, Natalia/U-1290-2019; Drapkina, Oksana/AAE-5376-2021; Khlebus, Eleonora/X-1674-2019; Boytsov, Sergey A/M-4486-2014; Kutsenko, Vladimir/AAB-6974-2019; Zharikova, Anastasiia/ABC-9625-2021; Chazova, Irina/AAK-6581-2021; Drapkina, Oxana/G-8443-2016; Ershova, Alexandra I/J-8772-2017; Kiseleva, Anna/J-8709-2017	Meshkov, Alexey N/0000-0001-5989-6233; Chazova, Irina/0000-0002-9822-4357; Shcherbakova, Natalia/0000-0002-6672-4242; Drapkina, Oksana/0000-0002-4453-8430; Khlebus, Eleonora/0000-0002-8355-8960; Boytsov, Sergey A/0000-0001-6998-8406; Kutsenko, Vladimir/0000-0001-9844-3122; Zharikova, Anastasiia/0000-0003-0723-0493; Chazova, Irina/0000-0002-9822-4357; Drapkina, Oxana/0000-0002-4453-8430; Ershova, Alexandra I/0000-0001-7989-0760; Kiseleva, Anna/0000-0003-4765-8021	Russian Scientific Foundation [14-15-00245]	Russian Scientific Foundation(Russian Science Foundation (RSF))	This research was supported by grant of Russian Scientific Foundation 14-15-00245.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Bustan SA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-157; Alves AC, 2014, HUM MOL GENET, V23, P1817, DOI 10.1093/hmg/ddt573; Au A, 2017, ATHEROSCLEROSIS, V265, P60, DOI 10.1016/j.atherosclerosis.2017.08.003; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benn M, 2008, J CLIN ENDOCR METAB, V93, P1038, DOI 10.1210/jc.2007-1365; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; Burnett John R, 2008, Clin Biochem Rev, V29, P11; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cash TP, 2014, AGING CELL, V13, P1087, DOI 10.1111/acel.12261; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chiou KR, 2012, GENE, V498, P100, DOI 10.1016/j.gene.2012.01.092; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P676, DOI 10.1161/CIRCGENETICS.112.963314; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Di Pietro N, 2016, VASC PHARMACOL, V84, P1, DOI 10.1016/j.vph.2016.05.013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Ershova AI, 2012, ULTRASOUND MED BIOL, V38, P417, DOI 10.1016/j.ultrasmedbio.2011.11.014; Rios-Gonzalez BE, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/150358; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernandez-Higuero JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18184; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaffney D, 1998, ATHEROSCLEROSIS, V137, P167, DOI 10.1016/S0021-9150(97)00242-6; Gu QL, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176613, 10.1590/1414-431x20176613]; Gu W, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0125-z; Huijgen R, 2012, HUM MUTAT, V33, P448, DOI 10.1002/humu.21660; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P157, DOI 10.1016/j.numecd.2009.03.016; Kanoni S, 2016, HUM MOL GENET, V25, P4094, DOI 10.1093/hmg/ddw227; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; [Хлебус Э.Ю. Khlebus E. YU.], 2017, [Российский кардиологический журнал, Russian Journal of Cardiology, Rossiiskii kardiologicheskii zhurnal], P49, DOI 10.15829/1560-4071-2017-10-49-54; Kim DS, 2013, J LIPID RES, V54, P1512, DOI 10.1194/jlr.P035238; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kulminski AM, 2013, AGING CELL, V12, P237, DOI 10.1111/acel.12046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lankin VZ, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1081, DOI 10.1134/S0006297907100069; Lankin VZ, 2012, MOL CELL BIOCHEM, V365, P93, DOI 10.1007/s11010-012-1247-5; Lankin V, 2014, MOL CELL BIOCHEM, V395, P241, DOI 10.1007/s11010-014-2131-2; Lankin Vadim Z, 2017, Curr Aging Sci, V10, P18; Lankin VZ, 2003, MOL CELL BIOCHEM, V249, P129, DOI 10.1023/A:1024742907379; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee Seunggeun, 2015, SKAT SNP SET SEQUENC; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao YC, 2008, CLIN BIOCHEM, V41, P306, DOI 10.1016/j.clinbiochem.2007.11.011; Lin WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21824; Linton M., 2015, ROLE LIPIDS LIPOPROT; Liu CQ, 2015, INT J CLIN EXP MED, V8, P16571; Liu XY, 2013, JPN J CLIN ONCOL, V43, P362, DOI 10.1093/jjco/hyt018; Lusis AJ, 2012, TRENDS GENET, V28, P267, DOI 10.1016/j.tig.2012.03.001; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Makela KM, 2013, CIRC-CARDIOVASC GENE, V6, P73, DOI 10.1161/CIRCGENETICS.112.964965; Malovini A, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00017; Maurer F, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14326; Muiya P, 2009, INT J DIABETES MELLI, V1, P16, DOI DOI 10.1016/J.IJDM.2009.05.003; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Peddareddygari Leema Reddy, 2015, Case Rep Genet, V2015, P219691, DOI 10.1155/2015/219691; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; [Прус Ю.А. Prus Y.A.], 2017, [Атеросклероз и дислипидемии, Journal of atherosclerosis and dyslipidemias, Ateroskleroz i dislipidemii], P84; Pullinger CR, 1996, HUM GENET, V98, P678, DOI 10.1007/s004390050283; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radovica-Spalvina I, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0230-x; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Rytova AI, 2017, RUSS J GENET+, V53, P1091, DOI 10.1134/S1022795417100088; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Starcevic JN, 2014, VASA, V43, P171, DOI 10.1024/0301-1526/a000346; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Ung C, 2017, VISION RES, V139, P168, DOI 10.1016/j.visres.2017.03.007; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiao D, 2015, GENES GENOM, V37, P621, DOI 10.1007/s13258-015-0292-3; Yoshida T, 2009, HYPERTENS RES, V32, P411, DOI 10.1038/hr.2009.22; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhou F, 2018, ONCOTARGET, V9, P2249, DOI 10.18632/oncotarget.23369; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	94	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217620	10.1371/journal.pone.0217620	http://dx.doi.org/10.1371/journal.pone.0217620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150472	Green Published, gold			2022-12-27	WOS:000469759100074
J	Kimm, MA; Gross, C; Dean-Ben, XL; Ron, A; Rummeny, EJ; Lin, HCA; Holtke, C; Razansky, D; Wildgruber, M				Kimm, Melanie A.; Gross, Claudia; Dean-Ben, Xose Luis; Ron, Avihai; Rummeny, Ernst J.; Lin, Hsiao-Chun Amy; Hoeltke, Carsten; Razansky, Daniel; Wildgruber, Moritz			Optoacoustic properties of Doxorubicin - A pilot study	PLOS ONE			English	Article							TOMOGRAPHY MSOT; TUMOR; MODEL; QUANTIFICATION; CHEMOTHERAPY; LIPOSOMES; DYNAMICS; CANCER; TISSUE; LIGHT	Doxorubicin (DOX) is a widely used chemotherapeutic anticancer drug. Its intrinsic fluorescence properties enable investigation of tumor response, drug distribution and metabolism. First phantom studies in vitro showed optoacoustic property of DOX. We therefore aimed to further investigate the optoacoustic properties of DOX in biological tissue in order to explore its potential as theranostic agent. We analysed doxorubicin hydrochloride (Dox center dot HCl) and liposomal encapsulated doxorubicin hydrochloride (Dox center dot Lipo), two common drugs for anticancer treatment in clinical medicine. Optoacoustic measurements revealed a strong signal of both doxorubicin substrates at 488 nm excitation wavelength. Post mortem analysis of intra-tumoral injections of DOX revealed a detectable optoacoustic signal even at three days after the injection. We thereby demonstrate the general feasibility of doxorubicin detection in biological tissue by means of optoacoustic tomography, which could be applied for high resolution imaging at mesoscopic depths dictated by effective penetration of visible light into the biological tissues.	[Kimm, Melanie A.; Gross, Claudia; Rummeny, Ernst J.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany; [Dean-Ben, Xose Luis; Razansky, Daniel] Univ Zurich, Fac Med, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Swiss Fed Inst Technol, Dept Informat Technol & Elect Engn, Zurich, Switzerland; [Ron, Avihai; Lin, Hsiao-Chun Amy; Razansky, Daniel] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Munich, Germany; [Ron, Avihai; Lin, Hsiao-Chun Amy; Razansky, Daniel] TranslaTUM, Ctr Translat Canc Res, Munich, Germany; [Hoeltke, Carsten; Wildgruber, Moritz] Univ Klinikum Munster, Dept Clin Radiol, Translat Res Imaging Ctr, Munster, Germany; [Gross, Claudia] Tech Univ Munich, Inst Pathol, Munich, Germany	Technical University of Munich; University of Geneva; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; Technical University of Munich	Wildgruber, M (corresponding author), Univ Klinikum Munster, Dept Clin Radiol, Translat Res Imaging Ctr, Munster, Germany.	moritz.wildgruber@ukmuenster.de	; Razansky, Daniel/B-8590-2015	Kimm, Melanie A./0000-0001-6833-9738; Razansky, Daniel/0000-0001-8676-0964; Lin, Hsiao-Chun Amy/0000-0002-1393-369X; Dean-Ben, Xose Luis/0000-0002-8557-7778				Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Becker A, 2018, EUR RADIOL, V28, P602, DOI 10.1007/s00330-017-5002-x; Blazkova I, 2014, ELECTROPHORESIS, V35, P1040, DOI 10.1002/elps.201300393; Carlson M, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.11.116010; Cook JR, 2011, BIOMED OPT EXPRESS, V2, P3193, DOI 10.1364/BOE.2.003193; CUMMINGS J, 1993, BIOCHEM PHARMACOL, V45, P2550, DOI 10.1016/0006-2952(93)90237-Q; DELANGE JHM, 1992, CYTOMETRY, V13, P571, DOI 10.1002/cyto.990130604; Ding L, 2017, IEEE T MED IMAGING, V36, P1858, DOI 10.1109/TMI.2017.2704019; Diot G, 2017, CLIN CANCER RES, V23, P6912, DOI 10.1158/1078-0432.CCR-16-3200; Dong X, 2017, DRUG DELIV, V24, P641, DOI 10.1080/10717544.2017.1289570; Ehrke MJ, 2000, INT J CANCER, V87, P101, DOI 10.1002/1097-0215(20000701)87:1<101::AID-IJC15>3.0.CO;2-B; Fan Y, 2011, ACTA PHARMACOL SIN, V32, P408, DOI 10.1038/aps.2010.217; Griffin JI, 2017, ACS NANO, V11, P11584, DOI 10.1021/acsnano.7b06524; Han SH, 2015, PROC SPIE, V9419, DOI 10.1117/12.2082439; Ibsen S, 2013, J MASS SPECTROM, V48, P768, DOI 10.1002/jms.3221; Idani H, 2000, INT J CANCER, V88, P645, DOI 10.1002/1097-0215(20001115)88:4<645::AID-IJC20>3.0.CO;2-4; Imai T, 2017, CANCER BIOL THER, V18, P101, DOI 10.1080/15384047.2016.1276137; Jansen K, 2014, ULTRASOUND MED BIOL, V40, P1037, DOI 10.1016/j.ultrasmedbio.2014.01.008; Kauffman Melinda K, 2016, React Oxyg Species (Apex), V2, P432, DOI 10.20455/ros.2016.873; Kress J, 2015, BIOMED OPT EXPRESS, V6, P3546, DOI 10.1364/BOE.6.003546; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lin HCA, 2017, THERANOSTICS, V7, P4470, DOI 10.7150/thno.20616; McNally LR, 2016, CLIN CANCER RES, V22, P3432, DOI 10.1158/1078-0432.CCR-16-0573; Motlagh NSH, 2016, BIOMED OPT EXPRESS, V7, P2400, DOI 10.1364/BOE.7.002400; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Ntziachristos Vasilis, 2013, Recent Results Cancer Res, V187, P133, DOI 10.1007/978-3-642-10853-2_4; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Omar M, 2015, NEOPLASIA, V17, P208, DOI 10.1016/j.neo.2014.12.010; Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98; Santos MA, 2017, THERANOSTICS, V7, P2718, DOI 10.7150/thno.19662; Stucke-Ring J, 2016, ONCOTARGET, V7, P82458, DOI 10.18632/oncotarget.12559; Tang ZH, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-16; Wong TTW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602168; Yang JM, 2009, OPT LETT, V34, P1591, DOI 10.1364/OL.34.001591	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217576	10.1371/journal.pone.0217576	http://dx.doi.org/10.1371/journal.pone.0217576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150471	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000469759100068
J	Miller, N; Liu, Y; Krivochenitser, R; Rokers, B				Miller, Nathaniel; Liu, Yao; Krivochenitser, Roman; Rokers, Bas			Linking neural and clinical measures of glaucoma with diffusion magnetic resonance imaging (dMRI)	PLOS ONE			English	Article							OPTIC-NERVE; WHITE-MATTER; VISUAL PATHWAYS; TENSOR MRI; CONNECTIVITY; TRACKING; MOUSE	Purpose To link optic nerve (ON) structural properties to clinical markers of glaucoma using advanced, semi-automated diffusion magnetic resonance imaging (dMRI) tractography in human glaucoma patients. Methods We characterized optic neuropathy in patients with unilateral advanced-stage glaucoma (n = 6) using probabilistic dMRI tractography and compared their results to those in healthy controls (n = 6). Results We successfully identified the ONs of glaucoma patients based on dMRI in all patients and confirmed that dMRI measures of the ONs correlated with clinical markers of glaucoma severity. Specifically, we found reduced fractional anisotropy (FA) in the ONs of eyes with advanced, as compared to mild, glaucoma (F(1,10) = 55.474, p < 0.0001, FDR < 0.0005). Furthermore, by comparing the ratios of ON FA in glaucoma patients to those of healthy controls (n = 6), we determined that this difference was beyond that expected from normal anatomical variation (F(1,9) = 20.276, p < 0. 005). Finally, we linked the dMRI measures of ON FA to standard clinical glaucoma measures. ON vertical cup-to-disc ratio (vCD) predicted ON FA (F(1,10) = 11.061, p < 0.01, R-2 = 0.66), retinal nerve fiber layer thickness (RNFL) predicted ON FA (F(1,10) = 11.477, p < 0.01, R-2 = 0.63) and ON FA predicted perceptual deficits (visual field index [VFI]) (F(1,10) = 15.308, p < 0.005, R-2 = 0.52). Conclusion We describe semi-automated methods to detect glaucoma-related structural changes using dMRI and confirm that they correlate with clinical measures of glaucoma.	[Miller, Nathaniel; Rokers, Bas] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Liu, Yao; Krivochenitser, Roman] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Liu, Yao; Rokers, Bas] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA; [Krivochenitser, Roman] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Rokers, B (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.; Rokers, B (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA.	rokers@wisc.edu		Rokers, Bas/0000-0003-0573-5332; LIU, YAO/0000-0002-0700-0148	University of Wisconsin-Madison Undergraduate Academic Awards Office; Wisconsin Alumni Research Foundation; Research to Prevent Blindness	University of Wisconsin-Madison Undergraduate Academic Awards Office; Wisconsin Alumni Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This research was supported by grants from University of Wisconsin-Madison Undergraduate Academic Awards Office (NM), the Wisconsin Alumni Research Foundation (BR), and Research to Prevent Blindness (YL and RK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allen B, 2018, INVEST OPHTH VIS SCI, V59, P921, DOI 10.1167/iovs.17-22930; Allen B, 2015, VISION RES, V114, P48, DOI 10.1016/j.visres.2014.12.021; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolacchi F, 2012, INVEST OPHTH VIS SCI, V53, P4191, DOI 10.1167/iovs.11-9345; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chang ST, 2014, J GLAUCOMA, V23, P513, DOI 10.1097/IJG.0b013e318294861d; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Davis BM, 2016, ACTA NEUROPATHOL, V132, P807, DOI 10.1007/s00401-016-1609-2; Engelhorn T, 2011, ACAD RADIOL, V18, P764, DOI 10.1016/j.acra.2011.01.014; Frezzotti P, 2016, HUM BRAIN MAPP, V37, P4581, DOI 10.1002/hbm.23330; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097445; Malania M, 2017, INVEST OPHTH VIS SCI, V58, P2939, DOI 10.1167/iovs.16-21191; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nouraeinejad A, 2016, BINOCULAR VISION ANO; Ohno N, 2015, BRIT J OPHTHALMOL, V99, P1051, DOI 10.1136/bjophthalmol-2014-305809; Ophthalmology AAo, 2015, ICD 10 GLAUC REF GUI; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rokem A, 2017, J VISION, V17, DOI 10.1167/17.2.4; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sidek S, 2014, EUR J RADIOL, V83, P1437, DOI 10.1016/j.ejrad.2014.05.014; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Xu JQ, 2008, NMR BIOMED, V21, P928, DOI 10.1002/nbm.1307; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yoshimine S, 2018, BRAIN STRUCT FUNCT, V223, P3889, DOI 10.1007/s00429-018-1702-5; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	43	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217011	10.1371/journal.pone.0217011	http://dx.doi.org/10.1371/journal.pone.0217011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150402	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100029
J	Morris, MD; Andrew, E; Tan, JY; Maher, L; Hoff, C; Darbes, L; Page, K				Morris, Meghan D.; Andrew, Erin; Tan, Judy Y.; Maher, Lisa; Hoff, Colleen; Darbes, Lynae; Page, Kimberly			Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIV RISK; MALE COUPLES; SEXUAL RISK; USERS; INFECTION; NEEDLE; PREVENTION; PEOPLE; INTERDEPENDENCE	Sharing of injection drug use paraphernalia is a dyadic process linked to the transmission of HIV and hepatitis C virus (HCV). Despite this, limited research exists identifying specific dyadic interpersonal factors driving injecting partners' engagement in needle/syringe and ancillary injecting equipment sharing among young adults. Using semi-structured in-depth interview data collected between 2014 and 2015 from twenty-seven people who inject drugs (PWID), we applied an inductive approach to identify key injection drug-related interpersonal factors and developed a conceptual model integrating the findings based on interdependence theory. Interactions between injecting partners resulted in varying levels of injecting-related trust, cooperation, intimacy, and power. These factors interacted to collectively influence the type and level of risk perceived and enacted by injecting partners. The relationship between these injecting-related interpersonal factors, on the one hand, and risk perception on the other was dynamic and fluctuated between actions that protect the self (person-centered) and those that protect the partnership (partnership-centered). These findings indicate that the interpersonal context exerts substantial influence that shapes risk perception in all types of injecting partnerships. Partnership-focused prevention strategies should consider the dynamics of trust, cooperation, intimacy, and power, in characterizing dyadic risk perceptions and in understanding risky injecting practices among PWID.	[Morris, Meghan D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Andrew, Erin] Univ Penn, Nursing Sci, Philadelphia, PA 19104 USA; [Tan, Judy Y.] Univ Calif San Francisco, Ctr Aids Prevent Sci, San Francisco, CA 94143 USA; [Maher, Lisa] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Hoff, Colleen] San Francisco State Univ, Ctr Res & Educ Gender & Sexual, San Francisco, CA 94132 USA; [Darbes, Lynae] Univ Michigan, Sch Nursing, Ctr Sexual & Hlth Dispar, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Page, Kimberly] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of California System; University of California San Francisco; University of Pennsylvania; University of California System; University of California San Francisco; University of New South Wales Sydney; Kirby Institute; California State University System; San Francisco State University; University of Michigan System; University of Michigan; University of New Mexico	Morris, MD (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Meghan.Morris@ucsf.edu		Darbes, Lynae/0000-0003-4738-6812; Morris, Meghan/0000-0003-2762-2953; Maher, Lisa/0000-0001-6020-6519	National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30-AI027763]; NIH, National Institute on Drug Abuse (NIDA) [R01DA016017]; NIH/NIDA Career Development Award [K01DA037802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA037802, R01DA016017] Funding Source: NIH RePORTER	National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research; NIH, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH/NIDA Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a grant from the National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30-AI027763 and NIH, National Institute on Drug Abuse (NIDA) research grant (R01DA016017). MDM is supported through an NIH/NIDA Career Development Award (K01DA037802).	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Albarracin D, 2010, AIDS BEHAV, V14, pS185, DOI 10.1007/s10461-010-9805-x; Gyarmathy VA, 2011, SCAND J INFECT DIS, V43, P32, DOI 10.3109/00365548.2010.513064; Chamaz K., 2006, CONSTRUCTING GROUNDE; Darbes LA, 2014, ARCH SEX BEHAV, V43, P47, DOI 10.1007/s10508-013-0206-x; Dwyer R, 2011, ADDICT RES THEORY, V19, P352, DOI 10.3109/16066359.2011.562619; El-Bassel N, 2015, JAIDS-J ACQ IMM DEF, V69, pS182, DOI 10.1097/QAI.0000000000000628; El-Bassel N, 2014, CURR HIV-AIDS REP, V11, P45, DOI 10.1007/s11904-013-0192-6; Falck RS, 1995, AIDS EDUC PREV, V7, P523; Fraser S, 2004, HEALTH-LONDON, V8, P199, DOI 10.1177/1363459304041070; Fraser S, 2014, DRUG-EDUC PREV POLIC, V21, P88, DOI 10.3109/09687637.2013.776517; GIBSON DR, 1993, INT J ADDICT, V28, P973, DOI 10.3109/10826089309062177; Gyarmathy VA, 2010, AIDS BEHAV, V14, P141, DOI 10.1007/s10461-008-9518-6; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Janulis P, 2016, INT J DRUG POLICY, V27, P56, DOI 10.1016/j.drugpo.2015.09.006; Johnson RA, 2002, ADDICTION, V97, P1011, DOI 10.1046/j.1360-0443.2002.00165.x; Kelley H. H, 1978, INTERPERSONAL RELATI; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Lewis MA, 2006, HEALTH EDUC RES, V21, P488, DOI 10.1093/her/cyh075; Louis GW, 2009, BIOL REPROD, P157; MacRae R, 2000, AIDS CARE, V12, P505, DOI 10.1080/09540120050123909; McMahon JM, 2015, PREV SCI, V16, P341, DOI 10.1007/s11121-014-0540-9; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Morris MD, 2017, SUBSTANCE USE MISUSE; Morris MD, 2017, CLIN INFECT DIS, V64, P860, DOI 10.1093/cid/ciw869; Morris MD, 2015, DRUG ALCOHOL DEPEN, V156, P275, DOI 10.1016/j.drugalcdep.2015.09.025; Morris MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109282; Morse J., 2009, DEV GROUNDED THEORY, V1st; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Rance J, 2018, HEALTH-LONDON, V22, P3, DOI 10.1177/1363459316660859; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2003, DRUG-EDUC PREV POLIC, V10, P303, DOI 10.1080/0968763031000077733; Rhodes T., 1997, RISK THEORY EPIDEMIC, DOI [10.1111/1467-9566.ep10934410, DOI 10.1111/1467-9566.EP10934410]; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Rhodes T, 2017, SOC SCI MED, V180, P125, DOI 10.1016/j.socscimed.2017.03.012; Riehman KS, 2003, DRUG ALCOHOL DEPEN, V70, P1, DOI 10.1016/S0376-8716(02)00332-0; Rusbult C.E., 1996, INTERDEPENDENCE PROC; Shaw SY, 2007, ADDICTION, V102, P1626, DOI 10.1111/j.1360-0443.2007.01940.x; Simmons J, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-7; Starks TJ, 2014, ARCH SEX BEHAV, V43, P139, DOI 10.1007/s10508-013-0216-8; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Strauss A., 1997, GROUNDED THEORY PRAC; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Syvertsen JL, 2013, CULT HEALTH SEX, V15, P540, DOI 10.1080/13691058.2013.773381; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Tracy D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004988; Treloar C, 2016, DRUG ALCOHOL DEPEN, V168, P170, DOI 10.1016/j.drugalcdep.2016.09.010; Treloar C, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0045-2; Unger JB, 2006, ADDICT BEHAV, V31, P1607, DOI 10.1016/j.addbeh.2005.12.007; Wilson H, 2014, DRUG ALCOHOL DEPEN, V144, P274, DOI 10.1016/j.drugalcdep.2014.08.018	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217811	10.1371/journal.pone.0217811	http://dx.doi.org/10.1371/journal.pone.0217811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150518	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100115
J	Wu, Q; Zhang, DD; Zhao, Q; Liu, L; He, ZS; Chen, Y; Huang, H; Hou, YY; Yang, XF; Gu, J				Wu, Qing; Zhang, Dandan; Zhao, Qi; Liu, Lin; He, Zhisong; Chen, Yan; Huang, Hui; Hou, Yunyin; Yang, Xiaofang; Gu, Jie			Effects of transitional health management on adherence and prognosis in elderly patients with acute myocardial infarction in percutaneous coronary intervention: A cluster randomized controlled trial	PLOS ONE			English	Article							SECONDARY PREVENTION; CARE; MEDICATION	Purpose This study aimed to assess the effects of transitional health management on adherence and prognosis in elderly patients with acute myocardial infarction undergoing percutaneous coronary intervention. Methods We conducted the trial from June 2016 to December 2016. A total of one hundred and fifty patients with acute myocardial infarction after PCI who met the inclusion criteria were randomly divided into an experimental (n = 75) group and a control (n = 75) group. The participants in the experimental group received transitional health management for three months. The two groups of patients were evaluated for treatment adherence, quality of life, clinical indicators, adverse cardiovascular events and statistics regarding readmission rates at baseline and 6 months after discharge. Results Compared with the controls, patients in the intervention group demonstrated better medication adherence, reexamination adherence, healthy lifestyle and clinical indicators (all P<0.05) and lower rates of adverse cardiovascular events and readmission (all P<0.05). Conclusion Transitional health management effectively improved adherence in elderly patients with acute myocardial infarction after PCI, ameliorated clinical indicators, and effectively reduced the incidence of adverse cardiovascular events and readmission rates. Transitional health management was an effective intervention for PCI patients after discharge.	[Wu, Qing; Zhang, Dandan; Liu, Lin; Hou, Yunyin; Yang, Xiaofang; Gu, Jie] Soochow Univ, Nursing Dept, Affiliated Hosp 1, Suzhou, Peoples R China; [Zhao, Qi] Soochow Univ, Dept Radiotherapy, Affiliated Hosp 1, Suzhou, Peoples R China; [He, Zhisong] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou, Peoples R China; [Chen, Yan; Huang, Hui] Soochow Univ, Nursing Dept, Affiliated Hosp 2, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhao, Q (corresponding author), Soochow Univ, Dept Radiotherapy, Affiliated Hosp 1, Suzhou, Peoples R China.	734867417@qq.com		Wu, Qing/0000-0003-1628-3933	Suzhou Science and Technology Bureau, China; Science, Education and Health Youth Science and Technology Project [KJXW2012008]	Suzhou Science and Technology Bureau, China; Science, Education and Health Youth Science and Technology Project	This work was supported by Suzhou Science and Technology Bureau, China. The program was financed by the Science, Education and Health Youth Science and Technology Project. (KJXW2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay VS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-924; Amberbir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197728; Bansilal S, 2015, INT J CARDIOL, V201, pS1, DOI 10.1016/S0167-5273(15)31026-3; Chen L, 2016, J CLIN MED PRACT, V20, P171; Chen SQ, 2010, CHINESE J NURSING ED, V7, P457; Chen WL., 2018, CHINESE CIRCULATION, V33, P1; Chouinard Maud-Christine, 2005, Nurs Res, V54, P243; Fermann GJ, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003581; Franklin MM, 2017, NURSE PRACT, V42, P12, DOI 10.1097/01.NPR.0000511701.94615.4f; Gabriel P, 2017, J PEDIATR-US, V188, P263, DOI 10.1016/j.jpeds.2017.05.066; Hagglund L, 2018, NURS OPEN, V5, P176, DOI 10.1002/nop2.127; Hamdi AHA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00410; Ho PM, 2014, JAMA INTERN MED, V174, P186, DOI 10.1001/jamainternmed.2013.12944; Jackson CT, 2013, HEALTH AFFAIR, V32, P1407, DOI 10.1377/hlthaff.2013.0047; Laake K, 2016, J LIPIDS, V2016, DOI 10.1155/2016/4945720; [李茂巍 Li Maowei], 2015, [第二军医大学学报, Academic Journal of Second Military Medical University], V36, P851; Liu Y., 2006, CHINESE J GEOLOGICAL, P61; Lv JF, 2016, INT HEART J, V57, P167, DOI 10.1536/ihj.15-259; Meisinger C, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-115; Morrison VL, 2015, VALUE HEALTH, V18, P206, DOI 10.1016/j.jval.2014.12.013; Murre JMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120644; Ning JL., 2016, TIANJIN J NURSING, V24, P35; Sanda B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188102; Schroter S, 2004, HEART, V90, P1460, DOI 10.1136/hrt.2003.021899; Sharoni SKA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192417; Shen XY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187745; Tillmann AC, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.6489; Wang J., 2016, WORLD CLIN DRUGS, V5; Wang ZH, 2014, CHINESE PHARMACOECON, V10, P112; Wong MCS, 2013, INT J CARDIOL, V168, P928, DOI 10.1016/j.ijcard.2012.10.048; Yang JH, 2014, CRIT CARE MED, V42, P17, DOI 10.1097/CCM.0b013e3182a2701d; Yin LZ, 2009, J NURSING, V24, P82; Yu GQ, 2018, GENES DIS, V5, P335, DOI 10.1016/j.gendis.2018.01.001; Zhang XW, 2017, CHINESE J HLTH MED, V19, P272; Zhou T, 2016, J BENGBU MED COL, V41, P126, DOI [10.13898/j.cnki.issn.1000-2200.2016.01.04, DOI 10.13898/J.CNKI.ISSN.1000-2200.2016.01.04]; Zink T, 2017, J AM BOARD FAM MED, V30, P16, DOI 10.3122/jabfm.2017.01.160118; 刘志辉, 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P5765	37	8	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217535	10.1371/journal.pone.0217535	http://dx.doi.org/10.1371/journal.pone.0217535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150451	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100063
J	Cerna-Turoff, I; Fischer, HT; Mayhewid, S; Devries, K				Cerna-Turoff, Ilan; Fischer, Hanna-Tina; Mayhewid, Susannah; Devries, Karen			Violence against children and natural disasters: A systematic review and meta-analysis of quantitative evidence	PLOS ONE			English	Review							HURRICANE KATRINA; SOCIAL SUPPORT; DOMESTIC VIOLENCE; MENTAL-HEALTH; ABUSE; SYMPTOMS; RISK; VICTIMIZATION; PREVALENCE; ADJUSTMENT	Objectives Reviews of violence against children in disaster settings focus on armed conflict. Little is understood about natural disasters which has implications in planning humanitarian response. We examined the magnitude and direction of the association between exposure to natural disasters and physical, emotional, and sexual violence against children, and assessed the quality of the evidence. Methods We searched 15 health and social science databases from first record until May 16, 2018. Publications describing all types of quantitative study design were eligible for inclusion. We presented study characteristics and quality in a narrative form and generated pooled estimates using a three-level random effects model. We evaluated Cochrane's Q with p-values below 0.10 and radial plots to assess heterogeneity. Planned subgroup analyses explored differential results by violence form, study design, and analysis method. Results 11 publications met inclusion criteria. The majority were cross-sectional studies examining physical or sexual violence in the United States. We found no evidence of a consistent association or directional influence between natural disasters and violence against children. Combined categorical violence outcomes had substantial heterogeneity [Q (df = 66) = 252.83, p < 0.001]. Subgroups without evidence of heterogeneity had confidence intervals that included a possible null effect. Our findings were mainly limited by inconsistencies in operational definitions of violence, a lack of representative sampling, and unclear establishment of temporal order between natural disaster exposure and violence outcomes. Conclusions Based on the available evidence, we cannot confidently conclude that natural disasters increase the level or severity of violence against children above non-disaster settings, however heterogeneity and study quality hamper our ability to draw firm conclusions. More nuanced and rigorous research is needed to inform practice and policy as natural disasters increasingly affect human populations.	[Cerna-Turoff, Ilan; Mayhewid, Susannah; Devries, Karen] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Fischer, Hanna-Tina] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University	Cerna-Turoff, I (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.	it2208@caa.columbia.edu	Fischer, Hanna-Tina/ABC-3579-2020; Devries, Karen/K-1083-2016	Cerna-Turoff, Ilan/0000-0002-0787-9068; Mayhew, Susannah/0000-0002-2433-3809; Devries, Karen/0000-0001-8935-2181				ADAMS PR, 1984, AM PSYCHOL, V39, P252, DOI 10.1037/0003-066X.39.3.252; Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049; Barton A., 1969, COMMUNITIES DISASTER, V1st; Becker-Blease KA, 2010, CHILD DEV, V81, P1040, DOI 10.1111/j.1467-8624.2010.01453.x; Bentzen J. S, 2015, 1506 U COP DEP EC; Berger LM, 2004, CHILD YOUTH SERV REV, V26, P725, DOI 10.1016/j.childyouth.2004.02.017; Biswas A, 2010, RURAL REMOTE HEALTH, V10; Boluyt N, 2008, ARCH PEDIAT ADOL MED, V162, P111, DOI 10.1001/archpediatrics.2007.40; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Breetzke GD, 2018, AUST NZ J CRIMINOL, V51, P135, DOI 10.1177/0004865816679687; Buttell F.P., 2009, TRAUMATOL INT J, V1, P6, DOI [10.1177/1534765609334822, DOI 10.1177/1534765609334822]; Callaghan WM, 2007, MATERN CHILD HLTH J, V11, P307, DOI 10.1007/s10995-007-0177-4; Calo-Blanco A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176885; Catani C, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-33; Cederman LE, 2011, AM POLIT SCI REV, V105, P478, DOI 10.1017/S0003055411000207; Centre for Research on the Epidemiology of Disasters United Nations Office for Disaster Risk Reduction., 2018, EC LOSS POV DIS 1998; Cerna-Turoff I, 2017, PROSPERO INT PROSPEC; Chan CS, 2012, AM J COMMUN PSYCHOL, V49, P168, DOI 10.1007/s10464-011-9445-y; Clemens P., 1999, APPL BEHAV SCI REV, V7, P199, DOI DOI 10.1016/S1068-8595(00)80020-3; Collier P., 2003, BREAKING CONFLICT TR; Curtis T, 2000, CHILD ABUSE NEGLECT, V24, P1151, DOI 10.1016/S0145-2134(00)00176-9; Devries KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013583; Doidge JC, 2017, CHILD ABUSE NEGLECT, V64, P47, DOI 10.1016/j.chiabu.2016.12.002; Doll JJ, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013503834; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; DRABEK TE, 1976, MASS EMERGENCIES, V1, P89; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Feder A, 2013, J AFFECT DISORDERS, V147, P156, DOI 10.1016/j.jad.2012.10.027; Finkelhor D, 2007, DEV PSYCHOPATHOL, V19, P149, DOI 10.1017/S0954579407070083; Fritz C.E., 1961, CONT SOCIAL PROBLEMS, P651; Fukuma S, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010501; Ganguly S, 2018, DAEDALUS-US, V147, P78, DOI 10.1162/DAED_a_00475; Gearhart S, 2018, VIOLENCE GEND, V5, P87, DOI 10.1089/vio.2017.0077; Groen JA, 2010, DEMOGRAPHY, V47, P821, DOI 10.1007/BF03214587; Hafstad GS, 2012, J CHILD FAM STUD, V21, P293, DOI 10.1007/s10826-011-9474-z; Hallward Peter, 2010, DAMMING FLOOD HAITI; Hamby S, 2010, CHILD ABUSE NEGLECT, V34, P734, DOI 10.1016/j.chiabu.2010.03.001; Heath CW, 1986, JAMA-J AM MED ASSOC, V255, P2500; Hebert Martine, 2017, J Child Adolesc Trauma, V10, P51, DOI 10.1007/s40653-016-0119-7; Henslee AM, 2015, J PSYCHOL, V149, P630, DOI 10.1080/00223980.2014.953441; Hikichi H, 2016, AM J EPIDEMIOL, V183, P902, DOI 10.1093/aje/kwv335; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Internal Displacement Monitoring Centre, 2017, GLOB REP INT DISPL G; Jackson D, 2017, RES SYNTH METHODS, V8, P290, DOI 10.1002/jrsm.1240; Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8; KANIASTY K, 1995, AM J COMMUN PSYCHOL, V23, P447, DOI 10.1007/BF02506964; KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Kelley ML, 2010, J TRAUMA STRESS, V23, P582, DOI 10.1002/jts.20573; Kelly JTD, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000668; Kolbe Athena R, 2010, Med Confl Surviv, V26, P281, DOI 10.1080/13623699.2010.535279; Kolbo JR, 1996, J INTERPERS VIOLENCE, V11, P281, DOI 10.1177/088626096011002010; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877; LeBeau J., 2002, CRIME PREV COMMUNITY, V4, P53, DOI [10.1057/palgrave.cpcs.8140114, DOI 10.1057/PALGRAVE.CPCS.8140114]; Leitner M, 2011, PROF GEOGR, V63, P244, DOI 10.1080/00330124.2010.547156; Levy BR, 2009, J RELIG HEALTH, V48, P38, DOI 10.1007/s10943-008-9162-5; Litrownik AJ, 2003, J FAM VIOLENCE, V18, P59, DOI 10.1023/A:1021405515323; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Madkour AS, 2011, J ADOLESCENT HEALTH, V49, P213, DOI 10.1016/j.jadohealth.2011.06.005; McConnell KM, 2006, J CLIN PSYCHOL, V62, P1469, DOI 10.1002/jclp.20325; Meinck F, 2015, CHILD ABUSE REV, V24, P182, DOI 10.1002/car.2283; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morrow B.H., 1997, HURRICANE ANDREW ETH, P141; Mytton J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004606.pub2; National Institutes of Health (NIH), 2021, STUD QUAL ASS TOOLS; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Pastor DA, 2018, MULTIVAR BEHAV RES, V53, P74, DOI 10.1080/00273171.2017.1365684; Peduzzi P, 2009, NAT HAZARD EARTH SYS, V9, P1149, DOI 10.5194/nhess-9-1149-2009; Peek L, 2011, J FAM ISSUES, V32, P1371, DOI 10.1177/0192513X11412496; Perrow C., 2011, NEXT CATASTROPHE RED; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; QUARANTELLI EL, 1977, ANNU REV SOCIOL, V3, P23, DOI 10.1146/annurev.so.03.080177.000323; Quarantelli EL, 2008, SOC RES, V75, P873; R Development Core Team, 2009, R LANG ENV STAT COMP; Rubenstein BL, 2017, TRAUMA VIOLENCE ABUS, P1; Schmahl C., 2010, IMPACT EARLY LIFE TR, P178, DOI [10.1017/CBO9780511777042, 10.1017/CBO9780511777042.021, DOI 10.1017/CBO9780511777042.021]; Schumacher JA, 2010, VIOLENCE VICTIMS, V25, P588, DOI 10.1891/0886-6708.25.5.588; Singh R., 2017, DIVERGING PATHWAYS W; Sloand E, 2017, J ADV NURS, V73, P3200, DOI 10.1111/jan.13316; Sriskandarajah V, 2015, SOC SCI MED, V146, P257, DOI 10.1016/j.socscimed.2015.10.010; Stark L, 2016, SOC SCI MED, V152, P125, DOI 10.1016/j.socscimed.2016.01.052; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Stewart F, 2002, BRIT MED J, V324, P342, DOI 10.1136/bmj.324.7333.342; Stockl Heidi, 2014, BMC Public Health, V14, P751, DOI 10.1186/1471-2458-14-751; Stoltenborgh M, 2013, INT J PSYCHOL, V48, P81, DOI 10.1080/00207594.2012.697165; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sutton A.J., 2000, METHODS METAANALYSIS; Temple Jeff R, 2011, Am J Disaster Med, V6, P201; Terranova AM, 2009, PSYCHOL SCHOOLS, V46, P333, DOI 10.1002/pits.20379; Thomas V, 2014, CLIMATIC CHANGE, V126, P381, DOI 10.1007/s10584-014-1232-y; Thoms ONT, 2007, HUM RIGHTS QUART, V29, P674, DOI 10.1353/hrq.2007.0034; United Nations Children's Fund, 2014, ENV FINANCE BLO 0116; United Nations Children's Fund, 2017, ANN REP 2016; United Nations International Strategy for Disaster Reduction, 2009, 2009 UNISDR TERM DIS; Varano SP, 2010, J CRIM JUST, V38, P42, DOI 10.1016/j.jcrimjus.2009.11.006; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weems CF, 2007, BEHAV RES THER, V45, P2295, DOI 10.1016/j.brat.2007.04.013; Wisner B., 2004, At risk: natural hazards, people's vulnerability and disasters; World Health Organization, 2002, GEND HLTH DIS; World Health Organization, 2005, VIOL DIS, DOI [10.1111/j.0361-3666.2005.00272.x, DOI 10.1111/J.0361-3666.2005.00272.X]; Zahran S., 2009, INT J MASS EMERGENCI, V27, P26	106	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217719	10.1371/journal.pone.0217719	http://dx.doi.org/10.1371/journal.pone.0217719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145758	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000469425500032
J	Segura, M; Lopez-Gigosos, R; Mariscal-Lopez, E; Gutierrez-Bedmar, M; Mariscal, A				Segura, Marina; Lopez-Gigosos, Rosa; Mariscal-Lopez, Eloisa; Gutierrez-Bedmar, Mario; Mariscal, Alberto			Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017	PLOS ONE			English	Article							ECONOMIC-IMPACT; TOURISM; TERRORISM	Crises and disasters affect the numbers of people traveling either for tourism or other reasons. Many studies have been published on the effects of such events on travel, especially on tourism, and based on the arrivals or departures of travelers to or from countries. Our aim was to assess the influence of these events on the demand for pre-travel medical consultation in an International Vaccination Centre (IVC). Data on 94683 international travelers who visited 113529 international destinations attended at the IVC of Malaga (Spain) during 2000-2017 were studied. A descriptive and time series analyses was conducted. The demand to IVC was 3.47 times higher in 2017 than in 2000. The increase has not been the same for all destinations: Travel to South-East Asia and Western Pacific World Health Organization (WHO) regions has multiplied by 10, while in the same period, Africa WHO region has declined from 36% to 20% of total demand. Thailand, India and Brazil were the countries with the highest demand (21% of all pre-travel consultations). We found out three periods, concurrent with some socioeconomic or health events, in which the number of travellers attend decline with respect to the previous years, or the growth was very slow. Growth in the demand for pre-travel medical advice in parallel with a foreseeable increase in the number of travelers is expected. Pre-travel medical services must be adapted to this increase. This study of the trend of demand for pre-travel medical information should new related problems to travel to be identified and quantified, and should assist improvement of policies and programs aimed at care of travelers.	[Segura, Marina; Lopez-Gigosos, Rosa] Port Hlth Author Malaga, Med Serv, Int Vaccinat Ctr, Malaga, Spain; [Lopez-Gigosos, Rosa; Mariscal-Lopez, Eloisa; Gutierrez-Bedmar, Mario; Mariscal, Alberto] Univ Malaga, Fac Med, Dept Publ Hlth & Psychiat, Malaga, Spain	Universidad de Malaga	Lopez-Gigosos, R (corresponding author), Port Hlth Author Malaga, Med Serv, Int Vaccinat Ctr, Malaga, Spain.; Lopez-Gigosos, R (corresponding author), Univ Malaga, Fac Med, Dept Publ Hlth & Psychiat, Malaga, Spain.	roslopgig@uma.es	Gutierrez-Bedmar, Mario/F-2364-2018; Mariscal, Alberto/ABH-5409-2020	Gutierrez-Bedmar, Mario/0000-0003-0898-8212; Mariscal, Alberto/0000-0002-4684-2161; Lopez-gigosos, Rosa/0000-0002-5303-3151; Mariscal-Lopez, Eloisa/0000-0002-5825-8579; Segura Moreno, Marina/0000-0001-8125-7980				Ahlfeldt GM, 2015, JAHRB NATL STAT, V235, P3; AlBattat A. R., 2013, INT BUSINESS RES, V6, P92; Ali A., 2012, CHALLENGES TOURISM C, V6, P1162; [Anonymous], 2016, ITB WORLD TRAV TREND; Arana JE, 2008, ANN TOURISM RES, V35, P299, DOI 10.1016/j.annals.2007.08.003; Bagans L, 2011, CRISES TOURISM IND T; Banki MB, 2016, TOUR MANAG PERSPECT, V18, P141, DOI 10.1016/j.tmp.2016.01.010; Beutels P, 2009, TROP MED INT HEALTH, V14, P85, DOI 10.1111/j.1365-3156.2008.02210.x; Cirer-Costa JC, 2017, TOUR MANAG PERSPECT, V22, P27, DOI 10.1016/j.tmp.2017.01.004; Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007; Harrison LH., 2018, PLOTKINS VACCINES, P619, DOI DOI 10.1016/B978-0-323-35761-6.00038-9; Henderson J. C., 2007, International Journal of Hospitality Management, V26, P228, DOI 10.1016/j.ijhm.2006.02.001; Hurtado TR, 2006, WILD ENVIRON MED, V17, P276, DOI 10.1580/06-WEME-RA-007R.1; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jiang YW, 2019, CURR ISSUES TOUR, V22, P1925, DOI 10.1080/13683500.2017.1408574; Keystone JS, 2013, TRAVEL MED; Ministerio de Sanidad Servicios Sociales e Igualdad, 2017, TAQBL SAL TAMB VIAJ; Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006; Pizam A., 2002, Journal of Travel Research, V40, P337, DOI 10.1177/0047287502040003011; Rangel-Buitrago N, 2013, TOURISM MANAGE, V35, P41, DOI 10.1016/j.tourman.2012.05.008; Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862; Ritchie BW, 2014, J TRAVEL RES, V53, P12, DOI 10.1177/0047287513482775; Roure S, 2015, REV CLIN ESP, V215, P439, DOI 10.1016/j.rce.2015.06.006; Stoney RJ, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav015; Suk JE, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25287; UNEP-WTO, 2005, MAK TOUR MOR SUST GU; UNWTO, 2017, UNWTO TOUR HIGHL 201, P1, DOI [10.18111/9789284419029, DOI 10.18111/9789284419029]; UNWTO, 2011, TOUR 2030 GLOB OV AD, DOI DOI 10.18111/9789284414024; Wang YS, 2009, TOURISM MANAGE, V30, P75, DOI 10.1016/j.tourman.2008.04.010; Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217588	10.1371/journal.pone.0217588	http://dx.doi.org/10.1371/journal.pone.0217588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145759	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500024
J	Iwelunmor, J; Ezechi, O; Obiezu-Umeh, C; Gbajabiamila, T; Musa, AZ; Oladele, D; Idigbe, I; Ohihoin, A; Gyamfi, J; Aifah, A; Salako, B; Ogedegbe, O				Iwelunmor, Juliet; Ezechi, Oliver; Obiezu-Umeh, Chisom; Gbajabiamila, Titilola; Musa, Adesola Z.; Oladele, David; Idigbe, Ifeoma; Ohihoin, Aigbe; Gyamfi, Joyce; Aifah, Angela; Salako, Babatunde; Ogedegbe, Olugbenga			Capabilities, opportunities and motivations for integrating evidence-based strategy for hypertension control into HIV clinics in Southwest Nigeria	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH-CARE; INTERVENTIONS; FACILITIES; SERVICES	Background Given the growing burden of cardiovascular diseases in sub-Saharan Africa, global donors and governments are exploring strategies for integrating evidence-based cardiovascular diseases prevention into HIV clinics. We assessed the capabilities, motivations and opportunities that exist for HIV clinics to apply evidence-based strategies for hypertension control among people living with HIV (PLHIV) in Nigeria. Methods We used a concurrent Quan-Qual-study approach (a quantitative first step using structured questionnaires followed by a qualitative approach using stakeholder meetings).We invited key stakeholders and representatives of HIV and non-communicable disease organizations in Lagos, Nigeria to 1) assess the capacity of HIV clinics (n = 29) to, and; 2) explore their attitudes and perceptions towards implementing evidence-based strategies for hypertension management in Lagos, Nigeria (n = 19)The quantitative data were analyzed using SPSS whereas responses from the stakeholders meeting were coded and analyzed using thematic approach and an implementation science framework, the COM-B (Capabilities, Opportunities, Motivations and Behavior) model, guided the mapping and interpretation of the data. Results Out of the 29 HIV clinics that participated in the study, 28 clinics were public, government owned facilities with 394 HIV patients per month with varying capabilities, opportunities and motivations for integrating evidence-based hypertension interventions within their services for PLHIV. Majority of the clinics (n = 26) rated medium-to-low on the psychological capability domains, while most of the clinics (n = 25) rated low on the physical capabilities of integrating evidence-based hypertension interventions within HIV clinics. There was high variability in the ratings for the opportunity domains, with physical opportunities rated high in only eight HIV clinics, two clinics with a medium rating and nineteen clinics with a low rating. Social opportunity domain tended to be rated low in majority of the HIV clinics (n = 21). Lastly, almost all the HIV clinics (n = 23) rated high on the reflective motivation domain although automatic motivations tended to be rated low across the HIV clinics. Conclusion In this study, we found that with the exception of motivations, the relative capabilities whether physical or psychological and the relative opportunities for integrating evidence based hypertension intervention within HIV clinics in Nigeria were minimal. Thus, there is need to strengthen the HIV clinics in Lagos for the implementation of evidence-based hypertension interventions within HIV clinics to improve patient outcomes and service delivery in Southwest Nigeria.	[Iwelunmor, Juliet] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO USA; [Ezechi, Oliver; Gbajabiamila, Titilola; Musa, Adesola Z.; Oladele, David; Idigbe, Ifeoma; Ohihoin, Aigbe; Salako, Babatunde] Nigerian Inst Med Res, Lagos, Nigeria; [Obiezu-Umeh, Chisom] NYU, Coll Global Publ Hlth, New York, NY USA; [Gyamfi, Joyce; Aifah, Angela; Ogedegbe, Olugbenga] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Obiezu-Umeh, Chisom] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA	Saint Louis University; New York University; New York University; Saint Louis University	Ezechi, O (corresponding author), Nigerian Inst Med Res, Lagos, Nigeria.	oezechi@yahoo.co.uk	Ohihoin, Aigbe/GPC-8137-2022	Musa, Adesola Z./0000-0002-6533-2984; Aifah, Angela/0000-0002-2811-8487				Aregbeshola BS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00048; Atkins L, 2015, P NUTR SOC, V74, P164, DOI 10.1017/S0029665115000075; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; DIMALA CA, 2016, PLOS ONE, V11; EHRHART MG, 2014, IMPLEMENT SCI, V9; Ekrikpo UE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019664; Ezechi OC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-46; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; IWELUNMOR J, 2016, IMPLEMENT SCI, V11; Iwuala SO, 2015, NIGER J CLIN PRACT, V18, P626, DOI 10.4103/1119-3077.154208; Kemp CG, 2018, AIDS, V32, pS93, DOI 10.1097/QAD.0000000000001897; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kumakech E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-810; LEEMAN J, 2017, IMPLEMENT SCI, V12; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; Mall S, 2012, AIDS CARE, V24, P319, DOI 10.1080/09540121.2011.608790; Michie S., 2011, IMPLEMENT SCI, V6; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Moore JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0160-6; Mwagomba BLM, 2018, AIDS, V32, pS21, DOI 10.1097/QAD.0000000000001885; Njuguna B, 2018, AIDS, V32, pS33, DOI 10.1097/QAD.0000000000001887; Odafe Solomon, 2013, Niger Med J, V54, P176, DOI 10.4103/0300-1652.114590; Ojo T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212296; Onovo A, 2016, OPEN FORUM INFECT S1, V3, P483, DOI DOI 10.1093/ofid/ofw172.346(Abstract); Owiti P, 2015, PUBLIC HEALTH ACTION, V5, P36, DOI 10.5588/pha.14.0092; Oyekale AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2112-8; Patel P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002523; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Rabkin M, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/137460; Shelton RC, 2018, ANNU REV PUBL HEALTH, V39, P55, DOI 10.1146/annurev-publhealth-040617-014731; Temu F, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.202.4086; Todowede OO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016602; UNICEF LSMoHa, 2012, RED HLTH DISP LAG ST	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217703	10.1371/journal.pone.0217703	http://dx.doi.org/10.1371/journal.pone.0217703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170220	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700049
J	Karatzas, N; Peter, T; Dave, S; Fogarty, C; Belinsky, N; Pai, NP				Karatzas, Nicolaos; Peter, Trevor; Dave, Sailly; Fogarty, Clare; Belinsky, Nandi; Pai, Nitika Pant			Are policy initiatives aligned to meet UNAIDS 90-90-90 targets impacting HIV testing and linkages to care? Evidence from a systematic review	PLOS ONE			English	Review								Background The Joint United Nations Programme on HIV/AIDS (UNAIDS) Fast-Track initiative seeks to eliminate AIDS as a health threat by 2030, with its focus on UNAIDS 90-90-90 targets. Effective policies and programs, if scaled nationally, have the potential to generate a greater impact on HIV control, yet a synthesis of successful HIV policies/programs aligned to the targets is currently unavailable. To fill this gap, we conducted a systematic review to evaluate successful HIV policies and programs to direct future interventions. Methods For the period 2007-2018, we searched 8 databases and classified eligible studies by country income level, UNAIDS targets, intervention type, and reported outcomes. Study outcomes were classified as per UNAIDS targets; proportionally: 90% target 1, 81% target 2, and 73% target 3. Results We retrieved 5201 citations and a final set of eight studies on policies. Break up by income: three (38%) from high income, one (12%) from middle income and four (50%) from low income. Break up by outcomes reported: 36% (4/11) focused on HIV testing, 46% (5/11) on antiretroviral therapy initiation, and 18% (2/11) on viral suppression. Across studies, UNAIDS targets were met in high-income countries, where policies and guidelines were adhered to, whereas in low and middle-income countries, non-adherence led to failure to reach the targets. Targets were also met when country infrastructure supported a targeted program and stakeholders were actively engaged. Conclusions From the studies identified, we deduced a clear, positive correlation between implementation of policies and programs that resulted in an increase in patient awareness and an increase in partner notification with services that encouraged them, and together these resulted in increasing testing rates, and deployment of linkage/retention programs that improved retention in care. An analysis of these studies also suggests that policies, combined with the scale-up incentives, are needed to change the status quo. Incentives to improve the targets must exist; performance incentives at the health care worker level and country level incentives that could transform the nature of care. Given the complexity in reporting of targets, a one size fits all model is not a feasible option. However, the policies created a strong framework to shape future interventions.	[Karatzas, Nicolaos; Dave, Sailly; Fogarty, Clare; Belinsky, Nandi; Pai, Nitika Pant] McGill Univ, Div Clin Epidemiol, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Peter, Trevor] Clinton Hlth Access Initiat, Gaborone, Botswana; [Pai, Nitika Pant] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University	Pai, NP (corresponding author), McGill Univ, Div Clin Epidemiol, Res Inst, Ctr Hlth, Montreal, PQ, Canada.; Peter, T (corresponding author), Clinton Hlth Access Initiat, Gaborone, Botswana.; Pai, NP (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	tpeter@clintonhealthaccess.org; nitika.pai@mcgill.ca		Pant Pai, Nitika/0000-0002-4672-0500	Fonds de recherche du Quebec (Sante) Senior Award; Canadian Institutes of Health Research Operating Grants [HHP 137872, PJT 153149]; Clinton Health Access Initiative	Fonds de recherche du Quebec (Sante) Senior Award; Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Clinton Health Access Initiative	The authors acknowledge the support of the following agencies: The Fonds de recherche du Quebec (Sante) Senior Award (NPP), the Canadian Institutes of Health Research Operating Grants HHP 137872 and PJT 153149 (NPP), and the Clinton Health Access Initiative (TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIS, PEER BAS SERV DEV ST, P106; Baggaley R, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21348; Bank W, WORLDB INC LEV; Bergman J, 2015, AIDS PATIENT CARE ST, V29, P419, DOI 10.1089/apc.2015.0033; Group N., 2016, NOUS PROJ EXPL VAL C; HealthPolicyProject, 2015, HIV POL ADV MON 2015; Hoffman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162085; Hoots BE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132962; Katz DA, 2016, AIDS PATIENT CARE ST, V30, P208, DOI 10.1089/apc.2016.0027; Maman D, 2016, TROP MED INT HEALTH, V21, P1442, DOI 10.1111/tmi.12772; McManus H, WEPEC181; Nuwagaba-Biribonwoha H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-889; PEPFAR, 2017, MON EV REP MER 2 0 I; Ribakare M, 2016, TOPICS ANTIVIRAL MED, V24, P442; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158253; UNAIDS, GLOB AIDS RESP REP 2; UNAIDS, 2000, EV 100 COND PROGR TH; UNAIDS, 2015, 15 15 GLOB TARG ACH; UNAIDS, 2018, MILES GO CLOSING GAP; UNAIDS, 2014, 90 90 90 AMB TREATM; Yang M, 2014, SEX TRANSM INFECT, V90, P592, DOI 10.1136/sextrans-2013-051495; Zeng W, 2014, AM J TROP MED HYG, V90, P740, DOI 10.4269/ajtmh.12-0697	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216936	10.1371/journal.pone.0216936	http://dx.doi.org/10.1371/journal.pone.0216936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166957	gold, Green Submitted, Green Published			2022-12-27	WOS:000470087800015
J	Maczynska, B; Secewicz, A; Smutnicka, D; Szymczyk, P; Dudek-Wicher, R; Junka, A; Bartoszewicz, M				Maczynska, Beata; Secewicz, Anna; Smutnicka, Danuta; Szymczyk, Patrycja; Dudek-Wicher, Ruth; Junka, Adam; Bartoszewicz, Marzenna			In vitro efficacy of gentamicin released from collagen sponge in eradication of bacterial biofilm preformed on hydroxyapatite surface	PLOS ONE			English	Article							ENTEROBACTERIACEAE; RESISTANCE; AMINOGLYCOSIDES; INFECTIONS; DELIVERY; ANTIBIOTICS; MANAGEMENT; SURGERY; EUROPE; SYSTEM	Biofilm-related infections of bones pose a significant therapeutic issue. In this article we present in vitro results of the efficacy of gentamicin released from a collagen sponge carrier against Staphylococcus aureus, Pseudomonas aeruginosa and Klebsiella pneumoniae biofilms preformed on hydroxyapatite surface. The results indicate that high local concentrations of gentamicin released from a sponge eradicate the biofilm formed not only by gentamicin-sensitive strains but, to some extent, also by those that display a resistance pattern in routine diagnostics. The data presented in this paper is of high clinical translational value and may find application in the treatment of bone infections.	[Maczynska, Beata; Secewicz, Anna; Smutnicka, Danuta; Dudek-Wicher, Ruth; Junka, Adam; Bartoszewicz, Marzenna] Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland; [Szymczyk, Patrycja] Wroclaw Univ Sci & Technol, Fac Mech Engn, Ctr Adv Mfg Technol CAMT FPC, Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology	Junka, A (corresponding author), Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland.	adam.junka@umed.wroc.pl	Dudek-Wicher, Ruth/AAY-4191-2020	Dudek-Wicher, Ruth/0000-0001-8033-3531; Maczynska, Beata/0000-0001-6388-7970; BARTOSZEWICZ, MARZENNA/0000-0002-6542-2525; Szymczyk-Ziolkowska, Patrycja/0000-0001-7742-7182; Junka, Adam/0000-0002-7559-8903				Andersson RE, 2010, WORLD J SURG, V34, P3042, DOI 10.1007/s00268-010-0763-2; Baraniak A, 2016, ANTIMICROB AGENTS CH, V60, P1912, DOI 10.1128/AAC.02756-15; Bartoszewicz M, 2012, LECZENIE RAN, V9, P147; Brehant O, 2013, INT J COLORECTAL DIS, V28, P119, DOI 10.1007/s00384-012-1557-9; Bueno MFC, 2013, ANTIMICROB AGENTS CH, V57, P2397, DOI 10.1128/AAC.02108-12; Chang WK, 2013, ANN SURG, V258, P59, DOI 10.1097/SLA.0b013e3182895b8c; Chew LC, 2006, ANN ACAD MED SINGAP, V35, P100; CIERNY III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62; Deshpande Payal, 2010, J Assoc Physicians India, V58, P147; DIRSCHL DR, 1993, DRUGS, V45, P29, DOI 10.2165/00003495-199345010-00004; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Dowd SE, 2010, RHOADS POLYMICROBIAL; Flemming HC, 2008, BIOFILM HIGHLIGHTS, V5; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1843, DOI 10.1128/AAC.01477-07; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gentry LO, 1997, INT J ANTIMICROB AG, V9, P37, DOI 10.1016/S0924-8579(97)00375-0; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hayes G, 2013, VET COMP ORTHOPAED, V26, P251, DOI 10.3415/VCOT-12-05-0065; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Humphrey JS, 1998, CLIN ORTHOP RELAT R, P218; Jung YG, 2015, APPL ENVIRON MICROB, V81, P211, DOI 10.1128/AEM.02311-14; Knaepler H, 2012, INT J SURG, V10, pS15, DOI 10.1016/j.ijsu.2012.05.020; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kowalewski M, 2015, J THORAC CARDIOV SUR, V149, P1631, DOI 10.1016/j.jtcvs.2015.01.034; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Koziol M, 2014, KARDIOCHIR TORAKOCHI, V11, P21, DOI 10.5114/kitp.2014.41925; Ktari S, 2006, ANTIMICROB AGENTS CH, V50, P4198, DOI 10.1128/AAC.00663-06; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lindemann PC, 2012, APMIS, V120, P495, DOI 10.1111/j.1600-0463.2011.02856.x; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Lovering AM, 2012, INT J SURG, V10, pS2, DOI 10.1016/j.ijsu.2012.05.013; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Mehta S, 1996, J ORTHOPAED RES, V14, P749, DOI 10.1002/jor.1100140511; Nevozhay Dmitry, 2007, Postepy Hig Med Dosw (Online), V61, P350; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9; Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343; Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007; Sobczak A, 2007, CZASOPISMO TECHNICZN, P149; Stemberger A, 1997, EUR J SURG, V163, P17; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P96, DOI 10.1128/AAC.01105-12; Wolcott R D, 2008, J Wound Care, V17, P145; Wolcott RD, 2010, ADV WOUND CARE-SER, V1, P311, DOI 10.1089/awc.2009.0104; Zacharczuk K, 2011, J MED MICROBIOL, V60, P1306, DOI 10.1099/jmm.0.024026-0; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07	50	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217769	10.1371/journal.pone.0217769	http://dx.doi.org/10.1371/journal.pone.0217769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163049	Green Submitted, gold, Green Published			2022-12-27	WOS:000470086200033
J	Welsch, R; von Castell, C; Hecht, H				Welsch, Robin; von Castell, Christoph; Hecht, Heiko			The anisotropy of personal space	PLOS ONE			English	Article							INTERPERSONAL SPACE; DISTANCE	Violations of personal space are associated with discomfort. However, the exact function linking the magnitude of discomfort to interpersonal distance has not yet been specified. In this study, we explore whether interpersonal distance and discomfort are isotropic with respect to uncomfortably far or close distances. We also extend previous findings with regard to intrusions into personal space as well as maintenance of distances outside of personal space. We presented subjects with 15 interpersonal distances ranging from 40 to 250 cm and obtained verbal and joystick-based ratings of discomfort. Whereas discomfort rose immediately when personal space was entered, the gradient was less steep for distances that exceeded the comfort region of personal space. Thus, personal space is anisotropic with regard to experienced discomfort.	[Welsch, Robin; von Castell, Christoph; Hecht, Heiko] Johannes Gutenberg Univ Mainz, Dept Psychol, Mainz, Germany	Johannes Gutenberg University of Mainz	Welsch, R (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychol, Mainz, Germany.	welsch@uni-mainz.de	von Castell, Christoph/AAE-2501-2021; Hecht, Heiko/H-3106-2011	Hecht, Heiko/0000-0001-9418-862X; Welsch, Robin/0000-0002-7255-7890; von Castell, Christoph/0000-0002-0677-1055				Aiello JR, 1980, BASIC APPL SOC PSYCH, V1, P65, DOI 10.1207/s15324834basp0101_5; Aldridge VK, 2017, EUR PSYCHOL, V22, P207, DOI 10.1027/1016-9040/a000298; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; ASHTON NL, 1980, B PSYCHONOMIC SOC, V15, P309; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burgoon, 1978, HUMAN COMMUNICATION, V4, P129, DOI [DOI 10.1111/J.1468-2958.1978.TB00603.X, 10.1111/j.1468-2958.1978]; Carpenter Bob, 2017, J Stat Softw, V76, DOI 10.18637/jss.v076.i01; DESOR JA, 1972, J PERS SOC PSYCHOL, V21, P79, DOI 10.1037/h0032112; FELIPE NJ, 1966, SOC PROBL, V14, P206, DOI 10.1525/sp.1966.14.2.03a00080; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1981, CAN J BEHAV SCI, V13, P274, DOI 10.1037/h0081182; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hecht H, 2019, ACTA PSYCHOL, V193, P113, DOI 10.1016/j.actpsy.2018.12.009; Heidiger H., 1950, WILD ANIMALS IN CAPT; Hunley SB, 2018, WIRES COGN SCI, V9, DOI 10.1002/wcs.1472; Iachini T, 2016, J ENVIRON PSYCHOL, V45, P154, DOI 10.1016/j.jenvp.2016.01.004; Iachini T, 2015, COGN PROCESS, V16, pS255, DOI 10.1007/s10339-015-0717-6; Iachini T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111511; Jones S.B., 1976, HUM COMMUN RES, V2, P131, DOI [10.1111/j.1468-2958.1976.tb00706.x, DOI 10.1111/J.1468-2958.1976.TB00706.X]; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; Kennedy DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103369; Lewin K, 1939, AM J SOCIOL, V44, P868, DOI 10.1086/218177; Morey R. D., 2015, R PACKAGE VERSION 0; Nandrino JL, 2017, EUR EAT DISORD REV, V25, P179, DOI 10.1002/erv.2506; NESBITT PD, 1974, SOCIOMETRY, V37, P105, DOI 10.2307/2786470; R Development Core Team, 2010, R A LANGUAGE AND ENV; Rouder JN, 2017, PSYCHOL METHODS, V22, P304, DOI 10.1037/met0000057; Ruggiero G, 2017, PSYCHOL RES-PSYCH FO, V81, P1232, DOI 10.1007/s00426-016-0806-x; Schoretsanitis G, 2016, EUR PSYCHIAT, V31, P1, DOI 10.1016/j.eurpsy.2015.10.001; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Sommer R., 2002, HANDBOOK OF ENVIRONM; Sorokowska A, 2017, J CROSS CULT PSYCHOL, V48, P577, DOI 10.1177/0022022117698039; SUNDSTROM E, 1976, HUM ECOL, V4, P47, DOI 10.1007/BF01531456; THOMPSON DE, 1979, J NONVERBAL BEHAV, V4, P113, DOI 10.1007/BF01006355; Walther S, 2015, BIOL PSYCHIAT, V77; Welsch R, 2018, CLIN PSYCHOL SCI, V6, P835, DOI 10.1177/2167702618788874; WILLIAMS JL, 1971, CAN J BEH SCI, V3, P156, DOI 10.1037/h0082257; WORMITH JS, 1984, J CLIN PSYCHOL, V40, P815, DOI 10.1002/1097-4679(198405)40:3<815::AID-JCLP2270400332>3.0.CO;2-G	41	20	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217587	10.1371/journal.pone.0217587	http://dx.doi.org/10.1371/journal.pone.0217587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163063	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200021
J	Alizadeh, E; Xu, WL; Castle, J; Foss, J; Prasad, A				Alizadeh, Elaheh; Xu, Wenlong; Castle, Jordan; Foss, Jacqueline; Prasad, Ashok			TISMorph: A tool to quantify texture, irregularity and spreading of single cells	PLOS ONE			English	Article							IMAGE-ANALYSIS; SHAPE; MECHANICS; ACTIN	A number of recent studies have shown that cell shape and cytoskeletal texture can be used as sensitive readouts of the physiological state of the cell. However, utilization of this information requires the development of quantitative measures that can describe relevant aspects of cell shape. In this paper we develop a toolbox, TISMorph, that calculates a set of quantitative measures to address this need. Some of the measures introduced here have been used previously, while others are new and have desirable properties for shape and texture quantification of cells. These measures, broadly classifiable into the categories of textural, irregularity and spreading measures, are tested by using them to discriminate between osteosarcoma cell lines treated with different cytoskeletal drugs. We find that even though specific classification tasks often rely on a few measures, these are not the same between all classification tasks, thus requiring the use of the entire suite of measures for classification and discrimination. We provide detailed descriptions of the measures, as well as the TISMorph package to implement them. Quantitative morphological measures that capture different aspects of cell morphology will help enhance large-scale image-based quantitative analysis, which is emerging as a new field of biological data.	[Alizadeh, Elaheh; Xu, Wenlong; Prasad, Ashok] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Castle, Jordan] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Foss, Jacqueline; Prasad, Ashok] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Foss, Jacqueline] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Alizadeh, Elaheh] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; University of Arizona	Prasad, A (corresponding author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.; Prasad, A (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	ashok.prasad@colostate.edu	Prasad, Ashok/HDN-5956-2022; Xu, Wenlong/G-9744-2017	Xu, Wenlong/0000-0002-2906-4724; Prasad, Ashok/0000-0002-0832-8153; Alizadeh, Elaheh/0000-0003-4742-7186	National Science Foundation [PHY-1151454]	National Science Foundation(National Science Foundation (NSF))	We acknowledge support from an National Science Foundation (www.nsf.gov) CAREER grant (PHY-1151454) to Ashok Prasad.	Alizadeh E, 2016, INTEGR BIOL-UK, V8, P1183, DOI 10.1039/c6ib00100a; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Cooper S, 2015, MOL BIOL CELL, V26, P4163, DOI 10.1091/mbc.E15-06-0382; Costa A, 2013, HAUSDORFF BOX COUNTI; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Ingber DE, 1994, SCIENCE, V7, DOI [10.1016/S0092-8674(03)00120-X, DOI 10.1016/S0092-8674(03)00120-X]; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Lyons SM, 2016, BIOL OPEN, V5, P289, DOI 10.1242/bio.013409; Marklein RA, 2018, TRENDS BIOTECHNOL, V36, P105, DOI 10.1016/j.tibtech.2017.10.007; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Pasqualato A, 2012, EXP CELL RES, V318, P835, DOI 10.1016/j.yexcr.2012.01.022; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prasad A, 2019, TRENDS BIOTECHNOL, V37, P347, DOI 10.1016/j.tibtech.2018.09.007; Ren Z., 2015, BIOSCIENCE REP, V35, P1; Sailem HZ, 2017, GENOME RES, V27, P196, DOI 10.1101/gr.202028.115; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Slater JH, 2015, ACS NANO, V9, P6128, DOI 10.1021/acsnano.5b01366; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Tahmasbi A, 2011, COMPUT BIOL MED, V41, P726, DOI 10.1016/j.compbiomed.2011.06.009; Uppuluri A., 2010, GCLM FEATURE CALCULA; Villanueva JD, 2015, DESIGN IMPLEMENTATIO; Welzl E, 2014, COMPUTATIONAL GEOMET	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217346	10.1371/journal.pone.0217346	http://dx.doi.org/10.1371/journal.pone.0217346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158241	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700012
J	Chang, YS; Park, H; Hong, SH; Chung, WH; Cho, YS; Moon, I				Chang, Young-Soo; Park, Heesung; Hong, Sung Hwa; Chung, Won-Ho; Cho, Yang-Sun; Moon, Il Joon			Predicting cochlear dead regions in patients with hearing loss through a machine learning-based approach: A preliminary study	PLOS ONE			English	Article							EQUALIZING NOISE TEST; THRESHOLD; PREVALENCE; ADULTS; MECHANISMS; DAMAGE; AIDS	We propose a machine learning (ML)-based model for predicting cochlear dead regions (DRs) in patients with hearing loss of various etiologies. Five hundred and fifty-five ears from 380 patients (3,770 test samples) diagnosed with sensorineural hearing loss (SNHL) were analyzed. A threshold-equalizing noise (TEN) test was applied to detect the presence of DRs. Data were collected on sex, age, side of the affected ear, hearing loss etiology, word recognition scores (WRS), and pure-tone thresholds at each frequency. According to the cause of hearing loss as diagnosed by the physician, we categorized the patients into six groups: 1) SNHL with unknown etiology; 2) sudden sensorineural hearing loss (SSNHL); 3) vestibular schwannoma (VS); 4) Meniere's disease (MD); 5) noise-induced hearing loss (NIHL); or 6) presbycusis or age-related hearing loss (ARHL). To develop a predictive model, we performed recursive partitioning and regression for classification, logistic regression, and random forest. The overall prevalence of one or more DRs in test ears was 20.36% (113 ears). Among the 3,770 test samples, the overall frequency-specific prevalence of DR was 6.7%. WRS, pure-tone thresholds at each frequency, disease type (VS or MD), and frequency information were useful for predicting DRs. Sex and age were not associated with detecting DRs. Based on these results, we suggest possible predictive factors for determining the presence of DRs. To improve the predictive power of the model, a more flexible model or more clinical features, such as the duration of hearing loss or risk factors for developing DRs, may be needed.	[Chang, Young-Soo] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Ansan, South Korea; [Chang, Young-Soo] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea; [Park, Heesung] Samsung Med Ctr, Hearing Res Lab, Seoul, South Korea; [Hong, Sung Hwa] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Chang Won, South Korea; [Chung, Won-Ho; Cho, Yang-Sun; Moon, Il Joon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, I (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.	moonij@skku.edu		MOON, IL JOON/0000-0002-3613-0734				Aazh H, 2007, J AM ACAD AUDIOL, V18, P97, DOI 10.3766/jaaa.18.2.2; Ahadi M, 2015, INT J PEDIATR OTORHI, V79, P1362, DOI 10.1016/j.ijporl.2015.06.013; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carhart R, 1959, J SPEECH HEAR DISORD; Choi JE, 2016, OTOL NEUROTOL, V37, P1503, DOI 10.1097/MAO.0000000000001202; Cox RM, 2012, EAR HEARING, V33, P573, DOI 10.1097/AUD.0b013e31824d8ef3; Cox RM, 2011, EAR HEARING, V32, P339, DOI 10.1097/AUD.0b013e318202e982; Gopinath B, 2009, ARCH INTERN MED, V169, P415, DOI 10.1001/archinternmed.2008.597; Gordo Angela, 2007, Braz J Otorhinolaryngol, V73, P299; Gouveris HT, 2007, LARYNGOSCOPE, V117, P680, DOI 10.1097/MLG.0b013e31803146c5; Halpin C, 2009, OTOLARYNG HEAD NECK, V140, P629, DOI 10.1016/j.otohns.2008.12.020; Halpin C, 2009, OTOLARYNG HEAD NECK, V140, P473, DOI 10.1016/j.otohns.2008.12.021; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21754-7; Kim DW, 2018, BONE; Kim J, 2015, J AUDIOL OTOL, V19, P68, DOI 10.7874/jao.2015.19.2.68; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee HY, 2015, J AUDIOL OTOL, V19, P20, DOI 10.7874/jao.2015.19.1.20; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; Lin WY, 2018, INT J MED INFORM, V111, P159, DOI 10.1016/j.ijmedinf.2018.01.002; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; Mackersie Carol L, 2004, J Am Acad Audiol, V15, P498, DOI 10.3766/jaaa.15.7.4; Mahmud MR, 2003, ANN OTO RHINOL LARYN, V112, P979, DOI 10.1177/000348940311201111; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Moore BCJ, 2004, EAR HEARING, V25, P478, DOI 10.1097/01.aud.0000145992.31135.89; Pepler A, 2014, EAR HEARING, V35, pE99, DOI 10.1097/AUD.0000000000000011; PRASHER DK, 1995, ACTA OTO-LARYNGOL, V115, P375, DOI 10.3109/00016489509139332; Soares VYR, 2016, NEURO-ONCOLOGY, V18, P1498, DOI 10.1093/neuonc/now099; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tillman T W, 1966, Tech Rep SAM-TR, P1; Vinay, 2007, EAR HEARING, V28, P231; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158285; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec	33	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217790	10.1371/journal.pone.0217790	http://dx.doi.org/10.1371/journal.pone.0217790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158267	Green Submitted, Green Published, gold			2022-12-27	WOS:000469915700026
J	Armenta-Paulino, N; Vazquez, MS; Bolumar, F				Armenta-Paulino, Nancy; Sandin Vazquez, Maria; Bolumar, Francisco			Obstacles and opportunities for monitoring ethnicity-based inequalities in maternal health care: Lessons from Mexico	PLOS ONE			English	Article							COVERAGE; EQUITY	Background Monitoring and reducing inequalities in health care has become more relevant since the adoption of the Sustainable Development Goals (SDGs). The SDGs bring an opportunity to put the assessment of inequalities by ethnicity on the agenda of decision-makers. The objective of this qualitative study is to know how current monitoring is carried out and to identify what factors influence the process in order to incorporate indicators that allow the evaluation of inequalities by ethnicity. Methods We conducted 17 semi-structured interviews with key informants from the health ministry, monitoring observatories, research centers, and international organizations, involved in maternal health care monitoring in Mexico. Our analysis was interpretative-phenomenological and focused on examining experiences about monitoring maternal health care in order to achieve a full picture of the current context in which it takes place and the factors that influence it. Results The obstacles and opportunities pointed out from the participants emerge from the limitations or advantages associated with the accuracy of evaluation, availability of information and resources, and effective management and decision-making. Technicians, coordinators, researchers or decision-makers are not only aware of the inequalities but also of its importance. However, this does not lead to political decisions permitting an indicator to be developed for monitoring it. As for opportunities, the role of international organizations and their links with the countries is crucial to carry out monitoring, due to political and technical support. Conclusions The success of a monitoring system to help decision-makers reduce inequalities in health care depends not only on accurate evaluations but also on the context in which it is implemented. Understanding the operation, obstacles and opportunities for monitoring could be a key issue if the countries want to advance towards assessing inequalities and reducing health inequities with the aid of concrete policies and initiatives.	[Armenta-Paulino, Nancy; Sandin Vazquez, Maria; Bolumar, Francisco] Univ Alcala, Fac Med, Publ Hlth Unit, Alcala De Henares, Spain; [Armenta-Paulino, Nancy; Sandin Vazquez, Maria; Bolumar, Francisco] Univ Alcala, Fac Med, Alcala De Henares, Spain	Universidad de Alcala; Universidad de Alcala	Vazquez, MS (corresponding author), Univ Alcala, Fac Med, Publ Hlth Unit, Alcala De Henares, Spain.; Vazquez, MS (corresponding author), Univ Alcala, Fac Med, Alcala De Henares, Spain.	maria.sandin@uah.es	Armenta-Paulino, Nancy Nayely/AFT-1657-2022	Armenta-Paulino, Nancy Nayely/0000-0001-8245-2841				AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Adrien M, 2008, BRIDGING GAP ROLE MO; Paulino NA, 2019, B WORLD HEALTH ORGAN, V97, P59, DOI 10.2471/BLT.18.216184; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181; Casas-Zamora JA, 2004, AM J PUBLIC HEALTH, V94, P2055, DOI 10.2105/AJPH.94.12.2055; Cash-Gibson L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191901; Heredia-Pi I, 2013, J MEXICAN PUBLIC HLT, V55, pS288; Hernandez-Avila JE, 2011, J MEXICAN PUBLIC HLT, V53, ps374, DOI [10.1590/S0036-36342011000900010, DOI 10.1590/S0036-36342011000900010]; Hosseinpoor AR, 2018, B WORLD HEALTH ORGAN, V96, P654, DOI 10.2471/BLT.18.210401; Hosseinpoor AR, 2018, GLOBAL HEALTH ACTION, V11, P70, DOI 10.1080/16549716.2017.1392216; Hosseinpoor AR, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29034; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Kuruvilla S, 2016, B WORLD HEALTH ORGAN, V94, P398, DOI 10.2471/BLT.16.170431; Valle AM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29030; Martinez-Salgado C, 2012, CIENC SAUDE COLETIVA, V17, P613, DOI 10.1590/S1413-81232012000300006; Maternal mortality observatory, 2009, OP GUID; Meljem-Moctezuma J, 2016, SALUD PUBLICA MEXICO, V58, P606, DOI 10.21149/spm.v58i6.8397; Mesenburg MA, 2018, LANCET GLOB HEALTH, V6, pE902, DOI 10.1016/s2214-109x(18)30300-0; Ministry of Health, 2013, SPEC ACT PLAN MAT PE; Mokdad AH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0034-4; Ostlin P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001115; Patton, 2015, QUALITATIVE RES EVAL; Florez CEP, 2016, REV PANAM SALUD PUBL, V39, P330; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Servan-Mori E, 2017, HEALTH POLICY PLANN, V32, P625, DOI 10.1093/heapol/czw161; Servan-Mori E, 2016, HEALTH POLICY PLANN, V31, P444, DOI 10.1093/heapol/czv082; Smith JA, 2003, QUALITATIVE PSYCHOL; Taylor S., 1987, INTRO METODOS CUALIT; Ulin P.R., 2006, INVESTIGACION APLICA; UNICEF, 2016, HLTH EQ REP 2016 AN; United Nations, 2015, TRANSF OUR WORLD 203; UNPFA UNICEF UN Women, 2018, IND WOM MAT HLTH MAT; World Bank Group, 2015, IND LAT AM 21 CENT 1; World Health Organization, 2017, NAT HLTH IN MON STEP; 2013, HDB HLTH IN MON SPEC, P1	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217557	10.1371/journal.pone.0217557	http://dx.doi.org/10.1371/journal.pone.0217557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150461	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100066
J	Ozaki, K; Yoshikawa, Y; Ishikawa, S; Katsumoto, T; Shibuya, M; Shoji, T; Kondo, H; Matsumoto, S; Shinoda, K				Ozaki, Kimitake; Yoshikawa, Yuji; Ishikawa, Sho; Katsumoto, Takeshi; Shibuya, Masayuki; Shoji, Takuhei; Kondo, Hiromi; Matsumoto, Soiti; Shinoda, Kei			Electroretinograms recorded with skin electrodes in silicone oil-filled eyes	PLOS ONE			English	Article							PHOTORECEPTOR RECOVERY; VITRECTOMY; DETACHMENT; REATTACHMENT; MANAGEMENT; REPAIR	Purpose To assess the physiology of the retina by electroretinography (ERG) with skin electrodes in eyes that had undergone vitrectomy with silicone oil (SO) tamponade. Design Retrospective case series. Method ERGs were recorded from eleven eyes with complex vitreoretinal disorders and from the normal fellow eyes. The affected eyes underwent pars plana vitrectomy (PPV) with SO tamponade. ERGs were recorded before and after the SO was removed. The amplitudes and implicit times of the a- and b-waves of the affected eyes were compared to those of the normal fellow eyes. In addition, the ratios of the amplitudes of the b-waves of the affected eyes to those of the fellow eyes were compared before and after the SO was removed. Results ERGs were recordable from 7 eyes (63.6%) before the SO was removed and 11 eyes (100%) after the SO was removed. The a- and b-wave amplitudes were significantly smaller in the affected eyes than those of the fellow eyes at the baseline. The b-wave amplitude before the removal of the SO was significantly and positively correlated with that after the SO removal. The ratios of the b-waves of the affected/normal fellow eye significantly increased after the SO was removed. Conclusion The results indicate that ERGs picked up by skin electrode can be used to assess the physiology of the retina in eyes with a SO tamponade. The amplitude of the b-waves of the ERGs in silicone-filled eyes can be used to predict the amplitude after the silicone is removed.	[Ozaki, Kimitake; Yoshikawa, Yuji; Ishikawa, Sho; Katsumoto, Takeshi; Shibuya, Masayuki; Shoji, Takuhei; Kondo, Hiromi; Matsumoto, Soiti; Shinoda, Kei] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Matsumoto, Soiti] Matsumoto Eye Clin, Tokushima, Japan	Saitama Medical University	Shinoda, K (corresponding author), Saitama Med Univ, Dept Ophthalmol, Saitama, Japan.	shinok@saitama-med.ac.jp	Shoji, Takuhei/W-1856-2017; Shinoda, Kei/ABC-7993-2020	Shoji, Takuhei/0000-0002-5464-2573; Shinoda, Kei/0000-0002-1543-9345	Japan Society for the Promotion of Science (JSPS; KAKENHI) [17K11430]	Japan Society for the Promotion of Science (JSPS; KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KS was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) (JSPS; KAKENHI grant number: 17K11430) to acquire equipment to record electroretinogram.	Alexandridis E, 1981, Dev Ophthalmol, V2, P24; ALEXANDRIDIS E, 1990, OPHTHALMOLOGICA, V200, P189, DOI 10.1159/000310105; ARMALY MF, 1962, ARCH OPHTHALMOL-CHIC, V68, P390, DOI 10.1001/archopht.1962.00960030394013; Azarmina Mohsen, 2011, J Ophthalmic Vis Res, V6, P109; Azen SP, 1998, OPHTHALMOLOGY, V105, P1587, DOI 10.1016/S0161-6420(98)99023-6; Beeler P, 2007, KLIN MONATSBL AUGENH, V224, P265, DOI 10.1055/s-2007-962856; CAMACHO H, 1992, ANN OPHTHALMOL, V24, P45; CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590; Coupland SG, 2006, PRINCIPLES PRACTICE, P245; DOSLAK MJ, 1988, INVEST OPHTH VIS SCI, V29, P1881; FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870, DOI 10.1016/s0161-6420(88)33080-0; FOERSTER MH, 1985, AM J OPHTHALMOL, V99, P201, DOI 10.1016/0002-9394(85)90233-8; FRUMAR KD, 1985, RETINA-J RET VIT DIS, V5, P16, DOI 10.1097/00006982-198500510-00004; Fukuo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36591; GABEL VP, 1987, GRAEF ARCH CLIN EXP, V225, P160, DOI 10.1007/BF02175441; GREY RHB, 1979, BRIT J OPHTHALMOL, V63, P355, DOI 10.1136/bjo.63.5.355; GUERIN CJ, 1989, INVEST OPHTH VIS SCI, V30, P1708; Han KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197058; Kato K, 2015, INVEST OPHTH VIS SCI, V56, P3684, DOI 10.1167/iovs.14-16349; Lapkovska A, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0311-4; LIM JI, 1994, OPHTHALMOLOGY, V101, P264; Lou BS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/713828; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; MEREDITH TA, 1985, BRIT J OPHTHALMOL, V69, P254, DOI 10.1136/bjo.69.4.254; Miura G, 2017, EYE, V31, P1589, DOI 10.1038/eye.2017.110; Miyake Y, 1998, GRAEF ARCH CLIN EXP, V236, P13, DOI 10.1007/s004170050036; Nakamura N, 2016, CLIN OPHTHALMOL, V10, P1175, DOI 10.2147/OPTH.S104721; Sakai T, 2003, INVEST OPHTH VIS SCI, V44, P416, DOI 10.1167/iovs.02-0633; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Shinoda K, 2001, JPN J OPHTHALMOL, V45, P276, DOI 10.1016/S0021-5155(01)00319-7; Watanabe A, 2017, DOC OPHTHALMOL, V134, P167, DOI 10.1007/s10633-017-9583-0	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216823	10.1371/journal.pone.0216823	http://dx.doi.org/10.1371/journal.pone.0216823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150414	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100024
J	Chemaitelly, H; Nagelkerke, N; Omori, R; Abu-Raddad, LJ				Chemaitelly, Hiam; Nagelkerke, Nico; Omori, Ryosuke; Abu-Raddad, Laith J.			Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States	PLOS ONE			English	Article							HIV ACQUISITION; INFECTION; TRENDS; AGE; GLYCOPROTEIN; PREVALENCE; ANTIBODY	Objective Assessing the epidemiological association between herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections in the United States, and characterizing the trends in the standardized HSV-1 and HSV-2 antibody prevalences (seroprevalences), 1999-2016. Methods Source of data was the cross-sectional and nationally-representative biennial surveys of the National Health and Nutrition Examination Survey (NHANES). All nine NHANES rounds for 1999-2016 were included in analysis. Datasets of these rounds were combined and analyzed accounting for survey design and applying weighting procedures. Logistic regressions were used to identify associations with seropositivity. Sensitivity analyses were conducted. Results Odds of HSV-1 infection declined by 2.84% (95% CI: 1.70%-4.00%) annually among men, and by 2.22% (95% CI: 1.23%-3.21%) among women. Declines were highest at younger ages. Odds of HSV-2 infection declined by 2.23% (95% CI: 0.71%-3.82%) annually among men, and by 2.89% (95% CI: 1.57%-4.28%) among women. Odds ratio of the association between HSV-2 and HSV-1 seropositivity was 0.71 (95% CI: 0.60-0.84) for men and 0.81 (95% CI: 0.72-0.91) for women, after adjustment for age, ethnicity, and year. Conclusion HSV-1 and HSV-2 seroprevalences showed a strong declining trend for at least two decades, for both sexes and for the different ethnicities, possibly reflecting improvements in hygiene and living conditions (for HSV-1), and safer sexual behavior (for HSV-2). HSV-1 seroprevalence declines are most pronounced among young individuals. There is evidence for cross protection between the two infections, suggestive of HSV-1 seropositivity being partially protective against HSV-2 infection.	[Chemaitelly, Hiam; Nagelkerke, Nico; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar; [Omori, Ryosuke] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, Ithaca, NY 14850 USA; [Abu-Raddad, Laith J.] Hamad bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hokkaido University; Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, Ithaca, NY 14850 USA.; Abu-Raddad, LJ (corresponding author), Hamad bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar.	lja2002@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Chemaitelly, Hiam/0000-0002-8756-6968	NPRP grant from theQatar National Research Fund (a member of Qatar Foundation) [9-040-3-008]; Biomedical Research Program; JST, PRESTO	NPRP grant from theQatar National Research Fund (a member of Qatar Foundation); Biomedical Research Program; JST, PRESTO(Japan Science & Technology Agency (JST))	This publication was made possible by NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The authors are also grateful for pilot funding provided by the Biomedical Research Program and infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine in Qatar. JST, PRESTO provided research funding support in the form of salary for RO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'Authors' Contributions' section.	Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Alsallaq RA, 2010, SEX TRANSM DIS, V37, P290, DOI 10.1097/OLQ.0b013e3181d3d023; [Anonymous], 2017, NAT HLTH NUTR EX SUR; Ayoub HH, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1285-x; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Catania JA, 1996, HEALTH PSYCHOL, V15, P362; Chaabane S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37833-8; Chandra Anjani, 2011, Natl Health Stat Report, P1; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dickson EL, 2015, EPIDEMIOL INFECT, V143, P1042, DOI 10.1017/S0950268814001538; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Fisman DN, 2002, SEX TRANSM DIS, V29, P608, DOI 10.1097/00007435-200210000-00008; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gnann JW, 2016, NEW ENGL J MED, V375, P666, DOI 10.1056/NEJMcp1603178; Gottlieb SL, 2019, VACCINE, V37, P7336, DOI 10.1016/j.vaccine.2017.03.074; Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Haddow Lewis J, 2006, Sex Health, V3, P1, DOI 10.1071/SH05041; Khadr L, 2019, CLIN INFECT DIS, V68, P757, DOI 10.1093/cid/ciy562; Kouyoumjian SP, 2018, AIDS, V32, P1343, DOI [10.1097/QAD.0000000000001828, 10.1097/qad.0000000000001828]; Kraut-Becher JR, 2006, INT J STD AIDS, V17, P378, DOI 10.1258/095646206777323481; LEE FK, 1986, J VIROL METHODS, V14, P111, DOI 10.1016/0166-0934(86)90041-8; LEE FK, 1985, J CLIN MICROBIOL, V22, P641, DOI 10.1128/JCM.22.4.641-644.1985; Lewis RM, 2018, VACCINE, V36, P2567, DOI 10.1016/j.vaccine.2018.03.083; Looker KJ, 2017, LANCET INFECT DIS, V17, P1303, DOI 10.1016/S1473-3099(17)30405-X; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Looker KJ, 2005, SEX TRANSM INFECT, V81, P103, DOI 10.1136/sti.2004.012039; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McQuillan Geraldine, 2018, NCHS Data Brief, P1; Omori R, 2018, SEX TRANSM INFECT, V94, P372, DOI 10.1136/sextrans-2017-053336; Omori R, 2017, AIDS, V31, P1721, DOI [10.1097/QAD.0000000000001542, 10.1097/qad.0000000000001542]; R Core Team, 2018, R LANG ENV STAT COMP; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; StataCorp, 2013, INVENTORSTATA STAT S; Sukik L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215487; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Weiss H, 2004, HERPES S, V11, p24A; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	48	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0214151	10.1371/journal.pone.0214151	http://dx.doi.org/10.1371/journal.pone.0214151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170140	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700004
J	Olson, KM; Duron, DI; Womer, D; Fell, R; Streicher, JM				Olson, Keith M.; Duron, David I.; Womer, Daniel; Fell, Ryan; Streicher, John M.			Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids	PLOS ONE			English	Article							MORPHINE ANALGESIA; SIGMA-1 RECEPTORS; BIASED LIGAND; MICE LACKING; IN-VIVO; TOLERANCE; PROTEIN; DISCOVERY; EFFICACY; PAIN	Most clinically used opioids are thought to induce analgesia through activation of the mu opioid receptor (MOR). However, disparities have been observed between the efficacy of opioids in activating the MOR in vitro and in inducing analgesia in vivo. In addition, some clinically used opioids do not produce cross-tolerance with each other, and desensitization produced in vitro does not match tolerance produced in vivo. These disparities suggest that some opioids could be acting through other targets in vivo, but this has not been comprehensively tested. We thus screened 9 clinically relevant opioids (buprenorphine, hydrocodone, hydromorphone, morphine, 0-desmethyl-tramadol, oxycodone, oxymorphone, tapentadol, tramadol) against 9 pain-related receptor targets (MOR, delta opioid receptor [DOR], kappa opioid receptor [KOR], nociceptin receptor [NOP], cannabinoid receptor type 1 [CB1], sigma-1 receptor [al R], and the monoamine transporters [NET/SERT/DAT]) expressed in cells using radioligand binding and functional activity assays. We found several novel interactions, including monoamine transporter activation by buprenorphine and al R binding by hydrocodone and tapentadol. Tail flick anti-nociception experiments with CD-1 mice demonstrated that the monoamine transporter inhibitor duloxetine selectively promoted buprenorphine anti-nociception while producing no effects by itself or in combination with the most MOR-selective drug oxymorphone, providing evidence that these novel interactions could be relevant in vivo. Our findings provide a comprehensive picture of the receptor interaction profiles of clinically relevant opioids, which has not previously been performed. Our findings also suggest novel receptor interactions for future investigation that could explain some of the disparities observed between opioid performance in vitro and in vivo.	[Olson, Keith M.; Duron, David I.; Streicher, John M.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Womer, Daniel; Fell, Ryan] Depomed Inc, Newark, CA USA	University of Arizona	Streicher, JM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	jstreicher@email.arzona.edu		Streicher, John/0000-0002-4173-7362; Olson, Keith/0000-0003-4068-5895	Depomed, Inc.; University of Arizona	Depomed, Inc.; University of Arizona	This work was supported by institutional funds from Depomed, Inc. and the University of Arizona to JMS. The funder (Depomed, Inc.) provided support in the form of salaries for authors DW and RF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Borgland S, 2001, CLIN EXP PHARMACOL P, V28, P147, DOI 10.1046/j.1440-1681.2001.03418.x; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Castany S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22217-9; CHIEN CC, 1993, EUR J PHARMACOL, V250, pR7, DOI 10.1016/0014-2999(93)90650-7; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dripps IJ, 2018, BRIT J PHARMACOL, V175, P891, DOI 10.1111/bph.14131; Gardell LR, 2002, PAIN, V100, P243, DOI 10.1016/S0304-3959(02)00173-2; Gharagozlou Parham, 2006, BMC Pharmacol, V6, P3, DOI 10.1186/1471-2210-6-3; Gharagozlou P, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-19; Grace PM, 2018, BRAIN BEHAV IMMUN, V72, P45, DOI 10.1016/j.bbi.2017.08.018; Grenald SA, 2017, NEUROPHARMACOLOGY, V116, P59, DOI 10.1016/j.neuropharm.2016.12.008; Hill R, 2018, BRIT J PHARMACOL, V175, P2492, DOI 10.1111/bph.14219; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Kallupi M, 2018, ADDICT BIOL, V23, P585, DOI 10.1111/adb.12513; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; Khroyan TV, 2015, BRIT J PHARMACOL, V172, P668, DOI 10.1111/bph.12796; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Kumar P, 2008, EUR J PHARMACOL, V597, P39, DOI 10.1016/j.ejphar.2008.08.025; Kumar V, 2014, J MED CHEM, V57, P4049, DOI 10.1021/jm401964y; Laggner C, 2005, J MED CHEM, V48, P4754, DOI 10.1021/jm049073+; Learned-Coughlin SM, 2003, BIOL PSYCHIAT, V54, P800, DOI 10.1016/S0006-3223(02)01834-6; Lei W, 2017, J BIOL CHEM, V292, P10414, DOI 10.1074/jbc.M116.769489; Madia PA, 2009, PSYCHOPHARMACOLOGY, V207, P413, DOI 10.1007/s00213-009-1673-6; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minami K, 2007, J PHARMACOL SCI, V103, P253, DOI 10.1254/jphs.CR0060032; Nielsen CK, 2000, J PHARMACOL EXP THER, V295, P91; Olson KM, 2018, J MED CHEM, V61, P6075, DOI 10.1021/acs.jmedchem.8b00403; Olson KM, 2017, YALE J BIOL MED, V90, P97; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pawar M, 2007, EUR J PHARMACOL, V563, P92, DOI 10.1016/j.ejphar.2007.01.059; Portoghese PS, 2017, ACS CHEM NEUROSCI, V8, P426, DOI 10.1021/acschemneuro.7b00002; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Ramos-Colon CN, 2016, J MED CHEM, V59, P10291, DOI 10.1021/acs.jmedchem.6b01411; Rossi D, 2017, BIOORGAN MED CHEM, V25, P11, DOI 10.1016/j.bmc.2016.10.005; Schmid CL, 2017, CELL, V171, P1165, DOI 10.1016/j.cell.2017.10.035; Smith HS, 2014, J PAIN RES, V7, P589, DOI 10.2147/JPR.S55782; Stefanucci A, 2017, FUTURE MED CHEM, V9, P859, DOI 10.4155/fmc-2016-0232; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; Tejada MA, 2018, PHARMACOL RES, V131, P224, DOI 10.1016/j.phrs.2018.02.008; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Viscusi ER, 2016, PAIN, V157, P264, DOI 10.1097/j.pain.0000000000000363; Volpe DA, 2011, REGUL TOXICOL PHARM, V59, P385, DOI 10.1016/j.yrtph.2010.12.007; Weiss RD, 2017, DRUG ALCOHOL DEPEN, V173, pS48, DOI 10.1016/j.drugalcdep.2016.12.001; Xu J, 2015, P NATL ACAD SCI USA, V112, P279, DOI 10.1073/pnas.1419183112; Yang PP, 2016, PHARMACOL RES, V111, P867, DOI 10.1016/j.phrs.2016.05.034; Zhao G, 2010, NEUROCHEM INT, V56, P168, DOI 10.1016/j.neuint.2009.09.015	55	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217371	10.1371/journal.pone.0217371	http://dx.doi.org/10.1371/journal.pone.0217371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170174	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700027
J	Rietveld, T; Vegter, RJK; van der Slikke, RMA; Hoekstra, AE; van der Woude, LHV; de Groot, S				Rietveld, Thomas; Vegter, Riemer J. K.; van der Slikke, Rienk M. A.; Hoekstra, Aldo E.; van der Woude, Lucas H. V.; de Groot, Sonja			Wheelchair mobility performance of elite wheelchair tennis players during four field tests: Inter-trial reliability and construct validity	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; PROPULSION TECHNIQUE; CONFIGURATION; KINEMATICS; DEMANDS	The purpose of the current study was to assess the inter-trial reliability and construct validity (talented juniors vs. international adult players) of four wheelchair tennis field tests using inertial measurement units (IMUs). Twenty-one elite wheelchair tennis players completed four tests, which evaluate the sprinting and manoeuvrability abilities in wheelchair tennis. During all tests 3 IMUs were attached to both wheels and the frame of the athlete's wheelchair. The IMUs enabled analysis of individual test dynamic characteristics, i.e. the linear/rotational velocity and acceleration data, as well as detected pushes. All tests showed high ICCs (0.95-0.99) for the inter-trial reliability for the IMU-based end times and also the construct validity was good, i.e. talented juniors could be discriminated from international adults. Also, velocities and accelerations during the tests could be consistently visualized, meaning that differences in test performance among participants could be designated. Within the experimental context, the field tests could be regarded as reliable and valid. With the use of IMUs it is possible to verify more detailed performance characteristics, visualize the test execution, as well as differentiate between a talented junior and international adult group and within individuals over time.	[Rietveld, Thomas; Vegter, Riemer J. K.; van der Woude, Lucas H. V.; de Groot, Sonja] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Slikke, Rienk M. A.] The Hague Univ Appl Sci, Human Kinet Technol, The Hague, Netherlands; [Hoekstra, Aldo E.] Royal Dutch Lawn Tennis Assoc, Almere, Netherlands; [van der Woude, Lucas H. V.] Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands; [de Groot, Sonja] Amsterdam Rehabil Res Ctr Reade, Amsterdam, Netherlands	University of Groningen; University of Groningen	de Groot, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; de Groot, S (corresponding author), Amsterdam Rehabil Res Ctr Reade, Amsterdam, Netherlands.	s.d.groot@reade.nl	S, Rienk/AAP-7510-2020; JK, Vegter Riemer/N-3385-2013; van der Woude, Lucas/E-7986-2018	S, Rienk/0000-0002-3630-3519; JK, Vegter Riemer/0000-0002-4294-6086; de Groot, Sonja/0000-0001-8463-2563; van der Woude, Lucas/0000-0002-8472-334X; Rietveld, Thomas/0000-0002-7753-9958				de Groot S, 2017, SCAND J MED SCI SPOR, V27, P918, DOI 10.1111/sms.12701; de Groot S, 2018, APPL ERGON, V71, P38, DOI 10.1016/j.apergo.2018.04.001; de Groot S, 2016, INT J SPORT PHYSIOL, V11, P1111, DOI 10.1123/ijspp.2015-0598; de Groot S, 2013, MED ENG PHYS, V35, P1476, DOI 10.1016/j.medengphy.2013.03.019; De Groot S, 2012, J SPORT SCI, V30, P879, DOI 10.1080/02640414.2012.675082; de Vet HW, 2011, MEASUREMENT MED PRAC; de Witte AMH, 2018, J SPORT SCI, V36, P23, DOI 10.1080/02640414.2016.1276613; Diaper NJ, 2009, J SPORT SCI MED, V8, P300; Gee CM, 2018, J SCI MED SPORT, V21, P753, DOI 10.1016/j.jsams.2017.12.006; Gold JR, 2007, J R SOC PROMO HEALTH, V127, P133, DOI 10.1177/1466424007077348; Goosey-Tolfrey VL, 2013, SPORTS MED, V43, P77, DOI 10.1007/s40279-012-0009-6; Goosey-Tolfrey VL, 2005, ADAPT PHYS ACT Q, V22, P291, DOI 10.1123/apaq.22.3.291; Hachana Y, 2013, J STRENGTH COND RES, V27, P2752, DOI 10.1519/JSC.0b013e3182890ac3; Haj-Sassi R, 2011, J STRENGTH COND RES, V25, P472, DOI 10.1519/JSC.0b013e3182018186; ITF Tennis, 2016, PAR TENN EV; Lin J, 2015, J REHABILITATION RES, V52; Mason BS, 2015, MED ENG PHYS, V37, P392, DOI 10.1016/j.medengphy.2015.02.001; Mason BS, 2013, SPORTS MED, V43, P23, DOI 10.1007/s40279-012-0005-x; Pansiot J, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/105801; Sindall P, 2013, INT J SPORT PHYSIOL, V8, P28, DOI 10.1123/ijspp.8.1.28; van der Slikke RMA, 2016, J BIOMECH, V49, P3340, DOI 10.1016/j.jbiomech.2016.08.022; van der Slikke RMA, 2015, PROCEDIA ENGINEER, V112, P207, DOI 10.1016/j.proeng.2015.07.201; van der Slikke RMA, 2015, J BIOMECH, V48, P3398, DOI 10.1016/j.jbiomech.2015.06.001; van der Slikke R, 2016, PROCEDIA ENGINEER, V147, P730, DOI 10.1016/j.proeng.2016.06.265; van der Slikke RMA, 2018, THESIS; van der Woude LHV, 2001, MED ENG PHYS, V23, P713, DOI 10.1016/S1350-4533(01)00083-2; van der Woude LHV, 2002, AM J PHYS MED REHAB, V81, P261, DOI 10.1097/00002060-200204000-00004	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217514	10.1371/journal.pone.0217514	http://dx.doi.org/10.1371/journal.pone.0217514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170186	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700039
J	Tanimine, N; Germana, SK; Fan, M; Hippen, K; Blazar, BR; Markmann, JF; Turka, LA; Priyadharshini, B				Tanimine, Naoki; Germana, Sharon K.; Fan, Martin; Hippen, Keli; Blazar, Bruce R.; Markmann, James F.; Turka, Laurence A.; Priyadharshini, Bhavana			Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets	PLOS ONE			English	Article							METABOLISM; ACTIVATION; INDUCTION; EXPANSION; RECEPTOR; SIGNALS	Regulatory T cells (Tregs) are required for the maintenance of immune tolerance and adoptive Treg infusion therapy has become a promising approach to suppress immune responses in diseases such as autoimmunity and transplant rejection. However, one critical challenge of Treg therapy is the requirement of in vitro expansion of functionally stable Tregs while preventing either the contamination of T effector and/or emergence of unstable pathogenic Tregs. Recent studies showing distinct metabolic requirements of T effectors and Tregs suggest that manipulation of cell metabolism may be an attractive strategy to achieve this goal. Here we show that human thymically derived Tregs (tTregs) and in vitro induced Tregs (iTregs) from naive T cells engage glycolysis equivalently upon activation. However, inhibiting glucose metabolism via 2-deoxy-D-glucose (2DG) has distinct effects on each of these subsets. While 2DG treatment at the onset of activation significantly reduced the proliferation and expression of suppressive molecules such as ICOS and CTLA-4 in tTregs, its effect on FOXP3 expression was small. In contrast, 2DG treatment during iTreg induction modestly decreased their proliferation but strongly reduced both ICOS and FOXP3 expression. Importantly, both Treg subsets became insensitive to 2DG after day 3 post activation with little effect on either proliferation or FOXP3 expression while T conventional Th0 cells showed reduced proliferation under the same conditions. Moreover, 2DG treatment at day 3 did not impair the suppressive capabilities of Treg subsets. Collectively, these findings suggest that there is a distinct temporal requirement of glycolysis in each of the activated human Treg subsets and T conventional cells. Furthermore, 2DG treatment at the onset as a strategy to impair contaminating T effector cell proliferation is unfavorable for optimal Treg generation as well.	[Tanimine, Naoki; Germana, Sharon K.; Fan, Martin; Markmann, James F.; Turka, Laurence A.; Priyadharshini, Bhavana] Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA; [Hippen, Keli; Blazar, Bruce R.] Univ Minnesota, Canc Ctr, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Minneapolis, MN USA; [Turka, Laurence A.; Priyadharshini, Bhavana] Rheos Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Priyadharshini, B (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA.; Priyadharshini, B (corresponding author), Rheos Med, Boston, MA USA.	bpriyadharshini@rheosrx.com	Tanimine, Naoki/AAQ-5317-2020	Tanimine, Naoki/0000-0003-2744-9097	NIH [P01HL018646]; Naito Foundation; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979, R01HL056067, P01HL018646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant P01HL018646 to LAT, Grant for Studying Overseas from The Naito Foundation to NT, and Research Fellowship from The Uehara Memorial Foundation to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelin A., 2017, CELL METAB; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bluestone JA, 2015, SCI TRANSL MED, V7; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cretenet G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24129; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gerriets V. A., 2016, NAT IMMUNOL; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howie D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89160; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jones N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01516; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; MATHEW JM, 2018, SCI REP, V8; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Priyadharshini B., 2018, J IMMUNOL; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tang QZ, 2017, J CLIN INVEST, V127, P2505, DOI 10.1172/JCI90598; Tanimine N., 2017, TRANSPLANTATION; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	34	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217761	10.1371/journal.pone.0217761	http://dx.doi.org/10.1371/journal.pone.0217761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170216	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700054
J	Yi, L; Liu, ZQ; Deng, CF; Li, XH; Wang, K; Deng, K; Mu, Y; Zhu, J; Li, Q; Wang, YP; Dai, L				Yi, Ling; Liu, Zhongqiang; Deng, Changfei; Li, Xiaohong; Wang, Ke; Deng, Kui; Mu, Yi; Zhu, Jun; Li, Qi; Wang, Yanping; Dai, Li			Epidemiological characteristics of holoprosencephaly in China, 2007-2014: A retrospective study based on the national birth defects surveillance system	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; METROPOLITAN ATLANTA; PREVALENCE; PROVINCE; ANOMALIES; GENETICS; CHILDREN; TRENDS	Objective To describe the epidemiology of holoprosencephaly (HPE) in China with special reference to prevalence and associated anomalies. Methods Data were abstracted from the Chinese Birth Defects Monitoring Network for the period 2007-2014. Birth prevalence of HPE were assessed by birth year, fetal/infant sex, maternal age, and maternal residential area. Poisson regressions were used to calculate the crude and adjusted prevalence ratios (PR) and their 95% confidence intervals, and linear chi-square test was used to explore time trend for the prevalence of HPE. Results A total of 1222 HPE cases were identified in 13,284,142 births, yielding an overall prevalence of 0.92 per 10,000 births. The annual prevalence of HPE presented an upward trend (P<0.001), from 0.54 per 10,000 births in 2007 to 1.21 per 10,000 births in 2014. Higher prevalence was found in older maternal-age groups (30-34 years, adjusted PR: 1.19, 95% CI: 1.02-1.40; >= 35 years, adjusted PR: 1.53, 95% CI: 1.26-1.86) in comparison with the maternal-age group of 25 to 29 years. Higher prevalence was also found in infants born to mothers resided in urban areas (adjusted PR: 1.23, 95% CI: 1.08-1.39) and female infants (adjusted PR: 1.30, 95% CI: 1.15-1.47). Conclusions HPE is an important perinatal health issue because of its poor prognosis. This is the first study depicting a picture of epidemiological characteristics of HPE in China, which can provide useful references for future studies.	[Yi, Ling; Deng, Changfei; Li, Xiaohong; Wang, Ke; Deng, Kui; Mu, Yi; Zhu, Jun; Li, Qi; Wang, Yanping; Dai, Li] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu, Sichuan, Peoples R China; [Yi, Ling; Liu, Zhongqiang; Dai, Li] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China; [Liu, Zhongqiang] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Intens Care Unit, Chengdu, Sichuan, Peoples R China; [Dai, Li] Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Dai, L (corresponding author), Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu, Sichuan, Peoples R China.; Dai, L (corresponding author), Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China.; Dai, L (corresponding author), Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China.	daili@scu.edu.cn		Li, Xiaohong/0000-0003-0336-7302	Ministry of Science and Technology of China [2127000074-1]; National Health and Family Planning Commission of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of China	This study was funded by a special grant from the Ministry of Science and Technology of China (no. 2127000074-1) and National Health and Family Planning Commission of China.	Agresti A, 2013, CATEGORICAL DATA ANA; Barr M, 1999, AM J MED GENET, V89, P116, DOI 10.1002/(SICI)1096-8628(19990625)89:2<116::AID-AJMG10>3.3.CO;2-W; Bendavid C, 2010, AM J MED GENET C, V154C, P86, DOI 10.1002/ajmg.c.30250; Bullen PJ, 2001, AM J OBSTET GYNECOL, V184, P1256, DOI 10.1067/mob.2001.111071; Chen CP, 2005, GENET COUNSEL, V16, P49; Cohen MM, 2002, AM J MED GENET, V109, P1, DOI 10.1002/ajmg.10258; Crider KS, 2008, AM J MED GENET A, V146A, P820, DOI 10.1002/ajmg.a.32200; Croen LA, 1996, AM J MED GENET, V64, P465, DOI 10.1002/(SICI)1096-8628(19960823)64:3<465::AID-AJMG4>3.0.CO;2-O; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dai L, 2010, BIRTH DEFECTS RES A, V88, P41, DOI 10.1002/bdra.20607; Deng CF, 2015, PRENATAL DIAG, V35, P311, DOI 10.1002/pd.4516; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Forrester MB, 2000, PAEDIATR PERINAT EP, V14, P61, DOI 10.1046/j.1365-3016.2000.00211.x; Hu Y H, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P20; ICBDSR, 2013, ANNUAL REPORT 2013 W; Kauvar EF, 2010, CURR OPIN PEDIATR, V22, P687, DOI 10.1097/MOP.0b013e32833f56d5; Leoncini E, 2008, BIRTH DEFECTS RES A, V82, P585, DOI 10.1002/bdra.20479; Levey EB, 2010, AM J MED GENET C, V154C, P183, DOI 10.1002/ajmg.c.30254; Liu JF, 2016, BIRTH DEFECTS RES A, V106, P267, DOI 10.1002/bdra.23486; Miller EA, 2010, AM J MED GENET C, V154C, P62, DOI 10.1002/ajmg.c.30244; MOH, 2003, CHINESE J REPRODUCTI, V2, P14; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; National Bureau of Statistics of China, 2009, RUL COMP STAT ZON CO; National Bureau of Statistics of China, 2016, COND MAT CHILDR HLTH; Olsen CL, 1997, AM J MED GENET, V73, P217, DOI 10.1002/(SICI)1096-8628(19971212)73:2<217::AID-AJMG20>3.0.CO;2-S; Ong S, 2007, PRENATAL DIAG, V27, P340, DOI 10.1002/pd.1677; ORAHILLY R, 1989, TERATOLOGY, V40, P409, DOI 10.1002/tera.1420400502; Orioli IM, 2007, AM J MED GENET A, V143A, P3088, DOI 10.1002/ajmg.a.32104; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Raam MS, 2011, INDIAN PEDIATR, V48, P457, DOI 10.1007/s13312-011-0078-x; Rasmussen SA, 1996, AM J MED GENET, V66, P320, DOI 10.1002/(SICI)1096-8628(19961218)66:3<320::AID-AJMG16>3.0.CO;2-O; Ren Ai-Guo, 2015, World J Clin Pediatr, V4, P41, DOI 10.5409/wjcp.v4.i3.41; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Shiota K, 2010, AM J MED GENET C, V154C, P22, DOI 10.1002/ajmg.c.30248; Solomon BD, 2010, AM J MED GENET C, V154C, P146, DOI 10.1002/ajmg.c.30232; Sun G, 2011, WORLD J PEDIATR, V7, P331, DOI 10.1007/s12519-011-0328-y; Szabo N, 2011, J CHILD NEUROL, V26, P1029, DOI 10.1177/0883073811399095; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tu L, 2012, IRAN J PUBLIC HEALTH, V41, P20; Whiteford ML, 1996, J MED GENET, V33, P578, DOI 10.1136/jmg.33.7.578; Zheng Xiao-ying, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P5	41	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217835	10.1371/journal.pone.0217835	http://dx.doi.org/10.1371/journal.pone.0217835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170204	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700064
J	Favotto, L; Michaelson, V; Pickett, W; Davison, C				Favotto, Lindsay; Michaelson, Valerie; Pickett, William; Davison, Colleen			The role of family and computer-mediated communication in adolescent loneliness	PLOS ONE			English	Article							MULTIDIMENSIONAL SCALE; SOCIAL SUPPORT; HEALTH; INTERNET; TECHNOLOGY; DEPRESSION; BEHAVIORS; ANXIETY; CHILDHOOD; GENDER	Adolescence is a developmental phase in which feelings of loneliness often increase. It is also a time period during which computer-mediated communication (CMC) is frequently used by youth to communicate with their peers. Strong family relationships protect youth from experiencing a wide range of adversities and mental health problems, including loneliness, and yet use of CMC to contact peers may leave adolescents feeling disconnected and lonely while also limiting the amount of time they spend with their family. This study examines the association between CMC and feelings of loneliness among Canadian youth, with family communication explored as an effect modifier. The study base was the Canadian 2013-2014 Health Behaviour in School-aged Children study used in a cross-sectional analysis (N = 30117; grades 6-10). Random-effects multilevel Poisson regression methods were used to quantify risks for adolescent loneliness among daily vs. non-daily users of verbal CMC (e.g., Skype, phone calls), text/instant messaging and social media CMC with friends. Effect modification was tested via the inclusion of modelled interaction terms. Family communication quality moderated the relationship between daily CMC use and loneliness among Canadian youth. Among youth experiencing high relative quality of family communication, daily use of verbal and social media CMC to contact friends was positively associated with reports of loneliness, compared to non-daily users. Findings suggest that family communication must remain central in societal discussions of youth loneliness, mental health and use of CMC.	[Favotto, Lindsay; Michaelson, Valerie; Pickett, William; Davison, Colleen] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Favotto, Lindsay; Pickett, William; Davison, Colleen] Kingston Gen Hosp, Res Inst, Kingston, ON, Canada; [Michaelson, Valerie] Queens Univ, Sch Relig, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Davison, C (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.; Davison, C (corresponding author), Kingston Gen Hosp, Res Inst, Kingston, ON, Canada.	davisonc@queensu.ca	Davison, Colleen M/L-3157-2016; Michaelson, Valerie/AAI-7917-2021; Michaelson, Valerie/ABF-5761-2020	Davison, Colleen M/0000-0002-0410-3352; 	Canadian Institutes for Health Research [130379]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Operating Grant #130379, http://www.cihr-irsc.gc.ca/e/193.html (CMD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Antognoli-Toland P. L., 1999, J THEORY CONSTRUCTIO, V3, P7; Balistreri KS, 2016, PUBLIC HEALTH, V132, P72, DOI 10.1016/j.puhe.2015.10.034; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Blackwell Debra L, 2010, Vital Health Stat 10, P1; Boniel-Nissim M, 2015, INT J PUBLIC HEALTH, V60, P189, DOI 10.1007/s00038-014-0636-9; Cacioppo JT., 2009, HDB INDIVIDUAL DIFFE, P227; Cheng ST, 2004, PERS INDIV DIFFER, V37, P1359, DOI 10.1016/j.paid.2004.01.006; Davison C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1636-2; DeLay D, 2013, INT J BEHAV DEV, V37, P29, DOI 10.1177/0165025412454031; Deniz L., 2010, J INSTRUCTIONAL PSYC, V37, P20; Elhai JD, 2017, J AFFECT DISORDERS, V207, P251, DOI 10.1016/j.jad.2016.08.030; Freeman J., 2016, HLTH BEHAV SCH AGED; Freeman J, 2014, HLTH BEHAVIOUR SCH A; Gallagher M, 2014, J ABNORM CHILD PSYCH, V42, P871, DOI 10.1007/s10802-013-9844-7; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Goodman E, 2007, J ADOLESCENT HEALTH, V41, P479, DOI 10.1016/j.jadohealth.2007.05.020; Goosby BJ, 2013, SOCIOL INQ, V83, P505, DOI 10.1111/soin.12018; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; Hart VA, 2010, J PSYCHOSOC NURS MEN, V48, P5, DOI 10.3928/02793695-20101102-02; Junco R, 2010, CYBERPSYCH BEH SOC N, V13, P619, DOI 10.1089/cyber.2009.0357; Kelsey JL., 1996, METHODS OBSERVATIONA; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Kuntsche E, 2009, INT J PUBLIC HEALTH, V54, P243, DOI 10.1007/s00038-009-5416-6; Langkamp DL, 2010, ACAD PEDIATR, V10, P205, DOI 10.1016/j.acap.2010.01.005; Lasky P, 1985, West J Nurs Res, V7, P40, DOI 10.1177/0092055X8500700105; Laursen B, 2013, J ADOLESCENCE, V36, P1261, DOI 10.1016/j.adolescence.2013.06.003; Leatherdale ST, 2010, J ADOLESCENT HEALTH, V47, P315, DOI 10.1016/j.jadohealth.2010.02.012; Leena K, 2005, J ADOLESCENCE, V28, P35, DOI 10.1016/j.adolescence.2004.05.004; Lenhart A., 2015, TEENS SOCIAL MEDIA T; Nicolaisen M, 2014, INT J AGING HUM DEV, V78, P229, DOI 10.2190/AG.78.3.b; Park N, 2012, CYBERPSYCH BEH SOC N, V15, P357, DOI 10.1089/cyber.2012.0121; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Peplau L, 1937, LONELINESS SOURCEBOO, P135; Perlman, 1984, DDH PUBLICATION, V1312, P13; Prezza M, 2004, COMPUT HUM BEHAV, V20, P691, DOI 10.1016/j.chb.2003.10.021; Przybylski AK, 2013, J SOC PERS RELAT, V30, P237, DOI 10.1177/0265407512453827; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rask K, 2003, SCAND J CARING SCI, V17, P129, DOI 10.1046/j.1471-6712.2003.00118.x; Riedl C, 2013, INT J HUM-COMPUT INT, V29, P670, DOI 10.1080/10447318.2013.768137; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Sanders CE, 2000, ADOLESCENCE, V35, P237; Sarmiento IG, 2018, CONCLUSIONS SYSTEMAT, V1, P3, DOI [10.1007/s40894-018-0095-2, DOI 10.1007/S40894-018-0095-2]; Schiffrin H, 2010, CYBERPSYCH BEH SOC N, V13, P299, DOI 10.1089/cyber.2009.0173; Schinka KC, 2013, J ADOLESCENCE, V36, P1251, DOI 10.1016/j.adolescence.2013.08.002; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Steeves V., 2014, MEDIASMARTS, P1; Stepanikova I, 2010, COMPUT HUM BEHAV, V26, P329, DOI 10.1016/j.chb.2009.11.002; Subrahmanyam K, 2011, ADV RESPONS ADOL DEV, P215, DOI 10.1007/978-1-4419-6278-2_12; Teppers E, 2014, J ADOLESCENCE, V37, P691, DOI 10.1016/j.adolescence.2013.11.003; Turkle S., 2008, HDB MOBILE COMMUNICA, P472, DOI [10.1201/9781420053890, DOI 10.1201/9781420053890]; Vaterlaus JM, 2016, COMPUT HUM BEHAV, V62, P594, DOI 10.1016/j.chb.2016.04.029; Weiss R.S., 1973, LONELINESS EXPERIENC; Wild F, 2014, INTERNAL PROTOCOL 20; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yen JY, 2012, PSYCHIAT RES, V200, P588, DOI 10.1016/j.psychres.2012.03.015; Young CMY, 2012, PERS INDIV DIFFER, V52, P78, DOI 10.1016/j.paid.2011.09.001; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	59	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0214617	10.1371/journal.pone.0214617	http://dx.doi.org/10.1371/journal.pone.0214617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166955	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800003
J	Ruiz-Miranda, CR; de Morais, MM; Dietz, LA; Alexandre, BR; Martins, AF; Ferraz, LP; Mickelberg, J; Hankerson, SJ; Dietz, JM				Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.; Dietz, Lou Ann; Alexandre, Brenda Rocha; Martins, Andreia F.; Ferraz, Luis Paulo; Mickelberg, Jennifer; Hankerson, Sarah J.; Dietz, James M.			Estimating population sizes to evaluate progress in conservation of endangered golden lion tamarins (Leontopithecus rosalia)	PLOS ONE			English	Article							LONG CALLS; SUCCESS	Efforts to reverse the decline of endangered golden lion tamarin monkeys have been relatively successful because the Brazilian organization dedicated to the species' conservation (Associac <comma> ao Mico-Leao-Dourado, AMLD) relies on science-based computer modeling to determine the number of tamarins necessary to achieve demographic and genetic goals, and a process of strategic planning to achieve those goals. Accurate estimates of the numbers of tamarins in forest fragments are essential to evaluate progress in achieving goals and adapt strategies as necessary. In this report we present the results of a new method to survey the number of tamarins in the wild, a modification of the point transect with lures procedure. Using this method, we estimate that in 2014 there were approximately 3,700 golden lion tamarins in 41,400 hectares of Atlantic Forest. Of these, 59% are from remnant wild populations, 34% are descendants of captive-born reintroduced animals and 7% are descendants of wild translocated groups. The number of tamarins and amount of forest estimated in this survey exceeded values necessary to meet AMLD's definition of a viable population, determined to be 2,000 tamarins in 25,000 hectares of connected and protected forest. However, the seven forest blocks and their tamarin populations are not yet adequately connected and protected. AMLD's strategic plan to achieve a viable population of golden lion tamarins includes 12 strategies that mitigate these and other threats or contribute directly to the conservation goal. The point transect with lures survey method provides a way to evaluate progress in achieving that goal and adapt strategies as appropriate.	[Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Rio De Janeiro, Brazil; [Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.; Dietz, Lou Ann; Alexandre, Brenda Rocha; Martins, Andreia F.; Ferraz, Luis Paulo; Mickelberg, Jennifer; Dietz, James M.] Assoc Mico Leao Dourado, Rio De Janeiro, Brazil; [Dietz, Lou Ann; Dietz, James M.] Save Golden Lion Tamarin, Silver Spring, MD USA; [Alexandre, Brenda Rocha] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Dept Ecol, Rio De Janeiro, Brazil; [Alexandre, Brenda Rocha] Univ Fed Fluminense, Inst Geociencias, Campus Praia Vermelha, Rio De Janeiro, Brazil; [Mickelberg, Jennifer] Zoo Atlanta, Atlanta, GA USA; [Hankerson, Sarah J.] Univ St Thomas, Dept Psychol, St Paul, MN USA	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; University of St Thomas Minnesota	Ruiz-Miranda, CR (corresponding author), Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Rio De Janeiro, Brazil.; Ruiz-Miranda, CR (corresponding author), Assoc Mico Leao Dourado, Rio De Janeiro, Brazil.	cruiz@uenf.br	Ruiz-Miranda, Carlos R/H-7308-2015; Ruiz-Miranda, Carlos R/A-4719-2008	Ruiz-Miranda, Carlos R/0000-0001-7360-0304; Ruiz-Miranda, Carlos R/0000-0001-9786-5315	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Pesquisa (CNPQ) [PQ 309660/2013]; Conservation Food and Health Foundation; Copenhagen Zoo; Disney Conservation Fund; Fundacao Grupo Boticario; Lion Tamarins of Brazil Fund; Philadelphia Zoo; Save the Golden Lion Tamarin; Zoo Atlanta	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation Food and Health Foundation; Copenhagen Zoo; Disney Conservation Fund; Fundacao Grupo Boticario; Lion Tamarins of Brazil Fund; Philadelphia Zoo; Save the Golden Lion Tamarin; Zoo Atlanta	CRRM was funded by fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and from the Conselho Nacional de Pesquisa (CNPQ) fellowship number PQ 309660/2013. The Associacao Mico Leao Dourado received funds from the Conservation Food and Health Foundation, Copenhagen Zoo, Disney Conservation Fund, Fundacao Grupo Boticario, Lion Tamarins of Brazil Fund, Philadelphia Zoo, Save the Golden Lion Tamarin and Zoo Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascensao F, 2018, SINGLE ROAD TH UNPUB; Atlantica SM. INPE, 2014, ATL REM FLOR MAT ATL; Atlantica SM. INPE, 2014, ATLAS REMANESCENTES; BAKER AJ, 1993, ANIM BEHAV, V46, P1091, DOI 10.1006/anbe.1993.1299; Baker AJ, 1996, AM J PRIMATOL, V38, P47, DOI 10.1002/(SICI)1098-2345(1996)38:1<47::AID-AJP5>3.0.CO;2-T; Balmford A, 2017, ORYX, V51, P191, DOI 10.1017/S0030605317000096; Bicca-Marques J.C., 2017, SCI ADV, V3, DOI DOI 10.1126/SCIADV.1600946; Buckland ST, 2006, J APPL ECOL, V43, P377, DOI 10.1111/j.1365-2664.2006.01135.x; COIMBRA-FILHO A F, 1973, Primates, V14, P47, DOI 10.1007/BF01730515; Dean W., 1995, With broadax and firebrand: the destruction of the Brazilian Atlantic forest.; DIETZ JM, 1994, AM J PRIMATOL, V34, P115, DOI 10.1002/ajp.1350340204; DIETZ JM, 1993, ANIM BEHAV, V46, P1067, DOI 10.1006/anbe.1993.1297; Dietz L., 1998, CULTURE MISSING ELEM; Dietz Lou Ann Hollingsworth, 1995, P64; Duchiade A., 2018, SCI AM; Estrada A, 2018, PEERJ, V6, DOI 10.7717/peerj.4869; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; Grantham HS, 2010, FRONT ECOL ENVIRON, V8, P431, DOI 10.1890/080151; Grativol AD, 2001, CONSERV GENET, V2, P1, DOI 10.1023/A:1011543401239; Grativol AD, 2005, THESIS; Green K., 1980, ASSESSMENT POCO ANTA; Hankerson SJ, 2014, ANIM BEHAV, V96, P87, DOI 10.1016/j.anbehav.2014.07.026; Holst B, 2006, LION TAMARIN POPULAT; Kierulff M, 2014, IUCN RED LIST THREAT; Kierulff M. C. M., 2012, International Zoo Yearbook, V46, P36, DOI 10.1111/j.1748-1090.2012.00170.x; Kierulff Maria Cecilia M., 2002, P271; Kierulff MCM, 2003, AM J PRIMATOL, V59, P29, DOI 10.1002/ajp.10064; Kleiman D.G., 1990, Endangered Species Update, V8, P82; Kleiman D. G., 2002, LION TAMARINS BIOL C; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Margoluis R, 2009, EVAL PROGRAM PLANN, V32, P138, DOI 10.1016/j.evalprogplan.2008.09.007; Matei A, 2006, R SAMPLINGPACKAGE; Mickelberg JL, 2011, LEONTOPITHECUS ROSAL; Miller P, 2005, VERSION 9 50 USERS M; Moraes AM, 2018, BIOL CONSERV, V224, P178, DOI 10.1016/j.biocon.2018.05.023; Moraes AM, 2017, CONSERV GENET, V18, P995, DOI 10.1007/s10592-017-0948-4; Padua Suzana M., 2002, P315; Partnership CM, OPEN STANDARDS PRACT; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Ruiz-Miranda C, 2010, REINTRODUCTION TRANS; Ruiz-Miranda CR, 2002, LION TAMARINS BRAZIL, P256; Ruiz-Miranda CR, 2002, FOLIA PRIMATOL, V718, P1; Russo G, 2009, NATURE, V462, P266, DOI 10.1038/462266a; Sabatini V, 2008, INT J PRIMATOL, V29, P207, DOI 10.1007/s10764-008-9240-2; Sabatini V, 2011, BIOACOUSTICS, V20, P137, DOI 10.1080/09524622.2011.9753640; Savage A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168324; Savage A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1030; Schwartz MW, 2012, BIOL CONSERV, V155, P169, DOI 10.1016/j.biocon.2012.06.014; SEABRA V.S., 2012, ANALISE PAISAGEM APO	49	12	12	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216664	10.1371/journal.pone.0216664	http://dx.doi.org/10.1371/journal.pone.0216664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166940	Green Submitted, gold, Green Published			2022-12-27	WOS:000470087800012
J	Wise, KA; Smith, D; Freije, A; Mueller, DS; Kandel, Y; Allen, T; Bradley, CA; Byamukama, E; Chilvers, M; Faske, T; Friskop, A; Hollier, C; Jackson-Ziems, TA; Kelly, H; Kemerait, B; Price, P; Robertson, A; Tenuta, A				Wise, Kiersten A.; Smith, Damon; Freije, Anna; Mueller, Daren S.; Kandel, Yuba; Allen, Tom; Bradley, Carl A.; Byamukama, Emmanuel; Chilvers, Martin; Faske, Travis; Friskop, Andrew; Hollier, Clayton; Jackson-Ziems, Tamra A.; Kelly, Heather; Kemerait, Bob; Price, Paul, III; Robertson, Alison; Tenuta, Albert			Meta-analysis of yield response of foliar fungicide-treated hybrid corn in the United States and Ontario, Canada	PLOS ONE			English	Article							TRIAZOLE-BASED FUNGICIDES; FUSARIUM HEAD BLIGHT; TOXICITY; WHEAT; EPOXICONAZOLE; AZOXYSTROBIN; PESTICIDES; SENESCENCE; BENEFITS	Background Foliar fungicide applications to corn (Zea mays L.) occur at one or more application timings ranging from early vegetative growth stages to mid-reproductive stages. Previous studies indicated that fungicide applications are profitable under high disease pressure when applied during the tasseling to silking growth stages. Few comprehensive studies in corn have examined the impact of fungicide applications at an early vegetative growth stage (V6) compared to late application timings (VT) for yield response and return on fungicide investment (ROI) across multiple locations. Objective Compare yield response of fungicide application timing across multiple fungicide classes and calculate the probability of positive ROI. Methods Data were collected specifically for this analysis using a uniform protocol conducted in 13 states in the United States and one province in Canada from 2014-2015. Data were subjected to a primary mixed-model analysis of variance. Subsequent univariate meta-analyses, with and without moderator variables, were performed using standard meta-analytic procedures. Follow-up power and prediction analyses were performed to aid interpretation and development of management recommendations. Results Fungicide application resulted in a range of yield responses from -2,683.0 to 3,230.9 kg/ha relative to the non-treated control, with 68.2% of these responses being positive. Evidence suggests that all three moderator variables tested (application timing, fungicide class, and disease base level), had some effect (alpha = 0.05) on the absolute difference in yield between fungicide treated and non-treated plots ((D) over bar). Application timing influenced (D) over bar, with V6 + VT and the VT application timings resulting in greater yield responses than the V6 application timing alone. Fungicide formulations that combined demethylation inhibitor and quinone outside inhibitor fungicides significantly increased yield response. Conclusion Foliar fungicide applications can increase corn grain yield. To ensure the likelihood of a positive ROI, farmers should focus on applications at VT and use fungicides that include a mix of demethylation inhibitor and quinone outside inhibitor active ingredients.	[Wise, Kiersten A.; Bradley, Carl A.] Univ Kentucky, Dept Plant Pathol, Res & Educ Ctr, Princeton, NJ 42445 USA; [Smith, Damon] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Freije, Anna] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Mueller, Daren S.; Kandel, Yuba; Robertson, Alison] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Allen, Tom] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Delta Res & Extens Ctr, Stoneville, MS USA; [Byamukama, Emmanuel] South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA; [Chilvers, Martin] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Faske, Travis] Lonoke Extens Ctr, Dept Plant Pathol, Div Agr, Lonoke, AR USA; [Friskop, Andrew] North Dakota State Univ, Dept Plant Pathol, Fargo, ND USA; [Hollier, Clayton; Price, Paul, III] LSU AgCtr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA USA; [Jackson-Ziems, Tamra A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Kelly, Heather] Univ Tennessee, Dept Entomol & Plant Pathol, West Tennessee Res & Educ Ctr, Jackson, TN USA; [Kemerait, Bob] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Tenuta, Albert] Univ Guelph Ridgetown, Ontario Minist Agr Food & Rural Affairs, Ridgetown, ON, Canada	University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Mississippi State University; South Dakota State University; Michigan State University; North Dakota State University Fargo; Louisiana State University System; Louisiana State University; University of Nebraska System; University of Nebraska Lincoln; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Wise, KA (corresponding author), Univ Kentucky, Dept Plant Pathol, Res & Educ Ctr, Princeton, NJ 42445 USA.	Kiersten.wise@uky.edu	Kandel, Yuba/AAF-5128-2021; Allen, Tom/ABC-8705-2020	Smith, Damon/0000-0003-3436-3718; Bradley, Carl/0000-0002-8334-0750	Arkansas Corn and Grain Sorghum Board; Louisiana Soybean and Grain Research and Promotion Board; Michigan Corn Marketing Program	Arkansas Corn and Grain Sorghum Board; Louisiana Soybean and Grain Research and Promotion Board; Michigan Corn Marketing Program	Funding for specific trials presented in the research analysis is acknowledged from the Arkansas Corn and Grain Sorghum Board (T.F.), the Louisiana Soybean and Grain Research and Promotion Board (P.P.) and the Michigan Corn Marketing Program (M.C.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adee E, 2017, PLANT HLTH PROG, V18, P129, DOI [10.1094/PHP-03-17-0020-RS, 10.1094/php-03-17-0020-rs]; Belden J, 2010, ENVIRON TOXICOL CHEM, V29, P2477, DOI 10.1002/etc.297; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; Bradley C. A., 2012, Journal of Extension, V50, p3RIB7; Bradley CA, 2010, PLANT DIS, V94, P83, DOI 10.1094/PDIS-94-1-0083; Bringolf RB, 2007, ENVIRON TOXICOL CHEM, V26, P2086, DOI 10.1897/06-522R.1; Byrne A. M., 2016, PLANT DIS MANAG REP, V10, pFC054; Cochran AM, 2016, PLANT DIS MANAG REP, V10; COLBY SR, 1967, WEEDS-U, V15, P20, DOI 10.2307/4041058; Esker PD, 2018, PHYTOPATHOLOGY, V108, P1078, DOI 10.1094/PHYTO-10-17-0342-R; Faske T, 2017, PLANT DIS MANAG REP, V11; Ferguson CG, 2016, PLANT DIS MANAG REP, V10, pFC131; FRAC, 2022, FUNGICIDE RESISTANCE; Grossmann K, 1997, PESTIC SCI, V50, P11, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;11::AID-PS556&gt;3.0.CO;2-8; Hagan AK, 2011, PLANT DIS MANAGE REP, V6; Harbour JD, 2016, PLANT DIS MANAG REP, V10; Johansson M, 2006, ENVIRON TOXICOL CHEM, V25, P3164, DOI 10.1897/05-685R1.1; Kandel YR, 2018, PLANT DIS, V102, P1093, DOI [10.1094/PDIS-10-17-1540-RE, 10.1094/pdis-10-17-1540-re]; Kleczewski N., 2016, PLANT DIS MANAG REP, V10; Kleczewski N., 2016, PLANT DIS MANAG REP, V11; Licht M., 2017, IOWA STATE U EXTENSI; Madden LV, 2011, PHYTOPATHOLOGY, V101, P16, DOI 10.1094/PHYTO-03-10-0069; Mallowa SO, 2015, PHYTOPATHOLOGY, V105, P1080, DOI 10.1094/PHYTO-08-14-0210-R; Mueller DS., 2013, FUNGICIDES FIELD CRO; Munkvold G.P., 2016, COMPENDIUM CORN DIS; Nason MA, 2007, PEST MANAG SCI, V63, P1191, DOI 10.1002/ps.1443; Opoku J., 2017, PLANT DIS MANAG REP, V11; Paul PA, 2008, PHYTOPATHOLOGY, V98, P999, DOI 10.1094/PHYTO-98-9-0999; Paul PA, 2011, PHYTOPATHOLOGY, V101, P1122, DOI 10.1094/PHYTO-03-11-0091; Paul PA, 2010, PHYTOPATHOLOGY, V100, P160, DOI 10.1094/PHYTO-100-2-0160; Rosburg A, 2018, J AGR RES EC, V43, P1; Schleicher CM, 2014, PLANT DIS MANAG REP, V8; Shelby RJ, 2018, CROP FORAGE TURF MAN, V4, DOI 10.2134/cftm2018.02.0006; Smith DL, 2014, PLANT DIS MANAG REP, V8; SMITLEY DR, 1986, ENTOMOL EXP APPL, V41, P255, DOI 10.1007/BF00221255; Tedford EC, 2017, CROP PROT, V91, P66, DOI 10.1016/j.cropro.2016.09.017; Wise K., 2011, APSNET FEATURES, DOI [10.1094/APSnetFeature-2011-0531, DOI 10.1094/APSNETFEATURE-2011-0531]; Wise K, 2018, 2011W CPN; Wu YX, 2001, PESTIC BIOCHEM PHYS, V71, P1, DOI 10.1006/pest.2001.2561	39	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217510	10.1371/journal.pone.0217510	http://dx.doi.org/10.1371/journal.pone.0217510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166965	Green Submitted, Green Published, gold			2022-12-27	WOS:000470087800032
J	Hope, TR; Selnes, P; Rektorova, I; Anderkova, L; Nemcova-Elfmarkova, N; Balazova, Z; Dale, A; Bjornerud, A; Fladby, T				Hope, Tuva R.; Selnes, Per; Rektorova, Irena; Anderkova, Lubomira; Nemcova-Elfmarkova, Nela; Balazova, Zuzana; Dale, Anders; Bjornerud, Atle; Fladby, Tormod			Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; LEWY BODIES; ALZHEIMERS-DISEASE; MOUSE MODEL; BRAIN; DEMENTIA; MICROSTRUCTURE; DEGENERATION; DIAGNOSIS; PATHOLOGY	To meet the need for Parkinson's disease biomarkers and evidence for amount and distribution of pathological changes, MRI diffusion tensor imaging (DTI) has been explored in a number of previous studies. However, conflicting results warrant further investigations. As tissue microstructure, particularly of the grey matter, is heterogeneous, a more precise diffusion model may benefit tissue characterization. The purpose of this study was to analyze the diffusion-based imaging technique restriction spectrum imaging (RSI) and DTI, and their ability to detect microstructural changes within brain regions associated with motor function in Parkinson's disease. Diffusion weighted (DW) MR images of a total of 100 individuals, (46 Parkinson's disease patients and 54 healthy controls) were collected using b-values of 0-4000s/mm(2). Output diffusion-based maps were estimated based on the RSI-model combining the full set of DW-images (Cellular Index (CI), Neurite Density (ND)) and DTI-model combining b = 0 and b = 1000 s/mm(2) (fractional anisotropy (FA), Axial-, Mean-and Radial diffusivity (AD, MD, RD)). All parametric maps were analyzed in a voxel-wise group analysis, with focus on typical brain regions associated with Parkinson's disease pathology. CI, ND and DTI diffusivity metrics (AD, MD, RD) demonstrated the ability to differentiate between groups, with strongest performance within the thalamus, prone to pathology in Parkinson's disease. Our results indicate that RSI may improve the predictive power of diffusion-based MRI, and provide additional information when combined with the standard diffusivity measurements. In the absence of major atrophy, diffusion techniques may reveal microstructural pathology. Our results suggest that protocols for MRI diffusion imaging may be adapted to more sensitive detection of pathology at different sites of the central nervous system.	[Hope, Tuva R.; Bjornerud, Atle] Oslo Univ Hosp, Rikshosp, Div Radiol & Nucl Med, Diagnost Phys, Oslo, Norway; [Selnes, Per; Fladby, Tormod] Akershus Univ Hosp, Dept Neurol, Loerenskog, Norway; [Selnes, Per; Fladby, Tormod] Univ Oslo, Inst Clin Med, Campus Ahus, Oslo, Norway; [Rektorova, Irena; Anderkova, Lubomira; Nemcova-Elfmarkova, Nela; Balazova, Zuzana] Masaryk Univ, Cent European Inst Technol, CEITEC, Brno, Czech Republic; [Rektorova, Irena] Masaryk Univ, Med Fac, Dept Neurol 1, Brno, Czech Republic; [Rektorova, Irena] St Annes Univ Hosp, Brno, Czech Republic; [Dale, Anders] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Dale, Anders] Univ Calif San Diego, Deparment Radiol, La Jolla, CA 92093 USA; [Dale, Anders] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo	Hope, TR (corresponding author), Oslo Univ Hosp, Rikshosp, Div Radiol & Nucl Med, Diagnost Phys, Oslo, Norway.	tuvarh@gmail.com	Novakova, Lubomira/AAX-9770-2021; Nemcova Elfmarkova, Nela/GWD-1264-2022; Nemcova Elfmarkova, Nela/GQZ-1872-2022	Novakova, Lubomira/0000-0002-8352-439X; Rektorova, Irena/0000-0002-5455-4573; Fladby, Tormod/0000-0002-9984-9797; Nemcova Elfmarkova, Nela/0000-0001-6181-0320; Selnes, Per/0000-0001-5131-9757	EU-JPND via the Research Council of Norway [237250]; South-Eastern Norway Regional Health Authority [20111093, 2014086]; Research Council of Norway [217780, 226074]; Akershus University Hospital grant; European Regional Development Fund-Project "National infrastructure for biological and medical imaging" [CZ.02.1.01/0.0/0.0/16_013/0001775]	EU-JPND via the Research Council of Norway; South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Akershus University Hospital grant; European Regional Development Fund-Project "National infrastructure for biological and medical imaging"	The work done by TRH, PS and TF was supported by the EU-JPND via the Research Council of Norway [grant number 237250]; South-Eastern Norway Regional Health Authority [grant numbers 20111093, 2014086]; Research Council of Norway [grant numbers 217780, 226074]; Akershus University Hospital grant; the work done by IR, LA, NNW, ZB was supported by the European Regional Development Fund-Project "National infrastructure for biological and medical imaging" [grant number CZ.02.1.01/0.0/0.0/16_013/0001775]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Radaideh AM, 2016, CLIN IMAG, V40, P987, DOI 10.1016/j.clinimag.2016.05.006; Anderkova L, 2017, MOVEMENT DISORDERS; Anderkova L, 2015, J ALZHEIMERS DIS, V48, P251, DOI 10.3233/JAD-150067; Andersson JL, 2007, TR07JA2 FMRIB AN GRO, V2; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Aung Wint Yan, 2013, Imaging Med, V5, P427; Auning E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003976; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brunsing RL, 2017, J MAGN RESON IMAGING, V45, P323, DOI 10.1002/jmri.25419; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Carper RA, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00610; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Doorn KJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0090-1; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Halliday GM, 2009, PARKINSONISM RELAT D, V15, pS152, DOI 10.1016/S1353-8020(09)70804-1; Hikishima K, 2015, NEUROSCIENCE, V300, P585, DOI 10.1016/j.neuroscience.2015.05.041; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Khairnar A, 2017, BRAIN BEHAV IMMUN, V61, P197, DOI 10.1016/j.bbi.2016.11.027; Khairnar A, 2016, J NEUROCHEM, V136, P1259, DOI 10.1111/jnc.13500; Khairnar A, 2015, NEUROTOX RES, V28, P281, DOI 10.1007/s12640-015-9537-9; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lanskey JH, 2018, BRAIN, V141, P2545, DOI 10.1093/brain/awy211; Lenfeldt N, 2015, EUR J NEUROL, V22, P1410, DOI 10.1111/ene.12760; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Modrego PJ, 2011, ACAD RADIOL, V18, P235, DOI 10.1016/j.acra.2010.09.022; PATT S, 1991, HISTOL HISTOPATHOL, V6, P373; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; Prakash BD, 2012, PARKINSONISM RELAT D, V18, P1029, DOI 10.1016/j.parkreldis.2012.05.021; Rektorova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085595; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Selnes P, 2017, ANN CLIN TRANSL NEUR, V4, P700, DOI 10.1002/acn3.446; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sowa P, 2019, MULT SCLER J, V25, P687, DOI 10.1177/1352458518765671; Stav AL, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2015.30; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang GH, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/207624	52	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217922	10.1371/journal.pone.0217922	http://dx.doi.org/10.1371/journal.pone.0217922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150514	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100127
J	Jung, YH; Park, Y; Kim, BI; Choi, CW				Jung, Young Hwa; Park, Youngmi; Kim, Beyong Il; Choi, Chang Won			Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; INTRAUTERINE GROWTH-RETARDATION; PATENT DUCTUS-ARTERIOSUS; FETAL ORIGINS; PREDICTORS; MECHANISMS	Objective We investigated whether the extent of fetal growth restriction (FGR) in terms of not only birth weight but length and head circumference at birth is correlated with an increased risk of bronchopulmonary dysplasia (BPD) in preterm infants. Study design A total of 4,940 very low birth weight (VLBW) infants born between 23 and 31 weeks of gestation from 2013 to 2015 who were registered in the Korean Neonatal Network (KNN) database were enrolled. Infants with major congenital malformations and those with incomplete data were excluded. Z-scores for weight, length, and head circumference at birth were calculated from the Fenton 2013 growth curve. Multivariable logistic regression analysis was performed to determine whether the z-score for length at birth was associated with BPD or death before 36 postmenstrual weeks. Results A total of 4,662 VLBW infants were analyzed: 518 infants died before 36 postmenstrual weeks; 1,388 infants developed BPD. Decreased length at birth z-scores were significantly associated with an increased risk of BPD or death when adjusted for covariates (odds ratio (OR) 1.25 per 1-point decrease of length at birth z-score, 95% confidence interval (CI) 1.14-1.37). The association was particularly evident in infants born earlier than 29 weeks of gestation (OR 1.57, 95% CI 1.31-1.89 in infants born at 23-25 weeks; OR 1.24, 95% CI 1.09-1.42 in infants born at 26-28 weeks). Conclusion Length at birth was inversely associated with an increased risk of BPD or death in VLBW infants born earlier than 32 weeks of gestation.	[Jung, Young Hwa; Kim, Beyong Il; Choi, Chang Won] Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam Si, Kyunggi Do, South Korea; [Park, Youngmi] Seoul Natl Univ, Med Res Collaborat Ctr, Bundang Hosp, Seongnam, South Korea; [Kim, Beyong Il; Choi, Chang Won] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, CW (corresponding author), Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam Si, Kyunggi Do, South Korea.; Choi, CW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	choic1029@gmail.com		CHOI, CHANG WON/0000-0003-1911-0253	National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A09059577]; Korean Centers for Disease Control and Prevention [2016-ER6307-02]	National Research Foundation of Korea - Ministry of Education; Korean Centers for Disease Control and Prevention	This study was supported by the Basic Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A09059577) and also supported by the Research Program funded by the Korean Centers for Disease Control and Prevention (2016-ER6307-02#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barud W, 1991, Ann Univ Mariae Curie Sklodowska Med, V46, P39; Baum M, 2003, CURR OPIN PEDIATR, V15, P166, DOI 10.1097/00008480-200304000-00005; Bose C, 2009, PEDIATRICS, V124, pE450, DOI 10.1542/peds.2008-3249; Bourbon JR, 2010, LUNG BIOL HEALTH DIS, V240, P56; Chang YS, 2015, J KOREAN MED SCI, V30, pS3, DOI 10.3346/jkms.2015.30.S1.S3; Cotten C Michael, 2005, J Perinatol, V25, P650; Feng K, 2011, J KOREAN MED SCI, V26, P1469, DOI 10.3346/jkms.2011.26.11.1469; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Hack M, 1998, EUR J CLIN NUTR, V52, pS65; Hansen AR, 2010, J PEDIATR-US, V156, P532, DOI 10.1016/j.jpeds.2009.10.018; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Jobe AH, 1998, EARLY HUM DEV, V53, P81, DOI 10.1016/S0378-3782(98)00045-0; Jobe AH, 2001, CURR OPIN PEDIATR, V13, P124, DOI 10.1097/00008480-200104000-00006; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00001; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Korhonen P, 1999, EARLY HUM DEV, V54, P245, DOI 10.1016/S0378-3782(98)00101-7; Kotecha SJ, 2018, PAEDIATR RESPIR REV, V28, P55, DOI 10.1016/j.prrv.2017.12.001; Lal CV, 2015, CLIN PERINATOL, V42, P739, DOI 10.1016/j.clp.2015.08.004; Lal MK, 2003, PEDIATRICS, V111, P483, DOI 10.1542/peds.111.3.483; MCDONNELL WF, 1991, EUR RESPIR J, V4, P279; Muscedere JG, 1994, AM J RESP CRIT CARE, V66, P2150; O'Shea JE, 2012, PEDIATR RES, V71, P210, DOI 10.1038/pr.2011.27; Redline RW, 2002, PEDIATR RES, V52, P713, DOI 10.1203/00006450-200211000-00017; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Speer CP, 2001, BIOL NEONATE, V79, P205; Tan ZH, 2016, CURR PEDIATR REV, V12, P83, DOI 10.2174/157339631202160506001309; Tauzin L, 2012, ACTA PAEDIATR, V101, P419, DOI 10.1111/j.1651-2227.2011.02550.x; Thureen P.J., 2001, NEOREVIEWS, V2, pe139, DOI DOI 10.1542/neo.2-6-e139; Trembath A, 2012, CLIN PERINATOL, V39, P585, DOI 10.1016/j.clp.2012.06.014; TURNER JA, 1951, PEDIATRICS, V7, P360; Zapletal A, 1987, LUNG FUNCTION CHILDR; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273	34	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217739	10.1371/journal.pone.0217739	http://dx.doi.org/10.1371/journal.pone.0217739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150480	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100094
J	Kuriakose, AE; Hu, WJ; Nguyen, KT; Menon, JU				Kuriakose, Aneetta E.; Hu, Wenjing; Nguyen, Kytai T.; Menon, Jyothi U.			Scaffold-based lung tumor culture on porous PLGA microparticle substrates	PLOS ONE			English	Article							DRUG-DELIVERY; CANCER CELLS; MICROSPHERES; MODEL; BEADS; DOXORUBICIN; RESISTANCE; SYSTEM; GROWTH; TOOL	Scaffold-based cancer cell culture techniques have been gaining prominence especially in the last two decades. These techniques can potentially overcome some of the limitations of current three-dimensional cell culture methods, such as uneven cell distribution, inadequate nutrient diffusion, and uncontrollable size of cell aggregates. Porous scaffolds can provide a convenient support for cell attachment, proliferation and migration, and also allows diffusion of oxygen, nutrients and waste. In this paper, a comparative study was done on porous poly (lactic-co-glycolic acid) (PLGA) microparticles prepared using three porogens-gelatin, sodium bicarbonate (SBC) or novel poly N-isopropylacrylamide [PNIPAAm] particles, as substrates for lung cancer cell culture. These fibronectin-coated, stable particles (19-42 mu m) supported A549 cell attachment at an optimal cell seeding density of 250,000 cells/mg of particles. PLGA-SBC porous particles had comparatively larger, more interconnected pores, and favored greater cell proliferation up to 9 days than their counterparts. This indicates that pore diameters and interconnectivity have direct implications on scaffold-based cell culture compared to substrates with minimally interconnected pores (PLGA-gelatin) or pores of uniform sizes (PLGA-PMPs). Therefore, PLGA-SBC-based tumor models were chosen for preliminary drug screening studies. The greater drug resistance observed in the lung cancer cells grown on porous particles compared to conventional cell monolayers agrees with previous literature, and indicates that the PLGA-SBC porous microparticle substrates are promising for in vitro tumor or tissue development.	[Kuriakose, Aneetta E.; Nguyen, Kytai T.; Menon, Jyothi U.] Univ Texas Arlington, Bioengn Dept, Arlington, TX 76019 USA; [Kuriakose, Aneetta E.; Nguyen, Kytai T.; Menon, Jyothi U.] UT Southwestern Med Ctr, Grad Biomed Engn Program, Dallas, TX 75390 USA; [Hu, Wenjing] Progenitec Inc, Arlington, TX USA; [Menon, Jyothi U.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rhode Island	Nguyen, KT; Menon, JU (corresponding author), Univ Texas Arlington, Bioengn Dept, Arlington, TX 76019 USA.; Nguyen, KT; Menon, JU (corresponding author), UT Southwestern Med Ctr, Grad Biomed Engn Program, Dallas, TX 75390 USA.; Menon, JU (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	knguyen@uta.edu; jmenon@uri.edu	Menon, Jyothi/S-9255-2019	Menon, Jyothi/0000-0002-0762-3513	NIH STTR grant [R41 MH106303]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103430]; University of Rhode Island Council for Research award; NIH [T32 HL 134613]; STTR grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	NIH STTR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); University of Rhode Island Council for Research award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STTR grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported through NIH STTR R41 MH106303 grant to WH and KTN. Progenitec Inc, provided support in the form of salary for author WH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions'. WH provided support in the form of funds to purchase research supplies and reagents, provided resources, and reviewed and edited the manuscript as part of the joint STTR grant with KTN. The work was also funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (#P20GM103430) and University of Rhode Island Council for Research award, both to JUM. AK was funded through NIH T32 HL 134613. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2012, EUR J CANCER PREV, V21, P407, DOI 10.1097/CEJ.0b013e32834ef194; Amin ARMR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124218; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]; Asghar W, 2015, MATER TODAY, V18, P539, DOI 10.1016/j.mattod.2015.05.002; Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274; Blandin Knight Sean, 2017, Open Biol, V7, DOI 10.1098/rsob.170070; Cai YP, 2013, INT J NANOMED, V8, P1111, DOI 10.2147/IJN.S41271; Choi SYC, 2014, ADV DRUG DELIVER REV, V79-80, P222, DOI 10.1016/j.addr.2014.09.009; Choi SW, 2012, J MATER CHEM, V22, P11442, DOI 10.1039/c2jm16019f; Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h; Choi SW, 2010, SMALL, V6, P1492, DOI 10.1002/smll.201000544; Choi Y, 2011, B KOREAN CHEM SOC, V32, P867, DOI 10.5012/bkcs.2011.32.3.867; Chou MJ, 2013, J BIOMED MATER RES A, V101, P2862, DOI 10.1002/jbm.a.34594; COLE SPC, 1986, CANCER CHEMOTH PHARM, V17, P259; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Dubiak-Szepietowska M, 2016, TOXICOL APPL PHARM, V294, P78, DOI 10.1016/j.taap.2016.01.016; Edelman MJ, 2001, CANCER CHEMOTH PHARM, V48, P141, DOI 10.1007/s002800000273; El Assal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39144; Fang JJ, 2014, ACTA BIOMATER, V10, P276, DOI 10.1016/j.actbio.2013.09.002; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jiang RD, 2010, ROM J MORPHOL EMBRYO, V51, P663; Justin AW, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0768; Kang SW, 2009, BIOMATERIALS, V30, P4227, DOI 10.1016/j.biomaterials.2009.04.025; Ke CJ, 2013, BIOMATERIALS, V34, P1, DOI 10.1016/j.biomaterials.2012.09.023; Kemala T, 2012, ARAB J CHEM, V5, P103, DOI 10.1016/j.arabjc.2010.08.003; Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571; Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031; Knight Eleanor, 2015, J Anat, V227, P746, DOI 10.1111/joa.12257; Kona S, 2012, INT J PHARMACEUT, V423, P516, DOI 10.1016/j.ijpharm.2011.11.043; Koppolu B, 2010, NANOMED-NANOTECHNOL, V6, P355, DOI 10.1016/j.nano.2009.07.008; Lee SH, 2012, ASME FLUID ENG DIV, P253; Lee YS, 2016, MOL THER, V24, P805, DOI 10.1038/mt.2016.22; Leong WY, 2015, TRENDS BIOTECHNOL, V33, P653, DOI 10.1016/j.tibtech.2015.09.003; Libby P, 2010, J NUCL MED, V51, p33S, DOI 10.2967/jnumed.109.069633; LIEBMANN JE, 1993, BRIT J CANCER, V68, P1104, DOI 10.1038/bjc.1993.488; Lim SM, 2009, J BIOMED MATER RES B, V90B, P521, DOI 10.1002/jbm.b.31313; Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]; Martinez-Ramos C, 2015, J BIOMED MATER RES B, V103, P1249, DOI 10.1002/jbm.b.33304; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Meng FB, 2019, ADV MATER, V31, DOI 10.1002/adma.201806899; Menon JU, 2014, ACTA BIOMATER, V10, P2643, DOI 10.1016/j.actbio.2014.01.033; Mitra A, 2013, TRENDS BIOTECHNOL, V31, P347, DOI 10.1016/j.tibtech.2013.03.006; Mittal A, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045001; Movia D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31332-6; Nguyen KT, 2009, J BIOMED MATER RES A, V88A, P1022, DOI 10.1002/jbm.a.31734; Nirmalanandhan VS, 2010, ASSAY DRUG DEV TECHN, V8, P581, DOI 10.1089/adt.2010.0276; Otterson GA, 2010, CLIN CANCER RES, V16, P2466, DOI 10.1158/1078-0432.CCR-09-3015; Parmar N, 2015, TISSUE ENG PART C-ME, V21, P404, DOI [10.1089/ten.tec.2014.0431, 10.1089/ten.TEC.2014.0431]; Pradhan S, 2017, BIOMATERIALS, V115, P141, DOI 10.1016/j.biomaterials.2016.10.052; Privalova AM, 2015, J NANOSCI NANOTECHNO, V15, P4806, DOI 10.1166/jnn.2015.10508; Qutachi O, 2014, ACTA BIOMATER, V10, P5090, DOI 10.1016/j.actbio.2014.08.015; Ravikumar P, 2016, NANOMED-NANOTECHNOL, V12, P811, DOI 10.1016/j.nano.2015.10.004; Ricci C., 2013, OA TISSUE ENG, V1, P1, DOI DOI 10.13172/2052-9643-1-1-607; ROMIJN HJ, 1988, BIOL CELL, V63, P263, DOI 10.1016/0248-4900(88)90116-5; Ruppen J, 2014, LAB CHIP, V14, P1198, DOI 10.1039/c3lc51093j; Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632; Scarpace Sarah L, 2015, Drugs Context, V4, P212289, DOI 10.7573/dic.212289; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; Tanaka M, 1997, AM J PHYSIOL-LUNG C, V273, pL1090, DOI 10.1152/ajplung.1997.273.5.L1090; Tocchio A, 2018, ADV MATER, V30, DOI 10.1002/adma.201705034; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wadajkar AS, 2013, BIOMATERIALS, V34, P3618, DOI 10.1016/j.biomaterials.2013.01.062; Wang CH, 2015, RSC ADV, V5, P81445, DOI 10.1039/c5ra15516a; Wang DD, 2016, RSC ADV, V6, P24083, DOI 10.1039/c6ra00229c; Wang M, 2018, ELECTROSPINNING ELEC; Wei DX, 2018, ADV MATER, V30, DOI 10.1002/adma.201802273; Xin YQ, 2013, TOXICOL LETT, V221, P73, DOI 10.1016/j.toxlet.2013.06.215; Xu B, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/035018; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yeung P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144139; Yu L, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4918754; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhang QC, 2012, MAT SCI ENG C-MATER, V32, P2589, DOI 10.1016/j.msec.2012.07.045; Zhang TZ, 2014, COLLOID SURFACE A, V452, P115, DOI 10.1016/j.colsurfa.2014.03.085; Zhao JG, 2014, TUMOR BIOL, V35, P12305, DOI 10.1007/s13277-014-2543-3	82	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217640	10.1371/journal.pone.0217640	http://dx.doi.org/10.1371/journal.pone.0217640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150477	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100078
J	Rowe, SY; Peters, DH; Holloway, KA; Chalker, J; Ross-Degnan, D; Rowe, AK				Rowe, Samantha Y.; Peters, David H.; Holloway, Kathleen A.; Chalker, John; Ross-Degnan, Dennis; Rowe, Alexander K.			A systematic review of the effectiveness of strategies to improve health care provider performance in low- and middle-income countries: Methods and descriptive results	PLOS ONE			English	Review							CHILDHOOD ILLNESS; INTEGRATED MANAGEMENT; HUMAN-RESOURCES; GLOBAL BURDEN; GUIDELINES; DEATHS; METAANALYSIS; BANGLADESH; FACILITIES; MORTALITY	Background Health care provider (HCP) performance in low-and middle-income countries (LMICs) is often inadequate. The Health Care Provider Performance Review (HCPPR) is a comprehensive systematic review of the effectiveness and cost of strategies to improve HCP performance in LMICs. We present the HCPPR's methods, describe methodological and contextual attributes of included studies, and examine time trends of study attributes. Methods The HCPPR includes studies from LMICs that quantitatively evaluated any strategy to improve HCP performance for any health condition, with no language restrictions. Eligible study designs were controlled trials and interrupted time series. In 2006, we searched 15 databases for published studies; in 2008 and 2010, we completed searches of 30 document inventories for unpublished studies. Data from eligible reports were double-abstracted and entered into a database, which is publicly available. The primary outcome measure was the strategy's effect size. We assessed time trends with logistic, Poisson, and negative binomial regression modeling. We were unable to register with PROSPERO (International Prospective Register of Systematic Reviews) because the protocol was developed prior to the PROSPERO launch. Results We screened 105,299 citations and included 824 reports from 499 studies of 161 intervention strategies. Most strategies had multiple components and were tested by only one study each. Studies were from 79 countries and had diverse methodologies, geographic settings, HCP types, work environments, and health conditions. Training, supervision, and patient and community supports were the most commonly evaluated strategy components. Only 33.6% of studies had a low or moderate risk of bias. From 1958-2003, the number of studies per year and study quality increased significantly over time, as did the proportion of studies from low-income countries. Only 36.3% of studies reported information on strategy cost or cost-effectiveness. Conclusions Studies have reported on the efficacy of many strategies to improve HCP performance in LMICs. However, most studies have important methodological limitations. The HCPPR is a publicly accessible resource for decision-makers, researchers, and others interested in improving HCP performance.	[Rowe, Samantha Y.; Rowe, Alexander K.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Rowe, Samantha Y.] CDC Fdn, Atlanta, GA 30308 USA; [Peters, David H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Holloway, Kathleen A.] WHO, Southeast Asia Reg Off, New Delhi, India; [Holloway, Kathleen A.] Int Inst Hlth Management Res, Jaipur, Rajasthan, India; [Chalker, John] Pharmaceut & Hlth Technol Grp, Management Sci Hlth, Arlington, VA USA; [Ross-Degnan, Dennis] Harvard Med Sch, Boston, MA 02115 USA; [Ross-Degnan, Dennis] Harvard Pilgr Hlth Care Inst, Boston, MA USA; [Holloway, Kathleen A.] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Harvard University; Harvard Medical School; University of Sussex	Rowe, SY (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.; Rowe, SY (corresponding author), CDC Fdn, Atlanta, GA 30308 USA.	say9@cdc.gov		Rowe, Alexander/0000-0002-1383-4341; Peters, David/0000-0001-8377-3444; Rowe, Samantha/0000-0003-3729-579X	CDC Foundation through Bill & Melinda Gates Foundation [OPP52730]; CDC Foundation through Centers for Disease Control and Prevention; World Bank Netherlands Partnership Program [P098685]	CDC Foundation through Bill & Melinda Gates Foundation; CDC Foundation through Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); World Bank Netherlands Partnership Program	This review was supported by funding from the CDC Foundation through a grant from the Bill & Melinda Gates Foundation (grant OPP52730), and from the Centers for Disease Control and Prevention, and a World Bank Netherlands Partnership Program Grant (project number P098685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas M, 2003, HARVARD REV PSYCHIAT, V11, P166, DOI 10.1080/10673220303954; Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; Amaral João Joaquim Freitas do, 2008, Rev. Bras. Saude Mater. Infant., V8, P151, DOI 10.1590/S1519-38292008000200002; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bickler SW, 2002, B WORLD HEALTH ORGAN, V80, P829; Bitera Raphael, 2002, Sante, V12, P233; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Bosch-Capblanch X, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006413.pub2; Bose S, 2001, 24 US AG INT DEV QUA, V2; Briggs CJ, 2001, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD003318PMID:11687187, DOI 10.1002/14651858.CD003318]; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Ciapponi A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011083.pub2; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Effective Practice and Organisation of Care (EPOC), 2015, SUGG RISK BIAS CRIT; Effective Practice and Organisation of Care (EPOC), 2015, EPOC TAX; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; English M, 2014, ARCH DIS CHILD, V99, P452, DOI 10.1136/archdischild-2013-305561; Frosch DL, 2010, AM J PUBLIC HEALTH, V100, P24, DOI 10.2105/AJPH.2008.153767; Gonzalez Ochoa E, 1996, Bull Pan Am Health Organ, V30, P106; Grace C, 2008, SELECTIVE REV WORK A; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hanefeld J, 2017, B WHO; Harris R., PATIENTS VULNERABLE; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; HERRERA CA, 2017, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD011085.PUB2; Hill J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001688; Holloway K, 2004, 2 INT C IMPR US MED; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Knebel E, 2001, 22 U RES CO US AG IN, V2; Knebel E, 2000, 12 U RES CO US AG IN, V1; Knebel E, 2000, 11 U RES CO US AG IN, V1; Kok G, 2016, HEALTH PSYCHOL REV, V10, P297, DOI 10.1080/17437199.2015.1077155; Kravitz RL, 2017, JAMA-J AM MED ASSOC, V317, P1124, DOI 10.1001/jama.2017.1364; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Merali HS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-280; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Montagu D, 2016, HEALTH POLICY PLANN, V31, P1117, DOI 10.1093/heapol/czw018; Morgan R, 2016, LANCET, V388, P606, DOI 10.1016/S0140-6736(16)00343-3; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; Opiyo N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007071.pub2; Pantoja T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011086.pub2; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Ross-Degnan D, 1997, INT C IMPR US MED CH; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Rowe AK, 2012, HEALTH POLICY PLANN, V27, P179, DOI 10.1093/heapol/czr033; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Shojania KG, 2004, AGENCY HEALTHC RES Q, V1, P1; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley LM, 2004, J MIDWIFERY WOM HEAL, V49, P298, DOI 10.1016/j.jmwh.2004.03.009; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; United Nations, 2014, A68970 UN; Vasan A, 2017, HEALTH POLICY PLANN, V32, P437, DOI 10.1093/heapol/czw144; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Whiting DR, 2003, J CARDIOVASC RISK, V10, P103, DOI 10.1097/00043798-200304000-00005; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; Wiysonge CS, 2017, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD011084.PUB2; Wootton R, 2001, J TELEMED TELECARE, V7, P3, DOI [10.1258/1357633011937245, 10.1258/1357633011936589]; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2001, WHOCDSCSRDRS20019; World Health Organization, 2009, MED US PRIM CAR DEV; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	80	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217617	10.1371/journal.pone.0217617	http://dx.doi.org/10.1371/journal.pone.0217617			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150458	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100073
J	Vrbova, E; Grillova, L; Mikalova, L; Pospisilova, P; Strnadel, R; Dastychova, E; Kojanova, M; Kreidlova, M; Vanousova, D; Rob, F; Prochazka, P; Krchnakova, A; Vasku, V; Woznicova, V; Heroldova, MD; Kuklova, I; Zakoucka, H; Smajs, D				Vrbova, Eliska; Grillova, Linda; Mikalova, Lenka; Pospisilova, Petra; Strnadel, Radim; Dastychova, Eliska; Kojanova, Martina; Kreidlova, Miluse; Vanousova, Daniela; Rob, Filip; Prochazka, Premysl; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova; Kuklova, Ivana; Zakoucka, Hana; Smajs, David			MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants	PLOS ONE			English	Article							SYPHILIS-CAUSING STRAINS; MACROLIDE RESISTANCE; IDENTIFIED GENOTYPES; PREVALENCE; GENE; MUTATIONS; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; PHYLOGENIES	A recently introduced Multilocus Sequence Typing scheme for Treponema pallidum subsp. pallidum was applied to clinical samples collected from 2004 to 2017 from the two largest cities (Prague and Brno) in the Czech Republic. Altogether, a total of 675 samples were tested in this study and 281 of them were found PCR-positive for treponemal DNA and typeable. Most of the typed samples (n = 281) were swabs from primary or secondary syphilis lesions (n = 231), and only a minority were whole blood or tissue samples (n = 50). Swab samples from patients with rapid plasma regain (RPR) values of 1-1024 were more frequently PCR-positive (84.6%) compared to samples from patients with non-reactive RPR test (46.5%; p-value = 0.0001). Out of 281 typeable samples, 136 were fully-typed at all TP0136, TP0548, and TP0705 loci. Among the fully and partially typed samples, 25 different allelic profiles were identified. Altogether, eight novel allelic variants were found among fully (n = 5) and partially (n = 3) typed samples. The distribution of TPA allelic profiles identified in the Czech Republic from 2004 to 2017 revealed a dynamic character with allelic profiles disappearing and emerging over time. While the number of samples with the A2058G mutation was seen to increase (86.7% in 2016/2017), the number of samples harboring the A2059G mutation was found to have decreased over time (3.3% in 2016/2017). In addition, we found several allelic profile associations with macrolide resistance or susceptibility, the gender of patients, as well as patient residence.	[Vrbova, Eliska; Grillova, Linda; Mikalova, Lenka; Pospisilova, Petra; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Strnadel, Radim] Fac Hosp Brno, Dept Dermatovenerol, Brno, Czech Republic; [Dastychova, Eliska; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova] St Annes Hosp, Fac Med, Dept Med Microbiol, Brno, Czech Republic; [Dastychova, Eliska; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova] Masaryk Univ, Brno, Czech Republic; [Kojanova, Martina; Kuklova, Ivana] Charles Univ Prague, Fac Med 1, Dept Dermatol, Prague, Czech Republic; [Kreidlova, Miluse] Charles Univ Prague, Fac Med 1, Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vanousova, Daniela; Rob, Filip] Charles Univ Prague, Fac Med 2, Dept Dermatovenerol, Prague, Czech Republic; [Prochazka, Premysl] Outpatient STI Clin Medictr, Prague, Czech Republic; [Zakoucka, Hana] Natl Inst Publ Hlth, Natl Reference Lab Diagnost Syphilis, Prague, Czech Republic; [Grillova, Linda] Inst Pasteur, Biol Spirochetes Unit, Paris, France	Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Grillova, Linda/AAA-8557-2020; Mikalová, Lenka/AAM-1068-2020; Kojanova, Martina/J-7224-2017	Kojanova, Martina/0000-0001-9890-9965; Pastekova, Lenka/0000-0003-4266-9952; Grillova, Linda/0000-0003-2371-3161	Grant Agency of the Czech Republic [GA17-25455S]; Ministry of Health of the Czech Republic [17-31333A]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by grants from the Grant Agency of the Czech Republic (GA17-25455S) and the Ministry of Health of the Czech Republic (17-31333A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; Cejkova D, 2013, J MED MICROBIOL, V62, P196, DOI 10.1099/jmm.0.050658-0; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Dai T, 2012, J CLIN MICROBIOL, V50, P3674, DOI 10.1128/JCM.01195-12; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flasarova M., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P105; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Vaulet LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172905; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Giacani L, 2018, SEX TRANSM DIS, V45, P237, DOI 10.1097/OLQ.0000000000000741; Godornes C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006113; Grange PA, 2016, SEX TRANSM DIS, V43, P517, DOI 10.1097/OLQ.0000000000000474; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Grillova L, 2019, PEERJ, V6, DOI 10.7717/peerj.6182; Grillova L, 2019, J INFECT DIS, V219, P1138, DOI 10.1093/infdis/jiy604; Grillova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200773; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Katz KA, 2010, SEX TRANSM DIS, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; Khairullin R, 2016, APMIS, V124, P595, DOI 10.1111/apm.12541; Kojima Y, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01148-18; Kumar S, 2015, MOL BIOL EVOL UNPUB; Li Z, 2017, APMIS, V125, P937, DOI 10.1111/apm.12724; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mikalova L, 2017, SEX TRANSM DIS, V44, P376, DOI 10.1097/OLQ.0000000000000600; Mikalova L, 2014, SEX TRANSM DIS, V41, P552, DOI 10.1097/OLQ.0000000000000165; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Noda AA, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.02.006; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Peng RR, 2012, SEX TRANSM DIS, V39, P42, DOI 10.1097/OLQ.0b013e318232697d; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Pospisilova P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201068; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Smajs D., 2016, FORUM IMMUN DIS THER, V7, P181, DOI DOI 10.1615/F0RUMIMMUNDISTHER.2017020184; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Strouhal M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006867; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tipple C, 2011, SEX TRANSM INFECT, V87, P486, DOI 10.1136/sextrans-2011-050082; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445; Zhang RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175477; Zhu BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159787	52	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217611	10.1371/journal.pone.0217611	http://dx.doi.org/10.1371/journal.pone.0217611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150464	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100071
J	Li, ZY; Jiang, CH; Yuan, YX				Li, Zaiye; Jiang, Canhua; Yuan, Yongxiang			TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; UP-REGULATION; DOWN-REGULATION; CANCER-CELLS; EXPRESSION; INVASION; PROMOTES; PROLIFERATION; HEAD; PROGRESSION	Objectives The study aimed to investigate the ceRNA network in biological development of Tongue Squamous Cell Carcinoma (TSCC) and to identify novel molecular subtypes of TSCC to screen potential biomarkers for target therapy and prognosis by using integrated genomic analysis based on The Cancer Genome Atlas (TCGA) database. Material and methods Data on gene expressions were downloaded from TCGA and GEO database. Differentially expressed RNAs (DERNAs) were shown by DESeq2 package in R. Functional enrichment analysis of DEmRNAs was performed using clusterprofilers in R. PPI network was established by referring to String website. Survival analysis of DERNAs was carried out by survival package in R. Interactions among mRNAs, miRNAs and lncRNAs were obtained from Starbase v3.0 and used to construct ceRNA network. Consensus Cluster Plus package was applied to identify molecular subtypes. All key genes were validated by comparing them with GEO microarray data. Statistical analyses of clinical features among different subtypes were performed using SPSS 22.0. Results A total of 2907 mRNAs (1366 up-regulated and 1541 down-regulated), 191miRNAs (98 upregulated and 93 down-regulated) and 1831 lncRNAs (1151 up-regulated and 680 downregulated) were identified from tumor and normal tissues. A ceRNA network was successfully constructed and 15 DEmRNAs, 1 DEmiRNA, 2 DElncRNAs associated with prognosis were employed. Furthermore, we firstly identified 2 molecular subtypes, basal and differentiated, and found that differentiated subtype consumed less alcohol and was related to a better overall survival. Conclusion The study constructed a ceRNA network and identified molecular subtypes of TSCC, and our findings provided a novel insight into this intractable cancer and potential therapeutic targets and prognostic indicators.	[Li, Zaiye; Jiang, Canhua; Yuan, Yongxiang] Cent South Univ, Xiangya Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China	Central South University	Li, ZY (corresponding author), Cent South Univ, Xiangya Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China.	zaiyl01@163.com		Li, Zaiye/0000-0002-1922-4237				Afsharpad M, 2019, PATHOL ONCOL RES, V25, P191, DOI 10.1007/s12253-017-0313-4; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Cai YY, 2016, MOL MED REP, V13, P4827, DOI 10.3892/mmr.2016.5134; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cheng XL, 2009, J BIOL CHEM, V284, P30897, DOI 10.1074/jbc.M109.011213; Feng L, 2017, ONCOTARGET, V8, P31521, DOI 10.18632/oncotarget.16358; Gupta B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113385; Hakami F, 2014, BRIT J CANCER, V111, P807, DOI 10.1038/bjc.2014.372; He BX, 2018, J CELL BIOCHEM, V119, P338, DOI 10.1002/jcb.26182; Hernandez-Plata E, 2012, INT J CANCER, V130, P2013, DOI 10.1002/ijc.26210; Hou XF, 2017, WORLD J GASTROENTERO, V23, P1796, DOI 10.3748/wjg.v23.i10.1796; Hu QC, 2019, ORAL ONCOL, V89, P14, DOI 10.1016/j.oraloncology.2018.12.006; Huang SH, 2018, J CELL BIOCHEM, V119, P2248, DOI 10.1002/jcb.26387; Ion Ciuca Marasescu F I, 2018, Curr Health Sci J, V44, P211, DOI 10.12865/CHSJ.44.03.03; Jia LF, 2014, INT J CANCER, V135, P2282, DOI 10.1002/ijc.28667; Jiang HB, 2010, J CANCER RES CLIN, V136, P1295, DOI 10.1007/s00432-010-0780-4; Kazemi-Oula G, 2015, CELL J, V17, P471; Kokemueller H, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-27; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02522-5; Li F, 2018, CLIN CHEM, V64, P1513, DOI 10.1373/clinchem.2018.290569; Li Q, 2015, ONCOL REP, V33, P2354, DOI 10.3892/or.2015.3812; Li SM, 2017, ORAL ONCOL, V73, P1, DOI 10.1016/j.oraloncology.2017.07.026; Liu PY, 2012, INVEST NEW DRUG, V30, P79, DOI 10.1007/s10637-010-9518-z; Liu WH, 2018, BIOMED PHARMACOTHER, V104, P94, DOI 10.1016/j.biopha.2018.05.015; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lu SX, 2017, CANCER LETT, V402, P71, DOI 10.1016/j.canlet.2017.05.018; Morita Y, 2015, CLIN EXP METASTAS, V32, P739, DOI 10.1007/s10585-015-9741-2; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nair S, 2016, EUR ARCH OTO-RHINO-L, V273, P3921, DOI 10.1007/s00405-016-4051-0; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Nohata N, 2016, ORAL ONCOL, V59, P58, DOI 10.1016/j.oraloncology.2016.05.014; Patel F, 2015, INT J DEV BIOL, V59, P357, DOI 10.1387/ijdb.150171wb; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Rastogi B, 2017, CANCER INVEST, V35, P152, DOI 10.1080/07357907.2017.1286669; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shan B, 2014, ONCOL LETT, V8, P345, DOI 10.3892/ol.2014.2110; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simoes-Sousa S, 2016, CELL CYCLE, V15, P1865, DOI 10.1080/15384101.2016.1188239; Song H, 2012, CANCER GENE THER, V19, P875, DOI 10.1038/cgt.2012.77; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Voelxen NF, 2018, CLIN ORAL INVEST, V22, P1033, DOI 10.1007/s00784-017-2185-0; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang KT, 2014, MOL MED REP, V9, P273, DOI 10.3892/mmr.2013.1804; Wang ZY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0752-2; Wang ZS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-76; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiang X, 2015, ONCOTARGET, V6, P22452, DOI 10.18632/oncotarget.4311; Xu K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4357647; Yin WW, 2016, J CLIN NEUROSCI, V33, P187, DOI 10.1016/j.jocn.2016.04.019; Yu JS, 2016, P NATL ACAD SCI USA, V113, P11549, DOI 10.1073/pnas.1612368113; Zevallos JP, 2019, LARYNGOSCOPE, V129, P154, DOI 10.1002/lary.27340; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0171-2; Zhang TF, 2013, MOL CARCINOGEN, V52, P581, DOI 10.1002/mc.21880; Zhang XA, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0120-2; Zhou XL, 2015, MOL MED REP, V12, P885, DOI 10.3892/mmr.2015.3467	58	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216834	10.1371/journal.pone.0216834	http://dx.doi.org/10.1371/journal.pone.0216834			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141819	Green Submitted, gold, Green Published			2022-12-27	WOS:000469323000026
J	Widia, M; Dawal, SZM; Yusoff, N				Widia, Mirta; Dawal, Siti Zawiah Md; Yusoff, Nukman			Maximum acceptable frequency of lift for combined manual material handling task in Malaysia	PLOS ONE			English	Article							MUSCLE FATIGUE; WEIGHTS; EXPOSURE; DESIGN; MODELS; LIMITS	Background Extensive studies have been carried out over the years to determine the maximum acceptable weight that a worker is capable of lifting in a given situation among Occidental populations across Europe and US. Nonetheless, studies that place emphasis on using lifting frequency as the quantifying task parameter, especially in developing countries such as Malaysia, appear to be in scarcity. Hence, this study determined the maximum acceptable frequency of lift (MAFL) for combined manual material handling (MMH) tasks amongst Malaysian males. Method Two lifting loads were considered in this study: 1 kg and 5 kg. Each subject adjusted his frequency of lifting using a psychophysical approach. The subjects were instructed to perform combined MMH task as fast as they could over a period of 45 minutes without exhausting themselves or becoming overheated. The physiological response energy expenditure was recorded during the experimental sessions. The ratings of perceived exertion (RPE) for four body parts (forearms, upper arm, lower back and entire body) were recorded after the subjects had completed the instructed task. Results The mean frequencies of the MMH task had been 6.8 and 5.5 cycles/minute for lifting load of 1 and 5 kg, respectively, while the mean energy expenditure values were 4.16 and 5.62 kcal/min for 1 and 5 kg load, respectively. These displayed a significant difference in the Maximum Acceptable Frequency of Lift (MAFL) between the two loads, energy expenditure and RPE (p < 0.05) whereby the subjects appeared to work harder physiologically for heavier load. Conclusion It can be concluded that it is significant to assess physiological response and RPE in determining the maximum acceptable lifting frequency at varied levels of load weight. The findings retrieved in this study can aid in designing tasks that do not exceed the capacity of workers in order to minimise the risk of WRMSDs.	[Widia, Mirta] Univ Malaysia Pahang, Fac Engn Technol, Occupat Safety & Hlth Program, Gambang, Pahang, Malaysia; [Dawal, Siti Zawiah Md; Yusoff, Nukman] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur, Malaysia	Universiti Malaysia Pahang; Universiti Malaya	Widia, M (corresponding author), Univ Malaysia Pahang, Fac Engn Technol, Occupat Safety & Hlth Program, Gambang, Pahang, Malaysia.	mirta@ump.edu.my	DAWAL, SITI ZAWIAH MD/B-9816-2010; Bin Yusoff, Nukman/B-5302-2010; widia, mirta/L-8165-2019	DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128; Bin Yusoff, Nukman/0000-0002-7389-2164; widia, mirta/0000-0003-3726-6868	Universiti Malaysia Pahang (UMP) [RDU190335]; Ministry of Higher Education Malaysia under the High Impact Research Grant [UM. C/HIR/MOHE/ENG/35 (D000035-16001)]	Universiti Malaysia Pahang (UMP); Ministry of Higher Education Malaysia under the High Impact Research Grant	This work are financially supported by Universiti Malaysia Pahang (UMP) Grant RDU190335 and the Ministry of Higher Education Malaysia under the High Impact Research Grant UM. C/HIR/MOHE/ENG/35 (D000035-16001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliraza Choobineh SHTaMB, 2009, INT J OCCUPATIONAL S, V15, P5; [Anonymous], 2004, LABOR DO INJURY STAT; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Arjmand N, 2012, CLIN BIOMECH, V27, P537, DOI 10.1016/j.clinbiomech.2011.12.015; Ayoub MM, 1999, ERGONOMICS, V42, P17, DOI 10.1080/001401399185775; Barreira T, 2009, INT J EXER SCI, V2, P60; Burdorf A, 1998, OCCUPATIONAL ENV MED, V55, P5; Cheng T-HLaT-S, 2011, INT J OCCUPATIONAL S, V17, P7; Ciriello VM, 2011, INT ARCH OCC ENV HEA, V84, P569, DOI 10.1007/s00420-010-0589-0; Ciriello VM, 2010, APPL ERGON, V41, P141, DOI 10.1016/j.apergo.2009.06.001; Conway H, 2001, J LABOR RES, V22, P29, DOI 10.1007/s12122-001-1002-2; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Das B, 2009, HUM FACTOR ERGON MAN, V19, P404, DOI 10.1002/hfm.20152; DOSH, 2011, SOCSO STAT REP ONL; Founooni-Fard H, 1993, INT J IND ERGONOM, V12, P127; Fox RR, 2014, INT J IND ERGONOM, V44, P238, DOI 10.1016/j.ergon.2012.11.004; GENAIDY AM, 1988, HUM FACTORS, V30, P319, DOI 10.1177/001872088803000306; Halim I, 2012, SAF HEALTH WORK, V3, P31, DOI 10.5491/SHAW.2012.3.1.31; Hidalgo J, 1997, ERGONOMICS, V40, P916, DOI 10.1080/001401397187748; Iridiastadi H, 2005, OCCUPATIONAL ERGONOM, V5, P7; Kamarudin NH, 2014, IEEE C BIOM ENG SCI; Karwowski W, 1999, ERGONOMICS, V42, P40, DOI 10.1080/001401399185793; Karwowski W, 1996, HUM FACT ERG SOC 40; Lee TH, 2003, APPL ERGON, V34, P629, DOI 10.1016/S0003-6870(03)00050-4; Maiti R, 2004, INT J IND ERGONOM, V34, P483, DOI 10.1016/j.ergon.2004.06.003; Maiti R, 2006, INT J IND ERGONOM, V36, P991, DOI 10.1016/j.ergon.2006.08.004; Malaysia TMoHRo, 2014, SOC SEC ORG ANN REP; Marras WS, 2009, APPL ERGON, V40, P15, DOI 10.1016/j.apergo.2008.01.018; Marras WS, 2006, CLIN BIOMECH, V21, P345, DOI 10.1016/j.clinbiomech.2005.10.004; MITAL A, 1987, ERGONOMICS, V30, P1137, DOI 10.1080/00140138708966003; MITAL A, 1985, J OCCUP ACCID, V7, P75, DOI 10.1016/0376-6349(85)90019-7; Mital A, 1999, ERGONOMICS, V42, P246, DOI 10.1080/001401399185928; MITAL A, 1984, J OCCUP ACCID, V5, P223, DOI 10.1016/0376-6349(84)90001-4; Punnett LWD, 2004, J ELECTROMYOGR KINES, V1, P10; Resnick ML, 1997, COMPUT IND ENG, V33, P4; Scuffham AM, 2010, APPL ERGON, V41, P444, DOI 10.1016/j.apergo.2009.09.009; Shin HJ, 2007, INT J IND ERGONOM, V37, P545, DOI 10.1016/j.ergon.2007.03.006; Shoaf C, 1997, ERGONOMICS, V40, P1183, DOI 10.1080/001401397187432; SNOOK SH, 1991, ERGONOMICS, V34, P1197, DOI 10.1080/00140139108964855; SOCSO, 2006, SOCSO STAT REP ONL; SOCSO, 2011, SOC SEC ORG SOCSO AN; Spielholz P SB, 2001, ERGONOMICS, V44, P25; Waters TR, 2007, ERGONOMICS, V50, P1761, DOI 10.1080/00140130701674364; WATERS TR, 1993, ERGONOMICS, V36, P749, DOI 10.1080/00140139308967940; Waters TR, 2013, HUMAN FACTORS J HUMA, V56, P203; Way Kai, P 2009 IEEE IEEM; Widia M, 2016, MALAYSIAN J PUBLIC H, V16, P9; Wu SP, 1997, APPL ERGON, V28, P237, DOI 10.1016/S0003-6870(96)00080-4; Wu SP, 2003, APPL ERGON, V34, P215, DOI 10.1016/S0003-6870(03)00010-3; Xu Z, 2012, COMPUT IND ENG, V62, P431, DOI 10.1016/j.cie.2011.10.008; Yeung SS, 2002, APPL ERGON, V33, P463, DOI 10.1016/S0003-6870(02)00023-6	51	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216918	10.1371/journal.pone.0216918	http://dx.doi.org/10.1371/journal.pone.0216918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141545	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000028
J	Pereg, M; Meiran, N				Pereg, Maayan; Meiran, Nachshon			Rapid instructed task learning (but not automatic effects of instructions) is influenced by working memory load	PLOS ONE			English	Article							RESPONSE ACTIVATION; REPRESENTATIONS; COMPATIBILITY; PERFORMANCE; CAPACITY; POWER	The ability to efficiently perform actions immediately following instructions and without prior practice has previously been termed Rapid Instructed Task Learning (RITL). In addition, it was found that instructions are so powerful that they can produce automatic effects, reflected in activation of the instructions in an inappropriate task context. RITL is hypothesized to rely on limited working memory (WM) resources for holding not-yet implemented task rules. Similarly, automatic effects of instructions presumably reflect the operation of task rules kept in WM. Therefore, both were predicted to be influenced by WM load. However, while the involvement of WM in RITL is implicated from prior studies, evidence regarding WM involvement in instructions-based automaticity is mixed. In the current study, we manipulated WM load by increasing the number of novel task rules to be held in WM towards performance in the NEXT paradigm. In this task, participants performed a series of novel tasks presented in mini-blocks, each comprising a) instructions of novel task rules; b) a NEXT phase measuring the automatic activation of these instructed rules, in which participants advance the screen using a key-press; and c) a GO phase in which the new rules are first implemented and RITL is measured. In three experiments, we show a dissociation: While RITL (rule implementation) was impaired by increased WM load, the automatic effects of instructions were not robustly influenced by WM load. Theoretical implications are discussed.	[Pereg, Maayan; Meiran, Nachshon] Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel; [Pereg, Maayan; Meiran, Nachshon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Pereg, M (corresponding author), Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel.	maayanru@post.bgu.ac.il	Meiran, Nachshon/AAH-3546-2020	Pereg, Maayan/0000-0003-2366-4953	US-Israel Binational Science Foundation [2011246]	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by a research grant from the US-Israel Binational Science Foundation Grant #2011246 to Nachshon Meiran and Todd S. Braver. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon A.S., 2016, J OPEN RES SOFTWARE, V4, pe43, DOI [DOI 10.5334/JORS.134, 10.5334/jors.134]; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Anderson JR, 1996, AM PSYCHOL, V51, P355, DOI 10.1037/0003-066X.51.4.355; Barrouillet P, 2015, PSYCHON B REV, V22, P1035, DOI 10.3758/s13423-014-0787-y; Cohen-Kdoshay O, 2007, Q J EXP PSYCHOL, V60, P1140, DOI 10.1080/17470210600896674; Cohen-Kdoshay O, 2009, EXP PSYCHOL, V56, P128, DOI 10.1027/1618-3169.56.2.128; Cole MW, 2017, NEUROSCI BIOBEHAV R, V81, P4, DOI 10.1016/j.neubiorev.2017.02.009; Cole MW, 2013, COGN AFFECT BEHAV NE, V13, P1, DOI 10.3758/s13415-012-0125-7; Cole MW, 2010, J NEUROSCI, V30, P14245, DOI 10.1523/JNEUROSCI.1662-10.2010; Cowan Nelson, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Ellenbogen R, 2008, MEM COGNITION, V36, P968, DOI 10.3758/MC.36.5.968; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gathercole SE, 2008, APPL COGNITIVE PSYCH, V22, P1019, DOI 10.1002/acp.1407; Gopher D, 2000, J EXP PSYCHOL GEN, V129, P308, DOI 10.1037/0096-3445.129.3.308; Haider H, 1999, J EXP PSYCHOL-APPL, V5, P129; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Liefooghe B, 2013, PSYCHON B REV, V20, P481, DOI 10.3758/s13423-013-0374-7; Liefooghe B, 2012, J EXP PSYCHOL LEARN, V38, P1325, DOI 10.1037/a0028148; LOGAN GD, 1988, HUM FACTORS, V30, P583, DOI 10.1177/001872088803000504; Meiran N, 2017, CURR DIR PSYCHOL SCI, V26, P509, DOI 10.1177/0963721417711638; Meiran N, 2016, NEUROPSYCHOLOGIA, V90, P180, DOI 10.1016/j.neuropsychologia.2016.06.037; Meiran N, 2015, J EXP PSYCHOL LEARN, V41, P768, DOI 10.1037/xlm0000063; Meiran N, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00104; Meiran N, 2012, ACTA PSYCHOL, V139, P309, DOI 10.1016/j.actpsy.2011.12.008; Neely J. H., 1991, BASIC PROCESSES READ, P264; Oberauer K, 2013, COGNITIVE PSYCHOL, V66, P157, DOI 10.1016/j.cogpsych.2012.11.001; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Pereg M, 2019, PSYCHOL RES-PSYCH FO, V83, P132, DOI 10.1007/s00426-018-1122-4; Ruge H, 2018, ACTA PSYCHOL, V184, P4, DOI 10.1016/j.actpsy.2017.04.005; Ruge H, 2010, CEREB CORTEX, V20, P1656, DOI 10.1093/cercor/bhp228; Sabb FW, 2007, NEUROIMAGE, V37, P311, DOI 10.1016/j.neuroimage.2007.04.050; Shahar N, 2014, J EXP PSYCHOL GEN, V143, P1837, DOI 10.1037/a0037190; Souza AD, 2012, Q J EXP PSYCHOL, V65, P1006, DOI 10.1080/17470218.2011.640403; Verbruggen F, 2018, PSYCHOL SCI, V29, P1113, DOI 10.1177/0956797618755322; Wilhelm O, 2006, EUR J COGN PSYCHOL, V18, P18, DOI 10.1080/09541440500215921; Yang TX, 2014, PSYCHON B REV, V21, P186, DOI 10.3758/s13423-013-0471-7	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217681	10.1371/journal.pone.0217681	http://dx.doi.org/10.1371/journal.pone.0217681			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170202	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700047
J	Yan, YY; Leontovich, AA; Gerdes, MJ; Desai, K; Dong, JH; Sood, A; Santamaria-Pang, A; Mansfield, AS; Chadwick, C; Zhang, R; Nevala, WK; Flotte, TJ; Ginty, F; Markovic, SN				Yan, Yiyi; Leontovich, Alexey A.; Gerdes, Michael J.; Desai, Keyur; Dong, Jinhong; Sood, Anup; Santamaria-Pang, Alberto; Mansfield, Aaron S.; Chadwick, Chrystal; Zhang, Rong; Nevala, Wendy K.; Flotte, Thomas J.; Ginty, Fiona; Markovic, Svetomir N.			Understanding heterogeneous tumor microenvironment in metastatic melanoma	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; EXOME ANALYSIS REVEALS; I ANTIGEN-EXPRESSION; MHC CLASS-I; HLA EXPRESSION; PD-1 BLOCKADE; IPILIMUMAB; CANCER; IMMUNOHISTOCHEMISTRY; DISEASE	A systemic analysis of the tumor-immune interactions within the heterogeneous tumor microenvironment is of particular importance for understanding the antitumor immune response. We used multiplexed immunofluorescence to elucidate cellular spatial interactions and T-cell infiltrations in metastatic melanoma tumor microenvironment. We developed two novel computational approaches that enable infiltration clustering and single cell analysis-cell aggregate algorithm and cell neighborhood analysis algorithm-to reveal and to compare the spatial distribution of various immune cells relative to tumor cell in sub-anatomic tumor microenvironment areas. We showed that the heterogeneous tumor human leukocyte antigen-1 expressions differently affect the magnitude of cytotoxic T-cell infiltration and the distributions of CD20+ B cells and CD4+ FOXP3+ regulatory T cells within and outside of T-cell infiltrated tumor areas. In a cohort of 166 stage III melanoma samples, high tumor human leukocyte antigen-1 expression is required but not sufficient for high T-cell infiltration, with significantly improved overall survival. Our results demonstrate that tumor cells with heterogeneous properties are associated with differential but predictable distributions of immune cells within heterogeneous tumor microenvironment with various biological features and impacts on clinical outcomes. It establishes tools necessary for systematic analysis of the tumor microenvironment, allowing the elucidation of the "homogeneous patterns" within the heterogeneous tumor microenvironment.	[Yan, Yiyi; Mansfield, Aaron S.; Markovic, Svetomir N.] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA; [Leontovich, Alexey A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Gerdes, Michael J.; Desai, Keyur; Sood, Anup; Santamaria-Pang, Alberto; Chadwick, Chrystal; Zhang, Rong; Ginty, Fiona] GE Global Res Ctr, Diagnost Imaging & Biomed Technol, Niskayuna, NY USA; [Dong, Jinhong] Mayo Clin, Clin Immunol & Immunotherapeut, Rochester, MN USA; [Nevala, Wendy K.] Mayo Clin, Div Hematol, Rochester, MN USA; [Flotte, Thomas J.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Flotte, Thomas J.] Mayo Clin, Div Dermatopathol & Cutaneous Immunopathol, Rochester, MN USA; [Desai, Keyur] Bristol Myers Squibb, Translat Med, Pennington, NJ USA	Mayo Clinic; Mayo Clinic; General Electric; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Bristol-Myers Squibb	Markovic, SN (corresponding author), Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA.	markovic.svetomir@mayo.edu	Mansfield, Aaron/AAQ-8298-2021	Mansfield, Aaron/0000-0002-9483-6903; Ginty, Fiona/0000-0001-6638-683X	NIH [R01 CA174377]; NCI [K12 CA090628]; Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; GE Global Research; NATIONAL CANCER INSTITUTE [K12CA090628, R01CA174377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; GE Global Research(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Author MJG was supported by NIH R01 CA174377, YY was supported by NCI K12 CA090628 and Mayo Clinic Fraternal Order of Eagles Cancer Research Fund awards during the period of this study. Authors MJG, KD, AS, AS-P, CC, RZ, FG were employees of GE Global Research during the period of this study. GE Global Research provided funds for the research activities. Other than the GE authors, neither GE Research or GE Healthcare played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A.RE, 2016, SPATIAL POINT PATTER, P829, DOI [10.1056/NEJMOA1604958, DOI 10.1056/NEJMOA1604958]; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Carretero R, 2012, INT J CANCER, V131, P387, DOI 10.1002/ijc.26471; Chew SF, 2007, TISSUE ANTIGENS, V69, P248, DOI 10.1111/j.1399-0039.2006.774_2.x; Concha A, 1991, Semin Cancer Biol, V2, P47; GARRIDO F, 1993, IMMUNOL TODAY, V14, P491, DOI 10.1016/0167-5699(93)90264-L; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Illian J, 2008, STAT ANAL MODELLING; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Kageshita T, 1999, AM J PATHOL, V154, P745, DOI 10.1016/S0002-9440(10)65321-7; Kitamura H, 2006, CLIN CANCER RES, V12, P4641, DOI 10.1158/1078-0432.CCR-06-0595; Levenson RM, 2015, LAB INVEST, V95, P397, DOI 10.1038/labinvest.2015.2; LEVIN I, 1991, CANCER, V68, P2591, DOI 10.1002/1097-0142(19911215)68:12<2591::AID-CNCR2820681212>3.0.CO;2-L; Madjd Z, 2005, INT J CANCER, V117, P248, DOI 10.1002/ijc.21163; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McKinley ET, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93487; Mendez R, 2007, CANCER IMMUNOL IMMUN, V56, P88, DOI 10.1007/s00262-006-0166-2; Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Sabbatino F, 2016, CLIN CANCER RES, V22, P470, DOI 10.1158/1078-0432.CCR-15-0715; Santamaria-Pang A, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P121, DOI 10.1109/BHI.2017.7897220; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Shehata M, 2009, BRIT J CANCER, V101, P1321, DOI 10.1038/sj.bjc.6605315; Sood A, US patent, Patent No. [9176032B2, 9176032]; Sood A, US Patent, Patent No. [9,984,199, 9984199]; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Houdt IS, 2008, INT J CANCER, V123, P609, DOI 10.1002/ijc.23543; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Wiegand T., 2014, HDB SPATIAL POIN PAT; Xiao X, 2016, CANCER DISCOV, V6, P546, DOI 10.1158/2159-8290.CD-15-1408; Yamaguchi R, 2012, HUM PATHOL, V43, P1688, DOI 10.1016/j.humpath.2011.12.013; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	46	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216485	10.1371/journal.pone.0216485	http://dx.doi.org/10.1371/journal.pone.0216485			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166985	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800010
J	Almahmoud, K; Abboud, A; Namas, RA; Zamora, R; Sperry, J; Peitzman, AB; Truitt, MS; Gaski, GE; McKinley, TO; Billiar, TR; Vodovotz, Y				Almahmoud, Khalid; Abboud, Andrew; Namas, Rami A.; Zamora, Ruben; Sperry, Jason; Peitzman, Andrew B.; Truitt, Michael S.; Gaski, Greg E.; McKinley, Todd O.; Billiar, Timothy R.; Vodovotz, Yoram			Computational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries	PLOS ONE			English	Article							EARLY TOTAL CARE; MULTIPLE TRAUMA PATIENTS; FEMORAL-SHAFT FRACTURES; BLUNT TRAUMA; OUTCOMES; FIXATION; MEDIATORS; IMPACT; MANAGEMENT; CYTOKINES	Extremity and soft tissue injuries contribute significantly to inflammation and adverse in-hospital outcomes for trauma survivors; accordingly, we examined the complex association between clinical outcomes inflammatory responses in this setting using in silico tools. Two stringently propensity-matched, moderately/severely injured (Injury Severity Score > 16) patient sub-cohorts of similar to 30 patients each were derived retrospectively from a cohort of 472 blunt trauma survivors and segregated based on their degree of extremity injury severity (above or below 3 on the Abbreviated Injury Scale). Serial blood samples were analyzed for 31 plasma inflammatory mediators. In addition to standard statistical analyses, Dynamic Network Analysis (DyNA) and Principal Component Analysis (PCA) were used to model systemic inflammation following trauma. Patients in the severe extremity injury sub-cohort experienced longer intensive care unit length of stay (LOS), total LOS, and days on a mechanical ventilator, with higher Marshall Multiple Organ Dysfunction (MOD) Scores over the first 7 days post-injury as compared to the mild/moderate extremity injury sub-cohort. The higher severity cohort had statistically significant elevated lactate, base deficit, and creatine phosphokinase on first blood draw, along with significant changes in multiple circulating inflammatory mediators. DyNA pointed to a sustained role for type 17 immunity in both sub-cohorts, along with IFN-gamma in the severe extremity injury group. DyNA network complexity increased over 7 days post-injury in the severe injury group, while generally decreasing over this same time period in the mild/moderate injury group. PCA suggested a more robust activation of multiple pathways in the severe extremity injury group as compared to the mild/moderate injury group. These studies thus point to the possibility of self-sustaining inflammation following severe extremity injury vs. resolving inflammation following less severe extremity injury.	[Almahmoud, Khalid; Abboud, Andrew; Namas, Rami A.; Zamora, Ruben; Sperry, Jason; Peitzman, Andrew B.; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Div Trauma & Crit Care Surg, Pittsburgh, PA 15260 USA; [Almahmoud, Khalid; Truitt, Michael S.] Methodist Dallas Hlth Syst, Dept Surg, Dept Grad Med Educ, Dallas, TX USA; [Namas, Rami A.; Zamora, Ruben; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA; [Gaski, Greg E.; McKinley, Todd O.] Indiana Univ Sch Med, Dept Orthoped Surg, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington	Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Div Trauma & Crit Care Surg, Pittsburgh, PA 15260 USA.; Vodovotz, Y (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Namas, Rami/AAD-5793-2020; Namas, Rami/AAD-5796-2020; Namas, Rami/GZK-4999-2022	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321; ALMAHMOUD, KHALID/0000-0001-9716-3778; Gaski, Greg/0000-0002-2795-4029; Abboud, Andrew/0000-0003-1527-1535	National Institutes of Health [P50-GM-53789]; Ruth L. Kirschstein National Research Service Award [T32-GM-008516-21]; Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program [W81XWH-18-2-0051, W81XWH-15-PRORP-OCRCA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant P50-GM-53789 as well as the Ruth L. Kirschstein National Research Service Award T32-GM-008516-21. This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program under Award No. W81XWH-18-2-0051 and W81XWH-15-PRORP-OCRCA. Opinions, interpretations, conclusions and recommendations are those of the authors and not necessarily endorsed by the Department of Defense.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Akkose S, 2007, ADV THER, V24, P955, DOI 10.1007/BF02877699; Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; Andreu-Ballester JC, 2014, INT IMMUNOPHARMACOL, V23, P73, DOI 10.1016/j.intimp.2014.08.015; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Billiar TR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002342; Brakenridge SC, 2018, J TRAUMA ACUTE CARE, V85, P247, DOI [10.1097/TA.0000000000001921, 10.1097/ta.0000000000001921]; BRENNEMAN FD, 1995, J TRAUMA, V39, P320, DOI 10.1097/00005373-199508000-00021; DAY RJ, 1994, MED J AUSTRALIA, V160, P675, DOI 10.5694/j.1326-5377.1994.tb125903.x; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Efron PA, 2018, SURGERY, V164, P178, DOI 10.1016/j.surg.2018.04.011; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; Fulkerson EW, 2009, BULL HOSP JT DIS, V67, P58; Gaski GE, 2018, J ORTHOPAEDIC TRA S1, V2018, pS1; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Giannoudis PV, 2002, CLIN ORTHOP RELAT R, P378, DOI 10.1097/01.blo.00000236813.17269.24; Glance LG, 2009, ARCH SURG-CHICAGO, V144, P326, DOI 10.1001/archsurg.2009.8; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Horst K, 2016, EUR J TRAUMA EMERG S, V42, P67, DOI 10.1007/s00068-015-0504-1; Huang L, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1193, DOI 10.1134/S0006297917100121; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679; Katsoulis E, 2006, INJURY, V37, P1133, DOI 10.1016/j.injury.2006.07.017; Lamparello AJ, 2019, J AM COLL SURGEONS, V228, P148, DOI 10.1016/j.jamcollsurg.2018.10.019; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Marshall JC, 1995, CRITICAL CARE MED, V23; McKinley TO, 2018, J ORTHOP TRAUMA, V32, pS1, DOI 10.1097/BOT.0000000000001114; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Nacionales DC, 2015, J IMMUNOL, V195, P2396, DOI 10.4049/jimmunol.1500984; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; Pape Hans-Christoph, 2005, J Orthop Trauma, V19, P551, DOI 10.1097/01.bot.0000161712.87129.80; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; PAPE HC, 1993, J TRAUMA, V35, P709, DOI 10.1097/00005373-199311000-00010; Pape HC, 2002, J TRAUMA, V53, P452, DOI 10.1097/00005373-200209000-00010; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Pfeifer R, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-9; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Tuttle MS, 2009, J TRAUMA, V67, P602, DOI 10.1097/TA.0b013e3181aa21c0; Vallier HA, 2013, J ORTHOP TRAUMA, V27, P543, DOI 10.1097/BOT.0b013e31829efda1; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Vodovotz, 2014, TRANSLATIONAL SYSTEM; Wardle TD, 1999, BRIT MED BULL, V55, P744, DOI 10.1258/0007142991902754; Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248; Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217577	10.1371/journal.pone.0217577	http://dx.doi.org/10.1371/journal.pone.0217577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163056	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200020
J	Izzo, VA; Donati, MA; Ramat, S; Primi, C				Izzo, Viola Angela; Donati, Maria Anna; Ramat, Silvia; Primi, Caterina			Impulse control disorders in Parkinson's disease: A systematic review on the psychometric properties of the existing measures	PLOS ONE			English	Review							DOPAMINE DYSREGULATION SYNDROME; COMPULSIVE DISORDERS; CLINICAL CHARACTERISTICS; REPETITIVE BEHAVIORS; AGONIST USE; SCALE; QUESTIONNAIRE; HYPERSEXUALITY; INSTRUMENTS; VALIDATION	Background A significant percentage of patients suffering from Parkinson's Disease (PD) experience Impulse Control Disorders (ICDs), contributing to reduced quality of life. As they can be managed by reducing the dopamine dosage, the detection of their presence is crucial for PD treatment plan. Nevertheless, they tend to be under-recognized in clinical practice, since routine screening is not common-despite existing instruments that may support clinicians. This work presents a systematic review on the psychometric properties of instruments measuring ICDs in PD, to test whether clinicians dispose of valid tools that may help them in clinical assessment. Method A systematic literature search in three databases (EMBASE, MEDLINE, and PsycINFO) was conducted. Quality of the instruments' psychometric properties was evaluated with Terwee et al.'s criteria, and methodological quality of the studies was evaluated with the COSMIN Checklist. Results Ten studies examining seven instruments were selected. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) and the Ardouin Scale of Behavior in Parkinson's Disease (ASBPD) resulted to be the best from a psychometric point of view. Conclusions Though the gold standard for diagnosis remains a detailed diagnostic interview, this review will encourage clinicians to use validated tools to accurately assess ICDs.	[Izzo, Viola Angela; Primi, Caterina] Univ Florence, Psychol Sect, NEUROFARBA Dept, Florence, Italy; [Donati, Maria Anna] Sapienza Univ Rome, Dept Dev & Social Psychol, Rome, Italy; [Ramat, Silvia] AOUC Azienda Osped Univ Careggi, Neurol 1, Florence, Italy	University of Florence; Sapienza University Rome; University of Florence; Azienda Ospedaliero Universitaria Careggi	Izzo, VA (corresponding author), Univ Florence, Psychol Sect, NEUROFARBA Dept, Florence, Italy.	violaangela.izzo@unifi.it	Ramat, Silvia/AAB-7743-2022	Ramat, Silvia/0000-0003-1301-9678				American Psychiatric Association, 2000, DIAGN STAT MAN; Ardouin C, 2009, REV NEUROL-FRANCE, V165, P845, DOI 10.1016/j.neurol.2009.06.003; Avila A, 2003, J CLIN PSYCHOPHARM, V23, P509, DOI 10.1097/01.jcp.0000088908.24613.db; Baldacci F, 2015, NEUROL SCI, V36, P43, DOI 10.1007/s10072-014-1903-5; Bastiaens J, 2013, MOVEMENT DISORD, V28, P327, DOI 10.1002/mds.25291; Baumann-Vogel H, 2015, EUR J NEUROL, V22, P603, DOI 10.1111/ene.12646; Bentivoglio AR, 2013, NEUROL SCI, V34, P1207, DOI 10.1007/s10072-012-1224-5; Carnes P, 1991, Tenn Nurse, V54, P29; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cornelius JR, 2010, SLEEP, V33, P81; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Embretson S, 2000, MULTIVARIATE APPL BO; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Frost RO, 2004, BEHAV RES THER, V42, P1163, DOI 10.1016/j.brat.2003.07.006; Gerlach M, 2003, J NEURAL TRANSM, V110, P1119, DOI 10.1007/s00702-003-0027-5; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Giovannoni G, 2000, BASAL GANGLIA, V68, P423; Gschwandtner U, 2001, CLIN NEUROPHARMACOL, V24, P170, DOI 10.1097/00002826-200105000-00009; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Isaias IU, 2008, MOVEMENT DISORD, V23, P411, DOI 10.1002/mds.21872; Isaias IU, 2008, PARKINSONISM RELA S4, V23, P411; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krieger Débora Mascella, 2017, J. bras. psiquiatr., V66, P111, DOI 10.1590/0047-2085000000158; Krieger DM, 2017, AMERICAN, V66, P111; Leeman RF, 2011, NEUROPSYCHIATRY-LOND, V1, P133, DOI 10.2217/NPY.11.11; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lim SY, 2008, ANN NY ACAD SCI, V1142, P85, DOI 10.1196/annals.1444.006; M C, PAR; Mamikonyan E, 2008, MOVEMENT DISORD, V23, P75, DOI 10.1002/mds.21770; Martinez-Martin P, 2016, MOVEMENT DISORD, V31, P270, DOI 10.1002/mds.26522; MCELROY SL, 1996, YEAR BOOK OF PSYCHIA, V338, P20; Merims D, 2008, PARKINSONISM RELAT D, V14, P273, DOI 10.1016/j.parkreldis.2007.09.007; Moher D, 2009, AMERICAN, V62, P1006; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Molina JA, 2000, MOVEMENT DISORD, V15, P869, DOI 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nakum S, 2016, PARKINSONISM RELAT D, V25, P10, DOI 10.1016/j.parkreldis.2016.02.017; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; O'Sullivan SS, 2009, CNS DRUGS, V23, P157, DOI 10.2165/00023210-200923020-00005; Okai D, 2016, MOV DISORD CLIN PRAC, V3, P494, DOI 10.1002/mdc3.12316; Papay K, 2011, PARKINSONISM RELAT D, V17, P153, DOI 10.1016/j.parkreldis.2010.11.015; Park T, 2013, QUAL LIFE RES, V22, P2639, DOI 10.1007/s11136-013-0395-8; Pereira B, 2013, PARKINSONISM RELAT D, V19, P242, DOI 10.1016/j.parkreldis.2012.10.017; Phu AL, 2014, J CLIN NEUROSCI, V21, P63, DOI 10.1016/j.jocn.2013.02.032; Pontone G, 2006, NEUROLOGY, V67, P1258, DOI 10.1212/01.wnl.0000238401.76928.45; Probst CC, 2014, J NEUROL, V261, P936, DOI 10.1007/s00415-014-7299-6; Probst CC, 2014, UBER, V261, P936; Quickfall J, 2007, PARKINSONISM RELAT D, V13, P535, DOI 10.1016/j.parkreldis.2006.10.001; Rieu I, 2015, MOVEMENT DISORD, V30, P705, DOI 10.1002/mds.26223; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Spencer AH, 2011, MOVEMENT DISORD, V26, P578, DOI 10.1002/mds.23508; Tanaka K, 2013, J NEUROL SCI, V331, P76, DOI 10.1016/j.jns.2013.05.013; Terwee CB, 2009, J CLIN EPIDEMIOL, V62, P1062, DOI 10.1016/j.jclinepi.2008.10.011; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vitale C, 2011, MOVEMENT DISORD, V26, P830, DOI 10.1002/mds.23567; VOGEL HP, 1983, PHARMACOPSYCHIATRIA, V16, P107, DOI 10.1055/s-2007-1017459; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P1089, DOI 10.1001/archneur.64.8.1089; Voon V, 2007, CURR OPIN NEUROL, V20, P484, DOI 10.1097/WCO.0b013e32826fbc8f; Voon V, 2011, ANN NEUROL, V69, P986, DOI 10.1002/ana.22356; WEINTRAUB D, 2017, PRESS, V679, P717; Weintraub D, 2006, AMERICAN, V63, P969; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Weintraub D, 2012, MOVEMENT DISORD, V27, P242, DOI 10.1002/mds.24023; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571	74	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217700	10.1371/journal.pone.0217700	http://dx.doi.org/10.1371/journal.pone.0217700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163065	Green Published, gold			2022-12-27	WOS:000470086200028
J	Tagne, AST; Takembo, CN; Ben-Bolie, HG; Ateba, PO				Tagne, A. S. Tankou; Takembo, C. N.; Ben-Bolie, H. G.; Ateba, P. Owona			Localized nonlinear excitations in diffusive memristor-based neuronal networks	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; BACKLUND TRANSFORMATION; MODEL	We extend the existing ordinary differential equations modeling neural electrical activity to include the memory effect of electromagnetic induction through magnetic flux, used to describe time varying electromagnetic field. Through the multi-scale expansion in the semi-discrete approximation, we show that the neural network dynamical equations can be governed by the complex Ginzburg-Landau equation. The analytical and numerical envelop soliton of this equation are reported. The results obtained suggest the possibility of collective information processing and sharing in the nervous system, operating in both the spatial and temporal domains in the form of localized modulated waves. The effects of memristive synaptic electromagnetic induction coupling and perturbation on the modulated action potential dynamics examined. Large electromagnetic induction coupling strength may contribute to signal block as the amplitude of modulated waves are observed to decrease. This could help in the development of a chemical brain anaesthesia for some brain pathologies.	[Tagne, A. S. Tankou; Ben-Bolie, H. G.; Ateba, P. Owona] Univ Yaounde I, Dept Phys, Nucl Phys Lab, Fac Sci, Yaounde, Cameroon; [Takembo, C. N.] Univ Yaounde I, Dept Phys, Biophys Lab, Fac Sci, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I	Takembo, CN (corresponding author), Univ Yaounde I, Dept Phys, Biophys Lab, Fac Sci, Yaounde, Cameroon.	takembontahkie@yahoo.com	Takembo, Clovis/AAM-3288-2020					Villacorta-Atienza JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057440; Bao H, 2019, NONLINEAR DYNAM, V95, P43, DOI 10.1007/s11071-018-4549-7; Brunak S, 1990, NEURAL NETWORKS COMP; Coobes S, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.148102, DOI 10.1103/PHYSREVLETT.94.148102]; Dauxois T, 2006, PHYS SOLITONS; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gao LN, 2017, NONLINEAR DYNAM, V89, P2233, DOI 10.1007/s11071-017-3581-3; Gu HG, 2015, NONLINEAR DYNAM, V82, P1191, DOI 10.1007/s11071-015-2226-7; Hasegawa A., 1989, SPRINGER TRACT MODER, V116; HINDMARSH JL, 1982, NATURE, V296, P162, DOI 10.1038/296162a0; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kilpatrick ZP, 2010, PHYSICA D, V239, P547, DOI 10.1016/j.physd.2009.06.003; Lu JQ, 2018, NONLINEAR DYNAM, V91, P1669, DOI 10.1007/s11071-017-3972-5; Lu X, 2016, COMMUN NONLINEAR SCI, V32, P241, DOI 10.1016/j.cnsns.2015.08.008; Lu X, 2016, COMMUN NONLINEAR SCI, V31, P40, DOI 10.1016/j.cnsns.2015.07.007; Lu X, 2015, APPL MATH LETT, V50, P37, DOI 10.1016/j.aml.2015.06.003; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, PHYSICA A, V486, P508, DOI 10.1016/j.physa.2017.05.075; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Mvogo A, 2017, PHYS LETT A, V381, P2264, DOI 10.1016/j.physleta.2017.05.020; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Novacek M., 2011, SIMULATION NEURAL IM; Qian Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12333-3; Qu LH, 2018, CHINESE PHYS B, V27, DOI 10.1088/1674-1056/27/11/118707; REMOISSENET M, 1986, PHYS REV B, V33, P2386, DOI 10.1103/PhysRevB.33.2386; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Shneider MN, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052713; Stefanescu RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000219; Takembo CN, 2019, NONLINEAR DYNAM, V96, P1083, DOI 10.1007/s11071-019-04841-w; Takembo CN, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218501655; Takembo CN, 2018, NONLINEAR DYN; Tchawoua C., 1992, THESIS U YAOUNDE 1; Wu FQ, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0031-2; Xu Y, 2018, NEUROCOMPUTING, V283, P196, DOI 10.1016/j.neucom.2017.12.036; Xu Y, 2017, CHAOS SOLITON FRACT, V104, P435, DOI 10.1016/j.chaos.2017.09.002; Yin YH, 2018, COMPUT MATH APPL, V76, P1275, DOI 10.1016/j.camwa.2018.06.020; Zhang G, 2018, CHAOS SOLITON FRACT, V108, P15, DOI 10.1016/j.chaos.2018.01.017; Zhu JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175039	42	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0214989	10.1371/journal.pone.0214989	http://dx.doi.org/10.1371/journal.pone.0214989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163037	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200003
J	Fernandes, FS; da Silva, GS; Hilel, AS; Carvalho, AC; Remor, KVT; Schlindwein, AD; Kanis, LA; Martins, DF; Kviecinski, MR				Fernandes, Flavia S.; da Silva, Gustavo S.; Hilel, Alexandre S.; Carvalho, Ana C.; Remor, Karina V. T.; Schlindwein, Aline D.; Kanis, Luiz A.; Martins, Daniel F.; Kviecinski, Maicon R.			Study of the potential adverse effects caused by the dermal application of Dillenia indica L. fruit extract standardized to betulinic acid in rodents	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; PHOTODYNAMIC THERAPY; PASSIFLORA-ALATA; PSORIASIS; TOXICITY; RATS; SAFETY; MICE; ANTIOXIDANT; DERMATITIS	This study aimed to evaluate the potential adverse effects of the dermal administration of Dillenia indica Linnaeus (D. indica) fruit extract in healthy rodents; the extract was standardized to betulinic acid. In the initial phase, the acute effects were evaluated on the skin application site of a single extract dose. A skin irritation test was performed in male Wistar rats (n = 8/group) receiving the extract (50-150 mg/mL) with betulinic acid (0.5-1.5%, respectively). A photosensitivity test was performed in male BALB/c mice (n = 6/group) receiving the extract (150 mg/mL). Afterwards, other BALB/c mice (n = 20, male: female, 1: 1) were used to assess the systemic alterations caused by 14 daily repeated doses (150 mg/mL) by monitoring the effects on mortality, body morphology, behavior, nutrition status, neuromotor reactions, organ morphology and weight, and blood tests. At this time, 0.5 mg/mL clobetasol was used as the positive control. The skin irritation index suggested that negligible skin irritation had occurred, even when the extract was applied to the rat skin at 150 mg/mL. However, the extract acted as a photosensitizer on mouse skin, showing a photosensitizing activity close to that of 10 mg/mL 5-methoxypsoralen. Repeated doses caused no mouse mortality, aggressiveness, piloerection, diarrhea, convulsions, neuromotor alterations or nutrition status changes. The mouse organ weights did not change, and the mice did not have alterations in their blood compositions. Clobetasol caused a reduction in the mononuclear leukocyte numbers. In general, the data suggest that the extract was safe in healthy rodents but indicate that caution should be taken with the photosensitizing activity; in addition, this activity should be further explored as it may be useful for phototherapeutic drug development.	[Fernandes, Flavia S.; da Silva, Gustavo S.; Hilel, Alexandre S.; Carvalho, Ana C.; Remor, Karina V. T.; Schlindwein, Aline D.; Kanis, Luiz A.; Martins, Daniel F.; Kviecinski, Maicon R.] Univ Sul Santa Catarina, Postgrad Program Hlth Sci, Palhoca, SC, Brazil	Universidade do Sul de Santa Catarina	Kviecinski, MR (corresponding author), Univ Sul Santa Catarina, Postgrad Program Hlth Sci, Palhoca, SC, Brazil.	maicon.kviecinski@gmail.com	da Silva, Gustavo Silveira/M-4104-2017; Martins, Daniel Fernandes/J-7125-2014; Martins, Daniel/D-3493-2018	da Silva, Gustavo Silveira/0000-0003-4571-2426; Kviecinski, Maicon Roberto/0000-0002-6703-4040; HILEL, ALEXANDRE/0000-0002-8450-7858; de Souza Fernandes, Flavia/0000-0002-9239-8698; Martins, Daniel/0000-0003-1484-3167				Acesio NO, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8942730; Adeleke GE, 2017, HUM EXP TOXICOL, V36, P734, DOI 10.1177/0960327116661399; Ahad A, 2017, BIOMED PHARMACOTHER, V89, P177, DOI 10.1016/j.biopha.2017.01.164; Alam MB, 2012, INT J PHARMACOL, V8, P243, DOI 10.3923/ijp.2012.243.251; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; Amichai B, 1993, J EUR ACAD DERMATOL, V2, P27, DOI 10.1111/j.1468-3083.1993.tb00006.x; Andris DA, 2006, SEMIOLOGIA BASES PRA; ANVISA (AGENCIA NACIONAL DE VIGILaNCIA SANITaRIA), 2013, GUIA COND EST NAO CL, P1; Apu As, 2010, J Young Pharm, V2, P50, DOI 10.4103/0975-1483.62213; Aregheore EM., 2003, SOUTH PAC J NAT APPL, V21, P51, DOI DOI 10.1071/SP03010; Acevedo JGA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-281; Bain BJ, 2007, CELULAS SANGUINEAS G; de Mello FB, 2007, LAT AM J PHARM, V26, P191; Bearhop S, 1999, ECOL LETT, V2, P352; Bloom J, 2012, FUNDAMENTOS TOXICOLO, P149; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Bordin D.C.M., 2015, SC, V7, P125, DOI [10.4322/sc.2015.022, DOI 10.4322/SC.2015.022]; Calkosinski I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/972535; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Costa Jessica Pereira, 2012, Revista de Ciencias Farmaceuticas Basica e Aplicada, V33, P421; Council of Scientific and Industrial Research (CSIR), 1952, WEALTH IND DICT IN D, VIII; Craig EA, 2015, J APPL TOXICOL, V35, P729, DOI 10.1002/jat.3036; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; De D, 2007, LEPROSY REV, V78, P401; de Mello JRB, 2010, LAT AM J PHARM, V29, P1431; de Oliveira BH, 2002, PHYTOCHEM ANALYSIS, V13, P95, DOI 10.1002/pca.628; De Souza PA, 2010, REV BRAS FARMACOGN, V20, P922, DOI 10.1590/S0102-695X2010005000042; Jaques JAD, 2012, REDOX REP, V17, P206, DOI 10.1179/1351000212Y.0000000024; Dyer Stephen M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P423, DOI 10.1016/j.cvex.2008.03.008; Failace RR, 2009, HEMOGRAMA MANUAL INT; Felipe KB, 2014, J ETHNOPHARMACOL, V155, P1492, DOI 10.1016/j.jep.2014.07.040; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; Gagne F, 2014, BIOCHEMICAL ECOTOXICOLOGY: PRINCIPLES AND METHODS, P1; Gandara L, 2014, J PHOTOCH PHOTOBIO B, V133, P55, DOI 10.1016/j.jphotobiol.2014.03.006; Gandhi D, 2013, J APP PHARM SCI, V3, P134, DOI DOI 10.7324/JAPS.2013.31124; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gordon ML, 1998, CLIN THER, V20, P26, DOI 10.1016/S0149-2918(98)80032-5; GUPTA AK, 1989, J AM ACAD DERMATOL, V20, P1088, DOI 10.1016/S0190-9622(89)70138-9; Gupta RC, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P1, DOI 10.5005/jp/books/10078; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hayes RB, 2001, CHEM-BIOL INTERACT, V135, P455, DOI 10.1016/S0009-2797(01)00182-X; Hoffbrand AV, 2013, FUNDAMENTOS HEMATOLO; Horobin RW, 2011, BIOTECH HISTOCHEM, V86, P36, DOI 10.3109/10520295.2010.515491; IMAI S, 1994, ANTICANCER RES, V14, P933; Jahn AI, 1997, REPROD TOXICOL, V11, P171, DOI 10.1016/S0890-6238(97)00003-8; Khare R, 2013, INDO AM PHARM RES, V3, P6076, DOI [10.1016/j.bcp.2008.07.038, DOI 10.1016/J.BCP.2008.07.038]; Klaasen CD, 2018, CASARETT DOULLS BASI; Klaassen CD., 2012, FUNDAMENTOS TOXICOLO; Kumar D, 2010, PHYTOMEDICINE, V17, P431, DOI 10.1016/j.phymed.2009.07.010; Kumar Sunil, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P570, DOI 10.3736/jcim20110517; Kummer N, 2016, CLIN BIOCHEM, V49, P1078, DOI 10.1016/j.clinbiochem.2016.05.007; Kviecinski M. R., 2016, Revista Brasileira de Plantas Medicinais, V18, P899, DOI 10.1590/1983-084X/0081; Kviecinski MR, 2017, PHARM BIOL, V55, P641, DOI 10.1080/13880209.2016.1266672; LARSEN HOWARD N., 1961, TRANS AMER FISH SOC, V90, P139, DOI 10.1577/1548-8659(1961)90[139:MOTMTW]2.0.CO;2; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001; LOADER S, 1995, AM J HUM GENET, V57, P1724; Lock EA, 1998, TOXICOL PATHOL, V26, P18, DOI 10.1177/019262339802600102; Martens-Lobenhoffer J, 1999, SKIN PHARMACOL APPL, V12, P266, DOI 10.1159/000066251; Matos LC, 2005, MED INTERN, V12, P239; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; MERSHON MM, 1990, FUND APPL TOXICOL, V15, P622, DOI 10.1016/0272-0590(90)90046-M; Meyer GM, 2016, BIOANALYSIS, V8, P457, DOI 10.4155/bio.16.15; Migliato KF, 2011, WOUNDS, V23, P111; Mueller T, 2001, ANGIOLOGY, V52, P605, DOI 10.1177/000331970105200904; Nelson D, 2011, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.10007210; Oliveira R., 2016, HEMOGRAMA COMO FAZER; Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P74, DOI 10.4103/0976-500X.81895; Rahman MA, 2011, PHARMACOLOGYONLINE, V1, P1247; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038; Schossler D, 2001, ACTA CIR BRAS, V16, P46; Schuhly W, 1999, PLANTA MED, V65, P740, DOI 10.1055/s-1999-14054; Setlik J, 2015, REV SAUDE DESENVOLV, V7, P195; Shara M, 2005, J INORG BIOCHEM, V99, P2161, DOI 10.1016/j.jinorgbio.2005.07.017; Sharma HK, 2001, FITOTERAPIA, V72, P146, DOI 10.1016/S0367-326X(00)00278-1; Sheldon J, 2004, BEST PRACT RES CL RH, V18, P249, DOI 10.1016/j.berh.2004.03.007; SHOME U, 1980, P INDIAN AS-PLANT SC, V89, P91; Silva E. R., 2009, REV BRAS FARM, V90, P211; Simoes C. A. M., 2001, FARMACOGNOSIA PLANTA; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; TAMURA J, 1980, Journal of Toxicological Sciences, V5, P177; Vasconcelos J., 2009, REV CIENTIFICA UFPA, V7, P1; Vicentini FTMC, 2010, J PHARM PHARM SCI, V13, P274, DOI 10.18433/J3830G; Vijayalakshmi T, 2000, J ETHNOPHARMACOL, V69, P9, DOI 10.1016/S0378-8741(99)00020-3; WHO, 2004, WHO GUID SAF MON HER, P82; World Health Organization (Who), 2002, IMP PHARM SAF MON ME, DOI [10.1002/0470853093, DOI 10.1002/0470853093]; Yeshwante SB, 2009, J YOUNG PHARM, V1, P63, DOI 10.4103/0975-1483.51885; Yi JN, 2016, PHARMACOL REP, V68, P95, DOI 10.1016/j.pharep.2015.07.003; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Yonezawa Y, 2015, J TOXICOL SCI, V40, P667, DOI 10.2131/jts.40.667; Zohra M., 2014, INT J PHARM SCI RES, V5, P495	98	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217718	10.1371/journal.pone.0217718	http://dx.doi.org/10.1371/journal.pone.0217718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150479	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100092
J	Li, Y; Nan, SR; Gong, XL; Ma, R				Li, Yan; Nan, Sirui; Gong, Xiaolin; Ma, Rui			A geometric design method for intersections with pre-signal systems using a phase swap sorting strategy	PLOS ONE			English	Article							BUS PRIORITY; OPTIMIZATION; CAPACITY; ALGORITHM; TIMINGS	Conventional geometric design methods for pre-signal systems usually use the expected traffic demand, which may obtain a short sorting area distance and lead to frequent queue spillbacks due to stochastic traffic arrivals. On the other hand, if one selects a longer sorting area distance, the geometric design will suffer from low spatial utilization with higher delay and lower capacity. In this paper, we propose a geometric design method for intersections with pre-signal systems using a phase swap strategy. The geometric design can balance the desire of storing more vehicles to prevent spillbacks and improve the spatial utilization of the road. We model the traffic dynamic within the pre-signal system using queue theory and shockwave theory to determine the furthest point a queue can reach. The length of the pre-signal system should be short enough to improve spatial utilization but longer than the furthest point of the queue to prevent queue spillback. The effectiveness of the pre-signal system is evaluated by the VISSIM Signal Control Application Programming Interfaces (SCAPI). The results indicate that the proposed design plan increases the spatial utilization of the pre-signal system by 7.5% while maintaining a similar delay, queue length and ratio of flow to saturation flow.	[Li, Yan; Nan, Sirui] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China; [Li, Yan] CCCC First Highway Consultants Co LTD, Xian, Shaanxi, Peoples R China; [Gong, Xiaolin] Tech Univ Munich, Dept Civil Geo & Environm Engn, Munich, Bavaria, Germany; [Ma, Rui] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	Chang'an University; Technical University of Munich; University of California System; University of California Davis	Ma, R (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	drma@ucdavis.edu	Ma, Rui/A-8533-2017	Ma, Rui/0000-0001-8568-6707	National Natural Science Foundation of China [51408049]; National RD Plan of China [2017YFC0803906]; China Postdoctoral Science Foundation [2016M590914]; Shaanxi Postdoctoral Science Research project [2016BSHEDZZ134]; Fundamental Research Funds for the Central Universities [300102218521]; CCCC First Highway Consultants Co., LTD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National RD Plan of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Postdoctoral Science Research project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CCCC First Highway Consultants Co., LTD	This work was funded by the National Natural Science Foundation of China (Grant No. 51408049) by YL (http://www.nsfc.gov.cn/english/site_1/index.html), the National R&D Plan of China (2017YFC0803906) by YL (http://www.most.gov.cn/eng/), the China Postdoctoral Science Foundation funded project (Grant No. 2016M590914) by YL (http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx), the Shaanxi Postdoctoral Science Research project (Grant No. 2016BSHEDZZ134) by YL (http://postdoc.shaanxi.gov.cn/), the Fundamental Research Funds for the Central Universities (Grant No. 300102218521) by YL (http://en.chd.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder ' CCCC First Highway Consultants Co., LTD' provided support in the form of salaries for authors YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Autey J, 2013, J ADV TRANSPORT, V47, P536, DOI 10.1002/atr.181; Bie YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177637; Cai ZY, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641292; El Esawey M, 2007, TRANSPORT RES REC, P10, DOI 10.3141/2023-02; El Esawey M, 2013, TRANSPORTMETRICA A, V9, P860, DOI 10.1080/18128602.2012.672344; Federal Highway Administration, 2013, MAN UN TRAFF CONTR D; Guler SI, 2016, TRANSPORT RES C-EMER, V63, P51, DOI 10.1016/j.trc.2015.12.005; Guler SI, 2014, TRANSPORT RES B-METH, V64, P41, DOI 10.1016/j.trb.2014.03.004; He HT, 2016, TRANSPORT RES C-EMER, V64, P28, DOI 10.1016/j.trc.2016.01.009; Kuang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138617; Li Yan, 2013, Journal of Traffic and Transportation Engineering, V13, P116; [李岩 LI Yan], 2011, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V11, P28; Li Yong, 2014, Cereal & Feed Industry, P1; Ma WJ, 2013, TRANSPORT RES REC, P93, DOI 10.3141/2355-10; Papageorgiou M, 2003, P IEEE, V91, P2043, DOI 10.1109/JPROC.2003.819610; Siam MRK, 2018, J TRAFFIC TRANSP ENG, V5, P28, DOI 10.1016/j.jtte.2017.04.004; Winston W.L, 2003, OPERATIONS RES APPL; Wolshon B., 2016, TRAFFIC ENG HDB; Wong CK, 2011, TRANSPORT RES B-METH, V45, P667, DOI 10.1016/j.trb.2010.12.001; Wong CK, 2003, TRANSPORT RES B-METH, V37, P63, DOI 10.1016/S0191-2615(01)00045-5; Wu JM, 2016, TRANSPORT RES C-EMER, V69, P228, DOI 10.1016/j.trc.2016.06.011; Wu JP, 1998, TRANSPORT RES A-POL, V32, P563, DOI 10.1016/S0965-8564(98)00008-1; Xuan YG, 2011, TRANSPORT RES B-METH, V45, P769, DOI 10.1016/j.trb.2011.02.009; Yan CW, 2014, TRANSPORT RES B-METH, V60, P85, DOI 10.1016/j.trb.2013.12.001; Yang QL, 2017, TRANSPORT RES C-EMER, V77, P366, DOI 10.1016/j.trc.2017.01.018; Zhao J, 2018, IET INTELL TRANSP SY, V12, P394, DOI 10.1049/iet-its.2017.0092; Zhao J, 2017, ACCIDENT ANAL PREV, V102, P31, DOI 10.1016/j.aap.2017.02.023; Zhao J, 2016, COMPUT-AIDED CIV INF, V31, P794, DOI 10.1111/mice.12211; Zhou YP, 2014, J ADV TRANSPORT, V48, P362, DOI 10.1002/atr.1222	29	2	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217741	10.1371/journal.pone.0217741	http://dx.doi.org/10.1371/journal.pone.0217741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150481	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100095
J	Rice, SJ; Liu, X; Wang, HG; Belani, CP				Rice, Shawn J.; Liu, Xin; Wang, Hong-Gang; Belani, Chandra P.			EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-CELLS; SURVIVAL; ABT-737; EXPRESSION; MARITOCLAX; RESISTANCE; APOPTOSIS; GROWTH; BIM; DISCOVERY	Lung cancer is among the common and deadly cancers. Although the treatment options for late-stage cancer patients have continued to increase in numbers, the overall survival rates for these patients have not shown significant improvement. This highlights the need for new targets and drugs to more effectively treat lung cancer patients. In this study, we characterize the MCL-1 inhibitor maritoclax alone or in combination with a BCL-2/xL inhibitor in a panel of lung cancer cell lines. BCL-2 family proteins, phosphorylated proteins, and apoptosis were monitored following the treatments. We found that maritoclax was effective at inhibiting growth in these lung cancer cells. We also establish that cell lines with EGFR mutations were most sensitive to the combined inhibition of MCL-1 and BCL-2/xL. In addition, a high level of phosphorylated AKT (S473) was identified as a marker for sensitivity to the combination treatment. This work has defined EGFR mutations and AKT phosphorylation as markers for sensitivity to combined MCL-1 and BCL-2/xL targeted therapy and establishes a rationale to explore multiple BCL-2 family members in patients who are refractory to EGFR inhibitor treatment. Our data support the design of a clinical trial that aims to employ inhibitors of the BCL-2 family of proteins in lung cancer patients.	[Rice, Shawn J.; Liu, Xin; Wang, Hong-Gang; Belani, Chandra P.] Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Belani, Chandra P.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Belani, CP (corresponding author), Penn State Hershey Canc Inst, Hershey, PA 17033 USA.; Belani, CP (corresponding author), Penn State Coll Med, Dept Med, Hershey, PA 17033 USA.	cbelani@psu.edu		Belani, Chandra/0000-0001-5049-5329				Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Costa C, 2014, CLIN CANCER RES, V20, P2001, DOI 10.1158/1078-0432.CCR-13-2233; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Doi K, 2014, CANCER BIOL THER, V15, P1077, DOI 10.4161/cbt.29186; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Frederick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101286; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Howlader N, 2012, AM J EPIDEMIOL, V176, P347, DOI 10.1093/aje/kwr512; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Jeon MY, 2018, MOLECULES, V23, DOI 10.3390/molecules23113030; Kathuria H, 2014, CANCERS, V6, P1157, DOI 10.3390/cancers6021157; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Nalluri S, 2015, CANCER BIOL THER, V16, P276, DOI 10.1080/15384047.2014.1002333; Pandey MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078570; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Varadarajan S, 2015, ONCOTARGET, V6, P12668, DOI 10.18632/oncotarget.3706; Wang B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-98; Whitsett TG, 2014, MOL CANCER RES, V12, P550, DOI 10.1158/1541-7786.MCR-13-0458; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217657	10.1371/journal.pone.0217657	http://dx.doi.org/10.1371/journal.pone.0217657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150457	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100081
J	Zhou, LP; Yuan, L; Zhao, BQ; Li, YT; Lin, ZA				Zhou, Liping; Yuan, Liang; Zhao, Bingqiang; Li, Yanting; Lin, Zhian			Structural characteristics of humic acids derived from Chinese weathered coal under different oxidizing conditions	PLOS ONE			English	Article							SIZE-FRACTIONS; LIGNITE; OXIDATION; SUBSTANCES; MATTER; BIOACTIVITY; SORPTION; GROWTH; SOILS; PEAT	Humic acids derived from Chinese weathered coal were oxidized with hydrogen peroxide (H2O2) under various conditions, and their chemical composition and structure were examined. The raw material humic acids (HA) and oxidized humic acids (OHAs) were characterized by elemental analysis and ultraviolet visible (UV-Vis), Fourier transform infrared (FTIR), and solid-state C-13 nuclear magnetic resonance (NMR) spectroscopy. Our results show that aromatic functional groups accounted for more than 70% of the HA and OHAs and there were significant differences in their structures and compositions. Compared to the HA, the average H and N contents of the OHAs decreased by 5.15% and 2.52%, respectively, and the average O content of those of the OHAs increased by 5.30%. The hydrophobicity index (HI) of HA is higher than those of the OHAs. Importantly, in the hypothesis test between the properties and preparation conditions of humic acid using SPSS, the partial eta(2) of the temperature, hydrogen peroxide concentration, liquid-solid ratio, and time were 0.809, 0.771, 0.748 and 0.729, respectively; thus, among the preparation conditions, temperature is the most important factor affecting the humic acids properties.	[Zhou, Liping; Yuan, Liang; Zhao, Bingqiang; Li, Yanting; Lin, Zhian] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Zhao, BQ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.	zhaobingqiang@caas.cn			National Key Research and Development Program of China [2016YFD0200402]	National Key Research and Development Program of China	The authors acknowledge the financial support provided by The National Key Research and Development Program of China (2016YFD0200402).	Abakumov EV, 2013, J SOIL SEDIMENT, V13, P491, DOI 10.1007/s11368-012-0579-9; Al Othman ZA, 2011, MOLECULES, V16, P10443, DOI 10.3390/molecules161210443; Al-Faiyz YSS, 2017, ARAB J CHEM, V10, pS839, DOI 10.1016/j.arabjc.2012.12.018; Amir S, 2010, J HAZARD MATER, V177, P524, DOI 10.1016/j.jhazmat.2009.12.064; Canellas LP, 2012, EUR J SOIL SCI, V63, P315, DOI 10.1111/j.1365-2389.2012.01439.x; Canellas LP, 2008, SOIL SCI, V173, P624, DOI 10.1097/SS.0b013e3181847ebf; Canellas LP, 2010, CHEMOSPHERE, V78, P457, DOI 10.1016/j.chemosphere.2009.10.018; Cao XY, 2016, ENVIRON SCI TECHNOL, V50, P1663, DOI 10.1021/acs.est.5b02859; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Conte P, 2007, CHEMOSPHERE, V69, P1032, DOI 10.1016/j.chemosphere.2007.04.043; de Oliveira LK, 2016, ACS APPL MATER INTER, V8, P1478, DOI 10.1021/acsami.5b10810; Dobbss LB, 2010, J AGR FOOD CHEM, V58, P3681, DOI 10.1021/jf904385c; Doskocil L, 2014, FUEL, V134, P406, DOI 10.1016/j.fuel.2014.06.011; [黄文辉 Huang Wenhui], 2010, [现代地质, Geoscience], V24, P1186; Garcia AC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20798; Garcia-Mina JM, 2006, ORG GEOCHEM, V37, P1960, DOI 10.1016/j.orggeochem.2006.07.027; de Melo BAG, 2016, MAT SCI ENG C-MATER, V62, P967, DOI 10.1016/j.msec.2015.12.001; Griffith S. M., 1989, Humic substances II. In search of structure., P69; Ho KJ, 2003, ARCH TOXICOL, V77, P100, DOI 10.1007/s00204-002-0378-y; Jindo K, 2012, PLANT SOIL, V353, P209, DOI 10.1007/s11104-011-1024-3; Karlsson T, 2010, GEOCHIM COSMOCHIM AC, V74, P30, DOI 10.1016/j.gca.2009.09.023; KIM JI, 1990, FRESEN J ANAL CHEM, V338, P245, DOI 10.1007/BF00323017; Li SX., 2002, HUMIC ACID, V3, P7; Liu FJ, 2013, FUEL, V109, P316, DOI 10.1016/j.fuel.2013.01.020; Lu JH, 2017, ENVIRON POLLUT, V220, P1418, DOI 10.1016/j.envpol.2016.10.092; MALCOLM RE, 1979, SOIL BIOL BIOCHEM, V11, P65, DOI 10.1016/0038-0717(79)90120-2; [МАЛЫШЕНКО НАТАЛЬЯ ВАСИЛЬЕВНА MALYSHENKO N.V.], 2015, [Химия в интересах устойчивого развития, Khimiya v interesakh ustoichivogo razvitiya], V23, P451, DOI 10.15372/KhUR20150415; Mao JD, 2004, ENVIRON SCI TECHNOL, V38, P2680, DOI 10.1021/es034770x; Mao JD, 2007, GEODERMA, V140, P17, DOI 10.1016/j.geoderma.2007.03.014; Mao JD, 2011, ORG GEOCHEM, V42, P891, DOI 10.1016/j.orggeochem.2011.03.023; Mao JD, 2010, GEOCHIM COSMOCHIM AC, V74, P2110, DOI 10.1016/j.gca.2009.12.029; Mathews JP, 2012, FUEL, V96, P1, DOI 10.1016/j.fuel.2011.11.025; Parsons J. W., 1989, HUMIC SUBSTANCES, P99; Pena-Mendez E. M., 2005, J APPL BIOMED, V3, P13, DOI DOI 10.32725/JAB.2005.002; Rajashekhar D, 2017, INT J PURE APP BIOSC, V5, P1254, DOI [10.18782/2320-7051.5454, DOI 10.18782/2320-7051.5454]; Savy D, 2015, MOLECULES, V20, P19958, DOI 10.3390/molecules201119671; SCHNITZER M, 1974, SOIL BIOL BIOCHEM, V6, P1, DOI 10.1016/0038-0717(74)90003-0; Stevenson F. J., 1989, HUMIC SUBSTANCES, VII, P121; Stevenson FJ., 1994, HUMIC CHEM GENESIS C, P236; Tahir MM, 2011, PEDOSPHERE, V21, P124, DOI 10.1016/S1002-0160(10)60087-2; Tang YF, 2017, ACS SUSTAIN CHEM ENG, V5, P10099, DOI 10.1021/acssuschemeng.7b02094; Tao ZY, 1995, TOXICOL ENVIRON CHEM, V49, P45, DOI DOI 10.1080/02772249509358175; Wang XL, 2011, ENVIRON SCI TECHNOL, V45, P9276, DOI 10.1021/es202258q; Wen Y, 2010, SCI TECH INFORM DEV, V33, P65; [武瑞平 WU Rui-ping], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1855; Zhang Q, 2012, J ENVIRON MANAGE, V102, P165, DOI 10.1016/j.jenvman.2011.12.036; Zhang SQ, 2017, CHEMOSPHERE, V166, P334, DOI 10.1016/j.chemosphere.2016.09.095; Zherebtsov SI, 2015, COKE CHEM, V58, P400, DOI 10.3103/S1068364X15100099; Zykova MV, 2018, MOLECULES, V23, DOI 10.3390/molecules23040753	49	17	18	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217469	10.1371/journal.pone.0217469	http://dx.doi.org/10.1371/journal.pone.0217469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150428	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100055
J	De Bari, B; Dixon, JA; Kay, BA; Kondepudi, D				De Bari, Benjamin; Dixon, James A.; Kay, Bruce A.; Kondepudi, Dilip			Oscillatory dynamics of an electrically driven dissipative structure	PLOS ONE			English	Article							ENTROPY PRODUCTION	Physical systems open to a flow of energy can exhibit spontaneous symmetry breaking and self-organization. These nonequilibrium self-organized systems are known as dissipative structures. We study the oscillatory mode of an electrically driven dissipative structure. Our system consists of aluminum beads in shallow oil, which, when subjected to a high voltage, self-organize into connected 'tree' structures. The tree structures serve as pathways for the conduction of charge to ground. This system shows a variety of spatio-temporal behaviors, such as oscillating movement of the tree structures. Utilizing a dynamical systems model of the electromagnetic phenomena, we explore a potential mechanism underlying the system's behavior and use the model to make additional empirical predictions. The model reproduces the oscillatory behavior observed in the real system, and the behavior of the real system is consistent with predictions from the model under various constraints. From the empirical results and the mathematical model, we observe a tendency for the system to select modes of behavior with increased dissipation, or higher rates of entropy production, in accord with the proposed Maximum Entropy Production (MEP) Principle.	[De Bari, Benjamin; Dixon, James A.; Kay, Bruce A.] Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA; [Kondepudi, Dilip] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA	University of Connecticut; Wake Forest University	De Bari, B (corresponding author), Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA.	Benjamin.de_bari@uconn.edu		De Bari, Benjamin/0000-0002-7894-7849	National Science Foundation's INSPIRE Track 1 Program [BCS-1344725]	National Science Foundation's INSPIRE Track 1 Program	This work was supported by a grant from the National Science Foundation's INSPIRE Track 1 Program, Grant number BCS-1344725, awarded to James. Dixon. The funder's website is: https://www.nsf.gov/pubs/2014/nsf14106/nsf14106.jsp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08323; Dixon J, 2015, WORLD SCI REV    AUG, DOI [10.1142/9789814730617_0009, DOI 10.1142/9789814730617_0009]; Eigen M, 1979, HYPER CYCLE; Endres RG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14485-8; Jun J., 2006, DYNAMICS SELF ORG RA; Kaufmann SA, 1993, ORIGINS ORDER; Kleidon A., 2005, NONEQUILIBRIUM THERM; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kondepudi D, 2017, CHAOS, V27, DOI 10.1063/1.5001195; Kondepudi D, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.050902; Kondepudi D, 2012, ECOL PSYCHOL, V24, P33, DOI 10.1080/10407413.2012.643716; KUGLER PN, 1988, HUM MOVEMENT SCI, V7, P97, DOI 10.1016/0167-9457(88)90009-7; Martyushev LM, 2006, PHYS REP, V426, P1, DOI 10.1016/j.physrep.2005.12.001; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Nicolis G., 1992, NEW PHYS; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Prigogine I., 1961, INTRO THERMODYNAMICS; Rosen R., 2000, ESSAYS LIFE ITSELF; SWENSON R, 1991, Ecological Psychology, V3, P317, DOI 10.1207/s15326969eco0304_2	19	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217305	10.1371/journal.pone.0217305	http://dx.doi.org/10.1371/journal.pone.0217305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141547	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000048
J	Nazari, G; MacDermid, JC; Bryant, D; Athwal, GS				Nazari, Goris; MacDermid, Joy C.; Bryant, Dianne; Athwal, George S.			The effectiveness of surgical vs conservative interventions on pain and function in patients with shoulder impingement syndrome. A systematic review and meta-analysis	PLOS ONE			English	Review							ROTATOR CUFF TENDINOPATHY; STAGE-II IMPINGEMENT; SUBACROMIAL IMPINGEMENT; ARTHROSCOPIC ACROMIOPLASTY; FOLLOW-UP; PREVALENCE; QUALITY; DECOMPRESSION; EXERCISES; COMMUNITY	Objective To assess the effectiveness of surgical vs conservative interventions on pain and function in patients with subacromial impingement syndrome. Design Systematic review and meta-analysis of randomized controlled trials. Setting Clinical setting. Participants Patients 18 years and older with subacromial impingement syndrome. Intervention/Comparison Surgical intervention plus postoperative physiotherapy / placebo surgery plus physiotherapy or physiotherapy only. Main outcome measures Pain and function. Results 11 RCTs (n = 919) were included. The pooled results displayed no statistically or clinically different between surgery plus physiotherapy vs physiotherapy alone on pain levels at 3-, 6-months, 5- and 10 years follow up (moderate quality, 3 RCTs, 300 patients, WMD -0.39, 95% CI: -1.02 to 0.23, p = 0.22; moderate quality, 3 RCTs, 310 patients, WMD -0.36, 95% CI: -1.02 to 0.29, p = 0.27; low quality, 1 RCT, 109 patients, WMD -0.30, 95% CI: -1.54 to 0.94, p = 0.64; low quality, 1 RCT, 90 patients, WMD -1.00, 95% CI: -0.24 to 2.24, p = 0.11) respectively. Similarly, the pooled results were not statistically or clinically different between groups for function at 3-, 6-month and 1-year follow ups (very low quality, 2 RCTs, 184 patients, SMD 0.11, 95% CI: -0.57 to 0.79, p = 0.75; moderate quality, 3 RCTs, 310 patients, SMD 0.15, 95% CI: -0.14 to 0.43, p = 0.31; very low quality, 2 RCTs, 197 patients, SMD 0.11, 95% CI: -0.46 to 0.69, p = 0.70) respectively. Conclusion The effects of surgery plus physiotherapy compared to physiotherapy alone on improving pain and function are too small to be clinically important at 3-, 6-months, 1-, 2-, 5- and >= 10-years follow up.	[Nazari, Goris; MacDermid, Joy C.; Bryant, Dianne] Western Univ, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada; [Nazari, Goris; Bryant, Dianne; Athwal, George S.] Western Univ, Bone & Joint Inst, Collaborat Program Musculoskeletal Hlth Res, London, ON, Canada; [MacDermid, Joy C.; Athwal, George S.] St Josephs Hosp, Roth McFarlane Hand & Upper Limb Ctr, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario)	Nazari, G (corresponding author), Western Univ, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada.; Nazari, G (corresponding author), Western Univ, Bone & Joint Inst, Collaborat Program Musculoskeletal Hlth Res, London, ON, Canada.	gnazari@uwo.ca	Bryant, Dianne M/K-6766-2013; Athwal, George S/H-1762-2015; MacDermid, Joy C/H-7837-2013	Bryant, Dianne M/0000-0002-7535-8707; MacDermid, Joy C/0000-0001-9311-7379				Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beard DJ, 2018, LANCET, V391, P329, DOI 10.1016/S0140-6736(17)32457-1; Bossuyt FM, 2018, DISABIL REHABIL, V40, P798, DOI 10.1080/09638288.2016.1276974; Brox JI, 1999, J SHOULDER ELB SURG, V8, P102, DOI 10.1016/S1058-2746(99)90001-0; Farfaras S, 2018, AM J SPORT MED, V46, P1397, DOI 10.1177/0363546518755759; Farfaras S, 2016, KNEE SURG SPORT TR A, V24, P2181, DOI 10.1007/s00167-014-3416-4; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haahr JP, 2006, SCAND J RHEUMATOL, V35, P224, DOI 10.1080/03009740600556167; Haahr JP, 2005, ANN RHEUM DIS, V64, P760, DOI 10.1136/ard.2004.021188; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hill CL, 2010, INT J RHEUM DIS, V13, P215, DOI 10.1111/j.1756-185X.2010.01475.x; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Ketola S, 2017, BONE JOINT J, V99B, P799, DOI 10.1302/0301-620X.99B6.BJJ-2016-0569.R1; Ketola S, 2013, BONE JOINT RES, V2, P132, DOI 10.1302/2046-3758.27.2000163; Ketola S, 2009, J BONE JOINT SURG BR, V91B, P1326, DOI 10.1302/0301-620X.91B10.22094; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Paavola M, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2860; Rahme H, 1998, SCAND J REHABIL MED, V30, P253; Saltychev M, 2015, DISABIL REHABIL, V37, P1, DOI 10.3109/09638288.2014.907364; Schopflocher D, 2011, PAIN RES MANAG, V16, P445, DOI 10.1155/2011/876306; Steuri R, 2017, BRIT J SPORT MED, V51, P1340, DOI 10.1136/bjsports-2016-096515; Tashjian RZ, 2009, J SHOULDER ELB SURG, V18, P927, DOI 10.1016/j.jse.2009.03.021; Toliopoulos P, 2014, CLIN RHEUMATOL, V33, P1373, DOI 10.1007/s10067-014-2563-9; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; Yeldan I, 2009, DISABIL REHABIL, V31, P935, DOI 10.1080/09638280802377985	27	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216961	10.1371/journal.pone.0216961	http://dx.doi.org/10.1371/journal.pone.0216961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141546	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000032
J	Asar, L; Pfefferle, S; Lutgehetmann, M; Hoffmann, A; Katchanov, J; Aepfelbacher, M; Rohde, H; Maurer, FP				Asar, Lucia; Pfefferle, Susanne; Luetgehetmann, Marc; Hoffmann, Armin; Katchanov, Juri; Aepfelbacher, Martin; Rohde, Holger; Maurer, Florian P.			Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods	PLOS ONE			English	Article							RESISTANT PSEUDOMONAS-AERUGINOSA; OUTBREAK; PNEUMONIAE; CRITERIA	Objectives To determine the influence of local spread of clonal strains and testing of follow-up isolates on categorical (CA) and essential agreement rates (EA) of common colistin (COL) drug susceptibility testing methods with the broth microdilution (BMD) reference method. Methods COL MICs were determined for 178 bacterial isolates (Enterobacteriaceae, n = 97; Pseudomonas aeruginosa, n = 81) collected within one year from 64 patients by BMD according to ISO standard 20776-1 (reference method), the SensiTest BMD panel (ST), agar dilution (AD), the VITEK 2 instrument, and gradient diffusion (GD) using antibiotic strips of two and Muller-Hinton agar plates of three manufacturers. CA and EA with BMD were calculated for all isolates and compared to the subset of 68 unique isolates. Results CA ranges were 79.4% to 94.1% for the unique isolateq panel and 89.9% to 96.1% for all tested isolates. EA ranges were 64.7% to 86.8% and 67.4% to 91.0%, respectively. In both panels, EA for all GD assays was lower than 90%. Both lower and higher EA values ranging from-18.3% (MTS on BD agar) to + 6.3% (AD, Vitek 2) were observed in the full one-year sample. Acquisition of colistin resistance under therapy was observed for 3 patients. Conclusions i) Repeat testing and local spread of clonal strains can positively or negatively affect CA and EA, ii) CA is more robust towards local influences than EA, iii) EA of GD and AD methods for COL with the reference BMD method is insufficient.	[Asar, Lucia; Pfefferle, Susanne; Luetgehetmann, Marc; Hoffmann, Armin; Aepfelbacher, Martin; Rohde, Holger; Maurer, Florian P.] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Katchanov, Juri] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany; [Maurer, Florian P.] Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Forschungszentrum Borstel	Maurer, FP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.; Maurer, FP (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany.	f.maurer@uke.de	Maurer, Florian/ABA-1918-2020; Maurer, Florian/Z-5028-2019	Maurer, Florian/0000-0001-8353-5964; Maurer, Florian/0000-0001-8353-5964; Rohde, Holger/0000-0001-8587-4433	German Center for Infection Research (DZIF) [TI 07.003]	German Center for Infection Research (DZIF)	This work was supported by internal funding and a grant by the German Center for Infection Research (DZIF) to LA and FPM (TI 07.003). There was no additional external funding received for this study.	Chabou S., 2016, New Microbes and New Infections, V13, P71, DOI 10.1016/j.nmni.2016.06.017; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Dafopoulou K, 2015, ANTIMICROB AGENTS CH, V59, P4625, DOI 10.1128/AAC.00868-15; European Committee on Antimicrobial Susceptibility Testing (EUCAST), ANT SUSC TEST COL PR; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Gibb AP, 2002, ANTIMICROB AGENTS CH, V46, P255, DOI 10.1128/AAC.46.1.255-258.2002; International Organization for Standardization, 2006, ISO207761 BSI; Katchanov J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195757; Kulengowski B, 2019, CLIN MICROBIOL INFEC, V25, P92, DOI 10.1016/j.cmi.2018.04.008; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Matuschek E, 2018, CLIN MICROBIOL INFEC, V24, P865, DOI 10.1016/j.cmi.2017.11.020; Matuschek E, 2017, ECCMID VIENN, V161; Rebelo AR, 2018, EUROSURVEILLANCE, V23, DOI [10.2807/1560-7917.ES, DOI 10.2807/1560-7917.ES]; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Skov RL, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.9.30155; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Spapen H, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-14; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zhang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134743	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217468	10.1371/journal.pone.0217468	http://dx.doi.org/10.1371/journal.pone.0217468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170167	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700033
J	Chambers, C; Kong, GQ; Wei, KL; Kording, K				Chambers, Claire; Kong, Gaiqing; Wei, Kunlin; Kording, Konrad			Pose estimates from online videos show that side-by-side walkers synchronize movement under naturalistic conditions	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; GAIT SYNCHRONIZATION; TREADMILL WALKING; ROCKING; BEAT	Marker-less video-based pose estimation promises to allow us to do movement science on existing video databases. We revisited the old question of how people synchronize their walking using real world data. We thus applied pose estimation to 348 video segments extracted from YouTube videos of people walking in cities. As in previous, more constrained, research, we find a tendency for pairs of people to walk in phase or in anti-phase with each other. Large video databases, along with pose-estimation algorithms, promise answers to many movement questions without experimentally acquiring new data.	[Chambers, Claire; Kong, Gaiqing; Kording, Konrad] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Chambers, Claire; Kong, Gaiqing; Kording, Konrad] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Kong, Gaiqing; Wei, Kunlin] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Wei, Kunlin] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China	University of Pennsylvania; University of Pennsylvania; Peking University; Peking University	Chambers, C (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Chambers, C (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	clairenc@seas.upenn.edu	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499; Kong, Gaiqing/0000-0002-3142-3730	NIH [5R01NS063399-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant 5R01NS063399-08, awarded to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Cao Z., 2016, ARXIV161108050; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; Ducourant T, 2005, NEUROSCI LETT, V389, P6, DOI 10.1016/j.neulet.2005.06.052; Guler RA, 180200434 ARXIV, DOI [10.1109/CVPR.2017.280, DOI 10.1109/CVPR.2017.280]; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Hreljac A, 2000, J BIOMECH, V33, P783, DOI 10.1016/S0021-9290(00)00014-2; Ingram JN, 2011, PROG BRAIN RES, V191, P3, DOI 10.1016/B978-0-444-53752-2.00016-3; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Krause J, 2002, LIVING GROUPS; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Loper M, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818013; Maas AL, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P22; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mickelborough J, 2000, GAIT POSTURE, V11, P32, DOI 10.1016/S0966-6362(99)00050-8; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Nessler JA, 2015, HUM MOVEMENT SCI, V41, P32, DOI 10.1016/j.humov.2015.02.005; Nessler JA, 2011, J APPL BIOMECH, V27, P322, DOI 10.1123/jab.27.4.322; Nessler JA, 2010, GAIT POSTURE, V31, P527, DOI 10.1016/j.gaitpost.2010.01.013; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Nessler JA, 2009, CHAOS, V19, DOI 10.1063/1.3125762; O'Brien B, 2010, ECOL PSYCHOL, V7413, P37; Ochoa J, 2017, J NEUROPHYSIOL, V118, P2089, DOI 10.1152/jn.00176.2017; Pachi A., 2005, STRUCT ENG, V83, P36, DOI DOI 10.1016/S0141-0296(00)00020-1; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Seethapathi N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0486; Sylos-Labini F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00179; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Wei KL, 2018, NAT NEUROSCI, V21, P1146, DOI 10.1038/s41593-018-0215-0; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28; Zivotofsky AZ, 2018, HUM MOVEMENT SCI, V59, P20, DOI 10.1016/j.humov.2018.03.009; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	39	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217861	10.1371/journal.pone.0217861	http://dx.doi.org/10.1371/journal.pone.0217861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170214	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700071
J	Moss, FC; Neuwirth, M; Harasim, D; Rohrmeier, M				Moss, Fabian C.; Neuwirth, Markus; Harasim, Daniel; Rohrmeier, Martin			Statistical characteristics of tonal harmony: A corpus study of Beethoven's string quartets	PLOS ONE			English	Article							SYNTAX; MUSIC; LAW	Tonal harmony is one of the central organization systems of Western music. This article characterizes the statistical foundations of tonal harmony based on the computational analysis of expert annotations in a large corpus. Using resampling methods, this study shows that 1) the rank-frequency distribution of chords resembles a power law, i.e. few chords govern a large proportion of the data; 2) chord transitions are referential and chord predictability is significantly affected by distinguished chord features; 3) tonal harmony conveys directedness in time; and 4) tonal harmony operates differently at the hierarchical levels of chords and keys. These results serve to characterize tonal harmony on empirical grounds and advance the methodological state-of-the-art in digital musicology.	[Moss, Fabian C.; Neuwirth, Markus; Harasim, Daniel; Rohrmeier, Martin] Ecole Polytech Fed Lausanne, Coll Humanities, Digital Humanities Inst, Digital & Cognit Musicol Lab, CH-1015 Lausanne, Vaud, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Moss, FC (corresponding author), Ecole Polytech Fed Lausanne, Coll Humanities, Digital Humanities Inst, Digital & Cognit Musicol Lab, CH-1015 Lausanne, Vaud, Switzerland.	fabian.mass@epfl.ch	Moss, Fabian/AAD-2243-2019	Moss, Fabian/0000-0001-9377-2066; Rohrmeier, Martin Alois/0000-0002-4323-7257	European Research Council (ERC) under the European Union [760081]; Volkswagen Foundation; Ecole Polytechnique Federale de Lausanne (EPFL); Latour Chair of Digital and Cognitive Musicology at EPFL	European Research Council (ERC) under the European Union(European Research Council (ERC)); Volkswagen Foundation(Volkswagen); Ecole Polytechnique Federale de Lausanne (EPFL); Latour Chair of Digital and Cognitive Musicology at EPFL	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (GA No 760081). Further funding was provided by the Volkswagen Foundation within the scope of the project "From Bach to the Beatles: Exploring compositional building blocks and style change with hermeneutic and computational methods", and the Ecole Polytechnique Federale de Lausanne (EPFL). The authors thank Claude Latour for supporting this research through the Latour Chair of Digital and Cognitive Musicology at EPFL.	Albrecht JD, 2014, MUSIC PERCEPT, V31, P223, DOI 10.1525/MP.2014.31.3.223; Aldwell Edward, 2011, HARMONY VOICE LEADIN; Bhatkhande VN, 1984, COMP STUDY SOME LEAD; Broze Y, 2013, MUSIC PERCEPT, V31, P32, DOI 10.1525/MP.2013.31.1.32; Cadwallader A., 2011, ANAL TONAL MUSIC SCH, VThird; COHN Richard, 1992, INDIANA THEORY REV, V1, P1; Cook Nicholas., 2013, SCORE MUSIC PERFORMA; Dahlhaus C., 2014, STUDIES ORIGIN HARMO; Dahlhaus C., 2001, NEW GROVE DICT MUSIC, V10, P858; Damschroder D., 2016, HARMONY BEETHOVEN; De Clercq T, 2011, POP MUSIC, V30, P47, DOI 10.1017/S026114301000067X; Dmitri Tymoczko, 2003, MUSURGIA, VX, P35; Efron B., 1994, MONOGRAPHS STAT APPL; FORTE A., 1962, TONAL HARMONY CONCEP, V1st; Fux Johann Joseph, 1742, GRADUS AD PARNASSUM; Gardonyi Zsolt., 2002, HARMONIK; Gauldin R, 1997, HARMONIC PRACTICE TO; Gauvin HL, 2015, EMPIR MUSICOL REV, V10, P215; Hauptmann Moritz, 1853, NATUR HARMONIK METRI; Hedges Thomas, 2011, Mathematics and Computation in Music. Proceedings of the Third International Conference, MCM 2011, P334, DOI 10.1007/978-3-642-21590-2_27; Huron D.B., 2006, SWEET ANTICIPATION M; Hyer B, 2001, NEW GROVE DICT MUSIC, P583; Jacoby N, 2015, J NEW MUSIC RES, V44, P219, DOI 10.1080/09298215.2015.1036888; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Lehman Frank, 2018, HOLLYWOOD HARMONY MU; Lerdahl Fred, 1983, GENERATIVE THEORY TO; Mandelbrot B., 1953, COMMUN THEOR, P486; Manning C.D., 2003, FDN STAT NATURAL LAN, V6th; Mauch M, 2008, P 10 INT C MUS PERC, P1; Mauch M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150081; Meyer L. B., 1967, MUSIC ARTS IDEAS; Moretti Franco, 2013, DISTANT READING; Narmour E., 1977, SCHENKERISM NEED ALT; Neuwirth M., 2018, FRONT DIGITAL HUMAN, V5, P16, DOI [10.3389/fdigh.2018.00016, DOI 10.3389/FDIGH.2018.00016]; Pearce MT, 2018, ANN NY ACAD SCI, V1423, P378, DOI 10.1111/nyas.13654; Piantadosi ST, 2014, PSYCHON B REV, V21, P1112, DOI 10.3758/s13423-014-0585-6; Piston W., 1941, HARMONY; RAMEAU J. P., 1722, TRAITE HARMONIE REDU; RANDEL DM, 1976, J AM MUSIC SOC, V29, P173, DOI 10.1525/jams.1976.29.2.03a00010; Riemann H., 1893, HARMONY SIMPLIFIED T; Zivic PHR, 2013, P NATL ACAD SCI USA, V110, P10034, DOI 10.1073/pnas.1222336110; Rohrmeier M., 2013, Z GESELLSCHAFT MUSIK, V10, P343, DOI [DOI 10.31751/724, 10.31751/724]; Rohrmeier M., 2008, P 10 INT C MUSIC PER, P619; Rohrmeier M, 2012, TOP COGN SCI, V4, P525, DOI 10.1111/j.1756-8765.2012.01223.x; Rohrmeier M, 2011, J MATH MUSIC, V5, P35, DOI 10.1080/17459737.2011.573676; Schenker H., 1935, DER FREIE SATZ; Schoenberg A., 1969, STRUCTURAL FUNCTIONS; Serra Joan, 2012, SCI REPORTS, V2, P1; Tymoczko Dmitri., 2011, GEOMETRY MUSIC HARMO; Weiss C, 2018, MUSIC SCI; White CW, 2014, MUSIC PERCEPT, V31, P244, DOI 10.1525/MP.2014.31.3.244; White CW, 2016, EMPIR MUSICOL REV, V11; Yang C, 2013, P NATL ACAD SCI USA, V110, P6324, DOI 10.1073/pnas.1216803110; Zanette DH, 2006, MUSIC SCI, V10, P3, DOI 10.1177/102986490601000101; Zarlino G, 1562, I HARMONICHE, Vfirst; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	56	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217242	10.1371/journal.pone.0217242	http://dx.doi.org/10.1371/journal.pone.0217242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170188	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700022
J	Deo, S; Jindal, P; Gupta, D; Khaparde, S; Rade, K; Sachdeva, KS; Vadera, B; Shah, D; Patel, K; Dave, P; Chopra, R; Jha, N; Papineni, S; Vijayan, S; Dewan, P				Deo, Sarang; Jindal, Pankaj; Gupta, Devesh; Khaparde, Sunil; Rade, Kiran; Sachdeva, Kuldeep Singh; Vadera, Bhavin; Shah, Daksha; Patel, Kamlesh; Dave, Paresh; Chopra, Rishabh; Jha, Nita; Papineni, Sirisha; Vijayan, Shibu; Dewan, Puneet			What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India	PLOS ONE			English	Article							PUBLIC-PRIVATE; MIX PROJECT; PRACTITIONERS; DISTRICT; HEALTH	Background Private providers dominate health care in India and provide most tuberculosis (TB) care. Yet efforts to engage private providers were viewed as unsustainably expensive. Three private provider engagement pilots were implemented in Patna, Mumbai and Mehsana in 2014 based on the recommendations in the National Strategic Plan for TB Control, 2012-17. These pilots sought to improve diagnosis and treatment of TB and increase case notifications by offering free drugs and diagnostics for patients who sought care among private providers, and monetary incentives for providers in one of the pilots. As these pilots demonstrated much higher levels of effectiveness than previously documented, we sought to understand program implementation costs and predict costs for their national scale-up. Methods and findings We developed a common cost structure across these three pilots comprising fixed and variable cost components. We conducted a retrospective, activity-based costing analysis using programmatic data and qualitative interviews with the respective program managers. We estimated the average recurring costs per TB case at different levels of program scale for the three pilots. We used these cost estimates to calculate the budget required for a national scale up of such pilots. The average cost per privately-notified TB case for Patna, Mumbai and Mehsana was estimated to be US$ 95, US$ 110 and US$ 50, respectively, in May 2016 when these pilots were estimated to cover 50%, 36% and 100% of the total private TB patients, respectively. For Patna and Mumbai pilots, the average cost per case at full scale, i.e. 100% coverage of private TB patients, was projected to be US$ 91 and US$ 101, respectively. In comparison, the national TB program's budget for 2015 averages out to $150 per notified TB case. The total annual additional budget for a national scale up of these pilots was estimated to be US$ 267 million. Conclusions As India seeks to eliminate TB, extensive national engagement of private providers will be required. The cost per privately-notified TB case from these pilots is comparable to that already being spent by the public sector and to the projected cost per privately-notified TB case required to achieve national scale-up of these pilots. With additional funds expected to execute against national TB elimination commitments, the scale-up costs of these operationally viable and effective private provider engagement pilots are likely to be financially viable.	[Deo, Sarang] Indian Sch Business, Hyderabad, Telangana, India; [Jindal, Pankaj] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA; [Gupta, Devesh; Khaparde, Sunil; Rade, Kiran; Sachdeva, Kuldeep Singh; Vadera, Bhavin] Cent TB Div, New Delhi, India; [Shah, Daksha] Mumbai Mission TB Control, Mumbai, Maharashtra, India; [Patel, Kamlesh; Dave, Paresh] RNTCP, Gandhinagar, Gujarat, India; [Chopra, Rishabh; Vijayan, Shibu] PATH, Connaught Pl, New Delhi, India; [Jha, Nita] World Hlth Partners, Patna, Bihar, India; [Papineni, Sirisha] Harvard Med Sch, Boston, MA 02115 USA	Indian School of Business (ISB); University of California System; University of California Los Angeles; Harvard University; Harvard Medical School	Deo, S (corresponding author), Indian Sch Business, Hyderabad, Telangana, India.	sarang_deo@isb.edu	Rade, Kiran/AAU-9564-2020; Deo, Sarang/B-5895-2015	Rade, Kiran/0000-0001-7601-0780; Deo, Sarang/0000-0002-3233-6014	Bill and Melinda Gates Foundation [46300]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Sarang Deo received funding from Bill and Melinda Gates Foundation grant no. 46300. Puneet Dewan, now an independent consultant, was an employee and received support from Bill and Melinda Gates Foundation in terms of salary during the study period. He was responsible for funding the interventions and their initial design. Rishabh Chopra and Shibu Vijayan received salaries from PATH whereas Nita Jha and Sirisha Papineni received salaries from WHP, both of which were funded by the Bill and Melinda Gates Foundation to implement the intervention. However, the funding agency (Bill and Melinda Gates Foundation), did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Arora VK, 2003, INT J TUBERC LUNG D, V7, P1131; Bhargava A., 2011, HYPOTHESIS, V9, P1, DOI DOI 10.5779/hypothesis.v9i1.214; Bhatia V, 2010, ENHANCING PRIVATE SE; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; De Costa A, 2008, INT J TUBERC LUNG D, V12, P1333; Division CT, 2012, NAT STRAT PLAN TB CO; Division CT Office WIC, 2016, UN ACC TB CAR UATBC; Division CT Office WIC, UN ACC TB CAR UATBC; Ferroussier O, 2007, INT J TUBERC LUNG D, V11, P755; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kaplan Robert S., 2007, TIME DRIVEN ACTIVITY; Khaparde S., WHO MEETING2016; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Murthy KJR, 2001, INT J TUBERC LUNG D, V5, P354; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Salve S, 2016, INT J HEALTH POLICY, V5, P631, DOI 10.15171/ijhpm.2016.52; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 2016, INT J TUBERC LUNG D, V20, P1424, DOI 10.5588/ijtld.15.0536; WHO, 2014, GLOB TUB REP 2014; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; Yellappa V, 2016, INT J TUBERC LUNG D, V20, P659, DOI 10.5588/ijtld.15.0724; Yellappa V, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1545-9	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0214928	10.1371/journal.pone.0214928	http://dx.doi.org/10.1371/journal.pone.0214928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166942	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800004
J	Gou, YP; Wang, G; Quandahor, P; Liu, Q; Liu, CZ				Gou, Yuping; Wang, Guang; Quandahor, Peter; Liu, Qian; Liu, Changzhong			Effects of sex ratio on adult fecundity, longevity and egg hatchability of Bradysia difformis Frey at different temperatures	PLOS ONE			English	Article							DIPTERA; SCIARIDAE; FUNGI	The fungus gnat Bradysia difformis Frey not only attacks edible and medicinal fungi, it also causes the damages to leek, green onion, garlic and other vegetable crops. To confirm the effects of temperature and sex ratio on adult fecundity, longevity and egg hatchability of B. difformis, we assayed the adults survival longevity and numbers of oviposition, as well as egg hatching rate under female-male ratios of 1:1, 1:2, 1:3, 2:1 and 3:1 at 10, 15, 20, 25 and 30 degrees C. Female fecundity and egg hatchability were increased with temperature and peaked at 25 degrees C, which, however, were adverse to adult longevity. Furthermore, female-male ratio of 1:1, 1:2 and 1:3 seemed suitable for female fecundity, of which the sex ratio of 1:1 was the most suitable ratio for its oviposition behavior. These results provide an insight for predicting the population density of B. difformis and offer a literature reference in the effective treatment of harmful insects by controlling and changing the sex ratio artificially.	[Gou, Yuping; Wang, Guang; Quandahor, Peter; Liu, Qian; Liu, Changzhong] Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Liu, CZ (corresponding author), Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests, Lanzhou, Gansu, Peoples R China.	liuchzh@gsau.edu.cn		Gou, Yuping/0000-0001-7001-5978	Discipline Construction Fund Project of Gansu Agricultural University [GAU-XKJS-2018-149]; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology [201303027]	Discipline Construction Fund Project of Gansu Agricultural University; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology	This study was supported by the Discipline Construction Fund Project of Gansu Agricultural University (GAU-XKJS-2018-149), and International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology (201303027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard RW, 2006, HYDROBIOLOGIA, V568, P403, DOI 10.1007/s10750-006-0200-6; Cao X., 2014, EFFECT DIFFERENT TEM; Dang Zhi-Hong, 2000, Entomological Knowledge, V37, P308; Deng YZ, 2014, STUDY SCREENING PEST; Dong Jun-Feng, 2001, Entomological Knowledge, V38, P173; Fei SM, 2011, J SICHUAN FORESTRY S, V32, P23; Fjerdingstad EJ, 2002, EVOLUTION, V56, P553, DOI 10.1111/j.0014-3820.2002.tb01366.x; Gong Ya-Jun, 2010, Chinese Bulletin of Entomology, V47, P63; [苟玉萍 Gou Yuping], 2015, [植物保护, Plant Protection], V41, P28; [何超 He Chao], 2017, [植物保护, Plant Protection], V43, P62; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hurley BP, 2007, SOUTH HEMISPH FOR J, V69, P103, DOI 10.2989/SHFJ.2007.69.2.5.291; Liu RL, 1983, J SHANXI U NATURAL S, V2, P11; Mei Zeng-Xia, 2004, Acta Entomologica Sinica, V47, P219; Pan Fei, 2014, Huanjing Kunchong Xuebao, V36, P240; Qin Qilian, 2001, Chinese Journal of Biological Control, V17, P155; Shen Deng-Rong, 2009, Acta Entomologica Sinica, V52, P934; Shen Ding, 2008, Electronic Components & Materials, V27, P48; Shi Pei-Jian, 2011, Chinese Journal of Applied Entomology, V48, P1149; Shin S, 2013, MOL ECOL RESOUR, V13, P200, DOI 10.1111/1755-0998.12057; Simon RL, 1994, B ENTOMOL RES, V84, P290; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; Tao Shu-Xia, 2014, Acta Entomologica Sinica, V57, P616; [姚永生 YAO Yongsheng], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P4351; ZHANG HR, 2008, EDIBLE FUNGI CHINA, V27, P54; Zhang XM, 1994, PEST CONTROL EDIBLE; Zhang Yan-Xia, 2016, Chinese Journal of Applied Entomology, V53, P1184, DOI 10.7679/j.issn.2095-1353.2016.146; Zhang ZhiJun, 2013, Acta Agriculturae Zhejiangensis, V25, P520; Zhang Ziyou, 1990, Scientia Silvae Sinicae, V26, P46; [赵海燕 ZHAO Hai-yan], 2009, [吉林农业科学, Journal of Jilin Agricultural Sciences], V34, P34; Zhao Ya-zhou, 2010, Shengtaixue Zazhi, V29, P1087	31	8	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217867	10.1371/journal.pone.0217867	http://dx.doi.org/10.1371/journal.pone.0217867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166959	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800045
J	Gupta, P; Sata, TN; Yadav, AK; Mishra, A; Vats, N; Hossain, MM; Sanal, MG; Venugopal, SK				Gupta, Parul; Sata, Teja Naveen; Yadav, Ajay K.; Mishra, Amit; Vats, Nisha; Hossain, Md. Musa; Sanal, M. G.; Venugopal, Senthil Kumar			TGF-beta induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MICRORNA-181A	Objective To study the role of miRNA-181a and augmenter of liver regeneration in TGF-beta-induced fibrosis in hepatic stellate cells. Methods LX2 cells were treated with 20 ng/ml TGF-beta for 24 h. miRNA-181a, ALR plasmid and empty vectors were transfected using siPORT NeoFx reagent. Cells were harvested after 48 h or 72 h of transfection for protein or RNA analysis. Western blotting was performed for ALR, TGF-beta receptor II (TGF beta-RII), collagen 1A1 (COLL1A1), alpha-smooth muscle cell actin (aSMA), rac1, E-cadherin and beta-actin. Quantitative RT-PCR was performed for ALR, GAPDH, miRNA-181a or 5S rRNA. Results TGF-beta induced the expression of miRNA-181a, which in turn down-regulated ALR thereby induced the fibrosis markers, such as COLL1A1, a-SMA and rac1 in hepatic stellate cells. Over-expression of miRNA-181a down-regulated expression of ALR and up-regulated expression of fibrosis markers. On the other hand, ALR over-expression resulted in a decrease in miRNA-181a expression and fibrosis markers. Over-expression of ALR also inhibited the expression of TGF beta-RII and increased expression E-cadherin. Conclusion TGF-beta induced miRNA-181a, which in turn induced fibrosis, at least in part, by inhibiting ALR. ALR inhibited TGF-beta action by decreasing the expression of TGF-RII, thereby inhibiting miRNA-181a expression and fibrosis markers. ALR could serve as a potential molecule to inhibit liver fibrosis.	[Gupta, Parul; Sata, Teja Naveen; Yadav, Ajay K.; Mishra, Amit; Hossain, Md. Musa; Venugopal, Senthil Kumar] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India; [Vats, Nisha; Sanal, M. G.] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India	South Asian University (SAU); Institute of Liver & Biliary Sciences (ILBS)	Venugopal, SK (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	drsenthil@sau.ac.in	Girija, Sanal Madhusudana/AAV-2072-2020	Girija, Sanal Madhusudana/0000-0003-0007-5718	Department of Science and Technology; University Grants Commission	Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	This work was supported by the Department of Science and Technology, Govt. of India, (SKV); University Grants Commission, Govt. of India (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2018, MED SCI MONITOR, V24, P4121, DOI 10.12659/MSM.908056; Davoodian Parivash, 2017, Gastroenterol Hepatol Bed Bench, V10, P112; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Guo DG, 2016, ACTA BIOCH BIOPH SIN, V48, P840, DOI 10.1093/abbs/gmw068; Gupta P, 2018, HEPATOL RES, V48, P587, DOI 10.1111/hepr.13077; Jiang Joy X, 2013, Curr Pathobiol Rep, V1, P215; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lei ZW, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2017.09.019; Li HH, 2015, INT J ONCOL, V47, P1379, DOI 10.3892/ijo.2015.3144; Meng XM, 2015, ONCOTARGET, V6, P36984, DOI 10.18632/oncotarget.6100; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Nithyamathi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0136709; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Qu F, 2016, ONCOL LETT, V11, P1592, DOI 10.3892/ol.2015.4073; Song M, 2011, BIOCHEM BIOPH RES CO, V415, P152, DOI 10.1016/j.bbrc.2011.10.039; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Torok NJ, 2008, J GASTROENTEROL, V43, P315, DOI 10.1007/s00535-008-2181-x; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang Y, 2017, WORLD J GASTROENTERO, V23, P2330, DOI 10.3748/wjg.v23.i13.2330; You K, 2018, MOL THER-NUCL ACIDS, V12, P57, DOI 10.1016/j.omtn.2018.04.016; Zhiping C, 2017, EUR REV MED PHARMACO, V21, P4835	22	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0214534	10.1371/journal.pone.0214534	http://dx.doi.org/10.1371/journal.pone.0214534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166951	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800002
J	Kang, S; Park, J; Yu, YM; Park, MS; Han, E; Chang, MJ				Kang, Soyoung; Park, Jimin; Yu, Yun Mi; Park, Min Soo; Han, Euna; Chang, Min Jung			Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit	PLOS ONE			English	Article							PIPERACILLIN-TAZOBACTAM; ANTIBIOTIC-THERAPY; MORTALITY; RISK; SEPSIS; COSTS	Antibiotics induced acute kidney injury (AKI) risk in critically ill patients is not well known. This study aimed to evaluate the AKI development and clinical outcomes in critically ill adult patients treated with vancomycin (VAN) or combined with piperacillin-tazobactam (TZP) or meropenem (MEM). This was a retrospective study on critically ill adult patients who were given VAN, TZP or MEM and maintained for at least 48 h. The risk of AKI development and clinical outcomes were compared using the simple analysis and multivariate logistic regression. Three hundred forty patients were eligible. The incidence of any AKI was significantly higher in patients treated with VAN + TZP than those with VAN + MEM or VAN alone (52.7% vs. 27.7% vs. 25.7%; p <.0001). The adjusted odds of AKI increased 2.43-fold in VAN + TZP versus VAN, but not different in VAN + MEM versus VAN. However, AKI duration and recovery rate were not statistically different. In addition, all-cause death within 30 days after AKI onset was not significantly associated with antibiotic regimens. AKI incidence is higher in critically ill patients administered with VAN + TZP than those with VAN + MEM or VAN. However, no obvious evidence was found to prove that antibiotic-induced AKI leads to poor clinical outcomes.	[Kang, Soyoung; Yu, Yun Mi; Park, Min Soo; Han, Euna; Chang, Min Jung] Yonsei Univ, Coll Med, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea; [Kang, Soyoung; Yu, Yun Mi; Park, Min Soo; Han, Euna; Chang, Min Jung] Yonsei Univ, Coll Pharm, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea; [Park, Jimin; Yu, Yun Mi; Han, Euna; Chang, Min Jung] Yonsei Univ, Coll Pharm, Dept Pharm, Incheon, South Korea; [Park, Jimin; Yu, Yun Mi; Han, Euna; Chang, Min Jung] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Park, Min Soo] Yonsei Univ, Coll Med, Severance Hosp, Dept Clin Pharmacol, Seoul, South Korea; [Park, Min Soo] Yonsei Univ, Coll Med, Severance Hosp, Dept Pediat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, MJ (corresponding author), Yonsei Univ, Coll Med, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Coll Pharm, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Coll Pharm, Dept Pharm, Incheon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon, South Korea.	mjchang@yonsei.ac.kr		Park, Min Soo/0000-0002-4395-9938; Yu, Yun Mi/0000-0002-8267-9453; Chang, Min Jung/0000-0002-8408-5907; Han, Euna/0000-0003-2656-7059	National Research Foundation of Korea - Korea government (Ministry of Science, ICT & Future Planning) [2017R1C1B5016737]	National Research Foundation of Korea - Korea government (Ministry of Science, ICT & Future Planning)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (Ministry of Science, ICT & Future Planning) grant number 2017R1C1B5016737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodi A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0087-y; Al Yami MS, 2017, J INFECT PUBLIC HEAL, V10, P770, DOI 10.1016/j.jiph.2016.11.007; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Archer KJ, 2007, COMPUT STAT DATA AN, V51, P4450, DOI 10.1016/j.csda.2006.07.006; Baby N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02432-16, 10.1128/aac.02432-16]; Balci C, 2018, INT J ANTIMICROB AG, V52, P180, DOI 10.1016/j.ijantimicag.2018.03.024; Bamgbola O, 2016, THER ADV ENDOCRINOL, V7, P136, DOI 10.1177/2042018816638223; Bellomo R, 2017, INTENS CARE MED, V43, P816, DOI 10.1007/s00134-017-4755-7; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Elyasi S, 2012, EUR J CLIN PHARMACOL, V68, P1243, DOI 10.1007/s00228-012-1259-9; Gilbert DN, 2018, SANFORD GUIDE ANTIMI; Gomez H, 2016, CURR OPIN CRIT CARE, V22, P546, DOI 10.1097/MCC.0000000000000356; Hanrahan TP, 2014, CRIT CARE MED, V42, P2527, DOI 10.1097/CCM.0000000000000514; Jensen JUS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000635; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Kanic V, 2018, J NEPHROL, V31, P713, DOI 10.1007/s40620-018-0504-4; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Legrand M, 2013, CRIT CARE, V17, DOI 10.1186/cc13133; Luther MK, 2018, CRIT CARE MED, V46, P12, DOI 10.1097/CCM.0000000000002769; Luyckx VA, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10061; Makris Konstantinos, 2016, Clin Biochem Rev, V37, P85; Navalkele B, 2017, CLIN INFECT DIS, V64, P116, DOI 10.1093/cid/ciw709; Neugarten J, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0937-y; Neugarten J, 2016, CLIN J AM SOC NEPHRO, V11, P2113, DOI 10.2215/CJN.03340316; Robertson AD, 2018, PHARMACOTHERAPY, V38, P1184, DOI 10.1002/phar.2179; Rutter WC, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.00264-18, 10.1128/AAC.00264-18]; Sawhney S, 2017, AM J KIDNEY DIS, V69, P18, DOI 10.1053/j.ajkd.2016.05.018; Schreier DJ, 2018, CLIN INFECT DIS; Spapen HD, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-26; Thomas Z, 2015, CRIT CARE MED, V43, P2527, DOI 10.1097/CCM.0000000000001294; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wlodzimirow KA, 2012, CRIT CARE, V16, DOI 10.1186/cc11808	33	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217908	10.1371/journal.pone.0217908	http://dx.doi.org/10.1371/journal.pone.0217908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166993	Green Submitted, Green Published, gold			2022-12-27	WOS:000470087800050
J	Pillet, S; Couillard, J; Trepanier, S; Poulin, JF; Yassine-Diab, B; Guy, B; Ward, BJ; Landry, N				Pillet, Stephane; Couillard, Julie; Trepanier, Sonia; Poulin, Jean-Francois; Yassine-Diab, Bader; Guy, Bruno; Ward, Brian J.; Landry, Nathalie			Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >= 50 years old adults	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSES; CONFIRMED INFLUENZA; MEDIATED-IMMUNITY; ANTIBODY-RESPONSE; PROTECTION; HOSPITALIZATIONS; HEMAGGLUTININ; IMMUNIZATION; EFFICACY	Background New influenza vaccines eliciting more effective protection are needed, particularly for the elderly who paid a large and disproportional toll of hospitalization and dead during seasonal influenza epidemics. Low (<= 15 mu g/strain) doses of a new plant-derived virus-like-particle (VLP) vaccine candidate have been shown to induce humoral and cellular responses against both homologous and heterologous strains in healthy adults 18-64 years of age. The two clinical trials reported here addressed the safety and immunogenicity of higher doses (<= 15 mu g/strain) of quadrivalent VLP candidate vaccine on 18-49 years old and. 50 years old subjects. We also investigated the impact of alum on the immunogenicity induced by lower doses of the vaccine candidate. Method In the first Phase II trial reported here (NCT02233816), 18-49 year old subjects received 15, 30 or 60 mu g/strain of a hemagglutinin-bearing quadrivalent virus-like particle (QVLP) vaccine or placebo. In the second trial (NCT02236052),. 50 years old subjects received QVLP as above or placebo with additional groups receiving 7.5 or 15 mu g/strain with alum. Along with safety recording, the humoral and cell-mediated immune responses were analyzed. Results Local and systemic side-effects were similar to those reported previously. The QVLP vaccine induced significant homologous and heterologous antibody responses at the two higher doses, the addition of alum having little-to-no effect. Serologic outcomes tended to be lower in. 50 years old subjects previously vaccinated. The candidate vaccine also consistently elicited both homologous and heterologous antigen-specific CD4(+) T cells characterized by their production of interferon-gamma (IFN-gamma), interleukine-2 (IL-2) and/or tumor-necrosis factor alpha (TNF-alpha) upon ex vivo antigenic restimulation. Conclusion Overall, the 30 mu g dose produced the most consistent humoral and cellular responses in both 18-49 and. 50 years old subjects, strongly supporting the clinical development of this candidate vaccine. That particular dose was chosen to test in the ongoing Phase III clinical trial.	[Pillet, Stephane; Couillard, Julie; Trepanier, Sonia; Ward, Brian J.; Landry, Nathalie] Medicago Inc, Quebec City, PQ, Canada; [Pillet, Stephane; Ward, Brian J.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Poulin, Jean-Francois; Yassine-Diab, Bader] Caprion Biosci Inc, Montreal, PQ, Canada	McGill University	Landry, N (corresponding author), Medicago Inc, Quebec City, PQ, Canada.	landryn@medicago.com		landry, Nathalie/0000-0003-3500-0484	Canadian Institutes of Health Research; Ministere de l'Economie, de la Science et de l'Innovation du Quebec; Medicago Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economie, de la Science et de l'Innovation du Quebec; Medicago Inc.	This work was supported in part by awards to BJW and SP from Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Ministere de l'Economie, de la Science et de l'Innovation du Quebec (https://www.economie.gouv.qc.ca/accueil/), and by Medicago Inc. Additionally, Medicago Inc. provided support for this study in the form of salaries for NL, JC, and SP. Caprion Biosciences Inc. also provided support for this study in the form of salaries for JFP and BYD. BG has received honoraria from Medicago Inc. The specific roles of these authors are articulated in the 'author contributions' section. As well, Medicago Inc. designed the protocols of the two clinical trials reported in this paper, decided to publish the results, and was involved in the preparation of the manuscript.	Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Beyer WEP, 2011, VACCINE, V29, P5785, DOI 10.1016/j.vaccine.2011.05.040; Chaves SS, 2013, J INFECT DIS, V208, P1305, DOI 10.1093/infdis/jit316; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; CPMP CfPMP, 1997, CPMPBWP21496 CPMP CF; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Des Roches A, 2015, J ALLER CL IMM-PRACT, V3, P138, DOI 10.1016/j.jaip.2014.08.008; Des Roches A, 2012, J ALLERGY CLIN IMMUN, V130, P1213, DOI 10.1016/j.jaci.2012.07.046; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Dunkle LM, 2017, NEW ENGL J MED, V376, P2427, DOI [10.1056/NEJMoa1608862, 10.1056/nejmoa1608862]; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Frasca D, 2016, BIOGERONTOLOGY, V17, P7, DOI 10.1007/s10522-015-9578-8; Fry AM, 2014, CLIN INFECT DIS, V59, P406, DOI 10.1093/cid/ciu328; GOLDING B, 1995, ANN NY ACAD SCI, V754, P126, DOI 10.1111/j.1749-6632.1995.tb44445.x; GOMES AC, 2017, VACCINES, V5; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Haq K, 2014, IMMUNOL LETT, V162, P323, DOI 10.1016/j.imlet.2014.06.009; Hayward AC, 2015, AM J RESP CRIT CARE, V191, P1422, DOI 10.1164/rccm.201411-1988OC; Hendin HE, 2017, VACCINE, V35, P2592, DOI 10.1016/j.vaccine.2017.03.058; Hodgins B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00273-17; Hopping AM, 2016, VACCINE, V34, P540, DOI 10.1016/j.vaccine.2015.11.058; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Hufford MM, 2015, CURR TOP MICROBIOL, V386, P423, DOI 10.1007/82_2014_397; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Kovacs EJ, 2017, CLIN GERIATR MED, V33, P459, DOI 10.1016/j.cger.2017.06.002; Landry N, 2014, CLIN IMMUNOL, V154, P164, DOI 10.1016/j.clim.2014.08.003; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Lin JP, 2010, VACCINE, V28, P5669, DOI 10.1016/j.vaccine.2010.06.053; Lindsay BJ, 2018, VACCINE; Makarkov AI, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0111-y; Makarkov AI, 2017, VACCINE, V35, P4629, DOI 10.1016/j.vaccine.2017.07.012; McElhaney JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00041; McElhaney JE, 2012, VACCINE, V30, P2060, DOI 10.1016/j.vaccine.2012.01.015; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; McKinstry KK, 2013, ARCH IMMUNOL THER EX, V61, P341, DOI 10.1007/s00005-013-0236-z; Mohn KGI, 2015, J INFECT DIS, V211, P1541, DOI 10.1093/infdis/jiu654; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Overgaard NH, 2017, VACCINE, V35, P5629, DOI 10.1016/j.vaccine.2017.08.057; Pillet S, 2015, VACCINE, V33, P6282, DOI 10.1016/j.vaccine.2015.09.065; Pillet S, 2016, CLIN IMMUNOL, V168, P72, DOI 10.1016/j.clim.2016.03.008; Pillet S, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-017-0043-3; Pinti M, 2016, EUR J IMMUNOL, V46, P2286, DOI 10.1002/eji.201546178; Potter CW, 2003, VACCINE, V21, P940, DOI 10.1016/S0264-410X(02)00544-3; Raymond DD, 2016, NAT MED, V22, P1465, DOI 10.1038/nm.4223; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Subbramanian RA, 2010, VACCINE, V28, P8258, DOI 10.1016/j.vaccine.2010.10.077; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Trombetta CM, 2016, EXPERT REV VACCINES, V15, P967, DOI 10.1586/14760584.2016.1164046; Tsang P, 2014, VACCINE, V32, P2507, DOI 10.1016/j.vaccine.2013.09.074; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028063; Wang JM, 2016, J AM PHARM ASSOC, V56, P95, DOI 10.1016/j.japh.2015.12.001; Ward BJ, 2018, HUM VACC IMMUNOTHER, V14, P647, DOI 10.1080/21645515.2017.1413518; Ward BJ, 2014, VACCINE, V32, P6098, DOI [10.1016/j.vaccine.2014.08.079, 10.10]; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Weinberger B, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-017-0107-2; WHO, MAN AN INFL DIAGN SU; Wilkins AL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01760; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Young KR, 2015, FASEB J, V29, P3817, DOI 10.1096/fj.15-270421; Zens KD, 2015, CURR TOP MICROBIOL, V386, P399, DOI 10.1007/82_2014_401; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	68	64	66	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216533	10.1371/journal.pone.0216533	http://dx.doi.org/10.1371/journal.pone.0216533			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166987	Green Published, gold			2022-12-27	WOS:000470087800011
J	Gebeyehu, E; Nigatu, D; Engidawork, E				Gebeyehu, Endalew; Nigatu, Desalegn; Engidawork, Ephrem			Helicobacter pylori eradication rate of standard triple therapy and factors affecting eradication rate at Bahir Dar city administration, Northwest Ethiopia: A prospective follow up study	PLOS ONE			English	Article							ADULT DYSPEPTIC PATIENTS; TREATMENT FAILURE; INFECTION; CLARITHROMYCIN; AMOXICILLIN; OMEPRAZOLE; MANAGEMENT; 1ST-LINE; EFFICACY; DISEASES	Background Eradication of Helicobacter pylori infection with standard triple therapy has been accepted to curb associated risks of chronic gastritis andpeptic ulcer disease. Objective To assess H. pylori eradication rate of standard triple therapy and patient related factors affecting eradication rate. Methods A facility based prospective follow up study was conducted in Bahir Dar City Administration, Ethiopia, on consented outpatients presented with gastritis and peptic ulcer disease and positive for H. pylori stool antigen test from May 2016 to April 2018. Eradication was confirmed with stool antigen test made after 4-6 weeks of standard triple therapy, comprising of proton pump inhibitor, clarithromycin and amoxicillin. Pre-developed questionnaire and data collection formats were used to collect variables before and after therapy. Bivariate and backward stepwise multivariate logistic regression was used to analyze data. P-value < 0.05 at 95% CI was considered as significant. Results The overall H. pylori eradication rate was 90.3% (379/421). Almost 80% of the patients were urban residents. Mean (+/- SD) age and body weight of patients were 30.63 (+/- 10.74) years and 56.79 (+/- 10.17) kg, respectively. Self-reported adverse drug effects and area of residence of patients were factors affecting eradication rate significantly. Patients with no self-reported adverse drug effect were 3.85 (AOR: 3.85; 95% CI (1.41-5.26)) times more likely to eradicate H. pylori infection compared to those reported adverse effects. Patients living in rural area were 2.7 (AOR: 2.7; 95% CI (1.19-20.0)) times more likely to achieve eradication compared to urban residents. Conclusion H. pylori eradication rate is within the recommended level for clinical practice, indicating that modifications of the standard triple therapy observed in the different healthcare institutions are not evidence-based. Emphasis should be given to adverse drug effects of medications and tailored counseling based on area of residence could have a contribution in improving eradication rate.	[Gebeyehu, Endalew; Engidawork, Ephrem] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia; [Gebeyehu, Endalew; Engidawork, Ephrem] Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Nigatu, Desalegn] Addis Ababa Univ, Coll Med & Hlth Sci, Dept Internal Med, Addis Ababa, Ethiopia	Bahir Dar University; Addis Ababa University; Addis Ababa University	Engidawork, E (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia.; Engidawork, E (corresponding author), Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	ephrem.engidawork@aau.edu.et	Engidawork, Ephrem/K-7551-2019	Engidawork, Ephrem/0000-0002-9931-6421	Addis Ababa University; Bahir Dar University	Addis Ababa University; Bahir Dar University	The authors would like to acknowledge Addis Ababa University and Bahir Dar University for funding this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi M, 2008, OBES SURG, V18, P1450, DOI 10.1007/s11695-008-9477-z; Alebie G, 2016, J BACTERIOL MYCOL, V3; [Anonymous], 2014, AUSTIN J NUTR FOOD S; Asrat D, 2004, ETHIOPIAN MED J, V42, P79; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Cho Dong Keun, 2010, Korean J Gastroenterol, V55, P368, DOI 201006254; De Francesco V, 2010, J GASTROINTESTINAL L, V19; Erramouspe J, 2002, J RURAL HEALTH, V18, P311, DOI 10.1111/j.1748-0361.2002.tb00893.x; Figer B, 2017, INDIAN J PHARM SCI, V79, P724, DOI 10.4172/pharmaceutical-sciences.1000285; FOCK KM, ALIMENTARY PHARM THE, V14, P225; Ganorkar P, 2013, INT FOOD RES J, V20; Ghosal N, 2016, J PHARM RES, V10, P351; Gisbert JP, 1996, REV ESP ENFERM DIG, V88, P317; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goyal A, 2014, J FOOD SCI TECH MYS, V51, P1633, DOI 10.1007/s13197-013-1247-9; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; GRAHAM DY, 1992, GASTROENTEROLOGY, V102, P493, DOI 10.1016/0016-5085(92)90095-G; Guo Yue, 2016, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V41, P757, DOI 10.11817/j.issn.1672-7347.2016.07.016; Hori K, 2017, CURR DRUG SAF, V12, P103, DOI 10.2174/1574886312666170310100209; Hsu PI, 2005, AM J GASTROENTEROL, V100, P2387, DOI 10.1111/j.1572-0241.2005.00264.x; Kabakambira JD, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0863-2; Kibru D, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0656-3; Lee JY, 2014, DIGEST DIS SCI, V59, P1235, DOI 10.1007/s10620-014-3093-7; Liu RP, 2018, SOUTH MED J, V111, P51, DOI 10.14423/SMJ.0000000000000747; Makristathis A, 1998, J CLIN MICROBIOL, V36, P2772, DOI 10.1128/JCM.36.9.2772-2774.1998; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Mekonnen Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184665; Moayyedi P, 1997, J GASTROENTEROL, V32, P24, DOI 10.1007/BF01213292; O'Connor John P Anthony, 2009, Therap Adv Gastroenterol, V2, P273, DOI 10.1177/1756283X09337342; Pai MP, 2007, PHARMACOTHERAPY, V27, P1081, DOI 10.1592/phco.27.8.1081; Prasertpetmanee S, 2013, HELICOBACTER, V18, P270, DOI 10.1111/hel.12041; Queiroz DMM, 2002, J CLIN GASTROENTEROL, V35, P315, DOI 10.1097/00004836-200210000-00007; Ramas M, 2017, GASTROENT HEPAT-BARC, V40, P658, DOI 10.1016/j.gastrohep.2017.05.017; Shakya Shrestha S, 2016, Kathmandu Univ Med J (KUMJ), V14, P58; Shimoyama T, 2013, WORLD J GASTROENTERO, V19, P8188, DOI 10.3748/wjg.v19.i45.8188; Silva F M, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P11; Singh Namrata, 2008, Trop Gastroenterol, V29, P26; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun WH, 2005, WORLD J GASTROENTERO, V11, P2477, DOI 10.3748/wjg.v11.i16.2477; Suzuki T, 2006, AM J MED, V119, P217, DOI 10.1016/j.amjmed.2005.10.003; Tsai CE, 2016, KAOHSIUNG J MED SCI, V32, P397, DOI 10.1016/j.kjms.2016.05.012; Vaira D, 1999, LANCET, V354, P30, DOI 10.1016/S0140-6736(98)08103-3; Wang B, 2014, WORLD J GASTROENTERO, V20, P14973, DOI 10.3748/wjg.v20.i40.14973; Xin YQ, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0491-7; Yoon JH, 2012, WORLD J GASTROENTERO, V18, P6628, DOI 10.3748/wjg.v18.i45.6628	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217645	10.1371/journal.pone.0217645	http://dx.doi.org/10.1371/journal.pone.0217645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163069	Green Submitted, Green Published, gold			2022-12-27	WOS:000470086200026
J	Jiwaji, M; Matcher, GF; de Bruyn, MM; Awando, JA; Moodley, H; Waterworth, D; Jarvie, RA; Dorrington, RA				Jiwaji, Meesbah; Matcher, Gwynneth Felicity; de Bruyn, Mart-Mari; Awando, Janet Awino; Moodley, Holisha; Waterworth, Dylan; Jarvie, Rachel Anne; Dorrington, Rosemary Ann			Providence virus: An animal virus that replicates in plants or a plant virus that infects and replicates in animal cells?	PLOS ONE			English	Article							NODAMURA VIRUS; RNA; INSECT; LARVAE	Introduction Emerging viral diseases, most of which are zoonotic, pose a significant threat to global health. There is a critical need to identify potential new viral pathogens and the challenge is to identify the reservoirs from which these viruses might emerge. Deep sequencing of invertebrate transcriptomes has revealed a plethora of viruses, many of which represent novel lineages representing both plant and animal viruses and little is known about the potential threat that these viruses pose. Methods Providence virus, an insect virus, was used to establish a productive infection in Vigna unguiculata (cowpea) plants. Providence virus particles purified from these cowpea plants were used to infect two mammalian cell lines. Findings Here, we present evidence that Providence virus, a non-enveloped insect RNA virus, isolated from a lepidopteran midgut cell line can establish a productive infection in plants as well as in animal cells. The observation that Providence virus can readily infect both plants and mammalian cell culture lines demonstrates the ability of an insect RNA virus to establish productive infections across two kingdoms, in plants and invertebrate and vertebrate animal cell lines. Conclusions The study highlights the potential of phytophagous insects as reservoirs for viral re-assortment and that plants should be considered as reservoirs for emerging viruses that may be potentially pathogenic to humans.	[Jiwaji, Meesbah; Matcher, Gwynneth Felicity; de Bruyn, Mart-Mari; Awando, Janet Awino; Moodley, Holisha; Waterworth, Dylan; Jarvie, Rachel Anne; Dorrington, Rosemary Ann] Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa	Rhodes University	Jiwaji, M (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa.	meesbahjiwaji@gmail.com			Rhodes University Research Committee Research Grant; NRF Emerging Researcher Fellowship [GUN 91468]; TWOS scholarship; NRF Scarce Skills Fellowship	Rhodes University Research Committee Research Grant; NRF Emerging Researcher Fellowship; TWOS scholarship; NRF Scarce Skills Fellowship	This research was supported by a Rhodes University Research Committee Research Grant. MJ was supported by an NRF Emerging Researcher Fellowship (GUN 91468), Janet Awino Awando by a TWOS scholarship and Holisha Moodley by an NRF Scarce Skills Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY L, 1975, J GEN VIROL, V26, P15, DOI 10.1099/0022-1317-26-1-15; Balique F, 2012, J CLIN VIROL, V55, P374, DOI 10.1016/j.jcv.2012.08.012; BALL LA, 1992, J VIROL, V66, P2326, DOI 10.1128/JVI.66.4.2326-2334.1992; Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114; Christian PD, 2001, BIOL CONTROL, V20, P65, DOI 10.1006/bcon.2000.0887; Colson P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010041; Dong XF, 1998, J VIROL, V72, P6024, DOI 10.1128/JVI.72.7.6024-6033.1998; Dorrington R. A., 2011, VIRUS TAXONOMY, P1091; Fan XX, 2015, BIOCHEM BIOPH RES CO, V460, P1035, DOI 10.1016/j.bbrc.2015.03.145; GARZON S, 1990, ARCH VIROL, V113, P165, DOI 10.1007/BF01316670; HANZLIK TN, 1993, J GEN VIROL, V74, P1805, DOI 10.1099/0022-1317-74-9-1805; Jiwaji M, 2016, J GEN VIROL, V97, P2763, DOI 10.1099/jgv.0.000578; Kemenesi G, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00403-16; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Poreddy S, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1149-5; Price BD, 1996, P NATL ACAD SCI USA, V93, P9465, DOI 10.1073/pnas.93.18.9465; Pringle FM, 2003, VIROLOGY, V306, P359, DOI 10.1016/S0042-6822(02)00052-1; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; SCHERER WF, 1968, AM J TROP MED HYG, V17, P120, DOI 10.4269/ajtmh.1968.17.120; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Short JR, 2013, J GEN VIROL, V94, P1073, DOI 10.1099/vir.0.047647-0; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Stork J, 2011, VIROLOGY, V409, P338, DOI 10.1016/j.virol.2010.10.015; TESH RB, 1980, J GEN VIROL, V48, P177, DOI 10.1099/0022-1317-48-1-177; Walter CT, 2010, J GEN VIROL, V91, P2826, DOI 10.1099/vir.0.023796-0; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7	27	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217494	10.1371/journal.pone.0217494	http://dx.doi.org/10.1371/journal.pone.0217494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163039	Green Published, gold, Green Submitted			2022-12-27	WOS:000470086200014
J	Forster, SD; Drueke, B; Britz, S; Gauggel, S; Mainz, V				Forster, Saskia Doreen; Drueke, Barbara; Britz, Sara; Gauggel, Siegfried; Mainz, Verena			How females think about themselves and how they assume that significant others think about them: The influence of perspective taking on self-referential processing	PLOS ONE			English	Article							EFFECT SIZE; ENHANCEMENT; ESTEEM; KNOWLEDGE; PEOPLE; MEMORY; PERSONALITY; STATISTICS; APPRAISALS; POSITIVITY	People maintain a positive self-concept through positive self-appraisals (Self-Serving Bias Effect, SSBE) and a diminished memory for self-threatening information (Mnemic-Neglect Effect, MNE). Other people also influence a person's self-concept. This study investigated SSBE and MNE in 60 females by using a trait-judgment paradigm applying two perspectives (self-and third-person appraisals) and a recall task. Additionally, self-esteem was assessed as an associated factor. SSBE and MNE were found in both kinds of appraisal perspectives. Interestingly, participants saw themselves as even more positive in reflected appraisals. SSBE and self-esteem were associated only in self-appraisals, indicating a larger SSBE on self-appraisals with raising self-esteem. In conclusion, both what females think about themselves and how they assume that others think about them preserve their overall positive self-concept.	[Forster, Saskia Doreen; Drueke, Barbara; Britz, Sara; Gauggel, Siegfried; Mainz, Verena] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Psychol & Med Sociol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Forster, SD (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Inst Med Psychol & Med Sociol, Aachen, Germany.	sforster@ukaachen.de		Forster, Saskia/0000-0002-7847-3700				Alexopoulos T, 2012, EUR J SOC PSYCHOL, V42, P770, DOI 10.1002/ejsp.1882; Alicke MD, 2009, EUR REV SOC PSYCHOL, V20, P1, DOI 10.1080/10463280802613866; ALICKE MD, 1985, J PERS SOC PSYCHOL, V49, P1621, DOI 10.1037/0022-3514.49.6.1621; [Anonymous], R LANG ENV STAT COMP; Asencio EK, 2013, SOC PSYCHOL QUART, V76, P291, DOI 10.1177/0190272513504222; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baumeister R. F., 1999, PERSONALITY CONT THE, P339; Bleidorn W, 2016, J PERS SOC PSYCHOL, V111, P396, DOI 10.1037/pspp0000078; Bora E, 2016, J AFFECT DISORDERS, V191, P49, DOI 10.1016/j.jad.2015.11.023; Britz S, 2019, J PSYCHOLINGUIST RES, V48, P1111, DOI 10.1007/s10936-019-09649-8; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P358, DOI 10.1177/0146167202286007; Carlson EN, 2011, J PERS SOC PSYCHOL, V101, P831, DOI 10.1037/a0024297; Cunningham SJ, 2008, CONSCIOUS COGN, V17, P312, DOI 10.1016/j.concog.2007.04.003; D'Argembeau A, 2005, BRIT J PSYCHOL, V96, P457, DOI 10.1348/000712605X53218; D'Argembeau A, 2008, MEMORY, V16, P538, DOI 10.1080/09658210802010463; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Diependaele K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00348; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Duval TS, 2002, J PERS SOC PSYCHOL, V82, P49, DOI 10.1037//0022-3514.82.1.49; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Forsyth D. R., 2008, INT ENCYCL SOC SCI, P429; Gallrein AMB, 2016, J RES PERS, V60, P1, DOI 10.1016/j.jrp.2015.10.002; Gallrein AMB, 2013, J RES PERS, V47, P464, DOI 10.1016/j.jrp.2013.04.001; HIXON JG, 1993, J PERS SOC PSYCHOL, V64, P35, DOI 10.1037/0022-3514.64.1.35; Hoyle R. H., 1999, SOCIAL PSYCHOL SERIE; Leising D, 2010, J PERS SOC PSYCHOL, V98, P668, DOI 10.1037/a0018771; Lepot M, 2017, WATER-SUI, V9, DOI 10.3390/w9100796; Li SF, 2016, NEUROREPORT, V27, P694, DOI 10.1097/WNR.0000000000000599; Luber B, 2012, EXP BRAIN RES, V223, P177, DOI 10.1007/s00221-012-3249-7; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Morrison AB, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00006; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Newman LS, 2014, SOC PSYCHOL-GERMANY, V45, P93, DOI 10.1027/1864-9335/a000164; O'Brien E, 2013, J GERONTOL B-PSYCHOL, V68, P168, DOI 10.1093/geronb/gbs055; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Orth U, 2013, CURR DIR PSYCHOL SCI, V22, P455, DOI 10.1177/0963721413492763; Rasch B, 2010, QUANTITATIVE METHODE, V2, P1; Ritter K, 2011, PSYCHIAT RES, V187, P241, DOI 10.1016/j.psychres.2010.09.013; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; ROSENBERG M, 1973, AM BEHAV SCI, V16, P829, DOI 10.1177/000276427301600603; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; Sedikides C., 2012, OXFORD HDB HUMAN MOT, P303, DOI DOI 10.1093/OXFORDHB/9780195399820.013.0017; Sedikides C, 2016, EUR REV SOC PSYCHOL, V27, P1, DOI 10.1080/10463283.2016.1183913; Sedikides C, 2009, SOC PERSONAL PSYCHOL, V3, P1055, DOI 10.1111/j.1751-9004.2009.00220.x; Serpe RT, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P225, DOI 10.1007/978-1-4419-7988-9_10; Shiota S, 2017, PSYCHOL MED, V47, P877, DOI 10.1017/S0033291716002956; Soler MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01172; Sui J, 2017, TRENDS NEUROSCI, V40, P643, DOI 10.1016/j.tins.2017.09.002; SWANN WB, 1989, J PERS SOC PSYCHOL, V57, P782, DOI 10.1037/0022-3514.57.5.782; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Todd AR, 2016, J EXP PSYCHOL GEN, V145, P1583, DOI 10.1037/xge0000237; Vazire S, 2010, SOC PERSONAL PSYCHOL, V4, P605, DOI 10.1111/j.1751-9004.2010.00280.x; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908; von Collani G., 2003, Z F R DIFFERENTIELLE, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Wade GL, 2017, ATTEN PERCEPT PSYCHO, V79, P1524, DOI 10.3758/s13414-017-1307-8; Walker WR, 2003, REV GEN PSYCHOL, V7, P203, DOI 10.1037/1089-2680.7.2.203; Watson LA, 2007, BRAIN RES, V1152, P106, DOI 10.1016/j.brainres.2007.03.049; Wolkenstein L, 2011, J AFFECT DISORDERS, V132, P104, DOI 10.1016/j.jad.2011.02.010; Wood D, 2016, PERS SOC PSYCHOL REV, V20, P79, DOI 10.1177/1088868315581119	62	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217870	10.1371/journal.pone.0217870	http://dx.doi.org/10.1371/journal.pone.0217870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150506	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100122
J	Halamek, J; Leinveber, P; Viscor, I; Smisek, R; Plesinger, F; Vondra, V; Lipoldova, J; Matejkova, M; Jurak, P				Halamek, Josef; Leinveber, Pavel; Viscor, Ivo; Smisek, Radovan; Plesinger, Filip; Vondra, Vlastimil; Lipoldova, Jolene; Matejkova, Magdalena; Jurak, Pavel			The relationship between ECG predictors of cardiac resynchronization therapy benefit	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; QRS DURATION; AREA; CRT	Introduction Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. Methods & results SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects-295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. Conclusion SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too " strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.	[Halamek, Josef; Viscor, Ivo; Smisek, Radovan; Plesinger, Filip; Vondra, Vlastimil; Jurak, Pavel] Czech Acad Sci, Inst Sci Instruments, Brno, Czech Republic; [Leinveber, Pavel; Lipoldova, Jolene; Matejkova, Magdalena] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC)	Halamek, J (corresponding author), Czech Acad Sci, Inst Sci Instruments, Brno, Czech Republic.	josef@isibrno.cz	Plešinger, Filip/G-1449-2014; Matejkova, Magdalena/AAI-7788-2021; Viscor, Ivo/D-3904-2012; Smíšek, Radovan/F-5329-2017; Jurak, Pavel/AAO-3084-2020; Leinveber, Pavel/I-3347-2016; Halamek, Josef/D-5110-2012; Vondra, Vlastimil/D-8086-2013	Plešinger, Filip/0000-0003-2875-3541; Matejkova, Magdalena/0000-0002-9268-7975; Viscor, Ivo/0000-0002-4298-3610; Smíšek, Radovan/0000-0003-0413-3604; Jurak, Pavel/0000-0002-3793-5075; Leinveber, Pavel/0000-0001-7267-4408; Halamek, Josef/0000-0001-8986-796X; Vondra, Vlastimil/0000-0002-5391-0919	Czech Science Foundation [GA17-13830S]; Ministry of Education, Youth and Sports of the Czech Republic [LO1212, LQ1605]; CAS project [RVO: 68081731]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CAS project(Chinese Academy of Sciences)	The research was supported by Czech Science Foundation, project GA17-13830S and by Ministry of Education, Youth and Sports of the Czech Republic, project LO1212 and LQ1605 and the CAS project RVO: 68081731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KP, 2018, J INTERV CARD ELECTR, V52, P353, DOI 10.1007/s10840-018-0426-z; Arrhythmia C, 2018, NORMALIZATION QRS DU, DOI [10.1161/CIRCEP.118.006767, DOI 10.1161/CIRCEP.118.006767]; Auricchio A, 2014, CONTROVERSIES ARRHYT, P532; Bertaglia E, 2017, PACE, V40, P850, DOI 10.1111/pace.13104; Birgersdotter U, 2018, EFFECT INTERVENTRICU, P1, DOI [10.1161/CIRCEP.117, DOI 10.1161/CIRCEP.117]; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Caputo ML, 2018, INT J CARDIOL, V269, P165, DOI 10.1016/j.ijcard.2018.07.060; Carita P, 2016, INT J CARDIOL, V225, P402, DOI 10.1016/j.ijcard.2016.09.037; Coppola G, 2016, INT J CARDIOL, V221, P450, DOI 10.1016/j.ijcard.2016.06.203; De Pooter J, 2017, J CARDIOVASC ELECTR, V28, P192, DOI 10.1111/jce.13132; Engels EB, 2016, J CARDIOVASC TRANSL, V9, P257, DOI 10.1007/s12265-016-9693-1; Gold MR, 2017, HEART RHYTHM, V14, P1748, DOI 10.1016/j.hrthm.2017.10.016; Gold MR, RATIONALE DESIGN SMA, DOI [10.1111/pace.13459, DOI 10.1111/PACE.13459]; Hussein AA, 2019, YEAR REV CARDIAC ELE, P1, DOI [10.1161/CIRCEP.118.007142, DOI 10.1161/CIRCEP.118.007142]; Jurak P, 2017, J INTERV CARD ELECTR, V49, P245, DOI 10.1007/s10840-017-0268-0; Maass AH, 2018, REFINING SUCCESS CAR, P1, DOI [10.1093/europace/euw445, DOI 10.1093/EUROPACE/EUW445]; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Niederer SA, 2018, INT J CARDIOL, V270, P183, DOI 10.1016/j.ijcard.2018.06.079; Padeletti L, ELECTROCARDIOGRAPHIC, DOI [10.1111/j.1540-8159.2012.03427.x, DOI 10.1111/J.1540-8159.2012.03427.X]; Plesinger F, 2016, PHYSIOL MEAS, V37, pN38, DOI 10.1088/0967-3334/37/7/N38; Plesinger F, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005719; Smisek R, 2019, IFMBE PROC, V68, P435, DOI 10.1007/978-981-10-9038-7_82; Spinale FG, 2019, HEART RHYTHM, V16, P743, DOI 10.1016/j.hrthm.2018.11.026; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Strik M, 2018, INT J CARDIOL, V270, P143, DOI 10.1016/j.ijcard.2018.06.005; Nguyen UC, 2018, J ELECTROCARDIOL, V51, P457, DOI 10.1016/j.jelectrocard.2018.01.009; van Deursen CJM, 2015, J ELECTROCARDIOL, V48, P45, DOI 10.1016/j.jelectrocard.2014.10.003; van Stipdonk AMW, 2019, INT J CARDIOL, V286, P61, DOI 10.1016/j.ijcard.2019.01.051; Vozda M, 2015, BIOMED SIGNAL PROCES, V19, P23, DOI 10.1016/j.bspc.2015.03.001; Zusterzeel R, 2018, J ELECTROCARDIOL, V51, pS25, DOI 10.1016/j.jelectrocard.2018.08.001	30	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217097	10.1371/journal.pone.0217097	http://dx.doi.org/10.1371/journal.pone.0217097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150418	Green Published, gold			2022-12-27	WOS:000469759100031
J	Hanscombe, KB; Coleman, JRI; Traylor, M; Lewis, CM				Hanscombe, Ken B.; Coleman, Jonathan R., I; Traylor, Matthew; Lewis, Cathryn M.			ukbtools: An R package to manage and query UK Biobank data	PLOS ONE			English	Article								Introduction The UK Biobank (UKB) is a resource that includes detailed health-related data on about 500,000 individuals and is available to the research community. However, several obstacles limit immediate analysis of the data: data files vary in format, may be very large, and have numerical codes for column names. Results ukbtools removes all the upfront data wrangling required to get a single dataset for statistical analysis. All associated data files are merged into a single dataset with descriptive column names. The package also provides tools to assist in quality control by exploring the primary demographics of subsets of participants; query of disease diagnoses for one or more individuals, and estimating disease frequency relative to a reference variable; and to retrieve genetic metadata. Conclusion Having a dataset with meaningful variable names, a set of UKB-specific exploratory data analysis tools, disease query functions, and a set of helper functions to explore and write genetic metadata to file, will rapidly enable UKB users to undertake their research.	[Hanscombe, Ken B.; Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England; [Coleman, Jonathan R., I; Lewis, Cathryn M.] Kings Coll London, Social Genet & Dev Psychiat Ctr, London, England; [Traylor, Matthew] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of London; King's College London; University of London; King's College London; University of Cambridge	Hanscombe, KB (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	ken.b.hanscombe@kcl.ac.uk	Coleman, Jonathan/T-9412-2019; Lewis, Cathryn M/A-5225-2010	Coleman, Jonathan/0000-0002-6759-0944; Lewis, Cathryn M/0000-0002-8249-8476; , Ken/0000-0002-3715-6805	National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Guy's and St Thomas' NHS Foundation and King's College London; NIHR BRC at South London and Maudsley NHS Foundation Trust and King's College London	National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Guy's and St Thomas' NHS Foundation and King's College London; NIHR BRC at South London and Maudsley NHS Foundation Trust and King's College London	This work was supported by the National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Guy's and St Thomas' NHS Foundation and King's College London and by the NIHR BRC at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8	3	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0214311	10.1371/journal.pone.0214311	http://dx.doi.org/10.1371/journal.pone.0214311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150407	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100010
J	Kang, TK; Ha, R; Oh, JH; Sunwoo, W				Kang, Tae Kyu; Ha, Ryun; Oh, Jae Hwan; Sunwoo, Woongsang			The potential protective effects of temporal bone pneumatization: A shock absorber in temporal bone fracture	PLOS ONE			English	Article							SECRETORY OTITIS-MEDIA; MASTOID PNEUMATIZATION; CLINICAL CHARACTERISTICS; CLASSIFICATION; ADULTS; MANAGEMENT; SINUS	Objectives We hypothesize that when temporal bone fractures occur, the pneumatic cells in the temporal bone are able to absorb most of the impact force during a traumatic event. This study aims to correlate the degree of pneumatization of the temporal bone with the severity of temporal bone fracture (TBF). Methods Charts and computed tomography scans representing 54 TBFs, diagnosed from 2012 to 2017 at a single tertiary hospital, were retrospectively reviewed. Temporal bone pneumatization (TBP) in the petrous apex and mastoid region was evaluated using previously published classification systems. TBP classifications and fracture types were correlated with TBF complications such as sensorineural hearing loss (SNHL), facial nerve palsy (FNP), and vestibular dysfunction. Results Patients with increased pneumatization of the temporal bone had significantly fewer and less severe SNHL. SNHL more strongly correlated with the degree of pneumatization in the mastoid (P = 0.005) than that in the petrous apex (P = 0.024). On the other hand, the degree of TBP correlated poorly with FNP and vestibular dysfunction. However, the mastoid hypop-neumatization demonstrated significant correlation with otic-capsule violations (P = 0.002). Fractures with otic-capsule violation were 4 times more likely to have vestibular dysfunction (P = 0.043) and 3 times more likely to have SNHL (P = 0.006). FNP was not associated with otic-capsule violating fractures but was 3.5 times more common in comminuted fractures (P = 0.025). Conclusions The degree of temporal bone pneumatization was negatively correlated to the incidence of otic-capsule violation and the severity of hearing impairment in patients with temporal bone fracture. This study substantiated the potential protective effect of temporal bone pneumatization in TBFs.	[Kang, Tae Kyu; Ha, Ryun; Oh, Jae Hwan; Sunwoo, Woongsang] Gachon Univ, Gil Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea	Gachon University	Sunwoo, W (corresponding author), Gachon Univ, Gil Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea.	sunwoo@gilhospital.com						Alvi A, 1998, OTOLARYNG HEAD NECK, V119, P609, DOI 10.1016/S0194-5998(98)70020-8; Asha'ari ZA, 2012, AURIS NASUS LARYNX, V39, P151, DOI 10.1016/j.anl.2011.02.010; Choi HG, 2015, OTOL NEUROTOL, V36, P1048, DOI 10.1097/MAO.0000000000000662; Cinamon T, 2003, OTOL NEUROTOL, V24, P839, DOI 10.1097/00129492-200311000-00002; Doyle WJ, 2003, OTOLARYNG HEAD NECK, V128, P732, DOI 10.1016/S0194-5998(02)23309-4; Han SJ, 2007, CLIN RADIOL, V62, P1110, DOI 10.1016/j.crad.2007.04.019; HERGILS L, 1990, ACTA OTO-LARYNGOL, V110, P92, DOI 10.3109/00016489009122520; Hill CA, 2008, J HUM EVOL, V55, P682, DOI 10.1016/j.jhevol.2008.03.010; Hill CA, 2011, ANAT REC, V294, P1103, DOI 10.1002/ar.21404; HOHMANN A, 1963, ARCHIV OTOLARYNGOL, V78, P578; Ilea A, 2014, AM J NEURORADIOL, V35, P1398, DOI 10.3174/ajnr.A3887; Ilea A, 2019, EUR ARCH OTO-RHINO-L, V276, P513, DOI 10.1007/s00405-018-5227-6; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Jadhav AB, 2014, OR SURG OR MED OR PA, V117, P376, DOI 10.1016/j.oooo.2013.12.398; Johnson F, 2008, OTOLARYNG CLIN N AM, V41, P597, DOI 10.1016/j.otc.2008.01.006; Kim MB, 2017, J INT ADV OTOL, V13, P374, DOI 10.5152/iao.2017.3424; Lee PH, 2018, J CRANIOFAC SURG, V29, P1842, DOI 10.1097/SCS.0000000000004641; Little SC, 2006, ARCH OTOLARYNGOL, V132, P1300, DOI 10.1001/archotol.132.12.1300; Ljiljana C, 2012, EUR ARCH OTO-RHINO-L, V269, P399, DOI 10.1007/s00405-011-1641-8; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Mun SK, 2017, INJURY, V48, P2879, DOI 10.1016/j.injury.2017.10.041; Ohlrogge M, 2004, OTOL NEUROTOL, V25, P195, DOI 10.1097/00129492-200403000-00021; Palva T, 1966, Acta Otolaryngol, V62, P237, DOI 10.3109/00016486609119570; SADE J, 1992, EUR ARCH OTO-RHINO-L, V249, P301; SADE J, 1994, EUR ARCH OTO-RHINO-L, V251, P191, DOI 10.1007/BF00628421; Sade J, 1996, ANN OTO RHINOL LARYN, V105, P643, DOI 10.1177/000348949610500810; SADE J, 1979, ARCH OTO-RHINO-LARYN, V225, P39, DOI 10.1007/BF00455874; SADE J, 1976, ANN OTO RHINOL LARYN, V85, P66, DOI 10.1177/00034894760850S214; Sade J, 1997, ANN OTO RHINOL LARYN, V106, P37, DOI 10.1177/000348949710600107; Schubl SD, 2016, INJURY, V47, P1893, DOI 10.1016/j.injury.2016.06.026; 이준희, 2015, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V58, P836, DOI 10.3342/kjorl-hns.2015.58.12.836; TURGUT S, 1992, J LARYNGOL OTOL, V106, P485, DOI 10.1017/S0022215100119942; Vrabec JT, 2002, ACTA OTO-LARYNGOL, V122, P831, DOI 10.1080/0036554021000028085	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217682	10.1371/journal.pone.0217682	http://dx.doi.org/10.1371/journal.pone.0217682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150482	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100084
J	Khalil, HA; Hong, SN; Rouch, JD; Scott, A; Cho, Y; Wang, JF; Lewis, MS; Martine, MG; Dunn, JCY; Stelzner, MG				Khalil, Hassan A.; Hong, Sung Noh; Rouch, Joshua D.; Scott, Andrew; Cho, Yonghoon; Wang, Jiafang; Lewis, Michael S.; Martine, Martin G.; Dunn, James C. Y.; Stelzner, Matthias G.			Intestinal epithelial replacement by transplantation of cultured murine and human cells into the small intestine	PLOS ONE			English	Article							IN-VITRO; STEM-CELLS	Adult intestinal epithelial stem cells are a promising resource for treatment of intestinal epithelial disorders that cause intestinal failure and for intestinal tissue engineering. We developed two different animal models to study the implantation of cultured murine and human intestinal epithelial cells in the less differentiated "spheroid" state and the more differentiated "enteroid" state into the denuded small intestine of mice. Engraftment of donor cells could not be achieved while the recipient intestine remained in continuity. However, we were able to demonstrate successful implantation of murine and human epithelial cells when the graft segment was in a bypassed loop of jejunum. Implantation of donor cells occurred in a random fashion in villus and crypt areas. Engraftment was observed in 75% of recipients for murine and 36% of recipients for human cells. Engrafted spheroid cells differentiated into the full complement of intestinal epithelial cells. These findings demonstrate for the first time successful engraftment into the small bowel which is optimized in a bypassed loop surgical model.	[Khalil, Hassan A.; Rouch, Joshua D.; Scott, Andrew; Cho, Yonghoon; Stelzner, Matthias G.] UCLA, David Geffen Sch Med, Dept Surg, CHS 72-215, Los Angeles, CA 90095 USA; [Hong, Sung Noh; Wang, Jiafang; Martine, Martin G.] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Div Gastroenterol & Nutr, Los Angeles, CA 90024 USA; [Hong, Sung Noh; Wang, Jiafang; Martine, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Michael S.] VA Greater Los Angeles Hlth Syst, Dept Pathol & Lab Med, Los Angeles, CA USA; [Dunn, James C. Y.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Stelzner, Matthias G.] VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Stelzner, MG (corresponding author), UCLA, David Geffen Sch Med, Dept Surg, CHS 72-215, Los Angeles, CA 90095 USA.; Stelzner, MG (corresponding author), VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA 90073 USA.	stelzner@ucla.edu	Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290; Dunn, James/0000-0002-6826-7065	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney; National Institute of Allergy and Infectious Diseases [DK085535]; NIH P30 grant [DK041301]; California Institute of Regenerative Medicine (CIRM) [RT2-01985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, U01DK085535] Funding Source: NIH RePORTER	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH P30 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney and the National Institute of Allergy and Infectious Diseases (DK085535) to MGM, JCYD and MGS, an NIH P30 grant (DK041301) to MGM, and the California Institute of Regenerative Medicine (CIRM), RT2-01985, to MGM.	Agopian VG, 2009, J GASTROINTEST SURG, V13, P971, DOI 10.1007/s11605-009-0806-x; Avansino JR, 2006, SURGERY, V140, P423, DOI 10.1016/j.surg.2006.03.012; Avansino JR, 2005, J AM COLL SURGEONS, V201, P710, DOI 10.1016/j.jamcollsurg.2005.06.270; Barthel ER, 2012, REGEN MED, V7, P807, DOI [10.2217/RME.12.91, 10.2217/rme.12.91]; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; Hong SN, 2017, STEM CELL TRANSL MED, V6, P666, DOI 10.5966/sctm.2016-0153; Jabaji Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107814; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Khalil HA, 2016, CELL TISSUE RES, V365, P123, DOI 10.1007/s00441-016-2367-0; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scott A, 2016, J PEDIATR SURG, V51, P995, DOI 10.1016/j.jpedsurg.2016.02.074; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012; Thiagarajah JR, 2018, GASTROENTEROLOGY, V154, P2045, DOI 10.1053/j.gastro.2018.03.067; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	21	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216326	10.1371/journal.pone.0216326	http://dx.doi.org/10.1371/journal.pone.0216326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150401	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100018
J	Lelwala, RV; Korhonen, PK; Young, ND; Scott, JB; Ades, PK; Gasser, RB; Taylor, PWJ				Lelwala, Ruvini, V; Korhonen, Pasi K.; Young, Neil D.; Scott, Jason B.; Ades, Peter K.; Gasser, Robin B.; Taylor, Paul W. J.			Comparative genome analysis indicates high evolutionary potential of pathogenicity genes in Colletotrichum tanaceti	PLOS ONE			English	Article							INDUCED POINT MUTATION; MOLECULAR EVOLUTION; FUNGAL PATHOGENS; DIVERGENCE TIMES; PLANT-PATHOGENS; ABSOLUTE RATES; CD-HIT; PROTEIN; SEQUENCE; TOOL	Colletotrichum tanaceti is an emerging foliar fungal pathogen of commercially grown pyrethrum (Tanacetum cinerariifolium). Despite being reported consistently from field surveys in Australia, the molecular basis of pathogenicity of C. tanaceti on pyrethrum is unknown. Herein, the genome of C. tanaceti (isolate BRIP57314) was assembled de novo and annotated using transcriptomic evidence. The inferred putative pathogenicity gene suite of C. tanaceti comprised a large array of genes encoding secreted effectors, proteases, CAZymes and secondary metabolites. Comparative analysis of its putative pathogenicity gene profiles with those of closely related species suggested that C. tanaceti likely has additional hosts to pyrethrum. The genome of C. tanaceti had a high repeat content and repetitive elements were located significantly closer to genes inferred to influence pathogenicity than other genes. These repeats are likely to have accelerated mutational and transposition rates in the genome, resulting in a rapid evolution of certain CAZyme families in this species. The C. tanaceti genome showed strong signals of Repeat Induced Point (RIP) mutation which likely caused its bipartite nature consisting of distinct gene-sparse, repeat and A-T rich regions. Pathogenicity genes within these RIP affected regions were likely to have a higher evolutionary rate than the rest of the genome. This "two-speed" genome phenomenon in certain Colletotrichum spp. was hypothesized to have caused the clustering of species based on the pathogenicity genes, to deviate from taxonomic relationships. The large repertoire of pathogenicity factors that potentially evolve rapidly due to the plasticity of the genome, indicated that C. tanaceti has a high evolutionary potential. Therefore, C. tanaceti poses a high-risk to the pyrethrum industry. Knowledge of the evolution and diversity of the putative pathogenicity genes will facilitate future research in disease management of C. tanaceti and other Colletotrichum spp.	[Lelwala, Ruvini, V; Korhonen, Pasi K.; Young, Neil D.; Gasser, Robin B.; Taylor, Paul W. J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Scott, Jason B.] Univ Tasmania, Tasmanian Inst Agr, Burnie, Tas, Australia; [Ades, Peter K.] Univ Melbourne, Fac Sci, Parkville, Vic, Australia	University of Melbourne; University of Tasmania; University of Melbourne	Taylor, PWJ (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia.	paulwjt@unimelb.edu.au	Scott, Jason B/C-2395-2014; Gasser, Robin/ABH-6185-2020; Young, Neil David/AAU-4572-2020; Scott, Jason B/D-4553-2011; Taylor, Paul WJ/K-4602-2015	Scott, Jason B/0000-0001-9443-4384; Gasser, Robin/0000-0002-4423-1690; Young, Neil David/0000-0001-8756-229X; Scott, Jason B/0000-0001-9443-4384; Taylor, Paul WJ/0000-0003-3076-2084; Lelwala, Ruvini/0000-0002-7873-1386; Korhonen, Pasi/0000-0002-9957-4674	Botanical Resources Australia - Agricultural Services, Pty. Ltd; University of Melbourne, Australia; NHMRC Career Development Fellowship [APP1109829]; NHMRC Early Career Research Fellowship [APP1127033]; Botanical Resources Australia-Agricultural Services, Pty. Ltd; NHMRC	Botanical Resources Australia - Agricultural Services, Pty. Ltd; University of Melbourne, Australia(University of Melbourne); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Botanical Resources Australia-Agricultural Services, Pty. Ltd; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by Botanical Resources Australia - Agricultural Services, Pty. Ltd-(https://www.botanicalresources.com/). Ruvini V. Lelwala received Melbourne International Fee Remission Scholarship and Melbourne International Research Scholarship from the University of Melbourne, Australia (https://www.unimelb.edu.au/).ND Young was supported by NHMRC Career Development Fellowship - APP1109829 (https://nhmrc.gov.au/).PK Korhonen was supported by NHMRC Early Career Research Fellowship - APP1127033 (https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish or Preparation of the manuscript.; We thank Dr Kym Pham and Dr Arthur Hsu for performing library preparation, sequencing and genome assembly which were conducted at the Melbourne Translational Genomics Platform (Department of Pathology, University of Melbourne). We also thank Botanical Resources Australia-Agricultural Services, Pty. Ltd for supporting the project. RVL received Melbourne International Fee Remission Scholarship and Melbourne International Research Scholarship from the University of Melbourne, Australia. NDY was supported by a Career Development Fellowship (CDF) from NHMRC. PKK was supported by an Early Career Fellowship (CDF) from NHMRC.	Aboukhaddour R, 2012, MOL PLANT PATHOL, V13, P318, DOI 10.1111/j.1364-3703.2011.00748.x; Afgan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140829; Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R; Andrews S., 2010, FASTQC QUALITY CONTR; Auyong ASM, 2012, J BASIC MICROB, V52, P372, DOI 10.1002/jobm.201100250; Aylward J, 2017, IMA FUNGUS, V8, P1, DOI 10.5598/imafungus.2017.08.01.01; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Baccelli I, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00769; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barimani M, 2013, PLANT PATHOL, V62, P1248, DOI 10.1111/ppa.12054; Baroncelli R, 2018, MOL PLANT MICROBE IN, V31, P979, DOI [10.1094/mpmi-03-18-0055-a, 10.1094/MPMI-03-18-0055-A]; Baroncelli R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2917-6; Baroncelli R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00112-14; Baroncelli R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00540-14; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Buiate EAS, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3457-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Chen XR, 2007, FEMS MICROBIOL LETT, V269, P280, DOI 10.1111/j.1574-6968.2007.00639.x; Chia N, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021906; Crouch JA, 2014, GENOMICS COLLETOTRIC; Crouch JA, 2008, FUNGAL GENET BIOL, V45, P190, DOI 10.1016/j.fgb.2007.08.004; Dallery JF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4083-x; Damm U, 2019, STUD MYCOL, P1, DOI 10.1016/j.simyco.2018.04.001; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; De Silva DD, 2017, FUNGAL BIOL REV, V31, P155, DOI 10.1016/j.fbr.2017.05.001; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Delserone LM, 1999, PHYSIOL MOL PLANT P, V55, P317, DOI 10.1006/pmpp.1999.0237; Derbyshire MK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar058; Doehlemann G, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0023-2016; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duke SO, 2010, TOXINS, V2, P1943, DOI 10.3390/toxins2081943; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gan P, 2017, Genome Announc, V5, DOI [10.1128/genomea.01733-16, 10.1128/genomeA.01733-16]; Gan P, 2016, GENOME BIOL EVOL, V8, P1467, DOI 10.1093/gbe/evw089; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Hane JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-478; Hay FS, 2015, PLANT DIS, V99, P1227, DOI 10.1094/PDIS-12-14-1357-RE; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Howlett BJ, 2006, CURR OPIN PLANT BIOL, V9, P371, DOI 10.1016/j.pbi.2006.05.004; Howlett BJ, 2015, MYCOLOGIA, V107, P441, DOI 10.3852/14-317; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jashni MK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00584; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kapabiosystems. Kapa Biosystems &VERBAR; Enzyme Solutions, 2015, NEXT GEN PCR; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KT, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpfs.2016.00186, 10.3389/fpls.2016.00186]; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Klosterman SJ, 2010, VERTICILLIUM DAHLIAE; Kojima K, 2002, MOL PLANT MICROBE IN, V15, P1268, DOI 10.1094/MPMI.2002.15.12.1268; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kubo Y., 1991, The fungal spore and disease initiation in plants and animals., P205; Kubo Y, 1997, COLLETOTRICHUM LAGEN, P4340; Kueck P, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0081-x; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li WC, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0825-x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang XF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196303; Liu P, 2015, FUNGAL GENET BIOL, V77, P31, DOI 10.1016/j.fgb.2015.03.003; Lu T, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas032; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mapleson D, 2017, BIOINFORMATICS, V33, P574, DOI 10.1093/bioinformatics/btw663; Marcais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944; Marin-Felix Y, 2019, STUD MYCOL, P47, DOI 10.1016/j.simyco.2018.04.002; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Meinken J, 2014, FUNSECKB2 FUNGAL PRO, P1; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mongkolporn O, 2018, PLANT PATHOL, V67, P1255, DOI 10.1111/ppa.12850; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Muszewska A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09644-w; Nash SG, 2000, J COMPUT APPL MATH, V124, P45, DOI 10.1016/S0377-0427(00)00426-X; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Nieuwenhuis BPS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0540; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Pattathil S, 2015, J EXP BOT, V66, P4279, DOI 10.1093/jxb/erv107; Pellicer J, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020088; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rao S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02367; Rao S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183567; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Saitoh H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002711; Sakaguchi A, 2010, MOL PLANT MICROBE IN, V23, P1563, DOI 10.1094/MPMI-03-10-0051; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santana MF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-536; Scholl JP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1334; Seidl MF, 2017, TRENDS GENET, V33, P842, DOI 10.1016/j.tig.2017.07.003; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Sharma KK, 2016, CRIT REV BIOTECHNOL, V36, P743, DOI 10.3109/07388551.2015.1015959; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Sonah H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00126; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stukenbrock EH, 2013, NEW PHYTOL, V199, P895, DOI 10.1111/nph.12374; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; Team RC., 2013, R LANG ENV STAT COMP; Testa AC, 2016, GENOME BIOL EVOL, V8, P2044, DOI 10.1093/gbe/evw121; Tsuji G, 2003, MOL PLANT MICROBE IN, V16, P315, DOI 10.1094/MPMI.2003.16.4.315; Urban M, 2017, NUCLEIC ACIDS RES, V45, pD604, DOI 10.1093/nar/gkw1089; Vargas WA, 2016, MOL PLANT MICROBE IN, V29, P83, DOI 10.1094/MPMI-09-15-0209-R; Velasquez AC, 2018, CURR BIOL, V28, pR619, DOI 10.1016/j.cub.2018.03.054; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yamada N, 2004, BIOSCI BIOTECH BIOCH, V68, P615, DOI 10.1271/bbb.68.615; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoder OC, 2001, CURR OPIN PLANT BIOL, V4, P315, DOI 10.1016/S1369-5266(00)00179-5; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zhu WJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01807	161	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0212248	10.1371/journal.pone.0212248	http://dx.doi.org/10.1371/journal.pone.0212248			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150449	Green Published, Green Accepted, gold			2022-12-27	WOS:000469759100006
J	Reinhardt, L; Schwesig, R; Lauenroth, A; Schulze, S; Kurz, E				Reinhardt, Lars; Schwesig, Rene; Lauenroth, Andreas; Schulze, Stephan; Kurz, Eduard			Enhanced sprint performance analysis in soccer: New insights from a GPS-based tracking system	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEMS; ELITE SOCCER; MATCH PERFORMANCE; RUNNING SPEED; ACCELERATION; RELIABILITY; VALIDITY; LEAGUE; STRENGTH; PLAYERS	The aim of this investigation was to establish the validity of a GPS-based tracking system (Polar Team Pro System, PTPS) for estimating sprint performance and to evaluate additional diagnostic indices derived from the temporal course of the movement velocity. Thirty-four male soccer players (20 +/- 4 years) performed a 20 m sprint test measured by timing gates (TG), and while wearing the PTPS. To evaluate the relevance of additional velocity-based parameters to discriminate between faster and slower athletes, the median-split method was applied to the 20-m times. Practical relevance was estimated using standardized mean differences (d) between the subgroups. Differences between the criterion reference (TG) and PTPS for the 10 and 20 m splits did not vary from zero (dt10: -0.01 +/- 0.07 s, P = 0.7, d < -0.1; dt20: -0.01 +/- 0.08 s, P = 0.4, d < -0.2). Although subgroups revealed large differences in their sprint times (d = -2.5), the average accelerations between 5 and 20 km/h as well as 20 and 25 km/h showed merely small effects (d < 0.5). Consequently, analyses of velocity curves derived from PTPS may help to clarify the occurrence of performance in outdoor sports. Thus, training consequences can be drawn which contribute to the differentiation and individualization of sprint training.	[Reinhardt, Lars; Schwesig, Rene; Lauenroth, Andreas; Schulze, Stephan; Kurz, Eduard] Martin Luther Univ Halle Wittenberg, Dept Orthoped & Trauma Surg, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Reinhardt, L (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Orthoped & Trauma Surg, Halle, Saale, Germany.	lars.reinhardt@uk-halle.de						Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P295, DOI 10.1123/ijspp.6.3.295; Bancroft JB, 2011, SENSORS-BASEL, V11, P6771, DOI 10.3390/s110706771; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Baumgart C, 2018, SPORTS, V6, DOI 10.3390/sports6040161; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Brown TD, 2004, J SPORT SCI MED, V3, P203; Buchheit M, 2014, J SPORT SCI, V32, P1906, DOI 10.1080/02640414.2014.965191; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Burgess DJ, 2006, J SCI MED SPORT, V9, P334, DOI 10.1016/j.jsams.2006.01.005; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Caron F, 2006, INFORM FUSION, V7, P221, DOI 10.1016/j.inffus.2004.07.002; Castellano J, 2011, J SPORT SCI MED, V10, P233; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Comfort P, 2014, J STRENGTH COND RES, V28, P173, DOI 10.1519/JSC.0b013e318291b8c7; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Di Salvo V, 2010, J SPORT SCI, V28, P1489, DOI 10.1080/02640414.2010.521166; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Gil S, 2018, J SPORT SCI, V36, P1923, DOI 10.1080/02640414.2018.1426346; Gray AJ, 2010, J SPORT SCI, V28, P1319, DOI 10.1080/02640414.2010.504783; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Hoppe MW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192708; HRELJAC A, 1995, HUM MOVEMENT SCI, V14, P205, DOI 10.1016/0167-9457(95)00017-M; Ingebrigtsen J, 2014, J STRENGTH COND RES, V28, P942, DOI 10.1519/JSC.0b013e3182a1f861; Jennings Denise, 2010, Int J Sports Physiol Perform, V5, P328; Kawamori N, 2014, J STRENGTH COND RES, V28, P2738, DOI 10.1519/JSC.0b013e3182915ed4; Little T, 2005, J STRENGTH COND RES, V19, P76; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; Mendez-Villanueva A, 2011, J SPORT SCI, V29, P477, DOI 10.1080/02640414.2010.536248; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Moir G, 2007, SPORT BIOMECH, V6, P285, DOI 10.1080/14763140701489793; Murphy Aron J, 2003, J Sports Sci Med, V2, P144; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Scott MTU, 2016, J STRENGTH COND RES, V30, P1470, DOI 10.1519/JSC.0000000000001221; Sleivert G, 2004, EUR J APPL PHYSIOL, V91, P46, DOI 10.1007/s00421-003-0941-0; Styles WJ, 2016, J STRENGTH COND RES, V30, P1534, DOI 10.1519/JSC.0000000000001243; Sweeting AJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00432; Varley MC, 2013, INT J SPORTS MED, V34, P34, DOI 10.1055/s-0032-1316315; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Vigne G, 2010, INT J SPORTS MED, V31, P304, DOI 10.1055/s-0030-1248320; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445; Yeadon MR, 1999, J SPORT SCI, V17, P249, DOI 10.1080/026404199366154	48	14	14	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217782	10.1371/journal.pone.0217782	http://dx.doi.org/10.1371/journal.pone.0217782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150503	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100106
J	Rubinson, M; Horowitz, I; Naim-Feil, J; Gothelf, D; Levit-Binnun, N; Moses, E				Rubinson, Mica; Horowitz, Itai; Naim-Feil, Jodie; Gothelf, Doron; Levit-Binnun, Nava; Moses, Elisha			Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; RESPONSE-INHIBITION; STIMULANT MEDICATION; CHILDREN; PERFORMANCE; ADOLESCENTS; P300	Methylphenidate (MPH) is a first line drug for attention-deficit/hyperactivity disorder (ADHD), yet the neuronal mechanisms underlying the condition and the treatment are still not fully understood. Previous EEG studies on the effect of MPH in ADHD found changes in evoked response potential (ERP) components that were inconsistent between studies. These inconsistencies highlight the need for a well-designed study which includes multiple baseline sessions and controls for possible fatigue, learning effects and between-days variability. To this end, we employ a double-blind placebo-controlled cross-over study and explore the effect of MPH on the ERP response of subjects with ADHD during a Go/No-Go cognitive task. Our ERP analysis revealed significant differences in ADHD subjects between the placebo and MPH conditions in the frontal-parietal region at 250ms-400ms post stimulus (P3). Additionally, a decrease in the late 650ms-800ms ERP component (LC) is observed in frontal electrodes of ADHD subjects compared to controls. The standard deviation of response time of ADHD subjects was significantly smaller in the MPH condition compared to placebo and correlated with the increased P3 ERP response in the frontoparietal electrodes. We suggest that mental fatigue plays a role in the decrease of the P3 response in the placebo condition compared to pre-placebo, a phenomenon that is significant in ADHD subjects but not in controls, and which is interestingly rectified by MPH.	[Rubinson, Mica; Naim-Feil, Jodie; Moses, Elisha] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel; [Horowitz, Itai] Beer Yaacov Ness Ziona Mental Hlth Ctr, Beer Yaagov, Israel; [Horowitz, Itai] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Child & Adolescent Psychiat Unit, Tel Hashomer, Israel; [Levit-Binnun, Nava] Sagol Ctr Brain & Mind, Interdisciplinary Ctr, Sch Psychol, Herzliyya, Israel	Weizmann Institute of Science; Tel Aviv University; Chaim Sheba Medical Center; Reichman University	Rubinson, M (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel.	micaboul@gmail.com		Naim-Feil, Jodie/0000-0001-7895-4021	Clore Center for Biological Physics; Israel Science Foundation [1169/11, 1835/16]; Minerva Foundation, Munich, Germany; Sagol Foundation; National Institute of Psychobiology in Israel; National Institute for Psychobiology in Israel [215-18-19]	Clore Center for Biological Physics; Israel Science Foundation(Israel Science Foundation); Minerva Foundation, Munich, Germany; Sagol Foundation; National Institute of Psychobiology in Israel; National Institute for Psychobiology in Israel	Elisha Moses is funded the Clore Center for Biological Physics, the Israel Science Foundation grant 1835/16 and the Minerva Foundation, Munich, Germany. Nava Levit-Binnun is supported by the Israel Science Foundation, grant 1169/11, by the Sagol Foundation and by the National Institute of Psychobiology in Israel. Dr. Itai Horowitz: The National Institute for Psychobiology in Israel -Founded by the Charles E. Smith Family. Grant serial number: 215-18-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-22; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Bioulac S, 2012, EUR J PAEDIATR NEURO, V16, P514, DOI 10.1016/j.ejpn.2012.01.006; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bonnefond A, 2010, BEHAV BRAIN RES, V211, P185, DOI 10.1016/j.bbr.2010.03.030; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brandeis D, 2002, INT C SERIES, V1232, P649, DOI [10.1016/S0531-5131(01)00673-2, DOI 10.1016/S0531-5131(01)00673-2]; Clarke AR, 2002, CLIN NEUROPHYSIOL, V113, P1036, DOI 10.1016/S1388-2457(02)00115-3; Clarke AR, 2002, CLIN NEUROPHYSIOL, V113, P194, DOI 10.1016/S1388-2457(01)00736-2; Davidovitch M, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0971-0; DeFrance JF, 1996, INT J NEUROSCI, V87, P41, DOI 10.3109/00207459608990752; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Epstein JN, 2011, NEUROPSYCHOLOGY, V25, P427, DOI 10.1037/a0022155; Epstein JN, 2011, NEUROPSYCHOPHARMACOL, V36, P1060, DOI 10.1038/npp.2010.243; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Fox AM, 2000, CLIN NEUROPHYSIOL, V111, P1045, DOI 10.1016/S1388-2457(00)00257-1; Groom MJ, 2008, BIOL PSYCHIAT, V63, P784, DOI 10.1016/j.biopsych.2007.09.018; Groom MJ, 2010, BIOL PSYCHIAT, V67, P624, DOI 10.1016/j.biopsych.2009.09.029; Hermens DF, 2006, EXPERT REV NEUROTHER, V6, P753, DOI 10.1586/14737175.6.5.753; Ilieva IP, 2015, J COGNITIVE NEUROSCI, V27, P1069, DOI 10.1162/jocn_a_00776; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; KLORMAN R, 1990, PSYCHOPHYSIOLOGY, V27, P328, DOI 10.1111/j.1469-8986.1990.tb00391.x; KLORMAN R, 1979, PSYCHOPHYSIOLOGY, V16, P23, DOI 10.1111/j.1469-8986.1979.tb01432.x; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Lawrence CA, 2005, PSYCHOPHARMACOLOGY, V183, P81, DOI 10.1007/s00213-005-0144-y; Liotti M, 2007, PSYCHOPHYSIOLOGY, V44, P936, DOI 10.1111/j.1469-8986.2007.00568.x; Liotti M, 2010, BRAIN COGNITION, V72, P228, DOI 10.1016/j.bandc.2009.09.007; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; MICHAEL RL, 1981, PSYCHOPHYSIOLOGY, V18, P665, DOI 10.1111/j.1469-8986.1981.tb01841.x; Mockel T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10113; Naim-Feil J, 2018, BIOL PSYCHIAT-COGN N, V3, P88, DOI 10.1016/j.bpsc.2017.03.017; Naim-Feil J, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5760141; Nandam LS, 2011, BIOL PSYCHIAT, V69, P902, DOI 10.1016/j.biopsych.2010.11.014; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Ogrim G, 2016, CLIN NEUROPHYSIOL, V127, P3277, DOI 10.1016/j.clinph.2016.07.011; PRICHEP LS, 1976, PSYCHOPHYSIOLOGY, V13, P419, DOI 10.1111/j.1469-8986.1976.tb00855.x; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Reimer Bryan, 2007, Traffic Inj Prev, V8, P290, DOI 10.1080/15389580701257842; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Sangal RB, 2006, CLIN NEUROPHYSIOL, V117, P1996, DOI 10.1016/j.clinph.2006.06.004; Sangal RB, 2004, CLIN NEUROPHYSIOL, V115, P188, DOI 10.1016/j.clinph.2003.08.023; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; Slopen N, 2012, ARCH GEN PSYCHIAT, V69, P1022, DOI 10.1001/archgenpsychiatry.2012.444; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Strandburg RJ, 1996, BIOL PSYCHIAT, V40, P964, DOI 10.1016/0006-3223(95)00545-5; Sunohara GA, 1999, NEUROPSYCHOPHARMACOL, V21, P218, DOI 10.1016/S0893-133X(99)00023-8; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; TAYLOR MJ, 1993, BIOL PSYCHOL, V36, P139, DOI 10.1016/0301-0511(93)90015-Z; VERBATEN MN, 1994, J ABNORM CHILD PSYCH, V22, P561, DOI 10.1007/BF02168938; Vostanis P, 2006, CURR OPIN PSYCHIATR, V19, P367, DOI 10.1097/01.yco.0000228755.72366.05; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiersema JR, 2009, J ABNORM CHILD PSYCH, V37, P327, DOI 10.1007/s10802-008-9288-7; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031	67	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217383	10.1371/journal.pone.0217383	http://dx.doi.org/10.1371/journal.pone.0217383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150439	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100042
J	Sinnige, T; Ciryam, P; Casford, S; Dobson, CM; de Bono, M; Vendruscolo, M				Sinnige, Tessa; Ciryam, Prashanth; Casford, Samuel; Dobson, Christopher M.; de Bono, Mario; Vendruscolo, Michele			Expression of the amyloid-beta peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response	PLOS ONE			English	Article							CARBON-DIOXIDE AVOIDANCE; CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; OXYGEN; TAU; VULNERABILITY; PROTEOSTASIS; DYSFUNCTION; GLUTAMATE; SYNAPSES	Although the aggregation of the amyloid-beta peptide (A beta) into amyloid fibrils is a well-established hallmark of Alzheimer's disease, the complex mechanisms linking this process to neurodegeneration are still incompletely understood. The nematode worm C. elegans is a valuable model organism through which to study these mechanisms because of its simple nervous system and its relatively short lifespan. Standard A beta-based C. elegans models of Alzheimer's disease are designed to study the toxic effects of the overexpression of A beta in the muscle or nervous systems. However, the wide variety of effects associated with the tissue-level overexpression of A beta makes it difficult to single out and study specific cellular mechanisms related to the onset of Alzheimer's disease. Here, to better understand how to investigate the early events affecting neuronal signalling, we created a C. elegans model expressing A beta 42, the 42-residue form of A beta, from a single-copy gene insertion in just one pair of glutamatergic sensory neurons, the BAG neurons. In behavioural assays, we found that the A beta 42-expressing animals displayed a subtle modulation of the response to CO2, compared to controls. Ca2+ imaging revealed that the BAG neurons in young A beta 42-expressing nematodes were activated more strongly than in control animals, and that neuronal activation remained intact until old age. Taken together, our results suggest that A beta 42-expression in this very subtle model of AD is sufficient to modulate the behavioural response but not strong enough to generate significant neurotoxicity, suggesting that slightly more aggressive perturbations will enable effectively studies of the links between the modulation of a physiological response and its associated neurotoxicity.	[Sinnige, Tessa; Ciryam, Prashanth; Casford, Samuel; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge, England; [de Bono, Mario] MRC, Cell Biol Div, Lab Mol Biol, Cambridge, England	University of Cambridge; MRC Laboratory Molecular Biology	Vendruscolo, M (corresponding author), Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge, England.	mv245@cam.ac.uk	Sinnige, Tessa/Y-7210-2019; Vendruscolo, Michele/F-5901-2012	Vendruscolo, Michele/0000-0002-3616-1610	MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Esposito Z, 2013, CNS NEUROSCI THER, V19, P549, DOI 10.1111/cns.12095; Ewald CY, 2012, EXP BRAIN RES, V217, P397, DOI 10.1007/s00221-011-2905-7; Fenk LA, 2015, P NATL ACAD SCI USA, V112, pE3525, DOI 10.1073/pnas.1423808112; Francis PT, 2003, INT J GERIATR PSYCH, V18, pS15, DOI 10.1002/gps.934; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Guillermin ML, 2017, CURR BIOL, V27, P2630, DOI 10.1016/j.cub.2017.07.023; Habchi J, 2017, P NATL ACAD SCI USA, V114, pE200, DOI 10.1073/pnas.1615613114; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Khabirova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102985; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LINK CD, 1992, GENETICS, V131, P867; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; McColl G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-57; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perni M, 2018, J NEUROSCI METH, V306, P57, DOI 10.1016/j.jneumeth.2018.02.005; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Soto C., 2013, J NEUROL TRANSL NEUR, V1, P19; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217746	10.1371/journal.pone.0217746	http://dx.doi.org/10.1371/journal.pone.0217746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150491	Green Published, gold			2022-12-27	WOS:000469759100097
J	Yang, YD; Song, JY; Wang, S; Wang, Y; Song, QY; Dong, YH; Li, CX; Wang, HJ; Ma, J				Yang, Yi-de; Song, Jie-Yun; Wang, Shuo; Wang, Yang; Song, Qi-Ying; Dong, Yan-hui; Li, Chen-Xiong; Wang, Hai-Jun; Ma, Jun			Combined effects of the rs9810888 polymorphism in calcium voltage-gated channel subunit alphal D (CACNA1D) and lifestyle behaviors on blood pressure level among Chinese children	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; GENETIC-VARIANTS; HERITABILITY; ASSOCIATION; SENSITIVITY; COMPONENTS; OBESITY; RISK	Backgrounds A recent GWAS Study found a new locus (rs9810888 in CACNA1D) was associated with blood pressure (BP) in Chinese adults. But whether the association exists in children is unknown. Whether lifestyle behaviors could interact with rs9810888 on BP is not clear. This study aimed to identify the association between rs9810888 and BP in children, and also explore the gene-lifestyle interaction. Methods A case-control study was conducted among 2030 Chinese children aged 7 to 18 years. Genotyping was conducted by using the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Lifestyle behaviors were investigated with questionnaire. Results With adjustment for age, age square, sex, study group and body mass index (BMI), rs9810888 was significantly associated with diastolic BP (DBP) (b = 1.69, p = 0.021) and mean arterial BP (MAP) (b = 1.56, p = 0.010). Stratified analysis showed that the rs9810888 GG genotype carriers had higher DBP than GT/TT carriers (b = 3.78, p = 0.023) in the subgroup having protein intake (meat/fish/soybeans/egg) <twice/day, but not in the subgroup >= twice/day. In addition, in the subgroup with screen time >= 2h/day, the rs9810888 GG genotype carriers had higher DBP than GT/TT carriers (b = 5.49, p = 0.012), but not in the subgroup with screen time<2h/day. For MAP, in the subgroup having either fruits or vegetables < twice/day, the rs9810888 GG genotype carriers had higher MAP than GT/TT carriers (b = 2.64, p = 0.037), but not in the subgroup with both fruits and vegetables intake >= twice/day. Additionally, in the subgroup with screen time >= 2h/day, the rs9810888 GG genotype carriers had higher MAP than GT/TT carriers (b = 4.80, p = 0.017), but not in those with screen time<2h/day. Conclusions The CACNAID rs9810888 polymorphism was significantly associated with DBP and MAP. In addition, unhealthy lifestyle behaviors and rs9810888 GG genotype had combined effects on BP level among Chinese children.	[Yang, Yi-de; Song, Jie-Yun; Wang, Shuo; Dong, Yan-hui; Ma, Jun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Yang, Yi-de] Hunan Normal Univ, Sch Med, Teaching & Researching Off Child & Adolescent Hlt, Key Lab Mol Epidemiol Hunan Prov, Changsha, Hunan, Peoples R China; [Wang, Yang; Song, Qi-Ying; Li, Chen-Xiong; Wang, Hai-Jun] Peking Univ, Hlth Sci Ctr, Dept Maternal & Child Hlth, Beijing, Peoples R China	Peking University; Hunan Normal University; Peking University	Ma, J (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.; Wang, HJ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Maternal & Child Hlth, Beijing, Peoples R China.	whjun1@bjmu.edu.cn; majunt@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Song, Qiying/AAV-6247-2021	Wang, Haijun/0000-0003-0849-2903; Dong, Yanhui/0000-0003-2519-3200; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81673192]; Hunan Provincial Natural Science Foundation of China [2019JJ50376]; Scientific Research Fund of Hunan Provincial Education Department [18C0072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This study was supported by Grants from National Natural Science Foundation of China (81573170, HW, http://www.nsfc.gov.cn/), National Natural Science Foundation of China (81673192, JM, http://www.nsfc.gov.cn/), Hunan Provincial Natural Science Foundation of China (2019JJ50376, YDY) and a Project Supported by Scientific Research Fund of Hunan Provincial Education Department (18C0072, YDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN J EVID BASED PE; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Chen CK, 2008, PROCEEDINGS OF THE 2008 CHINESE CONFERENCE ON PATTERN RECOGNITION (CCPR 2008), P36; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; de Moraes ACF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062006; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Graff M, 2013, PEDIATR OBES, V8, pE74, DOI 10.1111/j.2047-6310.2013.00195.x; Hartman S, 2015, DEV PSYCHOPATHOL, V27, P747, DOI 10.1017/S0954579414000856; Heshmat R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154502; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Hruby A, 2018, PUBLIC HEALTH NUTR, V21, P2998, DOI 10.1017/S1368980018001854; Kamide K, 2009, CIRC J, V73, P732, DOI 10.1253/circj.CJ-08-0761; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; MCILHANY ML, 1975, JOHNS HOPKINS MED J, V136, P57; Montasser ME, 2011, AM J HYPERTENS, V24, P1035, DOI 10.1038/ajh.2011.97; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pomeroy J, 2009, MED SPORT SCI, V54, P110, DOI 10.1159/000235700; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Smith CE, 2009, ATHEROSCLEROSIS, V206, P500, DOI 10.1016/j.atherosclerosis.2009.03.012; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Song JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170062; Tardieu Bernard, 1980, ESSENTIALS PRESSURE; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang S, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0352-9; Xi B, 2012, ATHEROSCLEROSIS, V225, P376, DOI 10.1016/j.atherosclerosis.2012.10.027; Yang YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025783; Zhang TH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081055	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216950	10.1371/journal.pone.0216950	http://dx.doi.org/10.1371/journal.pone.0216950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145748	gold, Green Submitted, Green Published			2022-12-27	WOS:000469425500007
J	Agostini, G; SturtzSreetharan, C; Wutich, A; Williams, D; Brewis, A				Agostini, Gina; SturtzSreetharan, Cindi; Wutich, Amber; Williams, Deborah; Brewis, Alexandra			Citizen sociolinguistics: A new method to understand fat talk	PLOS ONE			English	Article							BODY TALK; SCIENCE; WOMEN; CONSEQUENCES; MEN; ENGAGE; GENDER; AGE; IM	Fat talk and citizen science Fat talk is a spontaneous verbal interaction in which interlocutors make self- disparaging comments about the body, usually as a request for assessment. Fat talk often reflects concerns about the self that stem from broader sociocultural factors. It is therefore an important target for sociocultural linguistics. However, real- time studies of fat talk are uncommon due to the resource and time burdens required to capture these fleeting utterances. This limits the scope of data produced using standard sociolinguistic methods. Citizen science may alleviate these burdens by producing a scale of social observation not afforded via traditional methods. Here we present a proof- of- concept for a novel methodology, citizen sociolinguistics. This research approach involves collaborations with citizen researchers to capture forms of conversational data that are typically inaccessible, including fat talk. Aims and outcomes This study had two primary aims. Aim 1 focused on scientific output, testing a novel research strategy wherein citizen sociolinguists captured fat talk data in a diverse metropolitan region (Southwestern United States). Results confirm that citizen sociolinguistic research teams captured forms of fat talk that mirrored the scripted responses previously reported. However, they also capture unique forms of fat talk, likely due to greater diversity in sample and sampling environments. Aim 2 focused on the method itself via reflective exercises shared by the citizen sociolinguists throughout the project. In addition to confirming that the citizen sociolinguistic method produces reliable, scientifically valid data, we contend that citizen sociolinguist inclusion has broader scientific benefits which include applied scientific training, fostering sustained relationships between professional researchers and the public, and producing novel, meaningful scientific output that advances professional discourse.	[Agostini, Gina; SturtzSreetharan, Cindi; Wutich, Amber; Brewis, Alexandra] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Agostini, Gina] Midwestern Univ, Coll Dent Med, Glendale, AZ 85308 USA; [Williams, Deborah] Arizona State Univ, Coll Hlth Solut, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Agostini, Gina] Midwestern Univ, Coll Dent Med Arizona, Glendale, AZ 85308 USA	Arizona State University; Arizona State University-Tempe; Midwestern University; Midwestern University - College of Dental Medicine - Arizona; Arizona State University; Arizona State University-Downtown Phoenix; Midwestern University	Agostini, G; SturtzSreetharan, C (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.; Agostini, G (corresponding author), Midwestern Univ, Coll Dent Med, Glendale, AZ 85308 USA.; Agostini, G (corresponding author), Midwestern Univ, Coll Dent Med Arizona, Glendale, AZ 85308 USA.	gina.m.agostini@gmail.com; cindi.sturtzsreetharan@asu.edu		Agostini, Gina/0000-0002-4403-2253	Virginia G. Piper Charitable Trust	Virginia G. Piper Charitable Trust	This work was supported by funds from the Virginia G. Piper Charitable Trust. The funder had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Arroyo A, 2012, J APPL COMMUN RES, V40, P167, DOI 10.1080/00909882.2012.654500; Becker C. B., 2013, J EATING DISORDERS, V1, P1, DOI DOI 10.1186/2050-2974-1-10; Becker CB, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-6; Bernard H. R., 2000, SOCIAL RES METHODS Q; Boxer D., 1993, COMPLAINING COMMISER; Britton Lauren E, 2006, Body Image, V3, P247, DOI 10.1016/j.bodyim.2006.05.006; Bucholtz M, 2014, LANG LINGUIST COMPAS, V8, P144, DOI 10.1111/lnc3.12070; Cameron Deborah, 1992, RES LANGUAGE ISSUES; Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249; Chow CM, 2016, J HEALTH PSYCHOL, V21, P1597, DOI 10.1177/1359105314559621; Cochran ES, 2009, SEISMOL RES LETT, V80, P26, DOI 10.1785/gssrl.80.1.26; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Engeln R., 2015, NEW YORK TIMES; Engeln R, 2013, BODY IMAGE, V10, P300, DOI 10.1016/j.bodyim.2013.02.001; Evans M, 2002, MED EDUC, V36, P508, DOI 10.1046/j.1365-2923.2002.01225.x; Eveleigh A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P2985, DOI 10.1145/2556288.2557262; Flam L., 2016, TODAY; Guerrini CJ, 2018, SCIENCE, V361, P134, DOI 10.1126/science.aar8379; Guertin C, 2017, BODY IMAGE, V20, P7, DOI 10.1016/j.bodyim.2016.10.008; Heiss R, 2017, GAIA, V26, P22, DOI 10.14512/gaia.26.1.7; Herbert R., 1988, CONTRASTIVE PRAGMATI, P3; Himmelstein MS, 2018, OBESITY, V26, P968, DOI 10.1002/oby.22162; Hofmeister H., 2005, Z FAMILIENFORSCH, V17, P115; HOLMES J, 1986, ANTHROPOL LINGUIST, V28, P485; Irwin A, 2018, NATURE, V562, P480, DOI 10.1038/d41586-018-07106-5; Kasperowski D, 2018, MAKITALO EMBEDDING C; Kiesling SF, 2004, AM SPEECH, V79, P281, DOI 10.1215/00031283-79-3-281; Kim MS, 2015, PRAGMAT SOC, V6, P398, DOI 10.1075/ps.6.3.04kim; Martz DM, 2009, SEX ROLES, V61, P34, DOI 10.1007/s11199-009-9587-7; McCreary DR, 2000, J AM COLL HEALTH, V48, P297, DOI 10.1080/07448480009596271; Mills J, 2018, BODY IMAGE, V26, P38, DOI 10.1016/j.bodyim.2018.05.004; Mills J, 2017, PSYCHOL WOMEN QUART, V41, P114, DOI 10.1177/0361684316675317; Morgan JF, 2008, INVISIBLE MAN SELF H; Nichter M., 1994, MANY MIRRORS BODY IM, P109; Nichter M., 2000, FAT TALK WHAT GIRLS; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Ottinger G, 2010, SCI TECHNOL HUM VAL, V35, P244, DOI 10.1177/0162243909337121; Ousley Louise, 2008, Eat Disord, V16, P73, DOI 10.1080/10640260701773546; Palomeque C, 2018, RECALL, V30, P177, DOI 10.1017/S0958344017000374; Parsons J, 2011, NATURE, V471, P37, DOI 10.1038/471037a; Payne LO, 2011, SEX ROLES, V65, P557, DOI 10.1007/s11199-010-9881-4; Pomerantz Anita M., 1984, STUDIES CONVERSATION, P57, DOI DOI 10.1017/CBO9780511665868.008; Pope H.G., 2000, ADONIS COMPLEX SECRE; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Rochman B., 2010, TIME; Rotman D., 2012, P ACM 2012 C COMP SU, P217, DOI DOI 10.1145/2145204.2145238; Roy HE, 2012, UNDERSTANDING CITIZE; Rymes Betsy, 2017, DIVERSITY SUPER DIVE, P151; Rymes Betsy, 2014, WORKING PAPERS ED LI, V29, P25; Salk RH, 2011, PSYCHOL WOMEN QUART, V35, P18, DOI 10.1177/0361684310384107; Shannon A, 2015, BODY IMAGE, V15, P158, DOI 10.1016/j.bodyim.2015.09.003; Sladek MR, 2018, BODY IMAGE, V25, P66, DOI 10.1016/j.bodyim.2018.02.005; Sladek MR, 2014, BODY IMAGE, V11, P233, DOI 10.1016/j.bodyim.2014.02.005; Sturm U, 2017, RES IDEAS OUTCOMES; Sturtz Sreetharan CL, J SOCIOLINGUISTICS; Svendsen BA, 2018, J SOCIOLING, V22, P137, DOI 10.1111/josl.12276; Taylor N, 2015, SCHOOLED FAT WHAT TE; Tompkins KB, 2009, BODY IMAGE, V6, P292, DOI 10.1016/j.bodyim.2009.07.005; Tucker KL, 2007, BODY IMAGE, V4, P157, DOI 10.1016/j.bodyim.2006.12.005; Tzoneva M, 2015, EAT DISORD, V23, P439, DOI 10.1080/10640266.2015.1013396; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Vigliocco G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0292; Wolfram W., 2011, SAGE HDB SOCIOLINGUI, P296, DOI DOI 10.4135/9781446200957.N22; Wolfson N., 1988, 2 LANGUAGE DISCOURSE, P21	65	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217618	10.1371/journal.pone.0217618	http://dx.doi.org/10.1371/journal.pone.0217618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141560	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000068
J	Bruzzese, DJ; Wagner, DL; Harrison, T; Jogesh, T; Overson, RP; Wickett, NJ; Raguso, RA; Skogen, KA				Bruzzese, Daniel J.; Wagner, David L.; Harrison, Terry; Jogesh, Tania; Overson, Rick P.; Wickett, Norman J.; Raguso, Robert A.; Skogen, Krissa A.			Phylogeny, host use, and diversification in the moth family Momphidae (Lepidoptera: Gelechioidea)	PLOS ONE			English	Article							PALAEOMYSTELLA FLETCHER LEPIDOPTERA; PLANT ASSOCIATIONS; R-PACKAGE; ECOLOGICAL SPECIATION; HERBIVOROUS INSECTS; LIFE-HISTORY; EVOLUTION; DIVERSITY; BUTTERFLIES; PATTERNS	Insect herbivores and their hostplants constitute much of Earth's described biological diversity, but how these often-specialized associations diversify is not fully understood. We combined detailed hostplant data and comparative phylogenetic analyses of the lepidopteran family Momphidae to explore how shifts in the use of hostplant resources, not just hostplant taxon, contribute to the diversification of a phytophagous insect lineage. We inferred two phylogenetic hypotheses emphasizing relationships among species in the nominate genus, Mompha Hubner. A six-gene phylogeny was constructed with reared exemplars and collections from hostplants in the family Onagraceae from western and southwestern USA, and a cytochrome c oxidase subunit 1 (CO1) phylogeny was inferred from collections and publicly available accessions in the Barcode of Life Data System. Species delimitation analyses combined with morphological data revealed ca. 56 undescribed species-level taxa, many of which are hostplant specialists on Onagraceae in the southwestern USA. Our phylogenetic reconstructions divided Momphidae into six major clades: 1) an Onagraceae flower- and fruit-boring Glade, 2) a Melastomataceae-galling Glade, 3) a leafmining Glade A, 4) a leafmining Glade B, 5) a Zapyrastra Meyrick Glade, and 6) a monobasic lineage represented by Mompha eloisella (Clemens). Ancestral trait reconstructions using the COI phylogeny identified leafmining on Onagraceae as the ancestral state for Momphidae. Our study finds that shifts along three hostplant resource axes (plant taxon, plant tissue type, and larval feeding mode) have contributed to the evolutionary success and diversification of momphids.	[Bruzzese, Daniel J.; Wickett, Norman J.; Skogen, Krissa A.] Northwestern Univ, Dept Plant Biol & Conservat, Evanston, IL 60208 USA; [Bruzzese, Daniel J.; Jogesh, Tania; Overson, Rick P.; Wickett, Norman J.; Skogen, Krissa A.] Chicago Bot Garden, Div Plant Sci & Conservat, Glencoe, IL 60022 USA; [Wagner, David L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Overson, Rick P.] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Raguso, Robert A.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Bruzzese, Daniel J.] Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA	Northwestern University; University of Connecticut; Arizona State University; Arizona State University-Tempe; Cornell University; University of Notre Dame	Bruzzese, DJ (corresponding author), Northwestern Univ, Dept Plant Biol & Conservat, Evanston, IL 60208 USA.; Bruzzese, DJ (corresponding author), Chicago Bot Garden, Div Plant Sci & Conservat, Glencoe, IL 60022 USA.; Bruzzese, DJ (corresponding author), Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA.	dbruzzes@nd.edu	Skogen, Krissa/AAA-3370-2022; Wickett, Norman/AAV-8136-2021	Skogen, Krissa/0000-0002-7868-9632; Wickett, Norman/0000-0003-0944-1956; Overson, Rick/0000-0003-3728-6260; Bruzzese, Daniel/0000-0002-3115-6599	National Science Foundation [DEB 1342873, DEB 1342792]; Plant Biology and Conservation Program at Northwestern University; Hartford Foundation; USFS Co-op Agreement [14-CA-11420004-138]; Chicago Botanic Garden Division of Plant Science and Conservation	National Science Foundation(National Science Foundation (NSF)); Plant Biology and Conservation Program at Northwestern University; Hartford Foundation; USFS Co-op Agreement; Chicago Botanic Garden Division of Plant Science and Conservation	The authors thank the following for funding: National Science Foundation (https://www.nsf.gov/) DEB 1342873 to KAS and NJW, DEB 1342792 to RAR; the Plant Biology and Conservation Program at Northwestern University (https://www.plantbiology.northwestern.edu/) to DJB; USFS Co-op Agreement (https://www.fs.fed.us) 14-CA-11420004-138 to DLW; Richard P. Garmany Fund from the Hartford Foundation (http://www.hfpg.org/) to DLW, and the Chicago Botanic Garden Division of Plant Science and Conservation (https://www.chicagobotanic.org/) to DJB, TJ, RPO, NJW, and KAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Althoff DM, 2014, ECOL ENTOMOL, V39, P620, DOI 10.1111/een.12141; Althoff DM, 2012, MOL PHYLOGENET EVOL, V62, P898, DOI 10.1016/j.ympev.2011.11.024; Anstett DN, 2014, ECOLOGY, V95, P2915, DOI 10.1890/13-0932.1; Basilio DS, 2015, REV BRAS ENTOMOL, V59, P188, DOI 10.1016/j.rbe.2015.06.005; Becerra JX, 2015, P NATL ACAD SCI USA, V112, P6098, DOI 10.1073/pnas.1418643112; Becker VO, 2008, REV BRAS ENTOMOL, V52, P647, DOI 10.1590/S0085-56262008000400017; Becker Vitor O., 1999, Revista Brasileira de Zoologia, V16, P141; Bouckaert, 2015, BMODELTEST BAYESIAN, P1, DOI [10.1101/020792, DOI 10.1101/020792]; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Calatayud J, 2016, P NATL ACAD SCI USA, V113, P9840, DOI 10.1073/pnas.1608381113; Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Clausing G, 2001, AM J BOT, V88, P486, DOI 10.2307/2657114; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Condamine FL, 2018, SYST BIOL, V67, P940, DOI 10.1093/sysbio/syy009; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Cook JM, 2002, EVOLUTION, V56, P1821, DOI 10.1111/j.0014-3820.2002.tb00196.x; DOAK DF, 1992, ECOLOGY, V73, P2086, DOI 10.2307/1941457; Doorenweerd C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119586; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dugdale JS, 1988, LEPIDOPTERA ANNOTATE; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eiseman CS, 2016, P ENTOMOL SOC WASH, V118, P510, DOI 10.4289/0013-8797.118.4.510; Espeland M, 2015, MOL PHYLOGENET EVOL, V93, P296, DOI 10.1016/j.ympev.2015.08.006; Ezard T., 2009, SPLITS SPECIES LIMIT; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Forbes AA, 2017, EVOLUTION, V71, P1126, DOI 10.1111/evo.13164; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goodman KR, 2012, EVOLUTION, V66, P2798, DOI 10.1111/j.1558-5646.2012.01643.x; Hardy NB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2960; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; HODGES RW, 1992, J NEW YORK ENTOMOL S, V100, P203; Hodges RW, 1999, LEPIDOPTERA MOTHS BU; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jousselin E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-56; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kartesz J.T., 2015, N AM PLANT ATLAS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawakita A, 2010, P ROY SOC B-BIOL SCI, V277, P2765, DOI 10.1098/rspb.2010.0355; Lafontaine J Donald, 2013, Zookeys, P209, DOI 10.3897/zookeys.264.4441; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lin YP, 2015, ECOL ENTOMOL, V40, P299, DOI 10.1111/een.12191; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; Looney C, 2012, J LEPID SOC, V66, P233; Luz FA, 2014, ZOOKEYS, P97, DOI 10.3897/zookeys.433.7379; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Mayhew PJ, 2018, ENTOMOL EXP APPL, V166, P225, DOI 10.1111/eea.12673; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Moore LM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1819; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Nafus M.G., 2017, CLIMATE CHANGE RESPO, V4, P4, DOI DOI 10.1186/S40665-017-0032-9; Nakadai R, 2017, ECOL RES, V32, P811, DOI 10.1007/s11284-017-1500-1; Nakadai R, 2016, ECOL EVOL, V6, P4958, DOI 10.1002/ece3.2266; Nakadai R, 2015, ECOL ENTOMOL, V40, P14, DOI 10.1111/een.12148; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Ogilvie HA, 2017, MOL BIOL EVOL, V34, P2101, DOI 10.1093/molbev/msx126; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pellmyr O, 2006, SYST ENTOMOL, V31, P1, DOI 10.1111/j.1365-3113.2005.00301.x; Pohl G. R., 2015, Checklist of the Lepidoptera of British Columbia, Canada; Powell J. A., 2009, MOTHS W N AM; POWELL JA, 1980, ANNU REV ENTOMOL, V25, P133, DOI 10.1146/annurev.en.25.010180.001025; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Price PW, 2009, PLANT ANIMAL INTERAC, P3; Rambaut A., 2016, FIGTREE V1 4 3 2006; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RStudio Team, 2019, RSTUDIO INT DEV R; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P407, DOI 10.1016/j.baae.2005.07.001; Simonato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057192; Sohn JC, 2016, SYST ENTOMOL, V41, P112, DOI 10.1111/syen.12143; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Strong D., 1984, INSECTS PLANTS COMMU; Strutzenberger P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188430; Taylor RS, 2017, MOL ECOL, V26, P3330, DOI 10.1111/mec.14126; Toussaint EFA, 2016, ZOOL J LINN SOC-LOND, V178, P241, DOI 10.1111/zoj.12413; TOWNER HF, 1977, ANN MO BOT GARD, V64, P48, DOI 10.2307/2395236; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wagner DL, 2004, P ENTOMOL SOC WASH, V106, P1; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; White SN, 2016, NORTHEAST NAT, V23, P211, DOI 10.1656/045.023.0203; Wiens JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9370; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Yu H, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1239-5; Zhang B, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1649; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	117	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0207833	10.1371/journal.pone.0207833	http://dx.doi.org/10.1371/journal.pone.0207833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170152	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700001
J	Hong, M; Hwang, JT; Shin, EJ; Hur, HJ; Kang, K; Choi, HK; Chung, MY; Chung, S; Sung, MJ; Park, JH				Hong, Moonju; Hwang, Jin-Taek; Shin, Eun Ju; Hur, Haeng Jeon; Kang, Keunsoo; Choi, Hyo-Kyoung; Chung, Min-Yu; Chung, Sangwon; Sung, Mi Jeong; Park, Jae-Ho			Genome-wide analysis of DNA methylation identifies novel differentially methylated regions associated with lipid accumulation improved by ethanol extracts of Allium tubersosum and Capsella bursa-pastoris in a cell model	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HEPATIC STEATOSIS; HISTONE ACETYLATION; INSULIN-RESISTANCE; KAEMPFEROL; INHIBITION; GENES; DIET; EXPRESSION; PROMOTER	Hepatic steatosis is the most common chronic liver disease in Western countries. Both genetic and environmental factors are known as causes of the disease although their underlying mechanisms have not been fully understood. This study investigated the association of DNA methylation with oleic acid-induced hepatic steatosis. It also examined effects of food components on DNA methylation in hepatic steatosis. Genome-wide DNA methylation of oleic acid (OA)-induced lipid accumulation in vitro cell model was investigated using reduced representation bisulfite sequencing. Changes of DNA methylation were also analyzed after treatment with food components decreasing OA-induced lipid accumulation in the model. We identified total 81 regions that were hypermethylated by OA but hypomethylated by food components or vice versa. We determined the expression of seven genes proximally located at the selected differentially methylated regions. Expression levels of WDR27, GNAS, DOK7, MCF2L, PRKG1, and CMYA5 were significantly different between control vs OA and OA vs treatment with food components. We demonstrated that DNA methylation was associated with expression of genes in the model of hepatic steatosis. We also found that food components reversely changed DNA methylation induced by OA and alleviated lipid accumulation. These results suggest that DNA methylation is one of the mechanisms causing the hepatic steatosis and its regulation by food components provides insights that may prevent or alleviate lipid accumulation.	[Hong, Moonju; Hwang, Jin-Taek; Shin, Eun Ju; Hur, Haeng Jeon; Choi, Hyo-Kyoung; Chung, Min-Yu; Chung, Sangwon; Sung, Mi Jeong; Park, Jae-Ho] Korea Food Res Inst, Div Food Funct, Iseo Myeon, Wanju Gun, South Korea; [Hong, Moonju; Hwang, Jin-Taek] Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea; [Kang, Keunsoo] Dankook Univ, Coll Nat Sci, Dept Microbiol, Cheonan, South Korea	Korea Food Research Institute (KFRI); University of Science & Technology (UST); Dankook University	Park, JH (corresponding author), Korea Food Res Inst, Div Food Funct, Iseo Myeon, Wanju Gun, South Korea.	jaehopark@kfri.re.kr		PARK, JAE-HO/0000-0003-4428-436X; Kang, Keunsoo/0000-0003-0611-9320	Korea Food Research Institute [E0150301-05]	Korea Food Research Institute	This study was financially supported by grant from the Korea Food Research Institute (E0150301-05 to J-TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Al-Snafi AE, 2015, J PHARMACOL TOX MET, V5, P76; Alvarez MC, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0563-3; Aranaz P, 2017, FOOD FUNCT, V8, P3999, DOI [10.1039/c7fo00996h, 10.1039/C7FO00996H]; Arpon A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010015; Berger A, 2013, J NUTR BIOCHEM, V24, P977, DOI 10.1016/j.jnutbio.2012.07.001; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Cha JM, 2017, MOLECULES, V22, DOI 10.3390/molecules22061023; Chang CJ, 2011, PLANTA MED, V77, P1876, DOI 10.1055/s-0031-1279992; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Choi HK, 2017, J MED FOOD, V20, P251, DOI 10.1089/jmf.2016.3877; Choi NY, 2018, EPIGENETICS, V3, P1; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; D'Angelo CS, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0363-7; de Conti A, 2017, ONCOTARGET, V8, P88517, DOI 10.18632/oncotarget.19774; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Guo WL, 2014, NUCLEIC ACIDS RES, V42, P3009, DOI 10.1093/nar/gkt1306; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Heyman-Linden L, 2016, J NUTR BIOCHEM, V27, P79, DOI 10.1016/j.jnutbio.2015.08.022; Kanzleiter T, 2015, AM J PHYSIOL-ENDOC M, V308, pE912, DOI 10.1152/ajpendo.00289.2014; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Khalid N, 2014, J KOREAN SOC APPL BI, V57, P311, DOI 10.1007/s13765-014-4021-4; Khiewkamrop P, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0539-6; Lee J, 2017, MOL ASPECTS MED, V54, P78, DOI 10.1016/j.mam.2016.11.008; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Hoang MH, 2015, J NUTR BIOCHEM, V26, P868, DOI 10.1016/j.jnutbio.2015.03.005; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Park Jae-Ho, 2017, Mol Aspects Med, V54, P58, DOI 10.1016/j.mam.2017.01.008; Qiu W, 2017, CELL PHYSIOL BIOCHEM, V41, P1325, DOI 10.1159/000464435; Ramaiyan B, 2018, LIPIDS, V53, P581, DOI 10.1002/lipd.12074; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Shin EJ, 2017, CURR TOP NUTRACEUT R, V15, P1; Stockwell PA, 2014, BIOINFORMATICS, V30, P1814, DOI 10.1093/bioinformatics/btu126; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Turner ST, 2013, HYPERTENSION, V62, P391, DOI 10.1161/HYPERTENSIONAHA.111.00436; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014; Wang JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-11; Weinstein LS, 2010, INT J OBESITY, V34, P6, DOI 10.1038/ijo.2009.222; Wu JY, 2018, MED SCI MONITOR, V24, P6946, DOI 10.12659/MSM.909747; Yabuki Y, 2010, FOOD CHEM, V120, P343, DOI 10.1016/j.foodchem.2009.11.028; Yao H, 2018, PHARMACOL RES, V131, P51, DOI 10.1016/j.phrs.2018.03.017; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; YOSHIDA T, 1987, CHEM PHARM BULL, V35, P97; Yuk T, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/7420265; Zeng YW, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9402849; Zeybel M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0056-6; Zhang YH, 2015, INT J CLIN EXP MED, V8, P7535	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217877	10.1371/journal.pone.0217877	http://dx.doi.org/10.1371/journal.pone.0217877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170227	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700075
J	Kim, KH; Kim, HS; Kang, MS; Park, SS				Kim, Keong-Hwan; Kim, Han-Soo; Kang, Michael Seungcheol; Park, Soo-Sung			Varus shearing force is a main injury mechanism of pediatric trampoline-related injury in addition to compressive axial loading	PLOS ONE			English	Article							CHILDREN; FRACTURE; PATTERNS	Background Many case studies have been published about trampoline-related injury (TRI); however, a comparative study could allow a more specific analysis of the characteristics of TRI, and enable more differentiated approaches to prevent such injuries. We investigated the injury mechanism of TRI in children compared with other pediatric trauma. Methods Of 35,653 children (age 0-18 years) who visited the pediatric emergency department after traumatic injuries from January 2011 to June 2017, 372 patients with TRI (TRI group) were retrospectively identified. Among the remaining 35,281 patients with other trauma (non-TRI group), 372 were 1: 1 matched to the TRI group according to sex, age, injured body part, and body weight (matched-control group). The patients' data, injured site, and injury patterns were compared between the groups. Results The most frequently injured body part was the knee/lower leg in the TRI group and the head in the non-TRI group. The most frequent injury types were fractures in the TRI group and open wounds in the non-TRI group. In the comparison between the TRI and matched-control groups, the most common lower-extremity fractures were proximal tibial fractures with varus angulation in the TRI group and tibial shaft spiral fractures in the matched-control group. For the upper extremities, the risk of lateral condylar humeral fracture was higher in the TRI group. The TRI group presented more physeal involvements. Conclusions The risks of varus stress injury (proximal tibial fracture with varus angulation in lower extremity and lateral condylar humeral fracture in upper extremity) were higher in the TRI group than in matched-control group. Thus, varus shearing force seems to be an important injury mechanism in TRI in addition to compressive force. This varus force may increase the risk of physeal injury by generating additional shear force on the physis.	[Kim, Keong-Hwan; Kang, Michael Seungcheol; Park, Soo-Sung] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Keong-Hwan] Kangwon Natl Univ Hosp, Dept Orthopaed Surg, Chuncheon Si, Gangwon Do, South Korea; [Kim, Han-Soo] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kang, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea.	kang@amc.seoul.kr		Kang, Michael Seungcheol/0000-0002-0172-2721	Asan Medical Center Children's Hospital, Seoul, Korea [2017-0384]	Asan Medical Center Children's Hospital, Seoul, Korea	This study was supported by a grant (2017-0384) from Asan Medical Center Children's Hospital, Seoul, Korea.	Adams AL, 2013, INJURY PREV, V19, P191, DOI 10.1136/injuryprev-2012-040341; [Anonymous], 1999, Pediatrics, V103, P1053; Ashby K, 2015, AUST NZ J PUBL HEAL, V39, P491, DOI 10.1111/1753-6405.12404; Blumetti FC, 2016, J PEDIATR ORTHOP B, V25, P133, DOI 10.1097/BPB.0000000000000255; BOYER RS, 1986, AM J ROENTGENOL, V146, P83, DOI 10.2214/ajr.146.1.83; Briskin S, 2012, PEDIATRICS, V130, P774, DOI 10.1542/peds.2012-2082; Hurson C, 2007, J PEDIATR ORTHOPED, V27, P729, DOI 10.1097/BPO.0b013e318155ab1; John SD, 1996, RADIOGRAPHICS, V16, P1443, DOI 10.1148/radiographics.16.6.8946546; Kakel R, 2012, ORTHOP TRAUMATOL-SUR, V98, P446, DOI 10.1016/j.otsr.2012.02.007; Kang S, 2015, J ORTHOP TRAUMA, V29, pE253, DOI 10.1097/BOT.0000000000000322; Linakis JG, 2007, ACAD EMERG MED, V14, P539, DOI [10.1197/j.aem.2007.01.018, 10.1111/j.1553-2712.2007.tb01826.x]; McDermott C, 2006, J BONE JOINT SURG BR, V88B, P796, DOI 10.1302/0301-620X.88B6; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Sandler G, 2011, PEDIATR EMERG CARE, V27, P1052, DOI 10.1097/PEC.0b013e318235e9e0; Smith GA, 1998, PEDIATRICS, V101, P406, DOI 10.1542/peds.101.3.406; Smith GA, 1998, ARCH PEDIAT ADOL MED, V152, P694; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Wootton M, 2009, EMERG MED J, V26, P728, DOI 10.1136/emj.2008.069344	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217863	10.1371/journal.pone.0217863	http://dx.doi.org/10.1371/journal.pone.0217863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31167002	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800044
J	Bouassa, RSM; Nodjikouambaye, ZA; Sadjoli, D; Adawaye, C; Pere, H; Veyer, D; Matta, M; Robin, L; Tonen-Wolyec, S; Moussa, AM; Koyalta, D; Belec, L				Bouassa, Ralph-Sydney Mboumba; Nodjikouambaye, Zita Aleyo; Sadjoli, Damtheou; Adawaye, Chatte; Pere, Helene; Veyer, David; Matta, Mathieu; Robin, Leman; Tonen-Wolyec, Serge; Moussa, Ali Mahamat; Koyalta, Donato; Belec, Laurent			High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad	PLOS ONE			English	Article							ANYPLEX II HPV28; PERFORMANCE EVALUATION; CANCER; HEALTH; FEASIBILITY; ANTIBODIES; NEOPLASIA; AFRICA; BURDEN; ASSAY	Background We conducted in 2018 a descriptive, quantitative, population-based, cross-sectional survey estimating the prevalence of cervical high-risk human papillomavirus (HR-HPV) infection and associated risk factors among adult women living in N'Djamena, Chad. Methods Five of the 10 districts of N'Djamena were randomly selected for inclusion. Peer educators contacted adult women in community-churches or women association networks to participate in the survey and come to the clinic for women's sexual health "La Renaissance Plus", N'Djamena. Medical, socio-demographical and behavioral informations were collected. HPV DNA was detected and genotyped in endocervical swab using Anyplex II HPV28 genotyping test (Seegene, Seoul, South Korea). Results 253 women (mean age, 35.0 years; range, 25-65) including 3.5% of HIV-positive women were prospectively enrolled. The prevalence of HPV infection was 22.9%, including 68.9% of HR-HPV infection and 27.6% being infected with multiple genotypes, providing a total HR-HPV prevalence of 15.8% (95% CI%: 11.3-20.3). The most prevalent HR-HPV genotypes were HPV-58, HPV-35, HPV-56, HPV-31, HPV-16, HPV-45, HPV-52 and HPV18. HPV types targeted by the prophylactic Gardasil-9 vaccine were detected in nearly 70% (67.5%) and HPV-58 was the most frequently detected. HIV infection was a risk factor strongly associated with cervical infection with any HPV [adjusted Odds ratio (aOR): 17.4], multiple types of HPV (aOR: 8.9), HR-HPV (aOR: 13.2) and cervical infection with multiple HR-HPV (aOR: 8.4). Conclusion These observations highlight the unsuspected high burden of cervical HR-HPV infection in Chadian women, and point the potential risk of further development of HPV-associated cervical precancerous and neoplastic lesions in a large proportion of women in Chad. The high rate of preventable Gardasil-9 vaccine genotypes constitutes the rationale for introducing primary vaccine prevention against cervical cancer in young female adolescents living in Chad.	[Bouassa, Ralph-Sydney Mboumba; Nodjikouambaye, Zita Aleyo; Tonen-Wolyec, Serge] Ecole Doctorale Reg Infectiol Trop Franceville, Franceville, Gabon; [Bouassa, Ralph-Sydney Mboumba; Pere, Helene; Veyer, David; Matta, Mathieu; Robin, Leman; Belec, Laurent] Univ Paris Descartes Paris V, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Fac Med Paris Descartes,Lab Virol, Paris, France; [Nodjikouambaye, Zita Aleyo; Sadjoli, Damtheou] Hop Mere & Enfant, Serv Gynecol Obstet, Ndjamena, Chad; [Nodjikouambaye, Zita Aleyo; Sadjoli, Damtheou] Cabinet Med Gynecol Obstet La Renaissance Plus, Ndjamena, Chad; [Sadjoli, Damtheou; Moussa, Ali Mahamat] Univ NDjamena, Fac Sci Sante Humaine, Ndjamena, Chad; [Adawaye, Chatte] Inst Natl Super Sci & Tech Abeche, Abeche, Chad; [Tonen-Wolyec, Serge] Univ Bunia, Fac Med, Bunia, DEM REP CONGO; [Tonen-Wolyec, Serge] Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO; [Moussa, Ali Mahamat] Hop Gen Reference Natl, Serv Gastroenterol, Ndjamena, Chad; [Koyalta, Donato] UNAIDS, Ndjamena, Chad	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Nodjikouambaye, ZA (corresponding author), Ecole Doctorale Reg Infectiol Trop Franceville, Franceville, Gabon.; Nodjikouambaye, ZA (corresponding author), Hop Mere & Enfant, Serv Gynecol Obstet, Ndjamena, Chad.; Nodjikouambaye, ZA (corresponding author), Cabinet Med Gynecol Obstet La Renaissance Plus, Ndjamena, Chad.	aleyozita@gmail.com	Tonen-Wolyec, Serge/ADM-2951-2022	Tonen-Wolyec, Serge/0000-0002-7734-7729; Adawaye, Chatte/0000-0003-4363-0283; Nodjikouambaye, Zita Aleyo/0000-0002-0477-2652	Gabonese Government	Gabonese Government	The authors received support in the form of multiplex PCR kits from Bernard Chaffringeon, V-Veil-Up Pharma Ltd., Nicosia, Cyprus. Ralph-Sydney Mboumba Bouassa is a PhD student from the Ecole Doctorale en Infectiologie Tropicale, Franceville, Gabon, benefiting from a scholarship of the Gabonese Government and is holder of merit from the Agence Universitaire de la Francophonie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamowo SN, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00178; Adler D, 2013, J IMMUNOL TECH INFEC, V2, DOI [10.4172/2329-9541.1000106, DOI 10.4172/2329-9541.1000106]; Akarolo-Anthony SN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-656; Akarolo-Anthony SN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-521; Alliance for Cervical Cancer Prevention, 2004, CERV CANC PREV ISS D, V3; Bessimbaye N, 2014, Bull Soc Pathol Exot, V107, P327, DOI 10.1007/s13149-014-0386-1; Bouassa RSM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197845; Bouassa RSM, 2017, EXPERT REV ANTI-INFE, V15, P613, DOI 10.1080/14787210.2017.1322902; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Catarino R, 2016, CANCER EPIDEMIOL, V42, P159, DOI 10.1016/j.canep.2016.04.013; Catarino R, 2016, CANCER EPIDEMIOL, V40, P60, DOI 10.1016/j.canep.2015.11.008; Chen Y, 2017, WOMENS HEALTH, V13, P58, DOI 10.1177/1745505717731011; Cubie HA, 2017, J CLIN VIROL, V87, P1, DOI 10.1016/j.jcv.2016.11.014; Dartell M, 2013, SEX TRANSM DIS, V40, P737, DOI 10.1097/OLQ.0000000000000005; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Ebrahim S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146603; Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finocchario-Kessler S, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0306-6; Gallagher KE, 2017, PAPILLOMAVIRUS RES, V4, P72, DOI 10.1016/j.pvr.2017.09.001; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170189; Institut National de la Statistique des Etudes Economiques et De mographiques (INSEED) Ministerede la Sante Publique (MSP) et ICF International, 2014, ENQ DEM SANT IND MUL; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kennedy NT, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.85.8510; Kunckler M, 2017, CANCER MED-US, V6, P1752, DOI 10.1002/cam4.1089; Kwon MJ, 2014, J CLIN VIROL, V59, P246, DOI 10.1016/j.jcv.2014.01.015; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Lewis FMT, 2017, OBSTET GYNECOL, V129, P643, DOI [10.1097/aog.0000000000001932, 10.1097/AOG.0000000000001932]; Lynge E, 2014, APMIS, V122, P667, DOI 10.1111/apm.12279; Manga MM, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0035-8; Marcuccilli F, 2015, J VIROL METHODS, V217, P8, DOI 10.1016/j.jviromet.2015.02.018; Ruiz-Sternberg AM, 2018, PAPILLOMAVIRUS RES, V5, P63, DOI 10.1016/j.pvr.2017.12.004; Mbatha JN, 2017, INFECT DIS-NOR, V49, P601, DOI 10.1080/23744235.2017.1312513; Mbulawa ZZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190166; Mbulawa ZZA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1181-8; Meader N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3373-6; Mortier E, 2016, Bull Soc Pathol Exot, V109, P180, DOI 10.1007/s13149-016-0496-z; Ngabo F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1539-6; Ogembo RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122488; Okunade KS, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.227.13979; Omar VE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015653; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pasquier C, 2017, DIAGN MICR INFEC DIS, V87, P25, DOI 10.1016/j.diagmicrobio.2016.08.022; Petrelli A, 2016, J LOW GENIT TRACT DI, V20, P321, DOI 10.1097/LGT.0000000000000240; Robin L, 2018, J VIROL METHODS, V253, P1, DOI 10.1016/j.jviromet.2017.12.001; Sangwa-Lugoma G, 2011, SEX TRANSM DIS, V38, P308, DOI 10.1097/OLQ.0b013e3181fc6ec0; Scheurer ME, 2005, INT J GYNECOL CANCER, V15, P727, DOI 10.1111/j.1525-1438.2005.00246.x; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Teunis N., 2001, AIDS BEHAV, V5, P173, DOI DOI 10.1023/A:1011335129358; Traore I M A, 2016, Pak J Biol Sci, V19, P306, DOI 10.3923/pjbs.2016.306.311; Traore IMA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7092583; Watson-Jones D, 2013, SEX TRANSM INFECT, V89, P358, DOI 10.1136/sextrans-2012-050685; World Health Organization, 2016, PROJ MORT CAUS DEATH; World Health Organization (WHO), 2014, HUM PAP VACC WHO POS; Zhai LK, 2016, ANTIVIR RES, V130, P101, DOI 10.1016/j.antiviral.2016.03.016	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217486	10.1371/journal.pone.0217486	http://dx.doi.org/10.1371/journal.pone.0217486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158254	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700018
J	Kufa, T; Shubber, Z; MacLeod, W; Takuva, S; Carmona, S; Bor, J; Gorgens, M; Pillay, Y; Puren, A; Eaton, JW; Fraser-Hurt, N				Kufa, Tendesayi; Shubber, Zara; MacLeod, William; Takuva, Simbarashe; Carmona, Sergio; Bor, Jacob; Gorgens, Marelize; Pillay, Yogan; Puren, Adrian; Eaton, Jeffrey W.; Fraser-Hurt, Nicole			CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data	PLOS ONE			English	Article							ADVANCED HIV DISEASE; ART INITIATION; CELL RECOVERY; RISK; COVERAGE; BURDEN	Background We describe CD4 count recovery among HIV positive individuals who initiated antiretroviral therapy (ART) with and without severe immune suppression using complete laboratory data from South Africa's national HIV treatment programme between 2010 and 2014 and discuss implications for CD4 count monitoring. Methods Retrospective analysis of routinely collected laboratory data from South Africa's National Health Laboratory Service (NHLS). A probabilistic record linkage algorithm was used to create a cohort of HIV positive individuals who initiated ART between 2010 and 2014 based on timing of CD4 count and viral load measurements. A CD4 count < 50 copies/mu l at ART initiation was considered severe immunosuppression. A multivariable piecewise mixed-effects linear regression model adjusting for age, gender, year of starting ART, viral suppression in follow up and province was used to predict CD4 counts during follow up. Results 1,070,900 individuals had evidence of starting ART during 2010-2014 and met the criteria for inclusion in the cohort -46.6% starting ART with CD4 < 200 cells/mu l and 10.1% with CD4 < 50 cells/mu l. For individuals with CD4 counts < 200 cells/mu l, predicted CD4 counts > 200 cells/mu l, > 350 cells/mu l and > 500 cells/mu l corresponded with mean follow up durations of 1.5 years (standard deviation [s.d] 1.1), 1.9years (s.d 1.2) and 2.1 years (s.d 1.3 years). For those with CD4 counts < 50 cells/mu l, predicted CD4 count above these threshold corresponded with mean follow up durations of 2.5 years (s.d 0.9 years), 4.4 years (s.d 0.4 years) and 5.0 years (s.d 0.1years) for recovery to the same thresholds. CD4 count recovery varied mostly with duration on ART, CD4 count at the start of ART and gender. Conclusion For individuals starting with ART with severe immunosuppression, CD4 recovery to 200cells/mu l did not occur or took longer than 12 month for significant proportions. CD4 monitoring and interventions recommended for advanced HIV disease should continue until full recovery.	[Kufa, Tendesayi; Puren, Adrian] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Kufa, Tendesayi] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Shubber, Zara; Gorgens, Marelize; Fraser-Hurt, Nicole] World Bank Grp, Washington, DC USA; [MacLeod, William; Bor, Jacob] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [MacLeod, William] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off HE2RO,Dept Internal, Johannesburg, South Africa; [Takuva, Simbarashe] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Carmona, Sergio] Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Div Virol, Johannesburg, South Africa; [Eaton, Jeffrey W.] Imperial Coll, Dept Infect Dis Epidemiol, London, England	National Institute for Communicable Diseases (NICD); University of Witwatersrand; The World Bank; Boston University; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Imperial College London	Kufa, T (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Kufa, T (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	tendesayikc@nicd.ac.za	Pillay, Yogan/AAW-4966-2021; Puren, Adrian/AAC-2065-2020; Takuva, Simba/G-7735-2012	Pillay, Yogan/0000-0003-2700-6181; Puren, Adrian/0000-0001-7531-4010; Takuva, Simba/0000-0001-6030-2359; MacLeod, William/0000-0001-8003-8874; Eaton, Jeffrey/0000-0001-7728-728X; Kufa, Tendesayi/0000-0002-9797-616X	United Kingdom's Department for International Development (DFID); MRC [MR/R015600/1] Funding Source: UKRI	United Kingdom's Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Zara Shubber, Marelize Gorgens and Nicole Fraser-Hurt were funded by the United Kingdom's Department for International Development (DFID). The rest of the authors received no specific funding for the work. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Ballah N. J, 2016, DETERMINANTS CD4 IMM; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Department of Health Republic of South Africa, 2015, NAT CONS GUID PREV M; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Fatti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100273; Ford N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20061; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Fox MP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002589; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; He L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148915; Kanters S, 2014, ANTIVIR THER, V19, P31, DOI 10.3851/IMP2670; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kroeze S, 2018, AIDS, V32, P1043, DOI [10.1097/QAD.0000000000001801, 10.1097/qad.0000000000001801]; Kwofie Theophilus B, 2015, BMC Res Notes, V8, P413, DOI 10.1186/s13104-015-1406-3; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Means AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164148; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; National Department of Health, 2015, AN BIG DAT BETT TARG; National Department of Health Republic of South Africa, 2004, NAT ANT TREATM GUID; National Department of Health Republic of South Africa, 2016, IMPL UN TEST TREAT S; Osler M, 2018, CLIN INFECT DIS, V66, pS118, DOI 10.1093/cid/cix1140; Patten GE, 2014, CLIN INFECT DIS, V59, P456, DOI 10.1093/cid/ciu288; Simms V, 2018, AIDS; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Waters L, 2011, EXPERT REV ANTI-INFE, V9, P877, DOI [10.1586/eri.11.106, 10.1586/ERI.11.106]	33	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217742	10.1371/journal.pone.0217742	http://dx.doi.org/10.1371/journal.pone.0217742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150489	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100096
J	Tembo, T; Simuyandi, M; Chiyenu, K; Sharma, A; Chilyabanyama, ON; Mbwili-Muleya, C; Mazaba, ML; Chilengi, R				Tembo, Tannia; Simuyandi, Michelo; Chiyenu, Kanema; Sharma, Anjali; Chilyabanyama, Obvious N.; Mbwili-Muleya, Clara; Mazaba, Mazyanga Lucy; Chilengi, Roma			Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia	PLOS ONE			English	Article							MASS VACCINATION; DISEASE	Introduction In 2016, for the very first time, the Ministry of Health in Zambia implemented a reactive outbreak response to control the spread of cholera and vaccinated at-risk populations with a single dose of Shancol-an oral cholera vaccine (OCV). This study aimed to assess the costs of cholera illness and determine the cost-effectiveness of the 2016 vaccination campaign. Methodology From April to June 2017, we conducted a retrospective cost and cost-effectiveness analysis in three peri-urban areas of Lusaka. To estimate costs of illness from a household perspective, a systematic random sample of 189 in-patients confirmed with V. cholera were identified from Cholera Treatment Centre registers and interviewed for out-of-pocket costs. Vaccine delivery and health systems costs were extracted from financial records at the District Health Office and health facilities. The cost of cholera treatment was derived by multiplying the subsidized cost of drugs by the quantity administered to patients during hospitalisation. The cost-effectiveness analysis measured incremental cost-effectiveness ratio-cost per case averted, cost per life saved and cost per DALY averted-for a single dose OCV. Results The mean cost per administered vaccine was US$1.72. Treatment costs per hospitalized episode were US$14.49-US$18.03 for patients <= 15 years old and US$17.66-US$35.16 for older patients. Whereas households incurred costs on non-medical items such as communication, beverages, food and transport during illness, a large proportion of medical costs were borne by the health system. Assuming vaccine effectiveness of 88.9% and 63%, a life expectancy of 62 years and Gross Domestic Product (GDP) per capita of US$1,500, the costs per case averted were estimated US$369-US$532. Costs per life year saved ranged from US$18,515-US$27,976. The total cost per DALY averted was estimated between US $698-US$1,006 for patients. 15 years old and US$666-US$1,000 for older patients. Conclusion Our study determined that reactive vaccination campaign with a single dose of Shancol for cholera control in densely populated areas of Lusaka was cost-effective.	[Tembo, Tannia; Simuyandi, Michelo; Chiyenu, Kanema; Sharma, Anjali; Chilyabanyama, Obvious N.; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mbwili-Muleya, Clara] Minist Hlth, Lusaka Dist Hlth Off, Lusaka, Zambia; [Mazaba, Mazyanga Lucy] Zambia Natl Publ Hlth Inst, Lusaka, Zambia		Tembo, T (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	tanniatembo@gmail.com	Simuyandi, Michelo/I-5598-2018	Simuyandi, Michelo/0000-0002-7348-2835; Sharma, Anjali/0000-0002-8189-0732; Tembo, Tannia/0000-0003-3800-371X	Centre for Infectious Disease Research in Zambia; Agence de Medecine Preventive	Centre for Infectious Disease Research in Zambia; Agence de Medecine Preventive	This work was partially funded by the Centre for Infectious Disease Research in Zambia (CIDRZ-http://www.cidrz.org/) and Agence de Medecine Preventive (AMP-http://www.who.int/workforcealliance/members_partners/member_list/aamp/en/).CIDRZ designed the data tools, trained field staff, collected and analysed data and prepared the manuscript for publication. AMP provided technical assistance for the study design and development of data collection tools. They also participated in piloting the data tools.	Abubakar A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001901; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Awalime DK, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0182-2; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Central Statistical Office, 2014, 2010 CENS POP HOUS L; Chaignat CL, 2007, BMC J HLTH POPULATIO, V25; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Anh DD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001712; Deen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088139; Desai SN, 2016, LANCET GLOB HEALTH, V4, pE223, DOI 10.1016/S2214-109X(16)00037-1; DuBois AE, 2006, EPIDEMIOL INFECT, V134, P1226, DOI 10.1017/S0950268806006273; Ferreras E, 2018, NEW ENGL J MED, V378, P577, DOI 10.1056/NEJMc1711583; Ilboudo PG, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2885-8; Ilboudo PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185041; Ivers LC, 2015, LANCET GLOB HEALTH, V3, pE162, DOI 10.1016/S2214-109X(14)70368-7; IVI WHO DOVE., 2016, CHOLTOOL PLANN COST; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Kar SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002629; Khan AI, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006652; Khan IA, 2013, VACCINE, V31, P6058, DOI 10.1016/j.vaccine.2013.10.021; Kim SY, 2011, SAMJ S AFR MED J, V101, P659; Kimball AM, 2005, REV SCI TECH OIE, V24, P825, DOI 10.20506/rst.24.3.1619; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-8; Lantagne D., 2017, WASH INTERVENTIONS D; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Medical Stores Limited, 2016, MSL DRUG CAT; Mogasale V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005124; Morgan W, 2017, COSTING ORAL CHOLERA; Olu O, 2013, East Afr Med J, V90, P324; Parker LA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005652; Poncin M, 2018, B WORLD HEALTH ORGAN, V96, P86, DOI 10.2471/BLT.16.189241; Poulos C, 2011, EPIDEMIOLOGY INFECT, V18, P1, DOI DOI 10.1017/S095026881000316X; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Rice DP, 1967, AM J PUBLIC HLTH, V57; Sack DA, 2006, J HEALTH POPUL NUTR, V24, P1; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Schaetti C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001844; Sinyange N, 2018, MORBIDITY MORTALITY, V67; Siziya S, 2017, HLTH PRESS, V2, P6; Taylor DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135676; Teshome S, 2018, HUM VACC IMMUNOTHER, V14, P2427, DOI 10.1080/21645515.2018.1460295; Whittington D, 2017, EC COSTS BENEFITS CH; World Health Organisation, 2017, WHO POS PAP; World Health Organisation, 2008, CHOOD INT AR COST EF; World Health Organization, 2016, WHO PREQ VACC; World Health Organization, 2016, CHOL FACT SHEET; World Health Organization, 2001, MACR HLTH INV HLTH E	48	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0215972	10.1371/journal.pone.0215972	http://dx.doi.org/10.1371/journal.pone.0215972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150406	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100013
J	Maucieri, C; Nicoletto, C; Zanin, G; Birolo, M; Trocino, A; Sambo, P; Borin, M; Xiccato, G				Maucieri, Carmelo; Nicoletto, Carlo; Zanin, Giampaolo; Birolo, Marco; Trocino, Angela; Sambo, Paolo; Borin, Maurizio; Xiccato, Gerolamo			Effect of stocking density of fish on water quality and growth performance of European Carp and leafy vegetables in a low-tech aquaponic system	PLOS ONE			English	Article							CATFISH CLARIAS-GARIEPINUS; COMMON CARP; BODY-COMPOSITION; L.; SUSTAINABILITY; OPTIMIZATION; CHALLENGES; WELFARE; YIELD; PLANT	Aquaponics (AP) is a semi-closed system of food production that combines aquaculture and hydroponics and represents a new agricultural system integrating producers and consumers. The aim of this study was to test the effect of stocking densities (APL, 2.5 kg m(-3); APH, 4.6 kg m(-3)) on water quality, growth performance of the European Carp (Cyprinus carpio L.), and yield of leafy vegetables (catalogna, lettuce, and Swiss Chard) in a low-technology AP pilot system compared to a hydroponic cultivation. The AP daily consumption of water due to evapotranspiration was not different among treatments with an average value of 8.2 L d(-1), equal to 1.37% of the total water content of the system. Dissolved oxygen was significantly (p < 0.05) different among treatments with the lowest median value recorded with the highest stocking density of fish (5.6 mg L-1) and the highest median value in the hydroponic control (8.7 mg L-1). Marketable yield of the vegetables was significantly different among treatments with the highest production in the hydroponic control for catalogna (1.2 kg m(-2)) and in the APL treatment for Swiss Chard (5.3 kg m(-2)). The yield of lettuce did not differ significantly between hydroponic control and APL system (4.0 kg m(-2) on average). The lowest production of vegetables was obtained in the APH system. The final weight (515 g vs. 413 g for APL and APH, respectively), specific growth rate (0.79% d(-1) vs. 0.68% d(-1)), and feed conversion (1.55 vs. 1.86) of European Carp decreased when stocking density increased, whereas total yield of biomass was higher in the APH system (4.45 kg m(-3) vs. 6.88 kg m(-3)). A low mortality (3% on average) was observed in both AP treatments. Overall, the results showed that a low initial stocking density at 2.5 kg m(-3) improved the production of European Carp and of leafy vegetables by maintaining a better water quality in the tested AP system.	[Maucieri, Carmelo; Nicoletto, Carlo; Zanin, Giampaolo; Birolo, Marco; Sambo, Paolo; Borin, Maurizio; Xiccato, Gerolamo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy; [Trocino, Angela] Univ Padua, Dept Comparat Biomed & Food Sci BCA, Padua, Italy	University of Padua; University of Padua	Nicoletto, C (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	carlo.nicoletto@unipd.it	Maucieri, Carmelo/ABF-4069-2020; Zanin, Giampaolo/F-3362-2019; Birolo, Marco/AAH-1905-2019; XICCATO, GEROLAMO/AAR-6788-2020; borin, maurizio/AAY-1399-2021; sambo, Paolo/B-6742-2014	Maucieri, Carmelo/0000-0003-4004-6612; Zanin, Giampaolo/0000-0002-5366-1756; Birolo, Marco/0000-0002-1236-4456; XICCATO, GEROLAMO/0000-0003-4572-3635; borin, maurizio/0000-0002-4074-2098; sambo, Paolo/0000-0003-4348-8838	University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE) [BIRD 179231]; University of Padova	University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE); University of Padova	This project was realized through the following fund "Project Acquaponica: nuovi sistemi integrati per un'agricoltura sostenibile - 2017 - prot. BIRD 179231 -University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE)." The funder (University of Padova) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman S., 2015, THESIS; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Bassmann B, 2017, WATER-SUI, V9, DOI 10.3390/w9070504; Biswas JK, 2006, AQUACULTURE, V261, P952, DOI 10.1016/j.aquaculture.2006.08.021; Delaide B, 2016, WATER-SUI, V8, DOI 10.3390/w8100467; Ellis T, 2002, J FISH BIOL, V61, P493, DOI [10.1006/jfbi.2002.2057, 10.1111/j.1095-8649.2002.tb00893.x]; Endut A, 2016, DESALIN WATER TREAT, V57, P29531, DOI 10.1080/19443994.2016.1184593; Fallovo C, 2009, J SCI FOOD AGR, V89, P1682, DOI 10.1002/jsfa.3641; Goddek S, 2015, SUSTAINABILITY-BASEL, V7, P4199, DOI 10.3390/su7044199; HACHMANN TL, 2017, CADERNO CIENCIAS AGA, V9, P48; Hambly AC, 2015, WATER RES, V83, P112, DOI 10.1016/j.watres.2015.06.037; Hengsawat K, 1997, AQUACULTURE, V152, P67, DOI 10.1016/S0044-8486(97)00008-2; Hussain T, 2014, J WORLD AQUACULT SOC, V45, P652, DOI 10.1111/jwas.12159; Hussain T, 2015, AQUACULT INT, V23, P369, DOI 10.1007/s10499-014-9821-3; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Knaus U, 2017, AQUACULTURE, V473, P62, DOI 10.1016/j.aquaculture.2017.01.020; Konig B, 2018, J CLEAN PROD, V180, P232, DOI 10.1016/j.jclepro.2018.01.037; Ku┬nig B., 2016, ECOCYCLES, V2, P26, DOI [10.19040/ecocycles.v2i1.50, DOI 10.19040/ecocycles.v2i1.50]; Lam SS, 2015, INT BIODETER BIODEGR, V102, P107, DOI 10.1016/j.ibiod.2015.03.012; Lee PG, 2000, AQUACULT ENG, V23, P37, DOI 10.1016/S0144-8609(00)00046-7; Lennard WA, 2006, AQUACULT INT, V14, P539, DOI 10.1007/s10499-006-9053-2; Li DP, 2012, FISH PHYSIOL BIOCHEM, V38, P511, DOI 10.1007/s10695-011-9531-y; Losordo TM, 1999, SRAC PUBLICATION, V453, P1; Maucieri C, 2018, ITAL J AGRON, V13, P1, DOI 10.4081/ija.2017.1012; Nicoletto C, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050075; Nicoletto C, 2013, J SCI FOOD AGR, V93, P1397, DOI 10.1002/jsfa.5906; Oyugi DO, 2012, J THERM BIOL, V37, P89, DOI 10.1016/j.jtherbio.2011.11.005; Palm HW, 2018, AQUACULT INT, V26, P813, DOI 10.1007/s10499-018-0249-z; Palm Harry W., 2014, AACL Bioflux, V7, P162; dos Santos MJPL, 2016, URBAN FOR URBAN GREE, V20, P402, DOI 10.1016/j.ufug.2016.10.004; Pantanella E, 2012, ACTA HORTIC, V927, P887, DOI 10.17660/ActaHortic.2012.927.109; Peteri A., 2004, CULTURED AQUATIC SPE; Qi CL, 2016, J WORLD AQUACULT SOC, V47, P358, DOI 10.1111/jwas.12278; Rakocy J. E., 2006, SRAC Publication - Southern Regional Aquaculture Center, P1; Rakocy J.E., 2012, AQUACULTURE PRODUCTI, P344, DOI [10.1002/9781118250105.CH14, DOI 10.1002/9781118250105.CH14, 10.1002/9781118250105.ch14]; Rakocy JE, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.648.8; Rayhan M.Z., 2018, INT J ENV AGR BIOTEC, V3, P239073, DOI [/10.22161/ijeab/3, DOI 10.22161/IJEAB/3, 10.22161/ijeab/3.2.5, DOI 10.22161/IJEAB/3.2.5]; Refaey MM, 2018, AQUACULTURE, V492, P73, DOI 10.1016/j.aquaculture.2018.04.003; Sammouth S, 2009, AQUACULT ENG, V40, P72, DOI 10.1016/j.aquaeng.2008.11.004; Smith DC, 2001, SCI HORTIC-AMSTERDAM, V91, P393, DOI 10.1016/S0304-4238(01)00273-4; Somerville C., 2014, FAO FISH AQUAC TECH; Tan CX, 2018, TURK J FISH AQUAT SC, V18, P9, DOI 10.4194/1303-2712-v18_1_02; Tyson R. V., 2004, Proceedings of the Florida State Horticultural Society, V117, P79; Tyson RV, 2011, HORTTECHNOLOGY, V21, P6, DOI 10.21273/HORTTECH.21.1.6; Van Woensel L, 10 TECHNOLOGIES WHIC; Villaverde S, 1997, WATER RES, V31, P1180, DOI 10.1016/S0043-1354(96)00376-4; Yildiz HY, 2017, WATER-SUI, V9, DOI 10.3390/w9010013	47	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217561	10.1371/journal.pone.0217561	http://dx.doi.org/10.1371/journal.pone.0217561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145750	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500023
J	Fan, XY; Zhu, J; Dong, WB; Sun, YD; Lv, C; Guo, BJ; Xu, RG				Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen			Comparison of pasting properties measured from the whole grain flour and extracted starch in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							VISCO ANALYZER RVA; PHYSICOCHEMICAL PROPERTIES; MALT; RETROGRADATION; PROTEINS	Pasting properties of barley starch are important characteristics from a processing standpoint. The isolation of starch form barley grains is time consuming thus the whole grain flour is always used. To compare pasting properties of starch with those of the whole grain flour, we used a Rapid Visco Analyser (RVA) to measure pasting properties of three types of samples: grain flour and starches isolated using two different extraction methods. We also investigated compositional, morphological and structural properties of the two starch samples. Significant differences in pasting properties were found among the three sample types, but most of the parameters of pasting properties displayed significant correlations between flour and starch. No significant differences were found in amylose/amylopectin ratio, granule morphology, granule size distribution and crystal structure between starches extracted using two different methods. However, the starch isolated from water homogenization had a higher protein content and lower total starch, amylose and amylopectin contents than the starch extracted with homogenized extraction under alkaline conditions. We concluded that the whole grain flour can be used to predict the pasting properties in breeding programs.	[Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Jiangsu Key Lab Crop Genom & Mol Breeding, Key Lab Plant Funct Genom,Agr Coll,Minist Educ, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiangyun] Jiangsu Acad Agr Sci, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Jiangsu Academy of Agricultural Sciences	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Jiangsu Key Lab Crop Genom & Mol Breeding, Key Lab Plant Funct Genom,Agr Coll,Minist Educ, Yangzhou, Jiangsu, Peoples R China.; Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Key Research and Development Program of China [2018YFD1000703, 2018YFD1000700]; National Natural Science Foundation of China [31571648]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China (2018YFD1000703 & 2018YFD1000700), the National Natural Science Foundation of China (Nos. 31571648), the National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BeMiller JN, 2011, CARBOHYD POLYM, V86, P386, DOI 10.1016/j.carbpol.2011.05.064; Cai JW, 2015, INT J FOOD PROP, V18, P380, DOI 10.1080/10942912.2013.831443; Claver IP, 2010, INT J MOL SCI, V11, P3002, DOI 10.3390/ijms11083002; Cozzolino D, 2016, J FOOD MEAS CHARACT, V10, P474, DOI 10.1007/s11694-016-9326-z; Cozzolino D, 2016, J CEREAL SCI, V70, P282, DOI 10.1016/j.jcs.2016.07.003; Debet MR, 2006, CARBOHYD POLYM, V64, P452, DOI 10.1016/j.carbpol.2005.12.011; Delcour JA, 2010, ANNU REV FOOD SCI T, V1, P87, DOI 10.1146/annurev.food.102308.124211; Dev PM, 1990, METHODS PLANT BIOCH, V2; Fan XY, 2017, J AGR SCI-CAMBRIDGE, V155, P129, DOI 10.1017/S0021859615001331; Fox G, 2014, J I BREWING, V120, P183, DOI 10.1002/jib.137; Fu Z, 2015, STARCH-STARKE, V67, P69, DOI 10.1002/star.201300278; Gupta M, 2010, COMPR REV FOOD SCI F, V9, P318, DOI 10.1111/j.1541-4337.2010.00112.x; Israkarn K, 2014, CARBOHYD POLYM, V105, P34, DOI 10.1016/j.carbpol.2014.01.054; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Karim AA, 2008, FOOD HYDROCOLLOID, V22, P1044, DOI 10.1016/j.foodhyd.2007.05.011; Kaur B, 2011, FOOD BIOPROD PROCESS, V89, P463, DOI 10.1016/j.fbp.2010.09.003; KIM CS, 1992, J FOOD SCI, V57, P1009, DOI 10.1111/j.1365-2621.1992.tb14344.x; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Lai LN, 2004, J FOOD SCI, V69, pC249, DOI 10.1111/j.1365-2621.2004.tb06324.x; Li WH, 2014, FOOD RES INT, V58, P7, DOI 10.1016/j.foodres.2014.01.053; MacGregor A.W., 1993, BARLEY CHEM TECHNOLO; Sharma P, 2014, J FOOD SCI TECH MYS, V51, P3870, DOI 10.1007/s13197-013-0924-z; Srichuwong S, 2005, CARBOHYD POLYM, V62, P25, DOI 10.1016/j.carbpol.2005.07.003; Wang JM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113559; Wang JM, 2010, GENETICA, V138, P1191, DOI 10.1007/s10709-010-9511-7; Wang P, 2017, STARCH-STARKE, V69, DOI 10.1002/star.201600201; WU YV, 1973, CEREAL CHEM, V50, P481; Zhang GY, 2003, J AGR FOOD CHEM, V51, P2797, DOI 10.1021/jf0300341; Zhou M, 2005, J CEREAL SCI, V41, P31, DOI 10.1016/j.jcs.2004.04.003; Zhou MX, 2008, J CEREAL SCI, V48, P789, DOI 10.1016/j.jcs.2008.05.006; Zhou MX, 1999, J SCI FOOD AGR, V79, P585, DOI 10.1002/(SICI)1097-0010(19990315)79:4<585::AID-JSFA223>3.0.CO;2-0	31	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216978	10.1371/journal.pone.0216978	http://dx.doi.org/10.1371/journal.pone.0216978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141562	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000034
J	Jones, T; Divine, LM; Renner, H; Knowles, S; Lefebvre, KA; Burgess, HK; Wright, C; Parrish, JK				Jones, Timothy; Divine, Lauren M.; Renner, Heather; Knowles, Susan; Lefebvre, Kathi A.; Burgess, Hillary K.; Wright, Charlie; Parrish, Julia K.			Unusual mortality of Tufted puffins (Fratercula cirrhata) in the eastern Bering Sea	PLOS ONE			English	Article							ST-PAUL ISLAND; CLIMATE-CHANGE; MASS-MORTALITY; REPRODUCTIVE-PERFORMANCE; DETECTION PROBABILITIES; BREEDING SEABIRDS; PERSISTENCE RATES; POPULATION TRENDS; PRIBILOF ISLANDS; MOLT STRATEGIES	Mass mortality events are increasing in frequency and magnitude, potentially linked with ongoing climate change. In October 2016 through January 2017, St. Paul Island, Bering Sea, Alaska, experienced a mortality event of alcids (family: Alcidae), with over 350 carcasses recovered. Almost three-quarters of the carcasses were unscavenged, a rate much higher than in baseline surveys (17%), suggesting ongoing deposition and elevated mortality around St Paul over a 2-3 month period. Based on the observation that carcasses were not observed on the neighboring island of St. George, we bounded the at-sea distribution of moribund birds, and estimated all species mortality at 3,150 to 8,800 birds. The event was particularly anomalous given the late fall/ winter timing when low numbers of beached birds are typical. In addition, the predominance of Tufted puffins (Fratercula cirrhata, 79% of carcass finds) and Crested auklets (Aethia cristatella, 11% of carcass finds) was unusual, as these species are nearly absent from long-term baseline surveys. Collected specimens were severely emaciated, suggesting starvation as the ultimate cause of mortality. The majority (95%, N = 245) of Tufted puffins were adults regrowing flight feathers, indicating a potential contribution of molt stress. Immediately prior to this event, shifts in zooplankton community composition and in forage fish distribution and energy density were documented in the eastern Bering Sea following a period of elevated sea surface temperatures, evidence cumulatively suggestive of a bottom-up shift in seabird prey availability. We posit that shifts in prey composition and/ or distribution, combined with the onset of molt, resulted in this mortality event.	[Jones, Timothy; Burgess, Hillary K.; Wright, Charlie; Parrish, Julia K.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Divine, Lauren M.] Aleut Community St Paul Isl Ecosyst Conservat Off, Pribilof Isl, AK USA; [Renner, Heather] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Knowles, Susan] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Lefebvre, Kathi A.] NOAA, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Jones, T (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	timothy.t.jones@gmail.com		Knowles, Susan/0000-0002-0254-6491	National Science Foundation (NSF) EHR/DRL award [1322820]; Washington Department of Fish and Wildlife [13-1435]; NSF [OCE-1314088]	National Science Foundation (NSF) EHR/DRL award; Washington Department of Fish and Wildlife; NSF(National Science Foundation (NSF))	These analyses were supported by the National Science Foundation (NSF) EHR/DRL award 1322820 and Washington Department of Fish and Wildlife award 13-1435, to JKP. Support for algal toxin analyses was provided by NSF OCE-1314088 to KAL and Dr. David Marcinek at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AG, 2016, DEEP-SEA RES PT II, V134, P235, DOI 10.1016/j.dsr2.2015.10.008; [Anonymous], R LANG ENV STAT COMP; Arimitsu M, 2018, AL MAR SCI S 2018 AN; Auth TD, 2018, GLOBAL CHANGE BIOL, V24, P259, DOI 10.1111/gcb.13872; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; BIBBY CJ, 1977, BIOL CONSERV, V12, P295, DOI 10.1016/0006-3207(77)90048-9; Bond AL, 2013, CONDOR, V115, P348, DOI 10.1525/cond.2013.110062; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Bridge ES, 2004, J EXP BIOL, V207, P3003, DOI 10.1242/jeb.01116; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; Byrd G. Vernon, 2009, Marine Ornithology, V37, P197; Byrd GV, 2005, FISH OCEANOGR, V14, P139; Camphuysen C.J., 1999, ICES Cooperative Research Report, V232, P51; Castege I, 2007, ARDEOLA, V54, P289; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2002, PROG OCEANOGR, V55, P177, DOI 10.1016/S0079-6611(02)00077-0; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Docherty DE, 2004, EMERG INFECT DIS, V10, P907, DOI 10.3201/eid1005.030825; Dorresteijn I, 2012, MAR ECOL PROG SER, V454, P207, DOI 10.3354/meps09372; Duffy-Anderson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178955; Fey SB, 2015, P NATL ACAD SCI USA, V112, P1083, DOI 10.1073/pnas.1414894112; Flint PL, 1998, MAR POLLUT BULL, V36, P165, DOI 10.1016/S0025-326X(97)00178-1; Ford RG, 1996, AM FISH S S, V18, P684; Ford RG, 2006, ACUTE SEABIRD MORTAL, P46; Ford RG, 2001, UNPUB, P47; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Fowler AC, 1997, MAR POLLUT BULL, V34, P522, DOI 10.1016/S0025-326X(96)00153-1; Gall AE, 2013, CONT SHELF RES, V67, P96, DOI 10.1016/j.csr.2012.11.004; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gould PJ, 1982, FWSOBS8284 US DEP IN, P294; Goyert HF, 2017, BIOL CONSERV, V209, P178, DOI 10.1016/j.biocon.2017.02.011; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Harris MP, 2014, BIRD STUDY, V61, P182, DOI 10.1080/00063657.2014.909382; Harris MP, 2005, MAR ECOL PROG SER, V297, P283, DOI 10.3354/meps297283; Harris MP, 1996, BIRD STUDY, V43, P220, DOI 10.1080/00063659609461014; Hart CJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4519; HATCH SA, 1987, WILSON BULL, V99, P468; Hickey JJ, 1977, ENV ASSESSMENT ALASK, V2, P96; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hope Jones P, 1970, Br. Birds, V63, P97; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Hunt GL, 2018, MAR ECOL PROG SER, V593, P209, DOI 10.3354/meps12383; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, PROG OCEANOGR, V55, P5, DOI 10.1016/S0079-6611(02)00067-8; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Hunt GL, 1981, E BERING SEA SHELF O, P689; Hyrenbach D, 2013, FWS BERINGIAN SEABIR; Jahncke J, 2008, DEEP-SEA RES PT II, V55, P1809, DOI 10.1016/j.dsr2.2008.04.003; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; Jones T, 2018, GEOPHYS RES LETT, V45, P3193, DOI 10.1002/2017GL076164; Jones T, 2017, MAR ECOL PROG SER, V579, P111, DOI 10.3354/meps12253; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Lee DE, 2007, J ANIM ECOL, V76, P337, DOI 10.1111/j.1365-2656.2007.01198.x; Lefebvre KA, 2016, HARMFUL ALGAE, V55, P13, DOI 10.1016/j.hal.2016.01.007; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Parrish J., 2009, BEACHED BIRDS COASST; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Piatt JF, 1997, MAR POLLUT BULL, V34, P656, DOI 10.1016/S0025-326X(97)00008-8; Piatt JF, 2002, BIRDS N AM, DOI [10.2173/bna.708, DOI 10.2173/BNA.708]; PIERCE DJ, 1986, AUK, V103, P214; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Pyle P., 2008, IDENTIFICATION GUI 2, P787; Pyle Peter, 2009, Marine Ornithology, V37, P219; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Schacter C., 2017, THESIS, P242; Schacter CR, 2016, PAC SEAB GROUP ANN M, P10; Schneider David C., 1993, Reviews in Fisheries Science, V1, P311; Schreiber EA, 2001, BIOL MARINE BIRDS, P192; Sealy SG, 1968, THESIS, DOI [10.14288/1.0104305, DOI 10.14288/1.0104305]; Shearn-Bochsler V, 2014, J WILDLIFE DIS, V50, P933, DOI 10.7589/2013-11-296; Siddon E, 2018, NPFMC BERING SEA ALE, P230; Sowls A. L., 1978, FWSOBS7878 US DEP IN; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Stabeno PJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185464; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Sydeman WJ, 2017, ECOL INDIC, V78, P458, DOI 10.1016/j.ecolind.2017.03.013; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Thompson CW, 2004, AUK, V121, P35, DOI 10.1642/0004-8038(2004)121[0035:PFMSIT]2.0.CO;2; UNDERWOOD LA, 1984, BIRD STUDY, V31, P79, DOI 10.1080/00063658409476822; VanPelt TI, 1995, MAR POLLUT BULL, V30, P794, DOI 10.1016/0025-326X(95)00072-U; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiese FK, 2004, J WILDLIFE MANAGE, V68, P627, DOI 10.2193/0022-541X(2004)068[0627:ASMFCO]2.0.CO;2; Wiese FK, 2001, AUK, V118, P1062, DOI 10.1642/0004-8038(2001)118[1062:ESFAND]2.0.CO;2; Wiese Francis K., 2003, Marine Ornithology, V31, P65; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Young RC, 2014, ECOL SOC, V19, DOI 10.5751/ES-07158-190440; Youngren SM, 2018, 201803 AMNWR; Zador S, 2016, NPFMC BERING SEA ALE, P210	103	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216532	10.1371/journal.pone.0216532	http://dx.doi.org/10.1371/journal.pone.0216532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141532	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000015
J	Silva, JLSE; Cruz-Neto, O; Peres, CA; Tabarelli, M; Lopes, AV				Souza e Silva, Jessica Luiza; Cruz-Neto, Oswaldo; Peres, Carlos A.; Tabarelli, Marcelo; Lopes, Ariadna Valentina			Climate change will reduce suitable Caatinga dry forest habitat for endemic plants with disproportionate impacts on specialized reproductive strategies	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FUNCTIONAL TRAITS; TROPICAL FOREST; PROTECTED AREAS; RESPONSES; FUTURE; POLLINATOR; DIVERSITY; TEMPERATURE; PERFORMANCE	Global climate change alters the dynamic of natural ecosystems and directly affects species distributions, persistence and diversity. The impacts of climate change may lead to dramatic changes in biotic interactions, such as pollination and seed dispersal. Life history traits are extremely important to consider the vulnerability of a species to climate change, producing more robust models than those based primarily on species distributions. Here, we hypothesized that rising temperatures and aridity will reduce suitable habitats for the endemic flora of the Caatinga, the most diverse dry tropical forest on Earth. Specifically, species with specialized reproductive traits (e.g. vertebrate pollination, biotic dispersal, obligatory cross-pollination) should be more affected by climate change than those with generalist traits. We performed two ecological niche models (current and future) to simulate the effects of climate change on the distribution area of endemic species in relation to life-history traits. We used the MIROC-ESM and CCSM4 models for both intermediate (RCP4.5) and highest predicted (RCP8.5) GHG emission scenarios, with a resolution of 30' (similar to 1 km(2)). Habitat with high occurrence probability (>80%) of endemic species will be reduced (up to similar to 10% for trees, similar to 13% for non-arboreous, 10-28% for species with any pollination/reproductive system), with the greatest reductions for species with specialized reproductive traits. In addition, the likely concentration of endemic plants in the extreme northeastern portion of the Caatinga, in more mesic areas, coincides with the currently most human-modified areas of the ecosystem, which combined with climate change will further contract suitable habitats of endemic species. In conclusion, plant species endemic to the Caatinga are highly vulnerable to even conservative scenarios of future climate change and may lose much of their climatic envelopes. New protected areas should be located in the northeastern portion of the Caatinga, which hosts a more favorable climate, but is currently exposed to escalating agricultural intensification.	[Souza e Silva, Jessica Luiza] Univ Fed Pernambuco, Dept Bot, Programa Posgrad Biol Vegetal, Recife, PE, Brazil; [Cruz-Neto, Oswaldo; Tabarelli, Marcelo; Lopes, Ariadna Valentina] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; University of East Anglia	Lopes, AV (corresponding author), Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil.	avflopes@ufpe.br	Peres, Carlos A./ABE-8361-2020; Neto, Oswaldo OCN Cruz/I-3345-2015; Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019; Tabarelli, Marcelo/F-1088-2010; Lopes, Ariadna V/E-8432-2010	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Tabarelli, Marcelo/0000-0001-7573-7216; Lopes, Ariadna V/0000-0001-5750-5913; Silva, Jessica Luiza Souza e/0000-0001-8519-0891	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [403770/2012-2, 481755/2013-6, 308832/2014-0]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE [IBPG-0774-2.03/13, BCT-0208-2.05/17, APQ-0138-2.05/14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [001]; Royal Society [NMG/R2/170081]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Royal Society(Royal Society of London)	The study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (Long-Term Ecological Research Program-PELD/CNPq, grant number: 403770/2012-2 awarded to MT; CNPq/Chamada Universal, grant number: 481755/2013-6 awarded to AVL; PQ/CNPq, grant number: 308832/2014-0 awarded to AVL); the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE (PhD Fellowship to JLSS, grant number: IBPG-0774-2.03/13; Pos-doc grant to OCN, grant number: BCT-0208-2.05/17, and Programa de Apoio a Nucleos de Excelencia - PRONEX, grant number: APQ-0138-2.05/14 awarded to MT); the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (grant code 001 awarded to JLSS, MT and AVL); Royal Society (Newton Mobility Grant NMG/R2/170081 awarded to CAP, MT, AVF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbSaber A. N, 2003, OS DOMINIOS NATUREZA; Salvatierra LHA, 2017, BIOTROPICA, V49, P753, DOI 10.1111/btp.12459; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Andrade E.M., 2017, CAATINGA LARGEST TRO, P281, DOI [10.1007/978-3-319-68339-3_10, DOI 10.1007/978-3-319-68339-3_10]; [Anonymous], 2004, MATA ATLANTICA ARVOR; Antongiovanni M, 2018, LANDSCAPE ECOL, V33, P1353, DOI 10.1007/s10980-018-0672-6; Arnan X, 2018, SCI TOTAL ENVIRON, V631-632, P429, DOI 10.1016/j.scitotenv.2018.03.037; Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Bussotti F, 2015, ENVIRON EXP BOT, V111, P91, DOI 10.1016/j.envexpbot.2014.11.006; Camara T, 2018, J ANIM ECOL, V87, P1022, DOI 10.1111/1365-2656.12820; Cardoso Domingos Benício Oliveira Silva, 2007, Rodriguésia, V58, P379, DOI 10.1590/2175-7860200758212; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Costa WF, 2018, BIOL CONSERV, V218, P200, DOI 10.1016/j.biocon.2017.12.034; Dai A. G., 2011, Interdisciplinary Reviews: Climate Change, V2, P45, DOI 10.1002/wcc.81; de Oliveira G, 2012, BIODIVERS CONSERV, V21, P2913, DOI 10.1007/s10531-012-0346-7; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; Drumond MA, 2000, AVALIACAO IDENTIFICA; Dyderski MK, 2018, GLOBAL CHANGE BIOL, V24, P1150, DOI 10.1111/gcb.13925; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Endress P. K., 1994, DIVERSITY EVOLUTIONA; ESRI, 2010, ARCGIS DESKT REL 10; FAEGRI K, 1979, P244; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fonseca CR, 2017, CAATINGA THE LARGEST, P429, DOI [10.1007/978-3-319-68339-3_17, DOI 10.1007/978-3-319-68339-3_17]; Frankie G.W., 1983, P411; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Giannini TC, 2017, APIDOLOGIE, V48, P784, DOI 10.1007/s13592-017-0523-5; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Graeff O., 2015, FITOGEOGRAFIA BRASIL; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Kumar L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05034-4; Li DL, 2018, GLOBAL CHANGE BIOL, V24, P4095, DOI 10.1111/gcb.14327; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Lorenzi H., 2002, ARVORES BRASILEIRAS, V1; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Marengo JA, 2011, VARIABILIDADE MUDANC; Marengo JA, 2017, THEOR APPL CLIMATOL, V129, P1189, DOI 10.1007/s00704-016-1840-8; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Mathe A, 1999, MED AROMATIC PLANTS; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Ministerio do Meio Ambiente, 2007, ATL AR SUSC DES BRAS; Moro MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119166; Moro MF, 2014, PHYTOTAXA, V160, P1; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Prado DE., 2003, ECOLOGIA CONSERVA O, P3, DOI DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Proctor M., 1996, NATURAL HIST POLLINA; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; Queiroz L.P., 2017, CAATINGA LARGEST TRO, P23, DOI [10.1099/ijsem, DOI 10.1007/978-3-319-68339-3_2, 10.1007/978-3-319, DOI 10.1007/978-3-319]; R Core Team, 2016, R LANG ENV STAT COMP; Reyes-Fox M, 2014, NATURE, V510, P259, DOI 10.1038/nature13207; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Richards A. J., 1997; Rito KF, 2017, J ECOL, V105, P828, DOI 10.1111/1365-2745.12712; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Santos MG, 2014, THEOR EXP PLANT PHYS, V26, P83, DOI 10.1007/s40626-014-0008-0; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Shabani F., 2018, ACTA SCI HUM SOC SCI, V18, P6; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Sobrinho MS, 2016, BIOTROPICA, V48, P586, DOI 10.1111/btp.12334; Specht MJ, 2015, GLOB ECOL CONSERV, V3, P200, DOI 10.1016/j.gecco.2014.12.002; Spjut Richard W., 1994, Memoirs of the New York Botanical Garden, V70, P1; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Tayleur C, 2015, GLOBAL ECOL BIOGEOGR, V24, P859, DOI 10.1111/geb.12308; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; VANDERPIJL, 1982, PRINCIPLES DISPERSAL; Wasof S, 2013, GLOBAL ECOL BIOGEOGR, V22, P1130, DOI 10.1111/geb.12073; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Ziska L. H., 2014, Invasive species and global climate change, DOI 10.1079/9781780641645.0000	111	33	35	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217028	10.1371/journal.pone.0217028	http://dx.doi.org/10.1371/journal.pone.0217028			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141533	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000469323000036
J	Kang, J; Dietz, MJ; Li, BY				Kang, Jason; Dietz, Matthew J.; Li, Bingyun			Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTIONS; ANTIBACTERIAL ACTIVITY; RECOMBINANT LL-37; VANCOMYCIN; MODEL; SUSCEPTIBILITY; CYTOTOXICITY; INHIBITION; MECHANISMS; EXPRESSION	Our current challenge in the management of prosthetic joint infection is the eradication of biofilms which has driven the need for improved antimicrobial agents and regimens. In this study, the antimicrobial peptide, LL-37, and silver nanoparticles (AgNPs) were investigated for their antimicrobial efficacies against Staphylococcus aureus (S. aureus), a microorganism commonly implicated in biofilm-related infections. These antimicrobials were compared to conventional antibiotics and combination treatments with rifampin. Using a Centers for Disease Control reactor, 24 h S. aureus biofilms were formed on cobalt-chromium discs and the anti-biofilm activity was determined by quantifying the amount of colony forming units following treatments. We found that LL-37 was the most efficacious antimicrobial agent with a more than 4 log reduction in colony counts. In comparison, silver nanoparticles and conventional antibiotics were not as efficacious, with a less than 1 log reduction in colony counts. Antimicrobial combination treatments with rifampin significantly increased the log reduction for AgNPs and gentamicin, although still significantly less than LL-37 in isolation. Furthermore, kinetic studies revealed the rapid elimination of S. aureus biofilm with LL-37. Collectively, the results of this study demonstrated that LL-37 was an effective agent against S. aureus biofilms and may have potential clinical applications in the eradication of biofilms and treatment of prosthetic joint infection.	[Kang, Jason; Dietz, Matthew J.; Li, Bingyun] West Virginia Univ, Sch Med, Dept Orthopaed, Morgantown, WV 26506 USA	West Virginia University	Dietz, MJ; Li, BY (corresponding author), West Virginia Univ, Sch Med, Dept Orthopaed, Morgantown, WV 26506 USA.	mdietz@hsc.wvu.edu; bill@hsc.wvu.edu	Dietz, Matthew J/ABH-2691-2020		Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award [W81XWH1810203]; NIH [2U54GM104942-02, 5P20RR016477, U57GM104942, P30GM103488, P20GM109098, P20GM103434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488, P20GM109098, P20GM103434, U54GM104942] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award under Award No. W81XWH1810203 (BL). In addition, we acknowledge the use of the WVU Shared Research Facilities, we acknowledge the support of NIH grants 2U54GM104942-02, 5P20RR016477, U57GM104942, P30GM103488, P20GM109098, and P20GM103434. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies.	Abdelhady W, 2013, ANTIMICROB AGENTS CH, V57, P1447, DOI 10.1128/AAC.02073-12; Andersson DI, 2016, DRUG RESIST UPDATE, V26, P43, DOI 10.1016/j.drup.2016.04.002; [Anonymous], 2018, METH DIL ANT SUSC TE; Bjorstad A, 2009, ANTIMICROB AGENTS CH, V53, P1027, DOI 10.1128/AAC.01310-08; Cargill JS, 2009, J CLIN PATHOL, V62, P1112, DOI 10.1136/jcp.2009.069021; Chennupati SK, 2009, AM J RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261; Ciofu O, 2017, APMIS, V125, P304, DOI 10.1111/apm.12673; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cochran AR, 2016, J ARTHROPLASTY, V31, pS156, DOI 10.1016/j.arth.2016.03.028; Conlon BP, 2014, BIOESSAYS, V36, P991, DOI 10.1002/bies.201400080; Cox DL, 2003, PEPTIDES, V24, P1741, DOI 10.1016/j.peptides.2003.07.026; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Hamza T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0207-5; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Huotari K, 2015, ACTA ORTHOP, V86, P321, DOI 10.3109/17453674.2015.1035173; Iarikov D, 2012, CLIN INFECT DIS, V55, P1474, DOI 10.1093/cid/cis735; Inacio MCS, 2017, OSTEOARTHR CARTILAGE, V25, P1797, DOI 10.1016/j.joca.2017.07.022; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kim BS, 2017, 2017 31ST INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN), P63, DOI 10.1109/ICOIN.2017.7899476; Klemm K, 2001, CLIN MICROBIOL INFEC, V7, P28, DOI 10.1046/j.1469-0691.2001.00186.x; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Leszczynska K, 2013, J ANTIMICROB CHEMOTH, V68, P610, DOI 10.1093/jac/dks434; Li YF, 2012, PROTEIN EXPRES PURIF, V81, P201, DOI 10.1016/j.pep.2011.10.011; Lofton H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068875; Luo Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00544; Marschall J, 2013, INT J ANTIMICROB AG, V41, P272, DOI 10.1016/j.ijantimicag.2012.10.023; Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225; McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]; Mishra B, 2016, ACS MED CHEM LETT, V7, P117, DOI 10.1021/acsmedchemlett.5b00433; Mohamed MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29707; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Noore J, 2013, ANTIMICROB AGENTS CH, V57, P1283, DOI 10.1128/AAC.01650-12; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Osmon DR, 2013, CLIN INFECT DIS, V56, P1, DOI [10.1093/cid/cis966, 10.1093/cid/cis803]; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Post V, 2017, J ORTHOP RES, V35, P381, DOI 10.1002/jor.23291; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; Segev-Zarko L, 2015, BIOCHEM J, V468, P259, DOI 10.1042/BJ20141251; Siqueira MBP, 2015, J BONE JOINT SURG AM, V97A, P1220, DOI 10.2106/JBJS.N.00999; Snyder ADH, 2015, INFECT DIS THER, V4, P51, DOI 10.1007/s40121-014-0055-5; Strempel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082240; Svensson D, 2016, BIOCHEM J, V473, P87, DOI 10.1042/BJ20150798; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tavares LS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00412; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009	54	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216676	10.1371/journal.pone.0216676	http://dx.doi.org/10.1371/journal.pone.0216676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170191	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700008
J	Lee, CK; Lai, CL; Lee, MH; Su, FY; Yeh, TS; Cheng, LY; Hsieh, MY; Wu, YW; Liu, YB; Wu, CC				Lee, Chih-Kuo; Lai, Chao-Lun; Lee, Ming-Hsien; Su, Fang-Ying; Yeh, Tzu-Shan; Cheng, Li-Ying; Hsieh, Mu-Yang; Wu, Yen-Wen; Liu, Yen-Bin; Wu, Chih-Cheng			Reinforcement of patient education improved physicians' adherence to guideline-recommended medical therapy after acute coronary syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; AMERICAN-COLLEGE; ORDER SET; MANAGEMENT; RISK; OUTCOMES; MORTALITY; DISCHARGE; TAIWAN	Background Prescription of guideline-recommended medicines after acute coronary syndrome (ACS) has been suboptimal. Tools for improving the use of medications have been developed, but they mainly targeted physicians. Objective We evaluated the effects of reinforcement of patient and family education on the usage of guideline-recommended secondary prevention medications. Methods This was a retrospective analysis of a prospectively collected registry of patients with ACS who were admitted to a regional teaching hospital in Taiwan between February 2015 and April 2017. The control group included 76 patients discharged before implementing the electronic -based patient and family education (PFE) system. The intervention group included 206 patients discharged after implementation. The primary outcome was the prescription rate of all four guideline-recommended drugs. Predictors of adherence were also evaluated. Results The study cohort included 282 ACS patients (188 men and 94 women) with a mean age of 68.5 years (standard deviation, 14.2). The intervention group patients were younger, had more family history of premature cardiovascular disease, more dyslipidemia, and underwent more reperfusion therapy. The intervention group was prescribed more guideline-recommended drugs than the control group: dual antiplatelet agents, 79.61% vs. 47.37% (p<0.001); statins, 74.76% vs. 34.21% (p<0.001); beta-blockers, 81.07% vs. 46.05% (p<0.001); angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, 62.62% vs. 38.16% (p<0.001); and a combination of all four medications, 39.32% vs. 14.47% (p<0.001). After adjusting baseline variables, the PFE system remained a significant contributor to adherence to these drugs use (P = 0.02). Conclusions Reinforcement of patient education was associated with significant improvements in physicians' adherence to guideline-recommended medical therapy after acute coronary syndrome.	[Lee, Chih-Kuo; Lai, Chao-Lun; Hsieh, Mu-Yang; Liu, Yen-Bin] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lai, Chao-Lun; Hsieh, Mu-Yang; Wu, Yen-Wen; Liu, Yen-Bin; Wu, Chih-Cheng] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Lai, Chao-Lun] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Lee, Ming-Hsien; Yeh, Tzu-Shan; Cheng, Li-Ying] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Nursing, Hsinchu, Taiwan; [Su, Fang-Ying] Natl Taiwan Univ Hosp, Hsin Chu Branch, Biotechol R&D Ctr, Hsinchu, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wu, Chih-Cheng] Natl Taiwan Univ Hosp, Hsin Chu Branch, Cardiovasc Ctr, Hsinchu, Taiwan; [Wu, Chih-Cheng] Natl Tsing Hwa Univ, Inst Biomed Engn, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University	Hsieh, MY (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan.; Hsieh, MY; Wu, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Cardiovasc Ctr, Hsinchu, Taiwan.; Wu, CC (corresponding author), Natl Tsing Hwa Univ, Inst Biomed Engn, Hsinchu, Taiwan.	drake1128@gmail.com; chihchengwumd@gmail.com	Su, Fang-Ying/AAG-5790-2019; Fang-Ying, Su/AAG-6155-2019	Su, Fang-Ying/0000-0002-5103-7431; WU, CHIH-CHENG/0000-0002-9690-6573; WU, YEN-WEN/0000-0003-1520-1166	National Taiwan University Hospital, Hsinchu Branch [107-HCH027, 106-HCH037, 105-HCH050]; Ministry of Science and Technology [MOST 103-2325-B-418-001,105-2325-B-418-0011, MOST-106-2314-B-002-173-MY3]	National Taiwan University Hospital, Hsinchu Branch; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by grants from National Taiwan University Hospital, Hsinchu Branch (107-HCH027, 106-HCH037, and 105-HCH050) and Ministry of Science and Technology (MOST 103-2325-B-418-001,105-2325-B-418-0011, and MOST-106-2314-B-002-173-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan L, 2012, INT J QUAL HEALTH C, V24, P425, DOI 10.1093/intqhc/mzs022; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Ballard DJ, 2010, INT J QUAL HEALTH C, V22, P437, DOI 10.1093/intqhc/mzq051; Ballesca MA, 2014, J HOSP MED, V9, P155, DOI 10.1002/jhm.2149; Bauer T, 2010, EUR J CARDIOV PREV R, V17, P576, DOI 10.1097/HJR.0b013e328338e5da; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Chen KC, 2018, ACTA CARDIOL SIN, V34, P211, DOI 10.6515/ACS.201805_34(3).20180207B; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Hsiao AJ, 2015, J FORMOS MED ASSOC, V114, P679, DOI 10.1016/j.jfma.2013.12.003; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Motivala AA, 2011, J AM COLL CARDIOL, V58, P1760, DOI 10.1016/j.jacc.2011.06.050; Roe MT, 2006, AM HEART J, V151, P1205, DOI 10.1016/j.ahj.2005.08.006; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sequist TD, 2005, J AM MED INFORM ASSN, V12, P431, DOI 10.1197/jamia.M1788; Shyu KG, 2011, ACTA CARDIOL SIN, V27, P135; Spencer FA, 2005, AM HEART J, V150, P838, DOI 10.1016/j.ahj.2004.11.005; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217444	10.1371/journal.pone.0217444	http://dx.doi.org/10.1371/journal.pone.0217444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170175	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700029
J	Sugano, N; Maruyama, Y; Kidoguchi, S; Ohno, I; Wada, A; Shigematsu, T; Masakane, I; Yokoo, T				Sugano, Naoki; Maruyama, Yukio; Kidoguchi, Satoshi; Ohno, Iwao; Wada, Atsushi; Shigematsu, Takashi; Masakane, Ikuto; Yokoo, Takashi			Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study	PLOS ONE			English	Article							SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; KIDNEY-DISEASE; RENAL-DISEASE; ALLOPURINOL; MORTALITY; RISK; FEBUXOSTAT	Whether higher serum uric acid (UA) values comprise a risk factor for death and whether treatment for high UA is effective in patients undergoing hemodialysis (HD) are essentially unknown. To determine associations between UA and all-cause or cardiovascular (CV) mortality, interactions between UA or medication and effects on mortality, and significance of treatment for hyperuricemia in patients undergoing hemodialysis (HD). We collected the baseline data of 222,434 patients undergoing three HD sessions per week, extracted from a nationwide dialysis registry at the end of 2011 in Japan. Then we evaluated the interaction between serum uric acid level and all-cause and cardiovascular (CV) mortality by the end of 2012. Univariate and multivariate logistic regression and Cox regression analyses found higher all-cause and CV mortality rates among patients with lower, than higher UA values. Hazard ratios (HR) for all-cause and CV mortality were significantly lower in a group with, than without medication for hyperuricemia (HR, 0.837; 95% confidence interval (CI), 0.789-0.889 and HR, 0.830; 95%CI0.758-0.909, respectively). Lower UA values remained associated with all-cause and CV mortality rates even when in patients taking medication for hyperuricemia. The chief interacting factors for higher mortality rates due to lower UA were higher BMI and diabetes mellitus. In conclusion, lower UA levels were independently associated with higher all-cause and CV mortality among Japanese patients undergoing HD. Intervention for hyperuricemia is considered to improve patient outcomes.	[Sugano, Naoki; Maruyama, Yukio; Kidoguchi, Satoshi; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Ohno, Iwao] Jikei Univ, Sch Med, Dept Internal Med, Div Gen Med, Tokyo, Japan; [Wada, Atsushi; Shigematsu, Takashi; Masakane, Ikuto] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Jikei University; Jikei University	Sugano, N (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	n-sugano@jikei.ac.jp						Afshari M, 2004, BIOMED PHARMACOTHER, V58, P546, DOI 10.1016/j.biopha.2004.09.012; Beberashvili I, 2016, CLIN J AM SOC NEPHRO, V11, P1015, DOI 10.2215/CJN.10400915; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208; FANG J, JAMA, V283, P2404; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Go AS, 2014, NEW ENGL J MED, V351, P1296; Gondouin B, 2015, NEPHRON, V131, P167, DOI 10.1159/000441091; Gouri A, 2014, CLIN LAB, V60, P751, DOI 10.7754/Clin.Lab.2013.130310; Higgins P, 2012, CARDIOVASC THER, V30, P217, DOI 10.1111/j.1755-5922.2011.00277.x; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Kang Duk-Hee, 2014, Electrolyte Blood Press, V12, P1, DOI 10.5049/EBP.2014.12.1.1; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Kurra V, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0033-5; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Mortada I, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0770-x; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Sagor MAT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/478039; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Sueta D, 2017, INT J CARDIOL, V230, P97, DOI 10.1016/j.ijcard.2016.12.072; Tausche AK, 2014, RHEUMATOL INT, V34, P101, DOI 10.1007/s00296-013-2857-2; Tsai CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170393; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075	28	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217859	10.1371/journal.pone.0217859	http://dx.doi.org/10.1371/journal.pone.0217859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170241	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700070
J	Vodicka, EL; Chung, MH; Zimmermann, MR; Kosgei, RJ; Lee, F; Mugo, NR; Okech, TC; Sakr, SR; Stergachis, A; Garrison, LP; Babigumira, JB				Vodicka, Elisabeth L.; Chung, Michael H.; Zimmermann, Marita R.; Kosgei, Rose J.; Lee, Fan; Mugo, Nelly R.; Okech, Timothy C.; Sakr, Samah R.; Stergachis, Andy; Garrison, Louis P., Jr.; Babigumira, Joseph B.			Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya	PLOS ONE			English	Article							CARE	Objectives To estimate the modified societal costs of cervical cancer treatment in Kenya; and to compare the modified societal costs of treatment for pre-cancerous cervical lesions integrated into same-day HIV care compared to "non-integrated" treatment when the services are not coordinated on the same day. Materials and methods A micro-costing study was conducted at Coptic Hope Center for Infectious Diseases and Kenyatta National Hospital from July 1-October 31, 2014. Interviews were conducted with 54 patients and 23 staff. Direct medical, non-medical (e.g., overhead), and indirect (e.g., time) costs were calculated for colposcopy, cryotherapy, Loop Electrosurgical Excision Procedure (LEEP), and treatment of cancer. All costs are reported in 2017 US dollars. Results Patients had a mean age of 41 and daily earnings of $6; travel time to the facility averaged 2.8 hours. From the modified societal perspective, per-procedure costs of colposcopy were $41 (integrated) vs. $91 (non-integrated). Per-procedure costs of cryotherapy were $22 (integrated) vs. $46 (non-integrated), whereas costs of LEEP were $50 (integrated) and $99 (non-integrated). This represents cost savings of $25 for cryotherapy and $50 for colposcopy and LEEP when provided on the same day as an HIV-care visit. Treatment for cervical cancer cost $1,345-$6,514, depending on stage. Facility-based palliative care cost $59/day. Conclusions Integrating treatment of pre-cancerous lesions into HIV care is estimated to be cost-saving from a modified societal perspective. These costs can be applied to financial and economic evaluations in Kenya and similar urban settings in other low-income countries.	[Vodicka, Elisabeth L.; Chung, Michael H.; Zimmermann, Marita R.; Lee, Fan; Stergachis, Andy; Garrison, Louis P., Jr.; Babigumira, Joseph B.] Univ Washington, Seattle, WA 98195 USA; [Kosgei, Rose J.; Mugo, Nelly R.] Univ Nairobi, Nairobi, Kenya; [Kosgei, Rose J.; Mugo, Nelly R.] Kenyatta Natl Hosp, Nairobi, Kenya; [Mugo, Nelly R.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Okech, Timothy C.] US Int Univ, Nairobi, Kenya; [Sakr, Samah R.] Copt Hope Ctr Infect Dis, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Nairobi; Kenyatta National Hospital; Kenya Medical Research Institute; United States International University Africa	Vodicka, EL (corresponding author), Univ Washington, Seattle, WA 98195 USA.	evodicka@uw.edu			Centers for Disease Control and Prevention [1U2GPS002047-01]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS002047] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by Centers for Disease Control and Prevention, Grant/Award Number: 1U2GPS002047-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NATL GUIDELINES PREV; [Anonymous], 2015, IND AIDSINFO; [Anonymous], 2015, PINK RIBBON RED RIBB; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Chung MH, 2009, CURR HIV RES, V7, P441, DOI 10.2174/157016209788680552; CPI & Inflation Rates, 2005, Q CPI 1963 DAT; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hongoro C, 2011, J PAIN SYMPTOM MANAG, V41, P1015, DOI 10.1016/j.jpainsymman.2010.08.014; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Hyle EP, 2014, JAIDS-J ACQ IMM DEF, V67, pS87, DOI 10.1097/QAI.0000000000000254; Kendall T, 2014, JAIDS-J ACQ IMM DEF, V67, pS169, DOI 10.1097/QAI.0000000000000382; Kumakech E, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0183-4; Lince-Deroche N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141969; Maranga IO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078411; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Nelson S, 2016, NIH PUBLIC ACCESS, V10, P1; Odafe Solomon, 2013, Niger Med J, V54, P176, DOI 10.4103/0300-1652.114590; PALINKAS LA, 2015, NIH PUBLIC ACCESS, V42, P533, DOI DOI 10.1007/S10488-013-0528-Y; Sahasrabuddhe VV, 2012, CANCER PREV RES, V5, P11, DOI 10.1158/1940-6207.CAPR-11-0540; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; STEFAN C, 2017, CANC INCIDENCE 5 CON, V11; Topazian H, 2016, J Cancer Policy, V7, P36, DOI 10.1016/j.jcpo.2015.12.001; Vassall A, 2017, REFERENCE CASE ESTIM; Viviano M, 2017, INT J WOMENS HEALTH, V9, P69, DOI 10.2147/IJWH.S103868; Vodicka EL, 2017, INT J GYNECOL OBSTET, V136, P220, DOI 10.1002/ijgo.12025; White HL, 2017, INT J GYNECOL OBSTET, V138, P41, DOI 10.1002/ijgo.12194; World Development Indicators The World Bank, 2012, OFF EXCH RAT	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217331	10.1371/journal.pone.0217331	http://dx.doi.org/10.1371/journal.pone.0217331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170193	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700026
J	Wang, JX; Dang, RH; Miyasaka, Y; Hattori, K; Torigoe, D; Okamura, T; Tag-El-Din-Hassan, HT; Morimatsu, M; Mashimo, T; Agui, T				Wang, Jinxi; Dang, Ruihua; Miyasaka, Yoshiki; Hattori, Kousuke; Torigoe, Daisuke; Okamura, Tadashi; Tag-El-Din-Hassan, Hassan T.; Morimatsu, Masami; Mashimo, Tomoji; Agui, Takashi			Null mutation of the endothelin receptor type B gene causes embryonic death in the GK rat	PLOS ONE			English	Article							HIRSCHSPRUNGS-DISEASE; GERMLINE MUTATIONS; GDNF; RET; SEVERITY; DELETION; DEFECTS; SOX10	The Hirschsprung disease (HSCR) is an inherited disease that is controlled by multiple genes and has a complicated genetic mechanism. HSCR patients suffer from various extents of constipation due to dysplasia of the enteric nervous system (ENS), which can be so severe as to cause complete intestinal obstruction. Many genes have been identified as playing causative roles in ENS dysplasia and HSCR, among them the endothelin receptor type B gene (Ednrb) has been identified to play an important role. Mutation of Ednrb causes a series of symptoms that include deafness, pigmentary abnormalities, and aganglionosis. In our previous studies of three rat models carrying the same spotting lethal (sl) mutation on Ednrb, the haplotype of a region on chromosome (Chr) 2 was found to be responsible for the differing severities of the HSCR-like symptoms. To confirm that the haplotype of the responsible region on Chr 2 modifies the severity of aganglionosis caused by Ednrb mutation and to recreate a rat model with severe symptoms, we selected the GK inbred strain, whose haplotype in the responsible region on Chr 2 resembles that of the rat strain in which severe symptoms accompany the Ednrb(sl) mutation. An Ednrb mutation was introduced into the GK rat by crossing with F344-Ednrb(sl) and by genome editing. The null mutation of Ednrb was found to cause embryonic death in F2 progeny possessing the GK haplotype in the responsible region on Chr 2. The results of this study are unexpected, and they provide new clues and animal models that promise to contribute to studies on the genetic regulatory network in the development of ENS and on embryogenesis.	[Wang, Jinxi; Torigoe, Daisuke; Tag-El-Din-Hassan, Hassan T.; Morimatsu, Masami; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan; [Wang, Jinxi; Miyasaka, Yoshiki; Hattori, Kousuke; Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Osaka, Japan; [Dang, Ruihua] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Sect Anim Models, Tokyo, Japan; [Tag-El-Din-Hassan, Hassan T.] Mansoura Univ, Fac Agr, Poultry Prod Dept, Mansoura, Egypt; [Torigoe, Daisuke] Kumamoto Univ, Inst Resource Dev & Anal, Div Microbiol & Genet, Kumamoto, Japan	Hokkaido University; Osaka University; Northwest A&F University - China; National Center for Global Health & Medicine - Japan; Egyptian Knowledge Bank (EKB); Mansoura University; Kumamoto University	Agui, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan.	agui@vetmed.hokudai.ac.jp	EL-Din, Hassan Tag/Y-7984-2019; Morimatsu, Masami/A-6698-2012	Morimatsu, Masami/0000-0003-0740-0157; Agui, Takashi/0000-0001-6203-0502; Miyasaka, Yoshiki/0000-0003-4020-9290	Morinaga Foundation for Health and Nutrition	Morinaga Foundation for Health and Nutrition	This work was supported in part by a grant from the Morinaga Foundation for Health and Nutrition (MM), of which grant number and URL to sponsor's website were not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BADNER JA, 1990, AM J HUM GENET, V46, P568; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Brooks AS, 2005, CLIN GENET, V67, P6, DOI 10.1111/j.1399-0004.2004.00319.x; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027902; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Huang JP, 2016, GENE, V575, P144, DOI 10.1016/j.gene.2015.08.051; Huang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122068; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; LUO Y, 1993, HUM MOL GENET, V2, P1803, DOI 10.1093/hmg/2.11.1803; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; McKeown SJ, 2017, STEM CELL REP, V8, P476, DOI 10.1016/j.stemcr.2016.12.013; Momose K, 2006, MED MOL MORPHOL, V39, P146, DOI 10.1007/s00795-006-0324-9; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Semenova E, 2003, HUM MOL GENET, V12, P1301, DOI 10.1093/hmg/ddg140; Shen L, 2002, AM J HUM GENET, V70, P435, DOI 10.1086/338712; Syrris P, 1999, AM J MED GENET, V87, P69, DOI 10.1002/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.3.CO;2-I; Szymonska I., 2015, J GENET SYNDR GENE T, V6, DOI 10.4172/2157-7412.1000269; Welsh IC, 2000, DEV BIOL, V225, P151, DOI 10.1006/dbio.2000.9814	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217132	10.1371/journal.pone.0217132	http://dx.doi.org/10.1371/journal.pone.0217132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170185	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700020
J	Miller, KL; Rico, SC; Muletz-Wolz, CR; Campana, MG; McInerney, N; Augustine, L; Frere, C; Peters, AM; Fleischer, RC				Miller, Kyle L.; Rico, Susette Castaneda; Muletz-Wolz, Carly R.; Campana, Michael G.; McInerney, Nancy; Augustine, Lauren; Frere, Celine; Peters, Alan M.; Fleischer, Robert C.			Parthenogenesis in a captive Asian water dragon (Physignathus cocincinus) identified with novel microsatellites	PLOS ONE			English	Article							MOLECULAR-GENETIC EVIDENCE; FACULTATIVE PARTHENOGENESIS; GENOME; SHARK; BOA	Reptiles show varying degrees of facultative parthenogenesis. Here we use genetic methods to determine that an isolated, captive female Asian water dragon produced at least nine offspring via parthenogenesis. We identified microsatellites for the species from shotgun genomic sequences, selected and optimized primer sets, and tested all of the offspring for a set of seven microsatellites that were heterozygous in the mother. We verified that the seven loci showed high levels of polymorphism in four wild Asian water dragons from Vietnam. In all cases, the offspring (unhatched, but developed eggs, or hatched young) had only a single allele at each locus, and contained only alleles present in the mother's genotype (i.e., were homozygous or hemizygous). The probability that our findings resulted from the female mating with one or more males is extremely small, indicating that the offspring were derived from a single female gamete (either alone or via duplication and/or fusion) and implicating parthenogenesis. This is the first documented case of parthenogenesis in the Squamate family Agamidae.	[Miller, Kyle L.; Augustine, Lauren; Peters, Alan M.] Smithsonians Natl Zool Pk, Dept Anim Care Sci, Washington, DC 20008 USA; [Rico, Susette Castaneda; Muletz-Wolz, Carly R.; Campana, Michael G.; McInerney, Nancy; Fleischer, Robert C.] Natl Zool Pk, Ctr Conservat Genom, Smithsonian Conservat Biol Inst, Washington, DC USA; [Rico, Susette Castaneda] George Mason Univ, Fairfax, VA 22030 USA; [Augustine, Lauren] St Louis Zoo, One Govt Dr, St Louis, MO USA; [Frere, Celine] Univ Sunshine Coast, Sippy Downs, Qld, Australia	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; University of the Sunshine Coast	Miller, KL (corresponding author), Smithsonians Natl Zool Pk, Dept Anim Care Sci, Washington, DC 20008 USA.	millerkl@si.edu	Frere, Celine Henria/B-4905-2013; Frere, Celine Henria/GYJ-3882-2022; Muletz-Wolz, Carly/N-3816-2013	Frere, Celine Henria/0000-0002-9671-2138; Muletz-Wolz, Carly/0000-0001-5047-9601; Campana, Michael/0000-0003-0461-6462	Center for Conservation Genomics	Center for Conservation Genomics	We thank Assistant Curator of Herpetology at the Smithsonian's National Zoo, Matthew Evans for facilitating scheduling and communications with the Center for Conservation Genomics team to ensure this project came to fruition. We also thank National Zoo Herpetology keepers Robin Saunders and Matthew Neff, who collected the first clutch of eggs we suspected were the result of parthenogenesis and ensured their safe transition to the incubator. We appreciate Maya Rao's help with lab work. Funds for lab work were provided by the Center for Conservation Genomics. We thank Robert and Arlene Kogod for their support of the Secretary's Scholar Program. We acknowledge the Ambrose Monell Cryo Collection (AMCC) at the American Museum of Natural History, New York, and the curatorial staff David Dickey, David Kizirian, and Svetlana Katanova for providing samples for our research. Last, we thank female dragon WD-10, also known as Saphira, for providing research materials.	Allen L, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171901; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booth W, 2016, BIOL J LINN SOC, V118, P172, DOI 10.1111/bij.12744; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Booth W, 2011, BIOL J LINN SOC, V104, P934, DOI 10.1111/j.1095-8312.2011.01782.x; Booth W, 2011, J HERED, V102, P759, DOI 10.1093/jhered/esr080; Booth W, 2011, BIOL LETTERS, V7, P253, DOI 10.1098/rsbl.2010.0793; Chapman DD, 2008, J FISH BIOL, V73, P1473, DOI 10.1111/j.1095-8649.2008.02018.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dudgeon CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40537; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Frere CH, 2012, CONSERV GENET RESOUR, V4, P113, DOI 10.1007/s12686-011-9487-3; Georges A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0085-2; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; Kinney ME, 2012, ZOO BIOL, V32; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Portnoy DS, 2014, J FISH BIOL, V85, P502, DOI 10.1111/jfb.12415; Reynolds GR, 2016, BIOL J LINN SOC, V107, P566, DOI [10.1111/jfb.12415, DOI 10.1111/JFB.12415]; Shibata H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189654; Sinclair EA, 2010, EVOLUTION, V64, P1346, DOI 10.1111/j.1558-5646.2009.00893.x; van der Kooi CJ, 2015, CURR BIOL, V25, pR659, DOI 10.1016/j.cub.2015.06.055; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a	28	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217489	10.1371/journal.pone.0217489	http://dx.doi.org/10.1371/journal.pone.0217489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166974	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800031
J	Fleming, PJ; Lopez, WD; Ledon, C; Llanes, M; Waller, A; Harner, M; Martinez, R; Kruger, DJ				Fleming, Paul J.; Lopez, William D.; Ledon, Charo; Llanes, Mikel; Waller, Adreanne; Harner, Melanie; Martinez, Ramiro; Kruger, Daniel J.			I'm going to look for you and take your kids': Reproductive justice in the context of immigration enforcement	PLOS ONE			English	Article							DEPORTATION; HEALTH; SERVICES; COUNTY	Prior research has shown that immigration law enforcement contributes to poor health outcomes-including reproductive health outcomes-among Latinos. Yet no prior research has examined how immigration enforcement might inhibit reproductive justice and limit individual's reproductive autonomy. We utilized data from an existing study that consisted of a partnership with a Latino community in Michigan in which an immigration raid resulted in multiple arrests and deportations midway through data collection. Using cross-sectional survey data (n = 192) where no one was re-interviewed, we used ordinal logistic regression to compare desired pregnancy timing of individuals surveyed prior to and after the raid to determine the impact of an immigration raid on desired timing of next pregnancy. We then used qualitative data-including 21 in-depth interviews and participant observation-collected in the community after the raid to contextualize our findings. Controlling for socio-demographic characteristics, we found that Latinos surveyed in the aftermath of the raid were more likely to report a greater desire to delay childbearing than Latinos surveyed before the raid occurred. Our qualitative data showed that an immigration raid has financial and psychological effects on immigrant families and that a raid may impact reproductive autonomy because people are fearful of these impacts. These finding suggest that current immigration enforcement efforts may influence reproductive decision-making, impede Latinos reproductive autonomy, and that family-friendly immigration policy reform is needed.	[Fleming, Paul J.; Lopez, William D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Ledon, Charo] Accion Buenos Vecinos, Ypsilanti, MI USA; [Llanes, Mikel] Univ Michigan, Med Sch, Dept Family Med, Ann Arbor, MI 48109 USA; [Waller, Adreanne] Washtenaw Cty Publ Hlth, Ypsilanti, MI USA; [Harner, Melanie; Martinez, Ramiro] Washtenaw Interfaith Coalit Immigrant Rights, Ypsilanti, MI USA; [Kruger, Daniel J.] Univ Michigan, Populat Studies Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fleming, PJ (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.	pauljf@umich.edu	Zweigenthal, Virginia/AAW-6425-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Fleming, Paul/0000-0001-9150-1254	Rackham Graduate School; Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan; US Housing and Urban Development-Sustainable Communities Project; Michigan Institute for Clinical and Health Research Partnership [2UL1TR000433-06]; Michigan Department of Community Health-Health Equity Capacity Building Project; Washtenaw County Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER	Rackham Graduate School; Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan; US Housing and Urban Development-Sustainable Communities Project; Michigan Institute for Clinical and Health Research Partnership; Michigan Department of Community Health-Health Equity Capacity Building Project; Washtenaw County Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded in part by Rackham Graduate School and the Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan, the US Housing and Urban Development-Sustainable Communities Project, Michigan Institute for Clinical and Health Research Partnership (2UL1TR000433-06), Michigan Department of Community Health-Health Equity Capacity Building Project, and Washtenaw County Public Health.	Calvo JM, 2017, AM J PUBLIC HEALTH, V107, P1240, DOI [10.2105/AJPH.2017.303896, 10.2105/ajph.2017.303896]; Castaneda H, 2014, AM BEHAV SCI, V58, P1891, DOI 10.1177/0002764214550290; Cavazos-Rehg PA, 2007, J NATL MED ASSOC, V99, P1126; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Chavez LR, 2012, SOC SCI MED, V74, P887, DOI 10.1016/j.socscimed.2011.05.023; Delva J., 2013, J COMMUNITY POSITIVE, VXIII, P25; Doering-White J, 2016, J INT MIGR INTEGR, V17, P325, DOI 10.1007/s12134-014-0408-7; Doshi M, 2018, AM PUBL HLTH ASS ANN; Dreby J, 2012, J MARRIAGE FAM, V74, P829, DOI 10.1111/j.1741-3737.2012.00989.x; Evans K, 2009, NYU REV LAW SOC CHAN, V33, P561; Fleming P, 2018, DETROIT FREE PRESS; Fleming PJ, 2018, AM PUBL HLTH ASS ANN; Golash-Boza T, 2013, LAT STUD, V11, P271, DOI 10.1057/lst.2013.14; Hacker K, 2012, J HEALTH CARE POOR U, V23, P651, DOI 10.1353/hpu.2012.0052; Hansen R, 2013, STERILIZED BY THE STATE: EUGENICS, RACE, AND THE POPULATION SCARE IN TWENTIETH-CENTURY NORTH AMERICA, P1; Kopan T, 2018, CNN COM; Lopez WD, 2017, J IMMIGR MINOR HEALT, V19, P702, DOI 10.1007/s10903-016-0390-6; Lopez William D., 2018, TRAUMATOLOGY; Maldonado CZ, 2013, ACAD EMERG MED, V20, P155, DOI 10.1111/acem.12079; Medina J., 2017, NY TIMES; Miller ME, 2018, WASHINGTON POST; Novak NL, 2018, AM J PUBLIC HEALTH, V108, P611, DOI 10.2105/AJPH.2018.304369; Novak NL, 2017, INT J EPIDEMIOL, V46, P839, DOI 10.1093/ije/dyw346; Page KR, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1700829; Partners HI., 2013, FAMILY UNITY FAMILY; Purdy L, 2006, J MED ETHICS, V32, P287, DOI 10.1136/jme.2004.013193; Richards SE., 2018, ATLANTIC; Rohmy, 2016, MUSICA URBANA; Rosenblum M.R., 2014, DEPORTATION DISCRETI; Ross L., 2006, UNDERSTANDING REPROD; Ross Loretta., 2016, UNDIVIDED RIGHTS WOM; Simanski JF, 2014, ANN REPORT OFFICE IM, V1; Stevens Matt, 2018, NY TIMES; Strauss A., 1997, GROUNDED THEORY PRAC; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Sullivan MM, 2005, ADV NURS SCI, V28, P240, DOI 10.1097/00012272-200507000-00006; White K, 2014, J HEALTH CARE POOR U, V25, P1844, DOI 10.1353/hpu.2014.0194	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217898	10.1371/journal.pone.0217898	http://dx.doi.org/10.1371/journal.pone.0217898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163074	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200043
J	Gommers, LMM; Hill, TG; Ashcroft, FM; de Baaij, JHF				Gommers, Lisanne M. M.; Hill, Thomas G.; Ashcroft, Frances M.; de Baaij, Jeroen H. F.			Low extracellular magnesium does not impair glucose-stimulated insulin secretion	PLOS ONE			English	Article							SERUM MAGNESIUM; HYPOMAGNESEMIA; HOMEOSTASIS; IMPROVES; RISK; MG2+; RAT	There is an increasing amount of clinical evidence that hypomagnesemia (serum Mg2+ levels < 0.7 mmol/l) contributes to type 2 diabetes mellitus pathogenesis. Amongst other hypotheses, it has been suggested that Mg2+ deficiency affects insulin secretion. The aim of this study was, therefore, to investigate the acute effects of extracellular Mg2+ on glucose-stimulated insulin secretion in primary mouse islets of Langerhans and the rat insulinoma INS-1 cell line. Here we show that acute lowering of extracellular Mg2+ concentrations from 1.0 mM to 0.5 mM did not affect glucose-stimulated insulin secretion in islets or in insulin-secreting INS-1 cells. The expression of key genes in the insulin secretory pathway (e.g. Gck, Abcc8) was also unchanged in both experimental models. Knockdown of the most abundant Mg2+ channel Trpm7 by siRNAs in INS-1 cells resulted in a 3-fold increase in insulin secretion at stimulatory glucose conditions compared to mock-transfected cells. Our data suggest that insulin secretion is not affected by acute lowering of extracellular Mg2+ concentrations.	[Gommers, Lisanne M. M.; de Baaij, Jeroen H. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [Gommers, Lisanne M. M.; Hill, Thomas G.; Ashcroft, Frances M.; de Baaij, Jeroen H. F.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Radboud University Nijmegen; University of Oxford	de Baaij, JHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands.; de Baaij, JHF (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	jeroen.debaaij@radboudumc.nl	Gommers, Lisanne/O-8313-2016; de Baaij, Jeroen/P-5704-2015	de Baaij, Jeroen/0000-0003-2372-8486	Netherlands Organization for Scientific Research [NWO Rubicon 825.14.021, NWO VENI 016.186.012]; Wellcome Trust [884655, 089795]; Dutch Diabetes Research Foundation [2017.81.014]; Royal Society Research Wolfson Merit Award	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Diabetes Research Foundation; Royal Society Research Wolfson Merit Award	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO Rubicon 825.14.021, NWO VENI 016.186.012) and the Wellcome Trust (884655, 089795). Jeroen de Baaij is supported by the Dutch Diabetes Research Foundation (2017.81.014). Frances Ashcroft holds a European Research Council Advanced Investigatorship and a Royal Society Research Wolfson Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER I, 1983, Q J EXP PHYSIOL CMS, V68, P233, DOI 10.1113/expphysiol.1983.sp002715; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Cantley J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0140-6; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gommers LMM, 2016, DIABETES, V65, P3, DOI 10.2337/db15-1028; Gunther T, 2010, MAGNESIUM RES, V23, P5, DOI 10.1684/mrh.2009.0195; Guerrero-Romero F, 2014, CIR CIR, V82, P282; Guerrero-Romero F, 2011, EUR J CLIN INVEST, V41, P405, DOI 10.1111/j.1365-2362.2010.02422.x; Ishizuka Jin, 1994, Magnesium Research, V7, P17; Kieboom BCT, 2017, DIABETOLOGIA, V60, P843, DOI 10.1007/s00125-017-4224-4; Kurstjens S, 2019, DIABETOLOGIA, V62, P311, DOI 10.1007/s00125-018-4771-3; Kurstjens S, 2018, DIABETOLOGIA, V61, P2030, DOI 10.1007/s00125-018-4680-5; Kurstjens S, 2017, EUR J ENDOCRINOL, V176, P11, DOI 10.1530/EJE-16-0517; LEGRAND C, 1987, METABOLISM, V36, P160, DOI 10.1016/0026-0495(87)90011-4; Mittermeier L, 2019, P NATL ACAD SCI USA, V116, P4706, DOI 10.1073/pnas.1810633116; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; MURAKAMI M, 1992, P SOC EXP BIOL MED, V200, P490; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; PAOLISSO G, 1989, DIABETES CARE, V12, P265, DOI 10.2337/diacare.12.4.265; PAOLISSO G, 1989, ACTA ENDOCRINOL-COP, V121, P16, DOI 10.1530/acta.0.1210016; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Randell EW, 2008, ATHEROSCLEROSIS, V196, P413, DOI 10.1016/j.atherosclerosis.2006.11.024; Reis MAB, 2001, BRIT J NUTR, V85, P549, DOI 10.1079/BJN2000294; Rodriguez-Moran M, 2011, DIABETES-METAB RES, V27, P590, DOI 10.1002/dmrr.1206; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217925	10.1371/journal.pone.0217925	http://dx.doi.org/10.1371/journal.pone.0217925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163064	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200047
J	Lahlou, G; Rodallec, M; Nguyen, Y; Sterkers, O; Kalamarides, M				Lahlou, Ghizlene; Rodallec, Mathieu; Yann Nguyen; Sterkers, Olivier; Kalamarides, Michel			How to radiologically identify a spontaneous regression of sporadic vestibular schwannoma?	PLOS ONE			English	Article							RADIOSURGERY; MANAGEMENT	Background The natural history of sporadic vestibular schwannoma is unpredictable, with tumors growing, non-growing and even showing spontaneous regression in some rare cases. Objective This retrospective study aims to describe the radiologic signs characterizing and identifying the shrinking vestibular schwannoma. Methods Involution was considered to have occurred if tumor size had decreased by 2 mm or more on its largest diameter. All magnetic resonance imaging scans were reviewed for tumor size, internal auditory meatus size, and tumor characteristics. Volumetric measurements were performed on the first and last scan. Audiometric data were collected at the first and last visit. Results Fourteen patients with a confirmed spontaneous regression were included, with a mean follow-up of 5 +/- 2.6 years. The mean shrinkage rate was 0.9 +/- 0.59 mm/year on 2D measurements, and 0.2 +/- 0.17 cm(3)/year on volumetric measurements, with a relative shrinkage of 40 +/- 16.9%. Two remarkable radiologic features were observed: First, a festooned aspect, defined by multiple curves in the tumor outline, noticed in 12 cases (86%); second, the appearance of cerebrospinal fluid filling the internal auditory meatus, associated with an enlargement of the internal auditory meatus compared to the contralateral side, and observed in 10 out of 13 cases with internal auditory meatus invasion (77%). Those two aspects were associated in 64% of cases. Conclusion These two newly reported radiologic features could help neurosurgeons, oto-neurosurgeons and neuroradiologists to identify a spontaneous vestibular schwannoma involution at first visit. This could allow any treatment to be postponed, monitoring to be more widely spaced, and patients to be reassured.	[Lahlou, Ghizlene; Yann Nguyen; Sterkers, Olivier] Hop La Pitie Salpetriere, AP HP, Dept Otol Auditory Implants & Skull Base Surg, Paris, France; [Lahlou, Ghizlene; Yann Nguyen; Sterkers, Olivier] Sorbonne Univ, INSERM, Minimally Invas & Robot Based Surg Rehabil Hearin, Paris, France; [Rodallec, Mathieu] Ctr Cardiol Nord, Dept Radiol, St Denis, Reunion, France; [Kalamarides, Michel] Hop La Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France; [Kalamarides, Michel] Sorbonne Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lahlou, G (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Otol Auditory Implants & Skull Base Surg, Paris, France.; Lahlou, G (corresponding author), Sorbonne Univ, INSERM, Minimally Invas & Robot Based Surg Rehabil Hearin, Paris, France.	ghizlene.lahlou@aphp.fr	Nguyen, Yann/AAX-5740-2020	Nguyen, Yann/0000-0003-4635-0658				Battaglia A, 2006, OTOL NEUROTOL, V27, P705, DOI 10.1097/01.mao.0000226302.59198.87; Ferri GG, 2008, LARYNGOSCOPE, V118, P951, DOI 10.1097/MLG.0b013e31816a8955; Grayeli AB, 2005, ACTA OTO-LARYNGOL, V125, P1063, DOI 10.1080/00016480510038013; Hashimoto S, 2003, KEIO U INT SYMP LIFE, V10, P13; Huang X, 2013, J LARYNGOL OTOL, V127, P739, DOI 10.1017/S0022215113001266; Ikonomidis C, 2015, AUDIOL NEURO-OTOL, V20, P406, DOI 10.1159/000441119; Kirchmann M, 2017, NEUROSURGERY, V80, P49, DOI 10.1227/NEU.0000000000001414; Lees KA, 2018, OTOLARYNGOL HEAD NEC; Lin EP, 2017, AM J NEURORADIOL, P1; Luetje CM, 2000, AM J OTOL, V21, P393, DOI 10.1016/S0196-0709(00)80050-2; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P179; Nakamura H, 2000, AM J NEURORADIOL, V21, P1540; Pollock BE, 1998, J NEUROSURG, V89, P949, DOI 10.3171/jns.1998.89.6.0949; Stangerup SE, 2012, OTOLARYNG CLIN N AM, V45, P257, DOI 10.1016/j.otc.2011.12.008; Tikka T, 2018, OTOL NEUROTOL, V1; Torres R, 2017, OTOLARYNG HEAD NECK, V156, P525, DOI 10.1177/0194599816677711; Wu CC, 2017, J NEUROSURG, V127, P1384, DOI 10.3171/2016.9.JNS161510; Zhang Z, 2016, ACTA OTORHINOLARYNGO, V36, P408, DOI 10.14639/0392-100X-1176	18	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217752	10.1371/journal.pone.0217752	http://dx.doi.org/10.1371/journal.pone.0217752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163048	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200031
J	van Timmeren, JE; Carvalho, S; Leijenaar, RTH; Troost, EGC; van Elmpt, W; de Ruysscher, D; Muratet, JP; Denis, F; Schimek-Jasch, TA; Nestle, U; Jochems, A; Woodruff, HC; Oberije, C; Lambin, P				van Timmeren, Janna E.; Carvalho, Sara; Leijenaar, Ralph T. H.; Troost, Esther G. C.; van Elmpt, Wouter; de Ruysscher, Dirk; Muratet, Jean-Pierre; Denis, Fabrice; Schimek-Jasch, Tanj A.; Nestle, Ursula; Jochems, Arthur; Woodruff, Henry C.; Oberije, Cary; Lambin, Philippe			Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics	PLOS ONE			English	Article							CELL LUNG-CANCER; PROGNOSTIC VALUE; FEATURES; RECONSTRUCTION; SUV; DISCRETIZATION; VARIABILITY; PREDICTION; SURVIVAL; IMPACT	Background Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan acquired during treatment. Methods The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called 'cohort differences model' approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. Results The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. Conclusion The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of cohorts and of validation datasets, especially in retrospective multi-centric datasets.	[van Timmeren, Janna E.; Leijenaar, Ralph T. H.; Jochems, Arthur; Woodruff, Henry C.; Oberije, Cary; Lambin, Philippe] Maastricht Univ, Med Ctr, D Lab Decis Support Precis Med, Grow Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Timmeren, Janna E.; Carvalho, Sara; van Elmpt, Wouter; de Ruysscher, Dirk] Maastricht Univ, Med Ctr, Dept Radiat Oncol, Grow Sch Oncol & Dev Biol,MAASTRO Clin, Maastricht, Netherlands; [Troost, Esther G. C.] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Cal Gustav Carus, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Fac Med, Dept Radiotherapy & Radiat Oncol, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Troost, Esther G. C.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany; [Troost, Esther G. C.] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Troost, Esther G. C.] German Canc Res Ctr, Heidelberg, Germany; [Troost, Esther G. C.] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Troost, Esther G. C.] Helmholtz Zentrum Dresden Rossendorf, Helmholtz Assoc, Dresden, Germany; [Muratet, Jean-Pierre; Denis, Fabrice] Ctr Jean Bernard, Clin Victor Hugo, Le Mans, France; [Schimek-Jasch, Tanj A.; Nestle, Ursula] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Freiburg	van Timmeren, JE (corresponding author), Maastricht Univ, Med Ctr, D Lab Decis Support Precis Med, Grow Sch Oncol & Dev Biol, Maastricht, Netherlands.; van Timmeren, JE (corresponding author), Maastricht Univ, Med Ctr, Dept Radiat Oncol, Grow Sch Oncol & Dev Biol,MAASTRO Clin, Maastricht, Netherlands.	j.vantimmeren@maastrichuniversity.nl	Nestle, Ursula/ABG-2339-2021; Woodruff, Henry/AAS-5573-2021; Denis, Fabrice/T-7965-2019; Oberije, Cary/ABA-6178-2020; van Timmeren, Janita/AAL-4456-2020	Oberije, Cary/0000-0003-0749-5117; van Timmeren, Janita/0000-0002-8166-6853; Lambin, Philippe/0000-0001-7961-0191	ERC advanced grant (ERC-ADG-2015) [694812 -Hypoximmuno]; QuIC-ConCePT project - EFPI A companies; Innovative Medicine Initiative Joint Undertaking (IMI JU) [115151]; Dutch technology Foundation STW, which is the applied science division of NWO [P14-19]; Technology Programme of the Ministry of Economic Affairs; SME Phase 2 (RAIL) [673780]; EUROSTARS (DART, DECIDE); European Program H2020-2015-17 (ImmunoSABR) [733008]; European Program H2020-2015-17 (PREDICT -ITN) [766276]; Interreg V-A Euregio Meuse-Rhine ("Euradiomics"); Kankeronderzoekfonds Limburg from the Health Foundation Limburg	ERC advanced grant (ERC-ADG-2015); QuIC-ConCePT project - EFPI A companies; Innovative Medicine Initiative Joint Undertaking (IMI JU); Dutch technology Foundation STW, which is the applied science division of NWO(Technologiestichting STW); Technology Programme of the Ministry of Economic Affairs; SME Phase 2 (RAIL); EUROSTARS (DART, DECIDE); European Program H2020-2015-17 (ImmunoSABR); European Program H2020-2015-17 (PREDICT -ITN); Interreg V-A Euregio Meuse-Rhine ("Euradiomics"); Kankeronderzoekfonds Limburg from the Health Foundation Limburg	Authors acknowledge financial support from ERC advanced grant (ERC-ADG-2015, no 694812 -Hypoximmuno) and the QuIC-ConCePT project, which is partly funded by EFPI A companies and the Innovative Medicine Initiative Joint Undertaking (IMI JU) under Grant Agreement No. 115151. This research is also supported by the Dutch technology Foundation STW (no P14-19 Radiomics STRaTegy), which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. Authors also acknowledge financial support from SME Phase 2 (RAIL - no 673780), EUROSTARS (DART, DECIDE,), the European Program H2020-2015-17 (ImmunoSABR - no 733008 and PREDICT -ITN - no 766276), Interreg V-A Euregio Meuse-Rhine ("Euradiomics") and Kankeronderzoekfonds Limburg from the Health Foundation Limburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; Bailly C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159984; Banna GL, 2017, ONCOLOGY-BASEL, V92, P39, DOI 10.1159/000448005; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Cremonesi M, 2017, EUR J NUCL MED MOL I, V44, P1915, DOI 10.1007/s00259-017-3762-9; de Jong EEC, 2017, ACTA ONCOL, V56, P1459, DOI 10.1080/0284186X.2017.1346824; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Deist TM, 2018, MED PHYS, V45, P3449, DOI 10.1002/mp.12967; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fried DV, 2016, RADIOLOGY, V278, P214, DOI 10.1148/radiol.2015142920; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hastie T., 2008, ELEMENTS STAT LEARNI; Hofheinz F, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0208-5; Huang W, 2011, EUR J NUCL MED MOL I, V38, P1628, DOI 10.1007/s00259-011-1838-5; Kinahan PE, 2010, SEMIN ULTRASOUND CT, V31, P496, DOI 10.1053/j.sult.2010.10.001; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lambin P, 2017, ADV DRUG DELIVER REV, V109, P131, DOI 10.1016/j.addr.2016.01.006; Lambin P, 2013, NAT REV CLIN ONCOL, V10, P27, DOI 10.1038/nrclinonc.2012.196; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2017, ACTA ONCOL, V56, P1544, DOI 10.1080/0284186X.2017.1351624; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Mackin D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20713-6; Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Massaccesi M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-106; Nyflot MJ, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041002; Orlhac F, 2018, J NUCL MED, V59, P1321, DOI 10.2967/jnumed.117.199935; Paesmans M, 2015, EUR RESPIR J, V46, P1751, DOI 10.1183/13993003.00099-2015; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Peressutti D, 2017, MED PHYS, V44, P3159; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Sollini M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00426-y; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; Van de Wiele C, 2013, EUR J NUCL MED MOL I, V40, P290, DOI 10.1007/s00259-012-2280-z; van Elmpt W, 2012, J NUCL MED, V53, P1514, DOI 10.2967/jnumed.111.102566; van Timmeren JE, 2017, RADIOTHER ONCOL, V123, P363, DOI 10.1016/j.radonc.2017.04.016; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Visser EP, 2008, J NUCL MED, V49, P892, DOI 10.2967/jnumed.107.049585; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yossi S, 2015, CLIN NUCL MED, V40, pE215, DOI 10.1097/RLU.0000000000000615; Zwanenburg A, 2016, CORR; Zwanenburg A, 2018, RADIOTHER ONCOL, V127, P370, DOI 10.1016/j.radonc.2018.03.004	48	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217536	10.1371/journal.pone.0217536	http://dx.doi.org/10.1371/journal.pone.0217536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158263	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700019
J	Choi, Y; Ahn, KJ; Nam, Y; Jang, J; Shin, NY; Choi, HS; Jung, SL; Kim, BS				Choi, Yangsean; Ahn, Kook Jin; Nam, Yoonho; Jang, Jinhee; Shin, Na-Young; Choi, Hyun Seok; Jung, So-Lyung; Kim, Bum-soo			Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals	PLOS ONE			English	Article							MGMT PROMOTER METHYLATION; IDH MUTATION; SURVIVAL; HETEROGENEITY; TEMOZOLOMIDE; PERFORMANCE; MULTIFORME; RESECTION; EXTENT	Objectives The extent of peritumoral tumor cell infiltrations in glioblastoma contributes to poor prognosis. We aimed to assess additive prognostic value of Minkowski functionals in analyzing heterogeneity of peritumoral hyperintensity on T2WI in glioblastoma patients. Methods Clinical data (age, sex, extent of surgical resection), O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and pre-operative T2WI of 113 pathologically confirmed glioblastoma patients (from our institution, n = 61; from the Cancer Imaging Archive, n = 52) were retrospectively reviewed. The patients were randomly grouped into a training set (n = 80) and a test set (n = 33). Peritumoral T2 hyperintensity was manually segmented and Minkowski functionals-a texture analysis method capturing heterogeneity of MR images-were computed as a function of 11 grayscale thresholds. The Cox proportional hazards models were fitted with clinical variables, Minkowski functionals features as well as both combined. The risk prediction performances of the Minkowski functionals and combined models were validated on a separate test dataset. The sex-specific survival difference of the entire cohort was analyzed according to MGMT methylation status via Kaplan-Meier survival curves. Results Thirty-three Minkowski features (11 area, 11 perimeter and 11 genus) for each patient were acquired giving a total of 3729 features. Cox regression models fitted with clinical data, Minkowski features, and both combined had incremental concordance indices of 0.577 (P = 0.02), 0.706 (P = 0.02) and 0.714 (P = 0.01) respectively. The prediction error rate of the combined model-having clinical and Minkowski features-was lower than that of Minkowski functionals model (0.135 and 0.161, respectively) when validated on a test No sex-specific survival difference was found according to MGMT methylation status (male, P = 0.2; female, P = 0.22). Conclusions Minkowski functionals features computed from peritumoral hyperintensity can capture heterogeneity of glioblastoma on T2WI and have additive prognostic value in predicting survival, demonstrating their potential in complementing currently available prognostic parameters.	[Choi, Yangsean; Ahn, Kook Jin; Nam, Yoonho; Jang, Jinhee; Shin, Na-Young; Choi, Hyun Seok; Jung, So-Lyung; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Ahn, KJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	ahn-kj@catholic.ac.kr	KIM, Bum-soo/F-3086-2018; Choi, Yangsean/AAR-5274-2020	KIM, Bum-soo/0000-0002-3870-6813; 				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aubry M, 2015, ONCOTARGET, V6, P12094, DOI 10.18632/oncotarget.3297; Booth TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176528; Canuto HC, 2009, MAGN RESON MED, V61, P1218, DOI 10.1002/mrm.21946; Chaddad A, 2016, IEEE ENG MED BIO, P4035, DOI 10.1109/EMBC.2016.7591612; Chen Y, 2013, ARCH MED RES, V44, P281, DOI 10.1016/j.arcmed.2013.04.004; Chow D, 2018, AM J ROENTGENOL, V210, P30, DOI 10.2214/AJR.17.18754; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Fox MJ, 2016, J MAGN RESON IMAGING, V43, P903, DOI 10.1002/jmri.25057; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gutenberg A, 2013, BRIT J NEUROSURG, V27, P772, DOI 10.3109/02688697.2013.791664; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kickingereder P, 2018, NEURO-ONCOLOGY, V20, P848, DOI 10.1093/neuonc/nox188; Kickingereder P, 2016, RADIOLOGY, V280, P880, DOI 10.1148/radiol.2016160845; Kolakshyapati M, 2018, J NEUROSURG, V128, P667, DOI 10.3171/2016.10.JNS161694; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Larkin TJ, 2014, MAGN RESON MED, V71, P402, DOI 10.1002/mrm.24644; Lemee JM, 2015, NEURO-ONCOLOGY, V17, P1322, DOI 10.1093/neuonc/nov119; Li HL, 2016, CLIN NEUROL NEUROSUR, V151, P31, DOI 10.1016/j.clineuro.2016.10.004; Liu Y, 2017, AM J NEURORADIOL, V38, P1695, DOI 10.3174/ajnr.A5279; Mazaris P, 2014, CLIN NEUROL NEUROSUR, V120, P103, DOI 10.1016/j.clineuro.2014.03.001; McMillan KM, 2009, J MAGN RESON IMAGING, V29, P251, DOI 10.1002/jmri.21659; Michielsen K, 2001, PHYS REP, V347, P462; Mogensen UB, 2012, J STAT SOFTW, V50, P1; Molenaar RJ, 2014, NEURO-ONCOLOGY, V16, P1263, DOI 10.1093/neuonc/nou005; Ostrom QT, 2015, CANCER TREAT RES, V163, P1, DOI 10.1007/978-3-319-12048-5_1; Park CK, 2011, NEURO-ONCOLOGY, V13, P195, DOI 10.1093/neuonc/noq162; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Prasanna P, 2017, EUR RADIOL, V27, P4188, DOI 10.1007/s00330-016-4637-3; Sanai N, 2009, NEUROTHERAPEUTICS, V6, P478, DOI 10.1016/j.nurt.2009.04.005; Schiffgens S, 2016, ONCOTARGET, V7, P55169, DOI 10.18632/oncotarget.10465; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Yang P, 2015, ONCOTARGET, V6, P40896, DOI 10.18632/oncotarget.5683; Yang SH, 2012, J NEURO-ONCOL, V106, P243, DOI 10.1007/s11060-011-0668-4; Yang W, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aao5253	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217785	10.1371/journal.pone.0217785	http://dx.doi.org/10.1371/journal.pone.0217785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150499	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100107
J	Kubuga, CK; Abizari, AR; Song, WO				Kubuga, Clement Kubreziga; Abizari, Abdul-Razak; Song, Won O.			Iodine status of reproductive age women and their toddlers in northern Ghana improved through household supply of iodized salt and weekly indigenous meal consumption	PLOS ONE			English	Article							URINARY IODINE; DEFICIENCY; DIGESTION; NUTRITION; TRENDS; MILK	Iodine deficiency (ID) during pregnancy results in pregnancy losses, intrauterine growth retardation, and lower IQ in the offspring. Even after two decades of universal salt iodization (USI) implementation, the efficacy of USI has not been reported in high risk groups in vulnerable regions in Ghana. We aimed to assess and improve ID status in childbearing age women (all lactating women) and their toddlers in northern Ghana, a geographically and socioeconomically vulnerable region. We provided weekly supply of household iodized salt and community-based feeding of native Hibiscus Sabdariffaa leaves meal (HSM) prepared with iodized salt to women and their toddlers in intervention (n = 60) vs. control group (n = 60). At baseline, ID was prevalent in women (36%) and their toddlers (29%). For women, both median UIC values for intervention (57.4 ug/l) and control group (65.1 ug/l) were below the recommended UIC value of 100 ug/l with no significant differences between the two groups (p = 0.2778). At the endpoint, median UIC for the intervention group (123.6 ug/l) was significantly higher (p = 0.008) than the control group (59.7 ug/l). Our results suggest that weekly supply of iodized salt along with the feeding HSM is an effective channel for improving iodine status of economically disadvantaged groups in communities remote from coastal lands. Furthermore, our results suggest that decreased median UIC among lactating mothers does not necessarily imply lower iodine status for their breastfed toddlers. And finally, the observed median UIC<100 ug/l may point to a non-improvement in iodine status for the past decade for Ghana. There is a need to revisit, assess, and ascertain the challenges in preventing populations from attaining the intended benefits of the USI policy in Ghana.	[Kubuga, Clement Kubreziga; Abizari, Abdul-Razak] Univ Dev Studies, Nutr Sci Dept, Tamale, Ghana; [Song, Won O.] Michigan State Univ, Food Sci & Human Nutr Dept, E Lansing, MI 48824 USA	University for Development Studies; Michigan State University	Song, WO (corresponding author), Michigan State Univ, Food Sci & Human Nutr Dept, E Lansing, MI 48824 USA.	song@msu.edu		Song, Won/0000-0002-4372-4215	G Borlaug LEAP; BHEARD	G Borlaug LEAP; BHEARD	This project was mainly funded by G Borlaug LEAP and BHEARD, https://borlaugleap.org/; http://www.canr.msu.edu/bheard/received by CKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari A.-R., 2016, PUBLIC HEALTH NUTR, P1; Andersson M, 2007, PUBLIC HEALTH NUTR, V10, P1606, DOI 10.1017/S1368980007361004; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Bath S, 2008, J HUM NUTR DIET, V21, P280; Cappuccio F, 2014, 20 IEA WORLD C EP 17; Cogill B, 2003, ANTHROPOMETRIC INDIC; de Benoist B, 2008, FOOD NUTR BULL, V29, P195, DOI 10.1177/156482650802900305; DELANGE F, 1994, THYROID, V4, P107, DOI 10.1089/thy.1994.4.107; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Diosady L. L., 1997, Food and Nutrition Bulletin, V18, P388; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Haldimann M, 2015, PUBLIC HEALTH NUTR, V18, P1333, DOI 10.1017/S1368980014002018; Hedayati M, 2007, J CLIN LAB ANAL, V21, P286, DOI 10.1002/jcla.20185; Hedayati M, 2011, CLIN CHEM LAB MED, V49, P281, DOI 10.1515/CCLM.2011.053; Hess S. Y., 2016, PUBLIC HEALTH NUTR, P1; Hollowell JG, 1998, J CLIN ENDOCR METAB, V83, P3401, DOI 10.1210/jc.83.10.3401; Hurrell RF, 1997, EUR J CLIN NUTR, V51, pS9; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Kubuga CK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010198; Lee KW, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060325; Lee KW, 2016, INT J FOOD SCI NUTR, V67, P184, DOI 10.3109/09637486.2016.1144717; Li M, 2006, MED J AUSTRALIA, V184, P307, DOI 10.5694/j.1326-5377.2006.tb00248.x; Lynch SR, 2011, J NUTR, V141, p763S, DOI 10.3945/jn.110.130609; Nazeri P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020180; Nyumuah RO, 2012, FOOD NUTR BULL, V33, pS293, DOI 10.1177/15648265120334S305; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Ross AC, 2014, MODERN NUTR HLTH DIS, V11; Simpong DL, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0119-y; Spybrook J, OPTIMAL DESIGN PLUS, V5, P2012; Vanderpump MPJ, 2012, INT J EPIDEMIOL, V41, P601, DOI 10.1093/ije/dys059; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; World Health Organization, 2004, VIT MIN REQ HUM NUTR; World Health Organization, 2017, ABN DEV IOD DEF; World Health Organization, 2013, UR IOD CONC DET IOD; Zhao JK, 1999, PUBLIC HEALTH NUTR, V2, P173, DOI 10.1017/S1368980099000221; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216931	10.1371/journal.pone.0216931	http://dx.doi.org/10.1371/journal.pone.0216931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150410	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100027
J	Pedruzzi, G; Rouzine, IM				Pedruzzi, Gabriele; Rouzine, Igor M.			Epistasis detectably alters correlations between genomic sites in a narrow parameter window	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMPENSATORY MUTATIONS; BENEFICIAL MUTATIONS; STATISTICAL-METHODS; DRUG-RESISTANCE; HIV-1 PROTEASE; EVOLUTION; SELECTION; FITNESS; LINKAGE	Different genomic sites evolve inter-dependently due to the combined action of epistasis, defined as a non-multiplicative contribution of alleles at different loci to genome fitness, and the physical linkage of different loci in genome. Both epistasis and linkage, partially compensated by recombination, cause correlations between allele frequencies at the loci (linkage disequilibrium, LD). The interaction and competition between epistasis and linkage are not fully understood, nor is their relative sensitivity to recombination. Modeling an adapting population in the presence of random mutation, natural selection, pairwise epistasis, and random genetic drift, we compare the contributions of epistasis and linkage. For this end, we use a panel of haplotype-based measures of LD and their various combinations calculated for epistatic and non-epistatic pairs separately. We compute the optimal percentages of detected and false positive pairs in a one-time sample of a population of moderate size. We demonstrate that true interacting pairs can be told apart in a sufficiently short genome within a narrow window of time and parameters. Outside of this parameter region, unless the population is extremely large, shared ancestry of individual sequences generates pervasive stochastic LD for non-interacting pairs masking true epistatic associations. In the presence of sufficiently strong recombination, linkage effects decrease faster than those of epistasis, and the detection of epistasis improves. We demonstrate that the epistasis component of locus association can be isolated, at a single time point, by averaging haplotype frequencies over multiple independent populations. These results demonstrate the existence of fundamental restrictions on the protocols for detecting true interactions in DNA sequence sets.	[Pedruzzi, Gabriele; Rouzine, Igor M.] Sorbonne Univ, Inst Biol Paris Seine, Lab Biol Computationelle & Quantitat, LCQB, Paris, France	UDICE-French Research Universities; Sorbonne Universite	Rouzine, IM (corresponding author), Sorbonne Univ, Inst Biol Paris Seine, Lab Biol Computationelle & Quantitat, LCQB, Paris, France.	igor.rouzine@sorbonne-universite.fr	Rouzine, Igor M/AFO-3706-2022	Rouzine, Igor M/0000-0002-0744-6705	Agence National de Recherche, France [J16R389]	Agence National de Recherche, France(French National Research Agency (ANR))	Author IMR is funded by Agence National de Recherche, France, grant J16R389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; BARTON NH, 1995, GENETICS, V140, P821; Batorsky R, 2011, P NATL ACAD SCI USA, V108, P5661, DOI 10.1073/pnas.1102036108; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Brunet E, 2008, GENETICS, V179, P603, DOI 10.1534/genetics.107.079319; Bullock JM, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.010; Combarros O, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-22; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Desai MM, 2007, GENETICS, V177, P1001, DOI 10.1534/genetics.107.075812; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; FELSENSTEIN J, 1974, GENETICS, V78, P737; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gheorghiu-Svirschevski S, 2007, MOL BIOL EVOL, V24, P574, DOI 10.1093/molbev/msl189; Gonzalez-Ortega E, 2011, ANTIVIR RES, V92, P479, DOI 10.1016/j.antiviral.2011.10.010; Good BH, 2015, GENETICS, V199, P177, DOI 10.1534/genetics.114.172460; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Hallatschek O, 2011, P NATL ACAD SCI USA, V108, P1783, DOI 10.1073/pnas.1013529108; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; KIMURA M, 1965, GENETICS, V52, P875; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Levin BR, 2000, GENETICS, V154, P985; LEWONTIN RC, 1988, GENETICS, V120, P849; McKinney B. A., 2012, Frontiers in Genetics, V2, P109, DOI 10.3389/fgene.2011.00109; McVean GAT, 2000, GENETICS, V155, P929; Neher RA, 2010, GENETICS, V184, P467, DOI 10.1534/genetics.109.109009; Neher RA, 2013, P NATL ACAD SCI USA, V110, P437, DOI 10.1073/pnas.1213113110; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Neher RA, 2009, P NATL ACAD SCI USA, V106, P6866, DOI 10.1073/pnas.0812560106; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Pedruzzi G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006426; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; Rouzine IM, 2008, THEOR POPUL BIOL, V73, P24, DOI 10.1016/j.tpb.2007.10.004; Rouzine IM, 2010, THEOR POPUL BIOL, V77, P189, DOI 10.1016/j.tpb.2010.02.001; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926; Tsimring LS, 1996, PHYS REV LETT, V76, P4440, DOI 10.1103/PhysRevLett.76.4440; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Walczak AM, 2012, GENETICS, V190, P753, DOI 10.1534/genetics.111.134544; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Xiao YH, 2016, CELL HOST MICROBE, V19, P493, DOI 10.1016/j.chom.2016.03.009; Zhang Y, 2011, ANN HUM GENET, V75, P183, DOI 10.1111/j.1469-1809.2010.00621.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0214036	10.1371/journal.pone.0214036	http://dx.doi.org/10.1371/journal.pone.0214036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150393	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100009
J	Andersson, J; Rosell, M; Kockum, K; Lilja-Lund, O; Soderstrom, L; Laurell, K				Andersson, Johanna; Rosell, Michelle; Kockum, Karin; Lilja-Lund, Otto; Soderstrom, Lars; Laurell, Katarina			Prevalence of idiopathic normal pressure hydrocephalus: A prospective, population-based study	PLOS ONE			English	Article							SURGERY; MRI; SCALE	Background Idiopathic normal pressure hydrocephalus (iNPH) causing gait impairment, dementia and urinary incontinence among the elderly, is probably under-diagnosed and under-treated. Despite being known since the 1960s, there is still a lack of prospective, population-based studies on the prevalence of iNPH. Such studies are warranted to minimize selection bias and estimate the true prevalence of the disease. Methods The prevalence of iNPH was determined in a randomly selected sample of residents, aged 65 years and older, in the Swedish county of Jamtland. Out of 1,000 individuals invited to participate, 673 (67.3%) completed a questionnaire with seven questions on iNPH symptoms. A subgroup, with and without self-reported symptoms, participated in clinical and radiological evaluations and were diagnosed according to international guidelines. Measurement of cerebrospinal fluid opening pressure was not performed as it was considered too invasive. Results Those who reported at least two symptoms in the questionnaire (n = 117) and 51 randomly selected individuals with 0-1 symptom participated in further examinations. Out of them, 25 individuals received the diagnosis probable iNPH according to American-European guidelines (except for the criterion of CSF opening pressure) corresponding to a prevalence of 3.7%. The prevalence of iNPH was four times higher among those aged 80 years and older (8.9%) than among those aged 65-79 years (2.1%) (p < 0.001). The difference in prevalence between men (4.6%) and women (2.9%) was not significant (p = 0.24). When iNPH was diagnosed according to the Japanese guidelines the prevalence was 1.5% Conclusions In this prospective, population-based study the prevalence of iNPH was 3.7% among individuals 65 years and older, and more common in the higher age group, 80 years and above. INPH should be increasingly recognized since it is a fairly common condition and an important cause of gait impairment and dementia among the elderly that can be effectively treated by shunt surgery.	[Andersson, Johanna; Rosell, Michelle; Kockum, Karin; Lilja-Lund, Otto; Laurell, Katarina] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol, Umea, Sweden; [Soderstrom, Lars] Unit Res Dev & Educ, Ostersund, Sweden	Umea University	Andersson, J (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol, Umea, Sweden.	johanna.andersson@umu.se	Lilja-Lund, Otto/ABD-7387-2020	Lilja-Lund, Otto/0000-0001-5857-9287; Laurell, Katarina/0000-0002-7504-8354; Soderstrom, Lars/0000-0002-6474-6501	Region Jamtland Harjedalen; "Visare Norr"; Syskonen Persson; Jamtlands cancer och omvardnadsfond; donation fund "klinisk Neurovetenskap	Region Jamtland Harjedalen; "Visare Norr"; Syskonen Persson; Jamtlands cancer och omvardnadsfond; donation fund "klinisk Neurovetenskap	KL, JA, KK, OLL received governmental funding from Region Jamtland Harjedalen. KL received governmental funding from "Visare Norr". JA, OLL and KK received funding from the donation funds of "Syskonen Persson" and "Jamtlands cancer och omvardnadsfond". JA receiced funding from the donation fund "klinisk Neurovetenskap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Andersson J, 2017, eNeurologicalSci, V7, P27, DOI 10.1016/j.ensci.2017.04.002; Andren K, 2014, J NEUROL NEUROSUR PS, V85, P806, DOI 10.1136/jnnp-2013-306117; Brean A, 2008, ACTA NEUROL SCAND, V118, P48, DOI 10.1111/j.1600-0404.2007.00982.x; Brean A, 2009, ACTA NEUROL SCAND, V120, P314, DOI 10.1111/j.1600-0404.2009.01250.x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Factora R, 2008, GERIATRICS-US, V63, P32; Hashimoto M, 2010, FLUIDS BARRIERS CNS, V7, P2, DOI 10.1186/1743-8454-7-18; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Hiraoka K, 2008, NEUROL MED-CHIR, V48, P197, DOI 10.2176/nmc.48.197; Iseki C, 2014, J NEUROL SCI, V339, P108, DOI 10.1016/j.jns.2014.01.033; Iseki C, 2009, J NEUROL SCI, V277, P54, DOI 10.1016/j.jns.2008.10.004; Japanese Society of Normal Pressure Hydrocephalus Guidelines Committee. [Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus], 2004, GUID MAN ID NORM PRE; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Kockum K, 2018, EUR J NEUROL, V25, P569, DOI 10.1111/ene.13555; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Martin-Laez R, 2016, WORLD NEUROSURG, V87, P298, DOI 10.1016/j.wneu.2015.10.069; Martin-Laez R, 2015, WORLD NEUROSURG, V84, P2002, DOI 10.1016/j.wneu.2015.07.005; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; SCB Statistics Sweden, POP STAT; SPAR, SWED POP REG; Sundstrom N, 2017, BRIT J NEUROSURG, V31, P21, DOI 10.1080/02688697.2016.1229749; Tanaka N, 2009, NEUROEPIDEMIOLOGY, V32, P171, DOI 10.1159/000186501; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Virhammar J, 2014, J NEUROSURG, V120, P178, DOI 10.3171/2013.8.JNS13575	29	52	54	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217705	10.1371/journal.pone.0217705	http://dx.doi.org/10.1371/journal.pone.0217705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141553	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000074
J	Jablonska, PA; Diez-Valle, R; Perez-Larraya, JG; Moreno-Jimenez, M; Idoate, MA; Arbea, L; Tejada, S; de Eulate, MRG; Ramos, L; Arbizu, J; Dominguez, P; Aristu, JJ				Anna Jablonska, Paola; Diez-Valle, Ricardo; Gallego Perez-Larraya, Jaime; Moreno-Jimenez, Marta; Angel Idoate, Miguel; Arbea, Leire; Tejada, Sonia; Garcia de Eulate, Maria Reyes; Ramos, Luis; Arbizu, Javier; Dominguez, Pablo; Javier Aristu, Jose			Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience	PLOS ONE			English	Article							RANDOMIZED PHASE-III; ADJUVANT TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT; OLDER	Background Hypofractionated radiation therapy is a feasible and safe treatment option in elderly and frail patients with glioblastoma. The aim of this study was to evaluate the effectiveness of hypofractionated radiation therapy with concurrent temozolomide in terms of feasibility and disease control in primary glioblastoma patients with poor prognostic factors other than advanced age, such as post-surgical neurological complications, high tumor burden, unresectable or multifocal lesions, and potential low treatment compliance due to social factors or rapidly progressive disease. Material and methods GTV included the surgical cavity plus disease visible in T1WI-MRI, FLAIR-MRI and in the MET-uptake. The CTV was defined as the GTV plus 1.5-2 cm margin; the PTV was the CTV+0.3 cm margin. Forty, fourty-five, and fifty grays in 15 fractions were prescribed to 95% of PTV, CTV, and GTV, respectively. Treatment was delivered using IMRT or the VMAT technique. Simultaneously, 75 mg/m(2)/day of temozolomide were administered. Results Between January 2010 and November 2017, we treated a total of 17 patients. The median age at diagnosis was 68-years; median KPS was 50-70%. MGMT-methylation status was negative in 5 patients, and 8 patients were IDH-wildtype. Eight of 18 patients were younger than 65-years. Median tumor volume was 26.95cc; median PTV volume was 322cc. Four lesions were unresectable; 6 patients underwent complete surgical resection. Median residual volume was 1.14cc. Progression-free survival was 60% at 6 months, 33% at 1-year and 13% at 2-years (median OS = 7 months). No acute grade 3-5 toxicities were documented. Symptomatic grade 3 radiation necrosis was observed in one patient. Conclusions Patients with poor clinical factors other than advanced age can be selected for hypofractionated radiotherapy. The OS and PFS rates obtained in our series are similar to those in patients treated with standard fractionation, assuring good treatment adherence, low rates of toxicity and probable improved cost-effectiveness.	[Anna Jablonska, Paola; Moreno-Jimenez, Marta; Arbea, Leire; Ramos, Luis; Javier Aristu, Jose] Clin Univ Navarra, Dept Radiat Oncol, Pamplona, Spain; [Diez-Valle, Ricardo; Tejada, Sonia] Clin Univ Navarra, Dept Neurosurg, Pamplona, Spain; [Gallego Perez-Larraya, Jaime] Clin Univ Navarra, Dept Neurol, Pamplona, Spain; [Angel Idoate, Miguel] Clin Univ Navarra, Dept Anat Pathol, Pamplona, Spain; [Garcia de Eulate, Maria Reyes; Dominguez, Pablo] Clin Univ Navarra, Dept Radiol, Pamplona, Spain; [Arbizu, Javier] Clin Univ Navarra, Dept Nucl Med, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Jablonska, PA (corresponding author), Clin Univ Navarra, Dept Radiat Oncol, Pamplona, Spain.	pjablonska@unav.es	Arbizu, Javier/H-9255-2017; Aristu, Javier J/D-7594-2019; Jablonska, Paola Anna/AAN-2063-2021; Idoate, Miguel-Ángel/D-8502-2019; de Eulate, Maria Reyes Garcia/H-3031-2017; Dominguez, Pablo D./K-9067-2014	Arbizu, Javier/0000-0002-8370-5510; Aristu, Javier J/0000-0002-0382-2363; Idoate, Miguel-Ángel/0000-0002-1596-1192; de Eulate, Maria Reyes Garcia/0000-0002-2039-6634; Dominguez, Pablo D./0000-0002-9692-3808; Jablonska, Paola/0000-0001-5830-8321; Gallego Perez-Larraya, Jaime/0000-0003-2969-0116; Ramos Garcia, Luis Isaac/0000-0003-0491-5841; Moreno Jimenez, Marta/0000-0001-5614-4589				Arvold ND, 2015, INT J RADIAT ONCOL, V92, P384, DOI 10.1016/j.ijrobp.2015.01.017; BAUMAN GS, 1994, INT J RADIAT ONCOL, V29, P835, DOI 10.1016/0360-3016(94)90573-8; Chalmers AJ, 2009, INT J RADIAT ONCOL, V75, P1511, DOI 10.1016/j.ijrobp.2009.07.1703; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Mallick S, 2018, J NEURO-ONCOL, V140, P75, DOI 10.1007/s11060-018-2932-3; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Navarria P, 2018, RADIOTHER ONCOL, V127, P108, DOI 10.1016/j.radonc.2017.12.006; Perry JR, 2017, NEW ENGL J MED, V376, P1027, DOI 10.1056/NEJMoa1611977; Roa W, 2015, J CLIN ONCOL, V33, P4145, DOI 10.1200/JCO.2015.62.6606; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thakkar JP, 2014, EPIDEMIOLOGIC MOL PR, V23, P707; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Zhou XF, 2016, MOL CLIN ONCOL, V5, P289, DOI 10.3892/mco.2016.936	17	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217881	10.1371/journal.pone.0217881	http://dx.doi.org/10.1371/journal.pone.0217881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170245	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700077
J	Hong, I; Jung, WS; Jo, HH				Hong, Inho; Jung, Woo-Sung; Jo, Hang-Hyun			Gravity model explained by the radiation model on a population landscape	PLOS ONE			English	Article							ZIPFS LAW; SIZE DISTRIBUTION; MOBILITY; GROWTH; CITIES; PREDICTABILITY; NETWORK; COMPLEX	Understanding the mechanisms behind human mobility patterns is crucial to improve our ability to optimize and predict traffic flows. Two representative mobility models, i.e., radiation and gravity models, have been extensively compared to each other against various empirical data sets, while their fundamental relation is far from being fully understood. In order to study such a relation, we first model the heterogeneous population landscape by generating a fractal geometry of sites and then by assigning to each site a population independently drawn from a power-law distribution. Then the radiation model on this population landscape, which we call the radiation-on-landscape (RoL) model, is compared to the gravity model to derive the distance exponent in the gravity model in terms of the properties of the population landscape, which is confirmed by the numerical simulations. Consequently, we provide a possible explanation for the origin of the distance exponent in terms of the properties of the heterogeneous population landscape, enabling us to better understand mobility patterns constrained by the travel distance.	[Hong, Inho; Jung, Woo-Sung; Jo, Hang-Hyun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jung, Woo-Sung] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea; [Jung, Woo-Sung; Jo, Hang-Hyun] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Jung, Woo-Sung] Indiana Univ, Dept Informat, Bloomington, IN USA; [Jo, Hang-Hyun] Aalto Univ, Dept Comp Sci, Espoo, Finland	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Asia Pacific Center for Theoretical Physics; Indiana University System; Indiana University Bloomington; Aalto University	Jo, HH (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea.; Jo, HH (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, South Korea.; Jo, HH (corresponding author), Aalto Univ, Dept Comp Sci, Espoo, Finland.	hang-hyun.jo@apotp.org	Jung, Woo-Sung/B-1251-2008; Jo, Hang-Hyun/F-4666-2012; Hong, Inho/ABI-6931-2020	Jung, Woo-Sung/0000-0001-9590-3859; Jo, Hang-Hyun/0000-0002-4214-9204; Hong, Inho/0000-0002-8069-6110	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1D1A1A09081919, 2016R1D1A1B03932590]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	W.-S.J. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03932590, https://www.nrf.re.kr/index).H.-H.J.was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1A09081919, https://www.nrf.re.kr/index).	Arshad S, 2018, PHYSICA A, V492, P75, DOI 10.1016/j.physa.2017.10.005; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barbosa H, 2018, PHYS REP, V734, P1, DOI 10.1016/j.physrep.2018.01.001; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; BATTY M, 1992, URBAN STUD, V29, P1043, DOI 10.1080/00420989220081041; Batty M., 1994, FRACTAL CITIES; Benguigui L, 2000, ENVIRON PLANN B, V27, P507, DOI 10.1068/b2617; Berry BJL, 2012, CITIES, V29, pS17, DOI 10.1016/j.cities.2011.11.007; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; Goh S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026102; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gospodinov D, 2012, ACTA GEOPHYS, V60, P794, DOI 10.2478/s11600-012-0013-0; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Kang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138153; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140152; Lee SH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041009; Lenormand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045985; Li RQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01882-w; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; Palchykov V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06174; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Pappalardo L, 2018, DATA MIN KNOWL DISC, V32, P787, DOI 10.1007/s10618-017-0548-4; Park HJ, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aade6b; ROSEN KT, 1980, J URBAN ECON, V8, P165, DOI 10.1016/0094-1190(80)90043-1; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rybski D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042114; Sambrook RC, 2001, FRACTALS, V9, P241, DOI 10.1142/S0218348X01000749; Schweitzer F, 1998, APPL GEOGR, V18, P69, DOI 10.1016/S0143-6228(97)00047-7; Shen GQ, 2002, INT J GEOGR INF SCI, V16, P419, DOI 10.1080/13658810210137013; Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; SONEIRA RM, 1978, ASTRON J, V83, P845, DOI 10.1086/112268; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; Sornette D., 2006, CRITICAL PHENOMENA N; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Yan XY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0834; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	53	6	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218028	10.1371/journal.pone.0218028	http://dx.doi.org/10.1371/journal.pone.0218028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170235	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700096
J	Bulilete, O; Leiva, A; Rullan, M; Roca, A; Llobera, J; Soler, A; Gonzalez, MJ; Llorente, P; Gonzalez, L; Gonzalez, L; Mir, MA; Peiro, J; Cerdo, M; Bestard, F; Lopez, L; Jover, A; Lliteras, B; Gestoso, S; Gutierrez, M; Arguelles, R; Comas, C; Comas, F; Cifre, A; Ortuno, R; Ramirez, V; Cladera, M; Gutierrrez, MD				Bulilete, Oana; Leiva, Alfonso; Rullan, Manuel; Roca, Antonia; Llobera, Joan; Soler, Aina; Jose Gonzalez, Ma.; Llorente, Patricia; Gonzalez, Luis; Gonzalez, Luis; Antonia Mir, Ma.; Peiro, Joan; Cerdo, Maria; Bestard, Francisca; Lopez, Luis; Jover, Antoni; Lliteras, Biel; Gestoso, Salvador; Gutierrez, Merce; Arguelles, Rosemary; Comas, Catalina; Comas, Francisca; Cifre, Apolonia; Ortuno, Rosa; Ramirez, Violeta; Cladera, Marti; Dolores Gutierrrez, Ma.		PHN Grp	Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial	PLOS ONE			English	Article							NEUROPATHIC PAIN; AMITRIPTYLINE; VALACYCLOVIR; COMBINATION; MANAGEMENT; VACCINE	Background Postherpetic neuralgia (PHN) is the most common complication of herpes zoster (HZ). Previous trials have reported that gabapentin can relieve chronic neuropathic pain, but its effect on prevention of PHN is unclear. Objective To assess the efficacy of a 5-week course of gabapentin on acute herpetic pain and on the prevention of PHN at 12 weeks in patients with acute HZ. Methods This was a randomized, double blind, placebo-controlled trial conducted in 17 primary care health centers in Mallorca, Spain. All patients were older than 50 years, presented with HZ within 72 h of rash onset, and had moderate-severe pain (. 4 on a 10-point visual analogue scale [VAS]). Ninety-eight patients were randomized to receive gabapentin or placebo. All patients received valaciclovir for 7 days and analgesia if needed. The treatment period was 5 weeks, followed by 7 weeks of follow-up. Gabapentin was initiated at 300 mg/day and gradually titrated to a maximum of 1800 mg/day. The main outcome measure was pain at 12 weeks. Results Seventy-five patients completed the study, 33 in the gabapentin group and 42 in the control group. A total of 18.2% of patients in the gabapentin group and 9.5% in the control group reported pain at 12 weeks (p = 0.144). Four patients in the gabapentin group (12.1%), but no patients in the placebo group, reported pain of 4 or more on a 10-point VAS. Patients taking gabapentin reported worse health-related quality of life and poorer sleep quality. Three patients discontinued the trial due to adverse effects from gabapentin. Conclusion Addition of gabapentin to the usual treatment of HZ within 72 h of rash onset provided no significant relief from acute herpetic pain or prevention of PHN.	[Bulilete, Oana; Leiva, Alfonso; Llobera, Joan] Balear Hlth Serv, Primary Care Res Unit Mallorca, Palma De Mallorca, Spain; [Bulilete, Oana; Leiva, Alfonso; Llobera, Joan] Balear Isl Hlth Res Inst IdISBa, Palma De Mallorca, Spain; [Rullan, Manuel] Balear Hlth Serv, Pollenca Hlth Care Ctr, Palma De Mallorca, Spain; [Roca, Antonia] Balear Hlth Serv, Son Serra La Vileta Hlth Care Ctr, Palma De Mallorca, Spain; [Soler, Aina] Gerencia Atenc Primaria Mallorca, Unidad Invest, Palma De Mallorca, Spain; [Jose Gonzalez, Ma.] Balear Hlth Serv, Manacor Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Llorente, Patricia] Balear Hlth Serv, Santa Ponca Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Jose Gonzalez, Ma.; Gonzalez, Luis] Balear Hlth Serv, Escola Grad Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Antonia Mir, Ma.] Balear Hlth Serv, Inca Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Peiro, Joan] Balear Hlth Serv, Andratx Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Cerdo, Maria] Balear Hlth Serv, Coll Rabassa Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Bestard, Francisca] Balear Hlth Serv, Son Gotleu Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Lopez, Luis] Balear Hlth Serv, Cala dOr Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Jover, Antoni] Balear Hlth Serv, Arquitecto Bennassar Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Lliteras, Biel] Balear Hlth Serv, Llucmajor Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Gestoso, Salvador] Balear Hlth Serv, Son Pisa Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Gutierrez, Merce] Balear Hlth Serv, San Agusti Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Arguelles, Rosemary] Balear Hlth Serv, Muntanya Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Comas, Catalina] Balear Hlth Serv, Camp Redo Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Comas, Francisca] Balear Hlth Serv, Rafal Nou Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Cifre, Apolonia] Balear Hlth Serv, Platja Palma Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Ortuno, Rosa] Balear Hlth Serv, Pere Garau Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Ramirez, Violeta] Balear Hlth Serv, Alcudia Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Cladera, Marti] Balear Hlth Serv, Pollenca Primary Care Hlth Ctr, Palma De Mallorca, Spain; [Dolores Gutierrrez, Ma.] Balear Hlth Serv, Marti Serra Primary Care Hlth Ctr, Palma De Mallorca, Spain	Atencio Primaria de Mallorca; Institut Investigacio Sanitaria Illes Balears (IdISBa); Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca; Atencio Primaria de Mallorca	Leiva, A (corresponding author), Balear Hlth Serv, Primary Care Res Unit Mallorca, Palma De Mallorca, Spain.; Leiva, A (corresponding author), Balear Isl Hlth Res Inst IdISBa, Palma De Mallorca, Spain.	aleiva@ibsalut.caib.es; ainasoler@ibsalut.caib.es	Leiva, Alfonso/ABF-1361-2020; MIERAS, AINA SOLER/AAZ-3562-2020	Lorente, Patricia/0000-0002-7853-5174; Bulilete, Oana/0000-0002-9264-5142; Roca Casas, Antonia/0000-0003-2700-2842	Ministry of Economy and Competitiveness, Carlos III Institute [PI12/01813]; Health Promotion and Preventive Activities-Primary Health Care Network [RD16/0007/0008]; European Union ERDF funds	Ministry of Economy and Competitiveness, Carlos III Institute; Health Promotion and Preventive Activities-Primary Health Care Network; European Union ERDF funds(European Commission)	This study was funded by the Ministry of Economy and Competitiveness, Carlos III Institute (www.isciii.es), grant PI12/01813. We also received support from the Health Promotion and Preventive Activities-Primary Health Care Network, sustained by the Ministry of Health ISCIII-RediApp awards RD16/0007/0008, also supported with European Union ERDF funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Berry JD, 2005, NEUROLOGY, V65, P444, DOI 10.1212/01.WNL.0000168259.94991.8a; Bollaerts K, 2017, EPIDEMIOL INFECT, V145, P2666, DOI 10.1017/S0950268817001546; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; Carroll Stuart, 2013, BMC Res Notes, V6, P486, DOI 10.1186/1756-0500-6-486; Centers for Disease Control and Prevention, 2018, SHINGL HLTH CAR PROF; Chen N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005582.pub3; Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5; Dworkin RH, 2009, PAIN, V142, P209, DOI 10.1016/j.pain.2008.12.022; Erskine N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181565; European Medicines Agency, 2016, GUID CLIN DEV MED PR; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Forbes HJ, 2016, PAIN, V157, P30, DOI 10.1097/j.pain.0000000000000307; Gan EY, 2013, AM J CLIN DERMATOL, V14, P77, DOI 10.1007/s40257-013-0011-2; Goodman CW, 2017, NEW ENGL J MED, V377, P411, DOI 10.1056/NEJMp1704633; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; James KE, 1996, STAT MED, V15, P1421; Johnson P, 2013, CLIN DRUG INVEST, V33, P35, DOI 10.1007/s40261-012-0030-4; Johnson Robert W, 2015, Ther Adv Vaccines, V3, P109, DOI 10.1177/2051013615599151; Johnson RW, 2014, NEW ENGL J MED, V371, P1526, DOI 10.1056/NEJMcp1403062; Johnson RW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-37; Kanodia Sanjay Kumar, 2012, Indian J Dermatol, V57, P362, DOI 10.4103/0019-5154.100476; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Kremer M, 2016, NEUROSCIENCE, V338, P183, DOI 10.1016/j.neuroscience.2016.06.057; Kukkar A, 2013, ARCH PHARM RES, V36, P237, DOI 10.1007/s12272-013-0057-y; Kuraishi Y, 2004, LIFE SCI, V74, P2619, DOI 10.1016/j.lfs.2004.01.005; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Lapolla W, 2011, ARCH DERMATOL, V147, P901, DOI 10.1001/archdermatol.2011.81; Lee EG, 2016, DERMATOL THER, V29, P184, DOI 10.1111/dth.12331; Li QF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub2; Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918; Patel R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.205; Perez C, HLTH QUAL LIFE OUTCO; Rejas J, 2007, EUR J PAIN, V11, P329, DOI 10.1016/j.ejpain.2006.05.002; Rullan M, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1729-y; Singh S, 2016, INT J SCI STUDY, V3, P37, DOI 10.17354/ijss/2016/53; Thyregod HG, 2007, PAIN, V128, P148, DOI 10.1016/j.pain.2006.09.021; Tontodonati M, 2012, INT J GEN MED, V5, P861, DOI 10.2147/IJGM.S10371; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; van Wijck AJM, 2017, PAIN PRACT, V17, P738, DOI 10.1111/papr.12518; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Werner RN, 2017, J EUR ACAD DERMATOL, V31, P20, DOI 10.1111/jdv.13957; WHO, 1986, WHOS CANC PAIN LADD; Wiffen Philip J, 2017, Cochrane Database Syst Rev, V6, pCD007938, DOI 10.1002/14651858.CD007938.pub4; Yawn BP, 2013, NEUROLOGY, V81, P928, DOI 10.1212/WNL.0b013e3182a3516e	45	8	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217335	10.1371/journal.pone.0217335	http://dx.doi.org/10.1371/journal.pone.0217335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166976	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800025
J	Cheng, CH; Chen, HH				Cheng, Ching-Hsue; Chen, Hsien-Hsiu			Sentimental text mining based on an additional features method for text classification	PLOS ONE			English	Article							ONLINE PRODUCT REVIEWS; INTELLIGENCE	Owing to the emergence of the Internet and its rapid growth, people can use mobile devices on many social media platforms (blogs, Facebook forums, etc.), and the platforms provide wellknown websites for people to express and share their daily activities and ideas on global issues. Many consumers utilize product review websites before making a purchase. Many well-known websites are searched for relevant product reviews and experiences of product use. We can easily collect large amounts of structured and unstructured product data and further analyze the data to determine the desired product information. For this reason, many researchers are gradually focusing on sentiment analysis or opinion exploration (opinion mining) and use this technique to extract and analyze customer opinions and emotions. This paper proposes a sentimental text mining method based on an additional features method to enhance accuracy and reduce implementation time and uses singular value decomposition and principal component analysis for data dimension reduction. This study has four contributions: (1) the proposed algorithm for preprocessing the data for sentiment classification, (2) the additional features to enhance the accuracy of the sentiment classification, (3) the application of singular value decomposition and principal component analysis for data dimension reduction, and (4) the design of five modules based on different features, with or without stemming, to compare the performance results. The experimental results show that the proposed method has better accuracy than other methods and that the proposed method can decrease the implementation time.	[Cheng, Ching-Hsue; Chen, Hsien-Hsiu] Natl Yunlin Univ Sci & Tech, Dept Informat Management, Touliu, Yunlin, Taiwan		Cheng, CH (corresponding author), Natl Yunlin Univ Sci & Tech, Dept Informat Management, Touliu, Yunlin, Taiwan.	chcheng@yuntech.edu.tw	Cheng, Ching-Hsue/D-1785-2012	Cheng, Ching-Hsue/0000-0002-5509-6965				Abbasi A, 2011, IEEE T KNOWL DATA EN, V23, P447, DOI 10.1109/TKDE.2010.110; Alfonso J., 2007, P PRIS 2007 FUNCH PO, P59; [Anonymous], 2005, ACM INT C INF KNOWL, DOI DOI 10.1145/1099554.1099714; Archak N, 2011, MANAGE SCI, V57, P1485, DOI 10.1287/mnsc.1110.1370; Bollegala D, 2013, IEEE T KNOWL DATA EN, V25, P1719, DOI 10.1109/TKDE.2012.103; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng C, 2016, AER ADV ENG RES, V75, P150; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Hersh W., 1994, P 17 ANN INT ACM SIG, P192, DOI DOI 10.1007/978-1-4471-2099-5_20; Joachims T., 1998, PROC 10 EUROPEAN C M, P137, DOI DOI 10.1007/BFB0026683; Kang B, 2016, J PETROL SCI ENG, V141, P114, DOI 10.1016/j.petrol.2016.01.015; Kang D, 2014, EXPERT SYST APPL, V41, P1041, DOI 10.1016/j.eswa.2013.07.101; Lewis D. D., 1998, P EURP C MACH LEARN; Li ST, 2013, KNOWL-BASED SYST, V39, P23, DOI 10.1016/j.knosys.2012.10.005; Li YM, 2013, DECIS SUPPORT SYST, V55, P206, DOI 10.1016/j.dss.2013.01.023; Liu LY, 2005, PROCEEDINGS OF THE 2005 IEEE INTERNATIONAL CONFERENCE ON NATURAL LANGUAGE PROCESSING AND KNOWLEDGE ENGINEERING (IEEE NLP-KE'05), P597; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; McCallum A, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P662; Medhat W, 2014, AIN SHAMS ENG J, V5, P1093, DOI 10.1016/j.asej.2014.04.011; Montoyo A., 2012, SUBJECTIVITY SENTIME; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; Niles I, 2003, IKE'03: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P412; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pang B, 2004, ANN M ASS COMP LING, DOI DOI 10.3115/1218955.1218990; Parmar H., 2014, C INT C INF SCI KER; Rahate Rohini S., 2013, INT J COMPUTER APPL, V84, P24, DOI [10.5120/14573-2697, DOI 10.5120/14573-2697]; Ravi K, 2015, KNOWL-BASED SYST, V89, P14, DOI 10.1016/j.knosys.2015.06.015; Rui HX, 2013, DECIS SUPPORT SYST, V55, P863, DOI 10.1016/j.dss.2012.12.022; Saleh MR, 2011, EXPERT SYST APPL, V38, P14799, DOI 10.1016/j.eswa.2011.05.070; Tan SB, 2009, LECT NOTES COMPUT SC, V5478, P337; Tsytsarau M, 2012, DATA MIN KNOWL DISC, V24, P478, DOI 10.1007/s10618-011-0238-6; Weathers D, 2015, DECIS SUPPORT SYST, V79, P12, DOI 10.1016/j.dss.2015.07.009; Xiao SS, 2016, INFORM MANAGE-AMSTER, V53, P169, DOI 10.1016/j.im.2015.09.010; Yu X, 2014, OPTIK, V125, P1498, DOI 10.1016/j.ijleo.2013.09.013	35	4	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217591	10.1371/journal.pone.0217591	http://dx.doi.org/10.1371/journal.pone.0217591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166975	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800033
J	Bilibio, JP; Monego, HI; Binda, MLA; dos Reis, R				Bilibio, Joao Paolo; Monego, Heleusa Ione; Appel Binda, Marcia Luiza; dos Reis, Ricardo			Menopausal status is associated with a high risk for residual disease after cervical conization with positive margins	PLOS ONE			English	Article							COLD-KNIFE CONIZATION; LARGE LOOP EXCISION; INTRAEPITHELIAL NEOPLASIA; TRANSFORMATION ZONE; UTERINE CERVIX; SEX-HORMONES; LESIONS; PREVENTION; IMMUNITY	Background We aimed to determine demographic and clinicopathological predictors for residual disease in women with cervical intraepithelial neoplasia (CIN 2/3) with endocervical cone margin involvement. Methods and findings A cross-sectional study was conducted. The eligible patients were women who underwent hysterectomy as a treatment option after having a positive endocervical margin for CIN 2/3 in cervix conization specimens from 2000 to 2015. The patients were divided into two groups based on the persistence of CIN 2/3 and absence of CIN 2/3 in hysterectomy specimens. Demographic, clinical and histology information were collected in both groups. A total of 80 patients were eligible for the study; 37 (46.3%) had no persistence of CIN 2/3 and 43 (53.7%) had persistence of CIN 2/3 in the hysterectomy specimens. Demographic, clinical, and cone specimen characteristics, and a visible squamocolumnar junction and type of conization were analyzed as possible risk factors for the presence of residual lesions at hysterectomy, and none of these variables were associated with residual disease. Menopausal status was strongly associated with a high risk of persistent residual disease 81.2% (OR 4.9, CI 1.27-18.9), P = 0.014. In the multivariate analysis, only a menopausal status (P = 0.04) was associated with a high risk of persistent lesions. Conclusion This analysis found that menopausal status exhibited an important association with persistent residual disease. Menopausal women with endocervical margin involvement exhibit a greater than 80% risk of persistent lesions.	[Bilibio, Joao Paolo] Univ Fed Rio Grande do Sul, Postdoctoral Program, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil; [Bilibio, Joao Paolo] Univ Fed Para, Dept Obstet & Gynecol, Belem, Para, Brazil; [Monego, Heleusa Ione; Appel Binda, Marcia Luiza] Univ Fed Rio Grande do Sul, Dept Obstet & Gynecol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [dos Reis, Ricardo] Barretos Canc Hosp, Dept Gynecol Oncol, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Para; Universidade Federal do Rio Grande do Sul; Hospital de Cancer de Barretos	Bilibio, JP (corresponding author), Univ Fed Rio Grande do Sul, Postdoctoral Program, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil.	joaopaolobilibio@yahoo.com.br	Bilibio, João/AAN-1492-2020	Bilibio, Joao Paolo/0000-0003-4755-170X				Abdi F, 2016, CLIMACTERIC, V19, P234, DOI 10.3109/13697137.2016.1164136; [Anonymous], 2016, J BRAZ CERV CANC SCR; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Ayhan A, 2016, EUR J OBSTET GYN R B, V201, P1, DOI 10.1016/j.ejogrb.2016.03.021; Bae HS, 2013, ACTA OBSTET GYN SCAN, V92, P185, DOI 10.1111/aogs.12025; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Chambo Filho Antonio, 2015, J Clin Med Res, V7, P540, DOI 10.14740/jocmr2171w; Chikazawa K, 2016, J OBSTET GYNAECOL RE, V42, P457, DOI 10.1111/jog.12929; Das N, 2005, GYNECOL ONCOL, V97, P751, DOI 10.1016/j.ygyno.2005.01.003; Melli PPD, 2016, INT J GYNECOL OBSTET, V133, P234, DOI 10.1016/j.ijgo.2015.09.020; El-Nashar SA, 2017, J LOW GENIT TRACT DI, V21, P129, DOI 10.1097/LGT.0000000000000287; FELIX JC, 1994, OBSTET GYNECOL, V84, P996; Fonseca FV, 2011, REV BRAS GINECOL OBS, V33, P334, DOI 10.1590/S0100-72032011001100003; Gardeil F, 1997, OBSTET GYNECOL, V89, P419, DOI 10.1016/S0029-7844(96)00505-4; Kliemann LM, 2012, EUR J OBSTET GYN R B, V165, P342, DOI 10.1016/j.ejogrb.2012.08.016; MAHADEVAN N, 1993, BRIT J OBSTET GYNAEC, V100, P794, DOI 10.1111/j.1471-0528.1993.tb14292.x; Munk AC, 2007, APMIS, V115, P1409, DOI 10.1111/j.1600-0463.2007.00769.x; Papoutsis D, 2013, GYNECOL OBSTET INVES, V75, P163, DOI 10.1159/000345864; Papoutsis D, 2011, IN VIVO, V25, P691; Saslow D, 2012, J LOW GENIT TRACT DI, V16, P175, DOI 10.1097/LGT.0b013e31824ca9d5; Shaco-Levy R, 2014, INT J GYNECOL PATHOL, V33, P83, DOI 10.1097/PGP.0b013e3182763158; Siriaree Sitthicha, 2006, Asian Pac J Cancer Prev, V7, P463; Tasci T, 2015, J LOW GENIT TRACT DI, V19, P115, DOI 10.1097/LGT.0000000000000079; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P236, DOI 10.1111/aji.12252; Xiang LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131790	25	4	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217562	10.1371/journal.pone.0217562	http://dx.doi.org/10.1371/journal.pone.0217562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163055	Green Submitted, gold, Green Published			2022-12-27	WOS:000470086200018
J	Allen, A; Qin, ACR; Raj, N; Wang, JW; Uddin, S; Yao, Z; Tang, L; Meyers, PA; Taylor, BS; Berger, MF; Yaeger, R; Reidy-Lagunes, D; Pratilas, CA				Allen, Amy; Qin, Alice Can Ran; Raj, Nitya; Wang, Jiawan; Uddin, Sharmeen; Yao, Zhan; Tang, Laura; Meyers, Paul A.; Taylor, Barry S.; Berger, Michael F.; Yaeger, Rona; Reidy-Lagunes, Diane; Pratilas, Christine A.			Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition	PLOS ONE			English	Article							METASTATIC MELANOMA; FEEDBACK INHIBITION; IMPROVED SURVIVAL; MUTANT MELANOMA; OPEN-LABEL; CANCER; SENSITIVITY; PATHWAY; MULTICENTER; DABRAFENIB	The clinical significance of BRAF alterations in well-differentiated (WD) metastatic pancreatic neuroendocrine tumor (panNET) is unknown, but BRAF-mutated panNET could represent a subset characterized by an identifiable and clinically actionable driver. Following the identification of two patients with WD metastatic panNET whose tumors harbored BRAF mutations, we queried the MSK-IMPACT series of 80 patients with WD metastatic panNET for additional mutations in BRAF, and in other genes involved in RAS/RTK/PI3K signaling pathways. BRAF mutations were identified in six samples (7.5%): two tumors harbored V600E mutations, one tumor each expressed K601E, T599K, and T310I mutations, and one tumor expressed both G596D and E451K BRAF. Few additional actionable driver alterations were identified. To determine the ERK activating capability of four BRAF mutations not previously characterized, mutant constructs were tested in model systems. Biochemical characterization of BRAF mutations revealed both high and low activity mutants. Engineered cells expressing BRAF K601E and V600E were used for in vitro drug testing of RAF and MEK inhibitors currently in clinical use. BRAF K601E demonstrated reduced sensitivity to dabrafenib compared to BRAF V600E, but the combination of RAF plus MEK inhibition was effective in cells expressing this mutation. Herein, we describe the clinical course of a patient with BRAF K601E and a patient with BRAF V600E WD metastatic panNET, and the identification of four mutations in BRAF not previously characterized. The combined clinical and biochemical data support a potential role for RAF and MEK inhibitors, or a combination of these, in a selected panNET population.	[Allen, Amy; Qin, Alice Can Ran; Wang, Jiawan; Pratilas, Christine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA; [Raj, Nitya; Yaeger, Rona; Reidy-Lagunes, Diane] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Uddin, Sharmeen; Yao, Zhan] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Tang, Laura; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Meyers, Paul A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Taylor, Barry S.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA	Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pratilas, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.	cpratil1@jhmi.edu	Yao, Zhan/AAK-6756-2020	Wang, Jiawan/0000-0002-2137-1826; YAO, ZHAN/0000-0001-5391-5691	National Institutes of Health [K08-CA127350]; Giant Food Pediatric Cancer Fund; Cycle for Survival; National Cancer Institute MSK Cancer Center Core Grant [P30-CA008748]; Center for Molecular Oncology of MSKCC; NATIONAL CANCER INSTITUTE [R01CA204749, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Pediatric Cancer Fund; Cycle for Survival; National Cancer Institute MSK Cancer Center Core Grant; Center for Molecular Oncology of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institutes of Health (K08-CA127350, C.A.P). https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Giant Food Pediatric Cancer Fund (C.A.P.). https://giantfood.com.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cycle for Survival (D.R.-L.). https://www.cycleforsurvival.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Cancer Institute MSK Cancer Center Core Grant (P30-CA008748, B.S.T.). https://www.mskcc.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Center for Molecular Oncology of MSKCC. Center for Molecular Oncology of MSKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benten D, 2018, MOL CANCER RES, V16, P496, DOI 10.1158/1541-7786.MCR-17-0163; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chenard-Poirier M, 2017, RAS OR RAF MUTATED M; Dummer R, 2017, LANCET ONCOL, V18, P435, DOI 10.1016/S1470-2045(17)30180-8; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hofving T, 2018, ENDOCR-RELAT CANCER, V25, P367, DOI 10.1530/ERC-17-0445; Hyman DM, 2015, DRUG DISCOV TODAY, V20, P1422, DOI 10.1016/j.drudis.2015.08.005; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Park C, 2016, ONCOTARGET, V7, P4024, DOI 10.18632/oncotarget.6602; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Raj N, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00267; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tannapfel A, 2005, AM J CLIN PATHOL, V123, P256, DOI 10.1309/YQBR9C05RU4DD3RN; Vandamme T, 2015, J MOL ENDOCRINOL, V54, P137, DOI 10.1530/JME-14-0304; Vijayvergia N, 2016, BRIT J CANCER, V115, P564, DOI 10.1038/bjc.2016.229; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zimmer L, 2014, CLIN CANCER RES, V20, P4251, DOI 10.1158/1078-0432.CCR-14-0341	39	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217399	10.1371/journal.pone.0217399	http://dx.doi.org/10.1371/journal.pone.0217399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158244	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700015
J	Kageyama, M; Ota, T; Sasaoka, M; Katsuta, O; Shinomiya, K				Kageyama, Masaaki; Ota, Takashi; Sasaoka, Masaaki; Katsuta, Osamu; Shinomiya, Katsuhiko			Chemical proteasome inhibition as a novel animal model of inner retinal degeneration in rats	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NIGRAL DEGENERATION; CELL-DEATH; STRESS; NMDA; IMMUNOPROTEASOME; DEGRADATION; DISCOVERY; COMPLEX; SYSTEM	Chemical proteasome inhibition has been a valuable animal model of neurodegeneration to uncover roles for the ubiquitin-proteasome system in the central nervous system. However, little is known about the effects of chemical proteasome inhibitors on retinal integrity. Therefore, we characterized the effects of structurally different chemical proteasome inhibitors on the retinal morphology and the mechanisms of their action in the normal adult rat eyes. Intravitreal injection of MG-262 and other proteasome inhibitors led to inner retinal degeneration. MG-262-induced inner retinal degeneration was accompanied by reduced proteasome activity, increased poly-ubiquitinated protein levels, and increased positive immunostaining of ubiquitin, 20S proteasome subunit and GADD153/CHOP in the retina. Its retinal degenerative effect was also associated with reduced retinal neurofilament light chain gene expression, reflecting retinal ganglion cell death. MG-262-induced neurofilament light chain downregulation was largely resistant to pharmacological modulation including endoplasmic reticulum stress, apoptosis or MAP kinase inhibitors. Thus, this study provides further evidence of roles for the ubiquitin-proteasome system in the maintenance of the retinal structural integrity. Chemical proteasome inhibition may be used as a novel animal model of inner retinal degeneration, including retinal ganglion cell loss, which warrants further analysis of the molecular mechanisms underlying its retinal degenerative effect.	[Kageyama, Masaaki; Ota, Takashi; Sasaoka, Masaaki] Santen Pharmaceut Co Ltd, Global Alliances & External Res, Nara, Japan; [Katsuta, Osamu; Shinomiya, Katsuhiko] Santen Pharmaceut Co Ltd, Res & Dev Ctr, Nara, Japan	Santen Pharmaceutical Co Ltd; Santen Pharmaceutical Co Ltd	Kageyama, M (corresponding author), Santen Pharmaceut Co Ltd, Global Alliances & External Res, Nara, Japan.	masaaki.kageyama@santen.com		Kageyama, Masaaki/0000-0002-6520-7905; Ota, Takashi/0000-0003-2366-2819				Adams J, 1999, CANCER RES, V59, P2615; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Ando Ryo, 2014, Invest Ophthalmol Vis Sci, V55, P4682, DOI 10.1167/iovs.13-13272; Awai M, 2006, J NEUROCHEM, V96, P43, DOI 10.1111/j.1471-4159.2005.03502.x; Bentea E, 2017, J PARKINSON DIS, V7, P31, DOI 10.3233/JPD-160921; Caldeira MV, 2013, BBA-MOL BASIS DIS, V1832, P263, DOI 10.1016/j.bbadis.2012.10.009; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chiang WC, 2016, ADV EXP MED BIOL, V854, P185, DOI 10.1007/978-3-319-17121-0_25; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Choudhury S, 2014, ADV EXP MED BIOL, V801, P455, DOI 10.1007/978-1-4614-3209-8_58; Cromm PM, 2017, ACS CENTRAL SCI, V3, P830, DOI 10.1021/acscentsci.7b00252; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; Gomez-Vicente V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137826; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kummar S, 2010, EUR J CANCER, V46, P340, DOI 10.1016/j.ejca.2009.10.026; Laabich A, 1999, EXP EYE RES, V68, P703, DOI 10.1006/exer.1999.0664; Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Myeku N, 2018, TRENDS MOL MED, V24, P18, DOI 10.1016/j.molmed.2017.11.006; Nashine S, 2015, INVEST OPHTH VIS SCI, V56, P221, DOI 10.1167/iovs.14-15447; Niu CS, 2009, STEREOT FUNCT NEUROS, V87, P69, DOI 10.1159/000202972; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Perez-Alvarez S, 2009, BRIT J PHARMACOL, V158, P1121, DOI 10.1111/j.1476-5381.2009.00388.x; Rana T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.539; Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Shah SZA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00120; Shimazawa M, 2007, MOL VIS, V13, P578; Shirai Y, 2015, BIOL PHARM BULL, V38, P1076, DOI 10.1248/bpb.b15-00185; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; Yamano T, 2008, J BIOL CHEM, V283, P28060, DOI 10.1074/jbc.M803077200; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhou D, 2013, TOXICOL APPL PHARM, V273, P401, DOI 10.1016/j.taap.2013.09.018; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	52	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217945	10.1371/journal.pone.0217945	http://dx.doi.org/10.1371/journal.pone.0217945			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150519	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100131
J	Marchant, E; Todd, C; Cooksey, R; Dredge, S; Jones, H; Reynolds, D; Stratton, G; Dwyer, R; Lyons, R; Brophy, S				Marchant, Emily; Todd, Charlotte; Cooksey, Roxanne; Dredge, Samuel; Jones, Hope; Reynolds, David; Stratton, Gareth; Dwyer, Russell; Lyons, Ronan; Brophy, Sinead			Curriculum-based outdoor learning for children aged 9-11: A qualitative analysis of pupils' and teachers' views	PLOS ONE			English	Article							HEALTH INTERVENTIONS; SCHOOL TEACHERS; EDUCATION; BELIEFS; PLAY	The relationship between child health, wellbeing and education demonstrates that healthier and happier children achieve higher educational attainment. An engaging curriculum that facilitates children in achieving their academic potential has strong implications for educational outcomes, future employment prospects, and health and wellbeing during adulthood. Outdoor learning is a pedagogical approach used to enrich learning, enhance school engagement and improve pupil health and wellbeing. However, its non-traditional means of achieving curricular aims are not yet recognised beyond the early years by education inspectorates. This requires evidence into its acceptability from those at the forefront of delivery. This study aimed to explore headteachers', teachers' and pupils' views and experiences of an outdoor learning programme within the key stage two curriculum (ages 9-11) in South Wales, United Kingdom. We examine the process of implementation to offer case study evidence through 1:1 interviews with headteachers (n = 3) and teachers (n = 10) and focus groups with pupils aged 9-11 (n = 10) from three primary schools. Interviews and focus groups were conducted at baseline and six months into implementation. Schools introduced regular outdoor learning within the curriculum. This study found a variety of perceived benefits for pupils and schools. Pupils and teachers noticed improvements in pupils' engagement with learning, concentration and behaviour, as well as positive impacts on health and wellbeing and teachers' job satisfaction. Curriculum demands including testing and evidencing work were barriers to implementation, in addition to safety concerns, resources and teacher confidence. Participants supported outdoor learning as a curriculum-based programme for older primary school pupils. However, embedding outdoor learning within the curriculum requires education inspectorates to place higher value on this approach in achieving curricular aims, alongside greater acknowledgment of the wider benefits to children which current measurements do not capture.	[Marchant, Emily; Todd, Charlotte; Cooksey, Roxanne; Dredge, Samuel; Jones, Hope; Lyons, Ronan; Brophy, Sinead] Swansea Univ, Med Sch, Swansea, W Glam, Wales; [Reynolds, David] Swansea Univ, Sch Educ, Swansea, W Glam, Wales; [Stratton, Gareth] Swansea Univ, Sch Sport & Exercise Sci, Swansea, W Glam, Wales; [Dwyer, Russell] St Thomas Community Primary Sch, Swansea, W Glam, Wales	Swansea University; Swansea University; Swansea University	Marchant, E (corresponding author), Swansea Univ, Med Sch, Swansea, W Glam, Wales.	E.K.Marchant@swansea.ac.uk	Marchant, Emily/AAC-4917-2022; stratton, Gareth/Z-5471-2019	Marchant, Emily/0000-0002-9701-5991; stratton, Gareth/0000-0001-5618-0803; Brophy, Sinead/0000-0001-7417-2858; Cooksey, Roxanne/0000-0002-6763-9373; Todd, Charlotte/0000-0002-3183-2403	Economic and Social Research Council [ES/J500197/1]; National Centre for Population Health and Wellbeing Research; ESRC [ES/S007393/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Centre for Population Health and Wellbeing Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council [grant number ES/J500197/1] - EM - https://esrc.ukri.org/and National Centre for Population Health and Wellbeing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey P, 2004, PROFESSIONAL DEV TEA; Ayala GX, 2011, J PUBLIC HLTH DENT; Barfod KS, 2018, J ADVENTURE ED OUTDO; Becker C, 2017, INT J ENV RES PUB HE, V14, P1; Bentsen P, 2010, URBAN FOR URBAN GREE, V9, P235, DOI 10.1016/j.ufug.2010.02.001; Bird W., 2007, INVESTIGATING LINKS; Bolling M, 2018, INT J EDUC RES, V89, P22, DOI 10.1016/j.ijer.2018.03.004; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Briner R., 2007, WORKLIFE SUPPORT; Christian D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1557-0; Christie B, 2014, SCOTT ED REV; Christie B, 2016, BRIT EDUC RES J, V42, P417, DOI 10.1002/berj.3213; Covell K, 2010, IMPROV SCH; Creswell W. C., 2011, DESIGNING CONDUCTING; Deighton J, 2013, J PSYCHOEDUC ASSESS, V31, P247, DOI 10.1177/0734282912465570; Department for Education, 2018, FACT AFF TEACH RET Q; Dettweiler U, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00125; Edwards-Jones A, 2018, EDUC 3-13, V46, P49, DOI 10.1080/03004279.2016.1176066; Ernst J, 2014, ENVIRON EDUC RES, V20, P735, DOI 10.1080/13504622.2013.833596; Estyn, 2011, OUTD LEARN EV LEARN; Fagerstam E, 2014, J ADVENTURE EDUC OUT, V14, P56, DOI 10.1080/14729679.2013.769887; Fiennes C., 2015, EXISTING EVIDENCE BA; Fjortoft I., 2004, CHILD YOUTH ENV; Fossey E, 2002, J PSYCHIAT; Gibson F, 2007, J RES NURSING; Glackin M., 2018, BR J SOCIOL ED; Gustafsson PE, 2012, J ADVENTURE EDUC OUT, V12, P63, DOI 10.1080/14729679.2010.532994; International Play Association, 2016, CHILDR RIGHT PLAY EN; Kaplan R, 1989, **DROPPED REF**; Kernan M, 2010, CHILD SOC; King's College London, 2010, EARTH LEARN IDEA DEC, P9; King's College London, 2011, UND DIV BEN LEARN NA, P1; Kokkinos CM, 2007, BR J ED PSYCHOL; Kollmuss A, 2002, ENV ED RES, DOI 10.1080/13504620220145401; Landsverk J. A., 2012, DISSEMINATION IMPLEM, P225, DOI DOI 10.1093/ACPROF:OSO/9780199751877.001.0001/ACPROF-9780199751877-CHAPTER-12; Learning and Teaching Scotland, 2010, OUTD LEARN COV 19 IM; Little H, 2008, AUST J EARLY CHILD, V33, P33, DOI 10.1177/183693910803300206; Lochman JE, 2003, SCHOOL PSYCHOL REV, V32, P174; MACQUARRIE S, 2018, EDUC 3-13, V46, P345, DOI DOI 10.1080/03004279.2016.1263968; Maller C, 2006, INT J LEARN; Maller C., 2005, EINGANA J ENV ED, V28, P17; Maynard T, 2013, EARLY YEARS-ABINGDON, V33, P212, DOI 10.1080/09575146.2013.771152; McClintic S, 2015, J EARLY CHILD TEACH, V36, P24, DOI 10.1080/10901027.2014.997844; McCormick R, 2017, J PEDIATR NURS, V37, P3, DOI 10.1016/j.pedn.2017.08.027; Mygind E, 2019, EDUC 3-13, V47, P599, DOI 10.1080/03004279.2018.1513544; Natural England, 2016, NAT CONN DEM PROJ 20; Nel A, 2017, S AFR J CHILD EDUC, V7, DOI 10.4102/sajce.v7i1.482; Newell R., 2011, RES EVIDENCE BASED P; Norodahl K, 2015, J ADVENTURE ED OUTDO; OECD, 2006, P COP S MEAS EFF ED; Passy R., 2019, CURRICULUM PERSPECTI, V39, P73, DOI [10.1007/s41297-019-00070-8, DOI 10.1007/S41297-019-00070-8]; Pretty J, 2009, CHILDHOOD HLTH LIFE; Quibell T, 2017, BRIT EDUC RES J, V43, P572, DOI 10.1002/berj.3273; Rickinson M., 2012, SCH LEADER TEACHER I; Rickinson M., 2004, REV RES OUTDOOR LEAR; Rivkin M., 1995, GREAT OUTDOORS RESTO; Roffey S., 2012, ED CHILD PSYCHOL; Schneller MB, 2017, BMC PUBLIC HEALTH, V17, P1, DOI [10.1186/s12889-016-3954-4, DOI 10.1186/S12889-016-3954-4]; Schneller MB, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0534-7; Selhub EM, 2014, YOUR BRAIN NATURE SC; Skar M, 2016, CHILD GEOGR; Spilt JL, 2011, EDUC PSYCHOL REV, V23, P457, DOI 10.1007/s10648-011-9170-y; The Wildlife Trusts, 2019, NEW NAT FRIENDL SCH; Thompson CW, 2008, ENVIRON BEHAV, DOI [10.1177/0013916507309739, DOI 10.1177/0013916507309739]; Thorburn M, 2010, CURRIC J, V21, P97, DOI 10.1080/09585170903560824; Todd C, 2016, PERSPECT PUBLIC HEAL, V136, P115, DOI 10.1177/1757913916638231; Todd Charlotte, 2015, BMC Res Notes, V8, P161, DOI 10.1186/s13104-015-1091-2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 1989, UN CONV RIGHTS CHILD, V2004, P358; Waite S., 2008, 4 INT OUTD ED RES C; Wells NM, 2000, ENV BEHAV; Welsh Assembly Government, FDN PHAS OUTD LEARN; Welsh Government, 2015, FDN PHAS FRAM CURR W; White R, 2004, INTERACTION NATURE M; Wistoft K., 2013, J ADVENTURE ED OUTDO	75	35	35	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0212242	10.1371/journal.pone.0212242	http://dx.doi.org/10.1371/journal.pone.0212242			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150409	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000469759100005
J	McCoy, IE; Chertow, GM; Chang, TIH				McCoy, Ian Ellis; Chertow, Glenn Matthew; Chang, Tara I-Hsin			Patterns of diuretic use in the intensive care unit	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE KIDNEY INJURY; LOOP DIURETICS; MECHANICAL VENTILATION; CONTINUOUS-INFUSION; ACETAZOLAMIDE; BOLUS; MANAGEMENT; DURATION; THERAPY	Purpose To inform future outcomes research on diuretics, we sought to describe modern patterns of diuretic use in the intensive care unit (ICU), including diuretic type, combination, and dosing. We also investigated two possible quality improvement targets: furosemide dosing in renal impairment and inclusion of an initial bolus with continuous furosemide infusions. Materials and methods In this descriptive study, we retrospectively studied 46,037 adult ICU admissions from a publicly available database of patients in an urban, academic medical center. Results Diuretics were employed in nearly half (49%, 22,569/46,037) of ICU admissions. Mechanical ventilation, a history of heart failure, and admission to the post-cardiac surgery unit were associated with a higher frequency of diuretic use. Combination use of different diuretic classes was uncommon. Patients with severely impaired kidney function were less likely to receive diuretics. Furosemide was by far the most common diuretic given and the initial intravenous dose was only 20 mg in more than half of ICU admissions. Among patients treated with a continuous infusion, 30% did not receive a bolus on the day of infusion initiation. Conclusions Patterns of diuretic use varied by patient-specific factors and by ICU type. Diuretic dosing strategies may be suboptimal.	[McCoy, Ian Ellis; Chertow, Glenn Matthew; Chang, Tara I-Hsin] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA	Stanford University	McCoy, IE (corresponding author), Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA.	imccoy@stanford.edu	McCoy, Ian/AAS-7406-2020	McCoy, Ian/0000-0001-6470-6959; Chertow, Glenn/0000-0002-7599-0534	T-32 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007357]; K-24 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [2K24DK085446]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK085446, T32DK007357] Funding Source: NIH RePORTER	T-32 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; K-24 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	IEM was supported by a T-32 grant (5T32DK007357), and GMC was supported by a K-24 grant (2K24DK085446), both from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2017, ANN AM THORAC SOC, V14, P1086, DOI 10.1513/AnnalsATS.201701-016FR; Alqahtani F, 2014, J CRIT CARE, V29, P10, DOI 10.1016/j.jcrc.2013.03.015; Bagshaw SM, 2007, CONTRIB NEPHROL, V156, P236; Brater DC, 1998, NEW ENGL J MED, V339, P387, DOI 10.1056/NEJM199808063390607; Faisy C, 2016, JAMA-J AM MED ASSOC, V315, P480, DOI 10.1001/jama.2016.0019; Huang A, 2017, CRIT CARE RESUSC, V19, P142; Jentzer JC, 2010, J AM COLL CARDIOL, V56, P1527, DOI 10.1016/j.jacc.2010.06.034; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Johnson AEW, 2018, J AM MED INFORM ASSN, V25, P32, DOI 10.1093/jamia/ocx084; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lopez C, 2016, PEDIATR CRIT CARE ME, V17, pE551, DOI 10.1097/PCC.0000000000000971; Michaud CJ, 2017, ANN PHARMACOTHER, V51, P286, DOI 10.1177/1060028016683971; Cervera GR, 2017, PULM PHARMACOL THER, V44, P30, DOI 10.1016/j.pupt.2017.03.002; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RUDY DW, 1991, ANN INTERN MED, V115, P360, DOI 10.7326/0003-4819-115-5-360; Salvador DR, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003178.PUB2; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P733, DOI 10.2215/CJN.00060110; Silbert BI, 2016, CRIT CARE MED, V44, pE923, DOI 10.1097/CCM.0000000000001823; Silva J. R., 2018, CRIMINAL JUSTICE POL, P1, DOI [DOI 10.1097/CCM.0000000000002696, 10.1097/CCM.0000000000002696]; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Wallet F, 2004, ANN FR ANESTH, V23, P161, DOI 10.1016/j.annfar.2003.12.001; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217911	10.1371/journal.pone.0217911	http://dx.doi.org/10.1371/journal.pone.0217911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150512	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100126
J	Prabdial-Sing, N; Makhathini, L; Smit, SB; Manamela, MJ; Motaze, NV; Cohen, C; Suchard, MS				Prabdial-Sing, Nishi; Makhathini, Lillian; Smit, Sheilagh Brigitte; Manamela, Morubula Jack; Motaze, Nkengafac Villyen; Cohen, Cheryl; Suchard, Melinda Shelley			Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community- based febrile rash surveillance	PLOS ONE			English	Article							HIV-HBV COINFECTION; VIRUS-INFECTION; BLACK-CHILDREN; PREGNANT-WOMEN; WESTERN CAPE; EPIDEMIOLOGY; VACCINATION; TRANSMISSION; PREVENTION; EXPOSURE	Introduction and methods Hepatitis B is a vaccine preventable disease and is notifiable in South Africa. Hepatitis B vaccination was incorporated into the Expanded Programme on Immunisation in South Africa in 1995. We used a convenience sample from community-based febrile rash surveillance in 2013 to estimate hepatitis B sero-prevalence. Of samples serologically negative for acute measles infection, 450 samples spanning nine provinces of South Africa were tested for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and hepatitis B core antibody (anti-HBc). Results Two children (2/450; 0.4%) tested positive for HBsAg. Three hundred and three children (67.3%) had evidence of vaccine induced immunity. Vaccine induced immunity was present in 80.2% of 1-5 year olds, but only 60.3% of 10-14 year olds. Natural immunity, indicating exposure to circulating hepatitis B, was present in 13/450 (2.9%) children. Conclusion Chronic hepatitis B in South African has decreased in prevalence from highly endemic levels prior to vaccine introduction to approximately 0.4% in this sample, demonstrating impact of a successful vaccination programme 18 years after introduction. Decreased vaccine-induced immunity with increasing age may reflect waning antibody titres over time.	[Prabdial-Sing, Nishi; Makhathini, Lillian; Smit, Sheilagh Brigitte; Manamela, Morubula Jack; Motaze, Nkengafac Villyen; Suchard, Melinda Shelley] NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa; [Prabdial-Sing, Nishi] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Virol, Johannesburg, South Africa; [Motaze, Nkengafac Villyen] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa; [Cohen, Cheryl] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Suchard, Melinda Shelley] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Stellenbosch University; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand	Suchard, MS (corresponding author), NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa.; Suchard, MS (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol, Johannesburg, South Africa.	melinda@nicd.ac.za		Suchard, Melinda Shelley/0000-0002-6978-4654	National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa	National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa	The work was funded by the National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.	Amponsah-Dacosta E, 2014, J MED VIROL, V86, P918, DOI 10.1002/jmv.23910; Andersson MI, 2013, VACCINE, V31, P5579, DOI 10.1016/j.vaccine.2013.08.028; [Anonymous], 2012, S AFR NAT HIV PREV I; Ayuk J, 2013, SAMJ S AFR MED J, V103, P330, DOI 10.7196/SAMJ.6304; Bagheri-Jamebozorgi M, 2014, HUM VACC IMMUNOTHER, V10, P3731, DOI 10.4161/hv.34393; Barth H, 2011, J HEPATOL, V54, P844, DOI 10.1016/j.jhep.2010.10.008; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2012, VACCINE, V30, pC45, DOI 10.1016/j.vaccine.2012.02.021; Butler LM, 2010, TROP MED INT HEALTH, V15, P442, DOI 10.1111/j.1365-3156.2010.02474.x; Chotun N, 2015, VACCINE, V33, P4618, DOI 10.1016/j.vaccine.2015.06.076; Di Bisceglie AM, 2010, ANTIVIR THER, V15, P499, DOI 10.3851/IMP1494; Diale Q, 2016, SAMJ S AFR MED J, V106, P97, DOI [10.7196/SAMJ.2016.v106i1.9932, 10.7196/SAMJ.2016.V106I1.9932]; DIBISCEGLIE AM, 1986, BRIT MED J, V292, P1440, DOI 10.1136/bmj.292.6533.1440; Dlamini NR, 2016, SAMJ S AFR MED J, V106, P43, DOI [10.7196/samj.2016.v106i7.10956, 10.7196/SAMJ.2016.v106i7.10956]; DUSHEIKO GM, 1989, S AFR MED J, V75, P473; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hoffmann C J, 2012, Int J STD AIDS, V23, pe10, DOI 10.1258/ijsa.2009.009340; Hoffmann CJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18871; Jooste P, 2016, J CLIN VIROL, V85, P71, DOI 10.1016/j.jcv.2016.10.017; KARIM SA, 1988, INT J EPIDEMIOL, V17, P168; KARIM SSA, 1991, INT J EPIDEMIOL, V20, P495, DOI 10.1093/ije/20.2.495; Kew M. C., 2008, Southern African Journal of Epidemiology & Infection, V23, P4; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; KEW MC, 1973, S AFR MED J, V47, P2419; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Lodenyo H, 2000, E AFR MED J, V77, P13; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Mayaphi SH, 2012, SAMJ S AFR MED J, V102, P157, DOI 10.7196/SAMJ.4944; Mdlalose N, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.283; Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Sadeghi A, 2016, J VIRAL HEPATITIS, V23, P282, DOI 10.1111/jvh.12490; Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1; Simani OE, 2009, VACCINE, V27, P146, DOI 10.1016/j.vaccine.2008.10.004; Spengane Z, 2018, SAMJ S AFR MED J, V108, P278, DOI [10.7196/SAMJ.2017.v108i4.12830, 10.7196/SAMJ.2018.v108i4.12830, 10.7196/samj.2018.v108i4.12830]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thumbiran NV, 2014, SAMJ S AFR MED J, V104, P307, DOI [10.7196/samj.7299, 10.7196/SAMJ.7299]; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; Venter WDF, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4353-1; WHO, 2017, WHO WEEKLY EPIDEMIOL, V92, P129; World Health Organization, 2018, SNAK ENV NEGL TROP D, P1; Yousif M, 2014, INT J INFECT DIS, V29, P125, DOI 10.1016/j.ijid.2014.07.002; Zanetti AR, 2005, LANCET, V366, P1379, DOI 10.1016/S0140-6736(05)67568-X	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217415	10.1371/journal.pone.0217415	http://dx.doi.org/10.1371/journal.pone.0217415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150445	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100046
J	Sterchi, M; Faverjon, C; Sarasua, C; Vargas, ME; Berezowski, J; Bernstein, A; Grutter, R; Nathues, H				Sterchi, Martin; Faverjon, Celine; Sarasua, Cristina; Vargas, Maria Elena; Berezowski, John; Bernstein, Abraham; Gruetter, Rolf; Nathues, Heiko			The pig transport network in Switzerland: Structure, patterns, and implications for the transmission of infectious diseases between animal holdings	PLOS ONE			English	Article							LIVESTOCK MOVEMENTS; MOUTH-DISEASE; EPIDEMIC; DYNAMICS; PROTOCOLS; CATTLE	The topology of animal transport networks contributes substantially to how fast and to what extent a disease can transmit between animal holdings. Therefore, public authorities in many countries mandate livestock holdings to report all movements of animals. However, the reported data often does not contain information about the exact sequence of transports, making it impossible to assess the effect of truck sharing and truck contamination on disease transmission. The aim of this study was to analyze the topology of the Swiss pig transport network by means of social network analysis and to assess the implications for disease transmission between animal holdings. In particular, we studied how additional information about transport sequences changes the topology of the contact network. The study is based on the official animal movement database in Switzerland and a sample of transport data from one transport company. The results show that the Swiss pig transport network is highly fragmented, which mitigates the risk of a large-scale disease outbreak. By considering the time sequence of transports, we found that even in the worst case, only 0.34% of all farmpairs were connected within one month. However, both network connectivity and individual connectedness of farms increased if truck sharing and especially truck contamination were considered. Therefore, the extent to which a disease may be transmitted between animal holdings may be underestimated if we only consider data from the official animal movement database. Our results highlight the need for a comprehensive analysis of contacts between farms that includes indirect contacts due to truck sharing and contamination. As the nature of animal transport networks is inherently temporal, we strongly suggest the use of temporal network measures in order to evaluate individual and overall risk of disease transmission through animal transportation.	[Sterchi, Martin; Sarasua, Cristina; Vargas, Maria Elena; Bernstein, Abraham] Univ Zurich, Dept Informat, Zurich, Switzerland; [Sterchi, Martin; Vargas, Maria Elena; Gruetter, Rolf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Sterchi, Martin] Univ Appl Sci & Arts Northwestern Switzerland FHN, Sch Business, Olten, Switzerland; [Faverjon, Celine; Berezowski, John] Univ Bern, Vet Fac, Vet Publ Hlth Inst, Bern, Switzerland; [Nathues, Heiko] Univ Bern, Vet Fac, Clin Swine, Bern, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Bern; University of Bern	Sterchi, M (corresponding author), Univ Zurich, Dept Informat, Zurich, Switzerland.; Sterchi, M (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.; Sterchi, M (corresponding author), Univ Appl Sci & Arts Northwestern Switzerland FHN, Sch Business, Olten, Switzerland.	sterchi@ifi.uzh.ch	Nathues, Heiko/AAZ-2712-2020	Nathues, Heiko/0000-0002-0285-3731; Faverjon, Celine/0000-0001-6737-1883; Sterchi, Martin/0000-0002-1105-8780; Berezowski, John/0000-0003-3343-908X	Swiss National Science Foundation (SNSF) NRP75 [407540_167303]; University of Applied Sciences and Arts Northwestern Switzerland FHNW; Hasler foundation	Swiss National Science Foundation (SNSF) NRP75; University of Applied Sciences and Arts Northwestern Switzerland FHNW; Hasler foundation	This article is based upon work supported by the Swiss National Science Foundation (SNSF) NRP75, Project no 407540_167303 (http://www.snf.ch/en/researchinFocus/nrp/nfp-75/Pages/default.aspx).In addition, the University of Applied Sciences and Arts Northwestern Switzerland FHNW (www.fhnw.ch) as well as the Hasler foundation (www.haslerstiftung.ch) supported part of the work of MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Beltran-Alcrudo D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1800-5; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; BLV, 2018, TIERV; Clauset A, 2009, SIAM REV, V38, P3; Dee S, 2004, CAN J VET RES, V68, P208; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, REV SCI TECH OIE, V30, P425; Giacomini E, 2018, BMC VET RES, V14, DOI 10.1186/s12917-017-1328-5; Greger M, 2007, BIOSECUR BIOTERROR, V5, P301, DOI 10.1089/bsp.2007.0028; Guinat C, 2018, TRANSBOUND EMERG DIS, V65, pe264, DOI 10.1111/tbed.12748; Guinat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28429; Holme P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046119; Holme P, 2013, F1000PRIME REP, V5; Holme P, 2011, TEMPORAL NETWORKS, P1; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Koher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151209; Nathues C, 2016, TRANSBOUND EMERG DIS, V63, pE251, DOI 10.1111/tbed.12262; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Riklin AS, 2015, ANTIBIOTIKUMSEINSATZ; Rovira A, 2007, J VET DIAGN INVEST, V19, P492, DOI 10.1177/104063870701900506; Salines M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185858; Scharrer S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0468-8; Smith RP, 2013, PREV VET MED, V108, P167, DOI 10.1016/j.prevetmed.2012.08.011; Swiss Federal Council, 2017, SWISS PLAT; Swiss Federal Council, 2008, TIERSCH; Thakur KK, 2016, TRANSBOUND EMERG DIS, V63, pE14, DOI 10.1111/tbed.12225; Thakur KK, 2017, J SWINE HEALTH PROD, V25, P183; Vidondo B, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1406-3; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	37	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217974	10.1371/journal.pone.0217974	http://dx.doi.org/10.1371/journal.pone.0217974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150524	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000469759100136
J	Cui, Y; Cao, R; Li, G; Gong, TQ; Ou, YY; Huang, J				Cui, Yu; Cao, Rong; Li, Gen; Gong, Tianqing; Ou, Yingyu; Huang, Jing			The effect of lung recruitment maneuvers on post-operative pulmonary complications for patients undergoing general anesthesia: A meta-analysis	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; LOW-TIDAL-VOLUME; PROTECTIVE-VENTILATION; MECHANICAL VENTILATION; OBESE-PATIENTS; ATELECTASIS; OXYGENATION; PARALYSIS; SURGERY	Background Respiratory function would be impaired during general anesthesia period. Researchers devoted their energies to finding effective strategies for protecting respiratory function. Low tidal volume, positive end-expiratory pressure (PEEP), and lung recruitment maneuvers (LRMs) were recommended for patients under mechanical ventilation. However, based on the current evidence, there was no consensus on whether LRMs should be routinely used for anesthetized patients with healthy lungs, and the benefits of them remained to be determined. Materials and methods To evaluate the benefits of LRMs on patients undergoing surgery with general anesthesia, we searched relevant studies in PubMed, EMBASE, Ovid Medline and the Cochrane Library up to June 30, 2018. The primary outcome was postoperative pulmonary complications (PPCs). Results Twelve trials involving 2756 anesthetized patients were included. The results of our study showed a significant benefit of LRMs for reducing the incidence of PPCs (RR = 0.67; 95% CI, 0.49 to 0.90; P< 0.05; Chi(2) = 32.94, p for heterogeneity = 0.0005, I-2 = 67%). After subgroup analyses, we found LRMs combining with lung protective ventilation strategy and sustained recruitment maneuvers were associated with reducing the occurrence of PPCs. The results also revealed that the use of LRMs improved PaO2/ FiO(2) in non-obese patients, but with extremely high heterogeneity (I-2 = 95%). Conclusion According to the findings from contemporary meta-analysis, LRMs combining with lung protective ventilation strategy may have an association with decreasing in the incidence of PPCs and improvement of oxygenation on non-obese patients. However, the conclusions must be interpreted cautiously as the outcome may be influenced dramatically due to varied LRMs and ventilation patterns.	[Cui, Yu; Cao, Rong; Gong, Tianqing; Ou, Yingyu; Huang, Jing] Chengdu Womens & Childrens Cent Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Li, Gen] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA	Vanderbilt University	Cui, Y (corresponding author), Chengdu Womens & Childrens Cent Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.	cuiyu19831001@163.com		Cui, Yu/0000-0002-1481-9389; LI, GEN/0000-0002-8417-6569				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Aretha D, 2017, INT J OBSTET ANESTH, V30, P30, DOI 10.1016/j.ijoa.2016.12.004; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Choi ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183311; de Jong MAC, 2016, ANN SURG, V264, P362, DOI 10.1097/SLA.0000000000001499; Ferrando C, 2018, LANCET RESP MED, V6, P193, DOI 10.1016/S2213-2600(18)30024-9; Fichtner F, 2018, DTSCH ARZTEBL INT, V115, P840, DOI 10.3238/arztebl.2018.0840; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Ge Yeying, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P81, DOI 10.3969/j.issn.1672-7347.2013.01.015; Goligher EC, 2017, ANN AM THORAC SOC, V14, pS304, DOI 10.1513/AnnalsATS.201704-340OT; Gu WJ, 2015, CAN MED ASSOC J, V187, pE101, DOI 10.1503/cmaj.141005; Hartland BL, 2015, RESP CARE, V60, P609, DOI 10.4187/respcare.03488; Hartog A, 2000, CRIT CARE MED, V28, P1450, DOI 10.1097/00003246-200005000-00032; Hedenstierna G, 2015, ANESTHESIOLOGY, V123, P501, DOI 10.1097/ALN.0000000000000755; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jiang GQ, 2008, HEPATOB PANCREAT DIS, V7, P367; KRAYER S, 1989, ANESTHESIOLOGY, V70, P891, DOI 10.1097/00000542-198906000-00002; Kuchnicka K, 2013, ANAESTH INTENSIVE TH, V45, P164, DOI 10.5603/AIT.2013.0034; Martin Jennifer Bourgeois, 2015, JBI Database System Rev Implement Rep, V13, P211, DOI 10.11124/jbisrir-2015-1410; Mills GH, 2018, ANAESTHESIA, V73, P25, DOI 10.1111/anae.14137; Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002; Nestler C, 2017, BRIT J ANAESTH, V119, P1194, DOI 10.1093/bja/aex192; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Parameswaran Krishnan, 2006, Can Respir J, V13, P203; Pereira SM, 2018, ANESTHESIOLOGY, V129, P1070, DOI 10.1097/ALN.0000000000002435; Pi X, 2015, INT J CLIN EXP PATHO, V8, P14305; Pirrone M, 2016, CRIT CARE MED, V44, P300, DOI 10.1097/CCM.0000000000001387; Reinius H, 2009, ANESTHESIOLOGY, V111, P979, DOI 10.1097/ALN.0b013e3181b87edb; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; [沈子珒 Shen Zijin], 2015, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V35, P1632; Sulemanji DS, 2014, AM J RESP CRIT CARE, P189; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tusman G, 2012, CURR OPIN ANESTHESIO, V25, P1, DOI 10.1097/ACO.0b013e32834dd1eb; VANEEDEN AF, 1980, S AFR MED J, V58, P349; Villar J, 2010, CRIT CARE, V14, DOI 10.1186/cc8842; Weingarten TN, 2010, BRIT J ANAESTH, V104, P16, DOI 10.1093/bja/aep319; Whalen FX, 2006, ANESTH ANALG, V102, P298, DOI 10.1213/01.ane.0000183655.57275.7a; Xiong Wei, 2016, Nan Fang Yi Ke Da Xue Xue Bao, V36, P215	40	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217405	10.1371/journal.pone.0217405	http://dx.doi.org/10.1371/journal.pone.0217405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141541	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000055
J	Li, F; Dong, YZ; Zhang, D; Zhang, XM; Lin, ZJ; Zhang, B				Li, Fan; Dong, Yi-Zhu; Zhang, Dan; Zhang, Xiao-Meng; Lin, Zhi-Jian; Zhang, Bing			Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments	PLOS ONE			English	Article							URIC-ACID; TARGET IDENTIFICATION; METABOLIC SYNDROME; UCSF CHIMERA; WEB SERVER; HYPERURICEMIA; VISUALIZATION; UPDATE; TOOL; PROLIFERATION	As an important part of the comprehensive treatment methods, the urate-lowering Chinese herbs could provide favorable clinical effects on hyperuricemia in its ability to invigorate spleen and remove dampness. Owing to the long-term duration, it brought up the potential adverse reactions (ADRs) and concerns about the drug-induced liver injury from these herbs. To address this problem, the bioinformatics approaches which combined the network pharmacology, computer simulation and molecular biology experiments were undertaken to elucidate the underlying drug-induced liver injury molecular mechanisms of urate-lowering Chinese herbs. Several electronic databases were searched to identify the potential liver injury compounds in published research. Then, the putative target profile of liver injury was predicted, and the interaction network was constructed based on the links between the compounds, corresponding targets and core pathways. Accordingly, the molecular docking simulation was performed to recognize the representative compounds with hepatotoxicity. Finally, the cell experiments were conducted to investigate the biochemical indicators and expression of the crucial protein that were closely associated with liver injury. In conclusion, the current research revealed that the compounds with potential liver injury including diosgenin, baicalin, saikosaponin D, tetrandrine, rutaecarpine and evodiamine from urate-lowering Chinese herbs, could lead to decline the survival rate of L-02 cell, increase the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) in cell-culture medium, enhance the expression of p-p38/p38, while the p38 inhibitor could achieve the trend of regulating and controlling liver injury. These research findings bring further support to the growing evidence that the mechanism of the liver injury induced by the compounds from urate-lowering Chinese herbs may be associated with the activation of p38 alpha.	[Li, Fan; Dong, Yi-Zhu; Zhang, Dan; Zhang, Xiao-Meng; Lin, Zhi-Jian; Zhang, Bing] Beijing Univ Chinese Med, Sch Chinese Materia Med, Dept Clin Chinese Pharm, Beijing, Peoples R China	Beijing University of Chinese Medicine	Zhang, B (corresponding author), Beijing Univ Chinese Med, Sch Chinese Materia Med, Dept Clin Chinese Pharm, Beijing, Peoples R China.	zhangb@bucm.edu.cn						Barbarino JM, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1417; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Billiet Laura, 2014, ISRN Rheumatol, V2014, P852954, DOI 10.1155/2014/852954; Boezio B, 2017, MOL INFORM, V36, DOI 10.1002/minf.201700048; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Cai QY, 2014, MOLECULES, V19, P21168, DOI 10.3390/molecules191221168; Calogiuri Gianfranco, 2013, Inflammation & Allergy Drug Targets, V12, P19; Cao J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010067; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chatterjee B, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0100-z; Chen MF, 2013, J MED FOOD, V16, P793, DOI [10.1091/jmf.2013.2762, 10.1089/jmf.2013.2762]; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264; Dai CS, 2016, MOLECULES, V21, DOI 10.3390/molecules21081061; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gilbert D, 2005, BRIEF BIOINFORM, V6, P194, DOI 10.1093/bib/6.2.194; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Godyn J, 2017, ELECTROPHORESIS, V38, P1268, DOI 10.1002/elps.201600473; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; Hong M, 2017, MOLECULES, V22, DOI 10.3390/molecules22040632; Hu YY, 2015, MOLECULES, V20, P6443, DOI 10.3390/molecules20046443; Huang J, 2017, J NANOMATER, V2017, P1, DOI DOI 10.1155/2017/2084621; Jiang Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1834-9; Jiang Y, 2017, ONCOL LETT, V13, P4035, DOI 10.3892/ol.2017.6015; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kaufmann P, 2005, HEPATOLOGY, V41, P925, DOI 10.1002/hep.20634; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kojima S, 2017, J CARDIOL, V69, P169, DOI 10.1016/j.jjcc.2016.02.015; Korashy HM, 2011, CHEM RES TOXICOL, V24, P1540, DOI 10.1021/tx200141p; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00080; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Li L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-122; [李丽玉 Li Liyu], 2015, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V26, P284; Li S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33082; Li XX, 2013, CLIN RHEUMATOL, V32, P943, DOI 10.1007/s10067-013-2274-7; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Luo X, 2018, BRAIN BEHAV IMMUN, V72, P34, DOI 10.1016/j.bbi.2017.11.007; Maharani N, 2016, INT HEART J, V57, P395, DOI 10.1536/ihj.16-192; Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800; Meng AH, 2016, INT J CHRONIC OBSTR, V11, P909, DOI 10.2147/COPD.S99810; Merriman TR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0609-2; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases, 2017, Zhonghua Nei Ke Za Zhi, V56, P235, DOI 10.3760/cma.j.issn.0578-1426.2017.03.021; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Oughtred Rose, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top080754; Pathak Ashish, 2016, Central Nervous System Agents in Medicinal Chemistry, V16, P143, DOI 10.2174/1871524916666151210143347; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi XM, 2013, ACTA PHARMACOL SIN, V34, P1229, DOI 10.1038/aps.2013.62; Qiu L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-664; Rigsby RE, 2016, BIOCHEM MOL BIOL EDU, V44, P433, DOI 10.1002/bmb.20966; Robinson PC, 2015, EXPERT OPIN PHARMACO, V16, P533, DOI 10.1517/14656566.2015.997213; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030124; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Senior JR, 2012, CLIN PHARMACOL THER, V92, P332, DOI 10.1038/clpt.2012.108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Stamp LK, 2016, INTERN MED J, V46, P1075, DOI 10.1111/imj.13173; Su J, 2010, J TRAUMA, V68, P1317, DOI 10.1097/TA.0b013e3181bb9cd3; Sun HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00661-3; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Thornton C. E., 2010, BMC BIOINFORMATICS, V11, P91, DOI DOI 10.1186/1471-2105-11-91; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Tonder Alet, 2015, BMC Res Notes, V8, P47, DOI 10.1186/s13104-015-1000-8; Vilar S, 2017, CURR MED CHEM, V24, P4340, DOI 10.2174/0929867324666170724101448; Wang JB, 2015, FRONT MED-PRC, V9, P457, DOI 10.1007/s11684-015-0417-8; Wang L, 2018, MOL MED REP, V17, P789, DOI 10.3892/mmr.2017.7958; Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374; Wang Y, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0190-6; Wen B, 2014, DRUG METAB DISPOS, V42, P1044, DOI 10.1124/dmd.114.057414; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xiao YT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.523; Yang ZH, 2016, INT J MED SCI, V13, P783, DOI 10.7150/ijms.16663; Zhang ZX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0678-6; Zhou Q, 2014, PLANTA MED, V80, P1259, DOI 10.1055/s-0034-1383048; Zhu JJ, 2014, ANIMAL, V8, P1469, DOI 10.1017/S1751731114001323; Zuo T, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0379-z	87	12	17	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216948	10.1371/journal.pone.0216948	http://dx.doi.org/10.1371/journal.pone.0216948			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141540	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000031
J	Mulhall, RM; Bennett, DE; Bratcher, HB; Jolley, KA; Bray, JE; O'Lorcain, PP; Cotter, SM; Maiden, MCJ; Cunney, RJ				Mulhall, Robert M.; Bennett, Desiree E.; Bratcher, Holly B.; Jolley, Keith A.; Bray, James E.; O'Lorcain, Piaras P.; Cotter, Suzanne M.; Maiden, Martin C. J.; Cunney, Robert J.			cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; CLUSTER	Introduction and aims Since 2013 MenC and MenW disease incidence and associated mortality rates have increased in the Republic of Ireland. From 2002/2003 to 2012/2013, the average annual MenC incidence was 0.08/100,000, which increased to 0.34/100,000 during 2013/2014 to 2017/18, peaking in 2016/17 (0.72/100,000) with an associated case fatality rate (CFR) of 14.7%. MenW disease incidence has increased each year from 0.02/100,000 in 2013/2014, to 0.29/100,000 in 2017/18, with an associated CFR of 28.6%. We aimed to characterise and relate recent MenC isolates to the previously prevalent MenC:cc11 ET-15 clones, and also characterise and relate recent MenW isolates to the novel ` Hajj' clones. Methods Using WGS we characterised invasive (n = 74, 1997/98 to 2016/17) and carried (n = 16, 2016/17) MenC isolates, and invasive (n = 18, 2010/11 to 2016/17) and carried (n = 15, 2016/17) MenW isolates. Genomes were assembled using VelvethOptimiser and stored on the PubMLST Neisseria Bacterial Isolate Genome Sequence Database. Isolates were compared using the cgMLST approach. Results Most MenC and MenW isolates identified were cc11. A single MenC: cc11 sub- lineage contained the majority (68%, n = 19/28) of recent MenC: cc11 disease isolates and all carried MenC: cc11 isolates, which were interspersed and distinct from the historically significant ET-15 clones. MenW: cc11 study isolates clustered among international examples of both the original UK 2009 MenW: cc11, and novel 2013 MenW: cc11clones. Conclusions We have shown that the majority of recent MenC disease incidence was caused by strain types distinct from the MenC: cc11 ET-15 clone of the late 1990s, which still circulate but have caused only sporadic disease in recent years. We have identified that the same aggressive MenW clone now established in several other European countries, is endemic in the RoI and responsible for the recent MenW incidence increases. This data informed the National immunisation Advisory Committee, who are currently deliberating a vaccine policy change to protect teenagers.	[Mulhall, Robert M.; Bennett, Desiree E.; Cunney, Robert J.] Temple St Childrens Univ Hosp, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland; [Bratcher, Holly B.; Jolley, Keith A.; Bray, James E.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford, England; [O'Lorcain, Piaras P.; Cotter, Suzanne M.] Hlth Protect & Surveillance Ctr, Dublin, Ireland; [Cunney, Robert J.] Royal Coll Surgeons Ireland, Dept Microbiol, Dublin, Ireland	Childrens University Hospital - Temple Street; University of Oxford; Royal College of Surgeons - Ireland	Mulhall, RM (corresponding author), Temple St Childrens Univ Hosp, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland.	robert.mulhall@cuh.ie	Maiden, Martin C J/C-5055-2014; Jolley, Keith/ABE-8587-2020	Maiden, Martin C J/0000-0001-6321-5138; Jolley, Keith/0000-0002-0751-0287; Mulhall, Robert/0000-0003-0457-4661; BRAY, JAMES/0000-0003-3554-4254	Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin; European Union; Wellcome Trust	Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by the Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was awarded to RJC, DEB and RMM.; We wish to thank Sandra Morgan and Elizabeth Lynam (IMSRL, Dublin), and Sarah Lamble (Oxford Genomic Centre, Oxford University). The study used the Neisseria MLST website (pubmlst. org/neisseria) developed by Keith Jolley, and supported by the European Union and the Wellcome Trust.	Bassi C, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.28.30574; Bazan JA, 2017, CLIN INFECT DIS, V65, P92, DOI 10.1093/cid/cix215; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett DE, 2003, J MED MICROBIOL, V52, P781, DOI 10.1099/jmm.0.05225-0; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brundage J, 1987, EVOLUTION MENINGOCOC, P6; Bryant D, 1987, MOL BIOL EVOL, P255; Campbell H, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.12.30175; Campbell H, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21188; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641; Christensen H, 2011, LANCET INFECT DIS, V11, P584; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Eriksson L, 2018, J CLIN MICROBIOL, V469, P1; Folaranmi TA, 2017, CLIN INFECT DIS, V65, P756, DOI 10.1093/cid/cix438; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Health Protection Surveillance Centre (HPSC), 1999, ANN EP REP 1999 2016; Hong E, 2018, J INFECTION, V76, P149, DOI 10.1016/j.jinf.2017.10.015; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Knol MJ, 2018, EUROSURVEILLANCE, V12, P1; Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122; Kratz MM, 2016, EMERG INFECT DIS, V21, P2010; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Lucidarme J, 2017, J INFECTION, V75, P95, DOI 10.1016/j.jinf.2017.05.015; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin NV, 2016, COMMUN DIS INTELL Q, V40, P2013; Miglietta A, 2018, EUROSURVEILL, V23; Miglietta A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3598-3; Mustapha MM, 2015, EBIOMEDICINE, V2, P1447, DOI 10.1016/j.ebiom.2015.09.007; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Pollard AJ, 2001, VACCINE, V19, P1327, DOI 10.1016/S0264-410X(00)00333-9; Russcher A, 2017, EURO SURVEILL, V22; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Safadi MAP, 2015, VACCINE, V33, P6529, DOI 10.1016/j.vaccine.2015.10.055; Smith-Palmer A, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.45.30392; Stefanelli P, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.07.014; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Vogel U, 2000, J CLIN MICROBIOL, V38, P941, DOI 10.1128/JCM.38.2.941-942.2000; von Gottberg A, 2008, CLIN INFECT DIS, V46, P377, DOI 10.1086/525260; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216771	10.1371/journal.pone.0216771	http://dx.doi.org/10.1371/journal.pone.0216771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141820	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000021
J	White, CA; Uttl, B; Holder, MD				White, Carmela A.; Uttl, Bob; Holder, Mark D.			Meta-analyses of positive psychology interventions: The effects are much smaller than previously reported	PLOS ONE			English	Article							WELL-BEING THERAPY; RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT ABILITY; QUALITY-OF-LIFE; COUNTING BLESSINGS; FORGIVENESS THERAPY; HEALTH-BENEFITS; GOAL ATTAINMENT; HAPPINESS; GRATITUDE	For at least four decades, researchers have studied the effectiveness of interventions designed to increase well-being. These interventions have become known as positive psychology interventions (PPIs). Two highly cited meta-analyses examined the effectiveness of PPIs on well-being and depression: Sin and Lyubomirsky (2009) and Bolier et al. (2013). Sin and Lyubomirsky reported larger effects of PPIs on well-being (r =.29) and depression (r =.31) than Bolier et al. reported for subjective well-being (r =.17), psychological wellbeing (r =.10), and depression (r =.11). A detailed examination of the two meta-analyses reveals that the authors employed different approaches, used different inclusion and exclusion criteria, analyzed different sets of studies, described their methods with insufficient detail to compare them clearly, and did not report or properly account for significant small sample size bias. The first objective of the current study was to reanalyze the studies selected in each of the published meta-analyses, while taking into account small sample size bias. The second objective was to replicate each meta-analysis by extracting relevant effect sizes directly from the primary studies included in the meta-analyses. The present study revealed three key findings: (1) many of the primary studies used a small sample size; (2) small sample size bias was pronounced in many of the analyses; and (3) when small sample size bias was taken into account, the effect of PPIs on well-being were small but significant (approximately r =.10), whereas the effect of PPIs on depression were variable, dependent on outliers, and generally not statistically significant. Future PPI research needs to focus on increasing sample sizes. A future meta-analyses of this research needs to assess cumulative effects from a comprehensive collection of primary studies while being mindful of issues such as small sample size bias.	[White, Carmela A.; Holder, Mark D.] Univ British Columbia, Kelowna, BC, Canada; [Uttl, Bob] Mt Royal Univ, Calgary, AB, Canada	University of British Columbia; Mount Royal University	White, CA (corresponding author), Univ British Columbia, Kelowna, BC, Canada.	whitecarmela@gmail.com						Abbott J.A., 2009, E J APPL PSYCHOL, V5, P89, DOI [DOI 10.7790/EJAP.V5I1.145, 10.7790/ejap.v5i1.145]; [Anonymous], 2008, HDB DEPRESSION CHILD; [Anonymous], 2015, INT J WELLBEING, V5, P1, DOI [10.5502/ijw.v5i4.1, 10.5502/ijw.v5i4.449, DOI 10.5502/IJW.V5I4.1, DOI 10.5502/IJW.V5I4.449]; Becker B. J., 1993, HDB RES SYNTHESIS; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Boehm JK, 2011, COGNITION EMOTION, V25, P1263, DOI 10.1080/02699931.2010.541227; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Borenstein M, 2009, INTRO META ANAL; Buchanan KE, 2010, J SOC PSYCHOL, V150, P235, DOI 10.1080/00224540903365554; Burton CM, 2004, J RES PERS, V38, P150, DOI 10.1016/S0092-6566(03)00058-8; Cheavens JS, 2006, SOC INDIC RES, V77, P61, DOI 10.1007/s11205-005-5553-0; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cook E A, 1998, Health Care Women Int, V19, P109, DOI 10.1080/073993398246449; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Csikszentmihalyi M., 2014, FLOW FDN POSITIVE PS; Davis Marsha Courville, 2004, Issues Ment Health Nurs, V25, P503, DOI 10.1080/01612840490443455; Della Porta MD, 2009, SEARCHING PLACEBO EF; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Fava GA, 2005, PSYCHOTHER PSYCHOSOM, V74, P26, DOI 10.1159/000082023; Fava GA, 2003, J BEHAV THER EXP PSY, V34, P45, DOI 10.1016/S0005-7916(03)00019-3; Fava GA, 1998, PSYCHOL MED, V28, P475, DOI 10.1017/S0033291797006363; Feldman DB, 2012, J HAPPINESS STUD, V13, P745, DOI 10.1007/s10902-011-9292-4; FORDYCE MW, 1983, J COUNS PSYCHOL, V30, P483, DOI 10.1037/0022-0167.30.4.483; FORDYCE MW, 1977, J COUNS PSYCHOL, V24, P511, DOI 10.1037/0022-0167.24.6.511; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Freedman SR, 1996, J CONSULT CLIN PSYCH, V64, P983, DOI 10.1037/0022-006X.64.5.983; Frieswijk N, 2006, PATIENT EDUC COUNS, V61, P219, DOI 10.1016/j.pec.2005.03.011; Froh JJ, 2008, J SCHOOL PSYCHOL, V46, P213, DOI 10.1016/j.jsp.2007.03.005; Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0; Goldstein ED, 2007, J CLIN PSYCHOL, V63, P1001, DOI 10.1002/jclp.20402; Grant A.M., 2012, J SYST THER, V31, P21, DOI [10.1521/jsyt.2012.31.2.21, DOI 10.1521/JSYT.2012.31.2.21]; Grant AM, 2009, J POSIT PSYCHOL, V4, P396, DOI 10.1080/17439760902992456; Green L.S., 2006, J POSIT PSYCHOL, V1, P142, DOI [10.1080/17439760600619849, DOI 10.1080/17439760600619849]; Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501; Hedges L. V., 1989, CONTRIBUTIONS PROBAB, P447; Hempel S, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-107; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howell AJ, 2016, J HAPPINESS STUD, V17, P2347, DOI 10.1007/s10902-015-9697-6; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hurley DB, 2012, J HAPPINESS STUD, V13, P579, DOI 10.1007/s10902-011-9280-8; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; King LA, 2000, PERS SOC PSYCHOL B, V26, P220, DOI 10.1177/0146167200264008; King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003; Kremers IP, 2006, AGING MENT HEALTH, V10, P476, DOI 10.1080/13607860600841206; Kushlev K, 2017, CONTEMP CLIN TRIALS, V52, P62, DOI 10.1016/j.cct.2016.11.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Layous K, 2013, J HAPPINESS STUD, V14, P635, DOI 10.1007/s10902-012-9346-2; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; LICHTER S, 1980, NEW ZEAL PSYCHOL, V9, P57; Lin WF, 2004, J CONSULT CLIN PSYCH, V72, P1114, DOI 10.1037/0022-006X.72.6.1114; Low CA, 2006, HEALTH PSYCHOL, V25, P181, DOI 10.1037/0278-6133.25.2.181; Martinez-Marti ML, 2010, SPAN J PSYCHOL, V13, P886, DOI 10.1017/S1138741600002535; Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618; Luthans F, 2010, HUM RESOUR DEV Q, V21, P41, DOI 10.1002/hrdq.20034; Lyubomirsky S, 2006, J PERS SOC PSYCHOL, V90, P692, DOI 10.1037/0022-3514.90.4.692; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S., 2006, J HAPPINESS STUD, V7, P183, DOI [DOI 10.1007/S10902-005-4754-1, 10.1007/s10902-005-4754-1]; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; MacLeod AK, 2008, J HAPPINESS STUD, V9, P185, DOI 10.1007/s10902-007-9057-2; McMahan EA, 2015, J POSIT PSYCHOL, V10, P507, DOI 10.1080/17439760.2014.994224; Mitchell J, 2009, COMPUT HUM BEHAV, V25, P749, DOI 10.1016/j.chb.2009.02.003; Mongrain M, 2012, J CLIN PSYCHOL, V68, DOI 10.1002/jclp.21839; Mongrain M, 2011, J HAPPINESS STUD, V12, P963, DOI 10.1007/s10902-010-9239-1; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Niemiec R., 2012, J MENT HLTH COUNS, V34, P240, DOI [10.17744/mehc.34.3.34p6328x2v204v21, DOI 10.17744/MEHC.34.3.34P6328X2V204V21]; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Page KM, 2013, J HAPPINESS STUD, V14, P1007, DOI 10.1007/s10902-012-9366-y; Parks A. C., 2013, POSITIVE INTERVENTIO; Passmore B, 2016, 2016 IEEE 4TH WORKSHOP ON WIDE BANDGAP POWER DEVICES AND APPLICATIONS (WIPDA), P1, DOI 10.1109/WiPDA.2016.7799900; Peters ML, 2010, J POSIT PSYCHOL, V5, P204, DOI 10.1080/17439761003790963; Peterson C., 2005, J HAPPINESS STUD, V6, P25, DOI [https://doi.org/10.1007/s10902-004-1278-z, DOI 10.1007/S10902-004-1278-Z]; Pretorius C, 2008, J PSYCHOL AFR, V18, P301, DOI 10.1080/14330237.2008.10820202; Quoidbach J, 2009, J POSIT PSYCHOL, V4, P349, DOI 10.1080/17439760902992365; R Core Team, 2015, R LANG EN STAT COMP; Reed GL, 2006, J CONSULT CLIN PSYCH, V74, P920, DOI 10.1037/0022-006X.74.5.920; Rucker G, 2011, BIOMETRICAL J, V53, P351, DOI 10.1002/bimj.201000151; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Ruini C, 2006, PSYCHOTHER PSYCHOSOM, V75, P331, DOI 10.1159/000095438; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schmidt F.L., 2014, METHODS META ANAL CO; Schueller S, 2014, INT J WELLBEING, P4; Schueller SM, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.1850; Seligman M.E., 2012, FLOURISHA VISIONARY; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Sergeant S, 2011, J POSIT PSYCHOL, V6, P260, DOI 10.1080/17439760.2011.577089; Shapira LB, 2010, J POSIT PSYCHOL, V5, P377, DOI 10.1080/17439760.2010.516763; Sheldon K. M., 2006, J POSIT PSYCHOL, P73, DOI [10.1080/17439760500510676, DOI 10.1080/17439760500510676]; Sheldon KM, 2002, J PERS, V70, P5, DOI 10.1111/1467-6494.00176; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; SMITH WP, 1995, J CLIN PSYCHOL, V51, P269; Spence G.B., 2007, J POSIT PSYCHOL, V2, P185, DOI [https://doi.org/10.1080/17439760701228896, DOI 10.1080/17439760701228896]; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Surawy C, 2005, BEHAV COGN PSYCHOTH, V33, P103, DOI 10.1017/S135246580400181X; Tkach CT, 2005, UNLOCKING TREASURY H; Viechtbauer W, 2010, RES SYNTH METHODS, V1, P112, DOI 10.1002/jrsm.11; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wampold BE, 1997, PSYCHOL BULL, V122, P203, DOI 10.1037/0033-2909.122.3.203; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; Wing JF, 2006, J CLIN PSYCHOL, V62, P1291, DOI 10.1002/jclp.20292; Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408	109	59	60	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216588	10.1371/journal.pone.0216588	http://dx.doi.org/10.1371/journal.pone.0216588			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141537	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000016
J	Mendez, A; Rojas, DA; Ponce, CA; Bustamante, R; Beltran, CJ; Toledo, J; Garcia-Angulo, VA; Henriquez, M; Vargas, SL				Mendez, Andrea; Rojas, Diego A.; Ponce, Carolina A.; Bustamante, Rebeca; Beltran, Carol J.; Toledo, Jorge; Garcia-Angulo, Victor A.; Henriquez, Mauricio; Vargas, Sergio L.			Primary infection by Pneumocystis induces Notch-independent Clara cell mucin production in rat distal airways	PLOS ONE			English	Article							VALPROIC ACID; MUCOUS METAPLASIA; MUC5AC EXPRESSION; EPITHELIAL-CELLS; PROTEIN; ASTHMA; LUNG; ASSOCIATION; CARINII; MODEL	Clara cells are the main airway secretory cells able to regenerate epithelium in the distal airways through transdifferentiating into goblet cells, a process under negative regulation of the Notch pathway. Pneumocystis is a highly prevalent fungus in humans occurring between 2 and 5 months of age, a period when airways are still developing and respiratory morbidity typically increases. Pneumocystis induces mucus hyperproduction in immunocompetent host airways and whether it can stimulate Clara cells is unknown. Markers of Clara cell secretion and Notch1 activation were investigated in lungs of immunocompetent rats at 40, 60, and 80 days of age during Pneumocystis primary infection with and without Valproic acid (VPA), a Notch inducer. The proportion of rats expressing mucin increased in Pneumocystis-infected rats respect to controls at 60 and 80 days of age. Frequency of distal airways Clara cells was maintained while mRNA levels for the mucin-encoding genes Muc5B and Muc5ac in lung homogenates increased 1.9 and 3.9 times at 60 days of infection (P. = 0.1609 and P. = 0.0001, respectively) and protein levels of the Clara cell marker CC10 decreased in the Pneumocystis-infected rats at 60 and 80 days of age (P. = 0.0118 & P. = 0.0388). CC10 and Muc5b co-localized in distal airway epithelium of Pneumocystis-infected rats at day 60. Co-localization of Muc5b and Ki67 as marker of mitosis in distal airways was not observed suggesting that Muc5b production by Clara cells was independent of mitosis. Notch levels remained similar and no transnucleation of activated Notch associated to Pneumocystis infection was detected. Unexpectedly, mucus was greatly increased at day 80 in Pneumocystis-infected rats receiving VPA suggesting that a Notch-independent mechanism was triggered. Overall, data suggests a Clara to goblet cell transdifferentiation mechanism induced by Pneumocystis and independent of Notch.	[Mendez, Andrea; Rojas, Diego A.; Ponce, Carolina A.; Bustamante, Rebeca; Garcia-Angulo, Victor A.; Vargas, Sergio L.] Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed ICBM, Fac Med, Santiago, Chile; [Beltran, Carol J.] Univ Chile, Serv Gastroenterol, Hosp Clin Univ Chile, Santiago, Chile; [Beltran, Carol J.] Univ Chile, Fac Med, Santiago, Chile; [Toledo, Jorge] Univ Chile, Inst Neurociencias Biomed BNI, Lab Anal Imagenes Cient, SCIAN Lab,Fac Med, Santiago, Chile; [Henriquez, Mauricio] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Vargas, SL (corresponding author), Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed ICBM, Fac Med, Santiago, Chile.	svargas@med.uchile.cl	Rojas, Diego A./AAT-4173-2021; Vargas, Sergio L/E-5224-2016; Vargas, Sergio/AAC-1072-2022; /L-6849-2013	Rojas, Diego A./0000-0002-5388-1070; Vargas, Sergio/0000-0002-9299-6428; Toledo, Jorge/0000-0001-8678-558X; /0000-0001-7426-586X; Mendez, Andrea/0000-0001-8173-2921	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1140412]; Comision Nacional de Investigacion Cientifica y Tecnologica [ERANet LAC HID0254]; Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant [ENL 30/19]; Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica; Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant; Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program	This work was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico grant number 1140412 to SLV, Comision Nacional de Investigacion Cientifica y Tecnologica grant ERANet LAC HID0254 to SLV, Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant ENL 30/19 to SLV, and Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 2000, RRD ANTIMICROB AG CH, V4, P1; Bobolea I, 2019, J INVEST ALLERG CLIN, V29, P168, DOI 10.18176/jiaci.0361; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Cui YH, 2011, AM J RHINOL ALLERGY, V25, P145, DOI 10.2500/ajra.2011.25.3596; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Eddens T, 2016, AM J RESP CRIT CARE, V194, P807, DOI 10.1164/rccm.201511-2205OC; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Greenblatt DY, 2007, ONCOLOGIST, V12, P942, DOI 10.1634/theoncologist.12-8-942; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hayashi T, 2004, VIRCHOWS ARCH, V444, P66, DOI 10.1007/s00428-003-0926-8; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Ito T, 2000, DEVELOPMENT, V127, P3913; Iturra PA, 2018, AM J PATHOL, V188, P417, DOI 10.1016/j.ajpath.2017.10.019; Jang S, 2017, FEBS LETT, V591, P393, DOI 10.1002/1873-3468.12544; Kouznetsova I, 2007, AM J RESP CELL MOL, V36, P286, DOI 10.1165/rcmb.2006-0008OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; Okuda K, 2019, AM J RESP CRIT CARE, V199, P715, DOI 10.1164/rccm.201804-0734OC; Ou-Yang HF, 2013, RESPIRATION, V86, P341, DOI 10.1159/000350647; Perez Francisco J, 2014, Results Immunol, V4, P58, DOI 10.1016/j.rinim.2014.07.001; Phaybouth V, 2006, AM J PHYSIOL-LUNG C, V290, pL222, DOI 10.1152/ajplung.00148.2005; Platta CS, 2008, J SURG RES, V148, P31, DOI 10.1016/j.jss.2008.03.008; Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reid AT, 2018, PHARMACOL THERAPEUT, V185, P155, DOI 10.1016/j.pharmthera.2017.12.009; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rogers DF, 2003, INT J BIOCHEM CELL B, V35, P1, DOI 10.1016/S1357-2725(02)00083-3; Rojas DA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39079-4; Schnackenberg LK, 2006, OMICS, V10, P1, DOI 10.1089/omi.2006.10.1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Swain SD, 2012, AM J RESP CELL MOL, V46, P290, DOI 10.1165/rcmb.2011-0154OC; Swain SD, 2011, INFECT IMMUN, V79, P1905, DOI 10.1128/IAI.01273-10; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Valque H, 2011, HISTOCHEM CELL BIOL, V136, P699, DOI 10.1007/s00418-011-0872-5; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Vargas SL, 2013, CLIN INFECT DIS, V56, P171, DOI 10.1093/cid/cis870; Vargas SL, 1999, CLIN INFECT DIS, V29, P1489, DOI 10.1086/313521; VARGAS SL, 1995, J INFECT DIS, V172, P506, DOI 10.1093/infdis/172.2.506; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176; Zheng XF, 2017, EXP CELL RES, V358, P129, DOI 10.1016/j.yexcr.2017.06.006; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	51	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217684	10.1371/journal.pone.0217684	http://dx.doi.org/10.1371/journal.pone.0217684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170201	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700048
J	Shah, NB; Mitchell, RE; Proctor, ST; Choi, L; DeClercq, J; Jolly, JA; Hemnes, AR; Zuckerman, AD				Shah, Nisha B.; Mitchell, Rhonita E.; Proctor, Stephanie Terry; Choi, Leena; DeClercq, Joshua; Jolly, Jacob A.; Hemnes, Anna R.; Zuckerman, Autumn D.			High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach	PLOS ONE			English	Article							CARE; THERAPY; TRANSITIONS; MANAGEMENT	Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are in a unique position to mitigate barriers related to PAH therapy including medication adherence and costs. The primary objective of this study was to assess medication adherence to PDE-5I therapy within an integrated care model at an academic institution. The secondary objective was to assess the impact of out-of-pocket (OOP) cost, frequency of dosing, adverse events (AE) and PAH-related hospitalizations on medication adherence. We performed a retrospective cohort analysis of adult patients with PAH who were prescribed PDE-5I therapy by the center's outpatient pulmonary clinic and who received medication management through the center's specialty pharmacy. We defined optimal medication adherence as proportion of days covered (PDC) >= 80%. Clinical data including AEs and PAH-related hospitalizations were extracted from the electronic medical record, and financial data from pharmacy claims. Of the 131 patients meeting inclusion criteria, 94% achieved optimal adherence of >= 80% PDC. In this study population, 47% of patients experienced an AE and 27% had at least one hospitalization. The median monthly OOP cost was $0.62. Patients with PDC<80% were more likely to report an AE compared to patients with PDC >= 80% (p = 0.002). Hospitalization, OOP cost, and frequency of dosing were not associated with adherence in this cohort. Patients receiving PDE-5I therapy through an integrated model achieved high adherence rates and low OOP costs.	[Shah, Nisha B.; Mitchell, Rhonita E.; Jolly, Jacob A.; Zuckerman, Autumn D.] Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA; [Proctor, Stephanie Terry] Huntsville Dist Mem Hosp, Dept Pharm, Huntsville, AL USA; [Choi, Leena; DeClercq, Joshua] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Hemnes, Anna R.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Shah, NB (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA.	nisha.b.shah@vumc.org						Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Bagwell A, 2017, J MANAG CARE SPEC PH, V23, P815, DOI 10.18553/jmcp.2017.23.8.815; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Brantley AF, 2018, AM J HEALTH-SYST PH, V75, pS1, DOI 10.2146/ajhp160652; Burger CD, 2018, J MANAG CARE SPEC PH, V24, P834, DOI 10.18553/jmcp.2018.17391; Burger CD, 2014, CHEST, V146, P1263, DOI 10.1378/chest.14-0193; Cawthon C, 2012, J HEALTH COMMUN, V17, P312, DOI 10.1080/10810730.2012.712619; Copher Ronda, 2012, J Med Econ, V15, P947, DOI 10.3111/13696998.2012.690801; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01889-2018; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Grady D, 2017, PULM CIRC, V8, DOI 10.1177/2045893217743616; Hanson RL, 2014, AM J HEALTH-SYST PH, V71, P463, DOI 10.2146/ajhp130495; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Macaulay Tracy E, 2016, J Pharm Pract, V29, P67, DOI 10.1177/0897190015615902; Mcgoon MD, 2008, MAYO CLIN PROC, V83, P923, DOI 10.4065/83.8.923; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Nau DP, 2012, PROPORTION DAYS COVE, P1; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Waxman Aaron, 2013, J Med Econ, V16, P298, DOI 10.3111/13696998.2012.756399	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217798	10.1371/journal.pone.0217798	http://dx.doi.org/10.1371/journal.pone.0217798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170217	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700057
J	Burrola-Mendez, Y; Bonilla-Escobar, FJ; Goldberg, M; Pearlman, J				Burrola-Mendez, Yohali; Bonilla-Escobar, Francisco J.; Goldberg, Mary; Pearlman, Jon			Comparing the effectiveness of a hybrid and in-person courses of wheelchair service provision knowledge: A controlled quasi-experimental study in India and Mexico	PLOS ONE			English	Article							ASSISTIVE TECHNOLOGY; IMPACT; EDUCATION; CAPACITY	Background Evidence highlights a global shortage of wheelchair service provision education and training that results in inappropriate wheelchair provision with associated health and economic consequences. Two learning methodologies, a hybrid and an in-person course, based on the World Health Organization Wheelchair Service Training Package Basic Level, currently are available to train wheelchair service providers worldwide. The effectiveness of the in-person methodology, used as the standard of practice, has never been tested. Meanwhile, the Hybrid Course, which combines online and in-person training, was developed to reduce training costs and to scale training interventions and has shown potential effectiveness in increasing basic level wheelchair service provision knowledge. The objective of this study was to compare the effectiveness of both learning methodologies based on knowledge and satisfaction among a group of wheelchair service providers in India and Mexico. Methods We conducted a controlled quasi-experimental study to evaluate changes in basic wheelchair knowledge and levels of satisfaction between Hybrid and In-person course learners in India and Mexico. A convenience sampling method guided by local stakeholders' input was used to recruit participants. Outcomes were assessed using self-administered online surveys, the International Society of Wheelchair Professionals Wheelchair Service Provision Basic Test (primary outcome) completed pre-and post-the learning intervention and an anonymous Satisfaction Survey (secondary outcome) completed post-intervention. Baseline characteristics were compared among groups using hypothesis tests based on their assumptions. The primary analysis was intention-to-treat. To address missing values and lost to follow-up, multiple chained imputations were conducted. The primary outcome was analyzed using linear mixed models. The secondary outcome was analyzed using a two-tailed two independent samples t-test. Results A total of 81 participants, 43 (53.1%) in the In-person group and 38 (46.9%) in the Hybrid group, participated in the study. Mean baseline knowledge scores were below the passing cutoff of the test (53 points) in both groups. Both study groups experienced statistically significant improvements in the primary outcome when comparing pre-and post-test scores (p<0.0001) with total mean scores above the passing cutoff of the test. The in-person group experienced, on average, larger effects on the primary outcome. The difference in mean change from post-test to pre-tests between In-person groups and Hybrid was 3.6 (95% Confidence Interval: 1.7; 5.4), Cohen's d = 0.36, with a small effect size favoring the In-person training. With regards to satisfaction, the difference between the two interventions was 0.23 +/- 0.07 in favor of the In-person group (p = 0.0021). Conclusions Both learning methodologies had a statistically significant effect in increasing wheelchair service knowledge with overall high levels of satisfaction. However, the In-person group reported overall larger effects when compared with the Hybrid methodology. This study provided recommendations on how organizations can improve blended learning interventions to enhance participants' learning experiences and reduce potential barriers and limitations.	[Burrola-Mendez, Yohali; Goldberg, Mary; Pearlman, Jon] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA; [Burrola-Mendez, Yohali; Goldberg, Mary; Pearlman, Jon] Univ Pittsburgh, ISWP, Pittsburgh, PA 15260 USA; [Burrola-Mendez, Yohali] Consejo Nacl Ciencia & Tecnol CONACYT, Ciudad De Mexico, Mexico; [Bonilla-Escobar, Francisco J.] SCISCO Fdn, Cali, Colombia; [Bonilla-Escobar, Francisco J.] Univ Pittsburgh, Sch Med, Inst Clin Res & Translat Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goldberg, M (corresponding author), Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA.; Goldberg, M (corresponding author), Univ Pittsburgh, ISWP, Pittsburgh, PA 15260 USA.	mgoldberg@pitt.edu	Bonilla-Escobar, Francisco Javier/AAK-8367-2020	Bonilla-Escobar, Francisco Javier/0000-0002-0224-3482; Burrola-Mendez, Yohali/0000-0001-9357-7543	U.S. Agency for International Development [AID-OAA-A-12-00047, APC-GM-0068]; Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship	U.S. Agency for International Development(United States Agency for International Development (USAID)); Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship	This study was produced by ISWP in collaboration with the University of Pittsburgh, subaward number APC-GM-0068, through Advancing Partners & Communities (APC), a cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-12-00047, beginning October 1, 2012. This study is based upon work supported by Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship. The contents of this publication do not necessarily reflect the view of CONACYT.	Agrawal S, 2011, INT J TELEMEDICINE A, V2011, P1; [Anonymous], 2018, WHEELCHAIR SERVICE T; [Anonymous], 2008, GUIDELINES PROVISION; [Anonymous], 2011, WORLD REP DIS; Atkins S, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30524; Atkins S, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28145; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189996; Bolton P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001757; Bonilla-Escobar FJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208483; Borg J, 2009, LANCET, V374, P1863, DOI 10.1016/S0140-6736(09)61872-9; Burrola-Mendez Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204769; Burrola-Mendez Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199251; Carver J, 2016, DISABIL REHABIL-ASSI, V11, P468, DOI 10.3109/17483107.2015.1027295; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Correa Luciana, 2003, Eur J Dent Educ, V7, P111, DOI 10.1034/j.1600-0579.2003.00291.x; Dantas AM, 2008, ADV PHYSIOL EDUC, V32, P65, DOI 10.1152/advan.00006.2007; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Economic Commission for Latin America and the Caribbean (ELAC), 2012, SOC PAN LAT AM; Elwan A, 1999, POVERTY DISABILITY S; Erah P, 2008, INT J HLTH RES, V1, P63; Frehywot S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-4; Fung KH, 2017, AFR J DISABIL, V6, DOI 10.4102/ajod.v6i0.340; Gartz R, 2017, DISABIL REHABIL-ASSI, V12, P333, DOI 10.3109/17483107.2016.1166527; Green LW, 2008, FAM PRACT, V25, pI20, DOI 10.1093/fampra/cmn055; Greer N, 2012, ANN INTERN MED, V156, P141, DOI 10.7326/0003-4819-156-2-201201170-00010; Gupta N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-276; Handley MA, 2011, J AM BOARD FAM MED, V24, P589, DOI 10.3122/jabfm.2011.05.110067; Harden RM, 1999, MED TEACH, V21, P553, DOI 10.1080/01421599978960; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; International Society of Wheelchair Professionals (ISWP), ISWP WHEELCH SERV PR; Joynes C, 2011, DISTANCE LEARNING HL; Lewis PA, 2016, NURSE EDUC PRACT, V21, P59, DOI 10.1016/j.nepr.2016.10.001; Liyanagunawardena TR, 2018, GLOB HEALTH PROMOT, V25, P74, DOI 10.1177/1757975916680970; Lucas H, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.33429; Maloney S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4346; Marrinan H, 2015, INT J HEALTH POLICY, V4, P571, DOI 10.15171/ijhpm.2015.121; Mastellos N, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1175-5; Miller M, 2004, ETR&D-EDUC TECH RES, V52, P92, DOI 10.1007/BF02504777; Missen C., 2005, New Review of Information Networking, V11, P193, DOI 10.1080/13614570600573367; Motschnig-Pitrik R., 2006, 36 ASEE IEEE FRONT E; Mukherjee G, 2005, DISABIL REHABIL, V27, P591, DOI 10.1080/09638280400018387; Obura T, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-3; Oyo B, 2014, INT REV RES OPEN DIS, V15, P1; Protsiv M, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0136-x; Rubin DB, 1987, MULTIPLE IMPUTATION; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Stuart EA, 2015, PREV SCI, V16, P475, DOI 10.1007/s11121-014-0513-z; Sullivan Gail M, 2011, J Grad Med Educ, V3, P285, DOI 10.4300/JGME-D-11-00147.1; Sullivan Gail M, 2011, J Grad Med Educ, V3, P119, DOI 10.4300/JGME-D-11-00075.1; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; The United Nations, 2006, CONVENTION RIGHTS PE, DOI DOI 10.18356/53068D8F-EN; Vichitvejpaisal P, 2001, MED EDUC, V35, P983, DOI 10.1046/j.1365-2923.2001.01020.x; VINCENT DS, 2003, J TELEMED TELECAR S2, V9, pS7; Visagie S, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.63; Vyas R, 2010, DISTANCE EDUC, V31, P211, DOI 10.1080/01587919.2010.498856; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; 2017, DISABIL REHABIL-ASSI, P1, DOI DOI 10.1080/17483107.2017.1392621	59	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217872	10.1371/journal.pone.0217872	http://dx.doi.org/10.1371/journal.pone.0217872			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150509	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100123
J	Bychkov, M; Shenkarev, Z; Shulepko, M; Shlepova, O; Kirpichnikov, M; Lyukmanova, E				Bychkov, Maxim; Shenkarev, Zakhar; Shulepko, Mikhail; Shlepova, Olga; Kirpichnikov, Mikhail; Lyukmanova, Ekaterina			Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of alpha 7 nicotinic acetylcholine receptors	PLOS ONE			English	Article							PROTEIN-KINASE-C; BACTERIAL EXPRESSION; P38 MAPK; ACTIVATION; GENE; MECHANISMS; SLURP-1; P53; NEUROMODULATOR; PROLIFERATION	Lynx1 is the first three-finger prototoxin found in the mammalian central nervous system. It is a GPI-anchored protein modulating nicotinic acetylcholine receptors (nAChRs) in the brain. Besides the brain, the Lynx1 protein was found in the lung and kidney. Endogenous Lynx1 controls the nicotine-induced up-regulation of the expression of alpha 7 type nAChRs in lung adenocarcinoma A549 cells as well as the cell growth. Here, we analyzed the Lynx1 expression in the set of human epithelial cells. The Lynx1 expression both at the mRNA and protein level was detected in normal oral keratinocytes, and lung, colon, epidermal, and breast cancer cells, but not in embryonic kidney cells. Co-localization of Lynx1 with alpha 7-nAChRs was revealed in a cell membrane for lung adenocarcinoma A549 and colon carcinoma HT-29 cells, but not for breast adenocarcinoma MCF-7 and epidermoid carcinoma A431 cells. The recombinant water-soluble variant of Lynx1 without a GPI-anchor (wsLynx1) inhibited the growth of A549 cells causing cell cycle arrest via modulation of alpha 7-nAChRs and activation of different intracellular signaling cascades, including PKC/IP3, MAP/ERK, p38, and JNK pathways. A549 cells treatment with ws-Lynx1 resulted in phosphorylation of the proapoptotic tumor suppressor protein p53 and different kinases participated in the regulation of gene transcription, cell growth, adhesion, and differentiation. Externalization of phosphatidylserine, an early apoptosis marker, observed by flow cytometry, confirmed the induction of apoptosis in A549 cells upon the ws-Lynx1 treatment. Our data revealed the ability of ws-Lynx1 to regulate homeostasis of epithelial cancer cells.	[Bychkov, Maxim; Shenkarev, Zakhar; Shulepko, Mikhail; Shlepova, Olga; Lyukmanova, Ekaterina] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Shenkarev, Zakhar; Shlepova, Olga; Lyukmanova, Ekaterina] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Kirpichnikov, Mikhail] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Lomonosov Moscow State University	Lyukmanova, E (corresponding author), RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Lyukmanova, E (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia.	ekaterina-lyukmanova@yandex.ru	Shlepova, Olga/AAM-8065-2020; Shenkarev, Zakhar/P-1808-2015	Lyukmanova, Ekaterina/0000-0002-9728-9407; Kirpichnikov, Mikhail/0000-0001-8170-1607; Shenkarev, Zakhar/0000-0003-1383-3522	Russian Science Foundation [17-74-20161]; Russian Foundation of Basic Researches [18-29-01050]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR))	The study was supported by the Russian Science Foundation (http://www.rscf.ru/en/, project 17-74-20161 issued to M.S. and M.B.), and the Russian Foundation of Basic Researches (http://www.rfbr.ru/rffi/eng, the study of kinases phosphorylation, project 18-29-01050 issued to E.L., M.B., M.S., Z.S., and M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Allan CM, 2016, J INVEST DERMATOL, V136, P436, DOI 10.1016/j.jid.2015.11.003; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Betapudi V, 2016, FASEB J, V30, P3515, DOI 10.1096/fj.201500040; Bilal Erhan, 2010, Genes Cancer, V1, P1063, DOI 10.1177/1947601910395583; Bocharov EV, 2003, APPL MAGN RESON, V24, P247, DOI 10.1007/BF03166664; Bychkov ML, 2018, ACTA NATURAE, V10, P57; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; da Silva CP, 2000, BBA-MOL CELL RES, V1498, P122, DOI 10.1016/S0167-4889(00)00089-6; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fu XW, 2015, INT IMMUNOPHARMACOL, V29, P93, DOI 10.1016/j.intimp.2015.05.022; Fu XW, 2012, AM J PHYSIOL-LUNG C, V303, pL661, DOI 10.1152/ajplung.00075.2012; George AA, 2017, FASEB J, V31, P1398, DOI 10.1096/fj.201600733R; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Hu YQ, 2015, ONCOL LETT, V10, P1350, DOI 10.3892/ol.2015.3462; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ishii T, 2004, EUR RESPIR J, V23, P665, DOI 10.1183/09031936.04.00096204; Ji L, 2015, J BIOL CHEM, V290, P11729, DOI 10.1074/jbc.M115.639351; Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Kumar S, 1998, J BIOL CHEM, V273, P25654, DOI 10.1074/jbc.273.40.25654; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loughner CL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0074-2; Lyukmanova E, 2014, ACTA NATURAE, V6, P7; Lyukmanova EN, 2018, BRIT J PHARMACOL, V175, P1973, DOI 10.1111/bph.14194; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149733; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Min J, 2015, ONCOL REP, V34, P2871, DOI 10.3892/or.2015.4325; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Moriwaki Y, 2015, INT IMMUNOPHARMACOL, V29, P71, DOI 10.1016/j.intimp.2015.05.030; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Nissen NI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199643; Okada M, 2013, ONCOL REP, V30, P1957, DOI 10.3892/or.2013.2655; Parker RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188715; Perez C, 2016, AM J CLIN DERMATOL, V17, P63, DOI 10.1007/s40257-015-0157-1; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Pettersson A., 2008, Autonomic & Autacoid Pharmacology, V28, P109, DOI 10.1111/j.1474-8673.2008.00424.x; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; Summers AE, 2003, LIFE SCI, V72, P2091, DOI 10.1016/S0024-3205(03)00089-4; Suntsova M, 2013, P NATL ACAD SCI USA, V110, P19472, DOI 10.1073/pnas.1318172110; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thomsen MS, 2016, NEUROBIOL AGING, V46, P13, DOI 10.1016/j.neurobiolaging.2016.06.009; Thomsen MS, 2014, BRAIN STRUCT FUNCT, V219, P1923, DOI 10.1007/s00429-013-0611-x; Throm Verena M, 2018, Oncotarget, V9, P11734, DOI 10.18632/oncotarget.24312; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Tu SH, 2016, ONCOTARGET, V7, P77516, DOI 10.18632/oncotarget.12717; Vasilyeva NA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1702, DOI 10.1134/S0006297917130090; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wenzel U, 2004, CELL PHYSIOL BIOCHEM, V14, P65, DOI 10.1159/000076928; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	73	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217339	10.1371/journal.pone.0217339	http://dx.doi.org/10.1371/journal.pone.0217339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150435	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100040
J	Gasser, E; Braunwarth, E; Riedmann, M; Cardini, B; Fadinger, N; Presl, J; Klieser, E; Ellmerer, P; Dupre, A; Imai, K; Malik, H; Baba, H; Ulmer, H; Schneeberger, S; Ofner, D; Dinnewitzer, A; Stattner, S; Primavesi, F				Gasser, Elisabeth; Braunwarth, Eva; Riedmann, Marina; Cardini, Benno; Fadinger, Nikolaus; Presl, Jaroslav; Klieser, Eckhard; Ellmerer, Philipp; Dupre, Aurelien; Imai, Katsunori; Malik, Hassan; Baba, Hideo; Ulmer, Hanno; Schneeberger, Stefan; Oefner, Dietmar; Dinnewitzer, Adam; Staettner, Stefan; Primavesi, Florian			Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score	PLOS ONE			English	Article							SIDED COLON-CANCER; LONG-TERM SURVIVAL; HEPATIC RESECTION; MOLECULAR-FEATURES; DISTAL; PROGNOSIS; SURGERY; IMPACT; MODEL; SITE	Background Colorectal cancer (CRC) represents a major cause for cancer death and every third patient develops liver metastases (CRLM). Several factors including number and size of metastases and primary tumour lymph-node status have been linked to survival. The primary tumour location along the colo-rectum continuum (sidedness) was analysed in first-line chemotherapy trials, where right-sided CRCs showed decreased survival. This association has not yet been clearly established in patients undergoing resection for CRLM. Methods Clinicopathological differences in CRLM resections according to sidedness in two Austrian centres (2003-2016) are described and survival is compared through Kaplan-Meier and multivariable analysis. A risk-score is presented with time-dependent receiver operating curve analysis and international validation in two major hepatobiliary centres. Furthermore, a systematic meta-analysis of studies on primary tumour location and survival after CRLM resection was performed. Results 259 patients underwent hepatectomy. Right-sided CRC patients (n = 59) more often had positive primary tumour lymph-nodes (76.3%/61.3%; p = 0.043) and RAS-mutations (60%/34.9%; p = 0.036). The median overall and disease-free survival was 33.5 and 9.1 months in right-sided versus 55.5 (p = 0.051) and 12.1 months (p = 0.078) in left-sided patients. In multivariable analysis nodal-status (HR 1.52), right-sidedness (HR 1.53), extrahepatic disease (HR 1.71) and bilobar hepatic involvement (HR 1.41) were significantly associated with overall survival. Sidedness was not independently associated with disease-free survival (HR 1.33; p = 0.099). A clinical risk score including right-sidedness, nodal-positivity and extrahepatic involvement significantly predicted overall (p = 0.005) and disease-free survival (p = 0.027), which was confirmed by international validation in 527 patients (p = 0.001 and p = 0.011). Meta-analysis including 10 studies (n = 4312) showed a significant association of right-sidedness with overall survival after resection (HR 1.55; p< 0.001). There was no significant association with disease-free survival (HR 1.22; p = 0.077), except when rectal-cancers were excluded (HR 1.39; p = 0.006). Conclusions Patients with liver metastases from right-sided CRC experience worse survival after hepatic resection. Sidedness is a simple yet effective factor to predict outcome.	[Gasser, Elisabeth; Braunwarth, Eva; Cardini, Benno; Fadinger, Nikolaus; Schneeberger, Stefan; Oefner, Dietmar; Staettner, Stefan; Primavesi, Florian] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Riedmann, Marina; Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Presl, Jaroslav; Oefner, Dietmar; Dinnewitzer, Adam; Staettner, Stefan; Primavesi, Florian] Paracelsus Med Univ, Dept Surg, Salzburg, Austria; [Klieser, Eckhard] Paracelsus Med Univ, Inst Pathol, Salzburg, Austria; [Ellmerer, Philipp] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Dupre, Aurelien; Malik, Hassan] Aintree Univ Hosp NHS Fdn Trust, Liverpool Hepatobiliary Ctr, Liverpool, Merseyside, England; [Dupre, Aurelien] Ctr Leon Berard, Dept Surg Oncol, Lyon, France; [Imai, Katsunori; Baba, Hideo] Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan	Medical University of Innsbruck; Medical University of Innsbruck; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Innsbruck; Aintree University Hospitals NHS Foundation Trust; UNICANCER; Centre Leon Berard; Kumamoto University	Primavesi, F (corresponding author), Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria.; Primavesi, F (corresponding author), Paracelsus Med Univ, Dept Surg, Salzburg, Austria.	florian.primavesi@tirol-kliniken.at	Ulmer, Hanno/S-6615-2019; Stättner, Stefan/F-7470-2016; Primavesi, Florian/ABG-7924-2020; Primavesi, Florian/AAF-9645-2019; dupré, aurélien/J-4027-2019	Ulmer, Hanno/0000-0001-5911-1002; Stättner, Stefan/0000-0002-5226-7597; Primavesi, Florian/0000-0003-2707-6307; dupré, aurélien/0000-0002-5216-538X; Presl, Jaroslav/0000-0002-2899-6706; /0000-0001-7043-2309				Adair RA, 2012, BRIT J SURG, V99, P1278, DOI 10.1002/bjs.8845; Arnold D, 2017, ANN ONCOL, V28, P1713, DOI 10.1093/annonc/mdx175; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Braunwarth E, 2019, EJSO-EUR J SURG ONC, V45, P1077, DOI 10.1016/j.ejso.2019.02.021; Brudvik KW, 2019, ANN SURG, V269, P120, DOI 10.1097/SLA.0000000000002319; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Creasy JM, 2018, ANN SURG ONCOL, V25, P431, DOI 10.1245/s10434-017-6264-x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dupre A, 2018, EJSO-EUR J SURG ONC, V44, P80, DOI 10.1016/j.ejso.2017.10.218; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evrard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114404; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Gallois C, 2016, CRIT REV ONCOL HEMAT, V99, P74, DOI 10.1016/j.critrevonc.2015.11.001; Gallois C, 2018, DRUGS, V78, P789, DOI 10.1007/s40265-018-0921-7; Gasteiger L, 2018, EUR SURG, V50, P81, DOI 10.1007/s10353-018-0522-4; GOTO Y, 2018, J CLIN ONCOL S, V36; Hackl C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-810; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holch JW, 2017, EUR J CANCER, V70, P87, DOI 10.1016/j.ejca.2016.10.007; Imai K, 2019, HPB, V21, P405, DOI 10.1016/j.hpb.2018.08.012; Kamarudin AN, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0332-6; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; LEEYING RM, 2017, J CLIN ONCOL S, V35; Malvezzi M, 2018, ANN ONCOL, V29, P1016, DOI 10.1093/annonc/mdy033; Margonis GA, 2018, BRIT J SURG, V105, P1210, DOI 10.1002/bjs.10838; Margonis GA, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2018.0996; Marques MC, 2018, J SURG ONCOL, V117, P858, DOI 10.1002/jso.25048; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nitsche U, 2016, DIGEST SURG, V33, P157, DOI 10.1159/000443644; Price TJ, 2015, CANCER-AM CANCER SOC, V121, P830, DOI 10.1002/cncr.29129; Primavesi F, 2019, CANCERS, V11, DOI 10.3390/cancers11020218; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Rocha FG, 2012, HPB, V14, P283, DOI 10.1111/j.1477-2574.2012.00451.x; ROTHBERG PG, 1985, BRIT J CANCER, V52, P629, DOI 10.1038/bjc.1985.237; Sanz-Pamplona R, 2011, CLIN CANCER RES, V17, P7303, DOI 10.1158/1078-0432.CCR-11-1570; Sasaki K, 2016, ANN SURG ONCOL, V23, P3736, DOI 10.1245/s10434-016-5361-6; Sasaki R, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00030; Schmidt T, 2018, EJSO-EUR J SURG ONC, V44, P1610, DOI 10.1016/j.ejso.2018.07.051; Shen H, 2015, WORLD J GASTROENTERO, V21, P6470, DOI 10.3748/wjg.v21.i21.6470; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Stattner S, 2015, SURG TODAY, V45, P407, DOI 10.1007/s00595-014-0879-3; Starlinger P, 2018, HEPATOLOGY, V67, P1516, DOI 10.1002/hep.29651; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Voron T, 2019, J GASTROINTEST SURG, V23, P339, DOI 10.1007/s11605-018-3891-x; Wang K, 2018, EJSO-EUR J SURG ONC, V44, P771, DOI 10.1016/j.ejso.2018.02.210; Yahagi M, 2016, J GASTROINTEST SURG, V20, P648, DOI 10.1007/s11605-015-3026-6; Yamashita S, 2018, BRIT J SURG, V105, P618, DOI 10.1002/bjs.10834; Yamashita S, 2018, ANN SURG, V267, P514, DOI 10.1097/SLA.0000000000002087; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	57	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217411	10.1371/journal.pone.0217411	http://dx.doi.org/10.1371/journal.pone.0217411			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150437	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100045
J	Kim, WJ; Hur, KY; Park, HW; Lee, SW; Yoo, JY				Kim, Woo-Jong; Hur, Kye-Yeon; Park, Han Wook; Lee, Seung-Woo; Yoo, Joo-Yeon			Pathogenicity of the H1N1 influenza virus enhanced by functional synergy between the NPV100I and NA(D248N) pair	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEOPROTEIN; COVARIATION; HOST; COEVOLUTION; EMERGENCE; PROTEIN	By comparing and measuring covariations of viral protein sequences from isolates of the 2009 pH1N1 influenza A virus (IAV), specific substitutions that co-occur in the NP-NA pair were identified. To investigate the effect of these co-occurring substitution pairs, the V100I substitution in NP and the D248N substitution in NA were introduced into laboratory-adapted WSN IAVs. The recombinant WSN with the covarying NPV100I-NA(D248N) pair exhibited enhanced pathogenicity, as characterized by increased viral production, increased death and inflammation of host cells, and high mortality in infected mice. Although direct interactions between the NPV100I and NA(D248N) proteins were not detected, the RNA-binding ability of NPV100I was increased, which was further strengthened by NA D248N, in expression-plas-mid-transfected cells. Additionally, the NA D248N protein was frequently recruited within lipid rafts, indirectly affecting the RNA-binding ability of NP as well as viral release. Altogether, our data indicate that the covarying NPV100I-NA(D248N) pair obtained from 2009 pH1N1 IAV sequence information function together to synergistically augment viral assembly and release, which may explain the observed enhanced viral pathogenicity.	[Kim, Woo-Jong; Hur, Kye-Yeon; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Park, Han Wook; Lee, Seung-Woo] Pohang Univ Sci & Technol POSTECH, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Lee, Seung-Woo; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Organelle Network Res Ctr, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.; Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Organelle Network Res Ctr, Pohang, South Korea.	jyoo@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [NRF-2015R1A2A1A10054957, NRF-2017R1A5A1015366, NRF-2015R1A2A1A100549 57, NRF-2017R1A 5A1015366, NRF-2017R1A5A10153 66]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (NO. NRF-2015R1A2A1A10054957 and NRF-2017R1A5A1015366), Grant number to each author, W.-J. Kim (NO. NRF-2015R1A2A1A100549 57 and NRF-2017R1A5A1015366), J.-Y. Yoo (NO. NRF-2015R1A2A1A10054957 and NRF-2017R1A 5A1015366), H. W. Park (NRF-2017R1A5A10153 66), S.-W. Lee (NRF-2017R1A5A1015366).	Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Brooke CB, 2014, P NATL ACAD SCI USA, V111, P16854, DOI 10.1073/pnas.1415396111; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Clark NL, 2012, GENOME RES, V22, P714, DOI 10.1101/gr.132647.111; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cotter CR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003831; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Jo JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6433; Liang XZ, 2002, J VIROL, V76, P12320, DOI 10.1128/JVI.76.23.12320-12324.2002; Nagata Kyosuke, 1990, J BIOL CHEM, V265; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohkura T, 2014, J VIROL, V88, P10039, DOI 10.1128/JVI.00586-14; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; Sharma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020215; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064439; Talavera D, 2015, MOL BIOL EVOL, V32, P2456, DOI 10.1093/molbev/msv109; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wolpert David H., 1993, P NATL ACAD SCI USA, V90, P5; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Yang S, 2009, NUCLEIC ACIDS RES, V37, pD423, DOI 10.1093/nar/gkn881; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhao ZZ, 2014, J VIROL, V88, P2260, DOI 10.1128/JVI.03024-13; Zhu WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033383	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217691	10.1371/journal.pone.0217691	http://dx.doi.org/10.1371/journal.pone.0217691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150476	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100088
J	Kos, S; Lopes, A; Preat, V; Cemazar, M; Tratar, UL; Ucakar, B; Vanvarenberg, K; Sersa, G; Vandermeulen, G				Kos, Spela; Lopes, Alessandra; Preat, Veronique; Cemazar, Maja; Tratar, Ursa Lampreht; Ucakar, Bernard; Vanvarenberg, Kevin; Sersa, Gregor; Vandermeulen, Gaelle			Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma	PLOS ONE			English	Article							T-CELL RESPONSES; GENE ELECTROTRANSFER; MULTIELECTRODE ARRAY; CHECKPOINT BLOCKADE; VACCINES; SKIN; ELECTROPORATION; COMBINATION; DELIVERY; INHIBITOR	We aimed to explore whether the combination of intradermal DNA vaccination, to boost immune response against melanoma antigens, and immune checkpoint blockade, to alleviate immunosuppression, improves antitumor effectiveness in a murine B16F10 melanoma tumor model. Compared to single treatments, a combination of intradermal DNA vaccination (ovalbumin or gp100 plasmid adjuvanted with IL12 plasmid) and immune checkpoint CTLA-4/PD-1 blockade resulted in a significant delay in tumor growth and prolonged survival of treated mice. Strong activation of the immune response induced by combined treatment resulted in a significant antigen-specific immune response, with elevated production of antigen-specific IgG antibodies and increased intratumoral CD8(+) infiltration. These results indicate a potential application of the combined DNA vaccination and immune checkpoint blockade, specifically, to enhance the efficacy of DNA vaccines and to overcome the resistance to immune checkpoint inhibitors in certain cancer types.	[Kos, Spela; Cemazar, Maja; Tratar, Ursa Lampreht; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Lopes, Alessandra; Preat, Veronique; Ucakar, Bernard; Vanvarenberg, Kevin; Vandermeulen, Gaelle] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Sersa, Gregor] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia	Institute of Oncology - Slovenia; Universite Catholique Louvain; University of Primorska; University of Ljubljana	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Preat, V (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium.; Sersa, G (corresponding author), Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia.	veronique.preat@uclouvain.be; gsersa@onko-i.si	Cemazar, Maja/K-6182-2013	Cemazar, Maja/0000-0002-1418-1928; Sersa, Gregor/0000-0002-7641-5670	Universite Catholique de Louvain (Louvain Drug Research Institute); Institute of Oncology Ljubljana; state budget of the Slovenian Research Agency [P3-0003]; FIRST spin-off grant from the Walloon Region	Universite Catholique de Louvain (Louvain Drug Research Institute); Institute of Oncology Ljubljana; state budget of the Slovenian Research Agency; FIRST spin-off grant from the Walloon Region	The research is a result of an IL-EFIS Fellowship (European Federation of Immunological Societies), which supported the collaboration between Universite Catholique de Louvain (Louvain Drug Research Institute) and Institute of Oncology Ljubljana (S.K. received the award). The authors acknowledge financial support from the state budget of the Slovenian Research Agency (program no. P3-0003). G.V. is supported by a FIRST spin-off grant from the Walloon Region.; The research is a result of an IL-EFIS Fellowship (European Federation of Immunological Societies), which supported the collaboration between Universite Catholique de Louvain (Louvain Drug Research Institute) and Institute of Oncology Ljubljana. The authors acknowledge financial support from the state budget of the Slovenian Research Agency (program no. P3-0003). G.V. is supported by a FIRST spin-off grant from the Walloon Region. The authors acknowledge Thomas Michiels for providing the Cliniporator and AJE (American Journal Experts) for proofreading the paper.	Ali OA, 2016, CANCER IMMUNOL RES, V4, P95, DOI 10.1158/2326-6066.CIR-14-0126; Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5; Broderick KE, 2014, METHODS MOL BIOL, V1143, P123, DOI 10.1007/978-1-4939-0410-5_8; Cha E, 2012, HUM VACC IMMUNOTHER, V8, P1734, DOI 10.4161/hv.22573; Chiaruttini G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1294296; Cross RS, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2014.29; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; De Geest BG, 2012, ANGEW CHEM INT EDIT, V51, P3862, DOI 10.1002/anie.201200048; Donate A, 2013, BIOELECTROCHEMISTRY, V94, P1, DOI 10.1016/j.bioelechem.2013.04.004; Donate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019181; Duperret EK, 2018, MOL THER, V26, P435, DOI 10.1016/j.ymthe.2017.11.010; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Gerlini G, 2012, ONCOIMMUNOLOGY, V1, P1655, DOI 10.4161/onci.21991; Gothelf A, 2010, CURR GENE THER, V10, P287, DOI 10.2174/156652310791823443; Gregor PD, 2004, VACCINE, V22, P1700, DOI 10.1016/j.vaccine.2003.10.048; Guo SQ, 2011, J CONTROL RELEASE, V151, P256, DOI 10.1016/j.jconrel.2011.01.014; Heller R, 2015, ADV GENET, V89, P235, DOI 10.1016/bs.adgen.2014.10.006; Heller R, 2010, HUM GENE THER, V21, P357, DOI 10.1089/hum.2009.065; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Karaki S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040037; Kleponis J, 2015, CANCER BIOL MED, V12, P201, DOI 10.7497/j.issn.2095-3941.2015.0046; Kos S, 2016, IFMBE P; Kos S, 2017, BIOELECTROCHEMISTRY, V114, P33, DOI 10.1016/j.bioelechem.2016.12.002; Kos S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.65; Lambricht L, 2016, MOL THER, V24, P1686, DOI 10.1038/mt.2016.122; Lambricht L, 2016, EXPERT OPIN DRUG DEL, V13, P295, DOI 10.1517/17425247.2016.1121990; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Loiacono L, 2017, MEDIAT INFLAMM, V2017, P1; Lopes A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33933-7; Lopes A, 2017, MOL THER-NUCL ACIDS, V8, P404, DOI 10.1016/j.omtn.2017.07.011; Lussier DM, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0067-z; Madan RA, 2012, ONCOIMMUNOLOGY, V1, P1167, DOI 10.4161/onci.20591; Marshall HT, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00315; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Mcarthur HL, 2016, CLIN ADV HEMATOL ONC, V14; Naderi Malihe, 2013, Virologica Sinica, V28, P167, DOI 10.1007/s12250-013-3291-z; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Rekoske BT, 2015, CANCER IMMUNOL RES, V3, P946, DOI 10.1158/2326-6066.CIR-14-0206; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Salvadori C, 2017, RADIOL ONCOL, V51, P286, DOI 10.1515/raon-2017-0035; Shi LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12335; Smith TRF, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.54; SPECTOR SA, 1982, AM J MED, V73, P36, DOI 10.1016/0002-9343(82)90060-2; Stathopoulos A, 2012, ONCOIMMUNOLOGY, V1, P298, DOI 10.4161/onci.19068; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Vandermeulen G, 2015, VACCINE, V33, P3179, DOI 10.1016/j.vaccine.2015.05.005; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217762	10.1371/journal.pone.0217762	http://dx.doi.org/10.1371/journal.pone.0217762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150505	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100100
J	Popovic, M; Timper, K; Seelig, E; Nordmann, T; Erlanger, TE; Donath, MY; Christ-Crain, M				Popovic, Milica; Timper, Katharina; Seelig, Eleonora; Nordmann, Thierry; Erlanger, Tobias E.; Donath, Marc Y.; Christ-Crain, Mirjam			Exercise upregulates copeptin levels which is not regulated by interleukin-1	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; FLUID BALANCE; RELEASE; PLASMA; INTENSITY; RESPONSES; AVP; ELECTROLYTE; BIOMARKERS; IL-1-BETA	Objective Studies have suggested that arginine vasopressin (AVP) and its surrogate marker copeptin increase during exercise, independently of serum sodium and/or osmolality. In extreme cases, this can lead to runners-induced hyponatremia. Interleukin-1 (IL-1) increases during exercise and induces AVP in animal models. We here therefore investigate whether copeptin (a surrogate marker for AVP) increases upon exercise in young and healthy males, and whether this increase is regulated by IL-1. Design In a randomized, placebo-controlled, double-blind, crossover trial in 17 healthy male volunteers, the effect of the IL-1 receptor antagonist anakinra on exercise-induced copeptin was compared with placebo. Methods Participants exercised for one hour at 75% of VO2max and were not allowed to drink/eat 6 hours before and during the study. Participants received either 100 mg of anakinra or placebo 1h before exercise. Blood was drawn at certain time intervals. Results In both groups, copeptin levels were induced by 2.5-fold upon exercise (p<0.001), from 4.5-10.6 pmol/l in the placebo, and 4.3-11.3 pmol/l in the anakinra group, (p = 0.38). One hour after exercise, copeptin levels dropped to 7.7 and 7.9 pmol/l in the placebo and anakinra group, respectively (p = 0.58). The increase of copeptin levels was not explained by sodium concentrations. Conclusions Exercise induces a continuous rise of plasma copeptin levels in healthy male volunteers independently of sodium levels and fluid intake. This increase is not regulated by the IL-1 pathway.	[Popovic, Milica; Timper, Katharina; Seelig, Eleonora; Nordmann, Thierry; Donath, Marc Y.; Christ-Crain, Mirjam] Univ Hosp Basel, Clin Endocrinol Diabetol & Metab, Basel, Switzerland; [Popovic, Milica; Erlanger, Tobias E.; Christ-Crain, Mirjam] Univ Basel, Med Fac, Dept Clin Res, Basel, Switzerland; [Timper, Katharina; Seelig, Eleonora; Nordmann, Thierry; Donath, Marc Y.] Univ Basel, Dept Biomed, Basel, Switzerland; [Erlanger, Tobias E.] Univ Hosp Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Christ-Crain, M (corresponding author), Univ Hosp Basel, Clin Endocrinol Diabetol & Metab, Basel, Switzerland.; Christ-Crain, M (corresponding author), Univ Basel, Med Fac, Dept Clin Res, Basel, Switzerland.	mirjam.christ-crain@usb.ch		Christ-Crain, Mirjam/0000-0002-6336-0965	Swiss National Science Foundation [SNF-162608]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This investigation was funded by a grant of the Swiss National Science Foundation to Prof. Mirjam Christ-Crain (SNF-162608).	Aakre KM, 2018, CLIN BIOCHEM, V52, P8, DOI 10.1016/j.clinbiochem.2017.10.007; BAYLIS PH, 1987, AM J PHYSIOL, V253, pR671, DOI 10.1152/ajpregu.1987.253.5.R671; Broessner G, 2015, RESUSCITATION, V89, P75, DOI 10.1016/j.resuscitation.2015.01.013; CANNON JG, 1983, SCIENCE, V220, P617, DOI 10.1126/science.6836306; Coiro V, 2011, J INVEST MED, V59, P599, DOI 10.2310/JIM.0b013e318209a5b3; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Fenske WK, 2018, J CLIN ENDOCR METAB, V103, P505, DOI 10.1210/jc.2017-01891; Fenske WK, 2014, J AM SOC NEPHROL, V25, P2376, DOI 10.1681/ASN.2013080895; FREUND BJ, 1991, J APPL PHYSIOL, V70, P900, DOI 10.1152/jappl.1991.70.2.900; Hew-Butler T, 2011, CLIN J SPORT MED, V21, P211, DOI 10.1097/JSM.0b013e31821a62c2; Hew-Butler T, 2010, SPORTS MED, V40, P459, DOI 10.2165/11532070-000000000-00000; Hew-Butler T, 2008, EUR J ENDOCRINOL, V159, P729, DOI 10.1530/EJE-08-0064; Inder WJ, 1998, J APPL PHYSIOL, V85, P835, DOI 10.1152/jappl.1998.85.3.835; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Kerbert AJC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138264; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Krogh J, 2013, J AFFECT DISORDERS, V151, P284, DOI 10.1016/j.jad.2013.06.007; Kruger S, 2010, AM J RESP CRIT CARE, V182, P1426, DOI 10.1164/rccm.201003-0415OC; Lippi G, 2015, J CLIN LAB ANAL, V29, P15, DOI 10.1002/jcla.21720; Maeder MT, 2010, CLIN CHEM, V56, P674, DOI 10.1373/clinchem.2009.136309; Maresh CM, 2004, J APPL PHYSIOL, V97, P39, DOI 10.1152/japplphysiol.00956.2003; Moldoveanu AI, 2000, J APPL PHYSIOL, V89, P1499, DOI 10.1152/jappl.2000.89.4.1499; NAKATSURU K, 1991, BRAIN RES, V554, P38, DOI 10.1016/0006-8993(91)90169-V; Nickel NP, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-130; Nordmann TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139662; RABER J, 1994, NEUROENDOCRINOLOGY, V59, P208, DOI 10.1159/000126661; Ristagno G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0831-y; Roy BD, 2001, HORM METAB RES, V33, P540, DOI 10.1055/s-2001-17212; SCHRIER RW, 1980, YALE J BIOL MED, V53, P525; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; SHEPHARD RJ, 1994, INT J SPORTS MED, V15, pS154, DOI 10.1055/s-2007-1021131; Stacey MJ, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13851; Stacey MJ, 2018, EUR J APPL PHYSIOL, V118, P75, DOI 10.1007/s00421-017-3740-8; Staub D, 2009, CLIN CHIM ACTA, V399, P69, DOI 10.1016/j.cca.2008.09.016; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Takamata A, 2000, AM J PHYSIOL-REG I, V279, pR161, DOI 10.1152/ajpregu.2000.279.1.R161; WADE CE, 1980, J APPL PHYSIOL, V49, P930, DOI 10.1152/jappl.1980.49.6.930; WATANOBE H, 1993, NEUROENDOCRINOLOGY, V57, P593, DOI 10.1159/000126412; Zurek M, 2014, EUR J APPL PHYSIOL, V114, P815, DOI 10.1007/s00421-013-2815-4	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217800	10.1371/journal.pone.0217800	http://dx.doi.org/10.1371/journal.pone.0217800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150497	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100114
J	Sakurai, A; Ono, H; Ochi, A; Matsuura, M; Yoshimoto, S; Kishi, S; Murakami, T; Tominaga, T; Nagai, K; Abe, H; Doi, T				Sakurai, Akiko; Ono, Hiroyuki; Ochi, Arisa; Matsuura, Motokazu; Yoshimoto, Sakiya; Kishi, Seiji; Murakami, Taichi; Tominaga, Tatsuya; Nagai, Kojiro; Abe, Hideharu; Doi, Toshio			Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GLOMERULAR INJURY; EXPRESSION; PROTEIN; RECEPTOR; GENE; NEPHRIN; ALBUMIN; NUMBER; MICE	Diabetic nephropathy (DN) is among the most serious complications of diabetes mellitus, and often leads to end-stage renal disease ultimately requiring dialysis or renal transplantation. The loss of podocytes has been reported to have a role in the onset and progression of DN. Here, we addressed the activation mechanism of Smad3 signaling in podocytes. Expression of RII and activation of Smad3 were induced by AGE exposure (P<0.05). Reduction of the activation of RII-Smad3 signaling ameliorated podocyte injuries in Smad3-knockout diabetic mice. The bone morphogenetic protein 4 (BMP4) significantly regulated activation of RII-Smad3 signalings (P<0.05). Moreover, the epithelium-specific transcription factor, Elf3 was induced by AGE stimulation and, subsequently, upregulated RII expression in cultured podocytes. Induction of Elf3 and activation of RII-Smad3 signaling, leading to a decrease in WT1 expression, were observed in podocytes in diabetic human kidneys. Moreover, AGE treatment induced the secretion of Elf3-containing exosomes from cultured podocytes, which was dependent on the activation of the TGF-beta-Smad3 signaling pathway. In addition, exosomal Elf3 protein in urine could be measured only in urinary exosomes from patients with DN. The appearance of urinary exosomal Elf3 protein in patients with DN suggested the existence of irreversible injuries in podocytes. The rate of decline in the estimated Glomerular Filtration Rate (eGFR) after measurement of urinary exosomal Elf3 protein levels in patients with DN (R-2 = 0.7259) might be useful as an early non-invasive marker for podocyte injuries in DN.	[Sakurai, Akiko; Ono, Hiroyuki; Ochi, Arisa; Matsuura, Motokazu; Yoshimoto, Sakiya; Kishi, Seiji; Murakami, Taichi; Tominaga, Tatsuya; Nagai, Kojiro; Abe, Hideharu; Doi, Toshio] Tokushima Univ, Inst Biomed Sci, Dept Nephrol, Grad Sch, Tokushima, Japan	Tokushima University	Abe, H (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Nephrol, Grad Sch, Tokushima, Japan.	abeabe@tokushima-u.ac.jp			JSPS KAKENHI [18K08245, 18K07415]; AMED [JP17ek0310003]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED(Japan Agency for Medical Research and Development (AMED))	This research was supported by JSPS KAKENHI Grant Number 18K08245 (HA) and 18K07415 (AS) and in part by AMED under Grant Number JP17ek0310003 (HA). There was no additional external funding received for this study. Neither salaries for authors nor any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abe H, 2018, J MED INVESTIG, V65, P208, DOI 10.2152/jmi.65.208; Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Araki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31216; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; Chang J, 2000, ONCOGENE, V19, P151, DOI 10.1038/sj.onc.1203252; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Currie G, 2014, WORLD J DIABETES, V5, P763, DOI 10.4239/wjd.v5.i6.763; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Massague J, 2000, GENE DEV, V14, P627; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Ono H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28439-1; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Park SH, 2001, ONCOGENE, V20, P1235, DOI 10.1038/sj.onc.1204227; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sasaki S, 2016, CLIN EXP NEPHROL, V20, P450, DOI 10.1007/s10157-015-1176-1; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Sun YBY, 2015, KIDNEY INT, V88, P286, DOI 10.1038/ki.2015.121; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wang A, 2015, AM J PHYSIOL-RENAL, V293, pF1657; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Yoshida N, 2000, MECH DEVELOP, V97, P27, DOI 10.1016/S0925-4773(00)00419-6	31	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216788	10.1371/journal.pone.0216788	http://dx.doi.org/10.1371/journal.pone.0216788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150422	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100022
J	Wang, YY; Cao, S; Dong, Y; Xia, LX				Wang, Yueyue; Cao, Shen; Dong, Yan; Xia, Ling-Xiang			Hostile attribution bias and angry rumination: A longitudinal study of undergraduate students	PLOS ONE			English	Article							ANGER RUMINATION; TRAIT ANGER; BIG 5; AGGRESSION; MECHANISMS; PERSONALITY; VALIDATION; MODEL	Angry rumination and hostile attribution bias are important cognitive factors of aggression. Although prior theoretical models of aggression suggest that aggressive cognitive factors may influence each other, there are no studies examining the longitudinal relationship between angry rumination and hostile attribution bias. The present study used cross-lagged structural equation modeling to explore the longitudinal mutual relationship between hostile attribution bias and angry rumination; 941 undergraduate students (38.5% male) completed questionnaires assessing the variables at two time points. The results indicate that hostile attribution bias showed a small but statistically significant effect on angry rumination 6 months later, and angry rumination showed a quite small but marginally significant effect on hostile attribution bias across time. The present study supports the idea that hostile attribution bias influences angry rumination, and argue that the relationship between angry rumination and hostile attribution bias may be mutual. Additionally, the results suggest that there may be a causal relation of different aggression-related cognitive factors.	[Wang, Yueyue; Cao, Shen; Xia, Ling-Xiang] Southwest Univ, Res Ctr Psychol & Social Dev, Chongqing, Peoples R China; [Dong, Yan; Xia, Ling-Xiang] Renmin Univ China, Dept Psychol, Beijing, Peoples R China; [Dong, Yan; Xia, Ling-Xiang] Renmin Univ China, Lab Dept Psychol, Beijing, Peoples R China	Southwest University - China; Renmin University of China; Renmin University of China	Xia, LX (corresponding author), Southwest Univ, Res Ctr Psychol & Social Dev, Chongqing, Peoples R China.; Dong, Y; Xia, LX (corresponding author), Renmin Univ China, Dept Psychol, Beijing, Peoples R China.; Dong, Y; Xia, LX (corresponding author), Renmin Univ China, Lab Dept Psychol, Beijing, Peoples R China.	dong8958@126.com; xialx@swu.edu.cn	Dong, Yan/AAP-7903-2020	Xia, Lingxiang/0000-0003-4024-5312	fund for building world-class universities (disciplines) of Renmin University of China [RUCPSY0016]	fund for building world-class universities (disciplines) of Renmin University of China	This work was supported by the fund for building world-class universities (disciplines) of Renmin University of China (RUCPSY0016) to LX. There was no additional external funding received for this study.	Badra M, 2017, COGNITION EMOTION, V31, P1234, DOI 10.1080/02699931.2016.1193477; Brozovich F, 2008, CLIN PSYCHOL REV, V28, P891, DOI 10.1016/j.cpr.2008.01.002; Bushman BJ, 2005, J PERS SOC PSYCHOL, V88, P969, DOI 10.1037/0022-3514.88.6.969; Coccaro EF, 2009, J PSYCHIATR RES, V43, P915, DOI 10.1016/j.jpsychires.2009.01.012; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Denson TF, 2006, J PERS SOC PSYCHOL, V90, P1032, DOI 10.1037/0022-3514.90.6.1032; Denson TF, 2013, PERS SOC PSYCHOL REV, V17, P103, DOI 10.1177/1088868312467086; Denson TF, 2011, PERS SOC PSYCHOL B, V37, P850, DOI 10.1177/0146167211401420; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Fresnics A, 2017, MINDFULNESS, V8, P554, DOI 10.1007/s12671-016-0629-2; Gagnon J, 2016, INT J PSYCHOPHYSIOL, V110, P153, DOI 10.1016/j.ijpsycho.2016.08.007; Garcia-Sancho E, 2016, PERS INDIV DIFFER, V89, P143, DOI 10.1016/j.paid.2015.10.007; Hertel P, 2014, CLIN PSYCHOL SCI, V2, P714, DOI 10.1177/2167702614529111; Kline R.B, 2011, J AM STAT ASSOC, P101, DOI DOI 10.1002/0470013192.BSA655; Kokkinos CM, 2017, J APPL DEV PSYCHOL, V52, P101, DOI 10.1016/j.appdev.2017.07.007; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; [罗亚莉 Luo Yali], 2017, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V25, P667; MacKenzie SB, 2001, J CONSUM RES, V28, P159, DOI 10.1086/321954; Major DA, 2006, J APPL PSYCHOL, V91, P927, DOI 10.1037/0021-9010.91.4.927; Mor N, 2014, J BEHAV THER EXP PSY, V45, P67, DOI 10.1016/j.jbtep.2013.08.002; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Pedrero EF, 2012, STRUCTURAL EQUATION, P73; Peled M, 2010, J PSYCHOPATHOL BEHAV, V32, P108, DOI 10.1007/s10862-009-9136-2; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Quan FY, 2019, PERS INDIV DIFFER, V139, P228, DOI 10.1016/j.paid.2018.11.029; Robinson MD, 1998, COGNITION EMOTION, V12, P667, DOI 10.1080/026999398379493; Sukhodolsky DG, 2001, PERS INDIV DIFFER, V31, P689, DOI 10.1016/S0191-8869(00)00171-9; Turner KA, 2015, PERS INDIV DIFFER, V82, P199, DOI 10.1016/j.paid.2015.03.023; Wang YY, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00526; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Wilkowski BM, 2008, PERS SOC PSYCHOL REV, V12, P3, DOI 10.1177/1088868307309874; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x; Wothke W, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P219; Yeager DS, 2013, CHILD DEV, V84, P1651, DOI 10.1111/cdev.12062	34	11	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217759	10.1371/journal.pone.0217759	http://dx.doi.org/10.1371/journal.pone.0217759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150488	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100099
J	Saleh, ME; Gadalla, R; Hassan, H; Afifi, A; Gotte, M; El-Shinawi, M; Mohamed, MM; Ibrahim, SA				Saleh, Moshira Ezzat; Gadalla, Ramy; Hassan, Hebatallah; Afifi, Ahmed; Goette, Martin; El-Shinawi, Mohamed; Mohamed, Mona Mostafa; Ibrahim, Sherif Abdelaziz			The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients	PLOS ONE			English	Article							LATENT TGF-BETA; SULFATE BINDING; TH17 CELLS; PROMOTES; EXPRESSION; ACTIVATION; CARCINOMA; IL-17; DIFFERENTIATION; PROTEOGLYCAN	Herein, we aimed to identify the immunomodulatory role of tumor Syndecan-1 (CD138) in the polarization of CD4(+) T helper (Th) subsets isolated from the tumor microenvironment of inflammatory breast cancer (IBC) and non-IBC patients. Lymphocytes and mononuclear cells isolated from the axillary tributaries of non-IBC and IBC patients during modified radical mastectomy were either stimulated with the secretome as indirect co-culture or directly co-cultured with control and Syndecan-1-silenced SUM-149 IBC cells. In addition, peripheral blood mononuclear cells (PBMCs) of normal subjects were used for the direct co-culture. Employing flow cytometry, we analyzed the expression of the intracellular IFN-gamma, IL-4, IL-17, and Foxp3 markers as readout for basal and co-cultured Th-1, Th-2, Th-17, and T-reg CD4(+) subsets, respectively. Our data revealed that IBC displayed a lower basal frequency of Th1 and Th-2 subsets than non-IBC. Syndecan-1-silenced SUM-149 cells significantly upregulated only T-reg subset polarization of normal subjects relative to controls. However, Syndecan-1 silencing significantly enhanced the polarization of Th-17 and T-reg subsets of non-IBC under both direct and indirect conditions and induced only Th1 subset polarization under indirect conditions compared to control. Interestingly, qPCR revealed that there was a negative correlation between Syndecan-1 and each of IL-4, IL-17, and Foxp3 mRNA expression in carcinoma tissues of IBC and that the correlation was reversed in non-IBC. Mechanistically, Syndecan-1 knockdown in SUM-149 cells promoted Th17 cell expansion via upregulation of IL-23 and the Notch ligand DLL4. Overall, this study indicates a low frequency of the circulating antitumor Th1 subset in IBC and suggests that tumor Syndecan-1 silencing enhances ex vivo polarization of CD4(+) Th-17 and T-reg cells of non-IBC, whereby Th17 polarization is possibly mediated via upregulation of IL-23 and DLL4. These findings suggest the immunoregulatory role of tumor Syndecan-1 expression in Th cell polarization that may have therapeutic implications for breast cancer.	[Saleh, Moshira Ezzat; Gadalla, Ramy; Hassan, Hebatallah; Afifi, Ahmed; Mohamed, Mona Mostafa; Ibrahim, Sherif Abdelaziz] Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt; [Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany; [El-Shinawi, Mohamed] Ain Shams Univ, Fac Med, Dept Gen Surg, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; University of Munster; Egyptian Knowledge Bank (EKB); Ain Shams University	Ibrahim, SA (corresponding author), Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt.	isherif@sci.cu.edu.eg	Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; El-Shinawi, Mohamed/0000-0003-3645-2343; Ibrahim, Sherif Abdelaziz/0000-0001-6403-7345	Science and Technology Development Funds (STDF), Egypt [6309]; German Academic Exchange Service (DAAD) [56808461]; H2020 Marie Sklodowska-Curie Actions [645756]	Science and Technology Development Funds (STDF), Egypt(Science and Technology Development Fund (STDF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); H2020 Marie Sklodowska-Curie Actions	This work was supported by Science and Technology Development Funds (STDF), Egypt, Reintegration project ID#6309 (to SAI and HH), German Academic Exchange Service (DAAD) #56808461 Al Tawasul (to SAI and MG), and H2020 Marie Sklodowska-Curie Actions #645756 (to MG and SAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Al Absi A, 2018, CANCER RES, V78, P5631, DOI 10.1158/0008-5472.CAN-18-0441; Baba F, 2006, BREAST CANCER RES TR, V98, P91, DOI 10.1007/s10549-005-9135-2; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen Q, 2007, J BIOL CHEM, V282, P26418, DOI 10.1074/jbc.M703341200; Cochaud S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03456; Coutaz M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39117; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Dai H, 2015, EUR J IMMUNOL, V45, P3045, DOI 10.1002/eji.201545532; DAUBENER W, 1995, EUR J IMMUNOL, V25, P688, DOI 10.1002/eji.1830250309; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; El-Shinawi M, 2010, ANN SURG ONCOL, V17, P2677, DOI 10.1245/s10434-010-1029-9; Fluhr H, 2011, FERTIL STERIL, V95, P1272, DOI 10.1016/j.fertnstert.2010.04.061; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gao ZM, 2012, INT J CLIN EXP PATHO, V5, P626; Gong GQ, 2017, J HUAZHONG U SCI-MED, V37, P412, DOI 10.1007/s11596-017-1749-1; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hassan H, 2013, FEBS J, V280, P2216, DOI 10.1111/febs.12111; Heijink IH, 2002, IMMUNOLOGY, V107, P316, DOI 10.1046/j.1365-2567.2002.01501.x; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; Ibrahim AS, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/437971; Ibrahim SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085737; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Ibrahim SA, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0621-z; Jiang XG, 2014, MOL CELL ENDOCRINOL, V382, P673, DOI 10.1016/j.mce.2013.06.003; Kaminska K, 2015, J CELL MOL MED, V19, P283, DOI 10.1111/jcmm.12408; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Li J, 2017, ONCOTARGET, V8, P66656, DOI 10.18632/oncotarget.19105; Lim B, 2018, NAT REV CANCER, V18, P485, DOI 10.1038/s41568-018-0010-y; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Regos E, 2018, MATRIX BIOL, V68-69, P474, DOI 10.1016/j.matbio.2018.02.008; Ren Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0758-4; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rider CC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050713; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; Shiao SL, 2015, CANCER IMMUNOL RES, V3, P518, DOI 10.1158/2326-6066.CIR-14-0232; Smeets RL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-12; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tindemans I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00419; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; Welte T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/804347; Xiao J, 2011, ARTERIOSCL THROM VAS, V31, P2261, DOI 10.1161/ATVBAHA.111.229609; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	66	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217550	10.1371/journal.pone.0217550	http://dx.doi.org/10.1371/journal.pone.0217550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145753	Green Submitted, Green Published, gold			2022-12-27	WOS:000469425500021
J	del-Pino-Casado, R; Cardosa, MR; Lopez-Martinez, C; Orgeta, V				del-Pino-Casado, Rafael; Rodriguez Cardosa, Marta; Lopez-Martinez, Catalina; Orgeta, Vasiliki			The association between subjective caregiver burden and depressive symptoms in carers of older relatives: A systematic review and meta-analysis	PLOS ONE			English	Review							QUALITY-OF-LIFE; FAMILY CAREGIVERS; ALZHEIMER-DISEASE; SELF-EFFICACY; PSYCHOLOGICAL SYMPTOMS; INFORMAL CAREGIVERS; DEMENTIA CAREGIVERS; PERCEIVED BURDEN; ANXIETY; STROKE	Background Family carers are an important source of care for older people. Although several studies have reported that subjective caregiver burden is related to depressive symptoms there are no systematic reviews quantifying this association. Objective To establish the extent to which subjective caregiver burden is associated with depressive symptoms and whether this association would vary by study or care characteristics. Methods We searched major databases such as PubMed, CINAHL, PsycINFO, Scopus and ISI Proceedings up to March 2018, and conducted a meta-analysis of included studies. Summary estimates of the association were obtained using a random-effects model to improve generalisation of findings. Results After screening of 4,688 articles, 55 studies were included providing a total of 56 independent comparisons with a total of 9,847 carers from data across 20 countries. There was a large, positive association between subjective caregiver burden and depressive symptoms ((r) over bar = 0.514; 95% CI = 0.486, 0.541), with very low heterogeneity amongst individual studies (I-2 = 8.6%). Sensitivity analyses showed no differences between cross-sectional or repeated measures ((r) over bar = 0.521; 95% CI = 0.491, 0.550; 51 samples) and longitudinal studies ((r) over bar = 0.454; 95% CI = 0.398, 0.508; 6 samples). We found a higher effect size for those caring for people living with dementia compared to those caring for frail older people, and stroke survivors. Carer sex, age and kinship did not change the estimate of the effect. Conclusions Subjective caregiver burden is a significant risk factor for depressive symptoms in carers of older people and may precipitate clinical depression. Those caring for people with dementia experience greater burden. There is a need for longitudinal evaluations examining the effects of potential mediators of the association of subjective burden and depressive symptoms. Future interventions should test whether minimizing subjective burden may modify the risk of developing depression in carers of older relatives.	[del-Pino-Casado, Rafael; Rodriguez Cardosa, Marta; Lopez-Martinez, Catalina] Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain; [Orgeta, Vasiliki] UCL, Fac Brain Sci, Div Psychiat, London, England	Universidad de Jaen; University of London; University College London	del-Pino-Casado, R (corresponding author), Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain.	rdelpino@ujaen.es	López-Martínez, Catalina/HCI-9665-2022; del-Pino-Casado, Rafael/L-3733-2018	López-Martínez, Catalina/0000-0003-1303-7593; del-Pino-Casado, Rafael/0000-0003-2263-2415; Orgeta, Vasiliki/0000-0001-8643-5061				Alspaugh MEL, 1999, PSYCHOL AGING, V14, P34, DOI 10.1037/0882-7974.14.1.34; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Aneshensel C. S., 1995, PROFILES CAREGIVING; Ar Y, 2017, THESIS; Bachner YG, 2016, J AM PSYCHIAT NURSES, V22, P27, DOI 10.1177/1078390316629959; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Betts Adams K., 2008, DEMENTIA-LONDON, V7, P301, DOI DOI 10.1177/1471301208093286; Bianchi M, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.1379.2835; Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Borenstein M., 2009, INTRO METAANALYSIS, P45, DOI DOI 10.1002/9780470743386.CH7; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; Brandao D, 2017, SCAND J CARING SCI, V31, P984, DOI 10.1111/scs.12423; Byun E, 2013, THESIS; Carter JH, 2008, MOVEMENT DISORD, V23, P1211, DOI 10.1002/mds.21686; Cheng ST, 2013, AM J GERIAT PSYCHIAT, V21, P1029, DOI 10.1016/j.jagp.2013.01.041; Chow EOW, 2012, AGING MENT HEALTH, V16, P1016, DOI 10.1080/13607863.2012.692769; Clark MC, 2013, BIOL RES NURS, V15, P112, DOI 10.1177/1099800411414872; Clyburn LD, 2000, J GERONTOL B-PSYCHOL, V55, pS2, DOI 10.1093/geronb/55.1.s2; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper C, 2008, INT PSYCHOGERIATR, V20, P494, DOI 10.1017/S104161020700645X; Cooper H. M., 2009, HDB RES SYNTHESIS ME; Corazza Danilla I, 2014, Rev Esp Geriatr Gerontol, V49, P173, DOI 10.1016/j.regg.2014.03.007; D'Aoust RF, 2015, INT J OLDER PEOPLE N, V10, P14, DOI 10.1111/opn.12043; del-Pino-Casado R, 2019, J AFFECT DISORDERS, V242, P14, DOI 10.1016/j.jad.2018.08.002; del-Pino-Casado R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189874; del-Pino-Casado R, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0667-1; Del-Pino-Casado R, 2015, RES NURS HEALTH, V38, P384, DOI 10.1002/nur.21671; del-Pino-Casado R, 2011, J ADV NURS, V67, P2311, DOI 10.1111/j.1365-2648.2011.05725.x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Diehl-Schmid J, 2013, J GERIATR PSYCH NEUR, V26, P221, DOI 10.1177/0891988713498467; Domingues NS, 2018, AM J ALZHEIMERS DIS, V33, P401, DOI 10.1177/1533317518788151; dos Santos GD, 2017, PSYCHOGERIATRICS, V17, P317, DOI 10.1111/psyg.12241; DRINKA TJK, 1987, J AM GERIATR SOC, V35, P522, DOI 10.1111/j.1532-5415.1987.tb01398.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edelstein OE, 2018, AGING MENT HEALTH, V22, P639, DOI 10.1080/13607863.2017.1289363; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feast A, 2016, INT PSYCHOGERIATR, V28, P1761, DOI 10.1017/S1041610216000922; Gallagher D, 2011, AGING MENT HEALTH, V15, P663, DOI 10.1080/13607863.2011.562179; Geng HM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011863; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gonzalez-Abraldes I, 2013, ARCH GERONTOL GERIAT, V56, P91, DOI 10.1016/j.archger.2012.07.011; Graf R, 2017, TOP STROKE REHABIL, V24, P488, DOI 10.1080/10749357.2017.1338371; Grano C, 2017, INT PSYCHOGERIATR, V29, P1095, DOI 10.1017/S1041610217000059; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Heo GJ, 2013, J APPL GERONTOL, V32, P582, DOI 10.1177/0733464811433484; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hirschman KB, 2004, J AM GERIATR SOC, V52, P1724, DOI 10.1111/j.1532-5415.2004.52468.x; Jaracz K, 2012, NEUROL NEUROCHIR POL, V46, P224, DOI 10.5114/ninp.2012.29130; Jones SBW, 2015, J PSYCHOSOC ONCOL, V33, P178, DOI 10.1080/07347332.2014.1002657; Karabekiroglu A, 2018, SINGAP MED J, V59, P572, DOI 10.11622/smedj.2018066; Khalaila R, 2011, AGING MENT HEALTH, V15, P679, DOI 10.1080/13607863.2011.569479; Kim SK, 2017, INT PSYCHOGERIATR, V29, P227, DOI 10.1017/S1041610216001770; Kowalska J, 2017, AM J ALZHEIMERS DIS, V32, P509, DOI 10.1177/1533317517734350; Kruithof WJ, 2016, PATIENT EDUC COUNS, V99, P1632, DOI 10.1016/j.pec.2016.04.007; Lacey RE, 2019, PSYCHOL MED, V49, P1652, DOI 10.1017/S0033291718002222; Lai DWL, 2009, SOC WORK HEALTH CARE, V48, P432, DOI 10.1080/00981380802591759; LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181; Lazarus R., 1987, STRESS APPRAISAL COP, V1, P141, DOI https://doi.org/10.1002/per.2410010304; Li CY, 2013, AGING MENT HEALTH, V17, P924, DOI 10.1080/13607863.2013.814098; Liu HY, 2017, J ADV NURS, V73, P2962, DOI 10.1111/jan.13379; Liu J, 2012, ARCH GERONTOL GERIAT, V55, P560, DOI 10.1016/j.archger.2012.05.014; Loh AZ, 2017, J AM MED DIR ASSOC, V18, P111, DOI 10.1016/j.jamda.2016.08.014; Lopez-Martinez C, 2019, GAC SANIT, V33, P185, DOI 10.1016/j.gaceta.2017.09.005; Luther K, 2014, THESIS; Mausbach BT, 2012, AGING MENT HEALTH, V16, P27, DOI 10.1080/13607863.2011.615738; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Meader N, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-82; Medrano Martin, 2014, Dement. neuropsychol., V8, P384, DOI 10.1590/S1980-57642014DN84000013; Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morlett Paredes A, 2014, THESIS; OECD, 2017, HLTH GLANC 2017 OECD; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Parker LD, 2007, THESIS; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Powers SM, 2014, THESIS; Raveis VH, 1998, CANCER, V83, P1652, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1652::AID-CNCR22>3.0.CO;2-Q; Roche L, 2015, J GERIATR PSYCH NEUR, V28, P218, DOI 10.1177/0891988715588830; Roe B, 2007, REVIEWING RESEARCH EVIDENCE FOR NURSING PRACTICE: SYSTEMATIC REVIEWS, P9, DOI 10.1002/9780470692127.ch2; Romero-Moreno R, 2011, AGING MENT HEALTH, V15, P221, DOI 10.1080/13607863.2010.505231; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schoenmakers B, 2010, MATURITAS, V66, P191, DOI 10.1016/j.maturitas.2010.02.009; Sherwood PR, 2005, J AGING HEALTH, V17, P125, DOI 10.1177/0898264304274179; Shurgot G.S.R., 2005, HISPANIC HEALTHCARE, V3, P37; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutter M, 2016, J TRANSCULT NURS, V27, P376, DOI 10.1177/1043659615573081; van der Lee J, 2014, AGEING RES REV, V15, P76, DOI 10.1016/j.arr.2014.03.003; Viswanathan M, 2013, AHRQ METHODS EFFECTI; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wang W., 2017, J TEXTURE STUD, V10, P1111, DOI DOI 10.1161/CIRC0UTC0MES.116.003160; Watson B, 2018, GERONTOLOGIST; Williams F, 2019, AGING MENT HEALTH, V23, P1629, DOI 10.1080/13607863.2018.1515886; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zhu W, 2018, J STROKE CEREBROVASC, V27, P3636, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.037	99	62	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217648	10.1371/journal.pone.0217648	http://dx.doi.org/10.1371/journal.pone.0217648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141556	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000073
J	Ku, A; Ravi, N; Yang, MJ; Evander, M; Laurell, T; Lilja, H; Ceder, Y				Ku, Anson; Ravi, Naveen; Yang, Minjun; Evander, Mikael; Laurell, Thomas; Lilja, Hans; Ceder, Yvonne			A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing	PLOS ONE			English	Article							BIASES; IDENTIFICATION	Development of a robust automated platform for enrichment of extracellular vesicles from low sample volume that matches the needs for next-generation sequencing could remove major hurdles for genomic biomarker discovery. Here, we document a protocol for urinary EVs enrichment by utilizing an automated microfluidic system, termed acoustic trap, followed by next-generation sequencing of microRNAs (miRNAs) for biomarker discovery. Specifically, we compared the sequencing output from two small RNA library preparations, NEXTFlex and CATS, using only 130 pg of input total RNA. The samples prepared using NEXTflex was found to contain larger number of unique miRNAs that was the predominant RNA species whereas rRNA was the dominant RNA species in CATS prepared samples. A strong correlation was found between the miRNA expressions of the acoustic trap technical replicate in the NEXTFlex prepared samples, as well as between the acoustic trap and ultracentrifugation enrichment methods. Together, these results demonstrate a robust and automated strategy for biomarker discovery from small volumes of urine.	[Ku, Anson; Lilja, Hans] Lund Univ, Dept Translat Med, Malmo, Sweden; [Ravi, Naveen; Yang, Minjun] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden; [Evander, Mikael; Laurell, Thomas] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Ceder, Yvonne] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Ku, Anson] Lund Univ, Dept Lab Med, Lund, Sweden	Lund University; Lund University; Lund University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Lund University; Lund University	Ku, A (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.; Ku, A (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	anson.ku@med.lu.se	Yang, Minjun/AGJ-3201-2022; Lilja, Hans/S-9703-2019; Evander, Mikael/B-6327-2012	Lilja, Hans/0000-0001-5871-7846; ravi, naveen/0000-0002-3849-8487; Yang, Minjun/0000-0002-3324-1498; Evander, Mikael/0000-0002-7572-931X; Ceder, Yvonne/0000-0002-8705-8293	National Institutes of Health/National Cancer Institute (NIH/NCI); Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center [P30 CA008748]; SPORE grant in Prostate Cancer [P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK; Swedish Cancer Society [CAN 2017/559]; Swedish Research Council [VR-MH] [2016-02974]; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA092629] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center; SPORE grant in Prostate Cancer; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK(National Institute for Health Research (NIHR)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council [VR-MH]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health/National Cancer Institute (NIH/NCI) with a Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center [P30 CA008748], a SPORE grant in Prostate Cancer to Dr. H. Scher [P50-CA92629], the Sidney Kimmel Center for Prostate and Urologic Cancers, David H. Koch through the Prostate Cancer Foundation. This work was also supported in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK, the Swedish Cancer Society [CAN 2017/559], and the Swedish Research Council [VR-MH project no. 2016-02974].	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Campbell JD, 2015, RNA, V21, P164, DOI 10.1261/rna.046060.114; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dard-Dascot C, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4491-6; Evander M, 2015, LAB CHIP, V15, P2588, DOI 10.1039/c5lc00290g; Gebert D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4031-9; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hammarstrom B, 2012, LAB CHIP, V12, P4296, DOI 10.1039/c2lc40697g; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Ku A, 2018, ANAL CHEM, V90, P8011, DOI 10.1021/acs.analchem.8b00914; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066883; Michell DL, 2016, BBA-MOL CELL BIOL L, V1861, P2069, DOI 10.1016/j.bbalip.2016.01.011; Musante L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00149; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Rezeli M, 2016, ANAL CHEM, V88, P8577, DOI 10.1021/acs.analchem.6b01694; Rodriguez M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0726-4; Royo F, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29497; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	23	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217507	10.1371/journal.pone.0217507	http://dx.doi.org/10.1371/journal.pone.0217507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141544	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000057
J	Shiao, SH; Weng, SC; Luan, LQ; Vicente, MDH; Jiang, XJ; Ng, DKP; Kolli, BK; Chang, KP				Shiao, Shin-Hong; Weng, Shih-Che; Luan, Liqiang; Vicente, Maria da Graca H.; Jiang, Xiong-Jie; Ng, Dennis K. P.; Kolli, Bala Krishna; Chang, Kwang Poo			Novel phthalocyanines activated by dim light for mosquito larva-and cell-inactivation with inference for their potential as broadspectrum photodynamic insecticides	PLOS ONE			English	Article							TRANSGENIC LEISHMANIA; CATIONIC PORPHYRIN; ALPHA-TERTHIENYL; PHOTOSENSITIZERS; TOXICITY; UROPORPHYRIA; PHOTOLYSIS; EFFICACY; THERAPY; VISION	Mosquitoes are significant vectors, responsible for transmitting serious infectious diseases, including the recent epidemics of global significance caused by, for example, Zika, Dengue and Chikungunya viruses. The chemical insecticides in use for mosquito control are toxic and ineffective due to the development of resistance to them. The new approach to reduce mosquito population by releasing genetically modified males to cause female infertility is still under environmental safety evaluation. Photodynamic insecticides (PDI) have long been known as a safe and effective alternative by using dyes as the photosensitizers (PS) for activation with light to generate insecticidal singlet oxygen and reactive oxygen species. This approach warrants re-examination with advances in the chemical synthesis of novel PS, e.g. phthalocyanines (PC). Nine PC were compared with five porphyrin derivatives and two classic PS of halogenated fluoresceins, i. e. cyanosine and rose bengal experimentally for photodynamic treatment (PDT) of the larvae of laboratory-reared Aedes mosquitoes and their cell lines. Groups of 2 nd instar larvae were first exposed overnight to graded concentrations of each PS in the dark followed by their exposure to dim light for up to 7 hours. Larvae of both experimental and control groups were examined hourly for viability based on their motility. Monolayers of mosquito cells were similarly PS-sensitized and exposed briefly to light at the PS-specific excitation wavelengths. Cell viability was assessed by MTT reduction assays. Of the 16 PS examined for photodynamic inactivation of the mosquito larvae, effective are three novel PC, i.e. amino-Si-PC1 and -PC2, anilinium Zn-PC3.4, pyridyloxy SiPC14 and two porphyrin derivatives, i.e. TPPS2 and TMAP. Their EC50 values were determined, all falling in the nanomolar range lower than those of rose bengal and cyanosine. All PS effective in vivo were also found to dose-dependently inactivate mosquito cells photodynamically in vitro, providing cellular basis for their larvicidal activities. The present findings of novel PC with effective photodynamic larvicidal activities provide fresh impetus to the development of PDI with their established advantages in safety and efficacy. Toward that end, the insect cell lines are of value for rapid screening of new PC. The optimal excitability of PC with insect-invisible red light is inferred to have the potential to broaden the range of targetable insect pests.	[Shiao, Shin-Hong; Weng, Shih-Che] Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan; [Luan, Liqiang; Vicente, Maria da Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Jiang, Xiong-Jie; Ng, Dennis K. P.] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China; [Kolli, Bala Krishna; Chang, Kwang Poo] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA	National Taiwan University; Louisiana State University System; Louisiana State University; Chinese University of Hong Kong; Chicago Medical School; Rosalind Franklin University Medical & Science	Shiao, SH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan.; Chang, KP (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA.	shshiao@ntu.edu.tw; kwangpoo.chang@rosalindfranklin.edu		Weng, Shih-Che/0000-0003-3315-9125; SHIAO, SHIN-HONG/0000-0002-7749-7807; Ng, Dennis/0000-0001-9087-960X	NIH/NIAID [AI097830, AI7712375, AI68835]; NIH [R01 CA179902]; NATIONAL CANCER INSTITUTE [R01CA179902] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH/NIAID Grant #AI097830, AI7712375, AI68835 to KPC/BKK; NIH Grant #R01 CA179902 to GHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2016, ANTIMICROB AGENTS CH, V60, P2003, DOI 10.1128/AAC.01879-15; Arikawa K, 2017, J PHYSIOL-LONDON, V595, P5457, DOI 10.1113/JP273917; Bayona AMD, 2017, CHEM BIOL DRUG DES, V89, P192, DOI 10.1111/cbdd.12792; Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2; Chang CH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006307; Chang KP, 2018, PROC SPIE, V10479, DOI 10.1117/12.2281437; Chang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1674-3; Dondji B, 2005, J MED ENTOMOL, V42, P652, DOI 10.1603/0022-2585(2005)042[0652:AOLAFA]2.0.CO;2; DOSDALL LM, 1992, J AM MOSQUITO CONTR, V8, P166; Dougherty TJ, 2002, PHOTOCHEM PHOTOBIOL, V76, P91, DOI 10.1562/0031-8655(2002)076<0091:TROTPB>2.0.CO;2; DUKE SO, 1994, ACS SYM SER, V559, P1; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P4474, DOI 10.1128/AAC.49.11.4474-4484.2005; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; Dutta S, 2012, EUKARYOT CELL, V11, P430, DOI 10.1128/EC.05202-11; Dutta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020786; FABRIS C, 2012, PHOTOCH PHOTOBIO SCI, V11, P294, DOI DOI 10.1039/C1PP05154G; Fabris C, 2012, ACTA TROP, V123, P239, DOI 10.1016/j.actatropica.2012.05.011; Futahashi R, 2016, CURR OPIN INSECT SCI, V17, P32, DOI 10.1016/j.cois.2016.05.014; Guo B, 2017, SLAS TECHNOL, V22, P557, DOI 10.1177/2472630317698633; HASSPIELER BM, 1988, J AM MOSQUITO CONTR, V4, P479; Heitz J.R., 1987, ACS SYM SER, P1; Heitz JR, 1995, ACS SYM SER, V616, P1; HEITZ JR, 1987, ACS SYM SER, V339, P1; Hung CH, 2008, CHEM COMMUN, P978, DOI 10.1039/b714412a; Iqbal Z, 2015, CURR DRUG METAB, V16, P816, DOI 10.2174/1389200217666151120165404; Jiang XJ, 2011, J MED CHEM, V54, P320, DOI 10.1021/jm101253v; JORI G, 1989, CIBA F SYMP, V146, P78; Jori G., 1984, TOPICS PHOTOMEDICINE, P183; Latham JR, 2017, BIOTECHNOL GENET ENG, V33, P62, DOI 10.1080/02648725.2017.1357295; Li HR, 2008, J MED CHEM, V51, P502, DOI 10.1021/jm070781f; Lucantoni L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001434; Lucht JM, 2015, VIRUSES-BASEL, V7, P4254, DOI 10.3390/v7082819; Mangan RL, 2001, J ECON ENTOMOL, V94, P150, DOI 10.1603/0022-0493-94.1.150; NIVSARKAR M, 1991, ARCH INSECT BIOCHEM, V16, P249, DOI 10.1002/arch.940160404; Pavlidi N, 2018, CURR OPIN INSECT SCI, V27, P97, DOI 10.1016/j.cois.2018.04.007; REBEIZ CA, 1995, CRIT REV PLANT SCI, V14, P329, DOI 10.1080/07352689509382363; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7; Song RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42058; SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x; Thomas AP, 2012, J MED CHEM, V55, P5110, DOI 10.1021/jm300009q; Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x; Weng SC, 2015, INSECT BIOCHEM MOLEC, V61, P17, DOI 10.1016/j.ibmb.2015.03.010; Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156	44	9	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217355	10.1371/journal.pone.0217355	http://dx.doi.org/10.1371/journal.pone.0217355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141567	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000053
J	Li, X; Sivaganesan, M; Kelty, CA; Zimmer-Faust, A; Clinton, P; Reichman, JR; Johnson, Y; Matthews, W; Bailey, S; Shanks, OC				Li, Xiang; Sivaganesan, Mano; Kelty, Catherine A.; Zimmer-Faust, Amity; Clinton, Pat; Reichman, Jay R.; Johnson, York; Matthews, William; Bailey, Stephanie; Shanks, Orin C.			Large-scale implementation of standardized quantitative real-time PCR fecal source identification procedures in the Tillamook Bay Watershed	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTEROIDALES GENETIC-MARKERS; BACTERIAL PATHOGENS; POLLUTION; CONTAMINATION; ASSAYS; INDICATORS; SEWAGE; PERFORMANCE; WATERFOWL	Fecal pollution management remains one of the biggest challenges for water quality authorities worldwide. Advanced fecal pollution source identification technologies are now available that can provide quantitative information from many animal groups. As public interest in these methodologies grows, it is vital to use standardized procedures with clearly defined data acceptance metrics and conduct field studies demonstrating the use of these techniques to help resolve real-world water quality challenges. Here we apply recently standardized human-associated qPCR methods with custom data acceptance metrics (HF183/BacR287 and HumM2), along with established procedures for ruminant (Rum2Bac), cattle (CowM2 and CowM3), canine (DG3 and DG37), and avian (GFD) fecal pollution sources to (i) demonstrate the feasibility of implementing standardized qPCR procedures in a largescale field study, and (ii) characterize trends in fecal pollution sources in the research area. A total of 602 water samples were collected over a one-year period at 29 sites along the Trask, Kilchis, and Tillamook rivers and tributaries in the Tillamook Bay Watershed (OR, USA). Host-associated qPCR results were combined with high-resolution geographic information system (GIS) land use and general indicator bacteria (E. cols) measurements to elucidate water quality fecal pollution trends. Results demonstrate the feasibility of implementing standardized fecal source identification qPCR methods with established data acceptance metrics in a large-scale field study leading to new investigative leads suggesting that elevated E. coli levels may be linked to specific pollution sources and land use activities in the Tillamook Bay Watershed.	[Li, Xiang] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Sivaganesan, Mano; Kelty, Catherine A.; Shanks, Orin C.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Zimmer-Faust, Amity] Southern Calif Coastal Water Res Project, Costa Mesa, CA USA; [Clinton, Pat] US EPA, Off Res & Dev, Newport, OR USA; [Reichman, Jay R.] US EPA, Off Res & Dev, Corvallis, OR USA; [Johnson, York] Oregon Dept Environm Qual & Tillamook Estuaries P, Garibaldi, OR USA; [Matthews, William] Oregon Dept Agr, Salem, OR USA; [Bailey, Stephanie] US EPA, Reg Manchester Lab 10, Port Orchard, WA USA; [Li, Xiang] Southern Univ Sci & Technol, Sch Environm Sci & Engn, Shenzhen, Guangdong, Peoples R China	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; Southern California Coastal Water Research Project; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; Southern University of Science & Technology	Shanks, OC (corresponding author), US EPA, Off Res & Dev, Cincinnati, OH 45268 USA.	shank.orin@epa.gov		Reichman, Jay/0000-0002-5657-1115; Li, Xiang/0000-0001-6023-8561				Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Borok A, 2016, ISSUE PAPER REVISION; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao YP, 2018, WATER RES, V128, P148, DOI 10.1016/j.watres.2017.10.071; DeFlorio-Barker S, 2018, ENV HLTH, V17, P1, DOI [10.1186/s12940-017-0345-y, DOI 10.1186/S12940-017-0345-Y]; Devane ML, 2005, J APPL MICROBIOL, V98, P980, DOI 10.1111/j.1365-2672.2005.02541.x; Edge T.A., 2016, APPL ENVIRON MICROB, DOI [10.1128/AEM.01675-01616, DOI 10.1128/AEM.01675-01616]; Ervin JS, 2014, ENVIRON SCI TECHNOL, V48, P9043, DOI 10.1021/es502173s; Ervin JS, 2013, WATER RES, V47, P6873, DOI 10.1016/j.watres.2013.02.060; Fallacara DM, 2004, AVIAN DIS, V48, P759, DOI 10.1637/7185-032904R; Fallacara DM, 2001, AVIAN DIS, V45, P128, DOI 10.2307/1593019; Green HC, 2014, DEV RAPID CANINE FEC; Green HC, 2014, APPL ENVIRON MICROB, V80, P3086, DOI 10.1128/AEM.04137-13; Green HC, 2012, APPL ENVIRON MICROB, V78, P503, DOI 10.1128/AEM.05734-11; Hajj-Mohamad M, 2019, SCI TOTAL ENVIRON, V659, P548, DOI 10.1016/j.scitotenv.2018.12.378; Haugland RA, 2010, SYST APPL MICROBIOL, V33, P348, DOI 10.1016/j.syapm.2010.06.001; Helsel D. R., 2005, NONDETECTS DATA ANAL; Jokinen CC, 2019, WATER RES, V156, P148, DOI 10.1016/j.watres.2019.03.013; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Korajkic A, 2019, INT J ENV RES PUB HE, V15, pE2842; Kundu A, 2013, WATER RES, V47, P6309, DOI 10.1016/j.watres.2013.08.002; Lee CS, 2010, J MICROBIOL METH, V82, P311, DOI 10.1016/j.mimet.2010.07.012; Lee Sherline H, 2002, MMWR Surveill Summ, V51, P1; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Ly DK, 2012, WATER SCI TECHNOL, V66, P2659, DOI 10.2166/wst.2012.496; McMinn BR, 2019, ECOL ENG, V128, P48, DOI 10.1016/j.ecoleng.2018.11.026; Mieszkin S, 2010, J APPL MICROBIOL, V108, P974, DOI 10.1111/j.1365-2672.2009.04499.x; Newell A, 1998, TILLAMOOK BAY ENV CH; ODFW, 2018, BIG GAM POP SURV DAT; Peed LA, 2011, ENVIRON SCI TECHNOL, V45, P5662; Pickard BR, 2015, ECOSYSTEMS SERVICES, V14; Reischer GH, 2007, LETT APPL MICROBIOL, V44, P351, DOI 10.1111/j.1472-765X.2006.02094.x; Reischer GH, 2006, APPL ENVIRON MICROB, V72, P5610, DOI 10.1128/AEM.00364-06; Samadpour N, 2002, J ENVIRON HEALTH, V64, P16; Shanks OC, 2008, APPL ENVIRON MICROB, V74, P745, DOI 10.1128/AEM.01843-07; Shanks OC, 2006, APPL ENVIRON MICROB, V72, P5537, DOI 10.1128/AEM.03059-05; Shanks OC, 2016, APPL ENVIRON MICROB, V82, P2773, DOI 10.1128/AEM.03661-15; Shanks OC, 2014, APPL ENVIRON MICROB, V80, P1588, DOI 10.1128/AEM.03581-13; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shanks OC, 2010, ENVIRON SCI TECHNOL, V44, P6281, DOI 10.1021/es100311n; Shanks OC, 2010, APPL ENVIRON MICROB, V76, P1359, DOI 10.1128/AEM.02033-09; Shanks OC, 2009, APPL ENVIRON MICROB, V75, P5507, DOI 10.1128/AEM.00305-09; Shibata T, 2010, ENVIRON SCI TECHNOL, V44, P8175, DOI 10.1021/es100884w; Sivaganesan M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-120; Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049; Stachler E, 2017, ENVIRON SCI TECHNOL, V51, P9146, DOI 10.1021/acs.est.7b02703; Templar HA, 2016, WATER RES, V100, P556, DOI 10.1016/j.watres.2016.05.056; USEPA, 2002, METHOD 1603 ESCHERIC; USEPA, 2019, 1697 USEPA; USEPA, 2012, RECREATIONAL WATER Q; USEPA, 2019, 1696 USEPA; USEPA (United States Environmental Protection Agency), 2004, 833R04001 USEPA; Weidhass J.L., 2011, APPL ENVIRON MICROB, DOI [10.1128/ AEM.02555-02510, DOI 10.1128/AEM.02555-02510]; Wise DR, 2011, J AM WATER RESOUR AS, V47, P1110, DOI 10.1111/j.1752-1688.2011.00580.x; Yampara-Iquise H, 2008, J APPL MICROBIOL, V105, P1686, DOI 10.1111/j.1365-2672.2008.03895.x	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216827	10.1371/journal.pone.0216827	http://dx.doi.org/10.1371/journal.pone.0216827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170166	Green Published, gold			2022-12-27	WOS:000470263700010
J	Moerman, AM; Dilba, K; Korteland, S; Poot, DHJ; Klein, S; van der Lugt, A; Rouwet, EV; van Gaalen, K; Wentzel, JJ; van der Steen, AFW; Gijsen, FJH; Van der Heiden, K				Moerman, A. M.; Dilba, K.; Korteland, S.; Poot, D. H. J.; Klein, S.; van der Lugt, A.; Rouwet, E. V.; van Gaalen, K.; Wentzel, J. J.; van der Steen, A. F. W.; Gijsen, F. J. H.; Van der Heiden, K.			An MRI-based method to register patient specific wall shear stress data to histology	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ATHEROSCLEROTIC PLAQUE; HIGH-RISK; PROGRESSION; REGISTRATION; PREDICTION; HUMANS	Wall shear stress (WSS), the frictional force exerted on endothelial cells by blood flow, is hypothesised to influence atherosclerotic plaque growth and composition. We developed a methodology for image registration of MR and histology images of advanced human carotid plaques and corresponding WSS data, obtained by MRI and computational fluid dynamics. The image registration method requires four types of input images, in vivo MRI, ex vivo MRI, photographs of transversally sectioned plaque tissue and histology images. These images are transformed to a shared 3D image domain by applying a combination of rigid and non-rigid registration algorithms. Transformation matrices obtained from registration of these images are used to transform subject-specific WSS data to the shared 3D image domain as well. WSS values originating from the 3D WSS map are visualised in 2D on the corresponding lumen locations in the histological sections and divided into eight radial segments. In each radial segment, the correlation between WSS values and plaque composition based on histological parameters can be assessed. The registration method was successfully applied to two carotid endarterectomy specimens. The resulting matched contours from the imaging modalities had Hausdorff distances between 0.57 and 0.70 mm, which is in the order of magnitude of the in vivo MRI resolution. We simulated the effect of a mismatch in the rigid registration of imaging modalities on WSS results by relocating the WSS data with respect to the stack of histology images. A 0.6 mm relocation altered the mean WSS values projected on radial bins on average by 0.59 Pa, compared to the output of original registration. This mismatch of one image slice did not change the correlation between WSS and plaque thickness. In conclusion, we created a method to investigate correlations between WSS and plaque composition.	[Moerman, A. M.; Dilba, K.; Korteland, S.; van Gaalen, K.; Wentzel, J. J.; van der Steen, A. F. W.; Gijsen, F. J. H.; Van der Heiden, K.] Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands; [Dilba, K.; Poot, D. H. J.; Klein, S.; van der Lugt, A.] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Poot, D. H. J.; Klein, S.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Rouwet, E. V.] Erasmus MC, Dept Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Van der Heiden, K (corresponding author), Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands.	k.vanderheiden@erasmusmc.nl	van der Heiden, Kim/AAJ-7844-2021	Klein, Stefan/0000-0003-4449-6784	Netherlands Heart Foundation [NHS2014T096]	Netherlands Heart Foundation(Netherlands Heart Foundation)	AMM and KvdH are funded by the Netherlands Heart Foundation (NHS2014T096).	Antiga L, 2002, PATIENT SPECI FIC MO; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Cibis M, 2014, NMR BIOMED, V27, P826, DOI 10.1002/nbm.3126; Corban MT, 2014, ATHEROSCLEROSIS, V232, P271, DOI 10.1016/j.atherosclerosis.2013.11.049; Costopoulos C, 2019, EUR HEART J; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Duivenvoorden Raphael, 2010, Circ Cardiovasc Imaging, V3, P578, DOI 10.1161/CIRCIMAGING.109.916304; Eshtehardi P, 2017, INT J CARDIOVAS IMAG, V33, P1089, DOI 10.1007/s10554-016-1055-1; Groen HC, 2010, J BIOMECH, V43, P2087, DOI 10.1016/j.jbiomech.2010.04.005; Groen HC, 2010, J BIOMECH, V43, P2332, DOI 10.1016/j.jbiomech.2010.04.039; Huang XY, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-86; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Pichat J, 2018, MED IMAGE ANAL, V46, P73, DOI 10.1016/j.media.2018.02.004; Potters WV, 2015, J MAGN RESON IMAGING, V41, P505, DOI 10.1002/jmri.24560; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002; Shishikura D, 2018, ATHEROSCLEROSIS, V275, P68, DOI 10.1016/j.atherosclerosis.2018.04.022; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P401, DOI 10.1038/ncpcardio0274; Stone PH, 2007, EUR HEART J, V28, P705, DOI 10.1093/eurheartj/ehl575; Stone PH, 2018, JACC-CARDIOVASC IMAG, V11, P462, DOI 10.1016/j.jcmg.2017.01.031; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Tang DL, 2017, J BIOMECH, V50, P121, DOI 10.1016/j.jbiomech.2016.11.011; Timmins LH, 2015, ANN BIOMED ENG, V43, P94, DOI 10.1007/s10439-014-1155-9; Tuenter A, 2016, ATHEROSCLEROSIS, V251, P348, DOI 10.1016/j.atherosclerosis.2016.05.018; van den Bouwhuijsen QJA, 2012, EUR HEART J, V33, P221, DOI 10.1093/eurheartj/ehr227; van Engelen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094840; van Engelen A, 2012, PHYS MED BIOL, V57, P241, DOI 10.1088/0031-9155/57/1/241; van Ooij Pim, 2018, Eur Radiol Exp, V2, P27, DOI 10.1186/s41747-018-0058-1; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wijeyaratne SM, 2002, EUR J VASC ENDOVASC, V23, P370, DOI 10.1053/ejvs.2001.1562; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217271	10.1371/journal.pone.0217271	http://dx.doi.org/10.1371/journal.pone.0217271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170183	gold, Green Submitted, Green Published			2022-12-27	WOS:000470263700024
J	Amorim, TOS; de Castro, FR; Moron, JR; Duque, BR; Di Tullio, JC; Secchi, ER; Andriolo, A				Simoes Amorim, Thiago Orion; de Castro, Franciele Rezende; Moron, Juliana Rodrigues; Duque, Bruna Ribeiro; Di Tullio, Juliana Couto; Secchi, Eduardo Resende; Andriolo, Artur			Integrative bioacoustics discrimination of eight delphinid species in the western South Atlantic Ocean	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; ECHOLOCATION CLICKS; ACOUSTIC IDENTIFICATION; PORPOISE CLICKS; CLASSIFICATION; WHISTLE; SPINNER; ECOLOGY; SIGNALS; RISSOS	This study presents an integrative bioacoustics approach to discriminate eight species of odontocetes found on the outer continental shelf and slope of the western South Atlantic Ocean. Spinner, Atlantic spotted, rough-toothed, Risso's, bottlenose, short-beaked common dolphins, killer and long-finned pilot whales were visually confirmed during recordings with a 3-element omnidirectional hydrophone array. Spectral and time parameters of whistles and echolocation clicks were used in a discriminant function analysis and a classification tree model. As a first step, whistles and clicks were analysed separately; a further analysis consisted of both vocalisations jointly classified. All species showed species-specific properties in their vocalisations. Whistles had greater misclassification rates when compared to clicks. The correct classification was enhanced by the joint step, given the 5.8% error in the discriminant function analysis and a misclassification rate of 18.8% in the tree model. In addition, Receiver Operating Characteristic curves resulting from the tree algorithm analysis exhibited better model efficiency for all species in the joint classification. These findings on acoustical discrimination of such abundant and cosmopolitan species contribute to delphinid classification systems.	[Simoes Amorim, Thiago Orion; de Castro, Franciele Rezende; Moron, Juliana Rodrigues; Duque, Bruna Ribeiro; Andriolo, Artur] Univ Fed Juiz De Fora, Inst Ciencias Biol, Lab Ecol Comportamental & Bioacust LABEC, Juiz De Fora, MG, Brazil; [Simoes Amorim, Thiago Orion; de Castro, Franciele Rezende; Andriolo, Artur] Inst Aqualie, Juiz De Fora, MG, Brazil; [Di Tullio, Juliana Couto; Secchi, Eduardo Resende] Univ Fed Rio Grande FURG, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha EcoMega, Rio Grande, RS, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal do Rio Grande	Amorim, TOS (corresponding author), Univ Fed Juiz De Fora, Inst Ciencias Biol, Lab Ecol Comportamental & Bioacust LABEC, Juiz De Fora, MG, Brazil.; Amorim, TOS (corresponding author), Inst Aqualie, Juiz De Fora, MG, Brazil.	tosabio@gmail.com	Secchi, Eduardo R./ABF-1191-2020	Secchi, Eduardo R./0000-0001-9087-9909	Chevron Brasil Upstream Frade Ltda; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) scholarship; Universidade Federal de Juiz de Fora	Chevron Brasil Upstream Frade Ltda; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) scholarship; Universidade Federal de Juiz de Fora	This work had the logistical support of Instituto Aqualie and Auset, along with financial support from Chevron Brasil Upstream Frade Ltda and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) scholarship. We also want to thank Universidade Federal de Juiz de Fora for financial support in publishing this work. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriolo A, 2015, J ACOUST SOC AM, V138, P1696, DOI 10.1121/1.4928308; Anonymous, 2008, P401, DOI 10.1007/978-0-387-78365-9_10; Au W.W.L., 1993, SONAR DOLPHINS, P59; Au WWL, 2012, J ACOUST SOC AM, V132, P1199, DOI 10.1121/1.4730901; Au WWL, 2012, J ACOUST SOC AM, V131, P569, DOI 10.1121/1.3662077; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; Azzolin M, 2014, J ACOUST SOC AM, V135, P502, DOI 10.1121/1.4845275; Baumann-Pickering S, 2015, ENDANGER SPECIES RES, V28, P97, DOI 10.3354/esr00685; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Di Tullio JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155841; Frasier KE, 2016, MAR MAMMAL SCI, V32, P911, DOI 10.1111/mms.12303; Gillespie D, 2013, J ACOUST SOC AM, V134, P2427, DOI 10.1121/1.4816555; Hildebrand J., 2015, NAT SCI REP, V5, P1; Jones GJ, 2002, MAR MAMMAL SCI, V18, P374, DOI 10.1111/j.1748-7692.2002.tb01044.x; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; Madsen PT, 2005, BIOACOUSTICS, V15, P195, DOI 10.1080/09524622.2005.9753547; Moron JR, 2015, J ACOUST SOC AM, V138, P2495, DOI 10.1121/1.4931900; Nowacek DP, 2005, MAR MAMMAL SCI, V21, P587, DOI 10.1111/j.1748-7692.2005.tb01253.x; Oswald J.N., 2013, DETECTION CLASSIFICA, P245; Oswald JN, 2004, J ACOUST SOC AM, V116, P3178, DOI 10.1121/1.1804635; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Oswald JN, 2007, J ACOUST SOC AM, V122, P587, DOI 10.1121/1.2743157; Parada PP, 2014, J ACOUST SOC AM, V135, P3371, DOI 10.1121/1.4876439; Rankin S, 2017, MAR MAMMAL SCI, V33, P520, DOI 10.1111/mms.12381; Roch M., 2008, CAN ACOUST, V36, P41, DOI DOI 10.1007/3-540-35375-5; Roch MA, 2007, J ACOUST SOC AM, V121, P1737, DOI 10.1121/1.2400663; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; SAS Institute Inc, 2010, JMP 9 MOD MULT METH; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; STEINER WW, 1981, BEHAV ECOL SOCIOBIOL, V9, P241, DOI 10.1007/BF00299878; Vayssieres MP, 2000, J VEG SCI, V11, P679, DOI 10.2307/3236575; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Verfuss UK, 2013, J ACOUST SOC AM, V134, P2462, DOI 10.1121/1.4816571; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	38	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217977	10.1371/journal.pone.0217977	http://dx.doi.org/10.1371/journal.pone.0217977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170251	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700087
J	Suszko, AM; Nayyar, S; Porta-Sanchez, A; Das, M; Pinter, A; Crystal, E; Tomlinson, G; Dalvi, R; Chauhan, VS				Suszko, Adrian M.; Nayyar, Sachin; Porta-Sanchez, Andreu; Das, Moloy; Pinter, Arnold; Crystal, Eugene; Tomlinson, George; Dalvi, Rupin; Chauhan, Vijay S.			Quantification of abnormal QRS peaks predicts response to cardiac resynchronization therapy and tracks structural remodeling	PLOS ONE			English	Article							FRAGMENTED QRS; HEART-FAILURE; TASK-FORCE; ASSOCIATION; CARDIOMYOPATHY; DYSSYNCHRONY; CONDUCTION; RISK	Background Although QRS duration (QRSd) is an important determinant of cardiac resynchronization therapy (CRT) response, non-responder rates remain high. QRS fragmentation can also reflect electrical dyssynchrony. We hypothesized that quantification of abnormal QRS peaks (QRSp) would predict CRT response. Methods Forty-seven CRT patients (left ventricular ejection fraction =23 +/- 7%) were prospectively studied. Digital 12-lead ECGs were recorded during native rhythm at baseline and 6 months post-CRT. For each precordial lead, QRSp was defined as the total number of peaks detected on the unfiltered QRS minus those detected on a smoothed moving average template QRS. CRT response was defined as >5% increase in left ventricular ejection fraction post-CRT. Results Sixty-percent of patients responded to CRT. Baseline QRSd was similar in CRT responders and non-responders, and did not change post-CRT regardless of response. Baseline QRSp was greater in responders than non-responders (9.1 +/- 3.5 vs. 5.9 +/- 2.2, p = 0.001) and decreased in responders (9.2 +/- 3.6 vs. 7.9 +/- 2.8, p = 0.03) but increased in non-responders (5.5 +/- 2.3 vs. 7.5 +/- 2.8, p = 0.049) post-CRT. In multivariable analysis, QRSp was the only independent predictor of CRT response (Odds Ratio [95% Confidence Interval]: 1.5 [1.1-2.1], p = 0.01). ROC analysis revealed QRSp (area under curve = 0.80) to better discriminate response than QRSd (area under curve = 0.67). Compared to QRSd >= 150ms, QRSp >= 7 identified response with similar sensitivity but greater specificity (74 vs. 32%, p<0.05). Amongst patients with QRSd <150ms, more patients with QRSp >= 7 responded than those with QRSp <7 (75 vs. 0%, p<0.05). Conclusions Our novel automated QRSp metric independently predicts CRT response and decreases in responders. Electrical dyssynchrony assessed by QRSp may improve CRT selection and track structural remodeling, especially in those with QRSd <150ms.	[Suszko, Adrian M.; Nayyar, Sachin; Porta-Sanchez, Andreu; Das, Moloy; Tomlinson, George; Dalvi, Rupin; Chauhan, Vijay S.] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Das, Moloy] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England; [Pinter, Arnold] St Michaels Hosp, Div Cardiol, Toronto, ON, Canada; [Crystal, Eugene] Sunnybrook Hlth Sci Ctr, Cardiol Div, Toronto, ON, Canada	University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Newcastle Freeman Hospital; Newcastle University - UK; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Suszko, AM; Chauhan, VS (corresponding author), Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada.	adrian.suszko@uhn.ca; vijay.chauhan@uhn.ca	Nayyar, Sachin/AAM-8109-2021; Chauhan, Vijay/AAA-9872-2020; Porta-Sanchez, Andreu/M-2980-2016; Tomlinson, George/L-5432-2016	Nayyar, Sachin/0000-0002-7972-5375; Porta-Sanchez, Andreu/0000-0003-3510-1488; Tomlinson, George/0000-0002-9328-6399; Suszko, Adrian/0000-0001-8185-1998; Das, Moloy/0000-0002-4237-1630	Heart and Stroke Foundation of Ontario Career Award [MC 7577]; AFP Innovation Fund from the Ontario Ministry of Health	Heart and Stroke Foundation of Ontario Career Award; AFP Innovation Fund from the Ontario Ministry of Health	This study is supported by the Heart and Stroke Foundation of Ontario Career Award (MC 7577 to VSC) and the AFP Innovation Fund from the Ontario Ministry of Health to VSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Celikyurt U, 2015, ANN NONINVAS ELECTRO, V20, P126, DOI 10.1111/anec.12186; Celikyurt U, 2012, J INTERV CARD ELECTR, V35, P337, DOI 10.1007/s10840-012-9715-0; Cvijic M, 2017, J CARD FAIL, V23, P257, DOI 10.1016/j.cardfail.2016.10.014; Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284; Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019; Das MK, 2010, HEART RHYTHM, V7, P74, DOI 10.1016/j.hrthm.2009.09.065; Das M, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004874; Dizon J, 2004, J INTERV CARD ELECTR, V10, P47, DOI 10.1023/B:JICE.0000011484.61659.b1; Gold MR, 2011, EUR HEART J, V32, P2516, DOI 10.1093/eurheartj/ehr329; Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehi826; Igarashi M, 2017, J CARDIOVASC ELECTR, V28, P327, DOI 10.1111/jce.13139; Leyva F, 2014, J AM COLL CARDIOL, V64, P1047, DOI 10.1016/j.jacc.2014.06.1178; Oetgen WJ, 2013, J AM COLL CARDIOL, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Rickard J, 2017, PACE, V40, P482, DOI 10.1111/pace.13043; Rickard J, 2011, ANN NONINVAS ELECTRO, V16, P165, DOI 10.1111/j.1542-474X.2011.00424.x; Sebag FA, 2012, J CARDIOVASC ELECTR, V23, P1219, DOI 10.1111/j.1540-8167.2012.02376.x; Sinha SK, 2016, CARDIOL RES, V7, P140, DOI 10.14740/cr495w; Suszko AM, 2015, INT CONF ELECTRO INF, P20, DOI 10.1109/EIT.2015.7293317; Tigen K, 2009, CAN J CARDIOL, V25, P517, DOI 10.1016/S0828-282X(09)70137-0; Vanderheyden M, 2008, J AM COLL CARDIOL, V51, P129, DOI 10.1016/j.jacc.2007.07.087; Wang JF, 2017, J CARDIOVASC ELECTR, V28, P438, DOI 10.1111/jce.13171; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217875	10.1371/journal.pone.0217875	http://dx.doi.org/10.1371/journal.pone.0217875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170231	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700074
J	Hajjar, A; Ergun, MA; Alagoz, O; Rampurwala, M				Hajjar, Ali; Ergun, Mehmet A.; Alagoz, Oguzhan; Rampurwala, Murtuza			Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer	PLOS ONE			English	Article							CHEMOTHERAPY; HEALTH; SURVIVAL	Objectives Adjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive breast cancer. We investigated the cost-effectiveness of this regimen. Methods A Markov-based microsimulation model with six health states is used to simulate four adjuvant therapy options for women with early-stage node-negative, HER2-positive breast cancer at different age groups. The four treatment arms are 1) adjuvant paclitaxel and trastuzumab (TH), 2) doxorubicin, cyclophosphamide, paclitaxel and trastuzumab (ACTH), 3) docetaxel, carboplatin and trastuzumab (TCH), and 4) no adjuvant trastuzumab (NT). Data from randomized trials were used to estimate treatment efficacy. Societal perspective was used in this cost-effectiveness analysis. Costs were measured in 2016 US dollars (US $) and quality-adjusted life-years (QALYs) was used for health outcomes. Sensitivity analyses were performed to evaluate the impact of uncertainty in parameter estimation. Results We found that 40-year-old women undergoing TH treatment would have an average of 16.17 QALYs for the cost of $ 178,650 when lifetime horizon is used. Compared to NT, TH has incremental cost-effectiveness ratios ranged from $ 10,584 (ages 40-49) to $ 84,981 (age 80+) per additional QALYs. The sensitivity analysis showed that TH is cheaper and leads to higher QALYs compared to both ACTH and TCH for all age groups and time horizons. Conclusions TH is cost-effective for all age groups in the base case scenario and in the sensitivity analysis. In order to reduce the parameter uncertainty, clinical trials with longer follow-up times are needed.	[Hajjar, Ali; Alagoz, Oguzhan] Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI 53706 USA; [Ergun, Mehmet A.] Istanbul Sehir Univ, Dept Ind Engn, Istanbul, Turkey; [Rampurwala, Murtuza] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; Istanbul Sehir University; University of Chicago	Alagoz, O (corresponding author), Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI 53706 USA.	alagoz@engr.wisc.edu	Ergun, Mehmet/AAB-9782-2019; Hjaar, Ali/GSM-9720-2022	Ergun, Mehmet/0000-0002-2480-8077; Alagoz, Oguzhan/0000-0002-5133-1382; Hajjar, Ali/0000-0003-4654-9798	Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH) [2UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research is supported through grant 2UL1TR000427 from the Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH) to OA and AH.	Alagoz O, 2004, MANAGE SCI, V50, P1420, DOI 10.1287/mnsc.1040.0287; Ayvaci MUS, 2013, MED DECIS MAKING, V33, P521, DOI 10.1177/0272989X12470755; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; Fehrenbacher L, 2014, J CLIN ONCOL, V32, P2151, DOI 10.1200/JCO.2013.52.0858; Garrison LR, 2007, CANCER-AM CANCER SOC, V110, P489, DOI 10.1002/cncr.22806; Hedden L, 2012, RADIAT ONCOL, P3, DOI [10.1186/1748-717X-7-3, DOI 10.1186/1748-717X-7-3]; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kurian AW, 2007, J CLIN ONCOL, V25, P634, DOI 10.1200/JCO.2006.06.3081; Law A. M., 2000, SIMULATION MODELING; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; National Cancer Institute, 2017, COMM TERM CRIT ADV E; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 1993, CANC RES, V53; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skedgel C, 2013, ANN ONCOL, V24, P1834, DOI 10.1093/annonc/mdt069; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stemmler HJ, 2005, ONKOLOGIE, V28, P582, DOI 10.1159/000088296; Thomson Reuters Healthcare Inc, 2010, RED BOOK; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Tolaney SM, 2019, J CLIN ONCOL, V37; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winn AN, 2016, AM J PREV MED, V50, P241, DOI 10.1016/j.amepre.2015.08.009	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217778	10.1371/journal.pone.0217778	http://dx.doi.org/10.1371/journal.pone.0217778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166995	gold, Green Submitted, Green Published			2022-12-27	WOS:000470087800039
J	Trefan, L; Gartner, A; Alcock, A; Farewell, D; Morgan, J; Fone, D; Paranjothy, S				Trefan, Laszlo; Gartner, Andrea; Alcock, Amy; Farewell, Daniel; Morgan, Jennifer; Fone, David; Paranjothy, Shantini			Epidemiology of alcohol-related emergency hospital admissions in children and adolescents: An e-cohort analysis in Wales in 2006-2011	PLOS ONE			English	Article							INTOXICATED ADOLESCENTS; SOCIOECONOMIC-STATUS; BINGE DRINKING; CONSUMPTION; AGE; LEVEL; ONSET; HARM; VICTIMIZATION; BEHAVIORS	Objective Harmful levels of alcohol consumption in young people are prevalent and of increasing public concern in the western world. Rates of alcohol-related emergency hospital admissions in children and young people between 10 to 17 years were described, and the reasons for these admissions and their association with socio-demographic factors were examined. Methods E-cohort data were extracted from the Secure Anonymised Information Linkage Databank, which contained alcohol-related emergency hospital admissions (N = 2968) from 2006 to 2011 in children and adolescents aged 10 to 17 years in Wales. A generalised linear mixed model was fitted using a log-link with a population offset to the data to calculate incident rate ratios (IRRSs). Results There was a general decreasing trend from 2006 to 2011 in the number and rate of alcohol-related emergency hospital admissions; the mean age of admission was 15.4 (standard deviation 1.4) years. In each of the four youngest age groups (10-13,14,15,16 years), females had higher IRRs than males. Males had slightly higher IRR compared to females only in the oldest age group (17 years). IRRs increased with increasing deprivation. The majority (92%) of the admissions lasted one day and most of the admissions (70%) occured during the last three days of the week with a peak on Saturday. The length of stay in hospital was longer in cases when self-harm were present. Multiple admissions showed high prevalance of serious self-harm cases in females. The number of admissions with injuries and falls were higher for males than females. Conclusion Female children and adolescents were more likely to be admitted to hospital for alcohol-related reasons. These data illustrate the significant burden of alcohol-related harm in young people and highlight the need for interventions and policies that promote safe drinking practices among young people to prevent future alcohol-related harm during the life-course.	[Trefan, Laszlo; Gartner, Andrea; Farewell, Daniel; Fone, David; Paranjothy, Shantini] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales; [Alcock, Amy] Royal Gwent Hosp, Newport, Gwent, Wales; [Morgan, Jennifer] NHS Wales Delivery Unit, Pencoed, Wales	Cardiff University; Royal Gwent Hospital	Trefan, L (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales.	TrefanL@cardiff.ac.uk		Paranjothy, Shantini/0000-0002-0528-3121; Farewell, Daniel/0000-0002-8871-1653	Economic and Social Research Council; Medical Research Council; Alcohol Research UK [ES/L015471/1]; ESRC [ES/L015471/1] Funding Source: UKRI; MRC [MR/K023233/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alcohol Research UK; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funds from the Economic and Social Research Council, the Medical Research Council and Alcohol Research UK to the ELAStiC Project (ES/L015471/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouthoorn SH, 2011, EUR J PEDIATR, V170, P1023, DOI 10.1007/s00431-011-1394-9; Calabria B, 2011, ADDICTION, V106, P1406, DOI 10.1111/j.1360-0443.2011.03418.x; Champion HLO, 2004, J ADOLESCENT HEALTH, V35, P321, DOI 10.1016/j.jadohealth.2003.09.023; Dawson DA, 2008, ALCOHOL CLIN EXP RES, V32, P2149, DOI 10.1111/j.1530-0277.2008.00806.x; de Looze M, 2015, EUR J PUBLIC HEALTH, V25, P69, DOI 10.1093/eurpub/ckv031; Diestelkamp S, 2015, ADDICT BEHAV, V50, P51, DOI 10.1016/j.addbeh.2015.06.009; Dobson A.J., 2002, INTRO GEN LINEAR MOD; Fone D., 2016, NIHR J LIB, V4, P1, DOI DOI 10.3310/PHR04030; Fone D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-428; Ford D, 2009, BMC HEALTH SERV RES, V9, P24; Gartner A., 2014, ALCOHOL HLTH WALES 2; Green MA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4265-0; Healey C, 2014, INT J DRUG POLICY, V25, P124, DOI 10.1016/j.drugpo.2013.07.008; Hibell B, 2009, ESPAD REPORT 2007 SU; Hibell B., 2012, ESPAD REPORT 2011 SU; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Holdcraft LC, 2002, ADDICTION, V97, P1025, DOI 10.1046/j.1360-0443.2002.00142.x; Huckle T, 2008, ADDICTION, V103, P1614, DOI 10.1111/j.1360-0443.2008.02318.x; Jefferis BJMH, 2005, ADDICTION, V100, P543, DOI 10.1111/j.1360-0443.2005.01034.x; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Katikireddi SV, 2017, LANCET PUBLIC HEALTH, V2, pE267, DOI 10.1016/S2468-2667(17)30078-6; KIRKWOOD BR, 2003, ESSENTIAL MED STAT, P315; Livingston W, 2018, REV WORKING TOGETHER; Loxley WM, 2005, MED J AUSTRALIA, V182, P54, DOI 10.5694/j.1326-5377.2005.tb06574.x; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Measham F, 2008, HEALTH EDUC, V108, P207, DOI 10.1108/09654280810867088; Moore GF, 2015, J SCHOOL HEALTH, V85, P267, DOI 10.1111/josh.12242; Moore GF, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-6; Nienhuis K., 2019, Nederlands Tijdschrift voor Geneeskunde, V163, pD2384; Pawlowska-Kamieniak A, 2018, ANN AGR ENV MED, V25, P1, DOI 10.5604/12321966.1228397; Peng M, 2018, INT J POPUL DATA SCI, V3, P1; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; Rowland B, 2014, ADDICT BEHAV, V39, P282, DOI 10.1016/j.addbeh.2013.10.001; Shepherd JP, 2006, J ADOLESCENCE, V29, P539, DOI 10.1016/j.adolescence.2006.06.005; Simons-Morton BG, 2009, INT J PUBLIC HEALTH, V54, P199, DOI 10.1007/s00038-009-5411-y; Sindelar H A, 2004, Minerva Pediatr, V56, P291; Swahn MH, 2004, ADDICT BEHAV, V29, P959, DOI 10.1016/j.addbeh.2004.02.043; Team RC., 2022, LANG ENV STAT COMP; Toumbourou JW, 2007, LANCET, V369, P1391, DOI 10.1016/S0140-6736(07)60369-9; van Hoof JJ, 2015, J CHILD ADOLES SUBST, V24, P191, DOI 10.1080/1067828X.2013.803943; van Hoof JJ, 2011, J ADOLESCENT HEALTH, V48, P212, DOI 10.1016/j.jadohealth.2010.06.001; van Hoof JJ, 2010, J STUD ALCOHOL DRUGS, V71, P366, DOI 10.15288/jsad.2010.71.366; Van Zanten E, 2013, ALCOHOL CLIN EXP RES, V37, P1188, DOI 10.1111/acer.12090; Wachtel T, 2010, J CLIN NURS, V19, P605, DOI 10.1111/j.1365-2702.2009.03060.x; Warner LA, 2003, SUBST USE MISUSE, V38, P1983, DOI 10.1081/JA-120025123; WHO, 2010, INT STAT CLASS DIS R; Williams S, 2005, BRIT MED J, V330, p115A	47	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217598	10.1371/journal.pone.0217598	http://dx.doi.org/10.1371/journal.pone.0217598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163052	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000470086200024
J	Chan, M; Muriuki, EM; Emery, S; Kanthula, R; Chohan, V; Frenkel, LM; Wald, A; Chohan, B; Overbaugh, J; Roxby, AC				Chan, Mary; Muriuki, Eric Munene; Emery, Sandra; Kanthula, Ruth; Chohan, Vrasha; Frenkel, Lisa M.; Wald, Anna; Chohan, Bhavna; Overbaugh, Julie; Roxby, Alison C.			Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; VIRAL LOAD; RESISTANT HIV-1; PLUS; PREGNANCY; ADHERENCE; CARE; RETENTION; NEVIRAPINE	Background The Option B+ strategy streamlines delivery of HIV antiretroviral therapy (ART) to pregnant women, but concerns remain about ART treatment adherence and long term outcomes. Methods We conducted a retrospective analysis of a cohort of HIV-positive, postpartum breastfeeding women receiving ART via Option B+ in Nairobi, Kenya. The primary outcome was virologic failure in plasma (HIV RNA >1000 copies/mL), and detection in breast milk (>150 copies/mL) and endocervical secretions (>100 copies/mL) at 2 postpartum timepoints. Correlates of virologic failure were assessed using univariate tests and multivariate logistic regression. Results Of 42 women at 6-14 weeks postpartum, 21.4% of women had HIV RNA detected in plasma; 14.3% in breast milk, and 23.7% in endocervical secretions. At 18-24 weeks postpartum, the percentages were 21.1%, 7.1%, and 14.3%, respectively. Younger maternal age, intent to breastfeed for longer, and later ART start in pregnancy were significantly associated with plasma virologic failure (p < 0.05 for each). Odds of plasma virologic failure at 6-14 weeks postpartum were 1.25 times higher (95% CI 1.04, 1.51) for each increase in week of gestation at ART initiation. Only 3 women had resistance mutations to their regimen. Conclusions Despite months of ART, nearly one-quarter of the women in our cohort did not achieve plasma virologic suppression in the postpartum period. After adjusting for time on ART, earlier ART initiation in pregnancy was significantly associated with plasma suppression. Our findings suggest that postpartum HIV RNA monitoring in Option B+ programs will be needed to achieve elimination of MTCT.	[Chan, Mary; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Muriuki, Eric Munene] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Emery, Sandra] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Kanthula, Ruth; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA; [Chohan, Vrasha; Frenkel, Lisa M.; Wald, Anna; Roxby, Alison C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Frenkel, Lisa M.; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa M.; Chohan, Bhavna; Roxby, Alison C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chohan, Bhavna] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Nairobi; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Roxby, AC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Roxby, AC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	aroxby@uw.edu		Roxby, Alison/0000-0001-9449-8062	NICHD [K23 HD071788-01A1]; University of Washington Center for AIDS Research (CFAR) [P30 AI027757]; Fogarty Fellowship - Fogarty International Center; Office of AIDS Research [3R25TW009345]; Gilead Sciences; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002319]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD071788] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Washington Center for AIDS Research (CFAR); Fogarty Fellowship - Fogarty International Center; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by K23 HD071788-01A1 (ACR) from NICHD, by a New Investigator Award to ACR from the University of Washington Center for AIDS Research (CFAR) (P30 AI027757), and by a Fogarty Fellowship to EMM, funded by the Fogarty International Center and the Office of AIDS Research (3R25TW009345). EMM also received a travel award from Gilead Sciences. Analysis of HIV drug resistance was performed with assistance of the Clinical and Retrovirology Research Core and the Molecular Profiling and Computational Biology Core of the UW CFAR (P30 AI027757). Study data were collected and managed using REDCap electronic data capture tools hosted at the Institute of Translational Health Sciences, supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR002319). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002; Bispo S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21251; Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd; Council NAC, 2014, KEN AIDS RESP PROGR; Davis NL, 2016, JAIDS-J ACQ IMM DEF, V73, P572, DOI 10.1097/QAI.0000000000001145; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Gill MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168671; Graham SM, 2012, JAIDS-J ACQ IMM DEF, V60, P511, DOI 10.1097/QAI.0b013e31825bd703; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Kamuyango Alfred A, 2014, World J AIDS, V4, P332; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Koss CA, 2017, JAIDS-J ACQ IMM DEF, V74, P279, DOI 10.1097/QAI.0000000000001228; Landes M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3380-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McGrath CJ, 2018, AIDS CARE, V30, P765, DOI 10.1080/09540121.2017.1400642; Micek MA, 2012, J INFECT DIS, V205, P1811, DOI 10.1093/infdis/jis282; Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151; Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4; Mwau M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183860; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Panteleeff DD, 2002, J CLIN MICROBIOL, V40, P3929, DOI 10.1128/JCM.40.11.3929-3937.2002; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, FAST TRACK AIDS FREE; UNICEF, 2017, HIV EP CHILDR AD; Westreich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022778; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2015, GUID START ANT THER	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216252	10.1371/journal.pone.0216252	http://dx.doi.org/10.1371/journal.pone.0216252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150396	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100016
J	Esquerda-Canals, G; Marti-Clua, J; Villegas, S				Esquerda-Canals, Gisela; Marti-Clua, Joaquim; Villegas, Sandra			Pharmacokinetic parameters and mechanism of action of an efficient anti-A beta single chain antibody fragment	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; VARIABLE FRAGMENT; 3XTG-AD MICE; MOUSE MODEL; AMYLOID DEPOSITION; IMMUNOTHERAPY; IMMUNIZATION; STABILITY; TRIALS	The success of the targeting of amyloid-beta (A beta) oligomers through immunotherapy in Alzheimer's disease (AD) mouse models has not been translated into the clinics. The use of single-chain variable fragments (scFvs) has been proposed to prevent the potential severe effects of full-length mAbs by precluding crystallizable fraction-mediated microglia activation. The efficacy of scFv-h3D6, a bapineuzumab-derived anti-A beta scFv, has been extensively proven. In this work, we compared scFv-h3D6-EL, an elongated variant of the scFv-h3D6, with its original version to assess whether its characteristic higher thermodynamic stability improved its pharmacokinetic parameters. Although scFv-h3D6-EL had a longer half-life than its original version, its absorption from the peritoneal cavity into the systemic compartment was lower than that of the original version. Moreover, we attempted to determine the mechanism underlying the protective effect of scFv-h3D6. We found that scFv-h3D6 showed compartmental distribution and more interestingly crossed the blood-brain barrier. In the brain, scFv-h3D6 was engulfed by glial cells or internalized by A beta peptide-containing neurons in the early phase post-injection, and was colocalized with the A beta peptide almost exclusively in glial cells in the late phase post-injection. A beta peptide levels in the brain decreased simultaneously with an increase in scFv-h3D6 levels. This observation in addition to the increased tumor necrosis factor-a levels in the late phase post-injection suggested that the engulfment of A beta peptide/scFv-h3D6 complex extruded from large neurons by phagocytic cells was the mechanism underlying A beta peptide withdrawal. The mechanism of action of scFv-h3D6 demonstrates the effectivity of A beta-immunotherapy and lays the background for other studies focused on the finding of a treatment for AD.	[Esquerda-Canals, Gisela; Villegas, Sandra] Univ Autonoma Barcelona, Unitat Biociencies, Dept Bioquim & Biol Mol, Prot Design & Immunotherapy Grp, Cerdanyola Del Valles, Spain; [Esquerda-Canals, Gisela; Marti-Clua, Joaquim] Univ Autonoma Barcelona, Unitat Citol & Histol, Dept Biol Cellular Fisiol & Immunol, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Villegas, S (corresponding author), Univ Autonoma Barcelona, Unitat Biociencies, Dept Bioquim & Biol Mol, Prot Design & Immunotherapy Grp, Cerdanyola Del Valles, Spain.	sandra.villegas@uab.cat	Villegas, Sandra/ABF-8206-2021; Villegas, Sandra/D-8789-2011	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304	Instituto de Salud Carlos III [FIS-PI113-01330]; Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2017-89613]; Generalitat de Catalunya [2014-PROD00032]; FEDER; PIF-UAB student grant	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia, Industria y Competitividad (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); PIF-UAB student grant	SV received grants from the Instituto de Salud Carlos III [FIS-PI113-01330], the Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2017-89613], & the Generalitat de Catalunya [2014-PROD00032], all three co-funded by FEDER. GEC received a PIF-UAB student grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BENET LZ, 1984, EUR J RESPIR DIS, V65, P45; Boado RJ, 2010, BIOTECHNOL BIOENG, V105, P627, DOI 10.1002/bit.22576; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Das P, 2003, J NEUROSCI, V23, P8532; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V59, P1079, DOI 10.3233/JAD-170218; Esquerda-Canals G, 2013, MABS-AUSTIN, V5, P660, DOI 10.4161/mabs.25428; Fernandez-Funez P, 2015, HUM MOL GENET, V24, P6093, DOI 10.1093/hmg/ddv321; Franklin K. B. J., 2012, MOUSE BRAIN STEREOTA; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Fuller JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00235; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Gimenez-Llort L, 2013, MABS-AUSTIN, V5, P665, DOI 10.4161/mabs.25424; Guell-Bosch J., 2017, DIAGNOSTIC MONITORIT; Guell-Bosch J, 2016, FRONT CLIN DRUG RES, V4, P3; Guell-Bosch J, 2016, NEURODEGENER DIS MAN, V6, P179, DOI 10.2217/nmt-2016-0006; Harrison JR, 2016, BRIT J PSYCHIAT, V208, P1, DOI 10.1192/bjp.bp.115.167569; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang L, 2013, INT J MOL SCI, V14, P19109, DOI 10.3390/ijms140919109; Iwata A, 2013, NEUROL CLIN NEUROSCI, V1, P49, DOI 10.1002/ncn3.20; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Lee G, 2015, MOL CELLS, V38, P773, DOI 10.14348/molcells.2015.0073; Maier WE, 1997, NEUROCHEM INT, V30, P385, DOI 10.1016/S0197-0186(96)00073-3; Manoutcharian K, 2017, CURR NEUROPHARMACOL, V15, P779, DOI 10.2174/1570159X01666160930121647; Marin-Argany M, 2011, BIOCHEM J, V437, P25, DOI 10.1042/BJ20101712; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Monnier PP, 2013, ANTIBODIES, V2, P193, DOI 10.3390/antib2020193; Montoliu-Gaya L, 2018, BIOCHEM PHARMACOL, V155, P380, DOI 10.1016/j.bcp.2018.07.012; Montoliu-Gaya L, 2017, AMYLOID, V24, P167, DOI 10.1080/13506129.2017.1348347; Montoliu-Gaya L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181480; Montoliu-Gaya L, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.11; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Panza F, 2012, IMMUNOTHERAPY-UK, V4, P213, DOI [10.2217/IMT.11.170, 10.2217/imt.11.170]; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ramm K, 1999, J MOL BIOL, V290, P535, DOI 10.1006/jmbi.1999.2854; Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382; Robert R, 2012, ARCH BIOCHEM BIOPHYS, V526, P132, DOI 10.1016/j.abb.2012.02.022; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Wang YJ, 2009, NEUROBIOL AGING, V30, P364, DOI 10.1016/j.neurobiolaging.2007.06.013; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wisniewski T, 2014, BIOCHEM PHARMACOL, V88, P499, DOI 10.1016/j.bcp.2013.12.020; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217793	10.1371/journal.pone.0217793	http://dx.doi.org/10.1371/journal.pone.0217793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150495	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100112
J	Holzer, J				Holzer, Joshua			Reevaluating the presidential runoff rule: Does a provision promote the protection of human rights?	PLOS ONE			English	Article							WESTERN DEMOCRACIES; VOTER IDEOLOGY; COALITIONS; ELECTIONS; PLURALITY	In recent years, an increasing number of democracies have adopted a runoff rule to elect their president. Some have argued, however, that the benefits of such a rule are dubious at best. In this article, I seek to counter this claim, as I posit that a runoff rule promotes the protection of human rights by reducing outcomes that are negatively associated with high government respect for human rights. Using ordered logistic regression and an analysis of predicted probabilities, I find that democratic presidential elections held using a runoff rule produce presidents that are less likely to be associated with lower government respect for human rights, and more likely to be associated with greater government respect for human rights. I conclude by suggesting that politicians should consider embracing a presidential runoff rule, as its adoption could be a relatively easy way to reduce repression.	[Holzer, Joshua] Westminster Coll, Fulton, MO 65251 USA		Holzer, J (corresponding author), Westminster Coll, Fulton, MO 65251 USA.	joshua.holzer@gmail.com	Holzer, Joshua/V-8840-2019	Holzer, Joshua/0000-0002-3024-3703				Banks A.S., 2009, POLITICAL HDB WORLD; Banks A.S., 2010, POLITICAL HDB WORLD; Banks A.S., 2012, POLITICAL HDB WORLD; Banks A.S., 2008, POLITICAL HDB WORLD; Banks A. S., 2003, POLITICAL HDB WORLD; Banks A. S., 2011, POLITICAL HDB WORLD; Banks A.S., 2005, POLITICAL HDB WORLD; Bertoa FC, DATABASE WHO GOVERNS; Bormann NC, 2013, ELECT STUD, V32, P360, DOI 10.1016/j.electstud.2013.01.005; Boulding KE, 1966, EC ANAL; Bouton L, 2015, THEOR ECON, V10, P283, DOI 10.3982/TE1642; Bouton L, 2013, AM ECON REV, V103, P1248, DOI 10.1257/aer.103.4.1248; Brusco S, 2012, GAME ECON BEHAV, V74, P447, DOI 10.1016/j.geb.2011.08.004; Cheibub JA, 2004, BRIT J POLIT SCI, V34, P565, DOI 10.1017/S0007123404000195; Cingranelli David, CINGRANELLI RICHARDS; COX GW, 1987, AM J POLIT SCI, V31, P82, DOI 10.2307/2111325; Davenport C, 2004, AM J POLIT SCI, V48, P538, DOI 10.1111/j.0092-5853.2004.00086.x; Downs A., 1957, EC THEORY DEMOCRACY; Doyle D, 2016, BRIT J POLIT SCI, V46, P731, DOI 10.1017/S0007123414000465; Freudenreich J, 2016, LAT AM POLIT SOC, V58, P80, DOI 10.1111/laps.12003; Holzer J, 2019, POLIT SCI, V70, P253, DOI 10.1080/00323187.2018.1560590; Holzer J, 2021, SOC SCI J, V58, P237, DOI 10.1016/j.soscij.2019.04.006; Holzer J, 2018, INT J HUM RIGHTS, V22, P1087, DOI 10.1080/13642987.2018.1499622; Holzer J, 2018, RES POLITICS, V5, DOI 10.1177/2053168018794753; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Kim H, 2003, EUR J POLIT RES, V42, P95, DOI 10.1111/1475-6765.00076; Kim HM, 1998, EUR J POLIT RES, V33, P73, DOI 10.1023/A:1006882806861; Lehmann P., 2017, MANIFESTO DATA COLLE, DOI [10.25522/manifesto.mpdssa.2017a, DOI 10.25522/MANIFESTO.MPDSSA.2017A]; Linz JJ., 1990, J DEMOCR, V1, P51, DOI [DOI 10.1353/jod.1990.0059, 10.1353/jod.1990.0011, DOI 10.1353/JOD.1990.0011]; Martinez-Gallardo C, 2015, COMP POLIT STUD, V48, P231, DOI 10.1177/0010414014544361; Mesquita BB, 2003, LOGIC OF POLITICAL SURVIVAL, P1; Muller T.C., 2013, POLITICAL HDB WORLD; Neto OA, 2006, COMP POLIT STUD, V39, P415, DOI 10.1177/0010414005282381; OSBORNE MJ, 1995, CAN J ECON, V28, P261, DOI 10.2307/136033; Perez-Linan A, 2006, ELECT STUD, V25, P129, DOI 10.1016/j.electstud.2005.04.002; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; SHUGART MS, 1994, COMP POLIT STUD, V27, P323, DOI 10.1177/0010414094027003001; Volkens Andrea, 2017, MANIFESTO DATA COLLE, DOI [10.25522/manifesto.mpds.2017a, DOI 10.25522/MANIFESTO.MPDS.2017A]; Volkerink B., 2001, EUROP J POLIT EC, V17, P157, DOI DOI 10.1016/S0176-2680(00)00033-1	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217650	10.1371/journal.pone.0217650	http://dx.doi.org/10.1371/journal.pone.0217650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150462	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100080
J	Mokhber, M; Shahrbabak, MM; Sadeghi, M; Shahrbabak, HM; Stella, A; Nicolzzi, E; Williams, JL				Mokhber, Mahdi; Shahrbabak, Mohammad Moradi; Sadeghi, Mostafa; Shahrbabak, Hossein Moradi; Stella, Alessandra; Nicolzzi, Ezequiel; Williams, John L.			Study of whole genome linkage disequilibrium patterns of Iranian water buffalo breeds using the Axiom Buffalo Genotyping 90K Array	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; CATTLE; PREDICTION; SELECTION; PHASE; DNA	Accuracy of genome-wide association studies, and the successful implementation of genomic selection depends on the level of linkage disequilibrium (LD) across the genome and also the persistence of LD phase between populations. In the present study LD between adjacent SNPs and LD decay between SNPs was calculated in three Iranian water buffalo populations. Persistence of LD phase was evaluated across these populations and effective population size (Ne) was estimated from corrected r(2) information. A set of 404 individuals from three Iranian buffalo populations were genotyped with the Axiom Buffalo Genotyping 90K Array. Average r(2) and vertical bar D'vertical bar between adjacent SNP pairs across all chromosomes was 0.27 and 0.66 for AZI, 0.29 and 0.68 for KHU, and 0.32 and 0.72 for MAZ. The LD between the SNPs decreased with increasing physical distance from 100Kb to 1Mb between markers, from 0.234 to 0.018 for AZI, 0.254 to 0.034 for KHU, and 0.297 to 0.119 for MAZ, respectively. These results indicate that a density of 90K SNP is sufficient for genomic analyses relying on long range LD (e.g. GWAS and genomic selection). The persistence of LD phase decreased with increasing marker distances across all the populations, but remained above 0.8 for AZI and KHU for marker distances up to 100Kb. For multi-breed genomic evaluation, the 90K SNP panel is suitable for AZI and KHU buffalo breeds. Estimated effective population sizes for AZI, KHU and MAZ were 477, 212 and 32, respectively, for recent generations. The estimated effective population sizes indicate that the MAZ is at risk and requires careful management.	[Mokhber, Mahdi] Urmia Univ, Fac Agr, Dept Anim Sci, Orumiyeh, Iran; [Shahrbabak, Mohammad Moradi; Sadeghi, Mostafa; Shahrbabak, Hossein Moradi] Univ Tehran, Univ Coll Agr & Nat Resources UTCAN, Fac Agr Sci & Engn, Dept Anim Sci, Karaj, Iran; [Stella, Alessandra; Nicolzzi, Ezequiel] Fdn Parco Tecnol Padano, Lodi, Italy; [Williams, John L.] Univ Adelaide, Sch Anim & Vet Sci, Davies Res Ctr, Roseworthy, SA, Australia	Urmia University; University of Tehran; University of Adelaide	Mokhber, M (corresponding author), Urmia Univ, Fac Agr, Dept Anim Sci, Orumiyeh, Iran.	m.mokhber@urmia.ac.ir	Mokhber, Mahdi/AHC-3549-2022; Stella, Alessandra/AAY-7322-2020; stella, Alessandra/ABB-1952-2021; mokhber, mahdi/AAD-1763-2022; Moradi Shahrbabak, Mohammad/AFQ-9131-2022; stella, Alessandra/AAG-6401-2021	stella, Alessandra/0000-0003-2850-3964; mokhber, mahdi/0000-0002-7184-8426; stella, Alessandra/0000-0003-2850-3964; Williams, John/0000-0001-5188-7957	Iran's Ministry of Agriculture-Jahad [2014-800/91/20, 2014-888, 2014-1049, 2014-92/487, 2014-289, 2014-91/120/1771]; Iranian Buffalo Genomics project; Towsee Kesht va Dam Noandish Alborz Co (Takdna)	Iran's Ministry of Agriculture-Jahad; Iranian Buffalo Genomics project; Towsee Kesht va Dam Noandish Alborz Co (Takdna)	This study was supported by Iranian Buffalo Genomics project with 2014-800/91/20, 2014-888, 2014-1049, 2014-92/487, 2014-289 and 2014-91/120/1771 research grants from Iran's Ministry of Agriculture-Jahad, and Towsee Kesht va Dam Noandish Alborz Co (Takdna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts CC, 2010, GENET MOL RES, V9, P2429, DOI 10.4238/vol9-4gmr1027; Amaral MEJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-631; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bellwood P, 2007, CAMB ARCHAEOL J, V17, P87, DOI 10.1017/S0959774307000078; Bibi F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-50; Biegelmeyer P, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0339-8; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Borquis RRA, 2014, GENET MOL RES, V13, P4202, DOI 10.4238/2014.June.9.6; Bradley DG, 1999, GENETICS OF CATTLE, P15; Brito LF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0220-1; Bush WS, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-7; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Calus MP, 2009, BIOMED CENTRAL, P1; Cardoso D, 2015, P 10 WORLD C GEN APP; Colli L, 2018, FRONTIERS GENETICS, V9; Colli L., 2016, WATER BUFFALO GENOMI; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Flury C, 2010, J ANIM BREED GENET, V127, P339, DOI 10.1111/j.1439-0388.2010.00862.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Iamartino D, 2013, BUFFALO GENOME APPL, P151; Iamartino D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185220; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Kierstein G, 2004, MOL PHYLOGENET EVOL, V30, P308, DOI 10.1016/S1055-7903(03)00221-5; LEWONTIN RC, 1964, GENETICS, V49, P49; MAIJALA K, 1992, FAO ANIM PR, V104, P73; Marques E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-45; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Meuwissen T, 2009, ACTA AGR SCAND A-AN, V59, P71, DOI 10.1080/09064700903118148; Meuwissen THE, 2001, GENETICS, V157, P1819; Mokhber M., 2015, IRANIAN J ANIMAL SCI, V46, P119; Mokhber M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4759-x; Mokry FB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S6; Nagarajan M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-68; Nicolazzi EL, 2014, BIOINFORMATICS, V30, P3118, DOI 10.1093/bioinformatics/btu486; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2002, GENETICS, V160, P1179; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Schrooten C, 2000, J DAIRY SCI, V83, P795, DOI 10.3168/jds.S0022-0302(00)74942-3; Silva C, 2010, EXTENT LINKAGE DISEQ; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; SVED J A, 1971, Theoretical Population Biology, V2, P125; Teare MD, 2002, ANN HUM GENET, V66, P223, DOI 10.1017/S0003480002001082; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Yindee M, 2010, ANIM GENET, V41, P433, DOI 10.1111/j.1365-2052.2010.02020.x	59	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217687	10.1371/journal.pone.0217687	http://dx.doi.org/10.1371/journal.pone.0217687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150486	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100086
J	Bueno, M; Zank, D; Buendia-Roldan, I; Fiedler, K; Mays, BG; Alvarez, D; Sembrat, J; Kimball, B; Bullock, JK; Martin, JL; Nouraie, M; Kaufman, BA; Rojas, M; Pardo, A; Selman, M; Mora, AL				Bueno, Marta; Zank, Daniel; Buendia-Roldan, Ivette; Fiedler, Kaitlin; Mays, Brenton G.; Alvarez, Diana; Sembrat, John; Kimball, Brian; Bullock, Jordan K.; Martin, James L.; Nouraie, Mehdi; Kaufman, Brett A.; Rojas, Mauricio; Pardo, Annie; Selman, Moises; Mora, Ana L.			PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; MITOCHONDRIAL-DNA; RECEPTOR 9; LUNG FIBROBLASTS; TGF-BETA; INFLAMMATION; ACTIVATION; NUCLEAR; STRESS	We have previously shown that endoplasmic reticulum stress (ER stress) represses the PTEN inducible kinase 1 (PINK1) in lung type II alveolar epithelial cells (AECII) reducing mitophagy and increasing the susceptibility to lung fibrosis. Although increased circulating mitochondrial DNA (mtDNA) has been reported in chronic lung diseases, the contribution of mitophagy in the modulation of mitochondrial DAMP release and activation of profibrotic responses is unknown. In this study, we show that ER stress and PINK1 deficiency in AECII led to mitochondrial stress with significant oxidation and damage of mtDNA and subsequent extracellular release. Extracellular mtDNA was recognized by TLR9 in AECII by an endocytic-dependent pathway. PINK1 deficiency-dependent mtDNA release promoted activation of TLR9 and triggered secretion of the profibrotic factor TGF-beta which was rescued by PINK1 overexpression. Enhanced mtDNA oxidation and damage were found in aging and IPF human lungs and, in concordance, levels of circulating mtDNA were significantly elevated in plasma and bronchoalveolar lavage (BAL) from patients with IPF. Free mtDNA was found elevated in other ILDs with low expression of PINK1 including hypersensitivity pneumonitis and autoimmune interstitial lung diseases. These results support a role for PINK1 mediated mitophagy in the attenuation of mitochondrial damage associated molecular patterns (DAMP) release and control of TGF-beta mediated profibrotic responses.	[Bueno, Marta; Zank, Daniel; Alvarez, Diana; Sembrat, John; Kimball, Brian; Bullock, Jordan K.; Nouraie, Mehdi; Rojas, Mauricio; Mora, Ana L.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Bueno, Marta; Alvarez, Diana; Mora, Ana L.] Univ Pittsburgh, Dept Med, Aging Inst, Pittsburgh, PA 15260 USA; [Bueno, Marta; Fiedler, Kaitlin; Mays, Brenton G.; Martin, James L.; Kaufman, Brett A.; Mora, Ana L.] Univ Pittsburgh, Dept Med, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Buendia-Roldan, Ivette; Rojas, Mauricio; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Sembrat, John; Kimball, Brian; Bullock, Jordan K.; Nouraie, Mehdi] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA USA; [Martin, James L.; Kaufman, Brett A.] Univ Pittsburgh, Dept Med, Div Cardiol, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA; [Rojas, Mauricio] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad Nacional Autonoma de Mexico	Mora, AL (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Mora, AL (corresponding author), Univ Pittsburgh, Dept Med, Aging Inst, Pittsburgh, PA 15260 USA.; Mora, AL (corresponding author), Univ Pittsburgh, Dept Med, Vasc Med Inst, Pittsburgh, PA 15260 USA.	anamora@pitt.edu	Nouraie, Seyed Mehdi/O-4071-2018; Bueno, Marta/GXM-7181-2022	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Bueno, Marta/0000-0001-7140-9899; Buendia, Ivette/0000-0002-8230-0749	NIH [1R01 HL123766-01, R01 HL131789-01]; Vascular Medicine Institute at the University of Pittsburgh; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123766, R01HL131789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vascular Medicine Institute at the University of Pittsburgh; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH 1 R01 HL131789-01 (ALM), NIH 1R01 HL123766-01 (MR). This work was also supported in part by the Vascular Medicine Institute at the University of Pittsburgh, the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (ALM).	Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Bueno M, 2018, AGING CELL, V17, DOI 10.1111/acel.12720; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Evans Stephen O., 2016, Biology-Basel, V5, P39, DOI 10.3390/biology5040039; Fang F, 2016, ARTHRITIS RHEUMATOL, V68, P1989, DOI 10.1002/art.39655; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gabele E, 2008, BIOCHEM BIOPH RES CO, V376, P271, DOI 10.1016/j.bbrc.2008.08.096; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Gu XL, 2013, PLOS ONE, V8; Hammerling BC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14050; Hogaboam CM, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S3; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kim HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01142; Kirillov V, 2015, AM J PATHOL, V185, P943, DOI 10.1016/j.ajpath.2014.12.011; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Luckhardt TR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-18; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Meneghin A, 2008, HISTOCHEM CELL BIOL, V130, P979, DOI 10.1007/s00418-008-0466-z; Mora AL, 2017, NAT REV DRUG DISCOV, V16, P755, DOI 10.1038/nrd.2017.170; Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440; Moreira D, 2015, ONCOTARGET, V6, P17302, DOI 10.18632/oncotarget.4029; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nickerson KM, 2013, J IMMUNOL, V190, P3889, DOI 10.4049/jimmunol.1203525; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Ryu CW, 2017, AM J RESP CRIT CARE, V196, P1571, DOI 10.1164/rccm.201612-2480OC; Sanders Laurie H, 2018, Curr Protoc Toxicol, V76, pe50, DOI 10.1002/cptx.50; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sliter DA, 2018, NATURE; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231; Wei XW, 2015, CELL RES, V25, P237, DOI 10.1038/cr.2015.9; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Zannetti C, 2014, J IMMUNOL, V193, P3398, DOI 10.4049/jimmunol.1400249; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650	43	38	40	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218003	10.1371/journal.pone.0218003	http://dx.doi.org/10.1371/journal.pone.0218003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170232	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700092
J	Dekker, MM; Panja, D; Dijkstra, HA; Dekker, SC				Dekker, Mark M.; Panja, Debabrata; Dijkstra, Henk A.; Dekker, Stefan C.			Predicting transitions across macroscopic states for railway systems	PLOS ONE			English	Article							SOCIOTECHNICAL SYSTEMS; SIMULATION; TIME; BIFURCATION; MANAGEMENT; INNOVATION; NETWORKS; DELAYS	Railways are classic instances of complex socio-technical systems, whose defining characteristic is that they exist and function by integrating (continuous-time) interactions among technical components and human elements. Typically, unlike physical systems, there are no governing laws for describing their dynamics. Based purely on micro-unit data, here we present a data-driven framework to analyze macro-dynamics in such systems, leading us to the identification of specific states and prediction of transitions across them. It consists of three steps, which we elucidate using data from the Dutch railways. First, we form a dimensionally reduced phase-space by extracting a few relevant components, wherein relevance is proxied by dominance in terms of explained variance, as well as by persistence in time. Secondly, we apply a clustering algorithm to the reduced phase-space, resulting in the revelation of states of the system. Specifically, we identify 'rest' and 'disrupted' states, for which the system operations deviates respectively little and strongly from the planned timetable. Third, we define an early-warning metric based on the probability of transitions across states, predict whether the system is likely to transit from one state to another within a given time-frame and evaluate the performance of this metric using the Peirce skill score. Interestingly, using case studies, we demonstrate that the framework is able to predict large-scale disruptions up to 90 minutes beforehand with significant skill, demonstrating, for the railway companies, its potential to better track the evolution of large-scale disruptions in their networks. We discuss that the applicability of the three-step framework stretches to other systems as well-i.e., not only socio-technical ones-wherein real-time monitoring can help to prevent macro-scale state transitions, albeit the methods chosen to execute each step may depend on specific system-details.	[Dekker, Mark M.; Panja, Debabrata] Univ Utrecht, Dept Informat & Comp Sci, Princetonpl 5, NL-3584 CC Utrecht, Netherlands; [Dijkstra, Henk A.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Dept Phys, Princetonpl 5, NL-3584 CC Utrecht, Netherlands; [Dekker, Mark M.; Panja, Debabrata; Dijkstra, Henk A.] Univ Utrecht, Ctr Complex Syst Studies, Leuvenlaan 4, NL-3584 CE Utrecht, Netherlands; [Dekker, Stefan C.] Univ Utrecht, Copernicus Inst Sustainable Dev, Princetonlaan 8a, NL-3584 CB Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University	Dekker, MM (corresponding author), Univ Utrecht, Dept Informat & Comp Sci, Princetonpl 5, NL-3584 CC Utrecht, Netherlands.; Dekker, MM (corresponding author), Univ Utrecht, Ctr Complex Syst Studies, Leuvenlaan 4, NL-3584 CE Utrecht, Netherlands.	m.m.dekker@uu.nl	Panja, Debabrata/C-9062-2009	Panja, Debabrata/0000-0003-2141-9735; Dekker, Mark/0000-0002-3543-6889	Netherlands Organization for Scientific Research (NWO); Dutch Railways (NS); ProRail	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Railways (NS); ProRail	The authors gratefully acknowledge financial support from the Netherlands Organization for Scientific Research (NWO), the Dutch Railways (NS), and ProRail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge financial support from the Netherlands Organization for Scientific Research (NWO), the Dutch Railways (NS), and ProRail. They also thank NS and ProRail for many useful discussions and the availability of data.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Ashwin P, 2012, PHILOS T R SOC A, V370, P1166, DOI 10.1098/rsta.2011.0306; Ball RC, 2016, WARWICK RES ARCH; Bathiany S, 2012, CLIM DYNAM, V38, P1775, DOI 10.1007/s00382-011-1037-x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Chen V., 2009, INT J SCI TECHNIQUES, V3, P1054; Corman F, 2018, TRANSPORT RES C-EMER, V95, P599, DOI 10.1016/j.trc.2018.08.003; Corman F, 2014, J INTELL TRANSPORT S, V18, P106, DOI 10.1080/15472450.2013.801714; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dekker M.M., 2018, C ADV SYST PUBL TRAN; Dermody BJ, 2018, EARTH SYST DYNAM, V9, P103, DOI 10.5194/esd-9-103-2018; Gambardella LM, 2002, SIMUL-T SOC MOD SIM, V78, P293, DOI 10.1177/0037549702078005551; Geels FW, 2004, RES POLICY, V33, P897, DOI 10.1016/j.respol.2004.01.015; Ghaemi N., 2018, SHORT TURNING TRAINS; Goverde RMP, 2010, TRANSPORT RES C-EMER, V18, P269, DOI 10.1016/j.trc.2010.01.002; Hekkert MP, 2007, TECHNOL FORECAST SOC, V74, P413, DOI 10.1016/j.techfore.2006.03.002; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Jespersen-Groth J, 2009, LECT NOTES COMPUT SC, V5868, P399, DOI 10.1007/978-3-642-05465-5_18; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kecman P, 2015, PUBLIC TRANSPORT, V7, P295, DOI 10.1007/s12469-015-0106-7; Kecman P, 2015, IEEE T INTELL TRANSP, V16, P465, DOI 10.1109/TITS.2014.2347136; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Lessan J, 2019, COMPUT IND ENG, V127, P1214, DOI 10.1016/j.cie.2018.03.017; Li DW, 2016, J ADV TRANSPORT, V50, P877, DOI 10.1002/atr.1380; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Markovic N, 2015, TRANSPORT RES C-EMER, V56, P251, DOI 10.1016/j.trc.2015.04.004; Middelkoop AD, 2006, WIT TRANS BUILT ENV, V88, P501, DOI 10.2495/CR060501; Middelkoop D, 2012, P WINT SIM C, P1; Monechi B, 2017, COMPLEX DELAY DYNAMI; Nash A, 2004, ADV TRANSPORT, V15, P45; Nederlandse Spoorwegen ProRail Ministerie van Infrastructuur en Milieu, 2012, PRORAIL MIN INFR MIL; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oneto L, 2017, IEEE T SYST MAN CY-S, V47, P2754, DOI 10.1109/TSMC.2017.2693209; Peirce C S, 1884, Science, V4, P453, DOI 10.1126/science.ns-4.93.453-a; Righi AW, 2012, WORK, V41, P1811, DOI 10.3233/WOR-2012-0390-1811; Sahin I, 2017, J RAIL TRANSPORT PLA, V7, P101, DOI 10.1016/j.jrtpm.2017.08.006; Scarpino SV, 2017, PREDICTABILITY INFEC; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schobel A, 2012, OR SPECTRUM, V34, P491, DOI 10.1007/s00291-011-0251-6; Sebille E, 2012, ORIGIN DYNAMICS EVOL, V7; Sobkowicz P, 2012, GOV INFORM Q, V29, P470, DOI 10.1016/j.giq.2012.06.005; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tantet A, 2015, CHAOS, V25, DOI 10.1063/1.4908174; Thompson JMT, 2011, IMA J APPL MATH, V76, P27, DOI 10.1093/imamat/hxq060; Ulam S.M., 2004, PROBLEMS MODERN MATH; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217710	10.1371/journal.pone.0217710	http://dx.doi.org/10.1371/journal.pone.0217710			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170230	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700050
J	Karami, K; Zerehdaran, S; Javadmanesh, A; Shariati, MM; Fallahi, H				Karami, Keyvan; Zerehdaran, Saeed; Javadmanesh, Ali; Shariati, Mohammad Mandi; Fallahi, Hossein			Characterization of bovine (Bos taurus) imprinted genes from genomic to amino acid attributes by data mining approaches	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; DIRECT REPEAT ELEMENT; CODON USAGE; DNA METHYLATION; EXPRESSION LEVELS; X-CHROMOSOME; RNA; GENERATION; GROWTH; H19	Genomic imprinting results in monoallelic expression of genes in mammals and flowering plants. Understanding the function of imprinted genes improves our knowledge of the regulatory processes in the genome. In this study, we have employed classification and clustering algorithms with attribute weighting to specify the unique attributes of both imprinted (monoallelic) and biallelic expressed genes. We have obtained characteristics of 22 known monoallelically expressed (imprinted) and 8 biallelic expressed genes that have been experimentally validated alongside 208 randomly selected genes in bovine (Bos taurus). Attribute weighting methods and various supervised and unsupervised algorithms in machine learning were applied. Unique characteristics were discovered and used to distinguish mono and biallelic expressed genes from each other in bovine. To obtain the accuracy of classification, 10-fold cross-validation with concerning each combination of attribute weighting (feature selection) and machine learning algorithms, was used. Our approach was able to accurately predict mono and biallelic genes using the genomics and proteomics attributes.	[Karami, Keyvan; Zerehdaran, Saeed; Javadmanesh, Ali; Shariati, Mohammad Mandi] Ferdowsi Univ Mashhad, Dept Anim Sci, Fac Agr, Mashhad, Razavi Khorasan, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran	Ferdowsi University Mashhad; Razi University	Zerehdaran, S (corresponding author), Ferdowsi Univ Mashhad, Dept Anim Sci, Fac Agr, Mashhad, Razavi Khorasan, Iran.	zerehdaran@um.ac.ir	Javadmanesh, Ali/P-6065-2015; Karami, Keyvan/AAN-1498-2021; Zerehdaran, Saeed/G-8323-2017	Javadmanesh, Ali/0000-0001-6016-5905; Zerehdaran, Saeed/0000-0002-8073-8798; Fallahi, Hossein/0000-0002-8754-3491; Shariati, Mohammad Mahdi/0000-0003-4136-6634; Karami, Keyvan/0000-0002-1875-6741				Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Akashi H, 2003, GENETICS, V164, P1291; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angermueller C, 2017, BIORXIV; Armstrong L., 2013, EPIGENETICS; Bai L, 2011, PATTERN RECOGN, V44, P2843, DOI 10.1016/j.patcog.2011.04.024; Barahimipour R, 2015, PLANT J, V84, P704, DOI 10.1111/tpj.13033; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Beiki AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044164; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen ZY, 2016, EPIGENETICS-US, V11, P501, DOI 10.1080/15592294.2016.1184805; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; Cowley M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018953; Dahl G.E., 2014, ARXIV; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; EICKHOLT J, 2013, BMC BIOINFORMATICS, V14; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hiraoka Y, 2009, GENES CELLS, V14, P499, DOI 10.1111/j.1365-2443.2009.01284.x; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Imumorin IG, 2012, LIVESTOCK EPIGENETICS, P89; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Khatib H, 2007, MAMM GENOME, V18, P538, DOI 10.1007/s00335-007-9039-z; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Lewis A, 2004, MOL CELL BIOL, V24, P5650, DOI 10.1128/MCB.24.13.5650-5656.2004; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; MacQueen J, 1967, PROCEEDINGS OF THE F; Mannens M., 1994, European Journal of Human Genetics, V2, P3; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; McCallum A., 1998, AAAI 98 WORKSH LEARN; Michalski R S., 2013, MACHINE LEARNING ART; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rainier S, 1993, RELAXATION OF IMPRIN; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reed MR, 2001, MAMM GENOME, V12, P873, DOI 10.1007/s00335-001-2027-9; Rokach L, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P149, DOI 10.1007/978-0-387-09823-4_9; Sharp PM, 1993, CODON USAGE MUTATION; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Sonderby S.K., 2014, ARXIV14127828; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tan SB, 2008, EXPERT SYST APPL, V34, P2622, DOI 10.1016/j.eswa.2007.05.028; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Tian FL, 2012, MOL MED REP, V5, P1536, DOI 10.3892/mmr.2012.833; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Uyar A, 2014, CURR OPIN OBSTET GYN, V26, P210, DOI 10.1097/GCO.0000000000000071; Velmurugan T., 2010, Journal of Computer Sciences, V6, P363, DOI 10.3844/jcssp.2010.363.368; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang K, 2015, PROCEEDINGS OF THE 6; Wang LJ, 2006, PLANT MOL BIOL, V61, P699, DOI 10.1007/s11103-006-0041-8; Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18; Wei YJ, 2014, DEVELOPMENT, V141, P2516, DOI 10.1242/dev.105320; Yang XF, 2016, BRIEF FUNCT GENOMICS, V15, P399, DOI 10.1093/bfgp/elw013; Yoon HR, 2002, YONSEI MED J, V43, P557, DOI 10.3349/ymj.2002.43.5.557; Zeng J, 2010, GENOME BIOL EVOL, V2, P770, DOI 10.1093/gbe/evq060; Zeng X, 2004, NEUR NETW 2004 P 200; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113; Zycinski G, 2011, ENG MED BIOL SOC EMB	81	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217813	10.1371/journal.pone.0217813	http://dx.doi.org/10.1371/journal.pone.0217813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170205	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700059
J	Adu, MD; Malabu, UH; Malau-Aduli, AEO; Malau-Aduli, BS				Adu, Mary D.; Malabu, Usman H.; Malau-Aduli, Aduli E. O.; Malau-Aduli, Bunmi S.			Enablers and barriers to effective diabetes self-management: A multi-national investigation	PLOS ONE			English	Article							GLYCEMIC CONTROL; CARE; EDUCATION; EFFICACY; COMPLICATIONS; HYPOGLYCEMIA; FACILITATORS; ASSOCIATION; TECHNOLOGY; INTERVIEWS	Objective The study aimed to identify the common gaps in skills and self-efficacy for diabetes self-management and explore other factors which serve as enablers of, and barriers to, achieving optimal diabetes self-management. The information gathered could provide health professionals with valuable insights to achieving better health outcomes with self-management education and support for diabetes patients. Methods International online survey and telephone interviews were conducted on adults who have type 1 or type 2 diabetes. The survey inquired about their skills and self-efficacy in diabetes self-management, while the interviews assessed other enablers of, and barriers to, diabetes self-management. Surveys were analysed using descriptive and inferential statistics. Interviews were analysed using inductive thematic analysis. Results Survey participants (N = 217) had type 1 diabetes (38.2%) or type 2 diabetes (61.8%), with a mean age of 44.56 SD 11.51 and were from 4 continents (Europe, Australia, Asia, America). Identified gaps in diabetes self-management skills included the ability to: recognize and manage the impact of stress on diabetes, exercise planning to avoid hypoglycemia and interpreting blood glucose pattern levels. Self-efficacy for healthy coping with stress and adjusting medications or food intake to reach ideal blood glucose levels were minimal. Sixteen participants were interviewed. Common enablers of diabetes self-management included: (i) the will to prevent the development of diabetes complications and (ii) the use of technological devices. Issues regarding: (i) frustration due to dynamic and chronic nature of diabetes (ii) financial constraints (iii) unrealistic expectations and (iv) work and environment-related factors limited patients' effective self-management of diabetes. Conclusions Educational reinforcement using technological devices such as mobile application has been highlighted as an enabler of diabetes self-management and it could be employed as an intervention to alleviate identified gaps in diabetes self-management. Furthermore, improved approaches that address financial burden, work and environment-related factors as well as diabetes distress are essential for enhancing diabetes self-management.	[Adu, Mary D.; Malabu, Usman H.; Malau-Aduli, Bunmi S.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Malau-Aduli, Aduli E. O.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia	James Cook University; James Cook University	Adu, MD (corresponding author), James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia.	mary.adu@my.jcu.edu.au	Malau-Aduli, Aduli Enoch Othniel/C-2419-2014; Alletag, Maddelyn/AGZ-1346-2022	Malau-Aduli, Aduli Enoch Othniel/0000-0002-3660-7862; Adu, Damilola Mary/0000-0003-0046-9215	Australian Government International Research Training Program Scholarship	Australian Government International Research Training Program Scholarship	The first author of this study (MDA) is funded by the Australian Government International Research Training Program Scholarship. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Adu MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208942; Al-Rasheedi AAS, 2014, INT J HEALTH SCI-IJH, V8, P177, DOI 10.12816/0006084; Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309; [Anonymous], 2008, DIABETES EDUCATOR, V34, P445, DOI 10.1177/0145721708316625; Aronson R, 2018, DIABETES RES CLIN PR, V137, P128, DOI 10.1016/j.diabres.2017.10.028; Atak N, 2008, AUST J ADV NURS, V26, P66; Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bandura A., 1999, J COGN PSYCHOTHER, P158, DOI [10.1891/0889-8391.13.2.158, DOI 10.1891/0889-8391.13.2.158]; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Basu R, 2014, DIABETES TECHNOL THE, V16, P331, DOI 10.1089/dia.2014.0097; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burge MR, 2008, DIABETES SPECTR, V21, P112, DOI DOI 10.2337/DIASPECT.21.2.112; Byers D., 2016, J HLTH DISPARITIES R, V9, P164; Cagle Carolyn S., 2002, Ethnicity & Disease, V12, P555; Campbell DJT, 2017, DIABETES EDUCATOR, V43, P78, DOI 10.1177/0145721716679276; Carter P A, 1998, J Nurs Meas, V6, P195; Chao Jingdong, 2005, Res Social Adm Pharm, V1, P508, DOI 10.1016/j.sapharm.2005.09.002; Chen YQ, 2015, J DIABETES COMPLICAT, V29, P1228, DOI 10.1016/j.jdiacomp.2015.07.005; Cheng L, 2016, PATIENT PREFER ADHER, V10, DOI 10.2147/PPA.S94275; Chlebowy DO, 2013, WESTERN J NURS RES, V35, P703, DOI 10.1177/0193945912473370; Chlebowy DO, 2010, DIABETES EDUCATOR, V36, P897, DOI 10.1177/0145721710385579; Clark NM., 1991, SAGE J, V3, P3, DOI DOI 10.1177/089826439100300101; Cooper HC, 2003, HEALTH EDUC RES, V18, P191, DOI 10.1093/her/18.2.191; Creswell J. W., 2007, HDB MIXED METHODS SO, P209, DOI DOI 10.4135/9781506335193; Dou KL, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7886; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527; Ghazanfar Haider, 2016, Indian J Endocrinol Metab, V20, P506, DOI 10.4103/2230-8210.183472; Ghimire Saruna, 2017, Int Sch Res Notices, V2017, P1273084, DOI 10.1155/2017/1273084; Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Haas L, 2012, DIABETES EDUCATOR, V38, P619, DOI [10.1177/0145721712455997, 10.2337/dc12-1707]; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Heron KE, 2010, BRIT J HEALTH PSYCH, V15, P1, DOI 10.1348/135910709X466063; Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171; Hewson C, 2017, ETHICS GUIDELINES IN; Hunt CW, 2015, WORLD J DIABETES, V6, P225, DOI 10.4239/wjd.v6.i2.225; Hunt LM, 1998, J FAM PRACTICE, V46, P207; International Diabetes Federation, DIAB ATL; Iribarren SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170581; Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007; Jones L, 2014, J HEALTH PSYCHOL, V19, P441, DOI 10.1177/1359105312473786; Kaufman N, 2016, DIABETES TECHNOL THE, V18; Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Lim S, 2011, INT J MED INFORM, V80, pE189, DOI 10.1016/j.ijmedinf.2011.08.007; Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106; Mbuagbaw L, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0606-z; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Morowati -Sharifabad M, 2007, JSSU, V15, P85; Musselwhite K, 2007, INT J NURS STUD, V44, P1064, DOI 10.1016/j.ijnurstu.2006.05.014; Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063; Papatheodorou K, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/189525; Paterson B, 2000, Clin Nurs Res, V9, P402, DOI 10.1177/10547730022158663; Perlmuter LC, 2008, DIABETES CARE, V31, P2072, DOI 10.2337/dc08-1441; Persell SD, 2004, PREV MED, V39, P746, DOI 10.1016/j.ypmed.2004.02.045; Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Pouwer F, 2010, DISCOV MED, V9, P112; Povey RC, 2007, DIABETES EDUCATOR, V33, P931, DOI 10.1177/0145721707308408; Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schoenberg NE, 2001, J AGING HEALTH, V13, P443, DOI 10.1177/089826430101300401; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Toljamo M, 2001, J ADV NURS, V34, P780, DOI 10.1046/j.1365-2648.2001.01808.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van Keer RL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1158-4; Viswanathan V, 2005, DIABETES CARE, V28, P1019, DOI 10.2337/diacare.28.5.1019; WHO, 2018, TOP 10 CAUS DEATH; WHO Global Observatory for eHealth, 2011, MHEALTH NEW HORIZONS; Yoon KH, 2008, DIABETES RES CLIN PR, V79, P256, DOI 10.1016/j.diabres.2007.09.007	75	70	71	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217771	10.1371/journal.pone.0217771	http://dx.doi.org/10.1371/journal.pone.0217771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166971	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000470087800038
J	Ngowi, HA; Winkler, AS; Braae, UC; Mdegela, RH; Mkupasi, EM; Kabululu, ML; Lekule, FP; Johansen, MV				Ngowi, Helena Aminiel; Winkler, Andrea Sylvia; Braae, Uffe Christian; Mdegela, Robinson Hammerthon; Mkupasi, Ernatus Martin; Kabululu, Mwemezi Lutakyawa; Lekule, Faustin Peter; Johansen, Maria Vang			Taenia solium taeniosis and cysticercosis literature in Tanzania provides research evidence justification for control: A systematic scoping review	PLOS ONE			English	Review							PORCINE HELMINTH INFECTIONS; SUB-SAHARAN AFRICA; RISK-FACTORS; SOUTHERN HIGHLANDS; RURAL TANZANIA; MBULU DISTRICT; MBEYA REGION; PIGS; PREVALENCE; EPILEPSY	Background Despite Taenia solium taeniosis/cysticercosis (TSTC) having been put high on the global agenda of neglected tropical diseases (NTDs), which over the last years has received a lot of attention, there has been no control programmes in place in sub-Saharan Africa, a highly endemic region. This could be attributed to lack of awareness of many stakeholders on the burden and impact of T. solium. This information is essential in guiding TSTC policies, practices and research agendas as well as encouraging cross-sectoral collaboration in the control of this important zoonotic parasite using a One Health approach. National elimination of the parasite is the foundation for global eradication. This will require that substantial country-level information is provided to all key stakeholders. We have mapped out TSTC research evidence in Tanzania to inform on disease burden and potential for integrated control measures. Methodology/Principal findings A scoping review of all TSTC studies undertaken in Tanzania and published up to December 2018 was conducted. The articles were searched from PUBMED, AJOL, Google Scholar and Google in general. Fifty-one (51) articles met the inclusion criteria and were reviewed. Prevalence of taeniosis of 2.3% - 5.2% was estimated based on copro-antigen ELISA while human cysticercosis of >16% was estimated based on serum antigen ELISA (Ag-ELISA) or IgG Western Blot. Neurocysticercosis (NCC) contributed significantly to epilepsy in adults. Farm prevalence of porcine cysticercosis were 6.0% - 17.4% (lingual examination) and 1.5% - 33.3% (Ag-ELISA). Slaughter-slab prevalence were 0% - 18.2% (routine meat inspection). Lacking latrines, watering pigs with river or pond water, and feeding pigs with potato peels were associated with porcine cysticercosis prevalence. Washing hands by dipping method increased the risk of human cysticercosis. In 2012, the number of DALYs/1000 person-years for NCC-associated epilepsy was 0.7 (95% UI, 0.2-1.6), around 5 million USD (95% UI, 797,535-16,933,477) were spent due to NCC-associated epilepsy and nearly 3 million USD (95% UI, 1,095,960-5,366,038) were potentially lost due to porcine cysticercosis. Three rounds of annual treatment of school-age children with praziquantel significantly reduced prevalence of taeniosis and porcine cysticercosis. Health education was efficacious in improving knowledge and attitudes favourable for control of TSTC while a single dose of oxfendazole 30 mg/kg body weight was efficacious in eliminating T. solium cysticerci from pig musculature. Conclusions/Significance The observed high burden of TSTC and the significant contribution of NCC to epilepsy in Tanzania warrant urgent interventions. Evaluation of best control options should make use of disease transmission dynamics models such as cystiSim, taking into account findings from the field based intervention studies. In addition, locally adapted management guidelines for people suffering from NCC are urgently needed.	[Ngowi, Helena Aminiel; Mdegela, Robinson Hammerthon; Mkupasi, Ernatus Martin] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Winkler, Andrea Sylvia] Tech Univ Munich, Dept Neurol, Ctr Global Hlth, Munich, Germany; [Winkler, Andrea Sylvia] Univ Oslo, Ctr Global Hlth, Dept Community Med & Global Hlth, Inst Hlth & Soc, Oslo, Norway; [Braae, Uffe Christian] Ross Univ, Sch Vet Med, One Hlth Ctr Zoonoses & Trop Vet Med, Basseterre, St Kitts & Nevi; [Braae, Uffe Christian] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark; [Kabululu, Mwemezi Lutakyawa] Tanzania Livestock Res Inst TALIRI Uyole, Mbeya, Tanzania; [Lekule, Faustin Peter] Sokoine Univ Agr, Dept Anim Sci & Prod, Morogoro, Tanzania; [Johansen, Maria Vang] Univ Copenhagen, Dept Vet & Anim Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	Sokoine University of Agriculture; Technical University of Munich; University of Oslo; Statens Serum Institut; Sokoine University of Agriculture; University of Copenhagen	Ngowi, HA (corresponding author), Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania.	helenangowi@gmail.com	Braae, Uffe Christian/J-4720-2017; Ngowi, Helena/AAN-2659-2020	Braae, Uffe Christian/0000-0002-2743-4584; Ngowi, Helena/0000-0002-1379-700X	Rockefeller Foundation through the Bellagio Center Scientific Writing Residency 2018 programme	Rockefeller Foundation through the Bellagio Center Scientific Writing Residency 2018 programme	This study was partly funded by the Rockefeller Foundation through the Bellagio Center Scientific Writing Residency 2018 programme that supported HAN and RHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. In addition, there was not any other funding that was obtained from any other source.	Bao ME, 1995, J HELMINTHOL, V69, P270, DOI [10.1016/j.actatropica.2015.10.012, DOI 10.1016/J.ACTATROPICA.2015.10.012]; Blocher J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001185; Boa ME, 2006, VET PARASITOL, V139, P249, DOI 10.1016/j.vetpar.2006.02.012; Boa ME, 2002, VET PARASITOL, V106, P155, DOI 10.1016/S0304-4017(02)00037-7; Braae UC, 2014, PARASITE VECTOR, V7, P1; Braae UC, 2016, PLOS NEGLECT TROP D, V10, P1; Braae UC, 2017, ACTA TROP, V165, P246, DOI 10.1016/j.actatropica.2015.10.012; Braae Uffe Christian, 2016, Parasite Epidemiol Control, V1, P245; Braae UC, 2015, TROP ANIM HEALTH PRO, V47, P1523, DOI 10.1007/s11250-015-0892-6; Braae UC, 2015, VET PARASITOL, V214, P187, DOI 10.1016/j.vetpar.2015.08.009; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; COSTECH, 2016, RES PRIOR TANZ 2015; Eom KS, 2011, KOREAN J PARASITOL, V49, P399, DOI 10.3347/kjp.2011.49.4.399; Ertel RL, 2017, ACTA TROP, V165, P240, DOI 10.1016/j.actatropica.2015.10.022; Hunter E, 2015, TROP MED INT HEALTH, V20, P1171, DOI 10.1111/tmi.12529; Jarvis S, 2015, VET REC, V176, P85, DOI 10.1136/vr.h347; Johansen MV, 2017, PARASITOLOGY, V144, P59, DOI 10.1017/S0031182016000500; Kabululu ML, 2018, VET PARASITOL REG ST, V13, P64, DOI 10.1016/j.vprsr.2018.03.009; Kabululu ML, 2015, VET PARASITOL, V212, P460, DOI 10.1016/j.vetpar.2015.08.006; Kamuyu G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002908; Kavishe MDB, 2017, LIVEST RES RURAL DEV, V29, DOI [10.4236/aid.2012.23009, DOI 10.4236/AID.2012.23009]; Kay D., 2000, METHODOLOGY ASSESSME; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lipendele CP, 2015, TROP ANIM HEALTH PRO, V47, P1121, DOI 10.1007/s11250-015-0836-1; Makundi I, 2015, PORCINE CYSTICERCOSI; Maridadi A. F., 2011, International Journal of Animal and Veterinary Advances, V3, P196; Mkupasi E., 2018, TANZANIA VET, V35, P112; Mkupasi EM, 2015, J HELMINTHOL, V89, P559, DOI 10.1017/S0022149X14000418; Mkupasi EM, 2011, TROP ANIM HEALTH PRO, V43, P417, DOI 10.1007/s11250-010-9708-x; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Mwang'onde B. J., 2012, ADV INFECT DIS, V2, P62, DOI [10.4236/aid.2012.23009, DOI 10.4236/AID.2012.23009]; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwidunda SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118541; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi H. A., 2011, Livestock Research for Rural Development, V23, P2; Ngowi HA, 2009, INT J HEALTH PROMOT, V47, P24, DOI 10.1080/14635240.2009.10708154; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Ngowi HA, 2007, LIVEST RES RURAL DEV, V19; Ngowi HA, 2016, LIVEST RES RURAL DEV, V28; Ngowi HA, 2015, INT J CURR RES, V7, P16959; Ngowi HA, 2007, IMPLEMENTATION EVALU, P24; Ngowi Helena A., 2014, Scientia Parasitologica, V15, P1; Ngowi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000652; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; NIMR, 2013, 4 TANZ NAT HLTH RES; Nkwengulila G., 2014, Health, V6, P2959, DOI 10.4236/health.2014.621334; Nsengwa G. R. M., 1995, Bulletin of Animal Health and Production in Africa, V43, P161; OIE, 2018, INF TAEN SOL PORC CY; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Schmidt V, 2015, AFR HEALTH SCI, V15, P58, DOI 10.4314/ahs.v15i1.8; Schmidt V, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0209-7; Shonyela Seria M, 2017, Parasite Epidemiol Control, V2, P35, DOI 10.1016/j.parepi.2017.09.002; Torgerson PR, 2018, ONE HEALTH-AMSTERDAM, V5, P40, DOI 10.1016/j.onehlt.2017.11.003; Trevisan C, 2017, GEN COMP ENDOCR, V246, P23, DOI 10.1016/j.ygcen.2017.03.007; Trevisan C, 2017, VET PARASITOL, V235, P69, DOI 10.1016/j.vetpar.2017.01.008; Trevisan C, 2017, ACTA TROP, V165, P141, DOI 10.1016/j.actatropica.2015.12.021; Trevisan C, 2016, VET PARASITOL, V220, P67, DOI 10.1016/j.vetpar.2016.02.025; WHO, 2013, WHO TECH REP SER, V976, P1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Winskill P, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1988-9; Yohana C., 2013, International Journal of Animal and Veterinary Advances, V5, P251	65	13	13	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217420	10.1371/journal.pone.0217420	http://dx.doi.org/10.1371/journal.pone.0217420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166983	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800027
J	Pereira, CM; Filev, R; Dubiela, FP; Brandao, BB; Queiroz, CM; Ludwig, RG; Hipolide, D; Longo, BM; Mello, LE; Mori, MA; Castilho, BA				Pereira, Catia M.; Filev, Renato; Dubiela, Francisco P.; Brandao, Bruna B.; Queiroz, Claudio M.; Ludwig, Raissa G.; Hipolide, Debora; Longo, Beatriz M.; Mello, Luiz E.; Mori, Marcelo A.; Castilho, Beatriz A.			The GCN2 inhibitor IMPACT contributes to diet-induced obesity and body temperature control	PLOS ONE			English	Article							PROTEIN-KINASE GCN2; AMINO-ACID CONTROL; EIF2-ALPHA KINASE; BINDING-PROTEIN; GI DOMAIN; ELF2-ALPHA; MOUSE; ASSOCIATION; ACTIVATION; IMPAIRS	IMPACT, a highly conserved protein, is an inhibitor of the eIF2 alpha kinase GCN2. In mammals, it is preferentially expressed in neurons. Knock-down of IMPACT expression in neuronal cells increases basal GCN2 activation and eIF2 alpha phosphorylation and decreases translation initiation. In the mouse brain, IMPACT is particularly abundant in the hypothalamus. Here we describe that the lack of IMPACT in mice affects hypothalamic functions. Impact(-/-) mice (Imp-KO) are viable and have no apparent major phenotypic defect. The hypothalamus in these animals shows increased levels of eIF2 alpha phosphorylation, as expected from the described role of IMPACT in inhibiting GCN2 and from its abundance in this brain region. When fed a normal chow, animals lacking IMPACT weight slightly less than wild-type mice. When fed a high-fat diet, Imp-KO animals gain substantially less weight due to lower food intake when compared to wild-type mice. STAT3 signaling was depressed in Imp-KO animals even though leptin levels were identical to the wild-type mice. This finding supports the observation that Imp-KO mice have defective thermoregulation upon fasting. This phenotype was partially dependent on GCN2, whereas the lean phenotype was independent of GCN2. Taken together, our results indicate that IMPACT contributes to GCN2-dependent and -independent mechanisms involved in the regulation of autonomic functions in response to energy availability.	[Pereira, Catia M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Filev, Renato; Longo, Beatriz M.; Mello, Luiz E.] Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil; [Dubiela, Francisco P.; Hipolide, Debora] Univ Fed Sao Paulo, Dept Psychobiol, Escola Paulista Med, Sao Paulo, Brazil; [Brandao, Bruna B.; Mori, Marcelo A.] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil; [Queiroz, Claudio M.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [Ludwig, Raissa G.; Mori, Marcelo A.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Filev, Renato] Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med, Sao Paulo, Brazil; [Brandao, Bruna B.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	bacastilho@unifesp.br	Hipolide, Debora/AAC-9970-2020; Queiroz, Claudio M/O-9549-2015; Castilho, Beatriz A/C-2503-2012; Brandao, Bruna/AAY-3939-2021; Checchinato, Catia/AAK-8775-2021; Monteiro Longo, Beatriz/D-2216-2012; Mello, Luiz/B-4177-2009; Mori, Marcelo/R-2881-2018	Hipolide, Debora/0000-0001-5657-3447; Queiroz, Claudio M/0000-0001-5573-7702; Castilho, Beatriz A/0000-0003-4509-5237; Brandao, Bruna/0000-0001-8762-6310; Monteiro Longo, Beatriz/0000-0002-2638-8061; Mello, Luiz/0000-0002-6969-1108; Mori, Marcelo/0000-0001-7112-5263; Guimaraes Ludwig, Raissa/0000-0002-8181-8503	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/52047-5, 02/13871-5, 07/53176-8, 12/04079-8]; Conselho Nacional de Pesquisa [309860/2011-3, 478903/2012-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa	Funded by BAC: 09/52047-5 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.BAC: 309860/2011-3 and 478903/2012-0 Conselho Nacional de Pesquisa. http://www.cnpq.br.CMP: 02/13871-5 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.FPD: 07/53176-8 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.BBB: 12/04079-8 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Donnelly N, 2013, CELL MOL LIFE SCI; Ferraz RC, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0301-2; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; Maurin AC, 2014, CELL REP, V6, P438, DOI 10.1016/j.celrep.2014.01.006; Methippara MM, 2009, AM J PHYSIOL-REG I, V296, pR178, DOI 10.1152/ajpregu.90765.2008; Murguia JR, 2012, IUBMB LIFE, V64, P971, DOI 10.1002/iub.1090; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; Silva RC, 2016, J CELL SCI, V129, P4521, DOI 10.1242/jcs.194738; Silva RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131070; Trinh MA, 2013, NEUROBIOL LEARN MEM; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217287	10.1371/journal.pone.0217287	http://dx.doi.org/10.1371/journal.pone.0217287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166980	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800023
J	Ceccarelli, C; De Leo, A; Chieco, P; Zamagni, C; Zamagni, A; Rubino, D; Taffurelli, M; Santini, D				Ceccarelli, Claudio; De Leo, Antonio; Chieco, Pasquale; Zamagni, Claudio; Zamagni, Alice; Rubino, Daniela; Taffurelli, Mario; Santini, Donatella			A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; RECURRENCE SCORE; PROGESTERONE-RECEPTOR; PRIMARY THERAPY; CANCER HIGHLIGHTS; PROGNOSTIC VALUE; LABELING INDEX; EXPRESSION; ASSAY; KI67	Aim Our goal has been to evaluate the importance that the incorporation of Bcl2 in the ER/PGR/Her2/Ki67 bio-profile can have as predictor of the Oncotype Dx categories. Material and methods 156 consecutive cases of HR+/Her2-pN0/1 primary breast carcinoma were sent to the Oncotype Dx test. Immunohistochemical determination of Bcl2/ER/PGR/Ki67/Her2 expression was evaluated for each case. After the selection of the appropriate cut-off values for PGR and Ki67, explorative as well as confirmative statistical analyses were performed to build and validate predictive risk-of-recurrence immunohistochemical only bioprofiles. Results The predictive capacity of these immunohistochemical profiles was compared with both traditional and TAILORx Oncotype Dx risk class classification. This comparison showed that immunohistochemical bio-profiles select those cases not associated with high risk-of-recurrence of disease (luminal-A/B and luminal A/B Bcl2) and those that are instead at high risk and therefore worthy of chemotherapy (luminal-B ki67 and luminal-B Bcl2/Ki67), strongly suggesting to only submit PGR-positive/Bcl2-Ki67 altered cases to Oncotype Dx, thus reducing the number of cases to be tested. Conclusions Our results indicate that the addition of Bcl2 to an immunohistochemical bio-profile definitely improves its predictive capacity to correctly select which cases to send to the Oncotype Dx test. We have also suggested that institutions with a significant number of breast carcinomas sent to the Oncotype Dx test can use these latter to derive their own PGR and Ki67 cutoff values, overcoming the drawbacks of sharing common inter-laboratory values. Validation of these bio-profiles as predictors of the Oncotype Dx categories is ongoing in a prospective series of new cases.	[Ceccarelli, Claudio; De Leo, Antonio] Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Chieco, Pasquale] Univ Bologna, St Orsola Malpighi Hosp, Unified Ctr Biomed Appl Res CRBA, Bologna, Italy; [Zamagni, Claudio; Rubino, Daniela] St Orsola Malpighi Hosp, Dept Hematol & Oncol, Breast Med Oncol Unit, Bologna, Italy; [Zamagni, Alice] St Orsola Malpighi Hosp, Radiat Oncol Unit, Bologna, Italy; [Taffurelli, Mario] Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Santini, Donatella] St Orsola Malpighi Hosp, Dept Diagnost & Prevent Med, Surg Pathol Unit, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Ceccarelli, C (corresponding author), Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.	claudio.ceccarelli@unibo.it	Santini, Donatella/AAO-1490-2021; De Leo, Antonio/ADG-3906-2022; Zamagni, Alice/HIR-2414-2022; ceccarelli, claudio/AAS-6105-2020	Santini, Donatella/0000-0002-1692-6348; De Leo, Antonio/0000-0002-3761-5135; Zamagni, Alice/0000-0001-8942-793X; ceccarelli, claudio/0000-0003-0743-2087				Amin MB, 2017, AJCC CANC STAGING MA, V8th, DOI [10.1007/978-3-319-40618-3_2, DOI 10.1007/978-3-319-40618-3_2, 10.1007/978-3-319-40618-3]; Chaudhary Lubna N, 2016, Hematol Oncol Stem Cell Ther, V9, P48, DOI 10.1016/j.hemonc.2015.12.001; Clark BZ, 2013, APPL IMMUNOHISTO M M, V21, P287, DOI 10.1097/PAI.0b013e31826f80c9; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; GEE JMW, 1994, INT J CANCER, V59, P619, DOI 10.1002/ijc.2910590508; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greenacre M., 1993, MULTIVARIATE ANAL FU; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hanna MG, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/1257078; Harbeck N, 2013, BREAST CARE, V8, P110, DOI 10.1159/000350777; Hwang KT, 2012, INT J CANCER, V131, pE1109, DOI 10.1002/ijc.27539; Jonsdottir K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090642; Kraus JA, 2012, MODERN PATHOL, V25, P869, DOI 10.1038/modpathol.2011.219; Le MG, 1999, INT J CANCER, V84, P562, DOI 10.1002/(SICI)1097-0215(19991222)84:6<562::AID-IJC4>3.0.CO;2-0; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Milburn M, 2013, BREAST J, V19, P357, DOI 10.1111/tbj.12126; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Orucevic A, 2017, BREAST CANCER RES TR, V163, P51, DOI 10.1007/s10549-017-4170-3; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park MM, 2014, BREAST J, V20, P37, DOI 10.1111/tbj.12223; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sahebjam S, 2011, BRIT J CANCER, V105, P1342, DOI 10.1038/bjc.2011.402; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Snekha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190348; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Tang P, 2010, CANCER INVEST, V28, P978, DOI 10.3109/07357907.2010.496754; Trere D, 2007, ANN ONCOL, V18, P1004, DOI 10.1093/annonc/mdm074; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217937	10.1371/journal.pone.0217937	http://dx.doi.org/10.1371/journal.pone.0217937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158261	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700035
J	MacAskill, MG; Walton, T; Williams, L; Morgan, TEF; Alcaide-Corral, CJ; Dweck, MR; Gray, GA; Newby, DE; Lucatelli, C; Sutherland, A; Pimlott, SL; Tavares, AAS				MacAskill, Mark G.; Walton, Tashfeen; Williams, Lewis; Morgan, Timaeus E. F.; Alcaide-Corral, Carlos Jose; Dweck, Marc R.; Gray, Gillian A.; Newby, David E.; Lucatelli, Christophe; Sutherland, Andrew; Pimlott, Sally L.; Tavares, Adriana A. S.			Kinetic modelling and quantification bias in small animal PET studies with [F-18]AB5186, a novel 18 kDa translocator protein radiotracer	PLOS ONE			English	Article							INPUT FUNCTION; NEUROINFLAMMATION; INFLAMMATION; TSPO; BINDING; NOMENCLATURE; MICROGLIA; TARGET; BLOOD	Introduction Positron Emission Tomography (PET) imaging with selective 18 kDa translocator protein (TSPO) radiotracers has contributed to our understanding on the role of inflammation in disease development and progression. With an increasing number of rodent models of human disease and expansion of the preclinical PET imaging base worldwide, accurate quantification of longitudinal rodent TSPO PET datasets is necessary. This is particularly relevant as TSPO PET quantification relies on invasive blood sampling due to lack of a suitable tissue reference region. Here we investigate the kinetics and quantification bias of a novel TSPO radiotracer [F-18]AB5186 in rats using automatic, manual and image derived input functions. Methods [F-18]AB5186 was administered intravenously and dynamic PET imaging was acquired over 2 hours. Arterial blood was collected manually to derive a population based input function or using an automatic blood sampler to derive a plasma input function. Manually sampled blood was also used to analyze the [F-18]AB5186 radiometabolite profile in plasma and applied to all groups as a population based dataset. Kinetic models were used to estimate distribution volumes (V-T) and [F-18]AB5186 outcome measure bias was determined. Results [F-18]AB5186 distribution in rats was consistent with TSPO expression and at 2 h post-injection 50% of parent compound was still present in plasma. Population based manual sampling methods and image derived input function (IDIF) underestimated V-T by similar to 50% and 88% compared with automatic blood sampling, respectively. The V-T variability was lower when using IDIF versus arterial blood sampling methods and analysis of the Bland-Altman plots showed a good agreement between methods of analysis. Conclusion Quantification of TSPO PET rodent data using image-derived methods, which are more amenable for longitudinal scanning of small animals, yields outcome measures with reduced variability and good agreement, albeit biased, compared with invasive blood sampling methods.	[MacAskill, Mark G.; Walton, Tashfeen; Alcaide-Corral, Carlos Jose; Dweck, Marc R.; Gray, Gillian A.; Newby, David E.; Tavares, Adriana A. S.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [MacAskill, Mark G.; Walton, Tashfeen; Alcaide-Corral, Carlos Jose; Lucatelli, Christophe; Tavares, Adriana A. S.] Univ Edinburgh, Edinburgh Imaging, Edinburgh, Midlothian, Scotland; [Williams, Lewis; Morgan, Timaeus E. F.; Sutherland, Andrew] Univ Glasgow, Sch Chem, WestCHEM, Glasgow, Lanark, Scotland; [Pimlott, Sally L.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Pimlott, Sally L.] NHS Greater Glasgow & Clyde, West Scotland PET Ctr, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow	Tavares, AAS (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.; Tavares, AAS (corresponding author), Univ Edinburgh, Edinburgh Imaging, Edinburgh, Midlothian, Scotland.	adriana.tavares@ed.ac.uk	Dweck, Marc/AAY-1509-2021; Pimlott, Sally Louise/F-8098-2010; Newby, David Ernest/AAB-1364-2019	Pimlott, Sally Louise/0000-0002-8396-3392; Sutherland, Andrew/0000-0001-7907-5766; Tavares, Adriana/0000-0001-7505-9144; Williams, Lewis/0000-0003-2404-1985; Morgan, Timaeus/0000-0003-0220-8879; dweck, marc/0000-0001-9847-5917	British Heart Foundation [BHF PG/16/12/32022, RE/13/3/30183]; Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award) [EP/K5039031]; Engineering and Physical Sciences Research Council (DTP studentship) [EP/M506539/1]; MRC [G0701127] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award); Engineering and Physical Sciences Research Council (DTP studentship); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors greatly acknowledge the British Heart Foundation (BHF PG/16/12/32022 and RE/13/3/30183) and the Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award, EP/K5039031 and DTP studentship to TEFM, EP/M506539/1) for providing the funding to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Baumgartner R, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0366-8; Bird JLE, 2010, ATHEROSCLEROSIS, V210, P388, DOI 10.1016/j.atherosclerosis.2009.11.047; Blair A, 2015, CHEM SCI, V6, P4772, DOI 10.1039/c5sc01647a; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Fang YHD, 2008, J NUCL MED, V49, P606, DOI 10.2967/jnumed.107.047613; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Gaemperli O, 2012, EUR HEART J, V33, P1902, DOI 10.1093/eurheartj/ehr367; Gerhard A, 2016, CLIN TRANSL IMAGING, V4, P183, DOI 10.1007/s40336-016-0171-1; Gulyas B, 2012, CURR RADIOPHARM, V5, P19, DOI 10.2174/1874471011205010019; Hannestad J, 2012, NEUROIMAGE, V63, P232, DOI 10.1016/j.neuroimage.2012.06.055; Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Lanz B, 2014, J NUCL MED, V55, P1380, DOI 10.2967/jnumed.113.127381; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Meyer M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168667; Njiwa JY, 2017, J CEREBR BLOOD F MET, V37, P1251, DOI 10.1177/0271678X16653615; Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Pain F, 2004, J NUCL MED, V45, P1577; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; RAYLMAN RR, 1993, J NUCL MED, V34, P440; Repalli Jayanthi, 2014, Curr Aging Sci, V7, P168; Roeda D, 2012, J FLUORINE CHEM, V134, P107, DOI 10.1016/j.jfluchem.2011.03.020; Roivainen A, 2009, EUR J NUCL MED MOL I, V36, P671, DOI 10.1007/s00259-008-1000-1; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Seki C, 1998, Ann Nucl Med, V12, P7; Thackeray JT, 2018, J AM COLL CARDIOL, V71, P263, DOI 10.1016/j.jacc.2017.11.024; Thackeray JT, 2015, J NUCL MED, V56, P1615, DOI 10.2967/jnumed.115.160820; Warnock G, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-13	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217515	10.1371/journal.pone.0217515	http://dx.doi.org/10.1371/journal.pone.0217515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150436	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000469759100061
J	Marandi, RZ; Madeleine, P; Omland, O; Vuillerme, N; Samani, A				Marandi, Ramtin Zargari; Madeleine, Pascal; Omland, Oyvind; Vuillerme, Nicolas; Samani, Afshin			An oculometrics-based biofeedback system to impede fatigue development during computer work: A proof-of-concept study	PLOS ONE			English	Article							TRAPEZIUS MUSCLE-ACTIVITY; REST BREAKS; MAIN-SEQUENCE; PATTERN; SLEEPINESS; EEG; CLASSIFICATION; RECOGNITION; VARIABILITY; PERFORMANCE	A biofeedback system may objectively identify fatigue and provide an individualized timing plan for micro-breaks. We developed and implemented a biofeedback system based on oculometrics using continuous recordings of eye movements and pupil dilations to moderate fatigue development in its early stages. Twenty healthy young participants (10 males and 10 females) performed a cyclic computer task for 31-35 min over two sessions: 1) self-triggered micro-breaks (manual sessions), and 2) biofeedback-triggered micro-breaks (automatic sessions). The sessions were held with one-week inter-session interval and in a counterbalanced order across participants. Each session involved 180 cycles of the computer task and after each 20 cycles (a segment), the task paused for 5-s to acquire perceived fatigue using Karolinska Sleepiness Scale (KSS). Following the pause, a 25-s microbreak involving seated exercises was carried out whether it was triggered by the biofeed-back system following the detection of fatigue (KSS >= 5) in the automatic sessions or by the participants in the manual sessions. National Aeronautics and Space Administration Task Load Index (NASA-TLX) was administered after sessions. The functioning core of the biofeed-back system was based on a Decision Tree Ensemble model for fatigue classification, which was developed using an oculometrics dataset previously collected during the same computer task. The biofeedback system identified fatigue with a mean accuracy of approx. 70%. Perceived workload obtained from NASA-TLX was significantly lower in the automatic sessions compared with the manual sessions, p = 0.01 Cohen's d(z) = 0.89. The results give support to the effectiveness of integrating oculometrics-based biofeedback in timing plan of micro-breaks to impede fatigue development during computer work.	[Marandi, Ramtin Zargari; Madeleine, Pascal; Omland, Oyvind; Vuillerme, Nicolas; Samani, Afshin] Aalborg Univ, Dept Hlth Sci & Technol, Sport Sci, Aalborg, Denmark; [Marandi, Ramtin Zargari; Vuillerme, Nicolas] Univ Grenoble Alpes, AGEIS, Grenoble, France; [Omland, Oyvind] Aalborg Univ Hosp, Danish Ramazzini Ctr, Clin Occupat Med, Aalborg, Denmark; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Aalborg University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Aalborg University; Aalborg University Hospital; Institut Universitaire de France	Samani, A (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Sport Sci, Aalborg, Denmark.	afsamani@hst.aau.dk	Madeleine, Pascal/AAD-3201-2021; Zargari Marandi, Ramtin/J-6868-2019; VUILLERME, Nicolas/U-5767-2019	Zargari Marandi, Ramtin/0000-0001-9233-1656; VUILLERME, Nicolas/0000-0003-3773-393X	VELUX FONDEN [00010912]	VELUX FONDEN(Velux Fonden)	This project was funded by the VELUX FONDEN (project number: 00010912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelall Esraa S., 2018, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V62, P1042, DOI 10.1177/1541931218621240; Ackerman P.L., 2011, COGNITIVE FATIGUE MU, P11, DOI [10.1037/12343-001, DOI 10.1037/12343-001]; Ahn S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00219; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2014, J SLEEP RES, V23, P240, DOI 10.1111/jsr.12158; Al Shalabi L, 2006, DEPCOS-RELCOMEX 2006, P207; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Bailey BP, 2000, IEEE SYS MAN CYBERN, P757, DOI 10.1109/ICSMC.2000.885940; Barredo RDV, 2007, J PHYS THER SCI, V19, P151, DOI 10.1589/jpts.19.151; Benchetrit G, 2000, RESP PHYSIOL, V122, P123, DOI 10.1016/S0034-5687(00)00154-7; Bouchard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036169; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burg JM, 2011, COGNITIVE THER RES, V35, P179, DOI 10.1007/s10608-010-9343-x; Caffier PP, 2003, EUR J APPL PHYSIOL, V89, P319, DOI 10.1007/s00421-003-0807-5; Cao A, 2009, BEHAV RES METHODS, V41, P113, DOI 10.3758/BRM.41.1.113; Cazzoli D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087146; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chuang CH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00181; Clemes SA, 2004, INFLUENCE MENSTRUAL; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colligan TW, 2006, J WORKPLACE BEHAV HE, V21, P89, DOI 10.1300/J490v21n02_07; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; Comision Nacional Evaluadora de la Actividad Investigadora (CNEAI), 2011, PATTERN CLASSIFICATI, DOI DOI 10.1007/BF01237942; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Dawson D, 2011, ACCIDENT ANAL PREV, V43, P549, DOI 10.1016/j.aap.2009.12.030; Deschodt-Arsac V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201388; Di Stasi LL, 2013, EUR REV APPL PSYCHOL, V63, P335, DOI 10.1016/j.erap.2013.09.001; Di Stasi LL, 2015, EXP BRAIN RES, V233, P599, DOI 10.1007/s00221-014-4139-y; Di Stasi LL, 2014, ANN SURG, V259, P824, DOI 10.1097/SLA.0000000000000260; Di Stasi LL, 2013, EUR J NEUROSCI, V38, P2389, DOI 10.1111/ejn.12248; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Di Stasi LL, 2012, TRANSPORT RES C-EMER, V21, P122, DOI 10.1016/j.trc.2011.07.002; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Epling SL, 2016, EXP BRAIN RES, V234, P2979, DOI 10.1007/s00221-016-4700-y; Esposito G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106705; Evers F.T., 1999, FUZZY CLUSTER ANAL M; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Feldman G, 2010, BEHAV RES THER, V48, P1002, DOI 10.1016/j.brat.2010.06.006; Felton EA, 2012, ERGONOMICS, V55, P526, DOI 10.1080/00140139.2012.662526; Ferguson DP, 2019, MED SCI SPORTS EXERC; Fogelton A, 2016, COMPUT VIS IMAGE UND, V148, P23, DOI 10.1016/j.cviu.2016.03.011; Freund Y, 2009, ARXIV09052138; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Gergelyfi M, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015,00176, 10.3389/fnbeh.2015.00176]; Ghaoui, 2006, ENCY HUMAN COMPUTER, P211, DOI [DOI 10.1016/B978-044451020-4/50031-1, DOI 10.4018/978-1-59140-562-7.CH034]; Giggins OM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-60; Grohn M, 2012, P 18 INT C AUD DISP, P18; Hallbeck MS, 2017, APPL ERGON, V60, P334, DOI 10.1016/j.apergo.2016.12.006; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; Hart SG., 2006, PROC HUM FACTORS ERG, V50, P904, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Helton WS, 2017, HUM FACTORS, V59, P91, DOI 10.1177/0018720816683509; Henderson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064937; HEUER H, 1989, Z EXP ANGEW PSYCHOL, V36, P538; James G., 1998, MAJORITY VOTE CLASSI; Januario LB, 2016, J ELECTROMYOGR KINES, V30, P196, DOI 10.1016/j.jelekin.2016.07.009; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Katnani HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051843; Kawczynski A, 2007, SCAND J MED SCI SPOR, V17, P172, DOI 10.1111/j.1600-0838.2006.00551.x; Kelso D, 2001, EFFECTS FREQUENT ACT; Kim S, 2017, J ORGAN BEHAV, V38, P28, DOI [10.1002/job.2109, 10.9728/dcs.2016.17.1.1]; KOTHARI SC, 1993, ADV COMPUT, V37, P119, DOI 10.1016/S0065-2458(08)60404-0; Kouchaki S, 2018, BIOMED ENG-APP BAS C, V30, DOI 10.4015/S1016237218500230; Krejtz K, 2016, ACM T APPL PERCEPT, V13, DOI 10.1145/2896452; Krolak A, 2012, UNIVERSAL ACCESS INF, V11, P409, DOI 10.1007/s10209-011-0256-6; Kuhnel J, 2017, EUR J WORK ORGAN PSY, V26, P481, DOI 10.1080/1359432X.2016.1269750; Laring J, 2002, INT J IND ERGONOM, V30, P135, DOI 10.1016/S0169-8141(02)00091-4; Lee KE, 2015, J ENVIRON PSYCHOL, V42, P182, DOI 10.1016/j.jenvp.2015.04.003; Liu CC, 2009, J SAFETY RES, V40, P239, DOI 10.1016/j.jsr.2009.04.005; Madeleine P, 2010, ACTA PHYSIOL, V199, P1, DOI 10.1111/j.1748-1716.2010.02145.x; Madeleine P, 2008, EUR J APPL PHYSIOL, V102, P325, DOI 10.1007/s00421-007-0589-2; Madeleine P, 2006, ERGONOMICS, V49, P921, DOI 10.1080/00140130600665828; Madeleine P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-226; Mahachandra M., 2011, INT J BASIC APPL SCI, V11, P87; Marandi Ramtin Zargari, 2019, Proceedings of the 20th Congress of the International Ergonomics Association (IEA 2018). Volume IX: Aging, Gender and Work, Anthropometry, Ergonomics for Children and Educational Environments. Advances in Intelligent Systems and Computing (AISC 826), P104, DOI 10.1007/978-3-319-96065-4_14; Marandi RZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31577-1; Marandi RZ, 2018, IEEE ACCESS, V6, P17500, DOI 10.1109/ACCESS.2018.2819211; Marandi RZ, 2015, BEHAV RES METHODS, V47, P1404, DOI 10.3758/s13428-014-0549-9; Marandi RZ, 2014, BASIC CLIN NEUROSCI, V5, P55; Marandi RZ., 2019, WAME1 0 STANDARDIZED, DOI [10.17605/OSF.IO/2FC7S, DOI 10.17605/OSF.IO/2FC7S]; McKee MG., 2008, CLEVE CLIN J MED, V2, pS31, DOI [10.3949/ccjm.75.Suppl_2.S31, DOI 10.3949/CCJM.75.SUPPL_2.S31]; McLean L, 2001, APPL ERGON, V32, P225, DOI 10.1016/S0003-6870(00)00071-5; Michaelis J, 2013, RESTORATIVE EFFECTS; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; Morris D, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1817; Nakanishi M, 2014, IEICE P SERIES, P114, DOI [10.15248/proc.1.114, DOI 10.15248/PROC.1.114]; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; Ogino M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18124477; Pimenta A, 2016, NEUROCOMPUTING, V172, P413, DOI 10.1016/j.neucom.2015.03.105; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; Prinsloo GE, 2013, APPL PSYCHOPHYS BIOF, V38, P45, DOI 10.1007/s10484-012-9207-0; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Puspasari MA, 2018, INT CONF INTEL INFOR, P66, DOI 10.1109/ICIIBMS.2018.8549999; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Ren Q, 2017, AIP CONF PROC, V1820, DOI 10.1063/1.4977376; RIGGS LA, 1987, INVEST OPHTH VIS SCI, V28, P334; Roy RN, 2014, BIOMED SIGNAL PROCES, V14, P256, DOI 10.1016/j.bspc.2014.08.007; Samani A, 2017, EXP BRAIN RES, V235, P389, DOI 10.1007/s00221-016-4798-y; Samani A, 2010, EUR J APPL PHYSIOL, V110, P415, DOI 10.1007/s00421-010-1515-6; Samani A, 2010, MED BIOL ENG COMPUT, V48, P865, DOI 10.1007/s11517-010-0651-9; Samani A, 2009, J ELECTROMYOGR KINES, V19, pE430, DOI 10.1016/j.jelekin.2008.11.011; Sampei K, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7020020; Satterfield BC, 2013, FATIGUE, V1, P118, DOI 10.1080/21641846.2013.798923; Schalen L, 1983, ACTA OTO-LARYNGOL, V96, P212, DOI [10.3109/00016488309123036, DOI 10.3109/00016488309123036]; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Shahid A, 2010, J PSYCHOSOM RES, V69, P81, DOI 10.1016/j.jpsychores.2010.04.001; Silvian S. Paul, 2011, International Journal of Enterprise Network Management, V4, P247; Solomon SR, 2009, J MOD APPL STAT METH, V8, P448, DOI 10.22237/jmasm/1257034080; Steinborn MB, 2016, APPL COGNITIVE PSYCH, V30, P795, DOI 10.1002/acp.3255; Swaen GMH, 2003, OCCUP ENVIRON MED, V60, P88; Szegletes L, 2014, 2014 5TH IEEE CONFERENCE ON COGNITIVE INFOCOMMUNICATIONS (COGINFOCOM), P295, DOI 10.1109/CogInfoCom.2014.7020465; Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080; Tucker P, 2003, WORK STRESS, V17, P123, DOI 10.1080/0267837031000155949; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Waersted Morten, 2010, BMC Musculoskelet Disord, V11, P79, DOI 10.1186/1471-2474-11-79; Wakui Hideki, 2014, JAPANESE SOC MED BIO, V51, P328; Wascher E, 2014, BIOL PSYCHOL, V96, P57, DOI 10.1016/j.biopsycho.2013.11.010; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Wickens C.D., 1991, MULTIPLE TASK PERFOR, V1991, P3, DOI [10.1201/9781003069447-2, DOI 10.1201/9781003069447-2]; Wilhelm B, 2010, SOMNOLOGIE, V14, P200, DOI DOI 10.1007/; Williamson A, 2013, FATIGUE, V1, P81, DOI 10.1080/21641846.2012.744581; Xiong JS, 2012, PHYSCS PROC, V33, P2011, DOI 10.1016/j.phpro.2012.05.316; Xu R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00915; Yamada Y., 2018, United States patent application, Patent No. [US15/345,876, 15345876]; Yamada Y, 2018, ARTIF INTELL MED, V91, P39, DOI 10.1016/j.artmed.2018.06.005; Yang GS, 2010, INFORM SCIENCES, V180, P1942, DOI 10.1016/j.ins.2010.01.011; Yorzinski JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32471; Yung M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188468; Zhang C, 2009, EXPERT SYST APPL, V36, P4664, DOI 10.1016/j.eswa.2008.06.022; Zhang C, 2010, POL J MED PHYS ENG, V16, P67, DOI 10.2478/v10013-010-0007-7; Zheng YL, 2014, IEEE T BIO-MED ENG, V61, P2179, DOI 10.1109/TBME.2014.2318779	132	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0213704	10.1371/journal.pone.0213704	http://dx.doi.org/10.1371/journal.pone.0213704			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150405	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100007
J	Shahid, A; Patel, VB; Morton, JS; Stenson, TH; Davidge, ST; Oudit, GY; McMurtry, MS				Shahid, Anmol; Patel, Vaibhav B.; Morton, Jude S.; Stenson, Trevor H.; Davidge, Sandra T.; Oudit, Gavin Y.; McMurtry, Michael S.			Low altitude simulation without hypoxia improves left ventricular function after myocardial infarction by reducing ventricular afterload	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MORTALITY; CARDIOPROTECTION; DYSFUNCTION; METOPROLOL; REDUCTION; STROKE; RATES	Humans have a lower risk of death from myocardial infarction (MI) living at low elevations (<2500 m), which are not high enough to induce hypoxia. Both chronic hypoxia pre-MI, achieved by altitude simulation >5000 m, and intermittent hypobaric hypoxia post-MI can reduce MI size in rodents, and it is believed that hypoxia is the key stimulus. To explore mechanisms beyond hypoxia we studied whether altitude simulation <2500 m would also be associated with reduced infarct size. We performed left-anterior descending artery ligation on C57BL6 mice. Control mice (n = 12) recovered at 754 mmHg (atmospheric pressure, control), and treatment group mice (n = 13) were placed in a hypobaric chamber to recover 3-hours daily at 714 mmHg for 1 week. Echocardiographic evaluation of left ventricular function was performed on Day 0, Day 1 and Day 8. Intermittent hypobaric treatment was associated with a 14.2 +/- 5.3% improvement in ejection fraction for treatment group mice (p<0.01 vs. Day 1), with no change observed in control mice. Cardiac output, stroke volume, and infarct size were also improved in treated mice, but no changes were observed in HIF-1 activation or neovascularization. Next, we studied the acute hemodynamic effects of low altitude stimulation in intact mice breathing 100% oxygen using left ventricular catheterization and recording of pressure-volume loops. Acute reductions in barometric pressure from 754 mmHg to 714 mmHg and 674 mmHg were associated with reduced systemic vascular resistance, increased stroke volume and cardiac output, and no change in blood pressure or heart rate. Ex-vivo vascular function was studied using murine mesenteric artery segments. Acute reductions in barometric pressure were associated with greater vascular distensibility. We conclude that intermittent hypobaric treatment using simulated altitudes <2500 m reduces infarct size and increases ventricular function post-MI, and that these changes are related to altered arterial function and not hypoxia-associated neovascularization.	[Shahid, Anmol; Stenson, Trevor H.; Oudit, Gavin Y.; McMurtry, Michael S.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Patel, Vaibhav B.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta	McMurtry, MS (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	mcmurtry@ualberta.ca	Patel, Vaibhav/B-4163-2016	Patel, Vaibhav/0000-0001-5917-5962; Stenson, Trevor/0000-0001-7164-1137; Davidge, Sandra/0000-0002-5559-4905	Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis) [MOP 106515]	Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis)(Canadian Institutes of Health Research (CIHR))	The work was funded in part by an operating grant awarded to MSM from the Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis, MOP 106515). The funder's website is: http://www.cihr-irsc.gc.ca.The funder did not play a role in any part of the work.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 1973, J Appl Physiol, V34, P549; Baibas N, 2005, J EPIDEMIOL COMMUN H, V59, P274, DOI 10.1136/jech.2004.025510; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; Blettner M, 2003, INT J CANCER, V106, P946, DOI 10.1002/ijc.11328; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; Eltzschig H, 2011, ISCHEMIA REPERFUSION; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; GORDON RS, 1977, STROKE, V8, P274, DOI 10.1161/01.STR.8.2.274; GREENBERG BH, 1980, CIRCULATION, V61, P1212, DOI 10.1161/01.CIR.61.6.1212; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Honig CR, 1988, MODERN CARDIOVASCULA; Humphreys S, 2005, ANAESTHESIA, V60, P458, DOI 10.1111/j.1365-2044.2005.04124.x; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Ibanez B, 2012, AM HEART J, V164, P473, DOI 10.1016/j.ahj.2012.07.020; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kolk Mandy V V, 2009, J Vis Exp, DOI 10.3791/1438; Linnersjo A, 2011, SCAND J WORK ENV HEA, V37, P219, DOI 10.5271/sjweh.3134; Meng Xiang-yan, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P396; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; NICAS M, 1993, INFECT CONT HOSP EP, V14, P619; VOORS AW, 1979, J CHRON DIS, V32, P157, DOI 10.1016/0021-9681(79)90044-4; Wan CX, 2014, J GERIATR CARDIOL, V11, P237, DOI 10.11909/j.issn.1671-5411.2014.03.002; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Winkelmayer WC, 2009, JAMA-J AM MED ASSOC, V301, P508, DOI 10.1001/jama.2009.84; Wu J, 2013, AM J PHYSIOL-HEART C, V305, pH821, DOI 10.1152/ajpheart.00140.2013; Xu WQ, 2011, BASIC RES CARDIOL, V106, P329, DOI 10.1007/s00395-011-0159-y; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZANDER R, 1985, ADV EXP MED BIOL, V191, P965	33	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0215814	10.1371/journal.pone.0215814	http://dx.doi.org/10.1371/journal.pone.0215814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150412	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100012
J	Wei, D; Brigell, R; Khadka, A; Perales, N; Fink, G				Wei, Dorothy; Brigell, Rachel; Khadka, Aayush; Perales, Nicole; Fink, Guenther			Comprehensive school-based health programs to improve child and adolescent health: Evidence from Zambia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; GROWTH; PREVALENCE	Background While school-aged children in low-and middle-income countries remain highly exposed to acute infections, programs targeting this age group remain limited in scale and scope. In this paper, we evaluate the impact of a new and comprehensive primary school-based health intervention program on student-reported morbidity and anthropometric outcomes in Lusaka, Zambia. Methods A prospective matched control study identified 12 classes in 7 schools for the intervention and 12 classes in 7 matched schools as controls. Teachers in intervention schools were trained to deliver health lessons and to refer sick students to care. In addition, vitamin A and deworming medication were biannually administered to intervention students. The primary study outcome was student-reported morbidity. Secondary outcomes were weight, height, health knowledge, and absenteeism. Multivariable linear and logistic regression models were used to estimate program impact. Results 380 students ages 4-16 were enrolled in the study in 2015, and 97% were followed up at endline in 2016. The intervention decreased the adjusted odds of self-reported acute illnesses by 38% (95% CI: 0.48, 0.77) and the adjusted odds of stunting by 52% (95% CI: 0.26, 0.87). It also increased health knowledge by 0.53 standard deviations (95% CI: 0.24, 0.81). No impact was found on weight (adjusted mean difference beta = 0.17, 95% CI:-1.11, 1.44) and student absenteeism (adjusted odds ratio (aOR) = 0.89, 95% CI: 0.60, 1.33). Conclusion The results presented in this paper suggest that comprehensive school-based health programs may offer a highly effective way to improve students' health knowledge as well as their health status. Given their low cost, a more general adoption and implementation of such programs seems recommendable.	[Wei, Dorothy; Brigell, Rachel; Khadka, Aayush; Perales, Nicole; Fink, Guenther] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Perales, Nicole] Univ Calif Berkeley, Sch Publ Hlth, Dept Hlth Policy, Berkeley, CA 94720 USA; [Fink, Guenther] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; University of Basel; Swiss Tropical & Public Health Institute	Wei, D (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	dow738@mail.harvard.edu						Ademokun OM, 2014, AM J ED RES, V2, P1076, DOI [10.12691/education-2-11-12, DOI 10.12691/education-2-11-12]; Agnew-Blais J, 2010, J TROP PEDIATRICS, V56, P247, DOI 10.1093/tropej/fmp106; Ahmed AM, SCHISTOSOMA HAEMATOB; Ameratunga S, 2016, LANCET, V387, P2353, DOI 10.1016/S0140-6736(16)30296-3; [Anonymous], 1997, Trans R Soc Trop Med Hyg, V91, P1; [Anonymous], 2014, ZAMB NAT ED PROF 201; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Bundy D., RETHINKING SCH HLTH; Bundy DAP, 1998, T ROY SOC TROP MED H, V92, P254; Carnevale J, 2011, AIDS CARE, V23, P646, DOI 10.1080/09540121.2010.516347; Creative Associates International, 2005, HLTH ED WORK TOG CAS; Creative Associates International, 2005, HLTH CHILD HLTH SCH; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Drake L, 2002, SCN NEWS; Fink G, 2014, AM J CLIN NUTR, V100, P182, DOI 10.3945/ajcn.113.080960; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jomaa LH, 2011, NUTR REV, V69, P83, DOI 10.1111/j.1753-4887.2010.00369.x; Ki-moon B, 2016, LANCET, V387, P2356, DOI 10.1016/S0140-6736(16)30271-9; Kleinert S, 2016, LANCET, V387; Lundeen EA, 2014, PUBLIC HEALTH NUTR, V17, P2131, DOI 10.1017/S1368980013003017; Merete Borge A, 2008, E AFR J PUBLIC HLTH, V5; Muthayya S, 2009, AM J CLIN NUTR, V89, P1766, DOI 10.3945/ajcn.2008.26993; Partnership Child Dev, 1998, P NUTR SOC, V57, P149, DOI 10.1079/PNS19980021; Patton GC, 2014, LANCET, V383, P385, DOI 10.1016/S0140-6736(14)60039-8; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Rosso Del, 1996, CLASS ACTION IMPROVI; Schott WB, 2013, SOC SCI MED, V97, P278, DOI 10.1016/j.socscimed.2013.05.016; Shung-King M., 2014, South African Health Review, V2014, P59; StataCorp, 2015, STAT STAT SOFTW REL; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub6; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Welch VA, 2017, LANCET GLOB HEALTH, V5, pE40, DOI 10.1016/S2214-109X(16)30242-X; WHO, 2011, YOUTH HLTH RISKS REP; World Health Organization, 2022, SOIL TRANSM HELM INF; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; 2007, AM J CLIN NUTR, V86, P1082	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217893	10.1371/journal.pone.0217893	http://dx.doi.org/10.1371/journal.pone.0217893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150484	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000469759100125
J	Edens, C; Alden, NB; Danila, RN; Fill, MMA; Gacek, P; Muse, A; Parker, E; Poissant, T; Ryan, PA; Smelser, C; Tobin-D'Angelo, M; Schrag, SJ				Edens, Chris; Alden, Nisha B.; Danila, Richard N.; Fill, Mary-Margaret A.; Gacek, Paul; Muse, Alison; Parker, Erin; Poissant, Tasha; Ryan, Patricia A.; Smelser, Chad; Tobin-D'Angelo, Melissa; Schrag, Stephanie J.			Multistate analysis of prospective Legionnaires' disease cluster detection using SaTScan, 2011-2015	PLOS ONE			English	Article							NEW-YORK-CITY; COOLING-TOWER; UNITED-STATES; SURVEILLANCE; OUTBREAKS; LEGIONELLA; CARE	Detection of clusters of Legionnaires' disease, a leading waterborne cause of pneumonia, is challenging. Clusters vary in size and scope, are associated with a diverse range of aerosol producing devices, including exposures such as whirlpool spas and hotel water systems typically associated with travel, and can occur without an easily identified exposure source. Recently, jurisdictions have begun to use SaTScan spatio-temporal analysis software prospectively as part of routine cluster surveillance. We used data collected by the Active Bacterial Core surveillance platform to assess the ability of SaTScan to detect Legionnaires' disease clusters. We found that SaTScan analysis using traditional surveillance data and geocoded residential addresses was unable to detect many common Legionnaires' disease cluster types, such as those associated with travel or a prolonged time between cases. Additionally, signals from an analysis designed to simulate a real-time search for clusters did not align with clusters identified by traditional surveillance methods or a retrospective SaTScan analysis. A geospatial analysis platform better tailored to the unique characteristics of Legionnaires' disease epidemiology would improve cluster detection and decrease time to public health action.	[Edens, Chris; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Alden, Nisha B.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Danila, Richard N.] Minnesota Dept Hlth, St Paul, MN USA; [Fill, Mary-Margaret A.] Tennessee Dept Hlth, Nashville, TN USA; [Gacek, Paul] Connecticut Dept Publ Hlth, Hartford, CT USA; [Muse, Alison] New York State Dept Hlth, Albany, NY USA; [Parker, Erin] Calif Emerging Infect Program, Oakland, CA USA; [Poissant, Tasha] Oregon Hlth Author, Portland, OR USA; [Ryan, Patricia A.] Maryland Dept Hlth, Baltimore, MD USA; [Smelser, Chad] New Mexico Dept Hlth, Santa Fe, NM USA; [Tobin-D'Angelo, Melissa] Georgia Dept Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); Tennessee Department Health; State University of New York (SUNY) System; California Emerging Infections Program; New Mexico Department of Health	Edens, C (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	wedens@cdc.gov		Edens, William/0000-0002-7563-6201	Emerging Infections Program [FOA: CK17-1701];  [U50CK000482];  [U50CK000483];  [U50CK000488];  [U50CK000485];  [U50CK000487];  [U50CK000490];  [U50CK000489];  [U50CK000486];  [U50CK000484];  [U50CK000491]	Emerging Infections Program; ; ; ; ; ; ; ; ; ; 	This work was federally funded through the Emerging Infections Program cooperative agreement (FOA: CK17-1701). Authors and grant numbers are as follows: EP - U50CK000482; NBA - U50CK000483; PG - U50CK000488; MT - U50CK000485; PAR - U50CK000487; RND - U50CK000490; CS - U50CK000489; AM-U50CK000486; TP - U50CK000484; MAF - U50CK000491. The funders participated in the study design, data collection, analysis of the data, decision to publish, and preparation of the manuscript.	ADDISS DG, 1989, AM J EPIDEMIOL, V130, P557, DOI 10.1093/oxfordjournals.aje.a115370; Agost L, 2016, ARCH ARGENT PEDIATR, V114, P534, DOI 10.5546/aap.2016.eng.534; Bull M, 2012, EUROSURVEILLANCE, V17, P30; Centers for Disease Control and Prevention, NAT OUBTR REP SYST N; Centers for Disease Control and Prevention, NAT NOT DIS SURV SYS; Chen CC, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0072-6; Day SR, 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv164, 10.1093/ofid/ofv064]; Demirjian A, 2015, CLIN INFECT DIS, V60, P1596, DOI 10.1093/cid/civ153; Dooling KL, 2015, MMWR-MORBID MORTAL W, V64, P1190, DOI 10.15585/mmwr.mm6442a2; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fitzhenry R, 2017, EMERG INFECT DIS, V23, P1769, DOI 10.3201/eid2311.161584; Garrison LE, 2016, AM J TRANSPLANT, V16, P3049, DOI 10.1111/ajt.14024; Glatman-Freedman A, 2016, J INFECTION, V73, P99, DOI 10.1016/j.jinf.2016.04.038; Greene SK, 2016, EMERG INFECT DIS, V22, P1808, DOI 10.3201/eid2210.160097; Greene SK, 2012, FOODBORNE PATHOG DIS, V9, P431, DOI 10.1089/fpd.2011.1036; Greene SK, 2011, STAT MED, V30, P549, DOI 10.1002/sim.3883; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., SATSCAN V9 4 4 SOFTW; Levin-Rector A, 2015, EMERG INFECT DIS, V21, P265, DOI 10.3201/eid2102.140098; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Mathes RW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184419; McEvoy M, 2000, Commun Dis Public Health, V3, P43; Orkis LT, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268818002789, 10.1017/s095026881800273x]; Palmore TN, 2009, INFECT CONT HOSP EP, V30, P764, DOI 10.1086/598855; Peterson E. R., 2017, ONLINE J PUBLIC HLTH, V9, pe121, DOI DOI 10.5210/0JPHI.V9I1.7705; Rao HX, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2643-y; Sansom P, 2013, STAT MED, V32, P3522, DOI 10.1002/sim.5765; Smith P., 2007, Morbidity and Mortality Weekly Report, V56, P1261; Tang XY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2357-1; Weiss D, 2017, PUBLIC HEALTH REP, V132, P241, DOI 10.1177/0033354916689620; Yih WK, 2010, PUBLIC HEALTH REP, V125, P111, DOI 10.1177/003335491012500115	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217632	10.1371/journal.pone.0217632	http://dx.doi.org/10.1371/journal.pone.0217632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145765	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500028
J	Funaro, CF; Schal, C; Vargo, EL				Funaro, Colin F.; Schal, Coby; Vargo, Edward L.			Queen and king recognition in the subterranean termite, Reticulitermes flavipes: Evidence for royal recognition pheromones	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; MODULATORY COMMUNICATION; VIBRATION SIGNAL; ISOPTERA; REPRODUCTIVES; WORKERS; DIFFERENTIATION; DISCRIMINATION; IDENTIFICATION; POPULATION	Royal recognition is a central feature of insect societies, allowing them to maintain the reproductive division of labor and regulate colony demography. Queen recognition has been broadly demonstrated and queen recognition pheromones have been identified in social hymenopterans, and in one termite species. Here we describe behaviors that are elicited in workers and soldiers by neotenic queens and kings of the subterranean termite, Reticulitermes flavipes, and demonstrate the chemical basis for the behavior. Workers and soldiers readily perform a lateral or longitudinal shaking behavior upon antennal contact with queens and kings. When royal cuticular chemicals are transferred to live workers or inert glass dummies, they elicit antennation and shaking in a dose-dependent manner. The striking response to reproductives and their cuticular extracts suggests that royal-specific cuticular compounds act as recognition pheromones and that shaking behavior is a clear and measurable queen and king recognition response in this termite species.	[Funaro, Colin F.; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Vargo, Edward L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Funaro, Colin F.] North Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University	Funaro, CF (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Funaro, CF (corresponding author), North Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA.	colin.funaro@gmail.com	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358				Amsalem E, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1800; Bagneres AG, 1998, CHEMOECOLOGY, V8, P201, DOI 10.1007/s000490050026; BAGNERES AG, 1991, J CHEM ECOL, V17, P2397, DOI 10.1007/BF00994590; BAGNERES AG, 1990, J CHEM ECOL, V16, P3213, DOI 10.1007/BF00982094; Batista-Pereira LG, 2004, Z NATURFORSCH C, V59, P135; Bignell DE, 2014, BIOL TERMITES MODERN; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Darrouzet E, 2014, J INSECT PHYSIOL, V61, P25, DOI 10.1016/j.jinsphys.2013.12.006; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; ESPELIE KE, 1994, J CHEM ECOL, V20, P1677, DOI 10.1007/BF02059889; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Funaro CF, 2018, P NATL ACAD SCI USA, V115, P3888, DOI 10.1073/pnas.1721419115; Hager FA, 2013, J EXP BIOL, V216, P3249, DOI 10.1242/jeb.086991; Haverty MI, 1996, J CHEM ECOL, V22, P1813, DOI 10.1007/BF02028506; Himuro C, 2011, J INSECT PHYSIOL, V57, P962, DOI 10.1016/j.jinsphys.2011.04.012; Holldobler B., 1990, pi; Holman L, 2017, PEERJ, V5, DOI 10.7717/peerj.3332; Holman L, 2016, BEHAV ECOL SOCIOBIOL, V70, P387, DOI 10.1007/s00265-016-2058-6; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Howse P, 1965, INSECTES SOC, V12, P335; HOWSE PE, 1964, ANIM BEHAV, V12, P284, DOI 10.1016/0003-3472(64)90015-6; Hyland KM, 2007, ANIM BEHAV, V73, P541, DOI 10.1016/j.anbehav.2006.10.006; KIRCHNER WH, 1994, PHYSIOL ENTOMOL, V19, P187, DOI 10.1111/j.1365-3032.1994.tb01041.x; Korb J, 2005, NATURWISSENSCHAFTEN, V92, P45, DOI 10.1007/s00114-004-0589-6; Korb J, 2004, BEHAV ECOL SOCIOBIOL, V56, P89, DOI 10.1007/s00265-004-0757-x; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Liebig J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1799, DOI 10.1007/s00265-009-0807-5; LIGHT SF, 1951, J EXP ZOOL, V117, P397, DOI 10.1002/jez.1401170302; Luscher M., 1961, INSECT POLYMORPHISM, P57; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Nunes TM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07449; Ohmura W, 2009, SOCIOBIOLOGY, V54, P269; Penick CA, 2013, J INSECT BEHAV, V26, P23, DOI 10.1007/s10905-012-9332-x; Reinhard J, 2002, J INSECT BEHAV, V15, P95, DOI 10.1023/A:1014436313710; ROCCA JR, 1983, TETRAHEDRON LETT, V24, P1889, DOI 10.1016/S0040-4039(00)81798-0; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Smith AA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0947; Smith AA, 2013, J EXP BIOL, V216, P3917, DOI 10.1242/jeb.089482; Smith AA, 2012, BEHAV ECOL SOCIOBIOL, V66, P1267, DOI 10.1007/s00265-012-1380-x; SU NY, 1991, SOCIOBIOLOGY, V19, P349; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; VANDERMEER RK, 1980, ANN ENTOMOL SOC AM, V73, P609, DOI 10.1093/aesa/73.5.609; Weil T, 2009, NATURWISSENSCHAFTEN, V96, P315, DOI 10.1007/s00114-008-0475-8; WEST MJ, 1967, SCIENCE, V157, P1584, DOI 10.1126/science.157.3796.1584; Whitman JG, 2007, ANN ENTOMOL SOC AM, V100, P763, DOI 10.1603/0013-8746(2007)100[763:ONOSAI]2.0.CO;2; Yamamoto Y, 2012, BEHAV ECOL SOCIOBIOL, V66, P39, DOI 10.1007/s00265-011-1249-4	51	5	5	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0209810	10.1371/journal.pone.0209810	http://dx.doi.org/10.1371/journal.pone.0209810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145770	Green Published, Green Submitted, gold			2022-12-27	WOS:000469425500002
J	Hwang, YJ; Nam, SJ; Chun, W; Kim, SI; Park, SC; Kang, CD; Lee, SJ				Hwang, Young-Jae; Nam, Seung-Joo; Chun, Wanjoo; Kim, Song In; Park, Sung Chul; Kang, Chang Don; Lee, Sung Joon			Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXHALED BREATH CONDENSATE; NADPH OXIDASE; PATHOGENESIS; INCREASE; SYSTEM; IMMUNE; CELLS; IBD	Background and aim Various drugs have been developed for inflammatory bowel disease (IBD), but still there are limitations in the treatment due to the insufficient responses and significant adverse effects of immunosuppressant. Apocynin is an NADPH-oxidase inhibitor with established safety profiles. We aimed to investigate the protective efficacy of apocynin in IBD using chemical-induced mouse colitis model. Method We induced experimental colitis by administrating 5% dextran sulfate sodium (DSS) to 8-week old BALB/c mouse for 11 days. Apocynin (400 mg/kg) or sulfasalazine (150 mg/kg) were administeredduring7 days. We monitored bodyweight daily and harvested colon and spleen at day 11 to check weight and length. We also examined histopathologic change and pro-, anti-inflammatory cytokines and enzymes from harvested colons (iNOS, COX-2, TNF-alpha, MCP-1, p-NrF2, and HO-1). Result Apocynin significantly alleviated weight reduction induced by DSS treatment (21.64 +/- 0.55 for Apocynin group vs. 20.33 +/- 0.90 for DSS group, p = 0.005). Anti-inflammatory efficacy of apocynin was also shown by the recovery of colon weight and length. Histopathologic examination revealed significantly reduced inflammatory foci and erosions by apocynin treatment. Colonic expression of iNOS, COX-2, TNF-alpha, and MCP-1 was decreased significantly in the apocynin treated group. Anti-inflammatory mediators Nrf2 and HO-1 were activated significantly in apocynin treated mouse. Conclusion Apocynin showed significant anti-inflammatory efficacy against chemically induced colonic inflammation. This study also revealed the unique action of apocynin compared to the currently prescribed drug, sulfasalazine. Given its excellent safety profile and potent efficacy with novel action mechanism, apocynin can be a new therapeutic molecule for the IBD treatment, which can be added to the currently available drugs.	[Hwang, Young-Jae; Nam, Seung-Joo; Park, Sung Chul; Kang, Chang Don; Lee, Sung Joon] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; [Chun, Wanjoo; Kim, Song In] Kangwon Natl Univ, Sch Med, Dept Pharmacol, Chunchon, South Korea	Kangwon National University; Kangwon National University	Nam, SJ (corresponding author), Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea.	pinetrees@hanmail.net	Park, Sung Chul/AGO-1773-2022; Nam, Seung-Joo/AAD-2495-2022	Park, Sung Chul/0000-0003-3215-6838; Nam, Seung-Joo/0000-0002-0349-0901	2015 Kangwon National University Hospital Grant	2015 Kangwon National University Hospital Grant	This research was funded by a 2015 Kangwon National University Hospital Grant awarded to S-JN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AC, 2005, J INTERF CYTOK RES, V25, P540, DOI 10.1089/jir.2005.25.540; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cohen BL, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2505; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Gonzalez-Mauraza H, 2014, J PHYSIOL BIOCHEM, V70, P163, DOI 10.1007/s13105-013-0290-3; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Guan QD, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4810258; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kinkade K, 2013, INT J MOL SCI, V14, P17017, DOI 10.3390/ijms140817017; Kruse ML, 2016, INFLAMM BOWEL DIS, V22, P2593, DOI 10.1097/MIB.0000000000000925; Kryl'skii ED, 2015, B EXP BIOL MED+, V160, P24, DOI 10.1007/s10517-015-3089-0; Lam G, 2015, CURR MED CHEM, V22, P2100, DOI 10.2174/0929867322666150416095114; Lee SH, 2018, INTEST RES, V16, P26, DOI 10.5217/ir.2018.16.1.26; Marin M, 2013, PLANTA MED, V79, P1392, DOI 10.1055/s-0033-1350710; McLean LP, 2014, EXPERT REV GASTROENT, V8, P223, DOI 10.1586/17474124.2014.881715; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Mouzaoui S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/312484; Naito Y, 2004, ALIMENT PHARM THERAP, V20, P177, DOI 10.1111/j.1365-2036.2004.01992.x; Plevy S, 2007, GASTROENTEROLOGY, V133, P1414, DOI 10.1053/j.gastro.2007.08.035; Ramonaite R, 2014, WORLD J GASTROENTERO, V20, P12533, DOI 10.3748/wjg.v20.i35.12533; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Reinglas J, 2018, WORLD J GASTROENTERO, V24, P3567, DOI 10.3748/wjg.v24.i32.3567; Sebastian VP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01956; SHARMA ML, 1994, J ETHNOPHARMACOL, V41, P185, DOI 10.1016/0378-8741(94)90031-0; Singh UP, 2016, CYTOKINE, V77, P44, DOI 10.1016/j.cyto.2015.10.008; Stefanska J, 2012, PULM PHARMACOL THER, V25, P343, DOI 10.1016/j.pupt.2012.06.001; Stefanska J, 2012, EXP LUNG RES, V38, P90, DOI 10.3109/01902148.2011.649823; Tian T, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4535194; Wan WYH, 2016, CHEST, V149, P1445, DOI 10.1016/j.chest.2016.01.024	33	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217642	10.1371/journal.pone.0217642	http://dx.doi.org/10.1371/journal.pone.0217642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141554	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000071
J	Magallon, J; Chiem, K; Tran, T; Ramirez, MS; Jimenez, V; Tolmasky, ME				Magallon, Jesus; Chiem, Kevin; Tung Tran; Ramirez, Maria S.; Jimenez, Veronica; Tolmasky, Marcelo E.			Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc	PLOS ONE			English	Article							6'-N-ACETYLTRANSFERASE TYPE IB; ACINETOBACTER-BAUMANNII; AMINOGLYCOSIDE RESISTANCE; KLEBSIELLA-PNEUMONIAE; INHIBITION; MECHANISMS; STRAINS; ENZYMES	Gram-negative pathogens resistant to amikacin and other aminoglycosides of clinical relevance usually harbor the 6'-N-acetyltransferase type Ib [AAC(6')-Ib], an enzyme that catalyzes inactivation of the antibiotic by acetylation using acetyl-CoA as donor substrate. Inhibition of the acetylating reaction could be a way to induce phenotypic conversion to susceptibility in these bacteria. We have previously observed that Zn2+ acts as an inhibitor of the enzymatic acetylation of aminoglycosides by AAC(6')-Ib, and in complex with ionophores it effectively reduced the levels of resistance in cellulo. We compared the activity of 8-hydroxyquinoline, three halogenated derivatives, and 5-[N-Methyl-N-Propargylaminomethyl]- 8-Hydroxyquinoline in complex with Zn2+ to inhibit growth of amikacin-resistant Acinetobacter baumannii in the presence of the antibiotic. Two of the compounds, clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) and 5,7-diiodo-8-hydroxyquinoline, showed robust inhibition of growth of the two A. baumannii clinical isolates that produce AAC(6')-Ib. However, none of the combinations had any activity on another amikacin-resistant A. baumannii strain that possesses a different, still unknown mechanism of resistance. Time-kill assays showed that the combination of clioquinol or 5,7-diiodo-8-hydroxyquinoline with Zn2+ and amikacin was bactericidal. Addition of 8-hydroxyquinoline, clioquinol, or 5,7-diiodo-8-hydroxyquinoline, alone or in combination with Zn2+, and amikacin to HEK293 cells did not result in significant toxicity. These results indicate that ionophores in complex with Zn2+ could be developed into potent adjuvants to be used in combination with aminoglycosides to treat Gram-negative pathogens in which resistance is mediated by AAC(6')-Ib and most probably other related aminoglycoside modifying enzymes.	[Magallon, Jesus; Chiem, Kevin; Tung Tran; Ramirez, Maria S.; Jimenez, Veronica; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Coll Nat Sci & Math, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Tolmasky, ME (corresponding author), Calif State Univ Fullerton, Coll Nat Sci & Math, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA.	mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020	Tolmasky, Marcelo/0000-0002-6298-7811	Public Health Service grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [2R15AI047115]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant 2R15AI047115 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Arivett BA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00212-15; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Bohlmann L, 2018, MBIO, V9, DOI 10.1128/mBio.02391-18; Castanheira M, 2018, J ANTIMICROB CHEMOTH, V73, P3346, DOI 10.1093/jac/dky344; Chan SH, 2013, ACS MED CHEM LETT, V4, P170, DOI 10.1021/ml300238z; Chandrika NT, 2018, CHEM SOC REV, V47, P1189, DOI 10.1039/c7cs00407a; Chandrika NT, 2016, MEDCHEMCOMM, V7, P50, DOI 10.1039/c5md00453e; Chandrika NT, 2015, ACS MED CHEM LETT, V6, P1134, DOI 10.1021/acsmedchemlett.5b00255; Chiem K, 2018, INT J ANTIMICROB AG, V51, P271, DOI 10.1016/j.ijantimicag.2017.08.002; Chiem K, 2016, MEDCHEMCOMM, V7, P184, DOI 10.1039/c5md00316d; Chiem K, 2015, ANTIMICROB AGENTS CH, V59, P5851, DOI 10.1128/AAC.01106-15; Davies-Sala C, 2015, ANN NY ACAD SCI, V1354, P98, DOI 10.1111/nyas.12755; Garneau-Tsodikova S, 2016, MEDCHEMCOMM, V7, P11, DOI 10.1039/c5md00344j; Guan JM, 2018, CHEMBIOCHEM, V19, P2107, DOI 10.1002/cbic.201800368; Haas M J, 1975, Methods Enzymol, V43, P611; Jackson Alexis, 2016, Biol Methods Protoc, V1; Ju LC, 2018, TRENDS PHARMACOL SCI, V39, P635, DOI 10.1016/j.tips.2018.03.007; Labby KJ, 2013, FUTURE MED CHEM, V5, P1285, DOI 10.4155/fmc.13.80; Li YJ, 2015, ANTIMICROB AGENTS CH, V59, P4148, DOI 10.1128/AAC.00885-15; Lin DL, 2014, ANTIMICROB AGENTS CH, V58, P4238, DOI 10.1128/AAC.00129-14; Lind SE, 2009, TRANSL RES, V154, P153, DOI 10.1016/j.trsl.2009.06.002; Lopez C, 2015, ANTIMICROB AGENTS CH, V59, P5798, DOI 10.1128/AAC.01304-15; Maianti JP, 2016, MEDCHEMCOMM, V7, P170, DOI 10.1039/c5md00429b; Mao X, 2009, LEUKEMIA, V23, P585, DOI 10.1038/leu.2008.232; Mao XL, 2008, TOXICOL LETT, V182, P1, DOI 10.1016/j.toxlet.2008.08.015; Matsushita T, 2019, J AM CHEM SOC, V141, P5051, DOI 10.1021/jacs.9b01693; Papp-Wallace KM, 2016, INFECT DIS CLIN N AM, V30, P441, DOI 10.1016/j.idc.2016.02.007; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Ramirez MS, 2017, MOLECULES, V22, DOI 10.3390/molecules22122267; Ramirez MS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00121; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Sarno R, 2003, ANTIMICROB AGENTS CH, V47, P3296, DOI 10.1128/AAC.47.10.3296-3304.2003; Schmidt M, 2015, BIOCONJUGATE CHEM, V26, P1950, DOI 10.1021/acs.bioconjchem.5b00393; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2013, CURR MICROBIOL, V67, P9, DOI 10.1007/s00284-013-0326-5; Bistue AJCS, 2009, P NATL ACAD SCI USA, V106, P13230, DOI 10.1073/pnas.0906529106; Tolmasky ME, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P35; Tolmasky ME, 2017, FRONTIERS CLIN DRUG, P3; Traglia G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35377-5; Traglia G, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01146-14; Traglia GM, 2014, GENOME BIOL EVOL, V6, P2235, DOI 10.1093/gbe/evu176; Tran T, 2018, INT J ANTIMICROB AG, V51, P752, DOI 10.1016/j.ijantimicag.2018.01.019; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vilacoba E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01190-14; Vilacoba E, 2013, ANTIMICROB AGENTS CH, V57, P651, DOI 10.1128/AAC.01751-12; Vong K, 2012, MEDCHEMCOMM, V3, P397, DOI [10.1039/c2md00253a, 10.1039/C2MD00253A]; WOLOJ M, 1986, ANTIMICROB AGENTS CH, V29, P315, DOI 10.1128/AAC.29.2.315; Wright GD, 2003, CURR OPIN CHEM BIOL, V7, P563, DOI 10.1016/j.cbpa.2003.08.004; Wright PM, 2014, ANGEW CHEM INT EDIT, V53, P8840, DOI 10.1002/anie.201310843; Zarate SG, 2018, MOLECULES, V23, DOI 10.3390/molecules23020284	50	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217602	10.1371/journal.pone.0217602	http://dx.doi.org/10.1371/journal.pone.0217602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141575	Green Submitted, gold, Green Published			2022-12-27	WOS:000469323000066
J	Farzad, R; Kuhn, DD; Smith, SA; O'Keefe, SF; Ralston, NVC; Neilson, AP; Gatlin, DM				Farzad, Razieh; Kuhn, David D.; Smith, Stephen A.; O'Keefe, Sean F.; Ralston, Nicholas V. C.; Neilson, Andrew P.; Gatlin, Delbert M.			Trace minerals in tilapia fillets: Status in the United States marketplace and selenium supplementation strategy for improving consumer's health	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; INORGANIC SELENIUM; MUSCLE COMPOSITION; NILE TILAPIA; FISH; BIOAVAILABILITY; CONSUMPTION; MERCURY; GROWTH; SELENOMETHIONINE	This goal of this study was to highlight the importance of minerals in the diet of fish for meeting micronutrient requirements in the human diet. First arsenic, calcium, cadmium, copper, iron, molybdenum, magnesium, manganese, sodium, phosphorus, potassium, selenium, and zinc concentrations of twelve commercially available tilapia samples were measured. The nutritional value of fillets in regard to their mineral content were assessed to establish potential health benefits or risks for consumers. The health benefit value of selenium was also calculated. Positive health benefit values indicate that tilapia fillets in the United States marketplace of this study do not pose health risks associated with mercury exposures. Selenium was the trace mineral of interest. After the market study, a seven-week fish feeding trial was conducted to study the influence of organic versus inorganic dietary selenium on Nile tilapia (Oreochromis niloticus). Fish were fed two different diets enriched with the same concentration (0.01g kg(-1)) of selenium in form of inorganic (sodium selenite) or organic (seleno-L-methionine) selenium in triplicate groups. There were no significant differences between growth and biometrics of fish fed different diets (p>0.05). At the end of trial twelve fish from each treatment were collected. Fillets of fish fed organic selenium had selenium concentrations of 0.55 0.01 mu g g(-1) which were significantly (p<0.05) higher than fish fed inorganic selenium at levels of 0.22 +/- 0.008 mu g g(-1) or fish samples from the marketplace with a selenium level of 0.2 0.03 mu g g(-1). Fish fed organic selenium also had significantly higher (p<0.05) plasma and kidney selenium in comparison to fish fed inorganic selenium. No significant differences (p>0.05) were observed in glutathione peroxidase activities in either the plasma or liver of Nile tilapia in the different treatment groups. This study shows that organic selenium is a better option for production of Nile tilapia fillets rich in selenium.	[Farzad, Razieh; Kuhn, David D.; O'Keefe, Sean F.; Neilson, Andrew P.] Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA; [Smith, Stephen A.] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathol, Blacksburg, VA USA; [Ralston, Nicholas V. C.] Univ North Dakota, Dept Earth Syst Sci & Policy, Grand Forks, ND 58201 USA; [Gatlin, Delbert M.] Texas A&M Univ, Dept Fisheries & Wildlife Sci, College Stn, TX USA	Virginia Polytechnic Institute & State University; University of North Dakota Grand Forks; Texas A&M University System; Texas A&M University College Station	Kuhn, DD (corresponding author), Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA.	davekuhn@vt.edu	OKeefe, Sean F/N-3101-2016; Gatlin, Delbert/AAB-3615-2021	OKeefe, Sean F/0000-0002-2491-7900; Ralston, Nicholas/0000-0001-7686-2932; Kuhn, David/0000-0003-3368-0375	Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program; Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface	Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program; Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface	This study was funded by Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program and Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface.	Allison EH, 2013, INTEGRATING FI UNPUB; [Anonymous], 2018, USDA NAT NUTR DAT ST; AOCS (American Oil Chemists'' Society), 2010, OFFICIAL METHODS REC; APHA AWWA WEF, 2012, STANDARD METHODS EXA, P541; Avella-Garcia C. B., 2014, CURR ENV HLTH REP, V1, P46, DOI DOI 10.1007/s40572-013-0006-4; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Beveridge MCM, 2013, J FISH BIOL, V83, P1067, DOI 10.1111/jfb.12187; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Coppinger RJ, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P219; Daniels LA, 1996, BIOL TRACE ELEM RES, V54, P185, DOI 10.1007/BF02784430; Davidson PW, 2011, NEUROTOXICOLOGY, V32, P711, DOI 10.1016/j.neuro.2011.08.003; de la Guardia M, 2015, HDB MINERAL ELEMENTS, DOI [10.1002/9781118654316, DOI 10.1002/9781118654316]; Ed McCurdy GW, 2006, UNMATCHED REMOVAL SP; Eisler Ronald, 1994, Advances in Environmental Science and Technology, V27, P185; Evans P, 2001, BRIT J NUTR, V85, pS67, DOI 10.1079/BJN2000296; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; FDA 1990-2012, NAT MAR FISH SERV SU; Food and Agriculture Organization [FAO], 2018, STAT WORLD FISH AQ C; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Gillespie S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600002; Golding J, 2017, INT J HYG ENVIR HEAL, V220, P1161, DOI 10.1016/j.ijheh.2017.07.004; Hayat MA, 2000, PRINCIPLES TECHNIQUE, Vxix; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; HLPE, 2014, REP HIGH LEV PAN EXP; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP PROM I; Julvez J, 2016, AM J EPIDEMIOL, V183, P169, DOI 10.1093/aje/kwv195; Kucukbay FZ, 2009, AQUACULT NUTR, V15, P569, DOI 10.1111/j.1365-2095.2008.00624.x; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Le KT, 2014, AQUACULTURE, V420, P57, DOI 10.1016/j.aquaculture.2013.10.034; Lee S, 2016, AQUACULTURE, V464, P153, DOI 10.1016/j.aquaculture.2016.06.027; LI G, 1985, HUM PATHOL, V16, P602, DOI 10.1016/S0046-8177(85)80110-6; Lin YH, 2014, AQUACULTURE, V430, P114, DOI 10.1016/j.aquaculture.2014.03.048; Llop S, 2017, INT J EPIDEMIOL, V46, P827, DOI 10.1093/ije/dyw259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Olmedo P, 2013, FOOD CHEM TOXICOL, V62, P299, DOI 10.1016/j.fct.2013.08.076; Pacitti D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144681; Ralston NVC, 2016, BIOL TRACE ELEM RES, V171, P262, DOI 10.1007/s12011-015-0516-z; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Ralston NVC, 2018, FREE RADICAL BIOL ME; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrauzer GN, 2001, J AM COLL NUTR, V20, P1; Telli GS, 2014, FISH SHELLFISH IMMUN, V39, P305, DOI 10.1016/j.fsi.2014.05.025; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; United States Environmental Protection Agency (USEPA), 2000, EPA GUID DEV FISH AD; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; US Environmental Protection Agency (USEPA), 2007, INT RISK INF SYST AR; US Food and Drug Administration Center for Food Safety and Applied Nutrition, LAB NUTR LAB CLAIMS; USFDA, 2001, FDA CONS ADV; Vieira C, 2011, FOOD CHEM TOXICOL, V49, P923, DOI 10.1016/j.fct.2010.12.016; Wang CL, 1997, AQUACULTURE, V152, P223, DOI 10.1016/S0044-8486(96)01523-2; Wang YB, 2007, ANIM FEED SCI TECH, V134, P243, DOI 10.1016/j.anifeedsci.2006.12.007; Watt, 1973, AGR HDB, V74; Zhou XX, 2009, AQUACULTURE, V291, P78, DOI 10.1016/j.aquaculture.2009.03.007	58	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217043	10.1371/journal.pone.0217043	http://dx.doi.org/10.1371/journal.pone.0217043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170189	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700016
J	Linde, DS; Korsholm, M; Katanga, J; Rasch, V; Lundh, A; Andersen, MS				Linde, Ditte S.; Korsholm, Malene; Katanga, Johnson; Rasch, Vibeke; Lundh, Andreas; Andersen, Marianne S.			One-way SMS and healthcare outcomes in Africa: Systematic review of randomised trials with meta-analysis	PLOS ONE			English	Review							SHORT MESSAGE SERVICE; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; REMINDERS; ADHERENCE; HIV; IMMUNIZATION; IMPACT; INTERVENTIONS; COMMUNICATION	Background The impact of one-way SMS on health outcomes in Africa is unclear. We aimed to conduct a systematic review of one-way SMS randomised trials in Africa and a meta-analysis of their effect on healthcare appointments attendance and medicine adherence. Methods PubMed, Embase, CENTRAL, The Global Health Library, ClinicalTrials.gov, ICTRP, and PACTR were searched for published and unpublished trials in Africa without language restriction (up to April 2018). Trials reporting effect estimates on healthcare appointment attendance and medicine adherence were assessed for risk of bias and included in meta-analyses using random-effects models. Other outcomes were reported descriptively. The protocol is registered in PROSPERO, ID:CRD42018081062. Results We included 38 one-way SMS trials conducted in Africa within a broad range of clinical conditions. Eighteen trials were included in the meta-analyses, and four were assessed as overall low risk of bias. One-way SMS improved appointment attendance, OR:2.03; 95% CI:1.40-2-95 (12 trials, 6448 participants), but not medicine adherence, RR:1.10; 95% CI:0.98-1-23 (nine trials, 4213 participants). Subgroup analyses showed that one-way SMS had the highest impact on childhood immunization attendance, OR:3.69; 95% CI:1.67-8-13 (three trials, 1943 participants). There was no clear evidence of one-way SMS improving facility delivery, knowledge level (reproductive/antenatal health, hypertension), diabetes and hypertension management. Conclusion In an African setting, the clinical effect of one-way SMS is uncertain except for appointment attendance where the effect seems to vary depending on which clinical condition it is used in.	[Linde, Ditte S.; Korsholm, Malene; Rasch, Vibeke; Lundh, Andreas; Andersen, Marianne S.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Linde, Ditte S.; Korsholm, Malene; Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynaecol, Odense, Denmark; [Linde, Ditte S.; Lundh, Andreas] Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense, Denmark; [Korsholm, Malene] Univ Southern Denmark, Dept Publ Hlth, Danish Ctr Hlth Econ DaCHE, Odense, Denmark; [Katanga, Johnson] Ocean Rd Canc Inst, Dept Canc Prevent Serv, Dar Es Salaam, Tanzania; [Lundh, Andreas] Odense Univ Hosp, Ctr Evidence Based Med CEBMO, Odense, Denmark; [Lundh, Andreas] Hvidovre Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Andersen, Marianne S.] Odense Univ Hosp, Dept Med Endocrinol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Linde, DS (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.; Linde, DS (corresponding author), Odense Univ Hosp, Dept Obstet & Gynaecol, Odense, Denmark.; Linde, DS (corresponding author), Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense, Denmark.	dsonodergaard@health.sdu.dk	Andersen, Marianne Skovsager/AAE-1751-2019; Linde, Ditte Søndergaard/I-7750-2018; Rasch, Vibeke/G-9393-2019	Andersen, Marianne Skovsager/0000-0002-4603-9504; Linde, Ditte Søndergaard/0000-0002-0851-6760; Lundh, Andreas/0000-0002-4982-8680; Korsholm, Malene/0000-0002-9273-556X; Rasch, Vibeke/0000-0001-6557-0985	University of Southern Denmark; Denmark's International Development (Danida) [14-P +2-TAN/A26775]	University of Southern Denmark; Denmark's International Development (Danida)	Funding was provided by The University of Southern Denmark and by Denmark's International Development (Danida) grant no. 14-P +2-TAN/A26775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4973-5; Adler AJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011851.pub2; Agarwal S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1174; Amankwaa I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204091; Bangure D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1470-6; Beall J., 2018, BEALLS LIST PREDATOR; Bediang G, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-35; Beratarrechea A, 2014, TELEMED E-HEALTH, V20, P75, DOI 10.1089/tmj.2012.0328; Bigna JJR, 2014, LANCET INFECT DIS, V14, P600, DOI 10.1016/S1473-3099(14)70741-8; Bobrow K, 2016, CIRCULATION, V133, P592, DOI 10.1161/CIRCULATIONAHA.115.017530; Constant D, 2014, CONTRACEPTION, V90, P226, DOI 10.1016/j.contraception.2014.04.009; Crawford J, 2014, GLOB HEALTH-SCI PRAC, V2, P35, DOI 10.9745/GHSP-D-13-00155; Davey DJ, 2016, JAIDS-J ACQ IMM DEF, V73, pE23, DOI 10.1097/QAI.0000000000001115; de Jongh BE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-97; de Tolly K, 2012, TELEMED E-HEALTH, V18, P18, DOI 10.1089/tmj.2011.0058; Drake AL, 2017, CONTEMP CLIN TRIALS, V57, P44, DOI 10.1016/j.cct.2017.03.007; Gibson DG, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5030; Glanz K., 2002, HLTH BEHAV THEORY RE; Gurol-Urganci I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007456.pub2; Hacking D, 2016, JMIR MHEALTH UHEALTH, V4, P279, DOI 10.2196/mhealth.4569; Haji A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2823-5; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Joint United Nations Programme on HIV and AIDS, 2018, MIL GO CLOS GAPS BRE; Knight HE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-200; L'Engle KL, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3659; Lau YK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-284; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Linde DS, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2215-x; Linnemayr S, 2017, AM J PUBLIC HEALTH, V107, P1944, DOI 10.2105/AJPH.2017.304089; Liu JX, 2016, HEALTH POLICY PLANN, V31, P1374, DOI 10.1093/heapol/czw076; Mbabazi WB, 2015, HEALTH POLICY PLANN, V30, P638, DOI 10.1093/heapol/czu042; Nsagha Dickson Shey, 2016, Open AIDS J, V10, P93, DOI 10.2174/1874613601610010093; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Orrell C, 2015, JAIDS-J ACQ IMM DEF, V70, P495, DOI 10.1097/QAI.0000000000000770; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Qiang C, 2012, MOBILE APPL HLTH SEC; Raifman JRG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109032; Reid MJA, 2017, HEALTH PSYCHOL BEHAV, V5, P101, DOI 10.1080/21642850.2016.1271333; Rokicki S, 2017, AM J PUBLIC HEALTH, V107, P298, DOI 10.2105/AJPH.2016.303562; Rossing E, 2016, JMIR RES PROTOC, V5, P83, DOI 10.2196/resprot.5968; Schlumberger M, 2015, Bull Soc Pathol Exot, V108, P349, DOI 10.1007/s13149-015-0455-4; Steury EE, 2016, J NURS SCHOLARSHIP, V48, P354, DOI 10.1111/jnu.12216; Talisuna AO, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1702-6; The Nordic Cochrane Centre, 2015, REV MAN REVMAN; Thomas IF, 2017, PSYCHIAT SERV, V68, P75, DOI 10.1176/appi.ps.201500514; Unger JA, 2018, BJOG-INT J OBSTET GY, V125, P1620, DOI 10.1111/1471-0528.15337; Vodopivec-Jamsek V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007457.pub2; W.H. Organization, 2017, REPORT 3 GLOBAL SURV; Wagner Natascha, 2016, JMIR Res Protoc, V5, pe170, DOI 10.2196/resprot.5823; Wakadha H, 2013, VACCINE, V31, P987, DOI 10.1016/j.vaccine.2012.11.093; Wanyoro A.K., 2017, RES OBSTET GYNECOLOG, V5, P10; Watterson JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/153402; World Bank, 2016, WORLD DEV REP 2016 D	54	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217485	10.1371/journal.pone.0217485	http://dx.doi.org/10.1371/journal.pone.0217485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170176	Green Published, gold			2022-12-27	WOS:000470263700036
J	Soffe, R; Altenhuber, N; Bernach, M; Remus-Emsermann, MNP; Nock, V				Soffe, Rebecca; Altenhuber, Nicola; Bernach, Michel; Remus-Emsermann, Mitja N. P.; Nock, Volker			Comparison of replica leaf surface materials for phyllosphere microbiology	PLOS ONE			English	Article							RELATIVE-HUMIDITY; FRESH PRODUCE; UNITED-STATES; LOTUS-LEAF; PLANT; FABRICATION; AGAR; DEGRADATION; RHIZOSPHERE; TEMPERATURE	Artificial surfaces are routinely used instead of leaves to enable a reductionist approach in phyllosphere microbiology, the study of microorganisms residing on plant leaf surfaces. Commonly used artificial surfaces include, flat surfaces, such as metal and nutrient agar, and microstructured surfaces, such as isolate leaf cuticles or reconstituted leaf waxes. However, interest in replica leaf surfaces as an artificial surface is growing, as replica surfaces provide an improved representation of the complex topography of leaf surfaces. To date, leaf surfaces have predominantly been replicated for their superhydrophobic properties. In contrast, in this paper we investigated the potential of agarose, the elastomer polydimethylsiloxane (PDMS), and gelatin as replica leaf surface materials for phyllosphere microbiology studies. Using a test pattern of pillars, we investigated the ability to replicate microstructures into the materials, as well as the degradation characteristics of the materials in environmental conditions. Pillars produced in PDMS were measured to be within 10% of the mold master and remained stable throughout the degradation experiments. In agarose and gelatin the pillars deviated by more than 10% and degraded considerably within 48 hours in environmental conditions. Furthermore, we investigated the surface energy of the materials, an important property of a leaf surface, which influences resource availability and microorganism attachment. We found that the surface energy and bacterial viability on PDMS was comparable to isolated Citrus x aurantium and Populus x canescens leaf cuticles. Hence indicating that PDMS is the most suitable material for replica leaf surfaces. In summary, our experiments highlight the importance of considering the inherent material properties when selecting a replica leaf surface for phyllosphere microbiology studies. As demonstrated, a PDMS replica leaf offers a control surface that can be used for investigating microbe microbe and microbe-plant interactions in the phyllosphere, which will enable mitigation strategies against pathogens to be developed.	[Soffe, Rebecca; Altenhuber, Nicola; Bernach, Michel; Nock, Volker] Univ Canterbury, Dept Elect & Comp Engn, Christchurch, New Zealand; [Bernach, Michel; Remus-Emsermann, Mitja N. P.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	University of Canterbury; University of Canterbury	Soffe, R; Nock, V (corresponding author), Univ Canterbury, Dept Elect & Comp Engn, Christchurch, New Zealand.	rebecca.soffe@canterbury.ac.nz; volker.nock@canterbury.ac.nz	Nock, Volker/AAO-3259-2020; Remus-Emsermann, Mitja NP/R-3776-2016	Nock, Volker/0000-0001-5452-3083; Remus-Emsermann, Mitja NP/0000-0002-6378-9526; Soffe, Rebecca/0000-0003-3340-3642; Altenhuber, Nicola/0000-0003-2259-4535; Bernach, Michal/0000-0002-9743-0036	Biomolecular Interaction Centre; Marsden Grant [UOC1704]; National Science Challenge - Science for Technological Innovation	Biomolecular Interaction Centre; Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); National Science Challenge - Science for Technological Innovation	This work was funded by the Biomolecular Interaction Centre and Marsden Grant UOC1704. R.S. and N.A. thank the National Science Challenge - Science for Technological Innovation for Post-Doctoral Fellowship and Doctoral Scholarship funding.	Althaus D, 2012, J FOOD PROTECT, V75, P1338, DOI 10.4315/0362-028X.JFP-12-022; Aragon W, 2017, J EXP BOT, V68, P5339, DOI 10.1093/jxb/erx327; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; Compant S, 2010, FEMS MICROBIOL ECOL, V73, P197, DOI 10.1111/j.1574-6941.2010.00900.x; Divoux T, 2015, SOFT MATTER, V11, P3677, DOI 10.1039/c5sm00433k; Doan HK, 2015, PHYTOPATHOLOGY, V105, P1036, DOI 10.1094/PHYTO-02-15-0050-RVW; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Eckerson SH, 1908, BOT GAZ, V46, P221, DOI 10.1086/329698; Gekenidis MT, 2017, J APPL MICROBIOL, V123, P916, DOI 10.1111/jam.13532; Girard F, 2008, COLLOID SURFACE A, V323, P36, DOI 10.1016/j.colsurfa.2007.12.022; Gitlin L, 2009, LAB CHIP, V9, P3000, DOI 10.1039/b904684d; He JK, 2014, J BIONIC ENG, V11, P109, DOI 10.1016/S1672-6529(14)60025-1; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; Hemmila S, 2012, APPL SURF SCI, V258, P9864, DOI 10.1016/j.apsusc.2012.06.044; Herman KM, 2015, EPIDEMIOL INFECT, V143, P3011, DOI 10.1017/S0950268815000047; HOFSTEN BV, 1975, J GEN MICROBIOL, V87, P150, DOI 10.1099/00221287-87-1-150; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Intellicast, REL HUM; Jacobs JL, 2005, MICROB ECOL, V49, P104, DOI 10.1007/s00248-003-1061-4; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Koch K, 2007, ACTA BIOMATER, V3, P905, DOI 10.1016/j.actbio.2007.05.013; Koch K, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/4/046002; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Lemanceau P, 2017, ADV BOT RES, V82, P101, DOI 10.1016/bs.abr.2016.10.007; Lepore E, 2011, BIONANOSCIENCE, V1, P136, DOI 10.1007/s12668-011-0017-2; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103352, 10.1371/journal.pone.0080949, 10.1371/journal.pone.0109166]; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; McDonald B., 2013, CHEM ENG PROCESS TEC, V1, P1012; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Meyer KM, 2012, OECOLOGIA, V168, P621, DOI 10.1007/s00442-011-2138-2; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Murray LM, 2016, J BIOMED MATER RES A, V104, P1638, DOI 10.1002/jbm.a.35696; Mutreja I, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/2/025002; Nahavandi S, 2014, LAB CHIP, V14, P1496, DOI 10.1039/c3lc51124c; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; Newton AC, 2010, ANN APPL BIOL, V157, P343, DOI 10.1111/j.1744-7348.2010.00437.x; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Paguirigan AL, 2007, NAT PROTOC, V2, P1782, DOI 10.1038/nprot.2007.256; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Remus-Emsermann MNP, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00036-13; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Remus-Emsermann MNP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00197; Rivas L, 2007, INT J FOOD MICROBIOL, V115, P89, DOI 10.1016/j.ijfoodmicro.2006.10.027; Robson S, 2016, SOFT MATTER, V12, P4853, DOI 10.1039/c5sm03108g; ROCKLAND LB, 1960, ANAL CHEM, V32, P1375, DOI 10.1021/ac60166a055; Rusconi R, 2014, ANNU REV BIOPHYS, V43, P65, DOI 10.1146/annurev-biophys-051013-022916; Scheublin TR, 2014, ENVIRON MICROBIOL, V16, P2212, DOI 10.1111/1462-2920.12375; Schreiber L., 2009, WATER SOLUTE PERMEAB; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Sirinutsomboon B, 2011, BIOSYST ENG, V108, P244, DOI 10.1016/j.biosystemseng.2010.12.007; SMITH HL, 1958, J BACTERIOL, V76, P662, DOI 10.1128/JB.76.6.662-665.1958; Soffe R, 2017, SENSOR ACTUAT B-CHEM, V251, P963, DOI 10.1016/j.snb.2017.05.145; Sun MH, 2005, LANGMUIR, V21, P8978, DOI 10.1021/la050316q; Tayagui A, 2017, LAB CHIP, V17, P3643, DOI 10.1039/c7lc00725f; Vacher C, 2016, ANNU REV ECOL EVOL S, V47, P1, DOI 10.1146/annurev-ecolsys-121415-032238; Vogel C, 2012, APPL ENVIRON MICROB; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang FP, 2017, COLLOID SURFACE A, V513, P389, DOI 10.1016/j.colsurfa.2016.11.001; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xue C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05925; Yang LX, 2014, MICROSYST TECHNOL, V20, P1933, DOI 10.1007/s00542-013-2004-8; YASUDA T, 1994, LANGMUIR, V10, P2435, DOI 10.1021/la00019a068; Zhang BC, 2014, ACS APPL MATER INTER, V6, P12467, DOI 10.1021/am502384q	67	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0218102	10.1371/journal.pone.0218102	http://dx.doi.org/10.1371/journal.pone.0218102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170240	Green Submitted, Green Published, gold			2022-12-27	WOS:000470263700100
J	Wang, JF; Wu, Y				Wang, Jianfeng; Wu, Yan			Self-esteem modulates the ERP processing of emotional intensity in happy and angry faces	PLOS ONE			English	Article							ATTENTIONAL RESPONSES; NEGATIVITY BIAS; REJECTION; STIMULI; BRAIN; INFORMATION; FAILURE; STRESS	Previous studies have shown that self-esteem modulates attentional responses to emotional stimuli. However, it is well known that emotional stimuli can vary in intensity. The main objective of the present study was to further investigate self-esteem related emotional intensity processing in happy and anger faces. Event-related potentials (ERPs) were recorded while 27 high-esteem versus 27 low self-esteem participants carried out a visual oddball task, with neutral faces as the standard stimuli and deviant stimuli varying on valence (happy and anger) and intensity (40%, 70%, and 100% emotive) dimensions. The results showed only high self-esteem people, instead of those with low self-esteem, displayed significant emotion intensity effects for 100% than for 70% happy faces in P3 component. On the other hand, only people with low self-esteem exhibited pronounced intensity effects for anger faces in P3 amplitudes. Moreover, only people with low self-esteem displayed significant intensity effects for 100% compared to both 70% and 40% anger stimuli in N2 amplitudes at central sites. These findings indicate that high self-esteem individuals were typically more susceptible to highly as well as mildly positive stimuli yet less reactive to negative stimuli compared with people with low self-esteem.	[Wang, Jianfeng; Wu, Yan] Chengdu Med Coll, Dept Psychol, Chengdu, Sichuan, Peoples R China; [Wang, Jianfeng; Wu, Yan] Chengdu Med Coll, Sichuan Res Ctr Appl Psychol, Chengdu, Sichuan, Peoples R China	Chengdu Medical College; Chengdu Medical College	Wang, JF; Wu, Y (corresponding author), Chengdu Med Coll, Dept Psychol, Chengdu, Sichuan, Peoples R China.; Wang, JF; Wu, Y (corresponding author), Chengdu Med Coll, Sichuan Res Ctr Appl Psychol, Chengdu, Sichuan, Peoples R China.	wjfzy1985@163.com; wuyanzhicheng@163.com			National Natural Science Foundation of China [31700980, 31701001, 31500910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (31700980, 31701001, 31500910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, SELF; Baldwin MW, 1996, J PERS SOC PSYCHOL, V71, P1130, DOI 10.1037/0022-3514.71.6.1130; Boden JM, 2008, DEV PSYCHOPATHOL, V20, P319, DOI 10.1017/S0954579408000151; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Carretie L, 2013, SOC COGN AFFECT NEUR, V8, P764, DOI 10.1093/scan/nss068; Chen J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00376; Daffner KR, 2000, PSYCHOPHYSIOLOGY, V37, P737, DOI 10.1017/S0048577200990814; Dandeneau SP, 2004, J SOC CLIN PSYCHOL, V23, P584, DOI 10.1521/jscp.23.4.584.40306; Dandeneau SD, 2009, CONTEMP EDUC PSYCHOL, V34, P42, DOI 10.1016/j.cedpsych.2008.05.004; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Diener E., 1999, WELL BEING FDN HEDON, P213, DOI DOI 10.1037/0003-066X.61.4.305; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327; Ekman P., 1976, PICTURES FACIAL AFFE; Ellis A, 1991, J RATION-EMOT COGN-B, V9, P139, DOI [10.1007/BF01061227, DOI 10.1007/BF01061227]; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Grundy JG, 2015, SOC NEUROSCI-UK, V10, P100, DOI 10.1080/17470919.2014.965339; Gyurak A, 2007, PSYCHOL SCI, V18, P886, DOI 10.1111/j.1467-9280.2007.01996.x; Holmes A, 2009, COGN AFFECT BEHAV NE, V9, P323, DOI 10.3758/CABN.9.3.323; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Larsen RJ, 2000, PSYCHOL INQ, V11, P129, DOI 10.1207/S15327965PLI1103_01; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Li HJ, 2012, J RES PERS, V46, P459, DOI 10.1016/j.jrp.2012.02.010; Li HJ, 2012, PERS INDIV DIFFER, V53, P947, DOI 10.1016/j.paid.2012.03.004; Luck S. J., 2005, COGNITIVE NEUROSCIEN; Mauss IB, 2007, SOC PERSONAL PSYCHOL, V1, P146, DOI 10.1111/j.1751-9004.2007.00005.x; Murray SL, 2006, PSYCHOL BULL, V132, P641, DOI 10.1037/0033-2909.132.5.641; Murray SL, 2000, J PERS SOC PSYCHOL, V78, P478, DOI 10.1037//0022-3514.78.3.478; Murray SL, 2002, J PERS SOC PSYCHOL, V83, P556, DOI 10.1037//0022-3514.83.3.556; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Pruessner JC, 1999, PERS INDIV DIFFER, V27, P477, DOI 10.1016/S0191-8869(98)00256-6; Ralph JA, 1998, J ABNORM PSYCHOL, V107, P203, DOI 10.1037/0021-843X.107.2.203; Ridout N, 2009, COGNITION EMOTION, V23, P739, DOI 10.1080/02699930802121137; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Sommer KL, 2002, PERS SOC PSYCHOL B, V28, P926, DOI 10.1177/01467202028007006; Sommer KL, 2001, BASIC APPL SOC PSYCH, V23, P225, DOI 10.1207/S15324834BASP2304_1; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Wang JF, 2014, J RES PERS, V50, P90, DOI 10.1016/j.jrp.2014.03.005; Wang JF, 2011, J RES PERS, V45, P441, DOI 10.1016/j.jrp.2011.05.004; WHISMAN MA, 1993, J PERS SOC PSYCHOL, V65, P1054, DOI 10.1037/0022-3514.65.5.1054; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Wood JV, 2003, J PERS SOC PSYCHOL, V85, P566, DOI 10.1037/0022-3514.85.3.566; Young AW, 2002, FACIAL EXPRESSIONS E; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan Jiajin, 2015, Front Behav Neurosci, V9, P98, DOI 10.3389/fnbeh.2015.00098	51	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217844	10.1371/journal.pone.0217844	http://dx.doi.org/10.1371/journal.pone.0217844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170195	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700069
J	Takada, K; Shimokawa, M; Tanaka, K; Kohashi, K; Haro, A; Osoegawa, A; Tagawa, T; Azuma, K; Okamoto, I; Oda, Y; Mori, M				Takada, Kazuki; Shimokawa, Mototsugu; Tanaka, Kensuke; Kohashi, Kenichi; Haro, Akira; Osoegawa, Atsushi; Tagawa, Tetsuzo; Azuma, Koichi; Okamoto, Isamu; Oda, Yoshinao; Mori, Masaki			Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma	PLOS ONE			English	Article							DEATH-LIGAND 1; INDOLEAMINE 2,3-DIOXYGENASE 1; TO-LYMPHOCYTE RATIO; PD-L2 EXPRESSION; CLINICOPATHOLOGICAL ANALYSIS; PROTEIN EXPRESSION; OPEN-LABEL; CANCER; DOCETAXEL; NIVOLUMAB	We sought to identify peripheral blood markers associated with two immune-related factors -programmed cell death-ligand-2 (PD-L2) and indoleamine 2,3-dioxygenase-1 (IDO1)- that are expressed on tumor cells in primary lung adenocarcinoma (AD) specimens. We randomly selected 448 patients (70%) from 640 consecutive patients with resected stage I-III primary lung AD, who had been treated at that point with surgery alone. Expression of PD-L2 and IDO1 in these patients was assessed by immunohistochemistry, and evaluated with respect to peripheral blood markers measured before surgery, including white blood cells, absolute neutrophil count, absolute lymphocyte count, absolute monocyte count (AMC), absolute eosinophil count (AEC), serum C-reactive protein, and serum lactate dehydrogenase levels. Membrane PD-L2 expression and cytoplasmic IDO1 expression were defined by tumor proportion score (TPS); samples with TPS < 1% were considered negative. Logistic regression models were used to identify variables associated with the immune-related factors. Advanced stage (P = 0.0090), higher AMC (P = 0.0195), and higher AEC (P = 0.0015) were independent predictors of IDO1 expression. PD-L2 expression was not associated with any tested peripheral blood markers. Peripheral blood markers, especially AMC and AEC, could potential predict IDO1 expression in lung AD. This study should be replicated in another cohort; further efforts to explore other biomarkers that predict PD-L2 or IDO1 expression are also warranted.	[Takada, Kazuki; Tanaka, Kensuke; Haro, Akira; Osoegawa, Atsushi; Tagawa, Tetsuzo; Mori, Masaki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan; [Shimokawa, Mototsugu] Natl Kyushu Canc Ctr, Clin Res Inst, Fukuoka, Fukuoka, Japan; [Kohashi, Kenichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Fukuoka, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Fukuoka, Fukuoka, Japan; [Okamoto, Isamu] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu Cancer Center; Kyushu University; Kurume University; Kyushu University	Takada, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan.	k_takada@surg2.med.kyushu-u.ac.jp		Osoegawa, Atsushi/0000-0002-8327-3631				Akamine T, 2018, SURG ONCOL, V27, P88, DOI 10.1016/j.suronc.2018.01.002; Awad MM, 2018, J CLIN ONCOLOGY OF S, V36; Bagley SJ, 2017, LUNG CANCER, V106, P1, DOI 10.1016/j.lungcan.2017.01.013; Balar AV, 2018, J CLIN ONCOLOGY OF S, V36; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brustugun OT, 2016, J CLIN ONCOLOGY OFFI; Calles A, 2015, J THORAC ONCOL, V10, P1726, DOI 10.1097/JTO.0000000000000687; Casebeer AW, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.30_suppl.46; Cohen EEW, 2018, J CLIN ONCOLOGY OF S, V36; Daud A, 2018, J CLIN ONCOL S, V36; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Diem S, 2017, LUNG CANCER, V111, P176, DOI 10.1016/j.lungcan.2017.07.024; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hui RN, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS9104; Jotte RM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA9000; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Koh J, 2015, MODERN PATHOL, V28, P1154, DOI 10.1038/modpathol.2015.63; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Kozuma Y, 2018, EUR J CANCER, V101, P20, DOI 10.1016/j.ejca.2018.06.020; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Matsubara T, 2019, ANN SURG ONCOL, V26, P1925, DOI 10.1245/s10434-019-07257-3; Okuma Y, 2017, LUNG CANCER, V104, P1, DOI 10.1016/j.lungcan.2016.11.023; PAZARES LG, 2018, J CLIN ONCOL S, V36; Powles T, 2018, J CLIN ONCOLOGY OF S, V36; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Seeber A, 2018, CANCER SCI, V109, P1583, DOI 10.1111/cas.13560; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Takada K, 2019, LUNG CANCER, V128, P26, DOI 10.1016/j.lungcan.2018.12.008; Takada K, 2018, ANTICANCER RES, V38, P5295, DOI 10.21873/anticanres.12856; Takada K, 2017, CANCER MED-US, V6, P2552, DOI 10.1002/cam4.1215; Takada K, 2016, J THORAC ONCOL, V11, P1879, DOI 10.1016/j.jtho.2016.06.006; Takamori S, 2019, ANN SURG ONCOL, V26, P1916, DOI 10.1245/s10434-019-07231-z; Takamori S, 2018, ANTICANCER RES, V38, P5903, DOI 10.21873/anticanres.12934; Takamori S, 2018, ANTICANCER RES, V38, P5897, DOI 10.21873/anticanres.12933; Takamori S, 2018, CLIN LUNG CANCER, V19, P12, DOI 10.1016/j.cllc.2017.06.015; Tanizaki J, 2018, J THORAC ONCOL, V13, P97, DOI 10.1016/j.jtho.2017.10.030; Theate I, 2015, CANCER IMMUNOL RES, V3, P161, DOI 10.1158/2326-6066.CIR-14-0137; Toyokawa G, 2017, CLIN LUNG CANCER, V18, pE375, DOI 10.1016/j.cllc.2017.03.008; Zhai LJ, 2015, CLIN CANCER RES, V21, P5427, DOI 10.1158/1078-0432.CCR-15-0420; Zhang Y, 2014, ONCOTARGETS THER, V7, P567, DOI 10.2147/OTT.S59959	47	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217991	10.1371/journal.pone.0217991	http://dx.doi.org/10.1371/journal.pone.0217991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163080	gold, Green Submitted, Green Published			2022-12-27	WOS:000470086200050
J	Crivaro, AN; Mucci, JM; Bonder, CM; Ormazabal, ME; Ceci, R; Simonaro, C; Rozenfeld, PA				Crivaro, Andrea N.; Mucci, Juan M.; Bonder, Constanza M.; Ormazabal, Maximiliano E.; Ceci, Romina; Simonaro, Calogera; Rozenfeld, Paula A.			Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease	PLOS ONE			English	Article							BONE; IMMUNE; SODIUM; CELLS	Gaucher and Fabry diseases are the most prevalent sphingolipidoses. Chronic inflammation is activated in those disorders, which could play a role in pathogenesis. Significant degrees of amelioration occur in patients upon introduction of specific therapies; however, restoration to complete health status is not always achieved. The idea of an adjunctive therapy that targets inflammation may be a suitable option for patients. PPS is a mixture of semisynthetic sulfated polyanions that have been shown to have anti-inflammatory effects in mucopoly-saccharidosis type I and II patients and animal models of type I, IIIA and VI. We hypothesized PPS could be a useful adjunctive therapy to inflammation for Gaucher and Fabry diseases. The objective of this work is to analyze the in vitro effect of PPS on inflammatory cytokines in cellular models of Gaucher and Fabry diseases, and to study its effect in Gaucher disease associated in vitro bone alterations. Cultures of peripheral blood mononuclear cells from Fabry and Gaucher patients were exposed to PPS. The secretion of proinflammatory cytokines was significantly reduced. Peripheral blood cells exposed to PPS from Gaucher patients revealed a reduced tendency to differentiate to osteoclasts. Osteoblasts and osteocytes cell lines were incubated with an inhibitor of glucocerebrosidase, and conditioned media was harvested in order to analyze if those cells secrete factors that induce osteoclastogenesis. Conditioned media from this cell cultures exposed to PPS produced lower numbers of osteoclasts. We could demonstrate PPS is an effective molecule to reduce the production of proinflammatory cytokines in in vitro models of Fabry and Gaucher diseases. Moreover, it was effective at ameliorating bone alterations of in vitro models of Gaucher disease. These results serve as preclinical supportive data to start clinical trials in human patients to analyze the effect of PPS as a potential adjunctive therapy for Fabry and Gaucher diseases.	[Crivaro, Andrea N.; Mucci, Juan M.; Bonder, Constanza M.; Ormazabal, Maximiliano E.; Ceci, Romina; Rozenfeld, Paula A.] Univ Nacl La Plata, CONICET, IIFP, Fac Ciencias Exactas,Dept Ciencias Biol, La Plata, Buenos Aires, Argentina; [Simonaro, Calogera] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Icahn School of Medicine at Mount Sinai	Rozenfeld, PA (corresponding author), Univ Nacl La Plata, CONICET, IIFP, Fac Ciencias Exactas,Dept Ciencias Biol, La Plata, Buenos Aires, Argentina.	paularozenfeld@gmail.com		Ormazabal, Maximiliano Emanuel/0000-0003-0455-5532; , Paula/0000-0002-8138-3087				Beck M, 2018, DEV MED CHILD NEUROL, V60, P13, DOI 10.1111/dmcn.13600; Bondar C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010112; Chen KH, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.10.033; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Fujitsuka H, 2019, MOL GENET METAB REP, V19, DOI 10.1016/j.ymgmr.2019.100455; GRABOWSKI GA, 2009, ONLINE METABOLIC MOL; Grabowski GA, 2017, MOL GENET METAB, V120, P38, DOI 10.1016/j.ymgme.2016.11.388; Grosjean F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204366; Hennermann JB, 2016, J INHERIT METAB DIS, V39, P831, DOI 10.1007/s10545-016-9974-5; Kruger R, 2012, J CHROMATOGR B, V883, P128, DOI 10.1016/j.jchromb.2011.11.020; Kumar V, 2012, ROBBINS BASIC PATHOL; Liao HC, 2017, CLIN CHEM, V63, P1363, DOI 10.1373/clinchem.2016.264952; Mathur A, 2018, J LEUKOCYTE BIOL, V103, P233, DOI 10.1189/jlb.3MR0617-250R; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Morishita K, 2011, RHEUMATOLOGY, V50, pV19, DOI 10.1093/rheumatology/ker397; Mucci JM, 2015, BLOOD CELL MOL DIS, V55, P134, DOI 10.1016/j.bcmd.2015.05.009; Nagata M, 2017, P NATL ACAD SCI USA, V114, pE3285, DOI 10.1073/pnas.1618133114; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Okamoto K, 2017, PHYSIOL REV, V97, P1295, DOI 10.1152/physrev.00036.2016; Panicker LM, 2018, HUM MOL GENET, V27, P811, DOI 10.1093/hmg/ddx442; Rigante D, 2017, IMMUNOL LETT, V188, P79, DOI 10.1016/j.imlet.2017.07.004; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Sadhukhan PC, 2002, J UROLOGY, V168, P289, DOI 10.1016/S0022-5347(05)64909-9; Sampson MJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1754-3; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153136; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Stirnemann J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020441; Vistnes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089621; Wijekoon HMS, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1466-4; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Zancan I, 2015, HUM MOL GENET, V24, P1280, DOI 10.1093/hmg/ddu538	35	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217780	10.1371/journal.pone.0217780	http://dx.doi.org/10.1371/journal.pone.0217780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150494	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100105
J	Lu, CH; Chen, WT; Hsieh, CH; Kuo, YY; Chao, CY				Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu			Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; CELLULAR-RESPONSES; MILD HYPERTHERMIA; APOPTOSIS; GEMCITABINE; RADIATION; MITOCHONDRIA; INHIBITION; COFFEE; LINE	Hyperthermia (HT) has shown feasibility and potency as an anticancer therapy. Administration of HT in the chemotherapy has previously enhanced the cytotoxicity of drugs against pancreatic cancer. However, the drugs used when conducting these studies are substantially conventional chemotherapeutic agents that may cause unwanted side effects. Additionally, the thermal dosage in the treatment of cancer cells could also probably harm the healthy cells. The purpose of this work was to investigate the potential of the two natural polyphenolic compounds, epigallocatechin gallate (EGCG) and chlorogenic acid (CGA), as heat synergizers in the thermal treatment of the PANC-1 cells. Furthermore, we have introduced a unique strategy entitled the thermal cycling-hyperthermia (TC-HT) that is capable of providing a maximum synergy and minimal side effect with the anticancer compounds. Our results demonstrate that the combination of the TC-HT and the CGA or EGCG markedly exerts the anticancer effect against the PANC-1 cells, while none of the single treatment induced such changes. The synergistic activity was attributed to the cell cycle arrest at the G2/M phase and the induction of the ROS-dependent mitochondria-mediated apoptosis. These findings not only represent the first in vitro thermal synergistic study of natural compounds in the treatment of pancreatic cancer, but also highlight the potential of the TC-HT as an alternative strategy in thermal treatment.	[Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu] Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan; [Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/GMX-1452-2022; Hsieh, Chih-Hsiung/AFI-4085-2022		Ministry of Science and Technology of the Republic of China [MOST 105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [MOE 106R880708]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan)	This work was supported by grants from Ministry of Science and Technology (MOST 105-2112-M-002-006-MY3 to CYC) and Ministry of Education (MOE 106R880708 to CYC) of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, INT J HYPERTHER, V25, P210, DOI 10.1080/02656730802657036; Ahmed K, 2015, APOPTOSIS, V20, P1411, DOI 10.1007/s10495-015-1168-3; Au JLS, 2010, ONCOLOGY-NY, V24, P1155; Bakshandeh-Bath A, 2009, ANTICANCER RES, V29, P3069; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Bimonte Sabrina, 2017, Recenti Progressi in Medicina, V108, P282, DOI 10.1701/2715.27715; Calderwood SK, 2005, INT J HYPERTHER, V21, P713, DOI 10.1080/02656730500340794; Cesna V, 2018, WORLD J GASTROENTERO, V24, P1072, DOI 10.3748/wjg.v24.i10.1072; Cui ZG, 2014, CHEM-BIOL INTERACT, V215, P46, DOI 10.1016/j.cbi.2014.03.005; Cui ZG, 2014, EUR J PHARMACOL, V723, P99, DOI 10.1016/j.ejphar.2013.11.031; Curley SA, 2014, INT J ENV RES PUB HE, V11, P9142, DOI 10.3390/ijerph110909142; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; DEWEY WC, 1994, INT J HYPERTHER, V10, P457, DOI 10.3109/02656739409009351; Dong J, 2011, WORLD J GASTROENTERO, V17, P1204, DOI 10.3748/wjg.v17.i9.1204; Feng Q, 2006, J JILIN U MED EDITIO; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fryer RA, 2009, CURR CLIN PHARMACOL, V4, P102, DOI 10.2174/157488409788185007; Gee JR, 2017, CANCER PREV RES, V10, P298, DOI 10.1158/1940-6207.CAPR-16-0167; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hatashita M, 2014, INT J MOL MED, V33, P406, DOI 10.3892/ijmm.2013.1568; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Jin HB, 2018, ONCOL LETT, V16, P6742, DOI 10.3892/ol.2018.9455; Kampinga HH, 2006, INT J HYPERTHER, V22, P191, DOI 10.1080/02656730500532028; Kaur Punit, 2011, Cancers (Basel), V3, P3799, DOI 10.3390/cancers3043799; KIM JH, 1984, CANCER RES, V44, P102; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; Li XP, 2013, INT J HYPERTHER, V29, P678, DOI 10.3109/02656736.2013.837199; Lim CU, 2006, INT J HYPERTHER, V22, P77, DOI 10.1080/02656730500430538; Min KJ, 2014, INTEGR MED RES, V3, P16, DOI 10.1016/j.imr.2013.12.001; Miyamoto R, 2016, CANCER SCI, V107, P514, DOI 10.1111/cas.12888; Mohamed F, 2003, ANN SURG ONCOL, V10, P463, DOI 10.1245/ASO.2003.08.006; Oei AL, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0462-0; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; OVERGAARD J, 1989, INT J RADIAT ONCOL, V16, P535, DOI 10.1016/0360-3016(89)90470-7; Ponce AM, 2006, INT J HYPERTHER, V22, P205, DOI 10.1080/02656730600582956; RAAPHORST GP, 1979, RADIAT RES, V79, P390, DOI 10.2307/3575104; Refaat T, 2015, BREAST, V24, P418, DOI 10.1016/j.breast.2015.03.008; Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410; Rodriguez M, 2018, J CARCINOG MUTAG S, V6; Roti JLR, 2008, INT J HYPERTHER, V24, P3, DOI 10.1080/02656730701769841; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SMINIA P, 1994, INT J HYPERTHER, V10, P1, DOI 10.3109/02656739409009328; Song CW, 2009, INT J HYPERTHER, V25, P91, DOI 10.1080/02656730902744171; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tschoep-Lechner KE, 2013, INT J HYPERTHER, V29, P8, DOI 10.3109/02656736.2012.740764; Wang K, 2012, INT J HYPERTHER, V28, P645, DOI 10.3109/02656736.2012.713541; Ware MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10508-6; Xu RS, 2015, J ANAL METHODS CHEM, V2015, DOI 10.1155/2015/189328; Yamagata K, 2018, MOL CELL BIOCHEM, V441, P9, DOI 10.1007/s11010-017-3171-1; Zhao HX, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150665; Zhao PJ, 2015, MOL MED REP, V11, P327, DOI 10.3892/mmr.2014.2655	57	17	17	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217676	10.1371/journal.pone.0217676	http://dx.doi.org/10.1371/journal.pone.0217676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150487	Green Submitted, gold, Green Published			2022-12-27	WOS:000469759100083
J	Baker, S; Kessler, E; Darville-Bowleg, L; Merchant, M				Baker, Sarah; Kessler, Ethan; Darville-Bowleg, Lancia; Merchant, Mark			Different mechanisms of serum complement activation in the plasma of common (Chelydra serpentina) and alligator (Macrochelys temminckii) snapping turtles	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; PATHWAY; SYSTEM; TEMPERATURE; THIOESTER; PROTEINS	Reptiles are declining worldwide yet our understanding of their immune function lags far behind other taxa. The innate immune system is the primary mode of defense in reptiles, and the serum complement cascade is its major component. We assessed serum complement activity of plasma in two closely related aquatic turtle species, the common snapping turtle (CST; Chelydra serpentina) and alligator snapping turtle (AST; Macrochelys temminckii). We used a sheep red blood cell (SRBC) hemolysis assay to assess serum complement activity. Although the antibacterial activities of the plasma of these turtle species are similar, the hemolytic activity was much stronger in CST than AST. Treatment with inhibitors of the serum complement cascade indicated differences in the mechanisms of complement activation between the turtle species. We subjected plasma from both turtle species to mannan affinity chromatography and analyzed the eluate with SDS-PAGE, which revealed that plasma from the CSTs contained only small amounts of one C-type lectin protein while the AST plasma contained high concentrations of two C-type lectins (31.0 and 35.9 kDa). Edman degradation analyses confirmed that the two AST proteins contained identical N-terminal sequences. Thus, the CST appears to rely more heavily on the alternative mechanism of serum complement activation, while the AST appears to rely more on the lectin-mediated pathway, which is a pattern recognition response to prokaryotes not activated by the SRBCs. These results are unique in that the use of serum complement pathways are generally assumed to be conserved within clades.	[Baker, Sarah; Kessler, Ethan] Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Darville-Bowleg, Lancia] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Merchant, Mark] McNeese State Univ, Dept Chem, Lake Charles, LA 70605 USA; [Baker, Sarah] Arizona Game & Fish Dept, Phoenix, AZ 85086 USA	Illinois Natural History Survey; H Lee Moffitt Cancer Center & Research Institute; University of Louisiana System; McNeese State University	Baker, S (corresponding author), Illinois Nat Hist Survey, Champaign, IL 61820 USA.; Baker, S (corresponding author), Arizona Game & Fish Dept, Phoenix, AZ 85086 USA.	sbaker@azgfd.gov		Kessler, Ethan/0000-0001-8916-2070	McNeese State University College of Science Endowed Professorship [072]	McNeese State University College of Science Endowed Professorship	Funding for this work was provided by McNeese State University College of Science Endowed Professorship 072 awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTEN KF, 1961, J EXP MED, V114, P29, DOI 10.1084/jem.114.1.29; Baker SJ, 2018, J EXP ZOOL PART A, P1; Beck ML, 2017, J EXP ZOOL PART A, V327, P293, DOI 10.1002/jez.2089; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; BROWN GP, 1990, CAN J ZOOL, V68, P1659, DOI 10.1139/z90-246; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; DALMASSO AP, 1989, COMPLEMENT INFLAMMAT, V6, P36, DOI 10.1159/000463070; Darville LNF, 2012, COMP BIOCHEM PHYS B, V161, P161, DOI 10.1016/j.cbpb.2011.11.001; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Ernst C.H., 2009, TURTLES US CANADA, VSecond edition; Ferronato BO, 2009, ZOOLOGIA-CURITIBA, V26, P747, DOI 10.1590/S1984-46702009000400020; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GORSKI JP, 1980, J BIOL CHEM, V255, P25; Gotze O, 1977, Monogr Allergy, V12, P66; Kilpatrick DC, 2002, TRANSFUSION MED, V12, P335, DOI 10.1046/j.1365-3148.2002.00408.x; KNIGHT TW, 1990, COPEIA, P1067, DOI 10.2307/1446490; Law SKA, 1997, PROTEIN SCI, V6, P263; Li YM, 2012, PEPTIDES, V37, P207, DOI 10.1016/j.peptides.2012.07.001; Lovich JE, 2018, BIOSCIENCE, V68, P771, DOI 10.1093/biosci/biy095; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Merchant M, 2006, COMP BIOCHEM PHYS A, V143, P488, DOI 10.1016/j.cbpa.2006.01.009; Merchant M, 2012, ADV BIOL CHEM, V2, P353, DOI DOI 10.4236/ABC.2012.24043; Merchant M., 2014, INT J BIOCH RES REV, V4, P295, DOI DOI 10.9734/IJBCRI1/2014/7825; Merchant M., 2013, ENTOMOLOGY ORNITHOLO, V2, P110; Merchant M, 2010, VET IMMUNOL IMMUNOP, V133, P165, DOI 10.1016/j.vetimm.2009.07.016; Merchant ME, 2005, COMP BIOCHEM PHYS B, V141, P281, DOI 10.1016/j.cbpc.2005.03.009; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; PANGBURN MK, 1983, ANN NY ACAD SCI, V421, P291, DOI 10.1111/j.1749-6632.1983.tb18116.x; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Porter R R, 1979, Adv Protein Chem, V33, P1, DOI 10.1016/S0065-3233(08)60458-1; PRITCHARD P. C. H., 2006, ALLIGATOR SNAPPING T; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shaffer HB, 2017, MOL PHYLOGENET EVOL, V115, P7, DOI 10.1016/j.ympev.2017.07.006; Shipman PA, 2008, SOUTHEAST NAT, V7, P331, DOI 10.1656/1528-7092(2008)7[331:SADOTA]2.0.CO;2; Siroski PA, 2010, ZOOL STUD, V49, P64; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; WARDLAW ALASTAIR C., 1962, JOUR EXPTL MED, V115, P1231, DOI 10.1084/jem.115.6.1231; Warr GW, 2003, DEV COMP IMMUNOL, V27, P257, DOI 10.1016/S0145-305X(02)00070-8; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; West JM, 2018, GEN COMP ENDOCR, V262, P71, DOI 10.1016/j.ygcen.2018.03.016; WILLIAMSON LU, 1989, J THERM BIOL, V14, P33, DOI 10.1016/0306-4565(89)90027-2; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	43	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217626	10.1371/journal.pone.0217626	http://dx.doi.org/10.1371/journal.pone.0217626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170203	Green Submitted, gold, Green Published			2022-12-27	WOS:000470263700044
J	Cussell, PJG; Howe, MS; Illingworth, TA; Escalada, MG; Milton, NGN; Paterson, AWJ				Cussell, Peter J. G.; Howe, Michael S.; Illingworth, Thomas A.; Escalada, Margarita Gomez; Milton, Nathaniel G. N.; Paterson, Andrew W. J.			The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA	PLOS ONE			English	Article							FORMYLPEPTIDE RECEPTOR; GROWTH; PROTEINS; INTERNALIZATION; NEUTROPHILS; ROLES	The N-formyl peptide receptors (FPRs) have been identified within neuronal tissues and may serve as yet undetermined functions within the nervous system. The FPRs have been implicated in the progression and invasiveness of neuroblastoma and other cancers. In this study the effects of the synthetic FPR agonist FPRa14, FPR antagonists and FPR knockdown using siRNA on mouse neuroblastoma neuro2a (N2a) cell differentiation plus toxicity were examined. The FPRa14 (1-10 mu M) was found to induce a significant dose-dependent differentiation response in mouse neuroblastoma N2a cells. Interestingly, three distinct differentiated morphologies were observed, with two non-archetypal forms observed at the higher FPRa14 concentrations. These three forms were also observed in the human neuroblastoma cell-lines IMR-32 and SH-SY5Y when exposed to 100 mu M FPRa14. In N2a cells combined knockdown of FPR1 and FPR2 using siRNA inhibited the differentiation response to FPRa14, suggesting involvement of both receptor subtypes. Pre-incubating N2a cultures with the FPR1 antagonists Boc-MLF and cyclosporin H significantly reduced FPRa14-induced differentiation to near baseline levels. Meanwhile, the FPR2 antagonist WRW4 had no significant effect on FPRa14-induced N2a differentiation. These results suggest that the N2a differentiation response observed has an FPR1-dependent component. Toxicity of FPRa14 was only observed at higher concentrations. All three antagonists used blocked FPRa14-induced toxicity, whilst only siRNA knockdown of FPR2 reduced toxicity. This suggests that the toxicity and differentiation involve different mechanisms. The demonstration of neuronal differentiation mediated via FPRs in this study represents a significant finding and suggests a role for FPRs in the CNS. This finding could potentially lead to novel therapies for a range of neurological conditions including neuroblastoma, Alzheimer's disease, Parkinson's disease and neuropathic pain. Furthermore, this could represent a potential avenue for neuronal regeneration therapies.	[Cussell, Peter J. G.; Howe, Michael S.; Illingworth, Thomas A.; Escalada, Margarita Gomez; Milton, Nathaniel G. N.; Paterson, Andrew W. J.] Leeds Beckett Univ, Sch Clin & Appl Sci, Leeds, W Yorkshire, England	Leeds Beckett University	Paterson, AWJ (corresponding author), Leeds Beckett Univ, Sch Clin & Appl Sci, Leeds, W Yorkshire, England.	a.paterson@leedsbeckett.ac.uk	Milton, Nathaniel G N/E-8522-2012; Milton, Nathaniel Gavin Nicolas/GON-7735-2022	Milton, Nathaniel G N/0000-0002-7431-9060; Milton, Nathaniel Gavin Nicolas/0000-0002-7431-9060; Gomez Escalada, Margarita/0000-0002-7374-0048; Paterson, Andrew/0000-0002-3289-8738; Howe, Michael/0000-0002-4905-1920; Cussell, Peter/0000-0001-9494-7921; Illingworth, Thomas/0000-0001-9762-5071	Leeds Beckett University PhD studentship	Leeds Beckett University PhD studentship	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. P.J.G.C. is supported by a Leeds Beckett University PhD studentship.	Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Baracco EE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1139275; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Boer JC, 2013, BRIT J CANCER, V108, P587, DOI 10.1038/bjc.2012.603; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chang YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182303; FINNEY DA, 1983, CYTOMETRY, V4, P54, DOI 10.1002/cyto.990040108; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Haigh CL, 2011, FREE RADICAL BIO MED, V51, P594, DOI 10.1016/j.freeradbiomed.2011.03.035; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Huang J, 2008, CANCER LETT, V267, P254, DOI 10.1016/j.canlet.2008.03.014; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; JESAITIS AJ, 1984, J CELL BIOL, V98, P1378, DOI 10.1083/jcb.98.4.1378; JESAITIS AJ, 1989, J CELL BIOL, V109, P2783, DOI 10.1083/jcb.109.6.2783; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Prevete N, 2015, PHARMACOL RES, V102, P184, DOI 10.1016/j.phrs.2015.09.017; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Ries M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0692-6; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roberts HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171925; Schepetkin IA, 2007, MOL PHARMACOL, V71, P1061, DOI 10.1124/mol.106.033100; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Snapkov I, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2545-1; Soltys Z, 2005, J NEUROSCI METH, V146, P50, DOI 10.1016/j.jneumeth.2005.01.009; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Tokay T, 2008, GLIA, V56, P1380, DOI 10.1002/glia.20705; VALE RD, 1982, J CELL BIOL, V94, P710, DOI 10.1083/jcb.94.3.710; Wagener BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147442; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25946; Yan C, 2015, J HEPATOL, V63, P420, DOI 10.1016/j.jhep.2015.03.024; Yang Y, 2011, AM J PATHOL, V179, P1504, DOI 10.1016/j.ajpath.2011.05.059; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00314-5; Zhang L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078055; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P823, DOI 10.1093/jnci/dji142; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217815	10.1371/journal.pone.0217815	http://dx.doi.org/10.1371/journal.pone.0217815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170199	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000470263700060
J	Herman, PM; Yuan, AH; Cefalu, MS; Chu, K; Zeng, Q; Marshall, N; Lorenz, KA; Taylor, SL				Herman, Patricia M.; Yuan, Anita H.; Cefalu, Matthew S.; Chu, Karen; Zeng, Qing; Marshall, Nell; Lorenz, Karl A.; Taylor, Stephanie L.			The use of complementary and integrative health approaches for chronic musculoskeletal pain in younger US Veterans: An economic evaluation	PLOS ONE			English	Article							LOW-BACK-PAIN; ALTERNATIVE MEDICINE USE; HIERARCHICAL LINEAR-MODELS; CARE EXPENDITURES; PROPENSITY SCORE; MASSAGE THERAPY; METAANALYSIS; COSTS; MANIPULATION; ACUPUNCTURE	Objectives To estimate the cost-effectiveness to the US Veterans Health Administration (VA) of the use of complementary and integrative health (CIH) approaches by younger Veterans with chronic musculoskeletal disorder (MSD) pain. Perspective VA healthcare system. Methods We used a propensity score-adjusted hierarchical linear modeling (HLM), and 2010-2013 VA administrative data to estimate differences in VA healthcare costs, pain intensity (0-10 numerical rating scale), and opioid use between CIH users and nonusers. We identified CIH use in Veterans' medical records through Current Procedural Terminology, VA workload tracking, and provider-type codes. Results We identified 30,634 younger Veterans with chronic MSD pain as using CIH and 195,424 with no CIH use. CIH users differed from nonusers across all baseline covariates except the Charlson comorbidity index. They also differed on annual pre-CIH-start healthcare costs ($10,729 versus $5,818), pain (4.33 versus 3.76), and opioid use (66.6% versus 54.0%). The HLM results indicated lower annual healthcare costs (-$637; 95% CI: -$1,023, -$247), lower pain (-0.34; -0.40, -0.27), and slightly higher (less than a percentage point) opioid use (0.8; 0.6, 0.9) for CIH users in the year after CIH start. Sensitivity analyses indicated similar results for three most-used CIH approaches (acupuncture, chiropractic care, and massage), but higher costs for those with eight or more CIH visits. Conclusions On average CIH use appears associated with lower healthcare costs and pain and slightly higher opioid use in this population of younger Veterans with chronic musculoskeletal pain. Given the VA's growing interest in the use of CIH, further, more detailed analyses of its impacts are warranted.	[Herman, Patricia M.; Cefalu, Matthew S.] RAND Corp, Santa Monica, CA 90401 USA; [Yuan, Anita H.; Chu, Karen; Taylor, Stephanie L.] VA Greater Los Angeles Healthcare Syst, Ctr Study Healthcare Innovat Implementat & Policy, Los Angeles, CA USA; [Zeng, Qing] VA Washington DC Healthcare Syst, Ctr Hlth & Aging, Washington, DC USA; [Zeng, Qing] George Washington Univ, Biomed Informat Ctr, Washington, DC USA; [Marshall, Nell; Lorenz, Karl A.] VA Palo Alto Healthcare Syst, Ctr Study Innovat Implementat, Menlo Pk, CA USA; [Lorenz, Karl A.] Stanford Sch Med, Palo Alto, CA USA; [Taylor, Stephanie L.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90024 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of California System; University of California Los Angeles	Herman, PM (corresponding author), RAND Corp, Santa Monica, CA 90401 USA.	pherman@rand.org	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0002-3266-1132; Herman, Patricia/0000-0001-5579-5654	Department of Veterans Affairs, Health Services Research and Development Service [1 R01 HX001704-1]	Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs)	All authors were funded under a grant provided by the Department of Veterans Affairs, Health Services Research and Development Service, 1 R01 HX001704-1, Principal Investigator: Dr. Stephanie L Taylor. https://www.research.va.gov/services/hsrd.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2016, APP C CLIN CLASS SOF; [Anonymous], 2018, AHRQ PUB, V18-0033-EF; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Avogo W, 2008, HEALTH EDUC J, V67, P258, DOI 10.1177/0017896908097069; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; Boyd C, 2016, PAIN MED, V17, P1553, DOI 10.1093/pm/pnw100; Bureau of Labor Statistics, 2013, CONS PRIC IND; Caspi O, 2004, MED DECIS MAKING, V24, P64, DOI 10.1177/0272989X03261567; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Clare HA, 2004, AUST J PHYSIOTHER, V50, P209, DOI 10.1016/S0004-9514(14)60110-0; Coulter ID, 2018, SPINE J, V18, P866, DOI 10.1016/j.spinee.2018.01.013; Coulter ID, 2018, PAIN PHYS; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Crawford C, 2016, PAIN MED, V17, P1353, DOI 10.1093/pm/pnw099; Cui DW, 2014, PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON NUCLEAR ENGINEERING - 2013, VOL 3; Denneson LM, 2011, J REHABIL RES DEV, V48, P1119, DOI 10.1682/JRRD.2010.12.0243; Diagnosis and Treatment of Low Back Pain Work Group, 2017, VA DOD CLIN PRACT GU; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FELDMAN HA, 1988, J APPL PHYSIOL, V64, P1721, DOI 10.1152/jappl.1988.64.4.1721; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Gironda RJ, 2007, J REHABIL RES DEV, V44, P223, DOI 10.1682/JRRD.2006.06.0058; Goulet JL, 2016, PAIN, V157, P1696, DOI 10.1097/j.pain.0000000000000567; Grieves B, 2009, J MANIP PHYSIOL THER, V32, P734, DOI 10.1016/j.jmpt.2009.10.001; Haas M, 2014, SPINE J, V14, P1106, DOI 10.1016/j.spinee.2013.07.468; Hadlandsmyth K, 2018, J GEN INTERN MED, V33, P818, DOI 10.1007/s11606-017-4283-8; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Healthcare Analysis & Information Group, 2015, FY 2015 VHA COMPL IN; Healthcare Analysis & Information Group, 2011, 2011 COMPL ALT MED S; Healthcare Analysis & Information Group, 2002, SURV COMPL ALT MED; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Hilton L, 2017, ANN BEHAV MED, V51, P199, DOI 10.1007/s12160-016-9844-2; Imai K, 2014, J R STAT SOC B, V76, P243, DOI 10.1111/rssb.12027; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kerns RD, 2009, PAIN MED, V10, P1161, DOI 10.1111/j.1526-4637.2009.00722.x; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Legorreta AP, 2004, ARCH INTERN MED, V164, P1985, DOI 10.1001/archinte.164.18.1985; Lind BK, 2010, J ALTERN COMPLEM MED, V16, P411, DOI 10.1089/acm.2009.0261; Lorenz KA, 2009, J AM BOARD FAM MED, V22, P291, DOI 10.3122/jabfm.2009.03.080162; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; Machlin SR, 2018, CHARACTERISTICS HLTH; Martin BI, 2012, MED CARE, V50, P1029, DOI 10.1097/MLR.0b013e318269e0b2; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; McEachrane-Gross F Patricia, 2006, BMC Complement Altern Med, V6, P34, DOI 10.1186/1472-6882-6-34; Midboe AM, 2012, TRANSL BEHAV MED, V2, P57, DOI 10.1007/s13142-011-0104-5; Moritz S, 2011, J ALTERN COMPLEM MED, V17, P1015, DOI 10.1089/acm.2010.0619; National Pain Management Coordinating Committee, 2000, PAIN 5 VIT SIGN TOOL; O'Connell AA, 2004, EVAL HEALTH PROF, V27, P119, DOI 10.1177/0163278704264049; Owens JE, 1999, J ALTERN COMPLEM MED, V5, P529, DOI 10.1089/acm.1999.5.529; Perlman AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030248; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Posadzki P, 2011, CLIN RHEUMATOL, V30, P1257, DOI 10.1007/s10067-011-1764-8; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rickhi B, 2003, CAN J PSYCHIAT, V48, P475, DOI 10.1177/070674370304800708; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schwehr NA, 2018, ACUPUNCT MED; Sherman KJ, 2014, ANN FAM MED, V12, P112, DOI 10.1370/afm.1602; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sirois FM, 2002, J ALTERN COMPLEM MED, V8, P127, DOI 10.1089/107555302317371415; Smith M.W., 2010, FEE BASIS DATA GUIDE; Sparber A, 2002, J ALTERN COMPLEM MED, V8, P93, DOI 10.1089/107555302753507230; Swartzman LC, 2002, MED DECIS MAKING, V22, P431, DOI 10.1177/027298902236943; Taylor SL, 2019, J ALTERN COMPLEM MED, V25, P32, DOI 10.1089/acm.2018.0276; Thorne S, 2002, INT J NURS STUD, V39, P671, DOI 10.1016/S0020-7489(02)00005-6; Tian TY, 2013, J AM MED INFORM ASSN, V20, pE275, DOI 10.1136/amiajnl-2013-001856; VA Health Care, 2017, WHOL HLTH LIF EXP VA; VA Health Care, 2018, ENR PRIOR GROUPS WHA; Veterans Health Administration (VHA), 2017, CORP DAT WAR CDW; VHA Office of Patient Centered Care and Cultural Transformation, 2017, WHOL HLTH ITS ALL YO; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Wootton JC, 2001, J ALTERN COMPLEM MED, V7, P715, DOI 10.1089/10755530152755270; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	79	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217831	10.1371/journal.pone.0217831	http://dx.doi.org/10.1371/journal.pone.0217831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31167005	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800042
J	Onyeaghala, G; Lane, J; Pankratz, N; Nelson, HH; Thyagarajan, B; Walcheck, B; Anderson, KE; Prizment, AE				Onyeaghala, Guillaume; Lane, John; Pankratz, Nathan; Nelson, Heather H.; Thyagarajan, Bharat; Walcheck, Bruce; Anderson, Kristin E.; Prizment, Anna E.			Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SOLUBLE NKG2D LIGANDS; CHAIN-RELATED GENE; HEPATOCELLULAR-CARCINOMA; EXPRESSION; ALLELE; TUMOR; SUSCEPTIBILITY; INCREASE	Background Pancreatic tumor cells may avoid immune surveillance by releasing the transmembrane major histocompatibility complex class I chain-related A (MICA) protein in soluble form (s-MICA). We hypothesized that the presence of the A5.1 polymorphism in the MICA gene, which encodes a truncated MICA protein, is associated with higher s-MICA levels and increased pancreatic cancer risk. Methods MICA alleles and s-MICA levels were measured in 121 pancreatic cancer cases and 419 controls. General linear regression with a log transformation assessed geometric means of s-MICA levels across MICA alleles. Unconditional logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (CI) for pancreatic cancer associated with MICA alleles. Results After multivariate adjustment, participants with at least one copy of the A5.1 allele versus no A5.1 allele had 1.35 (95% CI: 1.05-1.74) times greater s-MICA levels (1.65 times higher for cases and 1.28, for controls) and increased risk of pancreatic cancer (OR = 1.91, 95% CI: 1.05-3.48). Conclusions Our study suggests higher risk of pancreatic cancer among those with the MICA A5.1 polymorphism, which may be explained by an increase in s-MICA secretion and impaired immune response. Impact These findings provide further evidence at the genetic and molecular level of the important role of MICA in pancreatic cancer development, and may have important implications with regards to pancreatic cancer screening.	[Onyeaghala, Guillaume; Nelson, Heather H.; Anderson, Kristin E.; Prizment, Anna E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Lane, John; Pankratz, Nathan; Nelson, Heather H.; Thyagarajan, Bharat; Walcheck, Bruce; Anderson, Kristin E.; Prizment, Anna E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Lane, John; Pankratz, Nathan; Thyagarajan, Bharat] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Prizment, AE (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.; Prizment, AE (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	prizm001@umn.edu		Nelson, Heather/0000-0003-1901-9513; prizment, anna/0000-0001-5924-6871	American Cancer Society [124166-IRG-58-001-55-IRG21]; National Center for Advancing Translational Sciences of the NIH [UL1 TR000114]; National Institutes of Health [R01CA203348]; NATIONAL CANCER INSTITUTE [R01CA203348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494, KL2TR002492] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research was supported by Institutional Research Grant #124166-IRG-58-001-55-IRG21 from the American Cancer Society (https://www.cancer.org). A.E.Prizment was supported by the National Center for Advancing Translational Sciences of the NIH Award Number UL1 TR000114 (https://www.nih.gov/). B.W. R01CA203348 from the National Institutes of Health (https://www.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2005, CANCER EPIDEM BIOMAR, V14, P2261, DOI 10.1158/1055-9965.EPI-04-0514; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chen D, 2014, CARCINOGENESIS, V35, P2633, DOI 10.1093/carcin/bgu215; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Chitadze G, 2013, INT J CANC; Choy MK, 2003, J MOL EVOL, V57, P38, DOI 10.1007/s00239-002-2444-8; Chung HW, 2013, CANCER-AM CANCER SOC, V119, P233, DOI 10.1002/cncr.27669; Dambrauskas Z, 2014, INT J ONCOL, V44, P99, DOI 10.3892/ijo.2013.2156; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Field SF, 2008, DIABETES, V57, P1753, DOI 10.2337/db07-1402; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Isernhagen A, 2016, IMMUNOGENETICS, V68, P109, DOI 10.1007/s00251-015-0884-8; Ji MY, 2015, INT J CLIN EXP MED, V8, P818; Jiang X, 2011, TISSUE ANTIGENS, V78, P143, DOI 10.1111/j.1399-0039.2011.01693.x; Jiang XX, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-62; Kennedy C, 2002, J INVEST DERMATOL, V118, P686, DOI 10.1046/j.1523-1747.2002.01712.x; Kopp R, 2009, J CLIN IMMUNOL, V29, P545, DOI 10.1007/s10875-009-9288-6; Kumar V, 2012, PLOS ONE; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu CJ, 2002, J ORAL PATHOL MED, V31, P323, DOI 10.1034/j.1600-0714.2002.310602.x; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; Lo SS, 2004, BRIT J CANCER, V90, P1809, DOI 10.1038/sj.bjc.6601750; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Onyeaghala G, 2017, MOL CARCINOGEN, V56, P2158, DOI 10.1002/mc.22667; Prizment AE, 2011, PANCREAS; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tamaki S, 2008, HUM IMMUNOL, V69, P88, DOI 10.1016/j.humimm.2008.01.010; Tamaki S, 2007, J ORAL PATHOL MED, V36, P351, DOI 10.1111/j.1600-0714.2007.00539.x; Tong HV, 2013, J VIRAL HEPATITIS, V20, P687, DOI 10.1111/jvh.12089; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wu J, 2019, J LEUKOCYTE BIOL; Xu XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-194; Yang X, 2018, BIOMEDICINE PHARMACO; Zhang JJ, 2014, PANCREAS, V43, P281, DOI 10.1097/MPA.0b013e3182a7c829; Zhang JJ, 2009, NUTR CANCER, V61, P457, DOI 10.1080/01635580902718941; Zhang JJ, 2005, ANN EPIDEMIOL, V15, P500, DOI 10.1016/j.annepidem.2004.11.005; Zhao J, 2011, J GASTROENTEROL HEPA	46	5	5	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217868	10.1371/journal.pone.0217868	http://dx.doi.org/10.1371/journal.pone.0217868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166958	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800046
J	Pelaez, I; Ferrera, D; Barjola, P; Fernandes, R; Mercado, F				Pelaez, Irene; Ferrera, David; Barjola, Paloma; Fernandes, Roberto; Mercado, Francisco			Subliminal emotional pictures are capable of modulating early cerebral responses to pain in fibromyalgia	PLOS ONE			English	Article							LASER-EVOKED POTENTIALS; ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; POSTERIOR CINGULATE; ATTENTIONAL BIAS; SPANISH VERSION; TIME-COURSE; STIMULI; MEMORY	Pain experience involves a complex relationship between sensory and both emotional and cognitive factors, which appear to be mediated by different neural pathways. Previous evidence has shown that whereas conscious processing of unpleasant stimuli enhances pain perception, the influence of emotions on pain under unaware conditions is much less known. The need to better characterise the relationship between pain processing and emotional factors is crucial for dealing with chronic pain conditions. Therefore, the present study aimed to explore the neural correlates relating to the influence of visual masking emotional stimulation on the processing of painful stimuli in chronic pain patients suffering from fibromyalgia (FM). Twenty FM and 22 healthy control (HC) women participated in the study. The experimental masking paradigm consisted of a rapid succession of two types of stimuli, where a masked picture (neutral, negative or pain-related) was followed by a laser stimulus (painful or not painful). LEP activity was recorded at sixty scalp electrodes. An LEP-amplitude approach was used to quantify the main cerebral waves linked to pain response. ANOVAs indicated that the posterior regions of the P1 component were sensitive to experimental manipulation (p<0.05). Specifically, FM patients showed higher amplitudes to painful stimuli preceded by pain-related pictures compared with painful trials preceded by other emotional pictures. The FM group also showed greater amplitudes than those in the HC group in P2a and P2b waves. In addition to the scalp data, at the neural level the posterior cingulate cortex, lingual gyrus and insular cortex showed higher activation in the FM group than in the HC group. Our findings show an early cerebral modulation of pain (as reflected by the P1) in FM patients, suggesting that only pain-related information, even when it is unconsciously perceived, is capable to enhance exogenous (automatic) attention, increasing the neural activity involved in processing painful stimulation. Further research is needed to fully understand unconscious emotional influences on pain in fibromyalgia.	[Pelaez, Irene; Ferrera, David; Barjola, Paloma; Fernandes, Roberto; Mercado, Francisco] Rey Juan Carlos Univ, Fac Hlth Sci, Unit Clin Psychol, Madrid, Spain	Universidad Rey Juan Carlos	Pelaez, I (corresponding author), Rey Juan Carlos Univ, Fac Hlth Sci, Unit Clin Psychol, Madrid, Spain.	irene.pelaez@urjc.es	Pelaéz, Irene/AAT-1399-2020; Ferrera, David/GXZ-8861-2022	Ferrera, David/0000-0002-2367-3051; Fernandes Magalhaes, Roberto/0000-0002-4541-7016; Pelaez, Irene/0000-0001-7635-5068	Ministerior de Economia y Competitividad de Espana [PSI2017-85241-R]; Comunidad de Madrid	Ministerior de Economia y Competitividad de Espana; Comunidad de Madrid(Comunidad de Madrid)	Funded by PSI2017-85241-R from the Ministerior de Economia y Competitividad de Espana and S2015/HUM-3327 EMO-CM from the Comunidad de Madrid The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'Absi M, 2016, NEUROSCIENCE PAIN ST, DOI [10.1016/C2013-0-16065-5, DOI 10.1016/C2013-0-16065-5]; Ambrose KR, 2012, REUMATISMO, V64, P206, DOI 10.4081/reumatismo.2012.206; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Balconi M, 2012, BRAIN SCI, V2, P85, DOI 10.3390/brainsci2020085; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bellato E, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/426130; Bentley DE, 2003, PAIN, V102, P265, DOI 10.1016/S0304-3959(02)00405-0; Bernat E, 2001, CLIN NEUROPHYSIOL, V112, P159, DOI 10.1016/S1388-2457(00)00445-4; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Brown CA, 2014, EUR J NEUROSCI, V39, P663, DOI 10.1111/ejn.12420; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Bubier JA, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00001; Carretie L, 2011, BIOL PSYCHOL, V86, P247, DOI 10.1016/j.biopsycho.2010.12.005; Chen ACN, 1998, PAIN FORUM, V7, P174, DOI 10.1016/S1082-3174(98)70001-7; Cliff N., 1987, ANAL MULTIVARIATE DA; Crofford LJ, 2017, KELLEY FIRESTEINS TX, DOI [10.1016/B978-0-323-31696-5.00052-8, DOI 10.1016/B978-0-323-31696-5.00052-8]; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; de Tommaso M, 2011, J PAIN, V12, P116, DOI 10.1016/j.jpain.2010.06.004; de Tommaso M, 2009, INT J PSYCHOPHYSIOL, V74, P139, DOI 10.1016/j.ijpsycho.2009.08.004; de Wied M, 2001, PAIN, V90, P163, DOI 10.1016/S0304-3959(00)00400-0; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Dien J, 2012, DEV NEUROPSYCHOL, V37, P497, DOI 10.1080/87565641.2012.697503; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Duschek S, 2014, PAIN MED, V15, P603, DOI 10.1111/pme.12360; Duschek S, 2013, BEHAV MED, V39, P11, DOI 10.1080/08964289.2012.708684; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; GarciaLarrea L, 1997, NEUROREPORT, V8, P3785, DOI 10.1097/00001756-199712010-00026; Glascher J, 2003, J NEUROSCI, V23, P10274; Gomez-Perez L, 2011, J PAIN, V12, P425, DOI 10.1016/j.jpain.2010.08.004; Gonzalez JL, 2010, J PSYCHOSOM RES, V69, P279, DOI 10.1016/j.jpsychores.2010.05.002; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Handy T. C., 2005, EVENT RELATED POTENT, P57; Hinojosa JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00024; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Kamping S, 2013, PAIN, V154, P1846, DOI 10.1016/j.pain.2013.06.003; Kenntner-Mabiala R, 2005, PSYCHOPHYSIOLOGY, V42, P559, DOI 10.1111/j.1469-8986.2005.00310.x; Kenntner-Mabiala R, 2008, BIOL PSYCHOL, V78, P114, DOI 10.1016/j.biopsycho.2008.01.007; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Klauer KC, 2007, CONSCIOUS COGN, V16, P63, DOI 10.1016/j.concog.2005.12.002; Kugler K., 1999, PHOTOGRAPH SERIES DA, V1; KUNDE V, 1993, ELECTROEN CLIN NEURO, V88, P280, DOI 10.1016/0168-5597(93)90052-Q; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liu XZ, 2017, BEHAV BRAIN RES, V326, P132, DOI 10.1016/j.bbr.2017.01.037; Loge-Hagen JS, 2019, J AFFECT DISORDERS, V245, P1098, DOI 10.1016/j.jad.2018.12.001; Lorenz J, 1996, EVOKED POTENTIAL, V100, P165, DOI 10.1016/0013-4694(95)00259-6; Low LA, 2012, PAIN RES TREAT, V2012, DOI [10.1155/2012/140832, DOI 10.1155/2012/140832]; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Meerman EE, 2013, INT J BEHAV MED, V20, P627, DOI 10.1007/s12529-012-9270-1; Meerman EE, 2012, J PSYCHOSOM RES, V72, P408, DOI 10.1016/j.jpsychores.2012.02.004; Meerman EE, 2011, J PSYCHOSOM RES, V70, P250, DOI 10.1016/j.jpsychores.2010.08.006; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P1, DOI 10.1007/s11682-012-9179-y; Mercado F., 2013, FUNCTIONAL BRAIN MAP, DOI [10.5772/56495, DOI 10.5772/56495]; Mercado F, 2013, INT J PSYCHOPHYSIOL, V88, P182, DOI 10.1016/j.ijpsycho.2013.03.017; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; MIRON D, 1989, PAIN, V39, P345, DOI 10.1016/0304-3959(89)90048-1; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; Pascual-Marqui RD, 2007, DISCRETE 3D DISTRI 1, P1, DOI DOI 10.1016/J.NEULET.2010.09.011; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Pelaez I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01636; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Reicherts P, 2013, PAIN, V154, P793, DOI 10.1016/j.pain.2013.02.012; Rhudy JL, 2008, PAIN, V136, P250, DOI 10.1016/j.pain.2007.06.031; Rhudy JL, 2005, PSYCHOPHYSIOLOGY, V42, P579, DOI 10.1111/j.1469-8986.2005.00313.x; Rhudy JL, 2001, CURR OPIN PSYCHIATR, V14, P241, DOI 10.1097/00001504-200105000-00012; Ring C, 2013, BIOL PSYCHOL, V93, P373, DOI 10.1016/j.biopsycho.2013.04.006; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Roelofs J, 2002, EUR J PAIN-LONDON, V6, P273, DOI 10.1053/eujp.2002.0337; Spielberger CD, 2010, CORSINI ENCY PSYCHOL, P1, DOI [10.1002/9780470479216.corpsy0942, DOI 10.1002/9780470479216.CORPSY0943, 10.1002/9780470479216.corpsy0942.1, DOI 10.1002/9780470479216.CORPSY0942.1]; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swannell ER, 2016, J PAIN, V17, P336, DOI 10.1016/j.jpain.2015.11.004; Tiemann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035068; Valeriani M, 1996, EVOKED POTENTIAL, V100, P343, DOI 10.1016/0168-5597(96)95625-7; Valeriani M, 2009, CLIN NEUROPHYSIOL, V120, P790, DOI 10.1016/j.clinph.2009.02.162; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; van Hooff JC, 2013, ACTA PSYCHOL, V143, P1, DOI 10.1016/j.actpsy.2013.02.001; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; Weiss T, 2003, NEUROSCI LETT, V340, P135, DOI 10.1016/S0304-3940(03)00103-4; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203755	98	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217909	10.1371/journal.pone.0217909	http://dx.doi.org/10.1371/journal.pone.0217909			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166997	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800051
J	Abriola, L; Hoyer, D; Caffrey, CR; Williams, DL; Yoshino, TP; Vermeire, JJ				Abriola, Laura; Hoyer, Denton; Caffrey, Conor R.; Williams, David L.; Yoshino, Timothy P.; Vermeire, Jon J.			Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics	PLOS ONE			English	Article							DRUG DISCOVERY; HOOKWORM; DISEASE	Hookworms remain a major health burden in the developing world, with hundreds of millions currently afflicted by these blood-feeding parasites. There exists a vital need for the discovery of novel drugs and identification of parasite drug targets for the development of chemotherapies. New drug development requires the identification of compounds that target molecules essential to parasite survival and preclinical testing in robust, standardized animal models of human disease. This process can prove costly and time consuming using conventional, low-throughput methods. We have developed a novel high-throughput screen ( HTS) to identify anthelmintics for the treatment of soil-transmitted helminths. Our high-throughput, plate reader-based assay was used to rapidly assess compound toxicity to Ancylostoma ceylanicum L1 larva. Using this method, we screened 39,568 compounds from several small molecule screening libraries at 10 mu M and identified 830 bioactive compounds that inhibit egg hatching of the human hookworm A. ceylanicum by > 50%. Of these, 132 compounds inhibited hookworm egg hatching by > 90% compared to controls. The nematicidal activities of 268 compounds were verified by retesting in the egg hatching assay and were also tested for toxicity against the human HeLa cell line at 10 mu M. Fifty-nine compounds were verified to inhibit A. ceylanicum egg hatching by > 80% and were < 20% toxic to HeLa cells. Half-maximal inhibitory concentration ( IC50) values were determined for the 59 hit compounds and ranged from 0.05-8.94 mu M. This stringent advancement of compounds was designed to 1) systematically assess the nematicidal activity of novel compounds against the egg stage of A. ceylanicum hookworms in culture and 2) define their chemotherapeutic potential in vivo by evaluating their toxicity to human cells. Information gained from these experiments may directly contribute to the development of new drugs for the treatment of human hookworm disease.	[Abriola, Laura; Hoyer, Denton] Yale Univ, Yale Ctr Mol Discovery, New Haven, CT USA; [Caffrey, Conor R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Williams, David L.] Rush Univ, Med Ctr, Dept Microbial Pathogens & Immun, Chicago, IL 60612 USA; [Yoshino, Timothy P.] Univ Wisconsin, Dept Pathobiol Sci, Cellular & Mol Parasitol Training Program, Madison, WI 53706 USA; [Vermeire, Jon J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	Yale University; University of California System; University of California San Diego; Rush University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco	Vermeire, JJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	jon.vermeire@gmail.com		Vermeire, Jon/0000-0001-6073-4071; Abriola, Laura/0000-0002-7304-6531	Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award; NIH/NIAID K22 RSDA	Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award; NIH/NIAID K22 RSDA	This work was funded by a private Yale-sponsored grant (Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award) to JJV and an NIH/NIAID K22 RSDA awarded to JJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bungiro RD, 2001, J INFECT DIS, V183, P1380, DOI 10.1086/319867; Bungiro Richard, 2011, Curr Infect Dis Rep, V13, P210, DOI 10.1007/s11908-011-0182-z; Burns AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8485; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Garcia-Longoria L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-239; Geary TG, 2015, J PARASITOL, V101, P125, DOI 10.1645/14-703.1; Geiger SM, 2004, CLIN EXP IMMUNOL, V136, P334, DOI 10.1111/j.1365-2249.2004.02449.x; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Lee JA, 2012, J MED CHEM, V55, P4527, DOI 10.1021/jm201649s; Leung CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062166; Loukas A, 2005, FEMS IMMUNOL MED MIC, V43, P115, DOI 10.1016/j.femsim.2004.11.006; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mansour NR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004659; Mendez S, 2005, VACCINE, V23, P3123, DOI 10.1016/j.vaccine.2004.12.022; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; ROBBINS PW, 1988, J BIOL CHEM, V263, P443; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Weicksel SE, 2016, DEVELOPMENT, V143, P3540, DOI 10.1242/dev.140046; World Health Organization; TDR Disease Reference Group on Helminth Infections, 2013, WHO TECH REP SER, Vxv, P1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217019	10.1371/journal.pone.0217019	http://dx.doi.org/10.1371/journal.pone.0217019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158236	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700006
J	Wittauer, EM; Oldhafer, F; Augstein, E; Beetz, O; Kleine, M; Schumacher, C; Sieg, L; Eismann, H; Johanning, K; Bleich, A; Vondran, FWR				Wittauer, Eva-Maria; Oldhafer, Felix; Augstein, Eva; Beetz, Oliver; Kleine, Moritz; Schumacher, Carsten; Sieg, Lion; Eismann, Hendrik; Johanning, Kai; Bleich, Andre; Vondran, Florian Wolfgang Rudolf			Porcine model for the study of liver regeneration enhanced by non-invasive C-13-methacetin breath test (LiMAx test) and permanent portal venous access	PLOS ONE			English	Article							SMALL-FOR-SIZE; HEPATOCYTE TRANSPLANTATION; EXTENDED HEPATECTOMY; RESECTION; PRESSURE; FAILURE; SURVIVAL; REMNANT; MANAGEMENT; CIRRHOSIS	Introduction Despite advances in perioperative management and surgical technique, postoperative liver failure remains a feared complication after hepatic resection. Various supportive treatment options are under current discussion, but lack of structured evaluation. We therefore established a porcine model of major liver resection to study regeneration after partial hepatectomy in a reliable and well-defined pre-clinical setting. Methods Major hepatectomy was performed on seven minipigs with the intention to set up a non-lethal but relevant transient impairment of liver function. For steady postoperative vascular access (e.g. for blood withdrawal, measurement of venous pressure), permanent catheters were implanted into the internal jugular and portal veins, respectively. Animals were followed up for 30 days; clinical and laboratory results were recorded in detail. Monitoring was enhanced by non-invasive determination of the maximum liver function capacity (LiMAx test). Results and conclusions The established porcine model appeared suitable for evaluation of postoperative liver regeneration. Clinical characteristics and progression of liver function impairment as well as subsequent recovery were comparable to courses known from surgery in humans. Laboratory parameters (e.g. liver enzymes, bilirubin, INR, coagulation factor II) showed relevant derangements during postoperative days (POD) 0 to 3 followed by normalization until POD 7. Application of the LiMAx test was feasible in minipigs, again showing values comparable to humans and kinetics in line with obtained laboratory parameters. The exteriorized portal vein catheters enabled intra- and postoperative monitoring of portal venous pressures as well as easy access for blood withdrawal without relevant risk of postoperative complications.	[Wittauer, Eva-Maria; Oldhafer, Felix; Augstein, Eva; Beetz, Oliver; Kleine, Moritz; Vondran, Florian Wolfgang Rudolf] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, ReMediES, Hannover, Germany; [Schumacher, Carsten; Sieg, Lion; Eismann, Hendrik; Johanning, Kai] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vondran, FWR (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplant Surg, ReMediES, Hannover, Germany.	vondran.florian@mh-hannover.de	Eismann, Hendrik/GVU-1519-2022	Sieg, Lion/0000-0002-0756-893X	German Research Foundation [SFB 738]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (SFB 738; to FWRV; project C11), http://sfb738.de/startseite-3/sonderforschungsbereich-738.html.	Allard MA, 2013, ANN SURG, V258, P822, DOI 10.1097/SLA.0b013e3182a64b38; Athanasiou A, 2016, J BUON, V21, P1403; Baccarani U, 2005, TRANSPLANT P, V37, P2702, DOI 10.1016/j.transproceed.2005.06.027; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; Cammann S, 2017, INT J SURG CASE REP, V39, P140, DOI 10.1016/j.ijscr.2017.08.003; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fahrner R, 2014, TRANSPLANTATION, V97, P892, DOI 10.1097/TP.0000000000000045; Fierbinteanu-Braticevici C, 2014, INDIAN J MED RES, V140, P123; Goetze O, 2007, ALIMENT PHARM THER, V26, P305, DOI 10.1111/j.1365-2036.2007.03360.x; Golriz M, 2017, CAN J GASTROENTEROL, V2017, DOI 10.1155/2017/5127178; Gorowska-Kowolik K, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/7397840; Guglielmi A, 2012, DIGEST SURG, V29, P6, DOI 10.1159/000335713; Inayat F, 2016, CUREUS, V8, DOI 10.7759/cureus.884; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Jara M, 2015, J SURG RES, V193, P184, DOI 10.1016/j.jss.2014.07.041; Kaffarnik MF, 2013, CRIT CARE, V17, DOI 10.1186/cc13089; Kaiser GM, 2005, EUR SURG RES, V37, P298, DOI 10.1159/000089241; Kawachi S, 1997, TRANSPLANTATION, V64, P205, DOI 10.1097/00007890-199707270-00004; Kelly DM, 2009, LIVER TRANSPLANT, V15, P1448, DOI 10.1002/lt.21863; Kim DS, 2018, ANN SURG TREAT RES, V94, P118, DOI 10.4174/astr.2018.94.3.118; Laurent C, 2003, BRIT J SURG, V90, P1131, DOI 10.1002/bjs.4202; Lee WC, 2014, TRANSPLANTATION, V97, P890, DOI 10.1097/TP.0000000000000067; Lock JF, 2017, ANN SURG ONCOL, V24, P2447, DOI 10.1245/s10434-017-5887-2; Luca A, 2006, LIVER TRANSPLANT, V12, P1237, DOI 10.1002/lt.20762; LYDTIN H, 1969, Z GESAMTE EXP MED, V149, P279, DOI 10.1007/BF02044484; Matrella E, 2001, ALIMENT PHARM THERAP, V15, P857, DOI 10.1046/j.1365-2036.2001.00996.x; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Oldhafer F, 2016, PATIENT SAF SURG, V10, DOI 10.1186/s13037-016-0104-y; Otsuka Y, 2007, LIVER TRANSPLANT, V13, P672, DOI 10.1002/lt.20917; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Ray S, 2018, ANN MED SURG, V34, P4, DOI 10.1016/j.amsu.2018.08.012; Rubin T, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027102; Shen XL, 2008, LAB ANIMAL, V37, P41, DOI 10.1038/laban0108-41; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Takada Y, 2004, LIVER TRANSPLANT, V10, P807, DOI 10.1002/lt.20164; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Troisi R, 2005, AM J TRANSPLANT, V5, P1397, DOI 10.1111/j.1600-6143.2005.00850.x; VANLEEUWEN P, 1995, J ANIM PHYSIOL AN N, V73, P38, DOI 10.1111/j.1439-0396.1995.tb00401.x; Vondran FWR, 2018, ANZ J SURG, V88, pE324, DOI 10.1111/ans.13944; Vondran Florian Wolfgang Rudolf, 2016, Case Rep Transplant, V2016, P7074636, DOI 10.1155/2016/7074636; Xia Q, 2008, HEPATOB PANCREAT DIS, V7, P601; Xiang L, 2016, TRANSPL P, V48, P234, DOI 10.1016/j.transproceed.2015.12.026	48	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217488	10.1371/journal.pone.0217488	http://dx.doi.org/10.1371/journal.pone.0217488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150446	gold, Green Submitted, Green Published			2022-12-27	WOS:000469759100057
J	Zhang, QY; Du, YC				Zhang, Qingyang; Du, Yuchun			Model-free feature screening for categorical outcomes: Nonlinear effect detection and false discovery rate control	PLOS ONE			English	Article							GENERALIZED LINEAR-MODELS; VARIABLE SELECTION; T-TEST; MULTIVARIATE; EXPRESSION; TUMOR	Feature screening has become a real prerequisite for the analysis of high-dimensional genomic data, as it is effective in reducing dimensionality and removing redundant features. However, existing methods for feature screening have been mostly relying on the assumptions of linear effects and independence (or weak dependence) between features, which might be inappropriate in real practice. In this paper, we consider the problem of selecting continuous features for a categorical outcome from high-dimensional data. We propose a powerful statistical procedure that consists of two steps, a nonparametric significance test based on edge count and a multiple testing procedure with dependence adjustment for false discovery rate control. The new method presents two novelties. First, the edge-count test directly targets distributional difference between groups, therefore it is sensitive to nonlinear effects. Second, we relax the independence assumption and adapt Efron's procedure to adjust for the dependence between features. The performance of the proposed procedure, in terms of statistical power and false discovery rate, is illustrated by simulated data. We apply the new method to three genomic datasets to identify genes associated with colon, cervical and prostate cancers.	[Zhang, Qingyang] Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA; [Du, Yuchun] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Zhang, QY (corresponding author), Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA.; Du, YC (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	qz008@uark.edu; ydu@uark.edu			Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000	Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000	This study was funded by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2006, INTRO CATEGORICAL DA, DOI [10.1002/0470114754, DOI 10.1002/0470114754]; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 1995, P NAT ACAD SCI, V96, P6745; Chen H, 2017, J AM STAT ASSOC, V112, P397, DOI 10.1080/01621459.2016.1147356; Cheriton D., 1976, SIAM Journal on Computing, V5, P724, DOI 10.1137/0205051; CRUTCHER HL, 1975, J APPL METEOROL, V14, P1600, DOI 10.1175/1520-0450(1975)014<1600:ANOTPM>2.0.CO;2; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Fan J, 2012, J AM STAT ASSOC, V40, P745; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Gertheiss J, 2013, STAT, V2, P86, DOI 10.1002/sta4.20; Gonzalez-Gonzalez L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00225; GUCCIARDI PG, 2008, J PHYS C SERIES, V19, DOI DOI 10.1088/0957-4484/19/21/215702; Guo CC, 2017, COMMUN STAT-THEOR M, V46, P2967, DOI 10.1080/03610926.2015.1053940; Jia DS, 2018, CANCER DISCOV, V8, P1422, DOI 10.1158/2159-8290.CD-18-0385; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li GR, 2012, ANN STAT, V40, P1846, DOI 10.1214/12-AOS1024; Li RZ, 2012, J AM STAT ASSOC, V107, P1129, DOI 10.1080/01621459.2012.695654; Li ZL, 2012, CAN J STAT, V40, P745, DOI 10.1002/cjs.11165; Liu WD, 2017, ANN STAT, V45, P2680, DOI 10.1214/17-AOS1539; Liu WD, 2013, ANN STAT, V41, P2948, DOI 10.1214/13-AOS1169; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; Mariot P, 2000, PROSTATE, V43, P205; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Sebban S, 2014, ONCOTARGET, V5, P9214, DOI 10.18632/oncotarget.2400; Shiba-Ishii A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0414-1; Steinskog DJ, 2007, MON WEATHER REV, V135, P1151, DOI 10.1175/MWR3326.1; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2013, J MULTIVARIATE ANAL, V117, P193, DOI 10.1016/j.jmva.2013.02.012; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tsagris M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2023-7; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Zhang Q, 2017, TECHNICAL REPORT; Zhang Q, 2018, BMC SYST BIOL, V12, P1; Zhang Qingyang, 2014, BMC Syst Biol, V8, P1338, DOI 10.1186/s12918-014-0136-9; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhou Nina, 2007, Genomics Proteomics & Bioinformatics, V5, P242, DOI 10.1016/S1672-0229(08)60011-X	38	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217463	10.1371/journal.pone.0217463	http://dx.doi.org/10.1371/journal.pone.0217463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150453	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100054
J	Ryuno, H; Nigo, F; Naguro, I; Sekimizu, K; Kaito, C				Ryuno, Hiroki; Nigo, Fuki; Naguro, Isao; Sekimizu, Kazuhisa; Kaito, Chikara			Staphylococcus aureus aggregation in the plasma fraction of silkworm hemolymph	PLOS ONE			English	Article							BOMBYX-MORI; LIPOTEICHOIC ACID; NODULE FORMATION; BINDING-PROTEIN; CLUMPING FACTOR; COAGULASE; VIRULENCE; RESISTANCE; MODEL; GENE	Staphylococcus aureus formed bacterial aggregates in the plasma fraction of the hemolymph of silkworm, the larva of Bombyx mori, in a growth-dependent manner. The addition of arabinose or galactose inhibited the formation of S. aureus aggregates in the silkworm plasma. Formation of the bacterial aggregates depended on S. aureus genes required for the synthesis of bacterial surface polysaccharides-ypfP and ltaA, which are involved in lipoteichoic acid synthesis, and the tagO gene, which is involved in wall teichoic acid synthesis. These findings suggest that S. aureus forms bacterial aggregates in the silkworm plasma via bacterial surface teichoic acids.	[Ryuno, Hiroki; Naguro, Isao] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Nigo, Fuki; Kaito, Chikara] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Sekimizu, Kazuhisa] Teikyo Univ, Inst Med Mycol, Tokyo, Japan	University of Tokyo; Okayama University; Teikyo University	Kaito, C (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	ckaito@okayama-u.ac.jp	Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Naguro, Isao/0000-0002-0338-8026	 [15H04727];  [15H05783];  [19H03466]	; ; 	This work was supported by Grants-in-aid for Scientific Research (CK, 15H04727; KS, 15H05783; CK, 19H03466). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimitsu N, 1999, ANTIMICROB AGENTS CH, V43, P3042, DOI 10.1128/AAC.43.12.3042; Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; BADDOUR LM, 1994, J MED MICROBIOL, V41, P259, DOI 10.1099/00222615-41-4-259; CAWDERY M, 1969, BRIT J EXP PATHOL, V50, P408; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Crossly KB, 1997, STAPHYLOCOCCI HUMAN; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GOLDSTEIN J, 1982, J CLIN MICROBIOL, V15, P848, DOI 10.1128/JCM.15.5.848-851.1982; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2012, ISJ-INVERT SURVIV J, V9, P163; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1016/S0378-1097(02)00603-1; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2016, DRUG DISCOV THER, V10, P30, DOI 10.5582/ddt.2016.01020; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Kochi Y, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw163; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Kyuma T, 2015, BIOCHIMIE, V119, P166, DOI 10.1016/j.biochi.2015.10.027; Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302; Loeb L, 1904, J MED RES, V10, P407; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; MORI H, 1989, J INVERTEBR PATHOL, V54, P112, DOI 10.1016/0022-2011(89)90147-X; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; MURRAY M, 1959, J BACTERIOL, V78, P450, DOI 10.1128/JB.78.3.450-451.1959; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Omae Y, 2013, J BIOL CHEM, V288, P25542, DOI 10.1074/jbc.M113.495051; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; PHONIMDAENG P, 1990, MOL MICROBIOL, V4, P393, DOI 10.1111/j.1365-2958.1990.tb00606.x; Qian Q, 2007, J CLIN MICROBIOL, V45, P2267, DOI 10.1128/JCM.00369-07; RATCLIFFE NA, 1977, TISSUE CELL, V9, P73, DOI 10.1016/0040-8166(77)90050-7; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Suzuki Asahi, 2011, Journal of Insect Biotechnology and Sericology, V80, P49; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Yoshikai H, 2016, J INFECT DIS, V213, P295, DOI 10.1093/infdis/jiv376	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217517	10.1371/journal.pone.0217517	http://dx.doi.org/10.1371/journal.pone.0217517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145754	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500020
J	Kaplan, WA; Cardenas, J; Mansilla, C; Tobar, T; Wirtz, VJ				Kaplan, Warren A.; Cardenas, Jorge; Mansilla, Cristian; Tobar, Tatiana; Wirtz, Veronika J.			The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data	PLOS ONE			English	Article							GENERIC MEDICINES; COUNTRIES	Background Affordability is a key barrier to access to medicines. Generic medicines policies can address this barrier and promote access. Successful uptake of generic medicines depends, in part, on ensuring that these products are interchangeable with reference products. Typically, bioequivalence certification is established in order to demonstrate such interchangeability. Objective To study the implementation of the bioequivalence certification policy in Chile. Methods We used Chilean Market Regulatory Authority data for analysis to study the number of products that obtained bioequivalence certification, the time until bioequivalence certification and associated factors to obtain bioequivalence. Results As of January 2017, out of 2,336 products with a valid market authorization containing at least one of the 167 APIs that required BE certification, 1,026 products actually have BE certification (1,026/ 2,336, 43.9% compliance). Where data were available, the time between submission of the market authorization as a bioequivalent product to final authorization by the national medicine regulatory authority for most products varied between 4-6 months. The fraction of all BE products containing a given API out of the total marketed products containing that API varies considerably, e.g. for the API olmesartan there was only a single BE product marketed, the API diclofenac had none. Conclusions Although the implementation of Chile's bioequivalence policy increased the number of bioequivalent products, over 50% of generic products requiring bioequivalence that did not obtain this certification. Also for some of the API none or very few BE products are marketed which limits the success of a substitution policy. Further studies are required to identify the apparent lack of incentives to obtain bioequivalence certification. Studies of sales volumes and prices of the products are needed to identify whether generic products without bioequivalence certification either become bioequivalent or eventually exit the market.	[Kaplan, Warren A.; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Cardenas, Jorge; Mansilla, Cristian; Tobar, Tatiana] Minist Hlth Santiago, Santiago, Chile	Boston University	Wirtz, VJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.	vwirtz@bu.edu	Wirtz, Veornika/AAG-9712-2019	Kaplan, Warren/0000-0001-6127-4820; Wirtz, Veronika J./0000-0002-0863-8768; Mansilla, Cristian/0000-0003-2377-0094	Pan American Health Organization (PAHO); Alliance for Health Policy and Systems Research; Norwegian Government Agency for Development Cooperation (Norad); Swedish International Development Cooperation Agency (Sida); UK Department for International Development (DFID)	Pan American Health Organization (PAHO); Alliance for Health Policy and Systems Research; Norwegian Government Agency for Development Cooperation (Norad); Swedish International Development Cooperation Agency (Sida); UK Department for International Development (DFID)	This is work undertaken under the auspices of the embedded implementation research initiative supported by the Pan American Health Organization (PAHO) and the Alliance for Health Policy and Systems Research, an international partnership hosted by the World Health Organization (WHO), with support from the Norwegian Government Agency for Development Cooperation (Norad: https://norad.no/en/front/), the Swedish International Development Cooperation Agency (Sidahttps://www.sida.se/English/) and the UK Department for International Development (DFID: https://www.gov.uk/government/organisations/department-for-international-development).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cristian Mansilla, BMJ GLOB HEALTH, DOI [10.1136/bmjgh-2018-000922, DOI 10.1136/BMJGH-2018-000922]; da Fonseca EM, 2015, REV PANAM SALUD PUBL, V37, P113; da Fonseca EM, 2014, POLICY SOC, V33, P65, DOI 10.1016/j.polsoc.2014.03.004; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP), 2010, CPMPEWPQWP140198; Fiscalia Nacional Economica Santiago Chile, 2013, STUD EFF BIOEQ PEN G; Fonseca EM, 2016, REV PANAM SALUD PUBL, V41, P1; Gomes Barra AC, 2011, J GENERIC MED, V2, P72, DOI DOI 10.1177/1741134311411266; Gonzalez C., 2008, J GENERIC MED, V6, P43; Gonzalez PE, 2011, WORKING HLTH POPULAT; Hill S., 2004, EMERGING CHALLENGES; Homedes N, 2005, B WORLD HEALTH ORGAN, V83, P64; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; Moise P, 2007, OECD HLTH WORKING PA; Moye-Holz D, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0281-1; Organisation for Economic Co-operation and Development, 2014, DAFCOMPGFWD20143 ORG, P3; Shadlen KC, 2013, POLIT SOC, V41, P561, DOI 10.1177/0032329213507552; Storpirtis S, 2014, PHARM POLICY LAW, V16, P22; US Food and Drug Administration, 2018, APPR PROD THER EQ OR; Vogler S, 2012, GABI J, V1, P93, DOI 10.5639/gabij.2012.0102.020; WHO Expert Committee on Specifications for Pharmaceutical Preparations, 40 WHO; World Health Organization, QUAL ASS MED TERM DA; 2006, WHO TECHN REP SER, V936, P1	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217334	10.1371/journal.pone.0217334	http://dx.doi.org/10.1371/journal.pone.0217334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141565	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000050
J	Haun, CT; Vann, CG; Osburn, SC; Mumford, PW; Roberson, PA; Romero, MA; Fox, CD; Johnson, CA; Parry, HA; Kavazis, AN; Moon, JR; Badisa, VLD; Mwashote, BM; Ibeanusi, V; Young, KC; Roberts, MD				Haun, Cody T.; Vann, Christopher G.; Osburn, Shelby C.; Mumford, Petey W.; Roberson, Paul A.; Romero, Matthew A.; Fox, Carlton D.; Johnson, Christopher A.; Parry, Hailey A.; Kavazis, Andreas N.; Moon, Jordan R.; Badisa, Veera L. D.; Mwashote, Benjamin M.; Ibeanusi, Victor; Young, Kaelin C.; Roberts, Michael D.			Muscle fiber hypertrophy in response to 6 weeks of high-volume resistance training in trained young men is largely attributed to sarcoplasmic hypertrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; MUSCULAR ADAPTATIONS; EXERCISE; STRENGTH; LOAD; GAINS	Cellular adaptations that occur during skeletal muscle hypertrophy in response to high-volume resistance training are not well-characterized. Therefore, we sought to explore how actin, myosin, sarcoplasmic protein, mitochondrial, and glycogen concentrations were altered in individuals that exhibited mean skeletal muscle fiber cross-sectional area (fCSA) hypertrophy following 6 weeks of high-volume resistance training. Thirty previously resistance-trained, college-aged males (mean +/- standard deviation: 21 +/- 2 years, 5 +/- 3 training years) had vastus lateralis (VL) muscle biopsies obtained prior to training (PRE), at week 3 (W3), and at week 6 (W6). Muscle tissue from 15 subjects exhibiting PRE to W6 VL mean fCSA increases ranging from 320-1600 mu m(2) was further interrogated using various biochemical and histological assays as well as proteomic analysis. Seven of these individuals donated a VL biopsy after refraining from training 8 days following the last training session (W7) to determine how deloading affected biomarkers. The 15 fCSA hypertrophic responders experienced a +23% increase in mean fCSA from PRE to W6 (p<0.001) and, while muscle glycogen concentrations remained unaltered, citrate synthase activity levels decreased by 24% (p<0.001) suggesting mitochondrial volume decreased. Interestingly, repeated measures ANOVAs indicated that p-values approached statistical significance for both myosin and actin (p = 0.052 and p = 0.055, respectively), and forced post hoc tests indicated concentrations for both proteins decreased similar to 30% from PRE to W6 (p<0.05 for each target). Phalloidin-actin staining similarly revealed actin concentrations per fiber decreased from PRE to W6. Proteomic analysis of the sarcoplasmic fraction from PRE to W6 indicated 40 proteins were up-regulated (p<0.05), KEGG analysis indicated that the glycolysis/gluconeogenesis pathway was upregulated (FDR sig. <0.001), and DAVID indicated that the following functionally-annotated pathways were upregulated (FDR value <0.05): a) glycolysis (8 proteins), b) acetylation (23 proteins), c) gluconeogenesis (5 proteins) and d) cytoplasm (20 proteins). At W7, sarcoplasmic protein concentrations remained higher than PRE (+66%, p<0.05), and both actin and myosin concentrations remained lower than PRE (similar to-50%, p<0.05). These data suggest that short-term high-volume resistance training may: a) reduce muscle fiber actin and myosin protein concentrations in spite of increasing fCSA, and b) promote sarcoplasmic expansion coincident with a coordinated up-regulation of sarcoplasmic proteins involved in glycolysis and other metabolic processes related to ATP generation. Interestingly, these effects seem to persist up to 8 days following training.	[Haun, Cody T.] LaGrange Coll, Dept Exercise Sci, La Grange, GA USA; [Vann, Christopher G.; Osburn, Shelby C.; Mumford, Petey W.; Roberson, Paul A.; Romero, Matthew A.; Fox, Carlton D.; Parry, Hailey A.; Kavazis, Andreas N.; Young, Kaelin C.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Johnson, Christopher A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Moon, Jordan R.] Impedimed, Carlsbad, CA USA; [Badisa, Veera L. D.; Mwashote, Benjamin M.; Ibeanusi, Victor] Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA; [Young, Kaelin C.; Roberts, Michael D.] Edward Via Coll Osteopath Med Auburn Campus, Dept Cell Biol & Physiol, Auburn, AL 36832 USA	Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; Florida A&M University	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Edward Via Coll Osteopath Med Auburn Campus, Dept Cell Biol & Physiol, Auburn, AL 36832 USA.	mdr0024@auburn.edu	Moon, James/AAA-9905-2020; Mumford, Petey/GLS-9565-2022	Moon, James/0000-0001-8071-1491; Mumford, Petey/0000-0002-4946-9702; Fox, Carlton/0000-0001-6142-6062	Impedimed, Inc.; Florida AM University	Impedimed, Inc.; Florida AM University	Funding for subject compensation and certain assays was provided through a contract awarded to KCY and MDR by Impedimed, Inc. The funder provided support in the form of salaries for one author (JRM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for proteomic analysis was provided through a Grant in Aid to MDR and VI from Florida A&M University. Additional funding was provided as a gift in kind to CTH and MDR through Renaissance Periodization by Dr. Mike Israetel and Nick Shaw. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles of all authors are articulated in the 'Author Contributions' section."	Abe T., 2013, INT J CLIN MED, V4, P114, DOI DOI 10.4236/IJCM.2013.42022; Brentano MA, 2011, J SPORT MED PHYS FIT, V51, P1; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Burd NA, 2013, EUR J APPL PHYSIOL, V113, P267, DOI 10.1007/s00421-012-2527-1; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Damas F, 2015, SPORTS MED, V45, P801, DOI 10.1007/s40279-015-0320-0; Duddy W, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0041-y; Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340; Haun CT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00247; Haun CT, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00084; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hyatt HW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12619; Jenkins NDM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00331; Jenkins NDM, 2016, J STRENGTH COND RES, V30, P2174, DOI 10.1519/JSC.0000000000001308; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; MACDOUGALL JD, 1982, EUR J APPL PHYSIOL O, V48, P117, DOI 10.1007/BF00421171; Martin JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13029; Meijer JP, 2015, EXP PHYSIOL, V100, P1331, DOI 10.1113/EP085267; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Mobley CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195203; Mobley CB, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00518; Morton RW, 2016, J APPL PHYSIOL, V121, P129, DOI 10.1152/japplphysiol.00154.2016; PENMAN KA, 1969, RES QUART, V40, P764, DOI 10.1080/10671188.1969.10614916; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Qaisar R, 2016, FREE RADICAL BIO MED, V98, P56, DOI 10.1016/j.freeradbiomed.2016.03.025; Reidy PT, 2017, MED SCI SPORT EXER, V49, P1197, DOI 10.1249/MSS.0000000000001224; Reidy PT, 2016, J NUTR, V146, P155, DOI 10.3945/jn.114.203208; Roberts MD, 2018, PEERJ, V6, DOI 10.7717/peerj.5338; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P3497, DOI 10.1519/JSC.0b013e3181bac2d7; Schuenke MD, 2012, EUR J APPL PHYSIOL, V112, P3585, DOI 10.1007/s00421-012-2339-3; STARON RS, 1991, J APPL PHYSIOL, V70, P631, DOI 10.1152/jappl.1991.70.2.631; Stone M.H., 1983, STRENGTH COND J, V5, P40; Toth MJ, 2012, J PHYSIOL-LONDON, V590, P1243, DOI 10.1113/jphysiol.2011.219659; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013	41	30	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0215267	10.1371/journal.pone.0215267	http://dx.doi.org/10.1371/journal.pone.0215267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166954	gold, Green Published, Green Submitted			2022-12-27	WOS:000470087800005
J	Beck, B; Smith, K; Mercier, E; Gabbe, B; Bassed, R; Mitra, B; Teague, W; Siedenburg, J; McLellan, S; Cameron, P				Beck, Ben; Smith, Karen; Mercier, Eric; Gabbe, Belinda; Bassed, Richard; Mitra, Biswadev; Teague, Warwick; Siedenburg, Josine; McLellan, Susan; Cameron, Peter			Differences in the epidemiology of out-of-hospital and in-hospital trauma deaths	PLOS ONE			English	Article							MAJOR TRAUMA; OLDER-ADULTS; SUICIDE; INJURY; OUTCOMES; PREVENTION; MORTALITY; BURDEN; ALCOHOL; TRENDS	Background Trauma is a leading cause of mortality. Holistic views of trauma systems consider injury as a public health problem that requires efforts in primary, secondary and tertiary prevention. However, the performance of trauma systems is commonly judged on the in-hospital mortality rate. Such a focus misses opportunities to consider all deaths within a population, to understand differences in in-hospital and out-of-hospital trauma deaths and to inform population-level injury prevention efforts. The aim of this study was to provide an epidemiological overview of out-of-hospital and in-hospital trauma deaths in a geographically-defined area over a 10-year period. Methods We performed a population-based review of out-of-hospital and in-hospital trauma deaths over the period of 01 July 2006 to 30 June 2016 in Victoria, Australia, using data from the National Coronial Information System and the Victorian State Trauma Registry. Temporal trends in population-based incidence rates were evaluated. Results Over the study period, there were 11,246 trauma deaths, of which 71% were out-of-hospital deaths. Out-of-hospital trauma deaths commonly resulted from intentional self-harm events (50%) and transport events (35%), while in-hospital trauma deaths commonly resulted from low falls (<= 1 metre) (50%). The incidence of overall trauma deaths did not change over the study period (incidence rate ratio 0.998; 95%CI: 0.991, 1.004; P = 0.56). Conclusions Out-of-hospital deaths accounted for most trauma deaths. Given the notable differences between out-of-hospital and in-hospital trauma deaths, monitoring of all trauma deaths is necessary to inform injury prevention activities and to reduce trauma mortality. The absence of a change in the incidence of both out-of-hospital and in-hospital trauma deaths demonstrates the need for enhanced activities across all aspects of injury prevention.	[Beck, Ben; Smith, Karen; Mercier, Eric; Gabbe, Belinda; Mitra, Biswadev; Siedenburg, Josine; McLellan, Susan; Cameron, Peter] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Smith, Karen] Ambulance Victoria, Ctr Res & Evaluat, Doncaster, Vic, Australia; [Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic, Australia; [Mercier, Eric] Laval Univ, Quebec City, PQ, Canada; [Mercier, Eric; Mitra, Biswadev; Cameron, Peter] The Alfred, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Gabbe, Belinda] Swansea Univ, Sch Med, Hlth Data Res UK, Swansea, W Glam, Wales; [Bassed, Richard] Monash Univ, Dept Forens Med, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Teague, Warwick] Royal Childrens Hosp, Trauma Serv, Parkville, Vic, Australia; [Teague, Warwick] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Teague, Warwick] Murdoch Childrens Res Inst, Surg Res Grp, Parkville, Vic, Australia	Monash University; Monash University; Laval University; Swansea University; Monash University; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute	Beck, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	ben.beck@monash.edu	Mitra, Biswadev/AAC-3724-2019; Teague, Warwick J/AAY-7260-2020; Beck, Ben/ABD-5556-2020	Mitra, Biswadev/0000-0002-0508-2450; Teague, Warwick J/0000-0003-4747-6025; Beck, Ben/0000-0003-3262-5956; Smith, Karen/0000-0002-9057-0685; Bassed, Richard/0000-0001-5473-055X	RACV Safety Research Fund; Victorian State Government Department of Health and Human Services; Royal Australasian College of Surgeons (RACS) Foundation of Surgery; Australian Resuscitation Council (Victorian Branch); Department of Health, State Government of Victoria and Transport Accident Commission; Australian Research Council Discovery Early Career Researcher Award Fellowship [DE180100825]; Australian Research Council Future Fellowship [FT170100048]; Royal Children's Hospital Foundation; National Health and Medical Research Council (NHMRC) Practitioner Fellowship [545926]	RACV Safety Research Fund; Victorian State Government Department of Health and Human Services; Royal Australasian College of Surgeons (RACS) Foundation of Surgery; Australian Resuscitation Council (Victorian Branch); Department of Health, State Government of Victoria and Transport Accident Commission; Australian Research Council Discovery Early Career Researcher Award Fellowship(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council); Royal Children's Hospital Foundation; National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was funded by the RACV Safety Research Fund: https://www.racv.com.au/.The project was also funded by the Victorian State Government Department of Health and Human Services: https://dhhs.vic.gov.au/.The project was funded by the Royal Australasian College of Surgeons (RACS) Foundation of Surgery: https://www.surgeons.org/.The project was funded by the Australian Resuscitation Council (Victorian Branch): https://resus.org.au/victorian-branch/.The Victorian State Trauma Registry (VSTR) is a Department of Health, State Government of Victoria and Transport Accident Commission funded project: https://www.tac.vic.gov.au/.BB received an Australian Research Council Discovery Early Career Researcher Award Fellowship (DE180100825): https://www.arc.gov.au/.BG received an Australian Research Council Future Fellowship (FT170100048): https://www.arc.gov.au/.WT received a grant from the Royal Children's Hospital Foundation: https://www.rchfoundation.org.au/.PC received a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#545926): https://nhmrc.gov.au/.	Ackland HM, 2016, INJURY, V47, P1109, DOI 10.1016/j.injury.2015.12.016; Ahlm K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-216; Aitken LM, 2010, J AM GERIATR SOC, V58, P442, DOI 10.1111/j.1532-5415.2010.02728.x; Australian Bureau of Statistics, 2016, POP AG SEX REG AUSTR; Australian Bureau of Statistics, 2015, 3303 0 CAUS DEATH AU; Australian Government Department of Health, 2016, NAT SUIC PREV STRAT; Australian Institute of Health and Welfare, 2018, DEATHS AUSTR CANB; Baker SP, 2013, AM J PREV MED, V44, P146, DOI 10.1016/j.amepre.2012.10.010; Beck B, 2018, BJS OPEN, V2, P310, DOI 10.1002/bjs5.80; Beck B, 2019, INJURY; Beck B, 2016, MED J AUSTRALIA, V204, P1; Beck B, 2017, MED J AUSTRALIA, V207, P244, DOI 10.5694/mja17.00015; Beck B, 2017, RESUSCITATION, V111, P14, DOI 10.1016/j.resuscitation.2016.11.011; Beck B, 2016, ACCIDENT ANAL PREV, V96, P219, DOI 10.1016/j.aap.2016.08.012; Belin MA, 2012, INT J INJ CONTROL SA, V19, P171, DOI 10.1080/17457300.2011.635213; Bugeja L, 2010, HEALTH INF MANAG J, V39, P16, DOI 10.1177/183335831003900303; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Gabbe BJ, 2015, ANN SURG, V261, P565, DOI 10.1097/SLA.0000000000000522; Gedeborg R, 2012, J TRAUMA ACUTE CARE, V72, P765, DOI 10.1097/TA.0b013e3182288272; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Krysinska K, 2008, AUST NZ J PSYCHIAT, V42, P763, DOI 10.1080/00048670802277255; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mercier E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022070; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; Mitra B, 2007, MED J AUSTRALIA, V186, P31, DOI 10.5694/j.1326-5377.2007.tb00785.x; Model Trauma System Planning and Evaluation, 2006, MOD TRAUM SYST PLANN; Moore L, 2017, JAMA SURG, V152, P168, DOI 10.1001/jamasurg.2016.4212; Morrison JJ, 2016, SURG-J R COLL SURG E, V14, P1, DOI 10.1016/j.surge.2015.02.001; Peden AE, 2017, ACCIDENT ANAL PREV, V98, P259, DOI 10.1016/j.aap.2016.10.009; Peden M M, 2003, Inj Control Saf Promot, V10, P195, DOI 10.1076/icsp.10.4.195.16772; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Spittal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044565; Victorian State Government, ZER 2016 2020 VICT R; Walls HL, 2012, ACCIDENT ANAL PREV, V49, P520, DOI 10.1016/j.aap.2012.03.024	40	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217158	10.1371/journal.pone.0217158	http://dx.doi.org/10.1371/journal.pone.0217158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163036	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200006
J	Werner, JU; Bohm, F; Lang, GE; Dreyhaupt, J; Lang, GK; Enders, C				Werner, Jens Ulrich; Boehm, Felix; Lang, Gabriele E.; Dreyhaupt, Jens; Lang, Gerhard K.; Enders, Christian			Comparison of foveal avascular zone between optical coherence tomography angiography and fluorescein angiography in patients with retinal vein occlusion	PLOS ONE			English	Article							AREA	Objective To compare area of foveal avascular zone (FAZ) in different retinal vascular layers in optical coherence tomography angiography (OCTA) and fluorescein angiography (FA) in patients with retinal vein occlusion (RVO). Design and methods Prospective cross-sectional comparative study in 47 eyes of 47 patients. FA was recorded with the Zeiss FF450plusIR camera and OCTA was obtained with the Zeiss Cirrus 5000 equipped with the AngioPlex module. Area of FAZ was graded by two independent investigators and calculated with Adobe Photoshop. Analysis for the total study population as well as subgroup analysis for branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO) and patients with and without macular edema (ME) was performed. Results For all patients, FAZ was 0.449 mm(2) in FA, 0.496 mm(2) in OCTA superficial capillary layer (SCL) and 3.168 in OCTA deep capillary layer (DCL). In patients without ME FAZ was 0.288 mm(2) in FA, 0.342 mm(2) in OCTA SCL and 1.384 mm(2) in OCTA DCL. FAZ area measurement in patients with ME revealed 0.482 mm(2) in FA, 0.527 mm(2) in OCTA SCL and 3.554 mm(2) in OCTA DCL. Conclusions Especially the SCL of OCTA shows a good agreement to FA in measurement of FAZ in all patients with low limits of variation in patients without ME. There were no considerable differences in BRVO and CRVO. OCTA could replace FA in FAZ area measurement in patients with RVO, especially in those without ME, achieving similar measurements whilst being non-invasive	[Werner, Jens Ulrich; Lang, Gabriele E.; Lang, Gerhard K.; Enders, Christian] Ulm Univ, Dept Ophthalmol, Ulm, Germany; [Boehm, Felix] Ulm Univ, Ulm, Germany; [Dreyhaupt, Jens] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	Ulm University; Ulm University; Ulm University	Werner, JU (corresponding author), Ulm Univ, Dept Ophthalmol, Ulm, Germany.	jens.werner@uniklinik-ulm.de		Boehm, Felix/0000-0002-7291-7737	Carl Zeiss Meditec AG, Jena, Germany	Carl Zeiss Meditec AG, Jena, Germany	The authors JUW, FB, GEL, JD, GKL and CE received financial support from Carl Zeiss Meditec AG, Jena, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhi M, 2016, INVEST OPHTH VIS SCI, V57, pOCT486, DOI 10.1167/iovs.15-18907; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; de Salles MC, 2016, INVEST OPHTH VIS SCI, V57, pOCT242, DOI 10.1167/iovs.15-18819; Feltgen N, 2015, OPHTHALMOLOGE, V112, P607, DOI 10.1007/s00347-015-0105-8; Ho J, 2019, RETINA-J RET VIT DIS, V39, P259, DOI 10.1097/IAE.0000000000001951; Kimura M, 2016, CLIN OPHTHALMOL, V10, P1291, DOI 10.2147/OPTH.S108630; Lang GE, 2016, KLIN MONATSBL AUGENH, V233, P613, DOI 10.1055/s-0042-105325; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Lira Rodrigo Pessoa Cavalcanti, 2007, Arq. Bras. Oftalmol., V70, P615, DOI 10.1590/S0004-27492007000400011; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Tsui I, 2011, RETINA-J RET VIT DIS, V31, P105, DOI 10.1097/IAE.0b013e3181e36c6d; Wons J, 2016, OPHTHALMOLOGICA, V235, P195, DOI 10.1159/000445482	14	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217849	10.1371/journal.pone.0217849	http://dx.doi.org/10.1371/journal.pone.0217849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163058	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200039
J	Chiao, C; Chen, YH; Yi, CC				Chiao, Chi; Chen, Yu-Hua; Yi, Chin-Chun			Loneliness in young adulthood: Its intersecting forms and its association with psychological well-being and family characteristics in Northern Taiwan	PLOS ONE			English	Article							HEALTH; PREVALENCE; BEHAVIOR; 6-ITEM; SCALE	Objectives Most researchers have examined forms of loneliness as discrete and emotional distress. The approach proposed in this study captures the reality that many persons experience more than one dimension of loneliness-varying degrees coupled with their psychological well-being in a family context. This study explores the latent structure of loneliness during young adulthood and its association with psychological well-being, as well as how these are related to their family characteristics in adolescence. Methods Data are from 2,748 young people, a cohort sample from the Taiwan Youth Project (TYP). Loneliness was assessed by a 6-item de Jong-Gierveld short scale with emotional and social loneliness domains. We describe the clustering between loneliness domains and psychological well-being, namely depressive symptoms, self-esteem, suicidal thoughts, and alcohol use using latent class cluster analysis. In addition to incorporating the Taiwanese family context, multivariate multinomial logistic regression models included data on family cohesion and parental guan (parental control) in adolescence. This might be associated with choices in partnership and childbearing, and influence loneliness in young adulthood. Results Our results demonstrate a three-cluster model of loneliness involving emotional loners, serious emotional loners, and severe emotional/social loners. We also found that a feeling of serious emotional loneliness and severe emotional/social loneliness were significantly associated with psychological well-being, even adjusting for individual characteristics. Among young adults who had a partner, the married adults were significantly less likely to feel serious emotional loneliness than those who were living alone. Furthermore, young adults with stronger family cohesion during early adolescence were less likely to suffer from serious emotional loneliness (Relative risk ratios [RRR] 0.77, 95% CI 0.65-0.91) and severe emotional/social loneliness (RRR 0.54, 95% CI 0.34-0.85) in young adulthood. Discussion This measurement strategy provides a foundation for future research into how experts can address loneliness clusters in order to better understand psychological well-being during young adulthood and family context in adolescence. This is important because our results suggest that the various loneliness domains do not occur independently, but rather are embedded in patterns and are associated with family characteristics.	[Chiao, Chi] Natl Yang Ming Univ, Sch Med, Inst Hlth & Welf Policy, Inst Publ Hlth, Taipei, Taiwan; [Chen, Yu-Hua] Natl Taiwan Univ, Dept Bioind Commun & Dev, Taipei, Taiwan; [Yi, Chin-Chun] Acad Sinica, Inst Sociol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; Academia Sinica - Taiwan	Chiao, C (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Hlth & Welf Policy, Inst Publ Hlth, Taipei, Taiwan.	cchiao@ym.edu.tw		Chen, Yu-Hua/0000-0001-6925-148X; Chiao, Chi/0000-0002-8904-918X	Ministry of Science and Technology in Taiwan [107-2511-H-010-001-MY2, 103-2410-H-002-114-MY3, 107-2410-H-001-001]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology in Taiwan under grants 107-2511-H-010-001-MY2 to CC, 103-2410-H-002-114-MY3 to YHC, and 107-2410-H-001-001 to CCY. The conclusions herein are those of the authors and do not represent the viewpoint of the Ministry.	Rico-Uribe LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145264; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Chiao C, 2013, PSYCHOL WELL BEING E; Chiao C, 2015, PSYCHOL HEALTH MED, V20, P972, DOI 10.1080/13548506.2014.987147; Chiao C, 2014, ADDICT BEHAV, V39, P7, DOI 10.1016/j.addbeh.2013.09.006; Chiao C, 2011, AIDS CARE, V23, P1083, DOI 10.1080/09540121.2011.555737; Corporation Stata, 2017, STAT STAT SOFTW REL; de Jong G., 2012, EUROPE DEMOGRAPHICS, V27, P167, DOI DOI 10.4054/DEMRES.2012.27.7; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; DEROGATIS LR, 1983, ARCH GEN PSYCHIAT, V40, P1152; Derogatis LR., 1977, SCL 90 ADM SCORING P; Dyal SR, 2015, SUBST USE MISUSE, P1, DOI DOI 10.3109/10826084.2014.935948; Gault-Sherman M, 2012, J YOUTH ADOLESCENCE, V41, P121, DOI 10.1007/s10964-011-9656-4; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; Leung GTY, 2008, INT PSYCHOGERIATR, V20, P1262, DOI 10.1017/S1041610208007552; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; Liu B, 2017, LANCET PUBLIC HEALTH, V2, pE248, DOI 10.1016/S2468-2667(17)30090-7; Mazza JJ, 2001, SUICIDE LIFE-THREAT, V31, P282, DOI 10.1521/suli.31.3.282.24245; MCWHIRTER BT, 1990, J COUNS DEV, V68, P417, DOI 10.1002/j.1556-6676.1990.tb02521.x; Perlman D., 1981, PERS RELATIONSHIP; Pitman A, 2018, LANCET PSYCHIAT, V5, P955, DOI 10.1016/S2215-0366(18)30436-X; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Richard A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181442; Rosenberg M., 1986, CONCEIVING SELF; Russell D, 2010, J PERS ASSESS, V42, P290; Stickley A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-366; Stickley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067978; Vermunt JK, 2002, APPL LATENT CLASS AN, P89, DOI DOI 10.1017/CBO9780511499531.004; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; Weiss R. S, 1973, LONELINESS EXPERIENC; Wong MM, 2012, J PSYCHIATR RES, V46, P953, DOI 10.1016/j.jpsychires.2012.04.008; Yi CC, 2009, INT SOCIOL, V24, P397, DOI 10.1177/0268580909102914	35	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217777	10.1371/journal.pone.0217777	http://dx.doi.org/10.1371/journal.pone.0217777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150498	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100104
J	Finda, MF; Moshi, IR; Monroe, A; Limwagu, AJ; Nyoni, AP; Swai, JK; Ngowo, HS; Minja, EG; Toe, LP; Kaindoa, EW; Coetzee, M; Manderson, L; Okumu, FO				Finda, Marceline F.; Moshi, Irene R.; Monroe, April; Limwagu, Alex J.; Nyoni, Anna P.; Swai, Johnson K.; Ngowo, Halfan S.; Minja, Elihaika G.; Toe, Lea P.; Kaindoa, Emmanuel W.; Coetzee, Maureen; Manderson, Lenore; Okumu, Fredros O.			Linking human behaviours and malaria vector biting risk in south-eastern Tanzania	PLOS ONE			English	Article							TRANSMISSION; AREA; IFAKARA	To accelerate malaria elimination in areas where core interventions such as insecticide-treated nets (ITNs) are already widely used, it is crucial to consider additional factors associated with persistent transmission. Qualitative data on human behaviours and perceptions regarding malaria risk was triangulated with quantitative data on Anopheles mosquito bites occurring indoors and outdoors in south-eastern Tanzania communities where ITNS are already used but lower level malaria transmission persists. Each night (18: 00h-07: 00h), trained residents recorded human activities indoors, in peri-domestic outdoor areas, and in communal gatherings. Host-seeking mosquitoes were repeatedly collected indoors and outdoors hourly, using miniaturized exposure-free double net traps (DN-Mini) occupied by volunteers. In-depth interviews were conducted with household representatives to explore perceptions on persistent malaria and its control. Higher proportions of people stayed outdoors than indoors in early-evening and early-morning hours, resulting in higher exposures outdoors than indoors during these times. However, exposure during late-night hours (22: 00h-05: 00h) occurred mostly indoors. Some of the popular activities that kept people outdoors included cooking, eating, relaxing and playing. All households had at least one bed net, and 83.9% of people had access to ITNs. Average ITN use was 96.3%, preventing most indoor exposure. Participants recorgnized the importance of ITNs but also noted that the nets were not perfect. No complementary interventions were reported being used widely. Most people believed transmission happens after midnight. We conclude that insecticide-treated nets, where properly used, can still prevent most indoor exposures, but significant risk continues unabated before bedtime, outdoors and at communal gatherings. Such exposure is greatest for rural and low-income households. There is therefore an urgent need for complementary interventions, particularly those targeting outdoor-biting and are applicable for all people including the marginalised populations such as migratory farmers and fishermen. Besides, the differences in community understanding of ongoing transmission, and feedback on imperfections of ITNs should be considered when updating malaria-related communication and interventions.	[Finda, Marceline F.; Moshi, Irene R.; Monroe, April; Limwagu, Alex J.; Nyoni, Anna P.; Swai, Johnson K.; Ngowo, Halfan S.; Minja, Elihaika G.; Kaindoa, Emmanuel W.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania; [Finda, Marceline F.; Moshi, Irene R.; Kaindoa, Emmanuel W.; Manderson, Lenore; Okumu, Fredros O.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Braamofontein, South Africa; [Monroe, April] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA; [Monroe, April] Univ Basel, Basel, Switzerland; [Monroe, April] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Toe, Lea P.; Okumu, Fredros O.] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Coetzee, Maureen] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Braamofontein, South Africa; [Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Ifakara Health Institute; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Witwatersrand; University of Glasgow	Finda, MF (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania.; Finda, MF (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Braamofontein, South Africa.	lfinda@ihi.or.tz	Coetzee, Maureen/AAW-4739-2020; Ngowo, Halfan/AFS-8039-2022; Coetzee, Maureen/AAI-1413-2020	Ngowo, Halfan/0000-0003-2789-0261; Coetzee, Maureen/0000-0003-2019-866X; Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694	World Health Organization's Tropical Disease Research (TDR) group [2015/590235-0]; Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine [WT102350/Z/13]; Consortium for Advanced Research Training (CARTA) grant - Wellcome Trust [087547/Z/08/Z]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]	World Health Organization's Tropical Disease Research (TDR) group; Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Consortium for Advanced Research Training (CARTA) grant - Wellcome Trust; Carnegie Corporation of New York; Sida	This work was supported by the World Health Organization's Tropical Disease Research (TDR) group [Ref: 2015/590235-0]. FO is also supported by a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (Grant Number: WT102350/Z/13). LF and IM were also supported through a Consortium for Advanced Research Training (CARTA) grant awarded by Wellcome Trust (Grant No: 087547/Z/08/Z), the Carnegie Corporation of New York [B 8606.R02], and Sida [54100029].	[Anonymous], 1975, MANUAL PRACTICAL ENT; Bernard H. R., 2000, SOCIAL RES METHODS Q; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bradley J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0679-2; Chacky F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2601-1; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P29, DOI 10.1017/S0007485300051981; Cresswell JW, 2003, ADV MIXED METHODS RE, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Finda MF, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2511-2; Geubbels E, 2015, INT J EPIDEMIOL, V44, P848, DOI 10.1093/ije/dyv068; Gillies M, 1987, ANOPHELINAE AFRICA S; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Heggenhougen H. K., 2003, BEHAV SOCIAL ASPECTS; John W., 2012, CDC MIN LIGHT TRAP M; Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807; Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8; Kilian A., 2013, MALARIA J, V12, P1, DOI [10.1186/1475-2875-12-1, DOI 10.1186/1475-2875-12-1]; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-150; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Makungu C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2056-9; Mathania MM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1332-4; Matowo Nancy S, 2017, Wellcome Open Res, V2, P96, DOI 10.12688/wellcomeopenres.12617.1; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; Michael D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1819-7; Moshi IR, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1924-7; Muir-Cochrane E., 2006, INT J QUAL METH, V5, P15, DOI DOI 10.1177/160940690600500107; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; Ngowo Halfan S, 2017, Wellcome Open Res, V2, P102, DOI 10.12688/wellcomeopenres.12928.1; NVIVO, NVIVO 12 PLUS POW AN; Qi QY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-403; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; Smithson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141112; Stretcher V, 1997, HLTH BEHAV HLTH ED T, DOI [10.1111/j.1365-2648, DOI 10.1111/J.1365-2648]; Swai JK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1616-8; Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735; Tanzania Ministry of Health Ministry of Health Zanzibar (NBS) NB of S, 2018, TANZ MAL IND SURV TM; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396	47	56	56	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217414	10.1371/journal.pone.0217414	http://dx.doi.org/10.1371/journal.pone.0217414			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158255	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000469915700016
J	Atif, RM; Mahmood, H; Liu, HY; Mao, HO				Atif, Rao Muhammad; Mahmood, Haider; Liu Haiyun; Mao, Haiou			Determinants and efficiency of Pakistan's chemical products' exports: An application of stochastic frontier gravity model	PLOS ONE			English	Article							EXCHANGE-RATE; TRADE; COUNTRIES; PERFORMANCE; DEMAND; IMPACT	The estimation of efficiency of industry-specific exports is very important to find exports' gap and to frame exports promotion policy for targeted industry. This study attempts to investigate the main determinants of chemical products' exports of Pakistan with 62 trading partners by applying Stochastic Frontier Analysis (SFA) on an augmented gravity model for a period 1995-2015. The results corroborate that chemical products' exports follow gravity patterns. This study finds a negative and significant impact of import tariff on exports of chemical products while the positive impact of devaluation has been observed. Further, the estimations also take into account the impact of Preferential Trade Agreements (PTA), colonial links, common language, political disputes and contiguity by incorporating dummy variable for each variable and the expected positive effects are found except an insignificant effect of Contiguity. Further, the negative impact of political disputes is observed. The exports' efficiency analyses reveal that Pakistan's chemical exports are well below the optimal level and there exists a huge untapped exports' potential with its neighboring, Middle Eastern and European countries.	[Atif, Rao Muhammad] COMSATS Univ Islamabad, Dept Econ, Lahore Campus, Lahore, Pakistan; [Mahmood, Haider] Prince Sattam bin Abdulaziz Univ, Coll Business Adm, Dept Finance, Alkharj, Saudi Arabia; [Liu Haiyun] Huazhong Univ Sci & Technol, Sch Econ, Wuhan, Hubei, Peoples R China; [Mao, Haiou] Wuhan Univ, China Inst Boundary & Ocean Studies, Sch Polit Sci & Publ Adm, Wuhan, Hubei, Peoples R China	COMSATS University Islamabad (CUI); Prince Sattam Bin Abdulaziz University; Huazhong University of Science & Technology; Wuhan University	Mao, HO (corresponding author), Wuhan Univ, China Inst Boundary & Ocean Studies, Sch Polit Sci & Publ Adm, Wuhan, Hubei, Peoples R China.	maohaiou77@163.com	Mahmood, Haider/AAN-3156-2020	Mahmood, Haider/0000-0002-6474-4338				Achy L, 2003, REV DEV ECON, V7, P563; Aigner D., 1977, J EC, V6, P21; Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; ANDERSON JE, 1979, AM ECON REV, V69, P106; [Anonymous], 1962, SHAPING WORLD EC SUG; Athanasoglou P. P., 2010, 114 U MUN MUN PERS R; Atif RM, 2017, J INT TRADE ECON DEV, V26, P257, DOI 10.1080/09638199.2016.1243724; Baier SL, 2009, J INT ECON, V77, P77, DOI 10.1016/j.jinteco.2008.10.004; Baltagi B, 2014, 4616 CESIFO; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Bayar G, 2015, EMERG MARK FINANC TR, V51, P1307, DOI 10.1080/1540496X.2015.1011506; Boughanmi H, 2008, J ECON INTEGR, V23, P42, DOI 10.11130/jei.2008.23.1.42; Cho G, 2002, AM J AGR ECON, V84, P931, DOI 10.1111/1467-8276.00044; Chou KH., 2015, INT TRADE J, V29, P191; Dahi OS, 2013, APPL ECON, V45, P4754, DOI 10.1080/00036846.2013.804169; Dincer N, 2011, J INT TRADE ECON DEV, V20, P809, DOI 10.1080/09638190903137214; Edwards L, 2004, WORLD DEV, V32, P1323, DOI 10.1016/j.worlddev.2004.03.005; FRANKEL J, 1995, J DEV ECON, V47, P61, DOI 10.1016/0304-3878(95)00005-4; Fugazza M., 2004, EXPORT PERFORMANCE I; FUNKE M, 1992, WELTWIRTSCH ARCH, V128, P498, DOI 10.1007/BF02707364; Guloglu B, 2016, J INT TRADE ECON DEV, V25, P959, DOI 10.1080/09638199.2016.1157886; Harb N, 2007, APPL ECON, V39, P2099, DOI 10.1080/00036840600722307; Hassan M.U., 2013, MIDDLE EAST J SCI RE, V14, P288; Hassan MS, 2017, ECON POLIT-ITALY, V34, P283, DOI 10.1007/s40888-017-0053-7; Head K, 2014, HBK ECON, P131, DOI 10.1016/B978-0-444-54314-1.00003-3; Kalirajan K., 2007, INT TRADE J, V21, P85; Latif Z, 2016, PAKISTAN DEV REV, V55, P191; Leamer EdwardE., 1995, HDB INT EC, V3, P1339, DOI [DOI 10.1016/S1573-4404(05)80006-1, 10.1016/S1573-4404(05)80006-1]; Mahmood H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207598; Mahmood H, 2017, ECON ANN-XXI, V165, P36, DOI 10.21003/ea.V165-08; Mao H, 2018, EMERG MARK FINANC TR, DOI [10.1080/1540496X.2018, DOI 10.1080/1540496X.2018]; Nasir S., 2016, ASIAN DEV REV, V33, P1, DOI [10.1162/ADEV_a_00059, DOI 10.1162/ADEV_A_00059, 10.1162/adev_a_00059]; Rao BB, 2007, APPL ECON LETT, V14, P799, DOI 10.1080/13504850600689931; Rauch JE, 1999, J INT ECON, V48, P7, DOI 10.1016/S0022-1996(98)00009-9; Ravishankar G, 2014, WORLD ECON, V37, P690, DOI 10.1111/twec.12144; Rodriguez G, 2003, APPL ECON, V35, P1043, DOI 10.1080/0003684032000079161; Roy S, DEMAND SUPPLY FACTOR; Senhadji AS, 1999, IMF STAFF PAPERS, V46, P259; Sertic MB, 2015, ECON RES-EKON ISTRAZ, V28, P384, DOI 10.1080/1331677X.2015.1043781; Siddiqui W, 2010, WORLD APPL SCI J, V16, P1171; State Bank of Pakistan, 2016, HDB STAT PAK EC; TOGAN S, 1993, REV WORLD ECON, V129, P777; Yasin M., 2011, LAHORE J EC, V16, P23, DOI DOI 10.35536/LJE.2011.V16.I1.A2	43	6	6	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217210	10.1371/journal.pone.0217210	http://dx.doi.org/10.1371/journal.pone.0217210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145736	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500013
J	Zhu, L; Liao, SE; Ai, YW; Fukunaga, R				Zhu, Li; Liao, Susan E.; Ai, Yiwei; Fukunaga, Ryuya			RNA methyltransferase BCDIN3D is crucial for female fertility and miRNA and mRNA profiles in Drosophila ovaries	PLOS ONE			English	Article							PRE-MIRNA; GENE; DICER-2; BINDING; EXPRESSION; EFFICIENT; DOMAIN; LENGTH; PIRNA; SIRNA	RNA methyltransferases post-transcriptionally add methyl groups to RNAs, which can regulate their fates and functions. Human BCDIN3D (Bicoid interacting 3 domain containing RNA methyltransferase) has been reported to specifically methylate the 5'-monophosphates of pre-miR-145 and cytoplasmic tRNA(His). Methylation of the 5'-monophosphate of pre-miR-145 blocks its cleavage by the miRNA generating enzyme Dicer, preventing generation of miR-145. Elevated expression of BCDIN3D has been associated with poor prognosis in breast cancer. However, the biological functions of BCDIN3D and its orthologs remain unknown. Here we studied the biological and molecular functions of CG1239, a Drosophila ortholog of BCDIN3D. We found that ovary-specific knockdown of Drosophila BCDIN3D causes female sterility. High-throughput sequencing revealed that miRNA and mRNA profiles are dysregulated in BCDIN3D knockdown ovaries. Pathway analysis showed that many of the dysregulated genes are involved in metabolic processes, ribonucleoprotein complex regulation, and translational control. Our results reveal BCDIN3D's biological role in female fertility and its molecular role in defining miRNA and mRNA profiles in ovaries.	[Zhu, Li; Liao, Susan E.; Ai, Yiwei; Fukunaga, Ryuya] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Fukunaga, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	fukunaga@jhmi.edu	Zhu, Li/S-7517-2018; Ai, Yiwei/AAU-7620-2021; Fukunaga, Ryuya/AAK-8609-2020	Zhu, Li/0000-0002-4919-1894; Fukunaga, Ryuya/0000-0002-5814-8206	National Institutes of Health [R01GM116841]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant from the National Institutes of Health [R01GM116841] to RF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Fukunaga R, 2018, BIOCHEM BIOPH RES CO, V498, P1022, DOI 10.1016/j.bbrc.2018.03.108; Fukunaga R, 2014, EMBO J, V33, P371, DOI 10.1002/embj.201387176; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Harcourt EM, 2017, NATURE, V541, P339, DOI 10.1038/nature21351; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jonkhout N, 2017, RNA, V23, P1754, DOI 10.1261/rna.063503.117; Kandasamy SK, 2017, RNA, V23, P1139, DOI 10.1261/rna.059915.116; Kandasamy SK, 2016, P NATL ACAD SCI USA, V113, P14031, DOI 10.1073/pnas.1612393113; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Liao SE, 2019, RNA, V25, P825, DOI 10.1261/rna.070268.118; Liao SE, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00706; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151930; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez A, 2017, NUCLEIC ACIDS RES, V45, P5423, DOI 10.1093/nar/gkx051; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vakrou S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94493; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yao L, 2016, ONCOTARGET, V7, P53895, DOI 10.18632/oncotarget.9656; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhu L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06404-w; Zhu L, 2018, NUCLEIC ACIDS RES, V46, P3726, DOI 10.1093/nar/gky043	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217603	10.1371/journal.pone.0217603	http://dx.doi.org/10.1371/journal.pone.0217603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145769	gold, Green Published, Green Submitted			2022-12-27	WOS:000469425500026
J	dos Santos, MF; Schoueri, JFL; Vidal, CT; Hamamoto, PT; Fukushima, FB; Vidal, EIO				dos Santos, Maria Fernanda; Schoueri, Joao F. L.; Vidal, Camila T.; Hamamoto Filho, Pedro T.; Fukushima, Fernanda B.; Vidal, Edison I. O.			Missed opportunities in the way medical schools evaluate the ethical domain in clerkship rotations	PLOS ONE			English	Article							STUDENT ABUSE; 3RD YEAR; PROFESSIONALISM; CULTURE; CURRICULUM; MISTREATMENT; PERCEPTIONS; PERSPECTIVE; RESIDENCY; BEHAVIOR	Background Several lines of evidence indicate that medical schools have been failing to adequately nurture empathy and the ethical dimension in their graduates, the lack of which may play a central role in the genesis of medical errors, itself a major source of avoidable deaths, incapacity and wasted resources. It has been widely proposed that medical schools should adopt evaluation strategies as a means to promote a culture of respectful relationships. However, it is not clear if evaluation strategies in medical schools have addressed key domains related to that aim, such as ethics, through the perspective of their students. Hence, we conducted a national survey of instruments used by Brazilian medical schools to assess clerkship rotations from the perspective of students, with a main focus on the ethical domain. Methods The authors invited 121 randomly selected institutions to participate in the study. Key informants answered a questionnaire about clerkship rotations and sent copies of any instrument used to assess the quality of clerkship rotations according to the students' perspectives. Results Twenty-six (53%) of 49 participating schools used an instrument to assess the quality of clerkship rotations according to the perspective of students. Just 13 (27%) schools had instruments containing at least one question encompassing the ethical domain. Only 2 (4%) schools asked students specifically about the occurrence of any negative experience concerning the ethical domain during rotations. Merely 1 (2%) school asked students about having witnessed patient mistreatment and none asked about mistreatment against students themselves. Conclusions There are several missed opportunities in the way medical schools assess the quality of clerkship rotations regarding the ethical domain. Closing the gap between usual institutional discourses regarding ethics and how that dimension is assessed within clerkship rotations might represent an important step towards the improvement of medical education and healthcare systems.	[dos Santos, Maria Fernanda] Sao Paulo State Univ UNESP, Botucatu Med Sch, Publ Hlth Dept, Botucatu, SP, Brazil; [dos Santos, Maria Fernanda] Univ Sorocaba UNISO, Occupat Therapy Dept, Sorocaba, SP, Brazil; [Schoueri, Joao F. L.; Vidal, Camila T.; Vidal, Edison I. O.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Internal Med Dept, Botucatu, SP, Brazil; [Hamamoto Filho, Pedro T.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Neurol Psychol & Psychiat Dept, Botucatu, SP, Brazil; [Fukushima, Fernanda B.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Anesthesiol Dept, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade de Sorocaba; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Vidal, EIO (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Internal Med Dept, Botucatu, SP, Brazil.	eiovidal.fmb@gmail.com	Vidal, Edison Iglesias de Oliveira/G-1882-2012; Fukushima, Fernanda Bono/AAR-2740-2021; Hamamoto Filho, Pedro Tadao/D-2800-2012; Fukushima, Fernanda/E-3196-2012	Vidal, Edison Iglesias de Oliveira/0000-0002-1573-4678; Hamamoto Filho, Pedro Tadao/0000-0001-6436-9307; Fukushima, Fernanda/0000-0001-8055-5425	Regional Medical Council of the State of Sao Paulo (CREMESP)	Regional Medical Council of the State of Sao Paulo (CREMESP)	JFLS received a grant from the Regional Medical Council of the State of Sao Paulo (CREMESP) for this study. Grant number: none. URL of CREMESP: www.cremesp.org.br. The sponsor did not play any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2012, ANN TROP MED PUBLIC, V5, P627, DOI 10.4103/1755-6783.109346; Altman DG., 2000, STAT CONFIDENCE CONF; American Academy of Medical Colleges, 2015, MED SCH GRAD QUEST 2; Brainard AH, 2007, ACAD MED, V82, P1010, DOI 10.1097/01.ACM.0000285343.95826.94; Celletti F, 2013, OXFOR TXB MED ED, P671, DOI [10.1093/med/9780199652679.003.0057, DOI 10.1093/MED/9780199652679.003.0057]; D'eon M, 2007, MED TEACH, V29, P295, DOI 10.1080/01421590701291485; Vidal EID, 2015, ANN FAM MED, V13, P176, DOI 10.1370/afm.1763; Deswal BS, 2016, INT J COMMUNITY MED, V3, P1905, DOI DOI 10.18203/2394-6040.IJCMPH20162063; Dickstein LJ, 2000, APPROPRIATE TREATMEN; DuPree E, 2011, JT COMM J QUAL PATIE, V37, P447, DOI 10.1016/S1553-7250(11)37057-2; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; FEUDTNER C, 1994, ACAD MED, V69, P670, DOI 10.1097/00001888-199408000-00017; Fleiss JL., 2003, STAT METHODS RATES P, V3rd ed; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Gaiser RR, 2009, ANESTH ANALG, V108, P948, DOI 10.1213/ane.0b013e3181935ac1; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Hicks LK, 2001, BRIT MED J, V322, P709, DOI 10.1136/bmj.322.7288.709; Hickson GB, 2007, ACAD MED, V82, P1040, DOI 10.1097/ACM.0b013e31815761ee; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Jsrgin KV, 2013, AM J MED STUD, V1, P4; Leape LL, 2012, ACAD MED, V87, P853, DOI 10.1097/ACM.0b013e3182583536; Leape LL, 2012, ACAD MED, V87, P845, DOI 10.1097/ACM.0b013e318258338d; MacAskill A, 2015, REUTERS; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Mavis B, 2014, ACAD MED, V89, P705, DOI 10.1097/ACM.0000000000000199; Morrison J, 2003, BMJ-BRIT MED J, V326, P385, DOI 10.1136/bmj.326.7385.385; Mullan Charles P, 2013, J Grad Med Educ, V5, P25, DOI 10.4300/JGME-D-12-00025.1; Nagata-Kobayashi S, 2009, MED EDUC, V43, P628, DOI 10.1111/j.1365-2923.2009.03388.x; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; O'Sullivan H, 2012, MED TEACH, V34, pE64, DOI 10.3109/0142159X.2012.655610; R Development Core Team, 2009, R LANG ENV STAT COMP; Roff S, 2004, J MED ETHICS, V30, P487, DOI 10.1136/jme.2003.003483; Satterwhite RC, 2000, J MED ETHICS, V26, P462, DOI 10.1136/jme.26.6.462; Shapiro J, 2014, JT COMM J QUAL PATIE, V40, P168, DOI 10.1016/S1553-7250(14)40022-9; SHEEHAN KH, 1990, JAMA-J AM MED ASSOC, V263, P533, DOI 10.1001/jama.263.4.533; SILVER HK, 1990, JAMA-J AM MED ASSOC, V263, P527, DOI 10.1001/jama.263.4.527; Speck RM, 2014, JT COMM J QUAL PATIE, V40, P161, DOI 10.1016/S1553-7250(14)40021-7; Stern DT, 1998, AM J MED, V104, P569, DOI 10.1016/S0002-9343(98)00109-0; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wilkes M, 1999, BRIT MED J, V318, P1269; World Federation for Medical Education, 2015, BAS MED ED WFME GLOB; Wormald BW, 2009, ANAT SCI EDUC, V2, P199, DOI 10.1002/ase.102	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217717	10.1371/journal.pone.0217717	http://dx.doi.org/10.1371/journal.pone.0217717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141551	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000076
J	Saralamba, N; Nosten, F; Sutherland, CJ; Arez, AP; Snounou, G; White, NJ; Day, NPJ; Dondorp, AM; Imwong, M				Saralamba, Naowarat; Nosten, Francois; Sutherland, Colin J.; Arez, Ana Paula; Snounou, Georges; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika			Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri	PLOS ONE			English	Article							DIVERSITY; MALARIAE; PVMSP1	Plasmodium ovale curtisi and Plasmodium ovale wallikeri are two sympatric human malaria species prevalent in Africa, Asia and Oceania. The reported prevalence of both P. ovale spp. was relatively low compared to other malaria species, but more sensitive molecular detection techniques have shown that asymptomatic low-density infections are more common than previously thought. Whole genome sequencing of both P. ovale spp. revealed genetic dissociation between P. ovale curtisi and P. ovale wallikeri suggesting a species barrier. In this study we further evaluate such a barrier by assessing polymorphisms in the genes of three vaccine candidate surface protein: circumsporozoite protein/ thrombospondin-related anonymous-related protein (ctrp), circumsporozoite surface protein (csp) and merozoite surface protein 1 (msp1). The complete coding sequence of ctrp and csp, and a partial fragment of msp1 were isolated from 25 P. ovale isolates and compared to previously reported reference sequences. A low level of nucleotide diversity (Pi = 0.02-0.10) was observed in all three genes. Various sizes of tandem repeats were observed in all ctrp, csp and msp1 genes. Both tandem repeat unit and nucleotide polymorphism in all three genes exhibited clear dimorphism between P. ovale curtisi and P. ovale wallikeri, supporting evidence of non-recombination between these two species.	[Saralamba, Naowarat; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Saralamba, Naowarat; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand; [Sutherland, Colin J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Immunol Unit, London, England; [Arez, Ana Paula] Univ Nova Lisboa, IHMT, GHTM, Lisbon, Portugal; [Snounou, Georges] Univ Paris Sud 11, Immunol Viral Infect & Autoimmune Dis IMVA, IDMIT Dept, CEA,INSERM U1184,IBFJ,DRF, Fontenay Aux Roses, France; [White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Saralamba, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.; Saralamba, N (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	naowarat.sar@mahidol.ac.th	White, Nick/AAC-6527-2019; Sutherland, Colin/AAN-3939-2020; Nosten, Francois/AAC-5509-2019; Arez, Ana Paula/I-1729-2012; Imwong, Mallika/ABE-6493-2020; Snounou, Georges/F-3352-2011	White, Nick/0000-0002-1897-1978; Sutherland, Colin/0000-0003-1592-6407; Nosten, Francois/0000-0002-7951-0745; Arez, Ana Paula/0000-0002-0497-6532; Snounou, Georges/0000-0002-6133-6398	Mahidol University; Wellcome Trust of Great Britain	Mahidol University; Wellcome Trust of Great Britain(Wellcome Trust)	This research project is supported by Mahidol University, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the patients and the other support staff for the samples from Shoklo Malaria Research Unit, Tak, Thailand. This research project is supported by Mahidol University, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain.	Ansari HR, 2016, INT J PARASITOL, V46, P685, DOI 10.1016/j.ijpara.2016.05.009; Garrido-Cardenas JA, 2019, PARASITOL RES, V118, P1, DOI 10.1007/s00436-018-6127-9; Bonilla JA, 2006, AM J TROP MED HYG, V75, P830, DOI 10.4269/ajtmh.2006.75.830; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Chen JT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2611-z; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Fong MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137734; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Le HG, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2513-0; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lo E, 2017, EMERG INFECT DIS, V23, P601, DOI 10.3201/eid2304.161245; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Nabarro LEB, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1204-6; Nolder D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002711; Oguike MC, 2015, INT J PARASITOL, V45, P449, DOI 10.1016/j.ijpara.2015.02.004; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Putaporntip C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058962; Rojo-Marcos G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2544-6; Roucher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087169; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saralamba N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2413-3; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tanomsing N, 2013, J CLIN MICROBIOL, V51, P4213, DOI 10.1128/JCM.01527-13; Tanomsing N, 2010, J CLIN MICROBIOL, V48, P3735, DOI 10.1128/JCM.00898-10; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	31	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217795	10.1371/journal.pone.0217795	http://dx.doi.org/10.1371/journal.pone.0217795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170213	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000470263700056
J	Pinto, M; Langer, TM; Huffer, T; Hofmann, T; Herndl, GJ				Pinto, Maria; Langer, Teresa M.; Hueffer, Thorsten; Hofmann, Thilo; Herndl, Gerhard J.			The composition of bacterial communities associated with plastic biofilms differs between different polymers and stages of biofilm succession	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; MARINE PLASTICS; SURFACE; DEGRADATION; RADIATION; COLONIZATION; HITCHHIKERS; ASSEMBLAGES; DIVERSITY; DYNAMICS	Once in the ocean, plastics are rapidly colonized by complex microbial communities. Factors affecting the development and composition of these communities are still poorly understood. Additionally, whether there are plastic-type specific communities developing on different plastics remains enigmatic. We determined the development and succession of bacterial communities on different plastics under ambient and dim light conditions in the coastal Northern Adriatic over the course of two months using scanning electron microscopy and 16S rRNA gene analyses. Plastics used were low-and high-density polyethylene (LDPE and HDPE, respectively), polypropylene (PP) and polyvinyl chloride with two typical additives (PVC DEHP and PVC DINP). The bacterial communities developing on the plastics clustered in two groups; one group was found on PVC and the other group on all the other plastics and on glass, which was used as an inert control. Specific bacterial taxa were found on specific surfaces in essentially all stages of biofilm development and in both ambient and dim light conditions. Differences in bacterial community composition between the different plastics and light exposures were stronger after an incubation period of one week than at the later stages of the incubation. Under both ambient and dim light conditions, one part of the bacterial community was common on all plastic types, especially in later stages of the biofilm development, with families such as Flavobacteriaceae, Rhodobacteraceae, Planctomycetaceae and Phyllobacteriaceae presenting relatively high relative abundances on all surfaces. Another part of the bacterial community was plastic-type specific. The plastic- type specific fraction was variable among the different plastic types and was more abundant after one week of incubation than at later stages of the succession.	[Pinto, Maria; Langer, Teresa M.; Herndl, Gerhard J.] Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria; [Pinto, Maria; Hueffer, Thorsten; Hofmann, Thilo; Herndl, Gerhard J.] Univ Vienna, Res Platform Plast Environm & Soc, Vienna, Austria; [Hueffer, Thorsten; Hofmann, Thilo] Univ Vienna, Dept Environm Geosci, Ctr Microbiol & Environm Syst Sci, Vienna, Austria; [Herndl, Gerhard J.] Univ Utrecht, NIOZ, Dept Marine Microbiol & Biogeochem, Royal Netherlands Inst Sea Res, Den Burg, Netherlands	University of Vienna; University of Vienna; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Pinto, M (corresponding author), Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria.; Pinto, M (corresponding author), Univ Vienna, Res Platform Plast Environm & Soc, Vienna, Austria.	maria.pinto@univie.ac.at	Hofmann, Thilo/A-8927-2008; Herndl, Gerhard J./B-1513-2013; Hüffer, Thorsten/M-5017-2013; Herndl, Gerhard J./S-3011-2019	Hofmann, Thilo/0000-0001-8929-6933; Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852	DOC from the OAW (Austrian Academy of Sciences) [24446]; Austrian Science Fund (FWF) project [P28781-B21]; research platform PLENTY (Plastics in the Environment and Society) - University of Vienna [326400]	DOC from the OAW (Austrian Academy of Sciences); Austrian Science Fund (FWF) project(Austrian Science Fund (FWF)); research platform PLENTY (Plastics in the Environment and Society) - University of Vienna	This work was supported by a doctoral grant DOC from the OAW (Austrian Academy of Sciences) awarded to M.P. (Grant number 24446), an Austrian Science Fund (FWF) project to G.J.H. (Project number P28781-B21), and by the research platform PLENTY (Plastics in the Environment and Society) financed by the University of Vienna (Project number 326400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2005, APPL ENVIRON MICROB, V71, P5282, DOI 10.1128/AEM.71.9.5282-5289.2005; Amaral-Zettler LA, 2015, FRONT ECOL ENVIRON, V13, P541, DOI 10.1890/150017; Bacosa HP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01325; Bengtsson MM, 2018, MOL ECOL, V27, P2913, DOI 10.1111/mec.14696; Benner R, 1998, LIMNOL OCEANOGR, V43, P1373, DOI 10.4319/lo.1998.43.6.1373; Characklis W.G., 1990, PHYSL ECOLOGY BIOFIL; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Datta MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11965; Davidson A, 2002, AQUAT MICROB ECOL, V27, P159, DOI 10.3354/ame027159; De Tender C, 2017, ENVIRON SCI TECHNOL, V51, P7350, DOI 10.1021/acs.est.7b00697; Debeljak P, 2017, ANAL METHODS-UK, V9, P1521, DOI 10.1039/c6ay03119f; Debroas D, 2017, SCI TOTAL ENVIRON, V599, P1222, DOI 10.1016/j.scitotenv.2017.05.059; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dussud C, 2018, ENVIRON POLLUT, V236, P807, DOI 10.1016/j.envpol.2017.12.027; Dussud C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01571; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Golyshin PN, 2002, INT J SYST EVOL MICR, V52, P901, DOI 10.1099/ijs.0.01890-0; Harrison JP., 2018, HDB ENV CHEM, V58, P181, DOI [10.1007/978-3-319-61615-5_9, DOI 10.1007/978-3-319-61615-5_9]; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; HERNDL GJ, 1993, NATURE, V361, P717, DOI 10.1038/361717a0; Hoellein TJ, 2017, FRESHW SCI, V36, P491, DOI 10.1086/693012; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Iwaki H, 2012, WORLD J MICROB BIOT, V28, P1321, DOI 10.1007/s11274-011-0925-x; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kapanen A, 2007, CHEMOSPHERE, V67, P2201, DOI 10.1016/j.chemosphere.2006.12.023; Kettner MT, 2017, ENVIRON MICROBIOL, V19, P4447, DOI 10.1111/1462-2920.13891; Khanna ND, 2010, J APPL POLYM SCI, V118, P1476, DOI 10.1002/app.32434; Kirstein IV, 2018, MAR ENVIRON RES, V142, P147, DOI 10.1016/j.marenvres.2018.09.028; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; McCormick AR, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1556; Miao LZ, 2019, SCI TOTAL ENVIRON, V650, P2395, DOI 10.1016/j.scitotenv.2018.09.378; Oberbeckmann S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02709; Oberbeckmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159289; Oberbeckmann S, 2014, FEMS MICROBIOL ECOL, V90, P478, DOI 10.1111/1574-6941.12409; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Ogonowski M, 2018, ENVIRON MICROBIOL, V20, P2796, DOI 10.1111/1462-2920.14120; Paluselli A, 2019, ENVIRON SCI TECHNOL, V53, P166, DOI 10.1021/acs.est.8b05083; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Rodrigues EM, 2018, MICROB ECOL, V75, P688, DOI 10.1007/s00248-017-1078-8; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Romani AM, 1999, FRESHWATER BIOL, V41, P729, DOI 10.1046/j.1365-2427.1999.00413.x; Romera-Castillo C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03798-5; Royer SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200574; Rummel CD, 2017, ENVIRON SCI TECH LET, V4, P258, DOI 10.1021/acs.estlett.7b00164; Salta M, 2013, ENVIRON MICROBIOL, V15, P2879, DOI 10.1111/1462-2920.12186; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Singh B, 2008, POLYM DEGRAD STABIL, V93, P561, DOI 10.1016/j.polymdegradstab.2007.11.008; Staples CA, 2009, ENVIRON TOXICOL CHEM, V16, P875; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; Wagner K, 2017, J GEOPHYS RES-BIOGEO, V122, P1806, DOI 10.1002/2016JG003727; Wagner K, 2015, ENVIRON MICROBIOL, V17, P5036, DOI 10.1111/1462-2920.12913; WHO (World Health Organisation), 1994, ULTR RAD; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	60	106	108	14	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217165	10.1371/journal.pone.0217165	http://dx.doi.org/10.1371/journal.pone.0217165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166981	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800018
J	Garcia, NA; Gonzalez-King, H; Grueso, E; Sanchez, R; Martinez-Romero, A; Javega, B; O'Connor, JE; Simons, PJ; Handberg, A; Sepulveda, P				Garcia, N. A.; Gonzalez-King, H.; Grueso, E.; Sanchez, R.; Martinez-Romero, A.; Javega, B.; O'Connor, J. E.; Simons, P. J.; Handberg, A.; Sepulveda, P.			Circulating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36	PLOS ONE			English	Article							NILE-RED; METABOLISM; PLASMA; MUSCLE	Regulation of circulating free fatty acid (FFA) levels and delivery is crucial to maintain tissue homeostasis. Exosomes are nanomembranous vesicles that are released from diverse cell types and mediate intercellular communication by delivering bioactive molecules. Here, we sought to investigate the uptake of FFAs by circulating exosomes, the delivery of FFAloaded exosomes to cardiac cells and the possible role of the FFA transporter CD36 in these processes. Circulating exosomes were purified from the serum of healthy donors after an overnight fast (F) or 20 minutes after a high caloric breakfast (postprandial, PP). Western blotting, Immunogold Electron Microscopy and FACS analysis of circulating exosomes showed that CD36 was expressed under both states, but was higher in postprandial-derived exosomes. Flow cytometry analysis showed that circulating exosomes were able to take-up FFA directly from serum. Importantly, preincubation of exosomes with a blocking CD36 antibody significantly impeded uptake of the FFA analogue BODIPY, pointing to the role of CD36 in FFA exosomal uptake. Finally, we found that circulating exosomes could delivery FFA analogue BODIPY into cardiac cells ex vivo and in vivo in a mice model. Overall, our results suggest a novel mechanism in which circulating exosomes can delivery FFAs from the bloodstream to cardiac tissue. Further studies will be necessary to understand this mechanism and, in particular, its potential involvement in metabolic pathologies such as obesity, diabetes and atherosclerosis.	[Garcia, N. A.] GECORP, Buenos Aires, DF, Argentina; [Gonzalez-King, H.; Grueso, E.; Sanchez, R.; Sepulveda, P.] Inst Invest Sanitaria La Fe, Regenerat Med & Heart Transplantat Unit, Valencia, Spain; [Gonzalez-King, H.; Grueso, E.; Sanchez, R.; O'Connor, J. E.; Sepulveda, P.] Joint Res Unit Cardiovasc Repair IISLAFE CIPF, Valencia, Spain; [Martinez-Romero, A.; O'Connor, J. E.] Joint Res Unit Cytom CIPF UVEG, Valencia, Spain; [Javega, B.] Univ Valencia, Dept Biochem, Valencia, Spain; [Simons, P. J.] Bioceros BV, Utrecht, Netherlands; [Handberg, A.] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Handberg, A.] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg, Denmark	University of Valencia; Bioceros B.V.; Aalborg University; Aalborg University Hospital; Aalborg University	Garcia, NA (corresponding author), GECORP, Buenos Aires, DF, Argentina.; Sepulveda, P (corresponding author), Inst Invest Sanitaria La Fe, Regenerat Med & Heart Transplantat Unit, Valencia, Spain.; Sepulveda, P (corresponding author), Joint Res Unit Cardiovasc Repair IISLAFE CIPF, Valencia, Spain.	gecorpinfo@gmail.com; pilar.sepulveda.sanchis@gmail.com	Jávega, Beatriz/AAE-6298-2022; Sepúlveda, Pilar/GWN-0626-2022; Sepulveda, Pilar/AAA-6636-2022; Martínez-Romero, Alicia/ABH-3160-2020	Sepulveda, Pilar/0000-0001-6071-7431; Martínez-Romero, Alicia/0000-0002-5197-0635; Javega, Beatriz/0000-0001-9585-0080; Garcia, Nahuel/0000-0001-6903-9972; Handberg, Aase/0000-0001-5719-203X; Grueso Navarro, Elena/0000-0002-5384-9978; O'Connor, Jose-Enrique/0000-0002-8792-5780	Instituto de Salud Carlos III - FEDER "una manera de hacer Europa [PI16/0107, (RD16/0011/0004) 354]	Instituto de Salud Carlos III - FEDER "una manera de hacer Europa	This work was supported by grants PI16/0107 and RETICS Program (RD16/0011/0004) 354 from Instituto de Salud Carlos III cofunded by FEDER "una manera de hacer Europa. GECORP provided support in the form of salaries for author [NAG] and Bioceros BV provided support in the form of salaries for author [PJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; ANDRES R, 1956, J CLIN INVEST, V35, P671, DOI 10.1172/JCI103324; BASSO L V, 1970, Journal of Clinical Investigation, V49, P537, DOI 10.1172/JCI106264; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Evans K, 2002, DIABETES, V51, P2684, DOI 10.2337/diabetes.51.9.2684; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Garcia NA, 2016, CARDIOVASC RES, V109, P397, DOI 10.1093/cvr/cvv260; GOLD M, 1964, AM J PHYSIOL, V206, P153, DOI 10.1152/ajplegacy.1964.206.1.153; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kimura K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02406-2; Miles JM, 2007, HORM METAB RES, V39, P726, DOI 10.1055/s-2007-990273; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rumin J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0220-4; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Susztak K CE, 2005, PLOS MED; Tanaka T, 2001, J LIPID RES, V42, P751; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	23	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217546	10.1371/journal.pone.0217546	http://dx.doi.org/10.1371/journal.pone.0217546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141569	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000059
J	Ehteram, M; Singh, VP; Ferdowsi, A; Mousavi, SF; Farzin, S; Karami, H; Mohd, NS; Afan, HA; Lai, SH; Kisi, O; Malek, MA; Ahmed, AN; El-Shafie, A				Ehteram, Mohammad; Singh, Vijay P.; Ferdowsi, Ahmad; Mousavi, Sayed Farhad; Farzin, Saeed; Karami, Hojat; Mohd, Nuruol Syuhadaa; Afan, Haitham Abdulmohsin; Lai, Sai Hin; Kisi, Ozgur; Malek, M. A.; Ahmed, Ali Najah; El-Shafie, Ahmed			An improved model based on the support vector machine and cuckoo algorithm for simulating reference evapotranspiration	PLOS ONE			English	Article							REGRESSION NEURAL-NETWORKS; SYSTEM	Reference evapotranspiration (ET0) plays a fundamental role in irrigated agriculture. The objective of this study is to simulate monthly ET0 at a meteorological station in India using a new method, an improved support vector machine (SVM) based on the cuckoo algorithm (CA), which is known as SVM-CA. Maximum temperature, minimum temperature, relative humidity, wind speed and sunshine hours were selected as inputs for the models used in the simulation. The results of the simulation using SVM-CA were compared with those from experimental models, genetic programming (GP), model tree (M5T) and the adaptive neuro-fuzzy inference system (ANFIS). The achieved results demonstrate that the proposed SVM-CA model is able to simulate ET0 more accurately than the GP, M5T and ANFIS models. Two major indicators, namely, root mean square error (RMSE) and mean absolute error (MAE), indicated that the SVM-CA outperformed the other methods with respective reductions of 5-15% and 5-17% compared with the GP model, 12-21% and 10-22% compared with the M5T model, and 7-15% and 5-18% compared with the ANFIS model, respectively. Therefore, the proposed SVM-CA model has high potential for accurate simulation of monthly ET0 values compared with the other models.	[Ehteram, Mohammad; Ferdowsi, Ahmad; Mousavi, Sayed Farhad; Farzin, Saeed; Karami, Hojat] Semnan Univ, Fac Civil Engn, Dept Water Engn & Hydraul Struct, Semnan, Iran; [Singh, Vijay P.] Texas A&M Univ, Zachry Dept Civil Engn, Dept Biol & Agr Engn, College Stn, TX USA; [Mohd, Nuruol Syuhadaa; Afan, Haitham Abdulmohsin; Lai, Sai Hin; El-Shafie, Ahmed] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Kisi, Ozgur] Ilia State Univ, Fac Nat Sci & Engn, Tbilisi, Georgia; [Malek, M. A.] Univ Tenaga Nas, ISE, Selangor, Malaysia; [Ahmed, Ali Najah] Univ Tenaga Nas, IEI, Selangor, Malaysia	Semnan University; Texas A&M University System; Texas A&M University College Station; Universiti Malaya; Ilia State University; Universiti Tenaga Nasional; Universiti Tenaga Nasional	El-Shafie, A (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	elshafie@um.edu.my	Farzin, Saeed/AAB-3877-2020; Ferdowsi, Ahmad/W-6478-2019; Lai, Sai Hin/H-3164-2018; MOHD, NURUOL SYUHADAA/B-9443-2010; El-Shafie, Ahmed/J-1799-2014; Karami, Hojat/AAU-1618-2020; Afan, Haitham/ABF-2282-2021; Afan, Haitham Abdulmohsin/G-6932-2018; Ahmed, Ali Najah/J-9456-2017; Kisi, Ozgur/AAD-8932-2019	Ferdowsi, Ahmad/0000-0003-3269-1355; Lai, Sai Hin/0000-0002-7143-4805; MOHD, NURUOL SYUHADAA/0000-0002-1965-1087; El-Shafie, Ahmed/0000-0001-5018-8505; Afan, Haitham Abdulmohsin/0000-0002-4957-756X; Ahmed, Ali Najah/0000-0002-5618-6663; 	Bold 2025 grant by Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional [RJO 10436494]; University of Malaya [UMRG RP025A-18SUS, BKS008-2016]	Bold 2025 grant by Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional; University of Malaya(Universiti Malaya)	The authors would like to appreciate the financial support received from Bold 2025 grant coded RJO 10436494 by Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional to ANA and the research grant coded UMRG RP025A-18SUS to AE and BKS008-2016 to SHL funded by the University of Malaya.	Allen RG, 2000, YB UN 2000, P1414, DOI [10.18356/25c78cba-en, DOI 10.18356/25C78CBA-EN]; Almorox J, 2018, THEOR APPL CLIMATOL, V131, P693, DOI 10.1007/s00704-016-1996-2; Citakoglu H, 2014, WATER RESOUR MANAG, V28, P99, DOI 10.1007/s11269-013-0474-1; Cobaner M, 2011, J HYDROL, V398, P292, DOI 10.1016/j.jhydrol.2010.12.030; Deo RC, 2016, STOCH ENV RES RISK A, V30, P1769, DOI 10.1007/s00477-015-1153-y; Feng Y, 2017, COMPUT ELECTRON AGR, V136, P71, DOI 10.1016/j.compag.2017.01.027; Gavili S, 2018, METEOROL APPL, V25, P128, DOI 10.1002/met.1676; Guven A, 2013, J HYDROL ELSEVIER BV, V498, P36, DOI [10.1016/j.jhydrol.2013.06.011, DOI 10.1016/J.JHYDROL.2013.06.011]; Guven A, 2011, IRRIGATION SCI, V29, P135, DOI 10.1007/s00271-010-0225-5; Karimaldini F, 2012, J IRRIG DRAIN ENG, V138, P21, DOI 10.1061/(ASCE)IR.1943-4774.0000343; Keshtegar B, 2018, WATER RESOUR MANAG, V32, P1101, DOI 10.1007/s11269-017-1857-5; Keshtegar B, 2016, COMPUT ELECTRON AGR, V127, P120, DOI 10.1016/j.compag.2016.05.018; Kim S, 2015, J COMPUT CIVIL ENG, V29, DOI 10.1061/(ASCE)CP.1943-5487.0000367; Kim S, 2015, HYDROLOG SCI J, V60, P1120, DOI 10.1080/02626667.2014.945937; Kisi O, 2006, HYDROLOG SCI J, V51, P1092, DOI 10.1623/hysj.51.6.1092; Kisi O, 2015, J HYDROL, V528, P312, DOI 10.1016/j.jhydrol.2015.06.052; Kumar M, 2002, J IRRIG DRAIN ENG, V128, P224, DOI 10.1061/(ASCE)0733-9437(2002)128:4(224); Ladlani I, 2012, METEOROL ATMOS PHYS, V118, P163, DOI 10.1007/s00703-012-0205-9; Makkink GF, 1957, J I WATER ENG; Malik A, 2018, J IRRIG DRAIN ENG, V144, DOI [10.1061/(ASCE)IR.1943-4774.0001336, 10.1061/(asce)ir.1943-4774.0001336]; Malik A, 2015, WATER RESOUR MANAG, V29, P1859, DOI 10.1007/s11269-015-0915-0; Maroufpoor Saman, 2020, ISH Journal of Hydraulic Engineering, V26, DOI 10.1080/09715010.2018.1474389; Mehdizadeh S, 2017, COMPUT ELECTRON AGR, V139, P103, DOI 10.1016/j.compag.2017.05.002; Ming B, 2017, WATER RESOUR MANAG, V31, P1173, DOI 10.1007/s11269-017-1569-x; Ming B, 2015, WATER RESOUR MANAG, V29, P5671, DOI 10.1007/s11269-015-1140-6; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Samui P, 2012, HYDROL PROCESS, V26, P1361, DOI 10.1002/hyp.8278; Sanikhani H, 2018, THEOR APPL CLIMATOL, DOI [10.1007/s00704-017-2169-7, DOI 10.1007/S00704-017-2169-7]; Tabari H, 2012, METEOROL ATMOS PHYS, V116, P147, DOI 10.1007/s00703-012-0184-x; Yaseen ZM, 2018, WATER RESOUR MANAG, V32, P2227, DOI 10.1007/s11269-018-1915-7	30	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217499	10.1371/journal.pone.0217499	http://dx.doi.org/10.1371/journal.pone.0217499			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150443	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100059
J	Stavrova, T; Borel, A; Daujeard, C; Vettese, D				Stavrova, T.; Borel, A.; Daujeard, C.; Vettese, D.			A GIS based approach to long bone breakage patterns derived from marrow extraction	PLOS ONE			English	Article							PERCUSSION MARKS; IMAGE-ANALYSIS; HAMMERSTONE PERCUSSION; EXAMPLE; DAMAGE; QUANTIFICATION; ARCHAEOFAUNA; NOTCHES; HOMINID	In archaeological assemblages the presence of percussion marks, on the surface of long bones, is an indicator of long bone marrow extraction. The form, quantity and distribution of percussion marks are analysed to gain a better understanding of the marrow extraction process. Patterns of bone percussion damage in archaeological assemblages may highlight standardized actions, possibly related to butchery traditions. However, additional factors could underlie these patterns and should also be considered. In this article we test intuitiveness as a factor in appearance of percussion mark patterns, to see if patterns can appear when bones are being fractured without prior experience with bone fracture properties. To test this hypothesis, for this study we selected a sample of 40 cattle (Bos taurus) long limb bones from a large bone breakage experiment (400 long limb bones), where participants had no previous experience in bone breakage and may thus have broken bones intuitively. We used Geographic Information System (GIS) software to analyse the distribution of percussion marks. Using ArcGIS Spatial Analysts tools, we identified and quantified significant concentrations of percussion marks. Results show that percussion mark patterns emerge for the same bone element, and that specific sides and zones were recurrently selected by experimenters. The distribution of patterns varies among the different long bone elements, and we attribute this variance to an adjustment to bone morphology. In addition, we calculated and identified bone damage patterns resulting from hammerstone percussion. Crossing bone survivorship with percussion mark patterns enabled us to recognise and evaluate the effects of fragmentation and surface visibility in controlled experimental conditions. The GIS method facilitates comparisons between different variables and provides a sophisticated visual representation of results. Enlarging the sample will allow to constitute a more substantial analogous model for fossil assemblages.	[Stavrova, T.; Borel, A.; Daujeard, C.; Vettese, D.] Sorbonne Univ, HNHP, UMR 7194, MNHN,Homme & Environm,CNRS,Inst Paleontol Humaine, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Stavrova, T (corresponding author), Sorbonne Univ, HNHP, UMR 7194, MNHN,Homme & Environm,CNRS,Inst Paleontol Humaine, Paris, France.	stavrovatrajanka@gmail.com	Daujeard, Camille/AAQ-4952-2020; Borel, Antony/AAT-6514-2020; Borel, Antony/GQA-8852-2022	Daujeard, Camille/0000-0001-7489-8691; Borel, Antony/0000-0002-6014-1863; Vettese, Delphine/0000-0001-6441-6054; Stavrova, Trajanka/0000-0003-1044-2913	Fondation Nestle France [SJ 671-16]; Centre d'Information des Viandes - Viande, sciences et societe [SJ 334-17]	Fondation Nestle France(Nestle SA); Centre d'Information des Viandes - Viande, sciences et societe	CD received funds from the Fondation Nestle France (SJ 671-16) (https://fondation.nestle.fr/) and DV from the Centre d'Information des Viandes - Viande, sciences et societe (SJ 334-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2002, AM ANTIQUITY, V67, P643, DOI 10.2307/1593796; Alcantara V., 2006, TRABAJOS PREHIST, V63, P25; Bailey MJ, 2006, MICROBIAL ECOLOGY AE; Barba Rebeca, 2005, Journal of Taphonomy, V3, P17; Bartram LE, 1999, J ARCHAEOL SCI, V26, P9; Benito-Calvo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121613; Blasco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055863; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Bolstad P., 2016, GIS FUNDAMENTALS 1 T, V5th; Brewer CA., 2016, DESIGNING BETTER MAP; Brouwer Burg M., 2017, J ARCHAEOLOGICAL SCI; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Costamagno S, 2002, ARCHAEOMETRY, V44, P495, DOI 10.1111/1475-4754.t01-1-00081; David W., 2000, MAP ARCHAEOL SPAT TE, V321, P1; Dempsey C., 2018, WHAT IS GIS; Dominguez-Rodrigo Manuel, 2007, P255; Dominguez-Solera SD, 2009, INT J OSTEOARCHAEOL, V19, P345, DOI 10.1002/oa.987; Egeland CP, 2003, PLAINS ANTHROPOL, V48, P39, DOI 10.1080/2052546.2003.11949279; FISHER P., 2003, GEOGRAPHICAL INFORM, V1, P191; Galan AB, 2009, J ARCHAEOL SCI, V36, P776, DOI 10.1016/j.jas.2008.11.003; Blasco JG, 2014, REV GEN DERECHO TRAB, P1; Garcia-Moreno A., 2015, CAA 2014 21 CENT ARC, P407; Grunwald A., 2016, SKELETON ILLUSTRATIO; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jernvall Jukka, 1999, Palaeontologia Electronica, V2, P1; Lyman R L, 2008, QUANTATIVE PALEOZOOL; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; Marean CW, 2001, AM ANTIQUITY, V66, P333, DOI 10.2307/2694612; MARSHALL F, 1993, AM ANTIQUITY, V58, P261, DOI 10.2307/281968; Masset C, 2016, BULL SOC PREHIST FR, V113, P691; Moclan A, 2018, J ARCHAEOL SCI, V96, P1, DOI 10.1016/j.jas.2018.05.007; Morin E, 2017, AM ANTIQUITY, V82, P96, DOI 10.1017/aaq.2016.16; Nilssen P., 2000, THESIS; Parkinson J.A., 2013, THESIS; Parkinson JA, 2015, J HUM EVOL, V80, P114, DOI 10.1016/j.jhevol.2014.10.011; Parkinson JA, 2014, PALAEOGEOGR PALAEOCL, V409, P57, DOI 10.1016/j.palaeo.2014.04.019; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2005, INT J OSTEOARCHAEOL, V15, P247, DOI 10.1002/oa.780; Scianna A, 2011, ARCHEOL CALC, V22, P337; Silverman B., 1986, DENSITY ESTIMATION S, V175; Smith D, 2017, UNDERSTANDING GIS; Smith D, 2016, SOCIETY OF VACUUM COATERS 59TH ANNUAL TECHNICAL CONFERENCE PROCEEDINGS, 2016, P3, DOI 10.14332/svc16.proc.0046; Verhagen P, 2018, NAT SCI ARCHAEOL, P11, DOI 10.1007/978-3-319-25316-9_2; Vettese D, 2017, J ARCHAEOL SCI-REP, V13, P151, DOI 10.1016/j.jasrep.2017.03.029; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; White T.D., 1992, PREHISTORIC CANNIBAL	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216733	10.1371/journal.pone.0216733	http://dx.doi.org/10.1371/journal.pone.0216733			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150420	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100021
J	Lovato, CV; Lovato, TL; Cripps, RM				Lovato, Candice, V; Lovato, TyAnna L.; Cripps, Richard M.			Crossveinless is a direct transcriptional target of Trachealess and Tango in Drosophila tracheal precursor cells	PLOS ONE			English	Article							BHLH-PAS PROTEIN; CNS MIDLINE; GENE ENCODES; GASTRULATION; EXPRESSION; MIGRATION; DRIFTER; BINDING; FAMILY	Understanding the transcriptional pathways controlling tissue-specific gene expression is critical to unraveling the complex regulatory networks that underlie developmental mechanisms. Here, we assessed how the Drosophila crossveinless (cv) gene, that encodes a BMP-binding factor, is transcriptionally regulated in the developing embryonic tracheal system. We identify an upstream regulatory region of cv that promotes reporter gene expression in the tracheal precursors. We further demonstrate that this promoter region is directly responsive to the basic, helix-loop-helix-PAS domain factors Trachealess (Trh) and Tango (Tgo), that function to specify tracheal fate. Moreover, cv expression in embryos is lost in trh mutants, and the integrity of the Trh/ Tgo binding sites are required for promoter-lacZ expression. These findings for the first time elucidate the transcriptional regulation of one member of a family of BMP binding proteins, that have diverse functions in animal development.	[Lovato, Candice, V; Lovato, TyAnna L.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Cripps, Richard M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of New Mexico; California State University System; San Diego State University	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Cripps, RM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rcripps@sdsu.edu			NIH [R01 GM061738]; NIH from the Institute Development Award (IDeA) Program of the National Center for Research Resources [P20 RR018754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Institute Development Award (IDeA) Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01 GM061738, awarded by the NIH to RMC. We acknowledge technical support from the Department of Biology's Molecular Biology Facility, supported by NIH grant P20 RR018754 from the Institute Development Award (IDeA) Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 1996, DEVELOPMENT, V122, P4169; Arias A.M., 1993, DEV DROSOPHILA, P609; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Chen CK, 1998, DEVELOPMENT, V125, P4959; Chung S, 2011, DEV BIOL, V360, P160, DOI 10.1016/j.ydbio.2011.09.014; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Jiang L, 2010, MECH DEVELOP, V127, P265, DOI 10.1016/j.mod.2010.03.003; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; Junell A, 2010, MOL CELL BIOL, V30, P3672, DOI 10.1128/MCB.00223-10; Morozova T, 2010, DEV GENES EVOL, V220, P191, DOI 10.1007/s00427-010-0339-z; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Patel NH, METHODS CELL BIOL, V44, P445; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Sedaghat Y, 2002, DEVELOPMENT, V129, P2591; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thummel CS, 1992, DROS INF SERV, V71, P150; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vilmos P, 2005, EMBO REP, V6, P262, DOI 10.1038/sj.embor.7400347; Vincent S, 1997, DEVELOPMENT, V124, P2741; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Zelzer E, 2000, MECH DEVELOP, V91, P163, DOI 10.1016/S0925-4773(99)00295-6	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217906	10.1371/journal.pone.0217906	http://dx.doi.org/10.1371/journal.pone.0217906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158257	Green Submitted, Green Published, gold			2022-12-27	WOS:000469915700033
J	Wang, GJ; Jia, SY; Li, HY; Song, XJ; Zhang, WB				Wang, Guangjun; Jia, Shuyong; Li, Hongyan; Song, Xiaojing; Zhang, Weibo			Exploring the relationship between the speed-resolved perfusion of blood flux and HRV following different thermal stimulations using MSE and MFE analyses	PLOS ONE			English	Article							DOPPLER FLOWMETRY SIGNALS; HEART-RATE-VARIABILITY; MULTISCALE ENTROPY; ENDOTHELIAL FUNCTION; DYNAMICS; FLOW; COMPLEXITY; OSCILLATIONS; PRESSURE	Our previous study employed the classic laser Doppler flux (LDF) to explore the complexity of local blood flow signals and their relationship with heart rate variability (HRV). However, microcirculation blood flow is composed of different velocity components. To investigate the complexity of local speed-resolved perfusion and HRV following stimulation with different temperatures in healthy subjects, multiscale entropy (MSE) and multiscale fuzzy entropy (MFE) were used to measure the complexity of local speed-resolved perfusion signals. MSE was also used to evaluate the complexity of HRV. The results indicated that thermal stimulation increased all components of local speed-resolved perfusion and that stimulation with different temperatures resulted in different changes in the complexity area index. However, the same stimulation had no effect on the MSE of HRV. Further research showed that 44 degrees C thermal stimulation resulted in a weak correlation between the composite speed-resolved perfusion and the HRV complexity. The current study provides a new approach for studying the relationship between speed-resolved perfusion signals and cardiac function.	[Wang, Guangjun; Jia, Shuyong; Li, Hongyan; Song, Xiaojing; Zhang, Weibo] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS	Wang, GJ (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China.	tjuwg@gmail.com; zhangweibo@hotmail.com	Wang, Guangjun/B-4288-2011	Wang, Guangjun/0000-0001-5344-4594	National Basic Research Program of China [2015CB554502]; Fundamental Research Funds for the Central Public Welfare Research Institutes [ZZ11-098]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Public Welfare Research Institutes	This research was supported by the National Basic Research Program of China (2015CB554502) and the Fundamental Research Funds for the Central Public Welfare Research Institutes (ZZ11-098) to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azami H, 2017, MED BIOL ENG COMPUT, V55, P2037, DOI 10.1007/s11517-017-1647-5; BERNARDI L, 1989, MICROVASC RES, V37, P16, DOI 10.1016/0026-2862(89)90069-1; Bernjak A, 2008, MICROVASC RES, V76, P224, DOI 10.1016/j.mvr.2008.07.006; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; Chen JL, 2014, AM J PHYSIOL-REG I, V307, pR179, DOI 10.1152/ajpregu.00108.2014; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa MD, 2014, EARLY HUM DEV, V90, P67, DOI 10.1016/j.earlhumdev.2013.10.002; Debbabi H, 2010, AM J HYPERTENS, V23, P541, DOI 10.1038/ajh.2010.10; Fredriksson I, P SPIE; Fredriksson I, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2854691; Fredriksson I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127004; Fredriksson I, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.047004; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Holowatz LA, 2008, J APPL PHYSIOL, V105, P370, DOI 10.1152/japplphysiol.00858.2007; Hsiu H, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq073; HUANG CM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1155/2011/751317; Humeau A, 2011, IEEE T BIO-MED ENG, V58, P2970, DOI 10.1109/TBME.2011.2160865; Humeau A, 2010, MED PHYS, V37, P6142, DOI 10.1118/1.3512796; IJzerman RG, 2003, EUR J CLIN INVEST, V33, P536, DOI 10.1046/j.1365-2362.2003.01179.x; Jan YK, 2012, PHYSIOL MEAS, V33, P1733, DOI 10.1088/0967-3334/33/10/1733; Jonasson H, 2017, DIABETES VASC DIS RE, V14, P363, DOI 10.1177/1479164117707706; Jonasson H, 2015, MICROVASC RES, V102, P70, DOI 10.1016/j.mvr.2015.08.006; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Kuntzelman K, 2018, BRAIN COGNITION, V123, P126, DOI 10.1016/j.bandc.2018.03.010; Kvandal P, 2006, MICROVASC RES, V72, P120, DOI 10.1016/j.mvr.2006.05.006; Li BZ, 2017, 2017 20TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P596; Liao FY, 2017, CLIN HEMORHEOL MICRO, V66, P197, DOI 10.3233/CH-160239; Liao FY, 2010, MICROVASC RES, V80, P44, DOI 10.1016/j.mvr.2010.03.009; LIPPMAN N, 1994, AM J PHYSIOL, V267, pH411, DOI 10.1152/ajpheart.1994.267.1.H411; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Lu WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144732; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Organization WH, 2008, WHO STAND AC POINT L; Pinter A, 2012, AUTON NEUROSCI-BASIC, V169, P107, DOI 10.1016/j.autneu.2012.05.005; Stromberg T, 2017, MICROVASC RES, V113, P50, DOI 10.1016/j.mvr.2017.04.005; Thanaj M, 2018, COMPUT BIOL MED, V102, P157, DOI 10.1016/j.compbiomed.2018.09.026; Thorn CE, 2009, AM J PHYSIOL-HEART C, V296, pH1289, DOI 10.1152/ajpheart.01192.2008; Van Den Houte M, 2018, PAIN MED, V19, P1587, DOI 10.1093/pm/pnx165; Wang G, 2017, ADV HIGH ENERGY PHYS, V2017, DOI 10.1155/2017/9240170; Wang GJ, 2017, WORLD J ACUPUNCT-MOX, V27, P47, DOI 10.1016/S1003-5257(17)30099-5; Wang GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27374-5; Wang GJ, 2015, J ACUPUNCT MERIDIAN, V8, P94, DOI 10.1016/j.jams.2014.10.009; Wang GJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/106940; Wang GJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/476064	48	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217973	10.1371/journal.pone.0217973	http://dx.doi.org/10.1371/journal.pone.0217973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31167001	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800055
J	Felix, TF; Lapa, RML; de Carvalho, M; Bertoni, N; Tokar, T; Oliveira, RA; Rodrigues, MAM; Hasimoto, CN; Oliveira, WK; Pelafsky, L; Spadella, CT; Llanos, JC; Silva, GF; Lam, WL; Rogatto, SR; Amorim, LS; Drigo, SA; Carvalho, RF; Reis, PP				Felix, Tainara F.; Lopez Lapa, Rainer M.; de Carvalho, Marcio; Bertoni, Natalia; Tokar, Tomas; Oliveira, Rogerio A.; Rodrigues, Maria A. M.; Hasimoto, Claudia N.; Oliveira, Walmar K.; Pelafsky, Leonardo; Spadella, Cesar T.; Llanos, Juan C.; Silva, Giovanni F.; Lam, Wan L.; Rogatto, Silvia Regina; Amorim, Luciana Schultz; Drigo, Sandra A.; Carvalho, Robson F.; Reis, Patricia P.			MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CANCER; SUBTYPES; IMMUNOTHERAPY; INTERLEUKIN-6; LEUKOPLAKIA; COMPLEXITY; SIGNATURE; CARCINOMA; DATABASE	Despite progress in treatment strategies, only similar to 24% of pancreatic ductal adenocarcinoma (PDAC) patients survive > 1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers. Global miRNA expression was identified in 19 PDAC, 6 AMP and 25 paired, histologically normal pancreatic tissues using the GeneChip 4.0 miRNA arrays. Computational approaches were used for miRNA target prediction/identification of miRNA-regulated pathways. Target gene expression was validated in 178 pancreatic cancer and 4 pancreatic normal tissues from The Cancer Genome Atlas (TCGA). 20 miRNAs were significantly deregulated (FC >= 2 and p< 0.05) (15 down-and 5 up-regulated) in PDAC. miR-216 family (miR-216a-3p, miR-216a5p, miR-216b-3p and miR-216b-5p) was consistently down-regulated in PDAC. miRNA-modulated pathways are associated with innate and adaptive immune system responses in PDAC. AMP cancers showed 8 down-and 1 up-regulated miRNAs (FDR p< 0.05). Most enriched pathways (p< 0.01) were RAS and Nerve Growth Factor signaling. PDAC and AMP display different global miRNA expression profiles and miRNA regulated networks/tumorigenesis pathways. The immune response was enriched in PDAC, suggesting the existence of immune checkpoint pathways more relevant to PDAC than AMP.	[Felix, Tainara F.; Bertoni, Natalia; Hasimoto, Claudia N.; Oliveira, Walmar K.; Pelafsky, Leonardo; Spadella, Cesar T.; Llanos, Juan C.; Drigo, Sandra A.; Reis, Patricia P.] Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP, Brazil; [Felix, Tainara F.; Lopez Lapa, Rainer M.; Bertoni, Natalia; Drigo, Sandra A.; Reis, Patricia P.] Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP, Brazil; [Lopez Lapa, Rainer M.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, Botucatu, SP, Brazil; [de Carvalho, Marcio] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin, Botucatu, SP, Brazil; [Tokar, Tomas] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Oliveira, Rogerio A.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [Rodrigues, Maria A. M.] Sao Paulo State Univ UNESP, Fac Med, Dept Pathol, Botucatu, SP, Brazil; [Silva, Giovanni F.] Sao Paulo State Univ UNESP, Fac Med, Dept Clin & Gastroenterol, Botucatu, SP, Brazil; [Lam, Wan L.] British Columbia Canc Ctr, Genet Unity, Integrat Oncol, Vancouver, BC, Canada; [Rogatto, Silvia Regina] Univ Southern Denmark, Vejle Hosp, Inst Reg Hlth Res, Dept Clin Genet, Odense, Denmark; [Amorim, Luciana Schultz] Inst Pathol Anat, Piracicaba, SP, Brazil; [Carvalho, Robson F.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; British Columbia Cancer Agency; University of Southern Denmark; Lillebaelt Hospital; Universidade Estadual Paulista	Reis, PP (corresponding author), Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP, Brazil.; Reis, PP (corresponding author), Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP, Brazil.	patricia.reis@unesp.br	dos Reis, Patricia Pintor/F-4701-2012; Carvalho, Robson Francisco/AAE-4134-2020; LINDE, SANDRA/S-3128-2019; Bertoni, Natália/B-7053-2018; Drigo, Sandra A/I-6514-2012; Amorim, Luciana Schultz/AAR-3947-2020; Felix, Tainara Francini/V-3420-2017	dos Reis, Patricia Pintor/0000-0003-3775-3797; Carvalho, Robson Francisco/0000-0002-4901-7714; LINDE, SANDRA/0000-0001-6747-6642; Bertoni, Natália/0000-0002-8623-0573; Drigo, Sandra A/0000-0001-6747-6642; Amorim, Luciana Schultz/0000-0002-9134-0216; Lopez Lapa, Rainer Marco/0000-0002-2879-5138; Rogatto, Silvia/0000-0003-4637-5687; Felix, Tainara Francini/0000-0003-3155-9088	Sao Paulo Research Foundation (FAPESP) [2016/03905-2]; Coordination for the Improvement of Higher Level Education (CAPES); FAPESP [2014/00367-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Level Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Research funds were obtained from Sao Paulo Research Foundation (FAPESP) (grant #2016/03905-2 to P. P. Reis). T.F.F. was funded, in separate time periods, through the Coordination for the Improvement of Higher Level Education (CAPES) and FAPESP -fellowship #2014/00367-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Daniel H, 2014, Am Soc Clin Oncol Educ Book, P112, DOI 10.14694/EdBook_AM.2014.34.112; Askew J, 2013, HPB, V15, P829, DOI 10.1111/hpb.12038; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Birnbaum DJ, 2018, BBA-REV CANCER, V1869, P248, DOI 10.1016/j.bbcan.2018.02.001; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cervigne NK, 2014, HUM MOL GENET, V23, P2618, DOI 10.1093/hmg/ddt657; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19454-3; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cid-Arregui A, 2015, WORLD J GASTROENTERO, V21, P9297, DOI 10.3748/wjg.v21.i31.9297; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cortesini R, 2007, J PANCREAS, V8, P697; Curtale G, 2013, INT J MOL SCI, V14, P17347, DOI 10.3390/ijms140917347; Dalla Venezia N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051226; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; DeVita VTJ, 2011, CANC PRINCIPLES PRAC, P961; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gigliozzi A, 2004, GASTROENTEROLOGY, V127, P1198, DOI 10.1053/j.gastro.2004.06.023; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Kellermeyer R, 2018, J DEV BIOL, V6, DOI 10.3390/jdb6040024; Kotlyar M, 2016, NUCLEIC ACIDS RES, V44, pD536, DOI 10.1093/nar/gkv1115; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Mao YX, 2017, ONCOTARGET, V8, P42537, DOI 10.18632/oncotarget.16451; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Martinez-Bosch N, 2018, CANCERS, V10, DOI 10.3390/cancers10010006; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Mazza T, 2017, ONCOTARGET, V8, P105320, DOI 10.18632/oncotarget.22184; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mikhitarian K, 2014, MODERN PATHOL, V27, P665, DOI 10.1038/modpathol.2013.185; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Morrison AH, 2018, TRENDS CANCER, V4, P418, DOI 10.1016/j.trecan.2018.04.001; Nugent M, 2017, CALCIFIED TISSUE INT, V101, P355, DOI 10.1007/s00223-017-0296-x; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Paladini L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0375-2; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Retamales-Ortega R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030507; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Shibuya KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096565; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Starruy J, 2014, BIOINFORMATICS, V30, P1331, DOI 10.1093/bioinformatics/btt772; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Thomas D, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0927-5; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Tu TC, 2015, J EXP MED, V212, P415, DOI 10.1084/jem.20131601; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Varricchi G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00424; Wang J, 2015, CANCER LETT, V356, P404, DOI 10.1016/j.canlet.2014.09.029; Wang LJ, 2015, ONCOTARGET, V6, P33805, DOI 10.18632/oncotarget.5668; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wormann SM, 2014, ONCOGENE, V33, P2956, DOI 10.1038/onc.2013.257; Xing HB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3195025; Yako YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154016; Yonemori K, 2017, ONCOTARGET, V8, P70097, DOI 10.18632/oncotarget.19591; Yuan HL, 2018, ONCOTARGETS THER, V11, P3891, DOI 10.2147/OTT.S156921; Zhang L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21573-w; Zhou L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0745-9	70	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217421	10.1371/journal.pone.0217421	http://dx.doi.org/10.1371/journal.pone.0217421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150430	gold, Green Published, Green Submitted			2022-12-27	WOS:000469759100048
J	Naing, C; Reid, SA; Aye, S; Htet, NH; Ambu, S				Naing, Cho; Reid, Simon A.; Aye, Saint Nway; Htet, Norah Htet; Ambu, Stephen			Risk factors for human leptospirosis following flooding: A meta-analysis of observational studies	PLOS ONE			English	Article							CLINICAL LEPTOSPIROSIS; CLIMATE-CHANGE; OUTBREAK; INFECTION; EPIDEMIC; THAILAND; ENVIRONMENT; COMMUNITY; DISEASE; INDIA	Leptospirosis is probably the most widespread zoonotic disease in the world especially in tropical countries. There has been an increase in individual studies, which assessed the frequency of leptospirosis in flood conditions. Some studies showed contact with floods was significantly associated with the occurrence of leptospirosis while other studies reported differently. The objective of this meta-analysis was to synthesize the evidence on the risk factors which are associated with human leptospirosis following flooding. We set up the inclusion criteria and searched for the original studies, addressing leptospirosis in human with related to flood in health-related electronic databases including PubMed, Embase, Ovid Medline, google scholar and Scopus sources. We used the terms 'leptospirosis', 'flood', 'risk factor' and terms from the categories were connected with "OR" within each category and by "AND" between categories. The initial search yielded 557 citations. After the title and abstract screening, 49 full-text papers were reviewed and a final of 18 observational studies met the pre-specified inclusion criteria. Overall, the pooled estimates of 14 studies showed that the contact with flooding was a significant factor for the occurrence of leptospirosis (pooled OR: 2.19, 95% CI: 1.48-3.24, I-2 : 86%). On stratification, the strength of association was greater in the case-control studies (pooled OR: 4.01, 95% CI: 1.26-12.72, I-2 : 82%) than other designs (pooled OR: 1.77,95% CI: 1.18-2.65, I-2 : 87%). Three factors such as 'being male'(pooled OR: 2.06, 95% CI: 1.29-2.83), the exposure to livestock animals (pooled OR: 1.95, 95% CI: 1.26-2.64), the lacerated wound (pooled OR: 4.35, 95% CI: 3.07-5.64) were the risk factors significantly associated with the incidence of leptospirosis following flooding in the absence of within-study heterogeneity (I-2 : 0%). We acknowledge study limitations such as publication bias and type 2 statistical errors. We recommended flood control and other environmental modifications that are expected to reduce the risk of leptospiral infection, and a multi-sectoral effort to this aspect would have long-term benefits.	[Naing, Cho; Aye, Saint Nway; Htet, Norah Htet; Ambu, Stephen] Int Med Univ, Kuala Lumpur, Malaysia; [Naing, Cho] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld, Australia; [Reid, Simon A.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	International Medical University Malaysia; James Cook University; University of Queensland	Naing, C (corresponding author), Int Med Univ, Kuala Lumpur, Malaysia.; Naing, C (corresponding author), James Cook Univ, Div Trop Hlth & Med, Townsville, Qld, Australia.	cho3699@gmail.com	Htet, Htet/Q-7956-2019; Reid, Simon/E-9884-2011	Htet, Htet/0000-0003-2143-8629; Reid, Simon/0000-0002-6103-4429; , Cho/0000-0003-3425-7149				Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626; Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892; Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59; Bello S, 2013, BIOMEDICA, V33, P153, DOI 10.7705/biomedica.v33i0.1608; Benacer D, 2016, ACTA TROP, V157, P162, DOI 10.1016/j.actatropica.2016.01.031; Bhardwaj Pankaj, 2008, Indian J Med Sci, V62, P431, DOI 10.4103/0019-5359.48454; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583; Brown L., 2013, DISASTER HLTH, V1, P117, DOI DOI 10.4161/dish.25216; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chusri S, 2014, J INFECT CHEMOTHER, V20, P709, DOI 10.1016/j.jiac.2014.07.016; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Dechet AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039672; Desai S, 2009, CLIN INFECT DIS, V48, P691, DOI 10.1086/597036; Dias JP, 2007, REV SOC BRAS MED TRO, V40, P499, DOI 10.1590/S0037-86822007000500002; Dreyfus A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004858; Eshetu Yimer, 2004, Ethiopian Journal of Health Development, V18, P48; Fajriyah SN, 2017, IOP C SER EARTH ENV, V55, DOI 10.1088/1755-1315/55/1/012013; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Guernier V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006503; Hadad E, 2006, AM J TROP MED HYG, V74, P127, DOI 10.4269/ajtmh.2006.74.127; Jena AB, 2004, TROP MED INT HEALTH, V9, P1016, DOI 10.1111/j.1365-3156.2004.01293.x; Kamath R, 2014, J GLOB INFECT DIS, V6, P3, DOI 10.4103/0974-777X.127941; Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Keenan J, 2010, AM J TROP MED HYG, V83, P633, DOI 10.4269/ajtmh.2010.09-0609; Keim ME, 2008, AM J PREV MED, V35, P508, DOI 10.1016/j.amepre.2008.08.022; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Kupek E, 2000, Braz J Infect Dis, V4, P131; Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Leal-Castellanos CB, 2003, EPIDEMIOL INFECT, V131, P1149, DOI 10.1017/S0950268803001201; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin CY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007008; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maskey M, 2006, Indian J Med Microbiol, V24, P337; Mathur M, 2009, INDIAN J MED MICROBI, V27, P153, DOI 10.4103/0255-0857.49431; Matono T, 2015, J TRAVEL MED, V22, P422, DOI 10.1111/jtm.12241; Matsushita N, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006331; Miyazato Katia Eiko, 2013, Int Arch Med, V6, P23, DOI 10.1186/1755-7682-6-23; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Munoz-Zanzi C, 2014, AM J TROP MED HYG, V90, P497, DOI 10.4269/ajtmh.13-0334; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Patz JA, 2002, BMJ-BRIT MED J, V325, P1094, DOI 10.1136/bmj.325.7372.1094; Radi MFM, 2018, AM J TROP MED HYG, V98, P1281, DOI 10.4269/ajtmh.16-0922; Regmi L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2733-x; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sarkar U, 2002, AM J TROP MED HYG, V66, P605; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Sehgal SC, 2002, NATL MED J INDIA, V15, P22; Smith JKG, 2013, EPIDEMIOL INFECT, V141, P585, DOI 10.1017/S0950268812001021; Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Suwanpakdee S, 2015, EPIDEMIOL INFECT, V143, P2106, DOI 10.1017/S0950268815000205; Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Vanasco NB, 2008, ACTA TROP, V107, P255, DOI 10.1016/j.actatropica.2008.06.007; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Wijerathne KBPCA, 2018, PROCEDIA ENGINEER, V212, P101, DOI 10.1016/j.proeng.2018.01.014; Wolgemuth CW, 2015, SEMIN CELL DEV BIOL, V46, P104, DOI 10.1016/j.semcdb.2015.10.015; World Health Organization, 2003, HUM LEPT GUID DIAGN; Yanagihara Y, 2007, COMP IMMUNOL MICROB, V30, P399, DOI 10.1016/j.cimid.2007.05.003	67	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217643	10.1371/journal.pone.0217643	http://dx.doi.org/10.1371/journal.pone.0217643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141558	Green Published, gold, Green Accepted			2022-12-27	WOS:000469323000072
J	Vlietstra, L; Stebbings, S; Meredith-Jones, K; Abbott, JH; Treharne, GJ; Waters, DL				Vlietstra, Lara; Stebbings, Simon; Meredith-Jones, Kim; Abbott, J. Haxby; Treharne, Gareth J.; Waters, Debra L.			Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity	PLOS ONE			English	Article							OLDER-ADULTS; BODY-COMPOSITION; NATIONAL-HEALTH; MUSCLE; MASS; HIP; VALIDATION; DISABILITY; MORTALITY; PAIN	Aim To determine if there is an association between sarcopenia, physical function and self reported fatigue in osteoarthritis (OA) and rheumatoid arthritis (RA). Methods A cross-sectional analysis of measurements from a cohort of 157 participants with OA or RA was performed. The relationship between muscle mass (appendicular muscle index (AMI)), physical function (timed up and go, 30-seconds sit-to-stand test, 40-meter fast-paced walk test and grip-strength) and two fatigue measures (Multidimensional Assessment of Fatigue (MAF) and a fatigue Visual Analogue Scale (VAS)) was explored using hierarchical linear regression or logistic regression with established AMI cut-offs for sarcopenia. Results There were no significant differences for perceived fatigue-related variables between OA or RA sarcopenic or non-sarcopenic participants. Participants with OA had worse physical function (TUG; P=0.029, STS; P=0.004, WS; P=0.003), but participants with RA had lower grip strength (P<0.001). The RA group had higher CRP (P=0.006), were more likely to receive glucocorticoids (P<0.001), and experienced worse fatigue (P=0.050). The hierarchical multiple regression showed that self-reported fatigue (VAS/MAF-distress) had a significant but weak association with AMI in RA. Participants with higher percentage body fat had a significantly stronger association with sarcopenia in both OA and RA. Conclusion Sarcopenia, when assessed by AMI, does not appear to be strongly associated with self reported fatigue or physical function in participants with either OA or RA. Higher body fat had a moderately strong association with sarcopenia in this cross-sectional study, suggesting that body composition may be an important factor in the health of patients with longstanding OA or RA.	[Vlietstra, Lara; Stebbings, Simon; Meredith-Jones, Kim; Waters, Debra L.] Univ Otago, Dept Med, Dunedin, New Zealand; [Abbott, J. Haxby] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand; [Treharne, Gareth J.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Waters, Debra L.] Univ Otago, Sch Physiotherapy, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Waters, DL (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.; Waters, DL (corresponding author), Univ Otago, Sch Physiotherapy, Dunedin, New Zealand.	debra.waters@otago.ac.nz	Vlietstra, Lara/ABA-7890-2020; ABBOTT, J. Haxby/AAH-3262-2019; Stebbings, simon/AAF-1894-2021; Meredith-Jones, Kim/AAJ-1949-2021; Abbott, J. Haxby/AAK-4346-2020; Treharne, Gareth/I-7645-2013	Meredith-Jones, Kim/0000-0002-5445-4871; Abbott, J. Haxby/0000-0001-6468-7284; Treharne, Gareth/0000-0002-0065-2995; Vlietstra, Lara/0000-0001-7397-1308	University of Otago Research Grant [106299.01]; Dunedin School of Medicine Dean's Bequest Fund [106154.01]	University of Otago Research Grant; Dunedin School of Medicine Dean's Bequest Fund	This work was supported by a University of Otago Research Grant (106299.01.R.ND) and a Dunedin School of Medicine Dean's Bequest Fund (project number 106154.01.Q.ND), which were received by Simon Stebbings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2005, EVID-BASED COMPL ALT, V2, P301, DOI 10.1093/ecam/neh117; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Bano G, 2017, MATURITAS, V96, P10, DOI 10.1016/j.maturitas.2016.11.006; Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bruce B, 2005, HLTH ASSESSMENT QUES; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEKKER J, 1993, BEHAV RES THER, V31, P203, DOI 10.1016/0005-7967(93)90073-4; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Dogan SC, 2015, EUR J RHEUMATOL, V2, P57, DOI 10.5152/eurjrheum.2015.0038; Donovan R, 2016, C REACTIVE PROTEIN T; dos Santos L, 2017, J CACHEXIA SARCOPENI, V8, P245, DOI 10.1002/jcsm.12160; Douglas-Withers J, 2018, INT J RHEUMATIC DIS; Faulkner JA, 2007, AGE RELATED CHANGES, P1091; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Giles JT, 2008, ARTHRIT RHEUM-ARTHR, V59, P1407, DOI 10.1002/art.24109; Giles JT, 2009, ABNORMAL BODY COMPOS, V59, P807; Go SW, 2013, KOREAN J FAM MED, V34, P281, DOI 10.4082/kjfm.2013.34.4.281; GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x; Hasselgren PO, 2010, CURR OPIN CLIN NUTR, V13, P423, DOI 10.1097/MCO.0b013e32833a5107; Hegarty RSM, 2015, ARTHRIT CARE RES, V67, P1230, DOI 10.1002/acr.22582; Herbolsheimer F, 2016, ARTHRIT CARE RES, V68, P228, DOI 10.1002/acr.22669; Hewlett S, 2011, MEASURES FATIGUE, V63; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Kemmler W, 2015, CLIN INTERV AGING, V10, P1565, DOI 10.2147/CIA.S89585; Kop W, 2015, ARTHRITIS RHEUMATISM, V52, P296; Lemmey AB, 2016, RHEUMATOLOGY, V55, P1736, DOI 10.1093/rheumatology/kew243; Manty M, 2016, ASS FATIGUE MID LATE, V77, P823; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Murphy SL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00326; Paul-dauphin A, 1999, BIAS PRECISION VISUA, V150; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ramos-Remus C, 2017, CLIN RHEUMATOL, V36, P485, DOI 10.1007/s10067-016-3481-9; ROUBENOFF R, 1994, J CLIN INVEST, V93, P2379, DOI 10.1172/JCI117244; Ryu M, 2013, AGE AGEING, V42, P734, DOI 10.1093/ageing/aft063; Saji Naoki, 2016, Nihon Rinsho, V74, P505; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Stebbings S., 2010, INT J CLIN RHEUMATOL, V5, P487, DOI 10.2217/ijr.10.30; Stebbings S, 2010, RHEUMATOLOGY, V2010, P2; van den Berg MH, 2007, JCR-J CLIN RHEUMATOL, V13, P181, DOI 10.1097/RHU.0b013e318124a8c4; Walston JD, 2012, CURR OPIN RHEUMATOL, V24, P623, DOI 10.1097/BOR.0b013e328358d59b; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515; Yang X, 2014, ADIPOCYTE, V3, P280, DOI 10.4161/21623945.2014.964075	50	33	38	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217462	10.1371/journal.pone.0217462	http://dx.doi.org/10.1371/journal.pone.0217462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170172	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700032
J	Campos, FG; Vieira, MAR; Amaro, ACE; delaCruz-Chacon, I; Marques, MOM; Ferreira, G; Boaro, CSF				Campos, Felipe Girotto; Ribeiro Vieira, Maria Aparecida; Esteves Amaro, Amanda Cristina; delaCruz-Chacon, Ivan; Mayo Marques, Marcia Ortiz; Ferreira, Gisela; Fernandes Boaro, Carmen Silvia			Nitrogen in the defense system of Annona emarginata (Schltdl.) H. Rainer	PLOS ONE			English	Article							ACID-DERIVED SIGNALS; NITRATE REDUCTASE; ANTIOXIDANT ENZYMES; CARBON-DIOXIDE; OXIDATIVE STRESS; DROUGHT STRESS; GAS-EXCHANGE; PHOTOSYNTHESIS; METABOLISM; ISOPRENE	The concentration of nitrogen can generate different strategies in plants in response to stress. In this study, we investigated how nitrogen concentration interferes with the defense system of Annona emarginata. Low concentrations of nitrogen increased the allocation of photosynthetic resources to carbon metabolism, resulting in an increase in the synthesis of volatile substances involved in signaling and defense that contributed to antioxidant enzymes in overcoming stress. The availability of nitrogen at 5.62 mM concentration might have helped to induce increased resistance in the plants because at this concentration, signaling substances and defense substances (monoterpenes and sesquiterpenes) were observed. Plants cultivated with the highest nitrate concentration displaced energy for the reduction of this ion, likely forming nitric oxide, a signaling molecule. This condition, together with the decrease in carbon skeletons, may have contributed to the lower synthesis of volatile substances of the specialized metabolism that are also involved with signaling. Varying the nitrogen in Annona emarginata cultivation revealed that depending on the concentration, volatile substances show higher or lower synthesis and participation in the system of signaling and defense in the plant. These results may suggest that volatile substances participate in resistance to pests and diseases, which is a necessary condition for Annona emarginata to be preferentially used as rootstock for Annona x atemoya.	[Campos, Felipe Girotto; Ribeiro Vieira, Maria Aparecida; Ferreira, Gisela; Fernandes Boaro, Carmen Silvia] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Bot, Campus Botucatu, Botucatu, SP, Brazil; [Esteves Amaro, Amanda Cristina] UNESP Univ Estadual Paulista, Fac Ciencias Agron, Dept Hort, Campus Botucatu, Botucatu, SP, Brazil; [delaCruz-Chacon, Ivan] Univ Ciencias & Artes Chiapas UNICACH, Inst Ciencias Biol, Lab Fisiol & Quim Vegetal, Tuxtla Gutierrez, Chiapas, Mexico; [Mayo Marques, Marcia Ortiz] Inst Agron IAC, Ctr Pesquisa Recursos Genet Vegetais, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC)	Boaro, CSF (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias, Dept Bot, Campus Botucatu, Botucatu, SP, Brazil.	csfboaro@ibb.unesp.br	DE-LA-CRUZ-CHACON, IVAN/F-3251-2014; Vieira, Maria/Q-2357-2019; Campos, Felipe/AAC-6975-2020; Esteves Amaro Baron, Amanda Cristina/AFS-2665-2022; Ferreira, Gisela/D-2481-2017	DE-LA-CRUZ-CHACON, IVAN/0000-0001-9908-6278; Vieira, Maria/0000-0002-7068-1468; Campos, Felipe/0000-0002-8470-8350; Esteves Amaro Baron, Amanda Cristina/0000-0001-6401-3984; Ferreira, Gisela/0000-0002-3065-2152				Adams R.P., 2007, IDENTIFICATION ESSEN, V4th, P102; Ahmad A, 1999, PLANT SCI, V143, P1, DOI 10.1016/S0168-9452(99)00016-3; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos F. G., 2019, Journal of Agricultural Science (Toronto), V11, P271, DOI 10.5539/jas.v11n4p271; Campos F. G., 2019, Journal of Agricultural Science (Toronto), V11, P210; Caser M, 2019, IND CROP PROD, V129, P85, DOI 10.1016/j.indcrop.2018.11.068; Chen Y, COTTON PLANT GOSSYPI, DOI [10.1007/s10886-008-9560-x, DOI 10.1007/S10886-008-9560-X]; CLEGG K. M., 1956, Journal of the Science of Food and Agriculture, V7, P40, DOI 10.1002/jsfa.2740070108; Cruz JL, 2014, PLANT SOIL, V374, P33, DOI 10.1007/s11104-013-1869-8; Devi SR, 1998, PLANT SCI, V138, P157, DOI 10.1016/S0168-9452(98)00161-7; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Farzadfar S, 2017, PLANT PHYSIOL BIOCH, V112, P207, DOI 10.1016/j.plaphy.2017.01.002; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Garcia I. S., 2006, Braz. J. Biol., V66, P739, DOI 10.1590/S1519-69842006000400018; Geiger M, 1999, PLANT CELL ENVIRON, V22, P1177, DOI 10.1046/j.1365-3040.1999.00466.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; JAWORSKI EG, 1971, BIOCHEM BIOPH RES CO, V43, P1274, DOI 10.1016/S0006-291X(71)80010-4; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kumari S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau120; LAWLOR DW, 1989, J EXP BOT, V40, P43, DOI 10.1093/jxb/40.1.43; Lopes Cruz J, 2004, BRAGANTIA, V63, P351, DOI [10.1590/S0006-87052004000300005, DOI 10.1590/S0006-87052004000300005]; Loreto F, 2004, TREE PHYSIOL, V24, P361, DOI 10.1093/treephys/24.4.361; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Machado F, 2017, ENVIRON EXP BOT, V140, P141, DOI 10.1016/j.envexpbot.2017.05.008; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; May A., 2010, Revista Brasileira de Ciencias Agrarias (Agraria), V5, P370, DOI 10.5039/agraria.v5i3a809; Melis A, 2012, ENERG ENVIRON SCI, V5, P5531, DOI 10.1039/c1ee02514g; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Misra N, 2006, J PLANT PHYSIOL, V163, P11, DOI 10.1016/j.jplph.2005.02.011; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Mur LAJ, 2017, ANN BOT-LONDON, V119, P703, DOI 10.1093/aob/mcw179; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Palmer-Young EC, 1999, SESQUITERPENES E BER; Rosales EP, 2011, PLANT PHYSIOL BIOCH, V49, P124, DOI 10.1016/j.plaphy.2010.10.009; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Passos L.P., 1996, METODOS ANALITICOS L, V1st ed., P223; Peixoto Paulo Henrique Pereira, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P137; Peng YF, 2014, ENVIRON EXP BOT, V99, P18, DOI 10.1016/j.envexpbot.2013.10.013; Perigo CV, 2016, IND CROP PROD, V94, P528, DOI 10.1016/j.indcrop.2016.09.028; Portes T.A., 1991, REV BRAS FISIOL VEG, V3, P53; RADFORD PJ, 1967, CROP SCI, V7, P171, DOI 10.2135/cropsci1967.0011183X000700030001x; Ribeiro RV, 2009, ENVIRON EXP BOT, V66, P203, DOI 10.1016/j.envexpbot.2009.03.011; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; Rubio-Wilhelmi MM, 2011, ENVIRON EXP BOT, V72, P167, DOI 10.1016/j.envexpbot.2011.03.005; Schmelz EA, 2003, PLANT PHYSIOL, V133, P295, DOI 10.1104/pp.103.024174; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; SHEN TC, 1976, PLANT PHYSIOL, V58, P292, DOI 10.1104/pp.58.3.292; Spinelli F, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P367; Stitt M, 2010, PLANT PHYSIOL, V152, P428, DOI 10.1104/pp.109.150821; Taghavi TS, 2007, SCI HORTIC-AMSTERDAM, V112, P393, DOI 10.1016/j.scienta.2007.01.002; Takshak S, 2019, J PHOTOCH PHOTOBIO B, V193, P51, DOI 10.1016/j.jphotobiol.2019.02.002; Teisseire H, 2000, PLANT SCI, V153, P65, DOI 10.1016/S0168-9452(99)00257-5; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Walker AP, 2014, ECOL EVOL, V4, P3218, DOI 10.1002/ece3.1173; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; Zhang SR, 2001, PHOTOSYNTHETICA, V39, P383, DOI 10.1023/A:1015130326683	70	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217930	10.1371/journal.pone.0217930	http://dx.doi.org/10.1371/journal.pone.0217930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170236	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700083
J	Cortina, ME; Ende, RJ; Bishop, RC; Bayne, C; Derre, I				Cortina, Maria Eugenia; Ende, Rachel J.; Bishop, R. Clayton; Bayne, Charlie; Derre, Isabelle			Chlamydia trachomatis and Chlamydia muridarum spectinomycin resistant vectors and a transcriptional fluorescent reporter to monitor conversion from replicative to infectious bacteria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; DEVELOPMENTAL CYCLE; MUTAGENESIS; EXPRESSION; REVEALS; MODEL; ADENYLTRANSFERASE; TRANSFORMATION; SEQUENCE	Chlamydia trachomatis infections are the leading cause of sexually transmitted infections of bacterial origin. Lower genital tract infections are often asymptomatic, and therefore left untreated, leading to ascending infections that have long-term consequences on female reproductive health. Human pathology can be recapitulated in mice with the mouse adapted strain C. muridarum. Eight years into the post-genetic era, significant advances to expand the Chlamydia genetic toolbox have been made to facilitate the study of this important human pathogen. However, the need for additional tools remains, especially for C. muridarum. Here, we describe a new set of spectinomycin resistant E. coli-Chlamydia shuttle vectors, for C. trachomatis and C. muridarum. These versatile vectors allow for expression and localization studies of Chlamydia effectors, such as Inc proteins, and will be instrumental for mutant complementation studies. In addition, we have exploited the differential expression of specific Chlamydia genes during the developmental cycle to engineer an omcA::gfp fluorescent transcriptional reporter. This novel tool allows for monitoring RB to EB conversion at the bacterial level. Spatiotemporal tracking of GFP expression within individual inclusions revealed that RB to EB conversion initiates in bacteria located at the edge of the inclusion and correlates with the time post initiation of bacterial replication and inclusion size. Comparison between primary and secondary inclusions potentially suggests that the environment in which the inclusions develop influences the timing of conversion. Altogether, the Chlamydia genetic tools described here will benefit the field, as we continue to investigate the molecular mechanisms underlying Chlamydia-host interaction and pathogenesis.	[Cortina, Maria Eugenia; Ende, Rachel J.; Bishop, R. Clayton; Bayne, Charlie; Derre, Isabelle] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA	University of Virginia	Derre, I (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	id8m@virginia.edu		Bayne, Charlie/0000-0003-1870-5298	National Institutes of Health [AI007046, AI101441, AI141841]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101441, T32AI007046, R21AI141841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI007046 to RJE and RCB, and AI101441 and AI141841 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aeberhard L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004883; Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101634; CLARKE IN, 1988, GENE, V71, P307, DOI 10.1016/0378-1119(88)90047-9; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fadel S, 2007, J MED MICROBIOL, V56, P15, DOI 10.1099/jmm.0.46801-0; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Han Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00079; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; JAY F, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/JOURNAL.PPAT.1002258; Keb G, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00479-18; Key CE, 2017, METHODS MOL BIOL, V1498, P163, DOI 10.1007/978-1-4939-6472-7_11; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02432-0; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lowden Nicole M, 2015, BMC Res Notes, V8, P570, DOI 10.1186/s13104-015-1542-9; Lutter EI, 2013, CELL REP, V3, P1921, DOI 10.1016/j.celrep.2013.04.027; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Lyons JM, 2005, J CLIN PATHOL, V58, P397, DOI 10.1136/jcp.2004.021543; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Mital J, 2015, BIOCHEM BIOPH RES CO, V462, P165, DOI 10.1016/j.bbrc.2015.04.116; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MOORE ER, 2014, FRONT CELL INFECT MI; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mueller KE, 2016, MBIO, V7, DOI 10.1128/mBio.01817-15; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; Nguyen PH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006911; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; SARDINIA LM, 1988, J GEN MICROBIOL, V134, P997; Schachter J, 1999, CHLAMYDIA, P139; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shima K, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00412-18; Sixt BS, 2017, CELL HOST MICROBE, V21, P113, DOI 10.1016/j.chom.2016.12.002; Skilton Rachel J, 2018, Wellcome Open Res, V3, P25, DOI 10.12688/wellcomeopenres.13905.1; Song LH, 2014, PATHOG DIS, V70, P189, DOI 10.1111/2049-632X.12104; Stanhope R, 2017, P NATL ACAD SCI USA, V114, P12039, DOI 10.1073/pnas.1709060114; Wang YB, 2014, PATHOG DIS, V72, P19, DOI 10.1111/2049-632X.12175; Weber MM, 2017, CELL REP, V19, P1406, DOI 10.1016/j.celrep.2017.04.058; Wesolowski J, 2017, MBIO, V8, DOI 10.1128/mBio.02280-16; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; XU S, 2013, BMC RES NOTES, V6	54	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217753	10.1371/journal.pone.0217753	http://dx.doi.org/10.1371/journal.pone.0217753			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170215	Green Published, gold, Green Submitted			2022-12-27	WOS:000470263700053
J	Li, YQ; Storozum, M; Tian, D; Frachetti, M; Su, K; Wang, X				Li, Yuqi; Storozum, Michael; Tian, Duo; Frachetti, Michael; Su, Kai; Wang, Xin			Farming strategies of 1st millennium CE agro-pastoralists on the southern foothills of the Tianshan Mountains: A geoarchaeological and macrobotanical investigation of the Mohuchahangoukou (MGK) site, Xinjiang, China	PLOS ONE			English	Article							BRONZE-AGE; XIAOHE CEMETERY; EURASIAN STEPPE; ORGANIC-MATTER; CENTRAL-ASIA; SOIL; AGRICULTURE; LANDSCAPE; MILLET; PASTORALISTS	Archaeological evidence emerging over the past decade clearly illustrates that agro-pastoralists living along the foothills of major mountain chains in Central Asia (the so-called "Inner Asian Mountain Corridor" or IAMC) facilitated the spread of domesticated grains through their direct involvement in farming. While the environmental conditions across the northwestern slopes of the IAMC provided adequate resources for incipient farming and herding as early as the mid-3rd mill. BCE, the development of local agricultural strategies on the extremely arid and eroded foothills on the southeastern, leeward side of the mountains remain comparatively less studied. Our study tackles this problem by combining geoarchaeological analysis with conventional macrobotanical identification in the investigation of a 1st-mill. CE agro-pastoralist farming site, Mohuchahangoukou (MGK), located on the arid foothills of the Tianshan range. Our results illustrate how ancient agro-pastoralists at MGK innovated irrigation systems both to combat water shortage and, importantly, to trap sediments carried by flood-water for crop cultivation. By synthesizing currently available data, we estimate that they managed to trap about 40 cm of fine-grained sediment within a span of 200 years or even less. These stone-built field systems helped water a diverse stand of crops and create deeper soils in an otherwise deflated landscape with thin desert soils. Since we detected high levels of salt concentration (>2 dSm(-1)) in the lower portions of all three test trenches we analyzed, we conclude that soil salinization might have affected the long-term sustainability of this form of irrigated field management. We also infer that, besides engineering efforts, the ancient agro-pastoralists at MGK had to resolve the scheduling conflicts between irrigated farming and animal herding through labor specialization.	[Li, Yuqi] Nanjing Univ, Sch Hist, Nanjing, Jiangsu, Peoples R China; [Storozum, Michael] Fudan Univ, Inst Archaeol Sci, Shanghai, Peoples R China; [Tian, Duo] Northwest Univ, Sch Cultural Heritage, Xian, Shaanxi, Peoples R China; [Tian, Duo] Northwest Univ, Inst Middle Eastern Studies, Xian, Shaanxi, Peoples R China; [Frachetti, Michael] Washington Univ, Dept Anthropol, SAIE Lab, St Louis, MO 63130 USA; [Frachetti, Michael; Su, Kai] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Wang, Xin] Hejing Cty Off Preservat Ancient Monuments, Hejing, Xinjiang, Peoples R China	Nanjing University; Fudan University; Northwest University Xi'an; Northwest University Xi'an; Washington University (WUSTL); Washington University (WUSTL)	Li, YQ (corresponding author), Nanjing Univ, Sch Hist, Nanjing, Jiangsu, Peoples R China.; Storozum, M (corresponding author), Fudan Univ, Inst Archaeol Sci, Shanghai, Peoples R China.	liyuqi@nju.edu.cn; mjstorozum@fudan.edu.cn	Frachetti, Michael/AAZ-1273-2020; Yuqi, Li/AAE-2192-2019; Storozum, Michael/Q-4849-2017	Yuqi, Li/0000-0003-4629-4027; Su, Kai/0000-0002-2337-4828; Storozum, Michael/0000-0002-3948-6074; Frachetti, Michael/0000-0001-6906-4334	National Science Foundation Doctoral Dissertation Improvement Grant [BCS-1458136]; National Geographic Society Young Explorer Grant [9555-14]; George Throop Endowment; Graduate School of Washington University in St. Louis	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Geographic Society Young Explorer Grant(National Geographic Society); George Throop Endowment; Graduate School of Washington University in St. Louis	This research was funded by the National Science Foundation Doctoral Dissertation Improvement Grant (BCS-1458136 to MS), https://www.nsf.gov/, the National Geographic Society Young Explorer Grant (9555-14 to YL), https://www.nationalgeographic.com/, the George Throop Endowment, and the Graduate School of Washington University in St. Louis, https://graduateschool.wustl.edu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov B.V., 2016, ANCIENT IRRIGATION S; [Anonymous], 1994, ENV MAGNETIC SUSCEPT; [Anonymous], 2014, BAICHENG DUOGANG MUD; [Anonymous], 2016, XINJIANG MOHUCHAHAN; Bado S., 2016, SPINGEROPEN, P1, DOI [10.1007/978-3-319-26590-2, DOI 10.1007/978-3-319-26590-2]; Barker G., 2017, ARCHAEOLOGY DESERTIF; Barth Fredrik, 1961, NOMADS S PERSIA BASS; Beckers B, 2013, J ARCHAEOL SCI, V40, P333, DOI 10.1016/j.jas.2012.06.041; Berben SMP, 2017, HOLOCENE, V27, P822, DOI 10.1177/0959683616675934; Betts A, 2018, ARCHAEOL RES ASIA; Cai Jiayi, 1985, MINZU YANJIU, V1, p[54, 61]; Capo RC, 1999, EARTH PLANET SC LETT, V170, P61, DOI 10.1016/S0012-821X(99)00090-4; Caspari G, 2017, J ARCHAEOL SCI-REP, V14, P12, DOI 10.1016/j.jasrep.2017.05.036; Celik I, 2005, SOIL TILL RES, V83, P270, DOI 10.1016/j.still.2004.08.001; Chang C., 2017, RETHINKING PREHISTOR; Chen T, 2016, QUATERN INT, V426, P166, DOI 10.1016/j.quaint.2016.03.015; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Davies CP, 2005, GEOARCHAEOLOGY, V20, P379, DOI 10.1002/gea.20055; Dearing JA, 1996, GEOPHYS J INT, V124, P228, DOI 10.1111/j.1365-246X.1996.tb06366.x; Desruelles S, 2016, QUATERNARY SCI REV, V150, P42, DOI 10.1016/j.quascirev.2016.08.007; Dirix K, 2013, J ARCHAEOL SCI, V40, P2961, DOI 10.1016/j.jas.2013.02.033; Doumani PN, 2015, ARCHAEOL RES ASIA, V1-2, P17, DOI 10.1016/j.ara.2015.01.001; FAN Y, 2017, HOUHANSHU; Frachetti MD, 2008, PASTORALIST LANDSCAPES AND SOCIAL INTERACTION IN BRONZE AGE EURASIA, P1; Frachetti MD, 2007, J FIELD ARCHAEOL, V32, P221, DOI 10.1179/009346907791071520; Frachetti MD, 2017, NATURE, V543, P193, DOI 10.1038/nature21696; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Frachetti MD, 2010, ANTIQUITY, V84, P993, DOI 10.1017/S0003598X0006703X; Frederick C.D., 2000, LANDSCAPE LAND USE P, P79; Fritts G. J., 2005, HDB ARCHAEOLOGICAL M, VII, P773; Gong YW, 2011, J ARCHAEOL SCI, V38, P470, DOI 10.1016/j.jas.2010.10.006; Gu Ban, 1962, HAN SHU; Guo Wu, 2012, XINJIANG SHIQIAN WAN; He WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143928; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hoare P.G, 2012, QUATERNARY SEDIMENTS; Huang X. Z, 2006, THESIS; Irons W., 1975, YOMUT TURKMEN STUDY; Jia PW, 2017, ANTIQUITY, V91, P621, DOI 10.15184/aqy.2017.67; Jiang HG, 2015, VEG HIST ARCHAEOBOT, V24, P165, DOI 10.1007/s00334-014-0495-6; Jiang HE, 2013, VEG HIST ARCHAEOBOT, V22, P129, DOI 10.1007/s00334-012-0365-z; Jordan A, 2010, CATENA, V81, P77, DOI 10.1016/j.catena.2010.01.007; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Li Linfu, 1992, TANG LIUDIAN; Li YQ, 2017, ARCHAEOL RES ASIA, V12, P23, DOI 10.1016/j.ara.2017.09.005; Linseele V, 2013, ENVIRON ARCHAEOL, V18, P5, DOI 10.1179/1461410313Z.00000000019; Lister DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196652; Liu XY, 2019, QUATERNARY SCI REV, V206, P21, DOI 10.1016/j.quascirev.2018.12.017; Matuzeviciute GM, 2017, QUATERN INT, V437, P35, DOI 10.1016/j.quaint.2015.06.065; Meister J, 2017, QUATERN INT, V434, P33, DOI 10.1016/j.quaint.2015.12.086; Miller NF, 2016, HOLOCENE, V26, P1566, DOI 10.1177/0959683616641742; Miller NF, 1999, VEG HIST ARCHAEOBOT, V8, P13, DOI 10.1007/BF02042837; Miller-Rosen A., 2000, ANTIQUITY, V74, P611, DOI DOI 10.1017/S0003598X00059974; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Oldfield F, 2007, PALAEOGEOGR PALAEOCL, V249, P362, DOI 10.1016/j.palaeo.2007.02.007; Oonk S, 2009, ARCHAEOL PROSPECT, V16, P35, DOI 10.1002/arp.344; Pearsall DeborahM., 2015, PALEOETHNOBOTANY HDB, V3rd ed; Rhoades J. D., 1996, Methods of soil analysis. Part 3 - chemical methods., P417; Shi Y., 2017, ZHONGGUO XINWEN 0706; SONON LS, 2012, 1019 U GEORG COOP EX; Spengler R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3382; Spengler RN, 2019, VEG HIST ARCHAEOBOT, V28, P215, DOI 10.1007/s00334-018-0669-8; Spengler RN, 2015, J WORLD PREHIST, V28, P215, DOI 10.1007/s10963-015-9087-3; Spengler RN, 2014, HUM ECOL, V42, P813, DOI 10.1007/s10745-014-9697-x; Spengler RN, 2014, QUATERN INT, V348, P147, DOI 10.1016/j.quaint.2014.03.039; Spengler RN, 2013, J ETHNOBIOL, V33, P125, DOI 10.2993/0278-0771-33.1.125; Spengler RN, 2013, J FIELD ARCHAEOL, V38, P68, DOI 10.1179/0093469012Z.00000000037; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Sun DH, 2002, SEDIMENT GEOL, V152, P263, DOI 10.1016/S0037-0738(02)00082-9; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Tian D, 2018, ENVIRON ARCHAEOL, V23, P416, DOI 10.1080/14614103.2017.1415121; Vreeland HH, 1957, MONGOL COMMUNITY KIN; Wang X, 2017, BIANJIANG KAOGU YANJ, V21, P43; Watson Patty Jo, 1976, MIDCONTINENTAL J ARC, V1, P77; Wells EC, 2010, J ARCHAEOL METHOD TH, V17, P209, DOI 10.1007/s10816-010-9087-7; Wilkinson T. J., 2012, Water History, V4, P155; Woodson MK, 2015, GEOARCHAEOLOGY, V30, P271, DOI 10.1002/gea.21513; Wunnemann B, 2006, PALAEOGEOGR PALAEOCL, V234, P223, DOI 10.1016/j.palaeo.2005.10.016; Xinjiang wenwu kaogu yanjiusuo, 2015, XINJIANG WENWU, V1, P76; Xinjiang Wenwu Kaogu Yanjiusuo, 2013, XINJ SAENS MUD; Xinjiang wenwu kaogu yanjiusuo, 2004, XINJIANG WENWU, V4, P40; Xinjiang wenwu kaogu yanjiusuo Hejing minzu wenhuaguan, 1999, XINJIANG WENWU, V3-4, P30; Yang RP, 2014, J ARCHAEOL SCI, V49, P42, DOI 10.1016/j.jas.2014.04.020; Yu X., 1999, XINJIANG CHAWUHU DAX, P413; Zhang GL, 2017, ARCHAEOL ANTHROP SCI, V9, P145, DOI 10.1007/s12520-015-0246-3; Zhang JP, 2017, VEG HIST ARCHAEOBOT, V26, P505, DOI 10.1007/s00334-017-0608-0; Zhang YF, 2017, J GEOGR SCI, V27, P752, DOI 10.1007/s11442-017-1404-6; Zhao KL, 2013, QUATERN INT, V311, P81, DOI 10.1016/j.quaint.2013.06.035; Zhao MZ, 2018, ARTIF CELL NANOMED B, V46, pS147, DOI 10.1080/21691401.2018.1489822; Zhao Z., 2010, ZHIWU KAOGUXUE LILUN; Zhong W., 2001, OCEANOLOGIA LIMNOLOG, V32, P213; Zhou C, 2016, GANHANQU DILI, V39, P1204	93	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217171	10.1371/journal.pone.0217171	http://dx.doi.org/10.1371/journal.pone.0217171			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31167227	Green Published, gold, Green Submitted			2022-12-27	WOS:000470087800019
J	Venugopala, KN; Chandrashekharappa, S; Pillay, M; Abdallah, HH; Mahomoodally, FM; Bhandary, S; Chopra, D; Attimarad, M; Aldhubiab, BE; Nair, AB; Sreeharsha, N; Morsy, MA; Pottathil, S; Venugopala, R; Odhav, B; Mlisana, K				Venugopala, Katharigatta Narayanaswamy; Chandrashekharappa, Sandeep; Pillay, Melendhran; Abdallah, Hassan H.; Mahomoodally, Fawzi M.; Bhandary, Subhrajyoti; Chopra, Deepak; Attimarad, Mahesh; Aldhubiab, Bandar E.; Nair, Anroop B.; Sreeharsha, Nagaraja; Morsy, Mohamed A.; Pottathil, Shinu; Venugopala, Rashmi; Odhav, Bharti; Mlisana, Koleka			Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; INDOLIZINE ANALOGS; INHIBITORS; DESIGN; RISK	Indolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) screening against susceptible (H37Rv) and multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) using the resazurin microplate assay method. The cytotoxicity was evaluated using the MTT assay. In silico molecular-docking study was conducted for compounds 5a-j against enoyl-[acyl-carrier] protein reductase, a key enzyme of the type II fatty acid synthesis that has attracted much interest for the development of novel anti-TB compounds. Thereafter, molecular dynamic (MD) simulation was undertaken for the most active inhibitors. Compounds 5i and 5j with the methoxy functional group at the meta position of the benzoyl group, which was at the third position of the indolizine nucleus, demonstrated encouraging anti-TB activity against MDR strains of MTB at 16 mu g/mL. In silico studies showed binding affinity within the range of 7.07-8.57 kcal/mol, with 5i showing the highest binding affinity. Hydrogen bonding, pi-pi- interactions, and electrostatic interactions were common with the active site. Most of these interactions occurred with the catalytic amino acids (Pro193, Tyr158, Phe149, and Lys165). MD simulation showed that 5j possessed the highest binding affinity toward the enzyme, according to the two calculation methods (MM/PBSA and MM/GBSA). The single-crystal X-ray studies of compounds 5c and 5d revealed that the molecular arrangements in these two structures were mostly guided by C-H center dot center dot center dot O hydrogen-bonded dimeric motifs and C-H center dot center dot center dot N hydrogen bonds, while various secondary interactions ( such as pi center dot center dot center dot pi and C-H center dot center dot center dot F) also contributed to crystal formation. Compounds 5a, 5c, 5i, and 5j exhibited no toxicity up to 500 mu g/mL. In conclusion, 5i and 5j are promising anti-TB compounds that have shown high affinity based on docking and MD simulation results.	[Venugopala, Katharigatta Narayanaswamy; Attimarad, Mahesh; Aldhubiab, Bandar E.; Nair, Anroop B.; Sreeharsha, Nagaraja; Morsy, Mohamed A.] King Faisal Univ, Dept Pharmaceut Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia; [Venugopala, Katharigatta Narayanaswamy; Odhav, Bharti] Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa; [Chandrashekharappa, Sandeep] GKVK, Inst Stem Cell Biol & Regenerat Med, NCBS, TIFR, Bangalore, Karnataka, India; [Pillay, Melendhran; Mlisana, Koleka] Inkosi Albert Luthuli Cent Hosp, Dept Microbiol, Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa; [Abdallah, Hassan H.] Univ Sains Malaysia, Sch Pharm, Nibong Tebal, Penang, Malaysia; [Abdallah, Hassan H.] Salahaddin Univ, Dept Chem, Coll Educ, Erbil, Iraq; [Mahomoodally, Fawzi M.] Univ Mauritius, Dept Hlth Sci, Fac Sci, Reduit, Mauritius; [Bhandary, Subhrajyoti; Chopra, Deepak] Indian Inst Sci Educ & Res Bhopal, Dept Chem, Bhopal, Madhya Pradesh, India; [Morsy, Mohamed A.] Menia Univ, Dept Pharmacol, Fac Med, El Minia, Egypt; [Pottathil, Shinu] King Faisal Univ, Dept Biomed Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia; [Venugopala, Rashmi] Univ KwaZulu Natal, Dept Publ Hlth Med, Howard Coll Campus, Durban, South Africa	King Faisal University; Durban University of Technology; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Universiti Sains Malaysia; Salahaddin University; University of Mauritius; Indian Institute of Science Education & Research (IISER) - Bhopal; Egyptian Knowledge Bank (EKB); Minia University; King Faisal University; University of Kwazulu Natal	Venugopala, KN (corresponding author), King Faisal Univ, Dept Pharmaceut Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia.; Venugopala, KN (corresponding author), Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa.	kvenugopala@kfu.edu.sa	Abdallah, Hassan H./AEE-4715-2022; Venugopala, Rashmi/AAF-2133-2021; Attimarad, Mahesh V/M-4095-2016; Pottathil, Shinu/AAN-9842-2020; Sreeharsha, Nagaraja/P-2189-2019; Chandrashekharappa, Dr. Sandeep/V-8205-2018; Nair, Anroop/L-9995-2014; Venugopala, Katharigatta N./M-4030-2016; Attimarad, Mahesh/U-9547-2019; Morsy, Mohamed/G-4809-2010; Mlisana, Koleka/N-6204-2013	Abdallah, Hassan H./0000-0002-9198-0475; Venugopala, Rashmi/0000-0002-1101-4577; Attimarad, Mahesh V/0000-0002-7007-9119; Pottathil, Shinu/0000-0003-4245-0803; Sreeharsha, Nagaraja/0000-0002-2058-255X; Chandrashekharappa, Dr. Sandeep/0000-0003-2475-7270; Nair, Anroop/0000-0003-2850-8669; Venugopala, Katharigatta N./0000-0003-0680-1549; Attimarad, Mahesh/0000-0002-7007-9119; Morsy, Mohamed/0000-0002-6752-9094; Mlisana, Koleka/0000-0002-8436-3268	Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia [17122011]	Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia	The authors are grateful to the Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia, for providing financial support (grant number: 17122011).	Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Barry CE, 2015, NAT MED, V21, P211, DOI 10.1038/nm.3823; Bruker Analytical X-ray Systems Inc, 2006, APEX2 VERS 2 US MAN; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Case D., 2015, AMBER, V14; Chandrashekharappa S, 2018, NEW J CHEM, V42, P4893, DOI 10.1039/c7nj05010k; Chandrashekharappa S, 2018, J MOL STRUCT, V1156, P377, DOI 10.1016/j.molstruc.2017.11.131; CINGOLANI GM, 1990, EUR J MED CHEM, V25, P709, DOI 10.1016/0223-5234(90)90138-S; Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385; DANNHARDT G, 1987, EUR J MED CHEM, V22, P505, DOI 10.1016/0223-5234(87)90290-X; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [10.1107/S0021889812029111, DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020]; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hagishita S, 1996, J MED CHEM, V39, P3636, DOI 10.1021/jm960395q; Hazra A, 2011, EUR J MED CHEM, V46, P2132, DOI 10.1016/j.ejmech.2011.02.066; Hu Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4563826; Jaisankar P, 2003, ARKIVOC, P150, DOI 10.3998/ark.5550190.0004.918; Khedr MA, 2018, J BIOMOL STRUCT DYN, V36, P2163, DOI 10.1080/07391102.2017.1345325; Ling LL, 2004, ANTIMICROB AGENTS CH, V48, P1541, DOI 10.1128/AAC.48.5.1541-1547.2004; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Martin A, 2005, INT J TUBERC LUNG D, V9, P901; Mederski W., 2012, U.S. Patent, Patent No. [8(106,067 B2), 8106067, 8106067-B2]; MIDDLEBROOK G, 1977, AM REV RESPIR DIS, V115, P1066; Mishra B. B., 2011, OPPORTUNITY CHALLENG, P1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Narayanaswamy VK, 2013, CHEM BIOL DRUG DES, V81, P219, DOI 10.1111/cbdd.12065; Narayanaswamy VK, 2011, J PEPT SCI, V17, P683, DOI 10.1002/psc.1389; Nasir AI, 1998, BIOORG MED CHEM LETT, V8, P1829, DOI 10.1016/S0960-894X(98)00313-8; Olejnikova P., 2009, SCI PHARM, V77, P216, DOI [DOI 10.3797/scipharm.oephg.21.PO-17, 10.3797/scipharm.oephg.21.PO-17, DOI 10.3797/SCIPHARM.OEPHG.21.PO-17]; Onodera Y, 2001, J ANTIMICROB CHEMOTH, V47, P447, DOI 10.1093/jac/47.4.447; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Sandeep C., 2016, J BASIC CLIN PHARM, V8, P49; Sandeep C., 2016, ASIAN J CHEM, V28, P1043, DOI [10.14233/ajchem.2016.19582, DOI 10.14233/AJCHEM.2016.19582]; Sandeep C, 2017, INDIAN J PHARM EDUC, V51, P452, DOI 10.5530/ijper.51.3.73; Sandeep C, 2016, CHEM BIOL DRUG DES, V88, P899, DOI 10.1111/cbdd.12823; Sheldrick G.M., 2014, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Siemens, 1995, SMART SYST; Smith SC, 2005, PEST MANAG SCI, V61, P16, DOI 10.1002/ps.980; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; VAUGHT JL, 1990, J PHARMACOL EXP THER, V255, P1; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Venugopala KN, 2019, MED CHEM, V15, P311, DOI 10.2174/1573406414666180703121815; Venugopala KN, 2016, DRUG DES DEV THER, V10, P2681, DOI 10.2147/DDDT.S109760; WHO, 2018, EX SUMM; WHO, 2017, EX SUMM; Zhang R, 2017, RSC ADV, V7, P1480, DOI 10.1039/c6ra25712g	47	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217270	10.1371/journal.pone.0217270	http://dx.doi.org/10.1371/journal.pone.0217270			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163040	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200010
J	Sileo, KM; Kizito, W; Wanyenze, RK; Chemusto, H; Reed, E; Stockman, JK; Musoke, W; Mukasa, B; Kiene, SM				Sileo, Katelyn M.; Kizito, Williams; Wanyenze, Rhoda K.; Chemusto, Harriet; Reed, Elizabeth; Stockman, Jamila K.; Musoke, William; Mukasa, Barbara; Kiene, Susan M.			Substance use and its effect on antiretroviral treatment adherence among male fisherfolk living with HIV/AIDS in Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ALCOHOL-CONSUMPTION; FISHING COMMUNITIES; SOUTH-AFRICA; LAKE VICTORIA; HIV CARE; THERAPY; RISK; INTERVENTION; NONADHERENCE	Background Fisherfolk are a most-at-risk population for HIV being prioritized for the scale up of HIV treatment in Uganda. Heavy alcohol use and potential drug use may be a major barrier to treatment adherence for men in this setting. Objective This study examines the prevalence of substance use, and its influence on antiretroviral treatment (ART) adherence, among male fisherfolk on ART in Wakiso District, Uganda. Methods This cross-sectional study included structured questionnaires (N = 300) with men attending HIV clinics near Lake Victoria. Using generalized logistic modeling analyses with a binomial distribution and logit link, we conducted multivariate models to test the association between each alcohol variable (quantity and frequency index, hazardous drinking) and missed pills, adjusting for covariates, and tested for interactions between number of pills prescribed and alcohol variables. Results Thirty-one percent of men reported sub-optimal adherence. Half (46.7%) reported drinking, of which 64.8% met criteria for hazardous drinking. Illicit drug use was low (6%). In the multivariate model, men with greater scores on the alcohol frequency and quantity index were more likely to report missed pills compared to those reporting no drinking (AOR: 1.60, 95% CI: 1.29-1.97). Hazardous drinking had a greater effect on missed ARV doses among men taking twice daily regimens compared to once daily (AOR: 4.91, 95% CI: 1.68-14.37). Conclusions Our findings highlight the need for targeted alcohol-reduction interventions for male fisherfolk on ART who drink at high quantities to improve ART adherence and to prevent the known negative health effects of alcohol for HIV-infected individuals.	[Sileo, Katelyn M.; Reed, Elizabeth; Kiene, Susan M.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Kizito, Williams; Chemusto, Harriet; Musoke, William; Mukasa, Barbara] Mildmay Uganda, Kampala, Uganda; [Wanyenze, Rhoda K.] Makerere Univ, Makerere Sch Publ Hlth, Kampala, Uganda; [Stockman, Jamila K.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Sileo, Katelyn M.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06510 USA	California State University System; San Diego State University; Makerere University; University of California System; University of California San Diego; Yale University	Sileo, KM (corresponding author), San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA.; Sileo, KM (corresponding author), Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06510 USA.	katelyn.sileo@gmail.com	Stockman, Jamila/AAK-8960-2020	Kiene, Susan/0000-0001-8922-5289	National Institute of Health Fogarty International Center [NIH/FIC 5R25TW009343-05]; University of California Global Health Institute [NIH/FIC 5R25TW009343-05]; T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse [T32 DA023356]; FOGARTY INTERNATIONAL CENTER [R25TW009343, D43TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA023356] Funding Source: NIH RePORTER	National Institute of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute; T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The GloCal Health Fellowship from the National Institute of Health Fogarty International Center and the University of California Global Health Institute awarded to Katelyn Sileo supported this study (NIH/FIC 5R25TW009343-05). Katelyn Sileo was also supported by a T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse T32 DA023356.	Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z; Braithwaite RS, 2008, ALCOHOL CLIN EXP RES, V32, P1645, DOI 10.1111/j.1530-0277.2008.00732.x; Braithwaite RS, 2010, ALCOHOL RES HEALTH, V33, P280; Carney T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008969.pub3; Chang L. W., 2016, LANCET, V3, P8; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Hahn JA, 2016, ADDICTION, V111, P272, DOI 10.1111/add.13173; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Howell D.C., 1998, STAT METHODS HUMAN S; Jenkins RA, 2018, AIDS EDUC PREV, V30, P225, DOI 10.1521/aeap.2018.30.3.225; Kader R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125088; Kahler CW, 2017, AIDS BEHAV, V21, P1825, DOI 10.1007/s10461-016-1474-y; Kaner E, 2007, COCHRANE DATABASE SY, V2; Kiwanuka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171200; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; L'Engle KL, 2014, JAIDS-J ACQ IMM DEF, V67, P446, DOI 10.1097/QAI.0000000000000335; Mertens JR, 2014, ALCOHOL ALCOHOLISM, V49, P430, DOI 10.1093/alcalc/agu030; NIDA, NIDA MOD ASSIST V2 0; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Peltzer K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-699; Pengpid S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-644; Pengpid S, 2013, INT J ENV RES PUB HE, V10, P2043, DOI 10.3390/ijerph10052043; Rendall-Mkosi K, 2013, ADDICTION, V108, P725, DOI 10.1111/add.12081; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Samet JH, 2004, ALCOHOL CLIN EXP RES, V28, P572, DOI 10.1097/01.ALC.0000122103.74491.78; Sankar A, 2007, AIDS BEHAV, V11, P195, DOI 10.1007/s10461-006-9144-0; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Sileo KM, 2019, AIDS CARE, V31, P35, DOI 10.1080/09540121.2018.1524564; Sileo KM, 2016, DRUG ALCOHOL DEPEN, V167, P103, DOI 10.1016/j.drugalcdep.2016.07.028; Sileo KM, 2016, AIDS BEHAV, V20, P537, DOI 10.1007/s10461-015-1077-z; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Swahn MH, 2012, INT J ALCOHOL DRUG R, V1, P13, DOI 10.7895/ijadr.v1i1.84; Truong William R, 2015, P T, V40, P44; Tucker JS, 2003, AM J MED, V114, P573, DOI 10.1016/S0002-9343(03)00093-7; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, P12, DOI 10.1186/1471-2458-12-12; Tumwesigye NM, 2003, GENDER ALCOHOL CULTU; Uganda MOH, 2013, ADD NAT ANT TREATM G; UNAIDS, 2018, COUNTR FACT SHEET UG; UNAIDS, 2014, 90 90 90 AMB TREATM; Wandera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126236; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2001, ALCOHOL USE DISORDER; World Health Organization, 2016, CONS GUID US ANT DRU	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216892	10.1371/journal.pone.0216892	http://dx.doi.org/10.1371/journal.pone.0216892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158232	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700004
J	Biddlecome, A; Habte, HH; McGrath, KM; Sambanthamoorthy, S; Wurm, M; Sykora, MM; Knobler, CM; Lorenz, IC; Lasaro, M; Elbers, K; Gelbart, WM				Biddlecome, Adam; Habte, Habtom H.; McGrath, Katherine M.; Sambanthamoorthy, Sharmila; Wurm, Melanie; Sykora, Martina M.; Knobler, Charles M.; Lorenz, Ivo C.; Lasaro, Marcio; Elbers, Knut; Gelbart, William M.			Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles	PLOS ONE			English	Article							PHYSICAL PRINCIPLES; ASSEMBLY PATHWAY; NODAMURA-VIRUS; NANOPARTICLES; CAPSIDS	Many mRNA-based vaccines have been investigated for their specific potential to activate dendritic cells (DCs), the highly-specialized antigen-presenting cells of the immune system that play a key role in inducing effective CD4(+) and CD8(+) T-cell responses. In this paper we report a new vaccine/gene delivery platform that demonstrates the benefits of using a self-amplifying ("replicon") mRNA that is protected in a viral-protein capsid. Purified capsid protein from the plant virus Cowpea Chlorotic Mottle Virus (CCMV) is used to in vitro assemble monodisperse virus-like particles (VLPs) containing reporter proteins (e.g., Luciferase or eYFP) or the tandem-repeat model antigen SIINFEKL in RNA gene form, coupled to the RNA-dependent RNA polymerase from the Nodamura insect virus. Incubation of immature DCs with these VLPs results in increased activation of maturation markers - CD80, CD86 and MHC-II - and enhanced RNA replication levels, relative to incubation with unpackaged replicon mRNA. Higher RNA uptake/replication and enhanced DC activation were detected in a dose-dependent manner when the CCMV-VLPs were pre-incubated with anti-CCMV antibodies. In all experiments the expression of maturation markers correlates with the RNA levels of the DCs. Overall, these studies demonstrate that: VLP protection enhances mRNA uptake by DCs; coupling replicons to the gene of interest increases RNA and protein levels in the cell; and the presence of anti-VLP antibodies enhances mRNA levels and activation of DCs in vitro. Finally, preliminary in vivo experiments involving mouse vaccinations with SIIN-FEKL-replicon VLPs indicate a small but significant increase in antigen-specific T cells that are doubly positive for IFN and TFN induction.	[Biddlecome, Adam; Knobler, Charles M.; Gelbart, William M.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Habte, Habtom H.; McGrath, Katherine M.; Sambanthamoorthy, Sharmila; Lasaro, Marcio] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA; [Wurm, Melanie; Sykora, Martina M.] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Lorenz, Ivo C.] Triinst Therapeut Discovery Inst, New York, NY USA; [Elbers, Knut] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	University of California System; University of California Los Angeles; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Elbers, K (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.	knut.elbers@boehringer-ingelheim.com; gelbart@chem.ucla.edu			Boehringer-Ingelheim International GmbH [272661]	Boehringer-Ingelheim International GmbH(Boehringer Ingelheim)	This work was supported by Boehringer-Ingelheim International GmbH (https://www.boehringer-ingelheim.com/) as part of its research contract number 272661 with the University of California, Los Angeles, from which AB received salary. No sponsors/funders other than the named authors played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all PLOS ONE policies on sharing data and materials.	A-Cadena-Nava R, 2012, J VIROL, V86, P12271, DOI [10.1128/JVI.01695-12, DOI 10.1128/JVI.01695-12]; Azizgolshani O, 2013, VIROLOGY, V441, P12, DOI 10.1016/j.virol.2013.03.001; Ball L, 2003, U.S. Patent, Patent No. 20030108863; Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133; CARBONE FR, 1992, INT IMMUNOL, V4, P861, DOI 10.1093/intimm/4.8.861; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Garmann RF, 2016, ACCOUNTS CHEM RES, V49, P48, DOI 10.1021/acs.accounts.5b00350; Garmann RF, 2014, J VIROL, V88, P10472, DOI 10.1128/JVI.01044-14; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Gitlin L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004529; Hovlid ML, 2012, NANOSCALE, V4, P3698, DOI 10.1039/c2nr30571b; Johnson KL, 2004, J VIROL, V78, P6698, DOI 10.1128/JVI.78.12.6698-6704.2004; Johnson KL, 2003, VIROLOGY, V305, P436, DOI 10.1006/viro.2002.1769; Kemnade JO, 2014, VACCINE, V32, P4228, DOI 10.1016/j.vaccine.2014.04.051; Kovacs EW, 2007, BIOCONJUGATE CHEM, V18, P1140, DOI 10.1021/bc070006e; Lam P, 2018, WIRES NANOMED NANOBI, V10, DOI 10.1002/wnan.1487; Maruggi G, 2019, MOL THERAPY, V27, P1; Rohovie MJ, 2017, BIOENG TRANSL MED, V2, P43, DOI 10.1002/btm2.10049; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Stephanopoulos N, 2010, ACS NANO, V4, P6014, DOI 10.1021/nn1014769; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005	27	28	28	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0215031	10.1371/journal.pone.0215031	http://dx.doi.org/10.1371/journal.pone.0215031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163034	Green Submitted, Green Published, gold			2022-12-27	WOS:000470086200004
J	Curry, CJ; White, PA; Derr, JN				Curry, Caitlin J.; White, Paula A.; Derr, James N.			Genetic analysis of African lions (Panthera leo) in Zambia support movement across anthropogenic and geographical barriers	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; LINKAGE DISEQUILIBRIUM; RE-IMPLEMENTATION; N-E; SOFTWARE; INFERENCE; PROGRAM; CONSERVATION; RAREFACTION; SOUTHERN	The Luangwa Valley in eastern Zambia is a transverse offshoot of the Great Rift Valley system. This region appears to have an isolating effect as evidenced by suspected endemic subspecies, such as the Cookson's wildebeest and Thornicroft's giraffe. Recent mitochondrial DNA studies demonstrated that African lions in Zambia consist of two highly diverse eastern and western sub-populations. Herein, we report nuclear and mitochondrial DNA results from 409 lions that support this population substructure across Zambia but proposes only partial isolation of the Luangwa Valley with more movement between the populations than previously thought. Population assignment analysis identifies two populations with little evidence of admixture assigning lions to either the eastern or western sub-populations. A high occurrence of private alleles and clear evidence for a Wahlund effect further justify the presence of a highly structured population. But, while mitochondrial DNA analysis still shows little to no matrilineal gene flow (F-ST = 0.53) between sub-populations, microsatellite analysis suggests there is gene flow (F-ST = 0.04) with low but significant isolation-by-distance and an average of 6 migrants per generation. Evidence of isolation-by-distance is also found in factorial correspondence analysis with the Lower Zambezi National Park and eastern corridor clusters overlapping isolated clusters of the Luangwa Valley and western subpopulation. From this evidence, the Luangwa Valley appears separated from the western sub-population with some dispersal through the southern regions of the eastern sub-population. Both the eastern and western sub-populations have high heterozygosity (0.68 and 0.69, respectively) and genetic diversity (0.47 and 0.50, respectively) values, indicative of genetically healthy populations.	[Curry, Caitlin J.; Derr, James N.] Texas A&M Univ, Interdisciplinary Program Genet, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles	Derr, JN (corresponding author), Texas A&M Univ, Interdisciplinary Program Genet, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jderr@cvm.tamu.edu		Curry, Caitlin/0000-0002-3853-7191	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	This research has been funded in part by the Zambia Wildlife Authority, Professional Hunters Association of Zambia (www.phazambia.com), Safari Hunters and Outfitters Association of Zambia, the Boore Family Foundation, Dallas Safari Club (biggame. org), Safari Club International Foundation (www.safariclub.org) and the Texas A&M Foundation (txamfoundation. com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; [Anonymous], 2018, SO AFR LION IND M MI; [Anonymous], SEQ VERS 4 8 SEQ AN, P8; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belkhir K, 2004, 5000 CNRS UMR; Bertola, 2015, GENETIC DIVERSITY LI; Bertola LD, 2012, CHAPTER CONSERVATION; Budowle B, 2009, BIOTECHNIQUES, V46, P339, DOI 10.2144/000113136; Cotterill F.P.D., 2000, BIODIVERSITY ZAMBEZI, P145; Curry CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143827; Curry CJ, 2019, DEV LION MINIS UNPUB; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Fennessy J, 2013, AFR J ECOL, V51, P635, DOI 10.1111/aje.12085; Garnier-Gere P., 2013, ENCY LIFE SCI ELS, DOI [DOI 10.1002/9780470015902.A0005446.PUB3, 10.1002/9780470015902.a0005446.pub3]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2006, CONS STRAT LION E SO; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kasiki S., 2014, CITES PERIODIC REV S; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; Lindsey PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094109; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Locke M, 2000, QUICK INTRO STRAND S, P1; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Nowell K., 1996, WILD CATS STATUS SUR; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pocock RI, 1897, ANN MAG NAT HIST, V20, P33, DOI [10.1080/00222939708680598, DOI 10.1080/00222939708680598]; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenblatt E, 2016, ECOL EVOL, V6, P3772, DOI 10.1002/ece3.2155; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang J, 2016, HEREDITY, V117, P193, DOI 10.1038/hdy.2016.43; Waples RS, 2016, MOL ECOL, V25, P4689, DOI 10.1111/mec.13814; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Zhivotovsky LA, 2015, J HERED, V106, P306, DOI 10.1093/jhered/esv019	55	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217179	10.1371/journal.pone.0217179	http://dx.doi.org/10.1371/journal.pone.0217179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150429	gold, Green Published			2022-12-27	WOS:000469759100034
J	Perez, SM; Biondi, E; Laurita, R; Proto, M; Sarti, F; Gherardi, M; Bertaccini, A; Colombo, V				Perez, Set Madian; Biondi, Enrico; Laurita, Romolo; Proto, Mariarita; Sarti, Fabio; Gherardi, Matteo; Bertaccini, Assunta; Colombo, Vittorio			Plasma activated water as resistance inducer against bacterial leaf spot of tomato	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BIOLOGICAL-CONTROL; OXIDATIVE BURST; XANTHOMONAS-PERFORANS; DISEASE RESISTANCE; PATHOGEN INFECTION; HYDROGEN-PEROXIDE; SIGNAL NETWORK; PLANT-GROWTH; ETHYLENE	Plant bacterial diseases are routinely managed with scheduled treatments based on heavy metal compounds or on antibiotics; to reduce the negative environmental impact due to the use of such chemical compounds, as pollution or selection of antibiotic resistant pathogens, the integrated control management is required. In the frame of a sustainable agriculture the use of bacterial antagonists, biological agents, plant defence response elicitors or resistant host plant genotypes are the most effective approaches. In this work, cold atmospheric pressure plasma (CAP) was applied to sterile distilled water, inducing the production of a hydrogen peroxide, nitrite and nitrate, and a pH reduction. In particular, an atmospheric pressure dielectric barrier discharge (DBD) has been used to produce plasma activated water (PAW), that was firstly assayed in in vitro experiments and then in planta through application at the root apparatus of tomato plants, against Xanthomonas vesicatoria (Xv), the etiological agent of bacterial leaf spot. Moreover, the transcription abundance of five genes related to the plant defense was investigated in response to PAW treatment. PAW did not show direct antimicrobial activity against Xv in in vitro experiments, but it enhanced the tomato plants defenses. It was effective in reducing the disease severity by giving relative protections of ca. 61, 51 and 38% when applied 1 h, 24 h and 6 days before the experimental inoculation, respectively. In addition, the experiments highlighted the pal gene involvement in response to the PAW treatments and against the pathogen; its transcription levels resulted significantly high from 1 to 48 h until their decrease 192 h after PAW application.	[Perez, Set Madian; Biondi, Enrico; Proto, Mariarita; Sarti, Fabio; Bertaccini, Assunta] Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci Distal, Plant Pathol, Bologna, Italy; [Perez, Set Madian] Univ OHiggins, Inst Ciencias Agron & Vet, Rancagua, Chile; [Laurita, Romolo; Gherardi, Matteo; Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Dept Ind Engn DIN, Bologna, Italy; [Gherardi, Matteo; Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Interdept Ctr Ind Res Adv Mech Engn Applicat & Ma, Bologna, Italy; [Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Interdept Ctr Ind Res Agrifood, Cesena, Italy	University of Bologna; Universidad de O'Higgins; University of Bologna; University of Bologna; University of Bologna	Biondi, E (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci Distal, Plant Pathol, Bologna, Italy.	enrico.biondi3@unibo.it	Gherardi, Matteo/AAX-6106-2021; Laurita, Romolo/U-6968-2017	Perez Fuentealba, Set/0000-0003-3643-0160; Laurita, Romolo/0000-0003-1744-3329; COLOMBO, VITTORIO/0000-0001-9145-198X; Biondi, Enrico/0000-0002-9310-5236; GHERARDI, MATTEO/0000-0001-6995-6754; Bertaccini, Assunta/0000-0002-5650-1512				Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Arasimowicz M, 2007, PLANT SCI, V172, P876, DOI 10.1016/j.plantsci.2007.02.005; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Byrne JM, 2005, BIOL CONTROL, V32, P408, DOI 10.1016/j.biocontrol.2004.12.001; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Carvalho RAM, 2005, QUIM NOVA, V28, P1006, DOI 10.1590/S0100-40422005000600014; Cellini A, 2014, ANN APPL BIOL, V165, P441, DOI 10.1111/aab.12150; CHAMBERS SC, 1975, AUST J AGR RES, V26, P657, DOI 10.1071/AR9750657; Clinical and Laboratory Standards Institute, 2006, M100S17 CLIN LAB STA; COOKSEY DA, 1993, MOL MICROBIOL, V7, P1, DOI 10.1111/j.1365-2958.1993.tb01091.x; Cortesi R, 2017, J PLANT DIS PROTECT, V124, P269, DOI 10.1007/s41348-016-0055-7; Danve C, 2010, THESIS; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P359, DOI 10.1016/0048-4059(83)90020-6; DYE D. W., 1962, NEW ZEALAND JOUR SCI, V5, P393; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; Fortunati E, 2019, J SCI FOOD AGR, V99, P986, DOI 10.1002/jsfa.9341; Giovanardi D, 2018, PLANT PATHOL, V67, P1168, DOI 10.1111/ppa.12839; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; Jiang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101169; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Julak J, 2012, PHYS MEDICA, V28, P230, DOI 10.1016/j.ejmp.2011.08.001; Koenraadt H, 2009, ACTA HORTIC, V808, P99, DOI 10.17660/ActaHortic.2009.808.13; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kostov KG, 2010, SURF COAT TECH, V204, P2954, DOI 10.1016/j.surfcoat.2010.01.052; Kuzniak E, 2000, ACTA PHYSIOL PLANT, V22, P195, DOI 10.1007/s11738-000-0076-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Laurita R, 2015, CLIN PLASMA MED, V3, P53, DOI 10.1016/j.cpme.2015.10.001; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Liu CJ, 1999, FUEL PROCESS TECHNOL, V58, P119, DOI 10.1016/S0378-3820(98)00091-5; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Louws FJ, 2001, PLANT DIS, V85, P481, DOI 10.1094/PDIS.2001.85.5.481; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Lund ST, 1998, PLANT CELL, V10, P371, DOI 10.1105/tpc.10.3.371; Mazzaglia A., 2017, NANOTECHNOL AGR FOOD, V96, P115; Michelotti V, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4967-4; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Moreau M, 2007, APPL ENVIRON MICROB, V73, P5904, DOI 10.1128/AEM.00662-07; Moreau M, 2005, J APPL MICROBIOL, V98, P1039, DOI 10.1111/j.1365-2672.2004.02535.x; Murshed R, 2013, PHYSIOL MOL BIOL PLA, V19, P363, DOI 10.1007/s12298-013-0173-7; Nehra V, 2008, INT J ENG-IRAN, V2, P53; Obradovic A, 2005, PLANT DIS, V89, P712, DOI 10.1094/PD-89-0712; Oostendorp M, 2001, EUR J PLANT PATHOL, V107, P19, DOI 10.1023/A:1008760518772; Paret ML, 2013, PHYTOPATHOLOGY, V103, P228, DOI 10.1094/PHYTO-08-12-0183-R; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; PENG M, 1992, PHYTOPATHOLOGY, V82, P696, DOI 10.1094/Phyto-82-696; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potnis N, 2015, MOL PLANT PATHOL, V16, P907, DOI 10.1111/mpp.12244; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Rep M, 2006, ANNU REV PHYTOPATHOL, V44; Scortichini M., 2013, Bulletin OEPP, V43, P7, DOI 10.1111/epp.12018; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Traylor M. J., 2011, J PHYS D, V44, P1; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005	66	23	23	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217788	10.1371/journal.pone.0217788	http://dx.doi.org/10.1371/journal.pone.0217788			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150501	Green Published, Green Submitted, gold			2022-12-27	WOS:000469759100109
J	Liu, JH; Liu, SS; Deng, XY; Rao, JY; Huang, KY; Xu, GR; Wang, XK				Liu, Jianghong; Liu, Shengshuo; Deng, Xiaoyan; Rao, Jiaoyu; Huang, Kaiyuan; Xu, Gengrui; Wang, Xiaokang			MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1	PLOS ONE			English	Article							UP-REGULATION; PROLIFERATION; STATISTICS; ACTIVATION; CARCINOMA; APOPTOSIS; PATHWAY; TARGET	Non-small cell lung cancer (NSCLC) is the most common cancer worldwide. MicroRNAs have been shown to be correlated with biological processes of various tumors. In this study, we observed that the expression of miR-582-5p was lower in NSCLC tissues than that in para-carcinoma tissues. Ectopic expression of miR-582-5p significantly inhibited NCI-H358 cell proliferation and invasion. Knockdown of miR-582-5p showed the opposite results, with cell growth rate and the invasive capacity of PC-9 cells enhanced. Furthermore, we elucidated that NOTCH1 is a target of miR-582-5p and there is an inverse correlation between miR-582-5p and NOTCH1 expression in NSCLC tissues. Overexpression of NOTCH1 in miR-582-5p-overexpressing NCI-H358 cells could partially reverse the inhibition of cell proliferation and invasion by miR-582-5p. Thus, our research demonstrated that miR-582-5p suppresses NSCLC cell lines' growth and invasion via targeting oncoprotein NOTCH1 and restoration of miR-582-5p might be feasible therapeutic strategy for NSCLC.	[Liu, Jianghong; Huang, Kaiyuan; Xu, Gengrui; Wang, Xiaokang] Shenzhen Longhua Dist Cent Hosp, Dept Pharm, Shenzhen, Peoples R China; [Liu, Shengshuo] Henan Univ, Sch Pharm, Kaifeng, Henan, Peoples R China; [Deng, Xiaoyan] Shenzhen Longhua Dist Cent Hosp, Dept Endocrinol, Shenzhen, Peoples R China; [Rao, Jiaoyu] Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Henan University; Jinan University	Wang, XK (corresponding author), Shenzhen Longhua Dist Cent Hosp, Dept Pharm, Shenzhen, Peoples R China.	kangtae.wang@yahoo.com	Wang, Xiaokang/GSD-7988-2022	Wang, Xiaokang/0000-0002-4325-9907	Shenzhen Longhua District Science and Technology Innovation Fund Projects [2017032]; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province [20182131]	Shenzhen Longhua District Science and Technology Innovation Fund Projects; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province	This work was supported by grants from the Shenzhen Longhua District Science and Technology Innovation Fund Projects (No. 2017032), and the Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (No. 20182131).	Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; An TH, 2017, MOL NEUROBIOL, V54, P6329, DOI 10.1007/s12035-016-0163-1; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen YP, 2012, PLOS ONE, V7; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Floyd DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096239; Hu HQ, 2016, INT J BIOL MARKER, V31, pE270, DOI 10.5301/jbm.5000194; Huang D., 2016, ACTA BIOCH BIOPHYS S, V48; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Jin Y, 2017, EUR REV MED PHARMACO, V21, P5112, DOI 10.26355/eurrev_201711_13827; Li JL, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1139-8; Li LL, 2018, SAUDI J BIOL SCI, V25, P965, DOI 10.1016/j.sjbs.2018.03.007; Licciulli S, 2013, CANCER RES, V73, P5974, DOI 10.1158/0008-5472.CAN-13-1384; Maeno A, 2014, PROSTATE, V74, P1604, DOI 10.1002/pros.22877; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Shu ZB, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0984-4; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchino K, 2013, MOL THER, V21, P610, DOI 10.1038/mt.2012.269; Wang WW, 2017, JPN J CLIN ONCOL, V47, P690, DOI 10.1093/jjco/hyx073; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; Xu YT, 2018, CANCER SCI, V109, P1055, DOI 10.1111/cas.13539; Zhang HD, 2015, BIOCHEM BIOPH RES CO, V465, P702, DOI 10.1016/j.bbrc.2015.08.053; Zhang X, 2015, CANCER GENE THER, V22, P475, DOI 10.1038/cgt.2015.44	36	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217652	10.1371/journal.pone.0217652	http://dx.doi.org/10.1371/journal.pone.0217652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170211	gold, Green Published, Green Submitted			2022-12-27	WOS:000470263700046
J	Schyra, J; Gbenyedji, JNBK; Korb, J				Schyra, Janine; Gbenyedji, Jean Norbert B. K.; Korb, Judith			A comparison of termite assemblages from West African savannah and forest ecosystems using morphological and molecular markers	PLOS ONE			English	Article							ANTHROPOGENIC DISTURBANCE; PHYLOGENETIC ANALYSIS; MODEL SELECTION; DIVERSITY; COMMUNITY; GRADIENT; ISOPTERA; PATTERNS; MOUNDS; EVOLUTION	Termites (Isoptera) are important ecosystem engineers of tropical ecosystems. However, they are notoriously difficult to identify, which hinders ecological research. To overcome these problems, we comparatively studied termite assemblages in the two major West African ecosystems, savannah and forest, both under natural settings and along disturbance gradients. We identified all species using morphological as well as molecular markers. We hypothesized species richness to be higher in the forest than the savannah and that it declines with disturbance in both ecosystems. Overall we found more species in the forest than in the savannah. However, alpha diversity per site did not differ between both ecosystems with on average around ten species. For both ecosystems, species diversity did not decrease along the studied disturbance gradient but encounter rates did. For the forest, we did not detect a decline in soil feeding termites and an increase of fungus grower Macrotermitinae with disturbance as some other studies did. Yet, soil feeders were generally rare. Strikingly, the set of morphologically difficult-to-identify Macrotermitinae (Microtermes and Ancistrotermes) was as high in the forest as in the savannah with little species overlap between both ecosystems. Using phylogenetic community analyses, we found little evidence for strong structuring mechanisms such as environmental filtering or interspecific competition. Most local assemblages did not differ significantly from random assemblages of the regional species pool. Our study is the most comprehensive of its kind. It provides the most reliable termite species list for West Africa that builds the basis for further ecological studies.	[Schyra, Janine; Korb, Judith] Univ Osnabrueck, Behav Biol, Osnabruck, Germany; [Gbenyedji, Jean Norbert B. K.] Univ Lome, Lab Entomol Appl, Dept Zool & Biol Anim, Lome, Togo; [Gbenyedji, Jean Norbert B. K.; Korb, Judith] Univ Freiburg, Evolutionary Biol & Ecol, Freiburg, Germany	University Osnabruck; University of Freiburg	Schyra, J (corresponding author), Univ Osnabrueck, Behav Biol, Osnabruck, Germany.	janine.schyra@gmail.com			Deutsche Forschungsgemeinschaft (DFG) [KO1895/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft (DFG) (Project KO1895/12-1) and JK received funding.	Adjonou K, 2010, ACTA BOT GALLICA, V157, P387, DOI 10.1080/12538078.2010.10516216; Basset Y, 2017, BIODIVERS CONSERV, V26, P151, DOI 10.1007/s10531-016-1231-6; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bouche P, 2004, AERIAL TOTAL COUNT W; BOUILLON A., 1965, Zooleo; Bourguignon T, 2013, MOL PHYLOGENET EVOL, V69, P694, DOI 10.1016/j.ympev.2013.07.007; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Coulibaly T, 2016, J INSECT CONSERV, V20, P1011, DOI 10.1007/s10841-016-9935-1; Dahlsjo CAL, 2015, INSECT SOC, V62, P141, DOI 10.1007/s00040-014-0385-z; Davies AB, 2014, J VEG SCI, V25, P1405, DOI 10.1111/jvs.12200; Davies RG, 2003, J BIOGEOGR, V30, P847, DOI 10.1046/j.1365-2699.2003.00883.x; Davies RG, 2002, OECOLOGIA, V133, P233, DOI 10.1007/s00442-002-1011-8; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Dosso K, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.13101; Dosso K, 2013, J INSECT CONSERV, V17, P1047, DOI 10.1007/s10841-013-9588-2; Eggleton P, 2002, AGR ECOSYST ENVIRON, V90, P189, DOI 10.1016/S0167-8809(01)00206-7; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Evans TA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1257; Gbenyedji JNBK, 2016, EUR SCI J, V12, P333; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Grasse PP, 1937, ANN SOC ENTOMOL FR, V106, P100; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; HARRIS WV, 1968, P ROY ENTOMOL SOC B, V37, P103; Hausberger B, 2016, BIOTROPICA, V48, P356, DOI 10.1111/btp.12278; Hausberger B, 2011, MOL PHYLOGENET EVOL, V61, P964, DOI 10.1016/j.ympev.2011.08.015; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jones DT, 2006, AUSTRAL ECOL, V31, P429, DOI 10.1111/j.1442-9993.2006.01630.x; Jones DT, 2000, J APPL ECOL, V37, P191, DOI 10.1046/j.1365-2664.2000.00464.x; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Joseph GS, 2013, J VEG SCI, V24, P702, DOI 10.1111/j.1654-1103.2012.01489.x; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kokutse AD, 2004, FOREST ECOL MANAG, V189, P37, DOI 10.1016/j.foreco.2003.07.041; Korb J, 2001, OECOLOGIA, V127, P324, DOI 10.1007/s004420000597; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Neoh KB, 2015, J INSECT CONSERV, V19, P1129, DOI 10.1007/s10841-015-9828-8; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Palin OF, 2011, BIOTROPICA, V43, P100, DOI 10.1111/j.1744-7429.2010.00650.x; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pearce MJ, 1993, WHAT TERMITE GUIDE I; Peveling R, 2003, J APPL ECOL, V40, P729, DOI 10.1046/j.1365-2664.2003.00833.x; Pringle RM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000377; Sands W., 1992, NAT RESOUR I B, V51, P1; Sands WA, 1998, INTEGRATION SUPRANAT, P1; Sands WA, 1965, B BRIT MUSEUM NATURA; Schyra J, 2017, TERMITE COMMUNITIES, DOI [10.1101/167692, DOI 10.1101/167692]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; UNDP, 2010, STRENGTH CONS ROL TO, P8; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb G. C., 1961, KEYS GENERA AFRICAN; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	59	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216986	10.1371/journal.pone.0216986	http://dx.doi.org/10.1371/journal.pone.0216986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166963	Green Submitted, Green Published, gold			2022-12-27	WOS:000470087800016
J	Hsouna, H; Abdessalem, R; Boukhris, O; Trabelsi, K; Chtourou, L; Tahri, N; Engel, FA; Shephard, RJ; Chtourou, H				Hsouna, Hsen; Abdessalem, Raouf; Boukhris, Omar; Trabelsi, Khaled; Chtourou, Lassaad; Tahri, Nabil; Engel, Florian A.; Shephard, Roy J.; Chtourou, Hamdi			Short-term maximal performance, alertness, dietary intake, sleep pattern and mood states of physically active young men before, during and after Ramadan observance	PLOS ONE			English	Article							BODY-COMPOSITION; EXERCISE; QUALITY; IMPACT; POWER	Purpose To assess changes in short-term maximal performance, alertness, dietary intake, sleep pattern and mood states of physically active young men before (BR), during and after Ramadan observance. Methods Twelve physically-active men (age: 21.9 +/- 2.4yrs, height: 1.77 +/- 0.09m, body-mass: 72.6 +/- 7.8kg, exercising: >= 3h/week) performed the 5-jump and the digit-cancellation (alertness) tests 15-days BR, on the first (FR) and last 10-days of Ramadan (ER) and 10-days (AR10) and 20-days (AR20) after Ramadan. During each period, sleep pattern (Pittsburgh-Sleep-Quality-Index (PSQI)), mood states (Profile-of-Mood-States (POMS)) and dietary intake were recorded. Results No significant changes in the 5-jump, digit-cancellation test and POMS parameters appeared during and after Ramadan relative to BR. However, the PSQI total score was lower during FR compared to AR10 (p<0.001). Specifically, the subjective sleep quality was lower (i) at BR compared to FR (p<0.05), AR10 (p<0.01) and AR20 (p<0.01) and (ii) at ER and AR20 compared to FR (p<0.05). The sleep duration (i) increased at FR (p<0.05) and (ii) decreased at AR10 (p<0.01) and AR20 (p<0.05) compared to BR. Sleep disturbances were significantly greater (i) at BR compared to FR (p<0.01), ER (p<0.01), AR10 (p<0.05) and AR20 (p<0.05) and (ii) at AR10 and AR20 compared to FR and ER (p<0.05). In terms of diet, the fractional contribution of carbohydrate (%) was lower and the dietary fat content (g) was higher during ER than AR10 and AR20 (p<0.05). Further, the dietary protein (in %) was significantly lower during FR compared to BR (p<0.01), ER (p<0.05), AR10 (p<0.05) and AR20 (p<0.05). Conclusion Ramadan had no-adverse effects on the 5-jump performance, alertness, or mood states in physically active young men. However, the sleep duration was shorter and the sleep quality was improved following compared to during Ramadan. The fractional intake of fat also increased at the expense of carbohydrate during Ramadan, and the protein intake was lower at the beginning of Ramadan than before, at the end of and after Ramadan.	[Hsouna, Hsen; Abdessalem, Raouf; Boukhris, Omar; Trabelsi, Khaled] Univ Sfax, High Inst Sport & Phys Educ, UR15JS01 Educ Motricite Sport & Sante EM2S, Sfax, Tunisia; [Chtourou, Lassaad; Tahri, Nabil] Hedi Chaker Hosp, Dept Gastroenterol & Hepatol, Sfax, Tunisia; [Engel, Florian A.] Heidelberg Univ, Dept Movement & Training, Inst Sport & Sport Sci, Heidelberg, Germany; [Shephard, Roy J.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Chtourou, Hamdi] Univ Sfax, Inst Super Sport & Educ Phys Sfax, Sfax, Tunisia; [Chtourou, Hamdi] Observ Natl Sport, UR18JS01, Act Phys Sport & Sante, Tunis, Tunisia	Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Ruprecht Karls University Heidelberg; University of Toronto; Universite de Sfax	Engel, FA (corresponding author), Heidelberg Univ, Dept Movement & Training, Inst Sport & Sport Sci, Heidelberg, Germany.	florian.engel@issw.uni-heidelberg.de	Trabelsi, Khaled/ABG-2717-2020; Chtourou, Hamdi/GVU-1967-2022; Engel, Florian/AAG-7158-2021	Trabelsi, Khaled/0000-0003-2623-9557; Chtourou, Hamdi/0000-0002-5482-9151; Engel, Florian/0000-0003-0998-2277; Lassaad, Chtourou/0000-0003-1654-5104	Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	We acknowledge and appreciate financial support by Deutsche Forschungsgemeinschaft within the funding program Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Abedelmalek Salma, 2011, Asian J Sports Med, V2, P154; Aloui A, 2013, BIOL RHYTHM RES, V44, P869, DOI 10.1080/09291016.2013.780697; Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; Aziz AR, 2017, SPORTS, V5, DOI 10.3390/sports5010004; Aziz AR, 2010, BRIT J SPORT MED, V44, P516, DOI 10.1136/bjsm.2009.070425; Baklouti H, 2017, PHYS THER SPORT, V24, P20, DOI 10.1016/j.ptsp.2016.10.002; Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; Bouhlel E, 2006, DIABETES METAB, V32, P617, DOI 10.1016/S1262-3636(07)70317-8; Bouhlel E., 2015, OPTIMIZING PHYS PERF; Bouhlel E, 2008, INT J SPORT NUTR EXE, V18, P617, DOI 10.1123/ijsnem.18.6.617; Bouhlel H, 2013, CLIN J SPORT MED, V23, P222, DOI 10.1097/JSM.0b013e318275d213; Boukhris O, 2019, CHRONOBIOL INT, V36, P1, DOI 10.1080/07420528.2018.1513943; Burke LM, 2012, J SPORT SCI, V30, pS21, DOI 10.1080/02640414.2012.680484; Cayrou S., 2003, J THERAPIE COMPORTEM, V13, P83; Chamari K, 2016, BIOL SPORT, V33, P49, DOI 10.5604/20831862.1185888; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Chaouachi A, 2009, J STRENGTH COND RES, V23, P2702, DOI 10.1519/JSC.0b013e3181bc17fc; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H, 2015, EFFECTS RAMADAN FAST; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Clark-Carter D., 1997, DOING QUANTITATIVE P; Farooq A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012848; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Girard O, 2012, SCI SPORT, V27, P237, DOI 10.1016/j.scispo.2011.09.006; Hammouda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079873; Hatta T, 2012, PSYCHOLOGIA, V55, P246, DOI 10.2117/psysoc.2012.246; Herrera CP, 2012, J SPORT SCI, V30, pS85, DOI 10.1080/02640414.2012.676666; Kirkendall DT, 2008, J SPORT SCI, V26, P15, DOI 10.1080/02640410802422199; Leiper JB, 2008, J SPORT SCI, V26, P55, DOI 10.1080/02640410802538176; Ramadan J, 2002, MED PRIN PRACT, V11, P41, DOI 10.1159/000066413; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Roky R, 2001, J SLEEP RES, V10, P319, DOI 10.1046/j.1365-2869.2001.00269.x; Simpson NS, 2017, SCAND J MED SCI SPOR, V27, P266, DOI 10.1111/sms.12703; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; SWEILEH N, 1992, J SPORT MED PHYS FIT, V32, P156; Trabelsi K., 2019, INT J SPORT STUD HLT; Trabelsi Khaled, 2011, Asian J Sports Med, V2, P134; Waterhouse J, 2010, BRIT J SPORT MED, V44, P509, DOI 10.1136/bjsm.2007.071712; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zarrouk N, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0130-2; Zerguini Y, 2007, BRIT J SPORT MED, V41, P398, DOI 10.1136/bjsm.2006.032037	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217851	10.1371/journal.pone.0217851	http://dx.doi.org/10.1371/journal.pone.0217851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163075	Green Published, Green Submitted, gold			2022-12-27	WOS:000470086200040
J	Lill, D; Timmer, J; Kaschek, D				Lill, Daniel; Timmer, Jens; Kaschek, Daniel			Local Riemannian geometry of model manifolds and its implications for practical parameter identifiability	PLOS ONE			English	Article							LIKELIHOOD	When non-linear models are fitted to experimental data, parameter estimates can be poorly constrained albeit being identifiable in principle. This means that along certain paths in parameter space, the log-likelihood does not exceed a given statistical threshold but remains bounded. This situation, denoted as practical non-identifiability, can be detected by Monte Carlo sampling or by systematic scanning using the profile likelihood method. In contrast, any method based on a Taylor expansion of the log-likelihood around the optimum, e.g., parameter uncertainty estimation by the Fisher Information Matrix, reveals no information about the boundedness at all. In this work, we present a geometric approach, approximating the original log-likelihood by geodesic coordinates of the model manifold. The Christoffel Symbols in the geodesic equation are fixed to those obtained from second order model sensitivities at the optimum. Based on three exemplary non-linear models we show that the information about the log-likelihood bounds and flat parameter directions can already be contained in this local information. Whereas the unbounded case represented by the Fisher Information Matrix is embedded in the geometric framework as vanishing Christoffel Symbols, non-vanishing constant Christoffel Symbols prove to define prototype non-linear models featuring boundedness and flat parameter directions of the log-likelihood. Finally, we investigate if those models could allow to approximate and replace computationally expensive objective functions originating from non-linear models by a surrogate objective function in parameter estimation problems.	[Lill, Daniel; Timmer, Jens; Kaschek, Daniel] Univ Freiburg, Inst Phys, Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg	Lill, D (corresponding author), Univ Freiburg, Inst Phys, Freiburg, Germany.	daniel.lill@physik.uni-freiburg.de		Lill, Daniel/0000-0002-1058-4826	Bundesministerium fur Bildung und Forschung [BMBF 031L0048]; German Research Foundation (DFG); University of Freiburg	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This work was supported by Bundesministerium fur Bildung und Forschung (Grantee: DL [Daniel Lill], Grant number: BMBF 031L0048, URL: lisym.org). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BATES DM, 1981, ANN STAT, V9, P1152, DOI 10.1214/aos/1176345633; Cash J. R., 2011, RECENT ADV COMPUTATI, P23; Faeder JR, 2005, COMPLEXITY, V10, P22, DOI 10.1002/cplx.20074; HARRIS IR, 1992, COMMUN STAT THEORY, V21, P637, DOI 10.1080/03610929208830804; Kass R.E., 1989, STAT SCI, V4, P188, DOI [10.1214/ss/1177012480, DOI 10.1214/SS/1177012480]; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Maiwald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162366; Merkt B, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012920; Michor P. W., 2008, TOPICS DIFFERENTIAL, V93; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Stumpf M, 2011, HANDBOOK OF STATISTICAL SYSTEMS BIOLOGY, pXVII; Transtrum MK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.098701; Transtrum MK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036701; Transtrum MK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060201; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217837	10.1371/journal.pone.0217837	http://dx.doi.org/10.1371/journal.pone.0217837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158252	Green Published, Green Submitted, gold			2022-12-27	WOS:000469915700029
J	Peytz, NC; Jabbari, R; Bojesen, SE; Nordestgaard, B; Schnohr, P; Prescott, E				Peytz, Nina Caroline; Jabbari, Reza; Bojesen, Stig Egil; Nordestgaard, Boerge; Schnohr, Peter; Prescott, Eva			Physical activity and risk of instant and 28-day case-fatality in myocardial infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; LEISURE-TIME; ALL-CAUSE; EXERCISE; MORTALITY; PROTECTION; ISCHEMIA; IMPACT; CARDIOPROTECTION	Background While physical activity reduces risk of developing myocardial infarction (MI), it is unknown whether a history of physical activity is also protective of fatal arrhythmia and case-fatality in patients who have suffered an acute MI. Methods 104,801 individuals included in 2003-2014 in the Copenhagen General Population Study (CGPS), a prospective population-based study with self-reported leisure time physical activity (LTPA) in three categories measured at baseline, were followed until 2014 through national registries. The 1,517 individuals who suffered a first time MI during follow-up constituted the study population. Outcomes were fatal MI, defined as date of death same as date of MI (including out-of-hospital deaths) and 28-day fatality. Through multivariable analyses the association between baseline LTPA and outcomes were assessed adjusted for CVD risk factors. Results Of 1,517 MI events, 117 (7.7%) were fatal and another 79 (5.6%) lead to death within 28 days. Median time from baseline to MI was 3.6 years (IQR 1.7-5.8). LTPA was associated with lower risk of fatal MI with odds ratios of 0.40 (95% CI: 0.22-0.73) for light and 0.41 (0.22-0.76) for moderate/high LTPA after multivariable adjustment with sedentary LTPA as reference. Age, alcohol-intake, education and smoking were identified as other predictors for fatal MI. We found no association between LTPA and 28-day case fatality. Conclusions Among individuals with MI, those that have engaged in any light or moderate physical activity were more likely to survive their MI. Results are consistent with effect of exercise preconditioning on risk of fatal arrhythmia.	[Peytz, Nina Caroline; Jabbari, Reza; Prescott, Eva] Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark; [Bojesen, Stig Egil; Nordestgaard, Boerge; Schnohr, Peter; Prescott, Eva] Univ Copenhagen, Herlev Hosp, Copenhagen City Heart Study, Herlev, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Peytz, NC (corresponding author), Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark.	nina.caroline.peytz.04@regionh.dk	Jabbari, Reza/AAM-6649-2021; Prescott, Eva/AAJ-7441-2020; Nordestgaard, Borge Gronne/ABF-1310-2020	Jabbari, Reza/0000-0002-9432-0632; Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133				Abildstrom SZ, 2003, HEART, V89, P507, DOI 10.1136/heart.89.5.507; Andersson J, 2016, EUR J PREV CARDIOL, V23, P1814, DOI 10.1177/2047487316659574; Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BOWLES DK, 1992, AM J PHYSIOL, V263, pH804, DOI 10.1152/ajpheart.1992.263.3.H804; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chambless L, 1997, CIRCULATION, V96, P3849; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC; Degano IR, 2015, HEART, V101, P1413, DOI 10.1136/heartjnl-2014-307310; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Domenech R, 2002, CARDIOVASC RES, V55, P561, DOI 10.1016/S0008-6363(02)00334-6; Ejlersen H, 2017, EUR J PREV CARDIOL; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Holtermann A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000556; Jabbari R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001399; Kavouras SA, 2007, MED SCI SPORT EXERC; Lambiase PD, 2003, J AM COLL CARDIOL, V41, P1174, DOI 10.1016/S0735-1097(03)00055-X; Langsted A, 2011, CLIN CHEM, V57, P482, DOI 10.1373/clinchem.2010.157164; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; Lennon SL, 2004, ACTA PHYSIOL SCAND, V182, P161, DOI 10.1111/j.1365-201X.2004.01346.x; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mannsverk J, 2015, CIRCULATION, V133; Marongiu E, 2014, CURR CARDIOL REV, V10, P336, DOI 10.2174/1573403X10666140404110229; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MORRIS JN, 1980, LANCET, V2, P1207; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Piccini JP, 2010, EUR HEART J, V31, P211, DOI 10.1093/eurheartj/ehp425; Quindry JC, 2013, CURR CARDIOL REV, V9, P220, DOI 10.2174/1573403X113099990033; Schnohr P, 2017, EUR J PREV CARDIOL, V24, P1615, DOI 10.1177/2047487317721021; Schnohr P, 2012, EUR J PREV CARDIOL, V19, P73, DOI 10.1177/1741826710393196; Schnohr P, 2009, DAN MED BULL, V56, P40; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Thijssen D, 2017, JAMA CARDIOL, P706, DOI [10.1084/jem.189.11.1699, DOI 10.1084/JEM.189.11.1699]; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217398	10.1371/journal.pone.0217398	http://dx.doi.org/10.1371/journal.pone.0217398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150433	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100043
J	Verhallen, AM; Renken, RJ; Marsman, JBC; ter Horst, GJ				Verhallen, Anne M.; Renken, Remco J.; Marsman, Jan-Bernard C.; ter Horst, Gert J.			Romantic relationship breakup: An experimental model to study effects of stress on depression (-like) symptoms	PLOS ONE			English	Article							MAJOR DEPRESSION; LIFE EVENTS; NEGATIVE AFFECT; INVENTORY; ONSET; COMPONENTS; RUMINATION; DISORDERS; FEMALE; NUMBER	The occurrence of a stressful event is considered to increase the risk of developing depression. In the present study we explore whether the breakup of a romantic relationship can be used as an experimental model to study a depression-like state during a period of stress in individuals without a psychiatric disorder. The primary aim of our study was to investigate: 1) whether individuals with a recent romantic relationship breakup ("heartbreak") demonstrate symptoms of depression, 2) how to describe heartbreak characteristics based on data from a comprehensive questionnaire battery, and 3) whether this description can capture severity of depression symptoms. Secondary, we were interested in gender differences with regard to the above study objectives. Subjects who have experienced a relationship breakup in the preceding six months (N = 71) or are in a romantic relationship (N = 46) participated in our study. A questionnaire battery was administered to acquire information related to depression, mood, the breakup and (former) relationship. Principal Component Analysis with Procrustes bootstrapping was performed to extract components from the questionnaire data. Even though our sample of individuals who recently have experienced a relationship breakup can be on average considered non-depressed, group-level depression scores were elevated compared to individuals in a relationship (p =.001) and 26.8% reported symptoms corresponding to mild, moderate or severe depression. We described heartbreak by two principal components interpreted as "sudden loss" and "lack of positive affect", respectively. Highly significant correlations between the component scores and depression scores were found (p<.001 and p<.001, respectively), although these correlations differed between the genders. Based on these findings, we propose that the experience of a romantic relationship breakup is a viable experimental model to examine symptoms of depression in individuals without a psychiatric disorder. This way, stress-related coping and depression vulnerability can be studied in further research.	[Verhallen, Anne M.; Renken, Remco J.; Marsman, Jan-Bernard C.; ter Horst, Gert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Cognit Neurosci Ctr, Groningen, Netherlands	University of Groningen	Verhallen, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Cognit Neurosci Ctr, Groningen, Netherlands.	a.m.verhallen@umcg.nl		Renken, Remco Jan/0000-0002-7777-9484; Verhallen, Anne/0000-0002-0022-6291				Barbara AM, 2000, J PERS INTERPERS LOS, V5, P315, DOI 10.1080/10811440008407850; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bech P, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0529-3; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Eisma MC, 2015, BRIT J CLIN PSYCHOL, V54, P163, DOI 10.1111/bjc.12067; Field T, 2009, ADOLESCENCE, V44, P705; Fletcher GJO, 2000, PERS SOC PSYCHOL B, V26, P340, DOI 10.1177/0146167200265007; Forsell Y, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-29; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Keyes KM, 2014, AM J PSYCHIAT, V171, P864, DOI 10.1176/appi.ajp.2014.13081132; Leary MR, 1998, J PERS SOC PSYCHOL, V74, P1225, DOI 10.1037/0022-3514.74.5.1225; Lin YH, 2008, CEREB CORTEX, V18, P2762, DOI 10.1093/cercor/bhn035; Marazziti D, 2004, PSYCHONEUROENDOCRINO, V29, P931, DOI 10.1016/j.psyneuen.2003.08.006; Monroe SM, 1999, J ABNORM PSYCHOL, V108, P606, DOI 10.1037/0021-843X.108.4.606; Najib A, 2004, AM J PSYCHIAT, V161, P2245, DOI 10.1176/appi.ajp.161.12.2245; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Stoessel C, 2011, NEUROPSYCHOBIOLOGY, V64, P52, DOI 10.1159/000325076; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163	28	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217320	10.1371/journal.pone.0217320	http://dx.doi.org/10.1371/journal.pone.0217320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150432	Green Published, gold, Green Submitted			2022-12-27	WOS:000469759100039
J	Rodrigues, R; Danskog, K; Overby, AK; Arnberg, N				Rodrigues, Raquel; Danskog, Katarina; Overby, Anna K.; Arnberg, Niklas			Characterizing the cellular attachment receptor for Langat virus	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; DENGUE VIRUS; HEPARAN-SULFATE; EXPRESSION PROFILES; ENVELOPE PROTEIN; MESSENGER-RNA; DC-SIGN; INFECTION; BINDING; IDENTIFICATION	Tick-borne encephalitis infections have increased the last 30 years. The mortality associated to this viral infection is 0.5 to 30% with a risk of permanent neurological sequelae, however, no therapeutic is currently available. The first steps of virus-cell interaction, such as attachment and entry, are of importance to understand pathogenesis and tropism. Several molecules have been shown to interact with tick-borne encephalitis virus (TBEV) at the plasma membrane surface, yet, no studies have proven that these are specific entry receptors. In this study, we set out to characterize the cellular attachment receptor(s) for TBEV using the naturally attenuated member of the TBEV complex, Langat virus (LGTV), as a model. Inhibiting or cleaving different molecules from the surface of A549 cells, combined with inhibition assays using peptide extracts from high LGTV binding cells, revealed that LGTV attachment to host cells is dependent on plasma membrane proteins, but not on glycans or glycolipids, and suggested that LGTV might use different cellular attachment factors on different cell types. Based on this, we developed a transcriptomic approach to generate a list of candidate attachment and entry receptors. Our findings shed light on the first step of the flavivirus life-cycle and provide candidate receptors that might serve as a starting point for future functional studies to identify the specific attachment and/or entry receptor for LGTV and TBEV.	[Rodrigues, Raquel; Danskog, Katarina; Overby, Anna K.; Arnberg, Niklas] Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden	Umea University	Rodrigues, R (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.	raquelorodrigues@hotmail.com	Arnberg, Niklas/K-5878-2019	Arnberg, Niklas/0000-0002-7069-6678	Umea Centre for Microbial Research (UCMR) Linnaeus Programme - Umea University; Swedish Research Council [349-2007-8673]	Umea Centre for Microbial Research (UCMR) Linnaeus Programme - Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was performed as a part of the Umea Centre for Microbial Research (UCMR) Linnaeus Programme supported by Umea University and the Swedish Research Council (349-2007-8673).	ABE A, 1995, J LIPID RES, V36, P611; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; BROCKHAUSEN I, 1992, BIOCHEM CELL BIOL, V70, P99, DOI 10.1139/o92-015; BRUNNGRABER EG, 1972, BRAIN RES, V38, P151, DOI 10.1016/0006-8993(72)90596-3; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ciani L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9302; Condamine T, 2010, J LEUKOCYTE BIOL, V88, P507, DOI 10.1189/jlb.1109738; ENGLUND PT, 1968, BIOCHEMISTRY-US, V7, P163, DOI 10.1021/bi00841a021; Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Han HQ, 2001, J MED VIROL, V64, P21, DOI 10.1002/jmv.1012; Han XQ, 2005, J MED VIROL, V77, P249, DOI 10.1002/jmv.20444; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Hirano M, 2014, J GEN VIROL, V95, P849, DOI 10.1099/vir.0.061432-0; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Jolly CL, 2013, ADV EXP MED BIOL, V790, P1, DOI 10.1007/978-1-4614-7651-1_1; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]; KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U; KORNFELD R, 1970, J BIOL CHEM, V245, P2536; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P937, DOI 10.1515/bchm2.1976.357.2.937; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P233; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006; Letschert S, 2014, ANGEW CHEM INT EDIT, V53, P10921, DOI 10.1002/anie.201406045; Liao XH, 2014, EXP DERMATOL, V23, P195, DOI 10.1111/exd.12340; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu P, 2017, TRAFFIC, V18, P218, DOI 10.1111/tra.12469; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malygin AA, 2010, BIOCH MOSC, V74, P1328; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Monath T.P., 1996, FIELDS VIROLOGY, P961; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; NIEDRIG M, 1994, ACTA VIROL, V38, P141; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10; Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shapoval A N, 1989, Tr Inst Im Pastera, V65, P133; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Terasaki H, 2002, INT J MOL MED, V9, P107; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Wichit S, 2011, MICROBIOL IMMUNOL, V55, P135, DOI 10.1111/j.1348-0421.2010.00293.x; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Zaitsev BN, 2014, J MOL RECOGNIT, V27, P727, DOI 10.1002/jmr.2399	83	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217359	10.1371/journal.pone.0217359	http://dx.doi.org/10.1371/journal.pone.0217359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163044	gold, Green Published, Green Submitted			2022-12-27	WOS:000470086200012
J	Lin, SW; Faust, L; Robles-Granda, P; Kajdanowicz, T; Chawla, NV				Lin, Suwen; Faust, Louis; Robles-Granda, Pablo; Kajdanowicz, Tomasz; Chawla, Nitesh V.			Social network structure is predictive of health and wellness	PLOS ONE			English	Article							COLLECTIVE DYNAMICS; SPREAD	Social networks influence health-related behavior, such as obesity and smoking. While researchers have studied social networks as a driver for diffusion of influences and behavior, it is less understood how the structure or topology of the network, in itself, impacts an individual's health behavior and wellness state. In this paper, we investigate whether the structure or topology of a social network offers additional insight and predictability on an individual's health and wellness. We develop a method called the Network-Driven health predictor (NetCARE) that leverages features representative of social network structure. Using a large longitudinal data set of students enrolled in the NetHealth study at the University of Notre Dame, we show that the NetCARE method improves the overall prediction performance over the baseline models that use demographics and physical attributes-by 38%, 65%, 55%, and 54% for the wellness states-stress, happiness, positive attitude, and self assessed health-considered in this paper.	[Lin, Suwen; Faust, Louis; Robles-Granda, Pablo; Chawla, Nitesh V.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Lin, Suwen; Faust, Louis; Robles-Granda, Pablo; Chawla, Nitesh V.] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Kajdanowicz, Tomasz; Chawla, Nitesh V.] Wroclaw Univ Sci & Technol, Dept Computat Intelligence, Wroclaw, Poland	University of Notre Dame; University of Notre Dame; Wroclaw University of Science & Technology	Chawla, NV (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.; Chawla, NV (corresponding author), Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA.; Chawla, NV (corresponding author), Wroclaw Univ Sci & Technol, Dept Computat Intelligence, Wroclaw, Poland.	nchawla@nd.edu	Robles, Pablo/AAE-8434-2019; Lin, Suwen/GOE-3935-2022; Chawla, Nitesh/F-2690-2016	Robles, Pablo/0000-0003-0604-7187; Kajdanowicz, Tomasz/0000-0002-8417-1012; Chawla, Nitesh/0000-0003-3932-5956; Faust, Louis/0000-0002-9741-7894	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health [R01HL117757]; National Science Centre, Poland [2016/23/B/ST6/01735]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117757] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Centre, Poland(National Science Centre, Poland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this paper was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under award number R01HL117757. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The project was also partially supported by The National Science Centre, Poland, research project no. 2016/23/B/ST6/01735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COHEN CI, 1985, GERONTOLOGIST, V25, P297, DOI 10.1093/geront/25.3.297; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Coppersmith Glen, 2014, P WORKSH COMP LING C, P51, DOI DOI 10.3115/V1/W14-3207; Diestel R, 2005, GRAD TEXTS MATH, V101; DIETTERICH TG, LECT NOTES COMPUT SC, V1857, P1; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; FitBit, 2016, WHAT AR ACT MIN; Flori KL, 2006, J GERONTOL B-PSYCHOL, V61, pP25, DOI 10.1093/geronb/61.1.P25; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Morgan WP, 2013, EXERCISE MENTAL HLTH; Muaremi A, 2013, BIONANOSCIENCE, V3, P172, DOI 10.1007/s12668-013-0089-2; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Purta R, 2016, IEEE INT SYM WRBL CO, P28, DOI 10.1145/2971763.2971767; Reece AG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12961-9; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Stieglitz S, 2013, J MANAGE INFORM SYST, V29, P217, DOI 10.2753/MIS0742-1222290408; Stutz T, 2015, LECT NOTES COMPUT SC, V9146, P240, DOI 10.1007/978-3-319-20267-9_20; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weerkamp W, 2012, SIGIR WORKSH TIM AW; Wenger GC, 1997, AGING MENT HEALTH, V1, P311, DOI 10.1080/13607869757001; World Health Organization, 2002, GEND MENT HLTH; Yoo JC, 2009, CIRC SYST SIGNAL PR, V28, P819, DOI [10.1007/s00034-009-9130-7, 10.1007/S00034-009-9130-7]	29	15	15	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217264	10.1371/journal.pone.0217264	http://dx.doi.org/10.1371/journal.pone.0217264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170181	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700023
J	Skrabanek, P; Zahradnikova, A				Skrabanek, Pavel; Zahradnikova, Alexandra, Jr.			Automatic assessment of the cardiomyocyte development stages from confocal microscopy images using deep convolutional networks	PLOS ONE			English	Article								Computer assisted image acquisition techniques, including confocal microscopy, require efficient tools for an automatic sorting of vast amount of generated image data. The complexity of the classification process, absence of adequate tools, and insufficient amount of reference data has made the automated processing of images challenging. Mastering of this issue would allow implementation of statistical analysis in research areas such as in research on formation of t-tubules in cardiac myocytes. We developed a system aimed at automatic assessment of cardiomyocyte development stages (SAACS). The system classifies confocal images of cardiomyocytes with fluorescent dye stained sarcolemma. We based SAACS on a densely connected convolutional network (DenseNet) topology. We created a set of labelled source images, proposed an appropriate data augmentation technique and designed a class probability graph. We showed that the DenseNet topology, in combination with the augmentation technique is suitable for the given task, and that high-resolution images are instrumental for image categorization. SAACS, in combination with the automatic high-throughput confocal imaging, will allow application of statistical analysis in the research of the tubular system development or remodelling and loss.	[Skrabanek, Pavel] Brno Univ Technol, Inst Automat & Comp Sci, Brno, Czech Republic; [Zahradnikova, Alexandra, Jr.] Ctr Biosci SAS, Inst Mol Physiol & Genet, Bratislava, Slovakia; [Zahradnikova, Alexandra, Jr.] Biomed Res Ctr SAS, Inst Expt Endocrinol, Dept Cellular Cardiol, Bratislava, Slovakia	Brno University of Technology; SAS Institute Inc; Slovak Academy of Sciences; SAS Institute Inc; Slovak Academy of Sciences	Skrabanek, P (corresponding author), Brno Univ Technol, Inst Automat & Comp Sci, Brno, Czech Republic.	pavel.skrabanek@vut.cz	Alexandra, Zahradnikova/C-2918-2009; Škrabánek, Pavel/AAB-5848-2022	Alexandra, Zahradnikova/0000-0001-5170-118X; Škrabánek, Pavel/0000-0001-6194-0467	national scholarship programme of the Slovak Republic; Slovak Research and Development Agency (SRDA, APVV) [15-0302]; Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA) [2/0095/15, VEGA 2/0143/17]; Research and Development Operational Program - European Regional Development Fund [ITMS 26230120006]	national scholarship programme of the Slovak Republic; Slovak Research and Development Agency (SRDA, APVV); Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Research and Development Operational Program - European Regional Development Fund	The work was supported by national scholarship programme of the Slovak Republic (PS), https://www.scholarships.sk/; Slovak Research and Development Agency (SRDA, APVV), 15-0302 (A. Zahradnikova), http://www.apvv.sk/agentura.html?lang=en; Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA), 2/0095/15 and VEGA 2/0143/17 (AZjr), http://vega.sav.sk/.This publication is also a result of implementation of the project ITMS 26230120006, supported by the Research and Development Operational Program funded by the European Regional Development Fund, https://ec.europa.eu/regional_policy/EN/atlas/programmes/2014-2020/slovakia/2014sk16rfop001.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, HIGH THROUGHPUT CALC; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Franzini-Armstrong C., 2018, J GEN PHYSL; Frisk M, 2016, CARDIOVASC RES, V112, P443, DOI 10.1093/cvr/cvw111; Gao ZM, 2017, IEEE J BIOMED HEALTH, V21, P416, DOI 10.1109/JBHI.2016.2526603; Guo A, 2014, BIOPHYS J, V106, P2729, DOI 10.1016/j.bpj.2014.05.013; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huang G, 2016, LECT NOTES COMPUT SC, V9908, P646, DOI 10.1007/978-3-319-46493-0_39; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; krabanek P, 2017, SCI PAPERS U PARDU D, V24, P181; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lemnaru C, 2012, LECT NOTES BUS INF P, V102, P35; Louch WE, 2015, J PHYSIOL-LONDON, V593, P1047, DOI 10.1113/jphysiol.2014.274712; Mackova K, 2017, EUR BIOPHYS J BIOPHY, V46, P691, DOI 10.1007/s00249-017-1249-z; Mao HZ, 2017, IEEE COMPUT SOC CONF, P1927, DOI 10.1109/CVPRW.2017.241; Parikh SS, 2017, CIRC RES, V121, P1323, DOI 10.1161/CIRCRESAHA.117.311920; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Ruder S., 2016, ARXIV; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Singh JK, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13540; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Wang SJ, 2016, IEEE IJCNN, P4368, DOI 10.1109/IJCNN.2016.7727770; Xu MJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005746; Xu Y, 2015, INT CONF ACOUST SPEE, P947, DOI 10.1109/ICASSP.2015.7178109; Yu Z, 2018, INFORM SCIENCES, V433, P241, DOI 10.1016/j.ins.2017.12.045; Zahradnikova jr A, 2019, CONFOCAL MICROSCOPY, DOI [10.6084/m9.figshare.8063369, DOI 10.6084/M9.FIGSHARE.8063369]; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang CM, 2017, J MOL CELL CARDIOL, V112, P123, DOI 10.1016/j.yjmcc.2017.08.007	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216720	10.1371/journal.pone.0216720	http://dx.doi.org/10.1371/journal.pone.0216720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145728	Green Published, gold, Green Submitted			2022-12-27	WOS:000469425500004
J	Garcia-Melo, JE; Oliveira, C; Silva, GJD; Ochoa-Orrego, LE; Pereira, LHG; Maldonado-Ocampo, JA				Garcia-Melo, Jorge E.; Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.; Garcia Pereira, Luiz Henrique; Maldonado-Ocampo, Javier A.			Species delimitation of neotropical Characins (Stevardiinae): Implications for taxonomy of complex groups	PLOS ONE			English	Article							GENUS BRYCONAMERICUS TELEOSTEI; CHARACIFORMES CHARACIDAE; MAGDALENA BASIN; RIVER; OSTARIOPHYSI; PHYLOGENY; REVISION; MODELS; CLADE; FISH	Accurate species delimitation is crucial for studies of phylogeny, phylogeography, ecology, conservation and biogeography. The limits of species and genera in the Characidae family are controversial due to its uncertain phylogenetic relationships, high level of morphological homoplasy and the use of ambiguous morphological characters for descriptions. Here we establish species boundaries for Bryconamericus, Hemibrycon, Knodus and Eretmobrycon (Stevardiinae: Characidae), previously diagnosed with morphology, using three different barcoding approaches (GMYC, PTP, ABGD). Results revealed that species delimitation was successful by the use of a single-gene approach and by following a workflow in the context of integrative taxonomy, making evident problems and mistakes in the cataloging of Characidae species. Hence, it was possible to infer boundaries at genus level for clusters in the trees (GMYC and PTP) and automatic partitions (ABGD) which were consistent with some of recent taxonomic changes proposed in Characidae. We found that discordance cases between methods were linked to limitations of the methods and associated to putative species cluster closely related, some historically problematic in their diagnosis and identification. Furthermore, we suggested taxonomic changes and possibly new species, revealing a high degree of hidden diversity. Finally, we propose a workflow as a fast, accurate and objective way to delimit species from mitochondrial DNA sequences and to help clarify the classification of this group.	[Garcia-Melo, Jorge E.; Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia; [Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.] Univ Estadual Paulista UNESP, Dept Morfol, Inst Biociencias, Campus Botucatu, Botucatu, SP, Brazil; [Da Costa Silva, Guilherme Jose] Univ Santo Amaro, Rua Prof Eneas de Siqueira Neto, Sao Paulo, SP, Brazil; [Garcia Pereira, Luiz Henrique] Univ Fed Integracao Latino Amer UNILA, Ctr Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil; [Garcia-Melo, Jorge E.] Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia	Pontificia Universidad Javeriana; Universidade Estadual Paulista; Universidade de Santo Amaro (UNISA); Universidade Federal da Integracao Latino-Americana	Garcia-Melo, JE (corresponding author), Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia.; Garcia-Melo, JE (corresponding author), Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia.	jgarcia-m@javeriana.edu.co	Oliveira, Claudio/D-7713-2012; García-Melo, Jorge E/AAU-3289-2020; Garcia Pereira, Luiz Henrique/S-4710-2017	Oliveira, Claudio/0000-0002-7010-8880; García-Melo, Jorge E/0000-0003-2885-5652; Garcia Pereira, Luiz Henrique/0000-0001-9435-6347; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Ochoa, Luz/0000-0003-4205-8510	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO) [567/2012]; Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana [00006552]; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17009-2, 2014/26502-3]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306054/2006-0]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO); Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JEGM was supported by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO, doctoral fellowship grant 567/2012) (www.colciencias.gov.co).JEGM and JAMO were supported by Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana (Project No 00006552) (www.javeriana.edu.co).CO was also financially supported by the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #2010/17009-2 and 2014/26502-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant #306054/2006-0) (www.fapesp.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210166; Bagley JC, 2015, MULTILOCUS SPECIES D, P1, DOI [10.1371/journal.pone.0121139, DOI 10.1371/JOURNAL.PONE.0121139]; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P737, DOI 10.1590/S1679-62252010000400005; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Casciotta JR, 2002, REV SUISSE ZOOL, V109, P155, DOI 10.5962/bhl.part.79584; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Silva José Francisco Pezzi da, 2004, Neotrop. ichthyol., V2, P55, DOI 10.1590/S1679-62252004000200002; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dellicour S, 2018, MOL ECOL RESOUR, V18, P1234, DOI 10.1111/1755-0998.12908; Dos Santos AR, 2012, HEREDITAS, V149, P24, DOI 10.1111/j.1601-5223.2011.02234.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2012, GENEIOUS V4 8 5; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eschmeyer W. N., 2018, CATALOG FISHES CALIF; Eschmeyer WN, 2018, CATALOG FISHES GENER; Escobar-Camacho D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135569; Ezard T, 2009, SPLITS SPECIES LIMIT, P1; Ferreira KM, 2007, ANALISE FILOGENETICA; FINK W L, 1976, Proceedings of the Biological Society of Washington, V88, P331; Fischer Johanne, 2013, FAO Fisheries and Aquaculture Technical Paper, V585, P3; Fujisawa T, 2016, SYST BIOL, V65, P759, DOI 10.1093/sysbio/syw028; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Melo JE, 2018, J FISH BIOL, V92, P1929, DOI 10.1111/jfb.13634; GERY J., 1977, CHARACOIDS WORLD; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Han ZL, 2012, 2012 INTERNATIONAL CONFERENCE ON OPTICAL MEMS AND NANOPHOTONICS (OMN), P27, DOI 10.1109/OMEMS.2012.6318785; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jacobs SJ, 2018, MOL ECOL, V27, P2397, DOI 10.1111/mec.14590; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larson ER, 2016, PEERJ, V4, DOI 10.7717/peerj.1915; Malabarba Luiz R., 2000, Ichthyological Exploration of Freshwaters, V11, P315; Malabarba Luiz R., 2003, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V16, P67; Malabarba MCSL, 1995, P BIOL SOC WASH, V108, P1; Maldonado-Ocampo JA, 2005, PECES ANDES COLOMBIA; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mazeti Camila Montoro, 2013, Acta Scientiarum Biological Sciences, V35, P241, DOI 10.4025/actascibiolsci.v35i2.11451; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Miquelarena AM, 1999, P BIOL SOC WASH, V112, P523; Miquelarena Amalia M., 1995, Revista Brasileira de Biologia, V55, P559; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; O'Connell KA, 2019, MOL PHYLOGENET EVOL, V134, P1, DOI 10.1016/j.ympev.2019.01.021; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paintner-Marques TR, 2002, HEREDITAS, V137, P107, DOI 10.1034/j.1601-5223.2002.01651.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pereira LHG, 2013, ANALISE DIVERSIDADE; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Piscor D, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-13; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reis R.E., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Roman-Valencia C, 2014, ANIM BIODIV CONSERV, V37, P107; Roman-Valencia C, 2013, ANIM BIODIV CONSERV, V36, P123; Roman-Valencia C, 2010, ANIM BIODIV CONSERV, V33, P195; Roman-Valencia C, 2002, REV BIOL TROP, V50, P173; Roman-Valencia C, 2000, REV BIOL TROP, V48, P449; Roman-Valencia C., 2008, Animal Biodiversity and Conservation, V31, P15; Roman-Valencia C., 2003, MEMORIAS FUNDACION S, V2003, P31; Roman-Valencia C., 2005, MEMORIA FUNDACION SA, V163, P27; Roman-Valencia C., 2003, B MUS REG SCI NAT TO, V31, P447; Roman-Valencia C., 2001, B MUSEUM REGIONALLI, V18, P469; Roman-Valencia C., 2003, REV ASOCIACION COLOM, P17; Roman-Valencia C, 2017, REV INVESTIG, V29, P38, DOI 10.33975/riuq.vol29n1.13; Roman-Valencia C, 2011, REV MEX BIODIVERS, V82, P844; Roman-Valencia C, 2010, REV BIOL TROP, V58, P339; Roman-Valencia C, 2009, CALDASIA, V31, P393; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P465; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P455; Roman-Valencia Cesar, 2003, Dahlia, V6, P7; Roman-Valencia C, 2008, REV BIOL TROP, V56, P1749; Roman-Valencia Cesar, 2004, Dahlia, V7, P23; Roman-Valencia Cesar, 1999, Actualidades Biologicas (Medellin), V20, P109; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Serra JP, 2006, BIOTA NEOTROP, P6; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Song C, 2018, ZOOL SCR, V47, P311, DOI 10.1111/zsc.12284; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Taphorn D, 1992, BIOLLANIA, V4, P1; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Van der Laan R., 2020, ESCHMEYERS CATALOG F; VARI RP, 1990, P BIOL SOC WASH, V103, P516; White BP, 2014, FRESHW SCI, V33, P338, DOI 10.1086/674982; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	111	32	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216786	10.1371/journal.pone.0216786	http://dx.doi.org/10.1371/journal.pone.0216786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166941	Green Published, Green Submitted, gold			2022-12-27	WOS:000470087800013
J	Fiocca, K; Barrett, M; Waddell, EA; Viveiros, J; McNair, C; O'Donnell, S; Marenda, DR				Fiocca, Katherine; Barrett, Meghan; Waddell, Edward A.; Viveiros, Jennifer; McNair, Cheyenne; O'Donnell, Sean; Marenda, Daniel R.			Mannitol ingestion causes concentration-dependent, sex-biased mortality in adults of the fruit fly (Drosophila melanogaster)	PLOS ONE			English	Article							LIFE-SPAN; SORBITOL DEHYDROGENASE; FEMALE; DIGESTIBILITY; REPRODUCTION; MODULATION; RECEPTORS; NUTRITION; FECUNDITY; SURVIVAL	Mannitol, a sugar alcohol used in commercial food products, has been previously shown to induce sex-biased mortality in female Drosophila melanogaster when ingested at a single concentration (1 M). We hypothesized that sex differences in energy needs, related to reproductive costs, contributed to the increased mortality we observed in females compared to males. To test this, we compared the longevity of actively mating and non-mating flies fed increasing concentrations of mannitol. We also asked whether mannitol-induced mortality was concentration-dependent for both males and females, and if mannitol's sex-biased effects were consistent across concentrations. Females and males both showed concentration-dependent increases in mortality, but female mortality was consistently higher at concentrations of 0.75 M and above. Additionally, fly longevity decreased further for both sexes when housed in mixed sex vials as compared to single sex vials. This suggests that the increased energetic demands of mating and reproduction for both sexes increased the ingestion of mannitol. Finally, larvae raised on mannitol produced expected adult sex ratios, suggesting that sex-biased mortality due to the ingestion of mannitol occurs only in adults. We conclude that sex and reproductive status differences in mannitol ingestion drive sex-biased differences in adult fly mortality.	[Fiocca, Katherine; Barrett, Meghan; Waddell, Edward A.; Viveiros, Jennifer; O'Donnell, Sean; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [McNair, Cheyenne; O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	Marenda, DR (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.; Marenda, DR (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA.	dm562@drexel.edu	Barrett, Meghan/AAQ-8194-2020	Marenda, Daniel/0000-0001-5388-8793; Viveiros, Jennifer/0000-0002-9785-7371; Barrett, Meghan/0000-0002-1270-4983; Fiocca, Katherine/0000-0002-5708-0641	Drexel University Office of Research; National Science Foundation	Drexel University Office of Research; National Science Foundation(National Science Foundation (NSF))	Funds from Drexel University Office of Research supported this work (to DRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of this material is based upon work supported by (while serving at) the National Science Foundation (for DRM). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bjork A, 2007, BIOL LETTERS, V3, P517, DOI 10.1098/rsbl.2007.0219; Bretman A, 2013, EVOLUTION, V67, P2413, DOI 10.1111/evo.12125; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Diegelmann S, 2017, JOVE-J VIS EXP, DOI 10.3791/55024; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Elhassan E., 2015, COMPREHENSIVE CLIN N, P85; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Freeman EG, 2014, P NATL ACAD SCI USA, V111, P1598, DOI 10.1073/pnas.1311724111; Fujii S, 2015, CURR BIOL, V25, P621, DOI 10.1016/j.cub.2014.12.058; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; GraphPad Software Inc., 2018, GRAPHPAD PRISM WIND; Grembecka M, 2015, EUR FOOD RES TECHNOL, V241, P1, DOI 10.1007/s00217-015-2437-7; Harrison JF, 2012, ECOL ENVIRON PHYSIOL, P140; Harvanek ZM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0152; IBM Corporation, 2016, IBM SPSS STAT WIND V; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jamieson P.R., 2012, ALTERNATIVE SWEETENE, P333; Kikuta S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207497; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Leech T, 2017, J INSECT PHYSIOL, V102, P12, DOI 10.1016/j.jinsphys.2017.08.008; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Lindstad RI, 1998, BIOCHEM J, V330, P479; Lints FA, 1998, DROSOPHILA MODEL ORG; Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277; Luque T, 1998, J BIOL CHEM, V273, P34293, DOI 10.1074/jbc.273.51.34293; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; MARTINEZ G, 1963, J BIOL CHEM, V238, P1598; Matos RC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S6; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Min X, 2013, ANIM SCI J, V84, P551, DOI 10.1111/asj.12041; NEGM FB, 1979, PLANT PHYSIOL, V64, P69, DOI 10.1104/pp.64.1.69; Nishiyama A, 2009, J NUTR SCI VITAMINOL, V55, P242, DOI 10.3177/jnsv.55.242; Nunney L, 2007, J EVOLUTION BIOL, V20, P141, DOI 10.1111/j.1420-9101.2006.01214.x; O'Donnell S, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew031; ONISHI H, 1968, APPL MICROBIOL, V16, P1847, DOI 10.1128/AEM.16.12.1847-1852.1968; Ozalp P, 2001, J APPL ENTOMOL, V125, P177, DOI 10.1046/j.1439-0418.2001.00528.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Saha BC, 2011, APPL MICROBIOL BIOT, V89, P879, DOI 10.1007/s00253-010-2979-3; Shell BC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29813-9; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Somashekar K, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13201; STROMNAES O, 1959, NATURE, V183, P409, DOI 10.1038/183409a0; Systat Software Inc., 2013, SIGMAPLOT WIND VERS; Takada T, 2017, PLOS ONE, V12, P1; Tang SB, 2017, J INSECT PHYSIOL, V101, P178, DOI 10.1016/j.jinsphys.2017.07.015; Uchizono S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172886; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Wallace IS, 2012, BBA-BIOMEMBRANES, V1818, P627, DOI 10.1016/j.bbamem.2011.11.032; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Yao CK, 2014, J HUM NUTR DIET, V27, P263, DOI 10.1111/jhn.12144	63	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0213760	10.1371/journal.pone.0213760	http://dx.doi.org/10.1371/journal.pone.0213760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150400	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100008
J	Ghazvinian, H; Mousavi, SF; Karami, H; Farzin, S; Ehteram, M; Hossain, MS; Fai, CM; Bin Hashim, H; Singh, VP; Ros, FC; Ahmed, AN; Afan, HA; Lai, SH; El-Shafie, A				Ghazvinian, Hamidreza; Mousavi, Sayed-Farhad; Karami, Hojat; Farzin, Saeed; Ehteram, Mohammad; Hossain, Md Shabbir; Fai, Chow Ming; Bin Hashim, Huzaifa; Singh, Vijay P.; Ros, Faizah Che; Ahmed, Ali Najah; Afan, Haitham Abdulmohsin; Lai, Sai Hin; El-Shafie, Ahmed			Integrated support vector regression and an improved particle swarm optimization-based model for solar radiation prediction	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; FIREFLY ALGORITHM; MACHINE; ANN; IRRADIANCE; SVM	Solar energy is a major type of renewable energy, and its estimation is important for decision-makers. This study introduces a new prediction model for solar radiation based on support vector regression (SVR) and the improved particle swarm optimization (IPSO) algorithm. The new version of algorithm attempts to enhance the global search ability for the PSO. In practice, the SVR method has a few parameters that should be determined through a trial-and-error procedure while developing the prediction model. This procedure usually leads to non-optimal choices for these parameters and, hence, poor prediction accuracy. Therefore, there is a need to integrate the SVR model with an optimization algorithm to achieve optimal choices for these parameters. Thus, the IPSO algorithm, as an optimizer is integrated with SVR to obtain optimal values for the SVR parameters. To examine the proposed model, two solar radiation stations, Adana, Antakya and Konya, in Turkey, are considered for this study. In addition, different models have been tested for this prediction, namely, the M5 tree model (M5T), genetic programming (GP), SVR integrated with four different optimization algorithms SVR-PSO, SVR-IPSO, Genetic Algorithm (SVR-GA), FireFly Algorithm (SVR-FFA) and the multivariate adaptive regression (MARS) model. The sensitivity analysis is performed to achieve the highest accuracy level of the prediction by choosing different input parameters. Several performance measuring indices have been considered to examine the efficiency of all the prediction methods. The results show that SVR-IPSO out-performed M5T and MARS.	[Ghazvinian, Hamidreza; Mousavi, Sayed-Farhad; Karami, Hojat; Farzin, Saeed; Ehteram, Mohammad] Semnan Univ, Fac Civil Engn, Dept Water Engn & Hydraul Struct, Semnan, Iran; [Hossain, Md Shabbir] Heriot Watt Univ, Dept Civil Engn, Sch Energy Geosci Infrastruct & Soc, Putrajaya, Malaysia; [Fai, Chow Ming; Ahmed, Ali Najah] Univ Tenaga Nas, Dept Civil Engn, IEI, Selangor, Malaysia; [Bin Hashim, Huzaifa; Afan, Haitham Abdulmohsin; Lai, Sai Hin; El-Shafie, Ahmed] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Singh, Vijay P.] Texas A&M Univ, Dept Biol & Agr Engn, Zachry Dept Civil Engn, College Stn, TX USA; [Ros, Faizah Che] UTM, MJIIT, Dept Environm & Green Technol, Kuala Lumpur, Malaysia	Semnan University; Universiti Tenaga Nasional; Universiti Malaya; Texas A&M University System; Texas A&M University College Station; Universiti Teknologi Malaysia	Afan, HA (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	haitham.afan@gmail.com	Afan, Haitham Abdulmohsin/G-6932-2018; Afan, Haitham/ABF-2282-2021; Lai, Sai Hin/H-3164-2018; Chow, M. F./I-1811-2016; Ahmed, Ali Najah/J-9456-2017; El-Shafie, Ahmed/J-1799-2014; Karami, Hojat/AAU-1618-2020; Hashim, Huzaifa/N-4079-2018; Farzin, Saeed/AAB-3877-2020; Ghazvinian, Hamidreza/AAQ-3628-2020	Afan, Haitham Abdulmohsin/0000-0002-4957-756X; Lai, Sai Hin/0000-0002-7143-4805; Chow, M. F./0000-0002-0732-5575; Ahmed, Ali Najah/0000-0002-5618-6663; El-Shafie, Ahmed/0000-0001-5018-8505; Hashim, Huzaifa/0000-0001-8780-4025; Che Ros, Faizah/0000-0001-7263-2531	Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional [RJO 10436494]; University of Malaya [UMRG RP025A-18SUS, BKS008-2016]	Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional; University of Malaya(Universiti Malaya)	The authors would like to appreciate the financial support received from Bold 2025 grant coded RJO 10436494 by Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional and the research grant coded UMRG RP025A-18SUS to AE-S and BKS008-2016 funded by the University of Malaya.	Alfadda A, 2018, SOL ENERGY, V170, P924, DOI 10.1016/j.solener.2018.05.089; Amrouche B, 2014, APPL ENERG, V130, P333, DOI 10.1016/j.apenergy.2014.05.055; Awange JL, 2018, PARTICLE SWARM OPTIM, P167; Belaid S, 2016, ENERG CONVERS MANAGE, V118, P105, DOI 10.1016/j.enconman.2016.03.082; Benmouiza K, 2013, ENERG CONVERS MANAGE, V75, P561, DOI 10.1016/j.enconman.2013.07.003; Bhardwaj S, 2013, SOL ENERGY, V93, P43, DOI 10.1016/j.solener.2013.03.020; Bou-Rabee M, 2017, RENEW SUST ENERG REV, V72, P434, DOI 10.1016/j.rser.2017.01.013; Deo RC, 2016, APPL ENERG, V168, P568, DOI 10.1016/j.apenergy.2016.01.130; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Ibrahim IA, 2017, ENERG CONVERS MANAGE, V138, P413, DOI 10.1016/j.enconman.2017.02.006; Keshtegar B, 2018, RENEW SUST ENERG REV, V81, P330, DOI 10.1016/j.rser.2017.07.054; Khatib T, 2012, RENEW SUST ENERG REV, V16, P2864, DOI 10.1016/j.rser.2012.01.064; Khosravi A, 2018, J CLEAN PROD, V176, P63, DOI 10.1016/j.jclepro.2017.12.065; Kumar N, 2017, INT J RENEWABLE ENER; Landeras G, 2012, ENERG CONVERS MANAGE, V62, P1, DOI 10.1016/j.enconman.2012.03.025; Liu HH, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/6076475; Loghmari I, 2018, RENEW SUST ENERG REV, V82, P837, DOI 10.1016/j.rser.2017.09.092; Lou I, 2015, APPL MATH MODEL, V39, P5907, DOI 10.1016/j.apm.2015.04.001; Meenal R, 2018, RENEW ENERG, V121, P324, DOI 10.1016/j.renene.2017.12.005; Moazenzadeh R, 2018, ENG APPL COMP FLUID, V12, P584, DOI 10.1080/19942060.2018.1482476; Mohammadi K, 2015, ENERG CONVERS MANAGE, V92, P162, DOI 10.1016/j.enconman.2014.12.050; Mohandes MA, 2012, SOL ENERGY, V86, P3137, DOI 10.1016/j.solener.2012.08.005; Notton G, 1991, RENEWABLE ENERGY; Nouiri M, 2018, J INTELL MANUF, V29, P603, DOI 10.1007/s10845-015-1039-3; Olatomiwa L, 2015, SOL ENERGY, V115, P632, DOI 10.1016/j.solener.2015.03.015; Ozgoren M, 2012, EXPERT SYST APPL, V39, P5043, DOI 10.1016/j.eswa.2011.11.036; Premalatha Neelamegam, 2016, J. appl. res. technol, V14, P206, DOI 10.1016/j.jart.2016.05.001; Qazi A, 2015, J CLEAN PROD, V104, P1, DOI 10.1016/j.jclepro.2015.04.041; Qin WM, 2018, RENEW SUST ENERG REV, V81, P579, DOI 10.1016/j.rser.2017.08.037; Quej VH, 2017, J ATMOS SOL-TERR PHY, V155, P62, DOI 10.1016/j.jastp.2017.02.002; Ramezani F, 2015, SOFT COMPUT, V19, P375, DOI 10.1007/s00500-014-1258-0; Renno C, 2016, J CLEAN PROD, V135, P1298, DOI 10.1016/j.jclepro.2016.07.049; Rohani A, 2018, RENEW ENERG, V115, P411, DOI 10.1016/j.renene.2017.08.061; Sengupta M, 2018, RENEW SUST ENERG REV, V89, P51, DOI 10.1016/j.rser.2018.03.003; Shamshirband S, 2016, RENEW SUST ENERG REV, V56, P428, DOI 10.1016/j.rser.2015.11.055; Shang CF, 2018, RENEW ENERG, V127, P269, DOI 10.1016/j.renene.2018.04.067; Tang XY, 2019, CMC-COMPUT MATER CON, V58, P463, DOI 10.32604/cmc.2019.03816; Turkish State Meteorological Service, 2018, MET GEN MUD; Vakili M, 2017, J CLEAN PROD, V141, P1275, DOI 10.1016/j.jclepro.2016.09.145; Vapnik V., 1998, STAT LEARNING THEORY; Voyant C, 2017, RENEW ENERG, V105, P569, DOI 10.1016/j.renene.2016.12.095; Wang LC, 2017, INT J CLIMATOL, V37, P1141, DOI 10.1002/joc.4762; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; Yadav AK, 2014, RENEW SUST ENERG REV, V33, P772, DOI 10.1016/j.rser.2013.08.055; Zhang S, 2017, PARAMETER ESTIMATION, DOI [10.1016/J.ENCONMAN.2012.03.025, DOI 10.1016/J.ENCONMAN.2012.03.025]; Zhou P, 2016, SCI TOTAL ENVIRON, V543, P591, DOI 10.1016/j.scitotenv.2015.11.063; Zhou YL, 2018, ENERGY, V143, P785, DOI 10.1016/j.energy.2017.11.035	47	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217634	10.1371/journal.pone.0217634	http://dx.doi.org/10.1371/journal.pone.0217634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150467	Green Submitted, Green Published, gold			2022-12-27	WOS:000469759100077
J	Wu, DM; Dai, QP; Liu, XZ; Fan, YP; Wang, JX				Wu, Dong-Mei; Dai, Qiu-Ping; Liu, Xue-Zhu; Fan, Ying-Ping; Wang, Jian-Xin			Comparison of bacterial community structure and potential functions in hypoxic and non-hypoxic zones of the Changjiang Estuary	PLOS ONE			English	Article							SEASONAL DYNAMICS; DIVERSITY; BIOLOGY; WATER; BIOGEOGRAPHY; POPULATIONS; SEDIMENTS; TAXA; SOIL	Bacterioplankton play a key role in the global cycling of elements. To characterize the effects of hypoxia on bacterioplankton, bacterial community structure and function were investigated in the Changjiang Estuary. Water samples were collected from three layers (surface, middle, and bottom) at ten sampling sites in the Changjiang Estuary hypoxic and non-hypoxic zones. The community structure was analyzed using high-throughput sequencing of 16S rDNA genes, and the predictive metagenomic approach was used to investigate the functions of the bacterial community. Co-occurrence networks are constructed to investigate the relationship between different bacterioplankton. The results showed that community composition in hypoxic and non-hypoxic zones were markedly different. The diversity and richness of bacterial communities in the bottom layer (hypoxic zone) were remarkably higher than that of the surface layer (non-hypoxic). In the non-hypoxic zone, it was found that Proteobacteria, Bacteroidetes, and Flavobacteriia were the dominant groups while Alphaproteobacteria, SAR406 and Deltaproteobacteria were the dominant groups in the hypoxic zone. From the RDA analysis, it was shown that dissolved oxygen (DO) explained most of the bacterial community variation in the redundancy analysis targeting only hypoxia zones, whereas nutrients and salinity explained most of the variation across all samples in the Changjiang Estuary. To understand the genes involved in nitrogen metabolism, an analysis of the oxidation state of nitrogen was performed. The results showed that the bacterial community in the surface layer (non-hypoxic) had more genes involved in dissimilatory nitrate reduction, assimilatory nitrate reduction, denitrification, and anammox, while that in the middle and bottom layers (hypoxic zone) had more abundant genes associated with nitrogen fixation and nitrification. Co-occurrence networks revealed that microbial assemblages in the middle and bottom layers shared more niche spaces than in the surface layer (non-hypoxic zone). The environmental heterogeneity in the hypoxic and non-hypoxic zones might be important environmental factors that determine the bacterial composition in these two zones.	[Wu, Dong-Mei; Liu, Xue-Zhu; Fan, Ying-Ping; Wang, Jian-Xin] Zhejiang Ocean Univ, Marine Microorganism Ecol & Applicat Lab, Zhoushan, Zhejiang, Peoples R China; [Dai, Qiu-Ping] Zhejiang Ocean Univ, Donghai Sci & Technol Coll, Zhoushan, Zhejiang, Peoples R China	Zhejiang Ocean University; Zhejiang Ocean University	Wang, JX (corresponding author), Zhejiang Ocean Univ, Marine Microorganism Ecol & Applicat Lab, Zhoushan, Zhejiang, Peoples R China.	jxwang@zjou.edu.cn			National Natural Science Foundation of China [31270160, J1310037]; Natural Science Foundation of Zhejiang Province, China [LY12C03003]; Zhejiang Public Welfare Technology Application Research Project [2016C33084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Zhejiang Public Welfare Technology Application Research Project	This work was supported by the National Natural Science Foundation of China [grant numbers 31270160, J1310037], the Natural Science Foundation of Zhejiang Province, China [grant number LY12C03003] and the Zhejiang Public Welfare Technology Application Research Project (grant numbers 2016C33084).	Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Catherine A. L., 2007, P NATL ACAD SCI USA, V104, P11436, DOI DOI 10.1073/PNAS.0611525104; Chen CL, 2004, APPL MICROBIOL BIOT, V63, P466, DOI 10.1007/s00253-003-1286-7; Chen JY, 1999, J SEA RES, V41, P129, DOI 10.1016/S1385-1101(98)00047-1; Cleary DFR, 2016, PLANT BIOLOGY, V18, P824, DOI 10.1111/plb.12459; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dong LX, 2004, CONT SHELF RES, V24, P1761, DOI 10.1016/j.csr.2004.06.006; Fani R, 2000, J MOL EVOL, V51, P1; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Freedman ZB, 2015, MOL ECOL, V24, P3170, DOI 10.1111/mec.13224; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hawley ER, 2014, MAR GENOM, V18, P97, DOI 10.1016/j.margen.2014.06.003; Heijs SK, 2008, FEMS MICROBIOL ECOL, V64, P362, DOI 10.1111/j.1574-6941.2008.00463.x; Heike S, 2010, ENVIRON MICROBIOL, V10, P1244, DOI [10.1111/j.1462-2920.2007.01539.x, DOI 10.1111/J.1462-2920.2007.01539.X]; Huang GX, 2012, WATER AIR SOIL POLL, V223, P4029, DOI 10.1007/s11270-012-1170-0; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Laas P, 2016, PLOS ONE, V11, DOI [10.1371/journalmone.0156147, DOI 10.1371/JOURNALMONE.0156147]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee J, 2018, OCEAN SCI J, V53, P251, DOI 10.1007/s12601-018-0006-2; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Liu JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00064; Liu M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/025001; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Martha S, 2010, ENVIRON MICROBIOL, V11, P2078, DOI [10.1111/j.1462-2920.2009.01929.x, DOI 10.1111/J.1462-2920.2009.01929.X]; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ollivier J, 2011, FEMS MICROBIOL ECOL, V78, P3, DOI 10.1111/j.1574-6941.2011.01165.x; Orita R, 2015, ESTUAR COAST SHELF S, V164, P204, DOI 10.1016/j.ecss.2015.07.028; Paerl HW, 2003, FEMS MICROBIOL ECOL, V46, P233, DOI 10.1016/S0168-6496(03)00200-9; Peschek GA, 1999, INT MICROBIOL, V2, P279, DOI [10.1007/978-1-4615-4827-0, DOI 10.1007/978-1-4615-4827-0]; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Richardson DJ, 1999, CURR OPIN CHEM BIOL, V3, P207, DOI 10.1016/S1367-5931(99)80034-9; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Shapleigh JP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P769, DOI 10.1007/0-387-30742-7_23; Sparacino-Watkins C, 2014, CHEM SOC REV, V43, P676, DOI 10.1039/c3cs60249d; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Sun M, 2015, APPL MICROBIOL BIOT, V99, P2911, DOI 10.1007/s00253-014-6194-5; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Thiele S, 2012, APPL ENVIRON MICROB, V78, P8803, DOI 10.1128/AEM.01814-12; Tiedje J.M., 1983, ANTON LEEUW INT J G, V48, P569, DOI DOI 10.1007/BF00399542; Urbanova Z, 2014, FEMS MICROBIOL ECOL, V90, P633, DOI 10.1111/1574-6941.12422; Vilisics F, 2011, BIOLOGIA, V66, P499, DOI 10.2478/s11756-011-0042-1; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Yang DF, 2008, CHIN J OCEANOL LIMN, V26, P486, DOI 10.1007/s00343-008-0486-5; YASSEN A, 2008, BIOINFORMATICS, V24, P282, DOI DOI 10.1093/BI0INF0RMATICS/BTM554; Ye Q, 2016, MICROBIOLOGYOPEN, V5, P323, DOI 10.1002/mbo3.330; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zheng HY, 2011, J ENVIRON SCI-CHINA, V23, P1888, DOI 10.1016/S1001-0742(10)60615-8; Zhou JZ, 2011, NAT REV MICROBIOL, V9, P452, DOI 10.1038/nrmicro2575; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	71	24	24	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217431	10.1371/journal.pone.0217431	http://dx.doi.org/10.1371/journal.pone.0217431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170168	Green Published, Green Submitted, gold			2022-12-27	WOS:000470263700028
J	Peteroy-Kelly, M; Brancaccio-Taras, L; Awong-Taylor, J; Balser, T; Jack, T; Lindsay, S; Marley, K; Romano, S; Uzman, JA; Pape-Lindstrom, P				Peteroy-Kelly, Marcy; Brancaccio-Taras, Loretta; Awong-Taylor, Judy; Balser, Teresa; Jack, Thomas; Lindsay, Sara; Marley, Kate; Romano, Sandra; Uzman, J. Akif; Pape-Lindstrom, Pamela			A qualitative analysis to identify the elements that support department level change in the life sciences: The PULSE Vision & Change Recognition Program	PLOS ONE			English	Article							HIGHER-EDUCATION; UNDERGRADUATE; CULTURE	The 2011 report, Vision and Change in Undergraduate Biology Education: A Call to Action, provided the impetus to mobilize the undergraduate life sciences education community to affect change in order to enhance the educational experiences of life sciences majors. The work of the appointed Partnership for Undergraduate Life Sciences Education (PULSE) Vision and Change (V&C) Leadership Fellows has focused on the development of programs and resources to support departmental change. In this report, we present a qualitative assessment of several documents generated from the PULSE V&C Leadership Fellow Recognition Team. The Recognition Team developed two initiatives to provide departments with feedback on their change process. The first initiative, the validated PULSE V&C Rubrics, enables departments to collaboratively self-assess their progress in enacting change. The second initiative, the PULSE Recognition Program, involves completion of the aforementioned Rubrics and a site-visit by two Recognition Team members to provide external insights and suggestions to foster a department's change process. Eight departments participated in the Recognition Program in 2014. An evaluation of the documents yielded from the Recognition Program review of seven of the eight departments and a comparison of Rubric scores from before and three years following the site-visits uncovered several common elements required for successful department level change. These elements include an institutional culture that values and supports excellence in teaching and learning with resources and infrastructure, a departmental emphasis on program and course level assessment, and, most importantly, a departmental champion who actively supports endeavors that enhance teaching excellence.	[Peteroy-Kelly, Marcy] Pace Univ, Dept Biol, New York, NY 10038 USA; [Brancaccio-Taras, Loretta] CUNY, Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY 11210 USA; [Awong-Taylor, Judy] Georgia Gwinnett Coll, Dept Biol, Lawrenceville, GA USA; [Balser, Teresa] Dalhousie Univ, Off Provost & Vice President Acad Affairs, Halifax, NS, Canada; [Jack, Thomas] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Lindsay, Sara] Univ Maine, Sch Marine Sci, Orono, ME USA; [Marley, Kate] Doane Univ, Dept Biol, Crete, NE USA; [Romano, Sandra] Univ Virgin Isl, Coll Sci & Math, St Thomas, VI USA; [Uzman, J. Akif] Univ Houston Downtown, Coll Sci & Technol, Houston, TX USA; [Pape-Lindstrom, Pamela] Harford Community Coll, Div Sci Technol Engn & Math, Bel Air, MD USA	Pace University; City University of New York (CUNY) System; University System of Georgia; Georgia Gwinnett College; Dalhousie University; Dartmouth College; University of Maine System; University of Maine Orono; University of the Virgin Islands; University of Houston System; University of Houston; University of Houston Downtown	Peteroy-Kelly, M (corresponding author), Pace Univ, Dept Biol, New York, NY 10038 USA.	mkelly2@pace.edu			National Science Foundation [DBI-1323223]	National Science Foundation(National Science Foundation (NSF))	Funded by 1. National Science Foundation DBI-1350120 to PPL. 2. National Science Foundation DBI-1323223 to TJ. Both at https://www.nsf.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre KM, 2013, CBE-LIFE SCI EDUC, V12, P579, DOI 10.1187/cbe.13-09-0183; Albertine S., 2011, PEER REV, V13, P4; Ambrose S.A., 2010, HOW LEARNING WORKS; American Association for the Advancement of Science, 2011, VISION CHANGE UNDERG; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; [Anonymous], 2001, IMPROVE ACAD RESOURC; Awong-Taylor J., 2016, COUNCIL UNDERGRADUAT, V37, P11, DOI [10.18833/curq/37/1/4, DOI 10.18833/CURQ/37/1/4]; Baldwin R. G., 2009, NEW DIRECTIONS TEACH, V2009, P9, DOI [10.1002/tl.340, DOI 10.1002/TL.340]; Bangera G, 2014, CBE-LIFE SCI EDUC, V13, P602, DOI 10.1187/cbe.14-06-0099; Benjamin E, 2012, PEER REV, P4; Borrego M, 2010, THEORETICAL PERSPECT; Borrego M, 2014, J ENG EDUC, V103, P220, DOI 10.1002/jee.20040; Brancaccio-Taras L, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.15-12-0260; Brownell SE, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-05-0092; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Dawson TA, 2012, TRANSPORT RES REC, P52, DOI 10.3141/2292-07; Ebert-May D, 2011, BIOSCIENCE, V61, P550, DOI 10.1525/bio.2011.61.7.9; Elgin SCR, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-03-0118; Elrod S., 2017, CHANGE, V49, P26, DOI [10.1080/00091383.2017.1357097, DOI 10.1080/00091383.2017.1357097]; Gilbert, 2010, CHANGE MAGAZINE HIGH, V42, P6, DOI DOI 10.1080/00091380903563035; Harvey L., 2004, J HIGH EDUC POLICY M, V26, P207, DOI DOI 10.1080/1360080042000218267; Hawke I., 2003, ASSESS EVAL HIGH EDU, V28, P323, DOI [DOI 10.1080/0260293032000059667, 10.1080/0260293032000059667]; Jacoby D, 2006, J HIGH EDUC-UK, V77, P1081, DOI 10.1353/jhe.2006.0050; Kezar A, 2014, LIBERAL ED; Kezar A, 2011, STUD HIGH EDUC, V36, P129, DOI 10.1080/03075070903532304; Kuh G.D., 2008, HIGH IMPACT ED PRACT; Ledda C, 2014, MET REL SUB DRINK-RE, P21; Lopatto D., 2010, SCI SOLUTION IMPACT; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; McCourt JS, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-08-0241; McLaren HJ, 2015, AUST UNIV REV, V57, P26; Narum JL, 2013, LIB ED           WIN, P26; National Research Council, 2000, PEOPLE LEARN BRAIN M, V2nd ed., DOI [10.17226/9853, DOI 10.17226/9853]; Nichols M., 2016, THESIS; Osborne KW., 2018, AM J PHARM EDUC, V82, P313; Pape-Lindstrom P, 2015, J MICROBIOL BIOL EDU, V16, P127, DOI 10.1128/jmbe.v16i2.974; Russell SH, 2007, SCIENCE, V316, P548, DOI 10.1126/science.1140384; Saldana J, 2013, CODING MANUAL QUALIT; Slavich GM, 2012, EDUC PSYCHOL REV, V24, P569, DOI 10.1007/s10648-012-9199-6; Suchman EL, 2014, TRENDS MICROBIOL, V22, P657, DOI 10.1016/j.tim.2014.09.006; Towns MH, 2010, J CHEM EDUC, V87, P91, DOI 10.1021/ed8000039; Whittaker JA, 2014, INNOV HIGH EDUC, V39, P263, DOI 10.1007/s10755-013-9277-9; Woodin T, 2010, CBE-LIFE SCI EDUC, V9, P71, DOI 10.1187/cbe.10-03-0044	43	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217088	10.1371/journal.pone.0217088	http://dx.doi.org/10.1371/journal.pone.0217088			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145735	Green Published, gold			2022-12-27	WOS:000469425500011
J	Matsuoi, A; Sasahara, K; Taguchi, Y; Karasawa, M				Matsuoi, Akiko; Sasahara, Kazutoshi; Taguchi, Yasuhiro; Karasawa, Minoru			Development and validation of the Japanese Moral Foundations Dictionary	PLOS ONE			English	Article								The Moral Foundations Dictionary (MFD) is a useful tool for applying the conceptual framework developed in Moral Foundations Theory and quantifying the moral meanings implicated in the linguistic information people convey. However, the applicability of the MFD is limited because it is available only in English. Translated versions of the MFD are therefore needed to study morality across various cultures, including non-Western cultures. The contribution of this paper is two-fold. We developed the first Japanese version of the MFD (referred to as the J-MFD) using a semi-automated method-this serves as a reference when translating the MFD into other languages. We next tested the validity of the J-MFD by analyzing open-ended written texts about the situations that Japanese participants thought followed and violated the five moral foundations. We found that the J-MFD correctly categorized the Japanese participants' descriptions into the corresponding moral foundations, and that the Moral Foundations Questionnaire (MFQ) scores correlated with the frequency of situations, of total words, and of J-MFD words in the participants' descriptions for the Harm and Fairness foundations. The J-MFD can be used to study morality unique to the Japanese and also multicultural comparisons in moral behavior.	[Matsuoi, Akiko] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Nagoya, Aichi, Japan; [Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat, Dept Complex Syst Sci, Nagoya, Aichi, Japan; [Taguchi, Yasuhiro] Aichi Univ, Sch Letters, Dept Humanities & Social Sci, Toyohashi, Aichi, Japan; [Karasawa, Minoru] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Sasahara, Kazutoshi] JST, PRESTO, Kawaguchi, Saitama, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Sasahara, K (corresponding author), Nagoya Univ, Grad Sch Informat, Dept Complex Syst Sci, Nagoya, Aichi, Japan.; Sasahara, K (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	sasahara@nagoya-u.jp	de Souza Luna, Luciano Kleber/L-1213-2013; Carlotti, Ana PCP/G-4893-2012; de Souza Luna, Luciano Kleber/AAG-6418-2019; Matsuno, Alessandra Kimie/H-9507-2012; Casale Aragon, Davi/R-6604-2016	de Souza Luna, Luciano Kleber/0000-0002-3552-5507; Carlotti, Ana PCP/0000-0003-2760-8801; de Souza Luna, Luciano Kleber/0000-0002-3552-5507; MATSUO, Akiko/0000-0002-6293-5501; Matsuno, Alessandra Kimie/0000-0002-3491-1641; Sasahara, Kazutoshi/0000-0003-2572-0648; Casale Aragon, Davi/0000-0003-1019-3654; STEIN, RENATO/0000-0003-0269-0757; Arruda, Eurico/0000-0002-0978-410X	JSPS/MEXT KAKENHI [15H03446, JP17H06383, 4903]; JST PRESTO [JPMJPR16D6]; JST CREST [JPMJCR17A4]	JSPS/MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was supported by JSPS/MEXT KAKENHI Grant Numbers 15H03446 and JP17H06383 in #4903, JST PRESTO Grant Number JPMJPR16D6, and JST CREST Grant Number JPMJCR17A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulbulia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080224; Clifford S, 2015, BEHAV RES METHODS, V47, P1178, DOI 10.3758/s13428-014-0551-2; Davis D, 2015, J PERS SOC PSYCHOL, V110, P56; Dehghani M, 2017, BEHAV RES METHODS, V49, P538, DOI 10.3758/s13428-016-0722-4; Dehghani M, 2016, J EXP PSYCHOL GEN, V145, P366, DOI 10.1037/xge0000139; Fulgoni D, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3730; GOOLSBY JR, 1992, J MARKETING, V56, P55, DOI 10.2307/1252132; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2015, VOLKSWAGEN MORAL PSY; Haidt J, 2008, PERSPECT PSYCHOL SCI, V3, P65, DOI 10.1111/j.1745-6916.2008.00063.x; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Honda S., 2017, B FACULTY ED YAMAGUC, V66, P95; Ji QH, 2015, MEDIA PSYCHOL, V18, P221, DOI 10.1080/15213269.2014.956939; Johnson KA, 2016, PERS INDIV DIFFER, V100, P56, DOI 10.1016/j.paid.2015.12.037; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Kanai R., 2013, NOU NI KIZAMARETA MO; Kaur R, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA), P2505, DOI 10.1109/BigData.2016.7840889; LaBouff JP, 2017, ARCH PSYCHOL RELIG, V39, P263, DOI 10.1163/15736121-12341343; Maekawa K, 2014, LANG RESOUR EVAL, V48, P345, DOI 10.1007/s10579-013-9261-0; Matsumoto K, 2005, P ASS NAT LANG PROC, P145; Mooijman M, 2017, J PERSONALITY SOCIAL; Pennebaker JW., 2001, LINGUISTIC INQUIRY W; Piazza J, 2018, SOCIAL PSYCHOL PERSO, P1; Reed A, 2007, J MARKETING, V71, P178, DOI 10.1509/jmkg.71.1.178; Sagi E, 2014, SOC SCI COMPUT REV, V32, P132, DOI 10.1177/0894439313506837; Takamatsu R., 2017, JPN J INTERPERS SOC, V17, P93; Yilmaz O, 2016, PERS INDIV DIFFER, V99, P149, DOI 10.1016/j.paid.2016.04.090	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213343	10.1371/journal.pone.0213343	http://dx.doi.org/10.1371/journal.pone.0213343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	31158256	gold, Green Submitted, Green Published			2022-12-27	WOS:000462157600010
J	Matsuno, AK; Gagliardi, TB; Paula, FE; Luna, LKS; Jesus, BLS; Stein, RT; Aragon, DC; Carlotti, APCP; Arruda, E				Matsuno, Alessandra K.; Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Stein, Renato T.; Aragon, Davi C.; Carlotti, Ana P. C. P.; Arruda, Eurico			Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: A one-year study in Southeast Brazil	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CHILDREN; INFECTIONS	Objective We aimed to assess the profile of respiratory viruses in young children hospitalized for acute lower respiratory tract infection (ALRI) and its association with disease severity, defined as need for pediatric intensive care unit (PICU) admission. Design Prospective observational cohort study. Setting A tertiary-care university hospital in Brazil. Patients Children younger than three years attending the pediatric emergency room with ALRI who were admitted to the hospital. Interventions None. Measurements and main results Nasopharyngeal aspirates were collected from patients from June 1 st, 2008 to May 31 st, 2009within the first 48 hours of hospitalization. Nasopharyngeal aspirates were tested for 17humanrespiratory viruses by molecular and immunofluorescence based assays. Simple and multiple log-binomial regression models were constructed to assess associations of virus type with a need for PICU admission. Age, prematurity, the presence of an underlying disease and congenital heart disease were covariates. Nasopharyngeal aspirates were positive for at least one virus in 236 patients. Rhinoviruses were detected in 85.6% of samples, with a preponderance of rhinovirus C (RV-C) (61.9%). Respiratory syncytial virus was detected in 59.8% and human coronavirus (HCoV) in 11% of the samples. Co-detections of two to five viruses were found in 78% of the patients. The detection of HCoV alone (adjusted relative risk (RR) 2.18; 95% CI 1.15-4.15) or in co-infection with RV-C (adjusted RR 2.37; 95% CI 1.23-4.58) was independently associated with PICU admission. Conclusions The detection of HCoV alone or in co-infection with RV-C was independently associated with PICU admission in young children hospitalized for ALRI.	[Matsuno, Alessandra K.; Aragon, Davi C.; Carlotti, Ana P. C. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil; [Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Arruda, Eurico] Univ Sao Paulo, Dept Cell Biol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Arruda, Eurico] Univ Sao Paulo, Virol Res Ctr, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Stein, Renato T.] Pontificia Univ Catolica Rio Grande do Sul, Dept Pediat, Sch Med, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidade Catolica Do Rio Grande Do Sul	Matsuno, AK (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil.	matsuno@fmrp.usp.br	de Souza Luna, Luciano Kleber/L-1213-2013; Carlotti, Ana PCP/G-4893-2012; de Souza Luna, Luciano Kleber/AAG-6418-2019; Matsuno, Alessandra Kimie/H-9507-2012; Casale Aragon, Davi/R-6604-2016	de Souza Luna, Luciano Kleber/0000-0002-3552-5507; Carlotti, Ana PCP/0000-0003-2760-8801; de Souza Luna, Luciano Kleber/0000-0002-3552-5507; MATSUO, Akiko/0000-0002-6293-5501; Matsuno, Alessandra Kimie/0000-0002-3491-1641; Sasahara, Kazutoshi/0000-0003-2572-0648; Casale Aragon, Davi/0000-0003-1019-3654; STEIN, RENATO/0000-0003-0269-0757; Arruda, Eurico/0000-0002-0978-410X	Abbott Laboratorios do Brasil Ltda; Sao Paulo State Research Foundation (FAPESP); FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia" ("Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto; Brazilian Research Council (CNPq)	Abbott Laboratorios do Brasil Ltda; Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia" ("Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto; Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AKM and EAN supported mainly by an academic grant from Abbott Laboratorios do Brasil Ltda based on an unrestricted investigatorgenerated proposal. EAN Additional funding was provided by a grant from the Sao Paulo State Research Foundation (FAPESP) and by FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia"(in English would be "Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto. EA has long standing scholarship support from the Brazilian Research Council (CNPq). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda E, 2014, PEDIATR INFECT DIS J, V33, P997, DOI 10.1097/INF.0000000000000349; Cebey-Lopez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152481; Chu HY, 2016, J PEDIAT INF DIS SOC, V5, P29, DOI 10.1093/jpids/piu099; Cintra OAL, 2001, J MED VIROL, V65, P408, DOI 10.1002/jmv.2049; Costa LF, 2014, PEDIATRICS, V133, pE312, DOI 10.1542/peds.2013-2216; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Fawkner-Corbett DW, 2016, J MED VIROL, V88, P58, DOI 10.1002/jmv.24300; Kelesidis T, 2016, INFECT CONT HOSP EP, V37, P70, DOI 10.1017/ice.2015.226; Lauinger IL, 2013, J CLIN VIROL, V58, P216, DOI 10.1016/j.jcv.2013.06.042; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Legg JP, 2005, PEDIATR INFECT DIS J, V24, P611, DOI 10.1097/01.inf.0000168747.94999.aa; Do LAH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160606; Miyaji Y, 2013, MICROBIOL IMMUNOL, V57, P811, DOI 10.1111/1348-0421.12102; Nathan AM, 2017, PEDIAT RESPIROL CRIT, V1, P46, DOI DOI 10.4103/PRCM.PRCM_2_17; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Scotta MC, 2016, J CLIN VIROL, V80, P45, DOI 10.1016/j.jcv.2016.04.019; Sonego M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116380; Varghese L, 2018, J PEDIAT INF DIS SOC, V7, P151, DOI 10.1093/jpids/pix027; Walsh EE., 2015, MANDELL BENNETTS PRI, V8th ed., P1948; Wishaupt JO, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2118-6; Zhang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033773	26	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217744	10.1371/journal.pone.0217744	http://dx.doi.org/10.1371/journal.pone.0217744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158256	Green Published, gold, Green Submitted			2022-12-27	WOS:000469915700024
